PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Polzien, L; Baljuls, A; Albrecht, M; Hekman, M; Rapp, UR				Polzien, Lisa; Baljuls, Angela; Albrecht, Marco; Hekman, Mirko; Rapp, Ulf R.			BAD Contributes to RAF-mediated Proliferation and Cooperates with B-RAF-V600E in Cancer Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BCL-2 PROTEIN FAMILY; DEATH AGONIST BAD; B-RAF; CELL-DEATH; MITOCHONDRIAL LOCALIZATION; C-RAF; KINASE; PHOSPHORYLATION; BRAF; BINDING	BAD (Bcl-2 antagonist of cell death) belongs to the proapoptotic BH3-only subfamily of Bcl-2 proteins. Physiological activity of BAD is highly controlled by phosphorylation. To further analyze the regulation of BAD function, we investigated the role of recently identified phosphorylation sites on BAD-mediated apoptosis. We found that in contrast to the N-terminal phosphorylation sites, the serines 124 and 134 act in an antiapoptotic manner because the replacement by alanine led to enhanced cell death. Our results further indicate that RAF kinases represent, besides PAK1, BAD serine 134 phosphorylating kinases. Importantly, in the presence of wild type BAD, co-expression of survival kinases, such as RAF and PAK1, leads to a strongly increased proliferation, whereas substitution of serine 134 by alanine abolishes this process. Furthermore, we identified BAD serine 134 to be strongly involved in survival signaling of B-RAF-V600E-containing tumor cells and found that phosphorylation of BAD at this residue is critical for efficient proliferation in these cells. Collectively, our findings provide new insights into the regulation of BAD function by phosphorylation and its role in cancer signaling.	[Polzien, Lisa; Baljuls, Angela; Albrecht, Marco; Hekman, Mirko; Rapp, Ulf R.] Univ Wurzburg, Dept Microbiol, Bioctr, D-97074 Wurzburg, Germany; [Polzien, Lisa; Rapp, Ulf R.] Max Planck Inst Heart & Lung Res, WG Kerckhoff Inst, D-61231 Bad Nauheim, Germany; [Rapp, Ulf R.] Max Planck Inst Biochem, D-82152 Martinsried, Germany	University of Wurzburg; Max Planck Society; Max Planck Society	Polzien, L (corresponding author), Univ Wurzburg, Dept Microbiol, Bioctr, D-97074 Wurzburg, Germany.	lisa.polzien@uni-wuerzburg.de		Albrecht, Marco/0000-0002-1156-0623	Deutsche Forschungsgemeinschaft [SFB 487, C3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 487 (Projects C3) and Graduate College 1141 Grant.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Amaravadi R, 2005, J CLIN INVEST, V115, P2618, DOI 10.1172/JCI26273; Boisvert-Adamo K, 2008, ONCOGENE, V27, P3301, DOI 10.1038/sj.onc.1211003; BOS JL, 1989, CANCER RES, V49, P4682; Brose MS, 2002, CANCER RES, V62, P6997; Cohen C, 2002, CLIN CANCER RES, V8, P3728; Cohen J, 2003, J NATL CANCER I, V95, P625, DOI 10.1093/jnci/95.8.625; Cragg MS, 2008, J CLIN INVEST, V118, P3651, DOI 10.1172/JCI35437; Danial NN, 2008, ONCOGENE, V27, pS53, DOI 10.1038/onc.2009.44; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dramsi S, 2002, J BIOL CHEM, V277, P6399, DOI 10.1074/jbc.M109990200; Eisenmann KM, 2003, CANCER RES, V63, P8330; Fischer A, 2009, J BIOL CHEM, V284, P3183, DOI 10.1074/jbc.M804795200; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Gnesutta N, 2001, J BIOL CHEM, V276, P14414, DOI 10.1074/jbc.M011046200; Gorden A, 2003, CANCER RES, V63, P3955; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Harada H, 1999, MOL CELL, V3, P413, DOI 10.1016/S1097-2765(00)80469-4; Hekman M, 2002, J BIOL CHEM, V277, P24090, DOI 10.1074/jbc.M200576200; Hekman M, 2006, J BIOL CHEM, V281, P17321, DOI 10.1074/jbc.M600292200; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Jin SH, 2005, J BIOL CHEM, V280, P24698, DOI 10.1074/jbc.M413374200; Karasarides M, 2004, ONCOGENE, V23, P6292, DOI 10.1038/sj.onc.1207785; Kebache S, 2007, J BIOL CHEM, V282, P21873, DOI 10.1074/jbc.M611066200; Klumpp S, 2004, NEUROCHEM INT, V45, P747, DOI 10.1016/j.neuint.2004.02.006; Konishi Y, 2002, MOL CELL, V9, P1005, DOI 10.1016/S1097-2765(02)00524-5; Lee MH, 2011, J CLIN ENDOCR METAB, V96, pE19, DOI 10.1210/jc.2010-1071; Macdonald A, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-1; Masters SC, 2001, MOL PHARMACOL, V60, P1325, DOI 10.1124/mol.60.6.1325; Panka DJ, 2006, CANCER RES, V66, P1611, DOI 10.1158/0008-5472.CAN-05-0808; Pavey S, 2004, ONCOGENE, V23, P4060, DOI 10.1038/sj.onc.1207563; Peyssonnaux C, 2001, BIOL CELL, V93, P53, DOI 10.1016/S0248-4900(01)01125-X; Polzien L, 2009, J BIOL CHEM, V284, P28004, DOI 10.1074/jbc.M109.010702; Rajagopalan H, 2002, NATURE, V418, P934, DOI 10.1038/418934a; Rajalingam K, 2007, BBA-MOL CELL RES, V1773, P1177, DOI 10.1016/j.bbamcr.2007.01.012; Rapp U. R., 2007, NAT PRECEDINGS  0823; Reed J. C., 2004, SCI STKE, V2004, pre9, DOI DOI 10.1126/STKE.2392004RE9; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; Schreck R, 2006, INT J CANCER, V119, P2261, DOI 10.1002/ijc.22144; Schurmann A, 2000, MOL CELL BIOL, V20, P453, DOI 10.1128/MCB.20.2.453-461.2000; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; She QB, 2002, J BIOL CHEM, V277, P24039, DOI 10.1074/jbc.M109907200; Shimamura A, 2000, CURR BIOL, V10, P127, DOI 10.1016/S0960-9822(00)00310-9; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Subramanian RR, 2001, EXP CELL RES, V271, P142, DOI 10.1006/excr.2001.5376; Wang HG, 1996, CELL, V87, P629, DOI 10.1016/S0092-8674(00)81383-5; Weber C. K., 2001, CANCER RES, V61, P3595; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhang JY, 2005, CANCER RES, V65, P8372, DOI 10.1158/0008-5472.CAN-05-0576	56	14	14	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17934	17944		10.1074/jbc.M110.177345	http://dx.doi.org/10.1074/jbc.M110.177345			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21317286	Green Published, hybrid			2022-12-27	WOS:000290585200056
J	Puskar, NL; Xiu, XA; Lester, HA; Dougherty, DA				Puskar, Nyssa L.; Xiu, Xinan; Lester, Henry A.; Dougherty, Dennis A.			Two Neuronal Nicotinic Acetylcholine Receptors, alpha 4 beta 4 and alpha 7, Show Differential Agonist Binding Modes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATION-PI INTERACTIONS; UNNATURAL AMINO-ACIDS; IN-VIVO INCORPORATION; GATED ION CHANNELS; BUNGAROTOXIN; PROTEIN; RIC-3; SITE; EXPRESSION; SUBUNIT	Nicotinic acetylcholine receptors (nAChRs) are pentameric, neurotransmitter-gated ion channels responsible for rapid excitatory neurotransmission in the central and peripheral nervous systems, resulting in skeletal muscle tone and various cognitive effects in the brain. These complex proteins are activated by the endogenous neurotransmitter ACh as well as by nicotine and structurally related agonists. Activation and modulation of nAChRs has been implicated in the pathology of multiple neurological disorders, and as such, these proteins are established therapeutic targets. Here we use unnatural amino acid mutagenesis to examine the ligand binding mechanisms of two homologous neuronal nAChRs: the alpha 4 beta 4 and alpha 7 receptors. Despite sequence identity among the residues that form the core of the agonist-binding site, we find that the alpha 4 beta 4 and alpha 7 nAChRs employ different agonist-receptor binding interactions in this region. The alpha 4 beta 4 receptor utilizes a strong cation-pi interaction to a conserved tryptophan (TrpB) of the receptor for both ACh and nicotine, and nicotine participates in a strong hydrogen bond with a backbone carbonyl contributed by TrpB. Interestingly, we find that the alpha 7 receptor also employs a cation-pi interaction for ligand recognition, but the site has moved to a different aromatic amino acid of the agonist-binding site depending on the agonist. ACh participates in a cation-pi interaction with TyrA, whereas epibatidine participates in a cation-pi interaction with TyrC2.	[Puskar, Nyssa L.; Xiu, Xinan; Dougherty, Dennis A.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Lester, Henry A.] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Dougherty, DA (corresponding author), CALTECH, Div Chem & Chem Engn, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	dadougherty@caltech.edu			National Institutes of Health [NS 34407, NS 11756]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH086383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS011756, R37NS034407, R01NS034407] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS 34407 and NS 11756.	Alkondon M, 1997, EUR J NEUROSCI, V9, P2734, DOI 10.1111/j.1460-9568.1997.tb01702.x; Arneric S, 1999, NEURONAL NICOTINIC R; Beene DL, 2002, BIOCHEMISTRY-US, V41, P10262, DOI 10.1021/bi020266d; BEERS WH, 1970, NATURE, V228, P917, DOI 10.1038/228917a0; Ben-Ami HC, 2005, J BIOL CHEM, V280, P28053, DOI 10.1074/jbc.M504369200; Blum AP, 2010, P NATL ACAD SCI USA, V107, P13206, DOI 10.1073/pnas.1007140107; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Cashin AL, 2005, J AM CHEM SOC, V127, P350, DOI 10.1021/ja0461771; Castillo M, 2005, J BIOL CHEM, V280, P27062, DOI 10.1074/jbc.M503746200; Cheng AX, 2005, J BIOL CHEM, V280, P22502, DOI 10.1074/jbc.M414341200; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Court JA, 1997, DEV BRAIN RES, V101, P93, DOI 10.1016/S0165-3806(97)00052-7; Dart M J, 2000, Pharm Acta Helv, V74, P115, DOI 10.1016/S0031-6865(99)00023-0; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Dougherty DA, 2008, CHEM REV, V108, P1642, DOI 10.1021/cr078207z; Espinoza-Fonseca LM, 2006, BIOORG MED CHEM LETT, V16, P3519, DOI 10.1016/j.bmcl.2006.03.093; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Glennon R A, 2000, Pharm Acta Helv, V74, P103, DOI 10.1016/S0031-6865(99)00022-9; Gotti C, 2004, PROG NEUROBIOL, V74, P363, DOI 10.1016/j.pneurobio.2004.09.006; Grutter T, 2003, EMBO J, V22, P1990, DOI 10.1093/emboj/cdg197; Halevi S, 2002, EMBO J, V21, P1012, DOI 10.1093/emboj/21.5.1012; Improgo MRD, 2010, PROG NEUROBIOL, V92, P212, DOI 10.1016/j.pneurobio.2010.05.003; Jensen AA, 2005, J MED CHEM, V48, P4705, DOI 10.1021/jm040219e; Lummis SCR, 2005, CHEM BIOL, V12, P993, DOI 10.1016/j.chembiol.2005.06.012; Martin LF, 2004, PSYCHOPHARMACOLOGY, V174, P54, DOI 10.1007/s00213-003-1750-1; Moroni M, 2006, MOL PHARMACOL, V70, P755, DOI 10.1124/mol.106.023044; Mu TW, 2003, J AM CHEM SOC, V125, P6850, DOI 10.1021/ja0348086; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; NOWAK MW, 1995, SCIENCE, V268, P439, DOI 10.1126/science.7716551; Nowak MW, 1998, METHOD ENZYMOL, V293, P504; O'Neill MJ, 2002, CNS NEUROL DISORD-DR, V1, P399, DOI 10.2174/1568007023339166; OrrUrtreger A, 1997, J NEUROSCI, V17, P9165; Parker MJ, 1998, MOL PHARMACOL, V54, P1132, DOI 10.1124/mol.54.6.1132; Placzek AN, 2005, MOL PHARMACOL, V68, P1863, DOI 10.1124/mol.105.016402; Romanelli MN, 2007, CHEMMEDCHEM, V2, P746, DOI 10.1002/cmdc.200600207; Saks ME, 1996, J BIOL CHEM, V271, P23169, DOI 10.1074/jbc.271.38.23169; SEGUELA P, 1993, J NEUROSCI, V13, P596; Sixma TK, 2003, ANNU REV BIOPH BIOM, V32, P311, DOI 10.1146/annurev.biophys.32.110601.142536; Stevens KE, 1998, PSYCHOPHARMACOLOGY, V136, P320, DOI 10.1007/s002130050573; Stevens KE, 1996, NEUROPSYCHOPHARMACOL, V15, P152, DOI 10.1016/0893-133X(95)00178-G; Torrice MM, 2009, P NATL ACAD SCI USA, V106, P11919, DOI 10.1073/pnas.0903260106; Trombino S, 2004, CANCER RES, V64, P135, DOI 10.1158/0008-5472.CAN-03-1672; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; VIJAYARAGHAVAN S, 1992, NEURON, V8, P353, DOI 10.1016/0896-6273(92)90301-S; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Williams ME, 2005, J BIOL CHEM, V280, P1257, DOI 10.1074/jbc.M410039200; Wu J, 2006, J PHYSIOL-LONDON, V576, P103, DOI 10.1113/jphysiol.2006.114645; XIU X, 2007, STRUCTURE FUNCTION S, P67; Xiu XA, 2009, NATURE, V458, P534, DOI 10.1038/nature07768; Zeisel SH, 2006, ANNU REV NUTR, V26, P229, DOI 10.1146/annurev.nutr.26.061505.111156; ZHANG ZW, 1994, NEURON, V12, P167, DOI 10.1016/0896-6273(94)90161-9; Zhong WG, 1998, P NATL ACAD SCI USA, V95, P12088, DOI 10.1073/pnas.95.21.12088	52	45	46	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14618	14627		10.1074/jbc.M110.206565	http://dx.doi.org/10.1074/jbc.M110.206565			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21343288	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000289556200081
J	Shen, N; Yu, XA; Pan, FY; Gao, XA; Xue, B; Li, CJ				Shen, Ning; Yu, Xiao; Pan, Fei-Yan; Gao, Xiang; Xue, Bin; Li, Chao-Jun			An Early Response Transcription Factor, Egr-1, Enhances Insulin Resistance in Type 2 Diabetes with Chronic Hyperinsulinism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; NECROSIS-FACTOR-ALPHA; RECEPTOR SUBSTRATE-1; C-JUN; TYROSINE PHOSPHORYLATION; CELL-GROWTH; ADIPOCYTES; EXPRESSION; IRS-1; PATHWAYS	One of the most important characteristics of type 2 diabetes is insulin resistance, during which the patients normally experienced hyperinsulinism stress that would alter insulin signal transduction in insulin target tissues. We have previously found that early growth responsive gene-1 (Egr-1), a zinc finger transcription factor, is highly expressed in db/db mice and in the fat tissue of individuals with type 2 diabetes. In this report, we found that chronic exposure to hyperinsulinism caused persistent Erk/MAPK activity in adipocytes and enhanced insulin resistance in an Egr-1-dependent manner. An elevation in Egr-1 augmented Erk1/2 activation via geranylgeranyl diphosphate synthase (GGPPS). Egr-1-promoted GGPPS transcription increased Ras prenylation and caused Erk1/2 activation. The sustained activation of Erk1/2 resulted in the phosphorylation of insulin receptor substrate-1 at Serine 612. Phosphorylation at this site impaired insulin signaling in adipocytes and reduced glucose uptake. The loss of Egr-1 function, knockdown of GGPPS, or inhibition of Erk1/2 activity in insulin-resistant adipocytes restored insulin receptor substrate-1 tyrosine phosphorylation and increased insulin sensitivity. Our results suggest a new mechanism by which the Egr-1/GGPPS/Erk1/2 pathway is responsible for insulin resistance during hyperinsulinism. This pathway provides a new therapeutic target for increasing insulin sensitivity: inhibiting the function of Egr-1.	[Shen, Ning; Gao, Xiang; Xue, Bin; Li, Chao-Jun] Nanjing Univ, Natl Resource Ctr Mutant Mice, Model Anim Res Ctr, Minist Educ,Key Lab Model Anim Dis Study, Nanjing 210061, Peoples R China; [Shen, Ning; Gao, Xiang; Xue, Bin; Li, Chao-Jun] Nanjing Univ, Natl Resource Ctr Mutant Mice, Sch Med, Nanjing 210061, Peoples R China; [Yu, Xiao; Pan, Fei-Yan] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Mol & Med Biotechnol, Nanjing 210046, Peoples R China	Nanjing University; Nanjing University; Nanjing Normal University	Xue, B (corresponding author), Nanjing Univ, Model Anim Res Ctr, Nanjing 210093, Peoples R China.	xuebin@nju.edu.cn; licj@nju.edu.cn		Li, Chaojun/0000-0001-9474-7321; Yu, Xiao/0000-0001-9441-1705	National Basic Research Program of China [2009CB918703, 2006CB943500]; National Natural Science Foundation of China [30671086, 30700394]; Natural Science Foundation of Jiangsu Province of China [BK2007598]; Foundation of the Jiangsu Key Laboratory for Molecular and Medical Biotechnology [NMB09KF03]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province); Foundation of the Jiangsu Key Laboratory for Molecular and Medical Biotechnology	This work was supported by National Basic Research Program of China Grants 2009CB918703 and 2006CB943500 and National Natural Science Foundation of China Grant 30671086 awarded (to C.-J. L.). This work was also supported by National Natural Science Foundation of China Grant 30700394, Natural Science Foundation of Jiangsu Province of China Grant BK2007598, and Foundation of the Jiangsu Key Laboratory for Molecular and Medical Biotechnology Grant NMB09KF03 (to B. X.).	Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Bae SS, 2003, J BIOL CHEM, V278, P49530, DOI 10.1074/jbc.M306782200; Bard-Chapeau EA, 2005, NAT MED, V11, P567, DOI 10.1038/nm1227; Baron V, 2003, ANN NY ACAD SCI, V1002, P197, DOI 10.1196/annals.1281.024; Begum N, 1998, AM J PHYSIOL-CELL PH, V275, pC42, DOI 10.1152/ajpcell.1998.275.1.C42; Benz AH, 2010, BRIT J PHARMACOL, V160, P1621, DOI 10.1111/j.1476-5381.2010.00812.x; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Boyle KB, 2009, CELL DEATH DIFFER, V16, P782, DOI 10.1038/cdd.2009.11; Cusi K, 2000, J CLIN INVEST, V105, P311, DOI 10.1172/JCI7535; Emanuelli B, 2008, P NATL ACAD SCI USA, V105, P3545, DOI 10.1073/pnas.0712275105; Eringa EC, 2004, AM J PHYSIOL-HEART C, V287, pH2043, DOI 10.1152/ajpheart.00067.2004; FARNSWORTH CC, 1989, J BIOL CHEM, V264, P20422; FARNSWORTH CC, 1990, SCIENCE, V247, P320, DOI 10.1126/science.2296721; Fujishiro M, 2003, MOL ENDOCRINOL, V17, P487, DOI 10.1210/me.2002-0131; GLOMSET JA, 1994, ANNU REV CELL BIOL, V10, P181, DOI 10.1146/annurev.cellbio.10.1.181; Goalstone ML, 1999, J BIOL CHEM, V274, P2880, DOI 10.1074/jbc.274.5.2880; Greene MW, 2003, J BIOL CHEM, V278, P8199, DOI 10.1074/jbc.M209153200; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hamilton TB, 1998, BIOCHEMISTRY-US, V37, P2051, DOI 10.1021/bi9717993; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hodge C, 1998, J BIOL CHEM, V273, P31327, DOI 10.1074/jbc.273.47.31327; Kainou T, 1999, BBA-MOL CELL BIOL L, V1437, P333, DOI 10.1016/S1388-1981(99)00028-1; Kaneto H, 2004, NAT MED, V10, P1128, DOI 10.1038/nm1111; Keeton AB, 2003, ENDOCRINOLOGY, V144, P5402, DOI 10.1210/en.2003-0592; Kim S, 2002, J NUTR, V132, P1135, DOI 10.1093/jn/132.6.1135; Levkovitz Y, 2001, J NEUROSCI, V21, P5893, DOI 10.1523/JNEUROSCI.21-16-05893.2001; Luan B, 2009, NATURE, V457, P1146, DOI 10.1038/nature07617; Moeschel K, 2004, J BIOL CHEM, V279, P25157, DOI 10.1074/jbc.M402477200; Mostecki J, 2005, J BIOL CHEM, V280, P2596, DOI 10.1074/jbc.M408938200; Paz K, 1997, J BIOL CHEM, V272, P29911, DOI 10.1074/jbc.272.47.29911; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Sambrook J, 2001, MOL CLONING LAB MANU; Samuelsson AM, 2006, AM J PHYSIOL-HEART C, V291, pH787, DOI 10.1152/ajpheart.00974.2005; Sartipy P, 2003, J BIOL CHEM, V278, P52298, DOI 10.1074/jbc.M306922200; Seboek D, 2004, J CLIN ENDOCR METAB, V89, P4833, DOI 10.1210/jc.2004-0271; Silverman ES, 1999, AM J PATHOL, V154, P665, DOI 10.1016/S0002-9440(10)65312-6; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; Tiraby C, 2003, J BIOL CHEM, V278, P33370, DOI 10.1074/jbc.M305235200; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Virolle T, 2001, NAT CELL BIOL, V3, P1124, DOI 10.1038/ncb1201-1124; Wang ZC, 2006, BIOCHEM BIOPH RES CO, V345, P976, DOI 10.1016/j.bbrc.2006.04.173; Weng LP, 2001, HUM MOL GENET, V10, P605, DOI 10.1093/hmg/10.6.605; Wick KR, 2003, J BIOL CHEM, V278, P8460, DOI 10.1074/jbc.M208518200; Yao J, 1997, J BIOL CHEM, V272, P17795, DOI 10.1074/jbc.272.28.17795; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325	46	60	70	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14508	14515		10.1074/jbc.M110.190165	http://dx.doi.org/10.1074/jbc.M110.190165			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21321112	hybrid, Green Published			2022-12-27	WOS:000289556200071
J	Ghosh, M; Schonbrunn, A				Ghosh, Madhumita; Schonbrunn, Agnes			Differential Temporal and Spatial Regulation of Somatostatin Receptor Phosphorylation and Dephosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGONIST-INDUCED DESENSITIZATION; MEDIATED ENDOCYTOSIS; PROTEIN-KINASE; SST2A; INTERNALIZATION; SEQUESTRATION; SPECIFICITY; TRAFFICKING; ARRESTINS; RHODOPSIN	The G(i)-coupled somatostatin 2A receptor (sst2A) mediates many of the neuromodulatory and neuroendocrine actions of somatostatin (SS) and is targeted by the SS analogs used to treat neuroendocrine tumors. As for other G protein-coupled receptors, agonists stimulate sst2A receptor phosphorylation on multiple residues, and phosphorylation at different sites has distinct effects on receptor internalization and uncoupling. To elucidate the spatial and temporal regulation of sst2A receptor phosphorylation, we examined agonist-stimulated phosphorylation of multiple receptor GPCR kinase sites using phospho-site-specific antibodies. SS increased receptor phosphorylation sequentially, first on Ser-341/343 and then on Thr-353/354, followed by receptor internalization. Reversal of receptor phosphorylation was determined by the duration of prior agonist exposure. In acutely stimulated cells, in which most receptors remained on the cell surface, dephosphorylation occurred only on Thr-353/354. In contrast, both Ser-341/343 and Thr-353/354 were rapidly dephosphorylated when cells were stimulated long enough to allow receptor internalization before agonist removal. Consistent with these observations, dephosphorylation of Thr-353/354 was not affected by either hypertonic sucrose or dynasore, which prevent receptor internalization, whereas dephosphorylation of Ser-341/343 was completely blocked. An okadaic acid- and fostriecin-sensitive phosphatase catalyzed the dephosphorylation of Thr-353/354 both intracellularly and at the cell surface. In contrast, dephosphorylation of Ser-3411343 was insensitive to these inhibitors. Our results show that the phosphorylation and dephosphorylation of neighboring GPCR kinase sites in the sst2A receptor are subject to differential spatial and temporal regulation. Thus, the pattern of receptor phosphorylation is determined by the duration of agonist stimulation and compartment-specific enzymatic activity.	[Ghosh, Madhumita; Schonbrunn, Agnes] Univ Texas Hlth Sci Ctr, Dept Integrat Biol & Pharmacol, Houston, TX 77225 USA	University of Texas System; University of Texas Health Science Center Houston	Schonbrunn, A (corresponding author), Univ Texas Hlth Sci Ctr, Dept Integrat Biol & Pharmacol, Houston, TX 77225 USA.	agnes.schonbrunn@uth.tmc.edu			National Institutes of Health [DK032234]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK032234, R01DK032234] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK032234 (to A. S.).	Brown BM, 2002, BIOCHEMISTRY-US, V41, P13526, DOI 10.1021/bi0204490; Busillo JM, 2010, J BIOL CHEM, V285, P7805, DOI 10.1074/jbc.M109.091173; Celver J, 2004, MOL PHARMACOL, V65, P528, DOI 10.1124/mol.65.3.528; COHEN P, 1989, FEBS LETT, V250, P596, DOI 10.1016/0014-5793(89)80803-8; Elberg G, 2002, MOL ENDOCRINOL, V16, P2502, DOI 10.1210/me.2002-0207; Gardner B, 2001, MOL PHARMACOL, V59, P310, DOI 10.1124/mol.59.2.310; Gu YZ, 1997, MOL ENDOCRINOL, V11, P527, DOI 10.1210/me.11.5.527; Gurevich V. V., 2008, V186, P15, DOI 10.1007/978-3-540-72843-6_2; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Hipkin RW, 2000, J BIOL CHEM, V275, P5591, DOI 10.1074/jbc.275.8.5591; Hipkin RW, 1997, J BIOL CHEM, V272, P13869, DOI 10.1074/jbc.272.21.13869; Horie K, 2000, J BIOL CHEM, V275, P29433, DOI 10.1074/jbc.M003413200; Iyer V, 2006, BRIT J PHARMACOL, V147, P249, DOI 10.1038/sj.bjp.0706551; Jones BW, 2007, J BIOL CHEM, V282, P12893, DOI 10.1074/jbc.M610854200; Kennedy MJ, 2001, NEURON, V31, P87, DOI 10.1016/S0896-6273(01)00340-3; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; Kohout TA, 2003, MOL PHARMACOL, V63, P9, DOI 10.1124/mol.63.1.9; Krueger KM, 1997, J BIOL CHEM, V272, P5; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Liu Q, 2008, MOL PHARMACOL, V73, P292, DOI 10.1124/mol.107.038570; Liu QS, 2009, MOL PHARMACOL, V76, P68, DOI 10.1124/mol.108.054262; Liu QS, 2005, MOL PHARMACOL, V68, P90, DOI 10.1124/mol.105.011767; Liu QS, 2003, J CLIN ENDOCR METAB, V88, P6073, DOI 10.1210/jc.2003-030986; Liu QS, 2001, J BIOL CHEM, V276, P3709, DOI 10.1074/jbc.M008873200; McLaughlin JP, 2003, J BIOL CHEM, V278, P34631, DOI 10.1074/jbc.M304022200; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; OHGURO H, 1993, BIOCHEMISTRY-US, V32, P5718, DOI 10.1021/bi00072a030; Olias G, 2004, J NEUROCHEM, V89, P1057, DOI 10.1111/j.1471-4159.2004.02402.x; Park PSH, 2008, ANNU REV PHARMACOL, V48, P107, DOI 10.1146/annurev.pharmtox.48.113006.094630; Patwardhan P, 2007, CELL SIGNAL, V19, P2218, DOI 10.1016/j.cellsig.2007.06.006; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; PIPPIG S, 1995, MOL PHARMACOL, V47, P666; Pollok-Kopp B, 2003, J BIOL CHEM, V278, P2190, DOI 10.1074/jbc.M209844200; Rajeswaran WG, 2001, J MED CHEM, V44, P1305, DOI 10.1021/jm0005048; Reubi JC, 2003, ENDOCR REV, V24, P389, DOI 10.1210/er.2002-0007; Reubi JC, 2008, J NUCL MED, V49, P1735, DOI 10.2967/jnumed.108.053041; Salazar C, 2009, FEBS J, V276, P3177, DOI 10.1111/j.1742-4658.2009.07027.x; SCHONBRUNN A, 2004, ENCY BIOL CHEM, P55; Seachrist JL, 2003, LIFE SCI, V74, P225, DOI 10.1016/j.lfs.2003.09.009; Swingle Mark, 2007, V365, P23; Tobin AB, 2008, BRIT J PHARMACOL, V153, pS167, DOI 10.1038/sj.bjp.0707662; Tobin AB, 2008, TRENDS PHARMACOL SCI, V29, P413, DOI 10.1016/j.tips.2008.05.006; Tran TM, 2004, MOL PHARMACOL, V65, P196, DOI 10.1124/mol.65.1.196; Tran TM, 2007, MOL PHARMACOL, V71, P47, DOI 10.1124/mol.106.028456; Trester-Zedlitz M, 2005, BIOCHEMISTRY-US, V44, P6133, DOI 10.1021/bi0475469; Violin JD, 2006, J BIOL CHEM, V281, P20577, DOI 10.1074/jbc.M513605200; Vishnivetskiy SA, 2007, J BIOL CHEM, V282, P32075, DOI 10.1074/jbc.M706057200; Weckbecker G, 2003, NAT REV DRUG DISCOV, V2, P999, DOI 10.1038/nrd1255; WEISER DC, 2003, CURR PROTOC MOL BIOL, V18; Yang W, 1999, J BIOL CHEM, V274, P11328, DOI 10.1074/jbc.274.16.11328; Zidar DA, 2009, P NATL ACAD SCI USA, V106, P9649, DOI 10.1073/pnas.0904361106	53	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13561	13573		10.1074/jbc.M110.215723	http://dx.doi.org/10.1074/jbc.M110.215723			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21343287	hybrid, Green Published			2022-12-27	WOS:000289282200076
J	Matsuo, Y; Kishimoto, H; Tanae, K; Kitamura, K; Katayama, S; Kawamukai, M				Matsuo, Yuzy; Kishimoto, Hayafumi; Tanae, Katsuhiro; Kitamura, Kenji; Katayama, Satoshi; Kawamukai, Makoto			Nuclear Protein Quality Is Regulated by the Ubiquitin-Proteasome System through the Activity of Ubc4 and San1 in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE CONTROL; SCHIZOSACCHAROMYCES-POMBE; MITOCHONDRIAL MAINTENANCE; SACCHAROMYCES-CEREVISIAE; CHROMOSOME SEGREGATION; CONJUGATING ENZYMES; 26S PROTEASOME; DEGRADATION; LOCALIZATION; GENE	Eukaryotic cells monitor and maintain protein quality through a set of protein quality control (PQC) systems whose role is to minimize the harmful effects of the accumulation of aberrant proteins. Although these PQC systems have been extensively studied in the cytoplasm, nuclear PQC systems are not well understood. The present work shows the existence of a nuclear PQC system mediated by the ubiquitin-proteasome system in the fission yeast Schizosaccharomyces pombe. Asf1-30, a mutant form of the histone chaperone Asf1, was used as a model substrate for the study of the nuclear PQC. A temperature-sensitive Asf1-30 protein localized to the nucleus was selectively degraded by the ubiquitin-proteasome system. The Asf1-30 mutant protein was highly ubiquitinated at higher temperatures, and it remained stable in an mts2-1 mutant, which lacks proteasome activity. The E2 enzyme Ubc4 was identified among 11 candidate proteins as the ubiquitin-conjugating enzyme in this system, and San1 was selected among 100 candidates as the ubiquitin ligase (E3) targeting Asf1-30 for degradation. San1, but not other nuclear E3s, showed specificity for the mutant nuclear Asf1-30, but did not show activity against wild-type Asf1. These data clearly showed that the aberrant nuclear protein was degraded by a defined set of E1-E2-E3 enzymes through the ubiquitin-proteasome system. The data also show, for the first time, the presence of a nuclear PQC system in fission yeast.	[Matsuo, Yuzy; Kishimoto, Hayafumi; Tanae, Katsuhiro; Katayama, Satoshi; Kawamukai, Makoto] Shimane Univ, Fac Life & Environm Sci, Dept Life Sci & Biotechnol, Matsue, Shimane 6908504, Japan; [Kitamura, Kenji] Hiroshima Univ, Ctr Gene Sci, Higashihiroshima 7398527, Japan	Shimane University; Hiroshima University	Kawamukai, M (corresponding author), Shimane Univ, Fac Life & Environm Sci, Dept Life Sci & Biotechnol, 1060 Nishikawatsu, Matsue, Shimane 6908504, Japan.	kawamuka@life.shimane-u.ac.jp	Kawamukai, Makoto/AET-1038-2022; Kitamura, Kenji/C-4173-2018	Kawamukai, Makoto/0000-0003-2929-8798; Kitamura, Kenji/0000-0003-1046-7133	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Japan Society for the Promotion of Science research fellowships for young scientists.	Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Chen ES, 2003, MOL CELL, V11, P175, DOI 10.1016/S1097-2765(03)00011-X; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Dasgupta A, 2004, J BIOL CHEM, V279, P26830, DOI 10.1074/jbc.M400894200; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; GORDON C, 1993, NATURE, V366, P355, DOI 10.1038/366355a0; Goshima G, 2003, EMBO J, V22, P2752, DOI 10.1093/emboj/cdg266; HAGAN I, 1995, J CELL BIOL, V129, P1033, DOI 10.1083/jcb.129.4.1033; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Heck JW, 2010, P NATL ACAD SCI USA, V107, P1106, DOI 10.1073/pnas.0910591107; Hershko A, 1997, CURR OPIN CELL BIOL, V9, P788, DOI 10.1016/S0955-0674(97)80079-8; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hughes BT, 2009, J BIOL CHEM, V284, P20512, DOI 10.1074/jbc.M109.002436; Iwata A, 2005, P NATL ACAD SCI USA, V102, P13135, DOI 10.1073/pnas.0505801102; Iwata A, 2009, J BIOL CHEM, V284, P9796, DOI 10.1074/jbc.M809739200; Javerzat JP, 1996, NUCLEIC ACIDS RES, V24, P4676, DOI 10.1093/nar/24.23.4676; Kato H, 2008, CELL CYCLE, V7, P1085; KAWAMUKAI M, 1992, MOL BIOL CELL, V3, P167, DOI 10.1091/mbc.3.2.167; Kitamura K, 2001, DEV CELL, V1, P389, DOI 10.1016/S1534-5807(01)00037-5; Laporte D, 2008, J CELL BIOL, V181, P737, DOI 10.1083/jcb.200711154; Le SY, 1997, YEAST, V13, P1029, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1029::AID-YEA160>3.0.CO;2-1; Lehmann A, 2004, GENES CELLS, V9, P367, DOI 10.1111/j.1356-9597.2004.00730.x; MATSUMOTO T, 1993, MOL BIOL CELL, V4, P337, DOI 10.1091/mbc.4.3.337; Matsuo Y, 2006, BIOSCI BIOTECH BIOCH, V70, P1992, DOI 10.1271/bbb.60087; Matsuo Y, 2010, BIOSCI BIOTECH BIOCH, V74, P685, DOI 10.1271/bbb.90967; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Munakata T, 2000, GENES CELLS, V5, P221, DOI 10.1046/j.1365-2443.2000.00319.x; Murata S, 2003, INT J BIOCHEM CELL B, V35, P572, DOI 10.1016/S1357-2725(02)00394-1; Noguchi E, 2004, MOL CELL BIOL, V24, P8342, DOI 10.1128/MCB.24.19.8342-8355.2004; Oowatari Y, 2009, BIOSCI BIOTECH BIOCH, V73, P1591, DOI 10.1271/bbb.90103; Osaka F, 1997, MOL CELL BIOL, V17, P3388, DOI 10.1128/MCB.17.6.3388; Ozoe F, 2002, MOL CELL BIOL, V22, P7105, DOI 10.1128/MCB.22.20.7105-7119.2002; Russell SJ, 1999, MOL CELL, V3, P687, DOI 10.1016/S1097-2765(01)80001-0; Sambrook J, 1989, J SAMBROOK MOL CLONI; Sato M, 2005, YEAST, V22, P583, DOI 10.1002/yea.1233; SCHNELL R, 1989, GENETICS, V122, P29; Seino H, 2003, MOL CELL BIOL, V23, P3497, DOI 10.1128/MCB.23.10.3497-3505.2003; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; Shastry BS, 2003, NEUROCHEM INT, V43, P1, DOI 10.1016/S0197-0186(02)00196-1; Shiozaki K, 1997, METHOD ENZYMOL, V283, P506; Takeda K, 2005, CELL, V122, P393, DOI 10.1016/j.cell.2005.05.023; Takeda K, 2010, AUTOPHAGY, V6, P564, DOI 10.4161/auto.6.4.11948; Takeda K, 2010, P NATL ACAD SCI USA, V107, P3540, DOI 10.1073/pnas.0911055107; Tanabe K, 2003, EUKARYOT CELL, V2, P1274, DOI 10.1128/EC.2.6.1274-1287.2003; Tatebe H, 2000, CURR BIOL, V10, P1329, DOI 10.1016/S0960-9822(00)00773-9; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Umehara T, 2002, GENES CELLS, V7, P59, DOI 10.1046/j.1356-9597.2001.00493.x; von Mikecz A, 2006, J CELL SCI, V119, P1977, DOI 10.1242/jcs.03008; Wilkinson CRM, 1998, EMBO J, V17, P6465, DOI 10.1093/emboj/17.22.6465; Wojcik C, 2003, INT J BIOCHEM CELL B, V35, P579, DOI 10.1016/S1357-2725(02)00380-1	55	21	22	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13775	13790		10.1074/jbc.M110.169953	http://dx.doi.org/10.1074/jbc.M110.169953			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21324894	Green Published, hybrid			2022-12-27	WOS:000289282200095
J	Moretti, R; Chang, A; Peltier-Pain, P; Bingman, CA; Phillips, GN; Thorson, JS				Moretti, Rocco; Chang, Aram; Peltier-Pain, Pauline; Bingman, Craig A.; Phillips, George N., Jr.; Thorson, Jon S.			Expanding the Nucleotide and Sugar 1-Phosphate Promiscuity of Nucleotidyltransferase RmlA via Directed Evolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATURAL-PRODUCT GLYCOSYLTRANSFERASE; RANDOM MUTAGENESIS LIBRARIES; ENZYME-CATALYZED SYNTHESIS; ESCHERICHIA-COLI; MEGAPRIMER PCR; TOOLS; REVERSIBILITY	Directed evolution is a valuable technique to improve enzyme activity in the absence of a priori structural knowledge, which can be typically enhanced via structure-guided strategies. In this study, a combination of both whole-gene error-prone polymerase chain reaction and site-saturation mutagenesis enabled the rapid identification of mutations that improved RmlA activity toward non-native substrates. These mutations have been shown to improve activities over 10-fold for several targeted substrates, including non-native pyrimidine- and purine-based NTPs as well as non-native D- and L-sugars (both alpha- and beta-isomers). This study highlights the first broadly applicable high throughput sugar-1-phosphate nucleotidyltransferase screen and the first proof of concept for the directed evolution of this enzyme class toward the identification of uniquely permissive RmlA variants.	[Moretti, Rocco; Chang, Aram; Phillips, George N., Jr.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Chang, Aram; Bingman, Craig A.; Phillips, George N., Jr.] Univ Wisconsin, Ctr Eukaryot Struct Genom, Madison, WI 53706 USA; [Moretti, Rocco; Peltier-Pain, Pauline; Thorson, Jon S.] Univ Wisconsin, Sch Pharm, Div Pharmaceut Sci, Madison, WI 53705 USA; [Moretti, Rocco; Peltier-Pain, Pauline; Thorson, Jon S.] Univ Wisconsin, Wisconsin Ctr Nat Prod, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Phillips, GN (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	Phillips@biochem.wisc.edu; jsthorson@pharmacy.wisc.edu	Thorson, Jon S/L-3696-2013	Thorson, Jon S/0000-0002-7148-0721	National Institutes of Health (NIH) [GM07215, AI552218, U54 GM074901, GM08293]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; United States Department of Energy, Basic Energy Sciences, Office of Science [W-31-102-ENG-38]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052218] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008293, T32GM007215, U54GM074901] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; United States Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Molecular Bioscience Training Grant GM07215 (to R. M., trainee) and NIH Grant AI552218 (to J. S. T. in support of R. M.), NIH Grant U54 GM074901 (to John L. Markley, Principal Investigator, for G. N. P., C. A. B., and A. C.), and NIH Molecular Biophysics Training Grant GM08293 (to A. C., trainee). The Life Sciences Collaborative Access Team was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor. Use of the Advanced Photon Source was supported by the United States Department of Energy, Basic Energy Sciences, Office of Science, under Contact W-31-102-ENG-38. J. S. T. is a co-founder of Centrose (Madison, WI).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bae J, 2005, CHEMBIOCHEM, V6, P1963, DOI 10.1002/cbic.200500183; Barton WA, 2002, P NATL ACAD SCI USA, V99, P13397, DOI 10.1073/pnas.192468299; Beaton SA, 2009, CHEM COMMUN, P238, DOI 10.1039/b808078j; Bloom JD, 2005, CURR OPIN STRUC BIOL, V15, P447, DOI 10.1016/j.sbi.2005.06.004; Boltje TJ, 2009, NAT CHEM, V1, P611, DOI [10.1038/NCHEM.399, 10.1038/nchem.399]; Bulter T, 1999, GLYCOCONJUGATE J, V16, P147, DOI 10.1023/A:1026444726698; Chica RA, 2005, CURR OPIN BIOTECH, V16, P378, DOI 10.1016/j.copbio.2005.06.004; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dougherty MJ, 2009, CURR OPIN BIOTECH, V20, P486, DOI 10.1016/j.copbio.2009.08.005; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fu X, 2005, ORG LETT, V7, P1513, DOI 10.1021/ol0501626; Gantt RW, 2008, ANGEW CHEM INT EDIT, V47, P8889, DOI 10.1002/anie.200803508; Hoffmeister D, 2003, P NATL ACAD SCI USA, V100, P13184, DOI 10.1073/pnas.2235011100; Huestis MP, 2008, ORG BIOMOL CHEM, V6, P477, DOI 10.1039/b716955h; Jakeman DL, 2008, BIOCHEMISTRY-US, V47, P8719, DOI 10.1021/bi800978u; Jiang JQ, 2003, CHEMBIOCHEM, V4, P443, DOI 10.1002/cbic.200200566; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Kiessling LL, 2010, ANNU REV BIOCHEM, V79, P619, DOI 10.1146/annurev.biochem.77.070606.100917; Kittl R, 2010, CARBOHYD RES, V345, P1272, DOI 10.1016/j.carres.2010.04.002; Ko KS, 2004, J AM CHEM SOC, V126, P13188, DOI 10.1021/ja045522j; Kren V, 2008, FEMS MICROBIOL REV, V32, P858, DOI 10.1111/j.1574-6976.2008.00124.x; Langenhan JM, 2005, J NAT PROD, V68, P1696, DOI 10.1021/np0502084; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lepenies B, 2010, CURR OPIN CHEM BIOL, V14, P404, DOI 10.1016/j.cbpa.2010.02.016; LEVER M, 1973, J LAB CLIN MED, V82, P649; Lutz S, 2004, CURR OPIN BIOTECH, V15, P291, DOI 10.1016/j.copbio.2004.05.004; Luzhetskyy A, 2008, CURR TOP MED CHEM, V8, P680, DOI 10.2174/156802608784221514; Miyazaki K, 1999, J MOL EVOL, V49, P716, DOI 10.1007/PL00006593; Miyazaki K, 2002, BIOTECHNIQUES, V33, P1033, DOI 10.2144/02335st03; Miyazaki Kentaro, 2003, Methods Mol Biol, V231, P23; Moretti R, 2008, ANAL BIOCHEM, V377, P251, DOI 10.1016/j.ab.2008.03.018; Moretti R, 2007, J BIOL CHEM, V282, P16942, DOI 10.1074/jbc.M701951200; Morley KL, 2005, TRENDS BIOTECHNOL, V23, P231, DOI 10.1016/j.tibtech.2005.03.005; Nahalka J, 2003, CHEM-EUR J, V9, P373, DOI 10.1002/chem.200390038; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Rupprath C, 2005, CURR MED CHEM, V12, P1637, DOI 10.2174/0929867054367167; Salamone PR, 2002, P NATL ACAD SCI USA, V99, P1070, DOI 10.1073/pnas.012603799; Thibodeaux CJ, 2008, ANGEW CHEM INT EDIT, V47, P9814, DOI 10.1002/anie.200801204; THORSON JS, 1994, J BACTERIOL, V176, P1840, DOI 10.1128/jb.176.7.1840-1849.1994; Timmons SC, 2008, ORG LETT, V10, P161, DOI 10.1021/ol7023949; Timmons SC, 2007, ORG LETT, V9, P857, DOI 10.1021/ol0630853; Tracewell CA, 2009, CURR OPIN CHEM BIOL, V13, P3, DOI 10.1016/j.cbpa.2009.01.017; Tseng WC, 2008, ANAL BIOCHEM, V375, P376, DOI 10.1016/j.ab.2007.12.013; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Voigt CA, 2001, J CELL BIOCHEM, V84, P58, DOI 10.1002/jcb.10066; Wagner GK, 2009, NAT PROD REP, V26, P1172, DOI 10.1039/b909621n; Weijers CAGM, 2008, BIOTECHNOL ADV, V26, P436, DOI 10.1016/j.biotechadv.2008.05.001; White-Phillip J, 2009, METHOD ENZYMOL, V459, P521, DOI 10.1016/S0076-6879(09)04621-7; Williams GJ, 2007, NAT CHEM BIOL, V3, P657, DOI 10.1038/nchembio.2007.28; Williams GJ, 2011, ACS CHEM BIOL, V6, P95, DOI 10.1021/cb100267k; Williams GJ, 2008, CURR OPIN CHEM BIOL, V12, P556, DOI 10.1016/j.cbpa.2008.07.013; Yang J, 2005, CHEM BIOL, V12, P657, DOI 10.1016/j.chembiol.2005.04.009; Zhang CS, 2006, J AM CHEM SOC, V128, P16420, DOI 10.1021/ja065950k; Zhang CS, 2006, SCIENCE, V313, P1291, DOI 10.1126/science.1130028	58	32	31	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13235	13243		10.1074/jbc.M110.206433	http://dx.doi.org/10.1074/jbc.M110.206433			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21317292	hybrid, Green Published			2022-12-27	WOS:000289282200044
J	Munoz, P; Humeres, A; Elgueta, C; Kirkwood, A; Hidalgo, C; Nunez, MT				Munoz, Pablo; Humeres, Alexis; Elgueta, Claudio; Kirkwood, Alfredo; Hidalgo, Cecilia; Nunez, Marco T.			Iron Mediates N-Methyl-D-aspartate Receptor-dependent Stimulation of Calcium-induced Pathways and Hippocampal Synaptic Plasticity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; NMDA RECEPTOR; LASTING POTENTIATION; CREB PHOSPHORYLATION; MEMORY FUNCTION; NADPH OXIDASE; NITRIC-OXIDE; CA2+; ACTIVATION; DEFICIENCY	Iron deficiency hinders hippocampus-dependent learning processes and impairs cognitive performance, but current knowledge on the molecular mechanisms underlying the unique role of iron in neuronal function is sparse. Here, we investigated the participation of iron on calcium signal generation and ERK1/2 stimulation induced by the glutamate agonist N-methyl-D-aspartate (NMDA), and the effects of iron addition/chelation on hippocampal basal synaptic transmission and long-term potentiation (LTP). Addition of NMDA to primary hippocampal cultures elicited persistent calcium signals that required functional NMDA receptors and were independent of calcium influx through L-type calcium channels or alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors; NMDA also promoted ERK1/2 phosphorylation and nuclear translocation. Iron chelation with desferrioxamine or inhibition of ryanodine receptor (RyR)-mediated calcium release with ryanodine-reduced calcium signal duration and prevented NMDA-induced ERK1/2 activation. Iron addition to hippocampal neurons readily increased the intracellular labile iron pool and stimulated reactive oxygen species production; the antioxidant N-acetyl-cysteine or the hydroxyl radical trapper MCI-186 prevented these responses. Iron addition to primary hippocampal cultures kept in calcium-free medium elicited calcium signals and stimulated ERK1/2 phosphorylation; RyR inhibition abolished these effects. Iron chelation decreased basal synaptic transmission in hippocampal slices, inhibited iron-induced synaptic stimulation, and impaired sustained LIP in hippocampal CA1 neurons induced by strong stimulation. In contrast, iron addition facilitated sustained LTP induction after suboptimal tetanic stimulation. Together, these results suggest that hippocampal neurons require iron to generate RyR-mediated calcium signals after NMDA receptor stimulation, which in turn promotes ERK1/2 activation, an essential step of sustained LTP.	[Munoz, Pablo; Elgueta, Claudio] Univ Valparaiso, Ctr Neurociencia, Valparaiso 2360102, Chile; [Munoz, Pablo] Ctr Reg Estudios Alimentos Saludables, Valparaiso 2362696, Chile; [Humeres, Alexis; Hidalgo, Cecilia] Univ Chile, Fac Med, Ctr Estudios Mol Celula, Santiago 8380453, Chile; [Kirkwood, Alfredo] Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21218 USA; [Hidalgo, Cecilia] Univ Chile, Fac Med, Inst Ciencias Biomed, Programa Fisiol & Biofis, Santiago 8389100, Chile; [Nunez, Marco T.] Univ Chile, Fac Ciencias, Dept Biol, Santiago 7800024, Chile; [Nunez, Marco T.] Univ Chile, Inst Cell Dynam & Biotechnol, Santiago 7800024, Chile	Universidad de Valparaiso; Universidad de Chile; Johns Hopkins University; Universidad de Chile; Universidad de Chile; Universidad de Chile	Munoz, P (corresponding author), Univ Valparaiso, Ctr Neurociencia, Valparaiso 2360102, Chile.	pmunoz@cnv.cl	HIDALGO, Cecilia/H-7107-2013; Nunez, Marco/H-6348-2014	Nunez, Marco/0000-0002-1967-8570	Millennium Scientific Initiative [ICM-P05-001-F]; Fondecyt-FONDAP [15010006]; Fondo Nacional de Desarrollo Cientifico y Tecnologico [FONDECYT 3080046]; NATIONAL INSTITUTE ON AGING [R01AG034606] Funding Source: NIH RePORTER	Millennium Scientific Initiative; Fondecyt-FONDAP(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYTCONICYT FONDAP); Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Millennium Scientific Initiative Grant ICM-P05-001-F (to M. T. N.), Fondecyt-FONDAP Grant 15010006 (to C. H.), and Fondo Nacional de Desarrollo Cientifico y Tecnologico Grant FONDECYT 3080046 (to P. M.).	Aguirre P, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-3; ALFORD S, 1993, J PHYSIOL-LONDON, V469, P693, DOI 10.1113/jphysiol.1993.sp019838; Bailey CH, 2004, NEURON, V44, P49, DOI 10.1016/j.neuron.2004.09.017; Bardo S, 2006, TRENDS PHARMACOL SCI, V27, P78, DOI 10.1016/j.tips.2005.12.008; BICKEL H, 1960, EXPERIENTIA, V16, P129, DOI 10.1007/BF02157712; Bindokas VP, 1996, J NEUROSCI, V16, P1324; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brennan AM, 2009, NAT NEUROSCI, V12, P857, DOI 10.1038/nn.2334; Bull R, 2008, J NEUROSCI, V28, P9463, DOI 10.1523/JNEUROSCI.2286-08.2008; Bull R, 2007, AM J PHYSIOL-CELL PH, V293, pC162, DOI 10.1152/ajpcell.00518.2006; Carlson ES, 2007, HIPPOCAMPUS, V17, P679, DOI 10.1002/hipo.20307; Carlson ES, 2009, J NUTR, V139, P672, DOI 10.3945/jn.108.096354; Cheah JH, 2006, NEURON, V51, P431, DOI 10.1016/j.neuron.2006.07.011; Cullen PJ, 2002, NAT REV MOL CELL BIO, V3, P339, DOI 10.1038/nrm808; Donoso P, 2000, BIOPHYS J, V79, P279, DOI 10.1016/S0006-3495(00)76290-4; Emptage N, 1999, NEURON, V22, P115, DOI 10.1016/S0896-6273(00)80683-2; Epsztejn S, 1997, ANAL BIOCHEM, V248, P31, DOI 10.1006/abio.1997.2126; Fedulov V, 2007, J NEUROSCI, V27, P8031, DOI 10.1523/JNEUROSCI.2003-07.2007; Garrick MD, 2006, BIOL RES, V39, P79, DOI 10.4067/S0716-97602006000100009; Girouard H, 2009, J NEUROSCI, V29, P2545, DOI 10.1523/JNEUROSCI.0133-09.2009; Gruart A, 2006, J NEUROSCI, V26, P1077, DOI 10.1523/JNEUROSCI.2834-05.2006; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Haeger P, 2010, NEUROTOX RES, V17, P238, DOI 10.1007/s12640-009-9096-z; Halliwell B, 2006, PLANT PHYSIOL, V141, P312, DOI 10.1104/pp.106.077073; Halliwell B, 2009, FREE RADICAL BIO MED, V46, P531, DOI 10.1016/j.freeradbiomed.2008.11.008; Hanley JG, 2005, EMBO J, V24, P3266, DOI 10.1038/sj.emboj.7600801; Hetman M, 2006, CURR TOP MED CHEM, V6, P787, DOI 10.2174/156802606777057553; Hidalgo C, 2005, IUBMB LIFE, V57, P315, DOI 10.1080/15216540500092328; Hidalgo C, 2007, IUBMB LIFE, V59, P280, DOI 10.1080/15216540701222906; Hidalgo C, 2007, ANTIOXID REDOX SIGN, V9, P245, DOI 10.1089/ars.2007.9.245; Jorgenson LA, 2005, HIPPOCAMPUS, V15, P1094, DOI 10.1002/hipo.20128; Kahlert S, 2005, J NEUROSCI RES, V79, P262, DOI 10.1002/jnr.20322; KEBERLE H, 1964, ANN NY ACAD SCI, V119, P758; Kemmerling U, 2007, CELL CALCIUM, V41, P491, DOI 10.1016/j.ceca.2006.10.001; Kishida KT, 2007, ANTIOXID REDOX SIGN, V9, P233, DOI 10.1089/ars.2007.9.233; Kishida KT, 2005, J NEUROCHEM, V94, P299, DOI 10.1111/j.1471-4159.2005.03189.x; Krapivinsky G, 2003, NEURON, V40, P775, DOI 10.1016/S0896-6273(03)00645-7; Kruszewski M, 2004, ACTA BIOCHIM POL, V51, P471; Lauri SE, 2003, NEURON, V39, P327, DOI 10.1016/S0896-6273(03)00369-6; Lozoff B, 1996, J PEDIATR-US, V129, P382, DOI 10.1016/S0022-3476(96)70070-7; Lu YF, 2002, J NEUROPHYSIOL, V88, P1270, DOI 10.1152/jn.2002.88.3.1270; Maaroufi K, 2009, PHYSIOL BEHAV, V96, P343, DOI 10.1016/j.physbeh.2008.10.019; Marengo JJ, 1998, BIOPHYS J, V74, P1263, DOI 10.1016/S0006-3495(98)77840-3; Martell A.E., 1982, CRITICAL STABILITY C, V5, P604; McEchron MD, 2005, NUTR NEUROSCI, V8, P277, DOI 10.1080/10284150500499644; Munoz P, 2006, BIOL RES, V39, P189, DOI 10.4067/S0716-97602006000100021; Myhre O, 2003, BIOCHEM PHARMACOL, V65, P1575, DOI 10.1016/S0006-2952(03)00083-2; NEILANDS JB, 1995, J BIOL CHEM, V270, P26723, DOI 10.1074/jbc.270.45.26723; Nunez MT, 2004, FREE RADICAL BIO MED, V37, P953, DOI 10.1016/j.freeradbiomed.2004.06.005; Nunez MT, 2003, BIOMETALS, V16, P83, DOI 10.1023/A:1020743405347; Nunez-Millacura C, 2002, J NEUROCHEM, V82, P240, DOI 10.1046/j.1471-4159.2002.00971.x; OBENAUS A, 1989, NEUROSCI LETT, V98, P172, DOI 10.1016/0304-3940(89)90505-3; Patterson SL, 2001, NEURON, V32, P123, DOI 10.1016/S0896-6273(01)00443-3; Pelizzoni I, 2008, BIOCHEM SOC T, V36, P1309, DOI 10.1042/BST0361309; Ranade SC, 2008, NEUROSCIENCE, V152, P859, DOI 10.1016/j.neuroscience.2008.01.002; Satoh K, 2002, REDOX REP, V7, P219, DOI 10.1179/135100002125000587; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Symons M., 1998, FREE RADICALS IRON C; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Yamamoto T, 1997, BRAIN RES, V762, P240, DOI 10.1016/S0006-8993(97)00490-3; Youdim MBH, 2008, NEUROTOX RES, V14, P45, DOI 10.1007/BF03033574	62	85	86	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13382	13392		10.1074/jbc.M110.213785	http://dx.doi.org/10.1074/jbc.M110.213785			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21296883	Green Published, hybrid			2022-12-27	WOS:000289282200058
J	Quack, I; Woznowski, M; Potthoff, SA; Palmer, R; Konigshausen, E; Sivritas, S; Schiffer, M; Stegbauer, J; Vonend, O; Rump, LC; Sellin, L				Quack, Ivo; Woznowski, Magdalena; Potthoff, Sebastian A.; Palmer, Romy; Koenigshausen, Eva; Sivritas, Sema; Schiffer, Mario; Stegbauer, Johannes; Vonend, Oliver; Rump, Lars Christian; Sellin, Lorenz			PKC alpha Mediates beta-Arrestin2-dependent Nephrin Endocytosis in Hyperglycemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; EXPERIMENTAL DIABETIC-NEPHROPATHY; BETA-ARRESTINS; SLIT DIAPHRAGM; RECEPTOR; EXPRESSION; MECHANISMS; PODOCYTES; PICK1	Nephrin, the key molecule of the glomerular slit diaphragm, is expressed on the surface of podocytes and is critical in preventing albuminuria. In diabetes, hyperglycemia leads to the loss of surface expression of nephrin and causes albuminuria. Here, we report a mechanism that can explain this phenomenon: hyperglycemia directly enhances the rate of nephrin endocytosis via regulation of the beta-arrestin2-nephrin interaction by PKC alpha. We identified PKC alpha and protein interacting with c kinase-1 (PICK1) as nephrin-binding proteins. Hyperglycemia induced up-regulation of PKC alpha and led to the formation of a complex of nephrin, PKC alpha, PICK1, and beta-arrestin2 in vitro and in vivo. Binding of beta-arrestin2 to the nephrin intracellular domain depended on phosphorylation of nephrin threonine residues 1120 and 1125 by PKC alpha. Further, cellular knockdown of PKC alpha and/or PICK1 attenuated the nephrin beta-arrestin2 interaction and abrogated the amplifying effect of high blood glucose on nephrin endocytosis. In C57BL/6 mice, hyperglycemia over 24 h caused a significant increase in urinary albumin excretion, supporting the concept of the rapid impact of hyperglycemia on glomerular permselectivity. In summary, we have provided a molecular model of hyperglycemia-induced nephrin endocytosis and subsequent proteinuria and highlighted PKC alpha and PICK1 as promising therapeutic targets for diabetic nephropathy.	[Quack, Ivo; Woznowski, Magdalena; Potthoff, Sebastian A.; Palmer, Romy; Koenigshausen, Eva; Sivritas, Sema; Stegbauer, Johannes; Vonend, Oliver; Rump, Lars Christian; Sellin, Lorenz] Univ Dusseldorf, Dept Nephrol, D-40225 Dusseldorf, Germany; [Stegbauer, Johannes] Duke Univ, Div Nephrol, Durham, NC 27710 USA; [Schiffer, Mario] Hannover Med Sch, Dept Nephrol, D-30625 Hannover, Germany	Heinrich Heine University Dusseldorf; Duke University; Hannover Medical School	Quack, I (corresponding author), Univ Dusseldorf, Univ Hosp, Dept Nephrol, Moorenstr 5, D-40225 Dusseldorf, Germany.	ivo.quack@med.uni-duesseldorf.de	Schiffer, Mario/U-7050-2019; Stegbauer, Johannes/L-7461-2013	Schiffer, Mario/0000-0002-8414-1470; 	Deutsche Forschungsgemeinschaft [QU280/3-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by Deutsche Forschungsgemeinschaft Grant QU280/3-1 (to I. Q.).	Aaltonen P, 2001, LAB INVEST, V81, P1185, DOI 10.1038/labinvest.3780332; Axelsson J, 2010, AM J PHYSIOL-RENAL, V298, pF1306, DOI 10.1152/ajprenal.00710.2009; Boleti H, 1999, J CELL SCI, V112, P1487; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Doublier S, 2003, DIABETES, V52, P1023, DOI 10.2337/diabetes.52.4.1023; Garg P, 2007, MOL CELL BIOL, V27, P8698, DOI 10.1128/MCB.00948-07; Gerke P, 2003, J AM SOC NEPHROL, V14, P918, DOI 10.1097/01.ASN.0000057853.05686.89; Hanley JG, 2008, PHARMACOL THERAPEUT, V118, P152, DOI 10.1016/j.pharmthera.2008.02.002; Huber TB, 2005, CURR OPIN NEPHROL HY, V14, P211, DOI 10.1097/01.mnh.0000165885.85803.a8; Huber TB, 2001, J BIOL CHEM, V276, P41543, DOI 10.1074/jbc.C100452200; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Kalaitzidis R, 2009, J CLIN HYPERTENS, V11, P636, DOI 10.1111/j.1751-7176.2009.00184.x; Kim JH, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/11/115609; Koop K, 2003, J AM SOC NEPHROL, V14, P2063, DOI 10.1097/01.ASN.0000078803.53165.C9; Lorenz S, 2007, ENDOCRINOLOGY, V148, P2398, DOI 10.1210/en.2006-1035; Meier M, 2009, DIABETOLOGIA, V52, P765, DOI 10.1007/s00125-009-1278-y; Menne J, 2006, KIDNEY INT, V70, P1456, DOI 10.1038/sj.ki.5001830; Noh H, 2007, KIDNEY INT, V72, pS49, DOI 10.1038/sj.ki.5002386; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; Qin XS, 2009, J AM SOC NEPHROL, V20, P2534, DOI 10.1681/ASN.2009010011; Quack I, 2006, P NATL ACAD SCI USA, V103, P14110, DOI 10.1073/pnas.0602587103; Rossing Peter, 2006, Curr Diab Rep, V6, P479, DOI 10.1007/s11892-006-0083-y; Sellin L, 2002, FASEB J, V16, P115, DOI 10.1096/fj.02-0242fje; Shankland SJ, 2007, KIDNEY INT, V72, P26, DOI 10.1038/sj.ki.5002291; Sitek B, 2006, PROTEOMICS, V6, P4337, DOI 10.1002/pmic.200500739; Tossidou I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010185; Tossidou I, 2009, CELL PHYSIOL BIOCHEM, V24, P627, DOI 10.1159/000257518; Tryggvason K, 2006, NEW ENGL J MED, V354, P1387, DOI 10.1056/NEJMra052131; Welsh GI, 2010, J PATHOL, V220, P328, DOI 10.1002/path.2661; Williams ME, 2003, J NEUROSCI, V23, P11279; Wolfe BL, 2007, TRAFFIC, V8, P462, DOI 10.1111/j.1600-0854.2007.00551.x; Xiang B, 2001, J BIOL CHEM, V276, P4709, DOI 10.1074/jbc.M006187200; Xu JY, 2006, NEUROSIGNALS, V15, P190, DOI 10.1159/000098482; Ziyadeh FN, 2008, CURR DIABETES REV, V4, P39, DOI 10.2174/157339908783502370	34	71	77	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					12959	12970		10.1074/jbc.M110.204024	http://dx.doi.org/10.1074/jbc.M110.204024			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21321125	Green Published, hybrid			2022-12-27	WOS:000289282200016
J	Zhang, YT; Conrad, AH; Conrad, GW				Zhang, Yuntao; Conrad, Abigail H.; Conrad, Gary W.			Effects of Ultraviolet-A and Riboflavin on the Interaction of Collagen and Proteoglycans during Corneal Cross-linking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KERATAN SULFATE PROTEOGLYCAN; RELATIVE TISSUE EXPRESSION; CHONDROITIN SULFATE; MOLECULAR-CLONING; KERATOCAN; LUMICAN; GLYCOSAMINOGLYCAN; DIAMETER; DECORIN; MIMECAN	Corneal cross-linking using riboflavin and ultraviolet-A (RFUVA) is a clinical treatment targeting the stroma in progressive keratoconus. The stroma contains keratocan, lumican, mimecan, and decorin, core proteins of major proteoglycans (PGs) that bind collagen fibrils, playing important roles in stromal transparency. Here, a model reaction system using purified, non-glycosylated PG core proteins in solution in vitro has been compared with reactions inside an intact cornea, ex vivo, revealing effects of RFUVA on interactions between PGs and collagen cross-linking. Irradiation with UVA and riboflavin cross-links collagen alpha and beta chains into larger polymers. In addition, RFUVA cross-links PG core proteins, forming higher molecular weight polymers. When collagen type I is mixed with individual purified, non-glycosylated PG core proteins in solution in vitro and subjected to RFUVA, both keratocan and lumican strongly inhibit collagen cross-linking. However, mimecan and decorin do not inhibit but instead form cross-links with collagen, forming new high molecular weight polymers. In contrast, corneal glycosaminoglycans, keratan sulfate and chondroitin sulfate, in isolation from their core proteins, are not cross-linked by RFUVA and do not form cross-links with collagen. Significantly, when RFUVA is conducted on intact corneas e,x vivo, both keratocan and lumican, in their natively glycosylated form, do form cross-links with collagen. Thus, RFUVA causes cross-linking of collagen molecules among themselves and PG core proteins among themselves, together with limited linkages between collagen and keratocan, lumican, mimecan, and decorin. RFUVA as a diagnostic tool reveals that keratocan and lumican core proteins interact with collagen very differently than do mimecan and decorin.	[Zhang, Yuntao; Conrad, Abigail H.; Conrad, Gary W.] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA	Kansas State University	Zhang, YT (corresponding author), Kansas State Univ, Div Biol, Ackert Hall, Manhattan, KS 66506 USA.	ytz@ksu.edu			National Institutes of Health [R01EY000952]; Research Career Development Core (Brychta) in the Division of Biology at Kansas State University [GOBO000657]; National Science Foundation [0521 587]; Terry C. Johnson Center for Basal Cancer Research at Kansas State University; NATIONAL EYE INSTITUTE [R01EY000952] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Career Development Core (Brychta) in the Division of Biology at Kansas State University; National Science Foundation(National Science Foundation (NSF)); Terry C. Johnson Center for Basal Cancer Research at Kansas State University; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01EY000952 (to G. W. C.). This work was also supported by the Research Career Development Core (Brychta) in the Division of Biology at Kansas State University GOBO000657 (to G. W. C.), by National Science Foundation Major Research Instrumentation Program Grant 0521 587 (to Kansas State University), and by the Terry C. Johnson Center for Basal Cancer Research at Kansas State University.	Al-Aqaba MA, 2010, BRIT J OPHTHALMOL, V94, P784, DOI 10.1136/bjo.2009.173799; BEUERMAN RNV, 1996, Microsc Res Tech, V33, P335; BIANCO P, 1990, J HISTOCHEM CYTOCHEM, V38, P1549, DOI 10.1177/38.11.2212616; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Carlson EC, 2005, J BIOL CHEM, V280, P25541, DOI 10.1074/jbc.M500249200; Chen R, 2009, J PROTEOME RES, V8, P651, DOI 10.1021/pr8008012; Christiansen DL, 2000, MATRIX BIOL, V19, P409, DOI 10.1016/S0945-053X(00)00089-5; Conrad AH, 2010, INVEST OPHTH VIS SCI, V51, P4500, DOI 10.1167/iovs.09-4914; CONRAD GW, 1982, J BIOL CHEM, V257, P464; Corpuz LM, 1996, J BIOL CHEM, V271, P9759, DOI 10.1074/jbc.271.16.9759; Corpuz LM, 2000, MATRIX BIOL, V19, P699, DOI 10.1016/S0945-053X(00)00117-7; Corpuz LM, 2000, MATRIX BIOL, V19, P693, DOI 10.1016/S0945-053X(00)00116-5; de La Rochette A, 2003, BBA-GEN SUBJECTS, V1621, P235, DOI 10.1016/S0304-4165(03)00072-2; Dhaliwal JS, 2009, CORNEA, V28, P62, DOI 10.1097/ICO.0b013e31818225c3; Dunlevy JR, 1998, J BIOL CHEM, V273, P9615, DOI 10.1074/jbc.273.16.9615; Edrington T B, 1995, Optom Clin, V4, P65; EPSTEIN EH, 1971, J BIOL CHEM, V246, P1718; Ertan A, 2007, J CATARACT REFR SURG, V33, P1303, DOI 10.1016/j.jcrs.2007.02.048; Funderburgh JL, 2000, GLYCOBIOLOGY, V10, P951, DOI 10.1093/glycob/10.10.951; FUNDERBURGH JL, 1991, BIOCHEM SOC T, V19, P871, DOI 10.1042/bst0190871; FUNDERBURGH JL, 1993, J BIOL CHEM, V268, P11874; Funderburgh JL, 1997, J BIOL CHEM, V272, P28089, DOI 10.1074/jbc.272.44.28089; Garcia-Lledo Magdalena, 2006, Compr Ophthalmol Update, V7, P47; Hassell JR, 2010, EXP EYE RES, V91, P326, DOI 10.1016/j.exer.2010.06.021; HAY ED, 1985, J CELL BIOCHEM, V27, P143, DOI 10.1002/jcb.240270208; Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843; ISEMURA M, 1975, BIOCHIM BIOPHYS ACTA, V411, P11, DOI 10.1016/0304-4165(75)90280-9; Kampik D, 2010, INVEST OPHTH VIS SCI, V51, P3929, DOI 10.1167/iovs.09-4524; Kao WWY, 2006, EXP EYE RES, V82, P3, DOI 10.1016/j.exer.2005.08.012; Kao WWY, 2002, GLYCOCONJUGATE J, V19, P275, DOI 10.1023/A:1025396316169; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; KOHLHAAS M, 2004, J CATARACT REFR SURG, V32, P279; KRISHNA CM, 1991, PHOTOCHEM PHOTOBIOL, V54, P51, DOI 10.1111/j.1751-1097.1991.tb01984.x; LI W, 1992, ARCH BIOCHEM BIOPHYS, V296, P190, DOI 10.1016/0003-9861(92)90562-B; Makareeva E, 2008, J BIOL CHEM, V283, P4787, DOI 10.1074/jbc.M705773200; Marfurt CF, 2010, EXP EYE RES, V90, P478, DOI 10.1016/j.exer.2009.12.010; McCall AS, 2010, INVEST OPHTH VIS SCI, V51, P129, DOI 10.1167/iovs.09-3738; Meek KM, 2003, MATRIX BIOL, V22, P467, DOI 10.1016/S0945-053X(03)00081-7; Mencucci R, 2010, CLIN EXP OPHTHALMOL, V38, P49, DOI 10.1111/j.1442-9071.2010.02207.x; Muller L, 1996, INVEST OPHTH VIS SCI, V37, P476; NEWSOME DA, 1982, INVEST OPHTH VIS SCI, V22, P376; PARRY DAD, 1988, BIOPHYS CHEM, V29, P195, DOI 10.1016/0301-4622(88)87039-X; Pramanik S, 2006, OPHTHALMOLOGY, V113, P1633, DOI 10.1016/j.ophtha.2006.02.058; Robert L, 2001, PATHOL BIOL, V49, P353, DOI 10.1016/S0369-8114(01)00144-4; Romero-Jimenez M, 2010, CONTACT LENS ANTERIO, V33, P157, DOI 10.1016/j.clae.2010.04.006; RUOSLAHTI E, 1980, BIOCHIM BIOPHYS ACTA, V631, P350, DOI 10.1016/0304-4165(80)90308-6; Schilde T, 2008, OPHTHALMOLOGE, V105, P165, DOI 10.1007/s00347-007-1587-9; SCOTT JE, 1991, BIOCHEM SOC T, V19, P877, DOI 10.1042/bst0190877; Seiler T, 2006, CORNEA, V25, P1057, DOI 10.1097/01.ico.0000225720.38748.58; Snibson GR, 2010, CLIN EXP OPHTHALMOL, V38, P141, DOI 10.1111/j.1442-9071.2010.02228.x; SPIRO RC, 1991, J CELL BIOL, V115, P1463, DOI 10.1083/jcb.115.5.1463; Spoerl E, 2004, CURR EYE RES, V29, P35, DOI 10.1080/02713680490513182; Spoerl E, 2004, OPHTHALMOLOGICA, V218, P136, DOI 10.1159/000076150; Sung HW, 2003, J BIOMED MATER RES A, V64A, P427, DOI 10.1002/jbm.a.10346; Tan DT, 2007, CURR OPIN OPHTHALMOL, V18, P284; Wollensak G, 2004, J CATARACT REFR SURG, V30, P689, DOI 10.1016/j.jcrs.2003.11.032; Wollensak G, 2004, CORNEA, V23, P503, DOI 10.1097/01.ico.0000105827.85025.7f; Wollensak G, 2003, OPHTHALMIC RES, V35, P324, DOI 10.1159/000074071; Wollensak G, 2003, OPHTHALMOLOGE, V100, P44, DOI 10.1007/s00347-002-0700-3; Wollensak G, 2003, J CATARACT REFR SURG, V29, P1780, DOI 10.1016/S0886-3350(03)00407-3; Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1; Wollensak G, 2009, J CATARACT REFR SURG, V35, P540, DOI 10.1016/j.jcrs.2008.11.036; WORTHINGTON CR, 1984, Q REV BIOPHYS, V17, P423, DOI 10.1017/S003358350000487X; Zhang Y, 2005, ANAL CHEM, V77, P902, DOI 10.1021/ac040074j; Zhang YT, 2005, INVEST OPHTH VIS SCI, V46, P1604, DOI 10.1167/iovs.04-1453	65	125	141	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13011	13022		10.1074/jbc.M110.169813	http://dx.doi.org/10.1074/jbc.M110.169813			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21335557	hybrid, Green Published			2022-12-27	WOS:000289282200021
J	Bray, MS; Young, ME				Bray, Molly S.; Young, Martin E.			Regulation of Fatty Acid Metabolism by Cell Autonomous Circadian Clocks: Time to Fatten up on Information?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CONTROLS LIPID-METABOLISM; GENE-EXPRESSION; CONTRACTILE FUNCTION; DIURNAL REGULATION; ENERGY-METABOLISM; NUCLEAR RECEPTOR; DIETARY-FAT; RHYTHMS; MICE; TRIGLYCERIDE	Molecular, cellular, and animal-based studies have recently exposed circadian clocks as critical regulators of energy balance. Invariably, mouse models of genetically manipulated circadian clock components display features indicative of altered lipid/fatty acid metabolism, including differential adiposity and circulating lipids. The purpose of this minireview is to provide a comprehensive summary of current knowledge regarding the regulation of fatty acid metabolism by distinct cell autonomous circadian clocks. The implications of these recent findings for cardiometabolic disease and human health are discussed.	[Young, Martin E.] Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, Birmingham, AL 35294 USA; [Bray, Molly S.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Young, ME (corresponding author), Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, Birmingham, AL 35294 USA.	meyoung@uab.edu			National Institutes of Health from NHLBI [HL-074259]; Kraft Foods Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074259] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Kraft Foods Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-074259 from NHLBI (to M. E. Y.). This work was also supported by Kraft Foods Inc. (to M. S. B. and M. E. Y.). This minireview will be reprinted in the 2011 Minireview Compendium, which will be available in January, 2012.	Allaman-Pillet N, 2004, MOL CELL ENDOCRINOL, V226, P59, DOI 10.1016/j.mce.2004.06.001; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bray MS, 2010, INT J OBESITY, V34, P1589, DOI 10.1038/ijo.2010.63; Bray MS, 2009, OBES REV, V10, P6, DOI 10.1111/j.1467-789X.2009.00684.x; Bray MS, 2008, AM J PHYSIOL-HEART C, V294, pH1036, DOI 10.1152/ajpheart.01291.2007; Bunger MK, 2005, GENESIS, V41, P122, DOI 10.1002/gene.20102; Duez H, 2009, J APPL PHYSIOL, V107, P1972, DOI 10.1152/japplphysiol.00570.2009; Durgan DJ, 2007, AM J PHYSIOL-HEART C, V293, pH2385, DOI 10.1152/ajpheart.01361.2006; Durgan DJ, 2006, J BIOL CHEM, V281, P24254, DOI 10.1074/jbc.M601704200; Edery I, 2000, PHYSIOL GENOMICS, V3, P59, DOI 10.1152/physiolgenomics.2000.3.2.59; EDWARDS PA, 1972, J LIPID RES, V13, P396; Escobar C, 1998, AM J PHYSIOL-REG I, V274, pR1309, DOI 10.1152/ajpregu.1998.274.5.R1309; Garbarino-Pico E, 2005, NEUROCHEM INT, V47, P260, DOI 10.1016/j.neuint.2005.04.024; Garbarino-Pico E, 2004, J NEUROSCI RES, V76, P642, DOI 10.1002/jnr.20126; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gimble JM, 2009, J APPL PHYSIOL, V107, P1629, DOI 10.1152/japplphysiol.00090.2009; Goodwin GW, 1998, J BIOL CHEM, V273, P29530, DOI 10.1074/jbc.273.45.29530; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Green CB, 2007, P NATL ACAD SCI USA, V104, P9888, DOI 10.1073/pnas.0702448104; Grimaldi B, 2010, CELL METAB, V12, P509, DOI 10.1016/j.cmet.2010.10.005; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; HEMS DA, 1975, BIOCHEM J, V150, P167, DOI 10.1042/bj1500167; Hirsch E, 2007, J ENDOCRINOL, V194, P243, DOI 10.1677/JOE-07-0097; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Hussain MM, 2009, TRENDS ENDOCRIN MET, V20, P177, DOI 10.1016/j.tem.2009.01.001; IRVINE RF, 2002, SCI STKE, pRE13; Kennaway DJ, 2007, AM J PHYSIOL-REG I, V293, pR1528, DOI 10.1152/ajpregu.00018.2007; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Lau P, 2008, J BIOL CHEM, V283, P18411, DOI 10.1074/jbc.M710526200; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Marquez S, 2004, FASEB J, V18, P519, DOI 10.1096/fj.03-0417fje; Martino T, 2004, J MOL MED, V82, P256, DOI 10.1007/s00109-003-0520-1; McCarthy JJ, 2007, PHYSIOL GENOMICS, V31, P86, DOI 10.1152/physiolgenomics.00066.2007; McGavock JM, 2007, CIRCULATION, V116, P1170, DOI 10.1161/CIRCULATIONAHA.106.645614; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Oishi K, 2006, FEBS LETT, V580, P127, DOI 10.1016/j.febslet.2005.11.063; OUAGUED M, 1980, J NUTR, V110, P2302, DOI 10.1093/jn/110.11.2302; Pan XY, 2007, J BIOL CHEM, V282, P24707, DOI 10.1074/jbc.M701305200; Pan XY, 2010, CELL METAB, V12, P174, DOI 10.1016/j.cmet.2010.05.014; Pan XY, 2009, J LIPID RES, V50, P1800, DOI 10.1194/jlr.M900085-JLR200; Ptitsyn AA, 2011, ANN MED, V43, P1, DOI 10.3109/07853890.2010.538078; Reddy AB, 2006, CURR BIOL, V16, P1107, DOI 10.1016/j.cub.2006.04.026; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Rudic RD, 2005, CIRCULATION, V112, P2716, DOI 10.1161/CIRCULATIONAHA.105.568626; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Sadacca LA, 2011, DIABETOLOGIA, V54, P120, DOI 10.1007/s00125-010-1920-8; Sahar S, 2009, NAT REV CANCER, V9, P886, DOI 10.1038/nrc2747; Scheving LA, 2000, GASTROENTEROLOGY, V119, P536, DOI 10.1053/gast.2000.9305; SCHLIERF G, 1973, J CLIN INVEST, V52, P732, DOI 10.1172/JCI107235; Sharma S, 2004, FASEB J, V18, P1692, DOI 10.1096/fj.04-2263com; Shimba S, 2005, P NATL ACAD SCI USA, V102, P12071, DOI 10.1073/pnas.0502383102; Sinclair AJ, 2002, LIPIDS, V37, P1113, DOI 10.1007/s11745-002-1008-x; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Sonoda J, 2007, P NATL ACAD SCI USA, V104, P5223, DOI 10.1073/pnas.0611623104; Stavinoha MA, 2004, AM J PHYSIOL-ENDOC M, V287, pE878, DOI 10.1152/ajpendo.00189.2004; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Tsai JY, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.077800; Tsutsumi K, 2002, BIOL PHARM BULL, V25, P1360, DOI 10.1248/bpb.25.1360; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Vieira E, 2008, AM J PHYSIOL-ENDOC M, V295, pE1032, DOI 10.1152/ajpendo.90510.2008; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Wang NN, 2008, CELL METAB, V8, P482, DOI 10.1016/j.cmet.2008.10.009; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Zhang EE, 2010, NAT MED, V16, P1152, DOI 10.1038/nm.2214	68	38	39	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.R110.214643	http://dx.doi.org/10.1074/jbc.R110.214643			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21296875	Green Published, hybrid			2022-12-27	WOS:000289077500001
J	Qian, YJ; Jung, YS; Chen, XB				Qian, Yingjuan; Jung, Yong-Sam; Chen, Xinbin			Delta Np63, a Target of DEC1 and Histone Deacetylase 2, Modulates the Efficacy of Histone Deacetylase Inhibitors in Growth Suppression and Keratinocyte Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE ARREST; P53 FAMILY; TRANSCRIPTION FACTOR; PROXIMAL PROMOTER; CANCER CELLS; C-TERMINUS; E-BOX; P63; EXPRESSION; STRA13	The p63 gene, a member of the p53 family, is expressed as TA and Delta N isoforms. Delta Np63 is the predominant isoform expressed in cells of epithelial origin and frequently overexpressed in cancers. However, what regulates p63 expression is uncertain. Here, we showed that Delta Np63 is regulated by the transcription factor DEC1, a p53 family target. We also showed that the ability of DEC1 to regulate Delta Np63 is enhanced by histone deacetylase (HDAC) inhibitors or knockdown of histone deacetylase 2 (HDAC2). Consistent with this, we found that DEC1 and HDAC2 physically interact and knockdown of HDAC2 leads to increased binding of DEC1 to the Delta Np63 promoter. Interestingly, we found that growth suppression induced by HDAC inhibitors is attenuated by ectopic expression of DEC1 in a Delta Np63-dependent manner. In addition, we showed that ectopic expression of DEC1 inhibits, whereas knockdown of DEC1 promotes, keratinocyte differentiation via modulating Delta Np63 expression. Finally, we showed that DEC1 cooperates with HDAC inhibitors to further decrease keratinocyte differentiation. Together, we conclude that Delta Np63 is a novel target of DEC1 and HDAC2 and modulates the efficacy of HDAC inhibitors in growth suppression and keratinocyte differentiation.	[Qian, Yingjuan; Jung, Yong-Sam; Chen, Xinbin] Univ Calif Davis, Comparat Oncol Lab, Davis, CA 95616 USA	University of California System; University of California Davis	Chen, XB (corresponding author), Univ Calif Davis, Comparat Oncol Lab, Davis, CA 95616 USA.	xbchen@ucdavis.edu			National Institutes of Health [CA102188]; NATIONAL CANCER INSTITUTE [R01CA102188] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA102188.	Boudjelal M, 1997, GENE DEV, V11, P2052, DOI 10.1101/gad.11.16.2052; Candi E, 2007, CELL CYCLE, V6, P274, DOI 10.4161/cc.6.3.3797; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Chakrabarti J, 2004, BRIT J CANCER, V91, P954, DOI 10.1038/sj.bjc.6602059; Crum CP, 2010, ANNU REV PATHOL-MECH, V5, P349, DOI 10.1146/annurev-pathol-121808-102117; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Deyrieux AF, 2007, CYTOTECHNOLOGY, V54, P77, DOI 10.1007/s10616-007-9076-1; Dohn M, 2001, ONCOGENE, V20, P3193, DOI 10.1038/sj.onc.1204427; Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Guo XC, 2009, NAT CELL BIOL, V11, P1451, DOI 10.1038/ncb1988; Hagiwara K, 1999, CANCER RES, V59, P4165; Hahn CK, 2008, P NATL ACAD SCI USA, V105, P9751, DOI 10.1073/pnas.0710413105; Harms KL, 2005, MOL CELL BIOL, V25, P2014, DOI 10.1128/MCB.25.5.2014-2030.2005; Helton ES, 2006, J BIOL CHEM, V281, P2533, DOI 10.1074/jbc.M507964200; Hibi K, 2000, P NATL ACAD SCI USA, V97, P5462, DOI 10.1073/pnas.97.10.5462; Ivanova AV, 2001, J BIOL CHEM, V276, P15306, DOI 10.1074/jbc.M010516200; King KE, 2003, ONCOGENE, V22, P3635, DOI 10.1038/sj.onc.1206536; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Ladd PA, 2003, J BIOL CHEM, V278, P35184, DOI 10.1074/jbc.M301666200; Li Y, 2006, ONCOGENE, V25, P3296, DOI 10.1038/sj.onc.1209363; Li YX, 2003, J BIOL CHEM, V278, P16899, DOI 10.1074/jbc.M300596200; Li YX, 2002, BIOCHEM J, V367, P413, DOI 10.1042/BJ20020514; Liu G, 2005, J BIOL CHEM, V280, P20111, DOI 10.1074/jbc.M413889200; Liu G, 2003, J BIOL CHEM, V278, P17557, DOI 10.1074/jbc.M210696200; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Mangiulli M, 2009, NUCLEIC ACIDS RES, V37, P6092, DOI 10.1093/nar/gkp674; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Muscolini M, 2008, MOL CANCER THER, V7, P1410, DOI 10.1158/1535-7163.MCT-08-0299; Ocker M, 2007, INT J BIOCHEM CELL B, V39, P1367, DOI 10.1016/j.biocel.2007.03.001; PILLAI S, 1992, J CELL PHYSIOL, V151, P623, DOI 10.1002/jcp.1041510323; Qian YJ, 2008, J BIOL CHEM, V283, P22410, DOI 10.1074/jbc.M800643200; Qian YJ, 2008, J BIOL CHEM, V283, P2896, DOI 10.1074/jbc.M708624200; Roy S, 2005, CELL DEATH DIFFER, V12, P482, DOI 10.1038/sj.cdd.4401581; Sabbisetti V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005877; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Shao YF, 2004, P NATL ACAD SCI USA, V101, P18030, DOI 10.1073/pnas.0408345102; Shen M, 2002, J BIOL CHEM, V277, P50112, DOI 10.1074/jbc.M206771200; St-Pierre B, 2004, DEV DYNAM, V230, P124, DOI 10.1002/dvdy.20013; St-Pierre B, 2002, J BIOL CHEM, V277, P46544, DOI 10.1074/jbc.M111652200; Su XH, 2009, CELL STEM CELL, V5, P64, DOI 10.1016/j.stem.2009.04.003; Sun H, 2000, P NATL ACAD SCI USA, V97, P4058, DOI 10.1073/pnas.070526297; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Turley H, 2004, J PATHOL, V203, P808, DOI 10.1002/path.1585; Yamada K, 2005, FRONT BIOSCI-LANDMRK, V10, P3151, DOI 10.2741/1772; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Yun Z, 2002, DEV CELL, V2, P331, DOI 10.1016/S1534-5807(02)00131-4; Zawel L, 2002, P NATL ACAD SCI USA, V99, P2848, DOI 10.1073/pnas.261714999; Zhang J, 2010, P NATL ACAD SCI USA, V107, P9614, DOI 10.1073/pnas.0912594107	52	22	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.207241	http://dx.doi.org/10.1074/jbc.M110.207241			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21317427	hybrid, Green Published			2022-12-27	WOS:000289077500017
J	Cha, J; Yuan, HY; Liu, Y				Cha, Joonseok; Yuan, Haiyan; Liu, Yi			Regulation of the Activity and Cellular Localization of the Circadian Clock Protein FRQ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIOD PROTEIN; NEUROSPORA CLOCK; FREQUENCY DETERMINES; NUCLEAR-LOCALIZATION; LIGHT RESPONSES; FEEDBACK LOOP; DOUBLE-TIME; PHOSPHORYLATION; DROSOPHILA; TRANSCRIPTION	Eukaryotic circadian clocks employ autoregulatory negative feedback loops to control daily rhythms. In the filamentous fungus Neurospora, FRQ, FRH, WC-1, and WC-2 are the core components of the circadian negative feedback loop. To close the transcription-based negative feedback loop, the FRQ-FRH complex inhibits the activity of the WC complex in the nucleus by promoting the casein kinases-mediated WC phosphorylation. Despite its essential role in the nucleus, most FRQ is found in the cytoplasm. In this study, we mapped the FRQ regions that are important for its cellular localization. We show that the C-terminal part of FRQ, particularly the FRQ-FRH interaction domain, plays a major role in controlling FRQ localization. Both the mutation of the FRQ-FRH interaction domain and the down-regulation of FRH result in the nuclear enrichment of FRQ, suggesting that FRH regulates FRQ localization via a physical interaction. To study the role of FRQ phosphorylation, we examined the FRQ localization in wild-type as well as an array of FRQ kinase, FRQ phosphatase, and FRQ phosphorylation site mutants. Collectively, our results suggest that FRQ phosphorylation does not play a significant role in regulating its cellular localization. Instead, we find that phosphorylation of FRQ inhibits its transcriptional repressor activity in the circadian negative feedback loop. Such an effect is achieved by inhibiting the ability of FRQ to interact with WCC and casein kinase 1a. Our results indicate that the rhythmic FRQ phosphorylation profile observed is an important part of the negative feedback mechanism that drives robust circadian gene expression.	[Cha, Joonseok; Yuan, Haiyan; Liu, Yi] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Liu, Y (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, ND13-214A,5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Yi.Liu@UTsouthwestern.edu	Cha, Joonseok/AAE-9918-2020	Cha, Joonseok/0000-0001-9362-5285	National Institutes of Health [GM068496, GM062591]; Welch Foundation [I-1560]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068496, R01GM062591] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by a National Institutes of Health Grants GM068496 and GM062591. This work was also supported by the Welch Foundation (I-1560) (to Y. L.).	Allada R, 2001, ANNU REV NEUROSCI, V24, P1091, DOI 10.1146/annurev.neuro.24.1.1091; ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; Baker CL, 2009, MOL CELL, V34, P354, DOI 10.1016/j.molcel.2009.04.023; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Cha J, 2007, COLD SPRING HARB SYM, V72, P185, DOI 10.1101/sqb.2007.72.010; Cha J, 2008, EMBO J, V27, P3246, DOI 10.1038/emboj.2008.245; Cheng P, 2005, GENE DEV, V19, P234, DOI 10.1101/gad.1266805; Cheng P, 2002, MOL CELL BIOL, V22, P517, DOI 10.1128/MCB.22.2.517-524.2002; Cheng P, 2001, P NATL ACAD SCI USA, V98, P7408, DOI 10.1073/pnas.121170298; Cheng P, 2001, EMBO J, V20, P101, DOI 10.1093/emboj/20.1.101; Choudhary S, 2007, MOL CELL BIOL, V27, P3995, DOI 10.1128/MCB.00186-07; Crosthwaite SK, 1997, SCIENCE, V276, P763, DOI 10.1126/science.276.5313.763; Cyran SA, 2005, J NEUROSCI, V25, P5430, DOI 10.1523/JNEUROSCI.0263-05.2005; Denault DL, 2001, EMBO J, V20, P109, DOI 10.1093/emboj/20.1.109; Diernfellner ACR, 2009, GENE DEV, V23, P2192, DOI 10.1101/gad.538209; Dunlap JC, 2006, J BIOL CHEM, V281, P28489, DOI 10.1074/jbc.R600018200; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Froehlich AC, 2003, P NATL ACAD SCI USA, V100, P5914, DOI 10.1073/pnas.1030057100; Garceau NY, 1997, CELL, V89, P469, DOI 10.1016/S0092-8674(00)80227-5; Gorl M, 2001, EMBO J, V20, P7074, DOI 10.1093/emboj/20.24.7074; Guo JH, 2010, J BIOL CHEM, V285, P11508, DOI 10.1074/jbc.M109.071688; Guo JH, 2009, CELL, V138, P1236, DOI 10.1016/j.cell.2009.06.043; He Q, 2005, GENE DEV, V19, P1518, DOI 10.1101/gad.1322205; He Q, 2003, EMBO J, V22, P4421, DOI 10.1093/emboj/cdg425; He Q, 2006, GENE DEV, V20, P2552, DOI 10.1101/gad.1463506; He QY, 2005, GENE DEV, V19, P2888, DOI 10.1101/gad.1369605; He QY, 2005, J BIOL CHEM, V280, P17526, DOI 10.1074/jbc.M414010200; Heintzen C, 2007, ADV GENET, V58, P25, DOI 10.1016/S0065-2660(06)58002-2; Hong CI, 2008, GENE DEV, V22, P3196, DOI 10.1101/gad.1706908; Huang GC, 2007, GENE DEV, V21, P3283, DOI 10.1101/gad.1610207; Lin JM, 2002, NATURE, V420, P816, DOI 10.1038/nature01235; Liu Y, 2000, P NATL ACAD SCI USA, V97, P234, DOI 10.1073/pnas.97.1.234; Liu Y, 1997, CELL, V89, P477, DOI 10.1016/S0092-8674(00)80228-7; Liu Y, 2006, EUKARYOT CELL, V5, P1184, DOI 10.1128/EC.00133-06; Luo CH, 1998, EMBO J, V17, P1228, DOI 10.1093/emboj/17.5.1228; Mehra A, 2009, CELL, V137, P749, DOI 10.1016/j.cell.2009.03.019; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; PRICE JL, 1995, EMBO J, V14, P4044, DOI 10.1002/j.1460-2075.1995.tb00075.x; Sathyanarayanan S, 2004, CELL, V116, P603, DOI 10.1016/S0092-8674(04)00128-X; Schafmeier T, 2005, CELL, V122, P235, DOI 10.1016/j.cell.2005.05.032; Schafmeier T, 2008, GENE DEV, V22, P3397, DOI 10.1101/gad.507408; Shafer OT, 2002, J NEUROSCI, V22, P5946; Shi M, 2010, GENETICS, V184, P351, DOI 10.1534/genetics.109.111393; Tang CT, 2009, P NATL ACAD SCI USA, V106, P10722, DOI 10.1073/pnas.0904898106; Vitalini MW, 2004, GENETICS, V167, P119, DOI 10.1534/genetics.167.1.119; VOSSHALL LB, 1994, SCIENCE, V263, P1606, DOI 10.1126/science.8128247; Yang YH, 2004, GENE DEV, V18, P255, DOI 10.1101/gad.1152604; Yang YH, 2003, MOL CELL BIOL, V23, P6221, DOI 10.1128/MCB.23.17.6221-6228.2003; Yang YH, 2002, GENE DEV, V16, P994, DOI 10.1101/gad.965102; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Yu WJ, 2006, J CELL SCI, V119, P4793, DOI 10.1242/jcs.03174	51	27	27	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11469	11478		10.1074/jbc.M111.219782	http://dx.doi.org/10.1074/jbc.M111.219782			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21300798	Green Published, hybrid			2022-12-27	WOS:000288797100058
J	Wang, HX; Song, PP; Du, L; Tian, WL; Yue, W; Liu, M; Li, DW; Wang, B; Zhu, YS; Cao, C; Zhou, J; Chen, QA				Wang, Hongxia; Song, Pingping; Du, Lei; Tian, Weili; Yue, Wen; Liu, Min; Li, Dengwen; Wang, Bin; Zhu, Yushan; Cao, Cheng; Zhou, Jun; Chen, Quan			Parkin Ubiquitinates Drp1 for Proteasome-dependent Degradation IMPLICATION OF DYSREGULATED MITOCHONDRIAL DYNAMICS IN PARKINSON DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR PATHWAYS; JUVENILE PARKINSONISM; PINK1/PARKIN PATHWAY; PROTEIN-DEGRADATION; OXIDATIVE STRESS; FISSION; PINK1; NEURODEGENERATION; MORPHOLOGY; DROSOPHILA	Mutations in Parkin, an E3 ubiquitin ligase that regulates protein turnover, represent one of the major causes of familial Parkinson disease, a neurodegenerative disorder characterized by the loss of dopaminergic neurons and impaired mitochondrial functions. The underlying mechanism by which pathogenic Parkin mutations induce mitochondrial abnormality is not fully understood. Here, we demonstrate that Parkin interacts with and subsequently ubiquitinates dynamin-related protein 1 (Drp1), for promoting its proteasome-dependent degradation. Pathogenic mutation or knockdown of Parkin inhibits the ubiquitination and degradation of Drp1, leading to an increased level of Drp1 for mitochondrial fragmentation. These results identify Drp1 as a novel substrate of Parkin and suggest a potential mechanism linking abnormal Parkin expression to mitochondrial dysfunction in the pathogenesis of Parkinson disease.	[Zhou, Jun; Chen, Quan] Nankai Univ, Coll Life Sci, Dept Genet & Cell Biol, Tianjin 300071, Peoples R China; [Zhou, Jun; Chen, Quan] Nankai Univ, Coll Life Sci, Tianjin Key Lab Prot Sci, Tianjin 300071, Peoples R China; [Du, Lei; Yue, Wen; Wang, Bin; Chen, Quan] Chinese Acad Sci, Natl Key Lab Biomembrane & Membrane Biotechnol, Inst Zool, Beijing 100101, Peoples R China; [Cao, Cheng] Beijing Inst Biotechnol, Beijing 100850, Peoples R China	Nankai University; Nankai University; Chinese Academy of Sciences; Institute of Zoology, CAS	Zhou, J (corresponding author), Nankai Univ, Coll Life Sci, Dept Genet & Cell Biol, Tianjin 300071, Peoples R China.	junzhou@nankai.edu.cn; chenquan@nankai.edu.cn	Zhou, Jun/D-4654-2017; Wang, Hongxia/D-8812-2014	Zhou, Jun/0000-0001-7858-8260; Chen, Quan/0000-0001-7539-8728	National Natural Science Foundation of China [2006CB910102, 2010CB912200, 30825022, 30630038]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Key Project Grant 30630038 and 973 Program Grants 2006CB910102 and 2010CB912200 from the National Natural Science Foundation of China (to Q. C.) and Grant 30825022 from the National Natural Science Foundation of China (to J. Z.).	Biskup S, 2008, J NEUROL, V255, P8, DOI 10.1007/s00415-008-5005-2; Bossy-Wetzel E, 2004, NAT MED, V10, pS2, DOI 10.1038/nm1067; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Corti O, 2003, HUM MOL GENET, V12, P1427, DOI 10.1093/hmg/ddg159; Cui M, 2010, J BIOL CHEM, V285, P11740, DOI 10.1074/jbc.M109.066662; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Dawson TM, 2007, PARKINSONISM RELAT D, V13, pS248, DOI 10.1016/S1353-8020(08)70010-5; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Dev KK, 2003, NEUROPHARMACOLOGY, V45, P1, DOI 10.1016/S0028-3908(02)00337-4; Farrer MJ, 2006, NAT REV GENET, V7, P306, DOI 10.1038/nrg1831; Ferrer I, 2009, PROG NEUROBIOL, V88, P89, DOI 10.1016/j.pneurobio.2009.02.004; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Giasson BI, 2001, NEURON, V31, P885, DOI 10.1016/S0896-6273(01)00439-1; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Ishikawa A, 1996, NEUROLOGY, V47, P160, DOI 10.1212/WNL.47.1.160; Kahle PJ, 2004, EMBO REP, V5, P681, DOI 10.1038/sj.embor.7400188; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Ko HS, 2006, J BIOL CHEM, V281, P16193, DOI 10.1074/jbc.C600041200; Ko HS, 2005, J NEUROSCI, V25, P7968, DOI 10.1523/JNEUROSCI.2172-05.2005; Kuroda Y, 2006, HUM MOL GENET, V15, P883, DOI 10.1093/hmg/ddl006; Lesage S, 2009, HUM MOL GENET, V18, pR48, DOI 10.1093/hmg/ddp012; Li H, 2009, J CLIN INVEST, V119, P442, DOI 10.1172/JCI38619; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774; Marin I., 2004, PHYSIOL GENOMICS, V17, P253; Mata IF, 2004, HUM MOL GENET, V13, pR127, DOI 10.1093/hmg/ddh089; Nakamura N, 2006, EMBO REP, V7, P1019, DOI 10.1038/sj.embor.7400790; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Orth M, 2001, AM J MED GENET, V106, P27, DOI 10.1002/ajmg.1425; Park J, 2009, BIOCHEM BIOPH RES CO, V378, P518, DOI 10.1016/j.bbrc.2008.11.086; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; Schon EA, 2003, J CLIN INVEST, V111, P303, DOI 10.1172/JCI200317741; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Sugioka R, 2004, J BIOL CHEM, V279, P52726, DOI 10.1074/jbc.M408910200; Tanaka K, 2004, BBA-MOL CELL RES, V1695, P235, DOI 10.1016/j.bbamcr.2004.09.026; Thomas B, 2007, HUM MOL GENET, V16, pR183, DOI 10.1093/hmg/ddm159; Van Laar VS, 2009, EXP NEUROL, V218, P247, DOI 10.1016/j.expneurol.2009.03.019; Wells RC, 2007, J BIOL CHEM, V282, P33769, DOI 10.1074/jbc.M700807200; Whitworth AJ, 2009, J BIOENERG BIOMEMBR, V41, P499, DOI 10.1007/s10863-009-9253-3; Xiong H, 2009, J CLIN INVEST, V119, P650, DOI 10.1172/JCI37617; Yaffe MP, 1999, NAT CELL BIOL, V1, pE149, DOI 10.1038/14101; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Zhu PP, 2004, J BIOL CHEM, V279, P35967, DOI 10.1074/jbc.M404105200; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	56	257	266	1	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11649	11658		10.1074/jbc.M110.144238	http://dx.doi.org/10.1074/jbc.M110.144238			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21292769	Green Published, hybrid			2022-12-27	WOS:000288797100073
J	Pellissier, LP; Barthet, G; Gaven, F; Cassier, E; Trinquet, E; Pin, JP; Marin, P; Dumuis, A; Bockaert, J; Baneres, JL; Claeysen, S				Pellissier, Lucie P.; Barthet, Gael; Gaven, Florence; Cassier, Elisabeth; Trinquet, Eric; Pin, Jean-Philippe; Marin, Philippe; Dumuis, Aline; Bockaert, Joel; Baneres, Jean-Louis; Claeysen, Sylvie			G Protein Activation by Serotonin Type 4 Receptor Dimers EVIDENCE THAT TURNING ON TWO PROTOMERS IS MORE EFFICIENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; COUPLED RECEPTOR; 5-HT4 RECEPTOR; CONFORMATIONAL-CHANGES; GPCR; OLIGOMERS; RHODOPSIN; AGONIST; BINDING; HETERODIMERIZATION	The discovery that class C G protein-coupled receptors (GPCRs) function as obligatory dimeric entities has generated major interest in GPCR oligomerization. Oligomerization now appears to be a common feature among all GPCR classes. However, the functional significance of this process remains unclear because, in vitro, some monomeric GPCRs, such as rhodopsin and beta(2)-adrenergic receptors, activate G proteins. By using wild type and mutant serotonin type 4 receptors (5-HT(4)Rs) (including a 5-HT4-RASSL) expressed in COS-7 cells as models of class A GPCRs, we show that activation of one protomer in a dimer was sufficient to stimulate G proteins. However, coupling efficiency was 2 times higher when both protomers were activated. Expression of combinations of 5-HT4, in which both protomers were able to bind to agonists but only one could couple to G proteins, suggested that upon agonist occupancy, protomers did not independently couple to G proteins but rather that only one G protein was activated. Coupling of a single heterotrimeric G(s) protein to a receptor dimer was further confirmed in vitro, using the purified recombinant WT RASSL 5-HT4R obligatory heterodimer. These results, together with previous findings, demonstrate that, differently from class C GPCR dimers, class A GPCR dimers have pleiotropic activation mechanisms.	[Pellissier, Lucie P.; Barthet, Gael; Gaven, Florence; Cassier, Elisabeth; Pin, Jean-Philippe; Marin, Philippe; Dumuis, Aline; Bockaert, Joel; Claeysen, Sylvie] Univ Montpellier, CNRS, Inst Genom Fonct, UMR5203, F-34094 Montpellier 5, France; [Pellissier, Lucie P.; Barthet, Gael; Gaven, Florence; Cassier, Elisabeth; Pin, Jean-Philippe; Marin, Philippe; Dumuis, Aline; Bockaert, Joel; Claeysen, Sylvie] CNRS, INSERM, U661, F-34094 Montpellier, France; [Baneres, Jean-Louis] Fac Pharm Montpellier, Inst Biomol Max Mousseron, F-34093 Montpellier, France; [Trinquet, Eric] CisBioInternational, F-30200 Bagnols Sur Ceze, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier	Claeysen, S (corresponding author), Univ Montpellier, CNRS, Inst Genom Fonct, UMR5203, 141 Rue Cardonille, F-34094 Montpellier 5, France.	sylvie.claeysen@igf.cnrs.fr	Pin, Jean-Philippe/Y-6668-2019; Claeysen, Sylvie/C-8599-2014; Pellissier, Lucie P/L-8239-2014	Pin, Jean-Philippe/0000-0002-1423-345X; Claeysen, Sylvie/0000-0002-0576-5518; Pellissier, Lucie P/0000-0001-7085-3242; Baneres, jean-louis/0000-0001-7078-1285; Barthet, Gael/0000-0003-4025-1616	CNRS; INSERM; Ministere Francais de la Recherche [ANR Blanc-2006-0087-02]; Universite de Montpellier	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ministere Francais de la Recherche(Ministry of Research, France); Universite de Montpellier	This work was supported by grants from CNRS, INSERM, Ministere Francais de la Recherche (ANR Blanc-2006-0087-02; "GPCR Dimers"), and Universite de Montpellier.	ADAMUS G, 1991, J NEUROIMMUNOL, V34, P89, DOI 10.1016/0165-5728(91)90118-Q; Albizu L, 2010, NAT CHEM BIOL, V6, P587, DOI [10.1038/NCHEMBIO.396, 10.1038/nchembio.396]; Arcemisbehere L, 2010, J BIOL CHEM, V285, P6337, DOI 10.1074/jbc.M109.083477; Baneres JL, 2003, J MOL BIOL, V329, P815, DOI 10.1016/S0022-2836(03)00439-X; Baneres JL, 2005, J BIOL CHEM, V280, P20253, DOI 10.1074/jbc.M412009200; Barthet G, 2005, J BIOL CHEM, V280, P27924, DOI 10.1074/jbc.M502272200; Barthet G, 2007, MOL BIOL CELL, V18, P1979, DOI 10.1091/mbc.E06-12-1080; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; Berthouze M, 2005, FEBS LETT, V579, P2973, DOI 10.1016/j.febslet.2005.04.040; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; Bulenger S, 2005, TRENDS PHARMACOL SCI, V26, P131, DOI 10.1016/j.tips.2005.01.004; Chang WC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001317; Chidiac P, 1997, BIOCHEMISTRY-US, V36, P7361, DOI 10.1021/bi961939t; Chinault SL, 2004, J BIOL CHEM, V279, P16091, DOI 10.1074/jbc.M311099200; Claeysen S, 2003, J BIOL CHEM, V278, P699, DOI 10.1074/jbc.C200588200; Claeysen S, 1999, MOL PHARMACOL, V55, P910; Conklin BR, 2008, NAT METHODS, V5, P673, DOI 10.1038/nmeth.1232; Damian M, 2008, J BIOL CHEM, V283, P21084, DOI 10.1074/jbc.M710419200; Damian M, 2006, EMBO J, V25, P5693, DOI 10.1038/sj.emboj.7601449; Decaillot FM, 2008, P NATL ACAD SCI USA, V105, P16045, DOI 10.1073/pnas.0804106105; Ernst OP, 2007, P NATL ACAD SCI USA, V104, P10859, DOI 10.1073/pnas.0701967104; Filipek S, 2004, PHOTOCH PHOTOBIO SCI, V3, P628, DOI 10.1039/b315661c; Gether U, 1997, EMBO J, V16, P6737, DOI 10.1093/emboj/16.22.6737; Goudet C, 2005, J BIOL CHEM, V280, P24380, DOI 10.1074/jbc.M502642200; Guo W, 2003, J BIOL CHEM, V278, P4385, DOI 10.1074/jbc.C200679200; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; Hamm HE, 2001, P NATL ACAD SCI USA, V98, P4819, DOI 10.1073/pnas.011099798; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Herrick-Davis K, 2005, J BIOL CHEM, V280, P40144, DOI 10.1074/jbc.M507396200; Hlavackova V, 2005, EMBO J, V24, P499, DOI 10.1038/sj.emboj.7600557; Jastrzebska B, 2006, J BIOL CHEM, V281, P11917, DOI 10.1074/jbc.M600422200; Johnston CA, 2007, MOL PHARMACOL, V72, P219, DOI 10.1124/mol.107.034348; Kniazeff J, 2004, NAT STRUCT MOL BIOL, V11, P706, DOI 10.1038/nsmb794; Kobilka BK, 2007, BBA-BIOMEMBRANES, V1768, P794, DOI 10.1016/j.bbamem.2006.10.021; Kuszak AJ, 2009, J BIOL CHEM, V284, P26732, DOI 10.1074/jbc.M109.026922; Kuwajima M, 2004, J COMP NEUROL, V474, P589, DOI 10.1002/cne.20158; Lohse MJ, 2010, CURR OPIN PHARMACOL, V10, P53, DOI 10.1016/j.coph.2009.10.007; Maurel D, 2004, ANAL BIOCHEM, V329, P253, DOI 10.1016/j.ab.2004.02.013; McEwen DP, 2001, ANAL BIOCHEM, V291, P109, DOI 10.1006/abio.2001.5011; Milligan G, 2001, J CELL SCI, V114, P1265; Novi F, 2005, J BIOL CHEM, V280, P19768, DOI 10.1074/jbc.M411281200; Park PSH, 2008, ANNU REV PHARMACOL, V48, P107, DOI 10.1146/annurev.pharmtox.48.113006.094630; Pellissier LP, 2009, MOL PHARMACOL, V75, P982, DOI 10.1124/mol.108.053686; Pin JP, 2005, FEBS J, V272, P2947, DOI 10.1111/j.1742-4658.2005.04728.x; Riad N, 2000, J COMP NEUROL, V417, P181, DOI 10.1002/(SICI)1096-9861(20000207)417:2<181::AID-CNE4>3.0.CO;2-A; Springael JY, 2006, MOL PHARMACOL, V69, P1652, DOI 10.1124/mol.105.019414; Urizar E, 2005, EMBO J, V24, P1954, DOI 10.1038/sj.emboj.7600686; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; Waldhoer M, 2005, P NATL ACAD SCI USA, V102, P9050, DOI 10.1073/pnas.0501112102; White JF, 2007, P NATL ACAD SCI USA, V104, P12199, DOI 10.1073/pnas.0705312104; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Xu H, 2004, P NATL ACAD SCI USA, V101, P14258, DOI 10.1073/pnas.0404384101	56	63	63	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					9985	9997		10.1074/jbc.M110.201939	http://dx.doi.org/10.1074/jbc.M110.201939			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21247891	Green Published, hybrid			2022-12-27	WOS:000288547000013
J	Desplats, P; Spencer, B; Coffee, E; Patel, P; Michael, S; Patrick, C; Adame, A; Rockenstein, E; Masliah, E				Desplats, Paula; Spencer, Brian; Coffee, Elizabeth; Patel, Pruthul; Michael, Sarah; Patrick, Christina; Adame, Anthony; Rockenstein, Edward; Masliah, Eliezer			alpha-Synuclein Sequesters Dnmt1 from the Nucleus A NOVEL MECHANISM FOR EPIGENETIC ALTERATIONS IN LEWY BODY DISEASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; DNA METHYLATION; EXPRESSION; MEMORY	DNA methylation is a major epigenetic modification that regulates gene expression. Dnmt1, the maintenance DNA methylation enzyme, is abundantly expressed in the adult brain and is mainly located in the nuclear compartment, where it has access to chromatin. Hypomethylation of CpG islands at intron 1 of the SNCA gene has recently been reported to result in overexpression of alpha-synuclein in Parkinson disease (PD) and related disorders. We therefore investigated the mechanisms underlying altered DNA methylation in PD and dementia with Lewy bodies (DLB). We present evidence of reduction of nuclear Dnmt1 levels in human postmortem brain samples from PD and DLB patients as well as in the brains of alpha-synuclein transgenic mice models. Furthermore, sequestration of Dnmt1 in the cytoplasm results in global DNA hypomethylation in human and mouse brains, involving CpG islands upstream of SNCA, SEPW1, and PRKAR2A genes. We report that association of Dnmt1 and alpha-synuclein might mediate aberrant subcellular localization of Dnmt1. Nuclear Dnmt1 levels were partially rescued by overexpression of Dnmt1 in neuronal cell cultures and in alpha-synuclein transgenic mice brains. Our results underscore a novel mechanism for epigenetic dysregulation in Lewy body diseases, which might underlie the decrease in DNA methylation reported for PD and DLB.	[Desplats, Paula; Spencer, Brian; Coffee, Elizabeth; Patel, Pruthul; Michael, Sarah; Patrick, Christina; Adame, Anthony; Rockenstein, Edward; Masliah, Eliezer] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; [Masliah, Eliezer] Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Desplats, P (corresponding author), Univ Calif San Diego, Sch Med, Dept Neurosci, 9500 Gilman Dr,MTF 344, La Jolla, CA 92093 USA.	pdesplat@ucsd.edu	Desplats, Paula/AFW-5030-2022	Desplats, Paula/0000-0002-4758-4280	National Institutes of Health [AG5131, AG18440, AG22074, AG3197, AG10435, NS05709]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS105709] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005131, R01AG018440, P01AG010435, P01AG022074, R37AG018440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG5131, AG18440, AG22074, AG3197, AG10435, and NS05709 (to E. M.).	Burn DJ, 2006, CURR OPIN NEUROL, V19, P572, DOI 10.1097/01.wco.0000247607.34697.a2; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; Day JJ, 2010, NAT NEUROSCI, V13, P1319, DOI 10.1038/nn.2666; George JM, 2002, GENOME BIOL, V3; HERNANDEZ DG, 2011, HUM MOL GEN IN PRESS; Jowaed A, 2010, J NEUROSCI, V30, P6355, DOI 10.1523/JNEUROSCI.6119-09.2010; Levy OA, 2009, APOPTOSIS, V14, P478, DOI 10.1007/s10495-008-0309-3; Liu L, 2009, NEUROBIOL AGING, V30, P549, DOI 10.1016/j.neurobiolaging.2007.07.020; Matsumoto L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015522; Miller CA, 2010, NAT NEUROSCI, V13, P664, DOI 10.1038/nn.2560; Rockenstein E, 2002, J NEUROSCI RES, V68, P568, DOI 10.1002/jnr.10231; Siegmund KD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000895; Simunovic F, 2009, BRAIN, V132, P1795, DOI 10.1093/brain/awn323; Spencer B, 2009, J NEUROSCI, V29, P13578, DOI 10.1523/JNEUROSCI.4390-09.2009; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stamper C, 2008, MOVEMENT DISORD, V23, P1588, DOI 10.1002/mds.22184; Takeda A, 1998, AM J PATHOL, V152, P367; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Urdinguio RG, 2009, LANCET NEUROL, V8, P1056, DOI 10.1016/S1474-4422(09)70262-5; Yacoubian TA, 2008, NEUROBIOL DIS, V29, P515, DOI 10.1016/j.nbd.2007.11.008	20	195	203	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9031	9037		10.1074/jbc.C110.212589	http://dx.doi.org/10.1074/jbc.C110.212589			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21296890	Green Published, hybrid			2022-12-27	WOS:000288247700034
J	Sakthivelu, V; Seidel, RP; Winklhofer, KF; Tatzelt, J				Sakthivelu, Vignesh; Seidel, Ralf P.; Winklhofer, Konstanze F.; Tatzelt, Joerg			Conserved Stress-protective Activity between Prion Protein and Shadoo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOSYLPHOSPHATIDYLINOSITOL ANCHOR; SCRAPIE; PRP; DISEASES; MICE; DOMAIN	Shadoo (Sho) is a neuronally expressed glycoprotein of unknown function. Although there is no overall sequence homology to the cellular prion protein (PrPC), both proteins contain a highly conserved internal hydrophobic domain (HD) and are tethered to the outer leaflet of the plasma membrane via a C-terminal glycosylphosphatidylinositol anchor. A previous study revealed that Sho can reduce toxicity of a PrP mutant devoid of the HD (PrP Delta HD). We have now studied the stress-protective activity of Sho in detail and identified domains involved in this activity. Like PrPC, Sho protects cells against physiological stressors such as the excitotoxin glutamate. Moreover, both PrPC and Sho required the N-terminal domain for this activity; the stress-protective capacity of PrP Delta N as well as Sho Delta N was significantly impaired. In both proteins, the HD promoted homodimer formation; however, deletion of the HD had different effects. Although Sho Delta HD lost its stress-protective activity, PrP Delta HD acquired a neurotoxic potential. Finally, we could show that the N-terminal domain of PrPC could be functionally replaced by that of Sho, suggesting a similar function of the N termini of Sho and PrPC. Our study reveals a conserved physiological activity between PrPC and Sho to protect cells from stress-induced toxicity and suggests that Sho and PrPC might act on similar signaling pathways.	[Sakthivelu, Vignesh; Winklhofer, Konstanze F.; Tatzelt, Joerg] Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany; [Seidel, Ralf P.] Max Planck Inst Mol Physiol, D-44227 Dortmund, Germany	University of Munich; Max Planck Society	Tatzelt, J (corresponding author), Univ Munich, Adolf Butenandt Inst, Schillerstr 44, D-80336 Munich, Germany.	Joerg.Tatzelt@med.uni-muenchen.de		Winklhofer, Konstanze/0000-0002-7256-8231; Tatzelt, Jorg/0000-0001-5017-5528	Deutsche Forschungsgemeinschaft [SFB 596]; Max Planck Society; Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie (BMBF) [BioDisc, DIP5.1]; Deutscher Akademischer Austauschdienst (DAAD); DZNE-German Center for Neurodegenerative Diseases	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck Society); Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); DZNE-German Center for Neurodegenerative Diseases	The work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB 596), the Max Planck Society, and the Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie (BMBF) (BioDisc, DIP5.1), by a Ph.D. fellowship from the Deutscher Akademischer Austauschdienst (DAAD) (to V. S.), and by support from the DZNE-German Center for Neurodegenerative Diseases (to J. T.).	Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Chesebro B, 2003, BRIT MED BULL, V66, P1, DOI 10.1093/bmb/66.1.1; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Kiachopoulos S, 2005, J BIOL CHEM, V280, P9320, DOI 10.1074/jbc.M412525200; Li AM, 2007, EMBO J, V26, P548, DOI 10.1038/sj.emboj.7601507; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Miesbauer M, 2006, BIOCHEM BIOPH RES CO, V341, P218, DOI 10.1016/j.bbrc.2005.12.168; Mitteregger G, 2007, BRAIN PATHOL, V17, P174, DOI 10.1111/j.1750-3639.2007.00061.x; Premzl M, 2003, GENE, V314, P89, DOI 10.1016/S0378-1119(03)00707-8; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Rambold AS, 2008, EMBO J, V27, P1974, DOI 10.1038/emboj.2008.122; Rambold AS, 2006, MOL BIOL CELL, V17, P3356, DOI 10.1091/mbc.E06-01-0083; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Tatzelt A, 2004, AMYLOID, V11, P162, DOI 10.1080/1350-612040000723; Tompa P, 2009, BIOESSAYS, V31, P328, DOI 10.1002/bies.200800151; Van den Brulle J, 2008, BIOTECHNIQUES, V45, P340, DOI 10.2144/000112953; Watts JC, 2007, EMBO J, V26, P4038, DOI 10.1038/sj.emboj.7601830; Weissmann C, 1996, COLD SPRING HARB SYM, V61, P511; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; Winklhofer KF, 2000, BIOL CHEM, V381, P463, DOI 10.1515/BC.2000.061; Winklhofer KF, 2003, J BIOL CHEM, V278, P14961, DOI 10.1074/jbc.M209942200; Winklhofer KF, 2008, EMBO J, V27, P336, DOI 10.1038/sj.emboj.7601930	30	27	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8901	8908		10.1074/jbc.M110.185470	http://dx.doi.org/10.1074/jbc.M110.185470			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21257747	hybrid, Green Published			2022-12-27	WOS:000288247700021
J	Jo, Y; Sguigna, PV; Debose-Boyd, RA				Jo, Youngah; Sguigna, Peter V.; Debose-Boyd, Russell A.			Membrane-associated Ubiquitin Ligase Complex Containing gp78 Mediates Sterol-accelerated Degradation of 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; HMG COA REDUCTASE; COENZYME-A REDUCTASE; AAA ATPASE CDC48/P97; MESSENGER-RNA; FEEDBACK-REGULATION; INSIG-1; PROTEIN; DOMAIN; ER	The endoplasmic reticulum (ER)-associated degradation (ERAD) pathway in the yeast Saccharomyces cerevisiae is mediated by two membrane-bound ubiquitin ligases, Doa10 and Hrd1. These enzymes are found in distinct multiprotein complexes that allow them to recognize and target a variety of substrates for proteasomal degradation. Although multiprotein complexes containing mammalian ERAD ubiquitin ligases likely exist, they have yet to be identified and characterized in detail. Here, we identify two ER membrane proteins, SPFH2 and TMUB1, as associated proteins of mammalian gp78, a membrane-bound ubiquitin ligase that bears significant sequence homology with mammalian Hrd1 and mediates sterol-accelerated ERAD of the cholesterol biosynthetic enzyme HMG-CoA reductase. Co-immunoprecipitation studies indicate that TMUB1 bridges SPFH2 to gp78 in ER membranes. The functional significance of these interactions is revealed by the observation that RNA interference (RNAi)-mediated knockdown of SPFH2 and TMUB1 blunts both the sterol-induced ubiquitination and degradation of endogenous reductase in HEK-293 cells. These studies mark the initial steps in the characterization of the mammalian gp78 ubiquitin ligase complex, the further elucidation of which may yield important insights into mechanisms underlying gp78-mediated ERAD.	[Debose-Boyd, Russell A.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Jo, Youngah; Sguigna, Peter V.; Debose-Boyd, Russell A.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Debose-Boyd, RA (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Russell.DeBose-Boyd@utsouthwestern.edu			National Institutes of Health [HL20948, GM090216]; Perot Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090216] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Perot Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL20948 and GM090216. This work was also supported by the Perot Family Foundation.	Brodsky JL, 2009, CURR OPIN CELL BIOL, V21, P516, DOI 10.1016/j.ceb.2009.04.006; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Browman DT, 2006, J CELL SCI, V119, P3149, DOI 10.1242/jcs.03060; BROWN MS, 1980, J LIPID RES, V21, P505; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; DeBose-Boyd RA, 2008, CELL RES, V18, P609, DOI 10.1038/cr.2008.61; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Hampton RY, 2009, CHEM REV, V109, P1561, DOI 10.1021/cr800544v; Hartman IZ, 2010, J BIOL CHEM, V285, P19288, DOI 10.1074/jbc.M110.134213; Jarosch E, 2003, INT REV CYTOL, V223, P39; Kostova Z, 2007, SEMIN CELL DEV BIOL, V18, P770, DOI 10.1016/j.semcdb.2007.09.002; Lee JN, 2008, J BIOL CHEM, V283, P33772, DOI 10.1074/jbc.M806108200; Lee JN, 2006, J BIOL CHEM, V281, P39308, DOI 10.1074/jbc.M608999200; Lee PCW, 2007, J LIPID RES, V48, P1944, DOI 10.1194/jlr.M700225-JLR200; LISCUM L, 1983, J BIOL CHEM, V258, P8450; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; NAKANISHI M, 1988, J BIOL CHEM, V263, P8929; Pearce MMP, 2007, J BIOL CHEM, V282, P20104, DOI 10.1074/jbc.M701862200; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Vij N, 2008, J CELL MOL MED, V12, P2511, DOI 10.1111/j.1582-4934.2008.00462.x; Wang Y, 2009, BBA-MOL CELL RES, V1793, P1710, DOI 10.1016/j.bbamcr.2009.09.004; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0; Yang HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002809; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a	33	65	68	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15022	15031		10.1074/jbc.M110.211326	http://dx.doi.org/10.1074/jbc.M110.211326			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21343306	hybrid, Green Published			2022-12-27	WOS:000289788300032
J	Grimm, MOW; Kuchenbecker, J; Grosgen, S; Burg, VK; Hundsdorfer, B; Rothhaar, TL; Friess, P; de Wilde, MC; Broersen, LM; Penke, B; Peter, M; Vigh, L; Grimm, HS; Hartmann, T				Grimm, Marcus O. W.; Kuchenbecker, Johanna; Groesgen, Sven; Burg, Verena K.; Hundsdoerfer, Benjamin; Rothhaar, Tatjana L.; Friess, Petra; de Wilde, Martijn C.; Broersen, Laus M.; Penke, Botond; Peter, Maria; Vigh, Laszlo; Grimm, Heike S.; Hartmann, Tobias			Docosahexaenoic Acid Reduces Amyloid beta Production via Multiple Pleiotropic Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODERATE ALZHEIMER-DISEASE; ALPHA-SECRETASE CLEAVAGE; DOUBLE-BLIND TRIAL; N-3 FATTY-ACIDS; PRECURSOR PROTEIN; GAMMA-SECRETASE; LIPID RAFTS; A-BETA; TRANSGENIC MICE; HUMAN BRAIN	Alzheimer disease is characterized by accumulation of the beta-amyloid peptide (A beta) generated by beta- and gamma-secretase processing of the amyloid precursor protein (APP). The intake of the polyunsaturated fatty acid docosahexaenoic acid (DHA) has been associated with decreased amyloid deposition and a reduced risk in Alzheimer disease in several epidemiological trials; however, the exact underlying molecular mechanism remains to be elucidated. Here, we systematically investigate the effect of DHA on amyloidogenic and nonamyloidogenic APP processing and the potential cross-links to cholesterol metabolism in vivo and in vitro. DHA reduces amyloidogenic processing by decreasing beta- and gamma-secretase activity, whereas the expression and protein levels of BACE1 and presenilin1 remain unchanged. In addition, DHA increases protein stability of alpha-secretase resulting in increased nonamyloidogenic processing. Besides the known effect of DHA to decrease cholesterol de novo synthesis, we found cholesterol distribution in plasma membrane to be altered. In the presence of DHA, cholesterol shifts from raft to non-raft domains, and this is accompanied by a shift in gamma-secretase activity and presenilin1 protein levels. Taken together, DHA directs amyloidogenic processing of APP toward nonamyloidogenic processing, effectively reducing A beta release. DHA has a typical pleiotropic effect; DHA-mediated A beta reduction is not the consequence of a single major mechanism but is the result of combined multiple effects.	[Grimm, Marcus O. W.; Kuchenbecker, Johanna; Groesgen, Sven; Burg, Verena K.; Hundsdoerfer, Benjamin; Rothhaar, Tatjana L.; Friess, Petra; Grimm, Heike S.; Hartmann, Tobias] Univ Saarland, Dept Neurodegenerat & Neurobiol, Deutsch Inst DemenzPravent, D-66421 Homburg, Germany; [de Wilde, Martijn C.; Broersen, Laus M.] Danone Res, Nutricia Adv Med Nutr, Ctr Specialised Nutr, NL-6700 CA Wageningen, Netherlands; [Penke, Botond] Hungarian Acad Sci, Supramol & Nanostruct Mat Res Grp, H-6723 Szeged, Hungary; [Penke, Botond] Univ Szeged, Dept Med Chem, Szeged, Hungary; [Peter, Maria; Vigh, Laszlo] Hungarian Acad Sci, Inst Biochem, Biol Res Ctr, H-6723 Szeged, Hungary	Saarland University; Danone Nutricia; Hungarian Academy of Sciences; Szeged University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Grimm, MOW (corresponding author), Kirrberger Str 1, D-66421 Homburg, Germany.	marcus.grimm@uks.eu; Tobias.Hartmann@uniklinikum-saarland.de	de Wilde, Martijn/A-3855-2012; Hartmann, Tobias/AAB-8297-2022; soler, martha maricel m gomez/L-6025-2014; Grimm, Marcus O. W./F-8134-2011	soler, martha maricel m gomez/0000-0002-4412-8108; Grimm, Marcus O. W./0000-0002-4160-6506; Hartmann, Tobias/0000-0001-7481-6430	European Union [211696]; Deutsche Forschungsgemeinschaft; Bundesministerium fur Bildung, Forschung, Wissenschaft, und Technologie; Kompetenznetz Degenerative Demenzen; Saarland University	European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung, Forschung, Wissenschaft, und Technologie(Federal Ministry of Education & Research (BMBF)); Kompetenznetz Degenerative Demenzen; Saarland University	This work was supported by European Union FP7 Project LipiDiDiet Grant 211696 (to T.H.), Deutsche Forschungsgemeinschaft, Bundesministerium fur Bildung, Forschung, Wissenschaft, und Technologie via NGFNplus (to T. H.), and Kompetenznetz Degenerative Demenzen (KNDD) (to T.H.), HOMFOR 2008 and HOMFOR 2009 Saarland University Research Grants (to M.O.W.G. and T.H.).	Abad-Rodriguez J, 2004, J CELL BIOL, V167, P953, DOI 10.1083/jcb.200404149; Albanese E, 2009, AM J CLIN NUTR, V90, P392, DOI 10.3945/ajcn.2009.27580; Allinson TMJ, 2004, EUR J BIOCHEM, V271, P2539, DOI 10.1111/j.1432-1033.2004.04184.x; ANSARI KA, 1990, NEUROCHEM RES, V15, P7, DOI 10.1007/BF00969177; Barberger-Gateau P, 2002, BRIT MED J, V325, P932, DOI 10.1136/bmj.325.7370.932; BAZAN NG, 1990, UPSALA J MED SCI, P97; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Calon F, 2004, NEURON, V43, P633, DOI 10.1016/j.neuron.2004.08.013; Cheng HP, 2009, J BIOL CHEM, V284, P1373, DOI 10.1074/jbc.M806380200; Chiu CC, 2008, PROG NEURO-PSYCHOPH, V32, P1538, DOI 10.1016/j.pnpbp.2008.05.015; CLADERA JL, 1985, DEV GENET, V6, P27, DOI 10.1002/dvg.1020060103; Cole GM, 2009, PROSTAG LEUKOTR ESS, V81, P213, DOI 10.1016/j.plefa.2009.05.015; Cordy JM, 2003, P NATL ACAD SCI USA, V100, P11735, DOI 10.1073/pnas.1635130100; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098; Feldman HH, 2010, NEUROLOGY, V74, P956, DOI 10.1212/WNL.0b013e3181d6476a; Frears ER, 1999, NEUROREPORT, V10, P1699, DOI 10.1097/00001756-199906030-00014; Freund-Levi Y, 2006, ARCH NEUROL-CHICAGO, V63, P1402, DOI 10.1001/archneur.63.10.1402; Grimm MOW, 2008, J BIOL CHEM, V283, P11302, DOI 10.1074/jbc.M801520200; Grimm MOW, 2005, NAT CELL BIOL, V7, P1118, DOI 10.1038/ncb1313; Guardia-Laguarta C, 2009, J NEUROCHEM, V110, P220, DOI 10.1111/j.1471-4159.2009.06126.x; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HAASS C, 1993, J BIOL CHEM, V268, P3021; Hooijmans CR, 2007, NEUROBIOL DIS, V28, P16, DOI 10.1016/j.nbd.2007.06.007; Horrocks LA, 2004, PROSTAG LEUKOTR ESS, V70, P361, DOI 10.1016/j.plefa.2003.12.011; Hunt CE, 2009, FEBS J, V276, P1845, DOI 10.1111/j.1742-4658.2009.06929.x; Hur JY, 2008, FEBS J, V275, P1174, DOI 10.1111/j.1742-4658.2008.06278.x; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; Kamphuis PJGH, 2010, J ALZHEIMERS DIS, V20, P765, DOI 10.3233/JAD-2010-091558; KANG J, 1990, BIOCHEM BIOPH RES CO, V166, P1192, DOI 10.1016/0006-291X(90)90992-V; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kim SH, 2003, J BIOL CHEM, V278, P33992, DOI 10.1074/jbc.M305834200; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Kotani S, 2006, NEUROSCI RES, V56, P159, DOI 10.1016/j.neures.2006.06.010; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Langelier B, 2010, J CELL BIOCHEM, V110, P1356, DOI 10.1002/jcb.22652; Lien EL, 2009, PROSTAG LEUKOTR ESS, V81, P125, DOI 10.1016/j.plefa.2009.05.004; Liu WW, 2009, J NEUROCHEM, V108, P341, DOI 10.1111/j.1471-4159.2008.05753.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu F, 2010, CHINESE MED J-PEKING, V123, P1864, DOI 10.3760/cma.j.issn.0366-6999.2010.14.007; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Marquer C, 2011, FASEB J, V25, P1295, DOI 10.1096/fj.10-168633; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Morris MC, 2003, ARCH NEUROL-CHICAGO, V60, P940, DOI 10.1001/archneur.60.7.940; Oksman M, 2006, NEUROBIOL DIS, V23, P563, DOI 10.1016/j.nbd.2006.04.013; Pappolla MA, 2003, NEUROLOGY, V61, P199, DOI 10.1212/01.WNL.0000070182.02537.84; Pawlosky RJ, 2001, J LIPID RES, V42, P1257; Perez SE, 2010, J NEUROSCI RES, V88, P1026, DOI 10.1002/jnr.22266; Prince M, 2009, ALZHEIMERS DIS INT W, P1; Rapoport SI, 2007, PROSTAG LEUKOTR ESS, V77, P251, DOI 10.1016/j.plefa.2007.10.023; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Sakurai T, 2008, J CELL BIOL, V183, P339, DOI 10.1083/jcb.200804075; Schaefer EJ, 2006, ARCH NEUROL-CHICAGO, V63, P1545, DOI 10.1001/archneur.63.11.1545; Scheltens P, 2010, ALZHEIMERS DEMENT, V6, P1, DOI 10.1016/j.jalz.2009.10.003; Schneider A, 2006, NEUROBIOL DIS, V23, P573, DOI 10.1016/j.nbd.2006.04.015; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shaikh SR, 2010, PROSTAG LEUKOTR ESS, V82, P159, DOI 10.1016/j.plefa.2010.02.026; Shaikh SR, 2009, BBA-BIOMEMBRANES, V1788, P2421, DOI 10.1016/j.bbamem.2009.08.019; Shaikh SR, 2009, J NUTR, V139, P1632, DOI 10.3945/jn.109.108720; Shie FS, 2002, NEUROREPORT, V13, P455, DOI 10.1097/00001756-200203250-00019; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons M, 2002, ANN NEUROL, V52, P346, DOI 10.1002/ana.10292; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SODERBERG M, 1991, LIPIDS, V26, P421, DOI 10.1007/BF02536067; Solomon A, 2010, NEURODEGENER DIS, V7, P180, DOI 10.1159/000295659; Sparks DL, 2005, ARCH NEUROL-CHICAGO, V62, P753, DOI 10.1001/archneur.62.5.753; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; TATE BA, 2006, SCI AGING KNOWLEDGE, pRE2; Tully AM, 2003, BRIT J NUTR, V89, P483, DOI 10.1079/BJN2002804; Tun H, 2002, J MOL NEUROSCI, V19, P31, DOI 10.1007/s12031-002-0007-5; van de Rest O, 2008, NEUROLOGY, V71, P430, DOI 10.1212/01.wnl.0000324268.45138.86; van Gelder BM, 2007, AM J CLIN NUTR, V85, P1142, DOI 10.1093/ajcn/85.4.1142; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vetrivel KS, 2009, J BIOL CHEM, V284, P3793, DOI 10.1074/jbc.M808920200; Wahrle S, 2002, NEUROBIOL DIS, V9, P11, DOI 10.1006/nbdi.2001.0470; Wakabayashi T, 2008, PHYSIOLOGY, V23, P194, DOI 10.1152/physiol.00009.2008; Woods AJ, 2004, EMBO J, V23, P2531, DOI 10.1038/sj.emboj.7600267	82	160	164	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14028	14039		10.1074/jbc.M110.182329	http://dx.doi.org/10.1074/jbc.M110.182329			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21324907	Green Published, hybrid			2022-12-27	WOS:000289556200025
J	Lu, SP; Lin, SJ				Lu, Shu-Ping; Lin, Su-Ju			Phosphate-responsive Signaling Pathway Is a Novel Component of NAD(+) Metabolism in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIFE-SPAN EXTENSION; EQUILIBRATIVE NUCLEOSIDE TRANSPORTERS; NICOTINAMIDE ADENINE-DINUCLEOTIDE; FUNCTIONAL-CHARACTERIZATION; CALORIE RESTRICTION; DIPHOSPHOPYRIDINE NUCLEOTIDE; ALKALINE-PHOSPHATASE; INORGANIC-PHOSPHATE; GENE DELETION; BIOSYNTHESIS	Nicotinamide adenine dinucleotide (NAD(+)) is an essential cofactor involved in various cellular biochemical reactions. To date the signaling pathways that regulate NAD(+) metabolism remain unclear due to the dynamic nature and complexity of the NAD(+) metabolic pathways and the difficulty of determining the levels of the interconvertible pyridine nucleotides. Nicotinamide riboside (NmR) is a key pyridine metabolite that is excreted and re-assimilated by yeast and plays important roles in the maintenance of NAD(+) pool. In this study we establish a NmR-specific reporter system and use it to identify yeast mutants with altered NmR/NAD(+) metabolism. We show that the phosphate-responsive signaling (PHO) pathway contributes to control NAD(+) metabolism. Yeast strains with activated PHO pathway show increases in both the release rate and internal concentration of NmR. We further identify Pho8, a PHO-regulated vacuolar phosphatase, as a potential NmR production factor. We also demonstrate that Fun26, a homolog of human ENT (equilibrative nucleoside transporter), localizes to the vacuolar membrane and establishes the size of the vacuolar and cytosolic NmR pools. In addition, the PHO pathway responds to depletion of cellular nicotinic acid mononucleotide (NaMN) and mediates nicotinamide mononucleotide (NMN) catabolism, thereby contributing to both NmR salvage and phosphate acquisition. Therefore, NaMN is a putative molecular link connecting the PHO signaling and NAD(+) metabolic pathways. Our findings may contribute to the understanding of the molecular basis and regulation of NAD(+) metabolism in higher eukaryotes.	[Lu, Shu-Ping; Lin, Su-Ju] Univ Calif Davis, Dept Microbiol, Coll Biol Sci, Davis, CA 95616 USA	University of California System; University of California Davis	Lin, SJ (corresponding author), Univ Calif Davis, Dept Microbiol, Coll Biol Sci, 1 Shields Ave, Davis, CA 95616 USA.	slin@ucdavis.edu			National Institutes of Health [AG24351]; NATIONAL INSTITUTE ON AGING [R01AG024351] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG24351 (NIA).	Auesukaree C, 2005, J BIOL CHEM, V280, P25127, DOI 10.1074/jbc.M414579200; Auesukaree C, 2004, J BIOL CHEM, V279, P17289, DOI 10.1074/jbc.M312202200; Baldwin SA, 2005, J BIOL CHEM, V280, P15880, DOI 10.1074/jbc.M414337200; Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024; Belenky PA, 2008, J BIOL CHEM, V283, P8075, DOI 10.1074/jbc.C800021200; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; BISSON LF, 1982, GENETICS, V102, P341; Bogan KL, 2009, J BIOL CHEM, V284, P34861, DOI 10.1074/jbc.M109.056689; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Brachmann CB, 1998, YEAST, V14, P115; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; BUNYA M, 1991, MOL CELL BIOL, V11, P3229, DOI 10.1128/MCB.11.6.3229; Burkle A, 2005, FEBS J, V272, P4576, DOI 10.1111/j.1742-4658.2005.04864.x; Chini EN, 2009, CURR PHARM DESIGN, V15, P57, DOI 10.2174/138161209787185788; CLARK DW, 1982, J BACTERIOL, V152, P865; Easlon E, 2008, GENE DEV, V22, P931, DOI 10.1101/gad.1648308; Emanuelli M, 1999, FEBS LETT, V455, P13, DOI 10.1016/S0014-5793(99)00852-2; Endo Y, 2007, CANCER SCI, V98, P1633, DOI 10.1111/j.1349-7006.2007.00581.x; Evans Charles, 2010, BMC Chemical Biology, V10, P2, DOI 10.1186/1472-6769-10-2; Gauthier S, 2008, MOL MICROBIOL, V68, P1583, DOI 10.1111/j.1365-2958.2008.06261.x; Grubmeyer CT, 1999, METHOD ENZYMOL, V308, P28; Itoh Roichi, 2003, BMC Biochem, V4, P4, DOI 10.1186/1471-2091-4-4; KANEKO Y, 1987, GENE, V58, P137; KLIONSKY DJ, 1989, EMBO J, V8, P2241, DOI 10.1002/j.1460-2075.1989.tb08348.x; Lee YS, 2008, NAT CHEM BIOL, V4, P25, DOI 10.1038/nchembio.2007.52; Lee YS, 2007, SCIENCE, V316, P109, DOI 10.1126/science.1139080; Lenburg ME, 1996, TRENDS BIOCHEM SCI, V21, P383, DOI 10.1016/S0968-0004(96)90127-9; Li SC, 2009, BBA-MOL CELL RES, V1793, P650, DOI 10.1016/j.bbamcr.2008.08.003; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2003, CURR OPIN CELL BIOL, V15, P241, DOI 10.1016/S0955-0674(03)00006-1; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lu SP, 2009, J BIOL CHEM, V284, P17110, DOI 10.1074/jbc.M109.004010; Lundh F, 2009, BIOCHEMISTRY-US, V48, P4497, DOI 10.1021/bi9001198; Mouillon JM, 2005, CURR GENET, V48, P226, DOI 10.1007/s00294-005-0019-0; Nakanishi T, 2002, J BIOL CHEM, V277, P22103, DOI 10.1074/jbc.M200573200; Neef DW, 2003, MOL CELL BIOL, V23, P3788, DOI 10.1128/MCB.23.11.3788-3797.2003; Noda T, 2008, METHOD ENZYMOL, V451, P33, DOI 10.1016/S0076-6879(08)03203-5; Oshima Y, 1997, GENES GENET SYST, V72, P323, DOI 10.1266/ggs.72.323; Panozzo C, 2002, FEBS LETT, V517, P97, DOI 10.1016/S0014-5793(02)02585-1; Persson BL, 2003, CURR GENET, V43, P225, DOI 10.1007/s00294-003-0400-9; Pinson B, 2009, GENE DEV, V23, P1399, DOI 10.1101/gad.521809; PREISS J, 1958, J BIOL CHEM, V233, P488; PREISS J, 1958, J BIOL CHEM, V233, P493; Revollo JR, 2007, CURR OPIN GASTROEN, V23, P164, DOI 10.1097/MOG.0b013e32801b3c8f; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; RUBIN GM, 1973, J BIOL CHEM, V248, P3860; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Sandmeier JJ, 2002, GENETICS, V160, P877; Shimoaraiso M, 2000, J BIOL CHEM, V275, P29623, DOI 10.1074/jbc.M910371199; Sporty J, 2009, YEAST, V26, P363, DOI 10.1002/yea.1671; Sporty JL, 2008, J SEP SCI, V31, P3202, DOI 10.1002/jssc.200800238; TOHE A, 1973, J BACTERIOL, V113, P727, DOI 10.1128/JB.113.2.727-738.1973; TOHE A, 1976, BIOCHIM BIOPHYS ACTA, V428, P182, DOI 10.1016/0304-4165(76)90119-7; UEDA Y, 1975, MOL GEN GENET, V136, P255, DOI 10.1007/BF00334020; Vickers MF, 2000, J BIOL CHEM, V275, P25931, DOI 10.1074/jbc.M000239200; Werner TP, 2005, ARCH MICROBIOL, V184, P129, DOI 10.1007/s00203-005-0031-2; Wiederhold E, 2009, MOL CELL PROTEOMICS, V8, P380, DOI 10.1074/mcp.M800372-MCP200; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wykoff DD, 2001, GENETICS, V159, P1491; Young JD, 2008, XENOBIOTICA, V38, P995, DOI [10.1080/00498250801927427, 10.1080/00498250801927427 ]	60	42	44	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14271	14281		10.1074/jbc.M110.217885	http://dx.doi.org/10.1074/jbc.M110.217885			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21349851	Green Published, hybrid			2022-12-27	WOS:000289556200050
J	Gentle, IE; Wong, WWL; Evans, JM; Bankovacki, A; Cook, WD; Khan, NR; Nachbur, U; Rickard, J; Anderton, H; Moulin, M; Lluis, JM; Moujalled, DM; Silke, J; Vaux, DL				Gentle, Ian E.; Wong, W. Wei-Lynn; Evans, Joseph M.; Bankovacki, Alexandra; Cook, Wendy D.; Khan, Nufail R.; Nachbur, Ulrich; Rickard, James; Anderton, Holly; Moulin, Maryline; Lluis, Josep Maria; Moujalled, Donia M.; Silke, John; Vaux, David L.			In TNF-stimulated Cells, RIPK1 Promotes Cell Survival by Stabilizing TRAF2 and cIAP1, which Limits Induction of Non-canonical NF-kappa B and Activation of Caspase-8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEATH DOMAIN KINASE; NECROSIS-FACTOR TNF; ALPHA-DEPENDENT APOPTOSIS; WEAK INDUCER; C-FLIP; UBIQUITINATION; DEGRADATION; COMPLEX; INHIBITOR; PROTEIN	RIPK1 is involved in signaling from TNF and TLR family receptors. After receptor ligation, RIPK1 not only modulates activation of both canonical and NIK-dependent NF-kappa B, but also regulates caspase-8 activation and cell death. Although overexpression of RIPK1 can cause caspase-8-dependent cell death, when RIPK1(-/-) cells are exposed to TNF and low doses of cycloheximide, they die more readily than wild-type cells, indicating RIPK1 has pro-survival as well as pro-apoptotic activities (1, 2). To determine how RIPK1 promotes cell survival, we compared wild-type and RIPK1(-/-) cells treated with TNF. Although TRAF2 levels remained constant in TNF-treated wild-type cells, TNF stimulation of RIPK1(-/-) cells caused TRAF2 and cIAP1 to be rapidly degraded by the proteasome, which led to an increase in NIK levels. This resulted in processing of p100 NF-kappa B2 to p52, a decrease in levels of cFLIP(L), and activation of caspase-8, culminating in cell death. Therefore, the pro-survival effect of RIPK1 is mediated by stabilization of TRAF2 and cIAP1.	[Vaux, David L.] La Trobe Univ, Dept Biochem, Bundoora, Vic 3086, Australia; La Trobe Univ, La Trobe Inst Mol Sci, Bundoora, Vic 3086, Australia	La Trobe University; La Trobe University	Vaux, DL (corresponding author), La Trobe Univ, Dept Biochem, Kingsbury Dr, Bundoora, Vic 3086, Australia.	d.vaux@latrobe.edu.au	Gentle, Ian/X-2888-2019; Cook, Wendy/N-7506-2019; Silke, John/B-7622-2008; Wong, W. Wei-Lynn/A-6851-2015; Vaux, David L/C-7249-2013	Gentle, Ian/0000-0002-6707-7809; Silke, John/0000-0002-7611-5774; Wong, W. Wei-Lynn/0000-0003-3155-1211; Vaux, David L/0000-0003-2703-1651; Anderton, Holly/0000-0003-3913-9686; Nachbur, Ueli/0000-0001-5968-2235; Moulin, Maryline/0000-0002-1851-8727	NHMRC [433013, 541901, 541902, 461221]; Leukemia and Lymphoma Society Center; NHMRC Australian [487348]; Swiss National Science Foundation	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Leukemia and Lymphoma Society Center(Leukemia and Lymphoma Society); NHMRC Australian(National Health and Medical Research Council (NHMRC) of Australia); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported in part by the NHMRC (433013, 541901, and 541902) (to J. S.), a Leukemia and Lymphoma Society Center Grant and the NHMRC (461221) (to D. L V.), an NHMRC Australian Postdoctoral Training Fellowship (487348) (to I. E. G.), and the Swiss National Science Foundation (to U. N.).	Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Blonska M, 2005, J BIOL CHEM, V280, P43056, DOI 10.1074/jbc.M507807200; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Feltham R, 2010, J BIOL CHEM, V285, P17525, DOI 10.1074/jbc.M109.087635; Geserick P, 2009, J CELL BIOL, V187, P1037, DOI 10.1083/jcb.200904158; Guiet C, 2002, CELL DEATH DIFFER, V9, P138, DOI 10.1038/sj/cdd/4400947; Habelhah H, 2004, EMBO J, V23, P322, DOI 10.1038/sj.emboj.7600044; He JQ, 2006, J EXP MED, V203, P2413, DOI 10.1084/jem.20061166; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Kreuz S, 2001, MOL CELL BIOL, V21, P3964, DOI 10.1128/MCB.21.12.3964-3973.2001; Lewis J, 2000, J BIOL CHEM, V275, P10519, DOI 10.1074/jbc.275.14.10519; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Lin Y, 2000, MOL CELL BIOL, V20, P6638, DOI 10.1128/MCB.20.18.6638-6645.2000; Mahoney DJ, 2008, P NATL ACAD SCI USA, V105, P11778, DOI 10.1073/pnas.0711122105; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Rauert H, 2010, J BIOL CHEM, V285, P7394, DOI 10.1074/jbc.M109.037341; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Silke J, 2005, P NATL ACAD SCI USA, V102, P16182, DOI 10.1073/pnas.0502828102; Silke J, 2010, CELL DEATH DIFFER, V17, P35, DOI 10.1038/cdd.2009.114; STANGER BZ, 1995, CELL, V81, P513, DOI 10.1016/0092-8674(95)90072-1; Tada K, 2001, J BIOL CHEM, V276, P36530, DOI 10.1074/jbc.M104837200; Takaesu G, 2003, J MOL BIOL, V326, P105, DOI 10.1016/S0022-2836(02)01404-3; Takeuchi M, 1996, J BIOL CHEM, V271, P19935, DOI 10.1074/jbc.271.33.19935; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Vandenabeele P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115re4; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2008, J CELL BIOL, V182, P171, DOI 10.1083/jcb.200801010; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Vince JE, 2009, J BIOL CHEM, V284, P35906, DOI 10.1074/jbc.M109.072256; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wicovsky A, 2009, CELL DEATH DIFFER, V16, P1445, DOI 10.1038/cdd.2009.80; Wong WWL, 2010, CELL DEATH DIFFER, V17, P482, DOI 10.1038/cdd.2009.178; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676; Zhang LQ, 2010, J MOL BIOL, V396, P528, DOI 10.1016/j.jmb.2010.01.008	40	76	79	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13282	13291		10.1074/jbc.M110.216226	http://dx.doi.org/10.1074/jbc.M110.216226			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21339290	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000289282200049
J	Keck, M; Gisch, N; Moll, H; Vorholter, FJ; Gerth, K; Kahmann, U; Lissel, M; Lindner, B; Niehaus, K; Hoist, O				Keck, Matthias; Gisch, Nicolas; Moll, Hermann; Vorhoelter, Frank-Joerg; Gerth, Klaus; Kahmann, Uwe; Lissel, Manfred; Lindner, Buko; Niehaus, Karsten; Hoist, Otto			Unusual Outer Membrane Lipid Composition of the Gram-negative, Lipopolysaccharide-lacking Myxobacterium Sorangium cellulosum So ce56	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SER/THR KINASE CASCADE; ABSOLUTE-CONFIGURATION; GLYCOSPHINGOLIPIDS; IDENTIFICATION; SPHINGOLIPIDS; PHOSPHOLIPIDS; BIOSYNTHESIS; CYSTOBACTER; BACTERIA	The Gram-negative myxobacterium Sorangium cellulosum So ce56 bears the largest bacterial genome published so far, coding for nearly 10,000 genes. Careful analysis of this genome data revealed that part of the genes coding for the very well conserved biosynthesis of lipopolysaccharides (LPS) are missing in this microbe. Biochemical analysis gave no evidence for the presence of LPS in the membranes of So ce56. By analyzing the lipid composition of its outer membrane sphingolipids were identified as the major lipid class, together with ornithine-containing lipids (OL) and ether lipids. A detailed analysis of these lipids resulted in the identification of more than 50 structural variants within these three classes, which possessed several interesting properties regarding to LPS replacement, mediators in myxobacterial differentiation, as well as potential bioactive properties. The sphingolipids with the basic structure C9-methyl-C-20-sphingosine possessed as an unusual trait C9-methylation, which is common to fungi but highly uncommon to bacteria. Such sphingolipids have not been found in bacteria before, and they may have a function in myxobacterial development. The OL, also identified in myxobacteria for the first time, contained acyloxyacyl groups, which are also characteristic for LPS and might replace those in certain functions. Finally, the ether lipids may serve as biomarkers in myxobacterial development.	[Keck, Matthias; Vorhoelter, Frank-Joerg; Lissel, Manfred; Niehaus, Karsten] Univ Bielefeld, Dept Proteome & Metabolome Res, Fac Biol, D-33615 Bielefeld, Germany; [Kahmann, Uwe] Univ Bielefeld, IIT GmbH, ZUD, D-33615 Bielefeld, Germany; [Gisch, Nicolas; Moll, Hermann; Lindner, Buko] Leibniz Ctr Med & Biosci, Div Immunochem, D-23845 Borstel, Germany; [Hoist, Otto] Leibniz Ctr Med & Biosci, Div Struct Biochem, Res Ctr Borstel, D-23845 Borstel, Germany; [Gerth, Klaus] Helmholtz Ctr Infect Res, Res Grp Microbial Drugs, D-38124 Braunschweig, Germany	University of Bielefeld; University of Bielefeld; Forschungszentrum Borstel; Helmholtz Association; Helmholtz-Center for Infection Research	Niehaus, K (corresponding author), Univ Bielefeld, Dept Proteome & Metabolome Res, Fac Biol, POB 100131, D-33615 Bielefeld, Germany.	kniehaus@cebitec.uni-bielefeld.de	Niehaus, Karsten/A-3966-2010; Lindner, Buko/G-9731-2014	Gisch, Nicolas/0000-0003-3260-5269	German Federal Ministry of Education and Research (BMBF) [32106669]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was funded by Grant 32106669 from the German Federal Ministry of Education and Research (BMBF) (GenoMik and GenoMikPlus).	Adosraku RK, 1996, BBA-LIPID LIPID MET, V1299, P167, DOI 10.1016/0005-2760(95)00181-6; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CAILLON E, 1983, J BACTERIOL, V153, P1348, DOI 10.1128/JB.153.3.1348-1351.1983; ECKAU H, 1984, Z NATURFORSCH C, V39, P1; Engels A, 1997, BBA-PROTEIN STRUCT M, V1340, P33, DOI 10.1016/S0167-4838(97)00025-3; Gao JM, 2001, LIPIDS, V36, P175, DOI 10.1007/s11745-001-0704-x; Geiger O, 2010, PROG LIPID RES, V49, P46, DOI 10.1016/j.plipres.2009.08.002; Gerth K, 1996, J ANTIBIOT, V49, P560, DOI 10.7164/antibiotics.49.560; Gerth K, 2003, J BIOTECHNOL, V106, P233, DOI 10.1016/j.jbiotec.2003.07.015; GERWIG GJ, 1979, CARBOHYD RES, V77, P1, DOI 10.1016/S0008-6215(00)83788-X; HARDY PH, 1983, P SOC EXP BIOL MED, V174, P47; HARVEY DJ, 1984, J CHROMATOGR, V301, P173, DOI 10.1016/S0021-9673(01)89187-1; Hubner G, 2009, J MASS SPECTROM, V44, P1676, DOI 10.1002/jms.1673; Jayasimhulu K, 2007, J AM SOC MASS SPECTR, V18, P394, DOI 10.1016/j.jasms.2006.10.014; JIN WZ, 1994, J ORG CHEM, V59, P144, DOI 10.1021/jo00080a023; KAWAHARA K, 1991, FEBS LETT, V292, P107, DOI 10.1016/0014-5793(91)80845-T; Kawahara K, 2000, EUR J BIOCHEM, V267, P1837, DOI 10.1046/j.1432-1327.2000.01189.x; KAWAI G, 1982, BIOCHIM BIOPHYS ACTA, V719, P612, DOI 10.1016/0304-4165(82)90252-5; KAWASAKI S, 1994, J BACTERIOL, V176, P284, DOI 10.1128/JB.176.2.284-290.1994; LAMKY JR, 1976, J BACTERIOL, V126, P1278; Leone S, 2006, GLYCOBIOLOGY, V16, P766, DOI 10.1093/glycob/cwj120; Li SR, 1999, J LIPID RES, V40, P764; Lopez-Lara IM, 2005, MOL PLANT MICROBE IN, V18, P973, DOI 10.1094/MPMI-18-0973; Lopez-Lara IM, 2003, MOL PLANT MICROBE IN, V16, P567, DOI 10.1094/MPMI.2003.16.7.567; MASON WT, 1972, BIOCHIM BIOPHYS ACTA, V280, P538, DOI 10.1016/0005-2760(72)90133-6; MCBROOM AJ, 2005, OUTER MEMBRANE VESIC; Metcalf WW, 2009, ANNU REV BIOCHEM, V78, P65, DOI 10.1146/annurev.biochem.78.091707.100215; Muller R, 2006, J BIOTECHNOL, V121, P192, DOI 10.1016/j.jbiotec.2005.10.012; Nariya H, 2005, MOL MICROBIOL, V58, P367, DOI 10.1111/j.1365-2958.2005.04826.x; Nariya H, 2006, MOL MICROBIOL, V60, P1205, DOI 10.1111/j.1365-2958.2006.05178.x; Olsen I, 2001, ANAEROBE, V7, P103, DOI 10.1006/anae.2001.0376; Oura T, 2010, MICROBIOL-SGM, V156, P1234, DOI 10.1099/mic.0.033985-0; Pradella S, 2002, ARCH MICROBIOL, V178, P484, DOI 10.1007/s00203-002-0479-2; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Ramamoorthy V, 2009, EUKARYOT CELL, V8, P217, DOI 10.1128/EC.00255-08; Reeves PR, 1996, TRENDS MICROBIOL, V4, P495, DOI 10.1016/S0966-842X(97)82912-5; RIETSCHEL ET, 1976, EUR J BIOCHEM, V64, P423, DOI 10.1111/j.1432-1033.1976.tb10318.x; Ring MW, 2006, J BIOL CHEM, V281, P36691, DOI 10.1074/jbc.M607616200; ROSENFELDER G, 1974, EUR J BIOCHEM, V44, P411, DOI 10.1111/j.1432-1033.1974.tb03499.x; Sperling P, 2003, BBA-MOL CELL BIOL L, V1632, P1, DOI 10.1016/S1388-1981(03)00033-7; STEINER S, 1973, J BACTERIOL, V116, P1199, DOI 10.1128/JB.116.3.1199-1211.1973; SUTHERLAND IW, 1979, J GEN MICROBIOL, V111, P211, DOI 10.1099/00221287-111-1-211; SUTHERLAND IW, 1973, J GEN MICROBIOL, V74, P259, DOI 10.1099/00221287-74-2-259; TAKAYAMA K, 1987, INFECT IMMUN, V55, P2311, DOI 10.1128/IAI.55.9.2311-2313.1987; WAI SN, 1995, MICROBIOL IMMUNOL, V39, P451, DOI 10.1111/j.1348-0421.1995.tb02228.x; Wenzel SC, 2007, NAT PROD REP, V24, P1211, DOI 10.1039/b706416k; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030; Yang YL, 2010, ORG BIOMOL CHEM, V8, P4252, DOI 10.1039/c0ob00169d; Zhang Y, 2007, LIPIDS, V42, P759, DOI 10.1007/s11745-007-3079-8	51	21	22	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					12850	12859		10.1074/jbc.M110.194209	http://dx.doi.org/10.1074/jbc.M110.194209			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21321121	Green Published, hybrid			2022-12-27	WOS:000289282200005
J	Zhu, H; Lin, PH; De, GJ; Choi, KH; Takeshima, H; Weisleder, N; Ma, JJ				Zhu, Hua; Lin, Peihui; De, Gejing; Choi, Kyoung-han; Takeshima, Hiroshi; Weisleder, Noah; Ma, Jianjie			Polymerase Transcriptase Release Factor (PTRF) Anchors MG53 Protein to Cell Injury Site for Initiation of Membrane Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL GENERALIZED LIPODYSTROPHY; MUSCULAR-DYSTROPHY; DYSFERLIN; CAVEOLIN-3; MUTATIONS; MUSCLE; SURFACE; CLONING; TYPE-4; CAVIN	Plasma membrane repair is an essential process for maintenance of homeostasis at the cellular and tissue levels, whereas compromised repair capacity contributes to degenerative human diseases. Our recent studies show that MG53 is essential for muscle membrane repair, and defects in MG53 function are linked to muscular dystrophy and cardiac dysfunction. Here we report that polymerase I and transcript release factor (PTRF), a gene known to regulate caveolae membrane structure, is an indispensable component of the membrane repair machinery. PTRF acts as a docking protein for MG53 during membrane repair potentially by binding exposed membrane cholesterol at the injury site. Cells lacking expression of endogenous PTRF show defective trafficking of MG53 to membrane injury sites. A mutation in PTRF associated with human disease results in aberrant nuclear localization of PTRF and disrupts MG53 function in membrane resealing. Although RNAi silencing of PTRF leads to defective muscle membrane repair, overexpression of PTRF can rescue membrane repair defects in dystrophic muscle. Our data suggest that membrane-delimited interaction between MG53 and PTRF contributes to initiation of cell membrane repair, which can be an attractive target for treatment or prevention of tissue injury in human diseases.	[Zhu, Hua; Lin, Peihui; De, Gejing; Choi, Kyoung-han; Weisleder, Noah; Ma, Jianjie] Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA; [Takeshima, Hiroshi] Kyoto Univ, Dept Biol Chem, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan	Rutgers State University New Brunswick; Rutgers State University Medical Center; Kyoto University	Ma, JJ (corresponding author), Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA.	maj2@umdnj.edu	Weisleder, Noah L/A-7098-2013; Zhu, Hua/G-4409-2010; Lin, Pei-Hui/I-3011-2015	Weisleder, Noah L/0000-0002-2619-8022; Lin, Pei-Hui/0000-0002-3894-5099; Weisleder, Noah/0000-0003-2710-3088; Zhu, Hua/0000-0001-7136-7326; Takeshima, Hiroshi/0000-0003-4525-3725	National Institutes of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R00AR054793] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health grants (to J. M., N. W., and H. T.). J. M. and N. W. are co-founders of TRIM-edicine, Inc., a university spin-off biotechnology company that is developing recombinant MG53 protein as a therapeutic agent for treatment of tissue injuries.	Aboulaich N, 2004, BIOCHEM J, V383, P237, DOI 10.1042/BJ20040647; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Bazan NG, 2005, ANN NY ACAD SCI, V1053, P137, DOI 10.1196/annals.1344.011; Cai CX, 2009, J BIOL CHEM, V284, P15894, DOI 10.1074/jbc.M109.009589; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; Cao CM, 2010, CIRCULATION, V121, P2565, DOI 10.1161/CIRCULATIONAHA.110.954628; Doherty KR, 2003, TRENDS MOL MED, V9, P327, DOI 10.1016/S1471-4914(03)00136-9; Dowler Simon, 2002, Sci STKE, V2002, ppl6, DOI 10.1126/stke.2002.129.pl6; Dwianingsih EK, 2010, MOL GENET METAB, V101, P233, DOI 10.1016/j.ymgme.2010.06.016; Glover L, 2007, TRAFFIC, V8, P785, DOI 10.1111/j.1600-0854.2007.00573.x; Han R, 2007, J CLIN INVEST, V117, P1805, DOI 10.1172/JCI30848; Hasegawa T, 2000, BIOCHEM J, V347, P55, DOI 10.1042/0264-6021:3470055; Hayashi YK, 2009, J CLIN INVEST, V119, P2623, DOI 10.1172/JCI38660; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Jansa P, 1998, EMBO J, V17, P2855, DOI 10.1093/emboj/17.10.2855; Kim CA, 2008, J CLIN ENDOCR METAB, V93, P1129, DOI 10.1210/jc.2007-1328; Liu LB, 2008, CELL METAB, V8, P310, DOI 10.1016/j.cmet.2008.07.008; McMahon KA, 2009, EMBO J, V28, P1001, DOI 10.1038/emboj.2009.46; McNally EM, 1998, HUM MOL GENET, V7, P871, DOI 10.1093/hmg/7.5.871; McNeil PL, 2005, NAT REV MOL CELL BIO, V6, P499, DOI 10.1038/nrm1665; McNeil PL, 2003, P NATL ACAD SCI USA, V100, P4592, DOI 10.1073/pnas.0736739100; Minetti C, 1998, NAT GENET, V18, P365, DOI 10.1038/ng0498-365; Miyake K, 1995, J CELL BIOL, V131, P1737, DOI 10.1083/jcb.131.6.1737; Pouvreau S, 2007, P NATL ACAD SCI USA, V104, P5235, DOI 10.1073/pnas.0700748104; Rajab A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000874; Shastry S, 2010, AM J MED GENET A, V152A, P2245, DOI 10.1002/ajmg.a.33578; STEINHARDT RA, 1994, SCIENCE, V263, P390, DOI 10.1126/science.7904084; Tang ZL, 1996, J BIOL CHEM, V271, P2255, DOI 10.1074/jbc.271.4.2255; Wang XL, 2010, J APPL PHYS, V107, DOI 10.1063/1.3358007	29	79	89	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					12820	12824		10.1074/jbc.C111.221440	http://dx.doi.org/10.1074/jbc.C111.221440			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21343302	Green Published, hybrid			2022-12-27	WOS:000289282200002
J	Ratovitski, T; Chighladze, E; Waldron, E; Hirschhorn, RR; Ross, CA				Ratovitski, Tamara; Chighladze, Ekaterine; Waldron, Elaine; Hirschhorn, Ricky R.; Ross, Christopher A.			Cysteine Proteases Bleomycin Hydrolase and Cathepsin Z Mediate N-terminal Proteolysis and Toxicity of Mutant Huntingtin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PC12 CELL MODEL; WILD-TYPE; INTRANUCLEAR INCLUSIONS; PALLIDOLUYSIAN ATROPHY; DEPENDENT PROTEOLYSIS; MEMBRANE ASSOCIATION; CASPASE CLEAVAGE; REDUCES TOXICITY; TRANSGENIC MICE; REPEAT LENGTH	N-terminal proteolysis of huntingtin is thought to be an important mediator of HD pathogenesis. The formation of short N-terminal fragments of huntingtin (cp-1/cp-2, cp-A/cp-B) has been demonstrated in cells and in vivo. We previously mapped the cp-2 cleavage site by mass spectrometry to position Arg(167) of huntingtin. The proteolytic enzymes generating short N-terminal fragments of huntingtin remain unknown. To search for such proteases, we conducted a genome-wide screen using an RNA-silencing approach and an assay for huntingtin proteolysis based on the detection of cp-1 and cp-2 fragments by Western blotting. The primary screen was carried out in HEK293 cells, and the secondary screen was carried out in neuronal HT22 cells, transfected in both cases with a construct encoding the N-terminal 511 amino acids of mutant huntingtin. For additional validation of the hits, we employed a complementary assay for proteolysis of huntingtin involving overexpression of individual proteases with huntingtin in two cell lines. The screen identified 11 enzymes, with two major candidates to carry out the cp-2 cleavage, bleomycin hydrolase (BLMH) and cathepsin Z, which are both cysteine proteases of a papain-like structure. Knockdown of either protease reduced cp-2 cleavage, and ameliorated mutant huntingtin induced toxicity, whereas their overexpression increased the cp-2 cleavage. Both proteases partially co-localized with Htt in the cytoplasm and within or in association with early and late endosomes, with some nuclear co-localization observed for cathepsin Z. BLMH and cathepsin Z are expressed in the brain and have been associated previously with neurodegeneration. Our findings further validate the cysteine protease family, and BLMH and cathepsin Z in particular, as potential novel targets for HD therapeutics.	[Ratovitski, Tamara; Chighladze, Ekaterine; Waldron, Elaine; Hirschhorn, Ricky R.; Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Div Neurobiol, Baltimore, MD 21287 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21287 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Pharmacol, Baltimore, MD 21287 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21287 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Program Cellular & Mol Med, Baltimore, MD 21287 USA; [Hirschhorn, Ricky R.] Hood Coll, Dept Biol, Frederick, MD 21701 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Ratovitski, T (corresponding author), CMSC 8-121,600 N Wolfe St, Baltimore, MD 21287 USA.	tratovi1@jhmi.edu; caross@jhu.edu			NINDS, National Institutes of Health [16375]; HDSA Coalition for the Cure; High Q Foundation CHDI	NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); HDSA Coalition for the Cure; High Q Foundation CHDI	This work was supported, in whole or in part, by NINDS, National Institutes of Health, Grant 16375. This work was also supported by HDSA Coalition for the Cure and the High Q Foundation CHDI.	AKIYAMA S, 1981, BIOCHEM BIOPH RES CO, V101, P55, DOI 10.1016/S0006-291X(81)80009-5; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Becher MW, 1998, NEUROBIOL DIS, V4, P387, DOI 10.1006/nbdi.1998.0168; Bizat N, 2003, J NEUROSCI, V23, P5020; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Cooper JK, 1998, HUM MOL GENET, V7, P783, DOI 10.1093/hmg/7.5.783; Deussing J, 2000, BBA-GENE STRUCT EXPR, V1491, P93, DOI 10.1016/S0167-4781(00)00021-X; Devanathan G, 2005, BIOCHEM BIOPH RES CO, V329, P445, DOI 10.1016/j.bbrc.2005.01.150; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; Engelender S, 1997, HUM MOL GENET, V6, P2205, DOI 10.1093/hmg/6.13.2205; Gafni J, 2004, J BIOL CHEM, V279, P20211, DOI 10.1074/jbc.M401267200; Gafni J, 2002, J NEUROSCI, V22, P4842, DOI 10.1523/JNEUROSCI.22-12-04842.2002; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Goffredo D, 2002, J BIOL CHEM, V277, P39594, DOI 10.1074/jbc.C200353200; Goulet B, 2004, MOL CELL, V14, P207, DOI 10.1016/S1097-2765(04)00209-6; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Harjes P, 2003, TRENDS BIOCHEM SCI, V28, P425, DOI 10.1016/S0968-0004(03)00168-3; Hermel E, 2004, CELL DEATH DIFFER, V11, P424, DOI 10.1038/sj.cdd.4401358; Igarashi S, 2003, NEUROREPORT, V14, P565, DOI 10.1097/00001756-200303240-00007; Kajiya A, 2006, PROTEIN PEPTIDE LETT, V13, P119, DOI 10.2174/092986606775101562; Kamata Y, 2007, J BIOCHEM, V141, P69, DOI 10.1093/jb/mvm005; Kegel KB, 2000, J NEUROSCI, V20, P7268, DOI 10.1523/jneurosci.20-19-07268.2000; Kegel KB, 2005, J BIOL CHEM, V280, P36464, DOI 10.1074/jbc.M503672200; Kim M, 1999, J NEUROSCI, V19, P964; Kim MH, 2003, EXP NEUROL, V183, P109, DOI 10.1016/S0014-4886(03)00132-8; Kim YJ, 2006, NEUROBIOL DIS, V22, P346, DOI 10.1016/j.nbd.2005.11.012; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; Koldamova RP, 1998, BIOCHEMISTRY-US, V37, P2282, DOI 10.1021/bi9722204; Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028; Lefterov IM, 2000, FASEB J, V14, P1837, DOI 10.1096/fj.99-0938com; Li X, 2008, NEUROREPORT, V19, P1643, DOI 10.1097/WNR.0b013e328315cd4c; Li XY, 2009, MOL CELL BIOL, V29, P6106, DOI 10.1128/MCB.00420-09; Lunkes A, 2002, MOL CELL, V10, P259, DOI 10.1016/S1097-2765(02)00602-0; Lunkes A, 1998, HUM MOL GENET, V7, P1355, DOI 10.1093/hmg/7.9.1355; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mende-Mueller LM, 2001, J NEUROSCI, V21, P1830, DOI 10.1523/JNEUROSCI.21-06-01830.2001; Miller JP, 2010, NEURON, V67, P199, DOI 10.1016/j.neuron.2010.06.021; Montoya SE, 2007, NEUROSCIENCE, V146, P890, DOI 10.1016/j.neuroscience.2007.02.027; Nagler DK, 1998, FEBS LETT, V434, P135, DOI 10.1016/S0014-5793(98)00964-8; Nagler DK, 1999, BIOCHEMISTRY-US, V38, P12648, DOI 10.1021/bi991371z; Namba Y, 1999, BRAIN RES, V830, P200, DOI 10.1016/S0006-8993(99)01435-3; O'Farrell PA, 1999, STRUCT FOLD DES, V7, P619, DOI 10.1016/S0969-2126(99)80083-5; Pal A, 2006, J CELL BIOL, V172, P605, DOI 10.1083/jcb.200509091; Peters MF, 2001, J BIOL CHEM, V276, P3188, DOI 10.1074/jbc.M008099200; Ratovitski T, 2007, CELL CYCLE, V6, P2970, DOI 10.4161/cc.6.23.4992; Ratovitski T, 2009, J BIOL CHEM, V284, P10855, DOI 10.1074/jbc.M804813200; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Ross CA, 1997, MEDICINE, V76, P305, DOI 10.1097/00005792-199709000-00001; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Rubinsztein DC, 2002, TRENDS GENET, V18, P202, DOI 10.1016/S0168-9525(01)02625-7; Sawa A, 2005, NEUROBIOL DIS, V20, P267, DOI 10.1016/j.nbd.2005.02.013; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Schilling G, 2007, J NEUROPATH EXP NEUR, V66, P313, DOI 10.1097/nen.0b013e318040b2c8; SHARP AH, 1995, NEURON, V14, P1065, DOI 10.1016/0896-6273(95)90345-3; Slow EJ, 2005, P NATL ACAD SCI USA, V102, P11402, DOI 10.1073/pnas.0503634102; Sun B, 2002, NEUROBIOL DIS, V11, P111, DOI 10.1006/nbdi.2002.0539; Tanaka Y, 2006, NEUROBIOL DIS, V21, P381, DOI 10.1016/j.nbd.2005.07.014; Truant R, 2006, BIOCHEM CELL BIOL, V84, P912, DOI 10.1139/O06-181; Velier J, 1998, EXP NEUROL, V152, P34, DOI 10.1006/exnr.1998.6832; Vonsattel JPG, 2008, ACTA NEUROPATHOL, V115, P55, DOI 10.1007/s00401-007-0306-6; Wellington CL, 2002, J NEUROSCI, V22, P7862; Wellington CL, 2000, J BIOL CHEM, V275, P19831, DOI 10.1074/jbc.M001475200; Wendt W, 2007, EXP NEUROL, V204, P525, DOI 10.1016/j.expneurol.2007.01.007; Yanai A, 2006, NAT NEUROSCI, V9, P824, DOI 10.1038/nn1702; Zheng WJ, 1998, CELL, V93, P103, DOI 10.1016/S0092-8674(00)81150-2; Zhou H, 2003, J CELL BIOL, V163, P109, DOI 10.1083/jcb.200306038	67	33	33	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.185348	http://dx.doi.org/10.1074/jbc.M110.185348			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21310951	hybrid, Green Published			2022-12-27	WOS:000289077500070
J	Zbidi, H; Jardin, I; Woodard, GE; Lopez, JJ; Berna-Erro, A; Salido, GM; Rosado, JA				Zbidi, Hanene; Jardin, Isaac; Woodard, Geoffrey E.; Lopez, Jose J.; Berna-Erro, Alejandro; Salido, Gines M.; Rosado, Juan A.			STIM1 and STIM2 Are Located in the Acidic Ca2+ Stores and Associates with Orai1 upon Depletion of the Acidic Stores in Human Platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-DINUCLEOTIDE PHOSPHATE; VACUOLAR H+-ATPASES; CALCIUM-ENTRY; TRPC CHANNELS; DIFFERENTIAL SENSITIVITY; OPERATED CHANNELS; MEMBRANE-VESICLES; MAMMALIAN-CELLS; RELEASE; PROTEIN	Mammalian cells accumulate Ca2+ into agonist-sensitive acidic organelles, vesicles that possess a vacuolar proton-ATPase. Acidic Ca2+ stores include secretory granules and lysosome-related organelles. Current evidence clearly indicates that acidic Ca2+ stores participate in cell signaling and function, including the activation of store-operated Ca2+ entry in human platelets upon depletion of the acidic stores, although the mechanism underlying the activation of store-operated Ca2+ entry controlled by the acidic stores remains unclear. STIM1 has been presented as the endoplasmic reticulum Ca2+ sensor, but its role sensing intraluminal Ca2+ concentration in the acidic stores has not been investigated. Here we report that STIM1 and STIM2 are expressed in the lysosome-related organelles and dense granules in human platelets isolated by immunomagnetic sorting. Depletion of the acidic Ca2+ stores using the specific vacuolar proton-ATPase inhibitor, bafilomycin A1, enhanced the association between STIM1 and STIM2 as well as between these proteins and the plasma membrane channel Orai1. Depletion of the acidic Ca2+ stores also induces time-dependent co-immunoprecipitation of STIM1 with the TRPC proteins hTRPC1 and hTRPC6, as well as between Orai1 and both TRPC proteins. In addition, bafilomycin A1 enhanced the association between STIM2 and SERCA3. These findings demonstrate the location of STIM1 and STIM2 in the acidic Ca2+ stores and their association with Ca2+ channels and ATPases upon acidic stores discharge.	[Zbidi, Hanene; Jardin, Isaac; Berna-Erro, Alejandro; Salido, Gines M.; Rosado, Juan A.] Univ Extremadura, Cell Physiol Res Grp, Dept Physiol, Caceres 10003, Spain; [Woodard, Geoffrey E.] NIDDK, NIH, Bethesda, MD 20892 USA; [Lopez, Jose J.] INSERM, Hemostase & Dynam Cellulaire Vasc U770, F-94276 Le Kremlin Bicetre, France	Universidad de Extremadura; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Institut National de la Sante et de la Recherche Medicale (Inserm)	Rosado, JA (corresponding author), Univ Extremadura, Dept Physiol, Caceres 10071, Spain.	jarosado@unex.es	Erro, Alejandro Berna/S-5909-2019; Salido, Gines M/A-4292-2009; Lopez, Jose J/F-4602-2016; Jardin, Isaac/E-8310-2016; Rosado, Juan A/H-3488-2015	Erro, Alejandro Berna/0000-0003-1459-6418; Salido, Gines M/0000-0002-8687-2445; Lopez, Jose J/0000-0002-5234-1478; Jardin, Isaac/0000-0003-4575-8264; Rosado, Juan A/0000-0002-9749-2325	Ministerio de Ciencia e Innovacion [BFU2010-21043-C02-01, BES-2008-002875]; Ministerio de Asuntos Exteriores y de Cooperacion Proyecto Conjunto de Investigacion [A/023417/09]; Junta de Extremadura-Fondo Europeo de Desarrollo Regional [GR10010]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Asuntos Exteriores y de Cooperacion Proyecto Conjunto de Investigacion; Junta de Extremadura-Fondo Europeo de Desarrollo Regional	This work was supported by Ministerio de Ciencia e Innovacion Grant BFU2010-21043-C02-01, Ministerio de Asuntos Exteriores y de Cooperacion Proyecto Conjunto de Investigacion Grant A/023417/09, and Junta de Extremadura-Fondo Europeo de Desarrollo Regional Grant GR10010.; Supported by Ministerio de Ciencia e Innovacion Fellowship BES-2008-002875.	ADUNYAH SE, 1986, J BIOL CHEM, V261, P3122; Beck A, 2006, FASEB J, V20, P962, DOI 10.1096/fj.05-5538fje; BERG TO, 1994, BIOCHEM J, V300, P229, DOI 10.1042/bj3000229; BOBE R, 1994, J BIOL CHEM, V269, P1417; Bode HP, 1996, PFLUG ARCH EUR J PHY, V432, P97, DOI 10.1007/s004240050110; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brailoiu E, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.C109.081943; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Camello C, 2000, CURR BIOL, V10, P161, DOI 10.1016/S0960-9822(00)00313-4; Camello-Almaraz C, 2000, BIOCHEM BIOPH RES CO, V271, P311, DOI 10.1006/bbrc.2000.2633; Cancela JM, 2003, PFLUG ARCH EUR J PHY, V446, P322, DOI 10.1007/s00424-003-1035-x; Cancela JM, 2001, ANNU REV PHYSIOL, V63, P99, DOI 10.1146/annurev.physiol.63.1.99; CAVALLINI L, 1995, BIOCHEM J, V310, P449, DOI 10.1042/bj3100449; CHAKRABARTI R, 1989, J BIOL CHEM, V264, P15494; Christensen KA, 2002, J CELL SCI, V115, P599; DHAR A, 1994, J BIOL CHEM, V269, P9123; Feske S, 2009, IMMUNOL REV, V231, P189, DOI 10.1111/j.1600-065X.2009.00818.x; Galione A, 2006, BIOCHEM SOC T, V34, P922, DOI 10.1042/BST0340922; GEAR ARL, 1994, CAN J PHYSIOL PHARM, V72, P285, DOI 10.1139/y94-044; Gerasimenko O, 2010, METHODS MOL BIOL, V591, P201, DOI 10.1007/978-1-60761-404-3_12; Ginger RS, 2008, J BIOL CHEM, V283, P5486, DOI 10.1074/jbc.M707521200; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Jardin I, 2008, J BIOL CHEM, V283, P25296, DOI 10.1074/jbc.M802904200; Jardin I, 2008, CELL SIGNAL, V20, P737, DOI 10.1016/j.cellsig.2007.12.010; Jardin I, 2007, BIOCHEM J, V401, P167, DOI 10.1042/BJ20060888; Jardin I, 2009, BBA-MOL CELL RES, V1793, P1614, DOI 10.1016/j.bbamcr.2009.07.003; Kinnear NP, 2004, J BIOL CHEM, V279, P54319, DOI 10.1074/jbc.M406132200; Kovacs T, 1997, BRIT J HAEMATOL, V97, P192, DOI 10.1046/j.1365-2141.1997.9982639.x; KRIEGERBRAUER HI, 1983, J NEUROCHEM, V41, P1269, DOI 10.1111/j.1471-4159.1983.tb00821.x; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lopez JJ, 2006, CELL SIGNAL, V18, P373, DOI 10.1016/j.cellsig.2005.05.006; Lopez JJ, 2005, BIOCHEM J, V390, P243, DOI 10.1042/BJ20050168; Lopez JJ, 2006, J BIOL CHEM, V281, P28254, DOI 10.1074/jbc.M604272200; Manji SSM, 2000, BBA-PROTEIN STRUCT M, V1481, P147, DOI 10.1016/S0167-4838(00)00105-9; McGuinness L, 2007, NEUROPHARMACOLOGY, V52, P126, DOI 10.1016/j.neuropharm.2006.07.029; Missiaen L, 2007, CELL CALCIUM, V41, P405, DOI 10.1016/j.ceca.2006.11.001; Mitchell KJ, 2001, J CELL BIOL, V155, P41, DOI 10.1083/jcb.200103145; Morgan AJ, 2007, BIOCHEM J, V402, P301, DOI 10.1042/BJ20060759; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; NIESSEN J, 2010, CURR PROTOC CELL BIO, V46; Nissen J, 2007, J IMMUNOL METHODS, V328, P89, DOI 10.1016/j.jim.2007.08.010; PAPP B, 1992, BIOCHEM J, V288, P297, DOI 10.1042/bj2880297; PAPP B, 1991, J BIOL CHEM, V266, P14593; Patel S, 2010, TRENDS CELL BIOL, V20, P277, DOI 10.1016/j.tcb.2010.02.003; Potier M, 2008, PFLUG ARCH EUR J PHY, V457, P405, DOI 10.1007/s00424-008-0533-2; Putney JW, 2010, MOL INTERV, V10, P209, DOI 10.1124/mi.10.4.4; Putney JW, 2007, CELL CALCIUM, V42, P103, DOI 10.1016/j.ceca.2007.01.011; Redondo PC, 2008, BBA-MOL CELL RES, V1783, P1163, DOI 10.1016/j.bbamcr.2007.12.008; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Rosado JA, 2004, J BIOL CHEM, V279, P29231, DOI 10.1074/jbc.M403509200; Rosado JA, 2002, J BIOL CHEM, V277, P42157, DOI 10.1074/jbc.M207320200; Rosado JA, 2010, ARTERIOSCL THROM VAS, V30, P419, DOI 10.1161/ATVBAHA.109.194530; Salido GM, 2009, CELL SIGNAL, V21, P457, DOI 10.1016/j.cellsig.2008.11.005; Salido GM, 2009, BBA-MOL CELL RES, V1793, P223, DOI 10.1016/j.bbamcr.2008.11.001; Schindl R, 2009, CELL CALCIUM, V46, P227, DOI 10.1016/j.ceca.2009.08.003; Sehgal S, 2007, J THROMB HAEMOST, V5, P2009, DOI 10.1111/j.1538-7836.2007.02698.x; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Vaca L, 2010, CELL CALCIUM, V47, P199, DOI 10.1016/j.ceca.2010.01.002; Worley PF, 2007, CELL CALCIUM, V42, P205, DOI 10.1016/j.ceca.2007.03.004; WUYTACK F, 1994, J BIOL CHEM, V269, P1410; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhu Michael X., 2010, Communicative & Integrative Biology, V3, P12	64	60	60	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.190694	http://dx.doi.org/10.1074/jbc.M110.190694			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21321120	Green Published, hybrid			2022-12-27	WOS:000289077500040
J	Yang, HC; Gu, JX; Zheng, QP; Li, M; Lian, XN; Miao, JC; Jiang, JT; Wei, WX				Yang, Huicui; Gu, Junxia; Zheng, Qiping; Li, Min; Lian, Xiaoning; Miao, Jingcheng; Jiang, Jingting; Wei, Wenxiang			RPB5-mediating Protein Is Required for the Proliferation of Hepatocellular Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; VIRUS X-PROTEIN; CYCLIN B1; TRANSCRIPTION; SUBUNIT; RPB5; TRANSACTIVATION; ORGANIZATION; CHECKPOINT; EXPRESSION	RPB5-mediating protein (RMP) is associated with the RNA polymerase II subunit RPB5. RMP functionally counteracts the transcriptional activation of hepatitis B virus X protein that has been shown to play a role in the development of hepatocellular carcinoma (HCC). However, the effect of RMP on the growth of HCC remains unclear. In this study, we characterized the potential role of RMP in the proliferation of human HCC cells using two cell lines, SMMC-7721 and HepG2. We found that RMP expression increased when HCC cells were treated with Co-60 gamma-irradiation. Cell growth and colony formation assays suggest that RMP plays an antiapoptotic role in the proliferation and growth of HCC cells. We also show that RMP depletion induced the G(2) arrest of HCC cells characterized by the decreased expression of Cdk1 and Cyclin B. Tumor formation assays further confirmed the in vivo requirement of RMP during HCC growth. In conclusion, our results demonstrate that RMP is a radiation-sensitive factor, and it may play essential roles in HCC growth by affecting the proliferation and apoptosis of HCC cells.	[Jiang, Jingting] Soochow Univ, Affiliated Hosp 3, Dept Tumor Biotherapy, Changzhou 213003, Peoples R China; [Yang, Huicui; Li, Min; Lian, Xiaoning; Miao, Jingcheng; Wei, Wenxiang] Soochow Univ, Sch Med, Dept Cell Biol, Suzhou 215123, Peoples R China; [Gu, Junxia] Jiangsu Univ, Sch Med Sci & Lab Med, Dept Hematol & Hematol Lab Sci, Zhenjiang 212013, Peoples R China; [Zheng, Qiping] Rush Univ, Med Ctr, Dept Anat & Cell Biol, Chicago, IL 60612 USA	Soochow University - China; Soochow University - China; Jiangsu University; Rush University	Jiang, JT (corresponding author), Soochow Univ, Affiliated Hosp 3, Dept Tumor Biotherapy, Changzhou 213003, Peoples R China.	jjtnew@163.com; wenxiangw@suda.edu.cn			Natural Science Foundation of Jiangsu Province [BK2005028, BK2009121]; Suzhou Foundation for Science and Technology [SYS201008]; National 973 Programs of China [2007CB947002, 2010CB945600]	Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Suzhou Foundation for Science and Technology; National 973 Programs of China(National Basic Research Program of China)	This work was supported in part by Natural Science Foundation of Jiangsu Province Grants BK2005028 and BK2009121, Suzhou Foundation for Science and Technology Grant SYS201008, and National 973 Programs of China Grants 2007CB947002 and 2010CB945600.	CHEONG JH, 1995, EMBO J, V14, P143, DOI 10.1002/j.1460-2075.1995.tb06984.x; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; Dong YY, 2002, CANCER LETT, V177, P13, DOI 10.1016/S0304-3835(01)00770-4; Dorjsuren D, 1998, MOL CELL BIOL, V18, P7546, DOI 10.1128/MCB.18.12.7546; Golfier S, 2009, RADIAT PROT DOSIM, V134, P55, DOI 10.1093/rpd/ncp061; Gstaiger M, 2003, SCIENCE, V302, P1208, DOI 10.1126/science.1088401; Gu JX, 2009, ACTA BIOCH BIOPH SIN, V41, P831, DOI 10.1093/abbs/gmp072; Hoffman B, 2008, ONCOGENE, V27, P6462, DOI 10.1038/onc.2008.312; Jin P, 1998, J CELL BIOL, V141, P875, DOI 10.1083/jcb.141.4.875; Kirchner J, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-36; Kuo TC, 2010, BIOCHEM PHARMACOL, V80, P1093, DOI 10.1016/j.bcp.2010.06.003; Li JQ, 2003, INT J ONCOL, V22, P1101; Li XH, 2008, CARCINOGENESIS, V29, P1587, DOI 10.1093/carcin/bgn052; Parusel CT, 2006, DEVELOPMENT, V133, P621, DOI 10.1242/dev.02235; Sakurai H, 2001, GENES CELLS, V6, P25, DOI 10.1046/j.1365-2443.2001.00394.x; Seo HR, 2006, CELL DEATH DIFFER, V13, P1475, DOI 10.1038/sj.cdd.4401822; SIMS RJ, 2004, GENE DEV, V18, P2437, DOI DOI 10.1101/GAD.1235904; Stark George R, 2004, Methods Mol Biol, V280, P51; Stark GR, 2006, MOL BIOTECHNOL, V32, P227, DOI 10.1385/MB:32:3:227; Takeno S, 2002, CANCER, V94, P2874, DOI 10.1002/cncr.10542; Tang H, 2006, CANCER SCI, V97, P977, DOI 10.1111/j.1349-7006.2006.00299.x; Todone F, 2000, P NATL ACAD SCI USA, V97, P6306, DOI 10.1073/pnas.97.12.6306; Turner J, 2005, BLOOD, V106, P3191, DOI 10.1182/blood-2005-03-1263; Van Leuven F, 1998, GENOMICS, V54, P511, DOI 10.1006/geno.1998.5609; Venters BJ, 2009, CRIT REV BIOCHEM MOL, V44, P117, DOI 10.1080/10409230902858785; Wei WX, 2003, CELL RES, V13, P111, DOI 10.1038/sj.cr.7290155; Wei WX, 2001, J BIOL CHEM, V276, P12266, DOI 10.1074/jbc.M009634200; Yart A, 2005, MOL CELL BIOL, V25, P5052, DOI 10.1128/MCB.25.12.5052-5060.2005; Zaros C, 2007, NUCLEIC ACIDS RES, V35, P634, DOI 10.1093/nar/gkl686	29	29	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11865	11874		10.1074/jbc.M110.136929	http://dx.doi.org/10.1074/jbc.M110.136929			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21310960	hybrid, Green Published			2022-12-27	WOS:000288797100093
J	Habtemichael, EN; Brewer, PD; Romenskaia, I; Mastick, CC				Habtemichael, Estifanos N.; Brewer, Paul Duffield; Romenskaia, Irina; Mastick, Cynthia Corley			Kinetic Evidence That Glut4 Follows Different Endocytic Pathways than the Receptors for Transferrin and alpha(2)-Macroglobulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; GLUCOSE-TRANSPORTER GLUT4; 3T3-L1 ADIPOCYTES; CELL-SURFACE; RATE-CONSTANT; SUBCELLULAR TRAFFICKING; STORAGE COMPARTMENTS; INSULIN INCREASES; RAT ADIPOCYTES; VESICLES	Insulin regulates glucose uptake through effects on the trafficking of the glucose transporter Glut4. To investigate the degree of overlap between Glut4 and the general endocytic pathways, the kinetics of trafficking of Glut4 and the receptors for transferrin (Tf) and alpha 2-macroglobulin (alpha-2-M; LRP-1) were compared using quantitative flow cytometric assays. Insulin increased the exocytic rate constant (k(ex)) for both Glut4 and Tf. However, the k(ex) of Glut4 was 5-15 times slower than Tf in both basal and insulin-stimulated cells. The endocytic rate constant (k(en)) of Glut4 was also five times slower than Tf. Insulin did not affect the k(en) of either protein. In basal cells, the k(en) for alpha-2-M/LRP-1 was similar to Glut4 but 5-fold slower than Tf. Insulin increased k(en) for alpha-2-M/LRP-1 by 30%. In contrast, the k(ex) for LRP-1 was five times faster than Glut4 in basal cells, and insulin did not increase this rate constant. Thus, although there is overlap in the protein machineries/compartments utilized, the differences in trafficking kinetics indicate that Glut4, the Tf receptor, and LRP-1 are differentially processed both within the cell and at the plasma membrane. It has been reported that insulin decreases the k(en) of Glut4 in adipocytes. However, the effect of exocytosis on the "internalization" assays was not considered. Because it is counterintuitive, the effect of exocytosis on these assays is often overlooked in endocytosis studies. Using mathematical modeling and simulation, we show that the reported decrease in Glut4 k(en) can be entirely accounted for by the well established increase in Glut4 k(ex).	[Habtemichael, Estifanos N.; Brewer, Paul Duffield; Romenskaia, Irina; Mastick, Cynthia Corley] Univ Nevada, Sch Med, Dept Biochem & Mol Biol, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno	Mastick, CC (corresponding author), Univ Nevada, Sch Med, Dept Biochem & Mol Biol, Mailstop 330, Reno, NV 89557 USA.	cmastick@unr.edu	Mastick, Cynthia/G-9841-2017	Mastick, Cynthia/0000-0003-4769-5412	National Institutes of Health [DK56197]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056197] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK56197. This work was also supported by grants from the American Diabetes Association.	Antonescu CN, 2008, TRAFFIC, V9, P1173, DOI 10.1111/j.1600-0854.2008.00755.x; Antonescu CN, 2009, BIOSCIENCE REP, V29, P1, DOI 10.1042/BSR20080105; Blot V, 2006, EMBO J, V25, P5648, DOI 10.1038/sj.emboj.7601462; Bogan JS, 2010, CURR OPIN CELL BIOL, V22, P506, DOI 10.1016/j.ceb.2010.03.012; CHAKRABARTI R, 1993, J CELL BIOL, V123, P79, DOI 10.1083/jcb.123.1.79; Cormont M, 1996, ENDOCRINOLOGY, V137, P3408, DOI 10.1210/en.137.8.3408; CORVERA S, 1989, J BIOL CHEM, V264, P10133; Coster ACF, 2004, TRAFFIC, V5, P763, DOI 10.1111/j.1600-0854.2004.00218.x; DAUTRYVARSAT A, 1983, P NATL ACAD SCI-BIOL, V80, P2258, DOI 10.1073/pnas.80.8.2258; Fazakerley DJ, 2010, J BIOL CHEM, V285, P1653, DOI 10.1074/jbc.M109.051185; Garza LA, 2000, J BIOL CHEM, V275, P2560, DOI 10.1074/jbc.275.4.2560; GONIAS SL, 1982, BIOCHIM BIOPHYS ACTA, V705, P306, DOI 10.1016/0167-4838(82)90252-7; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; HOLMAN GD, 1994, J BIOL CHEM, V269, P17516; Huang SH, 2007, MOL CELL BIOL, V27, P3456, DOI 10.1128/MCB.01719-06; Jedrychowski MP, 2010, J BIOL CHEM, V285, P104, DOI 10.1074/jbc.M109.040428; JHUN BH, 1992, J BIOL CHEM, V267, P17710; Karylowski O, 2004, MOL BIOL CELL, V15, P870, DOI 10.1091/mbc.E03-07-0517; KLAUSNER RD, 1983, P NATL ACAD SCI-BIOL, V80, P2263, DOI 10.1073/pnas.80.8.2263; Ko KWS, 2001, BIOCHEMISTRY-US, V40, P752, DOI 10.1021/bi001797+; Kupriyanova TA, 2000, J BIOL CHEM, V275, P36263, DOI 10.1074/jbc.M002797200; Kupriyanova TA, 2002, J BIOL CHEM, V277, P9133, DOI 10.1074/jbc.M106999200; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; Larance M, 2008, MOL ENDOCRINOL, V22, P226, DOI 10.1210/me.2007-0282; Leney SE, 2009, J ENDOCRINOL, V203, P1, DOI 10.1677/JOE-09-0037; Li J, 2007, J CELL BIOL, V178, P453, DOI 10.1083/jcb.200608033; Livingstone C, 1996, BIOCHEM J, V315, P487, DOI 10.1042/bj3150487; Martin OJ, 2006, J BIOL CHEM, V281, P484, DOI 10.1074/jbc.M505944200; Martin S, 2000, J CELL SCI, V113, P3427; Martin S, 1996, J CELL BIOL, V134, P625, DOI 10.1083/jcb.134.3.625; MAXFIELD FR, 1982, J CELL BIOL, V95, pA271; Mettlen M, 2010, J CELL BIOL, V188, P919, DOI 10.1083/jcb.200908078; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Muretta JM, 2008, J BIOL CHEM, V283, P311, DOI 10.1074/jbc.M705756200; Muretta JM, 2009, VITAM HORM, V80, P245, DOI 10.1016/S0083-6729(08)00610-9; Pryor PR, 2000, BIOCHEM J, V348, P83, DOI 10.1042/0264-6021:3480083; Ramm G, 2000, MOL BIOL CELL, V11, P4079, DOI 10.1091/mbc.11.12.4079; ROBINSON LJ, 1992, J CELL BIOL, V117, P1181, DOI 10.1083/jcb.117.6.1181; SATOH S, 1993, J BIOL CHEM, V268, P17820; SHEPHERD PR, 1995, BIOCHEM BIOPH RES CO, V211, P535, DOI 10.1006/bbrc.1995.1846; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; Sorkin A, 2004, CURR OPIN CELL BIOL, V16, P392, DOI 10.1016/j.ceb.2004.06.001; Stenkula KG, 2010, CELL METAB, V12, P250, DOI 10.1016/j.cmet.2010.08.005; TANNER LI, 1987, J BIOL CHEM, V262, P8975; Traub LM, 2003, J CELL BIOL, V163, P203, DOI 10.1083/jcb.200309175; TYCKO B, 1982, CELL, V28, P643, DOI 10.1016/0092-8674(82)90219-7; WARD JH, 1982, BIOCHEM J, V208, P19, DOI 10.1042/bj2080019; Watson RT, 2004, ENDOCR REV, V25, P177, DOI 10.1210/er.2003-0011; Wei ML, 1998, J CELL BIOL, V140, P565, DOI 10.1083/jcb.140.3.565; WILEY HS, 1982, J BIOL CHEM, V257, P4222; Yang J, 2005, J BIOL CHEM, V280, P4070, DOI 10.1074/jbc.M410213200; Zeigerer A, 2002, MOL BIOL CELL, V13, P2421, DOI 10.1091/mbc.E02-02-0071; Zeigerer A, 2004, MOL BIOL CELL, V15, P4406, DOI 10.1091/mbc.e04-04-0333	53	21	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10115	10125		10.1074/jbc.M111.217935	http://dx.doi.org/10.1074/jbc.M111.217935			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21252237	Green Published, hybrid			2022-12-27	WOS:000288547000026
J	Solaro, RJ; Stull, JT				Solaro, R. John; Stull, James T.			Thematic Minireview Series on Signaling in Cardiac Sarcomeres in Health and Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material									[Solaro, R. John] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA; [Stull, James T.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas	Solaro, RJ (corresponding author), Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA.	solarorj@uic.edu			NHLBI NIH HHS [R01 HL064035, R01 HL022231] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064035, R01HL022231] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Solaro RJ, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/105648	1	2	2	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					9895	9895		10.1074/jbc.R110.214403	http://dx.doi.org/10.1074/jbc.R110.214403			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21257756	Green Published, hybrid			2022-12-27	WOS:000288547000001
J	Sfeir, C; Lee, D; Li, JH; Zhang, XY; Boskey, AL; Kumta, PN				Sfeir, Charles; Lee, Donghyun; Li, Jinhua; Zhang, Xiaoyuan; Boskey, Adele L.; Kumta, Prashant N.			Expression of Phosphophoryn Is Sufficient for the Induction of Matrix Mineralization by Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOBLAST-LIKE CELLS; RAT INCISOR DENTIN; BONE SIALOPROTEIN; CASEIN KINASE; HYDROXYAPATITE FORMATION; BIOMINERALIZATION; OSTEOPONTIN; PHOSPHORYLATION; PROTEINS; BINDING	Mineralized tissues such as dentin and bone assemble extracellular matrices uniquely rich in a variety of acidic phosphoproteins. Although these proteins are presumed to play a role in the process of biomineralization, key questions regarding the nature of their contributions remain unanswered. First, it is not known whether highly phosphorylated proteins alone can induce matrix mineralization, or whether this activity requires the involvement of other bone/dentin non-collagenous proteins. Second, it remains to be established whether the protein kinases that phosphorylate these acidic proteins are unique to cells responsible for producing mineralized tissues. To begin to address these questions, we consider the case of phosphophoryn (PP), due to its high content of phosphate, high affinity for Ca2+, and its potential role in hydroxyapatite nucleation. We have created a model system of biomineralization in a cellular environment by expressing PP in NIH3T3 fibroblasts (which do not produce a mineralized matrix); as a positive control, PP was expressed in MC3T3-E1 osteoblastic cells, which normally mineralize their matrices. We show that expression of PP in NIH3T3 cells is sufficient for the induction of matrix mineralization. In addition, assessment of the phosphorylation status of PP in these cells reveals that the transfected NIH3T3 cells are able to phosphorylate PP. We suggest that the phosphorylation of PP is essential for mineral formation. The principle goal of this study is to enrich the current knowledge of mineralized tissue phosphorylation events by analyzing them in the context of a complete cellular environment.	[Sfeir, Charles; Li, Jinhua; Zhang, Xiaoyuan] Univ Pittsburgh, Dept Oral Biol, Pittsburgh, PA 15260 USA; [Sfeir, Charles; Li, Jinhua; Zhang, Xiaoyuan] Univ Pittsburgh, Ctr Craniofacial Regenerat, Pittsburgh, PA 15260 USA; [Lee, Donghyun; Kumta, Prashant N.] Univ Pittsburgh, Dept Bioengn Chem & Petr Engn, Pittsburgh, PA 15261 USA; [Boskey, Adele L.] Hosp Special Surg, Musculoskeletal Integr Program, New York, NY 10021 USA; [Lee, Donghyun] Chung Ang Univ, Dept Biomed Engn, Seoul 156756, South Korea	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Chung Ang University	Sfeir, C (corresponding author), 552 Salk Hall,3501 Terrace St, Pittsburgh, PA 15261 USA.	csfeir@pitt.edu		Boskey, Adele/0000-0002-6181-2219	National Institutes of Health [DE016123, DE04141]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE004141, R01DE016123, R37DE004141] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants DE016123 (to C.S.) and DE04141 (to A.L.B.).	BOSKEY AL, 1990, BONE MINER, V11, P55, DOI 10.1016/0169-6009(90)90015-8; BOSKEY AL, 1989, J PHYS CHEM-US, V93, P1628, DOI 10.1021/j100341a086; Boskey AL, 2003, CONNECT TISSUE RES, V44, P5, DOI 10.1080/03008200390152007; CAMPBELL KP, 1983, J BIOL CHEM, V258, P1267; DIMUZIO MT, 1978, CALC TISS RES, V25, P169, DOI 10.1007/BF02010765; FISHER LW, 1983, J BIOL CHEM, V258, P2723; Fisher LW, 2001, BIOCHEM BIOPH RES CO, V280, P460, DOI 10.1006/bbrc.2000.4146; GEORGE A, 1993, J BIOL CHEM, V268, P12624; Gorski JP, 1998, CRIT REV ORAL BIOL M, V9, P201, DOI 10.1177/10454411980090020401; Harris NL, 2000, BONE, V27, P795, DOI 10.1016/S8756-3282(00)00392-6; He G, 2005, J BIOL CHEM, V280, P33109, DOI 10.1074/jbc.M500159200; HEINONEN JK, 1981, ANAL BIOCHEM, V113, P313, DOI 10.1016/0003-2697(81)90082-8; Jadlowiec J, 2004, J BIOL CHEM, V279, P53323, DOI 10.1074/jbc.M404934200; Jadlowiec JA, 2006, J BIOL CHEM, V281, P5341, DOI 10.1074/jbc.M506158200; Lasa M, 1997, BIOCHEM BIOPH RES CO, V240, P602, DOI 10.1006/bbrc.1997.7702; Magne D, 2004, CONNECT TISSUE RES, V45, P101, DOI 10.1080/03008200490464839; MARK MP, 1988, CELL TISSUE RES, V251, P23, DOI 10.1007/BF00215443; Morais S, 1998, BIOMATERIALS, V19, P13, DOI 10.1016/S0142-9612(97)00149-X; NIEMANN A, 1990, BIOCHEM BIOPH RES CO, V170, P1216, DOI 10.1016/0006-291X(90)90523-P; NOMURA S, 1988, J CELL BIOL, V106, P441, DOI 10.1083/jcb.106.2.441; Pourmand EP, 2007, J CELL BIOCHEM, V100, P43, DOI 10.1002/jcb.20977; PRINCE CW, 1987, J BIOL CHEM, V262, P2900; Salih E, 1996, J BIOL CHEM, V271, P16897, DOI 10.1074/jbc.271.28.16897; Sfeir C, 1996, CONNECT TISSUE RES, V35, P215, DOI 10.3109/03008209609029194; SFEIR C, 1995, J BONE MINER RES, V10, P607; Silverman L, 2004, CALCIFIED TISSUE INT, V75, P494, DOI 10.1007/s00223-004-0019-y; STETLERSTEVENSON WG, 1987, CALCIFIED TISSUE INT, V40, P97, DOI 10.1007/BF02555712; Stubbs JT, 1997, J BONE MINER RES, V12, P1210, DOI 10.1359/jbmr.1997.12.8.1210; TERMINE JD, 1981, CELL, V26, P99, DOI 10.1016/0092-8674(81)90037-4; TRAUB W, 1992, MATRIX, V12, P197, DOI 10.1016/S0934-8832(11)80062-4; Ueno A, 2006, J CELL PHYSIOL, V209, P322, DOI 10.1002/jcp.20735; Veis A, 2005, SCIENCE, V307, P1419, DOI 10.1126/science.1109440; Veis A, 1998, EUR J ORAL SCI, V106, P234, DOI 10.1111/j.1600-0722.1998.tb02181.x; VEIS A, 1977, CALCIUM BINDING PROT, P409; WILLIS JB, 1960, SPECTROCHIM ACTA, V16, P259, DOI 10.1016/0371-1951(60)80089-6; WU CB, 1992, J BIOL CHEM, V267, P16588; Wu CB, 1996, CONNECT TISSUE RES, V34, P23, DOI 10.3109/03008209609028890	37	15	15	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20228	20238		10.1074/jbc.M110.209528	http://dx.doi.org/10.1074/jbc.M110.209528			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21343307	Green Published, hybrid			2022-12-27	WOS:000291267600010
J	Michael, DR; Phillips, AO; Krupa, A; Martin, J; Redman, JE; Altaher, A; Neville, RD; Webber, J; Kim, MY; Bowen, T				Michael, Daryn R.; Phillips, Aled O.; Krupa, Aleksandra; Martin, John; Redman, James E.; Altaher, Abdalsamed; Neville, Rachel D.; Webber, Jason; Kim, Min-young; Bowen, Timothy			The Human Hyaluronan Synthase 2 (HAS2) Gene and Its Natural Antisense RNA Exhibit Coordinated Expression in the Renal Proximal Tubular Epithelial Cell	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIABETIC-NEPHROPATHY; ACID RECEPTOR; FIBROSIS; TRANSCRIPTION; PROMOTER; DISEASE; CANCER; PROLIFERATION; BIOSYNTHESIS; INSIGHTS	Aberrant expression of the human hyaluronan synthase 2 (HAS2) gene has been implicated in the pathology of malignancy, pulmonary arterial hypertension, osteoarthritis, asthma, thyroid dysfunction, and large organ fibrosis. Renal fibrosis is associated with increased cortical synthesis of hyaluronan (HA), an extracellular matrix glycosaminoglycan, and we have shown that HA is a correlate of interstitial fibrosis in vivo. Our previous in vitro data have suggested that both HAS2 transcriptional induction and subsequent HAS2-driven HA synthesis may contribute to kidney fibrosis via phenotypic modulation of the renal proximal tubular epithelial cell (PTC). Post-transcriptional regulation of HAS2 mRNA synthesis by the natural antisense RNA HAS2-AS1 has recently been described in osteosarcoma cells, but the antisense transcript was not detected in kidney. In this study, PTC stimulation with IL-1 beta or TGF-beta 1 induced coordinated temporal profiles of HAS2-AS1 and HAS2 transcription. Constitutive activity of the putative HAS2-AS1 promoter was demonstrated, and transcription factor-binding sequence motifs were identified. Knockdown of Sp1/Sp3 expression by siRNA blunted IL-1 beta induction of both HAS2-AS1 and HAS2, and Smad2/Smad3 knockdown similarly attenuated TGF-beta 1 stimulation. Inhibition of IL-1 beta-stimulated HAS2-AS1 RNA induction using HAS2-AS1-specific siRNAs also suppressed up-regulation of HAS2 mRNA transcription. The thermodynamic feasibility of HAS2-AS1/HAS2 heterodimer formation was demonstrated in silico, and locus-specific cytoplasmic double-stranded RNA was detected in vitro. In summary, our data show that transcriptional induction of HAS2-AS1 and HAS2 occurs simultaneously in PTCs and suggest that transcription of the antisense RNA stabilizes or augments HAS2 mRNA expression in these cells via RNA/mRNA heteroduplex formation.	[Michael, Daryn R.; Phillips, Aled O.; Krupa, Aleksandra; Martin, John; Altaher, Abdalsamed; Neville, Rachel D.; Webber, Jason; Kim, Min-young; Bowen, Timothy] Cardiff Univ, Inst Nephrol, Sch Med, Cardiff CF14 4XN, S Glam, Wales; [Phillips, Aled O.; Martin, John; Neville, Rachel D.; Bowen, Timothy] Cardiff Medictr, Cardiff Inst Tissue Engn & Repair, Cardiff CF14 4UJ, S Glam, Wales; [Redman, James E.] Cardiff Univ, Sch Chem, Cardiff CF10 3AT, S Glam, Wales	Cardiff University; Cardiff University; Cardiff University	Bowen, T (corresponding author), Cardiff Univ, Inst Nephrol, Sch Med, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	bowent@cf.ac.uk	Webber, Jason P/O-1960-2017; Redman, James/B-7175-2008	Webber, Jason P/0000-0003-4772-3014; Redman, James/0000-0001-5492-2869	Libyan Government; Cardiff University School of Medicine; St. John's College (Cardiff, United Kingdom)	Libyan Government; Cardiff University School of Medicine; St. John's College (Cardiff, United Kingdom)	Recipient of a research fellowship from the Libyan Government.; Recipient of a Ph.D. studentship from the Cardiff University School of Medicine.; Recipient of a Nuffield Science Bursary coordinated by the Techniquest Science Discovery Centre (Cardiff, United Kingdom) and supported by St. John's College (Cardiff, United Kingdom).	Andhare RA, 2009, OSTEOARTHR CARTILAGE, V17, P892; Bernhart SH, 2006, ALGORITHM MOL BIOL, V1, DOI 10.1186/1748-7188-1-3; Bharadwaj AG, 2009, AM J PATHOL, V174, P1027, DOI 10.2353/ajpath.2009.080501; Carninci P, 2008, CURR OPIN CELL BIOL, V20, P274, DOI 10.1016/j.ceb.2008.03.008; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chao H, 2005, J BIOL CHEM, V280, P27513, DOI 10.1074/jbc.M411544200; Dallosso AR, 2007, RNA, V13, P2287, DOI 10.1261/rna.562907; El-Chemaly S, 2009, P NATL ACAD SCI USA, V106, P3958, DOI 10.1073/pnas.0813368106; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Frith MC, 2001, BIOINFORMATICS, V17, P878, DOI 10.1093/bioinformatics/17.10.878; Gingeras TR, 2007, GENOME RES, V17, P682, DOI 10.1101/gr.6525007; Gressner OA, 2007, J CELL MOL MED, V11, P1031, DOI 10.1111/j.1582-4934.2007.00092.x; HOFACKER WF, 1994, MONATSHEFTE CHEM CHE, V125, P167; Hoogendoorn B, 2003, HUM MOL GENET, V12, P2249, DOI 10.1093/hmg/ddg246; Hurst SM, 2002, J IMMUNOL, V169, P5244, DOI 10.4049/jimmunol.169.9.5244; Itano N, 2008, SEMIN CANCER BIOL, V18, P268, DOI 10.1016/j.semcancer.2008.03.006; Jenkins RH, 2004, J BIOL CHEM, V279, P41453, DOI 10.1074/jbc.M401678200; Jones S, 2001, KIDNEY INT, V59, P1739, DOI 10.1046/j.1523-1755.2001.0590051739.x; Lauer ME, 2009, J BIOL CHEM, V284, P5299, DOI 10.1074/jbc.M807965200; Lee JY, 2000, CURR OPIN CELL BIOL, V12, P581, DOI 10.1016/S0955-0674(00)00135-6; Lewis A, 2008, HISTOL HISTOPATHOL, V23, P731, DOI 10.14670/HH-23.731; Li YJ, 2000, AM J RESP CELL MOL, V23, P411, DOI 10.1165/ajrcmb.23.3.4102; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo DD, 2009, NEPHROL DIAL TRANSPL, V24, P2655, DOI 10.1093/ndt/gfp208; Makkonen KM, 2009, J BIOL CHEM, V284, P18270, DOI 10.1074/jbc.M109.012492; Matsui K, 2008, HEPATOLOGY, V47, P686, DOI 10.1002/hep.22036; Mattick JS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000459; Meran S, 2008, J BIOL CHEM, V283, P6530, DOI 10.1074/jbc.M704819200; Meran S, 2007, J BIOL CHEM, V282, P25687, DOI 10.1074/jbc.M700773200; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; Monslow J, 2004, J BIOL CHEM, V279, P20576, DOI 10.1074/jbc.M312666200; Monslow J, 2003, INT J BIOCHEM CELL B, V35, P1272, DOI 10.1016/S1357-2725(03)00048-7; Monslow J, 2006, J BIOL CHEM, V281, P18043, DOI 10.1074/jbc.M510467200; Nobili V, 2009, GASTROENTEROLOGY, V136, P160, DOI 10.1053/j.gastro.2008.09.013; Prasanth KV, 2007, GENE DEV, V21, P11, DOI 10.1101/gad.1484207; Rouschop KMA, 2004, J AM SOC NEPHROL, V15, P674, DOI 10.1097/01.ASN.0000115703.30835.96; Saavalainen K, 2007, J BIOL CHEM, V282, P11530, DOI 10.1074/jbc.M607871200; Sayo T, 2002, J INVEST DERMATOL, V118, P43, DOI 10.1046/j.0022-202x.2001.01613.x; Simpson RML, 2009, AM J PATHOL, V175, P1915, DOI 10.2353/ajpath.2009.090045; Soares LMM, 2006, EMBO J, V25, P923, DOI 10.1038/sj.emboj.7601023; Spicer AP, 1997, GENOMICS, V41, P493, DOI 10.1006/geno.1997.4696; Taft RJ, 2010, J PATHOL, V220, P126, DOI 10.1002/path.2638; Taft RJ, 2009, NAT GENET, V41, P572, DOI 10.1038/ng.312; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Wight TN, 2008, FRONT BIOSCI, V13, P4933, DOI 10.2741/3052	46	67	67	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19523	19532		10.1074/jbc.M111.233916	http://dx.doi.org/10.1074/jbc.M111.233916			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21357421	Green Published, hybrid			2022-12-27	WOS:000291027700035
J	Yin, K; Deng, XA; Mo, ZC; Zhao, GJ; Jiang, J; Cui, LB; Tan, CZ; Wen, GB; Fu, YC; Tang, CK				Yin, Kai; Deng, Xiang; Mo, Zhong-Cheng; Zhao, Guo-Jun; Jiang, Jin; Cui, Li-Bao; Tan, Chun-Zhi; Wen, Ge-Bo; Fu, Yuchang; Tang, Chao-Ke			Tristetraprolin-dependent Post-transcriptional Regulation of Inflammatory Cytokine mRNA Expression by Apolipoprotein A-I ROLE OF ATP-BINDING MEMBRANE CASSETTE TRANSPORTER A1 AND SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; TUMOR-NECROSIS-FACTOR; REVERSE CHOLESTEROL TRANSPORT; FACTOR-KAPPA-B; FACTOR-ALPHA; GENE-EXPRESSION; TNF-ALPHA; P38 MAPK; CARDIOVASCULAR EVENTS; APOA-I	Atherosclerosis is an inflammatory disease characterized by the accumulation of macrophages in the arterial intima. The activated macrophages secreted more pro-inflammatory cytokines, such as tumor necrosis factor (TNF)-alpha, which promote the development of the disease. Apolipoprotein A-I (apoA-I), the major component of high density lipoprotein, is involved in reverse cholesterol transport of lipid metabolism. Recently, it has been found that apoA-I suppresses inflammation via repression of inflammatory cytokine expression; the mechanisms of the apoA-I-suppressive action, however, are not yet well characterized. In this study, we have for the first time found that apoA-I suppresses the expression of some inflammatory cytokines induced by lipopolysaccharide via a specific post-transcriptional regulation process, namely mRNA destabilization, in macrophages. Our further studies have also shown that AU-rich elements in the 3'-untranslated region of TNF-alpha mRNA are responsive to the apoA-I-mediated mRNA destabilization. The apoA-I-induced inflammatory cytokine mRNA destabilization was associated with increased expression of mRNA-destabilizing protein tristetraprolin through a JAK2/STAT3 signaling pathway-dependent manner. When blocking interaction of apoA-I with ATP-binding membrane cassette transporter A1 (ABCA1), a major receptor for apoA-I in macrophages, it would almost totally abolish the effect of apoA-I on tristetraprolin expression. These results present not only a novel mechanism for the apoA-I-mediated inflammation suppression in macrophages but also provide new insights for developing strategies for modulating vascular inflammation and atherosclerosis.	[Yin, Kai; Mo, Zhong-Cheng; Zhao, Guo-Jun; Jiang, Jin; Cui, Li-Bao; Tan, Chun-Zhi; Wen, Ge-Bo; Tang, Chao-Ke] Univ S China, Affiliated Hosp 1, Key Lab Atherosclerol Hunan Prov, Life Sci Res Ctr,Inst Cardiovasc Res, Hengyang 421001, Peoples R China; [Yin, Kai; Wen, Ge-Bo] Univ S China, Affiliated Hosp 1, Dept Diagnost, Coll Med, Hengyang 421001, Peoples R China; [Deng, Xiang; Wen, Ge-Bo] Univ S China, Affiliated Hosp 1, Dept Endocrinol & Metab, Hengyang 421001, Peoples R China; [Fu, Yuchang] Univ Alabama, Dept Nutr Sci, Birmingham, AL 35294 USA	University of South China; University of South China; University of South China; University of Alabama System; University of Alabama Birmingham	Tang, CK (corresponding author), Univ S China, Affiliated Hosp 1, Key Lab Atherosclerol Hunan Prov, Life Sci Res Ctr,Inst Cardiovasc Res, Hengyang 421001, Peoples R China.	tchaoke@yahoo.com.cn	莫, 中成/AAY-8561-2020		National Natural Sciences Foundation of China [30470720, 81070220]; Post-doctoral Sciences Foundation of China [2005037157]; Hunan Provincial Natural Sciences Foundation of China [10JJ9019, 06jj5058]; Hunan Post-graduate Innovative Project [CX2010B379]; Science and Technology Department Funds of Heng Yang of Hunan Province [2010kj17]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Post-doctoral Sciences Foundation of China(China Postdoctoral Science Foundation); Hunan Provincial Natural Sciences Foundation of China; Hunan Post-graduate Innovative Project; Science and Technology Department Funds of Heng Yang of Hunan Province	This work was supported by National Natural Sciences Foundation of China Grants 30470720 and 81070220, Post-doctoral Sciences Foundation of China Grant 2005037157, Heng Yang Joint Funds of Hunan Provincial Natural Sciences Foundation of China Grant 10JJ9019, Hunan Post-graduate Innovative Project Grant CX2010B379, Hunan Provincial Natural Sciences Foundation of China Grant 06jj5058, and Science and Technology Department Funds of Heng Yang of Hunan Province Grant 2010kj17.	Anderson P, 2004, J LEUKOCYTE BIOL, V76, P42, DOI 10.1189/jlb.1103536; Asztalos BF, 2005, ARTERIOSCL THROM VAS, V25, P2185, DOI 10.1161/01.ATV.0000183727.90611.4f; Barter P, 2007, NEW ENGL J MED, V357, P1301, DOI 10.1056/NEJMoa064278; Barter Philip J, 2007, Curr Cardiol Rep, V9, P493, DOI 10.1007/BF02938394; Bevilacqua A, 2003, J CELL PHYSIOL, V195, P356, DOI 10.1002/jcp.10272; Bocharov AV, 2004, J BIOL CHEM, V279, P36072, DOI 10.1074/jbc.M314264200; Brook M, 2000, FEBS LETT, V483, P57, DOI 10.1016/S0014-5793(00)02084-6; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; Cheneval D, 2010, J BIOMOL SCREEN, V15, P609, DOI 10.1177/1087057110365897; Chou CF, 2006, MOL CELL BIOL, V26, P3695, DOI 10.1128/MCB.26.10.3695-3706.2006; Drouineaud V, 2007, MOL HUM REPROD, V13, P373, DOI 10.1093/molehr/gam019; Eberhardt W, 2007, PHARMACOL THERAPEUT, V114, P56, DOI 10.1016/j.pharmthera.2007.01.002; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; GEISTERFER M, 1993, CYTOKINE, V5, P1, DOI 10.1016/1043-4666(93)90017-Y; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; Han SS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-97; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hao XR, 2009, ATHEROSCLEROSIS, V203, P417, DOI 10.1016/j.atherosclerosis.2008.07.029; Hu Yan-Wei, 2009, Atherosclerosis, V204, pe35, DOI 10.1016/j.atherosclerosis.2008.11.003; Hyka N, 2001, BLOOD, V97, P2381, DOI 10.1182/blood.V97.8.2381; Ivashkiv LB, 2004, ARTHRITIS RES THER, V6, P159, DOI 10.1186/ar1197; JACOB CO, 1993, NUCLEIC ACIDS RES, V21, P2761, DOI 10.1093/nar/21.11.2761; Karwatsky J, 2010, J LIPID RES, V51, P1144, DOI 10.1194/jlr.M003145; Khabar KSA, 2007, J LEUKOCYTE BIOL, V81, P1335, DOI 10.1189/jlb.0207109; Kim KD, 2005, BIOCHEM BIOPH RES CO, V338, P1126, DOI 10.1016/j.bbrc.2005.10.065; King EM, 2009, J PHARMACOL EXP THER, V330, P575, DOI 10.1124/jpet.109.151423; Kleemann R, 2008, CARDIOVASC RES, V79, P360, DOI 10.1093/cvr/cvn120; Krishnamurthy P, 2009, CIRC RES, V104, pE9, DOI 10.1161/CIRCRESAHA.108.188243; Larigauderie G, 2004, ARTERIOSCL THROM VAS, V24, P504, DOI 10.1161/01.ATV.0000115638.27381.97; Lim HW, 2001, J BIOL CHEM, V276, P15913, DOI 10.1074/jbc.M100452200; Liu XH, 2010, J CARDIOVASC PHARM, V56, P309, DOI 10.1097/FJC.0b013e3181edaf69; Luo NL, 2010, DIABETES, V59, P791, DOI 10.2337/db09-1338; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; Ma PL, 2004, J LEUKOCYTE BIOL, V76, P278, DOI 10.1189/jlb.1203653; Mahtani KR, 2001, MOL CELL BIOL, V21, P6461, DOI 10.1128/MCB.21.9.6461-6469.2001; Maitra S, 2008, RNA, V14, P950, DOI 10.1261/rna.983708; Meng FM, 2005, AM J PHYSIOL-CELL PH, V289, pC971, DOI 10.1152/ajpcell.00081.2005; Murphy AJ, 2008, ARTERIOSCL THROM VAS, V28, P2071, DOI 10.1161/ATVBAHA.108.168690; Neininger A, 2002, J BIOL CHEM, V277, P3065, DOI 10.1074/jbc.C100685200; Patel S, 2009, J AM COLL CARDIOL, V53, P962, DOI 10.1016/j.jacc.2008.12.008; Patino WD, 2006, CIRC RES, V98, P1282, DOI 10.1161/01.RES.0000222284.48288.28; Rader DJ, 2009, J LIPID RES, V50, pS189, DOI 10.1194/jlr.R800088-JLR200; Rajasingh J, 2006, FASEB J, V20, P2112, DOI 10.1096/fj.06-6084fje; Ramsamy TA, 2003, J LIPID RES, V44, P733, DOI 10.1194/jlr.M200339-JLR200; Rigby WFC, 2005, J IMMUNOL, V174, P7883, DOI 10.4049/jimmunol.174.12.7883; Ronkina N, 2007, MOL CELL BIOL, V27, P170, DOI 10.1128/MCB.01456-06; Rye KA, 2008, ARTERIOSCL THROM VAS, V28, P1890, DOI 10.1161/ATVBAHA.108.173575; Sauer I, 2006, BLOOD, V107, P4790, DOI 10.1182/blood-2005-07-3058; Schaljo B, 2009, J IMMUNOL, V183, P1197, DOI 10.4049/jimmunol.0803883; Serio KJ, 2000, AM J RESP CELL MOL, V23, P234, DOI 10.1165/ajrcmb.23.2.4042; Skoog T, 1999, HUM MOL GENET, V8, P1443, DOI 10.1093/hmg/8.8.1443; Smoak KA, 2010, CELL METAB, V11, P493, DOI 10.1016/j.cmet.2010.04.006; Suzuki K, 2003, J EXP MED, V198, P1717, DOI 10.1084/jem.20031701; Tang CR, 2009, J BIOL CHEM, V284, P32336, DOI 10.1074/jbc.M109.047472; Tang CK, 2004, ACTA BIOCH BIOPH SIN, V36, P218, DOI 10.1093/abbs/36.3.218; Tellier E, 2008, J CELL PHYSIOL, V214, P687, DOI 10.1002/jcp.21265; Tolle M, 2008, ARTERIOSCL THROM VAS, V28, P1542, DOI 10.1161/ATVBAHA.107.161042; Van Linthout S, 2008, CIRCULATION, V117, P1563, DOI 10.1161/CIRCULATIONAHA.107.710830; Yin K, 2010, MOL MED, V16, P438, DOI 10.2119/molmed.2010.00004; Yoshida Y, 2004, J BIOL CHEM, V279, P1768, DOI 10.1074/jbc.M311498200; Yvan-Charvet L, 2008, CIRCULATION, V118, P1837, DOI 10.1161/CIRCULATIONAHA.108.793869; Zabalawi M, 2007, J LIPID RES, V48, P52, DOI 10.1194/jlr.M600370-JLR200; Zhu X, 2008, J BIOL CHEM, V283, P22930, DOI 10.1074/jbc.M801408200	63	55	62	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					13834	13845		10.1074/jbc.M110.202275	http://dx.doi.org/10.1074/jbc.M110.202275			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21339300	hybrid, Green Published			2022-12-27	WOS:000289556200006
J	Basford, JE; Wancata, L; Hofmann, SM; Silva, RAGD; Davidson, WS; Howles, PN; Hui, DY				Basford, Joshua E.; Wancata, Lauren; Hofmann, Susanna M.; Silva, R. A. Gangani D.; Davidson, W. Sean; Howles, Philip N.; Hui, David Y.			Hepatic Deficiency of Low Density Lipoprotein Receptor-related Protein-1 Reduces High Density Lipoprotein Secretion and Plasma Levels in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNOSE 6-PHOSPHATE RECEPTOR; SELECTIVE UPTAKE; ENDOTHELIAL LIPASE; IN-VIVO; APOA-I; TARGETED INACTIVATION; CHYLOMICRON REMNANTS; CHOLESTERYL ESTERS; LYSOSOMAL-ENZYMES; CATHEPSIN-D	The low density lipoprotein receptor-related protein-1 (LRP1) is known to serve as a chylomicron remnant receptor in the liver responsible for the binding and plasma clearance of apolipoprotein E-containing lipoproteins. Previous in vitro studies have provided evidence to suggest that LRP1 expression may also influence high density lipoprotein (HDL) metabolism. The current study showed that liver-specific LRP1 knock-out (hLrp1(-/-)) mice displayed lower fasting plasma HDL cholesterol levels when compared with hLrp1(+/+) mice. Lecithin:cholesterol acyl transferase and hepatic lipase activities in plasma of hLrp1(-/-) mice were comparable with those observed in hLrp1(+/+) mice, indicating that hepatic LRP1 inactivation does not influence plasma HDL remodeling. Plasma clearance of HDL particles and HDL-associated cholesteryl esters was also similar between hLrp1(+/+) and hLrp1(-/-) mice. In contrast, HDL secretion from primary hepatocytes isolated from hLrp1(-/-) mice was significantly reduced when compared with that observed with hLrp1(+/+) hepatocytes. Biotinylation of cell surface proteins revealed decreased surface localization of the ATP-binding cassette, subfamily A, member 1 (ABCA1) protein, but total cellular ABCA1 level was not changed in hLrp1(-/-) hepatocytes. Finally, hLrp1(-/-) hepatocytes displayed reduced binding capacity for extracellular cathepsin D, resulting in lower intracellular cathepsin D content and impairment of prosaposin activation, a process that is required for membrane translocation of ABCA1 to facilitate cholesterol efflux and HDL secretion. Taken together, these results documented that hepatic LRP1 participates in cellular activation of lysosomal enzymes and through this mechanism, indirectly modulates the production and plasma levels of HDL.	[Basford, Joshua E.; Wancata, Lauren; Hofmann, Susanna M.; Silva, R. A. Gangani D.; Davidson, W. Sean; Howles, Philip N.; Hui, David Y.] Univ Cincinnati, Coll Med, Metab Dis Inst, Dept Pathol & Lab Med, Cincinnati, OH 45237 USA	University System of Ohio; University of Cincinnati	Hui, DY (corresponding author), Univ Cincinnati, Coll Med, Metab Dis Inst, Dept Pathol, ML 0507,2120 E Galbraith Rd, Cincinnati, OH 45237 USA.	huidy@ucmail.uc.edu	Hofmann, Susanna/F-2654-2014	Hofmann, Susanna/0000-0001-7682-5840; Davidson, William/0000-0003-2756-2989	National Institutes of Health [DK74932, HL62542]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T35DK060444, R01DK074932] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK74932 (to D. Y. H.) and HL62542 (to W. S. D.).	Bacskai BJ, 2000, P NATL ACAD SCI USA, V97, P11551, DOI 10.1073/pnas.200238297; Badellino KO, 2004, CURR OPIN CARDIOL, V19, P392, DOI 10.1097/01.hco.0000130161.89169.02; Basford JE, 2009, ARTERIOSCL THROM VAS, V29, P1772, DOI 10.1161/ATVBAHA.109.194357; Basso F, 2003, J LIPID RES, V44, P296, DOI 10.1194/jlr.M200414-JLR200; Beaujouin M, 2010, J CELL SCI, V123, P3336, DOI 10.1242/jcs.070938; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Boucher P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000448; Chisholm JW, 2002, J LIPID RES, V43, P36; Dittmer F, 1999, J CELL SCI, V112, P1591; Edmondson AC, 2009, J CLIN INVEST, V119, P1042, DOI 10.1172/JCI37176; Fazio S, 2000, TRENDS CARDIOVAS MED, V10, P23, DOI 10.1016/S1050-1738(00)00033-5; Fuentealba RA, 2009, J BIOL CHEM, V284, P34045, DOI 10.1074/jbc.M109.021030; Gilham D, 2005, METHODS, V36, P139, DOI 10.1016/j.ymeth.2004.11.003; Gopalakrishnan MM, 2004, BIOCHEM J, V383, P507, DOI 10.1042/BJ20040175; Haidar B, 2006, J BIOL CHEM, V281, P39971, DOI 10.1074/jbc.M605095200; HERZ J, 1990, EMBO J, V9, P1769, DOI 10.1002/j.1460-2075.1990.tb08301.x; Herz J, 2009, J LIPID RES, V50, pS287, DOI 10.1194/jlr.R800077-JLR200; Hiesberger T, 1998, EMBO J, V17, P4617, DOI 10.1093/emboj/17.16.4617; Hofmann SM, 2007, J CLIN INVEST, V117, P3271, DOI 10.1172/JCI31929; HOMANICS GE, 1995, J BIOL CHEM, V270, P2974, DOI 10.1074/jbc.270.7.2974; ISHIBASHI S, 1994, P NATL ACAD SCI USA, V91, P4431, DOI 10.1073/pnas.91.10.4431; Jin WJ, 2003, J CLIN INVEST, V111, P357, DOI [10.1172/JCI16146, 10.1172/JCI200316146]; Kasper D, 1996, J CELL BIOL, V134, P615, DOI 10.1083/jcb.134.3.615; Kiss RS, 2006, J BIOL CHEM, V281, P12081, DOI 10.1074/jbc.M600621200; KOWAL RC, 1989, P NATL ACAD SCI USA, V86, P5810, DOI 10.1073/pnas.86.15.5810; Krimbou L, 2001, J BIOL CHEM, V276, P33241, DOI 10.1074/jbc.M100326200; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; LUDWIG T, 1995, TRENDS CELL BIOL, V5, P202, DOI 10.1016/S0962-8924(00)89000-5; May P, 2004, MOL CELL BIOL, V24, P8872, DOI 10.1128/MCB.24.20.8872-8883.2004; McCarthy JJ, 2004, J MED GENET, V41, P334, DOI 10.1136/jmg.2003.016584; Nijstad N, 2009, J BIOL CHEM, V284, P6093, DOI 10.1074/jbc.M807683200; Orr AW, 2003, J CELL SCI, V116, P2917, DOI 10.1242/jcs.00600; Orr AW, 2003, J CELL BIOL, V161, P1179, DOI 10.1083/jcb.200302069; PITTMAN RC, 1983, BIOCHEM J, V212, P791, DOI 10.1042/bj2120791; PITTMAN RC, 1987, J BIOL CHEM, V262, P2443; Pocathikorn A, 2003, ATHEROSCLEROSIS, V168, P115, DOI 10.1016/S0021-9150(03)00087-X; Rohlmann A, 1996, NAT BIOTECHNOL, V14, P1562, DOI 10.1038/nbt1196-1562; Rohlmann A, 1998, J CLIN INVEST, V101, P689, DOI 10.1172/JCI1240; Santo SMSE, 2004, BLOOD, V103, P3777, DOI 10.1182/blood-2003-11-4051; Strickland DK, 2002, TRENDS ENDOCRIN MET, V13, P66, DOI 10.1016/S1043-2760(01)00526-4; Terrand J, 2009, J BIOL CHEM, V284, P381, DOI 10.1074/jbc.M806538200; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; Vassiliou G, 2004, ARTERIOSCL THROM VAS, V24, P1669, DOI 10.1161/01.ATV.0000134295.09932.60; Vassiliou G, 2001, J BIOL CHEM, V276, P48823, DOI 10.1074/jbc.M103954200; Verges M, 2004, J BIOL CHEM, V279, P9030, DOI 10.1074/jbc.M312908200; Wang MD, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M700326200; WILLIAMS SE, 1992, J BIOL CHEM, V267, P9035; Witting SR, 2003, J BIOL CHEM, V278, P40121, DOI 10.1074/jbc.M305193200; Yu KCW, 2001, J CLIN INVEST, V107, P1387, DOI 10.1172/JCI11750; Zhou L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006853	51	36	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13079	13087		10.1074/jbc.M111.229369	http://dx.doi.org/10.1074/jbc.M111.229369			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21343303	Green Published, hybrid			2022-12-27	WOS:000289282200028
J	Helbig, L; Damrot, J; Hulsenbeck, J; Koberle, B; Brozovic, A; Osmak, M; Fiket, Z; Kaina, B; Fritz, G				Helbig, Lars; Damrot, Julia; Huelsenbeck, Johannes; Koeberle, Beate; Brozovic, Anamaria; Osmak, Maja; Fiket, Zeljka; Kaina, Bernd; Fritz, Gerhard			Late Activation of Stress-activated Protein Kinases/c-Jun N-terminal Kinases Triggered by Cisplatin-induced DNA Damage in Repair-defective Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; ABL TYROSINE KINASE; ENDOPLASMIC-RETICULUM STRESS; DOUBLE-STRANDED BREAKS; C-ABL; IONIZING-RADIATION; GROWTH-FACTOR; UV-LIGHT; SIGNAL-TRANSDUCTION; ULTRAVIOLET-LIGHT	Although stress-activated protein kinases/c-Jun N-terminal kinases (SAPK/JNK) are rapidly activated by genotoxins, the role of DNA damage in this response is not well defined. Here we show that the SEK1/MKK4-mediated dual phosphorylation of SAPK/JNK (Thr-183/Tyr-185) correlates with the level of cis-platin-DNA adducts at late times (16-24 h) after drug treatment in both human and mouse cells, Transfection of platinated plasmid DNA also caused SAPK/JNK activation. A defect in transcription-coupled nucleotide excision repair resting on a mutation in Cockayne syndrome group B protein promoted the late SAPK/JNK activation following cisplatin exposure. Signaling to SAPK/JNK was accompanied by activation of Ataxia telangiectasia mutated- and Rad3-related kinase, replication protein A, and checkpoint kinases as well as by the formation of DNA double strand breaks (DSBs). Ionizing radiation-induced DSBs did not provoke SAP K/JNK activation, and inhibition of transcription also failed to provoke this response. Late activation of SAPK/JNK stimulated by cisplatin-induced DNA lesions was reduced in the absence of specific DNA repair proteins, such as xeroderma pigmentosum protein C, pointing to an essential function of individual repair factors in DNA damage signaling to SAPK/JNK. Collectively, the data indicate that late SAPK/JNK activation is triggered by non-repaired cisplatin adducts in transcribed genes and involves replication-associated events, DSBs, tyrosine kinases, Rho GTPases, and specific repair factors.	[Helbig, Lars; Damrot, Julia; Huelsenbeck, Johannes; Koeberle, Beate; Kaina, Bernd; Fritz, Gerhard] Johannes Gutenberg Univ Mainz, Dept Toxicol, Univ Med Ctr, D-55131 Mainz, Germany; [Brozovic, Anamaria; Osmak, Maja] Rudjer Boskovic Inst, Div Mol Biol, Zagreb 10000, Croatia; [Fiket, Zeljka] Rudjer Boskovic Inst, Div Marine & Environm Res, Zagreb 10000, Croatia	Johannes Gutenberg University of Mainz; Rudjer Boskovic Institute; Rudjer Boskovic Institute	Fritz, G (corresponding author), Univ Dusseldorf, Inst Toxicol, Univ Str 1, D-40225 Dusseldorf, Germany.	fritz@uni-duesseldorf.de	Brozovic, Anamaria/D-5270-2016; Kaina, Bernd/AAE-4692-2020; Fiket, Zeljka/J-4985-2019	Brozovic, Anamaria/0000-0002-6820-2173; Fiket, Zeljka/0000-0002-7628-9045	Deutsche Forschungsgemeinschaft [Fr 1541/5-3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant Fr 1541/5-3.	Baskaran R, 1997, NATURE, V387, P516, DOI 10.1038/387516a0; Ben-Yehoyada M, 2009, MOL CELL, V35, P704, DOI 10.1016/j.molcel.2009.08.014; Benhar M, 2002, ONCOGENE, V21, P8723, DOI 10.1038/sj.onc.1205980; Benhar M, 2002, EMBO REP, V3, P420, DOI 10.1093/embo-reports/kvf094; Benhar M, 2001, MOL CELL BIOL, V21, P6913, DOI 10.1128/MCB.21.20.6913-6926.2001; BIEDERMANN KA, 1991, P NATL ACAD SCI USA, V88, P1394, DOI 10.1073/pnas.88.4.1394; Bogliolo M, 2007, EMBO J, V26, P1340, DOI 10.1038/sj.emboj.7601574; Brozovic A, 2004, INT J CANCER, V112, P974, DOI 10.1002/ijc.20522; Canman CE, 1996, NATURE, V384, P213, DOI 10.1038/384213a0; Christmann M, 2007, CARCINOGENESIS, V28, P183, DOI 10.1093/carcin/bgl119; Christmann M, 2006, NUCLEIC ACIDS RES, V34, P6530, DOI 10.1093/nar/gkl895; COFFER PJ, 1995, ONCOGENE, V11, P561; Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; D'Andrea A, 2003, CURR BIOL, V13, pR546, DOI 10.1016/S0960-9822(03)00467-6; Damrot J, 2009, J MOL BIOL, V385, P1409, DOI 10.1016/j.jmb.2008.12.015; de Boer J, 2000, CARCINOGENESIS, V21, P453, DOI 10.1093/carcin/21.3.453; Deng XM, 2001, J BIOL CHEM, V276, P23681, DOI 10.1074/jbc.M100279200; Dhar V, 1996, CELL GROWTH DIFFER, V7, P841; Dunkern TR, 2003, DNA REPAIR, V2, P49, DOI 10.1016/S1568-7864(02)00185-4; Durocher D, 2001, CURR OPIN CELL BIOL, V13, P225, DOI 10.1016/S0955-0674(00)00201-5; Fousteri M, 2008, CELL RES, V18, P73, DOI 10.1038/cr.2008.6; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES, P25; Fritz G, 2006, MOL BIOL CELL, V17, P851, DOI 10.1091/mbc.E05-07-0606; Furuta T, 2002, CANCER RES, V62, P4899; Gnad R, 2000, MOL PHARMACOL, V58, P1389, DOI 10.1124/mol.58.6.1389; Gross S, 1999, J BIOL CHEM, V274, P26378, DOI 10.1074/jbc.274.37.26378; Hamdi M, 2005, ONCOGENE, V24, P7135, DOI 10.1038/sj.onc.1208875; HANSSON J, 1989, NUCLEIC ACIDS RES, V17, P8073, DOI 10.1093/nar/17.20.8073; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hayakawa J, 2004, MOL CELL, V16, P521, DOI 10.1016/j.molcel.2004.10.024; Hayakawa J, 2003, J BIOL CHEM, V278, P20582, DOI 10.1074/jbc.M210992200; Jamieson ER, 1999, CHEM REV, V99, P2467, DOI 10.1021/cr980421n; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Kaina B, 1997, CANCER RES, V57, P2721; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; KHARBANDA S, 1995, NATURE, V376, P785, DOI 10.1038/376785a0; Kharbanda S, 2000, MOL CELL BIOL, V20, P4979, DOI 10.1128/MCB.20.14.4979-4989.2000; Kitagawa D, 2002, J BIOL CHEM, V277, P366, DOI 10.1074/jbc.M107110200; Koberle B, 2006, DNA REPAIR, V5, P641, DOI 10.1016/j.dnarep.2005.12.001; Kolbus A, 2000, MOL CELL BIOL, V20, P575, DOI 10.1128/MCB.20.2.575-582.2000; KRAMER M, 1993, J BIOL CHEM, V268, P6734; Lackinger D, 2000, MUTAT RES-FUND MOL M, V457, P113, DOI 10.1016/S0027-5107(00)00133-0; Laine JP, 2006, TRENDS GENET, V22, P430, DOI 10.1016/j.tig.2006.06.006; Liedert B, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl051; Liu ZG, 1996, NATURE, V384, P273, DOI 10.1038/384273a0; Ljungman M, 2005, MUTAT RES-FUND MOL M, V577, P203, DOI 10.1016/j.mrfmmm.2005.02.014; Ljungman M, 2004, NAT REV CANCER, V4, P727, DOI 10.1038/nrc1435; Ljungman M, 1999, ONCOGENE, V18, P583, DOI 10.1038/sj.onc.1202356; Ljungman M, 2007, CELL CYCLE, V6, P2252, DOI 10.4161/cc.6.18.4751; Lu CR, 2006, MOL CELL, V23, P121, DOI 10.1016/j.molcel.2006.05.023; Malinge JM, 1999, J INORG BIOCHEM, V77, P23, DOI 10.1016/S0162-0134(99)00148-8; Mandic A, 2003, J BIOL CHEM, V278, P9100, DOI 10.1074/jbc.M210284200; Mansouri A, 2003, J BIOL CHEM, V278, P19245, DOI 10.1074/jbc.M208134200; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Nehme A, 1999, BRIT J CANCER, V79, P1104, DOI 10.1038/sj.bjc.6690176; Nehme A, 1997, CANCER RES, V57, P3253; Ochs K, 2000, CANCER RES, V60, P5815; Pabla N, 2008, J BIOL CHEM, V283, P6572, DOI 10.1074/jbc.M707568200; Patel KJ, 2007, DNA REPAIR, V6, P885, DOI 10.1016/j.dnarep.2007.02.002; Paulsen RD, 2007, DNA REPAIR, V6, P953, DOI 10.1016/j.dnarep.2007.02.015; Pichierri P, 2004, EMBO J, V23, P1178, DOI 10.1038/sj.emboj.7600113; Potapova O, 1997, J BIOL CHEM, V272, P14041, DOI 10.1074/jbc.272.22.14041; Radi M, 2008, BIOORG MED CHEM LETT, V18, P1207, DOI 10.1016/j.bmcl.2007.11.112; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Rebillard A, 2008, CURR MED CHEM, V15, P2656, DOI 10.2174/092986708786242903; Rodemann HP, 2007, INT J RADIAT BIOL, V83, P781, DOI 10.1080/09553000701769970; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Rosette C, 1996, SCIENCE, V274, P1194, DOI 10.1126/science.274.5290.1194; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Sanchez-Perez I, 1998, ONCOGENE, V16, P533, DOI 10.1038/sj.onc.1201578; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Sandrock K, 2010, TRAFFIC, V11, P198, DOI 10.1111/j.1600-0854.2009.01015.x; Shafman T, 1997, NATURE, V387, P520, DOI 10.1038/387520a0; Shangary S, 2000, J BIOL CHEM, V275, P30163, DOI 10.1074/jbc.M004302200; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Stevnsner T, 2002, ONCOGENE, V21, P8675, DOI 10.1038/sj.onc.1205994; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Stiff T, 2006, EMBO J, V25, P5775, DOI 10.1038/sj.emboj.7601446; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; VANDAM H, 1995, EMBO J, V14, P1798, DOI 10.1002/j.1460-2075.1995.tb07168.x; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; von Bardeleben R, 2003, BIOCHEM BIOPH RES CO, V307, P401, DOI 10.1016/S0006-291X(03)01205-1; Wang HC, 2001, CANCER RES, V61, P270; Wilhelm D, 1997, MOL CELL BIOL, V17, P4792, DOI 10.1128/MCB.17.8.4792; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yoshizumi M, 2008, CELL BIOL INT, V32, P1405, DOI 10.1016/j.cellbi.2008.08.011; ZAMBLE DB, 1995, TRENDS BIOCHEM SCI, V20, P435, DOI 10.1016/S0968-0004(00)89095-7	91	16	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					12991	13001		10.1074/jbc.M110.190645	http://dx.doi.org/10.1074/jbc.M110.190645			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21324906	hybrid, Green Published			2022-12-27	WOS:000289282200019
J	Ma, XX; Guo, PC; Shi, WW; Luo, M; Tan, XF; Chen, YX; Zhou, CZ				Ma, Xiao-Xiao; Guo, Peng-Chao; Shi, Wei-Wei; Luo, Ming; Tan, Xiao-Feng; Chen, Yuxing; Zhou, Cong-Zhao			Structural Plasticity of the Thioredoxin Recognition Site of Yeast Methionine S-Sulfoxide Reductase Mxr1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ENZYMATIC REDUCTION; CATALYTIC MECHANISM; BACKBONE DYNAMICS; REDUCED FORM; LIFE-SPAN; PROTEIN; DISULFIDE; COMPLEX; DSBD	The methionine S-sulfoxide reductase MsrA catalyzes the reduction of methionine sulfoxide, a ubiquitous reaction depending on the thioredoxin system. To investigate interactions between MsrA and thioredoxin (Trx), we determined the crystal structures of yeast MsrA/Mxr1 in their reduced, oxidized, and Trx2-complexed forms, at 2.03, 1.90, and 2.70 angstrom, respectively. Comparative structure analysis revealed significant conformational changes of the three loops, which form a plastic "cushion" to harbor the electron donor Trx2. The flexible C-terminal loop enabled Mxr1 to access the methionine sulfoxide on various protein substrates. Moreover, the plasticity of the Trx binding site on Mxr1 provides structural insights into the recognition of diverse substrates by a universal catalytic motif of Trx.	[Ma, Xiao-Xiao; Guo, Peng-Chao; Shi, Wei-Wei; Luo, Ming; Tan, Xiao-Feng; Chen, Yuxing; Zhou, Cong-Zhao] Univ Sci & Technol China, Sch Life Sci, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS	Zhou, CZ (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China.	zcz@ustc.edu.cn	Chen, Yuxing/P-4156-2014; guo, peng/AAG-4052-2019; Zhou, Cong-Zhao/E-9174-2011; tan, xiao/GZL-0264-2022; Guo, Peng/GWC-0572-2022	Chen, Yuxing/0000-0002-7560-1922; Zhou, Cong-Zhao/0000-0002-6881-7151; 	National Natural Science Foundation of China [30870490]; Ministry of Science and Technology of China [2006CB910202]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by the National Natural Science Foundation of China (Program 30870490) and the Ministry of Science and Technology of China (Project 2006CB910202).	ABRAMS WR, 1981, P NATL ACAD SCI-BIOL, V78, P7483, DOI 10.1073/pnas.78.12.7483; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bao R, 2007, PROTEINS, V66, P246, DOI 10.1002/prot.21194; Boschi-Muller S, 2008, ARCH BIOCHEM BIOPHYS, V474, P266, DOI 10.1016/j.abb.2008.02.007; BROT N, 1981, P NATL ACAD SCI-BIOL, V78, P2155, DOI 10.1073/pnas.78.4.2155; Chartron J, 2007, BIOCHEMISTRY-US, V46, P3942, DOI 10.1021/bi700130e; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Coudevylle N, 2007, J MOL BIOL, V366, P193, DOI 10.1016/j.jmb.2006.11.042; Dai SD, 2007, NATURE, V448, P92, DOI 10.1038/nature05937; Davis DA, 2000, BIOCHEM J, V346, P305, DOI 10.1042/0264-6021:3460305; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Grimaud R, 2001, J BIOL CHEM, V276, P48915, DOI 10.1074/jbc.M105509200; Haebel PW, 2002, EMBO J, V21, P4774, DOI 10.1093/emboj/cdf489; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; KALLIS GB, 1980, J BIOL CHEM, V255, P261; Kim YK, 2009, MOL MICROBIOL, V72, P699, DOI 10.1111/j.1365-2958.2009.06680.x; Koc A, 2004, P NATL ACAD SCI USA, V101, P7999, DOI 10.1073/pnas.0307929101; Li Y, 2007, J BIOL CHEM, V282, P11078, DOI 10.1074/jbc.M700970200; Lin ZD, 2007, P NATL ACAD SCI USA, V104, P9597, DOI 10.1073/pnas.0703774104; Lowther WT, 2000, BIOCHEMISTRY-US, V39, P13307, DOI 10.1021/bi0020269; Lowther WT, 2000, P NATL ACAD SCI USA, V97, P6463, DOI 10.1073/pnas.97.12.6463; Maeda K, 2006, STRUCTURE, V14, P1701, DOI 10.1016/j.str.2006.09.012; Moskovitz J, 1997, P NATL ACAD SCI USA, V94, P9585, DOI 10.1073/pnas.94.18.9585; Moskovitz J, 1996, P NATL ACAD SCI USA, V93, P2095, DOI 10.1073/pnas.93.5.2095; Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Quinternet M, 2009, STRUCTURE, V17, P1024, DOI 10.1016/j.str.2009.05.011; Quinternet M, 2008, BIOCHEMISTRY-US, V47, P12710, DOI 10.1021/bi801343c; Ranaivoson FM, 2008, J MOL BIOL, V377, P268, DOI 10.1016/j.jmb.2008.01.021; Ranaivoson FM, 2009, J MOL BIOL, V394, P83, DOI 10.1016/j.jmb.2009.08.073; Rouhier N, 2007, J BIOL CHEM, V282, P3367, DOI 10.1074/jbc.M605007200; Ruan H, 2002, P NATL ACAD SCI USA, V99, P2748, DOI 10.1073/pnas.032671199; Saghert D, 2006, P NATL ACAD SCI USA, V103, P8656, DOI 10.1073/pnas.0602826103; Savage H, 1997, STRUCTURE, V5, P895, DOI 10.1016/S0969-2126(97)00244-X; Stirnimann CU, 2005, STRUCTURE, V13, P985, DOI 10.1016/j.str.2005.04.014; Sun HY, 1999, BIOCHEMISTRY-US, V38, P105, DOI 10.1021/bi981295k; Tarrago L, 2010, J BIOL CHEM, V285, P14964, DOI 10.1074/jbc.M110.108373; Tarrago L, 2009, J BIOL CHEM, V284, P18963, DOI 10.1074/jbc.M109.015487; Taylor AB, 2003, J BACTERIOL, V185, P4119, DOI 10.1128/JB.185.14.4119-4126.2003; Tete-Favier F, 2000, STRUCTURE, V8, P1167, DOI 10.1016/S0969-2126(00)00526-8; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vallee F, 1998, STRUCTURE, V6, P649, DOI 10.1016/S0969-2126(98)00066-5; Wang PF, 1996, BIOCHEMISTRY-US, V35, P4812, DOI 10.1021/bi9526793; Weissbach H, 2002, ARCH BIOCHEM BIOPHYS, V397, P172, DOI 10.1006/abbi.2001.2664; Zhang XH, 2008, BIOL REV, V83, P249, DOI 10.1111/j.1469-185X.2008.00042.x	47	22	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13430	13437		10.1074/jbc.M110.205161	http://dx.doi.org/10.1074/jbc.M110.205161			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21345799	Green Published, hybrid			2022-12-27	WOS:000289282200063
J	Spehr, J; Gelis, L; Osterloh, M; Oberland, S; Hatt, H; Spehr, M; Neuhaus, EM				Spehr, Jennifer; Gelis, Lian; Osterloh, Markus; Oberland, Sonja; Hatt, Hanns; Spehr, Marc; Neuhaus, Eva M.			G Protein-coupled Receptor Signaling via Src Kinase Induces Endogenous Human Transient Receptor Potential Vanilloid Type 6 (TRPV6) Channel Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER EPITHELIAL-CELLS; HUMAN PROSTATE-CANCER; CA2+-PERMEABLE CATIONIC CHANNELS; OPERATED CA2+ CHANNELS; CALCIUM-CHANNEL; PORE PROPERTIES; 2-AMINOETHYLDIPHENYL BORATE; ADENYLATE-CYCLASE; MAST-CELLS; INHIBITION	Ca2+ homeostasis plays a critical role in a variety of cellular processes. We showed previously that stimulation of the prostate-specific G protein-coupled receptor (PSGR) enhances cytosolic Ca2+ and inhibits proliferation of prostate cells. Here, we analyzed the signaling mechanisms underlying the PSGR-mediated Ca2+ increase. Using complementary molecular, biochemical, electrophysiological, and live-cell imaging techniques, we found that endogenous Ca2+-selective transient receptor potential vanilloid type 6 (TRPV6) channels are critically involved in the PSGR-induced Ca2+ signal. Biophysical characterization of the current activated by PSGR stimulation revealed characteristic properties of TRPV6. The molecular identity of the involved channel was confirmed using RNA interference targeting TrpV6. TRPV6-mediated Ca2+ influx depended on Src kinase activity. Src kinase activation occurred independently of G protein activation, presumably by direct interaction with PSGR. Taken together, we report that endogenous TRPV6 channels are activated downstream of a G protein-coupled receptor and present the first physiological characterization of these channels in situ.	[Spehr, Jennifer; Spehr, Marc] RTWH Aachen Univ, Dept Chemosensat, D-52074 Aachen, Germany; [Spehr, Jennifer; Gelis, Lian; Osterloh, Markus; Hatt, Hanns] Ruhr Univ Bochum, Dept Cellular Physiol, D-44780 Bochum, Germany; [Oberland, Sonja; Neuhaus, Eva M.] Charite, NeuroSci Res Ctr, D-10117 Berlin, Germany	RWTH Aachen University; Ruhr University Bochum; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Spehr, J (corresponding author), Rhein Westfal TH Aachen, Dept Chemosensor, 42D,Worringer Weg 1, D-52074 Aachen, Germany.	j.spehr@sensorik.rwth-aachen.de	Spehr, Marc/B-3140-2011; Spehr, Marc/AAK-3162-2021; Neuhaus, Eva M./L-1428-2015	Spehr, Marc/0000-0001-6616-4196; Spehr, Marc/0000-0001-6616-4196; Neuhaus, Eva M./0000-0003-3363-1231	Deutsche Forschungsgemeinschaft [SFB642, EXC257, SP724/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (SFB642, EXC257, and SP724/2-1).	Avila G, 2007, J PHYSIOL-LONDON, V584, P47, DOI 10.1113/jphysiol.2007.137687; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Bodding M, 2005, J BIOL CHEM, V280, P7022, DOI 10.1074/jbc.M410184200; Bodding M, 2003, J BIOL CHEM, V278, P50872, DOI 10.1074/jbc.M308800200; BURGESS GM, 1989, J NEUROSCI, V9, P3314; Chen S, 2000, J NEUROPHYSIOL, V84, P575, DOI 10.1152/jn.2000.84.1.575; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cox ME, 2000, J BIOL CHEM, V275, P13812, DOI 10.1074/jbc.275.18.13812; de Groot T, 2009, J AM SOC NEPHROL, V20, P1693, DOI 10.1681/ASN.2008080873; DeHaven WI, 2008, J BIOL CHEM, V283, P19265, DOI 10.1074/jbc.M801535200; DeHaven WI, 2007, J BIOL CHEM, V282, P17548, DOI 10.1074/jbc.M611374200; Fixemer T, 2003, ONCOGENE, V22, P7858, DOI 10.1038/sj.onc.1206895; Garcia DE, 1998, J NEUROSCI, V18, P2834; GUELLAEN G, 1977, BIOCHIM BIOPHYS ACTA, V484, P465, DOI 10.1016/0005-2744(77)90102-4; HARRIS DN, 1979, J CYCLIC NUCL PROT, V5, P125; Hoenderop JGJ, 2005, PHYSIOL REV, V85, P373, DOI 10.1152/physrev.00003.2004; Hoenderop JGJ, 2001, J PHYSIOL-LONDON, V537, P747; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Irnaten M, 2008, CELL CALCIUM, V44, P441, DOI 10.1016/j.ceca.2008.02.007; Jin XC, 2004, AM J PHYSIOL-CELL PH, V287, pC558, DOI 10.1152/ajpcell.00113.2004; Kawasaki BT, 2006, P NATL ACAD SCI USA, V103, P335, DOI 10.1073/pnas.0508030102; Lehen'kyi V, 2007, ONCOGENE, V26, P7380, DOI 10.1038/sj.onc.1210545; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; Liu J, 2004, J BIOL CHEM, V279, P8212, DOI 10.1074/jbc.M312230200; Lochner A, 2006, CARDIOVASC DRUG REV, V24, P261, DOI 10.1111/j.1527-3466.2006.00261.x; Luttrell DK, 2004, ONCOGENE, V23, P7969, DOI 10.1038/sj.onc.1208162; MA JY, 1994, P NATL ACAD SCI USA, V91, P12351, DOI 10.1073/pnas.91.25.12351; Mariappan MM, 2005, J BIOL CHEM, V280, P28402, DOI 10.1074/jbc.M504861200; Schnitzler MMY, 2008, EMBO J, V27, P3092, DOI 10.1038/emboj.2008.233; Neuhaus EM, 2009, J BIOL CHEM, V284, P16218, DOI 10.1074/jbc.M109.012096; Nilius B, 2000, J PHYSIOL-LONDON, V527, P239, DOI 10.1111/j.1469-7793.2000.00239.x; Peng JB, 2000, BIOCHEM BIOPH RES CO, V278, P326, DOI 10.1006/bbrc.2000.3716; Prakriya M, 2001, J PHYSIOL-LONDON, V536, P3, DOI 10.1111/j.1469-7793.2001.t01-1-00003.x; Raingo J, 2007, NAT NEUROSCI, V10, P285, DOI 10.1038/nn1848; ROUSSEL RR, 1991, P NATL ACAD SCI USA, V88, P10696, DOI 10.1073/pnas.88.23.10696; Sanchez MG, 2005, EUR J PHARMACOL, V515, P20, DOI 10.1016/j.ejphar.2005.04.010; Schindl R, 2002, J BIOL CHEM, V277, P26950, DOI 10.1074/jbc.M203700200; Schlessinger Joseph, 2003, Sci STKE, V2003, pRE12, DOI 10.1126/stke.2003.191.re12; SHAH GV, 1994, ENDOCRINOLOGY, V134, P596, DOI 10.1210/en.134.2.596; Spehr M, 2009, J NEUROCHEM, V109, P1570, DOI 10.1111/j.1471-4159.2009.06085.x; Sternfeld L, 2005, CELL SIGNAL, V17, P951, DOI 10.1016/j.cellsig.2004.11.012; Sternfeld L, 2007, CELL CALCIUM, V42, P91, DOI 10.1016/j.ceca.2006.11.008; Sun YT, 2007, EMBO J, V26, P53, DOI 10.1038/sj.emboj.7601502; Swayne LA, 2009, EMBO REP, V10, P873, DOI 10.1038/embor.2009.125; Sydorenko V, 2003, J PHYSIOL-LONDON, V548, P823, DOI 10.1113/jphysiol.2002.036772; Thebault S, 2006, CANCER RES, V66, P2038, DOI 10.1158/0008-5472.CAN-05-0376; Thebault S, 2003, J CLIN INVEST, V111, P1691, DOI 10.1172/JCI200316293; Vanden Abeele F, 2004, J BIOL CHEM, V279, P30326, DOI 10.1074/jbc.M400106200; Vanden Abeele F, 2003, J BIOL CHEM, V278, P15381, DOI 10.1074/jbc.M212106200; Vazquez G, 2004, J BIOL CHEM, V279, P40521, DOI 10.1074/jbc.M405280200; Vennekens R, 2001, J PHYSIOL-LONDON, V530, P183, DOI 10.1111/j.1469-7793.2001.0183l.x; Voets T, 2001, J BIOL CHEM, V276, P47767, DOI 10.1074/jbc.C100607200; Vriens J, 2009, MOL PHARMACOL, V75, P1262, DOI 10.1124/mol.109.055624; Wissenbach U, 2001, J BIOL CHEM, V276, P19461, DOI 10.1074/jbc.M009895200; Wozny C, 2008, J NEUROSCI, V28, P14358, DOI 10.1523/JNEUROSCI.4973-08.2008; Xu LL, 2000, CANCER RES, V60, P6568; Yeh BI, 2003, J BIOL CHEM, V278, P51044, DOI 10.1074/jbc.M306326200; Yue LX, 2001, NATURE, V410, P705, DOI 10.1038/35070596; Yun HM, 2007, J BIOL CHEM, V282, P5496, DOI 10.1074/jbc.M606215200; Zhang L, 2004, CANCER RES, V64, P8365, DOI 10.1158/0008-5472.CAN-04-2146; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	61	36	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13184	13192		10.1074/jbc.M110.183525	http://dx.doi.org/10.1074/jbc.M110.183525			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21349844	Green Published, hybrid			2022-12-27	WOS:000289282200039
J	Wu, D; Ahrens, R; Osterfeld, H; Noah, TK; Groschwitz, K; Foster, PS; Steinbrecher, KA; Rothenberg, ME; Shroyer, NF; Matthaei, KI; Finkelman, FD; Hogan, SP				Wu, David; Ahrens, Richard; Osterfeld, Heather; Noah, Taeko K.; Groschwitz, Katherine; Foster, Paul S.; Steinbrecher, Kris A.; Rothenberg, Marc E.; Shroyer, Noah F.; Matthaei, Klaus I.; Finkelman, Fred D.; Hogan, Simon P.			Interleukin-13 (IL-13)/IL-13 Receptor alpha 1 (IL-13R alpha 1) Signaling Regulates Intestinal Epithelial Cystic Fibrosis Transmembrane Conductance Regulator Channel-dependent Cl- Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IL-13 RECEPTOR; ULCERATIVE-COLITIS; CHLORIDE CHANNELS; APICAL MEMBRANE; TH2 CYTOKINE; MAST-CELLS; EXPRESSION; ACTIVATION; TRANSPORT; AIRWAY	Interleukin-13 (IL-13) has been linked to the pathogenesis of inflammatory diseases of the gastrointestinal tract. It is postulated that IL-13 drives inflammatory lesions through the modulation of both hematopoietic and nonhematopoietic cell function in the intestine. To delineate the relevant contribution of elevated levels of intestinal IL-13 to intestinal structure and function, we generated an intestinal IL-13 transgenic mouse (iIL-13Tg). We show that constitutive overexpression of IL-13 in the small bowel induces modification of intestinal epithelial architecture (villus blunting, goblet cell hyperplasia, and increased epithelial proliferation) and epithelial function (altered basolateral -> apical Cl- ion conductance). Pharmacological analyses in vitro and in vivo determined that elevated Cl- conductance is mediated by altered cystic fibrosis transmembrane conductance regulator expression and activity. Generation of iIL-13Tg/Il13r alpha 1(-/-), iIL-13Tg/Il13r alpha 2(-/-), and iIL-13Tg/Stat6(-/-) mice revealed that IL-13-mediated dysregulation of epithelial architecture and Cl- conductance is dependent on IL-13R alpha 1 and STAT-6. These observations demonstrate a central role for the IL-13/IL-13R alpha 1 pathway in the regulation of intestinal epithelial cell Cl- secretion via up-regulation of cystic fibrosis transmembrane conductance regulator, suggesting an important role for this pathway in secretory diarrhea.	[Wu, David; Ahrens, Richard; Osterfeld, Heather; Groschwitz, Katherine; Rothenberg, Marc E.; Hogan, Simon P.] Univ Cincinnati, Div Allergy & Immunol, Cincinnati Childrens Hosp, Med Ctr,Coll Med,Dept Pediat, Cincinnati, OH 45229 USA; [Noah, Taeko K.; Steinbrecher, Kris A.; Shroyer, Noah F.] Univ Cincinnati, Div Gastroenterol Hepatol & Nutr, Cincinnati Childrens Hosp, Med Ctr,Coll Med,Dept Pediat, Cincinnati, OH 45229 USA; [Foster, Paul S.] Univ Newcastle, Sch Biomed Sci, Asthma Allergy & Inflammat Res Ctr, Newcastle, NSW 2300, Australia; [Matthaei, Klaus I.] Australian Natl Univ, John Curtin Sch Med Res, Dept Biol Struct, Stem Cell & Gene Targeting Lab, Canberra, ACT 2601, Australia; [Matthaei, Klaus I.] King Saud Univ, Dept Anat, Stem Cell Unit, Riyadh 11745, Saudi Arabia; [Finkelman, Fred D.] Univ Cincinnati, Div Immunobiol, Cincinnati Childrens Hosp, Med Ctr,Coll Med,Dept Pediat, Cincinnati, OH 45229 USA; [Finkelman, Fred D.] Cincinnati Vet Affairs Med Ctr, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Newcastle; Australian National University; John Curtin School of Medical Research; King Saud University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center	Hogan, SP (corresponding author), Univ Cincinnati, Div Allergy & Immunol, Cincinnati Childrens Hosp, Med Ctr,Coll Med,Dept Pediat, 3333 Burnet Ave,ML7028, Cincinnati, OH 45229 USA.	simon.hogan@cchmc.org	Klaus, Matthaei/D-8691-2011; Foster, Paul/G-5057-2013	Shroyer, Noah/0000-0002-5934-2852	National Institutes of Health [R01AI073553-01]; Department of Veterans Affairs; American Heart Foundation Midwest Affiliate and Food Allergy and Anaphylaxis Network; NATIONAL CANCER INSTITUTE [R01CA142826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK084167] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); American Heart Foundation Midwest Affiliate and Food Allergy and Anaphylaxis Network; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI073553-01 (to S. P. H.). This work was also supported by a Department of Veterans Affairs merit award (to F. D. F.) and the American Heart Foundation Midwest Affiliate and Food Allergy and Anaphylaxis Network (to S. P. H.).	Akiho H, 2005, GASTROENTEROLOGY, V129, P131, DOI 10.1053/j.gastro.2005.03.049; Akiho H, 2002, AM J PHYSIOL-GASTR L, V282, pG226, DOI 10.1152/ajpgi.2002.282.2.G226; Amasheh S, 2004, GASTROENTEROLOGY, V126, P1711, DOI 10.1053/j.gastro.2004.03.010; ANDERSON MP, 1992, AM J PHYSIOL, V263, pL1, DOI 10.1152/ajplung.1992.263.1.L1; Anthony RM, 2006, NAT MED, V12, P955, DOI 10.1038/nm1451; Bhuiyan TR, 2009, INFECT IMMUN, V77, P1888, DOI 10.1128/IAI.01101-08; Brandt EB, 2009, J ALLERGY CLIN IMMUN, V123, P53, DOI 10.1016/j.jaci.2008.10.001; Ceponis PJM, 2000, J BIOL CHEM, V275, P29132, DOI 10.1074/jbc.M003516200; CHAO AC, 1994, EMBO J, V13, P1065, DOI 10.1002/j.1460-2075.1994.tb06355.x; Chen G, 2009, J CLIN INVEST, V119, P2914, DOI 10.1172/JCI39731; Chiaramonte MG, 2003, J EXP MED, V197, P687, DOI 10.1084/jem.20020903; CLARKE LL, 1992, SCIENCE, V257, P1125, DOI 10.1126/science.257.5073.1125; CLARKE LL, 1994, P NATL ACAD SCI USA, V91, P479, DOI 10.1073/pnas.91.2.479; Cliffe LJ, 2005, SCIENCE, V308, P1463, DOI 10.1126/science.1108661; Crutchley RD, 2010, ANN PHARMACOTHER, V44, P878, DOI 10.1345/aph.1M658; Donaldson DD, 1998, J IMMUNOL, V161, P2317; Escaffit F, 2005, J CELL PHYSIOL, V203, P15, DOI 10.1002/jcp.20189; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; Fichtner-Feigl S, 2008, GASTROENTEROLOGY, V135, P2003, DOI 10.1053/j.gastro.2008.08.055; Finkelman FD, 2010, J IMMUNOL, V184, P1663, DOI 10.4049/jimmunol.0902185; Forbes EE, 2008, J EXP MED, V205, P897, DOI 10.1084/jem.20071046; Fulkerson PC, 2006, AM J RESP CELL MOL, V35, P337, DOI 10.1165/rcmb.2005-0474OC; GABRIEL SE, 1994, SCIENCE, V266, P107, DOI 10.1126/science.7524148; GAZITUA S, 1982, PFLUG ARCH EUR J PHY, V394, P32, DOI 10.1007/BF01108305; GRASSET E, 1984, AM J PHYSIOL, V247, pC260, DOI 10.1152/ajpcell.1984.247.3.C260; Gregorieff A, 2009, GASTROENTEROLOGY, V137, P1333, DOI 10.1053/j.gastro.2009.06.044; Groschwitz KR, 2009, P NATL ACAD SCI USA, V106, P22381, DOI 10.1073/pnas.0906372106; GRUBB BR, 1995, AM J PHYSIOL-GASTR L, V268, pG505, DOI 10.1152/ajpgi.1995.268.3.G505; Gyomorey K, 2001, PFLUG ARCH EUR J PHY, V443, pS103, DOI 10.1007/s004240100654; HAWKER PC, 1980, GASTROENTEROLOGY, V79, P508; Heller F, 2008, MUCOSAL IMMUNOL, V1, pS58, DOI 10.1038/mi.2008.46; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; Heller F, 2002, IMMUNITY, V17, P629, DOI 10.1016/S1074-7613(02)00453-3; Herbert DR, 2009, J EXP MED, V206, P2947, DOI 10.1084/jem.20091268; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Hershey GKK, 2003, J ALLERGY CLIN IMMUN, V111, P677, DOI 10.1067/mai.2003.1333; Horsnell WGC, 2007, PLOS PATHOG, V3, P46, DOI 10.1371/journal.ppat.0030001; KARTNER N, 1991, CELL, V64, P681, DOI 10.1016/0092-8674(91)90498-N; Kellner J, 2007, INT ARCH ALLERGY IMM, V142, P199, DOI 10.1159/000097022; Khodoun M, 2007, J IMMUNOL, V179, P6429, DOI 10.4049/jimmunol.179.10.6429; Kirkpatrick BD, 2002, J INFECT DIS, V186, P94, DOI 10.1086/341296; Lee CG, 2001, J EXP MED, V194, P809, DOI 10.1084/jem.194.6.809; Madden KB, 2002, J IMMUNOL, V169, P4417, DOI 10.4049/jimmunol.169.8.4417; Mentink-Kane MM, 2004, IMMUNOL REV, V202, P191, DOI 10.1111/j.0105-2896.2004.00210.x; Moyer BD, 1999, J CLIN INVEST, V104, P1353, DOI 10.1172/JCI7453; Murata T, 1998, INT IMMUNOL, V10, P1103, DOI 10.1093/intimm/10.8.1103; Noah TK, 2010, EXP CELL RES, V316, P452, DOI 10.1016/j.yexcr.2009.09.020; Park KS, 2007, J CLIN INVEST, V117, P978, DOI 10.1172/JCI29176; Pawlowski SW, 2009, GASTROENTEROLOGY, V136, P1874, DOI 10.1053/j.gastro.2009.02.072; Prasad S, 2005, LAB INVEST, V85, P1139, DOI 10.1038/labinvest.3700316; SANDLE GI, 1986, GUT, V27, P309, DOI 10.1136/gut.27.3.309; Sasaki S, 2002, EUR J IMMUNOL, V32, P3197, DOI 10.1002/1521-4141(200211)32:11<3197::AID-IMMU3197>3.0.CO;2-1; Skowron-Zwarg M, 2007, EXP CELL RES, V313, P2695, DOI 10.1016/j.yexcr.2007.02.035; Strait RT, 2003, J IMMUNOL, V170, P3835, DOI 10.4049/jimmunol.170.7.3835; Su LP, 2009, GASTROENTEROLOGY, V136, P551, DOI 10.1053/j.gastro.2008.10.081; Surawicz Christina M, 2010, Curr Gastroenterol Rep, V12, P236, DOI 10.1007/s11894-010-0113-4; Urban JF, 1998, IMMUNITY, V8, P255, DOI 10.1016/S1074-7613(00)80477-X; VENGLARIK CJ, 1990, AM J PHYSIOL, V259, pC358; Weber CR, 2010, J BIOL CHEM, V285, P12037, DOI 10.1074/jbc.M109.064808; Wood N, 2003, J EXP MED, V197, P703, DOI 10.1084/jem.20020906; Wynn TA, 2003, ANNU REV IMMUNOL, V21, P425, DOI 10.1146/annurev.immunol.21.120601.141142; Zhao AP, 2008, GASTROENTEROLOGY, V135, P217, DOI 10.1053/j.gastro.2008.03.077; Zhao AP, 2003, J IMMUNOL, V171, P948, DOI 10.4049/jimmunol.171.2.948; Zheng T, 2000, J CLIN INVEST, V106, P1081, DOI 10.1172/JCI10458; Zheng T, 2003, J ALLERGY CLIN IMMUN, V111, P720, DOI 10.1067/mai.2003.1383; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909; Zund G, 1996, J BIOL CHEM, V271, P7460; ZURAWSKI SM, 1995, J BIOL CHEM, V270, P13869, DOI 10.1074/jbc.270.23.13869	68	39	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13357	13369		10.1074/jbc.M110.214965	http://dx.doi.org/10.1074/jbc.M110.214965			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21303908	Green Submitted, hybrid, Green Published			2022-12-27	WOS:000289282200056
J	Brunel, A; Wilson, A; Henry, L; Dorlet, P; Santolini, J				Brunel, Albane; Wilson, Adjele; Henry, Laura; Dorlet, Pierre; Santolini, Jerome			The Proximal Hydrogen Bond Network Modulates Bacillus subtilis Nitric-oxide Synthase Electronic and Structural Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA SYNTHETASE; DEINOCOCCUS-RADIODURANS; STAPHYLOCOCCUS-AUREUS; NO SYNTHASE; L-ARGININE; CATALYTIC PROFILES; HEME COORDINATION; BINDING-SITES; PROTEIN; COMPLEXES	Bacterial nitric-oxide synthase (NOS)-like proteins are believed to be genuine NOSs. As for cytochromes P450 (CYPs), NOS-proximal ligand is a thiolate that exerts a push effect crucial for the process of dioxygen activation. Unlike CYPs, this catalytic electron donation seems controlled by a hydrogen bond (H-bond) interaction between the thiolate ligand and a vicinal tryptophan. Variations of the strength of this H-bond could provide a direct way to tune the stability along with the electronic and structural properties of NOS. We generated five different mutations of bsNOS Trp(66), which can modulate this proximal H-bond. We investigated the effects of these mutations on different NOS complexes (Fe-III, (FeCO)-C-II, and (FeNO)-N-II), using a combination of UV-visible absorption, EPR, FTIR, and resonance Raman spectroscopies. Our results indicate that (i) the proximal H-bond modulation can selectively decrease or increase the electron donating properties of the proximal thiolate, (ii) this modulation controls the sigma-competition between distal and proximal ligands, (iii) this H-bond controls the stability of various NOS intermediates, and (iv) a fine tuning of the electron donation by the proximal ligand is required to allow at the same time oxygen activation and to prevent uncoupling reactions.	CEA, iBiTec S, SB2SM, F-91191 Gif Sur Yvette, France; CNRS, Lab Stress Oxydant & Detoxicat, URA 2096, F-91191 Gif Sur Yvette, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS)	Santolini, J (corresponding author), CEA Saclay, F-91191 Gif Sur Yvette, France.	jerome.santolini@cea.fr		Dorlet, Pierre/0000-0001-7394-3374; Wilson, Adjele Flore/0000-0003-2622-3600; Santolini, Jerome/0000-0001-8919-112X				Abu-Soud HM, 1998, BIOCHEMISTRY-US, V37, P3777, DOI 10.1021/bi972398q; Adak S, 1999, J BIOL CHEM, V274, P26907, DOI 10.1074/jbc.274.38.26907; Adak S, 2000, J BIOL CHEM, V275, P17434, DOI 10.1074/jbc.M000846200; Adak S, 2001, J INORG BIOCHEM, V83, P301, DOI 10.1016/S0162-0134(00)00176-8; Adak S, 2002, J BIOL CHEM, V277, P16167, DOI 10.1074/jbc.M201136200; Adak S, 2002, P NATL ACAD SCI USA, V99, P107, DOI 10.1073/pnas.012470099; Berka V, 2000, BIOCHEMISTRY-US, V39, P9373, DOI 10.1021/bi992769y; Bird LE, 2002, STRUCTURE, V10, P1687, DOI 10.1016/S0969-2126(02)00911-5; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bredt DS, 2003, J CELL SCI, V116, P9, DOI 10.1242/jcs.00183; Buddha MR, 2004, J BIOL CHEM, V279, P49567, DOI 10.1074/jbc.C400418200; Buddha MR, 2004, P NATL ACAD SCI USA, V101, P15881, DOI 10.1073/pnas.0405483101; Chabin RM, 1996, BIOCHEMISTRY-US, V35, P9567, DOI 10.1021/bi960476o; Chartier FJM, 2006, J BIOL CHEM, V281, P9953, DOI 10.1074/jbc.M513893200; Chartier FJM, 2004, BIOPHYS J, V87, P1939, DOI 10.1529/biophysj.104.042119; Chartier FJM, 2007, J BIOL CHEM, V282, P20877, DOI 10.1074/jbc.M701800200; Chartier FJM, 2007, BIOCHEM J, V401, P235, DOI 10.1042/BJ20060913; Couture M, 2001, J BIOL CHEM, V276, P38280; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Doukov T, 2009, BIOCHEMISTRY-US, V48, P10246, DOI 10.1021/bi9009743; Fan BC, 1997, BIOCHEMISTRY-US, V36, P12660, DOI 10.1021/bi9715369; Ghosh DK, 2003, FRONT BIOSCI-LANDMRK, V8, pD193, DOI 10.2741/959; Giroud C, 2010, J BIOL CHEM, V285, P7233, DOI 10.1074/jbc.M109.038240; Gorren ACF, 2002, BIOCHEMISTRY-US, V41, P7819, DOI 10.1021/bi025675o; Gusarov I, 2005, P NATL ACAD SCI USA, V102, P13855, DOI 10.1073/pnas.0504307102; Gusarov I, 2008, J BIOL CHEM, V283, P13140, DOI 10.1074/jbc.M710178200; Gusarov I, 2009, SCIENCE, V325, P1380, DOI 10.1126/science.1175439; Hughes MN, 2008, METHOD ENZYMOL, V436, P3, DOI 10.1016/S0076-6879(08)36001-7; Ignarro LJ, 2002, J PHYSIOL PHARMACOL, V53, P503; Johnson EG, 2008, CHEM BIOL, V15, P43, DOI 10.1016/j.chembiol.2007.11.014; Kers JA, 2004, NATURE, V429, P79, DOI 10.1038/nature02504; Lang J, 2009, J INORG BIOCHEM, V103, P1102, DOI 10.1016/j.jinorgbio.2009.05.011; Li D, 2007, J AM CHEM SOC, V129, P6943, DOI 10.1021/ja070683j; Li HY, 2006, J BIOL INORG CHEM, V11, P753, DOI 10.1007/s00775-006-0123-8; Lowenstein CJ, 2004, J CELL SCI, V117, P2865, DOI 10.1242/jcs.01166; Marechal A, 2010, FEBS J, V277, P3963, DOI 10.1111/j.1742-4658.2010.07786.x; Martinis SA, 1996, BIOCHEMISTRY-US, V35, P14530, DOI 10.1021/bi961511u; Meunier B, 2004, CHEM REV, V104, P3947, DOI 10.1021/cr020443g; Migita CT, 1997, BIOCHEMISTRY-US, V36, P10987, DOI 10.1021/bi970823+; Moreau M, 2008, J BIOL CHEM, V283, P32957, DOI 10.1074/jbc.M804838200; Mungrue IN, 2004, J CELL SCI, V117, P2627, DOI 10.1242/jcs.01187; Ogliaro F, 2002, J INORG BIOCHEM, V91, P554, DOI 10.1016/S0162-0134(02)00437-3; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Pant K, 2006, BIOCHEMISTRY-US, V45, P2537, DOI 10.1021/bi0518848; Pant K, 2002, BIOCHEMISTRY-US, V41, P11071, DOI 10.1021/bi0263715; Patel BA, 2009, P NATL ACAD SCI USA, V106, P18183, DOI 10.1073/pnas.0907262106; Poulos TL, 2007, DRUG METAB REV, V39, P557, DOI 10.1080/03602530701498240; Poulos TL, 1996, J BIOL INORG CHEM, V1, P356, DOI 10.1007/s007750050064; Poulos TL, 2005, DRUG METAB DISPOS, V33, P10, DOI 10.1124/dmd.104.002071; Presta A, 1998, BIOCHEMISTRY-US, V37, P298, DOI 10.1021/bi971944c; RAY GB, 1994, J AM CHEM SOC, V116, P162, DOI 10.1021/ja00080a019; Reece SY, 2009, BIOCHEMISTRY-US, V48, P5483, DOI 10.1021/bi900385g; Rousseau DL, 2005, J INORG BIOCHEM, V99, P306, DOI 10.1016/j.jinorgbio.2004.11.007; Salard I, 2006, J INORG BIOCHEM, V100, P2024, DOI 10.1016/j.jinorgbio.2006.09.017; Santolini J, 2001, J BIOL CHEM, V276, P48887, DOI 10.1074/jbc.M108666200; Santolini M, 2006, BIOCHEMISTRY-US, V45, P1480, DOI 10.1021/bi051710q; Sessa WC, 2004, J CELL SCI, V117, P2427, DOI 10.1242/jcs.01165; Shatalin K, 2008, P NATL ACAD SCI USA, V105, P1009, DOI 10.1073/pnas.0710950105; Sono M, 1996, CHEM REV, V96, P2841, DOI 10.1021/cr9500500; Spiro TG, 2005, J INORG BIOCHEM, V99, P34, DOI 10.1016/j.jinorgbio.2004.09.026; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Stuehr DJ, 2004, J BIOL CHEM, V279, P36167, DOI 10.1074/jbc.R400017200; Sudhamsu J, 2006, J BIOL CHEM, V281, P9623, DOI 10.1074/jbc.M510062200; Sudhamsu J, 2009, TRENDS MICROBIOL, V17, P212, DOI 10.1016/j.tim.2009.02.003; Tejero JS, 2008, J BIOL CHEM, V283, P33498, DOI 10.1074/jbc.M806122200; Voegtle HL, 2003, BIOCHEMISTRY-US, V42, P2475, DOI 10.1021/bi0271502; WANG JL, 1993, J BIOL CHEM, V268, P22255; WANG JL, 1994, P NATL ACAD SCI USA, V91, P10512, DOI 10.1073/pnas.91.22.10512; WANG JL, 1995, BIOCHEMISTRY-US, V34, P7080, DOI 10.1021/bi00021a020; Wang JL, 1997, BIOCHEMISTRY-US, V36, P4595, DOI 10.1021/bi962309u; Wang ZQ, 2007, J BIOL CHEM, V282, P2196, DOI 10.1074/jbc.M608206200; Wang ZQ, 2010, J INORG BIOCHEM, V104, P349, DOI 10.1016/j.jinorgbio.2009.11.006; Wang ZQ, 2004, J BIOL CHEM, V279, P19018, DOI 10.1074/jbc.M311663200; Zemojtel T, 2006, TRENDS PLANT SCI, V11, P524, DOI 10.1016/j.tplants.2006.09.008	74	18	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.195446	http://dx.doi.org/10.1074/jbc.M110.195446			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21310962	Green Published, hybrid			2022-12-27	WOS:000289077500013
J	Shanware, NP; Hutchinson, JA; Kim, SH; Zhan, LH; Bowler, MJ; Tibbetts, RS				Shanware, Naval P.; Hutchinson, John A.; Kim, Sang Hwa; Zhan, Lihong; Bowler, Michael J.; Tibbetts, Randal S.			Casein Kinase 1-dependent Phosphorylation of Familial Advanced Sleep Phase Syndrome-associated Residues Controls PERIOD 2 Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-BASIS; CKI-EPSILON; PROTEIN; MUTATION; DROSOPHILA; RHYTHM; DEGRADATION; CK1-EPSILON; GROWTH; PLAYS	The mammalian circadian clock component PERIOD2 (PER2) plays a critical role in circadian rhythm entrainment. Recently, a missense mutation at a putative phosphorylation site in hPER2, Ser-662, was identified in patients that suffer from familial advanced sleep phase syndrome (FASPS). Patients with FASPS display abnormal sleep-wake patterns characterized by a lifelong pattern of sleep onset in the early evening and offset in the early morning. Although the phosphorylation of PER2 is strongly implied from functional studies, it has not been possible to study the site-specific phosphorylation of PER2 on Ser-662, and the biochemical functions of this residue are unclear. Here, we used phospho-specific antibodies to show that PER2 is phosphorylated on Ser-662 and flanking casein kinase (CK) sites in vivo. The phosphorylation of PER2 was carried out by the combined activities of casein kinase 1 delta (CK1 delta) and casein kinase 1 epsilon (CK1 epsilon) and was antagonized by protein phosphatase 1. PER2 phosphorylation was rapidly induced in response to circadian entrainment of mammalian cell lines and occurred in both cytosolic and nuclear compartments. Importantly, we found that the pool of Ser-662-phosphorylated PER2 proteins was more stable than the pool of total PER2 molecules, implying that the FASPS phosphorylation cluster antagonizes PER2 degradation. Consistent with this idea, a Ser-662 -> Ala mutation that abrogated PER2 phosphorylation significantly reduced its half-life, whereas a phosphomimetic Ser-662 -> Asp substitution led to an elevation in half-life. Our combined findings provide new insights into PER2 regulation and the biochemical basis of FASPS.	[Tibbetts, Randal S.] Univ Wisconsin, Dept Pharmacol, Sch Med & Publ Hlth, Madison, WI 53705 USA; Univ Wisconsin, Mol & Cellular Pharmacol Program, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Tibbetts, RS (corresponding author), Univ Wisconsin, Dept Pharmacol, Sch Med & Publ Hlth, Madison, WI 53705 USA.	rstibbetts@wisc.edu		Tibbetts, Randal/0000-0003-2245-2297	National Institutes of Health [CA124722, T32ES007015]; American Cancer Society [RSG-06-113-01]; Greater Milwaukee Foundation; American Heart Association; NATIONAL CANCER INSTITUTE [R01CA124722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007015] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Greater Milwaukee Foundation; American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA124722 (to R. S. T.) and T32ES007015 (to J. A. H.). This work was also supported by American Cancer Society Grant RSG-06-113-01 and a Shaw scientist award (to R. S. T.) from the Greater Milwaukee Foundation.; Supported by an American Heart Association Predoctoral Fellowship.	Albrecht U, 2007, COLD SPRING HARB SYM, V72, P95, DOI 10.1101/sqb.2007.72.001; Arjona A, 2006, J INTERF CYTOK RES, V26, P645, DOI 10.1089/jir.2006.26.645; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Brockschmidt C, 2008, GUT, V57, P799, DOI 10.1136/gut.2007.123695; Connor JH, 1998, J BIOL CHEM, V273, P27716, DOI 10.1074/jbc.273.42.27716; Eide EJ, 2005, MOL CELL BIOL, V25, P2795, DOI 10.1128/MCB.25.7.2795-2807.2005; Eide EJ, 2001, CHRONOBIOL INT, V18, P389, DOI 10.1081/CBI-100103963; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Gallego M, 2006, BIOCHEM J, V399, P169, DOI 10.1042/BJ20060678; Gery S, 2006, MOL CELL, V22, P375, DOI 10.1016/j.molcel.2006.03.038; Kondratov RV, 2007, TRENDS CELL BIOL, V17, P311, DOI 10.1016/j.tcb.2007.07.001; Lee H, 2009, P NATL ACAD SCI USA, V106, P21359, DOI 10.1073/pnas.0906651106; Mackey SR, 2007, COLD SPRING HARB SYM, V72, P7, DOI 10.1101/sqb.2007.72.060; Martino TA, 2007, HYPERTENSION, V49, P1104, DOI 10.1161/HYPERTENSIONAHA.106.083568; Mehra A, 2009, TRENDS BIOCHEM SCI, V34, P483, DOI 10.1016/j.tibs.2009.06.006; Meng QJ, 2008, NEURON, V58, P78, DOI 10.1016/j.neuron.2008.01.019; Okamura H, 2004, MOL CELL BIOL, V24, P4184, DOI 10.1128/MCB.24.10.4184-4195.2004; Preuss F, 2004, MOL CELL BIOL, V24, P886, DOI 10.1128/MCB.24.2.886-898.2004; RALPH MR, 1988, SCIENCE, V241, P1225, DOI 10.1126/science.3413487; Reddy AB, 2006, CURR BIOL, V16, P1107, DOI 10.1016/j.cub.2006.04.026; Reischl S, 2007, J BIOL RHYTHM, V22, P375, DOI 10.1177/0748730407303926; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; Rosbash M, 2007, COLD SPRING HARB SYM, V72, P75, DOI 10.1101/sqb.2007.72.062; Sathyanarayanan S, 2004, CELL, V116, P603, DOI 10.1016/S0092-8674(04)00128-X; Shanware NP, 2007, J BIOL CHEM, V282, P6283, DOI 10.1074/jbc.M610674200; Shirogane T, 2005, J BIOL CHEM, V280, P26863, DOI 10.1074/jbc.M502862200; Siepka SM, 2007, COLD SPRING HARB SYM, V72, P251, DOI 10.1101/sqb.2007.72.052; Suri V, 2000, J NEUROSCI, V20, P7547; Swingle Mark, 2007, V365, P23; Takano A, 2006, BIOCHEM BIOPH RES CO, V346, P95, DOI 10.1016/j.bbrc.2006.05.082; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Udho E, 2002, BIOCHEM BIOPH RES CO, V297, P463, DOI 10.1016/S0006-291X(02)02236-2; Vanselow K, 2007, COLD SPRING HARB SYM, V72, P167, DOI 10.1101/sqb.2007.72.036; Vanselow K, 2006, GENE DEV, V20, P2660, DOI 10.1101/gad.397006; Virshup DM, 2007, COLD SPRING HARB SYM, V72, P413, DOI 10.1101/sqb.2007.72.048; Xu Y, 2007, CELL, V128, P59, DOI 10.1016/j.cell.2006.11.043; Xu Y, 2005, NATURE, V434, P640, DOI 10.1038/nature03453	37	50	53	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M111.224014	http://dx.doi.org/10.1074/jbc.M111.224014			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21324900	Green Published, hybrid			2022-12-27	WOS:000289077500087
J	Volkmann, K; Lucas, JL; Vuga, D; Wang, XP; Brumm, D; Stiles, C; Kriebel, D; Der-Sarkissian, A; Krishnan, K; Schweitzer, C; Liu, Z; Malyankar, UM; Chiovitti, D; Canny, M; Durocher, D; Sicheri, F; Patterson, JB				Volkmann, Kori; Lucas, Julie L.; Vuga, Danka; Wang, Xiaoping; Brumm, Duane; Stiles, Caryn; Kriebel, David; Der-Sarkissian, Ani; Krishnan, Kris; Schweitzer, Colleen; Liu, Zheng; Malyankar, Uriel M.; Chiovitti, David; Canny, Marella; Durocher, Dan; Sicheri, Frank; Patterson, John B.			Potent and Selective Inhibitors of the Inositol-requiring Enzyme 1 Endoribonuclease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; MESSENGER-RNA; TRANSMEMBRANE PROTEIN; TRANSCRIPTION FACTOR; ER STRESS; PYRIDOXAL-PHOSPHATE; MAMMALIAN-CELLS; KINASE-ACTIVITY; RIBONUCLEASE-A	Inositol-requiring enzyme 1 (IRE1) is the most highly conserved signaling node of the unfolded protein response (UPR) and represents a potential therapeutic target for a number of diseases associated with endoplasmic reticulum stress. IRE1 activates the XBP-1 transcription factor by site-specific cleavage of two hairpin loops within its mRNA to facilitate its nonconventional splicing and alternative translation. We screened for inhibitors using a construct containing the unique cytosolic kinase and endoribonuclease domains of human IRE1 alpha (hIRE1 alpha-cyto) and a mini-XBP-1 stem-loop RNA as the substrate. One class compounds was salicylaldehyde analogs from the hydrolyzed product of salicylaldimines in the library. Salicylaldehyde analogs were active in inhibiting the site-specific cleavage of several mini-XBP-1 stem-loop RNAs in a dose-dependent manner. Salicyaldehyde analogs were also active in inhibiting yeast Ire1 but had little activity inhibiting RNase L or the unrelated RNases A and T-1. Kinetic analysis revealed that one potent salicylaldehyde analog, 3-ethoxy-5,6-dibromosalicylaldehyde, is a non-competitive inhibitor with respect to the XBP-1 RNA substrate. Surface plasmon resonance studies confirmed this compound bound to IRE1 in a specific, reversible and dose-dependent manner. Salicylaldehydes inhibited XBP-1 splicing induced pharmacologically in human cells. These compounds also blocked transcriptional up-regulation of known XBP-1 targets as well as mRNAs targeted for degradation by IRE1. Finally, the salicylaldehyde analog 3-methoxy-6-bromosalicylaldehyde strongly inhibited XBP-1 splicing in an in vivo model of acute endoplasmic reticulum stress. To our knowledge, salicylaldehyde analogs are the first reported specific IRE1 endoribonuclease inhibitors.	[Volkmann, Kori; Lucas, Julie L.; Vuga, Danka; Wang, Xiaoping; Brumm, Duane; Stiles, Caryn; Kriebel, David; Der-Sarkissian, Ani; Krishnan, Kris; Schweitzer, Colleen; Liu, Zheng; Malyankar, Uriel M.; Patterson, John B.] MannKind Corp, Valencia, CA 91355 USA; [Chiovitti, David; Canny, Marella; Durocher, Dan; Sicheri, Frank] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Syst Biol, Toronto, ON M5G 1X5, Canada; [Durocher, Dan; Sicheri, Frank] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Patterson, JB (corresponding author), 28903 N Ave Paine, Valencia, CA 91355 USA.	jpatterson@mannkindcorp.com	Sicheri, Frank/F-8856-2013; Durocher, Daniel/A-7733-2010	Durocher, Daniel/0000-0003-3863-8635; Lucas, Julie/0000-0001-6094-1740	Multiple Myeloma Research Foundation	Multiple Myeloma Research Foundation	This work was supported in part by a Biotech Investment Award from the Multiple Myeloma Research Foundation.	Auf G, 2010, P NATL ACAD SCI USA, V107, P15553, DOI 10.1073/pnas.0914072107; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Carrasco DR, 2007, CANCER CELL, V11, P349, DOI 10.1016/j.ccr.2007.02.015; Carroll SS, 1996, J BIOL CHEM, V271, P4988; Copeland R. A., 2005, EVALUATION ENZYME IN; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Dong BH, 1999, NUCLEIC ACIDS RES, V27, P439, DOI 10.1093/nar/27.2.439; Dong BH, 2001, RNA, V7, P361, DOI 10.1017/S1355838201002230; DuRose JB, 2006, MOL BIOL CELL, V17, P3095, DOI 10.1091/mbc.E06-01-0055; GEORGALIS Y, 1991, BIOCHIM BIOPHYS ACTA, V1118, P1, DOI 10.1016/0167-4838(91)90434-2; Gonzalez TN, 1999, EMBO J, V18, P3119, DOI 10.1093/emboj/18.11.3119; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Harding HP, 2008, RNA, V14, P225, DOI 10.1261/rna.859908; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Hetz C, 2009, MOL CELL, V35, P551, DOI 10.1016/j.molcel.2009.08.021; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Iwawaki T, 2009, P NATL ACAD SCI USA, V106, P16657, DOI 10.1073/pnas.0903775106; Kao RYT, 2002, P NATL ACAD SCI USA, V99, P10066, DOI 10.1073/pnas.152342999; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2003, P NATL ACAD SCI USA, V100, P9946, DOI 10.1073/pnas.1334037100; Lee AS, 2006, CANCER BIOL THER, V5, P721, DOI 10.4161/cbt.5.7.3120; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lee KPK, 2008, CELL, V132, P89, DOI 10.1016/j.cell.2007.10.057; Li H, 2010, P NATL ACAD SCI USA, V107, P16113, DOI 10.1073/pnas.1010580107; MORI K, 1993, CELL, V74, P743; Niwa M, 1999, CELL, V99, P691, DOI 10.1016/S0092-8674(00)81667-0; Oikawa D, 2007, BIOCHEM BIOPH RES CO, V360, P122, DOI 10.1016/j.bbrc.2007.06.020; Papa FR, 2003, SCIENCE, V302, P1533, DOI 10.1126/science.1090031; Percudani R, 2003, EMBO REP, V4, P850, DOI 10.1038/sj.embor.embor914; Qiu YF, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000514; RAETZ CRH, 1972, BIOCHEMISTRY-US, V11, P2229, DOI 10.1021/bi00762a004; Raines RT, 1998, CHEM REV, V98, P1045, DOI 10.1021/cr960427h; RIQUELME P, 1975, INT J PEPT PROT RES, V7, P379; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; Smith M.B., 2007, ADV ORGANIC CHEM REA, V6th ed, DOI 10.1002/9780470084960.ch15; Spiotto MT, 2010, CANCER RES, V70, P78, DOI 10.1158/0008-5472.CAN-09-2747; Sriburi R, 2007, J BIOL CHEM, V282, P7024, DOI 10.1074/jbc.M609490200; Thakur CS, 2007, P NATL ACAD SCI USA, V104, P9585, DOI 10.1073/pnas.0700590104; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Ueno Y, 2003, BIOORGAN MED CHEM, V11, P5069, DOI 10.1016/j.bmc.2003.08.025; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wiseman RL, 2010, MOL CELL, V38, P291, DOI 10.1016/j.molcel.2010.04.001; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Ye JB, 2009, CURR MOL MED, V9, P411, DOI 10.2174/156652409788167096; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2009, CELL STRUCT FUNCT, V34, P1, DOI 10.1247/csf.06028; Zhou JH, 2006, P NATL ACAD SCI USA, V103, P14343, DOI 10.1073/pnas.0606480103	55	164	182	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.199737	http://dx.doi.org/10.1074/jbc.M110.199737			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21303903	hybrid, Green Published			2022-12-27	WOS:000289077500085
J	Bergeron, SE; Wedemeyer, EW; Lee, R; Wen, KK; McKane, M; Pierick, AR; Berger, AP; Rubenstein, PA; Bartlett, HL				Bergeron, Sarah E.; Wedemeyer, Elesa W.; Lee, Rose; Wen, Kuo-Kuang; McKane, Melissa; Pierick, Alyson R.; Berger, Anthony P.; Rubenstein, Peter A.; Bartlett, Heather L.			Allele-specific Effects of Thoracic Aortic Aneurysm and Dissection alpha-Smooth Muscle Actin Mutations on Actin Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST ACTIN; BUDDING YEAST; F-ACTIN; SACCHAROMYCES-CEREVISIAE; SKELETAL-MUSCLE; IN-VITRO; MITOCHONDRIAL INHERITANCE; MASS-SPECTROMETRY; GENE ACTA1; CELL-CYCLE	Twenty-two missense mutations in ACTA2, which encodes alpha-smooth muscle actin, have been identified to cause thoracic aortic aneurysm and dissection. Limited access to diseased tissue, the presence of multiple unresolvable actin isoforms in the cell, and lack of an animal model have prevented analysis of the biochemical mechanisms underlying this pathology. We have utilized actin from the yeast Saccharomyces cerevisiae, 86% identical to human alpha-smooth muscle actin, as a model. Two of the known human mutations, N115T and R116Q, were engineered into yeast actin, and their effect on actin function in vivo and in vitro was investigated. Both mutants exhibited reduced ability to grow under a variety of stress conditions, which hampered N115T cells more than R116Q cells. Both strains exhibited abnormal mitochondrial morphology indicative of a faulty actin cytoskeleton. In vitro, the mutant actins exhibited altered thermostability and nucleotide exchange rates, indicating effects of the mutations on monomer conformation, with R116Q the most severely affected. N115T demonstrated a biphasic elongation phase during polymerization, whereas R116Q demonstrated a markedly extended nucleation phase. Allele-specific effects were also seen on critical concentration, rate of depolymerization, and filament treadmilling. R116Q filaments were hypersensitive to severing by the actin-binding protein cofilin. In contrast, N115T filaments were hyposensitive to cofilin despite nearly normal binding affinities of actin for cofilin. The mutant-specific effects on actin behavior suggest that individual mechanisms may contribute to thoracic aortic aneurysm and dissection.	[Bergeron, Sarah E.; Lee, Rose; Wen, Kuo-Kuang; McKane, Melissa; Pierick, Alyson R.; Berger, Anthony P.; Rubenstein, Peter A.; Bartlett, Heather L.] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA; [Wedemeyer, Elesa W.; Lee, Rose; Pierick, Alyson R.; Bartlett, Heather L.] Univ Iowa, Dept Pediat, Roy A & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Bergeron, Sarah E.] Univ Iowa, Interdisciplinary Program Mol & Cellular Biol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa	Bartlett, HL (corresponding author), Univ Iowa, Dept Biochem, 200 Hawkins Dr,2801 JPP, Iowa City, IA 52242 USA.	heather-bartlett@uiowa.edu		Rubenstein, Peter/0000-0003-1225-4414; Bartlett, Heather/0000-0002-4224-6151; Berger, Anthony/0000-0002-1320-5887	National Institutes of Health (NIH) [DC008803]; NIH, NCRR [UL1RR024979]; American Heart Association [0830053N]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024979] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008803, R55DC008803] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grant DC008803 (to P.A.R.), and NIH, NCRR, Grant UL1RR024979 (to H.L.B. and P.A.R.). This work was also supported by American Heart Association Grant 0830053N (to H.L.B.).	Albornoz G, 2006, ANN THORAC SURG, V82, P1400, DOI 10.1016/j.athoracsur.2006.04.098; Amberg DC, 1998, MOL BIOL CELL, V9, P3259, DOI 10.1091/mbc.9.12.3259; Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; Blondin L, 2001, EUR J BIOCHEM, V268, P6426, DOI 10.1046/j.0014-2956.2001.02592.x; Boldogh IR, 2005, GENE, V354, P28, DOI 10.1016/j.gene.2005.03.049; Boldogh IR, 2001, TRAFFIC, V2, P368, DOI 10.1034/j.1600-0854.2001.002006368.x; BRETSCHER A, 1994, J CELL BIOL, V126, P821, DOI 10.1083/jcb.126.4.821; Bryan KE, 2006, J BIOL CHEM, V281, P20129, DOI 10.1074/jbc.M601514200; Bryan KE, 2009, J BIOL CHEM, V284, P18260, DOI 10.1074/jbc.M109.015818; Chen WZ, 2006, BIOPHYS J, V90, P1308, DOI 10.1529/biophysj.105.064634; CHOWDHURY S, 1992, J CELL BIOL, V118, P561, DOI 10.1083/jcb.118.3.561; COOK RK, 1992, J BIOL CHEM, V267, P9430; COOK RK, 1991, J BIOL CHEM, V266, P16825; Disabella E, 2011, HEART, V97, P321, DOI 10.1136/hrt.2010.204388; DRUBIN DG, 1990, CELL MOTIL CYTOSKEL, V15, P7, DOI 10.1002/cm.970150103; EGELMAN EH, 1995, J STRUCT BIOL, V115, P159, DOI 10.1006/jsbi.1995.1040; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; FATIGATI V, 1984, J BIOL CHEM, V259, P4383; Fehrenbacher KL, 2004, CURR BIOL, V14, P1996, DOI 10.1016/j.cub.2004.11.004; Feng L, 1997, J BIOL CHEM, V272, P16829, DOI 10.1074/jbc.272.27.16829; Galkin VE, 2001, J CELL BIOL, V153, P75, DOI 10.1083/jcb.153.1.75; GANCEDO C, 1968, EUR J BIOCHEM, V5, P165, DOI 10.1111/j.1432-1033.1968.tb00353.x; Guo DC, 2007, NAT GENET, V39, P1488, DOI 10.1038/ng.2007.6; Guo DC, 2009, AM J HUM GENET, V84, P617, DOI 10.1016/j.ajhg.2009.04.007; Hiratzka LF, 2010, CIRCULATION, V121, pE266, DOI 10.1161/CIR.0b013e3181d4739e; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Hoyert D L, 2001, Natl Vital Stat Rep, V49, P1; Kamal JKA, 2007, P NATL ACAD SCI USA, V104, P7910, DOI 10.1073/pnas.0611283104; Kim E, 1996, BIOCHEMISTRY-US, V35, P16566, DOI 10.1021/bi9623892; KLINGENBERG M, 1970, EUR J BIOCHEM, V13, P247, DOI 10.1111/j.1432-1033.1970.tb00924.x; Laing NG, 2009, HUM MUTAT, V30, P1267, DOI 10.1002/humu.21059; Lappalainen P, 1997, EMBO J, V16, P5520, DOI 10.1093/emboj/16.18.5520; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; McKane M, 2005, J BIOL CHEM, V280, P36494, DOI 10.1074/jbc.M506970200; Milewicz DM, 2008, ANNU REV GENOM HUM G, V9, P283, DOI 10.1146/annurev.genom.8.080706.092303; MILLER MJ, 1979, P NATL ACAD SCI USA, V76, P5222, DOI 10.1073/pnas.76.10.5222; Mohri K, 2006, MOL BIOL CELL, V17, P2190, DOI 10.1091/mbc.E05-11-1016; Morin M, 2009, HUM MOL GENET, V18, P3075, DOI 10.1093/hmg/ddp249; Morisaki H, 2009, HUM MUTAT, V30, P1406, DOI 10.1002/humu.21081; Morton WM, 2000, NAT CELL BIOL, V2, P376, DOI 10.1038/35014075; Moseley JB, 2006, J CELL SCI, V119, P1547, DOI 10.1242/jcs.02860; NG R, 1980, P NATL ACAD SCI-BIOL, V77, P3912, DOI 10.1073/pnas.77.7.3912; Oda T, 2010, STRUCTURE, V18, P761, DOI 10.1016/j.str.2010.05.009; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Olsson C, 2006, CIRCULATION, V114, P2611, DOI 10.1161/CIRCULATIONAHA.106.630400; Pearson GD, 2008, CIRCULATION, V118, P785, DOI 10.1161/CIRCULATIONAHA.108.783753; SHARTAVA A, 1995, J CELL BIOL, V128, P805, DOI 10.1083/jcb.128.5.805; Simon VR, 1997, CELL MOTIL CYTOSKEL, V37, P199, DOI 10.1002/(SICI)1097-0169(1997)37:3<199::AID-CM2>3.0.CO;2-2; Slaninova I, 2000, ARCH MICROBIOL, V173, P245, DOI 10.1007/s002030000136; Sparrow JC, 2003, NEUROMUSCULAR DISORD, V13, P519, DOI 10.1016/S0960-8966(03)00101-9; Stokasimov E, 2009, J BIOL CHEM, V284, P25421, DOI 10.1074/jbc.M109.013078; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Vorobiev S, 2003, P NATL ACAD SCI USA, V100, P5760, DOI 10.1073/pnas.0832273100; Wen KK, 2005, J BIOL CHEM, V280, P24168, DOI 10.1074/jbc.M502024200; Yoo EH, 2010, ANN CLIN LAB SCI, V40, P278; Zhu M, 2003, AM J HUM GENET, V73, P1082, DOI 10.1086/379286	56	19	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11356	11369		10.1074/jbc.M110.203174	http://dx.doi.org/10.1074/jbc.M110.203174			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21288906	Green Published, hybrid			2022-12-27	WOS:000288797100048
J	Heldsinger, A; Grabauskas, G; Song, I; Owyang, C				Heldsinger, Andrea; Grabauskas, Gintautas; Song, Il; Owyang, Chung			Synergistic Interaction between Leptin and Cholecystokinin in the Rat Nodose Ganglia Is Mediated by PI3K and STAT3 Signaling Pathways IMPLICATIONS FOR LEPTIN AS A REGULATOR OF SHORT TERM SATIETY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VAGAL AFFERENT NEURONS; FOOD-INTAKE; CCK RECEPTORS; OB-R; MICE; ACTIVATION; SECRETION; INVOLVEMENT; AFFINITY; STOMACH	Research has shown that the synergistic interaction between vagal cholecystokinin-A receptors (CCKARs) and leptin receptors (LRbs) mediates short term satiety. We hypothesize that this synergistic interaction is mediated by cross-talk between signaling cascades used by CCKARs and LRbs, which, in turn, activates closure of K+ channels, leading to membrane depolarization and neuronal firing. Whole cell patch clamp recordings were performed on isolated rat nodose ganglia neurons. Western immunoblots elucidated the intracellular signaling pathways that modulate leptin/CCK synergism. In addition, STAT3, PI3K, Src, and MAPK genes were silenced by lentiviral infection and transient Lipofectamine transfection of cultured rat nodose ganglia to determine the effect of these molecules on leptin/CCK synergism. Patch clamp studies showed that a combination of leptin and CCK-8 caused a significant increase in membrane input resistance compared with leptin or CCK-8 alone. Silencing the STAT3 gene abolished the synergistic action of leptin/CCK-8 on neuronal firing. Leptin/CCK-8 synergistically stimulated a 7.7-fold increase in phosphorylated STAT3 (pSTAT3), which was inhibited by AG490, C3 transferase, PP2, LY294002, and wortmannin, but not PD98059. Silencing the Src and PI3K genes resulted in a loss of leptin/CCK-stimulated pSTAT3. We conclude that the synergistic interaction between vagal CCKARs and LRbs is mediated by the phosphorylation of STAT3, which, in turn, activates closure of K+ channels, leading to membrane depolarization and neuronal firing. This involves the interaction between CCK/Src/PI3K cascades and leptin/JAK2/PI3K/STAT3 signaling pathways. Malfunctioning of these signaling molecules may result in eating disorders.	[Heldsinger, Andrea; Grabauskas, Gintautas; Song, Il; Owyang, Chung] Univ Michigan, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Owyang, C (corresponding author), Univ Michigan Hlth Syst, Taubman Ctr 3912L, 1150 E Med Ctr Dr,SPC 5362, Ann Arbor, MI 48109 USA.	cowyang@med.umich.edu	Grabauskas, Gintautas/CAG-1799-2022		National Institutes of Health, NIDDK [R01 DK 48419, P30 DK 39433]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048419] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK 48419 and P30 DK 39433 from NIDDK.	Bado A, 1998, NATURE, V394, P790, DOI 10.1038/29547; Baldwin BA, 1998, PROG NEUROBIOL, V55, P477, DOI 10.1016/S0301-0082(98)00005-7; Banks AS, 2000, J BIOL CHEM, V275, P14563, DOI 10.1074/jbc.275.19.14563; Barrachina MD, 1997, P NATL ACAD SCI USA, V94, P10455, DOI 10.1073/pnas.94.19.10455; Bjornholm M, 2007, J CLIN INVEST, V117, P1354, DOI 10.1172/JCI30688; Burdyga G, 2002, NEUROSCIENCE, V109, P339, DOI 10.1016/S0306-4522(01)00474-2; CRAWLEY JN, 1994, PEPTIDES, V15, P731, DOI 10.1016/0196-9781(94)90104-X; de Lartigue G, 2010, ENDOCRINOLOGY, V151, P3589, DOI 10.1210/en.2010-0106; Fei H, 1997, P NATL ACAD SCI USA, V94, P7001, DOI 10.1073/pnas.94.13.7001; Frontini A, 2008, BRAIN RES, V1215, P105, DOI 10.1016/j.brainres.2008.03.078; Grill HJ, 2010, FRONT NEUROENDOCRIN, V31, P61, DOI 10.1016/j.yfrne.2009.10.005; Jiang L, 2008, J BIOL CHEM, V283, P28066, DOI 10.1074/jbc.M805545200; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Loftus TM, 1999, SEMIN CELL DEV BIOL, V10, P11, DOI 10.1006/scdb.1998.0274; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Masuzaki H, 1997, NAT MED, V3, P1029, DOI 10.1038/nm0997-1029; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; MORAN TH, 1992, AM J PHYSIOL, V262, pR46, DOI 10.1152/ajpregu.1992.262.1.R46; Nozu F, 2000, EUR J CELL BIOL, V79, P803, DOI 10.1078/0171-9335-00108; Owyang C, 2008, GASTROENTEROLOGY, V134, pA96; Pan WH, 2001, LIFE SCI, V68, P2705, DOI 10.1016/S0024-3205(01)01085-2; PASSARO E, 1982, BRAIN RES, V241, P338, DOI 10.1016/0006-8993(82)91073-3; Peters JH, 2004, ENDOCRINOLOGY, V145, P3652, DOI 10.1210/en.2004-0221; Ritter RC, 1999, NEUROPEPTIDES, V33, P387, DOI 10.1054/npep.1999.0051; Ruiter M, 2010, ENDOCRINOLOGY, V151, P1509, DOI 10.1210/en.2009-0854; Sobhani I, 2000, GUT, V47, P178, DOI 10.1136/gut.47.2.178; Sutton GM, 2004, J NEUROSCI, V24, P10240, DOI 10.1523/JNEUROSCI.2764-04.2004; Tsunoda Y, 1996, BIOCHEM BIOPH RES CO, V227, P876, DOI 10.1006/bbrc.1996.1599; Wang YH, 1997, AM J PHYSIOL-REG I, V273, pR833, DOI 10.1152/ajpregu.1997.273.2.R833; WEATHERFORD SC, 1993, AM J PHYSIOL, V264, pR244, DOI 10.1152/ajpregu.1993.264.2.R244; White DW, 1997, J BIOL CHEM, V272, P4065, DOI 10.1074/jbc.272.7.4065; Williams DL, 2009, AM J PHYSIOL-REG I, V297, pR1238, DOI 10.1152/ajpregu.00182.2009; ZARBIN MA, 1981, LIFE SCI, V29, P697, DOI 10.1016/0024-3205(81)90022-9; Zhang XK, 1999, MOL CELL BIOL, V19, P7138; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	35	32	33	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11707	11715		10.1074/jbc.M110.198945	http://dx.doi.org/10.1074/jbc.M110.198945			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21270124	Green Published, hybrid			2022-12-27	WOS:000288797100078
J	Long, JY; Wang, Y; Wang, WJ; Chang, BHJ; Danesh, FR				Long, Jianyin; Wang, Yin; Wang, Wenjian; Chang, Benny H. J.; Danesh, Farhad R.			MicroRNA-29c Is a Signature MicroRNA under High Glucose Conditions That Targets Sprouty Homolog 1, and Its in Vivo Knockdown Prevents Progression of Diabetic Nephropathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO-KINASE INHIBITOR; KIDNEY GLOMERULI; GENE-EXPRESSION; GROWTH-FACTOR; PROTEIN; REGULATOR; APOPTOSIS; CANCER; MIR-29; DIFFERENTIATION	Although several recent publications have suggested that microRNAs contribute to the pathogenesis of diabetic nephropathy, the role of miRNAs in vivo still remains poorly understood. Using an integrated in vitro and in vivo comparative miRNA expression array, we identified miR-29c as a signature miRNA in the diabetic environment. We validated our profiling array data by examining miR-29c expression in the kidney glomeruli obtained from db/db mice in vivo and in kidney microvascular endothelial cells and podocytes treated with high glucose in vitro. Functionally, we found that miR-29c induces cell apoptosis and increases extracellular matrix protein accumulation. Indeed, forced expression of miR-29c strongly induced podocyte apoptosis. Conversely, knockdown of miR-29c prevented high glucose-induced cell apoptosis. We also identified Sprouty homolog 1 (Spry1) as a direct target of miR-29c with a nearly perfect complementarity between miR-29c and the 3'-untranslated region (UTR) of mouse Spry1. Expression of miR-29c decreased the luciferase activity of Spry1 when co-transfected with the mouse Spry1 3'-UTR reporter construct. Overexpression of miR-29c decreased the levels of Spry1 protein and promoted activation of Rho kinase. Importantly, knockdown of miR-29c by a specific antisense oligonucleotide significantly reduced albuminuria and kidney mesangial matrix accumulation in the db/db mice model in vivo. These findings identify miR-29c as a novel target in diabetic nephropathy and provide new insights into the role of miR-29c in a previously unrecognized signaling cascade involving Spry1 and Rho kinase activation.	[Long, Jianyin; Wang, Yin; Wang, Wenjian; Danesh, Farhad R.] Baylor Coll Med, Dept Med, Div Nephrol, Houston, TX 77030 USA; [Chang, Benny H. J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Danesh, Farhad R.] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Danesh, FR (corresponding author), Baylor Coll Med, Dept Med, Div Nephrol, 1 Baylor Plaza, Houston, TX 77030 USA.	danesh@bcm.edu	Long, Jianyin/H-8261-2013	Danesh, Farhad/0000-0001-6849-5239	National Institutes of Health through the NIDDK [RO1DK067604, RO1DK078900]; Diabetes and Endocrinology Research Center at the Baylor College of Medicine [DK079638]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079638, R01DK067604, R01DK078900] Funding Source: NIH RePORTER	National Institutes of Health through the NIDDK; Diabetes and Endocrinology Research Center at the Baylor College of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1DK067604 and RO1DK078900 through the NIDDK (to F. R. D.). This work was also partly supported by the Diabetes and Endocrinology Research Center (Grant DK079638) at the Baylor College of Medicine.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Basson MA, 2006, DEV BIOL, V299, P466, DOI 10.1016/j.ydbio.2006.08.051; Basson MA, 2005, DEV CELL, V8, P229, DOI 10.1016/j.devcel.2004.12.004; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Danesh FR, 2002, P NATL ACAD SCI USA, V99, P8301, DOI 10.1073/pnas.122228799; Del Re DP, 2007, J BIOL CHEM, V282, P8069, DOI 10.1074/jbc.M604298200; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Donello JE, 1998, J VIROL, V72, P5085, DOI 10.1128/JVI.72.6.5085-5092.1998; Du M, 2006, FEBS J, V273, P732, DOI 10.1111/j.1742-4658.2006.05106.x; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Esau CC, 2008, METHODS, V44, P55, DOI 10.1016/j.ymeth.2007.11.001; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Garofalo M, 2011, ANNU REV PHARMACOL, V51, P25, DOI 10.1146/annurev-pharmtox-010510-100517; Garzon R, 2009, BLOOD, V114, P5331, DOI 10.1182/blood-2009-03-211938; Gojo A, 2007, EUR J PHARMACOL, V568, P242, DOI 10.1016/j.ejphar.2007.04.011; Gross I, 2003, J BIOL CHEM, V278, P41420, DOI 10.1074/jbc.M306425200; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Hartshorne DJ, 1999, MOL CELL BIOCHEM, V190, P79, DOI 10.1023/A:1006917032557; Horwich MD, 2008, NAT PROTOC, V3, P1537, DOI 10.1038/nprot.2008.145; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Isermann B, 2007, NAT MED, V13, P1349, DOI 10.1038/nm1667; Kartha RV, 2010, J CARDIOVASC TRANSL, V3, P256, DOI 10.1007/s12265-010-9172-z; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Kikuchi Y, 2007, J ENDOCRINOL, V192, P595, DOI 10.1677/JOE-06-0045; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; Kolavennu V, 2008, DIABETES, V57, P714, DOI 10.2337/db07-1241; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Langley RR, 2003, CANCER RES, V63, P2971; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Lewko B, 2009, J CELL PHYSIOL, V221, P288, DOI 10.1002/jcp.21856; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loirand G, 2006, CIRC RES, V98, P322, DOI 10.1161/01.RES.0000201960.04223.3c; Long JY, 2010, J BIOL CHEM, V285, P23455, DOI 10.1074/jbc.M110.136168; Long JY, 2003, P NATL ACAD SCI USA, V100, P9791, DOI 10.1073/pnas.1733973100; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Miyoshi K, 2004, ONCOGENE, V23, P5567, DOI 10.1038/sj.onc.1207759; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Mukhopadhyay P, 2007, NAT PROTOC, V2, P2295, DOI 10.1038/nprot.2007.327; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Nagpal JK, 2010, CURR MOL MED, V10, P503, DOI 10.2174/156652410791608216; Narumiya S, 1996, J BIOCHEM-TOKYO, V120, P215; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Peng FF, 2008, DIABETES, V57, P1683, DOI 10.2337/db07-1149; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Sabatel C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-231; Sengupta S, 2008, P NATL ACAD SCI USA, V105, P5874, DOI 10.1073/pnas.0801130105; Stern P, 2008, P NATL ACAD SCI USA, V105, P13895, DOI 10.1073/pnas.0806907105; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.1.225; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; van Rooij E, 2009, CIRC RES, V104, P138, DOI 10.1161/CIRCRESAHA.108.192492; Varallyay E, 2008, NAT PROTOC, V3, P190, DOI 10.1038/nprot.2007.528; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Wang Q, 2008, FASEB J, V22, P4126, DOI 10.1096/fj.08-112326; Wang Y, 2008, GENE DEV, V22, P878, DOI 10.1101/gad.452908; Wang YQ, 2009, MOL CANCER THER, V8, P2103, DOI 10.1158/1535-7163.MCT-09-0282; Wolf G, 1999, KIDNEY INT, V56, P393, DOI 10.1046/j.1523-1755.1999.00590.x; Xiong YJ, 2010, HEPATOLOGY, V51, P836, DOI 10.1002/hep.23380; Yoneda A, 2007, MOL BIOL CELL, V18, P66, DOI 10.1091/mbc.E06-08-0684; Zeng LX, 2005, FASEB J, V19, P1845, DOI 10.1096/fj.05-4240fje; Zhao JJ, 2010, BLOOD, V115, P2630, DOI 10.1182/blood-2009-09-243147	70	213	240	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11837	11848		10.1074/jbc.M110.194969	http://dx.doi.org/10.1074/jbc.M110.194969			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21310958	Green Published, hybrid			2022-12-27	WOS:000288797100090
J	Pathak, N; Austin, CA; Drummond, IA				Pathak, Narendra; Austin, Christina A.; Drummond, Iain A.			Tubulin Tyrosine Ligase-like Genes ttll3 and ttll6 Maintain Zebrafish Cilia Structure and Motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-TUBULIN; POSTTRANSLATIONAL MODIFICATIONS; INTRAFLAGELLAR TRANSPORT; ALPHA-TUBULIN; POLYGLYCYLATION; MICROTUBULES; GLUTAMYLATION; GLYCYLATION; AXONEME; DOMAIN	Tubulin post-translational modifications generate microtubule heterogeneity and modulate microtubule function, and are catalyzed by tubulin tyrosine ligase-like (TTLL) proteins. Using antibodies specific to monoglycylated, polyglycylated, and glutamylated tubulin in whole mount immunostaining of zebrafish embryos, we observed distinct, tissue-specific patterns of tubulin modifications. Tubulin modification patterns in cilia correlated with the expression of ttll3 and ttll6 in ciliated cells. Expression screening of all zebrafish tubulin tyrosine ligase-like genes revealed additional tissue-specific expression of ttll1 in brain neurons, ttll4 in muscle, and ttll7 in otic placodes. Knockdown of ttll3 eliminated cilia tubulin glycylation but had surprisingly mild effects on cilia structure and motility. Similarly, knockdown of ttll6 strongly reduced cilia tubulin glutamylation but only partially affected cilia structure and motility. Combined loss of function of ttll3 and ttll6 caused near complete loss of cilia motility and induced a variety of axonemal ultrastructural defects similar to defects previously observed in zebrafish fleer mutants, which were shown to lack tubulin glutamylation. Consistently, we find that fleer mutants also lack tubulin glycylation. These results indicate that tubulin glycylation and glutamylation have overlapping functions in maintaining cilia structure and motility and that the fleer/dyf-1 TPR protein is required for both types of tubulin post-translational modification.	[Pathak, Narendra; Drummond, Iain A.] Massachusetts Gen Hosp, Div Nephrol, Charlestown, MA 02129 USA; [Austin, Christina A.; Drummond, Iain A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Drummond, IA (corresponding author), 149 13th St, Charlestown, MA 02129 USA.	idrummon@receptor.mgh.harvard.edu			National Institutes of Health [K01DK078741, RO1DK053093]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK078741, R01DK070263, R01DK053093] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K01DK078741 (to N. P.) and RO1DK053093 (to I. A. D.).	Absalon S, 2008, MOL BIOL CELL, V19, P929, DOI 10.1091/mbc.E07-08-0749; ADOUTTE A, 1991, BIOL CELL, V71, P227, DOI 10.1016/0248-4900(91)90069-Y; BLOOMFIELD P, 1987, TOXICOLOGY, V46, P237, DOI 10.1016/0300-483X(87)90130-2; Bonnet C, 2001, J BIOL CHEM, V276, P12839, DOI 10.1074/jbc.M011380200; Brown JM, 1999, MOL BIOL CELL, V10, P3081, DOI 10.1091/mbc.10.10.3081; Bulinski JC, 2009, DEV CELL, V16, P773, DOI 10.1016/j.devcel.2009.06.003; Dave D, 2009, EUKARYOT CELL, V8, P1397, DOI 10.1128/EC.00378-08; Davenport JR, 2007, CURR BIOL, V17, P1586, DOI 10.1016/j.cub.2007.08.034; Dossou SJY, 2007, CELL MOTIL CYTOSKEL, V64, P847, DOI 10.1002/cm.20229; Drummond IA, 1998, DEVELOPMENT, V125, P4655; EDDE B, 1990, SCIENCE, V247, P83, DOI 10.1126/science.1967194; FACKENTHAL JD, 1993, DEV BIOL, V158, P213, DOI 10.1006/dbio.1993.1180; Fennell BJ, 2008, INT J PARASITOL, V38, P527, DOI 10.1016/j.ijpara.2007.09.005; Gaertig J, 2008, CURR TOP DEV BIOL, V85, P83, DOI 10.1016/S0070-2153(08)00804-1; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Hoyle HD, 2008, CELL MOTIL CYTOSKEL, V65, P295, DOI 10.1002/cm.20261; Iftode F, 2000, BIOL CELL, V92, P615, DOI 10.1016/S0248-4900(00)01107-2; Ikegami K, 2008, FEBS LETT, V582, P1129, DOI 10.1016/j.febslet.2008.02.079; Ikegami K, 2010, P NATL ACAD SCI USA, V107, P10490, DOI 10.1073/pnas.1002128107; Ikegami K, 2009, FEBS LETT, V583, P1957, DOI 10.1016/j.febslet.2009.05.003; Insinna C, 2008, DEV BIOL, V316, P160, DOI 10.1016/j.ydbio.2008.01.025; Janke C, 2005, SCIENCE, V308, P1758, DOI 10.1126/science.1113010; Janke C, 2008, EMBO REP, V9, P636, DOI 10.1038/embor.2008.114; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Kubo T, 2010, CURR BIOL, V20, P441, DOI 10.1016/j.cub.2009.12.058; Liu Y, 2007, DEVELOPMENT, V134, P1111, DOI 10.1242/dev.02806; Maas C, 2009, P NATL ACAD SCI USA, V106, P8731, DOI 10.1073/pnas.0812391106; Ou GS, 2005, NATURE, V436, P583, DOI 10.1038/nature03818; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Pathak N, 2007, MOL BIOL CELL, V18, P4353, DOI 10.1091/mbc.E07-06-0537; Popodi EM, 2005, CELL MOTIL CYTOSKEL, V62, P48, DOI 10.1002/cm.20085; Redeker V, 2005, J BIOL CHEM, V280, P596, DOI 10.1074/jbc.M408324200; REDEKER V, 1994, SCIENCE, V266, P1688, DOI 10.1126/science.7992051; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Rogowski K, 2009, CELL, V137, P1076, DOI 10.1016/j.cell.2009.05.020; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; RUDIGER M, 1995, FEBS LETT, V364, P147, DOI 10.1016/0014-5793(95)00373-H; Schneider A, 1997, J CELL SCI, V110, P431; Suryavanshi S, 2010, CURR BIOL, V20, P435, DOI 10.1016/j.cub.2009.12.062; Thazhath R, 2004, MOL BIOL CELL, V15, P4136, DOI 10.1091/mbc.E04-03-0247; Thazhath R, 2002, NAT CELL BIOL, V4, P256, DOI 10.1038/ncb764; Thisse C., 1998, ZEBRAFISH SCI MON, V5, P8; van Dijk J, 2007, MOL CELL, V26, P437, DOI 10.1016/j.molcel.2007.04.012; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; Vinh J, 1999, BIOCHEMISTRY-US, V38, P3133, DOI 10.1021/bi982304s; Vladar EK, 2008, TRENDS CELL BIOL, V18, P517, DOI 10.1016/j.tcb.2008.08.004; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Wloga D, 2008, EUKARYOT CELL, V7, P1362, DOI 10.1128/EC.00084-08; Wloga D, 2010, J CELL SCI, V123, P3447, DOI 10.1242/jcs.063727; Wloga D, 2010, EUKARYOT CELL, V9, P184, DOI 10.1128/EC.00176-09; Wloga D, 2009, DEV CELL, V16, P867, DOI 10.1016/j.devcel.2009.04.008; Xia L, 2000, J CELL BIOL, V149, P1097, DOI 10.1083/jcb.149.5.1097	52	61	63	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11685	11695		10.1074/jbc.M110.209817	http://dx.doi.org/10.1074/jbc.M110.209817			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21262966	Green Published, hybrid			2022-12-27	WOS:000288797100076
J	Sun, QA; Ju, TZ; Cummings, RD				Sun, Qian; Ju, Tongzhong; Cummings, Richard D.			The Transmembrane Domain of the Molecular Chaperone Cosmc Directs Its Localization to the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN TRANSFERRIN RECEPTOR; PROTEIN O-GLYCOSYLATION; MEMBRANE-PROTEINS; GOLGI-APPARATUS; CYTOPLASMIC DOMAIN; SECRETORY PATHWAY; RETENTION SIGNAL; ANCHORED PROTEIN; CYTOCHROME B(5); INVARIANT CHAIN	The molecular basis for retention of integral membrane proteins in the endoplasmic reticulum (ER) is not well understood. We recently discovered a novel ER molecular chaperone termed Cosmc, which is essential for folding and normal activity of the Golgi enzyme T-synthase. Cosmc, a type II single-pass transmembrane protein, lacks any known ER retrieval/retention motifs. To explore specific ER localization determinants in Cosmc we generated a series of Cosmc mutants along with chimeras of Cosmc with a non-ER resident type II protein, the human transferrin receptor. Here we show that the 18 amino acid transmembrane domain (TMD) of Cosmc is essential for ER localization and confers ER retention to select chimeras. Moreover, mutations of a single Cys residue within the TMD of Cosmc prevent formation of disulfide-bonded dimers of Cosmc and eliminate ER retention. These studies reveal that Cosmc has a unique ER-retention motif within its TMD and provide new insights into the molecular mechanisms by which TMDs of resident ER proteins contribute to ER localization.	[Cummings, Richard D.] Emory Univ, Sch Med, O Wayne Rollins Res Ctr, Dept Biochem, Atlanta, GA 30322 USA	Emory University	Cummings, RD (corresponding author), Emory Univ, Sch Med, O Wayne Rollins Res Ctr, Dept Biochem, 1510 Clifton Rd,Suite 4001, Atlanta, GA 30322 USA.	rdcummi@emory.edu		Ju, Tongzhong/0000-0002-4429-1976	National Institutes of Health [R01 GM068559]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068559] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM068559 (to R. D. C.).	Abrami L, 2008, P NATL ACAD SCI USA, V105, P5384, DOI 10.1073/pnas.0710389105; Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; AOKI D, 1992, P NATL ACAD SCI USA, V89, P4319, DOI 10.1073/pnas.89.10.4319; Aryal RP, 2010, J BIOL CHEM, V285, P2456, DOI 10.1074/jbc.M109.065169; BAKKE O, 1990, CELL, V63, P707, DOI 10.1016/0092-8674(90)90137-4; BONIFACINO JS, 1990, CELL, V63, P503, DOI 10.1016/0092-8674(90)90447-M; Boulaflous A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-144; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cocquerel L, 2000, J VIROL, V74, P3623, DOI 10.1128/JVI.74.8.3623-3633.2000; Cocquerel L, 1998, J VIROL, V72, P2183, DOI 10.1128/JVI.72.3.2183-2191.1998; Cocquerel L, 1999, J VIROL, V73, P2641, DOI 10.1128/JVI.73.4.2641-2649.1999; Contreras I, 2004, PLANT J, V38, P685, DOI 10.1111/j.1365-313X.2004.02075.x; D'Alessio C, 2010, SEMIN CELL DEV BIOL, V21, P491, DOI 10.1016/j.semcdb.2009.12.014; Dietrich LEP, 2004, EMBO REP, V5, P1053, DOI 10.1038/sj.embor.7400277; DO SI, 1992, GLYCOBIOLOGY, V2, P345, DOI 10.1093/glycob/2.4.345; DO SI, 1990, J BIOL CHEM, V265, P114; Fang G., 2002, PCR MEDIATED RECOMBI; Fu J, 2000, J BIOL CHEM, V275, P3984, DOI 10.1074/jbc.275.6.3984; Fu J, 2000, EUR J CELL BIOL, V79, P219, DOI 10.1078/S0171-9335(04)70025-4; GAYNOR EC, 1994, J CELL BIOL, V127, P653, DOI 10.1083/jcb.127.3.653; Gomord V, 1999, BIOCHIMIE, V81, P607, DOI 10.1016/S0300-9084(99)80118-7; Hardt B, 2003, GLYCOBIOLOGY, V13, P159, DOI 10.1093/glycob/cwg013; Harter C, 1996, P NATL ACAD SCI USA, V93, P1902, DOI 10.1073/pnas.93.5.1902; Harter C, 1996, BBA-REV BIOMEMBRANES, V1286, P75, DOI 10.1016/0304-4157(96)00003-2; HAYES GR, 1992, GLYCOBIOLOGY, V2, P355, DOI 10.1093/glycob/2.4.355; Honsho M, 1998, J BIOL CHEM, V273, P20860, DOI 10.1074/jbc.273.33.20860; Hsieh SC, 2010, J VIROL, V84, P4782, DOI 10.1128/JVI.01963-09; JACKSON MR, 1993, J CELL BIOL, V121, P317, DOI 10.1083/jcb.121.2.317; Ju T., 2011, GLYCOBIOLOG IN PRESS; Ju T., 2011, ANGEW CHEM, V50, P2; Ju TZ, 2008, J CELL BIOL, V182, P531, DOI 10.1083/jcb.200711151; Ju TZ, 2005, NATURE, V437, P1252, DOI 10.1038/4371252a; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; KELLEHER DJ, 1992, CELL, V69, P55, DOI 10.1016/0092-8674(92)90118-V; LEWIS MJ, 1992, CELL, V68, P353, DOI 10.1016/0092-8674(92)90476-S; LOTTEAU V, 1990, NATURE, V348, P600, DOI 10.1038/348600a0; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; Narimatsu Y, 2008, BIOCHEM BIOPH RES CO, V366, P199, DOI 10.1016/j.bbrc.2007.11.121; NILSSON T, 1994, CURR OPIN CELL BIOL, V6, P517, DOI 10.1016/0955-0674(94)90070-1; Opat AS, 2000, J BIOL CHEM, V275, P11836, DOI 10.1074/jbc.275.16.11836; Pearse BR, 2010, BBA-MOL CELL RES, V1803, P684, DOI 10.1016/j.bbamcr.2009.10.008; Pedrazzini E, 2000, J CELL BIOL, V148, P899, DOI 10.1083/jcb.148.5.899; PELHAM HRB, 1990, TRENDS BIOCHEM SCI, V15, P483, DOI 10.1016/0968-0004(90)90303-S; PFEFFER SR, 1987, ANNU REV BIOCHEM, V56, P829, DOI 10.1146/annurev.biochem.56.1.829; Ponka P, 1999, INT J BIOCHEM CELL B, V31, P1111, DOI 10.1016/S1357-2725(99)00070-9; Rayner JC, 1997, EMBO J, V16, P1832, DOI 10.1093/emboj/16.8.1832; Reddy P, 1996, EMBO J, V15, P2077, DOI 10.1002/j.1460-2075.1996.tb00561.x; REZAIE AR, 1992, PROTEIN EXPRES PURIF, V3, P453, DOI 10.1016/1046-5928(92)90062-2; Rutledge EA, 1998, J BIOL CHEM, V273, P12169, DOI 10.1074/jbc.273.20.12169; Sato K, 2003, MOL BIOL CELL, V14, P3605, DOI 10.1091/mbc.E02-12-0777; Sato M, 1996, J CELL BIOL, V134, P279, DOI 10.1083/jcb.134.2.279; SCHNEIDER C, 1982, J BIOL CHEM, V257, P8516; SCHUTZE MP, 1994, EMBO J, V13, P1696, DOI 10.1002/j.1460-2075.1994.tb06434.x; Schweizer A, 1996, J CELL BIOL, V132, P577, DOI 10.1083/jcb.132.4.577; Sohn K, 1996, J CELL BIOL, V135, P1239, DOI 10.1083/jcb.135.5.1239; SONNICHSEN B, 1994, J CELL SCI, V107, P2705; STEARNS DJ, 1988, J BIOL CHEM, V263, P826; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; TOWNSLEY FM, 1994, EUR J CELL BIOL, V64, P211; TROWBRIDGE IS, 1986, BIOCHEM SOC SYMP, P117; Wang YC, 2010, P NATL ACAD SCI USA, V107, P9228, DOI 10.1073/pnas.0914004107; Wieland F, 1999, CURR OPIN CELL BIOL, V11, P440, DOI 10.1016/S0955-0674(99)80063-5; Yang M, 1997, J BIOL CHEM, V272, P1970, DOI 10.1074/jbc.272.3.1970	63	16	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11529	11542		10.1074/jbc.M110.173591	http://dx.doi.org/10.1074/jbc.M110.173591			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21262965	Green Published, hybrid			2022-12-27	WOS:000288797100063
J	Wong, WF; Kurokawa, M; Satake, M; Kohu, K				Wong, Won Fen; Kurokawa, Mineo; Satake, Masanobu; Kohu, Kazuyoshi			Down-regulation of Runx1 Expression by TCR Signal Involves an Autoregulatory Mechanism and Contributes to IL-2 Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-HELPER TYPE-1; TRANSCRIPTION FACTORS; CELLS; DIFFERENTIATION; THYMOCYTES; LINEAGE; CD4; DISTINCT; ROLES; GENE	Runx1 transcription factor plays multiple roles in T cell development, differentiation, and function. However, the regulatory mechanisms and functional significance of high Runx1 protein expression in resting peripheral CD4+ T cells is not well understood. Here, we demonstrate that T-cell receptor (TCR) activation down-regulates distal Runx1 transcription, resulting in a significant reduction of Runx1 protein. Interestingly, this downregulation of distal Runx1 transcription appears to be mediated through a negative auto-regulatory mechanism, whereby Runx1 protein binds to a Runx consensus site in the distal promoter. Through the use of Runx1-overexpressing cells from transgenic mice, we demonstrate that interference with TCR-mediated Runx1 down-regulation inhibits IL-2 production and proliferation in activated CD4+ T cells. In contrast, using Runx1-deficient cells prepared from targeted mice, we show that the absence of Runx1 in unstimulated CD4+ T cells results in IL-2 derepression. In summary, we propose that high levels of Runx1 in resting CD4+ T cells functions negatively in the regulation of IL-2 transcription, and that TCR activation-mediated downregulation of Runx1 involves negative auto-regulation of the distal Runx1 promoter and contributes to IL-2 production.	[Satake, Masanobu] Tohoku Univ, Inst Dev Aging & Canc, Dept Mol Immunol, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Kurokawa, Mineo] Univ Tokyo, Grad Sch Med, Dept Hematol & Oncol, Tokyo 1138655, Japan; [Satake, Masanobu] Tohoku Univ, Global COE Program Network Med, Sendai, Miyagi 9808575, Japan	Tohoku University; University of Tokyo; Tohoku University	Satake, M (corresponding author), Tohoku Univ, Inst Dev Aging & Canc, Dept Mol Immunol, Aoba Ku, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	satake@idac.tohoku.ac.jp; kohu@idac.tohoku.ac.jp	Wong, Won Fen/D-3087-2012	Wong, Won Fen/0000-0003-1082-1956	Ministry of Education, Science, Sports, Culture and Technology, Japan	Ministry of Education, Science, Sports, Culture and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a research grants from the Ministry of Education, Science, Sports, Culture and Technology, Japan.	Abe N, 2005, J IMMUNOL, V175, P4475, DOI 10.4049/jimmunol.175.7.4475; Bruhn L, 1997, GENE DEV, V11, P640, DOI 10.1101/gad.11.5.640; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Drissi H, 2000, J CELL PHYSIOL, V184, P341, DOI 10.1002/1097-4652(200009)184:3<341::AID-JCP8>3.0.CO;2-Z; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; Germain RN, 1999, ANNU REV IMMUNOL, V17, P467, DOI 10.1146/annurev.immunol.17.1.467; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hayashi K, 2000, J IMMUNOL, V165, P6816, DOI 10.4049/jimmunol.165.12.6816; Ichikawa M, 2004, NAT MED, V10, P299, DOI 10.1038/nm997; Ito K, 2009, ONCOGENE, V28, P1379, DOI 10.1038/onc.2008.496; KAGOSHIMA H, 1993, TRENDS GENET, V9, P338, DOI 10.1016/0168-9525(93)90026-E; Kanto S, 2000, LEUKEMIA, V14, P1253, DOI 10.1038/sj.leu.2401821; Kitoh A, 2009, IMMUNITY, V31, P609, DOI 10.1016/j.immuni.2009.09.003; Klunker S, 2009, J EXP MED, V206, P2701, DOI 10.1084/jem.20090596; Kohu K, 2005, J IMMUNOL, V174, P2627, DOI 10.4049/jimmunol.174.5.2627; Kohu K, 2009, J IMMUNOL, V183, P7817, DOI 10.4049/jimmunol.0802527; Kohu Kazuyoshi, 2008, Current Immunology Reviews, V4, P101, DOI 10.2174/157339508784325073; Komine O, 2003, J EXP MED, V198, P51, DOI 10.1084/jem.20021200; Levanon D, 1996, DNA CELL BIOL, V15, P175, DOI 10.1089/dna.1996.15.175; Levanon D, 2004, ONCOGENE, V23, P4211, DOI 10.1038/sj.onc.1207670; Naoe Y, 2007, J EXP MED, V204, P1749, DOI 10.1084/jem.20062456; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pozner A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213x-7-84; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; SATAKE M, 1995, MOL CELL BIOL, V15, P1662; Sato T, 2005, IMMUNITY, V22, P317, DOI 10.1016/j.immuni.2005.01.012; Spender LC, 2005, ONCOGENE, V24, P1873, DOI 10.1038/sj.onc.1208404; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Telfer JC, 2001, DEV BIOL, V229, P363, DOI 10.1006/dbio.2000.9991; Wong WF, 2010, IMMUNOLOGY, V130, P243, DOI 10.1111/j.1365-2567.2009.03230.x; Wong WF, 2011, IMMUNOLOGY, V132, P157, DOI 10.1111/j.1365-2567.2010.03381.x	33	30	31	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11110	11118		10.1074/jbc.M110.166694	http://dx.doi.org/10.1074/jbc.M110.166694			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21292764	hybrid, Green Published			2022-12-27	WOS:000288797100022
J	Han, XH; Jin, YR; Seto, M; Yoon, JK				Han, Xiang Hua; Jin, Yong-Ri; Seto, Marianne; Yoon, Jeong Kyo			A WNT/beta-Catenin Signaling Activator, R-spondin, Plays Positive Regulatory Roles during Skeletal Myogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DETERMINATION GENE MYF5; STEM-CELLS; MULTIPLE PHASES; MUSCLE; MYOD; EXPRESSION; FAMILY; R-SPONDIN1; PROTEINS; PATHWAY	R-spondins (RSPOs) are a recently characterized family of secreted proteins that activate WNT/beta-catenin signaling. In this study, we investigated the potential roles of the RSPO proteins during myogenic differentiation. Overexpression of the Rspo1 gene or administration of recombinant RSPO2 protein enhanced mRNA and protein expression of a basic helix-loop-helix (bHLH) class myogenic determination factor, MYF5, in both C2C12 myoblasts and primary satellite cells, whereas MYOD or PAX7 expression was not affected. RSPOs also promoted myogenic differentiation and induced hypertrophic myotube formation in C2C12 cells. In addition, Rspo2 and Rspo3 gene knockdown by RNA interference significantly compromised MYF5 expression, myogenic differentiation, and myotube formation. Furthermore, Myf5 expression was reduced in the developing limbs of mouse embryos lacking the Rspo2 gene. Finally, we demonstrated that blocking of WNT/beta-catenin signaling by DKK1 or a dominant-negative form of TCF4 reversed MYF5 expression, myogenic differentiation, and hypertrophic myotube formation induced by RSPO2, indicating that RSPO2 exerts its activity through the WNT/beta-catenin signaling pathway. Our results provide strong evidence that RSPOs are key positive regulators of skeletal myogenesis acting through the WNT/beta-catenin signaling pathway.	[Han, Xiang Hua; Jin, Yong-Ri; Seto, Marianne; Yoon, Jeong Kyo] Maine Med Ctr, Ctr Mol Med, Ctr Biomed Res Excellence Stem Cell Biol & Regene, Res Inst, Scarborough, ME 04074 USA; [Seto, Marianne] Univ Maine, Grad Sch Biomed Sci, Orono, ME 04469 USA	Maine Medical Center; University of Maine System; University of Maine Orono	Yoon, JK (corresponding author), Maine Med Ctr, Ctr Mol Med, Ctr Biomed Res Excellence Stem Cell Biol & Regene, Res Inst, 81 Res Dr, Scarborough, ME 04074 USA.	yoonje@mmc.org	jin, yongri/D-8392-2012		National Institutes of Health [P20 RR015555, R01 AR055278, P20 RR018789]; Maine Medical Center Research Institute [P20 RR018789]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015555, P20RR018789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055278] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maine Medical Center Research Institute; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Drs. Lucy Liaw and Doug Spicer for comments and suggestions and Norma Albrecht for proofreading the manuscript. We are grateful to Drs. Masanobu Kawai and Doug Spicer for providing reagents. We also thank Nancy Chandler-Conrey in Recombinant Viral Vector Core (supported by National Institutes of Health Grant P20 RR015555 to R. Friesel, Program Director) for producing Rspo1 and Delta NTCF4 retroviruses, and Bioinformatics core for qRT-PCR analyses (supported by P20 RR018789) at Maine Medical Center Research Institute.; This work was supported, in whole or in part, by National Institutes of Health Grants P20 RR018789 (to D.M. Wojchowski, Program Director and J.K.Y., Project Principal Investigator) and R01 AR055278 (to J.K.Y., Principal Investigator).	Aoki M, 2007, DEV BIOL, V301, P218, DOI 10.1016/j.ydbio.2006.08.018; Barton ER, 2006, APPL PHYSIOL NUTR ME, V31, P791, DOI 10.1139/h06-054; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Borello U, 2006, DEVELOPMENT, V133, P3723, DOI 10.1242/dev.02517; Bosnakovski D, 2008, EXP NEUROL, V214, P87, DOI 10.1016/j.expneurol.2008.07.022; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; BRAUN T, 1992, CELL, V71, P369, DOI 10.1016/0092-8674(92)90507-9; BRAUN T, 1994, DEVELOPMENT, V120, P3083; Brunelli S, 2007, DEV BIOL, V304, P604, DOI 10.1016/j.ydbio.2007.01.006; Buckingham M, 2008, CURR OPIN GENET DEV, V18, P330, DOI 10.1016/j.gde.2008.06.005; Cossu G, 1999, EMBO J, V18, P6867, DOI 10.1093/emboj/18.24.6867; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Dedieu S, 2002, INT J DEV BIOL, V46, P235; Gayraud-Morel B, 2007, DEV BIOL, V312, P13, DOI 10.1016/j.ydbio.2007.08.059; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Gros J, 2009, NATURE, V457, P589, DOI 10.1038/nature07564; Hadchouel J, 2003, DEVELOPMENT, V130, P3415, DOI 10.1242/dev.00552; Joulia-Ekaza D, 2006, EXP CELL RES, V312, P3458, DOI 10.1016/j.yexcr.2006.07.010; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Kim KA, 2008, MOL BIOL CELL, V19, P2588, DOI 10.1091/mbc.E08-02-0187; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Montarras D, 2000, BIOL CELL, V92, P565, DOI 10.1016/S0248-4900(00)01110-2; MUNSTERBERG AE, 1995, GENE DEV, V9, P2911, DOI 10.1101/gad.9.23.2911; Nam JS, 2006, J BIOL CHEM, V281, P13247, DOI 10.1074/jbc.M508324200; Nam JS, 2007, DEV BIOL, V311, P124, DOI 10.1016/j.ydbio.2007.08.023; Nam JS, 2007, GENE EXPR PATTERNS, V7, P306, DOI 10.1016/j.modgep.2006.08.006; Perez-Ruiz A, 2008, J CELL SCI, V121, P1373, DOI 10.1242/jcs.024885; Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9; RUDNICKI MA, 1992, CELL, V71, P383, DOI 10.1016/0092-8674(92)90508-A; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Tajbakhsh S, 1998, DEVELOPMENT, V125, P4155; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Teboul L, 2002, DEVELOPMENT, V129, P4571; Tomizuka K, 2008, HUM MOL GENET, V17, P1278, DOI 10.1093/hmg/ddn036; Ustanina S, 2007, STEM CELLS, V25, P2006, DOI 10.1634/stemcells.2006-0736; Vertino AM, 2005, MOL BIOL CELL, V16, P2039, DOI 10.1091/mbc.E04-08-0720; Wei Q, 2007, J BIOL CHEM, V282, P15903, DOI 10.1074/jbc.M701927200; Xu QH, 1998, DEVELOPMENT, V125, P4767; Yoshida N, 1998, J CELL SCI, V111, P769; Zammit PS, 2002, EXP CELL RES, V281, P39, DOI 10.1006/excr.2002.5653	48	71	76	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10649	10659		10.1074/jbc.M110.169391	http://dx.doi.org/10.1074/jbc.M110.169391			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21252233	Green Published, hybrid			2022-12-27	WOS:000288547000079
J	Tang, HP; Rothery, RA; Voss, JE; Weiner, JH				Tang, Huipo; Rothery, Richard A.; Voss, James E.; Weiner, Joel H.			Correct Assembly of Iron-Sulfur Cluster FS0 into Escherichia coli Dimethyl Sulfoxide Reductase (DmsABC) Is a Prerequisite for Molybdenum Cofactor Insertion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; MOLYBDOPTERIN GUANINE DINUCLEOTIDE; INDUCIBLE FORMATE DEHYDROGENASE; MENAQUINOL BINDING-SITE; NITRATE REDUCTASE; DIMETHYLSULFOXIDE REDUCTASE; SPECTROSCOPIC CHARACTERIZATION; FUMARATE REDUCTASE; CATALYTIC SUBUNIT; ELECTRON-TRANSFER	The FS0 [4Fe-4S] cluster of the catalytic subunit (DmsA) of Escherichia coli dimethyl sulfoxide reductase (DmsABC) plays a key role in the electron transfer relay. We have now established an additional role for the cluster in directing molybdenum cofactor assembly during enzyme maturation. EPR spectroscopy indicates that FS0 has a high spin ground state (S = 3/2) in its reduced form, resulting in an EPR spectrum with a peak at g similar to 5.0. The cluster is predicted to be in close proximity to the molybdo-bis(pyranopterin guanine dinucleotide) (Mo-bisPGD) cofactor, which provides the site of dimethyl sulfoxide reduction. Comparison with nitrate reductase A (NarGHI) indicates that a sequence of residues ((CTVNC22)-C-18) plays a role in both FS0 and Mo-bisPGD coordination. A DmsA(Delta N21) mutant prevented Mo-bisPGD binding and resulted in a degenerate [3Fe-4S] cluster form of FS0 being assembled. DmsA belongs to the Type II subclass of Mo-bisPGD-containing catalytic subunits that is distinguished from the Type I subclass by having three rather than two residues between the first two Cys residues coordinating FS0 and a conserved Arg residue rather than a Lys residue following the fourth cluster coordinating Cys. We introduced a Type I Cys group into DmsA in two stages. We changed its sequence from (18)C(A)TVNC(B)GSRC(C)P(27) to 18C(A)TYC(B)GVGC(C)G(26) (similar to that of formate dehydrogenase (FdnG)) and demonstrated that this eliminated both Mo-bisPGD binding and EPR-detectable FS0. We then combined this change with a DmsA(R61K) mutation and demonstrated that this additional change partially rescued Mo-bisPGD insertion.	[Tang, Huipo; Rothery, Richard A.; Voss, James E.; Weiner, Joel H.] Univ Alberta, Dept Biochem, Sch Mol & Syst Med, Edmonton, AB T6G 2H7, Canada	University of Alberta	Weiner, JH (corresponding author), Univ Alberta, Dept Biochem, Sch Mol & Syst Med, 474 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	jweiner@ualberta.ca		Rothery, Richard/0000-0003-3265-1783	Canadian Institutes of Health Research [MOP15292]; Natural Sciences and Engineering Research Council of Canada; Queen Elizabeth II graduate scholarship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Queen Elizabeth II graduate scholarship	This work was supported in part by Canadian Institutes of Health Research Grant MOP15292.; Supported by a Natural Sciences and Engineering Research Council of Canada graduate studentship and a Queen Elizabeth II graduate scholarship.	BERG BL, 1991, J BIOL CHEM, V266, P22386; BERG BL, 1990, GENETICS, V125, P691; Bertero MG, 2003, NAT STRUCT BIOL, V10, P681, DOI 10.1038/nsb969; BILOUS PT, 1985, J BACTERIOL, V162, P1151, DOI 10.1128/JB.162.3.1151-1155.1985; Blasco F, 1998, MOL MICROBIOL, V28, P435, DOI 10.1046/j.1365-2958.1998.00795.x; BLASCO F, 1989, MOL GEN GENET, V218, P249, DOI 10.1007/BF00331275; BLASCO F, 1990, MOL GEN GENET, V222, P104, DOI 10.1007/BF00283030; Bogachev AV, 1996, J BACTERIOL, V178, P6233, DOI 10.1128/jb.178.21.6233-6237.1996; BRETON J, 1994, FEBS LETT, V345, P76, DOI 10.1016/0014-5793(94)00445-5; CAMMACK R, 1990, BIOCHEMISTRY-US, V29, P8410, DOI 10.1021/bi00488a030; Chan CS, 2010, FEBS LETT, V584, P4553, DOI 10.1016/j.febslet.2010.10.043; Cheng VWT, 2005, BIOCHEMISTRY-US, V44, P8068, DOI 10.1021/bi050362p; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; Duderstadt RE, 1999, FEBS LETT, V454, P21, DOI 10.1016/S0014-5793(99)00766-8; FLINT DH, 1992, BIOCHEMISTRY-US, V31, P10331, DOI 10.1021/bi00157a022; GEORGE SJ, 1989, BIOCHEM J, V264, P275, DOI 10.1042/bj2640275; Gladyshev VN, 1996, J BIOL CHEM, V271, P8095, DOI 10.1074/jbc.271.14.8095; HEINZINGER NK, 1995, J BACTERIOL, V177, P2813, DOI 10.1128/jb.177.10.2813-2820.1995; Hettmann T, 2003, BIOCHEM BIOPH RES CO, V310, P40, DOI 10.1016/j.bbrc.2003.08.114; JOHNSON JL, 1991, J BIOL CHEM, V266, P12140; JOHNSON JL, 1984, J BIOL CHEM, V259, P5414; Jormakka M, 2002, SCIENCE, V295, P1863, DOI 10.1126/science.1068186; Jormakka M, 2008, NAT STRUCT MOL BIOL, V15, P730, DOI 10.1038/nsmb.1434; Kirillova O, 2007, ACTA CRYSTALLOGR D, V63, P348, DOI 10.1107/S0907444906055065; KOWAL AT, 1995, BIOCHEMISTRY-US, V34, P12284, DOI 10.1021/bi00038a024; KRAFFT T, 1992, EUR J BIOCHEM, V206, P503, DOI 10.1111/j.1432-1033.1992.tb16953.x; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Lanciano P, 2007, J PHYS CHEM B, V111, P13632, DOI 10.1021/jp075243t; Lanciano P, 2007, J BIOL CHEM, V282, P17468, DOI 10.1074/jbc.M700994200; Li HM, 2009, CAN J MICROBIOL, V55, P179, DOI [10.1139/W08-111, 10.1139/w08-111]; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Magalon A, 1998, BIOCHEMISTRY-US, V37, P7363, DOI 10.1021/bi972858f; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MULLER A, 1992, FEBS LETT, V303, P36, DOI 10.1016/0014-5793(92)80472-S; Oresnik IJ, 2001, MOL MICROBIOL, V40, P323, DOI 10.1046/j.1365-2958.2001.02391.x; PLUNKETT G, 1993, NUCLEIC ACIDS RES, V21, P3391, DOI 10.1093/nar/21.15.3391; Ray N, 2003, FEBS LETT, V534, P156, DOI 10.1016/S0014-5793(02)03839-5; ROTHERY RA, 1995, J BACTERIOL, V177, P2057, DOI 10.1128/jb.177.8.2057-2063.1995; Rothery RA, 1996, BIOCHEMISTRY-US, V35, P3247, DOI 10.1021/bi951584y; Rothery RA, 2005, FEBS J, V272, P313, DOI 10.1111/j.1742-4658.2004.04469.x; ROTHERY RA, 1991, BIOCHEMISTRY-US, V30, P8296, DOI 10.1021/bi00098a003; Rothery RA, 1998, BIOCHEM J, V332, P35, DOI 10.1042/bj3320035; Rothery RA, 1999, J BIOL CHEM, V274, P13002, DOI 10.1074/jbc.274.19.13002; Rothery RA, 1999, BIOCHEMISTRY-US, V38, P12747, DOI 10.1021/bi990533o; Rothery RA, 2004, BIOCHEMISTRY-US, V43, P5324, DOI 10.1021/bi049938l; Rothery RA, 1998, EUR J BIOCHEM, V254, P588, DOI 10.1046/j.1432-1327.1998.2540588.x; Rothery RA, 2008, BBA-BIOMEMBRANES, V1778, P1897, DOI 10.1016/j.bbamem.2007.09.002; Rothery RA, 2010, J BIOL CHEM, V285, P8801, DOI 10.1074/jbc.M109.066027; SAMBASIVARAO D, 1991, J BACTERIOL, V173, P5935, DOI 10.1128/jb.173.19.5935-5943.1991; SAMBASIVARAO D, 1990, J BACTERIOL, V172, P5938, DOI 10.1128/jb.172.10.5938-5948.1990; Sambasivarao D, 2000, J BIOL CHEM, V275, P22526, DOI 10.1074/jbc.M909289199; Sambasivarao D, 2002, BIOCHEM CELL BIOL, V80, P435, DOI 10.1139/O02-131; Sambasivarao D, 2001, J BIOL CHEM, V276, P20167, DOI 10.1074/jbc.M010369200; Sambrook J, 2001, MOL CLONING LAB MANU; Stanley NR, 2002, MOL MICROBIOL, V43, P1005, DOI 10.1046/j.1365-2958.2002.02797.x; Stevens CM, 2009, J MOL BIOL, V389, P124, DOI 10.1016/j.jmb.2009.03.069; Trieber CA, 1996, J BIOL CHEM, V271, P4620; TRIEBER CA, 1994, J BIOL CHEM, V269, P7103; VANARK G, 1977, BIOCHIM BIOPHYS ACTA, V459, P119, DOI 10.1016/0005-2728(77)90014-7; Vergnes A, 2006, J BIOL CHEM, V281, P2170, DOI 10.1074/jbc.M505902200; WEINER JH, 1992, BIOCHIM BIOPHYS ACTA, V1102, P1, DOI 10.1016/0167-4838(92)90493-W; Weiner JH, 1998, CELL, V93, P93, DOI 10.1016/S0092-8674(00)81149-6; Zhao ZW, 1998, J BIOL CHEM, V273, P20758, DOI 10.1074/jbc.273.33.20758	64	10	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15147	15154		10.1074/jbc.M110.213306	http://dx.doi.org/10.1074/jbc.M110.213306			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21357619	hybrid, Green Published			2022-12-27	WOS:000289788300046
J	Narayan, V; Halada, P; Hernychova, L; Chong, YP; Zakova, J; Hupp, TR; Vojtesek, B; Ball, KL				Narayan, Vikram; Halada, Petr; Hernychova, Lenka; Chong, Yuh Ping; Zakova, Jitka; Hupp, Ted R.; Vojtesek, Borivoj; Ball, Kathryn L.			A Multiprotein Binding Interface in an Intrinsically Disordered Region of the Tumor Suppressor Protein Interferon Regulatory Factor-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-LOCALIZATION SIGNALS; TRANSCRIPTIONAL REPRESSION; CELL-PROLIFERATION; GENE-EXPRESSION; IRF FAMILY; NUCLEOPHOSMIN; DOMAIN; YB-1; P53; IDENTIFICATION	The interferon-regulated transcription factor and tumor suppressor protein IRF-1 is predicted to be largely disordered outside of the DNA-binding domain. One of the advantages of intrinsically disordered protein domains is thought to be their ability to take part in multiple, specific but low affinity protein interactions; however, relatively few IRF-1-interacting proteins have been described. The recent identification of a functional binding interface for the E3-ubiquitin ligase CHIP within the major disordered domain of IRF-1 led us to ask whether this region might be employed more widely by regulators of IRF-1 function. Here we describe the use of peptide aptamer-based affinity chromatography coupled with mass spectrometry to define a multiprotein binding interface on IRF-1 (Mf2 domain; amino acids 106-140) and to identify Mf2-binding proteins from A375 cells. Based on their function as known transcriptional regulators, a selection of the Mf2 domain-binding proteins (NPM1, TRIM28, and YB-1) have been validated using in vitro and cell-based assays. Interestingly, although NPM1, TRIM28, and YB-1 all bind to the Mf2 domain, they have differing amino acid specificities, demonstrating the degree of combinatorial diversity and specificity available through linear interaction motifs.	[Narayan, Vikram; Chong, Yuh Ping; Ball, Kathryn L.] Univ Edinburgh, Edinburgh Canc Res UK Ctr, Cell Signalling Unit, CRUK Interferon & Cell Signalling Grp, Edinburgh EH4 2XR, Midlothian, Scotland; [Hupp, Ted R.] Univ Edinburgh, Edinburgh Canc Res UK Ctr, Cell Signalling Unit, CRUK P53 Signal Transduct Grp, Edinburgh EH4 2XR, Midlothian, Scotland; [Halada, Petr] Inst Microbiol AS CR Vvi, Prague 14220, Czech Republic; [Hernychova, Lenka; Zakova, Jitka] Univ Def, Fac Mil Hlth Sci, Hradec Kralove 50001, Czech Republic; [Vojtesek, Borivoj] Masaryk Mem Canc Inst, Dept Oncol & Expt Pathol, Brno 65653, Czech Republic	University of Edinburgh; University of Edinburgh; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of Defence - Czech Republic; Masaryk Memorial Cancer Institute	Ball, KL (corresponding author), Univ Edinburgh, Edinburgh Canc Res UK Ctr, Cell Signalling Unit, CRUK Interferon & Cell Signalling Grp, Crewe Rd S, Edinburgh EH4 2XR, Midlothian, Scotland.	kathryn.ball@ed.ac.uk	Narayan, Vikram/AAF-3964-2020; Halada, Petr/H-3330-2014; Hernychova, Lenka/J-6714-2014	Halada, Petr/0000-0002-7229-3450; Narayan, Vikram/0000-0002-6128-7944; Chong, Yuh Ping/0000-0002-9596-3242; Hernychova, Lenka/0000-0002-4352-0626	Czech Science Foundation [P304/10/0868]; Ministry of Defense, Czech Republic [FVZ0000604]; Ministry of Education, Youth, and Sports of the Czech Republic [LC07017]; Institutional Research Concept [AV0Z50200510]; Regional Center for Applied Molecular Oncology [CZ.1.05/2.1.00/03.0101]; Cancer Research UK [C377/A6355]	Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Defense, Czech Republic(Czech Republic Government); Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Institutional Research Concept; Regional Center for Applied Molecular Oncology; Cancer Research UK(Cancer Research UK)	This work was supported in part by Czech Science Foundation Grant P304/10/0868; Ministry of Defense, Czech Republic, Grant FVZ0000604; Ministry of Education, Youth, and Sports of the Czech Republic Grant LC07017; Institutional Research Concept AV0Z50200510; and Regional Center for Applied Molecular Oncology Grant CZ.1.05/2.1.00/03.0101 and Cancer Research UK Programme Grant C377/A6355.	Alter MD, 2008, NEURON, V60, P733, DOI 10.1016/j.neuron.2008.12.002; Basaki Y, 2007, ONCOGENE, V26, P2736, DOI 10.1038/sj.onc.1210084; Bauerle M, 2002, J BIOL CHEM, V277, P32480, DOI 10.1074/jbc.M202765200; Bertwistle D, 2004, MOL CELL BIOL, V24, P985, DOI 10.1128/MCB.24.3.985-996.2004; Brady SN, 2004, MOL CELL BIOL, V24, P9327, DOI 10.1128/MCB.24.21.9327-9338.2004; Braithwaite AW, 2006, CELL DEATH DIFFER, V13, P984, DOI 10.1038/sj.cdd.4401924; Briers S, 2009, J CELL SCI, V122, P937, DOI 10.1242/jcs.034793; Chatterjee M, 2008, BLOOD, V111, P3714, DOI 10.1182/blood-2007-05-089151; Clarke N, 2004, EMBO J, V23, P3051, DOI 10.1038/sj.emboj.7600302; Collins MO, 2008, MOL CELL PROTEOMICS, V7, P1331, DOI 10.1074/mcp.M700564-MCP200; Colombo E, 2002, NAT CELL BIOL, V4, P529, DOI 10.1038/ncb814; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dezso Z, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-36; Dornan D, 2004, MOL CELL BIOL, V24, P10083, DOI 10.1128/MCB.24.22.10083-10098.2004; Dror N, 2007, MOL IMMUNOL, V44, P338, DOI 10.1016/j.molimm.2006.02.026; Eschrich S, 2009, INT J RADIAT ONCOL, V75, P497, DOI 10.1016/j.ijrobp.2009.05.056; Fujii T, 2008, CANCER RES, V68, P1504, DOI 10.1158/0008-5472.CAN-07-2362; Gao H, 2005, J BIOL CHEM, V280, P10988, DOI 10.1074/jbc.M412720200; Garza AS, 2009, LIFE SCI, V84, P189, DOI 10.1016/j.lfs.2008.12.002; Ge F, 2010, J PROTEOME RES, V9, P5848, DOI 10.1021/pr100616g; Gobom J, 1999, J MASS SPECTROM, V34, P105, DOI 10.1002/(SICI)1096-9888(199902)34:2<105::AID-JMS768>3.0.CO;2-4; Gongora C, 2000, NUCLEIC ACIDS RES, V28, P2333, DOI 10.1093/nar/28.12.2333; Groner AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000869; Gsponer J, 2009, PROG BIOPHYS MOL BIO, V99, P94, DOI 10.1016/j.pbiomolbio.2009.03.001; Gsponer J, 2008, SCIENCE, V322, P1365, DOI 10.1126/science.1163581; HARLOW E, 1999, USING ANTIBODIES LAB, P323; Higashi K, 2003, J BIOL CHEM, V278, P43470, DOI 10.1074/jbc.M302339200; Ho J, 2009, J PROTEOME RES, V8, P583, DOI 10.1021/pr8007368; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Kohno K, 2003, BIOESSAYS, V25, P691, DOI 10.1002/bies.10300; Kondo T, 1997, ONCOGENE, V15, P1275, DOI 10.1038/sj.onc.1201286; Kroger A, 2002, J INTERF CYTOK RES, V22, P5, DOI 10.1089/107999002753452610; Latzer J, 2007, J MOL BIOL, V367, P262, DOI 10.1016/j.jmb.2006.12.006; Lee YK, 2007, J BIOL CHEM, V282, P1595, DOI 10.1074/jbc.M606306200; Liao GL, 2005, J VIROL, V79, P245, DOI 10.1128/JVI.79.1.245-256.2005; Lin RT, 1999, MOL CELL BIOCHEM, V191, P169, DOI 10.1023/A:1006850009017; Lindstrom MS, 2008, J BIOL CHEM, V283, P15568, DOI 10.1074/jbc.M801151200; Lorenz P, 2001, BIOL CHEM, V382, P637, DOI 10.1515/BC.2001.075; Lovegrove FE, 2007, AM J PATHOL, V171, P1894, DOI 10.2353/ajpath.2007.070630; Maggi LB, 2008, MOL CELL BIOL, V28, P7050, DOI 10.1128/MCB.01548-07; Marsili G, 2004, ANN NY ACAD SCI, V1030, P636, DOI 10.1196/annals.1329.074; Masumi A, 1999, MOL CELL BIOL, V19, P1810; Meani N, 2009, EXPERT REV ANTICANC, V9, P1283, DOI 10.1586/ERA.09.84; Miller M, 2009, CURR PROTEIN PEPT SC, V10, P244, DOI 10.2174/138920309788452164; Mittag T, 2010, J MOL RECOGNIT, V23, P105, DOI 10.1002/jmr.961; Moller A, 2010, J BIOL CHEM, V285, P38348, DOI 10.1074/jbc.M110.149476; Nakagawa K, 2002, FEBS LETT, V530, P204, DOI 10.1016/S0014-5793(02)03486-5; Narayan V, 2011, J BIOL CHEM, V286, P607, DOI 10.1074/jbc.M110.153122; Narayan V, 2009, J BIOL CHEM, V284, P25889, DOI 10.1074/jbc.M109.019505; Okamoto T, 2000, ONCOGENE, V19, P6194, DOI 10.1038/sj.onc.1204029; Park J, 2007, P NATL ACAD SCI USA, V104, P17028, DOI 10.1073/pnas.0609852104; Pinol-Roma S, 1999, MOL BIOL CELL, V10, P77, DOI 10.1091/mbc.10.1.77; Pion E, 2009, CELL SIGNAL, V21, P1479, DOI 10.1016/j.cellsig.2009.05.004; Romeo G, 2002, J INTERF CYTOK RES, V22, P39, DOI 10.1089/107999002753452647; Schaper F, 1998, BIOCHEM J, V335, P147, DOI 10.1042/bj3350147; Senger K, 2000, MOL CELL, V6, P931, DOI 10.1016/S1097-2765(05)00081-X; Sigalov AB, 2010, MOL BIOSYST, V6, P451, DOI 10.1039/b916030m; Szebeni A, 1997, BIOCHEMISTRY-US, V36, P3941, DOI 10.1021/bi9627931; SZEBENI A, 1995, BIOCHEMISTRY-US, V34, P8037, DOI 10.1021/bi00025a009; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; von Kriegsheim A, 2009, NAT CELL BIOL, V11, P1458, DOI 10.1038/ncb1994; Wang CG, 2005, EMBO J, V24, P3279, DOI 10.1038/sj.emboj.7600791; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; WATANABE N, 1991, NUCLEIC ACIDS RES, V19, P4421, DOI 10.1093/nar/19.16.4421; Wilkinson MF, 2001, BIOESSAYS, V23, P775, DOI 10.1002/bies.1113; Yang C, 2002, NUCLEIC ACIDS RES, V30, P2251, DOI 10.1093/nar/30.10.2251; Yu Y, 2006, MOL CELL BIOL, V26, P3798, DOI 10.1128/MCB.26.10.3798-3809.2006; Yung Benjamin Yat Ming, 2007, Chang Gung Med J, V30, P285	71	23	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14291	14303		10.1074/jbc.M110.204602	http://dx.doi.org/10.1074/jbc.M110.204602			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21245151	Green Published, hybrid			2022-12-27	WOS:000289556200052
J	Sumida, T; Fujimoto, K; Ito, M				Sumida, Tomomi; Fujimoto, Ken; Ito, Makoto			Molecular Cloning and Catalytic Mechanism of a Novel Glycosphingolipid-degrading beta-N-Acetylgalactosaminidase from Paenibacillus sp. TS12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-ASSISTED CATALYSIS; GLYCOSYL HYDROLASES; HEXOSAMINIDASE; SEQUENCE; ACETYLHEXOSAMINIDASE; CLASSIFICATION; PURIFICATION; INHIBITORS; KINETICS; BRAIN	We report here the molecular cloning, characterization, and catalytic mechanism of a novel glycosphingolipid-degrading beta-N-acetylgalactosaminidase (beta-NGA) from Paenibacillus sp. TS12 (NgaP). Consisting of 1034 putative amino acid residues, NgaP shares no sequence similarity with known proteins. Recombinant NgaP, expressed in Escherichia coli, cleaved the nonreducing terminal beta-GalNAc residues of gangliotriaosylceramide and globotetraosylceramide. The enzyme hydrolyzed para-nitrophenyl-beta-N-acetylgalactosaminide similar to 100 times faster than para-nitrophenyl-beta-N-acetylglucosaminide. GalNAc thiazoline, an analog of the oxazolinium intermediate and potent inhibitor for enzymes adopting substrate-assisted catalysis, competitively inhibited the enzyme. The K-i of the enzyme for GalNAc thiazoline was 1.3 nM, whereas that for GlcNAc thiazoline was 46.8 mu M. Comparison of the secondary structure with those of known enzymes exhibiting substrate-assisted catalysis and point mutation analysis indicated that NgaP adopts substrate-assisted catalysis in which Glu-608 and Asp-607 could function as a proton donor and a stabilizer of the 2-acetamide group of the beta-GalNAc at the active site, respectively. These results clearly indicate that NgaP is a beta-NGA showing substrate-assisted catalysis. This is the first report describing the molecular cloning of a beta-NGA adopting substrate-assisted catalysis.	[Sumida, Tomomi; Fujimoto, Ken; Ito, Makoto] Kyushu Univ, Dept Biosci & Biotechnol, Grad Sch Bioresource & Bioenvironm Sci, Higashi Ku, Fukuoka 8128581, Japan	Kyushu University	Ito, M (corresponding author), Kyushu Univ, Dept Biosci & Biotechnol, Grad Sch Bioresource & Bioenvironm Sci, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	makotoi@agr.kyushu-u.ac.jp	Ito, Makoto/Q-6164-2019	ito, Makoto/0000-0003-3159-7818	Ministry of Education, Culture, Sports, Science, and Technology of Japan [21380066]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-aid for Basic Research 21380066 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Dennis RJ, 2006, NAT STRUCT MOL BIOL, V13, P365, DOI 10.1038/nsmb1079; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; FROHWEIN YZ, 1967, BIOCHEMISTRY-US, V6, P2775, DOI 10.1021/bi00861a018; Gutternigg M, 2007, J BIOL CHEM, V282, P27825, DOI 10.1074/jbc.M704235200; Gutternigg M, 2009, BIOCHEM J, V419, P83, DOI 10.1042/BJ20081630; HENDERSON PJ, 1972, BIOCHEM J, V127, P321, DOI 10.1042/bj1270321; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; IZUMI T, 1983, J BIOL CHEM, V258, P6991; KANFER JN, 1969, METHOD ENZYMOL, V14, P660; Knapp S, 1996, J AM CHEM SOC, V118, P6804, DOI 10.1021/ja960826u; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEATHERBARROW RJ, 1990, TRENDS BIOCHEM SCI, V15, P455, DOI 10.1016/0968-0004(90)90295-M; Lemieux MJ, 2006, J MOL BIOL, V359, P913, DOI 10.1016/j.jmb.2006.04.004; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; Mark BL, 2001, J BIOL CHEM, V276, P10330, DOI 10.1074/jbc.M011067200; Markovic-Housley Z, 2000, STRUCTURE, V8, P1025, DOI 10.1016/S0969-2126(00)00511-6; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; SAITO H, 1963, BIOCHIM BIOPHYS ACTA, V72, P619, DOI 10.1016/0926-6550(63)90386-4; Shimizu T, 2002, P NATL ACAD SCI USA, V99, P996, DOI 10.1073/pnas.022493799; Sumida T, 2002, APPL ENVIRON MICROB, V68, P5241, DOI 10.1128/AEM.68.11.5241-5248.2002; Sumida T, 2002, J BIOCHEM, V132, P237, DOI 10.1093/oxfordjournals.jbchem.a003216; Sumida T, 2009, J MOL BIOL, V392, P87, DOI 10.1016/j.jmb.2009.06.025; SVENNERHOLM L, 1956, J NEUROCHEM, V1, P42, DOI 10.1111/j.1471-4159.1956.tb12053.x; Tanaka A, 1997, J BIOCHEM-TOKYO, V122, P330; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Aalten DMF, 2001, P NATL ACAD SCI USA, V98, P8979, DOI 10.1073/pnas.151103798; Williams SJ, 2002, J BIOL CHEM, V277, P40055, DOI 10.1074/jbc.M206481200; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156	31	20	20	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14065	14072		10.1074/jbc.M110.182592	http://dx.doi.org/10.1074/jbc.M110.182592			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21297160	Green Published, hybrid			2022-12-27	WOS:000289556200029
J	Shvadchak, VV; Falomir-Lockhart, LJ; Yushchenko, DA; Jovin, TM				Shvadchak, Volodymyr V.; Falomir-Lockhart, Lisandro J.; Yushchenko, Dmytro A.; Jovin, Thomas M.			Specificity and Kinetics of alpha-Synuclein Binding to Model Membranes Determined with Fluorescent Excited State Intramolecular Proton Transfer (ESIPT) Probe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-MEMBRANES; DISEASE; AGGREGATION; VESICLE; NMR; EPR; AFFINITY; BILAYERS; RELEASE; PACKING	Parkinson disease is characterized cytopathologically by the deposition in the midbrain of aggregates composed primarily of the presynaptic neuronal protein a-synuclein (AS). Neurotoxicity is currently attributed to oligomeric microaggregates subjected to oxidative modification and promoting mitochondrial and proteasomal dysfunction. Unphysiological binding to membranes of these and other organelles is presumably involved. In this study, we performed a systematic determination of the influence of charge, phase, curvature, defects, and lipid unsaturation on AS binding to model membranes using a new sensitive solvatochromic fluorescent probe. The interaction of AS with vesicular membranes is fast and reversible. The protein dissociates from neutral membranes upon thermal transition to the liquid disordered phase and transfers to vesicles with higher affinity. The binding of AS to neutral and negatively charged membranes occurs by apparently different mechanisms. Interaction with neutral bilayers requires the presence of membrane defects; binding increases with membrane curvature and rigidity and decreases in the presence of cholesterol. The association with negatively charged membranes is much stronger and much less sensitive to membrane curvature, phase, and cholesterol content. The presence of unsaturated lipids increases binding in all cases. These findings provide insight into the relation between membrane physical properties and AS binding affinity and dynamics that presumably define protein localization in vivo and, thereby, the role of AS in the physiopathology of Parkinson disease.	[Shvadchak, Volodymyr V.; Falomir-Lockhart, Lisandro J.; Yushchenko, Dmytro A.; Jovin, Thomas M.] Max Planck Inst Biophys Chem, Lab Cellular Dynam, D-37077 Gottingen, Germany	Max Planck Society	Jovin, TM (corresponding author), Max Planck Inst Biophys Chem, Lab Cellular Dynam, Fassberg 11, D-37077 Gottingen, Germany.	tjovin@gwdg.de	Yushchenko, Dmytro/J-1020-2017; Shvadchak, Volodymyr/E-1475-2017; Falomir Lockhart, Lisandro Jorge/V-7730-2019	Yushchenko, Dmytro/0000-0003-0355-6197; Shvadchak, Volodymyr/0000-0001-8302-8073; Falomir Lockhart, Lisandro Jorge/0000-0003-4815-5768	Max Planck Society; Deutsche Forschungsgemeinschaft Center for the Molecular Physiology of the Brain [EXC 171-FZT103]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft Center for the Molecular Physiology of the Brain(German Research Foundation (DFG))	This work was funded by the Max Planck Society, the Toxic Proteins Project (Innovation Fund of the Max Planck Society), and Excellence Cluster EXC 171-FZT103 "Microscopy at the Nanometer Range" associated with the Deutsche Forschungsgemeinschaft Center for the Molecular Physiology of the Brain.	Auluck PK, 2010, ANNU REV CELL DEV BI, V26, P211, DOI 10.1146/annurev.cellbio.042308.113313; Banerjee K, 2010, FEBS LETT, V584, P1571, DOI 10.1016/j.febslet.2010.03.012; Bar-On P, 2008, J NEUROCHEM, V105, P1656, DOI 10.1111/j.1471-4159.2008.05254.x; Bar-On P, 2006, J NEUROCHEM, V98, P1032, DOI 10.1111/j.1471-4159.2006.04017.x; Bartels T, 2010, BIOPHYS J, V99, P2116, DOI 10.1016/j.bpj.2010.06.035; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Bisaglia M, 2009, FASEB J, V23, P329, DOI 10.1096/fj.08-119784; Bodner CR, 2009, J MOL BIOL, V390, P775, DOI 10.1016/j.jmb.2009.05.066; Bortolus M, 2008, J AM CHEM SOC, V130, P6690, DOI 10.1021/ja8010429; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Bussell R, 2003, J MOL BIOL, V329, P763, DOI 10.1016/S0022-2836(03)00520-5; Celej MS, 2009, BIOCHEMISTRY-US, V48, P7465, DOI 10.1021/bi9003843; CHOU PT, 1993, J PHYS CHEM-US, V97, P2618, DOI 10.1021/j100113a024; Cole NB, 2002, J BIOL CHEM, V277, P6344, DOI 10.1074/jbc.M108414200; Cookson MR, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-9; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Demchenko AP, 2009, BIOPHYS J, V96, P3461, DOI 10.1016/j.bpj.2009.02.012; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Drescher M, 2008, CHEMBIOCHEM, V9, P2411, DOI 10.1002/cbic.200800238; Drescher M, 2008, J AM CHEM SOC, V130, P7796, DOI 10.1021/ja801594s; Ferreon ACM, 2009, P NATL ACAD SCI USA, V106, P5645, DOI 10.1073/pnas.0809232106; Georgieva ER, 2008, J AM CHEM SOC, V130, P12856, DOI 10.1021/ja804517m; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Golovko MY, 2009, MOL CELL BIOCHEM, V326, P55, DOI 10.1007/s11010-008-0008-y; Hoyer W, 2004, BIOCHEMISTRY-US, V43, P16233, DOI 10.1021/bi048453u; Jao CC, 2004, P NATL ACAD SCI USA, V101, P8331, DOI 10.1073/pnas.0400553101; Jao CC, 2008, P NATL ACAD SCI USA, V105, P19666, DOI 10.1073/pnas.0807826105; Jellinger KA, 2010, J CELL MOL MED, V14, P457, DOI 10.1111/j.1582-4934.2010.01010.x; Kamp F, 2006, J BIOL CHEM, V281, P9251, DOI 10.1074/jbc.M512292200; Kim HP, 2009, J ENG GAS TURB POWER, V131, DOI 10.1115/1.3095808; Kjaer L, 2009, BIOPHYS J, V96, P2857, DOI 10.1016/j.bpj.2008.12.3940; Klymchenko AS, 2004, BBA-BIOMEMBRANES, V1665, P6, DOI 10.1016/j.bbamem.2004.06.004; Klymchenko AS, 2004, NEW J CHEM, V28, P687, DOI 10.1039/b316149h; Kubo S, 2005, J BIOL CHEM, V280, P31664, DOI 10.1074/jbc.M504894200; Lee HJ, 2002, J BIOL CHEM, V277, P671, DOI 10.1074/jbc.M107045200; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Li CG, 2009, BIOCHEMISTRY-US, V48, P8578, DOI 10.1021/bi900872p; Liu JP, 2010, MOL CELL NEUROSCI, V43, P33, DOI 10.1016/j.mcn.2009.07.013; Maguire-Zeiss KA, 2008, PHARMACOL RES, V58, P271, DOI 10.1016/j.phrs.2008.09.006; Middleton ER, 2010, BIOPHYS J, V99, P2279, DOI 10.1016/j.bpj.2010.07.056; Mills TT, 2008, BIOPHYS J, V95, P669, DOI 10.1529/biophysj.107.127845; Nagle JF, 2000, CURR OPIN STRUC BIOL, V10, P474, DOI 10.1016/S0959-440X(00)00117-2; Necula M, 2003, J BIOL CHEM, V278, P46674, DOI 10.1074/jbc.M308231200; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Nuscher B, 2004, J BIOL CHEM, V279, P21966, DOI 10.1074/jbc.M401076200; Obeso JA, 2010, NAT MED, V16, P653, DOI 10.1038/nm.2165; Oncul S, 2010, BBA-BIOMEMBRANES, V1798, P1436, DOI 10.1016/j.bbamem.2010.01.013; Pfefferkorn CM, 2010, J PHYS CHEM B, V114, P4615, DOI 10.1021/jp908092e; Postupalenko VY, 2011, BBA-BIOMEMBRANES, V1808, P424, DOI 10.1016/j.bbamem.2010.09.013; Rao JN, 2010, J AM CHEM SOC, V132, P8657, DOI 10.1021/ja100646t; Rhoades E, 2006, BIOPHYS J, V90, P4692, DOI 10.1529/biophysj.105.079251; Shynkar VV, 2007, J AM CHEM SOC, V129, P2187, DOI 10.1021/ja068008h; Stockl M, 2008, J MOL BIOL, V375, P1394, DOI 10.1016/j.jmb.2007.11.051; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Trexler AJ, 2009, BIOCHEMISTRY-US, V48, P2304, DOI 10.1021/bi900114z; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Uversky VN, 2009, CURR PROTEIN PEPT SC, V10, P483, DOI 10.2174/138920309789351921; van Rooijen BD, 2009, BBA-BIOMEMBRANES, V1788, P1271, DOI 10.1016/j.bbamem.2009.03.010; Wang GF, 2010, PROTEIN SCI, V19, P1686, DOI 10.1002/pro.449; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Yushchenko DA, 2010, J AM CHEM SOC, V132, P7860, DOI 10.1021/ja102838n; Zakharov SD, 2007, BIOCHEMISTRY-US, V46, P14369, DOI 10.1021/bi701275p; Zhu M, 2003, J BIOL CHEM, V278, P40186, DOI 10.1074/jbc.M305326200	64	79	80	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13023	13032		10.1074/jbc.M110.204776	http://dx.doi.org/10.1074/jbc.M110.204776			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21330368	Green Published, hybrid			2022-12-27	WOS:000289282200022
J	Xu, YZ; Thuraisingam, T; Marino, R; Radzioch, D				Xu, Yong Zhong; Thuraisingam, Thusanth; Marino, Rafael; Radzioch, Danuta			Recruitment of SWI/SNF Complex Is Required for Transcriptional Activation of the SLC11A1 Gene during Macrophage Differentiation of HL-60 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN-REMODELING COMPLEX; ACTIN-RELATED PROTEINS; Z-DNA; NRAMP1 GENE; MUSCLE DIFFERENTIATION; NUCLEAR RECEPTORS; INDUCED APOPTOSIS; FORMERLY NRAMP1; MESSENGER-RNA; CYCLE CONTROL	The solute carrier family 11 member 1 (SLC11A1) gene is strictly regulated and exclusively expressed in myeloid lineage cells. However, little is known about the transcriptional regulation of the SLC11A1 gene during myeloid development. In this study, we used HL-60 cells as a model to investigate the regulatory elements/factors involved in the transactivation of the SLC11A1 gene during phorbol 12-myristate 13-acetate (PMA)-induced macrophage differentiation of HL-60 cells. Promoter deletion analysis showed that a 7-base AP-1-like element (TGACTCT) was critical for the responsiveness of the SLC11A1 promoter to PMA. Stimulation by PMA induced the binding of ATF-3 and the recruitment of two components of the SWI/SNF complex, BRG1 and beta-actin, to this element in an ATF-3-dependent manner. RNAi-mediated depletion of ATF-3 or BRG1 markedly decreased SLC11A1 gene expression and its promoter activity induced by PMA. Luciferase reporter experiments demonstrated that ATF-3 cooperated with BRG1 and beta-actin to activate the SLC11A1 promoter. Furthermore, we showed that PMA can induce the proximal (GT/AC)(n) repeat sequence to convert to the Z-DNA structure in the SLC11A1 gene promoter, and depletion of BRG1 resulted in a significant decrease of Z-DNA formation. Our results demonstrated that recruitment of the SWI/SNF complex initiated Z-DNA formation and subsequently helped to transactivate the SLC11A1 gene.	[Xu, Yong Zhong; Marino, Rafael; Radzioch, Danuta] McGill Univ, Dept Med, Div Expt Med, Montreal, PQ H3G 1A4, Canada; [Thuraisingam, Thusanth; Radzioch, Danuta] McGill Univ, Dept Human Genet, Montreal, PQ H3G 1A4, Canada; [Xu, Yong Zhong; Marino, Rafael; Radzioch, Danuta] McGill Univ, McGill Univ Hlth Ctr, Montreal Gen Hosp, Res Inst, Montreal, PQ H3G 1A4, Canada	McGill University; McGill University; McGill University	Radzioch, D (corresponding author), McGill Univ, Dept Med, Div Expt Med, 1650 Cedar Ave,L11-218, Montreal, PQ H3G 1A4, Canada.	danuta.radzioch@mcgill.ca		Radzioch, Danuta/0000-0002-1601-2757	Canadian Institute of Health Research; Natural Sciences and Engineering Research Council of Canada; Fonds de la Recherche en Sante du Quebec [17734]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by the Canadian Institute of Health Research and Natural Sciences and Engineering Research Council of Canada grants (to D. R.) and Fonds de la Recherche en Sante du Quebec Grant 17734 (to Y. Z. X.).	Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Albini S, 2010, EXP CELL RES, V316, P3073, DOI 10.1016/j.yexcr.2010.05.023; Averous J, 2004, J BIOL CHEM, V279, P5288, DOI 10.1074/jbc.M311862200; Bakshi R, 2010, J CELL PHYSIOL, V225, P569, DOI 10.1002/jcp.22240; Bayele HK, 2007, BLOOD, V110, P3039, DOI 10.1182/blood-2006-12-063289; Belandia B, 2002, EMBO J, V21, P4094, DOI 10.1093/emboj/cdf412; BLACKWELL JM, 1994, IMMUNOL LETT, V43, P99, DOI 10.1016/0165-2478(94)00161-8; Blackwell JM, 2001, CELL MICROBIOL, V3, P773, DOI 10.1046/j.1462-5822.2001.00150.x; BRADLEY DJ, 1977, CLIN EXP IMMUNOL, V30, P130; Bultman SJ, 2005, GENE DEV, V19, P2849, DOI 10.1101/gad.1364105; Cellier M, 1997, J LEUKOCYTE BIOL, V61, P96, DOI 10.1002/jlb.61.1.96; Cellier MF, 2007, MICROBES INFECT, V9, P1662, DOI 10.1016/j.micinf.2007.09.006; Cheng SWG, 1999, NAT GENET, V22, P102, DOI 10.1038/8811; Cohet N, 2010, J CELL PHYSIOL, V223, P667, DOI 10.1002/jcp.22072; Corey LL, 2003, GENE DEV, V17, P1392, DOI 10.1101/gad.1071803; de la Serna IL, 2001, J BIOL CHEM, V276, P41486, DOI 10.1074/jbc.M107281200; de la Serna IL, 2001, NAT GENET, V27, P187, DOI 10.1038/84826; Debril MB, 2004, J BIOL CHEM, V279, P16677, DOI 10.1074/jbc.M312288200; Donninger H, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013318; Fry CJ, 2002, SCIENCE, V295, P1847, DOI 10.1126/science.1070260; Fryer CJ, 1998, NATURE, V393, P88, DOI 10.1038/30032; Garcia-Pedrero JM, 2006, J BIOL CHEM, V281, P22656, DOI 10.1074/jbc.M602561200; Govoni G, 1998, INFLAMM RES, V47, P277, DOI 10.1007/s000110050330; Gresh L, 2005, EMBO J, V24, P3313, DOI 10.1038/sj.emboj.7600802; Hah N, 2010, CANCER RES, V70, P4402, DOI 10.1158/0008-5472.CAN-09-2767; Henderson A, 2004, MOL CELL BIOL, V24, P389, DOI 10.1128/MCB.24.1.389-397.2004; Hsiao PW, 2003, MOL CELL BIOL, V23, P6210, DOI 10.1128/MCB.23.17.6210-6220.2003; Juliandi B, 2010, CURR OPIN NEUROBIOL, V20, P408, DOI 10.1016/j.conb.2010.04.001; Kawauchi J, 2002, J BIOL CHEM, V277, P39025, DOI 10.1074/jbc.M202974200; Ko M, 2008, MUTAT RES-FUND MOL M, V647, P59, DOI 10.1016/j.mrfmmm.2008.08.004; Lal A, 2005, MOL CELL PROBE, V19, P385, DOI 10.1016/j.mcp.2005.06.007; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Liu H, 2006, MOL CELL BIOL, V26, P2550, DOI 10.1128/MCB.26.7.2550-2559.2006; Liu H, 2004, METHOD ENZYMOL, V377, P412; Liu R, 2001, CELL, V106, P309, DOI 10.1016/S0092-8674(01)00446-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lusic M, 2003, EMBO J, V22, P6550, DOI 10.1093/emboj/cdg631; Ma ZD, 2004, MOL CELL BIOL, V24, P5496, DOI 10.1128/MCB.24.12.5496-5509.2004; Moshkin YM, 2007, MOL CELL BIOL, V27, P651, DOI 10.1128/MCB.01257-06; Nagl NG, 2007, EMBO J, V26, P752, DOI 10.1038/sj.emboj.7601541; Nobori K, 2002, J MOL CELL CARDIOL, V34, P1387, DOI 10.1006/jmcc.2002.2091; Olave IA, 2002, ANNU REV BIOCHEM, V71, P755, DOI 10.1146/annurev.biochem.71.110601.135507; Pan YX, 2003, J BIOL CHEM, V278, P38402, DOI 10.1074/jbc.M304574200; Peterson CL, 2000, CURR OPIN GENET DEV, V10, P187, DOI 10.1016/S0959-437X(00)00068-X; PLANT J, 1976, J INFECT DIS, V133, P72, DOI 10.1093/infdis/133.1.72; Rando OJ, 2002, P NATL ACAD SCI USA, V99, P2824, DOI 10.1073/pnas.032662899; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; RICH A, 1984, ANNU REV BIOCHEM, V53, P791, DOI 10.1146/annurev.bi.53.070184.004043; Richer E, 2008, FEBS J, V275, P5074, DOI 10.1111/j.1742-4658.2008.06640.x; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Roig EA, 2002, J LEUKOCYTE BIOL, V71, P890; Salma N, 2004, MOL CELL BIOL, V24, P4651, DOI 10.1128/MCB.24.11.4651-4663.2004; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; SKAMENE E, 1982, NATURE, V297, P506, DOI 10.1038/297506a0; Song ZX, 2007, J CELL BIOCHEM, V102, P403, DOI 10.1002/jcb.21300; Soutoglou E, 2002, SCIENCE, V295, P1901, DOI 10.1126/science.1068356; Stober CB, 2007, INFECT IMMUN, V75, P5059, DOI 10.1128/IAI.00153-07; Sudarsanam P, 2000, TRENDS GENET, V16, P345, DOI 10.1016/S0168-9525(00)02060-6; Sudarsanam P, 2000, P NATL ACAD SCI USA, V97, P3364, DOI 10.1073/pnas.050407197; Trotter Kevin W, 2008, Nucl Recept Signal, V6, pe004, DOI 10.1621/nrs.06004; VIDAL SM, 1993, CELL, V73, P469, DOI 10.1016/0092-8674(93)90135-D; Villagra A, 2006, J BIOL CHEM, V281, P22695, DOI 10.1074/jbc.M511640200; Vradii D, 2006, J CELL PHYSIOL, V206, P112, DOI 10.1002/jcp.20432; Wang GL, 2007, FRONT BIOSCI-LANDMRK, V12, P4424, DOI 10.2741/2399; Wang J, 2003, J BIOL CHEM, V278, P32899, DOI 10.1074/jbc.M305456200; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Xu R, 2007, J BIOL CHEM, V282, P14992, DOI 10.1074/jbc.M610316200; Xu YZ, 2010, MOL BIOL CELL, V21, P811, DOI 10.1091/mbc.E09-06-0534; Xu YZ, 2005, MOL CELL BIOL, V25, P8139, DOI 10.1128/MCB.25.18.8139-8149.2005; Yoo AS, 2009, CURR OPIN NEUROBIOL, V19, P120, DOI 10.1016/j.conb.2009.04.006; Zaahl MG, 2005, CANCER GENET CYTOGEN, V159, P48, DOI 10.1016/j.cancergencyto.2004.09.017; Zhang B, 2007, ONCOGENE, V26, P7153, DOI 10.1038/sj.onc.1210509; Zhang JY, 2006, MOL CELL BIOL, V26, P7942, DOI 10.1128/MCB.00700-06; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	75	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					12839	12849		10.1074/jbc.M110.185637	http://dx.doi.org/10.1074/jbc.M110.185637			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21300803	Green Published, hybrid			2022-12-27	WOS:000289282200004
J	Yang, K; Proweller, A				Yang, Ke; Proweller, Aaron			Vascular Smooth Muscle Notch Signals Regulate Endothelial Cell Sensitivity to Angiogenic Stimulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORPUS-LUTEUM; BLOOD-VESSELS; GROWTH-FACTOR; MURAL CELLS; EXPRESSION; JAGGED1; MICE; DLL4; ANGIOPOIETIN-1; PERICYTES	The evolutionarily conserved Notch signaling pathway is required for normal vascular development and function, and genetic associations link select Notch receptors and ligands to human clinical syndromes featuring blood vessel abnormalities and stroke susceptibility. A previously described mouse model engineered to suppress canonical Notch signaling in vascular smooth muscle cells (vSMCs) revealed surprising anatomical defects in arterial patterning and vessel maturation, suggesting that vSMCs have the functional capacity to influence blood vessel formation in a Notch signaling-dependent manner. In further analyses using this model system, we now show that explanted aortic ring tissue and Matrigel implants from the smooth muscle Notch signaling-deficient mice yield markedly diminished responses to angiogenic stimuli. Furthermore, cultured Notch signaling-deficient primary vSMCs have reduced proliferation and migration capacities and reveal diminished expression of PDGF receptor beta and JAGGED1 ligand. These observations prompted a series of endothelial cell (EC)-vSMC co-culture experiments that revealed a requirement for intact vSMC Notch signals via JAGGED1 for efficient EC Notch1 receptor activation and EC proliferation. Taken together, these studies suggest a heterotypic model wherein Notch signaling in vSMCs provides early instructive cues to neighboring ECs important for optimal postnatal angiogenesis.	Case Western Reserve Univ, Case Cardiovasc Res Inst, Dept Med, Cleveland, OH 44106 USA; Case Western Reserve Univ, Inst Heart & Vasc, Univ Hosp Harrington McLaughlin, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Proweller, A (corresponding author), Case Western Reserve Univ, Dept Med, 4530 Wolstein Res Bldg,2103 Cornell Rd, Cleveland, OH 44122 USA.	aaron.proweller@case.edu			National Institutes of Health [K08-HL079072, R01-HL096603-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096603, K08HL079072] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants K08-HL079072 and R01-HL096603-01 (to A. P.).	Amselgruber WM, 1999, ANAT HISTOL EMBRYOL, V28, P157, DOI 10.1046/j.1439-0264.1999.00195.x; Aplin AC, 2008, METHOD ENZYMOL, V443, P119, DOI 10.1016/S0076-6879(08)02007-7; Arboleda-Velasquez JF, 2008, P NATL ACAD SCI USA, V105, P4856, DOI 10.1073/pnas.0709867105; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Benjamin LE, 1998, DEVELOPMENT, V125, P1591; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Campos AH, 2002, CIRC RES, V91, P999, DOI 10.1161/01.RES.0000044944.99984.25; de Chantemele EJB, 2008, ARTERIOSCL THROM VAS, V28, P2216, DOI 10.1161/ATVBAHA.108.171751; Domenga V, 2004, GENE DEV, V18, P2730, DOI 10.1101/gad.308904; Feng XS, 2010, DEVELOPMENT, V137, P4191, DOI 10.1242/dev.052043; Fischer A, 2003, TRENDS CARDIOVAS MED, V13, P221, DOI 10.1016/S1050-1738(03)00082-3; Fryer CJ, 2002, GENE DEV, V16, P1397, DOI 10.1101/gad.991602; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; High FA, 2008, P NATL ACAD SCI USA, V105, P1955, DOI 10.1073/pnas.0709663105; Hofmann JJ, 2007, CIRC RES, V100, P1556, DOI 10.1161/01.RES.0000266408.42939.e4; Hofmann JJ, 2010, DEVELOPMENT, V137, P4061, DOI 10.1242/dev.052118; Holderfield MT, 2008, CIRC RES, V102, P637, DOI 10.1161/CIRCRESAHA.107.167171; Jin S, 2008, CIRC RES, V102, P1483, DOI 10.1161/CIRCRESAHA.107.167965; Kitamoto T, 2005, BIOCHEM BIOPH RES CO, V331, P1154, DOI 10.1016/j.bbrc.2005.03.241; Li XD, 2009, NAT MED, V15, P1289, DOI 10.1038/nm.2021; Li YX, 2009, CIRCULATION, V119, P2686, DOI 10.1161/CIRCULATIONAHA.108.790485; Liu H, 2010, CIRC RES, V107, P860, DOI 10.1161/CIRCRESAHA.110.218271; Liu H, 2009, CIRC RES, V104, P466, DOI 10.1161/CIRCRESAHA.108.184846; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Ozerdem Ugur, 2003, Angiogenesis, V6, P241, DOI 10.1023/B:AGEN.0000021401.58039.a9; Proweller A, 2007, P NATL ACAD SCI USA, V104, P16275, DOI 10.1073/pnas.0707950104; Redmer DA, 2001, BIOL REPROD, V65, P879, DOI 10.1095/biolreprod65.3.879; Reynolds LP, 2000, ENDOCRINE, V12, P1, DOI 10.1385/ENDO:12:1:1; Rossant J, 2002, ANNU REV CELL DEV BI, V18, P541, DOI 10.1146/annurev.cellbio.18.012502.105825; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; Sundberg C, 2002, LAB INVEST, V82, P387, DOI 10.1038/labinvest.3780433; Uemura A, 2002, J CLIN INVEST, V110, P1619, DOI 10.1172/JCI200215621; Villa N, 2001, MECH DEVELOP, V108, P161, DOI 10.1016/S0925-4773(01)00469-5	35	26	26	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13741	13753		10.1074/jbc.M110.181842	http://dx.doi.org/10.1074/jbc.M110.181842			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21349836	Green Published, hybrid			2022-12-27	WOS:000289282200092
J	Zeng, WG; Horrocks, KJ; Robevska, G; Wong, CY; Azzopardi, K; Tauschek, M; Robins-Browne, RM; Jackson, DC				Zeng, Weiguang; Horrocks, Kylie J.; Robevska, Gorjana; Wong, Chinn Yi; Azzopardi, Kristy; Tauschek, Marija; Robins-Browne, Roy M.; Jackson, David C.			A Modular Approach to Assembly of Totally Synthetic Self-adjuvanting Lipopeptide-based Vaccines Allows Conformational Epitope Building	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTEROTOXIGENIC ESCHERICHIA-COLI; DISULFIDE BOND FORMATION; HEAT-STABLE ENTEROTOXIN; CD8(+) T-CELLS; IMMUNOCONTRACEPTIVE VACCINES; IMMUNE-RESPONSE; INFLUENZA-VIRUS; PEPTIDE; CHALLENGE; ANTIBODY	The technology described here allows the chemical synthesis of vaccines requiring correctly folded epitopes and that contain difficult or long peptide sequences. The final self-adjuvanting product promotes strong humoral and/or cell-mediated immunity. A module containing common components of the vaccine (T helper cell epitope and the adjuvanting lipid moiety S-[2,3-bis(palmitoyloxy)propyl] cysteine) was assembled to enable a plug and play approach to vaccine assembly. The inclusion within the module of a chemical group with chemical properties complementary and orthogonal to a chemical group present in the target epitope allowed chemoselective ligation of the two vaccine components. The heat-stable enterotoxin of enterotoxigenic Escherichia coli that requires strict conformational integrity for biological activity and the reproductive hormone luteinizing hormone-releasing hormone were used as the target epitopes for the antibody vaccines. An epitope from the acid polymerase of influenza virus was used to assemble a CD8(+) T cell vaccine. Evaluation of each vaccine candidate in animals demonstrated the feasibility of the approach and that the type of immune response required, viz, antibody or cytotoxic T lymphocyte, dictates the nature of the chemical linkage between the module and target epitope. The use of a thioether bond between the module and target epitope had little or no adverse effect on antibody responses, whereas the use of a disulfide bond between the module and target epitope almost completely abrogated the antibody response. In contrast, better cytotoxic T lymphocyte responses were obtained when a disulfide bond was used.	[Zeng, Weiguang; Horrocks, Kylie J.; Robevska, Gorjana; Wong, Chinn Yi; Azzopardi, Kristy; Tauschek, Marija; Robins-Browne, Roy M.; Jackson, David C.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia	University of Melbourne	Jackson, DC (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia.	davidcj@unimelb.edu.au	Robinsbrowne, Roy/ABF-8434-2020	Robinsbrowne, Roy/0000-0001-9179-7884; Jackson, David/0000-0001-7255-270X	National Health and Medical Research Council of Australia; Australian Research Council; Bill and Melinda Gates Foundation	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by grants from the National Health and Medical Research Council of Australia, the Australian Research Council and the Bill and Melinda Gates Foundation.	Alphs HH, 2008, P NATL ACAD SCI USA, V105, P5850, DOI 10.1073/pnas.0800868105; Batzloff MR, 2006, J INFECT DIS, V194, P325, DOI 10.1086/505146; Belz GT, 2000, J VIROL, V74, P3486, DOI 10.1128/JVI.74.8.3486-3493.2000; BenMohamed L, 2002, EUR J IMMUNOL, V32, P2274, DOI 10.1002/1521-4141(200208)32:8<2274::AID-IMMU2274>3.0.CO;2-C; BROWN LE, 1988, J VIROL, V62, P1746, DOI 10.1128/JVI.62.5.1746-1752.1988; Brown Lorena E., 2005, Current Drug Delivery, V2, P383, DOI 10.2174/156720105774370258; Chua BY, 2007, VACCINE, V25, P92, DOI 10.1016/j.vaccine.2006.07.012; Coles RM, 2002, J IMMUNOL, V168, P834, DOI 10.4049/jimmunol.168.2.834; Day EB, 2007, J IMMUNOL, V179, P2187, DOI 10.4049/jimmunol.179.4.2187; Deliyannis G, 2006, EUR J IMMUNOL, V36, P770, DOI 10.1002/eji.200535217; Fitzmaurice CJ, 2000, INT IMMUNOL, V12, P527, DOI 10.1093/intimm/12.4.527; Gali H, 2002, BIOCONJUGATE CHEM, V13, P224, DOI 10.1021/bc010062u; Ghosh S, 2001, IMMUNOLOGY, V104, P58, DOI 10.1046/j.0019-2805.2001.01271.x; Jackson DC, 2002, CURR DRUG TARGETS, V3, P175, DOI 10.2174/1389450024605436; Jackson DC, 2004, P NATL ACAD SCI USA, V101, P15440, DOI 10.1073/pnas.0406740101; JACKSON DC, 1994, VIROLOGY, V198, P613, DOI 10.1006/viro.1994.1073; Lau YF, 2006, INT IMMUNOL, V18, P1801, DOI 10.1093/intimm/dxl114; Ng WC, 2009, INFLUENZA OTHER RESP, V3, P177, DOI 10.1111/j.1750-2659.2009.00087.x; Pejoski D, 2010, IMMUNOL CELL BIOL, V88, P605, DOI 10.1038/icb.2010.15; Purcell AW, 2007, NAT REV DRUG DISCOV, V6, P404, DOI 10.1038/nrd2224; Robertson JM, 2000, J IMMUNOL, V164, P4706, DOI 10.4049/jimmunol.164.9.4706; ROBINSBROWNE RM, 1981, GASTROENTEROLOGY, V80, P321; Rose K, 1996, BIOCONJUGATE CHEM, V7, P552, DOI 10.1021/bc960039m; SHIMONISHI Y, 1987, FEBS LETT, V215, P165, DOI 10.1016/0014-5793(87)80134-5; Taxt A, 2010, INFECT IMMUN, V78, P1824, DOI 10.1128/IAI.01397-09; Walker J, 2007, VACCINE, V25, P7111, DOI 10.1016/j.vaccine.2007.07.047; Zeng WG, 2007, MOL IMMUNOL, V44, P3724, DOI 10.1016/j.molimm.2007.04.004; Zeng WG, 2011, MOL IMMUNOL, V48, P490, DOI 10.1016/j.molimm.2010.10.003; Zeng WG, 2005, VACCINE, V23, P4427, DOI 10.1016/j.vaccine.2005.04.015; Zeng WG, 2002, J IMMUNOL, V169, P4905, DOI 10.4049/jimmunol.169.9.4905; Zeng WG, 2001, VACCINE, V19, P3843, DOI 10.1016/S0264-410X(01)00152-9	31	26	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					12944	12951		10.1074/jbc.M111.227744	http://dx.doi.org/10.1074/jbc.M111.227744			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21321114	hybrid, Green Published			2022-12-27	WOS:000289282200014
J	Finan, GM; Okada, H; Kim, TW				Finan, Gina M.; Okada, Hirokazu; Kim, Tae-Wan			BACE1 Retrograde Trafficking Is Uniquely Regulated by the Cytoplasmic Domain of Sortilin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; SECRETASE CYTOSOLIC DOMAIN; ALZHEIMERS-DISEASE; BETA-SECRETASE; GGA PROTEINS; RETROMER COMPLEX; HUMAN BRAIN; CLEAVING ENZYME; RECEPTOR LR11; GROWTH-FACTOR	BACE1 (beta-site beta-amyloid precursor protein (APP)-cleaving enzyme 1) mediates the first proteolytic cleavage of APP, leading to amyloid beta-peptide (A beta) production. It has been reported that BACE1 intracellular trafficking, in particular endosome-to-TGN sorting, is mediated by adaptor complexes, such as retromer and Golgi-localized gamma-ear-containing ARF-binding proteins (GGAs). Here we investigated whether sortilin, a Vps10p domain-sorting receptor believed to participate in retromer- mediated transport of select membrane cargoes, contributes to the subcellular trafficking and activity of BACE1. Our initial studies revealed increased levels of sortilin in post-mortem brain tissue of AD patients and that overexpression of sortilin leads to increased BACE1-mediated cleavage of APP in cultured cells. In contrast, RNAi suppression of sortilin results in decreased BACE1-mediated cleavage of APP. We also found that sortilin interacts with BACE1 and that a sortilin construct lacking its cytoplasmic domain, which contains putative retromer sorting motifs, remains bound to BACE1. However, expression of this truncated sortilin redistributes BACE1 from the trans-Golgi network to the endosomes and substantially reduces the retrograde trafficking of BACE1. Site-directed mutagenesis and chimera experiments reveal that the cytoplasmic tail of sortilin, but not those from other VPS10p domain receptors (e. g. SorCs1b and SorLA), plays a unique role in BACE1 trafficking. Our studies suggest a new function for sortilin as a modulator of BACE1 retrograde trafficking and subsequent generation of A beta.	[Finan, Gina M.; Kim, Tae-Wan] Columbia Univ, Med Ctr, Grad Program Pathobiol & Mol Med, New York, NY 10032 USA; [Okada, Hirokazu; Kim, Tae-Wan] Columbia Univ, Med Ctr, Integrated Program Cellular Mol & Biophys Studies, New York, NY 10032 USA; [Finan, Gina M.; Okada, Hirokazu; Kim, Tae-Wan] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Kim, Tae-Wan] Columbia Univ, Med Ctr, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University	Kim, TW (corresponding author), Columbia Univ, Med Ctr, Grad Program Pathobiol & Mol Med, 630 W 168th St,P&S 12-430, New York, NY 10032 USA.	twk16@columbia.edu		Okada, Hirokazu/0000-0002-1065-2470	National Institutes of Health Alzheimer's Disease Research Center [AG08702]; American Health Assistance Foundation; National Institute of Neurological Disorders and Stroke Predoctoral National Research Service [NS051957]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS051957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG008702] Funding Source: NIH RePORTER	National Institutes of Health Alzheimer's Disease Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Assistance Foundation(BrightFocus Foundation); National Institute of Neurological Disorders and Stroke Predoctoral National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the National Institutes of Health Alzheimer's Disease Research Center (AG08702, to T.-W.K.), American Health Assistance Foundation (to T.-W.K.), and the National Institute of Neurological Disorders and Stroke Predoctoral National Research Service Award (NS051957, to G. M. F.).	Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; ARNOLD SE, 1994, ARCH NEUROL-CHICAGO, V51, P145, DOI 10.1001/archneur.1994.00540140051014; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Bonifacino JS, 2004, NAT REV MOL CELL BIO, V5, P23, DOI 10.1038/nrm1279; Canuel M, 2008, BIOCHEM BIOPH RES CO, V366, P724, DOI 10.1016/j.bbrc.2007.12.015; CAPORASO GL, 1992, P NATL ACAD SCI USA, V89, P2252, DOI 10.1073/pnas.89.6.2252; Cullen PJ, 2008, NAT REV MOL CELL BIO, V9, P574, DOI 10.1038/nrm2427; Cummings JL, 2004, NEW ENGL J MED, V351, P56, DOI 10.1056/NEJMra040223; Dodson SE, 2006, J NEUROPATH EXP NEUR, V65, P866, DOI 10.1097/01.jnen.0000228205.19915.20; He XY, 2005, J BIOL CHEM, V280, P11696, DOI 10.1074/jbc.M411296200; He XY, 2003, BIOCHEMISTRY-US, V42, P12174, DOI 10.1021/bi035199h; He XY, 2002, FEBS LETT, V524, P183, DOI 10.1016/S0014-5793(02)03052-1; Hermey G, 2009, CELL MOL LIFE SCI, V66, P2677, DOI 10.1007/s00018-009-0043-1; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Huse JT, 2001, TRAFFIC, V2, P75, DOI 10.1034/j.1600-0854.2001.020201.x; JOHNSON KF, 1992, J CELL BIOL, V119, P249, DOI 10.1083/jcb.119.2.249; Kang EL, 2010, J BIOL CHEM, V285, P24108, DOI 10.1074/jbc.M109.092742; Kim E, 2010, BIOCHEM BIOPH RES CO, V403, P167, DOI 10.1016/j.bbrc.2010.10.121; KOO EH, 1994, J BIOL CHEM, V269, P17386; Landman N, 2006, P NATL ACAD SCI USA, V103, P19524, DOI 10.1073/pnas.0604954103; Lane RF, 2010, J NEUROSCI, V30, P13110, DOI 10.1523/JNEUROSCI.3872-10.2010; Lefrancois S, 2003, EMBO J, V22, P6430, DOI 10.1093/emboj/cdg629; Mari M, 2008, TRAFFIC, V9, P380, DOI 10.1111/j.1600-0854.2007.00686.x; Muhammad A, 2008, P NATL ACAD SCI USA, V105, P7327, DOI 10.1073/pnas.0802545105; Nielsen MS, 2008, TRAFFIC, V9, P980, DOI 10.1111/j.1600-0854.2008.00731.x; Nielsen MS, 2007, MOL CELL BIOL, V27, P6842, DOI 10.1128/MCB.00815-07; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Offe K, 2006, J NEUROSCI, V26, P1596, DOI 10.1523/JNEUROSCI.4946-05.2006; Okada H, 2010, FASEB J, V24, P2783, DOI 10.1096/fj.09-146357; Petersen CM, 1997, J BIOL CHEM, V272, P3599, DOI 10.1074/jbc.272.6.3599; Rezgaoui M, 2001, MECH DEVELOP, V100, P335, DOI 10.1016/S0925-4773(00)00523-2; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Sarret P, 2003, J COMP NEUROL, V461, P483, DOI 10.1002/cne.10708; Scherzer CR, 2004, ARCH NEUROL-CHICAGO, V61, P1200, DOI 10.1001/archneur.61.8.1200; Schmidt V, 2007, J BIOL CHEM, V282, P32956, DOI 10.1074/jbc.M705073200; Seaman MNJ, 2007, J CELL SCI, V120, P2378, DOI 10.1242/jcs.009654; Seaman MNJ, 2005, TRENDS CELL BIOL, V15, P68, DOI 10.1016/j.tcb.2004.12.004; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Small SA, 2005, ANN NEUROL, V58, P909, DOI 10.1002/ana.20667; Spoelgen R, 2006, J NEUROSCI, V26, P418, DOI 10.1523/JNEUROSCI.3882-05.2006; Takahashi RH, 2002, HISTOL HISTOPATHOL, V17, P239, DOI 10.14670/HH-17.239; Takatsu H, 2001, J BIOL CHEM, V276, P28541, DOI 10.1074/jbc.C100218200; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Thal DR, 2000, J NEUROPATH EXP NEUR, V59, P733, DOI 10.1093/jnen/59.8.733; Tienari PJ, 1997, P NATL ACAD SCI USA, V94, P4125, DOI 10.1073/pnas.94.8.4125; Van Gassen G, 2003, NEUROSCIENTIST, V9, P117, DOI 10.1177/1073858403252227; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; von Arnim CAF, 2006, J NEUROSCI, V26, P9913, DOI 10.1523/JNEUROSCI.2290-06.2006; Wahle T, 2005, MOL CELL NEUROSCI, V29, P453, DOI 10.1016/j.mcn.2005.03.014; Wahle T, 2006, J NEUROSCI, V26, P12838, DOI 10.1523/JNEUROSCI.1982-06.2006; Walter J, 2001, CURR OPIN NEUROBIOL, V11, P585, DOI 10.1016/S0959-4388(00)00253-1; Walter J, 2001, J BIOL CHEM, V276, P14634, DOI 10.1074/jbc.M011116200; Westergaard UB, 2005, FEBS LETT, V579, P1172, DOI 10.1016/j.febslet.2004.12.088; Willnow TE, 2008, NAT REV NEUROSCI, V9, P899, DOI 10.1038/nrn2516; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007	57	89	94	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.170217	http://dx.doi.org/10.1074/jbc.M110.170217			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21245145	Green Published, hybrid			2022-12-27	WOS:000289077500072
J	Hoeppner, LH; Secreto, FJ; Razidlo, DF; Whitney, TJ; Westendorf, JJ				Hoeppner, Luke H.; Secreto, Frank J.; Razidlo, David F.; Whitney, Tiffany J.; Westendorf, Jennifer J.			Lef1 Delta N Binds beta-Catenin and Increases Osteoblast Activity and Trabecular Bone Mass	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENHANCER FACTOR-I; MESENCHYMAL STEM-CELLS; COLON-CANCER; DIFFERENTIATED OSTEOBLASTS; OSTEOGENIC DIFFERENTIATION; EXPRESSION; LEF1; PROMOTER; TRANSCRIPTION; ACTIVATION	Lymphoid enhancer-binding factor (Lef) 1 is a high mobility group protein best known as a Wnt-responsive transcription factor that associates with beta-catenin. Lef1 Delta N is a short isoform of Lef1 that lacks the first 113 amino acids and a well characterized high affinity beta-catenin binding domain present in the full-length protein. Both Lef1 isoforms bind DNA and regulate gene expression. We previously reported that Lef1 is expressed in proliferating osteoblasts and blocks osteocalcin expression. In contrast, Lef1 Delta N is only detectable in the later stages of osteoblast differentiation and promotes osteogenesis in vitro. Here, we show that Lef1 Delta N retains the ability to interact physically and functionally with beta-catenin. Unlike what has been reported in T cells and colon cancer cell lines, Lef1 Delta N activated gene transcription in the absence of exogenous beta-catenin and cooperated with constitutively active beta-catenin to stimulate gene transcription in mesenchymal and osteoblastic cells. Residues at the N terminus of Lef1 Delta N were required for beta-catenin binding and the expression of osteoblast differentiation genes. To determine the role of Lef1 Delta N on bone formation in vivo, a Lef1 Delta N transgene was expressed in committed osteoblasts using the 2.3-kb fragment of the type 1 collagen promoter. The Lef1 Delta N transgenic mice had higher trabecular bone volume in the proximal tibias and L5 vertebrae. Histological analyses of tibial sections revealed no differences in osteoblast, osteoid, or osteoclast surface areas. However, bone formation and mineral apposition rates as well as osteocalcin levels were increased in Lef1 Delta N transgenic mice. Together, our data indicate that Lef1 Delta N binds beta-catenin, stimulates Lef/Tcf reporter activity, and promotes terminal osteoblast differentiation.	[Westendorf, Jennifer J.] Mayo Clin, Dept Orthoped Surg, Rochester, MN 55905 USA; Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Westendorf, JJ (corresponding author), Mayo Clin, Dept Orthoped Surg, 200 1st St SW, Rochester, MN 55905 USA.	westendorf.jennifer@mayo.edu		Hoeppner, Luke/0000-0003-3948-4244	National Institutes of Health [AR050074, AR048147-S1]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050074, R01AR048147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR050074 and AR048147-S1.	Almeida M, 2005, J BIOL CHEM, V280, P41342, DOI 10.1074/jbc.M502168200; Arce L, 2006, ONCOGENE, V25, P7492, DOI 10.1038/sj.onc.1210056; Atcha FA, 2003, J BIOL CHEM, V278, P16169, DOI 10.1074/jbc.M213218200; Bennett CN, 2007, J BONE MINER RES, V22, P1924, DOI 10.1359/JBMR.070810; Boland GM, 2004, J CELL BIOCHEM, V93, P1210, DOI 10.1002/jcb.20284; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; de Boer J, 2004, BONE, V34, P818, DOI 10.1016/j.bone.2004.01.016; Filali M, 2002, J BIOL CHEM, V277, P33398, DOI 10.1074/jbc.M107977200; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Hadjiargyrou M, 2002, J BIOL CHEM, V277, P30177, DOI 10.1074/jbc.M203171200; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Hoeppner LH, 2009, J CELL PHYSIOL, V221, P480, DOI 10.1002/jcp.21879; Hoeppner LH, 2009, EXPERT OPIN THER TAR, V13, P485, DOI [10.1517/14728220902841961, 10.1517/14728220902841961 ]; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Hoppler S, 2007, J CELL SCI, V120, P385, DOI 10.1242/jcs.03363; Hovanes K, 2000, NUCLEIC ACIDS RES, V28, P1994, DOI 10.1093/nar/28.9.1994; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Kahler RA, 2006, J CELL BIOCHEM, V97, P969, DOI 10.1002/jcb.20702; Kahler RA, 2003, J BIOL CHEM, V278, P11937, DOI 10.1074/jbc.M211443200; Kang S, 2007, J BIOL CHEM, V282, P14515, DOI 10.1074/jbc.M700030200; Khosla S, 2008, J CLIN INVEST, V118, P421, DOI 10.1172/JCI33612; Kratochwil K, 1996, GENE DEV, V10, P1382, DOI 10.1101/gad.10.11.1382; Li TWH, 2006, MOL CELL BIOL, V26, P5284, DOI 10.1128/MCB.00105-06; Mariadason JM, 2001, CANCER RES, V61, P3465; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Niemann C, 2002, DEVELOPMENT, V129, P95; Noh T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005438; OOSTERWEGEL M, 1993, THYMUS, V22, P67; Secreto Frank J, 2009, Curr Osteoporos Rep, V7, P64; Shibamoto S, 2004, EXP CELL RES, V292, P11, DOI 10.1016/j.yexcr.2003.08.009; Skokowa J, 2006, NAT MED, V12, P1191, DOI 10.1038/nm1484; Smith E, 2005, J BIOL CHEM, V280, P2388, DOI 10.1074/jbc.M406294200; Takeda H, 2006, NAT MED, V12, P395, DOI 10.1038/nm1386; TRAVIS A, 1991, GENE DEV, V5, P880, DOI 10.1101/gad.5.5.880; vandeWetering M, 1996, MOL CELL BIOL, V16, P745; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Wang WB, 2005, ACTA BIOCH BIOPH SIN, V37, P173, DOI 10.1111/j.1745-7270.2005.00023.x; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Williams BO, 2009, J BONE MINER RES, V24, P171, DOI [10.1359/JBMR.081235, 10.1359/jbmr.081235]; Willinger T, 2006, J IMMUNOL, V176, P1439, DOI 10.4049/jimmunol.176.3.1439; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059; Yokoyama NN, 2010, NUCLEIC ACIDS RES, V38, P6375, DOI 10.1093/nar/gkq492; Zhou G, 2006, P NATL ACAD SCI USA, V103, P19004, DOI 10.1073/pnas.0605170103; ZHOU PB, 1995, GENE DEV, V9, P700, DOI 10.1101/gad.9.6.700	46	24	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					10950	10959		10.1074/jbc.M110.165100	http://dx.doi.org/10.1074/jbc.M110.165100			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21270130	Green Published, hybrid			2022-12-27	WOS:000288797100007
J	Hu, X; Kim, JA; Castillo, A; Huang, M; Liu, JX; Wang, B				Hu, Xin; Kim, Jin Ah; Castillo, Andy; Huang, Michael; Liu, Jianxin; Wang, Bin			NBA1/MERIT40 and BRE Interaction Is Required for the Integrity of Two Distinct Deubiquitinating Enzyme BRCC36-containing Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; BRCA1; CANCER; BRCC36; UBIQUITINATION; SUSCEPTIBILITY; RECOGNITION; DEGRADATION; PARTNERS; DOMAIN	BRCC36-deubiquitinating enzyme (DUB) forms two different complexes through interactions with two different adaptor proteins Abraxas and ABRO1 in cells. Abraxas mainly localizes in the nucleus, mediating the interaction of BRCC36 with BRCA1. ABRO1 is mainly localized in the cytoplasm. Because it lacks the BRCA1-interacting motif, the ABRO1 complex does not interact with BRCA1. Both BRCC36-containing complexes contain common components including BRE and NBA1/MERIT40. Here, we found that the two complexes are assembled in a similar manner and NBA1 and BRE interaction is critical for maintaining the integrity of both of the complexes. Knockdown of NBA1 or BRE leads to decreased levels of components of the two BRCC36-containing complexes. We provided evidence that NBA1 interacts with BRE through a C-terminal conserved motif of the NBA1 protein and a C-terminal UEV domain of the BRE protein. Furthermore, the NBA1-BRE interaction is required for cellular resistance to ionizing irradiation and NBA1's role in recruiting BRCA1 to DNA damage sites. Together, these studies reveal critical interactions required for the formation and function of BRCC36-containing DUB complexes.	[Hu, Xin; Kim, Jin Ah; Castillo, Andy; Liu, Jianxin; Wang, Bin] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Wang, Bin] Univ Texas Grad Sch Biomed Sci, Genes & Dev Program, Houston, TX 77030 USA; [Huang, Michael] Rice Univ, Houston, TX 77005 USA	University of Texas System; UTMD Anderson Cancer Center; Rice University	Wang, B (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genet, 1515 Holcombe Blvd, Houston, TX 77030 USA.	bwang3@mdanderson.org			National Institutes of Health; NCI [1K01CA116275-01]; Sidney Kimmel Foundation; M.D. Anderson Cancer Center; NATIONAL CANCER INSTITUTE [K01CA116275, R01CA155025] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Sidney Kimmel Foundation; M.D. Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by a National Institutes of Health, NCI Howard Temin Award (1K01CA116275-01) and a Sidney Kimmel Foundation Scholar Award (to B. W.) and an M.D. Anderson Cancer Center IRG fund.	Antoniou AC, 2010, NAT GENET, V42, P885, DOI 10.1038/ng.669; Bekker-Jensen S, 2010, NAT CELL BIOL, V12, P80, DOI 10.1038/ncb2008; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Bolton KL, 2010, NAT GENET, V42, P880, DOI 10.1038/ng.666; Chen XW, 2006, CANCER RES, V66, P5039, DOI 10.1158/0008-5472.CAN-05-4194; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cooper EM, 2010, J BIOL CHEM, V285, P10344, DOI 10.1074/jbc.M109.059667; Cooper EM, 2009, EMBO J, V28, P621, DOI 10.1038/emboj.2009.27; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dong YS, 2003, MOL CELL, V12, P1087, DOI 10.1016/S1097-2765(03)00424-6; Feng L, 2010, J BIOL CHEM, V285, P30982, DOI 10.1074/jbc.M110.135392; Feng L, 2009, GENE DEV, V23, P719, DOI 10.1101/gad.1770609; Gandhi TKB, 2006, NAT GENET, V38, P285, DOI 10.1038/ng1747; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Hofmann RM, 2001, J BIOL CHEM, V276, P27936, DOI 10.1074/jbc.M103378200; Love KR, 2007, NAT CHEM BIOL, V3, P697, DOI 10.1038/nchembio.2007.43; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; Patterson-Fortin J, 2010, J BIOL CHEM, V285, P30971, DOI 10.1074/jbc.M110.135319; Pornillos O, 2002, NAT STRUCT BIOL, V9, P812, DOI 10.1038/nsb856; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Shao G, 2009, GENE DEV, V23, P740, DOI 10.1101/gad.1739609; Shao G, 2009, P NATL ACAD SCI USA, V106, P3166, DOI 10.1073/pnas.0807485106; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; Sundquist WI, 2004, MOL CELL, V13, P783, DOI 10.1016/S1097-2765(04)00129-7; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang B, 2009, GENE DEV, V23, P729, DOI 10.1101/gad.1770309; Weger S, 2007, VIROLOGY, V362, P192, DOI 10.1016/j.virol.2006.12.010; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071	38	57	63	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11734	11745		10.1074/jbc.M110.200857	http://dx.doi.org/10.1074/jbc.M110.200857			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21282113	Green Published, hybrid			2022-12-27	WOS:000288797100081
J	Nishie, M; Sasaki, M; Nagao, J; Zendo, T; Nakayama, J; Sonomoto, K				Nishie, Mami; Sasaki, Makoto; Nagao, Jun-ichi; Zendo, Takeshi; Nakayama, Jiro; Sonomoto, Kenji			Lantibiotic Transporter Requires Cooperative Functioning of the Peptidase Domain and the ATP Binding Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUORUM-SENSING PATHWAY; FERMENTED RICE BRAN; CASSETTE TRANSPORTER; ESCHERICHIA-COLI; NUKACIN ISK-1; LACTOCOCCUS-LACTIS; ABC TRANSPORTER; GENE-CLUSTER; BIOSYNTHESIS; BACTERIOCIN	Lantibiotics are ribosomally synthesized and post-translationally modified peptide antibiotics that contain unusual amino acids such as dehydro and lanthionine residues. Nukacin ISK-1 is a class II lantibiotic, whose precursor peptide (NukA) is modified by NukM to form modified NukA. ATP-binding cassette (ABC) transporter NukT is predicted to cleave off the N-terminal leader peptide of modified NukA and secrete the mature peptide. Multiple sequence alignments revealed that NukT has an N-terminal peptidase domain (PEP) and a C-terminal ATP binding domain (ABD). Previously, in vitro reconstitution of NukT has revealed that NukT peptidase activity depends on ATP hydrolysis. Here, we constructed a series of NukT mutants and investigated their transport activity in vivo and peptidase activity in vitro. Most of the mutations of the conserved residues of PEP or ABD resulted in failure of nukacin ISK-1 production and accumulation of modified NukA inside the cells. NukT(N106D) was found to be the only mutant capable of producing nukacin ISK-1. Asn(106) is conserved as Asp in other related ABC transporters. Additionally, an in vitro peptidase assay of NukT mutants demonstrated that PEP is on the cytosolic side and all of the ABD mutants as well as PEP (with the exception of NukT(N106D)) did not have peptidase activity in vitro. Taken together, these observations suggest that the leader peptide is cleaved off inside the cells before peptide secretion; both PEP and ABD are important for NukT peptidase activity, and cooperation between these two domains inside the cells is indispensable for proper functioning of NukT.	[Nishie, Mami; Sasaki, Makoto; Zendo, Takeshi; Nakayama, Jiro; Sonomoto, Kenji] Kyushu Univ, Lab Microbial Technol, Div Appl Mol Microbiol & Biomass Chem, Dept Biosci & Biotechnol,Fac Agr,Grad Sch, Fukuoka 8128581, Japan; [Nagao, Jun-ichi] Fukuoka Dent Coll, Sect Infect Biol, Dept Funct Biosci, Fukuoka 8140193, Japan; [Sonomoto, Kenji] Kyushu Univ, Lab Funct Food Design, Dept Funct Metab Design, Bioarchitecture Ctr, Fukuoka 8128581, Japan	Kyushu University; Fukuoka Dental College (FDC); Kyushu University	Sonomoto, K (corresponding author), 6-10-1 Hakozaki,Higashi Ku, Fukuoka 8128581, Japan.	sonomoto@agr.kyushu-u.ac.jp		Zendo, Takeshi/0000-0001-5147-7026; Nagao, Jun-ichi/0000-0003-1489-4140	Japan Society for the Promotion of Science; Japan Science Society; Novartis Foundation (Japan) for the Promotion of Science; Nagase Science and Technology Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science Society; Novartis Foundation (Japan) for the Promotion of Science(Novartis); Nagase Science and Technology Foundation	This study was supported in part by grants from the Japan Society for the Promotion of Science, the Japan Science Society, the Novartis Foundation (Japan) for the Promotion of Science, Novozymes Japan Research Fund, and the Nagase Science and Technology Foundation.	ALTENDORF KH, 1974, J BACTERIOL, V117, P888, DOI 10.1128/JB.117.2.888-899.1974; Asaduzzaman SM, 2006, APPL ENVIRON MICROB, V72, P6012, DOI 10.1128/AEM.00678-06; Asaduzzaman SM, 2009, J BIOSCI BIOENG, V107, P475, DOI 10.1016/j.jbiosc.2009.01.003; Aso Y, 2004, J BIOSCI BIOENG, V98, P429, DOI 10.1263/jbb.98.429; AUGUSTIN J, 1990, FEMS MICROBIOL LETT, V54, P203; Chatterjee C, 2005, CHEM REV, V105, P633, DOI 10.1021/cr030105v; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; Davidson AL, 1997, J BACTERIOL, V179, P5458, DOI 10.1128/jb.179.17.5458-5464.1997; deRuyter PGGA, 1996, J BACTERIOL, V178, P3434, DOI 10.1128/jb.178.12.3434-3439.1996; DEVOS WM, 1995, MOL MICROBIOL, V17, P427, DOI 10.1111/j.1365-2958.1995.mmi_17030427.x; DRENTH J, 1976, BIOCHEMISTRY-US, V15, P3731, DOI 10.1021/bi00662a014; Franke CM, 1999, J BIOL CHEM, V274, P8484, DOI 10.1074/jbc.274.13.8484; HAVARSTEIN LS, 1995, MOL MICROBIOL, V16, P229, DOI 10.1111/j.1365-2958.1995.tb02295.x; Holo H, 1995, Methods Mol Biol, V47, P195; Hunke S, 2000, J BACTERIOL, V182, P1432, DOI 10.1128/JB.182.5.1432-1436.2000; Ihnken LAF, 2008, BIOCHEMISTRY-US, V47, P7352, DOI 10.1021/bi800278n; Ishii S, 2006, J BIOL CHEM, V281, P4726, DOI 10.1074/jbc.M512516200; Ishii S, 2010, J BIOL CHEM, V285, P10777, DOI 10.1074/jbc.M109.093781; JENSEN PR, 1993, APPL ENVIRON MICROB, V59, P4363, DOI 10.1128/AEM.59.12.4363-4366.1993; KABACK HR, 1972, BIOCHIM BIOPHYS ACTA, V265, P367, DOI 10.1016/0304-4157(72)90014-7; Kimura H, 1997, BIOSCI BIOTECH BIOCH, V61, P1049, DOI 10.1271/bbb.61.1049; Kimura H, 1998, ANN NY ACAD SCI, V864, P345, DOI 10.1111/j.1749-6632.1998.tb10336.x; Kotake Y, 2008, BIOCHEMISTRY-US, V47, P2531, DOI 10.1021/bi702253n; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Matsushita K, 2005, J BACTERIOL, V187, P4346, DOI 10.1128/JB.187.13.4346-4352.2005; Nagao J, 2005, BIOCHEM BIOPH RES CO, V336, P507, DOI 10.1016/j.bbrc.2005.08.125; Nagao JI, 2007, J MOL MICROB BIOTECH, V13, P235, DOI 10.1159/000104749; Nagao JI, 2006, J BIOSCI BIOENG, V102, P139, DOI 10.1263/jbb.102.139; Nicastro G, 2005, P NATL ACAD SCI USA, V102, P10493, DOI 10.1073/pnas.0501732102; Nishie M, 2009, J BIOSCI BIOENG, V108, P460, DOI 10.1016/j.jbiosc.2009.06.002; Pag U, 2002, CURR PHARM DESIGN, V8, P815, DOI 10.2174/1381612023395439; Peschel A, 1996, FEMS MICROBIOL LETT, V137, P279; Sambrook J., 2002, MOL CLONING LAB MANU; SIZEMORE C, 1991, MOL GEN GENET, V227, P377, DOI 10.1007/BF00273926; Wu KH, 2004, J BIOL CHEM, V279, P901, DOI 10.1074/jbc.M308296200; Xie LL, 2004, CURR OPIN CHEM BIOL, V8, P498, DOI 10.1016/j.cbpa.2004.08.005; Zhong XT, 1996, J BIOL CHEM, V271, P28057, DOI 10.1074/jbc.271.45.28057	37	26	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11163	11169		10.1074/jbc.M110.212704	http://dx.doi.org/10.1074/jbc.M110.212704			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21303905	Green Published, hybrid			2022-12-27	WOS:000288797100026
J	Rickert, KW; Patel, SB; Allison, TJ; Byrne, NJ; Darke, PL; Ford, RE; Guerin, DJ; Hall, DL; Kornienko, M; Lu, J; Munshi, SK; Reid, JC; Shipman, JM; Stanton, EF; Wilson, KJ; Young, JR; Soisson, SM; Lumb, KJ				Rickert, Keith W.; Patel, Sangita B.; Allison, Timothy J.; Byrne, Noel J.; Darke, Paul L.; Ford, Rachael E.; Guerin, David J.; Hall, Dawn L.; Kornienko, Maria; Lu, Jun; Munshi, Sanjeev K.; Reid, John C.; Shipman, Jennifer M.; Stanton, Elizabeth F.; Wilson, Kevin J.; Young, Jonathon R.; Soisson, Stephen M.; Lumb, Kevin J.			Structural Basis for Selective Small Molecule Kinase Inhibition of Activated c-Met	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASE; CRYSTAL-STRUCTURE; DISCOVERY; MUTATIONS; ALIGNMENT; DESIGN; POTENT	The receptor tyrosine kinase c-Met is implicated in oncogenesis and is the target for several small molecule and biologic agents in clinical trials for the treatment of cancer. Binding of the hepatocyte growth factor to the cell surface receptor of c-Met induces activation via autophosphorylation of the kinase domain. Here we describe the structural basis of c-Met activation upon autophosphorylation and the selective small molecule inhibiton of autophosphorylated c-Met. MK-2461 is a potent c-Met inhibitor that is selective for the phosphorylated state of the enzyme. Compound 1 is an MK-2461 analog with a 20-fold enthalpy-driven preference for the autophosphorylated over unphosphorylated c-Met kinase domain. The crystal structure of the unbound kinase domain phosphorylated at Tyr-1234 and Tyr-1235 shows that activation loop phosphorylation leads to the ejection and disorder of the activation loop and rearrangement of helix alpha C and the G loop to generate a viable active site. Helix alpha C adopts a orientation different from that seen in activation loop mutants. The crystal structure of the complex formed by the autophosphorylated c-Met kinase domain and compound 1 reveals a significant induced fit conformational change of the G loop and ordering of the activation loop, explaining the selectivity of compound 1 for the autophosphorylated state. The results highlight the role of structural plasticity within the kinase domain in imparting the specificity of ligand binding and provide the framework for structure-guided design of activated c-Met inhibitors.	[Rickert, Keith W.; Patel, Sangita B.; Allison, Timothy J.; Byrne, Noel J.; Darke, Paul L.; Ford, Rachael E.; Hall, Dawn L.; Kornienko, Maria; Lu, Jun; Munshi, Sanjeev K.; Reid, John C.; Shipman, Jennifer M.; Soisson, Stephen M.; Lumb, Kevin J.] Merck Res Labs, West Point, PA 19486 USA; [Guerin, David J.; Stanton, Elizabeth F.; Wilson, Kevin J.; Young, Jonathon R.] Merck Res Labs, Dept Chem, Boston, MA 02115 USA	Merck & Company; Merck & Company	Lumb, KJ (corresponding author), Merck Res Labs, 770 Sumneytown Pike, West Point, PA 19486 USA.	kevin.lumb@merck.com		Lumb, Kevin/0000-0003-2778-9956				Albrecht BK, 2008, J MED CHEM, V51, P2879, DOI 10.1021/jm800043g; Bellon SF, 2008, J BIOL CHEM, V283, P2675, DOI 10.1074/jbc.M705774200; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Boezio AA, 2009, BIOORG MED CHEM LETT, V19, P6307, DOI 10.1016/j.bmcl.2009.09.096; Buchanan SG, 2009, MOL CANCER THER, V8, P3181, DOI 10.1158/1535-7163.MCT-09-0477; D'Angelo ND, 2008, J MED CHEM, V51, P5766, DOI 10.1021/jm8006189; Di Renzo MF, 2000, ONCOGENE, V19, P1547, DOI 10.1038/sj.onc.1203455; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Johnson LN, 2009, Q REV BIOPHYS, V42, P1, DOI 10.1017/S0033583508004745; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Knudsen BS, 2008, CURR OPIN GENET DEV, V18, P87, DOI 10.1016/j.gde.2008.02.001; Kornienko M, 2005, ASSAY DRUG DEV TECHN, V3, P661, DOI 10.1089/adt.2005.3.661; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; Morotti A, 2002, ONCOGENE, V21, P4885, DOI 10.1038/sj.onc.1205622; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishii H, 2010, BIOORG MED CHEM LETT, V20, P1405, DOI 10.1016/j.bmcl.2009.12.109; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Pan BS, 2010, CANCER RES, V70, P1524, DOI 10.1158/0008-5472.CAN-09-2541; Porter J, 2009, BIOORG MED CHEM LETT, V19, P397, DOI 10.1016/j.bmcl.2008.11.062; Porter J, 2009, BIOORG MED CHEM LETT, V19, P2780, DOI 10.1016/j.bmcl.2009.03.110; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Schiering N, 2003, P NATL ACAD SCI USA, V100, P12654, DOI 10.1073/pnas.1734128100; Timofeevski SL, 2009, BIOCHEMISTRY-US, V48, P5339, DOI 10.1021/bi900438w; Underiner TL, 2010, ANTI-CANCER AGENT ME, V10, P7, DOI 10.2174/1871520611009010007; Wang WR, 2006, P NATL ACAD SCI USA, V103, P3563, DOI 10.1073/pnas.0600048103; Yamaguchi H, 1996, NATURE, V384, P484, DOI 10.1038/384484a0	30	27	28	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11218	11225		10.1074/jbc.M110.204404	http://dx.doi.org/10.1074/jbc.M110.204404			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21247903	Green Published, hybrid			2022-12-27	WOS:000288797100033
J	Lu, M; Zheng, LL; Han, B; Wang, LL; Wang, P; Liu, H; Sun, XL				Lu, Mei; Zheng, Lanlan; Han, Bo; Wang, Luanluan; Wang, Pin; Liu, Heng; Sun, Xiulian			REST Regulates DYRK1A Transcription in a Negative Feedback Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESTRICTIVE SILENCER FACTOR; CELL LUNG-CANCER; DOWN-SYNDROME; TARGET GENES; ALZHEIMER-DISEASE; FUNCTIONAL-LINK; KINASE DYRK1A; EXPRESSION; PROTEIN; REPRESSOR	DYRK1A (dual specificity tyrosine phosphorylation-regulated kinase 1A) has been shown to be involved in learning and memory impairments in Alzheimer disease and Down syndrome. As a homolog of Drosophila minibrain gene, DYRK1A also plays important roles in neurodevelopment; however, the function and regulatory mechanism of DYRK1A in neurodevelopment remain elusive. REST (RE1 silencing transcription factor) plays vital roles in neuronal differentiation. Here, we found that REST can activate DYRK1A transcription via a neuron-restrictive silencer element at bp -833 to -815 of human DYRK1A promoter. The coordinated expression of DYRK1A and REST in mouse brain further supports the cross-interaction of DYRK1A and REST during neurodevelopment. Moreover, we showed that DYRK1A dosage imbalance reduced REST protein stability and transcriptional activity through facilitating ubiquitination and subsequent degradation of REST protein. Therefore, the regulation of DYRK1A by REST in a negative feedback loop suggests that DYRK1A and REST are closely related in neurodevelopment.	[Lu, Mei; Zheng, Lanlan; Han, Bo; Wang, Luanluan; Wang, Pin; Liu, Heng; Sun, Xiulian] Shandong Univ, Qilu Hosp, Otolaryngol Lab, Jinan 250012, Shandong, Peoples R China; [Lu, Mei] Shandong Univ, Qilu Hosp, Dept Neurol, Jinan 250012, Shandong, Peoples R China; [Han, Bo] Chinese Acad Sci, Qingdao Inst Bioenegry & Bioproc Technol, Qingdao 266101, Peoples R China; [Liu, Heng] Shandong Univ Tradit Chinese Med, Inst Tradit Chinese Med Theory, Jinan 250014, Peoples R China	Shandong University; Shandong University; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; Shandong University of Traditional Chinese Medicine	Sun, XL (corresponding author), Shandong Univ, Qilu Hosp, Otolaryngol Lab, 107 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.	xiulians@gmail.com			National Natural Science Foundation of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China.	Altafaj X, 2001, HUM MOL GENET, V10, P1915, DOI 10.1093/hmg/10.18.1915; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Azorsa DO, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-25; Bahn S, 2002, LANCET, V359, P310, DOI 10.1016/S0140-6736(02)07497-4; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; Canzonetta C, 2008, AM J HUM GENET, V83, P388, DOI 10.1016/j.ajhg.2008.08.012; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Coulson JM, 2000, CANCER RES, V60, P1840; Dowjat WK, 2007, NEUROSCI LETT, V413, P77, DOI 10.1016/j.neulet.2006.11.026; Fernandez-Martinez J, 2009, J CELL SCI, V122, P1574, DOI 10.1242/jcs.044354; Fotaki V, 2004, BEHAV NEUROSCI, V118, P815, DOI 10.1037/0735-7044.118.4.815; Fotaki V, 2002, MOL CELL BIOL, V22, P6636, DOI 10.1128/MCB.22.18.6636-6647.2002; Guardavaccaro D, 2008, NATURE, V452, P365, DOI 10.1038/nature06641; Gurrola-Diaz C, 2003, ONCOGENE, V22, P5636, DOI 10.1038/sj.onc.1206790; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Hammerle B, 2003, EUR J NEUROSCI, V17, P2277, DOI 10.1046/j.1460-9568.2003.02665.x; Hara D, 2009, BIOCHEM BIOPH RES CO, V384, P506, DOI 10.1016/j.bbrc.2009.05.007; Kim MY, 2006, P NATL ACAD SCI USA, V103, P13074, DOI 10.1073/pnas.0601915103; Kimura R, 2007, HUM MOL GENET, V16, P15, DOI 10.1093/hmg/ddl437; Laguna A, 2008, DEV CELL, V15, P841, DOI 10.1016/j.devcel.2008.10.014; Lawinger P, 2000, NAT MED, V6, P826, DOI 10.1038/77565; Lepagnol-Bestel AM, 2009, HUM MOL GENET, V18, P1405, DOI 10.1093/hmg/ddp047; Liu F, 2008, FASEB J, V22, P3224, DOI 10.1096/fj.07-104539; Liu H, 2009, FASEB J, V23, P3383, DOI 10.1096/fj.09-134296; Maenz B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-30; Marti E, 2003, BRAIN RES, V964, P250, DOI 10.1016/S0006-8993(02)04069-6; Okui M, 1999, GENOMICS, V62, P165, DOI 10.1006/geno.1999.5998; Ryoo SR, 2008, J NEUROCHEM, V104, P1333, DOI 10.1111/j.1471-4159.2007.05075.x; Ryoo SR, 2007, J BIOL CHEM, V282, P34850, DOI 10.1074/jbc.M707358200; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Seifert A, 2008, FEBS J, V275, P6268, DOI 10.1111/j.1742-4658.2008.06751.x; Smith DJ, 1997, NAT GENET, V16, P28, DOI 10.1038/ng0597-28; Sun XL, 2005, FASEB J, V19, P739, DOI 10.1096/fj.04-3426com; Sun YM, 2005, MOL BIOL CELL, V16, P5630, DOI 10.1091/mbc.E05-07-0687; TEJEDOR F, 1995, NEURON, V14, P287, DOI 10.1016/0896-6273(95)90286-4; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Westbrook TF, 2008, NATURE, V452, P370, DOI 10.1038/nature06780	38	30	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10755	10763		10.1074/jbc.M110.174540	http://dx.doi.org/10.1074/jbc.M110.174540			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21252229	Green Published, hybrid			2022-12-27	WOS:000288547000089
J	Lyukmanova, EN; Shenkarev, ZO; Shulepko, MA; Mineev, KS; D'Hoedt, D; Kasheverov, IE; Filkin, SY; Krivolapova, AP; Janickova, H; Dolezal, V; Dolgikh, DA; Arseniev, AS; Bertrand, D; Tsetlin, VI; Kirpichnikov, MP				Lyukmanova, Ekaterina N.; Shenkarev, Zakhar O.; Shulepko, Mikhail A.; Mineev, Konstantin S.; D'Hoedt, Dieter; Kasheverov, Igor E.; Filkin, Sergey Yu.; Krivolapova, Alexandra P.; Janickova, Helena; Dolezal, Vladimir; Dolgikh, Dmitry A.; Arseniev, Alexander S.; Bertrand, Daniel; Tsetlin, Victor I.; Kirpichnikov, Mikhail P.			NMR Structure and Action on Nicotinic Acetylcholine Receptors of Water-soluble Domain of Human LYNX1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-NEUROTOXINS; CRYSTAL-STRUCTURE; WEAK TOXIN; FUNCTIONAL-PROPERTIES; PROTOTOXIN LYNX1; VENOM INTERACTS; NAJA-KAOUTHIA; IN-VIVO; SNAKE; BINDING	Discovery of proteins expressed in the central nervous system sharing the three-finger structure with snake alpha-neurotoxins provoked much interest to their role in brain functions. Prototoxin LYNX1, having homology both to Ly6 proteins and three-finger neurotoxins, is the first identified member of this family membrane-tethered by a GPI anchor, which considerably complicates in vitro studies. We report for the first time the NMR spatial structure for the water-soluble domain of human LYNX1 lacking a GPI anchor (ws-LYNX1) and its concentration-dependent activity on nicotinic acetylcholine receptors (nAChRs). At 5-30 mu M, ws-LYNX1 competed with I-125-alpha-bungarotoxin for binding to the acetylcholine-binding proteins (AChBPs) and to Torpedo nAChR. Exposure of Xenopus oocytes expressing alpha 7 nAChRs to 1 mu M ws-LYNX1 enhanced the response to acetylcholine, but no effect was detected on alpha 4 beta 2 and alpha 3 beta 2 nAChRs. Increasing ws-LYNX1 concentration to 10 mu M caused a modest inhibition of these three nAChR subtypes. A common feature for ws-LYNX1 and LYNX1 is a decrease of nAChR sensitivity to high concentrations of acetylcholine. NMR and functional analysis both demonstrate that ws-LYNX1 is an appropriate model to shed light on the mechanism of LYNX1 action. Computer modeling, based on ws-LYNX1 NMR structure and AChBP x-ray structure, revealed a possible mode of ws-LYNX1 binding.	[Lyukmanova, Ekaterina N.; Shenkarev, Zakhar O.; Shulepko, Mikhail A.; Mineev, Konstantin S.; Kasheverov, Igor E.; Filkin, Sergey Yu.; Krivolapova, Alexandra P.; Dolgikh, Dmitry A.; Arseniev, Alexander S.; Tsetlin, Victor I.; Kirpichnikov, Mikhail P.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; [D'Hoedt, Dieter; Bertrand, Daniel] Ctr Med Univ Geneva, Dept Neurosci, CH-1211 Geneva 4, Switzerland; [Janickova, Helena; Dolezal, Vladimir] Acad Sci Czech Republic, Inst Physiol, CR-14220 Prague, Czech Republic; [Dolgikh, Dmitry A.; Kirpichnikov, Mikhail P.] Moscow MV Lomonosov State Univ, Moscow 119991, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; University of Geneva; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Lomonosov Moscow State University	Tsetlin, VI (corresponding author), Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, 16-10 Miklukho Maklaya Str, Moscow 117997, Russia.	vits@mx.ibch.ru	Lyukmanova, Ekaterina/F-2340-2014; Shulepko, Mikhail/N-9124-2016; Dolezal, Vladimir/A-8732-2008; Tsetlin, Victor/X-2491-2018; Dolgikh, Dmitry A/F-2369-2014; Luginina, Aleksandra/AAO-3695-2020; Janickova, Helena/Q-7211-2017; Janickova, Helena/G-7748-2014; Mineev, Konstantin/E-4151-2010; Mineev, Konstantin/AAC-6662-2019; Mineev, Konstantin S/Q-3948-2018; Shenkarev, Zakhar O./P-1808-2015; Kasheverov, Igor E/F-6024-2014; Filkin, Sergey/B-9991-2016	Lyukmanova, Ekaterina/0000-0002-9728-9407; Dolezal, Vladimir/0000-0003-3412-256X; Luginina, Aleksandra/0000-0003-2697-456X; Janickova, Helena/0000-0003-0310-7893; Mineev, Konstantin/0000-0002-2418-9421; Mineev, Konstantin/0000-0002-2418-9421; Mineev, Konstantin S/0000-0002-2418-9421; Shenkarev, Zakhar O./0000-0003-1383-3522; Shulepko, Mikhail/0000-0002-0436-2127; Kirpichnikov, Mikhail/0000-0001-8170-1607; Dolgikh, Dmitry/0000-0002-9880-7202; Filkin, Sergey/0000-0002-4710-6051	Russian Academy of Sciences; Russian Foundation for Basic Research (RFBR) [08-04-01603, 09-04-01567]; RFBR-NWO (Netherlands Organization for Scientific Research) [06-04-89400]; FP7 Grant; Institute of Physiology [AV0Z50110509]; Agency of the Czech Republic [305/09/0681]	Russian Academy of Sciences(Russian Academy of Sciences); Russian Foundation for Basic Research (RFBR)(Russian Foundation for Basic Research (RFBR)); RFBR-NWO (Netherlands Organization for Scientific Research)(Netherlands Organization for Scientific Research (NWO)); FP7 Grant; Institute of Physiology; Agency of the Czech Republic(Grant Agency of the Czech Republic)	This work was supported by grants from the Russian Academy of Sciences "Molecular and Cellular Biology," Russian Foundation for Basic Research (RFBR) Grants 08-04-01603 and 09-04-01567, RFBR-NWO (Netherlands Organization for Scientific Research) Grant 06-04-89400, and FP7 Grant "Neurocypres."; Supported by Project AV0Z50110509 of the Institute of Physiology and Agency of the Czech Republic Grant 305/09/0681.	Antil-Delbeke S, 2000, J BIOL CHEM, V275, P29594, DOI 10.1074/jbc.M909746199; Arredondo J, 2006, J CELL PHYSIOL, V208, P238, DOI 10.1002/jcp.20661; ARSENIEV AS, 1984, FEBS LETT, V165, P57, DOI 10.1016/0014-5793(84)80014-9; BAX A, 1994, METHOD ENZYMOL, V239, P79; BETZEL C, 1991, J BIOL CHEM, V266, P21530; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; Chimienti F, 2003, HUM MOL GENET, V12, P3017, DOI 10.1093/hmg/ddg320; Delaglio F, 2001, J MAGN RESON, V149, P276, DOI 10.1006/jmre.2001.2297; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Dutertre S, 2007, EMBO J, V26, P3858, DOI 10.1038/sj.emboj.7601785; Ellison M, 2003, J BIOL CHEM, V278, P757, DOI 10.1074/jbc.M204565200; FLETCHER CM, 1994, STRUCTURE, V2, P185, DOI 10.1016/S0969-2126(00)00020-4; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hogg RC, 2008, J NEUROSCI METH, V169, P65, DOI 10.1016/j.jneumeth.2007.11.028; Hruska M, 2009, J NEUROSCI, V29, P14847, DOI 10.1523/JNEUROSCI.2271-09.2009; Ibanez-Tallon I, 2004, NEURON, V43, P305, DOI 10.1016/j.neuron.2004.07.015; Ibanez-Tallon I, 2002, NEURON, V33, P893, DOI 10.1016/S0896-6273(02)00632-3; Jakubik J, 2006, MOL PHARMACOL, V70, P656, DOI 10.1124/mol.106.023762; Kasheverov IE, 2009, J NEUROCHEM, V111, P934, DOI 10.1111/j.1471-4159.2009.06359.x; Leath KJ, 2007, ACTA CRYSTALLOGR F, V63, P648, DOI 10.1107/S1744309107033477; Liu ZW, 2009, J NEUROCHEM, V110, P1707, DOI 10.1111/j.1471-4159.2009.06274.x; Lomholt AF, 2009, BRIT J CANCER, V101, P992, DOI 10.1038/sj.bjc.6605228; Lyukmanova EN, 2010, RUSS J BIOORG CHEM+, V36, P137, DOI 10.1134/S1068162010020019; Lyukmanova EN, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1142, DOI 10.1134/S0006297909100101; Lyukmanova EN, 2007, J BIOL CHEM, V282, P24784, DOI 10.1074/jbc.M611263200; Lyukmanova EN, 2004, RUSS J BIOORG CHEM+, V30, P25, DOI 10.1023/B:RUBI.0000015770.38602.e3; Miwa JM, 1999, NEURON, V23, P105, DOI 10.1016/S0896-6273(00)80757-6; Miwa JM, 2006, NEURON, V51, P587, DOI 10.1016/j.neuron.2006.07.025; Montuori N, 2009, FRONT BIOSCI-LANDMRK, V14, P2494, DOI 10.2741/3392; Mordvintsev DY, 2009, FEBS J, V276, P5065, DOI 10.1111/j.1742-4658.2009.07203.x; Mordvitsev DY, 2007, COMPUT BIOL CHEM, V31, P72, DOI 10.1016/j.compbiolchem.2007.02.011; Moriwaki Y, 2009, NEUROSCI RES, V64, P403, DOI 10.1016/j.neures.2009.04.014; Nastopoulos V, 1998, ACTA CRYSTALLOGR D, V54, P964, DOI 10.1107/S0907444998005125; Nirthanan S, 2004, J PHARMACOL SCI, V94, P1, DOI 10.1254/jphs.94.1; Nirthanan S, 2002, J BIOL CHEM, V277, P17811, DOI 10.1074/jbc.M111152200; PILLET L, 1993, J BIOL CHEM, V268, P909; Rasch MG, 2008, FRONT BIOSCI-LANDMRK, V13, P6752, DOI 10.2741/3186; Rucktooa P, 2009, BIOCHEM PHARMACOL, V78, P777, DOI 10.1016/j.bcp.2009.06.098; Servent D, 2009, J NEUROCHEM, V109, P1193, DOI 10.1111/j.1471-4159.2009.06092.x; Song PF, 2008, CANCER RES, V68, P4693, DOI 10.1158/0008-5472.CAN-08-0183; Tekinay AB, 2009, P NATL ACAD SCI USA, V106, P4477, DOI 10.1073/pnas.0813109106; Tsetlin V, 1999, EUR J BIOCHEM, V264, P281, DOI 10.1046/j.1432-1327.1999.00623.x; Tsetlin VI, 2004, FEBS LETT, V557, P9, DOI 10.1016/S0014-5793(03)01454-6; Tsuji H, 2003, GENOMICS, V81, P26, DOI 10.1016/S0888-7543(02)00025-3; Utkin YN, 2001, J BIOL CHEM, V276, P15810, DOI 10.1074/jbc.M100788200; Wuthrich K, 1986, NMR PROTEINS NUCL AC	48	67	74	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10618	10627		10.1074/jbc.M110.189100	http://dx.doi.org/10.1074/jbc.M110.189100			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21252236	Green Published, hybrid			2022-12-27	WOS:000288547000076
J	Torres, J; Funk, HM; Zegers, MMP; ter Beest, MBA				Torres, Jacqueline; Funk, Holly M.; Zegers, Mirjam M. P.; ter Beest, Martin B. A.			The Syntaxin 4 N Terminus Regulates Its Basolateral Targeting by Munc18c-dependent and -independent Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLARIZED EPITHELIAL-CELLS; CANINE KIDNEY-CELLS; PLASMA-MEMBRANE; MDCK CELLS; SURFACE POLARITY; ADAPTER COMPLEX; EXCHANGE FACTOR; TIGHT JUNCTION; PROTEINS; SNARE	To generate and maintain epithelial cell polarity, specific sorting of proteins into vesicles destined for the apical and basolateral domain is required. Syntaxin 3 and 4 are apical and basolateral SNARE proteins important for the specificity of vesicle fusion at the apical and basolateral plasma membrane domains, respectively, but how these proteins are specifically targeted to these domains themselves is unclear. Munc18/SM proteins are potential regulators of this process. Like syntaxins, they are crucial for exocytosis and vesicle fusion. However, how munc18c and syntaxin 4 regulate the function of each other is unclear. Here, we investigated the requirement of syntaxin 4 in the delivery of basolateral membrane and secretory proteins, the basolateral targeting of syntaxin 4, and the role of munc18c in this targeting. Depletion of syntaxin 4 resulted in significant reduction of basolateral targeting, suggesting no compensation by other syntaxin forms. Mutational analysis identified amino acids Leu-25 and to a lesser extent Val-26 as essential for correct localization of syntaxin 4. Recently, it was shown that the N-terminal peptide of syntaxin 4 is involved in binding to munc18c. A mutation in this region that affects munc18c binding shows that munc18c binding is required for stabilization of syntaxin 4 at the plasma membrane but not for its correct targeting. We conclude that the N terminus serves two functions in membrane targeting. First, it harbors the sorting motif, which targets syntaxin 4 basolaterally in a munc18c-independent manner and second, it allows for munc18c binding, which stabilizes the protein in a munc18c-dependent manner.	[Torres, Jacqueline; Funk, Holly M.; Zegers, Mirjam M. P.; ter Beest, Martin B. A.] Univ Chicago, Dept Surg, Chicago, IL 60637 USA	University of Chicago	ter Beest, MBA (corresponding author), 5841 S Maryland Ave,AB532-MC5032, Chicago, IL 60637 USA.	mterbe@surgery.bsd.uchicago	Zegers, Mirjam M P/B-6818-2012; Zegers, Mirjam/L-3160-2019	Zegers, Mirjam M P/0000-0002-1190-4094; Zegers, Mirjam/0000-0002-1190-4094	American Cancer Society, Ohio Division; National Institutes of Health [GM076363]; Ohio Division; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076363] Funding Source: NIH RePORTER	American Cancer Society, Ohio Division(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio Division; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the American Cancer Society, Ohio Division (to M. B. A. t. B.) and by National Institutes of Health Grant GM076363 (to M. M. P. Z.).	ANDERSON JM, 1988, J CELL BIOL, V106, P1141, DOI 10.1083/jcb.106.4.1141; Arunachalam L, 2008, MOL BIOL CELL, V19, P722, DOI 10.1091/mbc.E07-07-0662; BALCAROVASTANDER J, 1984, EMBO J, V3, P2687, DOI 10.1002/j.1460-2075.1984.tb02194.x; Barth AIM, 1997, J CELL BIOL, V136, P693, DOI 10.1083/jcb.136.3.693; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Burgoyne RD, 2009, ANN NY ACAD SCI, V1152, P76, DOI 10.1111/j.1749-6632.2008.03987.x; Chen XY, 2006, METHOD ENZYMOL, V406, P362, DOI 10.1016/S0076-6879(06)06026-5; Cosen-Binker LI, 2008, WORLD J GASTROENTERO, V14, P2314, DOI 10.3748/wjg.14.2314; D'Andrea-Merrins M, 2007, J BIOL CHEM, V282, P16553, DOI 10.1074/jbc.M610818200; Deora AA, 2004, MOL BIOL CELL, V15, P4148, DOI 10.1091/mbc.E04-01-0058; Doray B, 2007, MOL BIOL CELL, V18, P1887, DOI 10.1091/mbc.E07-01-0012; Folsch H, 1999, CELL, V99, P189, DOI 10.1016/S0092-8674(00)81650-5; Fuellekrug Joachim, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-8; Gaisano HY, 1996, MOL BIOL CELL, V7, P2019, DOI 10.1091/mbc.7.12.2019; Gravotta D, 2007, P NATL ACAD SCI USA, V104, P1564, DOI 10.1073/pnas.0610700104; Han L, 2009, MOL BIOL CELL, V20, P4962, DOI 10.1091/mbc.E09-08-0712; He B, 2009, CURR OPIN CELL BIOL, V21, P900, DOI 10.1016/j.ceb.2009.08.008; HERZLINGER DA, 1984, J CELL BIOL, V98, P1777, DOI 10.1083/jcb.98.5.1777; Hinners I, 2003, EMBO REP, V4, P1182, DOI 10.1038/sj.embor.7400018; Hou JCQ, 2007, CURR OPIN CELL BIOL, V19, P466, DOI 10.1016/j.ceb.2007.04.018; Hu SH, 2007, P NATL ACAD SCI USA, V104, P8773, DOI 10.1073/pnas.0701124104; Humbert PO, 2006, TRENDS CELL BIOL, V16, P622, DOI 10.1016/j.tcb.2006.10.005; Jain RK, 2001, BIOCHEM J, V360, P645, DOI 10.1042/0264-6021:3600645; Jewell JL, 2010, AM J PHYSIOL-REG I, V298, pR517, DOI 10.1152/ajpregu.00597.2009; Kanda H, 2005, J CLIN INVEST, V115, P291, DOI 10.1172/JCI200522681; Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202; Latham CF, 2006, TRAFFIC, V7, P1408, DOI 10.1111/j.1600-0854.2006.00474.x; Li CX, 2007, MOL BIOL CELL, V18, P3081, DOI 10.1091/mbc.E07-02-0172; Low SH, 1998, J CELL BIOL, V141, P1503, DOI 10.1083/jcb.141.7.1503; Low SH, 1996, MOL BIOL CELL, V7, P2007, DOI 10.1091/mbc.7.12.2007; Luton F, 2005, METHOD ENZYMOL, V404, P332, DOI 10.1016/S0076-6879(05)04029-2; Malliri A, 2004, J BIOL CHEM, V279, P30092, DOI 10.1074/jbc.M401192200; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; NABI IR, 1991, J CELL BIOL, V115, P1573, DOI 10.1083/jcb.115.6.1573; Navarro C, 2005, ONCOGENE, V24, P4330, DOI 10.1038/sj.onc.1208632; Nejsum LN, 2007, J CELL BIOL, V178, P323, DOI 10.1083/jcb.200705094; Rodriguez-Boulan E, 2005, NAT REV MOL CELL BIO, V6, P233, DOI 10.1038/nrm1593; Schmidt U, 2006, J CELL SCI, V119, P2321, DOI 10.1242/jcs.02943; Sharma N, 2006, J CELL BIOL, V173, P937, DOI 10.1083/jcb.200603132; Sieber JJ, 2006, BIOPHYS J, V90, P2843, DOI 10.1529/biophysj.105.079574; Sieber JJ, 2007, SCIENCE, V317, P1072, DOI 10.1126/science.1141727; Steegmaier M, 2000, TRAFFIC, V1, P553, DOI 10.1034/j.1600-0854.2000.010705.x; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; ter Beest MBA, 2005, MOL BIOL CELL, V16, P5784, DOI 10.1091/mbc.E05-070-0661; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Toomre D, 1999, J CELL SCI, V112, P21; Toonen RFG, 2005, J NEUROCHEM, V93, P1393, DOI 10.1111/j.1471-4159.2005.03128.x; Toonen RFG, 2007, TRENDS NEUROSCI, V30, P564, DOI 10.1016/j.tins.2007.08.008; Torkko JM, 2008, J CELL SCI, V121, P1193, DOI 10.1242/jcs.015495; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Wakabayashi Y, 2007, HISTOCHEM CELL BIOL, V127, P463, DOI 10.1007/s00418-007-0274-x; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355; Yang CM, 2001, J CLIN INVEST, V107, P1311, DOI 10.1172/JCI12274; Yu W, 2005, MOL BIOL CELL, V16, P433, DOI 10.1091/mbc.e04-05-0435; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	56	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10834	10846		10.1074/jbc.M110.186668	http://dx.doi.org/10.1074/jbc.M110.186668			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21278252	hybrid, Green Published			2022-12-27	WOS:000288547000097
J	Welch, AK; Bostwick, CJ; Cain, BD				Welch, Amanda K.; Bostwick, Caleb J.; Cain, Brian D.			Manipulations in the Peripheral Stalk of the Saccharomyces cerevisiae F1F0-ATP Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL ATP SYNTHASE; ELASTIC POWER TRANSMISSION; ESCHERICHIA-COLI; B-SUBUNITS; 2ND STALK; YEAST; F-1-ATPASE; CATALYSIS; ABSENCE; REGION	The Saccharomyces cerevisiae F1F0-ATP synthase peripheral stalk is composed of the OSCP, h, d, and b subunits. The b subunit has two membrane-spanning domains and a large hydrophilic domain that extends along one side of the enzyme to the top of F-1. In contrast, the Escherichia coli peripheral stalk has two identical b subunits, and subunits with substantially altered lengths can be incorporated into a functional F1F0-ATP synthase. The differences in subunit structure between the eukaryotic and prokaryotic peripheral stalks raised a question about whether the two stalks have similar physical and functional properties. In the present work, the length of the S. cerevisiae b subunit has been manipulated to determine whether the F1F0-ATP synthase exhibited the same tolerances as in the bacterial enzyme. Plasmid shuffling was used for ectopic expression of altered b subunits in a strain carrying a chromosomal disruption of the ATP4 gene. Wild type growth phenotypes were observed for insertions of up to 11 and a deletion of four amino acids on a nonfermentable carbon source. In mitochondria-enriched fractions, abundant ATP hydrolysis activity was seen for the insertion mutants. ATPase activity was largely oligomycin-insensitive in these mitochondrial fractions. In addition, very poor complementation was seen in a mutant with an insertion of 14 amino acids. Lengthier deletions yielded a defective enzyme. The results suggest that although the eukaryotic peripheral stalk is near its minimum length, the b subunit can be extended a considerable distance.	[Welch, Amanda K.; Bostwick, Caleb J.; Cain, Brian D.] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Cain, BD (corresponding author), POB 100245,1600 SW Archer Rd, Gainesville, FL 32610 USA.	bcain@ufl.edu			USPHS [ROIGM070978]	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service)	This work supported by National Institutes of Health Service Grant ROIGM070978 from USPHS.	Ackerman Sharon H, 2007, Methods Mol Biol, V372, P363, DOI 10.1007/978-1-59745-365-3_26; Amberg DC, 2005, METHODS YEAST GENETI, P161; Bi YM, 2008, BBA-BIOENERGETICS, V1777, P583, DOI 10.1016/j.bbabio.2008.03.004; Boyer PD, 2002, FEBS LETT, V512, P29, DOI 10.1016/S0014-5793(02)02293-7; Claggett SB, 2007, J BACTERIOL, V189, P5463, DOI 10.1128/JB.00191-07; Claggett SB, 2009, J BIOL CHEM, V284, P16531, DOI 10.1074/jbc.M109.002980; COLLINSON IR, 1994, J MOL BIOL, V242, P408; Dickson VK, 2006, EMBO J, V25, P2911, DOI 10.1038/sj.emboj.7601177; Gavin PD, 2003, BBA-BIOENERGETICS, V1607, P167, DOI 10.1016/j.bbabio.2003.09.013; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Grabar TB, 2003, J BIOL CHEM, V278, P34751, DOI 10.1074/jbc.M303361200; Junge W, 2009, NATURE, V459, P364, DOI 10.1038/nature08145; Lau WCY, 2008, J MOL BIOL, V382, P1256, DOI 10.1016/j.jmb.2008.08.014; Lee LK, 2010, NAT STRUCT MOL BIOL, V17, P373, DOI 10.1038/nsmb.1761; Leslie AGW, 1999, BIOCHEM SOC T, V27, P37, DOI 10.1042/bst0270037; McLachlin DT, 2000, BIOCHEMISTRY-US, V39, P3486, DOI 10.1021/bi992586b; Meisinger Chris, 2006, Methods Mol Biol, V313, P33; MOORE D, 1996, CURRENT PROTOCOLS MO, V2; NAGLEY P, 1986, FEBS LETT, V195, P159, DOI 10.1016/0014-5793(86)80152-1; Okuno D, 2010, EUR BIOPHYS J BIOPHY, V39, P1589, DOI 10.1007/s00249-010-0616-9; PAUL MF, 1992, EUR J BIOCHEM, V205, P163, DOI 10.1111/j.1432-1033.1992.tb16764.x; Rees DM, 2009, P NATL ACAD SCI USA, V106, P21597, DOI 10.1073/pnas.0910365106; Rubinstein JL, 2003, EMBO J, V22, P6182, DOI 10.1093/emboj/cdg608; Sielaff H, 2008, P NATL ACAD SCI USA, V105, P17760, DOI 10.1073/pnas.0807683105; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sorgen PL, 1999, J BIOL CHEM, V274, P36261, DOI 10.1074/jbc.274.51.36261; Sorgen PL, 1998, J BIOL CHEM, V273, P27873, DOI 10.1074/jbc.273.43.27873; Soubannier V, 2002, J BIOL CHEM, V277, P10739, DOI 10.1074/jbc.M111882200; VELOURS J, 1988, EUR J BIOCHEM, V170, P637, DOI 10.1111/j.1432-1033.1988.tb13745.x; Velours J, 2001, J BIOL CHEM, V276, P8602, DOI 10.1074/jbc.M008123200; WAECHTER ABY, 2011, P NATL ACAD IN PRESS; Weber J, 2010, NAT CHEM BIOL, V6, P794, DOI 10.1038/nchembio.458; Weimann T, 2008, BIOCHEMISTRY-US, V47, P3556, DOI 10.1021/bi702000g; Welch AK, 2008, J BIOENERG BIOMEMBR, V40, P1, DOI 10.1007/s10863-008-9124-3; Wood KS, 2007, J BIOL CHEM, V282, P31920, DOI 10.1074/jbc.M706259200	35	5	6	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10155	10162		10.1074/jbc.M110.213447	http://dx.doi.org/10.1074/jbc.M110.213447			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21257750	hybrid, Green Published			2022-12-27	WOS:000288547000030
J	Banerjee, NS; Wang, HK; Broker, TR; Chow, LT				Banerjee, N. Sanjib; Wang, Hsu-Kun; Broker, Thomas R.; Chow, Louise T.			Human Papillomavirus (HPV) E7 Induces Prolonged G(2) following S Phase Reentry in Differentiated Human Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE ARREST; 14-3-3 PROTEIN-BINDING; DNA-DAMAGE CHECKPOINT; LARGE T-ANTIGEN; HUMAN CDC25C; HUMAN MYT1; PHOSPHORYLATES CDC2; INHIBITORY KINASE; LIFE-CYCLE; HIGH-RISK	The productive program of human papillomaviruses occurs in differentiated squamous keratinocytes. We have previously shown that HPV-18 DNA amplification initiates in spinous cells in organotypic cultures of primary human keratinocytes during prolonged G(2) phase, as signified by abundant cytoplasmic cyclin B1 (Wang, H. K., Duffy, A. A., Broker, T. R., and Chow, L. T. (2009) Genes Dev. 23, 181-194). In this study, we demonstrated that the E7 protein, which induces S phase reentry in suprabasal cells by destabilizing the p130 pocket protein (Genovese, N. J., Banerjee, N. S., Broker, T. R., and Chow, L. T. (2008) J. Virol. 82, 4862-4873), also elicited extensive G(2) responses. Western blots and indirect immunofluorescence assays were used to probe for host proteins known to control G(2)/M progression. E7 expression induced cytoplasmic accumulation of cyclin B1 and cdc2 in the suprabasal cells. The elevated cdc2 had inactivating phosphorylation on Thr(14) or Tyr(15), and possibly both, due to an increase in the responsible Wee1 and Myt1 kinases. In cells that harbored cytoplasmic cyclin B1 or cdc2, there was also an accumulation of the phosphatase-inactive cdc25C phosphorylated on Ser(216), unable to activate cdc2. Moreover, E7 expression induced elevated expression of phosphorylated ATM (Ser(1981)) and the downstream phosphorylated Chk1, Chk2, and JNKs, kinases known to inactivate cdc25C. Similar results were observed in primary human keratinocyte raft cultures in which the productive program of HPV-18 took place. Collectively, this study has revealed the mechanisms by which E7 induces prolonged G(2) phase in the differentiated cells following S phase induction.	[Banerjee, N. Sanjib; Wang, Hsu-Kun; Broker, Thomas R.; Chow, Louise T.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Chow, LT (corresponding author), 501 MCLM Bldg,1918 Univ Blvd, Birmingham, AL 35294 USA.	LTChow@uab.edu			National Institutes of Health [CA83679]; NATIONAL CANCER INSTITUTE [R01CA083679] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA83679.	ATHERTONFESSLER S, 1994, MOL BIOL CELL, V5, P989, DOI 10.1091/mbc.5.9.989; Banerjee NS, 2006, J VIROL, V80, P6517, DOI 10.1128/JVI.02499-05; Banerjee NS, 2005, METH MOLEC MED, V119, P187; Boichuk S, 2010, J VIROL, V84, P8007, DOI 10.1128/JVI.00334-10; Booher RN, 1997, J BIOL CHEM, V272, P22300, DOI 10.1074/jbc.272.35.22300; CHENG S, 1995, GENE DEV, V9, P2335, DOI 10.1101/gad.9.19.2335; Chien WM, 2000, CELL GROWTH DIFFER, V11, P425; Chien WM, 2002, J VIROL, V76, P2964, DOI 10.1128/JVI.76.6.2964-2972.2002; Chow LT, 2010, APMIS, V118, P422, DOI 10.1111/j.1600-0463.2010.02625.x; Chow LT, 2009, CELL CYCLE, V8, P1319, DOI 10.4161/cc.8.9.8242; COLEMAN TR, 1994, CURR OPIN CELL BIOL, V6, P877, DOI 10.1016/0955-0674(94)90060-4; Dahl J, 2005, J VIROL, V79, P13007, DOI 10.1128/JVI.79.20.13007-13017.2005; Dalal SN, 1999, MOL CELL BIOL, V19, P4465; Datta A, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-49; Davy C, 2007, VIROLOGY, V368, P219, DOI 10.1016/j.virol.2007.05.043; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Doorbar J, 1997, VIROLOGY, V238, P40, DOI 10.1006/viro.1997.8768; DUNPHY WG, 1991, CELL, V67, P189, DOI 10.1016/0092-8674(91)90582-J; Gabrielli BG, 1997, ONCOGENE, V15, P749, DOI 10.1038/sj.onc.1201254; Garner-Hamrick PA, 2004, J VIROL, V78, P9041, DOI 10.1128/JVI.78.17.9041-9050.2004; Genovese NJ, 2008, J VIROL, V82, P4862, DOI 10.1128/JVI.01202-07; Gutierrez GJ, 2010, J BIOL CHEM, V285, P14217, DOI 10.1074/jbc.M110.121848; Hardouin N, 2000, GENESIS, V26, P245, DOI 10.1002/(SICI)1526-968X(200004)26:4<245::AID-GENE50>3.0.CO;2-9; Hein J, 2009, J VIROL, V83, P117, DOI 10.1128/JVI.01515-08; HERZINGER T, 1995, ONCOGENE, V11, P2151; Karlsson C, 1999, J CELL BIOL, V146, P573, DOI 10.1083/jcb.146.3.573; Kino T, 2005, J VIROL, V79, P2780, DOI 10.1128/JVI.79.5.2780-2787.2005; Knight GL, 2011, VIROLOGY, V412, P196, DOI 10.1016/j.virol.2011.01.007; KORNBLUTH S, 1994, MOL BIOL CELL, V5, P273, DOI 10.1091/mbc.5.3.273; Kudoh A, 2004, J VIROL, V78, P104, DOI 10.1128/JVI.78.1.104-115.2004; Lilley CE, 2005, P NATL ACAD SCI USA, V102, P5844, DOI 10.1073/pnas.0501916102; Liu F, 1999, MOL CELL BIOL, V19, P5113; Liu F, 1997, MOL CELL BIOL, V17, P571, DOI 10.1128/MCB.17.2.571; Luo Y, 2011, J VIROL, V85, P133, DOI 10.1128/JVI.01534-10; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; MUELLER PR, 1995, SCIENCE, V270, P86, DOI 10.1126/science.270.5233.86; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Noya F, 2001, J VIROL, V75, P6121, DOI 10.1128/JVI.75.13.6121-6134.2001; Palmer A, 1998, EMBO J, V17, P5037, DOI 10.1093/emboj/17.17.5037; PARKER LL, 1992, SCIENCE, V257, P1955, DOI 10.1126/science.1384126; Peng CY, 1998, CELL GROWTH DIFFER, V9, P197; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; Rogoff HA, 2004, MOL CELL BIOL, V24, P2968, DOI 10.1128/MCB.24.7.2968-2977.2004; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Shi YL, 2005, J BIOL CHEM, V280, P40195, DOI 10.1074/jbc.C500400200; Shirata N, 2005, J BIOL CHEM, V280, P30336, DOI 10.1074/jbc.M500976200; SOLOMON MJ, 1992, MOL BIOL CELL, V3, P13, DOI 10.1091/mbc.3.1.13; Stracker TH, 2002, NATURE, V418, P348, DOI 10.1038/nature00863; STRAUSFELD U, 1991, NATURE, V351, P242, DOI 10.1038/351242a0; STRAUSFELD U, 1994, J BIOL CHEM, V269, P5989; Taylor WR, 1999, MOL BIOL CELL, V10, P3607, DOI 10.1091/mbc.10.11.3607; Toyoshima F, 1998, EMBO J, V17, P2728, DOI 10.1093/emboj/17.10.2728; Van Tine Brian A, 2005, Methods Mol Biol, V292, P215; Wang HK, 2009, GENE DEV, V23, P181, DOI 10.1101/gad.1735109; Wang ZQ, 2009, J CELL PHYSIOL, V221, P213, DOI 10.1002/jcp.21844; WILSON JL, 1992, CELL GROWTH DIFFER, V3, P471; Yoshizuka N, 2005, J VIROL, V79, P11366, DOI 10.1128/JVI.79.17.11366-11381.2005; Zhang BY, 2006, P NATL ACAD SCI USA, V103, P437, DOI 10.1073/pnas.0510012103; Zhao X, 2008, J VIROL, V82, P5316, DOI 10.1128/JVI.02677-07	60	80	83	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15473	15482		10.1074/jbc.M110.197574	http://dx.doi.org/10.1074/jbc.M110.197574			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21321122	Green Published, hybrid			2022-12-27	WOS:000289788300075
J	Gu, XB; Schroeder, SJ				Gu, Xiaobo; Schroeder, Susan J.			Different Sequences Show Similar Quaternary Interaction Stabilities in Prohead Viral RNA Self-assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA PACKAGING MOTOR; PORTAL MOTOR; PRNA; MECHANISM; DELIVERY; BINDING; DIMERS; DOMAIN; CONSTRUCTION; REQUIREMENT	Prohead RNA (pRNA) is an essential component of the self-assembling phi 29 bacteriophage DNA packaging motor. Different related species of bacteriophage share only 12% similarity in pRNA sequences. The secondary structure for pRNA is conserved, however. In this study, we present evidence for self-assembly in different pRNA sequences and new measurements of the energetics for the quaternary interactions in pRNA dimers and trimers. The energetics for self-assembly in different pRNA sequences are similar despite very different sequences in the loop-loop interactions. The architecture surrounding the interlocking loops contributes to the stability of the pRNA quaternary interactions, and sequence variation outside the interlocking loops may counterbalance the changes in the loop sequences. Thus, the evolutionary divergence of pRNA sequences maintains not only conservation of function and secondary structure but also stabilities of quaternary interactions. The self-assembly of pRNA can be fine-tuned with variations in magnesium chloride, sodium chloride, temperature, and concentration. The ability to control pRNA self-assembly holds promise for the development of nanoparticle therapeutic applications for this biological molecule. The pRNA system is well suited for future studies to further understand the energetics of RNA tertiary and quaternary interactions, which can provide insight into larger biological assemblies such as viruses and biomolecular motors.	[Schroeder, Susan J.] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA; Univ Oklahoma, Dept Bot & Microbiol, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman	Schroeder, SJ (corresponding author), Univ Oklahoma, Dept Chem & Biochem, 101 Stephenson Pkwy, Norman, OK 73019 USA.	susan.schroeder@ou.edu	gu, xiaobo/F-5817-2014	Schroeder, Susan/0000-0003-4755-2294	Oklahoma Center for the Advancement of Science and Technology [HR09-160]; American Chemical Society [090039]; National Science Foundation [0844913]	Oklahoma Center for the Advancement of Science and Technology; American Chemical Society(American Chemical Society); National Science Foundation(National Science Foundation (NSF))	This work was supported in part by Grant HR09-160 from the Oklahoma Center for the Advancement of Science and Technology and by Institutional Research Grant 090039 from the American Chemical Society (to the University of Oklahoma Cancer Center).; Supported by National Science Foundation CAREER Grant 0844913. To whom correspondence should be addressed: University of Oklahoma, 101 Stephenson Pkwy., Norman, OK 73019. Tel.: 405-325-3092; Fax: 405-325-6111; E-mail: susan.schroeder@ou.edu.	Afonin KA, 2008, J AM CHEM SOC, V130, P93, DOI 10.1021/ja071516m; Afonin KA, 2010, NAT NANOTECHNOL, V5, P676, DOI [10.1038/NNANO.2010.160, 10.1038/nnano.2010.160]; Atz R, 2007, J MOL BIOL, V369, P239, DOI 10.1016/j.jmb.2007.03.033; BAILEY S, 1990, J BIOL CHEM, V265, P22365; BORER PN, 1975, HDB BIOCH MOL BIOL N, V1, P589; Brookes E, 2006, PROG COLL POL SCI S, V131, P33, DOI 10.1007/2882_004; Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678; Chemla YR, 2005, CELL, V122, P683, DOI 10.1016/j.cell.2005.06.024; Chen CP, 1999, RNA, V5, P805, DOI 10.1017/S1355838299990350; Chen CP, 1997, J VIROL, V71, P495, DOI 10.1128/JVI.71.1.495-500.1997; Chworos A, 2004, SCIENCE, V306, P2068, DOI 10.1126/science.1104686; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; Fang Y, 2005, BIOCHEMISTRY-US, V44, P9348, DOI 10.1021/bi0475020; Fuller DN, 2007, P NATL ACAD SCI USA, V104, P11245, DOI 10.1073/pnas.0701323104; Garver K, 1997, RNA, V3, P1068; Grabow WW, 2011, NANO LETT, V11, P878, DOI 10.1021/nl104271s; GRIMES S, 1990, J MOL BIOL, V215, P559, DOI 10.1016/S0022-2836(05)80168-8; Guillerez J, 2005, P NATL ACAD SCI USA, V102, P5958, DOI 10.1073/pnas.0407141102; Guo PX, 2005, J NANOSCI NANOTECHNO, V5, P1964, DOI 10.1166/jnn.2005.446; GUO PX, 1987, SCIENCE, V236, P690, DOI 10.1126/science.3107124; Guo S, 2006, GENE THER, V13, P814, DOI 10.1038/sj.gt.3302716; Guo SC, 2005, HUM GENE THER, V16, P1097, DOI 10.1089/hum.2005.16.1097; Kitamura A, 2008, NUCLEIC ACIDS RES, V36, P839, DOI 10.1093/nar/gkm874; Ko SH, 2008, J AM CHEM SOC, V130, P17684, DOI 10.1021/ja806075d; Koyfman AY, 2005, J AM CHEM SOC, V127, P11886, DOI 10.1021/ja051144m; Lee TJ, 2009, ANN BIOMED ENG, V37, P2064, DOI 10.1007/s10439-009-9723-0; Liu HY, 2007, CANCER BIOL THER, V6, P697; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Moffitt JR, 2009, NATURE, V457, P446, DOI 10.1038/nature07637; Morais MC, 2008, STRUCTURE, V16, P1267, DOI 10.1016/j.str.2008.05.010; Nasalean L, 2006, NUCLEIC ACIDS RES, V34, P1381, DOI 10.1093/nar/gkl008; Nguyen MT, 2010, BIOCHEMISTRY-US, V49, P10574, DOI 10.1021/bi101521p; REID RJD, 1994, J BIOL CHEM, V269, P18656; REID RJD, 1994, J BIOL CHEM, V269, P9084; REID RJD, 1994, J BIOL CHEM, V269, P5157; Rickgauer JP, 2008, BIOPHYS J, V94, P159, DOI 10.1529/biophysj.107.104612; Robinson MA, 2006, NUCLEIC ACIDS RES, V34, P2698, DOI 10.1093/nar/gkl318; Severcan I, 2010, NAT CHEM, V2, P772, DOI [10.1038/nchem.733, 10.1038/NCHEM.733]; Severcan I, 2009, NANO LETT, V9, P1270, DOI 10.1021/nl900261h; Shu D, 2003, J NANOSCI NANOTECHNO, V3, P295, DOI 10.1166/jnn.2003.160; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; Trottier M, 2000, RNA, V6, P1257, DOI 10.1017/S1355838200992501; Turner DH, 2010, NUCLEIC ACIDS RES, V38, pD280, DOI 10.1093/nar/gkp892; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; Xiao F, 2008, NUCLEIC ACIDS RES, V36, P6620, DOI 10.1093/nar/gkn669; Yu J, 2010, J MOL BIOL, V400, P186, DOI 10.1016/j.jmb.2010.05.002; Zhang CL, 1997, RNA, V3, P315; Zhang F, 1998, MOL CELL, V2, P141, DOI 10.1016/S1097-2765(00)80123-9; Zhang HFM, 2009, ANTIVIR RES, V83, P307, DOI 10.1016/j.antiviral.2009.07.005; Zhao W, 2008, J MOL BIOL, V383, P520, DOI 10.1016/j.jmb.2008.08.056	50	14	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14419	14426		10.1074/jbc.M110.191064	http://dx.doi.org/10.1074/jbc.M110.191064			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21349846	Green Published, hybrid			2022-12-27	WOS:000289556200063
J	Hulikova, A; Vaughan-Jones, RD; Swietach, P				Hulikova, Alzbeta; Vaughan-Jones, Richard D.; Swietach, Pawel			Dual Role of CO2/HCO3- Buffer in the Regulation of Intracellular pH of Three-dimensional Tumor Growths	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBONIC-ANHYDRASE-IX; VENTRICULAR MYOCYTE; NA+/H+ EXCHANGER; EXTRACELLULAR PH; CDNA CLONING; GENE FAMILY; DNA-BINDING; CELLS; EXPRESSION; HYPOXIA	Intracellular pH (pH(i)), a major modulator of cell function, is regulated by acid/base transport across membranes. Excess intracellular H+ ions (e.g. produced by respiration) are extruded by transporters such as Na+/H+ exchange, or neutralized by HCO3- taken up by carriers such as Na+-HCO3- cotransport. Using fluorescence pH(i) imaging, we show that cancer-derived cell lines (colorectal HCT116 and HT29, breast MDA-MB-468, pancreatic MiaPaca2, and cervical HeLa) extrude acid by H+ efflux and HCO3- influx, largely sensitive to dimethylamiloride and 4,4'-diisothiocyanatostilbene-2,2'-disulfonate (DIDS), respectively. The magnitude of HCO3- influx was comparable among the cell lines and may represent a constitutive element of tumor pH(i) regulation. In contrast, H+ efflux varied considerably (MDA-MB-468 > HCT116 > HT29 > MiaPaca2 > HeLa). When HCO3- flux was pharmacologically inhibited, acid extrusion in multicellular HT29 and HCT116 spheroids (similar to 10,000 cells) was highly non-uniform and produced low pHi at the core. With depth, acid extrusion became relatively more DIDS-sensitive because the low extracellular pH at the spheroid core inhibits H+ flux more than HCO3- flux. HCO3- flux inhibition also decelerated HCT116 spheroid growth. In the absence of CO2/HCO3-, acid extrusion by H+ flux in HCT116 and MDA-MB-468 spheroids became highly non-uniform and inadequate at the core. This is because H+ transporters require extracellular mobile pH buffers, such asCO(2)/HCO3-, to overcome low H+ ion mobility and chaperone H+ ions away from cells. CO2/HCO3- exerts a dual effect: as substrate for membrane-bound HCO3- transporters and as a mobile buffer for facilitating extracellular diffusion of H+ ions extruded from cells. These processes can be augmented by carbonic anhydrase activity. We conclude that CO2/HCO3- is important for maintaining uniformly alkaline pH(i) in small, non-vascularized tumor growths and may be important for cancer disease progression.	[Hulikova, Alzbeta; Vaughan-Jones, Richard D.; Swietach, Pawel] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England	University of Oxford	Swietach, P (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Parks Rd, Oxford OX1 3PT, England.	pawel.swietach@dpag.ox.ac.uk	Swietach, Pawel/AAK-4169-2020	Swietach, Pawel/0000-0002-9945-9473	Royal Society; Medical Research Council; British Heart Foundation; British Heart Foundation [RG/08/016/26423] Funding Source: researchfish; Medical Research Council [G0700698] Funding Source: researchfish; MRC [G0700698] Funding Source: UKRI	Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Royal Society (to P.S.), Medical Research Council (to P.S.), and British Heart Foundation (to R.D.V.-J.).	ARONSON PS, 1985, ANNU REV PHYSIOL, V47, P545, DOI 10.1146/annurev.ph.47.030185.002553; Boron WF, 2004, ADV PHYSIOL EDUC, V28, P160, DOI 10.1152/advan.00045.2004; BORON WF, 1983, J GEN PHYSIOL, V81, P53, DOI 10.1085/jgp.81.1.53; BOYARSKY G, 1988, AM J PHYSIOL, V255, pC844, DOI 10.1152/ajpcell.1988.255.6.C844; CARLSSON J, 1988, INT J CANCER, V42, P715, DOI 10.1002/ijc.2910420515; Ch'en FT, 2008, BRIT J PHARMACOL, V153, P972, DOI 10.1038/sj.bjp.0707667; Chiche J, 2010, J CELL MOL MED, V14, P771, DOI 10.1111/j.1582-4934.2009.00994.x; Choi I, 2000, NATURE, V405, P571, DOI 10.1038/35014615; DEHEMPTINNE A, 1987, CAN J PHYSIOL PHARM, V65, P970, DOI 10.1139/y87-154; DEITMER JW, 1989, J PHYSIOL-LONDON, V411, P179, DOI 10.1113/jphysiol.1989.sp017567; Fang JS, 2008, SEMIN CANCER BIOL, V18, P330, DOI 10.1016/j.semcancer.2008.03.011; Gatenby RA, 2006, CANCER RES, V66, P5216, DOI 10.1158/0008-5472.CAN-05-4193; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gillies RJ, 2004, IEEE ENG MED BIOL, V23, P57, DOI 10.1109/MEMB.2004.1360409; GILLIES RJ, 1994, AM J PHYSIOL, V267, pC195, DOI 10.1152/ajpcell.1994.267.1.C195; GILLIES RJ, 1990, P NATL ACAD SCI USA, V87, P7414, DOI 10.1073/pnas.87.19.7414; IRVING M, 1990, BIOPHYS J, V57, P717, DOI 10.1016/S0006-3495(90)82592-3; Jones DT, 2006, CLIN CANCER RES, V12, P5384, DOI 10.1158/1078-0432.CCR-05-2380; Lauritzen G, 2010, EXP CELL RES, V316, P2538, DOI 10.1016/j.yexcr.2010.06.005; Lee AH, 1998, CANCER RES, V58, P1901; Leem CH, 1998, J PHYSIOL-LONDON, V509, P487, DOI 10.1111/j.1469-7793.1998.487bn.x; Li XJ, 2002, J BIOL CHEM, V277, P36085, DOI 10.1074/jbc.M111952200; MARTINEZZAGUILAN R, 1993, AM J PHYSIOL, V265, pC1015, DOI 10.1152/ajpcell.1993.265.4.C1015; McLachlan E, 2006, CANCER RES, V66, P9886, DOI 10.1158/0008-5472.CAN-05-4302; Morgan PE, 2007, AM J PHYSIOL-CELL PH, V293, pC738, DOI 10.1152/ajpcell.00157.2007; MUELLERKLIESER WF, 1982, BRIT J CANCER, V45, P256, DOI 10.1038/bjc.1982.41; MURER H, 1976, BIOCHEM J, V154, P597, DOI 10.1042/bj1540597; ORLOWSKI J, 1992, J BIOL CHEM, V267, P9331; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; PASTOREK J, 1994, ONCOGENE, V9, P2877; PEDERSEN PL, 1987, TRENDS BIOCHEM SCI, V12, P146, DOI 10.1016/0968-0004(87)90071-5; POUYSSEGUR J, 1984, P NATL ACAD SCI-BIOL, V81, P4833, DOI 10.1073/pnas.81.15.4833; Reshkin SJ, 2000, FASEB J, V14, P2185, DOI 10.1096/fj.00-0029com; Robey IF, 2009, CANCER RES, V69, P2260, DOI 10.1158/0008-5472.CAN-07-5575; Romero MF, 2000, J BIOL CHEM, V275, P24552, DOI 10.1074/jbc.M003476200; Romero MF, 1997, NATURE, V387, P409, DOI 10.1038/387409a0; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Sterling D, 2001, J BIOL CHEM, V276, P47886, DOI 10.1074/jbc.M105959200; Stewart AK, 1999, J PHYSIOL-LONDON, V516, P209, DOI 10.1111/j.1469-7793.1999.209aa.x; Svastova E, 2004, FEBS LETT, V577, P439, DOI 10.1016/j.febslet.2004.10.043; Swietach P, 2010, ONCOGENE, V29, P6509, DOI 10.1038/onc.2010.455; Swietach P, 2008, J BIOL CHEM, V283, P20473, DOI 10.1074/jbc.M801330200; Swietach P, 2009, J BIOL CHEM, V284, P20299, DOI 10.1074/jbc.M109.006478; THOMLINSON RH, 1955, BRIT J CANCER, V9, P539, DOI 10.1038/bjc.1955.55; Tureci O, 1998, P NATL ACAD SCI USA, V95, P7608, DOI 10.1073/pnas.95.13.7608; Vaughan-Jones RD, 2002, J PHYSIOL-LONDON, V541, P139, DOI 10.1113/jphysiol.2001.013267; VAUGHANJONES RD, 1990, J PHYSIOL-LONDON, V428, P441, DOI 10.1113/jphysiol.1990.sp018221; VAUPEL P, 1989, CANCER RES, V49, P6449; Wang CZ, 2000, J BIOL CHEM, V275, P35486, DOI 10.1074/jbc.C000456200; Wong P, 2002, BRIT J CANCER, V87, P238, DOI 10.1038/sj.bjc.6600424	50	67	70	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					13815	13826		10.1074/jbc.M111.219899	http://dx.doi.org/10.1074/jbc.M111.219899			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21345798	Green Published, hybrid			2022-12-27	WOS:000289556200004
J	Jung, K; Lee, D; Lim, HS; Lee, SI; Kim, YJ; Lee, GM; Kim, SC; Koh, GY				Jung, Keehoon; Lee, Donghun; Lim, Hye Song; Lee, Sang-Il; Kim, Yeon Jung; Lee, Gyun Min; Kim, Sun Chang; Koh, Gou Young			Double Anti-angiogenic and Anti-inflammatory Protein Valpha Targeting VEGF-A and TNF-alpha in Retinopathy and Psoriasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; SKIN INFLAMMATION; RHEUMATOID-ARTHRITIS; CANCER MODEL; IN-VIVO; RECEPTOR; MOUSE; NEOVASCULARIZATION	Pathological angiogenesis usually involves disrupted vascular integrity, vascular leakage, and infiltration of inflammatory cells, which are governed mainly by VEGF-A and TNF-alpha. Although many inhibitors targeting either VEGF-A or TNF-alpha have been developed, there is no single inhibitor molecule that simultaneously targets both molecules. Here, we designed and generated a novel chimeric decoy receptor (Valpha) that can simultaneously bind to VEGF-A and TNF-alpha and block their actions. In this experimental design, we have shown that Valpha, which is an effective synchronous blocker of VEGF-A and TNF-alpha, can drastically increase treatment effectiveness through its dual-blocking characteristics. Valpha contains the VEGF-A-binding domain of VEGFR1, the TNF-alpha-binding domain of TNFR2, and the Fc domain of IgG1. Valpha exhibited strong binding characteristics for its original counterparts, VEGF-A and TNF-alpha, but not for the extracellular matrix, resulting in a highly favorable pharmacokinetic profile in vivo. Compared with VEGF-Trap or Enbrel, both of which block either VEGF-A or TNF-alpha, singularly, Valpha is a highly effective molecule for reducing abnormal vascular tufts and the number of F4/80(+) macrophages in a retinopathy model. In addition, Valpha showed superior relief effects in a psoriasis model with regard to epidermal thickness and the area of blood and lymphatic vessels. Thus, the simultaneous blocking of VEGF-A and TNF-alpha using Valpha is an effective therapeutic strategy and cost-efficient for treatment of retinopathy and psoriasis.	[Jung, Keehoon; Koh, Gou Young] Korea Adv Inst Sci & Technol, Grad Sch Biomed Sci & Engn, Taejon 305701, South Korea; [Jung, Keehoon; Koh, Gou Young] Korea Adv Inst Sci & Technol, Natl Res Lab Vasc Biol & Stem Cells, Taejon 305701, South Korea; [Kim, Yeon Jung; Lee, Gyun Min; Kim, Sun Chang] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Koh, Gou Young] Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol, Taejon 305701, South Korea; [Lee, Donghun] Seoul Natl Univ, Coll Med, Dept Dermatol, Seoul 110744, South Korea; [Lim, Hye Song; Lee, Sang-Il] Gyeongsang Natl Univ, Sch Med, Inst Hlth Sci, Jinju 660702, South Korea; [Lim, Hye Song; Lee, Sang-Il] Gyeongsang Natl Univ, Sch Med, Dept Internal Med, Jinju 660702, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Seoul National University (SNU); Gyeongsang National University; Gyeongsang National University	Koh, GY (corresponding author), Korea Adv Inst Sci & Technol, Grad Sch Biomed Sci & Engn, 373-1 Guseong Dong, Taejon 305701, South Korea.	gykoh@kaist.ac.kr	Lee, Gyun Min/C-2020-2011; Kim, Sun Chang/C-2026-2011; Koh, Gou Young/C-1615-2011; Kim, Sun/GSN-4867-2022	Jung, Keehoon/0000-0002-2199-5292	Ministry of Education, Science and Technology, Korea [R2009-0079390, R31-2009-000-10071-0]	Ministry of Education, Science and Technology, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by National Research Foundation Grant R2009-0079390 (to G.Y.K.), World Class University (WCU) Grant R31-2009-000-10071-0 (to G.Y.K.), and a Korea Advanced Institute of Science and Technology (KAIST) institute grant (2009) funded by the Ministry of Education, Science and Technology, Korea.	Byrne AT, 2003, CLIN CANCER RES, V9, P5721; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Chen J, 2008, J CLIN INVEST, V118, P526, DOI [10.1172/JC133813, 10.1172/JCI33813]; Chua RA, 2009, AUTOIMMUNITY, V42, P574, DOI 10.1080/08916930903002461; De Bandt M, 2003, J IMMUNOL, V171, P4853, DOI 10.4049/jimmunol.171.9.4853; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Gardiner TA, 2005, AM J PATHOL, V166, P637, DOI 10.1016/S0002-9440(10)62284-5; Halin C, 2008, AM J PATHOL, V173, P265, DOI 10.2353/ajpath.2008.071074; Hickey MJ, 1997, J IMMUNOL, V158, P3391; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Hvid H, 2008, INT IMMUNOL, V20, P1097, DOI 10.1093/intimm/dxn068; Hwang SJ, 2005, PROTEIN EXPRES PURIF, V39, P175, DOI 10.1016/j.pep.2004.09.005; Ishida S, 2003, J EXP MED, V198, P483, DOI 10.1084/jem.20022027; Jung K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007403; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kim HZ, 2009, BBA-MOL CELL RES, V1793, P772, DOI 10.1016/j.bbamcr.2009.01.018; Kunstfeld R, 2004, BLOOD, V104, P1048, DOI 10.1182/blood-2003-08-2964; Lainer-Carr D, 2007, NAT CLIN PRACT RHEUM, V3, P434, DOI 10.1038/ncprheum0559; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Nagashima M, 1999, CLIN EXP IMMUNOL, V116, P360; PEPPEL K, 1991, J EXP MED, V174, P1483, DOI 10.1084/jem.174.6.1483; Rojanasakul Y, 1999, MOL CELL BIOCHEM, V200, P119, DOI 10.1023/A:1007051402840; Ruch C, 2007, NAT STRUCT MOL BIOL, V14, P249, DOI 10.1038/nsmb1202; Saint-Geniez M, 2004, INT J DEV BIOL, V48, P1045, DOI 10.1387/ijdb.041895ms; Saishin Y, 2003, J CELL PHYSIOL, V195, P241, DOI 10.1002/jcp.10246; SCHALL TJ, 1990, CELL, V61, P361, DOI 10.1016/0092-8674(90)90816-W; Schonthaler HB, 2009, P NATL ACAD SCI USA, V106, P21264, DOI 10.1073/pnas.0907550106; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; Shibuya M, 2001, INT J BIOCHEM CELL B, V33, P409, DOI 10.1016/S1357-2725(01)00026-7; Skoura A, 2007, J CLIN INVEST, V117, P2506, DOI 10.1172/JCI31123; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; TARTAGLIA LA, 1993, J BIOL CHEM, V268, P18542; Taylor PC, 2001, CURR OPIN RHEUMATOL, V13, P164, DOI 10.1097/00002281-200105000-00003; Teige I, 2009, J INVEST DERMATOL, V129, P1437, DOI 10.1038/jid.2008.375; VANDENABEELE P, 1995, TRENDS CELL BIOL, V5, P392, DOI 10.1016/S0962-8924(00)89088-1; Verheul HMW, 2007, CLIN CANCER RES, V13, P4201, DOI 10.1158/1078-0432.CCR-06-2553; Xia YP, 2003, BLOOD, V102, P161, DOI 10.1182/blood-2002-12-3793; Young HS, 2006, J INVEST DERMATOL, V126, P453, DOI 10.1038/sj.jid.5700096	43	36	38	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14410	14418		10.1074/jbc.M111.228130	http://dx.doi.org/10.1074/jbc.M111.228130			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21345791	hybrid, Green Published			2022-12-27	WOS:000289556200062
J	Kulkarni, SD; Muralidharan, B; Panda, AC; Bakthavachalu, B; Vindu, A; Seshadri, V				Kulkarni, Shardul D.; Muralidharan, Bhavana; Panda, Amaresh C.; Bakthavachalu, Baskar; Vindu, Arya; Seshadri, Vasudevan			Glucose-stimulated Translation Regulation of Insulin by the 5 ' UTR-binding Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLOROPLAST POLY(A)-BINDING PROTEIN; PROINSULIN MESSENGER-RNA; RAT PANCREATIC-ISLETS; DISULFIDE-ISOMERASE; 5'-UNTRANSLATED REGION; PROLYL 4-HYDROXYLASE; BETA-SUBUNIT; BIOSYNTHESIS; INITIATION; CELLS	Insulin is the key regulator of glucose homeostasis in mammals, and glucose-stimulated insulin biosynthesis is essential for maintaining glucose levels in a narrow range in mammals. Glucose specifically promotes the translation of insulin in pancreatic beta-islet, and the untranslated regions of insulin mRNA play a role in such regulation. Specific factors in the beta-islets bind to the insulin 5' UTR and regulate its translation. In the present study we identify protein-disulfide isomerase (PDI) as a key regulator of glucose-stimulated insulin biosynthesis. We show that both in vitro and in vivo PDI can specifically associate with the 5' UTR of insulin mRNA. Immunodepletion of PDI from the islet extract results in loss of glucose-stimulated translation indicating a critical role for PDI in insulin biosynthesis. Similarly, transient overexpression of PDI resulted in specific translation activation by glucose. We show that the RNA binding activity of PDI is mediated through PABP. PDI catalyzes the reduction of the PABP disulfide bond resulting in specific binding of PABP to the insulin 5' UTR. We also show that glucose stimulation of the islets results in activation of a specific kinase that can phosphorylate PDI. These findings identify PDI and PABP as important players in glucose homeostasis.	[Kulkarni, Shardul D.; Muralidharan, Bhavana; Panda, Amaresh C.; Bakthavachalu, Baskar; Vindu, Arya; Seshadri, Vasudevan] Natl Ctr Cell Sci, Pune 411007, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Seshadri, V (corresponding author), Natl Ctr Cell Sci, Pune 411007, Maharashtra, India.	seshadriv@nccs.res.in	Kulkarni, Shardul/AAD-2205-2020; Vindu, Arya/GQP-2981-2022; Panda, Amaresh C./H-5459-2019; Kulkarni, S/AAO-8388-2020	Kulkarni, Shardul/0000-0003-3814-4432; Panda, Amaresh C./0000-0003-3189-8995; Vindu, Arya/0000-0001-8711-2037; Bakthavachalu, Baskar/0000-0002-5114-3429; Muralidharan, Bhavana/0000-0003-1184-0833	Department of Biotechnology, India [BT/PR5813/BRB/10/411/2005]; National Centre for Cell Science, India; Council of Scientific and Industrial Research, India; Indian Council of Medical Research, India	Department of Biotechnology, India(Department of Biotechnology (DBT) India); National Centre for Cell Science, India; Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research, India(Indian Council of Medical Research (ICMR))	This work was supported in part by Department of Biotechnology, India, Grant BT/PR5813/BRB/10/411/2005 and a intramural grant from the National Centre for Cell Science, India (to V. S.).; Supported by fellowships from Council of Scientific and Industrial Research, India.; Supported by a fellowship from Indian Council of Medical Research, India.	Alanen HI, 2003, ANTIOXID REDOX SIGN, V5, P367, DOI 10.1089/152308603768295096; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; CAMPBELL IL, 1982, CLIN SCI, V62, P449, DOI 10.1042/cs0620449; CHEN K, 1992, BLOOD, V79, P2226; Coppari S, 2002, J CELL BIOCHEM, V85, P325, DOI 10.1002/jcb.10137; DANON A, 1994, EMBO J, V13, P2227, DOI 10.1002/j.1460-2075.1994.tb06500.x; DANON A, 1994, SCIENCE, V266, P1717, DOI 10.1126/science.7992056; Deo RC, 1999, CELL, V98, P835, DOI 10.1016/S0092-8674(00)81517-2; Fong CL, 2000, J BIOL CHEM, V275, P8275, DOI 10.1074/jbc.275.12.8275; Gerner C, 1999, J CELL BIOCHEM, V74, P145, DOI 10.1002/(SICI)1097-4644(19990801)74:2<145::AID-JCB1>3.0.CO;2-#; Greenman IC, 2005, BIOCHEM J, V391, P291, DOI 10.1042/BJ20050468; Hernandez-Sanchez C, 2003, EMBO J, V22, P5582, DOI 10.1093/emboj/cdg515; Hotchkiss KA, 1998, BBA-PROTEIN STRUCT M, V1388, P478, DOI 10.1016/S0167-4838(98)00211-8; ITOH N, 1978, FEBS LETT, V93, P343, DOI 10.1016/0014-5793(78)81136-3; ITOH N, 1980, NATURE, V283, P100, DOI 10.1038/283100a0; JAHR H, 1980, EUR J BIOCHEM, V110, P499, DOI 10.1111/j.1432-1033.1980.tb04892.x; Kim J, 2002, PLANT CELL PHYSIOL, V43, P1238, DOI 10.1093/pcp/pcf129; Kim JM, 1997, SCIENCE, V278, P1954, DOI 10.1126/science.278.5345.1954; KNAACK D, 1994, DIABETES, V43, P1413, DOI 10.2337/diabetes.43.12.1413; KOIVU J, 1987, J BIOL CHEM, V262, P6447; Leibiger B, 2000, J BIOL CHEM, V275, P30153, DOI 10.1074/jbc.M005216200; Li SJ, 2006, J BIOL CHEM, V281, P6581, DOI 10.1074/jbc.M508422200; Muralidharan B, 2007, FEBS LETT, V581, P4103, DOI 10.1016/j.febslet.2007.07.050; PERMUTT MA, 1975, FED PROC, V34, P1549; PERMUTT MA, 1974, J BIOL CHEM, V249, P2738; PIHLAJANIEMI T, 1987, EMBO J, V6, P643, DOI 10.1002/j.1460-2075.1987.tb04803.x; Qi HH, 2008, NATURE, V455, P421, DOI 10.1038/nature07186; Shalev A, 2002, ENDOCRINOLOGY, V143, P2541, DOI 10.1210/en.143.7.2541; TERADA K, 1995, J BIOL CHEM, V270, P20410, DOI 10.1074/jbc.270.35.20410; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Tillmar L, 2002, J BIOL CHEM, V277, P1099, DOI 10.1074/jbc.M108340200; Turano C, 2002, J CELL PHYSIOL, V193, P154, DOI 10.1002/jcp.10172; VanderWaal RP, 2002, J CELL BIOCHEM, V85, P689, DOI 10.1002/jcb.10169; WELSH M, 1986, BIOCHEM J, V235, P459, DOI 10.1042/bj2350459; WETTERAU JR, 1990, J BIOL CHEM, V265, P9800; Wicksteed B, 2001, J BIOL CHEM, V276, P22553, DOI 10.1074/jbc.M011214200; Wicksteed B, 2007, CELL METAB, V5, P221, DOI 10.1016/j.cmet.2007.02.007; WROBLEWSKI VJ, 1992, DIABETES, V41, P539, DOI 10.2337/diabetes.41.4.539; Yao Y, 1997, EMBO J, V16, P651, DOI 10.1093/emboj/16.3.651; YOSHIMORI T, 1990, J BIOL CHEM, V265, P15984; Zhang LL, 2009, J BIOL CHEM, V284, P5289, DOI 10.1074/jbc.M805477200	41	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14146	14156		10.1074/jbc.M110.190553	http://dx.doi.org/10.1074/jbc.M110.190553			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21357685	Green Published, hybrid			2022-12-27	WOS:000289556200038
J	Habchi, J; Blangy, S; Mamelli, L; Jensen, MR; Blackledge, M; Darbon, H; Oglesbee, M; Shu, YL; Longhi, S				Habchi, Johnny; Blangy, Stephanie; Mamelli, Laurent; Jensen, Malene Ringkjobing; Blackledge, Martin; Darbon, Herve; Oglesbee, Michael; Shu, Yaoling; Longhi, Sonia			Characterization of the Interactions between the Nucleoprotein and the Phosphoprotein of Henipavirus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; MEASLES-VIRUS NUCLEOPROTEIN; INTRINSICALLY UNSTRUCTURED PROTEINS; MOLECULAR RECOGNITION FEATURES; NUCLEOCAPSID-BINDING DOMAIN; RESIDUAL DIPOLAR COUPLINGS; DISORDERED PROTEINS; CRYSTAL-STRUCTURE; STRUCTURE PREDICTION; STRUCTURAL DISORDER	The Henipavirus genome is encapsidated by the nucleoprotein (N) within a helical nucleocapsid that recruits the polymerase complex via the phosphoprotein (P). In a previous study, we reported that in henipaviruses, the N-terminal domain of the phosphoprotein and the C-terminal domain of the nucleoprotein (N-TAIL) are both intrinsically disordered. Here we show that Henipavirus N-TAIL domains are also disordered in the context of full-length nucleoproteins. We also report the cloning, purification, and characterization of the C-terminal X domains (P-XD) of Henipavirus phosphoproteins. Using isothermal titration calorimetry, we show that N-TAIL and P-XD form a 1:1 stoichiometric complex that is stable under NaCl concentrations as high as 1 M and has a K-D in the mu M range. Using far-UV circular dichroism and nuclear magnetic resonance, we show that P-XD triggers an increase in the alpha-helical content of N-TAIL. Using fluorescence spectroscopy, we show that P-XD has no impact on the chemical environment of a Trp residue introduced at position 527 of the Henipavirus N-TAIL domain, thus arguing for the lack of stable contacts between the C termini of N-TAIL and P-XD. Finally, we present a tentative structural model of the interaction in which a short, order-prone region of N-TAIL (alpha-MoRE; amino acids 473 493) adopts an alpha-helical conformation and is embedded between helices alpha 2 and alpha 3 of P-XD leading to a relatively small interface dominated by hydrophobic contacts. The present results provide the first detailed experimental characterization of the N-P interaction in henipaviruses and designate the N-TAIL-P-XD interaction as a valuable target for rational antiviral approaches.	[Habchi, Johnny; Blangy, Stephanie; Mamelli, Laurent; Darbon, Herve; Longhi, Sonia] Aix Marseille Univ, CNRS, UMR 6098, Lab Architecture & Fonct Macromol Biol, F-13288 Marseille 09, France; [Jensen, Malene Ringkjobing; Blackledge, Martin] UJF, Inst Biol Struct Jean Pierre Ebel, Prot Dynam & Flexibil NMR Grp, CEA,CNRS,UMR 5075, F-38027 Grenoble, France; [Oglesbee, Michael; Shu, Yaoling] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; University System of Ohio; Ohio State University	Longhi, S (corresponding author), Aix Marseille Univ, CNRS, UMR 6098, Lab Architecture & Fonct Macromol Biol, 163 Ave Luminy,Case 932, F-13288 Marseille 09, France.	Sonia.Longhi@afmb.univ-mrs.fr	LONGHI, Sonia/M-5305-2014	LONGHI, Sonia/0000-0002-6829-6771; Jensen, Malene R./0000-0003-0419-2196	Agence Nationale de la Recherche [ANR-08-PCVI-0020-01, ANR-09-BLAN-0100]; CNRS	Agence Nationale de la Recherche(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the Agence Nationale de la Recherche, specific program "Physico-Chimie du Vivant", ANR-08-PCVI-0020-01, and in part by the ANR-specific program ANR-09-BLAN-0100.; Supported by a postdoctoral fellowship from the CNRS.	Albeck S, 2006, ACTA CRYSTALLOGR D, V62, P1184, DOI 10.1107/S090744490602991X; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Assenberg R, 2010, ANTIVIR RES, V87, P149, DOI 10.1016/j.antiviral.2010.02.322; Belle V, 2008, PROTEINS, V73, P973, DOI 10.1002/prot.22125; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bernado P, 2005, P NATL ACAD SCI USA, V102, P17002, DOI 10.1073/pnas.0506202102; Bernard C, 2009, FEBS LETT, V583, P1084, DOI 10.1016/j.febslet.2009.03.004; Bhella D, 2004, J MOL BIOL, V340, P319, DOI 10.1016/j.jmb.2004.05.015; Bhella D, 2002, J GEN VIROL, V83, P1831, DOI 10.1099/0022-1317-83-8-1831; BHELLA D, 2007, MEASLES VIRUS NUCLEO, P37; Bischak CG, 2010, BIOPHYS J, V99, P1676, DOI 10.1016/j.bpj.2010.06.060; Blanchard L, 2004, VIROLOGY, V319, P201, DOI 10.1016/j.virol.2003.10.029; Bourhis J.-M., 2005, Virologie (Montrouge), V9, P367, DOI 10.1684/vir.2011.2399; Bourhis J.M., 2007, MEASLES VIRUS NUCLEO, P1; Bourhis JM, 2004, VIRUS RES, V99, P157, DOI 10.1016/j.virusres.2003.11.007; Bourhis JM, 2006, VIROLOGY, V344, P94, DOI 10.1016/j.virol.2005.09.025; Bourhis JM, 2005, PROTEIN SCI, V14, P1975, DOI 10.1110/ps.051411805; Bowden TA, 2008, NAT STRUCT MOL BIOL, V15, P567, DOI 10.1038/nsmb.1435; Bowden TA, 2010, J VIROL, V84, P6208, DOI 10.1128/JVI.00317-10; Bowden TA, 2008, J VIROL, V82, P11628, DOI 10.1128/JVI.01344-08; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Canard B, 2008, ANTIVIR RES, V78, P47, DOI 10.1016/j.antiviral.2007.09.007; Carsillo T, 2006, J VIROL, V80, P2904, DOI 10.1128/JVI.80.6.2904-2912.2006; Chan YP, 2004, J GEN VIROL, V85, P1675, DOI 10.1099/vir.0.19752-0; Cheng Y, 2006, TRENDS BIOTECHNOL, V24, P435, DOI 10.1016/j.tibtech.2006.07.005; Coutard B, 2010, ANTIVIR RES, V87, P85, DOI 10.1016/j.antiviral.2010.02.326; Couturier M, 2010, J MOL RECOGNIT, V23, P301, DOI 10.1002/jmr.982; Curran J, 1999, ADV VIRUS RES, V54, P403, DOI 10.1016/S0065-3527(08)60373-5; DahlmanWright K, 1996, BIOCHEMISTRY-US, V35, P1323, DOI 10.1021/bi952409k; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W. L., 2002, PROTEIN-STRUCT FUNCT, V30, P442, DOI DOI 10.1234/12345678; Dey S, 2010, J MOL BIOL, V398, P146, DOI 10.1016/j.jmb.2010.02.020; Drexler JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006367; Dunker AK, 2010, CURR OPIN PHARMACOL, V10, P782, DOI 10.1016/j.coph.2010.09.005; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dunker AK, 2001, NAT BIOTECHNOL, V19, P805, DOI 10.1038/nbt0901-805; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Eaton BT, 2006, NAT REV MICROBIOL, V4, P23, DOI 10.1038/nrmicro1323; Eaton BT, 2007, FIELDS VIROLOGY, P1587; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferreon JC, 2009, P NATL ACAD SCI USA, V106, P13260, DOI 10.1073/pnas.0906770106; Ferron F, 2005, J GEN VIROL, V86, P743, DOI 10.1099/vir.0.80590-0; Fogg MJ, 2006, ACTA CRYSTALLOGR D, V62, P1196, DOI 10.1107/S0907444906030915; Fontana A, 1997, FOLD DES, V2, pR17, DOI 10.1016/S1359-0278(97)00010-2; FONTANA A, 1995, FEBS LETT, V362, P266, DOI 10.1016/0014-5793(95)00237-4; Fontana A., 2010, INSTRUMENTAL ANAL IN, P569, DOI DOI 10.1002/9780470602614.CH20; Freyer MW, 2008, METHOD CELL BIOL, V84, P79, DOI 10.1016/S0091-679X(07)84004-0; Frottin F, 2006, MOL CELL PROTEOMICS, V5, P2336, DOI 10.1074/mcp.M600225-MCP200; Fuxreiter M, 2004, J MOL BIOL, V338, P1015, DOI 10.1016/j.jmb.2004.03.017; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Gely S, 2010, J MOL RECOGNIT, V23, P435, DOI 10.1002/jmr.1010; Gerard FCA, 2009, J MOL BIOL, V388, P978, DOI 10.1016/j.jmb.2009.03.061; Gorbalenya AE, 2010, ANTIVIR RES, V87, P95, DOI 10.1016/j.antiviral.2010.02.005; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Habchi J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011684; Halpin K, 2004, J GEN VIROL, V85, P701, DOI 10.1099/vir.0.19685-0; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hosse RJ, 2006, PROTEIN SCI, V15, P14, DOI 10.1110/ps.051817606; Houben K, 2007, J VIROL, V81, P6807, DOI 10.1128/JVI.00338-07; Hua QX, 1998, BIOCHEMISTRY-US, V37, P5858, DOI 10.1021/bi9800808; Hwang TL, 1998, J MAGN RESON, V135, P280, DOI 10.1006/jmre.1998.1598; Ivanov I, 2010, J VIROL, V84, P3707, DOI 10.1128/JVI.02557-09; Jensen MR, 2008, J AM CHEM SOC, V130, P8055, DOI 10.1021/ja801332d; Jha AK, 2005, P NATL ACAD SCI USA, V102, P13099, DOI 10.1073/pnas.0506078102; Johansson K, 2003, J BIOL CHEM, V278, P44567, DOI 10.1074/jbc.M308745200; KALININ NL, 1995, ANAL BIOCHEM, V228, P238, DOI 10.1006/abio.1995.1345; Karchin R, 2003, PROTEINS, V51, P504, DOI 10.1002/prot.10369; Karlin D, 2002, VIROLOGY, V302, P420, DOI 10.1006/viro.2002.1634; Karlin D, 2002, VIROLOGY, V296, P251, DOI 10.1006/viro.2001.1296; Karplus K, 2005, PROTEINS, V61, P135, DOI 10.1002/prot.20730; Karplus K, 2003, PROTEINS, V53, P491, DOI 10.1002/prot.10540; Kerdiles YM, 2006, VIRAL IMMUNOL, V19, P324, DOI 10.1089/vim.2006.19.324; Kingston RL, 2008, J MOL BIOL, V379, P719, DOI 10.1016/j.jmb.2007.12.080; Kingston RL, 2004, J VIROL, V78, P8630, DOI 10.1128/JVI.78.16.8630-8640.2004; Kingston RL, 2004, P NATL ACAD SCI USA, V101, P8301, DOI 10.1073/pnas.0402690101; Kiss R, 2008, FEBS LETT, V582, P2149, DOI 10.1016/j.febslet.2008.05.032; Kolakofsky D, 2004, VIROLOGY, V318, P463, DOI 10.1016/j.virol.2003.10.031; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kriwacki RW, 1996, P NATL ACAD SCI USA, V93, P11504, DOI 10.1073/pnas.93.21.11504; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leyrat C, 2010, PROTEIN PEPTIDE LETT, V17, P979, DOI 10.2174/092986610791498939; Longhi S, 2003, J BIOL CHEM, V278, P18638, DOI 10.1074/jbc.M300518200; Longhi S, 2009, CURR TOP MICROBIOL, V329, P103; Lou ZY, 2006, FEBS J, V273, P4538, DOI 10.1111/j.1742-4658.2006.05459.x; Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200; Malet H, 2009, J VIROL, V83, P6534, DOI 10.1128/JVI.00189-09; Marion D, 2001, J BIOMOL NMR, V21, P75, DOI 10.1023/A:1011990021282; Mastrangelo E, 2007, J MOL BIOL, V372, P444, DOI 10.1016/j.jmb.2007.06.055; Meszaros B, 2007, J MOL BIOL, V372, P549, DOI 10.1016/j.jmb.2007.07.004; Mittag T, 2008, P NATL ACAD SCI USA, V105, P17772, DOI 10.1073/pnas.0809222105; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Morin B, 2006, J PHYS CHEM B, V110, P20596, DOI 10.1021/jp063708u; Morin B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001038; Oglesbee M., 2007, MEASLES VIRUS NUCLEO, P53; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Omi-Furutani M, 2010, J VIROL, V84, P9793, DOI 10.1128/JVI.00339-10; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Receveur-Brechot V, 2006, PROTEINS, V62, P24, DOI 10.1002/prot.20750; RIBEIRO ED, 2009, J MOL BIOL; Ribeiro EA, 2008, J MOL BIOL, V382, P525, DOI 10.1016/j.jmb.2008.07.028; Sambrook J, 1989, MOL CLONING LAB; Schoehn G, 2004, J MOL BIOL, V339, P301, DOI 10.1016/j.jmb.2004.03.073; Schuck P, 1997, ANNU REV BIOPH BIOM, V26, P541, DOI 10.1146/annurev.biophys.26.1.541; Sue SC, 2008, J MOL BIOL, V380, P917, DOI 10.1016/j.jmb.2008.05.048; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Tarbouriech N, 2000, VIROLOGY, V266, P99, DOI 10.1006/viro.1999.0066; Tarbouriech N, 2000, NAT STRUCT BIOL, V7, P777; Tell G, 1998, BIOCHEM J, V329, P395, DOI 10.1042/bj3290395; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Turoverov KK, 2010, PROG BIOPHYS MOL BIO, V102, P73, DOI 10.1016/j.pbiomolbio.2010.01.003; Uversky VN, 2010, EXPERT REV PROTEOMIC, V7, P543, DOI [10.1586/epr.10.36, 10.1586/EPR.10.36]; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Uversky VN, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/568068; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2003, CELL MOL LIFE SCI, V60, P1852, DOI 10.1007/s00018-003-3096-6; UVERSKY VN, 1993, BIOCHEMISTRY-US, V32, P13288, DOI 10.1021/bi00211a042; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang LF, 2000, J VIROL, V74, P9972, DOI 10.1128/JVI.74.21.9972-9979.2000; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pD593, DOI 10.1093/nar/gkh077; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Xu B, 1999, BIOTECHNOL PROGR, V15, P81, DOI 10.1021/bp9801087; Yegambaram K, 2010, PROTEIN SCI, V19, P893, DOI 10.1002/pro.354; Zhang XS, 2005, VIROLOGY, V337, P162, DOI 10.1016/j.virol.2005.03.035; Zhang XS, 2002, J VIROL, V76, P8737, DOI 10.1128/JVI.76.17.8737-8746.2002	136	54	54	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13583	13602		10.1074/jbc.M111.219857	http://dx.doi.org/10.1074/jbc.M111.219857			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21317293	Green Published, hybrid			2022-12-27	WOS:000289282200078
J	Jenkins, RW; Clarke, CJ; Canals, D; Snider, AJ; Gault, CR; Heffernan-Stroud, L; Wu, BX; Simbari, F; Roddy, P; Kitatani, K; Obeid, LM; Hannun, YA				Jenkins, Russell W.; Clarke, Christopher J.; Canals, Daniel; Snider, Ashley J.; Gault, Christopher R.; Heffernan-Stroud, Linda; Wu, Bill X.; Simbari, Fabio; Roddy, Patrick; Kitatani, Kazuyuki; Obeid, Lina M.; Hannun, Yusuf A.			Regulation of CC Ligand 5/RANTES by Acid Sphingomyelinase and Acid Ceramidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NIEMANN-PICK-DISEASE; DELTA-MEDIATED PHOSPHORYLATION; RANTES CHEMOKINE GENE; LUNG EPITHELIAL-CELLS; SMOOTH-MUSCLE-CELLS; BETA-GLUCOSIDASE 1; SECRETORY SPHINGOMYELINASE; SPHINGOSINE 1-PHOSPHATE; TNF-ALPHA; LYSOSOMAL SPHINGOMYELINASE	Acid sphingomyelinase (aSMase) generates the bioactive lipid ceramide (Cer) from hydrolysis of sphingomyelin (SM). However, its precise roles in regulating specific sphingolipid-mediated biological processes remain ill defined. Interestingly, the aSMase gene gives rise to two distinct enzymes, lysosomal sphingomyelinase (L-SMase) and secretory sphingomyelinase (S-SMase) via alternative trafficking of a shared protein precursor. Previously, our laboratory identified Ser(508) as a crucial residue for the constitutive and regulated secretion of S-SMase in response to inflammatory cytokines, and demonstrated a role for S-SMase in formation of select cellular Cer species (Jenkins, R. W., Canals, D., Idkowiak-Baldys, J., Simbari, F., Roddy, P., Perry, D. M., Kitatani, K., Luberto, C., and Hannun, Y. A. (2010) J. Biol. Chem. 285, 35706-35718). In the present study using a chemokine/cytokine screen, we identified the chemokine CCL5 (formerly known as RANTES) as a candidate-specific downstream target for aSMase. Regulation of CCL5 by aSMase was subsequently validated using both loss-of-function and gain-of-function models indicating that aSMase is both necessary and sufficient for CCL5 production. Interestingly, cells deficient in acid ceramidase (aCDase) also exhibited defects in CCL5 induction, whereas cells deficient in sphingosine kinase- 1 and -2 exhibited higher levels of CCL5, suggesting that sphingosine and not sphingosine 1-phosphate (S1P) is responsible for the positive signal to CCL5. Consistent with this, co-expression of aSMase and aCDase was sufficient to strongly induce CCL5. Taken together, these data identify a novel role for aSMase (particularly S-SMase) in chemokine elaboration by pro-inflammatory cytokines and highlight a novel and shared function for aSMase and aCDase.	[Jenkins, Russell W.; Clarke, Christopher J.; Canals, Daniel; Wu, Bill X.; Roddy, Patrick; Kitatani, Kazuyuki; Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Snider, Ashley J.; Gault, Christopher R.; Heffernan-Stroud, Linda; Obeid, Lina M.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Snider, Ashley J.; Gault, Christopher R.; Heffernan-Stroud, Linda; Obeid, Lina M.] Ralph H Johnson Vet Affairs Hosp, Charleston, SC 29401 USA; [Simbari, Fabio] CSIC, Inst Adv Chem Catalonia, Dept Biomed Chem, ES-08034 Barcelona, Spain; [Kitatani, Kazuyuki] Tottori Univ Hosp, Dept Clin Lab, Yonago, Tottori 6838504, Japan	Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Quimica Avanzada de Cataluna (IQAC); Tottori University	Hannun, YA (corresponding author), 173 Ashley Ave,POB 250509, Charleston, SC 29425 USA.	hannun@musc.edu	Canals, Daniel/AAW-1998-2021; Canals, Daniel/AAJ-8176-2021; Kitatani, Kazuyuki/H-7100-2019	Canals, Daniel/0000-0002-9293-5123; Kitatani, Kazuyuki/0000-0002-8516-6135; obeid, lina/0000-0002-0734-0847	National Institutes of Health [P01 CA097132]; NCI; MSTP Training [GM08716, GM062887]; NIGMS [CA097132]; American Heart Association [AHA 081509E]; Medical University of South Carolina Hollings Cancer Center Abney Foundation; Ministerio de Educacion y Ciencia (Spain) [AP2006-02190]; Japan Society for the Promotion of Science [21890144]; NATIONAL CANCER INSTITUTE [P01CA097132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008716, R01GM062887] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MSTP Training; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Heart Association(American Heart Association); Medical University of South Carolina Hollings Cancer Center Abney Foundation; Ministerio de Educacion y Ciencia (Spain)(Spanish Government); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 CA097132 (to Y. A. H.) from the NCI, MSTP Training Grant GM08716 (to R. W. J.), Grant GM062887 from the NIGMS (to L. M. O.), Grant CA097132 from the NCI (to L M. O.), American Heart Association Pre-doctoral Fellowship AHA 081509E (to R. W. J.), a Medical University of South Carolina Hollings Cancer Center Abney Foundation Scholarship (to R. W. J.), Ministerio de Educacion y Ciencia (Spain) Predoctoral Fellowship AP2006-02190 (to F. S.), and the Japan Society for the Promotion of Science Grant-in-aid for Young Scientists (Start-up) 21890144 (to K. K.).	Ahn YT, 2007, MOL CELL BIOL, V27, P253, DOI 10.1128/MCB.01071-06; Alam R, 1996, AM J RESP CRIT CARE, V153, P1398, DOI 10.1164/ajrccm.153.4.8616572; Appay V, 2001, TRENDS IMMUNOL, V22, P83, DOI 10.1016/S1471-4906(00)01812-3; BARTKE N, 2001, J LIPID RES S, V50, pS91; Bianco F, 2009, EMBO J, V28, P1043, DOI 10.1038/emboj.2009.45; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Billich A, 2005, CELL SIGNAL, V17, P1203, DOI 10.1016/j.cellsig.2004.12.005; Billich A, 2009, INT J BIOCHEM CELL B, V41, P1547, DOI 10.1016/j.biocel.2009.01.001; Boiardi L, 1999, CLIN EXP RHEUMATOL, V17, P419; Brinkman J, 2005, J INHERIT METAB DIS, V28, P13, DOI 10.1007/s10545-005-4416-9; Canals D, 2010, J BIOL CHEM, V285, P32476, DOI 10.1074/jbc.M110.141028; Cao JX, 2009, EMBO J, V28, P1505, DOI 10.1038/emboj.2009.101; Casola A, 2002, AM J PHYSIOL-LUNG C, V283, pL1280, DOI 10.1152/ajplung.00162.2002; Catalfamo M, 2004, IMMUNITY, V20, P219, DOI 10.1016/S1074-7613(04)00027-5; Chandru H, 2007, GENE, V391, P150, DOI 10.1016/j.gene.2006.12.011; Clarke CJ, 2007, J BIOL CHEM, V282, P1384, DOI 10.1074/jbc.M609216200; Claus RA, 2005, FASEB J, V19, P1719, DOI 10.1096/fj.04-2842fje; Dhami R, 2006, MOL THER, V13, P556, DOI 10.1016/j.ymthe.2005.08.020; Dhami R, 2001, LAB INVEST, V81, P987, DOI 10.1038/labinvest.3780311; Doehner W, 2007, EUR HEART J, V28, P821, DOI 10.1093/eurheartj/ehl541; Ehlert Karoline, 2007, Pediatr Rheumatol Online J, V5, P15; Elojeimy S, 2006, FEBS LETT, V580, P4751, DOI 10.1016/j.febslet.2006.07.071; Grassme H, 2007, PROG LIPID RES, V46, P161, DOI 10.1016/j.plipres.2007.03.002; Gulbins E, 2006, AM J PHYSIOL-REG I, V290, pR11, DOI 10.1152/ajpregu.00416.2005; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; Hait NC, 2006, BBA-BIOMEMBRANES, V1758, P2016, DOI 10.1016/j.bbamem.2006.08.007; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; He XX, 2003, J BIOL CHEM, V278, P32978, DOI 10.1074/jbc.M301936200; Herz J, 2009, NAT IMMUNOL, V10, P761, DOI 10.1038/ni.1757; HURWITZ R, 1994, BIOL CHEM H-S, V375, P447, DOI 10.1515/bchm3.1994.375.7.447; Jenkins RW, 2010, J BIOL CHEM, V285, P35706, DOI 10.1074/jbc.M110.125609; Jenkins RW, 2009, CELL SIGNAL, V21, P836, DOI 10.1016/j.cellsig.2009.01.026; KAMEYOSHI Y, 1992, J EXP MED, V176, P587, DOI 10.1084/jem.176.2.587; Kapoor S, 2008, J HUM GENET, V53, P377, DOI 10.1007/s10038-008-0270-6; Kawata T, 2005, BIOCHEM BIOPH RES CO, V331, P640, DOI 10.1016/j.bbrc.2005.03.223; Kitatani K, 2009, J BIOL CHEM, V284, P12979, DOI 10.1074/jbc.M809500200; Kitatani K, 2009, J BIOL CHEM, V284, P12972, DOI 10.1074/jbc.M802790200; Koch J, 1996, J BIOL CHEM, V271, P33110, DOI 10.1074/jbc.271.51.33110; Koenen RR, 2009, NAT MED, V15, P97, DOI 10.1038/nm.1898; Kovacic JC, 2010, J CLIN INVEST, V120, P303, DOI 10.1172/JCI40364; Krensky AM, 2007, NAT CLIN PRACT NEPHR, V3, P164, DOI 10.1038/ncpneph0418; Lebovic DI, 2004, J CLIN ENDOCR METAB, V89, P1397, DOI 10.1210/jc.2003-031010; Levy JA, 2009, J IMMUNOL, V182, P3945, DOI 10.4049/jimmunol.0990015; Lindstrom TM, 2008, MOL PHARMACOL, V74, P109, DOI 10.1124/mol.107.042838; Maceyka M, 2005, J BIOL CHEM, V280, P37118, DOI 10.1074/jbc.M502207200; Makino Y, 2002, CLIN IMMUNOL, V102, P302, DOI 10.1006/clim.2001.5178; Mao CG, 2008, BBA-MOL CELL BIOL L, V1781, P424, DOI 10.1016/j.bbalip.2008.06.002; Marathe S, 1998, J BIOL CHEM, V273, P4081, DOI 10.1074/jbc.273.7.4081; Maune S., 1996, Rhinology (Utrecht), V34, P210; Mendez-Samperio P, 2007, CELL IMMUNOL, V249, P94, DOI 10.1016/j.cellimm.2007.11.008; MIYAKE Y, 1995, BIOCHEM BIOPH RES CO, V211, P396, DOI 10.1006/bbrc.1995.1827; Miyamoto NG, 2000, J NEUROIMMUNOL, V105, P78, DOI 10.1016/S0165-5728(00)00195-8; Moran CJ, 2002, CLIN CANCER RES, V8, P3803; Mori N, 2004, INT J CANCER, V111, P548, DOI 10.1002/ijc.20266; Mrowietz U, 1999, BRIT J CANCER, V79, P1025, DOI 10.1038/sj.bjc.6690164; NELSON PJ, 1993, J IMMUNOL, V151, P2601; Nelson PJ, 2001, IMMUNITY, V14, P377, DOI 10.1016/S1074-7613(01)00118-2; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; Nixon GF, 2009, BRIT J PHARMACOL, V158, P982, DOI 10.1111/j.1476-5381.2009.00281.x; Okada T, 2005, J BIOL CHEM, V280, P36318, DOI 10.1074/jbc.M504507200; ORCI L, 1991, CELL, V64, P1183; Ortiz BD, 1996, MOL CELL BIOL, V16, P202; Ortiz BD, 1997, IMMUNOL TODAY, V18, P468, DOI 10.1016/S0167-5699(97)01128-6; Oskeritzian CA, 2008, BLOOD, V111, P4193, DOI 10.1182/blood-2007-09-115451; Park JH, 2006, BBA-BIOMEMBRANES, V1758, P2133, DOI 10.1016/j.bbamem.2006.08.019; Pettus BJ, 2005, MOL PHARMACOL, V68, P330, DOI 10.1124/mol.104.008722; Pettus BJ, 2004, CURR MOL MED, V4, P405, DOI 10.2174/1566524043360573; Roviezzo F, 2004, P NATL ACAD SCI USA, V101, P11170, DOI 10.1073/pnas.0401439101; Rozenova KA, 2010, J BIOL CHEM, V285, P21103, DOI 10.1074/jbc.M109.080671; SCHALL TJ, 1991, CYTOKINE, V3, P165, DOI 10.1016/1043-4666(91)90013-4; SCHALL TJ, 1988, J IMMUNOL, V141, P1018; Schissel SL, 1998, J BIOL CHEM, V273, P18250, DOI 10.1074/jbc.273.29.18250; Schissel SL, 1996, J BIOL CHEM, V271, P18431, DOI 10.1074/jbc.271.31.18431; Schuchman EH, 2007, J INHERIT METAB DIS, V30, P654, DOI 10.1007/s10545-007-0632-9; Smith EL, 2008, FASEB J, V22, P3419, DOI 10.1096/fj.08-108043; Snider AJ, 2010, BIOCHIMIE, V92, P707, DOI 10.1016/j.biochi.2010.02.008; Soria G, 2008, CYTOKINE, V44, P191, DOI 10.1016/j.cyto.2008.08.002; Spiegel S, 2007, J BIOL CHEM, V282, P2125, DOI 10.1074/jbc.R600028200; Tabas I, 1999, CHEM PHYS LIPIDS, V102, P123, DOI 10.1016/S0009-3084(99)00080-8; Takahashi T, 2002, J PEDIAT HEMATOL ONC, V24, P401, DOI 10.1097/00043426-200206000-00016; Tani M, 2007, CELL SIGNAL, V19, P229, DOI 10.1016/j.cellsig.2006.07.001; Tyner JW, 2005, NAT MED, V11, P1180, DOI 10.1038/nm1303; von Hundelshausen P, 2001, CIRCULATION, V103, P1772, DOI 10.1161/01.CIR.103.13.1772; WANG E, 1991, J BIOL CHEM, V266, P14486; Wong ML, 2000, P NATL ACAD SCI USA, V97, P8681, DOI 10.1073/pnas.150098097; Zeidan YH, 2010, CURR MOL MED, V10, P454, DOI 10.2174/156652410791608225; Zeidan YH, 2008, CURR DRUG TARGETS, V9, P653, DOI 10.2174/138945008785132358; Zeidan YH, 2008, FASEB J, V22, P183, DOI 10.1096/fj.07-8967com; Zeidan YH, 2007, J BIOL CHEM, V282, P11549, DOI 10.1074/jbc.M609424200; Zeidan YH, 2006, J BIOL CHEM, V281, P24695, DOI 10.1074/jbc.M604713200; Zhi L, 2006, J CELL PHYSIOL, V208, P109, DOI 10.1002/jcp.20646	93	26	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13292	13303		10.1074/jbc.M110.163378	http://dx.doi.org/10.1074/jbc.M110.163378			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21335555	Green Published, hybrid			2022-12-27	WOS:000289282200050
J	Meur, G; Qian, QW; Xavier, GD; Pullen, TJ; Tsuboi, T; McKinnon, C; Fletcher, L; Tavare, JM; Hughes, S; Johnson, P; Rutter, GA				Meur, Gargi; Qian, Qingwen; Xavier, Gabriela da Silva; Pullen, Timothy J.; Tsuboi, Takashi; McKinnon, Caroline; Fletcher, Laura; Tavare, Jeremy M.; Hughes, Stephen; Johnson, Paul; Rutter, Guy A.			Nucleo-cytosolic Shuttling of FoxO1 Directly Regulates Mouse Ins2 but Not Ins1 Gene Expression in Pancreatic Beta Cells (MIN6)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED INSULIN-SECRETION; GROWTH-FACTOR; PHOSPHATIDYLINOSITOL 3-KINASE; RESPONSE ELEMENT; PROTEIN-KINASE; GLUCOSE; TRANSCRIPTION; ACTIVATION; BINDING; PROMOTER	The Forldiead box transcription factor FoxO1 regulates metabolic gene expression in mammals. FoxO1 activity is tightly controlled by phosphatidylinositol 3-kinase (PI3K) signaling, resulting in its phosphorylation and nuclear exclusion. We sought here to determine the mechanisms involved in glucose and insulin-stimulated nuclear shuttling of FoxO1 in pancreatic beta cells and its consequences for preproinsulin (Ins1, Ins2) gene expression. Nuclearlocalized endogenous FoxO1 translocated to the cytosol in response to elevated glucose (3 versus 16.7 mm) in human islet beta cells. Real-time confocal imaging of nucleo-cytosolic shuttling of a FoxO1-EGTP chimera in primary mouse and clonal MIN6 beta cells revealed a time-dependent glucose-responsive nuclear export, also mimicked by exogenous insulin, and blocked by suppressing insulin secretion. Constitutively active PI3K or protein kinase B/Akt exerted similar effects, while inhibitors of PI3K, but not of glycogen synthase kinase-3 or p70 S6 kinase, blocked nuclear export. FoxO1 overexpression reversed the activation by glucose of pancreatic duodenum homeobox-1 (Pdx1) transcription. Silencing of FoxO1 significantly elevated the expression of mouse Ins2, but not Ins1, mRNA at 3 mm glucose. Putative FoxO1 binding sites were identified in the distal promoter of rodent Ins2 genes and direct binding of FoxO1 to the Ins2 promoter was demonstrated by chromatin immunoprecipitation. A 915-bp glucose-responsive Ins2 promoter was inhibited by constitutively active FoxO1, an effect unaltered by simultaneous overexpression of PDX1. We conclude that nuclear import of FoxO1 contributes to the suppression of Pdx1 and ins2 gene expression at low glucose, the latter via a previously unsuspected and direct physical interaction with the Ins2 promoter.	[Meur, Gargi; Qian, Qingwen; Xavier, Gabriela da Silva; Pullen, Timothy J.; McKinnon, Caroline; Rutter, Guy A.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Sect Cell Biol, Div Diabet Endocrinol & Metab,Dept Med, London SW7 2AZ, England; [McKinnon, Caroline; Fletcher, Laura; Tavare, Jeremy M.] Univ Bristol, Sch Med Sci, Henry Wellcome Labs Integrated Cell Signalling, Bristol BS8 1TD, Avon, England; [McKinnon, Caroline; Fletcher, Laura; Tavare, Jeremy M.] Univ Bristol, Sch Med Sci, Dept Biochem, Bristol BS8 1TD, Avon, England; [Hughes, Stephen; Johnson, Paul] John Radcliffe Hosp, Nuffield Dept Surg, Oxford OX3 9DU, England; [Tsuboi, Takashi] Univ Tokyo, Dept Life Sci, Tokyo 1538902, Japan	Imperial College London; University of Bristol; University of Bristol; University of Oxford; University of Tokyo	Rutter, GA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Sect Cell Biol, Div Diabet Endocrinol & Metab,Dept Med, Sir Alexander Fleming Bldg,Exhibit Rd, London SW7 2AZ, England.	g.rutter@imperial.ac.uk	Pullen, Timothy J/H-2143-2011; TSUBOI, Takashi/AAD-7976-2019	Pullen, Timothy J/0000-0002-6853-5701; TSUBOI, Takashi/0000-0001-8290-2021; da Silva Xavier, Gabriela/0000-0002-0678-012X; Meur, Gargi/0000-0002-8466-2997; Rutter, Guy/0000-0001-6360-0343	Juvenile Diabetes Research Fund (JDRF) [1-2003-235]; Wellcome Trust [067081/Z/02/Z, 081958/Z/07/Z]; Research Leave Fellowship; BBSRC; MRC (UK); European Union; MRC [G0401641, G7708269] Funding Source: UKRI; Medical Research Council [G0401641, G7708269] Funding Source: researchfish	Juvenile Diabetes Research Fund (JDRF)(Juvenile Diabetes Research Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Research Leave Fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Juvenile Diabetes Research Fund (JDRF) Project Grant 1-2003-235, Wellcome Trust Programme Grants 067081/Z/02/Z and 081958/Z/07/Z, and Research Leave Fellowship (to G. A. R.) as well as grants from the BBSRC and MRC (UK), and the European Union (FP6, Save Beta).	Ainscow EK, 2001, BIOCHEM J, V353, P175, DOI 10.1042/0264-6021:3530175; Andreolas C, 2002, DIABETES, V51, P2536, DOI 10.2337/diabetes.51.8.2536; Bengtsson M, 2005, GENOME RES, V15, P1388, DOI 10.1101/gr.3820805; BOAM DSW, 1990, J BIOL CHEM, V265, P8285; Bouche C, 2010, P NATL ACAD SCI USA, V107, P4770, DOI 10.1073/pnas.1000002107; Briaud I, 2003, DIABETES, V52, P974, DOI 10.2337/diabetes.52.4.974; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Buteau J, 2007, J BIOL CHEM, V282, P287, DOI 10.1074/jbc.M606118200; Cahill CM, 2001, J BIOL CHEM, V276, P13402, DOI 10.1074/jbc.M010042200; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Cross SE, 2008, TRANSPLANTATION, V86, P907, DOI 10.1097/TP.0b013e318186df87; Deltour L, 2004, GENE EXPR PATTERNS, V5, P297, DOI 10.1016/j.modgep.2004.04.013; DHAND R, 1994, EMBO J, V13, P511, DOI 10.1002/j.1460-2075.1994.tb06289.x; Durham SK, 1999, ENDOCRINOLOGY, V140, P3140, DOI 10.1210/en.140.7.3140; ELAYAT AA, 1995, J ANAT, V186, P629; Finlay D, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-15; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Gannon M, 2000, GENESIS, V26, P139, DOI 10.1002/(SICI)1526-968X(200002)26:2<139::AID-GENE12>3.0.CO;2-7; GERMAN M, 1995, DIABETES, V44, P1002, DOI 10.2337/diab.44.8.1002; Guillemain G, 2004, BIOCHEM J, V378, P219, DOI 10.1042/BJ20031549; Hettiarachchi KD, 2006, CELL BIOL TOXICOL, V22, P169, DOI 10.1007/s10565-006-0054-8; Kennedy HJ, 1997, J BIOL CHEM, V272, P20636, DOI 10.1074/jbc.272.33.20636; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Lantz KA, 2005, CLIN SCI, V108, P195, DOI 10.1042/CS20040309; Lee CS, 2002, DIABETES, V51, P2546, DOI 10.2337/diabetes.51.8.2546; Leibiger B, 1998, P NATL ACAD SCI USA, V95, P9307, DOI 10.1073/pnas.95.16.9307; Leibiger IB, 1998, MOL CELL, V1, P933, DOI 10.1016/S1097-2765(00)80093-3; Leroux L, 2001, DIABETES, V50, pS150, DOI 10.2337/diabetes.50.2007.S150; Lingohr MK, 2002, DIABETES, V51, P966, DOI 10.2337/diabetes.51.4.966; Martinez SC, 2006, DIABETES, V55, P1581, DOI 10.2337/db05-0678; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; McKinnon CM, 2006, J BIOL CHEM, V281, P39358, DOI 10.1074/jbc.M605022200; Melloul D, 2002, DIABETOLOGIA, V45, P309, DOI 10.1007/s00125-001-0728-y; Meur G, 2010, DIABETES, V59, P653, DOI 10.2337/db09-1091; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Noordeen NA, 2010, DIABETES, V59, P153, DOI 10.2337/db08-0868; Rafiq I, 2000, J BIOL CHEM, V275, P15977, DOI 10.1074/jbc.275.21.15977; Rafiq I, 1998, J BIOL CHEM, V273, P23241, DOI 10.1074/jbc.273.36.23241; Ravier MA, 2005, DIABETES, V54, P1789, DOI 10.2337/diabetes.54.6.1789; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Rutter CA, 2000, NEWS PHYSIOL SCI, V15, P149; Rutter GA, 1999, CURR BIOL, V9, pR443, DOI 10.1016/S0960-9822(99)80277-2; Shih DQ, 2002, P NATL ACAD SCI USA, V99, P3818, DOI 10.1073/pnas.062605899; SOARES MB, 1985, MOL CELL BIOL, V5, P2090, DOI 10.1128/MCB.5.8.2090; Trumper A, 2001, MOL ENDOCRINOL, V15, P1559, DOI 10.1210/me.15.9.1559; Wicksteed B, 2010, DIABETES, V59, P3090, DOI 10.2337/db10-0624; Xavier GD, 2000, J BIOL CHEM, V275, P36269, DOI 10.1074/jbc.M006597200; Xavier GD, 2003, BIOCHEM J, V371, P761; Xavier GD, 2004, BIOCHEM J, V377, P149, DOI 10.1042/BJ20031260; Xuan SH, 2002, J CLIN INVEST, V110, P1011, DOI 10.1172/JCI200215276	53	22	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13647	13656		10.1074/jbc.M110.204248	http://dx.doi.org/10.1074/jbc.M110.204248			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21335550	Green Published, hybrid			2022-12-27	WOS:000289282200083
J	Schober, DA; Gill, MB; Yu, H; Gernert, DL; Jeffries, MW; Ornstein, PL; Kato, AS; Felder, CC; Bredt, DS				Schober, Douglas A.; Gill, Martin B.; Yu, Hong; Gernert, Douglas L.; Jeffries, Matthew W.; Ornstein, Paul L.; Kato, Akihiko S.; Felder, Christian C.; Bredt, David S.			Transmembrane AMPA Receptor Regulatory Proteins and Cornichon-2 Allosterically Regulate AMPA Receptor Antagonists and Potentiators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMDA GLUTAMATE-RECEPTOR; 2 DISTINCT MECHANISMS; SYNAPTIC PLASTICITY; AUXILIARY SUBUNITS; PARKINSONS-DISEASE; MOLECULAR-BIOLOGY; TARP GAMMA-8; STARGAZIN; TRAFFICKING; EXPRESSION	AMPA receptors mediate fast excitatory transmission in the brain. Neuronal AMPA receptors comprise GluA pore-forming principal subunits and can associate with multiple modulatory components, including transmembrane AMPA receptor regulatory proteins (TARPs) and CNIHs (cornichons). AMPA receptor potentiators and non-competitive antagonists represent potential targets for a variety of neuropsychiatric disorders. Previous studies showed that the AMPA receptor antagonist GYKI-53655 displaces binding of a potentiator from brain receptors but not from recombinant Cilia subunits. Here, we asked whether AMPA receptor modulatory subunits might resolve this discrepancy. We find that the cerebellar TARP, stargazin (gamma-2), enhances the binding affinity of the AMPA receptor potentiator [H-3]-LY450295 and confers sensitivity to displacement by non-competitive antagonists. In cerebellar membranes from stargazer mice, [H-3]-LY450295 binding is reduced and relatively resistant to displacement by non-competitive antagonists. Coexpression of AMPA receptors with CNIH-2, which is expressed in the hippocampus and at low levels in the cerebellar Purkinje neurons, confers partial sensitivity of [H-3] -LY450295 potentiator binding to displacement by non-competitive antagonists. Autoradiography of [H-3]-LY450295 binding to stargazer and gamma-8-deficient mouse brain sections, demonstrates that TARPs regulate the pharmacology of allosteric AMPA potentiators and antagonists in the cerebellum and hippocampus, respectively. These studies demonstrate that accessory proteins define AMPA receptor pharmacology by functionally linking allosteric AMPA receptor potentiator and antagonist sites.	[Jeffries, Matthew W.] Eli Lilly & Co, Lilly Res Lab, Lilly Corp Ctr, Biotechnol Discovery Res, Indianapolis, IN 46285 USA; [Schober, Douglas A.; Gill, Martin B.; Yu, Hong; Kato, Akihiko S.; Felder, Christian C.; Bredt, David S.] Eli Lilly & Co, Lilly Res Lab, Lilly Corp Ctr, Discovery Neurosci Res, Indianapolis, IN 46285 USA; [Gernert, Douglas L.; Ornstein, Paul L.] Eli Lilly & Co, Lilly Res Lab, Lilly Corp Ctr, Discovery Chem Res, Indianapolis, IN 46285 USA	Eli Lilly; Eli Lilly; Eli Lilly	Bredt, DS (corresponding author), Eli Lilly & Co, Lilly Res Lab, Lilly Corp Ctr, Biotechnol Discovery Res, Indianapolis, IN 46285 USA.	dbredt@gmail.com	Ornstein, Paul/E-4212-2016	Ornstein, Paul/0000-0002-4335-1877; Felder, Christian/0000-0003-1134-8881				Arai AC, 2007, CURR DRUG TARGETS, V8, P583, DOI 10.2174/138945007780618490; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Bai F, 2003, NEUROPHARMACOLOGY, V44, P1013, DOI 10.1016/S0028-3908(03)00104-7; Balannik V, 2005, NEURON, V48, P279, DOI 10.1016/j.neuron.2005.09.024; Bedoukian MA, 2006, J BIOL CHEM, V281, P23908, DOI 10.1074/jbc.M600679200; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Cho CH, 2007, NEURON, V55, P890, DOI 10.1016/j.neuron.2007.08.024; Cokic B, 2008, NEUROPHARMACOLOGY, V54, P1062, DOI 10.1016/j.neuropharm.2008.02.012; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Coombs ID, 2009, NEUROSCIENCE, V162, P656, DOI 10.1016/j.neuroscience.2009.01.004; DONEVAN SD, 1993, NEURON, V10, P51, DOI 10.1016/0896-6273(93)90241-I; Fukaya M, 2006, EUR J NEUROSCI, V24, P2177, DOI 10.1111/j.1460-9568.2006.05081.x; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Grove SJA, 2010, J MED CHEM, V53, P7271, DOI 10.1021/jm1000419; Hashimoto K, 1999, J NEUROSCI, V19, P6027, DOI 10.1523/JNEUROSCI.19-14-06027.1999; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HONORE T, 1988, SCIENCE, V241, P701, DOI 10.1126/science.2899909; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Kandel ER, 2001, BIOSCIENCE REP, V21, P565, DOI 10.1023/A:1014775008533; Kato AS, 2008, NEURON, V59, P986, DOI 10.1016/j.neuron.2008.07.034; Kato AS, 2010, NEURON, V68, P1082, DOI 10.1016/j.neuron.2010.11.026; Lauterborn JC, 2000, J NEUROSCI, V20, P8, DOI 10.1523/JNEUROSCI.20-01-00008.2000; Linden AM, 2001, NEUROPHARMACOLOGY, V40, P1010, DOI 10.1016/S0028-3908(01)00013-2; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Menniti FS, 2000, MOL PHARMACOL, V58, P1310, DOI 10.1124/mol.58.6.1310; Menuz K, 2007, SCIENCE, V318, P815, DOI 10.1126/science.1146317; Nicoll RA, 1999, ANN NY ACAD SCI, V868, P515, DOI 10.1111/j.1749-6632.1999.tb11320.x; Nicoll RA, 2006, SCIENCE, V311, P1253, DOI 10.1126/science.1123339; NOEBELS JL, 1990, EPILEPSY RES, V7, P129, DOI 10.1016/0920-1211(90)90098-G; O'Neill MJ, 2007, CURR DRUG TARGETS, V8, P603, DOI 10.2174/138945007780618517; O'Neill MJ, 2005, CNS DRUG REV, V11, P77; Osten P, 2006, CURR OPIN NEUROBIOL, V16, P275, DOI 10.1016/j.conb.2006.04.002; PARTIN KM, 1994, MOL PHARMACOL, V46, P129; Priel A, 2005, J NEUROSCI, V25, P2682, DOI 10.1523/JNEUROSCI.4834-04.2005; Rouach N, 2005, NAT NEUROSCI, V8, P1525, DOI 10.1038/nn1551; Schwenk J, 2009, SCIENCE, V323, P1313, DOI 10.1126/science.1167852; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; Sekiguchi M, 1997, J NEUROSCI, V17, P5760; Shi Y, 2010, P NATL ACAD SCI USA, V107, P16315, DOI 10.1073/pnas.1011706107; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; STAUBLI U, 1994, P NATL ACAD SCI USA, V91, P777, DOI 10.1073/pnas.91.2.777; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; TANG CM, 1991, SCIENCE, V254, P288, DOI 10.1126/science.1681589; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Tomita S, 2007, NEUROPHARMACOLOGY, V52, P87, DOI 10.1016/j.neuropharm.2006.07.012; Tomita S, 2006, P NATL ACAD SCI USA, V103, P10064, DOI 10.1073/pnas.0603128103; Turetsky D, 2005, J NEUROSCI, V25, P7438, DOI 10.1523/JNEUROSCI.1108-05.2005; Vandenberghe W, 2005, J NEUROSCI, V25, P1095, DOI 10.1523/JNEUROSCI.3568-04.2005; Vandenberghe W, 2005, P NATL ACAD SCI USA, V102, P485, DOI 10.1073/pnas.0408269102; von Engelhardt J, 2010, SCIENCE, V327, P1518, DOI 10.1126/science.1184178; Ward SE, 2010, J MED CHEM, V53, P5801, DOI 10.1021/jm1005429; Xia H, 2001, NEUROPHARMACOLOGY, V41, P714, DOI 10.1016/S0028-3908(01)00103-4; YAMADA KA, 1993, J NEUROSCI, V13, P3904; Yamazaki M, 2004, NEUROSCI RES, V50, P369, DOI 10.1016/j.neures.2004.10.002; Ziff EB, 1997, NEURON, V19, P1163, DOI 10.1016/S0896-6273(00)80409-2; Ziff EB, 2007, NEURON, V53, P627, DOI 10.1016/j.neuron.2007.02.006; ZORUMSKI CF, 1993, NEURON, V10, P61, DOI 10.1016/0896-6273(93)90242-J	63	16	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13134	13142		10.1074/jbc.M110.212522	http://dx.doi.org/10.1074/jbc.M110.212522			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21343286	hybrid, Green Published			2022-12-27	WOS:000289282200034
J	Bammens, L; Chavez-Gutierrez, L; Tolia, A; Zwijsen, A; De Strooper, B				Bammens, Leen; Chavez-Gutierrez, Lucia; Tolia, Alexandra; Zwijsen, An; De Strooper, Bart			Functional and Topological Analysis of Pen-2, the Fourth Subunit of the gamma-Secretase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; CATALYTIC PORE; PRESENILIN ENDOPROTEOLYSIS; TRANSMEMBRANE DOMAIN-4; INTRACELLULAR DOMAIN; TERMINAL FRAGMENT; NICASTRIN; NOTCH; CLEAVAGE; APH-1	The gamma-secretase complex is a member of the family of intramembrane cleaving proteases, involved in the generation of the A beta peptides in Alzheimer disease. One of the four subunits of the complex, presenilin, harbors the catalytic site, although the role of the other three subunits is less well understood. Here, we studied the role of the smallest subunit, Pen-2, in vivo and in vitro. We found a profound Notch-deficiency phenotype in Pen-2(-/-) embryos confirming the essential role of Pen-2 in the gamma-secretase complex. We used Pen-2(-/-) fibroblasts to investigate the structure-function relation of Pen-2 by the scanning cysteine accessibility method. We showed that glycine 22 and proline 27 in hydrophobic domain 1 of Pen-2 are essential for complex formation and stability of gamma-secretase. We also demonstrated that hydrophobic domain 1 and the loop domain of Pen-2 are located in a water-containing cavity and are in short proximity to the presenilin C-terminal fragment. We finally demonstrated the essential role of Pen-2 for the proteolytic activity of the complex. Our study supports the hypothesis that Pen-2 is more than a structural component of the gamma-secretase complex and may contribute to the catalytic mechanism of the enzyme.	[Bammens, Leen; Chavez-Gutierrez, Lucia; Tolia, Alexandra; De Strooper, Bart] Katholieke Univ Leuven, Ctr Human Genet, Lab Res Neurodegenerat Dis, B-3000 Louvain, Belgium; [Bammens, Leen; Chavez-Gutierrez, Lucia; Tolia, Alexandra; Zwijsen, An; De Strooper, Bart] Katholieke Univ Leuven VIB, Dept Mol & Dev Genet, B-3000 Louvain, Belgium; [Zwijsen, An] Katholieke Univ Leuven VIB, Ctr Human Genet, Lab Dev Signaling, B-3000 Louvain, Belgium	KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven	De Strooper, B (corresponding author), Katholieke Univ Leuven, Ctr Human Genet, Lab Res Neurodegenerat Dis, B-3000 Louvain, Belgium.	Bart.DeStrooper@cme.vib-kuleuven.be	Zwijsen, An/AAK-2897-2020; De Strooper, Bart/F-6507-2012; Chávez-Gutiérrez, Lucía/E-2657-2017; de+Strooper, Bart/Z-1638-2019	De Strooper, Bart/0000-0001-5455-5819; Zwijsen, An/0000-0002-8583-1721	Vlaams Instituut voor Biotechnologie; Fonds voor Wetenschappelijk Onderzoek-Vlaanderen; Stichting Alzheimer Onderzoek-Fondation pour la Recherche de la Maladie d'Alzheimer; Federal Office for Scientific Affairs, Belgium [IUAP P6/43/]; KULeuven; Flemish Government; European Union [FZ-2007-200611]	Vlaams Instituut voor Biotechnologie; Fonds voor Wetenschappelijk Onderzoek-Vlaanderen(FWO); Stichting Alzheimer Onderzoek-Fondation pour la Recherche de la Maladie d'Alzheimer; Federal Office for Scientific Affairs, Belgium; KULeuven(KU Leuven); Flemish Government(European Commission); European Union(European Commission)	This work was supported in part by Vlaams Instituut voor Biotechnologie, Fonds voor Wetenschappelijk Onderzoek-Vlaanderen, and Stichting Alzheimer Onderzoek-Fondation pour la Recherche de la Maladie d'Alzheimer, the Federal Office for Scientific Affairs, Belgium, Grant IUAP P6/43/, Methusalem grant from KULeuven, and Flemish Government and Memosad Grant FZ-2007-200611 from the European Union.	Ahn K, 2010, P NATL ACAD SCI USA, V107, P21435, DOI 10.1073/pnas.1013246107; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; ALTONA C, 1972, J AM CHEM SOC, V94, P8205, DOI 10.1021/ja00778a043; Annaert WG, 2001, NEURON, V32, P579, DOI 10.1016/S0896-6273(01)00512-8; Bergman A, 2004, J BIOL CHEM, V279, P16744, DOI 10.1074/jbc.M313999200; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Cordes FS, 2002, J MOL BIOL, V323, P951, DOI 10.1016/S0022-2836(02)01006-9; Crystal AS, 2003, J BIOL CHEM, V278, P20117, DOI 10.1074/jbc.M213107200; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Esselens C, 2004, J CELL BIOL, V166, P1041, DOI 10.1083/jcb.200406060; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P323, DOI 10.1021/bi035748j; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Fukumori A, 2010, J NEUROSCI, V30, P7853, DOI 10.1523/JNEUROSCI.1443-10.2010; Goutte C, 2000, DEVELOPMENT, V127, P2481; Hasegawa H, 2004, J BIOL CHEM, V279, P46455, DOI 10.1074/jbc.M406289200; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Huppert SS, 2000, NATURE, V405, P966, DOI 10.1038/35016111; Isoo N, 2007, J BIOL CHEM, V282, P12388, DOI 10.1074/jbc.M611549200; Kakuda N, 2006, J BIOL CHEM, V281, P14776, DOI 10.1074/jbc.M513453200; Kim SH, 2005, J BIOL CHEM, V280, P41953, DOI 10.1074/jbc.M509070200; Kim SH, 2005, J BIOL CHEM, V280, P1992, DOI 10.1074/jbc.M412404200; Kim SH, 2003, J BIOL CHEM, V278, P33992, DOI 10.1074/jbc.M305834200; Kornilova AY, 2005, P NATL ACAD SCI USA, V102, P3230, DOI 10.1073/pnas.0407640102; Kounnas MZ, 2010, NEURON, V67, P769, DOI 10.1016/j.neuron.2010.08.018; Laudon H, 2004, J BIOL CHEM, V279, P23925, DOI 10.1074/jbc.M401277200; LEVITAN D, 1995, NATURE, V377, P351, DOI 10.1038/377351a0; Li JH, 2003, J BIOL CHEM, V278, P33445, DOI 10.1074/jbc.M301288200; Li T, 2003, J NEUROSCI, V23, P3272; Luo WJ, 2003, J BIOL CHEM, V278, P7850, DOI 10.1074/jbc.C200648200; Ma GJ, 2005, J NEUROSCI, V25, P192, DOI 10.1523/JNEUROSCI.3814-04.2005; Nyabi O, 2003, J BIOL CHEM, V278, P43430, DOI 10.1074/jbc.M306957200; Osenkowski P, 2009, J MOL BIOL, V385, P642, DOI 10.1016/j.jmb.2008.10.078; Parker MH, 1997, PROTEIN ENG, V10, P487, DOI 10.1093/protein/10.5.487; PerezTur J, 1995, NEUROREPORT, V7, P297; Prihar G, 1999, NAT MED, V5, P1090, DOI 10.1038/13383; Prokop S, 2005, J NEUROCHEM, V94, P57, DOI 10.1111/j.1471-4159.2005.03165.x; Prokop S, 2004, J BIOL CHEM, V279, P23255, DOI 10.1074/jbc.M401789200; RAMACHAN.GN, 1970, BIOCHIM BIOPHYS ACTA, V221, P165, DOI 10.1016/0005-2795(70)90257-6; Sansom MSP, 2000, TRENDS PHARMACOL SCI, V21, P445; Sato C, 2008, J NEUROSCI, V28, P6264, DOI 10.1523/JNEUROSCI.1163-08.2008; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; Serneels L, 2005, P NATL ACAD SCI USA, V102, P1719, DOI 10.1073/pnas.0408901102; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Shiraishi H, 2004, J NEUROCHEM, V90, P1402, DOI 10.1111/j.1471-4159.2004.02597.x; Sobhanifar S, 2010, P NATL ACAD SCI USA, V107, P9644, DOI 10.1073/pnas.1000778107; Steiner H, 2002, J BIOL CHEM, V277, P39062, DOI 10.1074/jbc.C200469200; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Tolia A, 2008, J BIOL CHEM, V283, P19793, DOI 10.1074/jbc.M802461200; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; Uemura K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007893; Watanabe N, 2005, J BIOL CHEM, V280, P41967, DOI 10.1074/jbc.M509066200; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wong PC, 1997, NATURE, V387, P288, DOI 10.1038/387288a0; Zhao B, 2008, J BIOL CHEM, V283, P2927, DOI 10.1074/jbc.M708870200; Zhao GJ, 2010, J NEUROSCI, V30, P1648, DOI 10.1523/JNEUROSCI.3826-09.2010	60	37	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.216978	http://dx.doi.org/10.1074/jbc.M110.216978			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21296884	hybrid, Green Published			2022-12-27	WOS:000289077500041
J	Bu, QY; Zhu, L; Dennis, MD; Yu, L; Lu, SEX; Person, MD; Tobin, EM; Browning, KS; Huq, E				Bu, Qingyun; Zhu, Ling; Dennis, Michael D.; Yu, Lu; Lu, Sheen X.; Person, Maria D.; Tobin, Elaine M.; Browning, Karen S.; Huq, Enamul			Phosphorylation by CK2 Enhances the Rapid Light-induced Degradation of Phytochrome Interacting Factor 1 in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE CK2; TRANSLATION INITIATION-FACTORS; REGULATED GENE-EXPRESSION; TRANSCRIPTION FACTORS; MEDIATED DEGRADATION; OSCILLATOR FUNCTION; SIGNALING NETWORKS; RED-LIGHT; PHOTOMORPHOGENESIS; SEEDLINGS	The phytochrome family of sensory photoreceptors interacts with phytochrome interacting factors (PIFs), repressors of photomorphogenesis, in response to environmental light signals and induces rapid phosphorylation and degradation of PIFs to promote photomorphogenesis. However, the kinase that phosphorylates PIFs is still unknown. Here we show that CK2 directly phosphorylates PIF1 at multiple sites. alpha 1 and alpha 2 subunits individually phosphorylated PIF1 weakly in vitro. However, each of four beta subunits strongly stimulated phosphorylation of PIF1 by alpha 1 or alpha 2. Mapping of the phosphorylation sites identified seven Ser/Thr residues scattered throughout PIF1. Ser/Thr to Ala scanning mutations at all seven sites eliminated CK2-mediated phosphorylation of PIF1 in vitro. Moreover, the rate of degradation of the Ser/Thr to Ala mutant PIF1 was significantly reduced compared with wild-type PIF1 in transgenic plants. In addition, hypocotyl lengths of the mutant PIF1 transgenic plants were much longer than the wild-type PIF1 transgenic plants under light, suggesting that the mutant PIF1 is suppressing photomorphogenesis. Taken together, these data suggest that CK2-mediated phosphorylation enhances the light-induced degradation of PIF1 to promote photomorphogenesis.	[Huq, Enamul] Univ Texas Austin, Sect Mol Cell & Dev Biol, Biol Labs 311 A6700, Austin, TX 78712 USA; [Dennis, Michael D.; Browning, Karen S.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Person, Maria D.; Browning, Karen S.; Huq, Enamul] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Lu, Sheen X.; Tobin, Elaine M.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of California System; University of California Los Angeles	Huq, E (corresponding author), Univ Texas Austin, Sect Mol Cell & Dev Biol, Biol Labs 311 A6700, 205 W 24th St, Austin, TX 78712 USA.	huq@mail.utexas.edu	Zhu, Ling/G-1142-2015	Dennis, Michael/0000-0002-0645-6864; Huq, Enamul/0000-0001-7692-5139	National Institutes of Health [GM-23167]; NIEHS National Institutes of Health [P30ES007784]; Department of Energy [DE-FG02-04ER15575]; National Science Foundation [MCB0214996, IOS-0822811, IOS-0849287]; Welch Foundation [F1339]; Direct For Biological Sciences [1052530] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023167] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Welch Foundation(The Welch Foundation); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-23167 (to E. M. T.) and NIEHS National Institutes of Health Grant P30ES007784 (to M. D. P.). This work was also supported by Department of Energy Grant DE-FG02-04ER15575, National Science Foundation Grant MCB0214996, and Welch Foundation Grant F1339 (to K. S. B.); and by National Science Foundation Grants IOS-0822811 and IOS-0849287 (to E. H.).	Al-Sady B, 2006, MOL CELL, V23, P439, DOI 10.1016/j.molcel.2006.06.011; Andronis C, 2008, MOL PLANT, V1, P58, DOI 10.1093/mp/ssm005; Bae G, 2008, ANNU REV PLANT BIOL, V59, P281, DOI 10.1146/annurev.arplant.59.032607.092859; Castillon A, 2007, TRENDS PLANT SCI, V12, P514, DOI 10.1016/j.tplants.2007.10.001; Castillon A, 2009, GENETICS, V182, P161, DOI 10.1534/genetics.108.099887; Chen M, 2010, CELL, V141, P1230, DOI 10.1016/j.cell.2010.05.007; Daniel X, 2004, P NATL ACAD SCI USA, V101, P3292, DOI 10.1073/pnas.0400163101; Dennis MD, 2009, J BIOL CHEM, V284, P20602, DOI 10.1074/jbc.M109.006692; Dennis MD, 2009, J BIOL CHEM, V284, P20615, DOI 10.1074/jbc.M109.007658; Duek PD, 2005, TRENDS PLANT SCI, V10, P51, DOI 10.1016/j.tplants.2004.12.005; Fankhauser C, 2008, TRENDS PLANT SCI, V13, P596, DOI 10.1016/j.tplants.2008.08.007; Franklin KA, 2010, J EXP BOT, V61, P11, DOI 10.1093/jxb/erp304; Hardtke CS, 2000, EMBO J, V19, P4997, DOI 10.1093/emboj/19.18.4997; Henriques R, 2009, CURR OPIN PLANT BIOL, V12, P49, DOI 10.1016/j.pbi.2008.10.009; Hornitschek P, 2009, EMBO J, V28, P3893, DOI 10.1038/emboj.2009.306; Huq E, 2006, TRENDS PLANT SCI, V11, P4, DOI 10.1016/j.tplants.2005.11.005; Huq E, 2005, HANDBOOK OF PHOTOSENSORY RECEPTORS, P151, DOI 10.1002/352760510X.ch7; Jang IC, 2010, PLANT CELL, V22, P2370, DOI 10.1105/tpc.109.072520; Jiao YL, 2007, NAT REV GENET, V8, P217, DOI 10.1038/nrg2049; Karimi M, 2005, TRENDS PLANT SCI, V10, P103, DOI 10.1016/j.tplants.2005.01.008; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kato T, 2003, MOL CELL, V12, P829, DOI 10.1016/S1097-2765(03)00358-7; Khanna R, 2004, PLANT CELL, V16, P3033, DOI 10.1105/tpc.104.025643; Lee Y, 1999, PLANT PHYSIOL, V119, P989, DOI 10.1104/pp.119.3.989; Leivar P, 2008, CURR BIOL, V18, P1815, DOI 10.1016/j.cub.2008.10.058; Leivar P, 2008, PLANT CELL, V20, P337, DOI 10.1105/tpc.107.052142; Leivar P, 2011, TRENDS PLANT SCI, V16, P19, DOI 10.1016/j.tplants.2010.08.003; Leivar P, 2009, PLANT CELL, V21, P3535, DOI 10.1105/tpc.109.070672; Ma LG, 2001, PLANT CELL, V13, P2589, DOI 10.1105/tpc.13.12.2589; Martinez-Garcia JF, 2000, SCIENCE, V288, P859, DOI 10.1126/science.288.5467.859; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Moon J, 2008, P NATL ACAD SCI USA, V105, P9433, DOI 10.1073/pnas.0803611105; Moreno-Romero J, 2008, PLANT J, V55, P118, DOI 10.1111/j.1365-313X.2008.03494.x; Oh E, 2007, PLANT CELL, V19, P1192, DOI 10.1105/tpc.107.050153; Oh E, 2009, PLANT CELL, V21, P403, DOI 10.1105/tpc.108.064691; Park HJ, 2008, J BIOL CHEM, V283, P23264, DOI 10.1074/jbc.M801720200; Portoles S, 2007, PLANT J, V51, P966, DOI 10.1111/j.1365-313X.2007.03186.x; Quail PH, 2007, J INTEGR PLANT BIOL, V49, P11, DOI 10.1111/j.1744-7909.2006.00422.x; Riera M, 2004, P NATL ACAD SCI USA, V101, P9879, DOI 10.1073/pnas.0306154101; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Rubio V, 2005, PLANT J, V41, P767, DOI 10.1111/j.1365-313X.2004.02328.x; Salinas P, 2006, PLANT CELL PHYSIOL, V47, P1295, DOI 10.1093/pcp/pcj100; Scaglioni PP, 2006, CELL, V126, P269, DOI 10.1016/j.cell.2006.05.041; Schafer E., 2006, FUNCTION SIGNAL TRAN, V3rd; Seo HS, 2003, NATURE, V423, P995, DOI 10.1038/nature01696; Shen H, 2005, PLANT J, V44, P1023, DOI 10.1111/j.1365-313X.2005.02606.x; Shen H, 2008, PLANT CELL, V20, P1586, DOI 10.1105/tpc.108.060020; Shen Y, 2007, PLANT PHYSIOL, V145, P1043, DOI 10.1104/pp.107.105601; Shin J, 2009, P NATL ACAD SCI USA, V106, P7660, DOI 10.1073/pnas.0812219106; Stemmer C, 2003, BIOCHEMISTRY-US, V42, P3503, DOI 10.1021/bi027350d; Sugano S, 1998, P NATL ACAD SCI USA, V95, P11020, DOI 10.1073/pnas.95.18.11020; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; Toledo-Ortiz G, 2010, P NATL ACAD SCI USA, V107, P11626, DOI 10.1073/pnas.0914428107; Yeh KC, 1998, P NATL ACAD SCI USA, V95, P13976, DOI 10.1073/pnas.95.23.13976	54	71	83	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.186882	http://dx.doi.org/10.1074/jbc.M110.186882			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21330376	Green Published, hybrid			2022-12-27	WOS:000289077500021
J	Wu, XM; Gao, H; Ke, WX; Hager, M; Xiao, S; Freeman, MR; Zhu, ZL				Wu, Xiaoming; Gao, Hong; Ke, Weixiong; Hager, Martin; Xiao, Sheng; Freeman, Michael R.; Zhu, Zhenglun			VentX trans-Activates p53 and p16(ink4a) to Regulate Cellular Senescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE MYELOID-LEUKEMIA; TRANSCRIPTION FACTOR LEF-1; BETA-CATENIN; STEM-CELLS; IN-VIVO; INDUCE SENESCENCE; SIGNALING PATHWAY; TUMOR-SUPPRESSOR; CANCER-TREATMENT	Cell senescence is a process of irreversible arrest of cell proliferation and plays an important role in tumor suppression. Recent studies showed that Wnt inhibition is a trigger of cellular senescence. Using methods of reverse genetics, we recently identified VentX, a human homolog of the vertebrate Xenopus Vent family of homeobox genes, as a novel Wnt repressor and a putative tumor suppressor in lymphocytic leukemia. Here, we show that VentX is a direct transcriptional activator of p53-p21 and p16(ink4a)-Rb tumor suppression pathways. Ectopic expression of VentX in cancer cells caused an irreversible cell cycle arrest with a typical senescence-like phenotype. Conversely, inhibition of VentX expression by RNA interference ameliorated chemotherapeutic agent-induced senescence in lymphocytic leukemia cells. The results of our study further reveal the mechanisms underlying tumor suppression function of VentX and suggest a role of VentX as a potential target in cancer prevention and treatment.	[Wu, Xiaoming; Gao, Hong; Ke, Weixiong; Zhu, Zhenglun] Harvard Univ, Brigham & Womens Hosp, Div Gastroenterol, Sch Med,Dept Med, Boston, MA 02115 USA; [Xiao, Sheng] Harvard Univ, Brigham & Womens Hosp, Dept Pathol, Sch Med, Boston, MA 02115 USA; [Hager, Martin; Freeman, Michael R.] Childrens Hosp, Urol Dis Res Ctr, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital	Zhu, ZL (corresponding author), Harvard Univ, Brigham & Womens Hosp, Div Gastroenterol, Sch Med,Dept Med, Boston, MA 02115 USA.	zzhu@partners.org			National Institutes of Health; Department of Defense; American Cancer Society; Brigham and Women's Hospital	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); American Cancer Society(American Cancer Society); Brigham and Women's Hospital	Supported by grants from the National Institutes of Health, Department of Defense, American Cancer Society, and research fund from Brigham and Women's Hospital. To whom correspondence should be addressed. Tel.: 617-732-5467; Fax: 617-730-5807; E-mail: zzhu@partners.org.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Agirre X, 2003, MOL CARCINOGEN, V38, P201, DOI 10.1002/mc.10159; Ahuja D, 2005, ONCOGENE, V24, P7729, DOI 10.1038/sj.onc.1209046; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chen YH, 2006, CANCER RES, V66, P8749, DOI 10.1158/0008-5472.CAN-06-0581; Choi YL, 2007, ONCOGENE, V26, P1245, DOI 10.1038/sj.onc.1209898; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Espada J, 2009, CLIN TRANSL ONCOL, V11, P411, DOI 10.1007/s12094-009-0380-4; Funayama R, 2007, CHROMOSOMA, V116, P431, DOI 10.1007/s00412-007-0115-7; Gao H, 2007, CELL RES, V17, P345, DOI 10.1038/cr.2007.20; Gao H, 2010, CANCER RES, V70, P202, DOI 10.1158/0008-5472.CAN-09-2668; Goodwin EC, 2000, P NATL ACAD SCI USA, V97, P12513, DOI 10.1073/pnas.97.23.12513; Hara E, 1996, MOL CELL BIOL, V16, P859; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hemann MT, 2007, GENE DEV, V21, P1, DOI 10.1101/gad.1514207; Huber O, 1996, MECH DEVELOP, V59, P3, DOI 10.1016/0925-4773(96)00597-7; Kahlem P, 2004, J CLIN INVEST, V113, P169, DOI 10.1172/JCI200420784; Knudsen ES, 1997, MOL CELL BIOL, V17, P5771, DOI 10.1128/MCB.17.10.5771; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Lu DS, 2004, P NATL ACAD SCI USA, V101, P3118, DOI 10.1073/pnas.0308648100; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Moretti PAB, 2001, GENOMICS, V76, P21, DOI 10.1006/geno.2001.6574; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Omura-Minamisawa M, 2000, CLIN CANCER RES, V6, P1219; Polager S, 2009, NAT REV CANCER, V9, P738, DOI 10.1038/nrc2718; Prieur A, 2008, CURR OPIN CELL BIOL, V20, P150, DOI 10.1016/j.ceb.2008.01.007; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Raman V, 2000, NATURE, V405, P974, DOI 10.1038/35016125; Rawat VPS, 2010, P NATL ACAD SCI USA, V107, P16946, DOI 10.1073/pnas.1001878107; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rochette PJ, 2005, J MOL BIOL, V352, P44, DOI 10.1016/j.jmb.2005.06.033; Roninson IB, 2003, CANCER RES, V63, P2705; Roninson IB, 2003, J CELL BIOCHEM, V88, P83, DOI 10.1002/jcb.10320; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Simon M, 2005, ONCOGENE, V24, P2410, DOI 10.1038/sj.onc.1208431; te Poele RH, 2002, CANCER RES, V62, P1876; Ye XF, 2007, MOL CELL, V27, P183, DOI 10.1016/j.molcel.2007.05.034; Ysebaert L, 2006, LEUKEMIA, V20, P1211, DOI 10.1038/sj.leu.2404239; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003	46	13	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.206078	http://dx.doi.org/10.1074/jbc.M110.206078			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21325273	hybrid, Green Published			2022-12-27	WOS:000289077500080
J	Gambus, A; Khoudoli, GA; Jones, RC; Blow, JJ				Gambus, Agnieszka; Khoudoli, Guennadi A.; Jones, Richard C.; Blow, J. Julian			MCM2-7 Form Double Hexamers at Licensed Origins in Xenopus Egg Extract	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC DNA-REPLICATION; MINICHROMOSOME MAINTENANCE PROTEIN; DORMANT ORIGINS; HUMAN-CELLS; HELICASE ACTIVITY; EXCESS MCM2-7; GINS COMPLEX; S-PHASE; CDC45; INITIATION	In late mitosis and G1, Mcm2-7 are assembled onto replication origins to license them for initiation in the upcoming S phase. After initiation, Mcm2-7 provide helicase activity to unwind DNA at the replication fork. Here we examine the structure of Mcm2-7 on chromatin in Xenopus egg extracts. We show that prior to replication initiation, Mcm2-7 is present at licensed replication origins in a complex with a molecular mass close to double that of the Mcm2-7 hexamer. This complex has approximately stoichiometric quantities of the 6 Mcm2-7 proteins and we conclude that it consists of a double heterohexamer. This provides a configuration potentially capable of initiating a pair of bidirectional replication forks in S phase. We also show that after initiation, Mcm2-7 associate with Cdc45 and GINS to form a relatively stable CMG (Cdc45-MCM-GINS) complex. The CMG proteins also associate less strongly with other replication proteins, consistent with the idea that a single CMG complex forms the core of the replisome.	[Gambus, Agnieszka; Khoudoli, Guennadi A.; Blow, J. Julian] Univ Dundee, Wellcome Trust Ctr Gene Regulat & Express, Coll Life Sci, Dundee DD1 5EH, Scotland; [Jones, Richard C.] NextGen Sci Inc, Ann Arbor, MI 48108 USA	University of Dundee	Blow, JJ (corresponding author), Univ Dundee, Wellcome Trust Ctr Gene Regulat & Express, Coll Life Sci, Dundee DD1 5EH, Scotland.	j.j.blow@dundee.ac.uk	Gambus, Aga/AAK-4687-2021; Blow, J. Julian/B-3977-2009	Gambus, Aga/0000-0002-4648-0332; Blow, J. Julian/0000-0002-9524-5849	CRUK [C303/A3135, C303/A8102, C303/A7399, C303/A5434]; BBSRC [BB/H013024/1]; Wellcome Trust [08136/Z/06/Z, 083524/Z/07/Z]; Biotechnology and Biological Sciences Research Council [BB/H013024/1] Funding Source: researchfish	CRUK(Cancer Research UK); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by CRUK (Grants C303/A3135, C303/A8102, C303/A7399, and C303/A5434, BBSRC (Grant BB/H013024/1), and the Wellcome Trust (Grants 08136/Z/06/Z and 083524/Z/07/Z).	Aparicio T, 2009, NUCLEIC ACIDS RES, V37, P2087, DOI 10.1093/nar/gkp065; Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Bauerschmidt C, 2007, GENES CELLS, V12, P745, DOI 10.1111/j.1365-2443.2007.01090.x; Blow JJ, 2009, EMBO REP, V10, P406, DOI 10.1038/embor.2009.5; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Chong JPJ, 1997, METHOD ENZYMOL, V283, P549; Chong JPJ, 2000, P NATL ACAD SCI USA, V97, P1530, DOI 10.1073/pnas.030539597; Costa A, 2006, J STRUCT BIOL, V156, P210, DOI 10.1016/j.jsb.2006.04.001; DePamphilis ML, 2006, CURR OPIN CELL BIOL, V18, P231, DOI 10.1016/j.ceb.2006.04.001; DINGMAN CW, 1974, J THEOR BIOL, V43, P187, DOI 10.1016/S0022-5193(74)80052-4; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Falaschi A, 2000, TRENDS GENET, V16, P88, DOI 10.1016/S0168-9525(99)01917-4; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Frolova NS, 2002, MOL BIOL CELL, V13, P1298, DOI 10.1091/mbc.01-08-0382; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gambus A, 2009, EMBO J, V28, P2992, DOI 10.1038/emboj.2009.226; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; Gillespie PJ, 2007, CURR BIOL, V17, P1657, DOI 10.1016/j.cub.2007.08.041; Gillespie PJ, 2001, BMC BIOCHEM, V2, DOI 10.1186/1472-2091-2-15; Gillespie PJ, 2000, NUCLEIC ACIDS RES, V28, P472, DOI 10.1093/nar/28.2.472; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Im JS, 2009, P NATL ACAD SCI USA, V106, P15628, DOI 10.1073/pnas.0908039106; Khoudoli GA, 2008, CURR BIOL, V18, P838, DOI 10.1016/j.cub.2008.04.075; Kitamura E, 2006, CELL, V125, P1297, DOI 10.1016/j.cell.2006.04.041; Kubota Y, 2003, GENE DEV, V17, P1141, DOI 10.1101/gad.1070003; Labib K, 2001, CURR OPIN GENET DEV, V11, P64, DOI 10.1016/S0959-437X(00)00158-1; Ligasova A, 2009, J STRUCT BIOL, V165, P204, DOI 10.1016/j.jsb.2008.11.004; Machida YJ, 2005, CELL, V123, P13, DOI 10.1016/j.cell.2005.09.019; Marinsek N, 2006, EMBO REP, V7, P539, DOI 10.1038/sj.embor.7400649; Mimura S, 2000, GENES CELLS, V5, P439, DOI 10.1046/j.1365-2443.2000.00340.x; Morohashi H, 2009, CURR BIOL, V19, P1943, DOI 10.1016/j.cub.2009.09.062; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Oehlmann M, 2004, J CELL BIOL, V165, P181, DOI 10.1083/jcb.200311044; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Pereverzeva I, 2000, MOL CELL BIOL, V20, P3667, DOI 10.1128/MCB.20.10.3667-3676.2000; Prokhorova TA, 2000, J BIOL CHEM, V275, P2491, DOI 10.1074/jbc.275.4.2491; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Shechter DF, 2000, J BIOL CHEM, V275, P15049, DOI 10.1074/jbc.M000398200; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Takahashi TS, 2005, TRENDS BIOCHEM SCI, V30, P437, DOI 10.1016/j.tibs.2005.06.007; Tanaka H, 2009, GENES CELLS, V14, P949, DOI 10.1111/j.1365-2443.2009.01322.x; Thommes P, 1997, EMBO J, V16, P3312, DOI 10.1093/emboj/16.11.3312; Walter JC, 2000, J BIOL CHEM, V275, P39773, DOI 10.1074/jbc.M008107200; Wigley DB, 2009, CURR OPIN STRUC BIOL, V19, P72, DOI 10.1016/j.sbi.2008.12.010; Woodward AM, 2006, J CELL BIOL, V173, P673, DOI 10.1083/jcb.200602108	48	95	95	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11855	11864		10.1074/jbc.M110.199521	http://dx.doi.org/10.1074/jbc.M110.199521			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21282109	hybrid, Green Published			2022-12-27	WOS:000288797100092
J	Gebhardt, M; Hoffgaard, F; Hamacher, K; Kast, SM; Moroni, A; Thiel, G				Gebhardt, Manuela; Hoffgaard, Franziska; Hamacher, Kay; Kast, Stefan M.; Moroni, Anna; Thiel, Gerhard			Membrane Anchoring and Interaction between Transmembrane Domains are Crucial for K+ Channel Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM CHANNEL; CRYSTAL-STRUCTURE; EVOLUTIONARY CONSERVATION; PROTEINS; BINDING; RESIDUES; DYNAMICS; SEQUENCE; CONSURF; IDENTIFICATION	The small viral channel Kcv is a Kir-like K+ channel of only 94 amino acids. With this simple structure, the tetramer of Kcv represents the pore module of all complex K+ channels. To examine the structural contribution of the transmembrane domains (TMDs) to channel function, we performed Ala scanning mutagenesis of the two domains and tested the functionality of the mutants in a yeast complementation assay. The data reveal, in combination with computational models, that the upper halves of both TMDs, which face toward the external medium, are rather rigid, whereas the inner parts are more flexible. The rigidity of the outer TMD is conferred by a number of essential aromatic amino acids that face the membrane and probably anchor this domain in the bilayer. The inner TMD is intimately connected with the rigid part of the outer TMD via pi center dot center dot center dot pi interactions between a pair of aromatic amino acids. This structural principle is conserved within the viral K+ channels and also present in Kir2.2, implying a general importance of this architecture for K+ channel function.	[Gebhardt, Manuela; Thiel, Gerhard] Tech Univ Darmstadt, Inst Bot, D-64287 Darmstadt, Germany; [Hoffgaard, Franziska; Hamacher, Kay] Tech Univ Darmstadt, Computat Biol Grp, D-64287 Darmstadt, Germany; [Kast, Stefan M.] Tech Univ Dortmund, D-44227 Dortmund, Germany; [Moroni, Anna] Univ Milan, Dept Biol, I-20122 Milan, Italy; [Moroni, Anna] Univ Milan, CNR, Ist Biofis Milano, I-20122 Milan, Italy	Technical University of Darmstadt; Technical University of Darmstadt; Dortmund University of Technology; University of Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Milan	Thiel, G (corresponding author), Schnittspahnstr 3-5, D-64287 Darmstadt, Germany.	thiel@bio.tu-darmstadt.de	moroni, anna/H-2097-2014	moroni, anna/0000-0002-1860-406X; Hamacher, Kay/0000-0002-6921-8345; Thiel, Gerhard/0000-0002-2335-1351	Deutsche Forschungsgemeinschaft [TH558/19-1]; Adolf-Messer-Stiftung; Fonds der Chemischen Industrie; European Drug Initiative on Channels and Transporters (EDICT) [201924]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Adolf-Messer-Stiftung; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); European Drug Initiative on Channels and Transporters (EDICT)(European Commission)	This work was supported in part by the Deutsche Forschungsgemeinschaft (to G. T. (TH558/19-1), the Adolf-Messer-Stiftung (to S. M. K.), the Fonds der Chemischen Industrie (to S. M. K.) and K. H.) and the European Drug Initiative on Channels and Transporters (EDICT) project EU FP7 (201924) (to A. M.).	Adamian L, 2001, J MOL BIOL, V311, P891, DOI 10.1006/jmbi.2001.4908; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Bahar I, 1998, PHYS REV LETT, V80, P2733, DOI 10.1103/PhysRevLett.80.2733; Balss J, 2008, P NATL ACAD SCI USA, V105, P12313, DOI 10.1073/pnas.0805709105; Barrera FN, 2008, BIOCHEMISTRY-US, V47, P2123, DOI 10.1021/bi700778c; Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; Bhattacharyya R, 2003, J PROTEOME RES, V2, P255, DOI 10.1021/pr025584d; Bhosale S, 2006, ORG BIOMOL CHEM, V4, P3031, DOI 10.1039/b606487f; Bowie JU, 2005, NATURE, V438, P581, DOI 10.1038/nature04395; Brandl M, 2001, J MOL BIOL, V307, P357, DOI 10.1006/jmbi.2000.4473; BRICKMANN J, 1995, DATA VISUALIZATION M, P83; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; de Planque MRR, 2003, MOL MEMBR BIOL, V20, P271, DOI 10.1080/09687680310001605352; Delaroque N, 2001, VIROLOGY, V287, P112, DOI 10.1006/viro.2001.1028; Di Cera E, 1998, CHEM REV, V98, P1563, DOI 10.1021/cr960135g; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; FernandezRecio J, 1997, J MOL BIOL, V267, P184, DOI 10.1006/jmbi.1996.0831; Gazzarrini S, 2004, J BIOL CHEM, V279, P28443, DOI 10.1074/jbc.M401184200; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Hamacher K, 2008, GENE, V422, P30, DOI 10.1016/j.gene.2008.06.007; Hamacher K, 2006, J CHEM THEORY COMPUT, V2, P873, DOI 10.1021/ct050247s; Heyda J, 2010, J PHYS CHEM B, V114, P8744, DOI 10.1021/jp101031v; Holst B, 1998, MOL PHARMACOL, V53, P166, DOI 10.1124/mol.53.1.166; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Killian JA, 2003, FEBS LETT, V555, P134, DOI 10.1016/S0014-5793(03)01154-2; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Li TB, 2009, J BIOL CHEM, V284, P4689, DOI 10.1074/jbc.M805302200; Lundbaek JA, 2008, J GEN PHYSIOL, V131, P421, DOI 10.1085/jgp.200709948; Marius P, 2008, BIOPHYS J, V94, P1689, DOI 10.1529/biophysj.107.117507; Minor DL, 1999, CELL, V96, P879, DOI 10.1016/S0092-8674(00)80597-8; Nishio M, 1998, METH STEREO, P1; Plugge B, 2000, SCIENCE, V287, P1641, DOI 10.1126/science.287.5458.1641; POPOT JL, 1990, BIOCHEMISTRY-US, V29, P4031, DOI 10.1021/bi00469a001; SHOEMAKER KR, 1990, BIOPOLYMERS, V29, P1, DOI 10.1002/bip.360290104; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Tayefeh S, 2007, BIOCHEMISTRY-US, V46, P4826, DOI 10.1021/bi602468r; Tayefeh S, 2009, BIOPHYS J, V96, P485, DOI 10.1016/j.bpj.2008.09.050; Thiel G, 2011, BBA-BIOMEMBRANES, V1808, P580, DOI 10.1016/j.bbamem.2010.04.008; Tozzini V, 2010, Q REV BIOPHYS, V43, P333, DOI 10.1017/S0033583510000132; Valiyaveetil FI, 2002, BIOCHEMISTRY-US, V41, P10771, DOI 10.1021/bi026215y; Wang LJ, 2006, BIOCHEMISTRY-US, V45, P13750, DOI 10.1021/bi0615689; Yang HY, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000151; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c	46	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11299	11306		10.1074/jbc.M110.211672	http://dx.doi.org/10.1074/jbc.M110.211672			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21310959	Green Published, hybrid			2022-12-27	WOS:000288797100042
J	Gupta, R; Asomugha, CO; Srivastava, OP				Gupta, Ratna; Asomugha, Chinwe O.; Srivastava, Om P.			The Common Modification in alpha A-Crystallin in the Lens, N101D, Is Associated with Increased Opacity in a Mouse Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGE-RELATED-CHANGES; POSTERIOR SUBCAPSULAR CATARACTS; OPTICAL-QUALITY; B-CRYSTALLIN; POSTTRANSLATIONAL MODIFICATIONS; CELL-DIFFERENTIATION; PROTEIN INTERACTIONS; MASS-SPECTROMETRY; EPITHELIAL-CELLS; PLASMA-MEMBRANE	To elucidate the morphological and cellular changes due to introduction of a charge during development and the possible mechanism that underlies cataract development in humans as a consequence of an additional charge, we generated a transgenic mouse model mimicking deamidation of Asn at position 101. The mouse model expresses a human alpha A-crystallin gene in which Asn-101 was replaced with Asp, which is referred to as alpha AN101D-transgene and is considered to be "deamidated" in this study. Mice expressing alpha AN101D-transgene are referred to here CRYAA(N101D) mice. All of the lines showed the expression of alpha AN101D-transgene. Compared with the lenses of mice expressing wild-type (WT) alpha A-transgene (referred to as CRYAA(WT) mice), the lenses of CRYAA(N101D) mice showed (a) altered alpha A-crystallin membrane protein (aquaporin-0 (AQP0), a specific lens membrane protein) interaction, (b) extracellular spaces between outer cortical fiber cells, (c) attenuated denucleation during confocal microscopic examination, (d) disrupted normal fiber cell organization and structure during scanning electron microscopic examination, (e) distorted posterior suture lines by bright field microscopy, and (f) development of a mild anterior lens opacity in the superior cortical region during the optical coherence tomography scan analysis. Relative to lenses with WT alpha A-crystallin, the lenses containing the deamidated alpha A-crystallin also showed an aggregation of alpha A-crystallin and a higher level of water-insoluble proteins, suggesting that the morphological and cellular changes in these lenses are due to the N101D mutation. This study provides evidence for the first time that expression of deamidated alpha A-crystallin caused disruption of fiber cell structural integrity, protein aggregation, insolubilization, and mild cortical lens opacity.	[Gupta, Ratna; Asomugha, Chinwe O.; Srivastava, Om P.] Univ Alabama, Dept Vis Sci, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Srivastava, OP (corresponding author), Univ Alabama, Dept Vis Sci, Worrell Bldg,924 S 18th St, Birmingham, AL 35294 USA.	srivasta@uab.edu			National Institutes of Health [EY06400, P30-EY03039]; National Institutes of Health, NCRR [S10RR026887]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026887] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY003039, R01EY006400] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY06400 and P30-EY03039 and National Institutes of Health, NCRR, Grant S10RR026887 (for the purchase of the Bioptigen SDOCT system).	Al-Ghoul KJ, 1998, EXP EYE RES, V67, P163, DOI 10.1006/exer.1998.0505; Al-Khudari Samer, 2007, BMC Ophthalmol, V7, P19, DOI 10.1186/1471-2415-7-19; AlGhoul KJ, 1996, EXP EYE RES, V62, P237, DOI 10.1006/exer.1996.0029; Andersson M, 2003, EXP EYE RES, V76, P175, DOI 10.1016/S0014-4835(02)00283-X; Andley UP, 2008, INT J BIOCHEM CELL B, V40, P317, DOI 10.1016/j.biocel.2007.10.034; Andley UP, 2009, BMC OPHTHALMOL, V9, DOI 10.1186/1471-2415-9-4; Beebe D, 2004, INT J DEV BIOL, V48, P845, DOI 10.1387/ijdb.041869db; Blankenship TN, 2001, INVEST OPHTH VIS SCI, V42, P735; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; Boyle Daniel L, 2003, BMC Ophthalmol, V3, P3, DOI 10.1186/1471-2415-3-3; Boyle DL, 2000, MOL VIS, V6, P63; BROWN NAP, 1989, EYE, V3, P597, DOI 10.1038/eye.1989.93; Cain S, 2008, DEV BIOL, V321, P420, DOI 10.1016/j.ydbio.2008.07.002; Chaves JM, 2008, BIOCHEMISTRY-US, V47, P10069, DOI 10.1021/bi8001902; Chung J, 2007, EXP EYE RES, V84, P513, DOI 10.1016/j.exer.2006.11.004; Clark JI, 1999, EYE, V13, P417, DOI 10.1038/eye.1999.116; Clark JI, 2000, INT REV CYTOL, V192, P171; Cobb BA, 2002, BIOCHEMISTRY-US, V41, P483, DOI 10.1021/bi0112457; Cobb BA, 2000, BIOCHEMISTRY-US, V39, P15791, DOI 10.1021/bi001453j; DELAYE M, 1983, NATURE, V302, P415, DOI 10.1038/302415a0; Donaldson P, 2001, NEWS PHYSIOL SCI, V16, P118; DUNIA I, 1990, EUR J CELL BIOL, V53, P59; Freel Christopher D, 2003, BMC Ophthalmol, V3, P1, DOI 10.1186/1471-2415-3-1; GOPALAKRISHNAN S, 1992, CURR EYE RES, V11, P929, DOI 10.3109/02713689209033490; Grey AC, 2003, EXP EYE RES, V77, P567, DOI 10.1016/S0014-4835(03)00192-1; Gupta R, 2004, J BIOL CHEM, V279, P44258, DOI 10.1074/jbc.M405648200; Gupta R, 2004, INVEST OPHTH VIS SCI, V45, P206, DOI 10.1167/iovs.03-0720; Hains PG, 2007, J PROTEOME RES, V6, P3935, DOI 10.1021/pr070138h; Hains PG, 2010, INVEST OPHTH VIS SCI, V51, P3107, DOI 10.1167/iovs.09-4308; Hammond CJ, 2001, INVEST OPHTH VIS SCI, V42, P601; Hanson SRA, 2000, EXP EYE RES, V71, P195, DOI 10.1006/exer.2000.0868; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Hsu CD, 2006, INVEST OPHTH VIS SCI, V47, P2036, DOI 10.1167/iovs.05-0524; Kim YH, 2002, BIOCHEMISTRY-US, V41, P14076, DOI 10.1021/bi026288h; Kumari SS, 2009, BIOCHEM BIOPH RES CO, V390, P1034, DOI 10.1016/j.bbrc.2009.10.103; Kuszak JR, 2004, EXP EYE RES, V78, P673, DOI 10.1016/j.exer.2003.09.016; KUSZAK JR, 1991, INVEST OPHTH VIS SCI, V32, P2119; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lampi KJ, 1998, EXP EYE RES, V67, P31, DOI 10.1006/exer.1998.0481; Lampi KJ, 2006, BIOCHEMISTRY-US, V45, P3146, DOI 10.1021/bi052051k; Lovicu FJ, 2005, DEV BIOL, V280, P1, DOI 10.1016/j.ydbio.2005.01.020; Ma ZX, 1998, EXP EYE RES, V67, P21, DOI 10.1006/exer.1998.0482; Ponce A, 2006, MOL VIS, V12, P879; RAMAEKERS FCS, 1982, P NATL ACAD SCI-BIOL, V79, P3208, DOI 10.1073/pnas.79.10.3208; Sandilands A, 2003, EXP EYE RES, V76, P385, DOI 10.1016/S0014-4835(02)00330-5; SIVAK JG, 1994, EXP EYE RES, V59, P505, DOI 10.1006/exer.1994.1137; Song SH, 2008, MOL VIS, V14, P1282; SRIVASTAVA OP, 1994, EXP EYE RES, V58, P595, DOI 10.1006/exer.1994.1054; Takata T, 2008, PROTEIN SCI, V17, P1565, DOI 10.1110/ps.035410.108; Takemoto L, 2000, MOL VIS, V6, P164; Takemoto LJ, 1998, CURR EYE RES, V17, P247, DOI 10.1076/ceyr.17.3.247.5218; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Wang XH, 2004, INVEST OPHTH VIS SCI, V45, P3608, DOI 10.1167/iovs.04-0423; West-Mays JA, 2002, DEV BIOL, V245, P13, DOI 10.1006/dbio.2002.0624; Wilmarth PA, 2006, J PROTEOME RES, V5, P2554, DOI 10.1021/pr050473a; Wong AL, 2009, BRIT J OPHTHALMOL, V93, P61, DOI 10.1136/bjo.2008.137653; Xi JH, 2003, J CELL SCI, V116, P1073, DOI 10.1242/jcs.00325; Xi JH, 2006, FASEB J, V20, P846, DOI 10.1096/fj.05-5532com; Yu XS, 2004, J CELL SCI, V117, P871, DOI 10.1242/jcs.00945; Zillig M, 2005, INVEST OPHTH VIS SCI, V46, P223, DOI 10.1167/iovs.04-0988	60	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11579	11592		10.1074/jbc.M110.148627	http://dx.doi.org/10.1074/jbc.M110.148627			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21245144	hybrid, Green Published			2022-12-27	WOS:000288797100068
J	Hatakeyama, T; Kamiya, T; Kusunoki, M; Nakamura-Tsuruta, S; Hirabayashi, J; Goda, S; Unno, H				Hatakeyama, Tomomitsu; Kamiya, Takuro; Kusunoki, Masami; Nakamura-Tsuruta, Sachiko; Hirabayashi, Jun; Goda, Shuichiro; Unno, Hideaki			Galactose Recognition by a Tetrameric C-type Lectin, CEL-IV, Containing the EPN Carbohydrate Recognition Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INVERTEBRATE CUCUMARIA-ECHINATA; MANNOSE-BINDING PROTEINS; AMINO-ACID-SEQUENCE; POLYANDROCARPA-MISAKIENSIS; N-ACETYLGALACTOSAMINE; ANIMAL LECTINS; DOMAIN; RICIN; EXPRESSION; APOPTOSIS	CEL-IV is a C-type lectin isolated from a sea cucumber, Cucumaria echinata. This lectin is composed of four identical C-type carbohydrate- recognition domains (CRDs). X-ray crystallographic analysis of CEL-IV revealed that its tetrameric structure was stabilized by multiple interchain disulfide bonds among the subunits. Although CEL-IV has the EPN motif in its carbohydrate- binding sites, which is known to be characteristic of mannose binding C-type CRDs, it showed preferential binding of galactose and N-acetylgalactosamine. Structural analyses of CEL-IV-melibiose and CEL-IV-raffinose complexes revealed that their galactose residues were recognized in an inverted orientation compared with mannose binding C-type CRDs containing the EPN motif, by the aid of a stacking interaction with the side chain of Trp-79. Changes in the environment of Trp-79 induced by binding to galactose were detected by changes in the intrinsic fluorescence and UV absorption spectra of WT CEL-IV and its site-directed mutants. The binding specificity of CEL-IV toward complex oligosaccharides was analyzed by frontal affinity chromatography using various pyridylamino sugars, and the results indicate preferential binding to oligosaccharides containing Gal beta 1-3/4(Fuc alpha 1-3/4) GlcNAc structures. These findings suggest that the specificity for oligosaccharides may be largely affected by interactions with amino acid residues in the binding site other than those determining the monosaccharide specificity.	[Hatakeyama, Tomomitsu; Kamiya, Takuro; Goda, Shuichiro; Unno, Hideaki] Nagasaki Univ, Fac Engn, Dept Appl Chem, Nagasaki 8528521, Japan; [Kusunoki, Masami] Osaka Univ, Inst Prot Res, Res Ctr Struct & Funct Prote, Suita, Osaka 5650871, Japan; [Nakamura-Tsuruta, Sachiko; Hirabayashi, Jun] Natl Inst Adv Ind Sci & Technol, Res Ctr Med Glycosci, Tsukuba, Ibaraki 3058568, Japan	Nagasaki University; Osaka University; National Institute of Advanced Industrial Science & Technology (AIST)	Hatakeyama, T (corresponding author), Nagasaki Univ, Fac Engn, Dept Appl Chem, 1-14 Bunkyo Machi, Nagasaki 8528521, Japan.	thata@nagasaki-u.ac.jp	Hirabayashi, Jun/M-3998-2018; Hideaki, UNNO/ABG-9471-2020; Goda, Shuichiro/E-7177-2013	Hirabayashi, Jun/0000-0002-8571-359X; Hideaki, UNNO/0000-0001-5917-269X; Goda, Shuichiro/0000-0002-0525-6887; Hatakeyama, Tomomitsu/0000-0002-9505-1980	Institute for Protein Research, Osaka University; Japan Society for the Promotion of Science [20580100]	Institute for Protein Research, Osaka University; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was conducted under the Cooperative Research Program of Institute for Protein Research, Osaka University and was supported by Grant-in-aid for Scientific Research 20580100 from the Japan Society for the Promotion of Science.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; COWGILL RW, 1967, BIOCHIM BIOPHYS ACTA, V133, P6, DOI 10.1016/0005-2795(67)90034-7; DeLano W.L, PYMOL MOL GRAPHICS S; DRICKAMER K, 1992, NATURE, V360, P183, DOI 10.1038/360183a0; DRICKAMER K, 1986, J BIOL CHEM, V261, P6878; Drickamer K, 1999, CURR OPIN STRUC BIOL, V9, P585, DOI 10.1016/S0959-440X(99)00009-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENDO Y, 1988, EUR J BIOCHEM, V171, P45, DOI 10.1111/j.1432-1033.1988.tb13756.x; Gourdine JP, 2008, J BIOL CHEM, V283, P30112, DOI 10.1074/jbc.M804353200; HATAKEYAMA T, 1995, BIOSCI BIOTECH BIOCH, V59, P1314, DOI 10.1271/bbb.59.1314; Hatakeyama T, 2006, BBA-GEN SUBJECTS, V1760, P318, DOI 10.1016/j.bbagen.2006.01.011; HATAKEYAMA T, 1995, J BIOL CHEM, V270, P3560, DOI 10.1074/jbc.270.8.3560; HATAKEYAMA T, 1994, J BIOCHEM, V116, P209, DOI 10.1093/oxfordjournals.jbchem.a124495; Hatakeyama T, 2002, BIOSCI BIOTECH BIOCH, V66, P157, DOI 10.1271/bbb.66.157; Hatakeyama T, 2007, J BIOL CHEM, V282, P37826, DOI 10.1074/jbc.M705604200; Hazes B, 1996, PROTEIN SCI, V5, P1490, DOI 10.1002/pro.5560050805; Hirabayashi J, 2004, GLYCOCONJUGATE J, V21, P35, DOI 10.1023/B:GLYC.0000043745.18988.a1; Ho MR, 2010, J MOL BIOL, V402, P682, DOI 10.1016/j.jmb.2010.07.061; Hosono M, 2005, BBA-GEN SUBJECTS, V1725, P160, DOI 10.1016/j.bbagen.2005.07.009; IOBST ST, 1994, J BIOL CHEM, V269, P15512; Kilpatrick DC, 2002, BBA-GEN SUBJECTS, V1572, P187, DOI 10.1016/S0304-4165(02)00308-2; Kuramoto T, 2005, J BIOCHEM, V137, P41, DOI 10.1093/jb/mvi005; Kuroda J, 2010, MOL CANCER RES, V8, P994, DOI 10.1158/1541-7786.MCR-10-0040; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lehotzky RE, 2010, P NATL ACAD SCI USA, V107, P7722, DOI 10.1073/pnas.0909449107; Liu B, 2008, BMB REP, V41, P369, DOI 10.5483/BMBRep.2008.41.5.369; Liu YC, 2007, MOL IMMUNOL, V44, P598, DOI 10.1016/j.molimm.2006.01.015; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura S, 2005, FEBS J, V272, P2784, DOI 10.1111/j.1742-4658.2005.04698.x; Ng KKS, 2002, J BIOL CHEM, V277, P16088, DOI 10.1074/jbc.M200493200; Olsnes S, 2004, TOXICON, V44, P361, DOI 10.1016/j.toxicon.2004.05.003; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Poget SF, 1999, J MOL BIOL, V290, P867, DOI 10.1006/jmbi.1999.2910; Sugawara H, 2004, J BIOL CHEM, V279, P45219, DOI 10.1074/jbc.M408840200; SundarRaj S, 2009, MOL IMMUNOL, V46, P3411, DOI 10.1016/j.molimm.2009.07.013; SUZUKI T, 1990, J BIOL CHEM, V265, P1274; Tasumi S, 2002, J BIOL CHEM, V277, P27305, DOI 10.1074/jbc.M202648200; Uchida T, 2004, J BIOL CHEM, V279, P37133, DOI 10.1074/jbc.M404065200; Yamanishi T, 2007, J BIOCHEM, V142, P587, DOI 10.1093/jb/mvm164; YAMASAKI N, 1985, J BIOCHEM-TOKYO, V98, P1555, DOI 10.1093/oxfordjournals.jbchem.a135424; YANARI S, 1960, J BIOL CHEM, V235, P2818; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x	43	21	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10305	10315		10.1074/jbc.M110.200576	http://dx.doi.org/10.1074/jbc.M110.200576			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21247895	Green Submitted, hybrid, Green Published			2022-12-27	WOS:000288547000048
J	Shields, MA; Dangi-Garimella, S; Krantz, SB; Bentrem, DJ; Munshi, HG				Shields, Mario A.; Dangi-Garimella, Surabhi; Krantz, Seth B.; Bentrem, David J.; Munshi, Hidayatullah G.			Pancreatic Cancer Cells Respond to Type I Collagen by Inducing Snail Expression to Promote Membrane Type 1 Matrix Metalloproteinase-dependent Collagen Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITIONS; 3-DIMENSIONAL EXTRACELLULAR-MATRIX; TRANSCRIPTION FACTOR SNAIL; INTEGRIN-LINKED KINASE; N-CADHERIN EXPRESSION; TGF-BETA; CARCINOMA-CELLS; HEPATOCYTE GROWTH; TISSUE INHIBITOR	Pancreatic ductal adenocarcinoma (PDAC) is characterized by pronounced fibrotic reaction composed primarily of type I collagen. Although type I collagen functions as a barrier to invasion, pancreatic cancer cells have been shown to respond to type I collagen by becoming more motile and invasive. Because epithelial-mesenchymal transition is also associated with cancer invasion, we examined the extent to which collagen modulated the expression of Snail, a well known regulator of epithelial-mesenchymal transition. Relative to cells grown on tissue culture plastic, PDAC cells grown in three-dimensional collagen gels induced Snail. Inhibiting the activity or expression of the TGF-beta type I receptor abrogated collagen-induced Snail. Downstream of the receptor, we showed that Smad3 and Smad4 were critical for the induction of Snail by collagen. In contrast, Smad2 or ERK1/2 was not involved in collagen-mediated Snail expression. Overexpression of Snail in PDAC cells resulted in a robust membrane type 1-matrix metalloproteinase (MT1-MMP, MMP-14)-dependent invasion through collagen-coated transwell chambers. Snail-expressing PDAC cells also demonstrated MT1-MMP-dependent scattering in three-dimensional collagen gels. Mechanistically, Snail increased the expression of MT1-MMP through activation of ERK-MAPK signaling, and inhibiting ERK signaling in Snail-expressing cells blocked two-dimensional collagen invasion and attenuated scattering in three-dimensional collagen. To provide in vivo support for our findings that Snail can regulate MT1-MMP, we examined the expression of Snail and MT1-MMP in human PDAC tumors and found a statistically significant positive correlation between MT1-MMP and Snail in these tumors. Overall, our data demonstrate that pancreatic cancer cells increase Snail on encountering collagen-rich milieu and suggest that the desmoplastic reaction actively contributes to PDAC progression.	[Shields, Mario A.; Dangi-Garimella, Surabhi; Munshi, Hidayatullah G.] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Hematol Oncol, Chicago, IL 60611 USA; [Krantz, Seth B.; Bentrem, David J.] Northwestern Univ, Feinberg Sch Med, Dept Surg, Div Gastrointestinal & Oncol Surg, Chicago, IL 60611 USA; [Bentrem, David J.; Munshi, Hidayatullah G.] Northwestern Univ, Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60611 USA; [Bentrem, David J.; Munshi, Hidayatullah G.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	Munshi, HG (corresponding author), Northwestern Univ, Sch Med, Dept Med, 303 E Super Ave,Lurie 3-117, Chicago, IL 60611 USA.	h-munshi@northwestern.edu	Krantz, Seth/T-3900-2019		National Institutes of Health [R01CA126888]; Rosenberg Family Foundation; Baseball Charities Foundation; NATIONAL CANCER INSTITUTE [R01CA126888] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rosenberg Family Foundation; Baseball Charities Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA126888 (NCI; to H. G. M.). This work was also supported by the Rosenberg Family Foundation (to H. G. M.) and the Baseball Charities Foundation (to M. A. S.).	Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; Bardeesy N, 2006, GENE DEV, V20, P3130, DOI 10.1101/gad.1478706; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chun TH, 2004, J CELL BIOL, V167, P757, DOI 10.1083/jcb.200405001; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; Deckers M, 2006, CANCER RES, V66, P2202, DOI 10.1158/0008-5472.CAN-05-3560; Diamond ME, 2008, J CELL SCI, V121, P2197, DOI 10.1242/jcs.021782; Garamszegi N, 2010, ONCOGENE, V29, P2368, DOI 10.1038/onc.2009.514; Grotegut S, 2006, EMBO J, V25, P3534, DOI 10.1038/sj.emboj.7601213; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hernandez-Barrantes S, 2000, J BIOL CHEM, V275, P12080, DOI 10.1074/jbc.275.16.12080; Heyer J, 1999, P NATL ACAD SCI USA, V96, P12595, DOI 10.1073/pnas.96.22.12595; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Horiguchi K, 2009, J BIOL CHEM, V284, P245, DOI 10.1074/jbc.M804777200; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Izeradjene K, 2007, CANCER CELL, V11, P229, DOI 10.1016/j.ccr.2007.01.017; Jorda M, 2005, J CELL SCI, V118, P3371, DOI 10.1242/jcs.02465; Joseph MJ, 2009, J CELL BIOCHEM, V108, P726, DOI 10.1002/jcb.22309; Ju WJ, 2006, MOL CELL BIOL, V26, P654, DOI 10.1128/MCB.26.2.654-667.2006; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim KK, 2009, J CLIN INVEST, V119, P213, DOI 10.1172/JCI36940; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Margadant C, 2010, EMBO REP, V11, P97, DOI 10.1038/embor.2009.276; Medici D, 2010, MATRIX BIOL, V29, P161, DOI 10.1016/j.matbio.2009.12.003; Miyoshi A, 2004, BRIT J CANCER, V90, P1265, DOI 10.1038/sj.bjc.6601685; Munshi HG, 2004, J BIOL CHEM, V279, P39042, DOI 10.1074/jbc.M404958200; Munshi HG, 2002, J BIOL CHEM, V277, P41480, DOI 10.1074/jbc.M207695200; Munshi HG, 2002, METHOD CELL BIOL, V69, P195, DOI 10.1016/S0091-679X(02)69013-2; Nishimura SL, 2009, AM J PATHOL, V175, P1362, DOI 10.2353/ajpath.2009.090393; Olmeda D, 2007, ONCOGENE, V26, P1862, DOI 10.1038/sj.onc.1209997; Ota I, 2009, P NATL ACAD SCI USA, V106, P20318, DOI 10.1073/pnas.0910962106; Ottaviano AJ, 2006, CANCER RES, V66, P7032, DOI 10.1158/0008-5472.CAN-05-4421; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Phanish MK, 2006, BIOCHEM J, V393, P601, DOI 10.1042/BJ20051106; Piek E, 2001, J BIOL CHEM, V276, P19945, DOI 10.1074/jbc.M102382200; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Roberts AB, 2006, CYTOKINE GROWTH F R, V17, P19, DOI 10.1016/j.cytogfr.2005.09.008; Rowe RG, 2009, ANNU REV CELL DEV BI, V25, P567, DOI 10.1146/annurev.cellbio.24.110707.175315; Rowe RG, 2009, J CELL BIOL, V184, P399, DOI 10.1083/jcb.200810113; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shintani Y, 2006, CANCER RES, V66, P11745, DOI 10.1158/0008-5472.CAN-06-2322; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Sun LM, 2008, MOL CANCER RES, V6, P10, DOI 10.1158/1541-7786.MCR-07-0208; Tan C, 2001, ONCOGENE, V20, P133, DOI 10.1038/sj.onc.1204052; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Waldrip WR, 1998, CELL, V92, P797, DOI 10.1016/S0092-8674(00)81407-5; Will H, 1996, J BIOL CHEM, V271, P17119, DOI 10.1074/jbc.271.29.17119; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Yang YC, 2003, P NATL ACAD SCI USA, V100, P10269, DOI 10.1073/pnas.1834070100	56	93	93	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10495	10504		10.1074/jbc.M110.195628	http://dx.doi.org/10.1074/jbc.M110.195628			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21288898	Green Published, hybrid			2022-12-27	WOS:000288547000066
J	Zimmer, SL; McEvoy, SM; Li, J; Qu, J; Read, LK				Zimmer, Sara L.; McEvoy, Sarah M.; Li, Jun; Qu, Jun; Read, Laurie K.			A Novel Member of the RNase D Exoribonuclease Family Functions in Mitochondrial Guide RNA Metabolism in Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIFE-CYCLE STAGES; INDUCIBLE EXPRESSION SYSTEM; MESSENGER-RNA; ESCHERICHIA-COLI; RIBOSOMAL-RNA; DEVELOPMENTAL REGULATION; NADH DEHYDROGENASE; APOCYTOCHROME-B; BINDING COMPLEX; ZINC-FINGER	RNA turnover and RNA editing are essential for regulation of mitochondrial gene expression in Trypanosoma brucei. RNA turnover is controlled in part by RNA 3' adenylation and uridylation status, with trans-acting factors also impacting RNA homeostasis. However, little is known about the mitochondrial degradation machinery or its regulation in T. brucei. We have identified a mitochondrial exoribonuclease, TbRND, whose expression is highly up-regulated in the insect proliferative stage of the parasite. TbRND shares sequence similarity with RNase D family enzymes but differs from all reported members of this family in possessing a CCHC zinc finger domain. In vitro, TbRND exhibits 3' to 5' exoribonuclease activity, with specificity toward uridine homopolymers, including the 3' oligo(U) tails of guide RNAs (gRNAs) that provide the sequence information for RNA editing. Several lines of evidence generated from RNAi-mediated knockdown and overexpression cell lines indicate that TbRND functions in gRNA metabolism in vivo. First, TbRND depletion results in gRNA tails extended by 2-3 nucleotides on average. Second, overexpression of wild type but not catalytically inactive TbRND results in a substantial decrease in the total gRNA population and a consequent inhibition of RNA editing. The observed effects on the gRNA population are specific as rRNAs, which are also 3'-uridylated, are unaffected by TbRND depletion or overexpression. Finally, we show that gRNA binding proteins co-purify with TbRND. In summary, TbRND is a novel 3' to 5' exoribonuclease that appears to have evolved a function highly specific to the mitochondrion of trypanosomes.	[Zimmer, Sara L.; McEvoy, Sarah M.; Read, Laurie K.] SUNY Buffalo, Sch Med & Biomed Sci, Dept Microbiol & Immunol, Buffalo, NY 14214 USA; [Li, Jun; Qu, Jun] SUNY Buffalo, Dept Pharmaceut Sci, Amherst, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Read, LK (corresponding author), SUNY Buffalo, Sch Med & Biomed Sci, Dept Microbiol & Immunol, Buffalo, NY 14214 USA.	lread@buffalo.edu	Li, Jun/N-3806-2014	Li, Jun/0000-0001-9940-3421; Zimmer, Sara/0000-0002-1707-1839	National Institutes of Health [RO1 AI077520]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AI077520 (to L. K. R.).	Acestor N, 2009, RNA, V15, P277, DOI 10.1261/rna.1353209; ADLER BK, 1991, MOL CELL BIOL, V11, P5878, DOI 10.1128/MCB.11.12.5878; Anderson JT, 2009, CRIT REV BIOCHEM MOL, V44, P16, DOI [10.1080/10409230802640218 , 10.1080/10409230802640218]; Aphasizheva I, 2010, MOL CELL BIOL, V30, P1555, DOI 10.1128/MCB.01281-09; Aphasizheva I, 2009, RNA, V15, P1322, DOI 10.1261/rna.1538809; Belostotsky D, 2009, CURR OPIN CELL BIOL, V21, P352, DOI 10.1016/j.ceb.2009.04.011; BHAT GJ, 1992, MOL BIOCHEM PARASIT, V52, P231, DOI 10.1016/0166-6851(92)90055-O; BLUM B, 1990, CELL, V62, P391, DOI 10.1016/0092-8674(90)90375-O; Borowski LS, 2010, BBA-BIOENERGETICS, V1797, P1066, DOI 10.1016/j.bbabio.2010.01.028; Callahan KP, 2010, J BIOL CHEM, V285, P3540, DOI 10.1074/jbc.M109.058396; Callahan KP, 2008, NUCLEIC ACIDS RES, V36, P6645, DOI 10.1093/nar/gkn743; Carneiro T, 2007, MOL CELL BIOL, V27, P4157, DOI 10.1128/MCB.00120-07; Carnes J, 2005, P NATL ACAD SCI USA, V102, P16614, DOI 10.1073/pnas.0506133102; Carpousis AJ, 2007, ANNU REV MICROBIOL, V61, P71, DOI 10.1146/annurev.micro.61.080706.093440; Clay NK, 2005, PLANT CELL, V17, P1994, DOI 10.1105/tpc.105.032771; Cristodero M, 2007, NUCLEIC ACIDS RES, V35, P7023, DOI 10.1093/nar/gkm736; CUDNY H, 1981, J BIOL CHEM, V256, P5633; DECKER CJ, 1990, CELL, V61, P1001, DOI 10.1016/0092-8674(90)90065-M; Duan XT, 2009, J PROTEOME RES, V8, P2838, DOI 10.1021/pr900001t; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Engstler M, 2004, GENE DEV, V18, P2798, DOI 10.1101/gad.323404; Etheridge RD, 2008, EMBO J, V27, P1596, DOI 10.1038/emboj.2008.87; Evguenieva-Hackenberg E, 2009, PROG MOL BIOL TRANSL, V85, P275, DOI 10.1016/S0079-6603(08)00807-6; FEAGIN JE, 1985, NUCLEIC ACIDS RES, V13, P4577, DOI 10.1093/nar/13.12.4577; FEAGIN JE, 1988, MOL CELL BIOL, V8, P1259, DOI 10.1128/MCB.8.3.1259; Fisk JC, 2008, J BIOL CHEM, V283, P23016, DOI 10.1074/jbc.M801021200; Fisk JC, 2010, EUKARYOT CELL, V9, P866, DOI 10.1128/EC.00018-10; Graham AC, 2006, MOL BIOL CELL, V17, P1399, DOI 10.1091/mbc.e05-08-0805; Grams J, 2000, EMBO J, V19, P5525, DOI 10.1093/emboj/19.20.5525; Haile S, 2003, RNA, V9, P1491, DOI 10.1261/rna.5940703; Haile S, 2007, CURR OPIN MICROBIOL, V10, P569, DOI 10.1016/j.mib.2007.10.001; Haile S, 2007, MOL BIOCHEM PARASIT, V151, P52, DOI 10.1016/j.molbiopara.2006.10.005; HARRIS ME, 1990, J BIOL CHEM, V265, P11368; Hashimi H, 2008, RNA, V14, P970, DOI 10.1261/rna.888808; Hashimi H, 2009, RNA, V15, P588, DOI 10.1261/rna.1411809; Hayman ML, 1999, J BIOL CHEM, V274, P12067, DOI 10.1074/jbc.274.17.12067; Henriksson N, 2010, J BIOL CHEM, V285, P163, DOI 10.1074/jbc.M109.043893; Hernandez A, 2010, J BIOL CHEM, V285, P1220, DOI 10.1074/jbc.M109.051862; Ibrahim F, 2010, P NATL ACAD SCI USA, V107, P3906, DOI 10.1073/pnas.0912632107; Jensen BC, 2007, MOL BIOCHEM PARASIT, V151, P28, DOI 10.1016/j.molbiopara.2006.10.002; Kang XD, 2005, P NATL ACAD SCI USA, V102, P1017, DOI 10.1073/pnas.0409275102; Kao CY, 2007, MOL BIOCHEM PARASIT, V154, P158, DOI 10.1016/j.molbiopara.2007.04.014; Kao CY, 2005, MOL CELL BIOL, V25, P1634, DOI 10.1128/MCB.25.5.1634-1644.2005; Keene JD, 2010, ENDOCRINOLOGY, V151, P1391, DOI 10.1210/en.2009-1250; Koslowsky DJ, 1997, MOL BIOCHEM PARASIT, V90, P81, DOI 10.1016/S0166-6851(97)00133-3; KOSLOWSKY DJ, 1992, MOL CELL BIOL, V12, P2043, DOI 10.1128/MCB.12.5.2043; KOSLOWSKY DJ, 1990, CELL, V62, P901, DOI 10.1016/0092-8674(90)90265-G; Koslowsky Donna J, 2004, RNA Biol, V1, P28; Lange H, 2008, MOL CELL BIOL, V28, P3038, DOI 10.1128/MCB.02064-07; Lange H, 2009, TRENDS PLANT SCI, V14, P497, DOI 10.1016/j.tplants.2009.06.007; Leung SS, 2001, NUCLEIC ACIDS RES, V29, P703, DOI 10.1093/nar/29.3.703; Li ZW, 1998, P NATL ACAD SCI USA, V95, P2856, DOI 10.1073/pnas.95.6.2856; Lin-Chao S, 2007, J BIOMED SCI, V14, P523, DOI 10.1007/s11373-007-9178-y; Lorkovic ZJ, 2009, TRENDS PLANT SCI, V14, P229, DOI 10.1016/j.tplants.2009.01.007; Lykke-Andersen S, 2009, J CELL SCI, V122, P1487, DOI 10.1242/jcs.047399; Malecki M, 2007, J MOL BIOL, V372, P23, DOI 10.1016/j.jmb.2007.06.074; Mattiacio JL, 2008, NUCLEIC ACIDS RES, V36, P319, DOI 10.1093/nar/gkm690; Mattiacio JL, 2009, FEBS LETT, V583, P2333, DOI 10.1016/j.febslet.2009.06.024; Militello KT, 1999, NUCLEIC ACIDS RES, V27, P1377, DOI 10.1093/nar/27.5.1377; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Mullen TE, 2008, GENE DEV, V22, P50, DOI 10.1101/gad.1622708; Narayanan N, 2006, BIOCHEMISTRY-US, V45, P12617, DOI 10.1021/bi060925c; Niemann M, 2009, NUCLEIC ACIDS RES, V37, P1897, DOI 10.1093/nar/gkp049; Osato D, 2009, RNA, V15, P1338, DOI 10.1261/rna.1642809; Panigrahi AK, 2008, MOL CELL PROTEOMICS, V7, P534, DOI 10.1074/mcp.M700430-MCP200; Panigrahi AK, 2006, RNA, V12, P1038, DOI 10.1261/rna.45506; Panigrahi AK, 2009, PROTEOMICS, V9, P434, DOI 10.1002/pmic.200800477; Penschow JL, 2004, EUKARYOT CELL, V3, P1206, DOI 10.1128/EC.3.5.1206-1216.2004; Phillips S, 2003, RNA, V9, P1098, DOI 10.1261/rna.5560903; Picard F, 2009, CR BIOL, V332, P958, DOI 10.1016/j.crvi.2009.09.005; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; POLLARD VW, 1991, MOL CELL BIOL, V11, P1668, DOI 10.1128/MCB.11.3.1668; Portnoy V, 2006, NUCLEIC ACIDS RES, V34, P5923, DOI 10.1093/nar/gkl763; Ramachandran V, 2008, SCIENCE, V321, P1490, DOI 10.1126/science.1163728; READ LK, 1994, MOL BIOCHEM PARASIT, V68, P297, DOI 10.1016/0166-6851(94)90174-0; READ LK, 1992, J BIOL CHEM, V267, P1123; READ LK, 1994, MOL CELL BIOL, V14, P2629, DOI 10.1128/MCB.14.4.2629; Regnier P, 2009, PROG MOL BIOL TRANSL, V85, P137, DOI 10.1016/S0079-6603(08)00804-0; RILEY GR, 1994, J BIOL CHEM, V269, P6101; Rissland OS, 2009, NAT STRUCT MOL BIOL, V16, P616, DOI 10.1038/nsmb.1601; Rogers K, 2007, J BIOL CHEM, V282, P29073, DOI 10.1074/jbc.M704551200; ROUSSELL DL, 1993, P NATL ACAD SCI USA, V90, P9300, DOI 10.1073/pnas.90.20.9300; Rusche LN, 1997, EMBO J, V16, P4069, DOI 10.1093/emboj/16.13.4069; Ryan CM, 2006, MOL BIOCHEM PARASIT, V146, P68, DOI 10.1016/j.molbiopara.2005.10.019; Ryan CM, 2003, J BIOL CHEM, V278, P32753, DOI 10.1074/jbc.M303552200; Schimanski B, 2005, EUKARYOT CELL, V4, P1942, DOI 10.1128/EC.4.11.1942-1950.2005; Schnaufer A, 2001, SCIENCE, V291, P2159, DOI 10.1126/science.1058655; Schnaufer A, 2010, J BIOL CHEM, V285, P5282, DOI 10.1074/jbc.M109.059378; Schuster G, 2009, PROG MOL BIOL TRANSL, V85, P393, DOI 10.1016/S0079-6603(08)00810-6; SEIWERT SD, 1994, SCIENCE, V266, P114, DOI 10.1126/science.7524149; SHAPIRO TA, 1995, ANNU REV MICROBIOL, V49, P117, DOI 10.1146/annurev.mi.49.100195.001001; SOUZA AE, 1993, MOL CELL BIOL, V13, P6832, DOI 10.1128/MCB.13.11.6832; SOUZA AE, 1992, MOL CELL BIOL, V12, P2100, DOI 10.1128/MCB.12.5.2100; Stuart KD, 2005, TRENDS BIOCHEM SCI, V30, P97, DOI 10.1016/j.tibs.2004.12.006; Stuart K, 2008, J CLIN INVEST, V118, P1301, DOI 10.1172/JCI33945; Taghbalout A, 2008, MOL MICROBIOL, V70, P780, DOI 10.1111/j.1365-2958.2008.06457.x; Tan THP, 2002, MOL CELL BIOL, V22, P3707, DOI 10.1128/MCB.22.11.3707-3716.2002; Vondruskova E, 2005, J BIOL CHEM, V280, P2429, DOI 10.1074/jbc.M405933200; WEBB JR, 1993, J BIOL CHEM, V268, P13994; Weng J, 2008, MOL CELL, V32, P198, DOI 10.1016/j.molcel.2008.08.023; Wickens M, 2008, SCIENCE, V319, P1344, DOI 10.1126/science.1154946; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Yu LE, 2006, RNA, V12, P1050, DOI 10.1261/rna.3406; Zuo YH, 2005, STRUCTURE, V13, P973, DOI 10.1016/j.str.2005.04.015; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017	106	19	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10329	10340		10.1074/jbc.M110.152439	http://dx.doi.org/10.1074/jbc.M110.152439			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21252235	Green Published, hybrid			2022-12-27	WOS:000288547000050
J	Caccamo, A; Maldonado, MA; Majumder, S; Medina, DX; Holbein, W; Magri, A; Oddo, S				Caccamo, Antonella; Maldonado, Monica A.; Majumder, Smita; Medina, David X.; Holbein, Walter; Magri, Andrea; Oddo, Salvatore			Naturally Secreted Amyloid-beta Increases Mammalian Target of Rapamycin (mTOR) Activity via a PRAS40-mediated Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; LONG-TERM-MEMORY; PROTEIN-TAU TAU; P70 S6 KINASE; ALZHEIMERS-DISEASE; A-BETA; LIFE-SPAN; SIGNALING PATHWAY; TRANSGENIC MICE; IN-VIVO	Reducing the mammalian target of rapamycin (mTOR) activity increases lifespan and health span in a variety of organisms. Alterations in protein homeostasis and mTOR activity and signaling have been reported in several neurodegenerative disorders, including Alzheimer disease (AD); however, the causes of such deregulations remain elusive. Here, we show that mTOR activity and signaling are increased in cell lines stably transfected with mutant amyloid precursor protein (APP) and in brains of 3xTg-AD mice, an animal model of AD. In addition, we show that in the 3xTg-AD mice, mTOR activity can be reduced to wild type levels by genetically preventing A beta accumulation. Similarly, intrahippocampal injections of an anti-A beta antibody reduced A beta levels and normalized mTOR activity, indicating that high A beta levels are necessary for mTOR hyperactivity in 3xTg-AD mice. We also show that the intrahippocampal injection of naturally secreted A beta is sufficient to increase mTOR signaling in the brains of wild type mice. The mechanism behind the A beta-induced mTOR hyperactivity is mediated by the proline- rich Akt substrate 40 (PRAS40) as we show that the activation of PRAS40 plays a key role in the A beta-induced mTOR hyperactivity. Taken together, our data show that A beta accumulation, which has been suggested to be the culprit of AD pathogenesis, causes mTOR hyperactivity by regulating PRAS40 phosphorylation. These data further indicate that the mTOR pathway is one of the pathways by which A beta exerts its toxicity and further support the idea that reducing mTOR signaling in AD may be a valid therapeutic approach.	[Caccamo, Antonella; Maldonado, Monica A.; Majumder, Smita; Medina, David X.; Holbein, Walter; Magri, Andrea; Oddo, Salvatore] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Caccamo, Antonella; Maldonado, Monica A.; Majumder, Smita; Medina, David X.; Magri, Andrea; Oddo, Salvatore] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Oddo, S (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	oddo@uthscsa.edu	Magrì, Andrea/K-4580-2016	Magrì, Andrea/0000-0002-3080-2667; Oddo, Salvatore/0000-0001-7304-7430	National Institutes of Health [K99/R00 AG29729-4]; NIA [RC2AG036613]; NATIONAL INSTITUTE ON AGING [R00AG029729, R01AG037637, RC2AG036613, K99AG029729] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants K99/R00 AG29729-4 (to S. O.) and RC2AG036613 (to S. O., Sub-Principal Investigator) from the NIA.	An WL, 2003, AM J PATHOL, V163, P591, DOI 10.1016/S0002-9440(10)63687-5; Bhaskar K, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-14; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Bolduc FV, 2008, NAT NEUROSCI, V11, P1143, DOI 10.1038/nn.2175; Caccamo A, 2010, J BIOL CHEM, V285, P13107, DOI 10.1074/jbc.M110.100420; Caccamo A, 2009, J BIOL CHEM, V284, P27416, DOI 10.1074/jbc.M109.031278; Cao RF, 2009, J NEUROSCI, V29, P12372, DOI 10.1523/JNEUROSCI.3486-09.2009; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Chang RCC, 2002, NEUROREPORT, V13, P2429, DOI 10.1097/00001756-200212200-00011; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Choo AY, 2009, CELL CYCLE, V8, P567, DOI 10.4161/cc.8.4.7659; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Cohen E, 2009, CELL, V139, P1157, DOI 10.1016/j.cell.2009.11.014; Cuervo AM, 2004, MOL CELL BIOCHEM, V263, P55, DOI 10.1023/B:MCBI.0000041848.57020.57; Das F, 2008, CELL SIGNAL, V20, P409, DOI 10.1016/j.cellsig.2007.10.027; Easton JB, 2006, CANCER CELL, V9, P153, DOI 10.1016/j.ccr.2006.02.027; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Glabe CC, 2005, SUB CELL BIOCHEM, V38, P167; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Griffin RJ, 2005, J NEUROCHEM, V93, P105, DOI 10.1111/j.1471-4159.2004.02949.x; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; IHARA Y, 1986, J BIOCHEM-TOKYO, V99, P1807, DOI 10.1093/oxfordjournals.jbchem.a135662; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Ito S, 2007, EXP GERONTOL, V42, P532, DOI 10.1016/j.exger.2006.11.012; Ito S, 2006, NEUROSCI RES, V56, P294, DOI 10.1016/j.neures.2006.07.009; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Khurana V, 2006, CURR BIOL, V16, P230, DOI 10.1016/j.cub.2005.12.042; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Klein WL, 2002, NEUROCHEM INT, V41, P345, DOI 10.1016/S0197-0186(02)00050-5; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; KOO EH, 1994, J BIOL CHEM, V269, P17386; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009; Malagelada C, 2010, J NEUROSCI, V30, P1166, DOI 10.1523/JNEUROSCI.3944-09.2010; Martin D, 2001, J NEUROCHEM, V78, P1000, DOI 10.1046/j.1471-4159.2001.00472.x; Martinez-Vicente M, 2007, LANCET NEUROL, V6, P352, DOI 10.1016/S1474-4422(07)70076-5; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Meske V, 2008, J BIOL CHEM, V283, P100, DOI 10.1074/jbc.M704292200; Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002; Nascimento EBM, 2010, CELL SIGNAL, V22, P961, DOI 10.1016/j.cellsig.2010.02.002; Oddo S, 2006, J BIOL CHEM, V281, P1599, DOI 10.1074/jbc.M507892200; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2004, NEURON, V43, P321, DOI 10.1016/j.neuron.2004.07.003; Oddo S, 2006, AM J PATHOL, V168, P184, DOI 10.2353/ajpath.2006.050593; Oddo S, 2008, J CELL MOL MED, V12, P363, DOI 10.1111/j.1582-4934.2008.00276.x; Oddo S, 2007, J NEUROCHEM, V102, P1053, DOI 10.1111/j.1471-4159.2007.04607.x; Oddo S, 2009, BRAIN PATHOL, V19, P421, DOI 10.1111/j.1750-3639.2008.00194.x; Oddo S, 2008, J NEUROSCI, V28, P12163, DOI 10.1523/JNEUROSCI.2464-08.2008; Oddo S, 2006, J BIOL CHEM, V281, P39413, DOI 10.1074/jbc.M608485200; Onuki R, 2004, EMBO J, V23, P959, DOI 10.1038/sj.emboj.7600049; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Peel AL, 2003, NEUROBIOL DIS, V14, P52, DOI 10.1016/S0969-9961(03)00086-X; Pei JJ, 2008, J ALZHEIMERS DIS, V14, P385; Pei JJ, 2008, J CELL MOL MED, V12, P2525, DOI 10.1111/j.1582-4934.2008.00509.x; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; PODLISNY MB, 1995, J BIOL CHEM, V270, P9564, DOI 10.1074/jbc.270.16.9564; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Puighermanal E, 2009, NAT NEUROSCI, V12, P1152, DOI 10.1038/nn.2369; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Ruan BF, 2008, P NATL ACAD SCI USA, V105, P33, DOI 10.1073/pnas.0710424105; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979; Thoreen CC, 2009, AUTOPHAGY, V5, P725, DOI 10.4161/auto.5.5.8504; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Tischmeyer W, 2003, EUR J NEUROSCI, V18, P942, DOI 10.1046/j.1460-9568.2003.02820.x; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang LF, 2007, J BIOL CHEM, V282, P20036, DOI 10.1074/jbc.M702376200; WELSH KA, 1992, ARCH NEUROL-CHICAGO, V49, P448, DOI 10.1001/archneur.1992.00530290030008; Wilcock DM, 2003, J NEUROSCI, V23, P3745, DOI 10.1523/jneurosci.23-09-03745.2003; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zeng LH, 2009, J NEUROSCI, V29, P6964, DOI 10.1523/JNEUROSCI.0066-09.2009; Zhang F, 2009, CANCER BIOL THER, V8, P846, DOI 10.4161/cbt.8.9.8210; Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com	84	119	125	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8924	8932		10.1074/jbc.M110.180638	http://dx.doi.org/10.1074/jbc.M110.180638			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21266573	hybrid, Green Published			2022-12-27	WOS:000288247700024
J	Kotian, S; Liyanarachchi, S; Zelent, A; Parvin, JD				Kotian, Shweta; Liyanarachchi, Sandhya; Zelent, Arthur; Parvin, Jeffrey D.			Histone Deacetylases 9 and 10 Are Required for Homologous Recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; HDAC INHIBITORS; IN-VIVO; MAMMALIAN-CELLS; DIRECTED REPAIR; CANCER; EXPRESSION; DOMAIN; BRCA1; TRANSCRIPTION	We tested the role of histone deacetylases (HDACs) in the homologous recombination process. A tissue-culture based homology-directed repair assay was used in which repair of a double-stranded break by homologous recombination results in gene conversion of an inactive GFP allele to an active GFP gene. Our rationale was that hyperacetylation caused by HDAC inhibitor treatment would increase chromatin accessibility to repair factors, thereby increasing homologous recombination. Contrary to expectation, treatment of cells with the inhibitors significantly reduced homologous recombination activity. Using RNA interference to deplete each HDAC, we found that depletion of either HDAC9 or HDAC10 specifically inhibited homologous recombination. By assaying for sensitivity of cells to the interstrand cross-linker mitomycin C, we found that treatment of cells with HDAC inhibitors or depletion of HDAC9 or HDAC10 resulted in increased sensitivity to mitomycin C. Our data reveal an unanticipated function of HDAC9 and HDAC10 in the homologous recombination process.	[Kotian, Shweta; Parvin, Jeffrey D.] Ohio State Univ, Dept Biomed Informat, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Zelent, Arthur] Inst Canc Res, Sect Haemato Oncol, Sutton SM2 5NG, Surrey, England	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of London; Institute of Cancer Research - UK	Parvin, JD (corresponding author), Ohio State Univ, Dept Biomed Informat, Ctr Comprehens Canc, Columbus, OH 43210 USA.	jeffrey.parvin@osumc.edu	Zelent, Arthur/B-3532-2009; Kotian, Shweta/GMX-3418-2022; Parvin, Jeffrey D/C-8955-2009	Zelent, Arthur/0000-0002-7968-9888	NCI [R01 CA141090]; NATIONAL CANCER INSTITUTE [R01CA141090] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA141090 from the NCI (to J. D. P.).	Adimoolam S, 2007, P NATL ACAD SCI USA, V104, P19482, DOI 10.1073/pnas.0707828104; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Bhaskara S, 2010, CANCER CELL, V18, P436, DOI 10.1016/j.ccr.2010.10.022; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; BOFFA LC, 1978, J BIOL CHEM, V253, P3364; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Braunstein M, 1996, MOL CELL BIOL, V16, P4349; Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324; Fischer DD, 2002, J BIOL CHEM, V277, P6656, DOI 10.1074/jbc.M108055200; Garber K, 2007, NAT BIOTECHNOL, V25, P17, DOI 10.1038/nbt0107-17; GINSBURG E, 1973, P NATL ACAD SCI USA, V70, P2457, DOI 10.1073/pnas.70.8.2457; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Guidez F, 2001, CURR TOP MICROBIOL, V254, P165; Han JW, 2000, CANCER RES, V60, P6068; HEBBES TR, 1994, EMBO J, V13, P1823, DOI 10.1002/j.1460-2075.1994.tb06451.x; Ikeda K, 1999, MOL CELL BIOL, V19, P855; Kadosh D, 1998, MOL CELL BIOL, V18, P5121, DOI 10.1128/MCB.18.9.5121; Kuo MH, 1998, GENE DEV, V12, P627, DOI 10.1101/gad.12.5.627; Kwon SH, 2002, J BIOL CHEM, V277, P2073, DOI 10.1074/jbc.M106699200; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Lai IL, 2010, J BIOL CHEM, V285, P7187, DOI 10.1074/jbc.M109.061861; Lane AA, 2009, J CLIN ONCOL, V27, P5459, DOI 10.1200/JCO.2009.22.1291; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Marks PA, 2009, J CELL BIOCHEM, V107, P600, DOI 10.1002/jcb.22185; Miller KM, 2010, NAT STRUCT MOL BIOL, V17, P1144, DOI 10.1038/nsmb.1899; Moynahan ME, 2001, CANCER RES, V61, P4842; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Pan LN, 2007, CELL MOL IMMUNOL, V4, P337; Petrie K, 2003, J BIOL CHEM, V278, P16059, DOI 10.1074/jbc.M212935200; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; Ransburgh DJR, 2010, CANCER RES, V70, P988, DOI 10.1158/0008-5472.CAN-09-2850; Uhl M, 2010, DNA REPAIR, V9, P383, DOI 10.1016/j.dnarep.2009.12.020; Vigushin DM, 2001, CLIN CANCER RES, V7, P971; Westermark UK, 2003, MOL CELL BIOL, V23, P7926, DOI 10.1128/MCB.23.21.7926-7936.2003; Wilson AJ, 2006, J BIOL CHEM, V281, P13548, DOI 10.1074/jbc.M510023200; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yuan Z, 2007, CELL CYCLE, V6, P2869, DOI 10.4161/cc.6.23.5026; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhou XB, 2001, P NATL ACAD SCI USA, V98, P10572, DOI 10.1073/pnas.191375098; Zhu P, 2004, CANCER CELL, V5, P455, DOI 10.1016/S1535-6108(04)00114-X	42	66	69	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7722	7726		10.1074/jbc.C110.194233	http://dx.doi.org/10.1074/jbc.C110.194233			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21247901	Green Published, hybrid			2022-12-27	WOS:000288013300002
J	Xia, CW; Hamdane, D; Shen, AL; Choi, V; Kasper, CB; Pearl, NM; Zhang, HM; Im, SC; Waskell, L; Kim, JJP				Xia, Chuanwu; Hamdane, Djemel; Shen, Anna L.; Choi, Vivian; Kasper, Charles B.; Pearl, Naw May; Zhang, Haoming; Im, Sang-Choul; Waskell, Lucy; Kim, Jung-Ja P.			Conformational Changes of NADPH-Cytochrome P450 Oxidoreductase Are Essential for Catalysis and Cofactor Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-TRANSFER; DISULFIDE BOND; OXIDATION-REDUCTION; P-450 REDUCTASE; PROTEIN; FMN; STABILIZATION; MECHANISM; SITE; FAD	The crystal structure of NADPH-cytochrome P450 reductase (CYPOR) implies that a large domain movement is essential for electron transfer from NADPH via FAD and FMN to its redox partners. To test this hypothesis, a disulfide bond was engineered betweenresiduesAsp(147) and Arg(514) in the FMN and FAD domains, respectively. The cross-linked form of this mutant protein, designated 147CC514, exhibited a significant decrease in the rate of interflavin electron transfer and large (>= 90%) decreases in rates of electron transfer to its redox partners, cytochrome c and cytochrome P450 2B4. Reduction of the disulfide bond restored the ability of the mutant to reduce its redox partners, demonstrating that a conformational change is essential for CYPOR function. The crystal structures of the mutant without and with NADP(+) revealed that the two flavin domains are joined by a disulfide linkage and that the relative orientations of the two flavin rings are twisted similar to 20 degrees compared with the wild type, decreasing the surface contact area between the two flavin rings. Comparison of the structures without and with NADP(+) shows movement of the Gly(631)-Asn(635) loop. IntheNADP(+) -free structure, the loop adopts a conformation that sterically hinders NADP( H) binding. The structure with NADP(+) shows movement of the Gly(631)-Asn(635) loop to a position that permits NADP(H) binding. Furthermore, comparison of these mutant and wild type structures strongly suggests that the Gly(631)-Asn(635) loop movement controls NADPH binding and NADP(+) release; this loop movement in turn facilitates the flavin domain movement, allowing electron transfer from FMN to the CYPOR redox partners.	[Waskell, Lucy] Univ Michigan, Dept Anesthesiol, Ann Arbor, MI 48105 USA; [Hamdane, Djemel; Pearl, Naw May; Zhang, Haoming; Im, Sang-Choul; Waskell, Lucy] Vet Affairs Med Res Ctr, Ann Arbor, MI 48105 USA; [Xia, Chuanwu; Kim, Jung-Ja P.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Shen, Anna L.; Choi, Vivian; Kasper, Charles B.] Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA	University of Michigan System; University of Michigan; Medical College of Wisconsin; University of Wisconsin System; University of Wisconsin Madison	Waskell, L (corresponding author), Univ Michigan, Dept Anesthesiol, 2215 Fuller Rd, Ann Arbor, MI 48105 USA.	waskell@umich.edu; jjkim@mcw.edu	Zhang, Haoming/AAE-3749-2020	Zhang, Haoming/0000-0002-8765-4394; Choi, Vivian/0000-0003-4787-0735	National Institutes of Health [CA22484, GM35533, GM52682]; Veterans Affairs; NATIONAL CANCER INSTITUTE [P01CA022484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052682, R01GM035533] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA22484 (to A. L. S. and C. B. K.), GM35533 (to L. W.), and GM52682 (to J.-J. P. K.). This work was also supported by a Veterans Affairs merit review grant (to L. W.).	Aigrain L, 2009, EMBO REP, V10, P742, DOI 10.1038/embor.2009.82; Ausubel F.A., 1997, CURRENT PROTOCOLS MO, DOI DOI 10.1.4; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; Bridges A, 1998, J BIOL CHEM, V273, P17036, DOI 10.1074/jbc.273.27.17036; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; CAREAGA CL, 1992, BIOPHYS J, V62, P209, DOI 10.1016/S0006-3495(92)81806-4; CAREAGA CL, 1992, J MOL BIOL, V226, P1219, DOI 10.1016/0022-2836(92)91063-U; DAGGETT V, 1993, ANNU REV BIOPH BIOM, V22, P353, DOI 10.1146/annurev.bb.22.060193.002033; de Montellano PRO, 2010, CHEM REV, V110, P932, DOI 10.1021/cr9002193; Ellis J, 2009, J BIOL CHEM, V284, P36628, DOI 10.1074/jbc.M109.054304; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gainer JV, 2008, J AM SOC NEPHROL, V19, P1606, DOI 10.1681/ASN.2008010063; GRUENKE LD, 1995, J BIOL CHEM, V270, P24707, DOI 10.1074/jbc.270.42.24707; Guengerich F.P., 2005, CYTOCHROME P450 STRU, V3rd ed., P377, DOI [10.1007/0-387-27447-2_10, DOI 10.1007/0-387-27447-2_10]; GUSEV NB, 1991, J BIOL CHEM, V266, P16622; Gutierrez A, 2002, BIOCHEMISTRY-US, V41, P4626, DOI 10.1021/bi0159433; Gutierrez A, 2001, BIOCHEMISTRY-US, V40, P1964, DOI 10.1021/bi001719m; Hamdane D, 2009, J BIOL CHEM, V284, P11374, DOI 10.1074/jbc.M807868200; Hay S, 2010, J AM CHEM SOC, V132, P9738, DOI 10.1021/ja1016206; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hubbard PA, 2001, J BIOL CHEM, V276, P29163, DOI 10.1074/jbc.M101731200; Hull RV, 2001, BIOPHYS CHEM, V90, P9, DOI 10.1016/S0301-4622(00)00239-8; IYANAGI T, 1974, BIOCHEMISTRY-US, V13, P1701, DOI 10.1021/bi00705a023; JENG MF, 1995, BIOCHEMISTRY-US, V34, P611, DOI 10.1021/bi00002a028; KANAYA S, 1991, J BIOL CHEM, V266, P6038; KUTHAN H, 1982, BIOCHEM J, V203, P551, DOI 10.1042/bj2030551; Lamb DC, 2006, STRUCTURE, V14, P51, DOI 10.1016/j.str.2005.09.015; MASTERS BSS, 1965, J BIOL CHEM, V240, P921; MATSUMURA M, 1989, NATURE, V342, P291, DOI 10.1038/342291a0; MATTHEWS RG, 1991, FLAVINS AND FLAVOPROTEINS 1990, P593; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McPherson A., 1999, CRYSTALLIZATION BIOL; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; NISIMOTO Y, 1986, J BIOL CHEM, V261, P14232; OMURA T, 1964, J BIOL CHEM, V239, P2379; OPRIAN DD, 1982, J BIOL CHEM, V257, P8935; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Page CC, 2003, CURR OPIN CHEM BIOL, V7, P551, DOI 10.1016/j.cbpa.2003.08.005; Paine M.J.I., 2005, CYTOCHROME P450 STRU, P115, DOI DOI 10.1007/0-387-27447-2_4; PANTOLIANO MW, 1987, BIOCHEMISTRY-US, V26, P2077, DOI 10.1021/bi00382a002; PERRY LJ, 1984, SCIENCE, V226, P555, DOI 10.1126/science.6387910; Saribas AS, 2001, PROTEIN EXPRES PURIF, V21, P303, DOI 10.1006/prep.2000.1377; Scott EE, 2004, J BIOL CHEM, V279, P27294, DOI 10.1074/jbc.M403349200; SEM DS, 1994, BIOCHEMISTRY-US, V33, P12012, DOI 10.1021/bi00206a002; SHEN AL, 1991, J BIOL CHEM, V266, P19976; SHEN AL, 1989, J BIOL CHEM, V264, P7584; SHEN AL, 1995, J BIOL CHEM, V270, P27475, DOI 10.1074/jbc.270.46.27475; Shen AL, 1999, J BIOL CHEM, V274, P5391, DOI 10.1074/jbc.274.9.5391; Shen AL, 2000, J BIOL CHEM, V275, P41087, DOI 10.1074/jbc.M008380200; VERMILION JL, 1981, J BIOL CHEM, V256, P266; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411	52	79	83	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M111.230532	http://dx.doi.org/10.1074/jbc.M111.230532			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21345800	hybrid, Green Published			2022-12-27	WOS:000290022800064
J	Kiris, E; Ventimiglia, D; Sargin, ME; Gaylord, MR; Altinok, A; Rose, K; Manjunath, BS; Jordan, MA; Wilson, L; Feinstein, SC				Kiris, Erkan; Ventimiglia, Donovan; Sargin, Mehmet E.; Gaylord, Michelle R.; Altinok, Alphan; Rose, Kenneth; Manjunath, B. S.; Jordan, Mary Ann; Wilson, Leslie; Feinstein, Stuart C.			Combinatorial Tau Pseudophosphorylation MARKEDLY DIFFERENT REGULATORY EFFECTS ON MICROTUBULE ASSEMBLY AND DYNAMIC INSTABILITY THAN THE SUM OF THE INDIVIDUAL PARTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLINE-DIRECTED PHOSPHORYLATION; PAIRED HELICAL FILAMENTS; AXONAL-TRANSPORT DEFECTS; ALZHEIMERS-DISEASE; PROTEIN-TAU; NEUROFIBRILLARY TANGLES; NEURODEGENERATIVE DISEASES; INDIVIDUAL MICROTUBULES; STABILIZED MICROTUBULES; SYNTHASE KINASE-3-BETA	Tau is a multiply phosphorylated protein that is essential for the development and maintenance of the nervous system. Errors in Tau action are associated with Alzheimer disease and related dementias. A huge literature has led to the widely held notion that aberrant Tau hyperphosphorylation is central to these disorders. Unfortunately, our mechanistic understanding of the functional effects of combinatorial Tau phosphorylation remains minimal. Here, we generated four singly pseudophosphorylated Tau proteins (at Thr(231), Ser(262), Ser(396), and Ser(404)) and four doubly pseudophosphorylated Tau proteins using the same sites. Each Tau preparation was assayed for its abilities to promote microtubule assembly and to regulate microtubule dynamic instability in vitro. All four singly pseudophosphorylated Tau proteins exhibited loss-of-function effects. In marked contrast to the expectation that doubly pseudophosphorylated Tau would be less functional than either of its corresponding singly pseudophosphorylated forms, all of the doubly pseudophosphorylated Tau proteins possessed enhanced microtubule assembly activity and were more potent at regulating dynamic instability than their compromised singly pseudophosphorylated counterparts. Thus, the effects of multiple pseudophosphorylations were not simply the sum of the effects of the constituent single pseudophosphorylations; rather, they were generally opposite to the effects of singly pseudophosphorylated Tau. Further, despite being pseudophosphorylated at different sites, the four singly pseduophosphorylated Tau proteins often functioned similarly, as did the four doubly pseudophosphorylated proteins. These data lead us to reassess the conventional view of combinatorial phosphorylation in normal and pathological Tau action. They may also be relevant to the issue of combinatorial phosphorylation as a general regulatory mechanism.	[Kiris, Erkan; Ventimiglia, Donovan; Gaylord, Michelle R.; Jordan, Mary Ann; Wilson, Leslie; Feinstein, Stuart C.] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Kiris, Erkan; Ventimiglia, Donovan; Gaylord, Michelle R.; Jordan, Mary Ann; Wilson, Leslie; Feinstein, Stuart C.] Univ Calif Santa Barbara, Dept Mol & Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Kiris, Erkan; Sargin, Mehmet E.; Altinok, Alphan; Rose, Kenneth; Manjunath, B. S.; Wilson, Leslie; Feinstein, Stuart C.] Univ Calif Santa Barbara, Ctr Bioimage Informat, Santa Barbara, CA 93106 USA; [Sargin, Mehmet E.; Altinok, Alphan; Rose, Kenneth; Manjunath, B. S.] Univ Calif Santa Barbara, Dept Elect & Comp Engn, Santa Barbara, CA 93106 USA; [Kiris, Erkan] TRUE Res Fdn, San Antonio, TX 78217 USA; [Kiris, Erkan] NCI, NIH, Ft Detrick, MD 21702 USA; [Ventimiglia, Donovan] Rockefeller Univ, New York, NY 10065 USA; [Altinok, Alphan] CALTECH, Pasadena, CA 91125 USA; [Gaylord, Michelle R.] Univ Calif San Diego, La Jolla, CA 92093 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Rockefeller University; California Institute of Technology; University of California System; University of California San Diego	Feinstein, SC (corresponding author), Univ Calif Santa Barbara, Neurosci Res Inst, Bldg 571,Rm 6129, Santa Barbara, CA 93106 USA.	feinstei@lifesci.ucsb.edu	Kiris, Erkan/AAZ-6719-2020; Manjunath, B S/AAM-8190-2020	Kiris, Erkan/0000-0003-2095-0460; Manjunath, B S/0000-0003-2804-3611	National Institutes of Health [NS-35010, NS-13560, CA-57291]; National Science Foundation [ITR-0331697]; NATIONAL CANCER INSTITUTE [R01CA057291] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035010, R01NS013560] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS-35010 (to S. C. F.), NS-13560 (to L. W.), and CA-57291 (to M. A. J.). This work was also supported by National Science Foundation Grant ITR-0331697 (to B. S. M., K. R., S. C. F., and L. W.).	ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Berger Z, 2007, J NEUROSCI, V27, P3650, DOI 10.1523/JNEUROSCI.0587-07.2007; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; Bunker JM, 2006, J BIOL CHEM, V281, P11856, DOI 10.1074/jbc.M509420200; Bunker JM, 2004, MOL BIOL CELL, V15, P2720, DOI 10.1091/mbc.E04-01-0062; BUTNER KA, 1991, J CELL BIOL, V115, P717, DOI 10.1083/jcb.115.3.717; CACERES A, 1991, J NEUROSCI, V11, P1515; Cho JH, 2004, J NEUROCHEM, V88, P349, DOI 10.1046/j.1471-4159.2003.02155.x; Choi MC, 2009, BIOPHYS J, V97, P519, DOI 10.1016/j.bpj.2009.04.047; CLEVELAND DW, 1977, J MOL BIOL, V116, P207, DOI 10.1016/0022-2836(77)90213-3; Delobel P, 2002, J BIOL CHEM, V277, P9199, DOI 10.1074/jbc.M107716200; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Devred F, 2002, FEBS LETT, V523, P247, DOI 10.1016/S0014-5793(02)02999-X; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; Drewes G, 2004, TRENDS BIOCHEM SCI, V29, P548, DOI 10.1016/j.tibs.2004.08.001; DRUBIN DG, 1985, J CELL BIOL, V101, P1799, DOI 10.1083/jcb.101.5.1799; Duncan JE, 2006, PLOS GENET, V2, P1275, DOI 10.1371/journal.pgen.0020124; Eidenmuller J, 2000, BIOCHEMISTRY-US, V39, P13166, DOI 10.1021/bi001290z; Eidenmuller J, 2001, BIOCHEM J, V357, P759, DOI 10.1042/0264-6021:3570759; ENNULAT DJ, 1989, J BIOL CHEM, V264, P5327; ESMAELIAZAD B, 1994, J CELL SCI, V107, P869; Fath T, 2002, J NEUROSCI, V22, P9733; Feinstein SC, 2005, BBA-MOL BASIS DIS, V1739, P268, DOI 10.1016/j.bbadis.2004.07.002; Flaherty DB, 2000, J NEUROSCI RES, V62, P463, DOI 10.1002/1097-4547(20001101)62:3<463::AID-JNR16>3.0.CO;2-7; Gamblin TC, 2003, BIOCHEMISTRY-US, V42, P15009, DOI 10.1021/bi035722s; Geschwind DH, 2003, NEURON, V40, P457, DOI 10.1016/S0896-6273(03)00681-0; Goedert M, 2004, SEMIN CELL DEV BIOL, V15, P45, DOI 10.1016/j.semcdb.2003.12.015; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Goncalves A, 2001, P NATL ACAD SCI USA, V98, P11737, DOI 10.1073/pnas.191388598; Gong CX, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/31825; Goode BL, 1997, MOL BIOL CELL, V8, P353, DOI 10.1091/mbc.8.2.353; GOODE BL, 1994, J CELL BIOL, V124, P769, DOI 10.1083/jcb.124.5.769; Goode BL, 2000, J BIOL CHEM, V275, P38182, DOI 10.1074/jbc.M007489200; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; Haase C, 2004, J NEUROCHEM, V88, P1509, DOI 10.1046/j.1471-4159.2003.02287.x; Hanger DP, 2007, J BIOL CHEM, V282, P23645, DOI 10.1074/jbc.M703269200; Hanger DP, 1998, J NEUROCHEM, V71, P2465; HILLER G, 1978, CELL, V14, P795, DOI 10.1016/0092-8674(78)90335-5; HIMMLER A, 1989, MOL CELL BIOL, V9, P1381, DOI 10.1128/MCB.9.4.1381; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Hooper C, 2008, J NEUROCHEM, V104, P1433, DOI 10.1111/j.1471-4159.2007.05194.x; Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Johnson GVW, 2006, J ALZHEIMERS DIS, V9, P243; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kar S, 2003, EMBO J, V22, P70, DOI 10.1093/emboj/cdg001; Kelleher I, 2007, J NEUROCHEM, V103, P2256, DOI 10.1111/j.1471-4159.2007.04930.x; KENESSEY A, 1993, BRAIN RES, V629, P40, DOI 10.1016/0006-8993(93)90478-6; KNOPS J, 1991, J CELL BIOL, V114, P725, DOI 10.1083/jcb.114.4.725; KOPKE E, 1993, J BIOL CHEM, V268, P24374; KOSIK KS, 1989, NEURON, V2, P1389, DOI 10.1016/0896-6273(89)90077-9; Kraemer BC, 2003, P NATL ACAD SCI USA, V100, P9980, DOI 10.1073/pnas.1533448100; KSIEZAKREDING H, 1992, BRAIN RES, V597, P209, DOI 10.1016/0006-8993(92)91476-U; Kuret J, 2005, BBA-MOL BASIS DIS, V1739, P167, DOI 10.1016/j.bbadis.2004.06.016; Leboeuf AC, 2008, J BIOL CHEM, V283, P36406, DOI 10.1074/jbc.M803519200; LEE G, 1989, NEURON, V2, P1615, DOI 10.1016/0896-6273(89)90050-0; Levy SF, 2005, J BIOL CHEM, V280, P13520, DOI 10.1074/jbc.M413490200; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Lim JN, 2005, BBA-MOL BASIS DIS, V1739, P311, DOI 10.1016/j.bbadis.2004.10.003; Lu PJ, 1999, NATURE, V399, P784; Miller HP, 2010, METHOD CELL BIOL, V95, P3, DOI 10.1016/S0091-679X(10)95001-2; Morfini GA, 2009, J NEUROSCI, V29, P12776, DOI 10.1523/JNEUROSCI.3463-09.2009; MORISHIMAKAWASHIMA M, 1995, NEUROBIOL AGING, V16, P365, DOI 10.1016/0197-4580(95)00027-C; MORISHIMAKAWASHIMA M, 1995, J BIOL CHEM, V270, P823, DOI 10.1074/jbc.270.2.823; Necula M, 2004, J BIOL CHEM, V279, P49694, DOI 10.1074/jbc.M405527200; Panda D, 1996, J BIOL CHEM, V271, P29807, DOI 10.1074/jbc.271.47.29807; PANDA D, 1995, BIOCHEMISTRY-US, V34, P11117, DOI 10.1021/bi00035a017; Panda D, 2003, P NATL ACAD SCI USA, V100, P9548, DOI 10.1073/pnas.1633508100; Peck A, 2011, CYTOSKELETON, V68, P44, DOI 10.1002/cm.20494; Probst A, 2000, ACTA NEUROPATHOL, V99, P469, DOI 10.1007/s004010051148; Rankin CA, 2005, MOL BRAIN RES, V138, P84, DOI 10.1016/j.molbrainres.2005.04.012; Roy S, 2005, ACTA NEUROPATHOL, V109, P5, DOI 10.1007/s00401-004-0952-x; Seifert F, 2007, BIOCHEMISTRY-US, V46, P6277, DOI 10.1021/bi700083z; SEUBERT P, 1995, J BIOL CHEM, V270, P18917, DOI 10.1074/jbc.270.32.18917; Singh TJ, 1996, FEBS LETT, V387, P145, DOI 10.1016/0014-5793(96)00485-1; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Spittaels K, 1999, AM J PATHOL, V155, P2153, DOI 10.1016/S0002-9440(10)65533-2; Steinhilb ML, 2007, MOL BIOL CELL, V18, P5060, DOI 10.1091/mbc.E07-04-0327; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; TOSO RJ, 1993, BIOCHEMISTRY-US, V32, P1285, DOI 10.1021/bi00056a013; TRINCZEK B, 1995, MOL BIOL CELL, V6, P1887, DOI 10.1091/mbc.6.12.1887; VULLIET R, 1992, J BIOL CHEM, V267, P22570; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; Wang JZ, 2008, PROG NEUROBIOL, V85, P148, DOI 10.1016/j.pneurobio.2008.03.002; Wang JZ, 2007, EUR J NEUROSCI, V25, P59, DOI 10.1111/j.1460-9568.2006.05226.x; WATANABE A, 1993, J BIOL CHEM, V268, P25712; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; Yi JJ, 2010, CELL, V142, P144, DOI 10.1016/j.cell.2010.06.010; Yvon AMC, 1999, MOL BIOL CELL, V10, P947, DOI 10.1091/mbc.10.4.947; ZHAI Y, 1994, J CELL SCI, V107, P881; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	95	28	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14257	14270		10.1074/jbc.M111.219311	http://dx.doi.org/10.1074/jbc.M111.219311			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21288907	Green Published, Green Submitted, hybrid, Green Accepted			2022-12-27	WOS:000289556200049
J	Zerrad, L; Merli, A; Schroder, GF; Varga, A; Graczer, E; Pernot, P; Round, A; Vas, M; Bowler, MW				Zerrad, Louiza; Merli, Angelo; Schroeder, Gunnar F.; Varga, Andrea; Graczer, Eva; Pernot, Petra; Round, Adam; Vas, Maria; Bowler, Matthew W.			A Spring-loaded Release Mechanism Regulates Domain Movement and Catalysis in Phosphoglycerate Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGSTROM RESOLUTION STRUCTURE; 3-PHOSPHOGLYCERATE KINASE; COMPLEX; NUCLEOTIDE; REFINEMENT; SCATTERING; MOTIONS; BINDING; CLOSURE; HINGE	Phosphoglycerate kinase (PGK) is the enzyme responsible for the first ATP-generating step of glycolysis and has been implicated extensively in oncogenesis and its development. Solution small angle x-ray scattering (SAXS) data, in combination with crystal structures of the enzyme in complex with substrate and product analogues, reveal a new conformation for the resting state of the enzyme and demonstrate the role of substrate binding in the preparation of the enzyme for domain closure. Comparison of the x-ray scattering curves of the enzyme in different states with crystal structures has allowed the complete reaction cycle to be resolved both structurally and temporally. The enzyme appears to spend most of its time in a fully open conformation with short periods of closure and catalysis, thereby allowing the rapid diffusion of substrates and products in and out of the binding sites. Analysis of the open apoenzyme structure, defined through deformable elastic network refinement against the SAXS data, suggests that interactions in a mostly buried hydrophobic region may favor the open conformation. This patch is exposed on domain closure, making the open conformation more thermodynamically stable. Ionic interactions act to maintain the closed conformation to allow catalysis. The short time PGK spends in the closed conformation and its strong tendency to rest in an open conformation imply a spring-loaded release mechanism to regulate domain movement, catalysis, and efficient product release.	[Zerrad, Louiza; Pernot, Petra; Bowler, Matthew W.] European Synchrotron Radiat Facil, Struct Biol Grp, F-38043 Grenoble, France; [Merli, Angelo] Univ Parma, Dept Biochem & Mol Biol, I-43100 Parma, Italy; [Schroeder, Gunnar F.] Forschungszentrum Julich, Inst Struct Biol & Biophys, D-52425 Julich, Germany; [Varga, Andrea; Graczer, Eva; Vas, Maria] Hungarian Acad Sci, Inst Enzymol, Biol Res Ctr, H-1518 Budapest, Hungary; [Round, Adam] European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble, France	European Synchrotron Radiation Facility (ESRF); University of Parma; Helmholtz Association; Research Center Julich; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Research Centre for Natural Sciences; European Molecular Biology Laboratory (EMBL)	Bowler, MW (corresponding author), European Synchrotron Radiat Facil, Struct Biol Grp, 6 Rue Jules Horowitz, F-38043 Grenoble, France.	bowler@esrf.fr	Bowler, Matthew/B-5722-2011; Graczer, Eva/N-1053-2016; Bowler, Matthew/I-7461-2019; Schröder, Gunnar F/H-5261-2013	Bowler, Matthew/0000-0003-0465-3351; Bowler, Matthew/0000-0003-0465-3351; Schröder, Gunnar F/0000-0003-1803-5431; Round, Adam/0000-0002-0723-8228	Hungarian National Research Grant [77978]	Hungarian National Research Grant	This work was supported in part by Hungarian National Research Grant 77978.	Auerbach G, 1997, STRUCTURE, V5, P1475, DOI 10.1016/S0969-2126(97)00297-9; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balog E, 2007, BIOPHYS J, V92, P1709, DOI 10.1529/biophysj.106.093195; BANKS RD, 1979, NATURE, V279, P773, DOI 10.1038/279773a0; Bernstein BE, 1997, NATURE, V385, P275, DOI 10.1038/385275a0; Bowler MW, 2007, J BIOL CHEM, V282, P14238, DOI 10.1074/jbc.M700203200; Bowler MW, 2010, NEW J CHEM, V34, P784, DOI 10.1039/b9nj00718k; Cliff MJ, 2010, J AM CHEM SOC, V132, P6507, DOI 10.1021/ja100974t; DAVIES GJ, 1994, ACTA CRYSTALLOGR D, V50, P202, DOI 10.1107/S0907444993011138; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flachner B, 2005, BIOCHEMISTRY-US, V44, P16853, DOI 10.1021/bi051726g; Flachner B, 2004, BIOCHEMISTRY-US, V43, P3436, DOI 10.1021/bi035022n; Flores S, 2006, NUCLEIC ACIDS RES, V34, pD296, DOI 10.1093/nar/gkj046; Frederick KK, 2007, NATURE, V448, P325, DOI 10.1038/nature05959; GERSTEIN M, 1994, BIOCHEMISTRY-US, V33, P6739, DOI 10.1021/bi00188a001; Gondeau C, 2008, NUCLEIC ACIDS RES, V36, P3620, DOI 10.1093/nar/gkn212; HARLOS K, 1992, PROTEINS, V12, P133, DOI 10.1002/prot.340120207; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kovari Z, 2002, BIOCHEMISTRY-US, V41, P8796, DOI 10.1021/bi020210j; Krishnan P, 2003, J BIOL CHEM, V278, P36726, DOI 10.1074/jbc.M307052200; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Lay AJ, 2000, NATURE, V408, P869, DOI 10.1038/35048596; Lay AJ, 2002, J BIOL CHEM, V277, P9062, DOI 10.1074/jbc.M111531200; LESLIE AG, 1992, JOINT CCP4 EACMB NEW, V26; Mathe C, 2006, ANTIVIR RES, V71, P276, DOI 10.1016/j.antiviral.2006.04.017; May A, 1996, PROTEINS, V24, P292; Mildvan AS, 1997, PROTEINS, V29, P401, DOI 10.1002/(SICI)1097-0134(199712)29:4<401::AID-PROT1>3.3.CO;2-#; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OPPERDOES FR, 1987, ANNU REV MICROBIOL, V41, P127, DOI 10.1146/annurev.mi.41.100187.001015; Palmai Z, 2009, PROTEINS, V77, P319, DOI 10.1002/prot.22437; Pernot P, 2010, J PHYS CONF SER, V247, DOI 10.1088/1742-6596/247/1/012009; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Sanchez-Weatherby J, 2009, ACTA CRYSTALLOGR D, V65, P1237, DOI 10.1107/S0907444909037822; Sawyer GM, 2008, PROTEINS, V71, P1134, DOI 10.1002/prot.21801; Schroder GF, 2007, STRUCTURE, V15, P1630, DOI 10.1016/j.str.2007.09.021; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Szabo J, 2008, BIOCHEMISTRY-US, V47, P6735, DOI 10.1021/bi800411w; Szilagyi AN, 2001, J MOL BIOL, V306, P499, DOI 10.1006/jmbi.2000.4294; Varga A, 2005, FEBS J, V272, P1867, DOI 10.1111/j.1742-4658.2005.04618.x; Varga A, 2006, FEBS LETT, V580, P2698, DOI 10.1016/j.febslet.2006.04.024; Varga A, 2009, FEBS LETT, V583, P3660, DOI 10.1016/j.febslet.2009.10.048	44	45	49	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14040	14048		10.1074/jbc.M110.206813	http://dx.doi.org/10.1074/jbc.M110.206813			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21349853	Green Published, hybrid			2022-12-27	WOS:000289556200026
J	Lee, SA; Belyaeva, OV; Wu, LZ; Kedishvili, NY				Lee, Seung-Ah; Belyaeva, Olga V.; Wu, Lizhi; Kedishvili, Natalia Y.			Retinol Dehydrogenase 10 but Not Retinol/Sterol Dehydrogenase(s) Regulates the Expression of Retinoic Acid-responsive Genes in Human Transgenic Skin Raft Culture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHORT-CHAIN DEHYDROGENASES/REDUCTASES; BINDING-PROTEIN; VITAMIN-A; CLONING; CANCER; DIFFERENTIATION; KERATINOCYTES; METABOLISM; OXIDATION; CELLS	Retinoic acid is essential for skin growth and differentiation, and its concentration in skin is controlled tightly. In humans, four different members of the short-chain dehydrogenase/reductase (SDR) superfamily of proteins were proposed to catalyze the rate-limiting step in the biosynthesis of retinoic acid (the oxidation of retinol to retinaldehyde). Epidermis contains at least three of these enzymes, but their relative importance for retinoic acid biosynthesis and regulation of gene expression during growth and differentiation of epidermis is not known. Here, we investigated the effect of the four human SDRs on retinoic acid biosynthesis, and their impact on growth and differentiation of keratinocytes using organotypic skin raft culture model of human epidermis. The results of this study demonstrate that ectopic expression of retinol dehydrogenase 10 (RDH10, SDR16C4) in skin rafts dramatically increases proliferation and inhibits differentiation of keratinocytes, consistent with the increased steady-state levels of retinoic acid and activation of retinoic acid-inducible genes in RDH10 rafts. In contrast, SDRs with dual retinol/sterol substrate specificity, namely retinol dehydrogenase 4 (RoDH4, SDR9C8), RoDH-like 3 alpha-hydroxysteroid dehydrogenase (RL-HSD, SDR9C6), and RDH-like SDR (RDHL, SDR9C4) do not affect the expression of retinoic acid-inducible genes but alter the expression levels of several components of extracellular matrix. These results reveal essential differences in the metabolic contribution of RDH10 versus retinol/sterol dehydrogenases to retinoic acid biosynthesis and provide the first evidence that non-retinoid metabolic products of retinol/sterol dehydrogenases affect gene expression in human epidermis.	[Kedishvili, Natalia Y.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Sch Med, Birmingham, AL 35294 USA; [Kedishvili, Natalia Y.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Sch Dent, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Kedishvili, NY (corresponding author), Univ Alabama Birmingham, Dept Biochem & Mol Genet, Sch Med, 720 20th St S,440B Kaul Genet Bldg, Birmingham, AL 35294 USA.	nkedishvili@uab.edu		Kedishvili, Natalia/0000-0001-6917-4891	National Institute on Alcohol Abuse and Alcoholism [AA12153]; National Institutes of Health [RR19231, P30 CA13148, P50 AT00477, U54 CA100949, P30 AR50948, P30 DK079337]; NATIONAL CANCER INSTITUTE [P30CA013148, U54CA100949] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [P50AT000477] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR050948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012153] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institute on Alcohol Abuse and Alcoholism Grant AA12153 (to N. Y. K.). The University of Alabama-Birmingham Targeted Metabolomics and Proteomics Laboratory is supported by the National Institutes of Health Grants RR19231, P30 CA13148, P50 AT00477, U54 CA100949, P30 AR50948, and P30 DK079337.	ANDERSSON E, 1994, BBA-MOL CELL RES, V1224, P349, DOI 10.1016/0167-4889(94)90267-4; ASSELINEAU D, 1989, DEV BIOL, V133, P322, DOI 10.1016/0012-1606(89)90037-7; Banerjee NS, 2005, METH MOLEC MED, V119, P187; Baron JM, 2005, J INVEST DERMATOL, V125, P143, DOI 10.1111/j.0022-202X.2005.23791.x; Belyaeva OV, 2008, J BIOL CHEM, V283, P20299, DOI 10.1074/jbc.M800019200; Belyaeva OV, 2007, ENDOCRINOLOGY, V148, P2148, DOI 10.1210/en.2006-1491; Belyaeva OV, 2006, GENOMICS, V88, P820, DOI 10.1016/j.ygeno.2006.06.004; Belyaeva OV, 2005, BIOCHEMISTRY-US, V44, P7035, DOI 10.1021/bi050226k; Bernard FX, 2002, EXP DERMATOL, V11, P59, DOI 10.1034/j.1600-0625.2002.110107.x; Biswas MG, 1997, J BIOL CHEM, V272, P15959, DOI 10.1074/jbc.272.25.15959; BUSCH C, 1992, J INVEST DERMATOL, V99, P795, DOI 10.1111/1523-1747.ep12614757; Chatellard-Gruaz D, 1998, J LIPID RES, V39, P1421; CHENG S, 1995, GENE DEV, V9, P2335, DOI 10.1101/gad.9.19.2335; Chetyrkin SV, 2001, J BIOL CHEM, V276, P22278, DOI 10.1074/jbc.M102076200; Chetyrkin SV, 2001, ARCH BIOCHEM BIOPHYS, V386, P1, DOI 10.1006/abbi.2000.2203; Cheung C, 1999, BIOCHEM BIOPH RES CO, V261, P100, DOI 10.1006/bbrc.1999.0943; Chintala S, 2005, P NATL ACAD SCI USA, V102, P10964, DOI 10.1073/pnas.0502856102; Fisher GJ, 1996, FASEB J, V10, P1002, DOI 10.1096/fasebj.10.9.8801161; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; Gough WH, 1998, J BIOL CHEM, V273, P19778, DOI 10.1074/jbc.273.31.19778; Gudas Lorraine J., 1994, P443; Hedblom E, 1997, J BIOL CHEM, V272, P15346, DOI 10.1074/jbc.272.24.15346; Hoover F, 2001, J COMP NEUROL, V436, P324; Itoh Y, 2008, GLYCOBIOLOGY, V18, P74, DOI 10.1093/glycob/cwm118; Jin N, 2005, CELL TISSUE RES, V321, P173, DOI 10.1007/s00441-005-1130-8; Jurukovski V, 1999, MOL GENET METAB, V67, P62, DOI 10.1006/mgme.1999.2840; Kallberg Y, 2010, FEBS J, V277, P2375, DOI 10.1111/j.1742-4658.2010.07656.x; Kang S, 2005, CUTIS, V75, P10; KANG SW, 1995, J INVEST DERMATOL, V105, P549, DOI 10.1111/1523-1747.ep12323445; Karlsson T, 2003, BIOCHEM BIOPH RES CO, V303, P273, DOI 10.1016/S0006-291X(03)00332-2; Karlsson T, 2002, EXP DERMATOL, V11, P143, DOI 10.1034/j.1600-0625.2002.110206.x; Karlsson T, 2010, J DERMATOL SCI, V57, P207, DOI 10.1016/j.jdermsci.2009.12.013; Lapshina EA, 2003, BIOCHEMISTRY-US, V42, P776, DOI 10.1021/bi026836r; Leclerc EA, 2009, J CELL SCI, V122, P2699, DOI 10.1242/jcs.050302; Lo M, 2008, J CELL PHYSIOL, V215, P593, DOI 10.1002/jcp.21366; Lorie EP, 2009, ARCH DERMATOL RES, V301, P475, DOI 10.1007/s00403-009-0937-7; Mangelsdorf David J., 1994, P319; Markova NG, 2003, MOL GENET METAB, V78, P119, DOI 10.1016/S1096-7192(02)00226-3; Matsumoto M, 2008, P NATL ACAD SCI USA, V105, P6720, DOI 10.1073/pnas.0709345105; Meyer-Hoffert U, 2010, J BIOL CHEM, V285, P32174, DOI 10.1074/jbc.M109.091850; Molotkov A, 2004, BIOCHEM J, V383, P295, DOI 10.1042/BJ20040621; NAPOLI JL, 1987, ARCH BIOCHEM BIOPHYS, V255, P95, DOI 10.1016/0003-9861(87)90298-0; Napoli JL, 1998, METH MOL B, V89, P29; Pares X, 2008, CELL MOL LIFE SCI, V65, P3936, DOI 10.1007/s00018-008-8591-3; Park SW, 2009, P NATL ACAD SCI USA, V106, P6950, DOI 10.1073/pnas.0808722106; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pure E, 2009, EXPERT OPIN THER TAR, V13, P967, DOI 10.1517/14728220903103841; RANDOLPH RK, 1993, J BIOL CHEM, V268, P9198; Sani BP, 1997, BIOCHEM PHARMACOL, V53, P1049, DOI 10.1016/S0006-2952(97)00076-2; Sato H, 2000, ANTIOXID REDOX SIGN, V2, P665, DOI 10.1089/ars.2000.2.4-665; Takehara A, 2007, CANCER RES, V67, P9704, DOI 10.1158/0008-5472.CAN-07-2099; Tang XH, 2008, EXP CELL RES, V314, P38, DOI 10.1016/j.yexcr.2007.07.016; Torma H, 1999, ARCH DERMATOL RES, V291, P339, DOI 10.1007/s004030050419; WILSON JL, 1992, CELL GROWTH DIFFER, V3, P471; Wu BX, 2002, INVEST OPHTH VIS SCI, V43, P3365; Wu XR, 2009, KIDNEY INT, V75, P1153, DOI 10.1038/ki.2009.73; Yi Y, 2010, J BIOL CHEM, V285, P21233, DOI 10.1074/jbc.M109.082875; Zafrakas M, 2006, INT J CANCER, V118, P1453, DOI 10.1002/ijc.21517	58	26	27	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13550	13560		10.1074/jbc.M110.181065	http://dx.doi.org/10.1074/jbc.M110.181065			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21345790	hybrid, Green Published			2022-12-27	WOS:000289282200075
J	Mushtaq, M; Nam, TS; Kim, UH				Mushtaq, Mazhar; Nam, Tae-Sik; Kim, Uh-Hyun			Critical Role for CD38-mediated Ca2+ Signaling in Thrombin-induced Procoagulant Activity of Mouse Platelets and Hemostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; CYCLIC ADP-RIBOSE; HEAVY-CHAIN IIA; NONMUSCLE MYOSIN; TYROSINE KINASE; STIMULATED PLATELETS; SYNTHESIZING CD38; ACIDIC ORGANELLES; GLYCOPROTEIN VI; CALCIUM	CD38, a multifunctional enzyme that catalyzes the synthesis of intracellular Ca2+ messengers, cyclic ADP-ribose (cADPR) and nicotinic acid adenine dinucleotide phosphate (NAADP), is known to be expressed on platelets. However, the role of CD38 in platelets remains unclear. Our present results show that treatment of platelets with thrombin results in a rapid and sustained Ca2+ signal, resulting from a coordinated interplay of Ca2+-mobilizing messengers, inositol 1,4,5-trisphosphate, cADP R, and NAADP. By dissecting the signaling pathway using various agents, we delineated that cADPR and NAADP are sequentially produced through CD38 internalization by protein kinase C via myosin heavy chain IIA following phospholipase C activation in thrombin-induced platelets. An inositol 1,4,5-trisphosphate receptor antagonist blocked the thrombin-induced formation of cADPR and NAADP as well as Ca2+ signals. An indispensable response of platelets relying on cytosolic calcium is the surface exposure of phosphatidylserine (PS), which implicates platelet procoagulant activity. Scrutinizing this parameter reveals that CD38(+/+) platelets fully express PS on the surface when stimulated with thrombin, whereas this response was decreased on CD38(-/-) platelets. Similarly, PS exposure and Ca2+ signals were attenuated when platelets were incubated with 8-bromo-cADPR, bafilomycin A1, and a PKC inhibitor. Furthermore, in vivo, CD38-deficient mice exhibited longer bleeding times and unstable formation of thrombus than wild type mice. These results demonstrate that CD38 plays an essential role in thrombin-induced procoagulant activity of platelets and hemostasis via Ca2+ signaling mediated by its products, cADPR and NAADP.	[Mushtaq, Mazhar; Nam, Tae-Sik; Kim, Uh-Hyun] Chonbuk Natl Univ, Dept Biochem, Sch Med, Jeonju 561182, South Korea; [Kim, Uh-Hyun] Chonbuk Natl Univ, Inst Cardiovasc Res, Sch Med, Jeonju 561182, South Korea	Jeonbuk National University; Jeonbuk National University	Kim, UH (corresponding author), Chonbuk Natl Univ, Dept Biochem, Sch Med, Jeonju 561182, South Korea.	uhkim@chonbuk.ac.kr	Mushtaq, Mazhar/L-3366-2019	Mushtaq, Mazhar/0000-0002-2126-924X; Kim, Uh-Hyun/0000-0003-3304-7190	Korea Science and Engineering Foundation (National Research Laboratory) [R0A-2007-000-20121-0]	Korea Science and Engineering Foundation (National Research Laboratory)(Korea Science and Engineering Foundation)	This work was supported by the Korea Science and Engineering Foundation (National Research Laboratory Grant R0A-2007-000-20121-0) (to U.-H. K.).	ARDLIE NG, 1986, THROMB RES, V42, P115, DOI 10.1016/0049-3848(86)90288-4; BEDNAR B, 1995, THROMB RES, V77, P453, DOI 10.1016/0049-3848(95)93881-Y; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Crosby D, 2003, J BIOL CHEM, V278, P24533, DOI 10.1074/jbc.M301847200; Crosby D, 2002, J BIOL CHEM, V277, P9958, DOI 10.1074/jbc.M108965200; DAVIES TA, 1989, J BIOL CHEM, V264, P19600; DeFlora A, 1997, J BIOL CHEM, V272, P12945, DOI 10.1074/jbc.272.20.12945; Giambelluca MS, 2007, BLOOD COAGUL FIBRIN, V18, P303, DOI 10.1097/MBC.0b013e3281223535; Gilio K, 2010, J BIOL CHEM, V285, P23629, DOI 10.1074/jbc.M110.108696; Harper MT, 2010, J BIOL CHEM, V285, P19865, DOI 10.1074/jbc.M109.085654; Heemskerk JWM, 2005, TRENDS CARDIOVAS MED, V15, P86, DOI 10.1016/j.tcm.2005.03.003; Heemskerk JWM, 1997, BLOOD, V90, P2615, DOI 10.1182/blood.V90.7.2615.2615_2615_2625; IKEBE M, 1990, BIOCHEMISTRY-US, V29, P2713, DOI 10.1021/bi00463a014; Jardin I, 2008, TRENDS CARDIOVAS MED, V18, P57, DOI 10.1016/j.tcm.2007.12.004; KAWAMOTO S, 1989, J BIOL CHEM, V264, P2258; Keuren JFW, 2005, ARTERIOSCL THROM VAS, V25, P1499, DOI 10.1161/01.ATV.0000167526.31611.f6; KHAN WA, 1993, J BIOL CHEM, V268, P5063; Kriajevska M, 1998, J BIOL CHEM, V273, P9852, DOI 10.1074/jbc.273.16.9852; Lee HC, 2000, J MEMBRANE BIOL, V173, P1, DOI 10.1007/s002320001001; LEE VS, 1992, J BIOCHEM BIOPH METH, V24, P215, DOI 10.1016/0165-022X(94)90074-4; Lopez JJ, 2006, CELL SIGNAL, V18, P373, DOI 10.1016/j.cellsig.2005.05.006; Lopez JJ, 2005, BIOCHEM J, V390, P243, DOI 10.1042/BJ20050168; Ludowyke RI, 2006, J IMMUNOL, V177, P1492, DOI 10.4049/jimmunol.177.3.1492; LYONS RM, 1975, J CLIN INVEST, V56, P924, DOI 10.1172/JCI108172; Michelangeli F, 2005, CURR OPIN CELL BIOL, V17, P135, DOI 10.1016/j.ceb.2005.01.005; MOUSSAVI RS, 1993, MOL CELL BIOCHEM, V128, P219, DOI 10.1007/BF01076773; Ohlmann P, 1998, BIOCHEM J, V331, P431, DOI 10.1042/bj3310431; Paul BZS, 1999, J BIOL CHEM, V274, P28293, DOI 10.1074/jbc.274.40.28293; Pestina TI, 1997, ARTERIOSCL THROM VAS, V17, P3278, DOI 10.1161/01.ATV.17.11.3278; Rah SY, 2007, J BIOL CHEM, V282, P5653, DOI 10.1074/jbc.M609478200; Rah SY, 2005, J BIOL CHEM, V280, P2888, DOI 10.1074/jbc.M409592200; Ramaschi G, 1996, BLOOD, V87, P2308, DOI 10.1182/blood.V87.6.2308.bloodjournal8762308; Renne T, 2005, J EXP MED, V202, P271, DOI 10.1084/jem.20050664; Ribeiro JMC, 2001, J EXP BIOL, V204, P3887; Roberts DE, 2004, J BIOL CHEM, V279, P19421, DOI 10.1074/jbc.M308864200; Rosado JA, 2006, ARCH BIOCHEM BIOPHYS, V452, P9, DOI 10.1016/j.abb.2006.05.011; SIFFERT W, 1988, J BIOL CHEM, V263, P4223; Straussman R, 2001, J CELL SCI, V114, P3047; Torti M, 1998, FEBS LETT, V431, P19, DOI 10.1016/S0014-5793(98)00712-1; Torti M, 1998, FEBS LETT, V428, P200, DOI 10.1016/S0014-5793(98)00516-X; Wang XK, 2005, THROMB RES, V115, P95, DOI 10.1016/j.thromres.2004.07.009; WATSON SP, 1988, BIOCHEM J, V249, P345, DOI 10.1042/bj2490345; Williamson P, 2001, BIOCHEMISTRY-US, V40, P8065, DOI 10.1021/bi001929z; Wolfs JL, 2006, BLOOD, V108, P2223, DOI 10.1182/blood-2006-01-009613; Zwaal RFA, 2005, CELL MOL LIFE SCI, V62, P971, DOI 10.1007/s00018-005-4527-3	45	39	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					12952	12958		10.1074/jbc.M110.207100	http://dx.doi.org/10.1074/jbc.M110.207100			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21339289	Green Published, hybrid			2022-12-27	WOS:000289282200015
J	Tian, YM; Yeoh, KK; Lee, MK; Eriksson, T; Kessler, BM; Kramer, HB; Edelmann, MJ; Willam, C; Pugh, CW; Schofield, CJ; Ratcliffe, PJ				Tian, Ya-Min; Yeoh, Kar Kheng; Lee, Myung Kyu; Eriksson, Tuula; Kessler, Benedikt M.; Kramer, Holger B.; Edelmann, Mariola J.; Willam, Carsten; Pugh, Christopher W.; Schofield, Christopher J.; Ratcliffe, Peter J.			Differential Sensitivity of Hypoxia Inducible Factor Hydroxylation Sites to Hypoxia and Hydroxylase Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN SENSING PATHWAY; ANKYRIN REPEAT DOMAIN; ASPARAGINYL HYDROXYLASE; PROLYL 4-HYDROXYLASES; FACTOR HIF; TRANSCRIPTIONAL ACTIVITY; STRUCTURAL BASIS; FACTOR-ALPHA; FACTOR FIH; HIF-1-ALPHA	Hypoxia inducible factor (HIF) is regulated by dual pathways involving oxygen-dependent prolyl and asparaginyl hydroxylation of its alpha-subunits. Prolyl hydroxylation at two sites within a central degradation domain promotes association of HI F-alpha with the von Hippel-Lindau ubiquitin E3 ligase and destruction by the ubiquitin-proteasome pathways. Asparaginyl hydroxylation blocks the recruitment of p300/CBP co-activators to a C-terminal activation domain in HIF-alpha. These hydroxylations are catalyzed by members of the FOLD and 2-oxoglutarate (2-OG) oxygenase family. Activity of the enzymes is suppressed by hypoxia, increasing both the abundance and activity of the HIF transcriptional complex. We have used hydroxy residue-specific antibodies to compare and contrast the regulation of each site of prolyl hydroxylation (Pro(402), Pro(564)) with that of asparaginyl hydroxylation (Asn(803)) in human HIF-1 alpha. Our findings reveal striking differences in the sensitivity of these hydroxylations to hypoxia and to different inhibitor types of 2-OG oxygenases. Hydroxylation at the three sites in endogenous human HIF-1 alpha proteins was suppressed by hypoxia in the order Pro(402) > Pro(564) > Asn(803). In contrast to some predictions from in vitro studies, prolyl hydroxylation was substantially more sensitive than asparaginyl hydroxylation to inhibition by iron chelators and transition metal ions; studies of a range of different small molecule 2-OG analogues demonstrated the feasibility of selectively inhibiting either prolyl or asparaginyl hydroxylation within cells.	[Tian, Ya-Min; Eriksson, Tuula; Kessler, Benedikt M.; Kramer, Holger B.; Edelmann, Mariola J.; Pugh, Christopher W.; Ratcliffe, Peter J.] Univ Oxford, Nuffield Dept Clin Med, Oxford OX3 7BN, England; [Yeoh, Kar Kheng; Schofield, Christopher J.] Univ Oxford, Chem Res Lab, Dept Chem, Oxford OX1 3TA, England; [Lee, Myung Kyu] Korea Inst Biosci & Biotechnol, BioNanotechnol Res Ctr, Taejon 305333, South Korea; [Willam, Carsten] Univ Erlangen Nurnberg, Med Klin 4, D-91054 Erlangen, Germany	University of Oxford; University of Oxford; University of Erlangen Nuremberg	Ratcliffe, PJ (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Henry Wellcome Bldg Mol Physiol,Roosevelt Dr, Oxford OX3 7BN, England.	pjr@well.ox.ac.uk	Kramer, Holger/AAL-4433-2020; Eriksson, Tuula/J-5984-2012; Kessler, Benedikt/AAY-8614-2021	Kramer, Holger/0000-0002-6400-0945; Kessler, Benedikt/0000-0002-8160-2446; Pugh, Chris/0000-0002-5170-1662; Ratcliffe, Peter/0000-0002-2853-806X; Edelmann, Mariola/0000-0003-0459-7716; Schofield, Christopher/0000-0002-0290-6565	Wellcome Trust; European Union; Malaysian government; Univerisiti Sains Malaysia	Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); Malaysian government; Univerisiti Sains Malaysia	This work was supported by the Wellcome Trust, the European Union 7th framework, the Malaysian government, and a Univerisiti Sains Malaysia fellowship (to K. K. Y.).	Banerji B, 2005, CHEM COMMUN, P5438, DOI 10.1039/b510707e; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Braun RD, 2001, AM J PHYSIOL-HEART C, V280, pH2533, DOI 10.1152/ajpheart.2001.280.6.H2533; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Chan DA, 2005, MOL CELL BIOL, V25, P6415, DOI 10.1128/MCB.25.15.6415-6426.2005; Chowdhury R, 2008, CHEM SOC REV, V37, P1308, DOI 10.1039/b701676j; Cockman ME, 2006, P NATL ACAD SCI USA, V103, P14767, DOI 10.1073/pnas.0606877103; Cockman ME, 2009, MOL CELL PROTEOMICS, V8, P535, DOI 10.1074/mcp.M800340-MCP200; Coleman ML, 2007, J BIOL CHEM, V282, P24027, DOI 10.1074/jbc.M704102200; Dames SA, 2002, P NATL ACAD SCI USA, V99, P5271, DOI 10.1073/pnas.082121399; Dayan F, 2006, CANCER RES, V66, P3688, DOI 10.1158/0008-5472.CAN-05-4564; Doege K, 2005, BLOOD, V106, P2311, DOI 10.1182/blood-2005-03-1138; Ehrismann D, 2007, BIOCHEM J, V401, P227, DOI 10.1042/BJ20061151; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Flashman E, 2008, J BIOL CHEM, V283, P3808, DOI 10.1074/jbc.M707411200; Fraisl P, 2009, NAT REV DRUG DISCOV, V8, P139, DOI 10.1038/nrd2761; Ginouves A, 2008, P NATL ACAD SCI USA, V105, P4745, DOI 10.1073/pnas.0705680105; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Hirsila M, 2005, FASEB J, V19, P1308, DOI 10.1096/fj.04-3399fje; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Koivunen P, 2004, J BIOL CHEM, V279, P9899, DOI 10.1074/jbc.M312254200; Koivunen P, 2006, J BIOL CHEM, V281, P28712, DOI 10.1074/jbc.M604628200; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lee SH, 2008, J BIOMOL SCREEN, V13, P494, DOI 10.1177/1087057108318800; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; McDonough MA, 2005, J AM CHEM SOC, V127, P7680, DOI 10.1021/ja050841b; McNeill LA, 2005, MOL BIOSYST, V1, P321, DOI 10.1039/b511249b; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Myllyharju J, 2009, CURR PHARM DESIGN, V15, P3878, DOI 10.2174/138161209789649457; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Semenza GL, 2007, SCIENCE, V318, P62, DOI 10.1126/science.1147949; Sowter HM, 2003, CANCER RES, V63, P6130; Stiehl DP, 2006, J BIOL CHEM, V281, P23482, DOI 10.1074/jbc.M601719200; Stolze IP, 2004, J BIOL CHEM, V279, P42719, DOI 10.1074/jbc.M406713200; Stubbs CJ, 2009, J MED CHEM, V52, P2799, DOI 10.1021/jm900285r; To KKW, 2005, J BIOL CHEM, V280, P38102, DOI 10.1074/jbc.M504342200; Vaupel P, 2001, SEMIN ONCOL, V28, P29, DOI 10.1016/S0093-7754(01)90210-6; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268; Wilkins SE, 2009, INT J BIOCHEM CELL B, V41, P1563, DOI 10.1016/j.biocel.2009.01.005; Zheng X, 2008, P NATL ACAD SCI USA, V105, P3368, DOI 10.1073/pnas.0711591105	50	134	143	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13041	13051		10.1074/jbc.M110.211110	http://dx.doi.org/10.1074/jbc.M110.211110			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21335549	Green Published, hybrid			2022-12-27	WOS:000289282200024
J	Zhang, C; Chen, XH; Zhang, X; Gao, L; Kong, PY; Peng, XG; Liang, X; Gao, L; Gong, Y; Wang, QY				Zhang, Cheng; Chen, Xing-Hua; Zhang, Xi; Gao, Lei; Kong, Pei-Yan; Peng, Xian-gui; Liang, Xue; Gao, Li; Gong, Yi; Wang, Qing-Yu			Human Umbilical Cord Blood-derived Stromal Cells, a New Resource in the Suppression of Acute Graft-versus-host Disease in Haploidentical Stem Cell Transplantation in Sublethally Irradiated Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-MARROW-TRANSPLANTATION; NATURAL-KILLER-CELLS; NK CELLS; HEMATOLOGIC MALIGNANCIES; ACUTE GVHD; IN-VITRO; PROLIFERATION; PROPHYLAXIS; RESISTANT; GLOBULIN	Human umbilical cord blood-derived stromal cells (hUCBDSCs), a novel population isolated from CD34(+) cells by our laboratory, exerted an immunosuppressive effect on xenogenic T cells. This study aimed to investigate whether hUCBDSCs play a critical role in the suppression of acute graft-versus-host disease (aGVHD). The hUCBDSCs were co-cultured with splenocytes (SPCs) of donor C57BL/6 mice. The aGVHD in the recipient (B6 x BALB/c) F1 mice was induced by the infusion of bone marrow cells and SPCs from donor mice following sublethal irradiation. The shift in vivo for hUCBDSCs was detected. The proliferation and cell cycle of SPCs were tested by cell counting kit-8 and flow cytometry, respectively. The expression of CD49b natural killer (NK) cells and CD3 T cells was detected by flow cytometry in co-culture and post-transplantation. IL-4, and IFN-gamma were detected by ELISA in the serum of co-culture and post-transplantation. The survival tune, body weight, clinical score, and histopathological score were recorded for mice post-transplantation. The hUCBDSCs promoted the proliferation of SPCs and significantly increased the ratio of the S and G(2)/M phase (p < 0.05). The hUCBDSCs significantly increased the expression of CD49b NK cells and IL-4 protein and decreased the expression of CD3 T cells and IFN-gamma protein both in vitro and in vivo. The survival time of mice with co-transplantation of hUCBDSCs was significantly prolonged, and decreased clinical and histopathological scores were also observed. The hUCBDSCs were continually detected in the target organs of GVHD. These results suggest that hUCBDSCs possess the capability of suppressing aGVHD, possibly via their influence on CD3 T cells, NK cells, and cytokines.	[Zhang, Cheng; Chen, Xing-Hua; Zhang, Xi; Gao, Lei; Kong, Pei-Yan; Peng, Xian-gui; Liang, Xue; Gao, Li; Gong, Yi; Wang, Qing-Yu] Third Mil Med Univ, Xinqiao Hosp, Dept Hematol, Chongqing 400037, Peoples R China	Army Medical University	Zhang, C (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Hematol, Chongqing 400037, Peoples R China.	chzhang2003@tom.com; xhchen888@yahoo.com.cn			National Natural Science Foundation [30971109]; Chong Qing Chongqing Science and Technology Commission [2009BA5011]; Innovation Foundation for Young Scientists of Third Military Medical University [2009D226]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chong Qing Chongqing Science and Technology Commission; Innovation Foundation for Young Scientists of Third Military Medical University	This work was supported by National Natural Science Foundation Grant 30971109, Natural Science Foundation Project of Chong Qing Chongqing Science and Technology Commission 2009BA5011, and the Innovation Foundation for Young Scientists of Third Military Medical University Grant 2009D226.	Alyea EP, 2008, BEST PRACT RES CL HA, V21, P239, DOI 10.1016/j.beha.2008.02.012; Ball LM, 2007, BLOOD, V110, P2764, DOI 10.1182/blood-2007-04-087056; Barrett AJ, 2008, BEST PRACT RES CL HA, V21, P165, DOI 10.1016/j.beha.2008.02.004; Boissel L, 2008, BIOL BLOOD MARROW TR, V14, P1031, DOI 10.1016/j.bbmt.2008.06.016; Cao DL, 2009, TRANSPL IMMUNOL, V20, P243, DOI 10.1016/j.trim.2008.10.011; Chen XH, 2009, BLOOD CELL MOL DIS, V43, P98, DOI 10.1016/j.bcmd.2009.02.005; Chen XH, 2009, BIOL BLOOD MARROW TR, V15, P266, DOI 10.1016/j.bbmt.2008.11.029; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Gao L, 2006, BLOOD CELL MOL DIS, V36, P322, DOI 10.1016/j.bcmd.2005.12.036; Grass JA, 1999, BLOOD, V93, P3140; Hao L, 2009, CROAT MED J, V50, P351, DOI 10.3325/cmj.2009.50.351; Ho VT, 2008, BEST PRACT RES CL HA, V21, P223, DOI 10.1016/j.beha.2008.02.009; Itakura S, 2007, AM J TRANSPLANT, V7, P336, DOI 10.1111/j.1600-6143.2006.01643.x; Koh LP, 2008, BLOOD CELL MOL DIS, V40, P20, DOI 10.1016/j.bcmd.2007.06.017; Krampera M, 2006, STEM CELLS, V24, P386, DOI 10.1634/stemcells.2005-0008; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Min CK, 2007, BONE MARROW TRANSPL, V39, P637, DOI 10.1038/sj.bmt.1705644; Nash RA, 2000, BLOOD, V96, P2062; Rasmusson I, 2003, TRANSPLANTATION, V76, P1208, DOI 10.1097/01.TP.0000082540.43730.80; Ringden O, 2006, TRANSPLANTATION, V81, P1390, DOI 10.1097/01.tp.0000214462.63943.14; Ruggeri L, 2008, BLOOD CELL MOL DIS, V40, P84, DOI 10.1016/j.bcmd.2007.06.029; Ruggeri L, 2006, SEMIN CANCER BIOL, V16, P404, DOI 10.1016/j.semcancer.2006.07.007; Savani BN, 2007, LEUKEMIA, V21, P2145, DOI 10.1038/sj.leu.2404892; Schulze A, 2008, EXP HEMATOL, V36, P378, DOI 10.1016/j.exphem.2007.12.006; Spaggiari GM, 2006, BLOOD, V107, P1484, DOI 10.1182/blood-2005-07-2775; Tanaka J, 2009, HUM IMMUNOL, V70, P701, DOI 10.1016/j.humimm.2009.06.002; Tisato V, 2007, LEUKEMIA, V21, P1992, DOI 10.1038/sj.leu.2404847; Toubai T, 2008, BEST PRACT RES CL HA, V21, P101, DOI 10.1016/j.beha.2008.02.005; Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9; Zeiser R, 2004, ANN HEMATOL, V83, P551, DOI 10.1007/s00277-004-0890-7; Zhang C, 2010, TRANSFUSION MED, V20, P169, DOI 10.1111/j.1365-3148.2010.00990.x; Zhang Cheng, 2008, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V16, P1437	33	16	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13723	13732		10.1074/jbc.M110.144691	http://dx.doi.org/10.1074/jbc.M110.144691			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21349838	Green Published, hybrid			2022-12-27	WOS:000289282200090
J	Cheon, S; Lee, JH; Park, S; Bang, SI; Lee, WJ; Yoon, DY; Yoon, SS; Kim, T; Min, H; Cho, BJ; Lee, HJ; Lee, KW; Jeong, SH; Park, H; Cho, D				Cheon, Soyoung; Lee, Ji Hyung; Park, Sunyoung; Bang, Sa Ik; Lee, Wang Jae; Yoon, Do-Young; Yoon, Sung-Soo; Kim, Taesung; Min, Hyeyoung; Cho, Byung Joo; Lee, Hyong Joo; Lee, Ki Woong; Jeong, Seung Hwan; Park, Hyunjeong; Cho, Daeho			Overexpression of IL-32 alpha Increases Natural Killer Cell-mediated Killing through Up-regulation of Fas and UL16-binding protein 2 (ULBP2) Expression in Human Chronic Myeloid Leukemia Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NKG2D IMMUNORECEPTOR; T-CELLS; INTERLEUKIN-32; ACTIVATION; CANCER; LIGANDS; ROLES; IL-32; APOPTOSIS; CYTOKINE	IL-32 was recently identified as a proinflammatory cytokine that is induced by IL-18 in natural killer (NK) cells and is highly correlated with inflammatory disorders. However, the relationship between IL-32 and tumor progression is still unknown. In this study, we investigated whether overexpression of IL-32 affects susceptibility of chronic myeloid leukemia (CML) cells to NK cells. Interestingly, IL-32 alpha-overexpressing CML cell lines, K562, Kcl22, and BV173, showed higher NK cell-mediated killing. Flow cytometry analysis revealed that overexpression of IL-32 alpha induced increased expression of Fas and UL16-binding protein 2 (ULBP2) in CML cells. The direct relationship between overexpression of surface molecules by IL-32 alpha and increased NK cell-mediated killing was confirmed by Fas or ULBP2 siRNA transfection. IL-32 alpha-induced Fas and ULBP2 expression are regulated p38 MAPK. In addition, the transcription factor Ets1 plays a key role in ULBP2 specific expression by IL-32 alpha overexpression in ULBP family members. Taken together, these data show that IL-32 alpha stimulates Fas and ULBP2 expression via activation of p38 MAPK, which increases NK susceptibility of CML cells. Enhanced NK cell susceptibility of CML cells by IL-32 alpha overexpression may improve the efficiency of NK cell-based immunotherapy.	[Cheon, Soyoung; Park, Sunyoung; Cho, Daeho] Sookmyung Womens Univ, Dept Life Sci, Seoul 140742, South Korea; [Lee, Ji Hyung] Konkuk Univ, Dept Biosci & Biotechnol, Seoul 143701, South Korea; [Bang, Sa Ik] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Plast Surg, Seoul 136710, South Korea; [Lee, Wang Jae] Seoul Natl Univ, Coll Med, Dept Anat, Seoul 110799, South Korea; [Lee, Wang Jae] Seoul Natl Univ, Coll Med, Tumor Immun Med Res Ctr, Seoul 110799, South Korea; [Yoon, Do-Young] Konkuk Univ, Bio Mol Informat Ctr, Dept Biosci & Biotechnol, Seoul 143701, South Korea; [Yoon, Sung-Soo] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 110799, South Korea; [Kim, Taesung] Korea Univ, Grad Sch, Sch Life Sci & Technol, Seoul 136701, South Korea; [Min, Hyeyoung] Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea; [Cho, Byung Joo] Konkuk Univ, Konkuk Univ Hosp, Sch Med, Dept Ophthalmol, Seoul 143729, South Korea; [Lee, Hyong Joo; Lee, Ki Woong] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea; [Lee, Ki Woong; Jeong, Seung Hwan] Namyang Dairy Co Ltd, Ctr Res & Dev, Gongju 314914, South Korea; [Park, Hyunjeong] Catholic Univ Korea, Coll Med, St Marys Hosp, Dept Dermatol, Seoul 137701, South Korea	Sookmyung Women's University; Konkuk University; Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU); Seoul National University (SNU); Konkuk University; Seoul National University (SNU); Korea University; Chung Ang University; Konkuk University; Konkuk University Medical Center; Seoul National University (SNU); Catholic University of Korea; Catholic University Korea Hospital; Seoul St. Mary's Hospital	Park, H (corresponding author), Catholic Univ Korea, Coll Med, St Marys Hosp, Dept Dermatol, 62 Youido Dong, Seoul 150716, South Korea.	hjpark@catholic.ac.kr; cdhkor@sm.ac.kr	Yoon, Sung-Soo/J-2773-2012; Lee, Wang Jae/J-5586-2012; Lee, Ji Hyung/D-5374-2011	, Tae Sung/0000-0002-0384-4407	Korean government (Ministry of Education & Science Technology) [R11-2005-017-05003-0, 10033778]	Korean government (Ministry of Education & Science Technology)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by Grant 10033778 (2009) from the Ministry of Knowledge Economy and National Research Foundation of Korea Grant R11-2005-017-05003-0 funded by the Korean government (Ministry of Education & Science Technology).	BAHRAM S, 1994, P NATL ACAD SCI USA, V91, P6259, DOI 10.1073/pnas.91.14.6259; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Chen KC, 2009, J CELL BIOCHEM, V106, P93, DOI 10.1002/jcb.21979; Choi JD, 2009, IMMUNOLOGY, V126, P535, DOI 10.1111/j.1365-2567.2008.02917.x; Dai Zhiming, 2009, Genomics Proteomics & Bioinformatics, V7, P155, DOI 10.1016/S1672-0229(08)60045-5; Gannage M, 2008, TRANSPLANTATION, V85, P911, DOI 10.1097/TP.0b013e31816691ef; Gloire G, 2008, BIOCHEM PHARMACOL, V76, P1451, DOI 10.1016/j.bcp.2008.06.023; Goda C, 2006, INT IMMUNOL, V18, P233, DOI 10.1093/intimm/dxh339; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Jamieson AM, 2002, IMMUNITY, V17, P19, DOI 10.1016/S1074-7613(02)00333-3; Joosten LAB, 2006, P NATL ACAD SCI USA, V103, P3298, DOI 10.1073/pnas.0511233103; Kim KE, 2007, ONCOGENE, V26, P1468, DOI 10.1038/sj.onc.1209926; Kim KH, 2008, J IMMUNOL METHODS, V333, P38, DOI 10.1016/j.jim.2007.12.017; Kim SH, 2005, IMMUNITY, V22, P131, DOI 10.1016/j.immuni.2004.12.003; Kondo M, 2009, IMMUNOLOGY, V128, pe589, DOI 10.1111/j.1365-2567.2008.03039.x; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lee HR, 2009, IMMUNOL LETT, V123, P72, DOI 10.1016/j.imlet.2009.02.008; Liang SJ, 2005, INT IMMUNOPHARMACOL, V5, P839, DOI 10.1016/j.intimp.2004.12.016; Logan SK, 1996, J BIOL CHEM, V271, P774, DOI 10.1074/jbc.271.2.774; Lopez-Soto A, 2009, ONCOGENE, V28, P2370, DOI 10.1038/onc.2009.117; Marcondes AM, 2008, P NATL ACAD SCI USA, V105, P2865, DOI 10.1073/pnas.0712391105; Netea MG, 2008, P NATL ACAD SCI USA, V105, P3515, DOI 10.1073/pnas.0712381105; Nishida A, 2009, J BIOL CHEM, V284, P17868, DOI 10.1074/jbc.M900368200; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Seo EH, 2008, J MICROBIOL BIOTECHN, V18, P1606; Song H, 2008, IMMUNOL LETT, V120, P103, DOI 10.1016/j.imlet.2008.07.007; Sutherland CL, 2006, BLOOD, V108, P1313, DOI 10.1182/blood-2005-11-011320; Wajant H, 2006, CANC TREAT, V130, P141; Watanabe D, 2004, AM J PATHOL, V164, P1827, DOI 10.1016/S0002-9440(10)63741-8	29	35	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.159756	http://dx.doi.org/10.1074/jbc.M110.159756			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21321117	hybrid, Green Published			2022-12-27	WOS:000289077500019
J	Shechtman, CF; Henneberry, AL; Seimon, TA; Tinkelenberg, AH; Wilcox, LJ; Lee, E; Fazlollahi, M; Munkacsi, AB; Bussemaker, HJ; Tabas, I; Sturley, SL				Shechtman, Caryn F.; Henneberry, Annette L.; Seimon, Tracie A.; Tinkelenberg, Arthur H.; Wilcox, Lisa J.; Lee, Eunjee; Fazlollahi, Mina; Munkacsi, Andrew B.; Bussemaker, Harmen J.; Tabas, Ira; Sturley, Stephen L.			Loss of Subcellular Lipid Transport Due to ARV1 Deficiency Disrupts Organelle Homeostasis and Activates the Unfolded Protein Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; ELECTRON-MICROSCOPY; FUNCTIONAL-ANALYSIS; MEMBRANE-PROTEINS; GENE-EXPRESSION; QUALITY-CONTROL; MESSENGER-RNA; YEAST ARV1; CHOLESTEROL	The ARV1-encoded protein mediates sterol transport from the endoplasmic reticulum (ER) to the plasma membrane. Yeast ARV1 mutants accumulate multiple lipids in the ER and are sensitive to pharmacological modulators of both sterol and sphingolipid metabolism. Using fluorescent and electron microscopy, we demonstrate sterol accumulation, subcellular membrane expansion, elevated lipid droplet formation, and vacuolar fragmentation in ARV1 mutants. Motif-based regression analysis of ARV1 deletion transcription profiles indicates activation of Hac1p, an integral component of the unfolded protein response (UPR). Accordingly, we show constitutive splicing of HAC1 transcripts, induction of a UPR reporter, and elevated expression of UPR targets in ARV1 mutants. IRE1, encoding the unfolded protein sensor in the ER lumen, exhibits a lethal genetic interaction with ARV1, indicating a viability requirement for the UPR in cells lacking ARV1. Surprisingly, ARV1 mutants expressing a variant of Ire1p defective in sensing unfolded proteins are viable. Moreover, these strains also exhibit constitutive HAC1 splicing that interacts with DTT-mediated perturbation of protein folding. These data suggest that a component of UPR induction in arv1 Delta strains is distinct from protein misfolding. Decreased ARV1 expression in murine macrophages also results in UPR induction, particularly up-regulation of activating transcription factor-4, CHOP (C/EBP homologous protein), and apoptosis. Cholesterol loading or inhibition of cholesterol esterification further elevated CHOP expression in ARV1 knockdown cells. Thus, loss or down-regulation of ARV1 disturbs membrane and lipid homeostasis, resulting in a disruption of ER integrity, one consequence of which is induction of the UPR.	[Shechtman, Caryn F.; Henneberry, Annette L.; Tinkelenberg, Arthur H.; Wilcox, Lisa J.; Tabas, Ira; Sturley, Stephen L.] Columbia Univ, Med Ctr, Inst Human Nutr, New York, NY 10032 USA; [Munkacsi, Andrew B.; Sturley, Stephen L.] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA; [Seimon, Tracie A.; Tabas, Ira] Columbia Univ, Med Ctr, Dept Med, New York, NY 10032 USA; [Tabas, Ira] Columbia Univ, Med Ctr, Dept Anat & Cell Biol, New York, NY 10032 USA; [Bussemaker, Harmen J.] Columbia Univ, Med Ctr, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA; [Lee, Eunjee; Bussemaker, Harmen J.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Fazlollahi, Mina] Columbia Univ, Dept Phys, New York, NY 10027 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Sturley, SL (corresponding author), Columbia Univ, Med Ctr, Inst Human Nutr, 630 W 168th St, New York, NY 10032 USA.	sls37@columbia.edu		Munkacsi, Andrew/0000-0003-3033-395X	National Institutes of Health [DK54320, 5TL1RR02415803, T32GM008798, T32GM082797, R01HG003008, U54CA121852, HL075662, HL057560]; American Heart Association [0735594T]; American Diabetes Association; Ara Parseghian Medical Research Foundation; Canadian Institutes of Health Research; National Institutes of Health, NHLBI [T32HL07343]; Charles H. Revson Foundation; Irving Institute for Clinical and Translational Research (National Institutes of Health) [UL1 RR024156]; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024156] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007343, R01HL075662, R01HL057560] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008798, T32GM082797] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Diabetes Association(American Diabetes Association); Ara Parseghian Medical Research Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Charles H. Revson Foundation; Irving Institute for Clinical and Translational Research (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant DK54320 (to S. L. S.). This work was also supported by the American Heart Association, the American Diabetes Association, and the Ara Parseghian Medical Research Foundation.; Supported by National Institutes of Health, Clinical and Translational Science Award Training Grant 5TL1RR02415803.; Supported by a fellowship from the Canadian Institutes of Health Research.; Supported by American Heart Association Grant 0735594T.; Supported by a National Institutes of Health, NHLBI, postdoctoral training fellowship in atherosclerosis (Grant T32HL07343).; Supported by National Institutes of Health Training Grant T32GM008798.; Supported by National Institutes of Health Training Grant T32GM082797.; Supported by the Charles H. Revson Foundation and the Irving Institute for Clinical and Translational Research (National Institutes of Health Grant UL1 RR024156).; Supported by National Institutes of Health Grants R01HG003008 and U54CA121852.; Supported by National Institutes of Health Grants HL075662 and HL057560.	Ausubel FM, 1998, CURRENT PROTOCOLS MO; Beh CT, 2004, J CELL SCI, V117, P2983, DOI 10.1242/jcs.01157; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Cronin SR, 2002, J CELL BIOL, V157, P1017, DOI 10.1083/jcb.200203052; DeVries-Seimon T, 2005, J CELL BIOL, V171, P61, DOI 10.1083/jcb.200502078; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Erdeniz N, 1997, GENOME RES, V7, P1174, DOI 10.1101/gr.7.12.1174; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Fujita M, 2006, MOL BIOL CELL, V17, P5253, DOI 10.1091/mbc.E06-08-0715; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gulati S, 2010, PROG LIPID RES, V49, P353, DOI 10.1016/j.plipres.2010.03.003; Han SM, 2010, P NATL ACAD SCI USA, V107, P5851, DOI 10.1073/pnas.0911617107; Hanada K, 2007, BBA-MOL CELL BIOL L, V1771, P644, DOI 10.1016/j.bbalip.2007.01.009; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kajiwara K, 2008, MOL BIOL CELL, V19, P2069, DOI 10.1091/mbc.E07-08-0740; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; KAPLAN MR, 1985, J CELL BIOL, V101, P446, DOI 10.1083/jcb.101.2.446; Lee E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.64; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lin JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004170; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malathi K, 2004, J CELL BIOL, V164, P547, DOI 10.1083/jcb.200310046; Metzger MB, 2009, MOL BIOL CELL, V20, P1006, DOI 10.1091/mbc.E08-02-0140; NISHIMURA H, 1992, FEBS LETT, V297, P155, DOI 10.1016/0014-5793(92)80349-L; Orlean P, 2007, J LIPID RES, V48, P993, DOI 10.1194/jlr.R700002-JLR200; PINKHAM JL, 1985, MOL CELL BIOL, V5, P3410, DOI 10.1128/MCB.5.12.3410; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; REINHART MP, 1990, EXPERIENTIA, V46, P599, DOI 10.1007/BF01939699; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sato BK, 2006, YEAST, V23, P1053, DOI 10.1002/yea.1407; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Silberstein S, 1998, J CELL BIOL, V143, P921, DOI 10.1083/jcb.143.4.921; Spassieva SD, 2009, BIOCHEM J, V424, P273, DOI 10.1042/BJ20090699; Sturley SL, 2000, BBA-MOL CELL BIOL L, V1529, P155, DOI 10.1016/S1388-1981(00)00145-1; Swain E, 2002, J BIOL CHEM, V277, P36152, DOI 10.1074/jbc.M206624200; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Tinkelenberg AH, 2000, J BIOL CHEM, V275, P40667, DOI 10.1074/jbc.C000710200; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tong FM, 2010, J BIOL CHEM, V285, P33632, DOI 10.1074/jbc.M110.165761; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Wang XZ, 1998, EMBO J, V17, P3619, DOI 10.1093/emboj/17.13.3619; Wilcox LJ, 2002, J BIOL CHEM, V277, P32466, DOI 10.1074/jbc.M204707200; Wright R, 2000, MICROSC RES TECHNIQ, V51, P496, DOI 10.1002/1097-0029(20001215)51:6<496::AID-JEMT2>3.3.CO;2-0; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	49	28	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.215038	http://dx.doi.org/10.1074/jbc.M110.215038			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21266578	hybrid, Green Published			2022-12-27	WOS:000289077500008
J	Sun, H; Wu, YM; Qi, JP; Pan, YD; Ge, GX; Chen, JF				Sun, Hao; Wu, YuMei; Qi, JunPeng; Pan, YouDong; Ge, Gaoxiang; Chen, JianFeng			The CC ' and DE Loops in Ig Domains 1 and 2 of MAdCAM-1 Play Different Roles in MAdCAM-1 Binding to Low- and High-affinity Integrin alpha(4)beta(7)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULE-1; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; FIRM ADHESION; RECOGNITION; IMMUNOGLOBULIN; SUBUNIT; SITES; LYMPHOCYTES; SPECIFICITY	Lymphocyte homing is regulated by the dynamic interaction between integrins and their ligands. Integrin alpha(4)beta(7) mediates both rolling and firm adhesion of lymphocytes by modulating its affinity to the ligand, mucosal addressin cell adhesion molecule-1 (MAdCAM-1). Although previous studies have revealed some mechanisms of alpha(4)beta(7)-MAdCAM-1 binding, little is known about the different molecular bases of the low- and high-affinity alpha(4)beta(7)-MAdCAM-1 interactions, which mediate rolling and firm adhesion of lymphocytes, respectively. Here, we found that two loops in immunoglobulin domains 1 and 2 (D1 and D2) of MAdCAM-1 played different roles in MAdCAM-1 binding to low-affinity (inactive) and high-affinity (activated) alpha(4)beta(7). The Asp-42 in the CC` loop of D1 was indispensable for MAdCAM-1 binding to both low-affinity and high-affinity alpha(4)beta(7). The other CC` loop residues except for Arg-39 and Ser-44 were essential for MAdCAM-1 binding to both inactive alpha(4)beta(7) and alpha(4)beta(7) activated by SDF-1 alpha or talin, but not required for MAdCAM-1 binding to Mn2+-activated alpha(4)beta(7). Single amino acid substitution of the DE loop residues mildly decreased MAdCAM-1 binding to both inactive and activated alpha(4)beta(7). Notably, removal of the DE loop greatly impaired MAdCAM-1 binding to inactive and SDF-1 alpha- or talin-activated alpha(4)beta(7), but only decreased 60% of MAdCAM-1 binding to Mn2+-activated alpha(4)beta(7). Moreover, DE loop residues were important for stabilizing the low-affinity alpha(4)beta(7)-MAdCAM-1 interaction. Thus, our findings demonstrate the distinct roles of the CC` and DE loops in the recognition of MAdCAM-1 by low-and high-affinity alpha(4)beta(7) and suggest that the inactive alpha(4)beta(7) and alpha(4)beta(7) activated by different stimuli have distinct conformations with different structural requirements for MAdCAM-1 binding.	[Sun, Hao; Wu, YuMei; Qi, JunPeng; Pan, YouDong; Chen, JianFeng] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai 200031, Peoples R China; [Ge, Gaoxiang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Chen, JF (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, 320 YueYang Rd, Shanghai 200031, Peoples R China.	jfchen@sibs.ac.cn	Sun, Hao/L-7372-2018; Qi, Junpeng/G-6949-2019; Qi, Junpeng/AAH-5525-2020	Sun, Hao/0000-0002-4790-8847; 	National Basic Research Program of China [2010CB529703]; National Natural Science Foundation of China [30700119, 30970604]; Chinese Academy of Sciences [KSCX2-YW-R-67]; Shanghai Pujiang Program [08PJ14106]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Pujiang Program(Shanghai Pujiang Program)	This work was supported by grants from the National Basic Research Program of China (Grant 2010CB529703), National Natural Science Foundation of China (Grants 30700119 and 30970604), the Chinese Academy of Sciences (Grant KSCX2-YW-R-67), and the Shanghai Pujiang Program (Grant 08PJ14106).	Adams DH, 2006, NAT REV IMMUNOL, V6, P244, DOI 10.1038/nri1784; Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Bleul CC, 1997, P NATL ACAD SCI USA, V94, P1925, DOI 10.1073/pnas.94.5.1925; Briskin MJ, 1996, J IMMUNOL, V156, P719; BRISKIN MJ, 1993, NATURE, V363, P461, DOI 10.1038/363461a0; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; Chen JF, 2004, J BIOL CHEM, V279, P55556, DOI 10.1074/jbc.M407773200; Chen JF, 2003, NAT STRUCT BIOL, V10, P995, DOI 10.1038/nsb1011; Chen J, 2006, P NATL ACAD SCI USA, V103, P13062, DOI 10.1073/pnas.0605666103; Dando J, 2002, ACTA CRYSTALLOGR D, V58, P233, DOI 10.1107/S0907444901020522; de Chateau M, 2001, BIOCHEMISTRY-US, V40, P13972, DOI 10.1021/bi011582f; Eksteen B, 2008, INFLAMM BOWEL DIS, V14, P1298, DOI 10.1002/ibd.20453; ERLE DJ, 1994, J IMMUNOL, V153, P517; Gorfu G, 2009, CURR MOL MED, V9, P836, DOI 10.2174/156652409789105525; Green N, 1999, CELL ADHES COMMUN, V7, P167, DOI 10.3109/15419069909010800; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kunkel EJ, 2002, IMMUNITY, V16, P1, DOI 10.1016/S1074-7613(01)00261-8; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Leitinger B, 2000, BBA-MOL CELL RES, V1498, P91, DOI 10.1016/S0167-4889(00)00086-0; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Luo BH, 2006, CURR OPIN CELL BIOL, V18, P579, DOI 10.1016/j.ceb.2006.08.005; Newham P, 1997, J BIOL CHEM, V272, P19429, DOI 10.1074/jbc.272.31.19429; Pan YP, 2010, P NATL ACAD SCI USA, V107, P21388, DOI 10.1073/pnas.1015487107; Shyjan AM, 1996, J IMMUNOL, V156, P2851; Springer TA, 2004, ADV PROTEIN CHEM, V68, P29; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Tan K, 1998, STRUCTURE, V6, P793, DOI 10.1016/S0969-2126(98)00080-X; Tidswell M, 1997, J IMMUNOL, V159, P1497; Valdramidou D, 2008, J BIOL CHEM, V283, P32704, DOI 10.1074/jbc.M802066200; Viney JL, 1996, J IMMUNOL, V157, P2488; Wright N, 2002, J IMMUNOL, V168, P5268, DOI 10.4049/jimmunol.168.10.5268; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2009, J CELL BIOL, V186, P589, DOI 10.1083/jcb.200905085; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018	38	11	11	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.208900	http://dx.doi.org/10.1074/jbc.M110.208900			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21296888	Green Published, hybrid			2022-12-27	WOS:000289077500023
J	Vorster, PJ; Guo, J; Yoder, A; Wang, WF; Zheng, YF; Xu, XH; Yu, DY; Spear, M; Wu, YT				Vorster, Paul J.; Guo, Jia; Yoder, Alyson; Wang, Weifeng; Zheng, Yanfang; Xu, Xuehua; Yu, Dongyang; Spear, Mark; Wu, Yuntao			LIM Kinase 1 Modulates Cortical Actin and CXCR4 Cycling and Is Activated by HIV-1 to Initiate Viral Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CHEMOKINE RECEPTOR CXCR4; COFILIN PHOSPHORYLATION; T-LYMPHOCYTES; REVERSE TRANSCRIPTION; HUMAN MACROPHAGES; HOMOSEXUAL MEN; CDNA CLONING; NEF PROTEIN; CELL	Almost all viral pathogens utilize a cytoskeleton for their entry and intracellular transport. In HIV-1 infection, binding of the virus to blood resting CD4 T cells initiates a temporal course of cortical actin polymerization and depolymerization, a process mimicking the chemotactic response initiated from chemokine receptors. The actin depolymerization has been suggested to promote viral intracellular migration through cofilin-mediated actin treadmilling. However, the role of the virus-mediated actin polymerization in HIV infection is unknown, and the signaling molecules involved remain unidentified. Here we describe a pathogenic mechanism for triggering early actin polymerization through HIV-1 envelope-mediated transient activation of the LIM domain kinase (LIMK), a protein that phosphorylates cofilin. We demonstrate that HIV-mediated LIMK activation is through gp120-triggered transient activation of the Rack-PAK-LIMK pathway, and that knockdown of LIMK through siRNA decreases filamentous actin, increases CXCR4 trafficking, and diminishes viral DNA synthesis. These results suggest that HIV-mediated early actin polymerization may directly regulate the CXCR4 receptor during viral entry and is involved in viral DNA synthesis. Furthermore, we also demonstrate that in resting CD4 T cells, actin polymerization can be triggered through transient treatment with a pharmacological agent, okadaic acid, that activates LIMK and promotes HIV latent infection of resting CD4 T cells. Taken together, our results suggest that HIV hijacks LIMK to control the cortical actin dynamics for the initiation of viral infection of CD4 Tcells.	[Vorster, Paul J.; Guo, Jia; Yoder, Alyson; Wang, Weifeng; Zheng, Yanfang; Yu, Dongyang; Spear, Mark; Wu, Yuntao] George Mason Univ, Dept Mol & Microbiol, Manassas, VA 20110 USA; [Xu, Xuehua] Georgetown Univ, Sch Med, Dept Oncol, Washington, DC 20057 USA	George Mason University; Georgetown University	Wu, YT (corresponding author), 10900 Univ Blvd, Manassas, VA 20110 USA.	ywu8@gmu.edu	Guo, Jia/L-2102-2013; wang, weifeng/N-4140-2013; xu, xuehua/R-1163-2019; Guo, Jia/C-8678-2014	xu, xuehua/0000-0002-3863-9593; Love, Zelda/0000-0002-2478-7720	NIAID National Institutes of Health [AI069981, 1R01AI081568]; New York City to Washington, D.C. AIDS Ride; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI069981, R01AI081568] Funding Source: NIH RePORTER	NIAID National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); New York City to Washington, D.C. AIDS Ride; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by NIAID National Institutes of Health Grants AI069981 and 1R01AI081568 (to Y. W.). This work was also supported by the 2009 New York City to Washington, D.C. AIDS Ride (to Y. W.).	AIKEN C, 1995, J VIROL, V69, P5048, DOI 10.1128/JVI.69.8.5048-5056.1995; Amano T, 2002, J BIOL CHEM, V277, P22093, DOI 10.1074/jbc.M201444200; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Balabanian K, 2004, J IMMUNOL, V173, P7150, DOI 10.4049/jimmunol.173.12.7150; BAMBURG JR, 1980, FEBS LETT, V121, P178, DOI 10.1016/0014-5793(80)81292-0; Barrero-Villar M, 2009, J CELL SCI, V122, P103, DOI 10.1242/jcs.035873; Bernard O, 1996, GENOMICS, V35, P593, DOI 10.1006/geno.1996.0403; Bukrinskaya A, 1998, J EXP MED, V188, P2113, DOI 10.1084/jem.188.11.2113; Bukrinsky M, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-85; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; CHOWERS MY, 1995, VIROLOGY, V212, P451, DOI 10.1006/viro.1995.1502; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Dan C, 2001, J BIOL CHEM, V276, P32115, DOI 10.1074/jbc.M100871200; Davila M, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-40; DE BP, 1993, J BIOL CHEM, V268, P5703; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Endres MJ, 1996, CELL, V87, P745, DOI 10.1016/S0092-8674(00)81393-8; Fackler OT, 1997, EUR J BIOCHEM, V247, P843, DOI 10.1111/j.1432-1033.1997.00843.x; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; GOTTLIEB MS, 1981, NEW ENGL J MED, V305, P1425, DOI 10.1056/NEJM198112103052401; Harmon B, 2008, J VIROL, V82, P9191, DOI 10.1128/JVI.00424-08; HOTTIGER M, 1995, NUCLEIC ACIDS RES, V23, P736; Ikebe C, 1997, GENOMICS, V46, P504, DOI 10.1006/geno.1997.5060; Iyengar S, 1998, J VIROL, V72, P5251, DOI 10.1128/JVI.72.6.5251-5255.1998; Jimenez-Baranda S, 2007, NAT CELL BIOL, V9, P838, DOI 10.1038/ncb1610; Jolly C, 2007, J VIROL, V81, P5547, DOI 10.1128/JVI.01469-06; Kaji N, 2008, J BIOL CHEM, V283, P4983, DOI 10.1074/jbc.M708644200; Kelly J, 2008, VIROLOGY, V372, P300, DOI 10.1016/j.virol.2007.11.007; Lappalainen P, 1997, NATURE, V388, P78, DOI 10.1038/40418; Liu BD, 1999, J VIROL, V73, P2901, DOI 10.1128/JVI.73.4.2901-2908.1999; Liu Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.266pe23; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Misra UK, 2005, J BIOL CHEM, V280, P26278, DOI 10.1074/jbc.M414467200; Naghavi MH, 2007, CURR OPIN IMMUNOL, V19, P402, DOI 10.1016/j.coi.2007.07.003; Naghavi MH, 2007, EMBO J, V26, P41, DOI 10.1038/sj.emboj.7601475; NIEDERMAN TMJ, 1993, VIROLOGY, V197, P420, DOI 10.1006/viro.1993.1605; Nishita M, 2002, MOL CELL BIOL, V22, P774, DOI 10.1128/MCB.22.3.774-783.2002; PFEIFFER JR, 1985, J CELL BIOL, V101, P2145, DOI 10.1083/jcb.101.6.2145; Ploubidou A, 2001, CURR OPIN CELL BIOL, V13, P97, DOI 10.1016/S0955-0674(00)00180-0; Pontow SE, 2004, J VIROL, V78, P7138, DOI 10.1128/JVI.78.13.7138-7147.2004; Rey O, 1996, VIROLOGY, V220, P530, DOI 10.1006/viro.1996.0343; Saeed MF, 2006, J VIROL METHODS, V135, P143, DOI 10.1016/j.jviromet.2006.02.011; SCHWARTZ O, 1995, J VIROL, V69, P4053, DOI 10.1128/JVI.69.7.4053-4059.1995; Signoret N, 1998, J CELL SCI, V111, P2819; Signoret N, 1997, J CELL BIOL, V139, P651, DOI 10.1083/jcb.139.3.651; Singer II, 2001, J VIROL, V75, P3779, DOI 10.1128/JVI.75.8.3779-3790.2001; STAHL RE, 1982, AM J MED, V73, P171, DOI 10.1016/0002-9343(82)90174-7; Stolp B, 2009, CELL HOST MICROBE, V6, P174, DOI 10.1016/j.chom.2009.06.004; Turlure F, 2004, FRONT BIOSCI-LANDMRK, V9, P3187, DOI 10.2741/1472; Ugolini S, 1997, J IMMUNOL, V159, P3000; Unutmaz D, 1999, J EXP MED, V189, P1735, DOI 10.1084/jem.189.11.1735; Wilk T, 1999, J VIROL, V73, P1931, DOI 10.1128/JVI.73.3.1931-1940.1999; Wu YT, 2001, SCIENCE, V293, P1503, DOI 10.1126/science.1061548; Wu YT, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-12; Wu Y, 2007, CURR HIV RES, V5, P394; Wu YT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000520; Wu YT, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-95; Xiao XD, 1999, P NATL ACAD SCI USA, V96, P7496, DOI 10.1073/pnas.96.13.7496; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yoder A, 2008, CELL, V134, P782, DOI 10.1016/j.cell.2008.06.036; Yu DY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000633; Zaitseva M, 2005, J LEUKOCYTE BIOL, V78, P1306, DOI 10.1189/jlb.0105043	62	72	74	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.182238	http://dx.doi.org/10.1074/jbc.M110.182238			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21321123	Green Published, hybrid			2022-12-27	WOS:000289077500068
J	Domercq, M; Alberdi, E; Sanchez-Gomez, MV; Ariz, U; Perez-Samartin, A; Matute, C				Domercq, Maria; Alberdi, Elena; Victoria Sanchez-Gomez, Maria; Ariz, Usue; Perez-Samartin, Alberto; Matute, Carlos			Dual-specific Phosphatase-6 (Dusp6) and ERK Mediate AMPA Receptor-induced Oligodendrocyte Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN; MULTIPLE-SCLEROSIS; OXIDATIVE TOXICITY; NMDA RECEPTORS; CELL-DEATH; KINASE; EXPRESSION; APOPTOSIS; PHOSPHORYLATION; ACTIVATION	Oligodendrocytes, the myelinating cells of the CNS, are highly vulnerable to glutamate excitotoxicity, a mechanism involved in tissue damage in multiple sclerosis. Thus, understanding oligodendrocyte death at the molecular level is important to develop new therapeutic approaches to treat the disease. Here, using microarray analysis and quantitative PCR, we observed that dual-specific phosphatase-6 (Dusp6), an extracellular regulated kinase-specific phosphatase, is up-regulated in oligodendrocyte cultures as well as in optic nerves after AMPA receptor activation. In turn, Dusp6 is overexpressed in optic nerves from multiple sclerosis patients before the appearance of evident damage in this structure. We further analyzed the role of Dusp6 and ERK signaling in excitotoxic oligodendrocyte death and observed that AMPA receptor activation induces a rapid increase in ERK1/2 phosphorylation. Blocking Dusp6 expression, which enhances ERK1/2 phosphorylation, significantly diminished AMPA receptor-induced oligodendrocyte death. In contrast, MAPK/ERK pathway inhibition with UO126 significantly potentiates excitotoxic oligodendrocyte death and increases cytochrome c release, mitochondrial depolarization, and mitochondrial calcium overload produced by AMPA receptor stimulation. Upstream analysis demonstrated that MAPK/ERK signaling alters AMPA receptor properties. Indeed, Dusp6 overexpression as well as incubation with UO126 produced an increase in AMPA receptor-induced inward currents and cytosolic calcium overload. Together, these data suggest that levels of phosphorylated ERK, controlled by Dusp6 phosphatase, regulate glutamate receptor permeability and oligodendroglial excitotoxicity. Therefore, targeting Dusp6 may be a useful strategy to prevent oligodendrocyte death in multiple sclerosis and other diseases involving CNS white matter.	[Domercq, Maria; Alberdi, Elena; Victoria Sanchez-Gomez, Maria; Ariz, Usue; Perez-Samartin, Alberto; Matute, Carlos] Univ Basque Country, Dept Neurociencias, E-48940 Leioa, Spain; [Domercq, Maria; Alberdi, Elena; Victoria Sanchez-Gomez, Maria; Matute, Carlos] Univ Basque Country, Ctr Invest Biomed Red Enfermedades Neurodegenerat, E-48940 Leioa, Spain	University of Basque Country; CIBERNED; University of Basque Country	Matute, C (corresponding author), Univ Basque Country, Dept Neurociencias, E-48940 Leioa, Spain.	carlos.matute@ehu.es	Matute, Carlos/N-5559-2014; Sánchez-Gómez, M Victoria/AAU-9720-2021; Alberdi, Elena/D-6383-2017; Domercq, Maria/Z-2274-2019; Samartín, Alberto Pérez/AAB-6428-2019; Samartín, Alberto Pérez/AAB-1336-2019; Alberdi, Elena/AAH-1757-2019	Matute, Carlos/0000-0001-8672-711X; Sánchez-Gómez, M Victoria/0000-0001-5730-8194; Alberdi, Elena/0000-0002-8000-142X; Domercq, Maria/0000-0002-4918-9276; Samartín, Alberto Pérez/0000-0003-0834-0424; Alberdi, Elena/0000-0002-8000-142X	Fundacion de Investigacion Medica Mutua Madrilena, Centro de Investigaciones Biomedicas en Red Enfermedades Neurodegenerativas; Spanish Ministry of Education and Science; Basque Government; European Leukodystrophy Association	Fundacion de Investigacion Medica Mutua Madrilena, Centro de Investigaciones Biomedicas en Red Enfermedades Neurodegenerativas; Spanish Ministry of Education and Science(Spanish Government); Basque Government(Basque Government); European Leukodystrophy Association	This work was supported by the Fundacion de Investigacion Medica Mutua Madrilena, Centro de Investigaciones Biomedicas en Red Enfermedades Neurodegenerativas, the Spanish Ministry of Education and Science, the Basque Government, and the European Leukodystrophy Association.	Allan LA, 2003, NAT CELL BIOL, V5, P647, DOI 10.1038/ncb1005; Boschert U, 1998, NEUROREPORT, V9, P4081, DOI 10.1097/00001756-199812210-00014; Breitschopf K, 2000, MOL CELL BIOL, V20, P1886, DOI 10.1128/MCB.20.5.1886-1896.2000; Camps M, 1998, SCIENCE, V280, P1262, DOI 10.1126/science.280.5367.1262; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; Cheung Eric C C, 2004, Sci STKE, V2004, pPE45; de Bernardo S, 2004, J NEUROCHEM, V91, P667, DOI 10.1111/j.1471-4159.2004.02744.x; Deng WB, 2006, J BIOL CHEM, V281, P36004, DOI 10.1074/jbc.M606459200; Domercq M, 2010, GLIA, V58, P730, DOI 10.1002/glia.20958; Galluzzi L, 2009, NAT REV NEUROSCI, V10, P481, DOI 10.1038/nrn2665; Grewal SS, 1999, CURR OPIN NEUROBIOL, V9, P544, DOI 10.1016/S0959-4388(99)00010-0; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Hayashi T, 1999, NATURE, V397, P72, DOI 10.1038/16269; Jin KL, 2002, J NEUROCHEM, V80, P119, DOI 10.1046/j.0022-3042.2001.00678.x; Karadottir R, 2005, NATURE, V438, P1162, DOI 10.1038/nature04302; Kawahara N, 2004, J CEREBR BLOOD F MET, V24, P212, DOI 10.1097/01.WCB.0000106012.33322.A2; Lawrence MS, 1996, J NEUROSCI, V16, P486; Levinthal DJ, 2005, J BIOL CHEM, V280, P5875, DOI 10.1074/jbc.M410771200; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Liu Y, 2010, NAT NEUROSCI, V13, P223, DOI 10.1038/nn.2474; Lu AG, 2003, J CEREBR BLOOD F MET, V23, P786, DOI 10.1097/01.WCB.0000062340.80057.06; Luo Y, 2006, J BIOL CHEM, V281, P16436, DOI 10.1074/jbc.M512430200; Matute C, 1998, P NATL ACAD SCI USA, V95, P10229, DOI 10.1073/pnas.95.17.10229; Matute C, 1997, P NATL ACAD SCI USA, V94, P8830, DOI 10.1073/pnas.94.16.8830; McDonald JW, 1998, NAT MED, V4, P291, DOI 10.1038/nm0398-291; Micu I, 2006, NATURE, V439, P988, DOI 10.1038/nature04474; Muda M, 1996, J BIOL CHEM, V271, P27205, DOI 10.1074/jbc.271.44.27205; Ness JK, 2004, GLIA, V46, P183, DOI 10.1002/glia.10360; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Perkinton MS, 1999, J NEUROSCI, V19, P5861, DOI 10.1523/JNEUROSCI.19-14-05861.1999; Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555; Prineas J. W., 2002, GREENFIELDS NEUROPAT, V2, P471; Rossig L, 2000, J BIOL CHEM, V275, P25502, DOI 10.1074/jbc.M002283200; Salter MG, 2005, NATURE, V438, P1167, DOI 10.1038/nature04301; Sanchez-Gomez MV, 1999, NEUROBIOL DIS, V6, P475, DOI 10.1006/nbdi.1999.0264; Sanchez-Gomez MV, 2003, J NEUROSCI, V23, P9519; Sarchielli P, 2003, ARCH NEUROL-CHICAGO, V60, P1082, DOI 10.1001/archneur.60.8.1082; Schenk U, 2004, BIOL CELL, V96, P257, DOI 10.1016/j.biolcel.2004.01.008; Smith T, 2000, NAT MED, V6, P62, DOI 10.1038/71548; Soriano MA, 2000, J CEREBR BLOOD F MET, V20, P1045, DOI 10.1097/00004647-200007000-00004; Stanciu M, 2000, J BIOL CHEM, V275, P12200, DOI 10.1074/jbc.275.16.12200; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; Steinman L, 2002, ANNU REV NEUROSCI, V25, P491, DOI 10.1146/annurev.neuro.25.112701.142913; Subramaniam S, 2010, FEBS J, V277, P22, DOI 10.1111/j.1742-4658.2009.07367.x; Tashker JS, 2002, MOL BIOL CELL, V13, P393, DOI 10.1091/mbc.01-06-0291; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Vallejo-Illarramendi A, 2006, NEUROBIOL DIS, V21, P154, DOI 10.1016/j.nbd.2005.06.017; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang CX, 2006, CELL DEATH DIFFER, V13, P1203, DOI 10.1038/sj.cdd.4401804; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Zhang XD, 2003, ONCOGENE, V22, P2869, DOI 10.1038/sj.onc.1206427	52	28	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11825	11836		10.1074/jbc.M110.153049	http://dx.doi.org/10.1074/jbc.M110.153049			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21300799	hybrid, Green Published			2022-12-27	WOS:000288797100089
J	Szeto, GL; Pomerantz, JL; Graham, DRM; Clements, JE				Szeto, Gregory L.; Pomerantz, Joel L.; Graham, David R. M.; Clements, Janice E.			Minocycline Suppresses Activation of Nuclear Factor of Activated T Cells 1 (NFAT1) in Human CD4(+) T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RHEUMATOID-ARTHRITIS; DOUBLE-BLIND; LYMPHOCYTE-ACTIVATION; TRANSCRIPTION FACTORS; GENE-EXPRESSION; CALCIUM; FAMILY; LUPUS; CA2+	Minocycline is a tetracycline family antibiotic that has anti-inflammatory and immunomodulatory properties. These properties have shown promise in the treatment of conditions such as rheumatoid arthritis, Huntington disease, and multiple sclerosis. As lymphocyte activation is involved in the pathogenesis of many of these diseases, T cells are postulated to be a primary target in minocycline therapy. Previous studies have demonstrated attenuation of CD4(+) T cell activation by minocycline, but a specific mechanism has not been elucidated. In this study, we investigated the effect of minocycline on the activity of three key transcription factors regulating CD4(+) T cell activation: NF-kappa B, AP-1 (activator protein 1), and NFAT (nuclear factor of activated T) cells. Our data demonstrate that minocycline selectively impairs NFAT-mediated transcriptional activation, a result of increased phosphorylation and reduced nuclear translocation of the isoform NFAT1. Minocycline increased the activity of the NFAT kinase GSK3 and decreased intracellular Ca2+ flux, both of which facilitate NFAT1 phosphorylation. These findings provide a novel mechanism for minocycline induced suppression of CD4(+) T cell activation and may better inform the application of minocycline as an immunomodulatory agent.	[Szeto, Gregory L.; Graham, David R. M.; Clements, Janice E.] Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21205 USA; [Pomerantz, Joel L.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Graham, David R. M.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Clements, JE (corresponding author), 733 N Broadway,BRB 839, Baltimore, MD 21205 USA.	jclement@jhmi.edu	Szeto, Gregory/N-9648-2019; Szeto, Gregory/A-6932-2013	Szeto, Gregory/0000-0001-7604-1333; Szeto, Gregory/0000-0001-7604-1333; Pomerantz, Joel L./0000-0002-5030-1018	National Institutes of Health [NS055648, MH087233]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH087233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055648] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS055648 and MH087233.	ALBERT PR, 1984, J BIOL CHEM, V259, P5350; Antonenko YN, 2010, J BIOENERG BIOMEMBR, V42, P151, DOI 10.1007/s10863-010-9271-1; Baksh S, 2002, MOL CELL, V10, P1071, DOI 10.1016/S1097-2765(02)00701-3; Benito DM, 2005, JAIDS-J ACQ IMM DEF, V38, P373, DOI 10.1097/01.qai.0000153105.42455.c2; BRION M, 1981, INORG CHIM A-BIOINOR, V55, P47, DOI 10.1016/S0020-1693(00)90781-3; Brundula V, 2002, BRAIN, V125, P1297, DOI 10.1093/brain/awf133; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; Cron RQ, 2001, DNA CELL BIOL, V20, P761, DOI 10.1089/104454901753438570; Cron RQ, 2000, CLIN IMMUNOL, V94, P179, DOI 10.1006/clim.1999.4831; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Du YS, 2001, P NATL ACAD SCI USA, V98, P14669, DOI 10.1073/pnas.251341998; Fagan SC, 2010, STROKE, V41, P2283, DOI 10.1161/STROKEAHA.110.582601; Fernandez-Gomez FJ, 2005, NEUROSCIENCE, V133, P959, DOI 10.1016/j.neuroscience.2005.03.019; Fujii Y, 2006, CLIN IMMUNOL, V119, P297, DOI 10.1016/j.clim.2006.01.001; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Giuliani F, 2005, J LEUKOCYTE BIOL, V78, P135, DOI 10.1189/jlb.0804477; GOMEZ DA, 2000, J BIOL CHEM, V275, P13872; Gougeon ML, 1996, J IMMUNOL, V156, P3509; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Ho S, 1996, CLIN IMMUNOL IMMUNOP, V80, pS40, DOI 10.1006/clin.1996.0140; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hoth M, 1997, J CELL BIOL, V137, P633, DOI 10.1083/jcb.137.3.633; Kloppenburg M, 1995, CLIN EXP IMMUNOL, V102, P635; Kyttaris VC, 2007, J IMMUNOL, V178, P1960, DOI 10.4049/jimmunol.178.3.1960; Loh C, 1996, MOL CELL BIOL, V16, P3945; Lori F, 2008, CURR OPIN HIV AIDS, V3, P99, DOI 10.1097/COH.0b013e3282f525cf; Luo C, 1996, MOL CELL BIOL, V16, P3955; Lyakh L, 1997, MOL CELL BIOL, V17, P2475, DOI 10.1128/MCB.17.5.2475; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Marchetti G, 2006, AIDS, V20, P1727, DOI 10.1097/01.aids.0000242819.72839.db; Massanella M, 2010, AIDS, V24, P959, DOI 10.1097/QAD.0b013e328337b957; Mehta J, 2010, ARTHRITIS RHEUM-US, V62, P2499, DOI 10.1002/art.27554; Midtvedt K., 2004, TRANSPL P, V36, p430S; NEGULESCU PA, 1994, P NATL ACAD SCI USA, V91, P2873, DOI 10.1073/pnas.91.7.2873; NIEDEL JE, 1983, P NATL ACAD SCI-BIOL, V80, P36, DOI 10.1073/pnas.80.1.36; Nikodemova M, 2007, J BIOL CHEM, V282, P15208, DOI 10.1074/jbc.M611907200; Nikodemova M, 2010, J NEUROIMMUNOL, V219, P33, DOI 10.1016/j.jneuroim.2009.11.009; O'Dell JR, 1999, ARTHRITIS RHEUM, V42, P1691, DOI 10.1002/1529-0131(199908)42:8<1691::AID-ANR18>3.0.CO;2-S; ODell JR, 1997, ARTHRITIS RHEUM, V40, P842, DOI 10.1002/art.1780400510; Okamura H, 2004, MOL CELL BIOL, V24, P4184, DOI 10.1128/MCB.24.10.4184-4195.2004; Pessler F, 2004, GENES IMMUN, V5, P158, DOI 10.1038/sj.gene.6364047; Quintana A, 2007, P NATL ACAD SCI USA, V104, P14418, DOI 10.1073/pnas.0703126104; Quintana A, 2006, J BIOL CHEM, V281, P40302, DOI 10.1074/jbc.M607896200; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Robichaud GA, 2002, J BIOL CHEM, V277, P23733, DOI 10.1074/jbc.M201563200; Schlienger RG, 2000, DERMATOLOGY, V200, P223, DOI 10.1159/000018387; Schwindling C, 2010, J IMMUNOL, V184, P184, DOI 10.4049/jimmunol.0902872; SHAW KTY, 1995, P NATL ACAD SCI USA, V92, P11205, DOI 10.1073/pnas.92.24.11205; SIMMONDS P, 1991, LANCET, V338, P1159, DOI 10.1016/0140-6736(91)92029-2; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Szeto GL, 2010, J INFECT DIS, V201, P1132, DOI 10.1086/651277; TILLEY BC, 1995, ANN INTERN MED, V122, P81, DOI 10.7326/0003-4819-122-2-199501150-00001; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; YOSHIDA S, 1992, J PHYSIOL-LONDON, V458, P307, DOI 10.1113/jphysiol.1992.sp019419; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769; Zink MC, 2005, JAMA-J AM MED ASSOC, V293, P2003, DOI 10.1001/jama.293.16.2003	59	37	41	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11275	11282		10.1074/jbc.M110.210518	http://dx.doi.org/10.1074/jbc.M110.210518			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21282105	Green Published, hybrid			2022-12-27	WOS:000288797100039
J	Teufel, R; Gantert, C; Voss, M; Eisenreich, W; Haehnel, W; Fuchs, G				Teufel, Robin; Gantert, Carla; Voss, Michaela; Eisenreich, Wolfgang; Haehnel, Wolfgang; Fuchs, Georg			Studies on the Mechanism of Ring Hydrolysis in Phenylacetate Degradation A METABOLIC BRANCHING POINT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HARVEYI ALDEHYDE DEHYDROGENASE; SITE-DIRECTED MUTAGENESIS; TROPODITHIETIC ACID BIOSYNTHESIS; ACYL-COENZYME-A; VIBRIO-HARVEYI; CATABOLIC PATHWAY; CATALYTIC MECHANISM; BIOCHEMICAL-CHARACTERIZATION; NUCLEOTIDE SPECIFICITY; PSEUDOMONAS-PUTIDA	The widespread, long sought-after bacterial aerobic phenylalanine/phenylacetate catabolic pathway has recently been elucidated. It proceeds via coenzyme A (CoA) thioesters and involves the epoxidation of the aromatic ring of phenylacetyl-CoA, subsequent isomerization to an uncommon seven-membered C-O-heterocycle (oxepin-CoA), and non-oxygenolytic ring cleavage. Here we characterize the hydrolytic oxepin-CoA ring cleavage catalyzed by the bifunctional fusion protein PaaZ. The enzyme consists of a C-terminal (R)-specific enoyl-CoA hydratase domain (formerly MaoC) that cleaves the ring and produces a highly reactive aldehyde and an N-terminal NADP(+)-dependent aldehyde dehydrogenase domain that oxidizes the aldehyde to 3-oxo-5,6-dehydrosuberyl-CoA. In many phenylacetate-utilizing bacteria, the genes for the pathway exist in a cluster that contains an NAD(+)-dependent aldehyde dehydrogenase in place of PaaZ, whereas the aldehyde-producing hydratase is encoded outside of the cluster. If not oxidized immediately, the reactive aldehyde condenses intramolecularly to a stable cyclic derivative that is largely prevented by PaaZ fusion in vivo. Interestingly, the derivative likely serves as the starting material for the synthesis of antibiotics (e. g. tropodithietic acid) and other tropone/tropolone related compounds as well as for omega-cycloheptyl fatty acids. Apparently, bacteria made a virtue out of the necessity of disposing the dead-end product with ring hydrolysis as a metabolic branching point.	[Haehnel, Wolfgang] Univ Freiburg, Fak Biol, Lehrstuhl Biochem, D-79104 Freiburg, Germany; [Eisenreich, Wolfgang] Tech Univ Munich, Ctr Isotopologue Profiling, Lehrstuhl Biochem, D-85748 Munich, Germany; Univ Freiburg, Fak Biol, Lehrstuhl Mikrobiol, D-79104 Freiburg, Germany	University of Freiburg; Technical University of Munich; University of Freiburg		georg.fuchs@biologie.uni-freiburg.de	Eisenreich, Wolfgang/A-1258-2013	Eisenreich, Wolfgang/0000-0002-9832-8279; Teufel, Robin/0000-0001-5863-7248	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (to G. F., W. E., and W. H.).	Ahvazi B, 2000, BIOCHEM J, V349, P853, DOI 10.1042/bj3490853; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bains J, 2008, J MOL BIOL, V379, P597, DOI 10.1016/j.jmb.2008.04.031; Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gkp1024, 10.1093/nar/gkt1030, 10.1093/nar/gks1195, 10.1093/nar/gkw1070, 10.1093/nar/gkq1079, 10.1093/nar/gkn723, 10.1093/nar/gkr1202, 10.1093/nar/gkx1094]; Bentley R, 2008, NAT PROD REP, V25, P118, DOI 10.1039/b711474e; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Binstock J F, 1981, Methods Enzymol, V71 Pt C, P403; Boch J, 1997, ARCH MICROBIOL, V168, P282, DOI 10.1007/s002030050500; Boll M, 1995, EUR J BIOCHEM, V234, P921, DOI 10.1111/j.1432-1033.1995.921_a.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brinkhoff T, 2004, APPL ENVIRON MICROB, V70, P2560, DOI 10.1128/AEM.70.4.2560-2565.2003; Butler CS, 1997, ADV MICROB PHYSIOL, V38, P47; CANE DE, 1992, J AM CHEM SOC, V114, P8479, DOI 10.1021/ja00048a019; Cobessi D, 2000, J MOL BIOL, V300, P141, DOI 10.1006/jmbi.2000.3824; D'Alvise PW, 2010, APPL ENVIRON MICROB, V76, P2366, DOI 10.1128/AEM.02717-09; DECKER K, 1959, AKTIVIERTE ESSIGSAUR, P84; Diaz E, 2001, MICROBIOL MOL BIOL R, V65, P523, DOI 10.1128/MMBR.65.4.523-569.2001; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; Erb TJ, 2008, CURR MICROBIOL, V57, P27, DOI 10.1007/s00284-008-9147-3; Erb TJ, 2007, P NATL ACAD SCI USA, V104, P10631, DOI 10.1073/pnas.0702791104; FARRES J, 1995, BIOCHEMISTRY-US, V34, P2592, DOI 10.1021/bi00008a025; Fuchs G, 2008, ANN NY ACAD SCI, V1125, P82, DOI 10.1196/annals.1419.010; Geng HF, 2008, APPL ENVIRON MICROB, V74, P1535, DOI 10.1128/AEM.02339-07; Geng HF, 2010, J BACTERIOL, V192, P4377, DOI 10.1128/JB.00410-10; Gescher J, 2006, J BACTERIOL, V188, P2919, DOI 10.1128/JB.188.8.2919-2927.2006; Gibson DT, 2000, CURR OPIN BIOTECH, V11, P236, DOI 10.1016/S0958-1669(00)00090-2; HEMPEL J, 1993, PROTEIN SCI, V2, P1890, DOI 10.1002/pro.5560021111; Hisano T, 2003, J BIOL CHEM, V278, P617, DOI 10.1074/jbc.M205484200; Holden HM, 2001, ACCOUNTS CHEM RES, V34, P145, DOI 10.1021/ar000053l; Ismail W, 2003, EUR J BIOCHEM, V270, P3047, DOI 10.1046/j.1432-1033.2003.03683.x; KORTH H, 1982, ZBL BAKT-INT J MED M, V252, P83, DOI 10.1016/S0174-3031(82)80090-5; Koski MK, 2004, J BIOL CHEM, V279, P24666, DOI 10.1074/jbc.M400293200; Koski MK, 2003, ACTA CRYSTALLOGR D, V59, P1302, DOI 10.1107/S090744490300982X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Law RJ, 2008, J BACTERIOL, V190, P7209, DOI 10.1128/JB.00481-08; Liu ZJ, 1997, NAT STRUCT BIOL, V4, P317, DOI 10.1038/nsb0497-317; Luengo JM, 2001, MOL MICROBIOL, V39, P1434, DOI 10.1046/j.1365-2958.2001.02344.x; MARTINEZBLANCO H, 1990, J BIOL CHEM, V265, P7084; Moore BS, 1997, J ORG CHEM, V62, P2173, DOI 10.1021/jo962402o; Olivera ER, 1998, P NATL ACAD SCI USA, V95, P6419, DOI 10.1073/pnas.95.11.6419; Park SJ, 2003, J BACTERIOL, V185, P5391, DOI 10.1128/JB.185.18.5391-5397.2003; Perozich J, 2000, EUR J BIOCHEM, V267, P6197, DOI 10.1046/j.1432-1327.2000.01697.x; Perozich J, 1999, ADV EXP MED BIOL, V463, P1; Perozich J, 2001, CHEM-BIOL INTERACT, V130, P115, DOI 10.1016/S0009-2797(00)00227-1; Qin YM, 2000, J BIOL CHEM, V275, P4965, DOI 10.1074/jbc.275.7.4965; Rather LJ, 2010, J BIOL CHEM, V285, P20615, DOI 10.1074/jbc.M110.124156; Rost R, 2002, MOL GENET GENOMICS, V267, P656, DOI 10.1007/s00438-002-0699-9; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHACHTER D, 1953, J BIOL CHEM, V203, P925; Shenoy AR, 2003, ANAL BIOCHEM, V319, P335, DOI 10.1016/S0003-2697(03)00286-0; STADTMAN ER, 1957, METHOD ENZYMOL, V3, P931, DOI 10.1016/S0076-6879(57)03481-3; Steinmetz CG, 1997, STRUCTURE, V5, P701, DOI 10.1016/S0969-2126(97)00224-4; SUGINO H, 1992, J BACTERIOL, V174, P2485, DOI 10.1128/jb.174.8.2485-2492.1992; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teufel R, 2010, P NATL ACAD SCI USA, V107, P14390, DOI 10.1073/pnas.1005399107; Thiel V, 2010, ORG BIOMOL CHEM, V8, P234, DOI 10.1039/b909133e; Vedadi M, 1997, BIOCHEM BIOPH RES CO, V238, P448, DOI 10.1006/bbrc.1997.7300; Vedadi M, 1995, BIOCHEMISTRY-US, V34, P16725, DOI 10.1021/bi00051a022; VITOVSKI S, 1993, FEMS MICROBIOL LETT, V108, P1; WEINER H, 1995, ADV EXP MED BIOL, V372, P1; Zhang L, 1999, BIOCHEMISTRY-US, V38, P11440, DOI 10.1021/bi991101g; Zhang L, 2001, CHEM-BIOL INTERACT, V130, P29, DOI 10.1016/S0009-2797(00)00219-2; Zhang L, 2000, BIOCHEMISTRY-US, V39, P14409, DOI 10.1021/bi0014913	63	47	49	1	26	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11021	11034		10.1074/jbc.M110.196667	http://dx.doi.org/10.1074/jbc.M110.196667			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21296885	hybrid, Green Published			2022-12-27	WOS:000288797100014
J	Bekes, M; Prudden, J; Srikumar, T; Raught, B; Boddy, MN; Salvesen, GS				Bekes, Miklos; Prudden, John; Srikumar, Tharan; Raught, Brian; Boddy, Michael N.; Salvesen, Guy S.			The Dynamics and Mechanism of SUMO Chain Deconjugation by SUMO-specific Proteases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN CONJUGATION SITES; MASS-SPECTROMETRY; POLYUBIQUITIN CHAINS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; CELL-DIVISION; ACTIVE-SITE; UBIQUITIN; COMPLEX; SUMOYLATION	SUMOylation of proteins is a cyclic process that requires both conjugation and deconjugation of SUMO moieties. Besides modification by a single SUMO, SUMO chains have also been observed, yet the dynamics of SUMO conjugation/deconjugation remain poorly understood. Using a non-deconjugatable form of SUMO we demonstrate the underappreciated existence of SUMO chains in vivo, we highlight the importance of SUMO deconjugation, and we demonstrate the highly dynamic nature of the SUMO system. We show that SUMO-specific proteases (SENPs) play a crucial role in the dynamics of SUMO chains in vivo by constant deconjugation. Preventing deSUMOylation in Schizosaccharomyces pombe results in slow growth and a sensitivity to replication stress, highlighting the biological requirement for deSUMOylation dynamics. Furthermore, we present the mechanism of SUMO chain deconjugation by SENPs, which occurs via a stochastic mechanism, resulting in cleavage anywhere within a chain. Our results offer mechanistic insights into the workings of deSUMOylating proteases and highlight their importance in the homeostasis of (poly)SUMO-modified substrates.	[Bekes, Miklos; Salvesen, Guy S.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Bekes, Miklos; Salvesen, Guy S.] Univ Calif San Diego, Mol Pathol Grad Program, La Jolla, CA 92037 USA; [Prudden, John; Boddy, Michael N.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Srikumar, Tharan; Raught, Brian] Ontario Canc Inst, Toronto, ON M5G 1L7, Canada; [Srikumar, Tharan; Raught, Brian] MaRS Ctr, McLaughlin Ctr Mol Med, Toronto, ON M5G 1L7, Canada	Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego; Scripps Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Salvesen, GS (corresponding author), Sanford Burnham Med Res Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gsalvesen@sanfordburnham.org	Srikumar, Tharan/Q-5642-2016		National Institutes of Health (NIH) [GM068608, GM081840, AI061139, NS061758, RR020843]; Leukemia and Lymphoma Society; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI061139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068608, R01GM081840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS061758] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grants GM068608 and GM081840, a Scholar Award from the Leukemia and Lymphoma Society, and NIH Grants AI061139, NS061758, and RR020843 (to M. N. B. and G. S. S.).	Bekes M, 2010, BIOCHEM RES TRENDS, P5; Borges HL, 2005, P NATL ACAD SCI USA, V102, P15587, DOI 10.1073/pnas.0503925102; Bremm A, 2010, NAT STRUCT MOL BIOL, V17, P939, DOI 10.1038/nsmb.1873; Bylebyl GR, 2003, J BIOL CHEM, V278, P44113, DOI 10.1074/jbc.M308357200; Capili AD, 2007, J MOL BIOL, V369, P608, DOI 10.1016/j.jmb.2007.04.006; DAHLBACK B, 1995, THROMB HAEMOSTASIS, V74, P139; Di Bacco A, 2006, MOL CELL BIOL, V26, P4489, DOI 10.1128/MCB.02301-05; Dix MM, 2008, CELL, V134, P679, DOI 10.1016/j.cell.2008.06.038; Drag M, 2008, BIOCHEM J, V409, P461, DOI 10.1042/BJ20070940; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Golebiowski F, 2010, NAT PROTOC, V5, P873, DOI 10.1038/nprot.2010.40; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Hay RT, 2007, TRENDS CELL BIOL, V17, P370, DOI 10.1016/j.tcb.2007.08.002; HERSHKO A, 1983, CELL, V34, P11, DOI 10.1016/0092-8674(83)90131-9; Hsiao HH, 2009, MOL CELL PROTEOMICS, V8, P2664, DOI 10.1074/mcp.M900087-MCP200; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Jeram SM, 2010, PROTEOMICS, V10, P254, DOI 10.1002/pmic.200900648; Jeram SM, 2009, PROTEOMICS, V9, P922, DOI 10.1002/pmic.200800666; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Kang XL, 2010, MOL CELL, V38, P191, DOI 10.1016/j.molcel.2010.03.005; Knipscheer P, 2007, EMBO J, V26, P2797, DOI 10.1038/sj.emboj.7601711; KOLLI N, 2010, BIOCH J; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Lima CD, 2008, J BIOL CHEM, V283, P32045, DOI 10.1074/jbc.M805655200; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; Makhnevych T, 2009, MOL CELL, V33, P124, DOI 10.1016/j.molcel.2008.12.025; Matic I, 2008, MOL CELL PROTEOMICS, V7, P132, DOI 10.1074/mcp.M700173-MCP200; Mikolajczyk J, 2007, J BIOL CHEM, V282, P26217, DOI 10.1074/jbc.M702444200; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Mukhopadhyay D, 2010, J CELL BIOL, V188, P681, DOI 10.1083/jcb.200909008; Olsen SK, 2010, NATURE, V463, P906, DOI 10.1038/nature08765; Owerbach D, 2005, BIOCHEM BIOPH RES CO, V337, P517, DOI 10.1016/j.bbrc.2005.09.090; Pedrioli PGA, 2006, NAT METHODS, V3, P533, DOI 10.1038/NMETH891; Perry JJP, 2008, TRENDS BIOCHEM SCI, V33, P201, DOI 10.1016/j.tibs.2008.02.001; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Reverter D, 2004, STRUCTURE, V12, P1519, DOI 10.1016/j.str.2004.05.023; Reverter D, 2006, NAT STRUCT MOL BIOL, V13, P1060, DOI 10.1038/nsmb1168; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schimmel J, 2008, MOL CELL PROTEOMICS, V7, P2107, DOI 10.1074/mcp.M800025-MCP200; Schwartz DC, 2007, MOL CELL BIOL, V27, P6948, DOI 10.1128/MCB.00774-07; Schwartz DC, 2003, TRENDS BIOCHEM SCI, V28, P321, DOI 10.1016/S0968-0004(03)00113-0; Shen LN, 2006, BIOCHEM J, V397, P279, DOI 10.1042/BJ20052030; Srikumar T, 2010, PROTEOMICS, V10, P337, DOI 10.1002/pmic.200900627; Sun SC, 2010, CELL DEATH DIFFER, V17, P25, DOI 10.1038/cdd.2009.43; SYDORSKYY Y, 2010, MOL CELL BIOL; Tanaka K, 1999, MOL CELL BIOL, V19, P8660; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Uchimura Y, 2004, ANAL BIOCHEM, V331, P204, DOI 10.1016/j.ab.2004.04.034; Ulrich HD, 2008, MOL CELL, V32, P301, DOI 10.1016/j.molcel.2008.10.010; Vertegaal ACO, 2006, MOL CELL PROTEOMICS, V5, P2298, DOI 10.1074/mcp.M600212-MCP200; Virdee S, 2010, NAT CHEM BIOL, V6, P750, DOI [10.1038/NCHEMBIO.426, 10.1038/nchembio.426]; Wertz IE, 2010, CELL DEATH DIFFER, V17, P14, DOI 10.1038/cdd.2009.168; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Zhu SS, 2009, MOL CELL, V33, P570, DOI 10.1016/j.molcel.2009.02.008	60	59	60	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10238	10247		10.1074/jbc.M110.205153	http://dx.doi.org/10.1074/jbc.M110.205153			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21247896	hybrid, Green Published			2022-12-27	WOS:000288547000041
J	Barbagallo, APM; Wang, ZL; Zheng, H; D'Adamio, L				Barbagallo, Alessia P. M.; Wang, Zilai; Zheng, Hui; D'Adamio, Luciano			A Single Tyrosine Residue in the Amyloid Precursor Protein Intracellular Domain Is Essential for Developmental Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JNK-INTERACTING PROTEIN-1; NEURAL STEM-CELLS; FAMILY-MEMBERS; DEFICIENT MICE; APP; PHOSPHORYLATION; GENE; FE65; PROLIFERATION; GENERATION	The A beta-precursor protein (APP) intracellular domain is highly conserved and contains many potentially important residues, in particular the (YENPTY687)-Y-682 motif. To dissect the functions of this sequence in vivo, we created an APP knock-in allele mutating Tyr(682) to Gly (Y682G). Crossing this allele to APP-like protein 2 (APLP2) knock-out background showed that mutation of Tyr(682) results in postnatal lethality and neuromuscular synapse defects similar to doubly deficient APP/APLP2 mice. Our results demonstrate that a single residue in the APP intracellular region, Tyr(682), is indispensable for the essential function of APP in developmental regulation.	[Barbagallo, Alessia P. M.; D'Adamio, Luciano] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Wang, Zilai; Zheng, Hui] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; [D'Adamio, Luciano] Inst Cellular Biol & Neurobiol, Natl Res Council Italy, I-00143 Rome, Italy	Yeshiva University; Albert Einstein College of Medicine; Baylor College of Medicine; Consiglio Nazionale delle Ricerche (CNR)	D'Adamio, L (corresponding author), 1300 Morris Pk Ave, Bronx, NY 10461 USA.	luciano.dadamio@einstein.yu.edu		D'Adamio, Luciano/0000-0002-2204-9441; D'Adamio, Luciano/0000-0002-9820-4882	National Institutes of Health [AG033007, AG020670, AG032051]; Alzheimer Disease Research Grant [A2003-076, NIRG-10-173876]; NATIONAL INSTITUTE ON AGING [R01AG020670, R01AG032051, R01AG033007] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer Disease Research Grant; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG033007 (to L. D.) and AG020670 and AG032051 (to H.Z.). This work was also supported in part by Alzheimer Disease Research Grants A2003-076 (to L. D.) and NIRG-10-173876 (to A. P. M. B.).	Barbagallo APM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015503; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Biederer T, 2000, J BIOL CHEM, V275, P39803, DOI 10.1074/jbc.C000656200; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Dawson GR, 1999, NEUROSCIENCE, V90, P1, DOI 10.1016/S0306-4522(98)00410-2; Giliberto L, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-12; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hata Y, 1996, J NEUROSCI, V16, P2488; HAYASHI Y, 1994, BIOCHEM BIOPH RES CO, V205, P936, DOI 10.1006/bbrc.1994.2755; Heber S, 2000, J NEUROSCI, V20, P7951; Hornsten A, 2007, P NATL ACAD SCI USA, V104, P1971, DOI 10.1073/pnas.0603997104; King GD, 2004, EXP NEUROL, V185, P208, DOI 10.1016/j.expneurol.2003.10.011; Li HM, 2010, P NATL ACAD SCI USA, V107, P17362, DOI 10.1073/pnas.1012568107; Li HM, 2010, J BIOL CHEM, V285, P30598, DOI 10.1074/jbc.M110.137729; Matsuda S, 2003, J BIOL CHEM, V278, P38601, DOI 10.1074/jbc.M304379200; Meziane H, 1998, P NATL ACAD SCI USA, V95, P12683, DOI 10.1073/pnas.95.21.12683; MULLER U, 1994, CELL, V79, P755, DOI 10.1016/0092-8674(94)90066-3; Ohsawa I, 1999, EUR J NEUROSCI, V11, P1907, DOI 10.1046/j.1460-9568.1999.00601.x; Passer Brent, 2000, Journal of Alzheimer's Disease, V2, P289; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; ROCH JM, 1994, P NATL ACAD SCI USA, V91, P7450, DOI 10.1073/pnas.91.16.7450; Russo C, 2002, J BIOL CHEM, V277, P35282, DOI 10.1074/jbc.M110785200; Scheinfeld MH, 2003, P NATL ACAD SCI USA, V100, P1729, DOI 10.1073/pnas.0437908100; Swistowski A, 2009, J NEUROSCI, V29, P15703, DOI 10.1523/JNEUROSCI.4351-09.2009; Tamayev R, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-28; Tarr PE, 2002, BIOCHEM BIOPH RES CO, V295, P324, DOI 10.1016/S0006-291X(02)00678-2; Tarr PE, 2002, J BIOL CHEM, V277, P16798, DOI 10.1074/jbc.M110286200; Tremml P, 1998, BEHAV BRAIN RES, V95, P65, DOI 10.1016/S0166-4328(97)00211-8; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cb.09.110193.001021; Von Koch CS, 1997, NEUROBIOL AGING, V18, P661, DOI 10.1016/S0197-4580(97)00151-6; Wang B, 2007, P NATL ACAD SCI USA, V104, P14140, DOI 10.1073/pnas.0704070104; Wang P, 2005, J NEUROSCI, V25, P1219, DOI 10.1523/JNEUROSCI.4660-04.2005; Wang ZL, 2009, J NEUROSCI, V29, P10788, DOI 10.1523/JNEUROSCI.2132-09.2009; Zhang ZT, 1997, EMBO J, V16, P6141, DOI 10.1093/emboj/16.20.6141; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X; Zhou DW, 2009, J ALZHEIMERS DIS, V16, P301, DOI 10.3233/JAD-2009-0970; Zhou DW, 2004, J BIOL CHEM, V279, P25374, DOI 10.1074/jbc.M400488200	38	38	38	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8717	8721		10.1074/jbc.C111.219873	http://dx.doi.org/10.1074/jbc.C111.219873			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21266574	Green Published, hybrid			2022-12-27	WOS:000288247700002
J	Kim, SH; Serezani, CH; Okunishi, K; Zaslona, Z; Aronoff, DM; Peters-Golden, M				Kim, Sang-Hoon; Serezani, Carlos Henrique; Okunishi, Katsuhide; Zaslona, Zbigniew; Aronoff, David M.; Peters-Golden, Marc			Distinct Protein Kinase A Anchoring Proteins Direct Prostaglandin E-2 Modulation of Toll-like Receptor Signaling in Alveolar Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; CYCLIC-AMP; PERITONEAL-MACROPHAGES; ARACHIDONIC-ACID; HOST-DEFENSE; EXPRESSION; CAMP; INHIBITION; CYCLOOXYGENASE-2	Toll-like receptors (TLRs) direct a proinflammatory program in macrophages. One mediator whose generation is induced by TLR ligation is prostaglandin E-2 (PGE(2)), which is well known to increase intracellular cAMP upon G protein-coupled receptor ligation. How PGE(2)/cAMP shapes the nascent TLR response and the mechanisms by which it acts remain poorly understood. Here we explored PGE(2)/cAMP regulation of NO production in primary rat alveolar macrophages stimulated with the TLR4 ligand LPS. Endogenous PGE(2) synthesis accounted for nearly half of the increment in NO production in response to LPS. The enhancing effect of PGE(2) on LPS-stimulated NO was mediated via cAMP, generated mainly upon ligation of the E prostanoid 2 receptor and acting via protein kinase A (PKA) rather than via the exchange protein activated by cAMP. Isoenzyme-selective cAMP agonists and peptide disruptors of protein kinase A anchoring proteins (AKAPs) implicated PKA regulatory subunit type I (RI) interacting with an AKAP in this process. Gene knockdown of potential RI-interacting AKAPs expressed in alveolar macrophages revealed that AKAP10 was required for PGE(2) potentiation of LPS-induced NO synthesis. AKAP10 also mediated PGE(2) potentiation of the expression of cytokines IL-10 and IL-6, whereas PGE(2) suppression of TNF-alpha was mediated by AKAP8-anchored PKA-RII. Our data illustrate the pleiotropic manner in which G protein-coupled receptor-derived cAMP signaling can influence TLR responses in primary macrophages and suggest that AKAP10 may coordinate increases in gene expression.	[Kim, Sang-Hoon; Serezani, Carlos Henrique; Okunishi, Katsuhide; Zaslona, Zbigniew; Peters-Golden, Marc] Univ Michigan Hlth Syst, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA; [Aronoff, David M.] Univ Michigan Hlth Syst, Div Infect Dis, Dept Internal Med, Ann Arbor, MI 48109 USA; [Aronoff, David M.] Univ Michigan Hlth Syst, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Kim, Sang-Hoon] Eulji Univ, Sch Med, Div Allergy & Resp Med, Dept Internal Med, Seoul 139711, South Korea	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Eulji University	Peters-Golden, M (corresponding author), Univ Michigan Hlth Syst, Div Pulm & Crit Care Med, 6301 MSRB 3,Box 5642,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	petersm@umich.edu	; serezani, C. Henrique/H-1675-2013	Aronoff, David/0000-0003-4587-6121; Zaslona, Zbigniew/0000-0003-3361-4140; serezani, C. Henrique/0000-0002-5363-415X	National Institutes of Health [HL58897, HD057176]; American Lung Association; Uehara Memorial Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057176] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL103777, R01HL058897, R56HL058897] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association; Uehara Memorial Foundation(Uehara Memorial Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL58897 (to M. P.-G.) and HD057176 (to D. M. A.). This work was also supported by American Lung Association Senior Postdoctoral Research Fellowships (to C. H. S. and K. O.) and a Uehara Memorial Foundation research fellowship (to K. O.).	ADEREM AA, 1986, J EXP MED, V164, P165, DOI 10.1084/jem.164.1.165; Aronoff DM, 2007, J IMMUNOL, V178, P1628, DOI 10.4049/jimmunol.178.3.1628; Aronoff DM, 2006, J INTERF CYTOK RES, V26, P827, DOI 10.1089/jir.2006.26.827; Aronoff DM, 2009, J IMMUNOL, V183, P2642, DOI 10.4049/jimmunol.0900129; Aronoff DM, 2005, J IMMUNOL, V174, P595, DOI 10.4049/jimmunol.174.2.595; Aronoff DM, 2004, J IMMUNOL, V173, P559, DOI 10.4049/jimmunol.173.1.559; Avni D, 2010, MOL IMMUNOL, V47, P1396, DOI 10.1016/j.molimm.2010.02.015; Best JL, 2004, P NATL ACAD SCI USA, V101, P17622, DOI 10.1073/pnas.0406374101; Bos JL, 2003, NAT REV MOL CELL BIO, V4, P733, DOI 10.1038/nrm1197; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Carlson CR, 2006, J BIOL CHEM, V281, P21535, DOI 10.1074/jbc.M603223200; Chen CC, 1999, J BIOL CHEM, V274, P31559, DOI 10.1074/jbc.274.44.31559; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; FERNANDEZREPOLLET E, 1982, J HISTOCHEM CYTOCHEM, V30, P466, DOI 10.1177/30.5.6804558; GASTON B, 1994, AM J RESP CRIT CARE, V149, P538, DOI 10.1164/ajrccm.149.2.7508323; Harbrecht BG, 1997, J LEUKOCYTE BIOL, V61, P712, DOI 10.1002/jlb.61.6.712; Jarnaess E, 2007, BIOCHEM SOC T, V35, P931, DOI 10.1042/BST0350931; Khanduja KL, 2006, LIFE SCI, V78, P1662, DOI 10.1016/j.lfs.2005.07.033; Kleinert H, 2004, EUR J PHARMACOL, V500, P255, DOI 10.1016/j.ejphar.2004.07.030; Kleinert H, 2003, BIOL CHEM, V384, P1343, DOI 10.1515/BC.2003.152; KONOPSKI Z, 1993, SCAND J IMMUNOL, V37, P587, DOI 10.1111/j.1365-3083.1993.tb02576.x; KUNKEL SL, 1988, J BIOL CHEM, V263, P5380; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Moon EY, 2005, J NEUROSCI RES, V81, P38, DOI 10.1002/jnr.20535; OGREID D, 1989, EUR J BIOCHEM, V181, P19; Pang LH, 1997, BIOCHEM PHARMACOL, V53, P493, DOI 10.1016/S0006-2952(96)00737-X; Pautz A, 2010, NITRIC OXIDE-BIOL CH, V23, P75, DOI 10.1016/j.niox.2010.04.007; PETERSGOLDEN M, 1987, AM REV RESPIR DIS, V135, P1020; RADDASSI K, 1993, CELL IMMUNOL, V149, P50, DOI 10.1006/cimm.1993.1135; Serezani CH, 2008, AM J RESP CELL MOL, V39, P127, DOI 10.1165/rcmb.2008-0091TR; Serezani CH, 2007, AM J RESP CELL MOL, V37, P562, DOI 10.1165/rcmb.2007-0153OC; Serezani CH, 2006, J IMMUNOL, V177, P3201, DOI 10.4049/jimmunol.177.5.3201; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Spooren A, 2010, CELL SIGNAL, V22, P871, DOI 10.1016/j.cellsig.2010.01.018; Stokka AJ, 2006, BIOCHEM J, V400, P493, DOI 10.1042/BJ20060962; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Vancheri C, 2004, TRENDS IMMUNOL, V25, P40, DOI 10.1016/j.it.2003.11.001; Verstrepen L, 2008, CELL MOL LIFE SCI, V65, P2964, DOI 10.1007/s00018-008-8064-8; Wall EA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000202; Welsh DA, 2001, MED CLIN N AM, V85, P1329, DOI 10.1016/S0025-7125(05)70383-7; WILBORN J, 1995, AM J PHYSIOL-LUNG C, V268, pL294, DOI 10.1152/ajplung.1995.268.2.L294; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527	42	52	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8875	8883		10.1074/jbc.M110.187815	http://dx.doi.org/10.1074/jbc.M110.187815			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21247892	Green Published, hybrid			2022-12-27	WOS:000288247700018
J	Shen, BY; Wu, N; Yang, JM; Gould, SJ				Shen, Beiyi; Wu, Ning; Yang, Jr-Ming; Gould, Stephen J.			Protein Targeting to Exosomes/Microvesicles by Plasma Membrane Anchors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAENORHABDITIS-ELEGANS; TUMOR-GROWTH; HIV GAG; EXOSOMES; CELLS; MACROPHAGES; VESICLES; RELEASE; INFECTIVITY; SECRETION	Animal cells secrete small vesicles, otherwise known as exosomes and microvesicles (EMVs). A short, N-terminal acylation tag can target a highly oligomeric cytoplasmic protein, TyA, into secreted vesicles (Fang, Y., Wu, N., Gan, X., Yan, W., Morell, J. C., and Gould, S. J. (2007) PLoS Biol. 5, 1267-1283). However, it is not clear whether this is true for other membrane anchors or other highly oligomeric, cytoplasmic proteins. We show here that a variety of plasma membrane anchors can target TyA-GFP to sites of vesicle budding and into EMVs, including: (i) a myristoylation tag; (ii) a phosphatidylinositol-(4,5)-bisphosphate (PIP2)-binding domain; (iii), a phosphatidylinositol-(3,4,5)-trisphosphate- binding domain; (iv) a prenylation/palmitoylation tag, and (v) a type-1 plasma membrane protein, CD43. However, the relative budding efficiency induced by these plasma membrane anchors varied over a 10-fold range, from 100% of control (AcylTyA-GFP) for the myristoylation tag and PIP2-binding domain, to one-third or less for the others, respectively. Targeting TyA-GFP to endosome membranes by fusion to a phosphatidylinositol 3-phosphate-binding domain induced only a slight budding of TyA-GFP, similar to 2% of control, and no budding was observed when TyA-GFP was targeted to Golgi membranes via a phosphatidylinositol 4-phosphate-binding domain. We also found that a plasma membrane anchor can target two other highly oligomeric, cytoplasmic proteins to EMVs. These observations support the hypothesis that plasma membrane anchors can target highly oligomeric, cytoplasmic proteins to EMVs. Our data also provide additional parallels between EMV biogenesis and retrovirus budding, as the anchors that induced the greatest budding of TyA-GFP are the same as those that mediate retrovirus budding.	[Shen, Beiyi; Wu, Ning; Yang, Jr-Ming; Gould, Stephen J.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Gould, SJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, 725 N Wolfe St, Baltimore, MD 21205 USA.	sgould@jhmi.edu		Yang, Jr-Ming/0000-0002-6296-8987	National Institutes of Health [DK45787]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045787] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported, in whole or in part, by National Institutes of Health Grant DK45787.	ADAMSON P, 1992, J BIOL CHEM, V267, P20033; Alais S, 2008, BIOL CELL, V100, P603, DOI 10.1042/BC20080025; Booth AM, 2006, J CELL BIOL, V172, P923, DOI 10.1083/jcb.200508014; Brodsky JL, 2009, CURR OPIN CELL BIOL, V21, P516, DOI 10.1016/j.ceb.2009.04.006; Charollais J, 2009, MOL MEMBR BIOL, V26, P55, DOI 10.1080/09687680802620369; Chen K, 2008, BIOCHEMISTRY-US, V47, P1928, DOI 10.1021/bi701984h; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Coffin JM, 1997, RETROVIRUSES; De Matteis MA, 2005, BBA-MOL CELL RES, V1744, P396, DOI 10.1016/j.bbamcr.2005.04.013; Denek M, 2007, J CELL BIOL, V177, P329, DOI 10.1083/jcb.200609050; Dukers DF, 2000, J IMMUNOL, V165, P663, DOI 10.4049/jimmunol.165.2.663; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Freed EO, 2006, P NATL ACAD SCI USA, V103, P11101, DOI 10.1073/pnas.0604715103; Gillooly DJ, 2003, HISTOCHEM CELL BIOL, V120, P445, DOI 10.1007/s00418-003-0591-7; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; GOTTLINGER HG, 1989, P NATL ACAD SCI USA, V86, P5781, DOI 10.1073/pnas.86.15.5781; Hamard-Peron E, 2010, J VIROL, V84, P503, DOI 10.1128/JVI.01134-09; Hanson PI, 2009, CURR OPIN CELL BIOL, V21, P568, DOI 10.1016/j.ceb.2009.06.002; Haugh JM, 2000, J CELL BIOL, V151, P1269, DOI 10.1083/jcb.151.6.1269; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; James SR, 1996, BIOCHEM J, V315, P709, DOI 10.1042/bj3150709; Keller S, 2009, CANCER LETT, V278, P73, DOI 10.1016/j.canlet.2008.12.028; Kolotuev I, 2009, TRAFFIC, V10, P803, DOI [10.1111/j.1600-0854.2009.00871.x, 10.1111/j.1600-0854.2008.00871.x]; Krishnamoorthy L, 2009, NAT CHEM BIOL, V5, P244, DOI 10.1038/nchembio.151; Leblanc P, 2006, EMBO J, V25, P2674, DOI 10.1038/sj.emboj.7601162; Liegeois S, 2006, J CELL BIOL, V173, P949, DOI 10.1083/jcb.200511072; Logozzi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005219; Mager DL, 2000, J VIROL, V74, P7221, DOI 10.1128/JVI.74.16.7221-7229.2000; Marsh M, 2009, BIOCHEM SOC T, V37, P185, DOI 10.1042/BST0370185; Nazarenko I, 2010, CANCER RES, V70, P1668, DOI 10.1158/0008-5472.CAN-09-2470; Nguyen DG, 2003, J BIOL CHEM, V278, P52347, DOI 10.1074/jbc.M309009200; PAN BT, 1983, CELL, V33, P967, DOI 10.1016/0092-8674(83)90040-5; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Raposo G, 2002, TRAFFIC, V3, P718, DOI 10.1034/j.1600-0854.2002.31004.x; Roth JF, 2000, YEAST, V16, P785, DOI 10.1002/1097-0061(20000630)16:9<785::AID-YEA550>3.0.CO;2-L; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Schorey JS, 2008, TRAFFIC, V9, P871, DOI 10.1111/j.1600-0854.2008.00734.x; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; TRAMS EG, 1981, BIOCHIM BIOPHYS ACTA, V645, P63, DOI 10.1016/0005-2736(81)90512-5; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2; Welsch S, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030036; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Yu X, 2006, CANCER RES, V66, P4795, DOI 10.1158/0008-5472.CAN-05-4579; Yu X, 2009, FEBS J, V276, P2201, DOI 10.1111/j.1742-4658.2009.06949.x; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zimmermann P, 2002, MOL CELL, V9, P1215, DOI 10.1016/S1097-2765(02)00549-X	54	186	193	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14383	14395		10.1074/jbc.M110.208660	http://dx.doi.org/10.1074/jbc.M110.208660			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21300796	Green Published, hybrid			2022-12-27	WOS:000289556200060
J	Kirk, KL; Wang, W				Kirk, Kevin L.; Wang, Wei			A Unified View of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gating: Combining the Allosterism of a Ligand-gated Channel with the Enzymatic Activity of an ATP-binding Cassette (ABC) Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							NUCLEOTIDE-BINDING; CL-CHANNEL; CONFORMATIONAL-CHANGE; CHLORIDE CHANNELS; DOMAIN; MECHANISM; PHOSPHORYLATION; ACTIVATION; CYCLE; SITES	The cystic fibrosis transmembrane conductance regulator (CFTR) is a unique ion channel in that its gating is coupled to an intrinsic enzymatic activity (ATP hydrolysis). This enzymatic activity derives from the evolutionary origin of CETR as an ATP-binding cassette transporter. CFTR gating is distinct from that of a typical ligand-gated channel because its ligand (ATP) is usually consumed during the gating cycle. However, recent findings indicate that CFTR gating exhibits allosteric properties that are common to conventional ligand-gated channels (e.g. unliganded openings and constitutive mutations). Here, we provide a unified view of CFTR gating that combines the allosterism of a ligand-gated channel with its unique enzymatic activity.	[Kirk, Kevin L.] Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Kirk, KL (corresponding author), Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA.	klkirk@uab.edu						Aleksandrov AA, 2000, J PHYSIOL-LONDON, V528, P259, DOI 10.1111/j.1469-7793.2000.00259.x; Aleksandrov AA, 1998, FEBS LETT, V431, P97, DOI 10.1016/S0014-5793(98)00713-3; Aleksandrov AA, 2007, PFLUG ARCH EUR J PHY, V453, P693, DOI 10.1007/s00424-006-0140-z; Aleksandrov AA, 2009, J PHYSIOL-LONDON, V587, P2875, DOI 10.1113/jphysiol.2009.170258; Aleksandrov L, 2002, J BIOL CHEM, V277, P15419, DOI 10.1074/jbc.M111713200; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Basso C, 2003, J GEN PHYSIOL, V122, P333, DOI 10.1085/jgp.200308798; BAUKROWITZ T, 1994, NEURON, V12, P473, DOI 10.1016/0896-6273(94)90206-2; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Bompadre SG, 2007, J GEN PHYSIOL, V129, P285, DOI 10.1085/jgp.200609667; Cadugan DJ, 2010, BIOPHYS J, V99, P798, DOI 10.1016/j.bpj.2010.05.008; Cai ZW, 2003, J GEN PHYSIOL, V122, p22A; CARSON MR, 1995, J BIOL CHEM, V270, P1711, DOI 10.1074/jbc.270.4.1711; Chang YC, 1999, BIOPHYS J, V77, P2542, DOI 10.1016/S0006-3495(99)77089-X; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; Changeux JP, 1998, NEURON, V21, P959, DOI 10.1016/S0896-6273(00)80616-9; Chen TY, 2008, PHYSIOL REV, V88, P351, DOI 10.1152/physrev.00058.2006; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Csanady L, 2006, J GEN PHYSIOL, V128, P523, DOI 10.1085/jgp.200609558; Csanady L, 2010, P NATL ACAD SCI USA, V107, P1241, DOI 10.1073/pnas.0911061107; Csanady L, 2009, J GEN PHYSIOL, V134, P129, DOI 10.1085/jgp.200910268; Cui JM, 2000, BIOCHEMISTRY-US, V39, P15612, DOI 10.1021/bi001509+; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; DEBRAEKELEER M, 2006, MOL HUM REPROD, V2, P669; EDELSTEIN SJ, 1975, ANNU REV BIOCHEM, V44, P209, DOI 10.1146/annurev.bi.44.070175.001233; Farber PJ, 2011, J MOL BIOL, V405, P819, DOI 10.1016/j.jmb.2010.11.016; GABRIEL SE, 1994, SCIENCE, V266, P107, DOI 10.1126/science.7524148; Galzi JL, 1996, P NATL ACAD SCI USA, V93, P1853, DOI 10.1073/pnas.93.5.1853; Gardino AK, 2007, METHOD ENZYMOL, V423, P149, DOI 10.1016/S0076-6879(07)23006-X; Gerber S, 2008, SCIENCE, V321, P246, DOI 10.1126/science.1156213; GUNDERSON KL, 1995, CELL, V82, P231, DOI 10.1016/0092-8674(95)90310-0; He LH, 2008, J BIOL CHEM, V283, P26383, DOI 10.1074/jbc.M803894200; Hennager DJ, 2001, P NATL ACAD SCI USA, V98, P3594, DOI 10.1073/pnas.051633298; HWANG TC, 1994, P NATL ACAD SCI USA, V91, P4698, DOI 10.1073/pnas.91.11.4698; Hwang TC, 2009, J PHYSIOL-LONDON, V587, P2151, DOI 10.1113/jphysiol.2009.171595; Li CH, 1996, J BIOL CHEM, V271, P28463, DOI 10.1074/jbc.271.45.28463; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Luque I, 2002, ANNU REV BIOPH BIOM, V31, P235, DOI 10.1146/annurev.biophys.31.082901.134215; Mathews CJ, 1998, J PHYSIOL-LONDON, V508, P365, DOI 10.1111/j.1469-7793.1998.365bq.x; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Miki H, 2010, J BIOL CHEM, V285, P19967, DOI 10.1074/jbc.M109.092684; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Pedemonte N, 2005, MOL PHARMACOL, V67, P1797, DOI 10.1124/mol.105.010959; Purohit P, 2009, P NATL ACAD SCI USA, V106, P115, DOI 10.1073/pnas.0809272106; RIORDAN JR, 1989, SCIENCE, V245, P1066; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Sheppard David N., 1999, Physiological Reviews, V79, pS23; Szellas T, 2003, FEBS LETT, V535, P141, DOI 10.1016/S0014-5793(02)03892-9; Szollosi A, 2010, J GEN PHYSIOL, V136, P407, DOI 10.1085/jgp.201010434; Tsai CJ, 2001, PROTEINS, V44, P418, DOI 10.1002/prot.1107; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Vergani P, 2003, J GEN PHYSIOL, V121, P17, DOI 10.1085/jgp.20028673; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; Wang F, 2000, J PHYSIOL-LONDON, V524, P637, DOI 10.1111/j.1469-7793.2000.00637.x; Wang W, 2005, J BIOL CHEM, V280, P23622, DOI 10.1074/jbc.M503118200; WANG W, 2010, P NATL ACAD SCI USA, V1088, P3893; Wang W, 2007, J BIOL CHEM, V282, P4533, DOI 10.1074/jbc.M609942200; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Wilkinson DJ, 1997, AM J PHYSIOL-LUNG C, V273, pL127, DOI 10.1152/ajplung.1997.273.1.L127; Zhou Z, 2001, J PHYSIOL-LONDON, V532, P435, DOI 10.1111/j.1469-7793.2001.0435f.x	64	37	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					12813	12819		10.1074/jbc.R111.219634	http://dx.doi.org/10.1074/jbc.R111.219634			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21296873	hybrid, Green Published			2022-12-27	WOS:000289282200001
J	Lim, EJ; Lu, TX; Blanchard, C; Rothenberg, ME				Lim, Eun Jin; Lu, Thomas X.; Blanchard, Carine; Rothenberg, Marc E.			Epigenetic Regulation of the IL-13-induced Human Eotaxin-3 Gene by CREB-binding Protein-mediated Histone 3 Acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CC-CHEMOKINE; EPITHELIAL-CELLS; ACETYLTRANSFERASE ACTIVITY; EOSINOPHILIC ESOPHAGITIS; EXPRESSION; CBP; INTERLEUKIN-13; INFLAMMATION; TRANSCRIPTION; ASTHMA	The etiology of a variety of chronic inflammatory disorders has been attributed to the interaction of genetic and environmental factors. Herein, we identified a link between epigenetic regulation and IL-13-driven eotaxin-3 in the pathogenesis of chronic allergic inflammation. We first demonstrated that the cAMP-responsive element (CRE) site in the eotaxin-3 promoter affects IL-13-induced eotaxin-3 promoter activity. Furthermore, the CRE-binding protein-binding protein (CBP), a histone acetyltransferase, induced base-line and IL-13-induced eotaxin-3 promoter activity. Additionally, IL-13 treatment promoted global histone 3 acetylation as well as the formation of a complex containing CBP and STAT6 and the subsequent acetylation of histone 3 at the eotaxin-3 promoter. CBP gene silencing decreased IL-13-induced transcription of eotaxin-3. Conversely, inhibition of histone deacetylation increased IL-13-induced eotaxin-3 production. Clinical studies demonstrated markedly increased global acetylation of histone 3 in the inflamed tissue of patients with allergic inflammation. Collectively, these results identify an epigenetic mechanism involving CBP and chromatin remodeling in regulating IL-13-induced chemokine transcription.	[Lim, Eun Jin; Lu, Thomas X.; Blanchard, Carine; Rothenberg, Marc E.] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp, Div Allergy & Immunol,Dept Pediat, Cincinnati, OH 45229 USA; [Lu, Thomas X.] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp, Grad Program Mol & Dev Biol, Cincinnati, OH 45229 USA; [Lu, Thomas X.] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp, Phys Scientist Training Program, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Rothenberg, ME (corresponding author), Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp, Div Allergy & Immunol,Dept Pediat, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	Rothenberg@cchmc.org		Lu, Thomas/0000-0001-9712-180X	National Institutes of Health [RO1 DK76893, U19 A1070235]; Food Allergy Project, Food and Anaphylaxis Network; Campaign Urging Research; Buckeye Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076893] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Food Allergy Project, Food and Anaphylaxis Network; Campaign Urging Research; Buckeye Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK76893 and U19 A1070235. This work was also supported by the Food Allergy Project, Food and Anaphylaxis Network Grant, the Campaign Urging Research for Eosinophilic Disorders, and the Buckeye Foundation. M. E. R. has an equity interest in reslizumab,a drug being developed by Cephalon, Inc.	Adcock IM, 2007, CURR OPIN IMMUNOL, V19, P694, DOI 10.1016/j.coi.2007.07.016; Ait-Si-Ali S, 1998, NATURE, V396, P184, DOI 10.1038/24190; ARANY Z, 1995, NATURE, V374, P81, DOI 10.1038/374081a0; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Barnes Peter J, 2009, Proc Am Thorac Soc, V6, P693, DOI 10.1513/pats.200907-071DP; Barnes PJ, 2005, EUR RESPIR J, V25, P1084, DOI 10.1183/09031936.05.00139104; Blanchard C, 2006, J CLIN INVEST, V116, P536, DOI 10.1172/JCI26679; Blanchard C, 2005, CLIN EXP ALLERGY, V35, P1096, DOI 10.1111/j.1365-2222.2005.02299.x; Blanchard C, 2005, INT J BIOCHEM CELL B, V37, P2559, DOI 10.1016/j.biocel.2005.06.010; Blanchard Carine, 2008, Gastrointest Endosc Clin N Am, V18, P133, DOI 10.1016/j.giec.2007.09.016; Blanchard C, 2007, J ALLERGY CLIN IMMUN, V120, P1292, DOI 10.1016/j.jaci.2007.10.024; Blanchard C, 2006, J ALLERGY CLIN IMMUN, V118, P1054, DOI 10.1016/j.jaci.2006.07.038; Chan EM, 2007, EXP HEMATOL, V35, P1782, DOI 10.1016/j.exphem.2007.07.015; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Foster PS, 2002, PHARMACOL THERAPEUT, V94, P253, DOI 10.1016/S0163-7258(02)00220-6; Fukasawa M, 2004, CLIN CANCER RES, V10, P3327, DOI 10.1158/1078-0432.CCR-03-0820; Furuta GT, 1997, GASTROENTEROLOGY, V113, P1560, DOI 10.1053/gast.1997.v113.pm9352858; Gingras S, 1999, NUCLEIC ACIDS RES, V27, P2722, DOI 10.1093/nar/27.13.2722; Goodman RH, 2000, GENE DEV, V14, P1553; Grausenburger R, 2010, J IMMUNOL, V185, P3489, DOI 10.4049/jimmunol.0903610; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Han S, 2007, IMMUNOL LETT, V108, P143, DOI 10.1016/j.imlet.2006.12.001; Ho SM, 2010, J ALLERGY CLIN IMMUN, V126, P453, DOI 10.1016/j.jaci.2010.07.030; Hoeck J, 2001, J IMMUNOL, V167, P3216, DOI 10.4049/jimmunol.167.6.3216; Ito K, 2004, BIOCHEM BIOPH RES CO, V315, P240, DOI 10.1016/j.bbrc.2004.01.046; Ito K, 2007, PHARMACOL THERAPEUT, V116, P249, DOI 10.1016/j.pharmthera.2007.06.009; Jegga AG, 2002, GENOME RES, V12, P1408, DOI 10.1101/gr.255002; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Karamouzis MV, 2007, CELL RES, V17, P324, DOI 10.1038/cr.2007.10; Kawasaki H, 2000, NATURE, V405, P195, DOI 10.1038/35012097; Kitaura M, 1999, J BIOL CHEM, V274, P27975, DOI 10.1074/jbc.274.39.27975; Konikoff MR, 2006, GASTROENTEROLOGY, V131, P1381, DOI 10.1053/j.gastro.2006.08.033; Kumar RK, 2009, DIS MODEL MECH, V2, P549, DOI 10.1242/dmm.001719; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Lim EJ, 2007, AM J PHYSIOL-HEART C, V293, pH3340, DOI 10.1152/ajpheart.00921.2007; Lim EJ, 2007, GENE, V386, P183, DOI 10.1016/j.gene.2006.09.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marmorstein R, 2001, CURR OPIN GENET DEV, V11, P155, DOI 10.1016/S0959-437X(00)00173-8; McDonald C, 1999, J INTERF CYTOK RES, V19, P711, DOI 10.1089/107999099313550; NISHIHIRA T, 1993, J CANCER RES CLIN, V119, P441, DOI 10.1007/BF01215923; Pearce EL, 2006, IMMUNOL REV, V211, P197, DOI 10.1111/j.0105-2896.2006.00399.x; Perissi V, 1999, P NATL ACAD SCI USA, V96, P3652, DOI 10.1073/pnas.96.7.3652; Ravnskjaer K, 2007, EMBO J, V26, P2880, DOI 10.1038/sj.emboj.7601715; Reid JL, 1998, EMBO J, V17, P4469, DOI 10.1093/emboj/17.15.4469; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Richardson B, 2007, NAT CLIN PRACT RHEUM, V3, P521, DOI 10.1038/ncprheum0573; Rosato RR, 2003, CANCER BIOL THER, V2, P30; Rothenberg ME, 2010, NAT GENET, V42, P289, DOI 10.1038/ng.547; Rothenberg ME, 2004, J ALLERGY CLIN IMMUN, V113, P11, DOI 10.1016/j.jaci.2003.10.047; ROTHENBERG ME, 2004, CLIN IMMUNOL, V113, P29; Ruffell D, 2009, P NATL ACAD SCI USA, V106, P17475, DOI 10.1073/pnas.0908641106; Schmeck B, 2008, J IMMUNOL, V181, P940, DOI 10.4049/jimmunol.181.2.940; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Shankaranarayanan P, 2001, J BIOL CHEM, V276, P42753, DOI 10.1074/jbc.M102626200; Shinkai A, 1999, J IMMUNOL, V163, P1602; Su RC, 2008, J ALLERGY CLIN IMMUN, V121, P57, DOI 10.1016/j.jaci.2007.09.004; van Wetering S, 2007, MOL IMMUNOL, V44, P803, DOI 10.1016/j.molimm.2006.04.008; WALTON KM, 1990, MOL NEUROBIOL, V4, P197, DOI 10.1007/BF02780341; Wierda RJ, 2010, J CELL MOL MED, V14, P1225, DOI 10.1111/j.1582-4934.2010.01022.x; Wills-Karp M, 2004, IMMUNOL REV, V202, P175, DOI 10.1111/j.0105-2896.2004.00215.x; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Yang M, 2003, J ALLERGY CLIN IMMUN, V112, P935, DOI 10.1016/j.jaci.2003.08.010; Zimmermann N, 2003, J CLIN INVEST, V111, P1863, DOI 10.1172/JCI200317912	65	33	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13193	13204		10.1074/jbc.M110.210724	http://dx.doi.org/10.1074/jbc.M110.210724			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21325281	Green Published			2022-12-27	WOS:000289282200040
J	Wu, XH; Chen, S; Orlando, SA; Yuan, J; Kim, ET; Munugalavadla, V; Mali, RS; Kapur, R; Yang, FC				Wu, Xiaohua; Chen, Shi; Orlando, Selina A.; Yuan, Jin; Kim, Edward T.; Munugalavadla, Veerendra; Mali, Raghuveer S.; Kapur, Reuben; Yang, Feng-Chun			p85 alpha Regulates Osteoblast Differentiation by Cross-talking with the MAPK Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; GROWTH-FACTOR; OSTEOGENIC DIFFERENTIATION; NEGATIVE REGULATION; SIGNALING PROMOTES; SUBUNIT P85-ALPHA; IN-VITRO; INHIBITION	Class IA phosphoinositide 3-kinase (PI3K) is involved in regulating many cellular functions including cell growth, proliferation, cell survival, and differentiation. The p85 regulatory subunit is a critical component of the PI3K signaling pathway. Mesenchymal stem cells (MSC) are multipotent cells that can be differentiated into osteoblasts (OBs), adipocytes, and chondrocytes under defined culture conditions. To determine whether p85 alpha subunit of PI3K affects biological functions of MSCs, bone marrow-derived wild type (WT) and p85 alpha-deficient (p85 alpha(-/-)) cells were employed in this study. Increased cell growth, higher proliferation rate and reduced number of senescent cells were observed in MSCs lacking p85 alpha compare with WT MSCs as evaluated by CFLT-F assay, thymidine incorporation assay, and beta-galactosidase staining, respectively. These functional changes are associated with the increased cell cycle, increased expression of cyclin cyclin E, and reduced expression of p16 and p19 in p85 alpha(-/-) MSCs. In addition, a time-dependent reduction in alkaline phosphatase (ALP) activity and osteocalcin mRNA expression was observed in p85 alpha(-/-) MSCs compared with WT MSCs, suggesting impaired osteoblast differentiation due to p85 alpha deficiency in MSCs. The impaired p85 alpha(-/-) osteoblast differentiation was associated with increased activation of Akt and MAPK. Importantly, bone morphogenic protein 2 (BMP2) was able to intensify the differentiation of osteoblasts derived from WT MSCs, whereas this process was significantly impaired as a result of p85 alpha deficiency. Addition of LY294002, a PI3K inhibitor, did not alter the differentiation of osteoblasts in either genotype. However, application of PD98059, a Mek/MAPK inhibitor, significantly enhanced osteoblast differentiation in WT and p85 alpha(-/-) MSCs. These results suggest that p85 alpha plays an essential role in osteoblast differentiation from MSCs by repressing the activation of MAP K pathway.	[Yang, Feng-Chun] Indiana Univ Sch Med, Canc Res Inst, Dept Pediat, Indianapolis, IN 46202 USA; [Wu, Xiaohua; Chen, Shi; Orlando, Selina A.; Yuan, Jin; Kim, Edward T.; Munugalavadla, Veerendra; Kapur, Reuben; Yang, Feng-Chun] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Kapur, Reuben] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Yang, Feng-Chun] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Yang, FC (corresponding author), Indiana Univ Sch Med, Canc Res Inst, Dept Pediat, 1044 W Walnut St,R4-427, Indianapolis, IN 46202 USA.	fyang@iupui.edu			National Institutes of Health [R01 HL075816, R01 HL077177]; Department of Defense (DOD) [NF043032, DOD073112]; March of Dimes [MOD 6-FY08-246]; Fanconi Anemia Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075816, R01HL077177] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense (DOD)(United States Department of Defense); March of Dimes(March of Dimes); Fanconi Anemia Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL075816 (to R. K.) and R01 HL077177 (to R. K.), and grants from the Department of Defense (DOD) NF043032 (to F.-C. Y.), DOD073112 (to F.-C. Y.), March of Dimes (MOD 6-FY08-246, to F.-C. Y.), and Fanconi Anemia Research Fund (to F.-C. Y.).	Barbour LA, 2005, J BIOL CHEM, V280, P37489, DOI 10.1074/jbc.M506967200; Boiret N, 2005, EXP HEMATOL, V33, P219, DOI 10.1016/j.exphem.2004.11.001; Brandstrom H, 2001, BIOCHEM BIOPH RES CO, V280, P831, DOI 10.1006/bbrc.2000.4223; Butt AJ, 2008, ADV EXP MED BIOL, V630, P189; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chackalaparampil I, 1996, ONCOGENE, V12, P1457; Chen QH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015288; DiGirolamo CM, 1999, BRIT J HAEMATOL, V107, P275, DOI 10.1046/j.1365-2141.1999.01715.x; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Fruman DA, 2009, IMMUNOL REV, V228, P253, DOI 10.1111/j.1600-065X.2008.00750.x; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Ghosh-Choudhury N, 2002, J BIOL CHEM, V277, P33361, DOI 10.1074/jbc.M205053200; Giuliani N, 2001, BLOOD, V98, P3527, DOI 10.1182/blood.V98.13.3527; Golden LH, 2004, BONE, V34, P3, DOI 10.1016/j.bone.2003.09.005; Gori F, 2000, ENDOCRINOLOGY, V141, P4768, DOI 10.1210/endo.141.12.7840; Hamidouche Z, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-44; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Hay E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008284; Higuchi C, 2002, J BONE MINER RES, V17, P1785, DOI 10.1359/jbmr.2002.17.10.1785; Honczarenko M, 2006, STEM CELLS, V24, P1030, DOI 10.1634/stemcells.2005-0319; Kassem M, 1997, OSTEOPOROSIS INT, V7, P514, DOI 10.1007/BF02652556; Kassem M, 2008, CELL TISSUE RES, V331, P157, DOI 10.1007/s00441-007-0509-0; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Lee JH, 2010, BONE, V46, P1522, DOI 10.1016/j.bone.2010.02.013; Ling L, 2010, J BIOL CHEM, V285, P26233, DOI 10.1074/jbc.M110.122069; Luo J, 2005, CELL CYCLE, V4, P1309, DOI 10.4161/cc.4.10.2062; Mannova P, 2005, J VIROL, V79, P8742, DOI 10.1128/JVI.79.14.8742-8749.2005; Martin SK, 2010, J BONE MINER RES, V25, P2126, DOI 10.1002/jbmr.114; Meirelles LD, 2003, BRIT J HAEMATOL, V123, P702, DOI 10.1046/j.1365-2141.2003.04669.x; Miura M, 2006, STEM CELLS, V24, P1095, DOI 10.1634/stemcells.2005-0403; Munugalavadla V, 2008, MOL CELL BIOL, V28, P7182, DOI 10.1128/MCB.00920-08; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Osyczka AM, 2005, ENDOCRINOLOGY, V146, P3428, DOI 10.1210/en.2005-0303; OWEN M, 1988, CIBA F SYMP, V136, P42; Payne KA, 2010, TISSUE ENG PT A, V16, P3647, DOI 10.1089/ten.TEA.2009.0738; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Rifas L, 2007, J CELL BIOCHEM, V100, P824, DOI 10.1002/jcb.21132; Rubio D, 2005, CANCER RES, V65, P3035, DOI 10.1158/0008-5472.CAN-04-4194; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Suzuki H, 1999, SCIENCE, V283, P390, DOI 10.1126/science.283.5400.390; Tamama K, 2008, STEM CELLS DEV, V17, P897, DOI 10.1089/scd.2007.0155; Tamama K, 2006, STEM CELLS, V24, P686, DOI 10.1634/stemcells.2005-0176; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Taniguchi CM, 2006, P NATL ACAD SCI USA, V103, P12093, DOI 10.1073/pnas.0604628103; Taniguchi CM, 2010, CANCER RES, V70, P5305, DOI 10.1158/0008-5472.CAN-09-3399; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Ueki K, 2002, MOL CELL BIOL, V22, P965, DOI 10.1128/MCB.22.3.965-977.2002; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Vanhaesebroeck B, 2005, TRENDS BIOCHEM SCI, V30, P194, DOI 10.1016/j.tibs.2005.02.008; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Windahl SH, 1999, J CLIN INVEST, V104, P895, DOI 10.1172/JCI6730; Wu M, 2006, ONCOGENE, V25, P2297, DOI 10.1038/sj.onc.1209264; Wu XH, 2006, HUM MOL GENET, V15, P2837, DOI 10.1093/hmg/ddl208; Yu JH, 1998, MOL CELL BIOL, V18, P1379, DOI 10.1128/MCB.18.3.1379	59	19	20	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13512	13521		10.1074/jbc.M110.187351	http://dx.doi.org/10.1074/jbc.M110.187351			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21324896	Green Published, hybrid			2022-12-27	WOS:000289282200071
J	Frasch, SC; Fernandez-Boyanapalli, RF; Berry, KZ; Leslie, CC; Bonventre, JV; Murphy, RC; Henson, PM; Bratton, DL				Frasch, S. Courtney; Fernandez-Boyanapalli, Ruby F.; Berry, Karin Zemski; Leslie, Christina C.; Bonventre, Joseph V.; Murphy, Robert C.; Henson, Peter M.; Bratton, Donna L.			Signaling via Macrophage G2A Enhances Efferocytosis of Dying Neutrophils by Augmentation of Rac Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC GRANULOMATOUS-DISEASE; COUPLED-RECEPTOR G2A; CYTOSOLIC PHOSPHOLIPASE A(2); OXIDATION-SPECIFIC EPITOPES; PROSTAGLANDIN-E RECEPTORS; PROGRAMMED CELL-DEATH; FREE FATTY-ACIDS; APOPTOTIC CELLS; PHOSPHATIDYLSERINE RECEPTOR; 9-HYDROXYOCTADECADIENOIC ACID	Phosphatidylserine (PS) and oxidized PS species have been identified as key ligands on apoptotic cells important for their recognition and removal (efferocytosis) by phagocytes, a requisite step for resolution of inflammation. We have recently demonstrated that lysophosphatidylserine (lyso-PS) generated and retained on neutrophils following short term activation of the NADPH oxidase in vitro and in vivo enhanced their clearance via signaling through the macrophage G-protein-coupled receptor G2A. Here, we investigated the signaling pathway downstream of G2A. Lyso-PS, either made endogenously in apoptosing neutrophils or supplied exogenously in liposomes along with lyso-PSneg apoptotic cells, signaled to macrophages in a G2A-dependent manner for their enhanced production of prostaglandin E-2 (PGE(2)) via a calcium-dependent cytosolic phospholipase A(2)/cyclooxygenase-mediated mechanism. Subsequent signaling by PGE(2) via EP2 receptors activated macrophage adenylyl cyclase and protein kinase A. These events, in turn, culminated in enhanced activity of Rac1, resulting in an increase in both the numbers of macrophages efferocytosing apoptotic cells and the numbers of cells ingested per macrophage. These data were surprising in light of previous reports demonstrating that signaling by PGE(2) and adenylyl cyclase activation are associated with macrophage deactivation and inhibition of apoptotic cell uptake. Further investigation revealed that the impact of this pathway, either the enhancement or inhibition of efferocytosis, was exquisitely sensitive to concentration effects of these intermediaries. Together, these data support the hypothesis that lyso-PS presented on the surface of activated and dying neutrophils provides a tightly controlled, proresolution signal for high capacity clearance of neutrophils in acute inflammation.	[Frasch, S. Courtney; Fernandez-Boyanapalli, Ruby F.; Leslie, Christina C.; Henson, Peter M.; Bratton, Donna L.] Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA; [Leslie, Christina C.; Henson, Peter M.; Bratton, Donna L.] Natl Jewish Hlth, Cell Biol Program, Denver, CO 80206 USA; [Berry, Karin Zemski; Murphy, Robert C.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA; [Bonventre, Joseph V.] Brigham & Womens Hosp, Div Renal, Boston, MA 02115 USA	National Jewish Health; National Jewish Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Harvard University; Brigham & Women's Hospital	Frasch, SC (corresponding author), Natl Jewish Hlth, Dept Pediat, 1400 Jackson St, Denver, CO 80206 USA.	fraschc@njhealth.org	Murphy, Robert/AAO-5349-2020	Murphy, Robert/0000-0002-9430-6515	National Institutes of Health [AI058228, HL34303, GM61031, HL81151]; Chronic Granulomatous Disorder Research Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081151, P01HL034303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI058228, R01AI058228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061031] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chronic Granulomatous Disorder Research Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI058228 (to D. L. B.), HL34303 (to D. L. B., C. C. L., and R. C. M.), and GM61031 and HL81151 (to P. M. H.). This work was also supported by the Chronic Granulomatous Disorder Research Trust (to D.L.B.).	Albert ML, 2000, NAT CELL BIOL, V2, P899, DOI 10.1038/35046549; Aronoff DM, 2007, J IMMUNOL, V178, P1628, DOI 10.4049/jimmunol.178.3.1628; Aronoff DM, 2005, J IMMUNOL, V174, P595, DOI 10.4049/jimmunol.174.2.595; Arroyo A, 2002, J BIOL CHEM, V277, P49965, DOI 10.1074/jbc.M204513200; Bolick DT, 2007, CIRC RES, V100, P572, DOI 10.1161/01.RES.0000258877.57836.d2; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Bystrom J, 2008, BLOOD, V112, P4117, DOI 10.1182/blood-2007-12-129767; Chang MK, 2004, J EXP MED, V200, P1359, DOI 10.1084/jem.20031763; Chang MK, 1999, P NATL ACAD SCI USA, V96, P6353, DOI 10.1073/pnas.96.11.6353; Coxon A, 1996, IMMUNITY, V5, P653, DOI 10.1016/S1074-7613(00)80278-2; deCathelineau AM, 2003, ESSAYS BIOCHEM, V39, P105, DOI 10.1042/bse0390105; FADOK VA, 1992, J IMMUNOL, V149, P4029; FADOK VA, 1992, J IMMUNOL, V148, P2207; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fadok VA, 2001, J IMMUNOL, V166, P6847, DOI 10.4049/jimmunol.166.11.6847; Fernandez-Boyanapalli R, 2010, BLOOD, V116, P4512, DOI 10.1182/blood-2010-02-272005; Fernandez-Boyanapalli RF, 2009, BLOOD, V113, P2047, DOI 10.1182/blood-2008-05-160564; FOLCH J, 1957, J BIOL CHEM, V226, P497; Frasch SC, 2007, J IMMUNOL, V178, P6540, DOI 10.4049/jimmunol.178.10.6540; Frasch SC, 2008, J BIOL CHEM, V283, P33736, DOI 10.1074/jbc.M807047200; Freire-de-Lima CG, 2006, J BIOL CHEM, V281, P38376, DOI 10.1074/jbc.M605146200; Gijon MA, 2007, J LIPID RES, V48, P716, DOI 10.1194/jlr.M600508-JLR200; Greenberg ME, 2006, J EXP MED, V203, P2613, DOI 10.1084/jem.20060370; Hall LM, 1998, J AM SOC MASS SPECTR, V9, P527, DOI 10.1016/S1044-0305(98)00013-0; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hara S, 2010, BIOCHIMIE, V92, P651, DOI 10.1016/j.biochi.2010.02.007; HASLETT C, 1985, AM J PATHOL, V119, P101; Hattori T, 2008, J INVEST DERMATOL, V128, P1123, DOI 10.1038/sj.jid.5701172; Henson PM, 2009, PHAGOCYTE-PATHOGEN INTERACTIONS: MACROPHAGES AND THE HOST RESPONSE TO INFECTION, P341; Ikegami R, 2001, J IMMUNOL, V166, P4689, DOI 10.4049/jimmunol.166.7.4689; Kabarowski JH, 2009, PROSTAG OTH LIPID M, V89, P73, DOI 10.1016/j.prostaglandins.2009.04.007; Kagan VE, 2002, J IMMUNOL, V169, P487, DOI 10.4049/jimmunol.169.1.487; Kasahara Y, 1997, BLOOD, V89, P1748, DOI 10.1182/blood.V89.5.1748.1748_1748_1753; Kinchen JM, 2007, J CELL SCI, V120, P2143, DOI 10.1242/jcs.03463; Kiss RS, 2006, CURR BIOL, V16, P2252, DOI 10.1016/j.cub.2006.09.043; Le LQ, 2001, IMMUNITY, V14, P561, DOI 10.1016/S1074-7613(01)00145-5; Medeiros AI, 2009, J EXP MED, V206, P61, DOI 10.1084/jem.20082058; Mevorach D, 1998, J EXP MED, V188, P2313, DOI 10.1084/jem.188.12.2313; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Morimoto K, 2006, J IMMUNOL, V176, P7657, DOI 10.4049/jimmunol.176.12.7657; Nakaya M, 2006, J BIOL CHEM, V281, P8836, DOI 10.1074/jbc.M510972200; Nakaya M, 2008, P NATL ACAD SCI USA, V105, P9198, DOI 10.1073/pnas.0803677105; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Obinata H, 2005, J BIOL CHEM, V280, P40676, DOI 10.1074/jbc.M507787200; Obinata H, 2009, PROSTAG OTH LIPID M, V89, P66, DOI 10.1016/j.prostaglandins.2008.11.002; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Park SY, 2008, CELL DEATH DIFFER, V15, P192, DOI 10.1038/sj.cdd.4402242; Peter C, 2008, J BIOL CHEM, V283, P5296, DOI 10.1074/jbc.M706586200; Pulfer M, 2003, MASS SPECTROM REV, V22, P332, DOI 10.1002/mas.10061; Rajakariar R, 2009, J IMMUNOL, V182, P3262, DOI 10.4049/jimmunol.0801739; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Richens TR, 2009, AM J RESP CRIT CARE, V179, P1011, DOI 10.1164/rccm.200807-1148OC; Rossi AG, 1998, J IMMUNOL, V160, P3562; Sanford AN, 2006, RHEUMATOLOGY, V45, P178, DOI 10.1093/rheumatology/kei135; SAVILL J, 1991, CHEST, V99, pS6, DOI 10.1378/chest.99.3_Supplement.6S-a; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Suram S, 2010, J BIOL CHEM, V285, P30676, DOI 10.1074/jbc.M110.143800; Taylor PR, 2000, J EXP MED, V192, P359, DOI 10.1084/jem.192.3.359; Tosello-Trampont AC, 2003, J BIOL CHEM, V278, P49911, DOI 10.1074/jbc.M306079200; Tosello-Trampont AC, 2001, J BIOL CHEM, V276, P13797, DOI 10.1074/jbc.M011238200; Wang L, 2005, MOL BIOL CELL, V16, P2234, DOI 10.1091/mbc.E04-12-1044; Yan JJ, 2004, NAT MED, V10, P161, DOI 10.1038/nm989; Yang LV, 2005, BLOOD, V105, P1127, DOI 10.1182/blood-2004-05-1916; Yin H, 2009, J BIOL CHEM, V284, P12328, DOI 10.1074/jbc.M806516200	67	64	66	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.181800	http://dx.doi.org/10.1074/jbc.M110.181800			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21297111	Green Published, hybrid			2022-12-27	WOS:000289077500026
J	Ratti, J; Rostkova, E; Gautel, M; Pfuhl, M				Ratti, Joyce; Rostkova, Elena; Gautel, Mathias; Pfuhl, Mark			Structure and Interactions of Myosin-binding Protein C Domain C0 CARDIAC-SPECIFIC REGULATION OF MYOSIN AT ITS NECK?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; MODEL-FREE APPROACH; DIFFERENTIAL SCANNING CALORIMETRY; MAGNETIC-RESONANCE RELAXATION; LIGHT-CHAIN PHOSPHORYLATION; SMOOTH-MUSCLE TROPOMYOSIN; F-ACTIN; NOESY SPECTRA; MYBP-C; M-BAND	Myosin-binding protein C (MyBP-C) is a multidomain protein present in the thick filaments of striated muscles and is involved in both sarcomere formation and contraction regulation. The latter function is believed to be located at the N terminus, which is close to the motor domain of myosin. The cardiac isoform of MyBP-C is linked to hypertrophic cardiomyopathy. Here, we use NMR spectroscopy and biophysical and biochemical assays to study the three-dimensional structure and interactions of the cardiac-specific Ig-like domain C0, a part of cardiac MyBP-C of which little is known. The structure confirmed that C0 is a member of the IgI class of proteins, showing many of the characteristic features of this fold. Moreover, we identify a novel interaction between C0 and the regulatory light chain of myosin, thus placing the N terminus of the protein in proximity to the motor domain of myosin. This novel interaction is disrupted by several cardiomyopathy-linked mutations in the MYBPC3 gene. These results provide new insights into how cardiac MyBP-C incorporates in the sarcomere and how it can contribute to the regulation of muscle contraction.	[Rostkova, Elena; Gautel, Mathias; Pfuhl, Mark] Kings Coll London, Randall Div Cell & Mol Biophys, BHF Ctr Res Excellence, London SE1 1UL, England; [Rostkova, Elena; Gautel, Mathias; Pfuhl, Mark] Kings Coll London, Div Cardiovasc, BHF Ctr Res Excellence, London SE1 1UL, England; Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England	University of London; King's College London; University of London; King's College London; University of Leicester	Pfuhl, M (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, BHF Ctr Res Excellence, London SE1 1UL, England.	Mark.Pfuhl@kcl.ac.uk	Gautel, Mathias/AAB-9860-2019	Pfuhl, Mark/0000-0001-9592-6639; Gautel, Mathias/0000-0003-4027-9803	BHF; Medical Research Council of Great Britain; MRC [G0600251] Funding Source: UKRI; Medical Research Council [G0600251, G0200496] Funding Source: researchfish	BHF(British Heart Foundation); Medical Research Council of Great Britain(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a BHF studentship (to M.P.) and the Medical Research Council of Great Britain (to M.G.).	Ababou A, 2007, J BIOL CHEM, V282, P9204, DOI 10.1074/jbc.M610899200; Ababou A, 2008, J MOL BIOL, V384, P615, DOI 10.1016/j.jmb.2008.09.065; Auerbach D, 1999, MOL BIOL CELL, V10, P1297, DOI 10.1091/mbc.10.5.1297; BAGSHAW C R, 1977, Biochemistry, V16, P59, DOI 10.1021/bi00620a010; BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; BAX A, 1990, J MAGN RESON, V87, P620, DOI 10.1016/0022-2364(90)90320-9; Bennett PM, 1999, REV PHYSIOL BIOCH P, V138, P203, DOI 10.1007/BF02346664; CLORE GM, 1990, J AM CHEM SOC, V112, P4989, DOI 10.1021/ja00168a070; CLORE GM, 1991, ANNU REV BIOPHYS BIO, V20, P29, DOI 10.1146/annurev.biophys.20.1.29; Colson BA, 2010, J PHYSIOL-LONDON, V588, P981, DOI 10.1113/jphysiol.2009.183897; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DANGOOR M, 1990, J MUSCLE RES CELL M, V11, P216, DOI 10.1007/BF01843575; Davis JS, 2001, CELL, V107, P631, DOI 10.1016/S0092-8674(01)00586-4; GAUTEL M, 1995, EMBO J, V14, P1952, DOI 10.1002/j.1460-2075.1995.tb07187.x; GRONENBORN AM, 1989, FEBS LETT, V243, P93, DOI 10.1016/0014-5793(89)81224-4; Gruen M, 1999, FEBS LETT, V453, P254, DOI 10.1016/S0014-5793(99)00727-9; Gruen M, 1999, J MOL BIOL, V286, P933, DOI 10.1006/jmbi.1998.2522; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; HARPAZ Y, 1994, J MOL BIOL, V238, P528, DOI 10.1006/jmbi.1994.1312; Harris SP, 2004, CIRC RES, V95, P930, DOI 10.1161/01.RES.0000147312.02673.56; HEMMINGSEN JM, 1994, PROTEIN SCI, V3, P1927, DOI 10.1002/pro.5560031104; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Herron TJ, 2006, CIRC RES, V98, P1290, DOI 10.1161/01.RES.0000222059.54917.ef; HOLTZER ME, 1990, BIOPOLYMERS, V30, P985, DOI 10.1002/bip.360300913; Idowu SM, 2003, J MOL BIOL, V329, P745, DOI 10.1016/S0022-2836(03)00425-X; Jeffries CM, 2008, J MOL BIOL, V377, P1186, DOI 10.1016/j.jmb.2008.01.080; Kunst G, 2000, CIRC RES, V86, P51, DOI 10.1161/01.RES.86.1.51; Lange S, 2005, J MOL BIOL, V345, P289, DOI 10.1016/j.jmb.2004.10.040; Levine R, 2001, BIOPHYS J, V81, P1070, DOI 10.1016/S0006-3495(01)75764-5; Levitsky DI, 2000, EUR J BIOCHEM, V267, P1869, DOI 10.1046/j.1432-1327.2000.01192.x; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; MAJUMDAR A, 1993, J MAGN RESON SER B, V102, P242, DOI 10.1006/jmrb.1993.1093; MARGOSSIAN SS, 1985, J BIOL CHEM, V260, P3747; MARGOSSIAN SS, 1987, J MUSCLE RES CELL M, V8, P437, DOI 10.1007/BF01578433; Mayans O, 2001, STRUCTURE, V9, P331, DOI 10.1016/S0969-2126(01)00591-3; McClellan G, 2001, BIOPHYS J, V81, P1083, DOI 10.1016/S0006-3495(01)75765-7; MERABET EK, 1993, BIOCHIM BIOPHYS ACTA, V1161, P272, DOI 10.1016/0167-4838(93)90224-F; Meurs KM, 2005, HUM MOL GENET, V14, P3587, DOI 10.1093/hmg/ddi386; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Niimura H, 2002, CIRCULATION, V105, P446, DOI 10.1161/hc0402.102990; Oakley CE, 2004, CELL RES, V14, P95, DOI 10.1038/sj.cr.7290208; Offer G, 1996, J MOL BIOL, V256, P407, DOI 10.1006/jmbi.1996.0096; Orlov VN, 1998, FEBS LETT, V433, P241, DOI 10.1016/S0014-5793(98)00923-5; RATTI J, 2009, THESIS U LEICESTER; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; RICHARDSON JS, 1978, P NATL ACAD SCI USA, V75, P2574, DOI 10.1073/pnas.75.6.2574; Scruggs SB, 2009, J BIOL CHEM, V284, P5097, DOI 10.1074/jbc.M807414200; Shaffer JF, 2009, J BIOL CHEM, V284, P12318, DOI 10.1074/jbc.M808850200; Takashima S, 2009, CIRC J, V73, P208, DOI 10.1253/circj.CJ-08-1041; Van Driest SL, 2004, J AM COLL CARDIOL, V44, P1903, DOI 10.1016/j.jacc.2004.07.045; WANG AC, 1994, J MAGN RESON SER B, V105, P196, DOI 10.1006/jmrb.1994.1123; Weisberg A, 1996, P NATL ACAD SCI USA, V93, P8999, DOI 10.1073/pnas.93.17.8999; Whitten AE, 2008, P NATL ACAD SCI USA, V105, P18360, DOI 10.1073/pnas.0808903105; Winegrad S, 2003, ADV EXP MED BIOL, V538, P31; Winegrad S, 2000, CIRC RES, V86, P6, DOI 10.1161/01.RES.86.1.6; XIE X, 1994, NATURE, V368, P306, DOI 10.1038/368306a0	58	86	87	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.156646	http://dx.doi.org/10.1074/jbc.M110.156646			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21297165	Green Published, hybrid			2022-12-27	WOS:000289077500076
J	Sela, DA; Li, YH; Lerno, L; Wu, SA; Marcobal, AM; German, JB; Chen, X; Lebrilla, CB; Mills, DA				Sela, David A.; Li, Yanhong; Lerno, Larry; Wu, Shuai; Marcobal, Angela M.; German, J. Bruce; Chen, Xi; Lebrilla, Carlito B.; Mills, David A.			An Infant-associated Bacterial Commensal Utilizes Breast Milk Sialyloligosaccharides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIALIC-ACID TRANSPORTER; MASS-SPECTROMETRY; BIFIDOBACTERIAL CONSUMPTION; SUBSTRATE-SPECIFICITY; BACTEROIDES-FRAGILIS; EPITHELIAL-CELLS; OLIGOSACCHARIDES; IDENTIFICATION; PROTECTION; STRATEGY	Lactating mothers secrete milk sialyloligosaccharides (MSOs) that function as anti-adhesives once provided to the neonate. Particular infant-associated commensals, such as Bifidobacterium longum subsp. infantis, consume neutral milk oligosaccharides, although their ability to utilize acidic oligosaccharides has not been assessed. Temporal glycoprofiling of acidic HMO consumed during fermentation demonstrated a single composition, with several isomers, corresponding to sialylated lacto-N-tetraose. To utilize MSO, B. longum subsp. infantis deploys a sialidase that cleaves alpha 2-6 and alpha 2-3 linkages. NanH2, encoded within the HMO catabolic cluster is up-regulated during HMO fermentation and is active on sialylated lacto-N-tetraose. These results demonstrate that commensal microorganisms do utilize MSO, a substrate that may be enriched in the distal gastrointestinal tract.	[Mills, David A.] Univ Calif Davis, Robert Mondavi Inst, Dept Viticulture & Enol, RMI N Lab, Davis, CA 95616 USA; [Sela, David A.] Univ Calif Davis, Robert Mondavi Inst, Microbiol Grad Grp, Davis, CA 95616 USA; [Li, Yanhong; Lerno, Larry; Wu, Shuai; Chen, Xi; Lebrilla, Carlito B.] Univ Calif Davis, Robert Mondavi Inst, Dept Chem, Davis, CA 95616 USA; [German, J. Bruce] Univ Calif Davis, Robert Mondavi Inst, Dept Food Sci & Technol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Mills, DA (corresponding author), Univ Calif Davis, Robert Mondavi Inst, Dept Viticulture & Enol, RMI N Lab, 595 Hilgard Lane, Davis, CA 95616 USA.	damills@ucdavis.edu	Wu, Shuai/I-8696-2012; Chen, Xi/H-1811-2018; Mills, David/GXF-1821-2022; Lebrilla, Carlito Bangeles/ABE-6369-2020; Mills, David Andrew/G-2282-2011; Wu, Shuai/N-8552-2014	Chen, Xi/0000-0002-3160-614X; Mills, David Andrew/0000-0003-1913-9865; 	National Institutes of Health NICHD [5R01HD059127, 1R01HD061923]; National Institutes of Health-NIGMS [3R01GM076360, T32-GM08799]; University of California; Dairy Management Inc.; California Dairy Research Foundation; USDA NRI-CSREES [2008-35200-18776]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059127, R01HD061923, R01HD065122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076360] Funding Source: NIH RePORTER	National Institutes of Health NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health-NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of California(University of California System); Dairy Management Inc.; California Dairy Research Foundation; USDA NRI-CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health NICHD Awards 5R01HD059127 and 1R01HD061923 and by National Institutes of Health-NIGMS 3R01GM076360. This work was also supported by grant support from the University of California Discovery Grant Program, Dairy Management Inc., the California Dairy Research Foundation, and the USDA NRI-CSREES Award 2008-35200-18776.; Supported by a predoctoral training grant (National Institutes of Health-NIGMS T32-GM08799).	Allen S, 2005, INFECT IMMUN, V73, P5291, DOI 10.1128/IAI.73.9.5291-5300.2005; Almagro-Moreno S, 2009, INFECT IMMUN, V77, P3807, DOI 10.1128/IAI.00279-09; Ashida H, 2009, GLYCOBIOLOGY, V19, P1010, DOI 10.1093/glycob/cwp082; Bao YW, 2007, ANAL BIOCHEM, V370, P206, DOI 10.1016/j.ab.2007.07.004; Barthelson R, 1998, INFECT IMMUN, V66, P1439, DOI 10.1128/IAI.66.4.1439-1444.1998; Bode L, 2006, J NUTR, V136, P2127, DOI 10.1093/jn/136.8.2127; Brigham C, 2009, J BACTERIOL, V191, P3629, DOI 10.1128/JB.00811-08; Brigham CJ, 2005, J BACTERIOL, V187, P890, DOI 10.1128/JB.187.3.890-901.2005; Cao HZ, 2009, ORG BIOMOL CHEM, V7, P5137, DOI 10.1039/b916305k; Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI [10.1093/nar/gkm900, 10.1093/nar/gkt1103]; Chokhawala HA, 2007, CHEMBIOCHEM, V8, P194, DOI 10.1002/cbic.200600410; Clowers BH, 2008, ANAL BIOCHEM, V381, P205, DOI 10.1016/j.ab.2008.06.041; Dodds ED, 2007, ANAL CHEM, V79, P9547, DOI 10.1021/ac701763t; Dodds ED, 2009, ANAL CHEM, V81, P5533, DOI 10.1021/ac9008918; Engfer MB, 2000, AM J CLIN NUTR, V71, P1589; Falony G, 2006, APPL ENVIRON MICROB, V72, P7835, DOI 10.1128/AEM.01296-06; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; GASKELL A, 1995, STRUCTURE, V3, P1197, DOI 10.1016/S0969-2126(01)00255-6; GYORGY P, 1974, EUR J BIOCHEM, V43, P29, DOI 10.1111/j.1432-1033.1974.tb03380.x; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Le Blay G, 1999, J NUTR, V129, P2231, DOI 10.1093/jn/129.12.2231; Lewis AL, 2009, P NATL ACAD SCI USA, V106, P13552, DOI 10.1073/pnas.0902431106; Lievin V, 2000, GUT, V47, P646, DOI 10.1136/gut.47.5.646; Locascio RG, 2007, J AGR FOOD CHEM, V55, P8914, DOI 10.1021/jf0710480; LoCascio RG, 2009, MICROB BIOTECHNOL, V2, P333, DOI 10.1111/j.1751-7915.2008.00072.x; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; Marcobal A, 2010, J AGR FOOD CHEM, V58, P5334, DOI 10.1021/jf9044205; Markowitz Victor M., 2007, V395, P35; MARTINEZ J, 1995, J BACTERIOL, V177, P6005, DOI 10.1128/jb.177.20.6005-6010.1995; Mavromatis K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007979; Morrow AL, 2004, J PEDIATR-US, V145, P297, DOI 10.1016/j.jpeds.2004.04.054; Ninonuevo M, 2005, ELECTROPHORESIS, V26, P3641, DOI 10.1002/elps.200500246; Parche S, 2006, J BACTERIOL, V188, P1260, DOI 10.1128/JB.188.4.1260-1265.2006; Post DMB, 2005, INFECT IMMUN, V73, P6727, DOI 10.1128/IAI.73.10.6727-6735.2005; RUIZPALACIOS GM, 1990, J PEDIATR-US, V116, P707, DOI 10.1016/S0022-3476(05)82652-6; Schauer R, 2000, GLYCOCONJUGATE J, V17, P485, DOI 10.1023/A:1011062223612; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; Severi E, 2007, MICROBIOL-SGM, V153, P2817, DOI 10.1099/mic.0.2007/009480-0; Simon PM, 1997, INFECT IMMUN, V65, P750, DOI 10.1128/IAI.65.2.750-757.1997; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tao N, 2008, J DAIRY SCI, V91, P3768, DOI 10.3168/jds.2008-1305; TAYLOR G, 1992, J MOL BIOL, V225, P1135, DOI 10.1016/0022-2836(92)90112-W; VIMR ER, 1985, J BACTERIOL, V164, P845, DOI 10.1128/JB.164.2.845-853.1985; Vimr ER, 2004, MICROBIOL MOL BIOL R, V68, P132, DOI 10.1128/MMBR.68.1.132-153.2004; Ward RE, 2007, MOL NUTR FOOD RES, V51, P1398, DOI 10.1002/mnfr.200700150; Ward RE, 2006, APPL ENVIRON MICROB, V72, P4497, DOI 10.1128/AEM.02515-05; Wilson D, 2007, NUCLEIC ACIDS RES, V35, pD308, DOI 10.1093/nar/gkl910; Xie YM, 2004, ANAL CHEM, V76, P5186, DOI 10.1021/ac0496953; YOLKEN RH, 1992, J CLIN INVEST, V90, P1984, DOI 10.1172/JCI116078; Zhang JH, 2004, ANAL CHEM, V76, P5990, DOI 10.1021/ac049666s	52	138	142	1	24	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.193359	http://dx.doi.org/10.1074/jbc.M110.193359			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21288901	Green Published, hybrid			2022-12-27	WOS:000289077500004
J	Clausen, JD; McIntosh, DB; Woolley, DG; Andersen, JP				Clausen, Johannes D.; McIntosh, David B.; Woolley, David G.; Andersen, Jens Peter			Modulatory ATP Binding Affinity in Intermediate States of E2P Dephosphorylation of Sarcoplasmic Reticulum Ca2+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-INSENSITIVE PHOSPHOENZYME; NUCLEOTIDE-BINDING; CALCIUM-PUMP; CATALYTIC SITE; ADENOSINE-TRIPHOSPHATASE; FUNCTIONAL CONSEQUENCES; INORGANIC-PHOSPHATE; ACTUATOR DOMAIN; TRANSPORT SITES; CA2+ BINDING	The mechanism of ATP modulation of E2P dephosphorylation of sarcoplasmic reticulum Ca2+-ATPase wild type and mutant forms was examined in nucleotide binding studies of states analogous to the various intermediates of the dephosphorylation reaction, obtained by binding of metal fluorides, vanadate, or thapsigargin. Wild type Ca2+-ATPase displays an ATP affinity of 4 mu M for the E2P ground state analog, 1 mu M for the E2P transition state and product state analogs, and 11 mu M for the E2 dephosphoenzyme. Hence, ATP binding stabilizes the transition and product states relative to the ground state, thereby explaining the accelerating effect of ATP on dephosphorylation. Replacement of Phe(487) (N-domain) with serine, Arg(560) (N-domain) with leucine, or Arg(174) (A-domain) with alanine or glutamate reduces ATP affinity in all E2/E2P intermediate states. Alanine substitution of Ile(188) (A-domain) increases the ATP affinity, although ATP acceleration of dephosphorylation is disrupted, thus indicating that the critical role of Ile(188) in ATP modulation is mechanistically based rather than being associated with the binding of nucleotide. Mutants with alanine replacement of Lys(205) (A-domain) or Glu(439) (N-domain) exhibit an anomalous inhibition by ATP of E2P dephosphorylation, due to ATP binding increasing the stability of the E2P ground state relative to the transition state. The ATP affinity of Ca(2)E2P, stabilized by inserting four glycines in the A-M1 linker, is similar to that of the E2P ground state, but the Ca2+-free E1 state of this mutant exhibits 3 orders of magnitude reduction of ATP affinity.	[Clausen, Johannes D.; Andersen, Jens Peter] Aarhus Univ, Dept Physiol & Biophys, DK-8000 Aarhus C, Denmark; [McIntosh, David B.; Woolley, David G.] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Div Chem Pathol, ZA-7925 Cape Town, South Africa	Aarhus University; University of Cape Town	Andersen, JP (corresponding author), Ole Worms Alle 6,Bldg 1180, DK-8000 Aarhus C, Denmark.	jpa@fi.au.dk		Andersen, Jens Peter/0000-0003-0654-4300	Danish Medical Research Council; Novo Nordisk Foundation; Danish National Research Foundation (PUMPKIN Centre); Centre for Membrane Pumps in Cells and Disease, PUMPKIN, Danish National Research Foundation	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish National Research Foundation (PUMPKIN Centre)(Danmarks Grundforskningsfond); Centre for Membrane Pumps in Cells and Disease, PUMPKIN, Danish National Research Foundation(Danmarks Grundforskningsfond)	This work was supported in part by grants from the Danish Medical Research Council (to J. P. A.), the Novo Nordisk Foundation (to J. P. A.), and the Danish National Research Foundation (PUMPKIN Centre).; Supported by the Centre for Membrane Pumps in Cells and Disease, PUMPKIN, Danish National Research Foundation.	Abu-Abed M, 2002, BIOCHEMISTRY-US, V41, P1156, DOI 10.1021/bi015703n; ANDERSEN JP, 1985, BIOCHIM BIOPHYS ACTA, V815, P9, DOI 10.1016/0005-2736(85)90467-5; ARIKI M, 1980, BIOCHEMISTRY-US, V19, P2001, DOI 10.1021/bi00550a042; BISHOP JE, 1987, J BIOL CHEM, V262, P4658; BODLEY AL, 1987, J BIOL CHEM, V262, P13997; CABLE MB, 1985, BIOCHEMISTRY-US, V24, P5612, DOI 10.1021/bi00341a049; CANTLEY LC, 1978, J BIOL CHEM, V253, P7361; CHAMPEIL P, 1985, BIOCHEMISTRY-US, V24, P69, DOI 10.1021/bi00322a012; CHAMPEIL P, 1986, BIOCHEMISTRY-US, V25, P7623, DOI 10.1021/bi00371a053; CHAMPEIL P, 1988, J BIOL CHEM, V263, P12288; CHAMPEIL P, 1978, J BIOL CHEM, V253, P1179; Champeil P, 1998, J BIOL CHEM, V273, P6619, DOI 10.1074/jbc.273.12.6619; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHOWDHRY V, 1979, ANNU REV BIOCHEM, V48, P293, DOI 10.1146/annurev.bi.48.070179.001453; Clausen JD, 2004, P NATL ACAD SCI USA, V101, P2776, DOI 10.1073/pnas.0400122101; Clausen JD, 2003, J BIOL CHEM, V278, P20245, DOI 10.1074/jbc.M301122200; Clausen JD, 2007, J BIOL CHEM, V282, P20686, DOI 10.1074/jbc.M702365200; Clausen JD, 2010, J BIOL CHEM, V285, P20780, DOI 10.1074/jbc.M110.116459; Clausen JD, 2008, J BIOL CHEM, V283, P35703, DOI 10.1074/jbc.M806795200; Daiho T, 2007, J BIOL CHEM, V282, P34429, DOI 10.1074/jbc.M707665200; Daiho T, 2010, J BIOL CHEM, V285, P24538, DOI 10.1074/jbc.M110.144535; Danko S, 2004, J BIOL CHEM, V279, P14991, DOI 10.1074/jbc.M313363200; FORGE V, 1993, J BIOL CHEM, V268, P10953; Hilge M, 2003, NAT STRUCT BIOL, V10, P468, DOI 10.1038/nsb924; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P946, DOI 10.1128/MCB.9.3.946; KOTZYBAHIBERT F, 1995, ANGEW CHEM INT EDIT, V34, P1296, DOI 10.1002/anie.199512961; Laursen M, 2009, J BIOL CHEM, V284, P13513, DOI 10.1074/jbc.C900031200; Liu XY, 2009, J BIOL CHEM, V284, P25190, DOI 10.1074/jbc.M109.034140; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; MCINTOSH DB, 1983, BIOCHEMISTRY-US, V22, P2867, DOI 10.1021/bi00281a015; McIntosh DB, 1996, J BIOL CHEM, V271, P25778, DOI 10.1074/jbc.271.42.25778; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; PICK U, 1982, J BIOL CHEM, V257, P6111; REYNOLDS JA, 1985, P NATL ACAD SCI USA, V82, P3658, DOI 10.1073/pnas.82.11.3658; SAGARA Y, 1992, J BIOL CHEM, V267, P1286; SCOFANO HM, 1979, J BIOL CHEM, V254, P227; SEEBREGTS CJ, 1989, J BIOL CHEM, V264, P2043; SHIGEKAWA M, 1978, J BIOL CHEM, V253, P1451; Sorensen T, 1997, J BIOL CHEM, V272, P30244, DOI 10.1074/jbc.272.48.30244; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2007, P NATL ACAD SCI USA, V104, P19831, DOI 10.1073/pnas.0709978104; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; VILSEN B, 1991, J BIOL CHEM, V266, P16157; VILSEN B, 1989, J BIOL CHEM, V264, P21024; WAKABAYASHI S, 1990, BIOCHEMISTRY-US, V29, P7309, DOI 10.1021/bi00483a022; WAKABAYASHI S, 1986, J BIOL CHEM, V261, P9762	52	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11792	11802		10.1074/jbc.M110.206094	http://dx.doi.org/10.1074/jbc.M110.206094			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21288896	hybrid, Green Published			2022-12-27	WOS:000288797100086
J	Lim, YS; Hwang, SB				Lim, Yun-Sook; Hwang, Soon B.			Hepatitis C Virus NS5A Protein Interacts with Phosphatidylinositol 4-Kinase Type III alpha and Regulates Viral Propagation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTRUCTURAL 5A PROTEIN; RNA REPLICATION COMPLEX; EXIT SITES; KINASE; IDENTIFICATION; EXPRESSION; INFECTION; SCREEN	Hepatitis C Virus (HCV) nonstructural 5A (NS5A) is a pleiotropic protein involved in viralRNAreplication and modulation of the cellular physiology in HCV-infected cells. Toelucidate the mechanisms of the HCV life cycle, we identified cellular factors interacting with the NS5A protein in HCV-infected cells. Huh7.5 cells were electroporated with HCV Jc1 RNA. Cellular factors associated with HCV NS5A were identified by immunoprecipitation with Dynabead-conjugated NS5A antibody and LC-MS/MS. Phosphatidylinositol 4-kinase type III alpha (PI4KIII alpha) was identified as a binding partner for the NS5A protein. NS5A derived from both genotypes 1b and 2a interacted with PI4KIII alpha. NS5A interacted with PI4KIII alpha through amino acids 401-600 of PI4KIII alpha and domain I of NS5A. Interference of the protein interaction between NS5A and PI4KIII alpha decreased HCV propagation. Knockdown of PI4KIII alpha significantly reduced HCV replication in Huh7 cells harboring the subgenomic replicon and in Huh7.5 cells infected with cell culture grown virus (HCVcc). Silencing of PI4KIII alpha further inhibited HCV release into the tissue culture medium. NS5A may recruit PI4KIII alpha to the HCV RNA replication complex. These data suggest that PI4KIII alpha is an essential host factor that supports HCV proliferation and therefore PI4KIII alpha may be a legitimate target for anti-HCV therapy.	[Lim, Yun-Sook; Hwang, Soon B.] Hallym Univ, Natl Res Lab Hepatitis Virus C, Ilsong Inst Life Sci, Anyang 431060, South Korea	Hallym University	Hwang, SB (corresponding author), 1605-4 Gwanyang Dong, Anyang 431060, South Korea.	sbhwang@hallym.ac.kr			Ministry of Education, Science and Technology, Korea [ROA-2007-000-20051-0]; Ministry for Health and Welfare, Korea [1020290]	Ministry of Education, Science and Technology, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry for Health and Welfare, Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by National Research Laboratory Grant ROA-2007-000-20051-0 from the Ministry of Education, Science and Technology, Korea, and the National R&D Program for Cancer Control, Ministry for Health and Welfare, Korea (1020290).	Ahn J, 2004, J BIOCHEM MOL BIOL, V37, P741; Berger KL, 2009, P NATL ACAD SCI USA, V106, P7577, DOI 10.1073/pnas.0902693106; Blumental-Perry A, 2006, DEV CELL, V11, P671, DOI 10.1016/j.devcel.2006.09.001; Borawski J, 2009, J VIROL, V83, P10058, DOI 10.1128/JVI.02418-08; Brass V, 2002, J BIOL CHEM, V277, P8130, DOI 10.1074/jbc.M111289200; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; El-Serag HB, 2002, J CLIN GASTROENTEROL, V35, pS72, DOI 10.1097/00004836-200211002-00002; Farhan H, 2008, EMBO J, V27, P2043, DOI 10.1038/emboj.2008.136; Gale MJ, 1997, VIROLOGY, V230, P217, DOI 10.1006/viro.1997.8493; Gao L, 2004, J VIROL, V78, P3480, DOI 10.1128/JVI.78.7.3480-3488.2004; Gehrmann T, 1999, BBA-MOL CELL BIOL L, V1437, P341, DOI 10.1016/S1388-1981(99)00029-3; Gosert R, 2003, J VIROL, V77, P5487, DOI 10.1128/JVI.77.9.5487-5492.2003; He YP, 2002, J VIROL, V76, P9207, DOI 10.1128/JVI.76.18.9207-9217.2002; Hughes M, 2009, J VIROL, V83, P10788, DOI 10.1128/JVI.02406-08; Kato T, 2006, NAT PROTOC, V1, P2334, DOI 10.1038/nprot.2006.395; Kim WR, 2002, HEPATOLOGY, V36, pS30, DOI 10.1053/jhep.2002.36791; Li QS, 2009, P NATL ACAD SCI USA, V106, P16410, DOI 10.1073/pnas.0907439106; Macdonald A, 2004, J GEN VIROL, V85, P721, DOI 10.1099/vir.0.19691-0; Park CY, 2009, J HEPATOL, V51, P853, DOI 10.1016/j.jhep.2009.06.026; Park CY, 2009, J BIOL CHEM, V284, P9237, DOI 10.1074/jbc.M808773200; Park KJ, 2003, J BIOL CHEM, V278, P30711, DOI 10.1074/jbc.M209623200; Reiss S, 2011, CELL HOST MICROBE, V9, P32, DOI 10.1016/j.chom.2010.12.002; Shelton H, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-24; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001; Targett-Adams P, 2008, J VIROL, V82, P2182, DOI 10.1128/JVI.01565-07; Tellinghuisen TL, 2004, J BIOL CHEM, V279, P48576, DOI 10.1074/jbc.M407787200; Trotard M, 2009, FASEB J, V23, P3780, DOI 10.1096/fj.09-131920; Vaillancourt FH, 2009, VIROLOGY, V387, P5, DOI 10.1016/j.virol.2009.02.039; Wang AG, 2009, J PATHOL, V219, P253, DOI 10.1002/path.2592	30	82	83	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11290	11298		10.1074/jbc.M110.194472	http://dx.doi.org/10.1074/jbc.M110.194472			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21297162	Green Published, hybrid			2022-12-27	WOS:000288797100041
J	Mansfield, RE; Musselman, CA; Kwan, AH; Oliver, SS; Garske, AL; Davrazou, F; Denu, JM; Kutateladze, TG; Mackay, JP				Mansfield, Robyn E.; Musselman, Catherine A.; Kwan, Ann H.; Oliver, Samuel S.; Garske, Adam L.; Davrazou, Foteini; Denu, John M.; Kutateladze, Tatiana G.; Mackay, Joel P.			Plant Homeodomain (PHD) Fingers of CHD4 Are Histone H3-binding Modules with Preference for Unmodified H3K4 and Methylated H3K9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN-REMODELING FACTOR; NURD REPRESSOR COMPLEX; BINDING MODULES; DNA-DAMAGE; LYSINE-4 METHYLATION; AUTOIMMUNE REGULATOR; HETEROCHROMATIN FORMATION; TUMOR-SUPPRESSOR; GENE REPRESSION; MOLECULAR-BASIS	A major challenge in chromatin biology is to understand the mechanisms by which chromatin is remodeled into active or inactive states as required during development and cell differentiation. One complex implicated in these processes is the nucleosome remodeling and histone deacetylase (NuRD) complex, which contains both histone deacetylase and nucleosome remodeling activities and has been implicated in the silencing of subsets of genes involved in various stages of cellular development. Chromodomain-helicase-DNA-binding protein 4 (CHD4) is a core component of the NuRD complex and contains a nucleosome remodeling ATPase domain along with two chromodomains and two plant homeodomain (PHD) fingers. We have previously demonstrated that the second PHD finger of CHD4 binds peptides corresponding to the N terminus of histone H3 methylated at Lys(9). Here, we determine the solution structure of PHD2 in complex with H3K9me3, revealing the molecular basis of histone recognition, including a cation-pi recognition mechanism for methylated Lys(9). Additionally, we demonstrate that the first PHD finger also exhibits binding to the N terminus of H3, and we establish the histone-binding surface of this domain. This is the first instance where histone binding ability has been demonstrated for two separate PHD modules within the one protein. These findings suggest that CHD4 could bind to two H3 N-terminal tails on the same nucleosome or on two separate nucleosomes simultaneously, presenting exciting implications for the mechanism by which CHD4 and the NuRD complex could direct chromatin remodeling.	[Mansfield, Robyn E.; Kwan, Ann H.; Mackay, Joel P.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Musselman, Catherine A.; Davrazou, Foteini; Kutateladze, Tatiana G.] Univ Colorado Denver, Dept Pharmacol, Sch Med, Aurora, CO 80045 USA; [Oliver, Samuel S.; Garske, Adam L.; Denu, John M.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA	University of Sydney; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Wisconsin System; University of Wisconsin Madison	Mackay, JP (corresponding author), Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.	joel.mackay@sydney.edu.au	; Mackay, Joel/D-6834-2011	Kwan, Ann/0000-0002-1506-2226; Musselman, Catherine/0000-0002-8356-7971; Mackay, Joel/0000-0001-7508-8033; Kutateladze, Tatiana/0000-0001-7375-6990	National Institutes of Health [R01 CA113472]; National Health and Medical Research Council of Australia; Australian Research Council; Australian postgraduate award; Australian postdoctoral fellowship; NATIONAL CANCER INSTITUTE [R01CA113472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059785, R37GM059785] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Australian postgraduate award(Australian Government); Australian postdoctoral fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA113472 Grant (to T. G. K.). This work was also supported in part by a Program Grant from the National Health and Medical Research Council of Australia (to J. P. M.) and a Discovery Project Grant from the Australian Research Council (to A. H. K.).; Supported by an Australian postgraduate award.; Supported by an Australian postdoctoral fellowship.	Ayed A, 2001, NAT STRUCT BIOL, V8, P756, DOI 10.1038/nsb0901-756; Bagchi A, 2007, CELL, V128, P459, DOI 10.1016/j.cell.2006.11.052; Bardiaux B, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-30; Bienz M, 2006, TRENDS BIOCHEM SCI, V31, P35, DOI 10.1016/j.tibs.2005.11.001; Bouazoune K, 2002, EMBO J, V21, P2430, DOI 10.1093/emboj/21.10.2430; Bouazoune K, 2006, CHROMOSOME RES, V14, P433, DOI 10.1007/s10577-006-1067-0; Brandl M, 2001, J MOL BIOL, V307, P357, DOI 10.1006/jmbi.2000.4473; Chakravarty S, 2009, STRUCTURE, V17, P670, DOI 10.1016/j.str.2009.02.017; Chignola F, 2009, NUCLEIC ACIDS RES, V37, P2951, DOI 10.1093/nar/gkp166; Chou DM, 2010, P NATL ACAD SCI USA, V107, P18475, DOI 10.1073/pnas.1012946107; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DeLano W.L, PYMOL MOL GRAPHICS S; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Garske AL, 2008, BIOCHEMISTRY-US, V47, P8094, DOI 10.1021/bi800766k; Garske AL, 2010, NAT CHEM BIOL, V6, P283, DOI [10.1038/NCHEMBIO.319, 10.1038/nchembio.319]; GODDARD T, 2005, SPARKY VERSION 3 113; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Hughes RM, 2007, CHEM-EUR J, V13, P5753, DOI 10.1002/chem.200601753; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Karagianni P, 2008, MOL CELL BIOL, V28, P705, DOI 10.1128/MCB.01598-07; Kim D, 2010, NAT STRUCT MOL BIOL, V17, P1027, DOI 10.1038/nsmb.1856; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kowalski K, 2002, J BIOL CHEM, V277, P35720, DOI 10.1074/jbc.M204663200; Kwan AHY, 2003, STRUCTURE, V11, P803, DOI 10.1016/S0969-2126(03)00122-9; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Larsen DH, 2010, J CELL BIOL, V190, P731, DOI 10.1083/jcb.200912135; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Linge JP, 2003, BIOINFORMATICS, V19, P315, DOI 10.1093/bioinformatics/19.2.315; McDonel P, 2009, INT J BIOCHEM CELL B, V41, P108, DOI 10.1016/j.biocel.2008.07.022; Miccio A, 2010, EMBO J, V29, P442, DOI 10.1038/emboj.2009.336; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Musselman CA, 2009, BIOCHEM J, V423, P179, DOI 10.1042/BJ20090870; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; Ogas J, 1999, P NATL ACAD SCI USA, V96, P13839, DOI 10.1073/pnas.96.24.13839; Ogas J, 1997, SCIENCE, V277, P91, DOI 10.1126/science.277.5322.91; Org T, 2008, EMBO REP, V9, P370, DOI [10.1038/embor.2008.11, 10.1038/sj.embor.2008.11]; Pacifico F, 2007, J CLIN ENDOCR METAB, V92, P1458, DOI 10.1210/jc.2006-2199; Palacios A, 2006, FEBS LETT, V580, P6903, DOI 10.1016/j.febslet.2006.11.055; Pegoraro G, 2009, NAT CELL BIOL, V11, P1261, DOI 10.1038/ncb1971; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Polo SE, 2010, EMBO J, V29, P3130, DOI 10.1038/emboj.2010.188; ROBERTS GCK, 1993, NMR MACROMOLECULES, P315; Scanlon MJ, 1997, STRUCTURE, V5, P1585, DOI 10.1016/S0969-2126(97)00307-9; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Smeenk G, 2010, J CELL BIOL, V190, P741, DOI 10.1083/jcb.201001048; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thompson PM, 2003, ONCOGENE, V22, P1002, DOI 10.1038/sj.onc.1206211; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; Unhavaithaya Y, 2002, CELL, V111, P991, DOI 10.1016/S0092-8674(02)01202-3; van Ingen H, 2008, STRUCTURE, V16, P1245, DOI 10.1016/j.str.2008.04.015; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; WADDELL WJ, 1956, J LAB CLIN MED, V48, P311; Wade PA, 1998, CURR BIOL, V8, P843, DOI 10.1016/S0960-9822(98)70328-8; Wang GG, 2009, NATURE, V459, P847, DOI 10.1038/nature08036; Wen H, 2010, J BIOL CHEM, V285, P9322, DOI 10.1074/jbc.C109.097667; Williams CJ, 2004, IMMUNITY, V20, P719, DOI 10.1016/j.immuni.2004.05.005; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Yoshida T, 2008, GENE DEV, V22, P1174, DOI 10.1101/gad.1642808; Zegerman P, 2002, J BIOL CHEM, V277, P11621, DOI 10.1074/jbc.C200045200; Zeng L, 2010, NATURE, V466, P258, DOI 10.1038/nature09139; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4	76	115	116	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11779	11791		10.1074/jbc.M110.208207	http://dx.doi.org/10.1074/jbc.M110.208207			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21278251	Green Published, hybrid			2022-12-27	WOS:000288797100085
J	Richard, D; Bartfai, R; Volz, J; Ralph, SA; Muller, S; Stunnenberg, HG; Cowman, AF				Richard, Dave; Bartfai, Richard; Volz, Jennifer; Ralph, Stuart A.; Muller, Sylke; Stunnenberg, Hendrik G.; Cowman, Alan F.			A Genome-wide Chromatin-associated Nuclear Peroxiredoxin from the Malaria Parasite Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOREDOXIN PEROXIDASES; ANTIOXIDANT SYSTEMS; OXIDATIVE STRESS; HISTONE H1; PROTEIN; REDOX; ERYTHROCYTE; INVASION; DOMAIN; GLUTAREDOXIN	Malaria parasites are subjected to high levels of oxidative stress during their development inside erythrocytes and the ability of the parasite to defend itself against this assault is critical to its survival. Therefore, Plasmodium possesses an effective antioxidant defense system that could potentially be used as a target for the development of inhibitor-based therapy. We have identified an unusual peroxiredoxin protein that localizes to the nucleus of Plasmodium falciparum and have renamed it Pfn Prx (PF10_0268, earlier called MCP1). Our work reveals that Pfn Prx has a broad specificity of substrate being able to utilize thioredoxin and glutaredoxin as reductants and having the ability to reduce simple and complex peroxides. Intriguingly, chromatin immunoprecipitation followed by deep sequencing reveals that the enzyme associates with chromatin in a genome-wide manner with a slight enrichment in coding regions. Our results represent the first description of a dedicated chromatin-associated peroxiredoxin and potentially represent an ingenious way by which the parasite can survive the highly oxidative environment within its human host.	[Richard, Dave; Volz, Jennifer; Cowman, Alan F.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia; [Bartfai, Richard; Stunnenberg, Hendrik G.] Radboud Univ Nijmegen, Dept Mol Biol, Nijmegen Ctr Mol Life Sci, NL-6525 GA Nijmegen, Netherlands; [Ralph, Stuart A.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3052, Australia; [Muller, Sylke] Univ Glasgow, Fac Biomed & Life Sci, Div Infect & Immun, Glasgow G12 8QQ, Lanark, Scotland; [Muller, Sylke] Univ Glasgow, Fac Biomed & Life Sci, Wellcome Ctr Parasitol, Glasgow G12 8QQ, Lanark, Scotland; [Cowman, Alan F.] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3052, Australia	Walter & Eliza Hall Institute; Radboud University Nijmegen; University of Melbourne; University of Glasgow; University of Glasgow; University of Melbourne	Cowman, AF (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Melbourne, Vic 3052, Australia.	cowman@wehi.edu.au	Stunnenberg, Hendrik G./D-6875-2012; Bartfai, Richard/E-2083-2012; Cowman, Alan F/C-7642-2013; Ralph, Stuart/C-8590-2014	Stunnenberg, Hendrik G./0000-0002-0066-1576; Bartfai, Richard/0000-0002-8460-6477; Cowman, Alan F/0000-0001-5145-9004; Ralph, Stuart/0000-0003-0114-7808	National Health and Medical Research Council of Australia (NHMRC); Canadian Institutes of Health Research; Netherlands Organization for Scientific Research	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by the National Health and Medical Research Council of Australia (NHMRC).; Supported by a Canadian Institutes of Health Research postdoctoral fellowship.; Supported by the Netherlands Organization for Scientific Research.	Akerman SE, 2005, J BIOL CHEM, V280, P564, DOI 10.1074/jbc.M406367200; Akerman SE, 2003, MOL BIOCHEM PARASIT, V130, P75, DOI 10.1016/S0166-6851(03)00161-0; Andersson R, 2009, GENOME RES, V19, P1732, DOI 10.1101/gr.092353.109; Bartfai R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001223; Becker K, 2004, INT J PARASITOL, V34, P163, DOI 10.1016/j.ijpara.2003.09.011; Boucher IW, 2006, MOL MICROBIOL, V61, P948, DOI 10.1111/j.1365-2958.2006.05303.x; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Brehelin C, 2003, PLANT PHYSIOL, V132, P2045, DOI 10.1104/pp.103.022533; Butterfield LH, 1999, ANTIOXID REDOX SIGN, V1, P385, DOI 10.1089/ars.1999.1.4-385; Cox AG, 2010, METHOD ENZYMOL, V474, P51, DOI 10.1016/S0076-6879(10)74004-0; Flueck C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000569; Gilberger TW, 2003, J CELL BIOL, V162, P317, DOI 10.1083/jcb.200301046; Gilberger TW, 1997, J BIOL CHEM, V272, P29584, DOI 10.1074/jbc.272.47.29584; Go YM, 2010, ANTIOXID REDOX SIGN, V13, P489, DOI 10.1089/ars.2009.3021; HAYASHI T, 1987, J BIOCHEM-TOKYO, V102, P369, DOI 10.1093/oxfordjournals.jbchem.a122063; Hendzel MJ, 2004, J BIOL CHEM, V279, P20028, DOI 10.1074/jbc.M400070200; HUDSONTAYLOR DE, 1995, MOL MICROBIOL, V15, P463, DOI 10.1111/j.1365-2958.1995.tb02260.x; HUNT NH, 1990, BLOOD CELLS, V16, P499; Kasinsky HE, 2001, FASEB J, V15, P34, DOI 10.1096/fj.00-0237rev; Kawazu S, 2000, MOL BIOCHEM PARASIT, V109, P165, DOI 10.1016/S0166-6851(00)00243-7; KIM KW, 1988, J BIOL CHEM, V263, P4704; KLOTZ FW, 1989, MOL BIOCHEM PARASIT, V36, P177, DOI 10.1016/0166-6851(89)90190-4; Krnajski Z, 2001, MOL BIOCHEM PARASIT, V112, P219, DOI 10.1016/S0166-6851(00)00372-8; Krnajski Z, 2001, MOL BIOCHEM PARASIT, V113, P303, DOI 10.1016/S0166-6851(01)00219-5; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Muller S, 2004, MOL MICROBIOL, V53, P1291, DOI 10.1111/j.1365-2958.2004.04257.x; Neumann CA, 2007, CURR OPIN PHARMACOL, V7, P375, DOI 10.1016/j.coph.2007.04.007; Park SY, 2007, CANCER RES, V67, P9294, DOI 10.1158/0008-5472.CAN-07-0651; Przyborski JM, 2005, EMBO J, V24, P2306, DOI 10.1038/sj.emboj.7600720; Rahlfs S, 2001, EUR J BIOCHEM, V268, P1404, DOI 10.1046/j.1432-1327.2001.02005.x; Ralph SA, 2005, P NATL ACAD SCI USA, V102, P5414, DOI 10.1073/pnas.0408883102; Richard D, 2010, J BIOL CHEM, V285, P14815, DOI 10.1074/jbc.M109.080770; Richard D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000328; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Rouhier N, 2002, J BIOL CHEM, V277, P13609, DOI 10.1074/jbc.M111489200; Rouhier N, 2001, PLANT PHYSIOL, V127, P1299, DOI 10.1104/pp.010586; Rouhier N, 2008, BBA-GEN SUBJECTS, V1780, P1249, DOI 10.1016/j.bbagen.2007.12.007; Rug M, 2004, INFECT IMMUN, V72, P6095, DOI 10.1128/IAI.72.10.6095-6105.2004; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Salcedo-Amaya AM, 2009, P NATL ACAD SCI USA, V106, P9655, DOI 10.1073/pnas.0902515106; Sarma GN, 2005, J MOL BIOL, V346, P1021, DOI 10.1016/j.jmb.2004.12.022; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; SUBIRANA JA, 1990, BIOPOLYMERS, V29, P1351, DOI 10.1002/bip.360291003; Syed SH, 2010, P NATL ACAD SCI USA, V107, P9620, DOI 10.1073/pnas.1000309107; Sztajer H, 2001, J BIOL CHEM, V276, P7397, DOI 10.1074/jbc.M008631200; Tilgner H, 2009, NAT STRUCT MOL BIOL, V16, P996, DOI 10.1038/nsmb.1658; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; VERNET G, 1990, BIOCHIM BIOPHYS ACTA, V1048, P281, DOI 10.1016/0167-4781(90)90068-D; Wang XM, 2010, MOL BIOL CELL, V21, P2987, DOI 10.1091/mbc.E10-02-0160; White NJ, 2008, SCIENCE, V320, P330, DOI 10.1126/science.1155165; Wood ZA, 2002, BIOCHEMISTRY-US, V41, P5493, DOI 10.1021/bi012173m; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; ZYKOVA TA, 2010, J BIOL CHEM	54	38	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11746	11755		10.1074/jbc.M110.198499	http://dx.doi.org/10.1074/jbc.M110.198499			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21282103	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000288797100082
J	Cross, PJ; Dobson, RCJ; Patchett, ML; Parker, EJ				Cross, Penelope J.; Dobson, Renwick C. J.; Patchett, Mark L.; Parker, Emily J.			Tyrosine Latching of a Regulatory Gate Affords Allosteric Control of Aromatic Amino Acid Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DEOXY-D-ARABINO-HEPTULOSONATE 7-PHOSPHATE SYNTHASE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; CONFORMATIONAL SELECTION; CHORISMATE MUTASE; SHIKIMATE PATHWAY; DAHP SYNTHASE; ACT DOMAIN; PURIFICATION; ENZYMES	The first step of the shikimate pathway for aromatic amino acid biosynthesis is catalyzed by 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase (DAH7PS). Thermotoga maritima DAH7PS (TmaDAH7PS) is tetrameric, with monomer units comprised of a core catalytic (beta/alpha)(8) barrel and an N-terminal domain. This enzyme is inhibited strongly by tyrosine and to a lesser extent by the presence of phenylalanine. A truncated mutant of TmaDAH7PS lacking the N-terminal domain was catalytically more active and completely insensitive to tyrosine and phenylalanine, consistent with a role for this domain in allosteric inhibition. The structure of this protein was determined to 2.0 angstrom. In contrast to the wild-type enzyme, this enzyme is dimeric. Wild-type TmaDAH7PS was co-crystallized with tyrosine, and the structure of this complex was determined to a resolution of 2.35 angstrom. Tyrosine was found to bind at the interface between two regulatory N-terminal domains, formed from diagonally located monomers of the tetramer, revealing a major reorganization of the regulatory domain with respect to the barrel relative to unliganded enzyme. This significant conformational rearrangement observed in the crystal structures was also clearly evident from small angle X-ray scattering measurements recorded in the presence and absence of tyrosine. The closed conformation adopted by the protein on tyrosine binding impedes substrate entry into the neighboring barrel, revealing an unusual tyrosine-controlled gating mechanism for allosteric control of this enzyme.	[Parker, Emily J.] Univ Canterbury, Dept Chem, Biomol Interact Ctr, Christchurch 8040, New Zealand; [Cross, Penelope J.; Parker, Emily J.] Univ Canterbury, Dept Chem, Christchurch 8140, New Zealand; [Dobson, Renwick C. J.] Univ Canterbury, Sch Biol Sci, Christchurch 8140, New Zealand; [Dobson, Renwick C. J.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [Patchett, Mark L.] Massey Univ, Inst Mol Biosci, Palmerston North 4442, New Zealand	University of Canterbury; University of Canterbury; University of Canterbury; University of Melbourne; Massey University	Parker, EJ (corresponding author), Univ Canterbury, Dept Chem, Biomol Interact Ctr, Private Bag 4800, Christchurch 8040, New Zealand.	emily.parker@canterbury.ac.nz	Dobson, Renwick/AAZ-7020-2021	Dobson, Renwick/0000-0002-5506-4939; Parker, Emily/0000-0002-9571-9987	University of Canterbury; New Zealand Marsden Fund [UOC0710]; C.R. Roper Bequest for Fellowship	University of Canterbury; New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); C.R. Roper Bequest for Fellowship	This work was supported by a doctoral scholarship from the University of Canterbury (for P.J.C.), Grant UOC0710 from the New Zealand Marsden Fund, and the C.R. Roper Bequest for Fellowship (to R.C.J.D.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bakan A, 2009, P NATL ACAD SCI USA, V106, P14349, DOI 10.1073/pnas.0904214106; BENTLEY R, 1990, CRIT REV BIOCHEM MOL, V25, P307, DOI 10.3109/10409239009090615; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cho Y, 2003, J BIOL CHEM, V278, P8333, DOI 10.1074/jbc.M212124200; Curien G, 2008, PLANT PHYSIOL BIOCH, V46, P325, DOI 10.1016/j.plaphy.2007.12.006; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gosset G, 2001, J BACTERIOL, V183, P4061, DOI 10.1128/JB.183.13.4061-4070.2001; Grant GA, 2006, J BIOL CHEM, V281, P33825, DOI 10.1074/jbc.R600024200; Hammes GG, 2009, P NATL ACAD SCI USA, V106, P13737, DOI 10.1073/pnas.0907195106; Hartmann M, 2003, P NATL ACAD SCI USA, V100, P862, DOI 10.1073/pnas.0337566100; Helmstaedt K, 2005, P NATL ACAD SCI USA, V102, P9784, DOI 10.1073/pnas.0504238102; Herrmann KM, 1999, ANNU REV PLANT PHYS, V50, P473, DOI 10.1146/annurev.arplant.50.1.473; HERRMANN KM, 1991, CURR TOP PLANT PHYSL, V7, P12; HOFFMANN PJ, 1972, BIOCHIM BIOPHYS ACTA, V268, P550, DOI 10.1016/0005-2744(72)90352-X; Jensen RA, 2002, J MOL EVOL, V54, P416, DOI 10.1007/s00239-001-0031-z; Laskowski RA, 2009, FEBS LETT, V583, P1692, DOI 10.1016/j.febslet.2009.03.019; Leatherbarrow R J, 2007, GRAFIT VERSION 6; Liberles JS, 2005, AMINO ACIDS, V28, P1, DOI 10.1007/s00726-004-0152-y; Ma BY, 2010, CURR OPIN CHEM BIOL, V14, P652, DOI 10.1016/j.cbpa.2010.08.012; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Mills RD, 2009, J MOL BIOL, V388, P1043, DOI 10.1016/j.jmb.2009.03.070; OGINO T, 1982, P NATL ACAD SCI-BIOL, V79, P5828, DOI 10.1073/pnas.79.19.5828; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Roberts F, 1998, NATURE, V393, P801, DOI 10.1038/31723; Sasso S, 2009, EMBO J, V28, P2128, DOI 10.1038/emboj.2009.165; Schofield LR, 2005, BIOCHEMISTRY-US, V44, P11950, DOI 10.1021/bi050577z; Schofield LR, 2004, PROTEIN EXPRES PURIF, V34, P17, DOI 10.1016/j.pep.2003.11.008; SCHONER R, 1976, J BIOL CHEM, V251, P5440; Shumilin IA, 2004, J MOL BIOL, V341, P455, DOI 10.1016/j.jmb.2004.05.077; Shumilin IA, 2002, J MOL BIOL, V320, P1147, DOI 10.1016/S0022-2836(02)00545-4; Steller I, 1997, J APPL CRYSTALLOGR, V30, P1036, DOI 10.1107/S0021889897008777; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Tang C, 2007, NATURE, V449, P1078, DOI 10.1038/nature06232; TRIBE DE, 1976, J BACTERIOL, V127, P1085, DOI 10.1128/JB.127.3.1085-1097.1976; Walker GE, 1996, MICROBIOL-SGM, V142, P1973, DOI 10.1099/13500872-142-8-1973; Webby CJ, 2010, J BIOL CHEM, V285, P30567, DOI 10.1074/jbc.M110.111856; Webby CJ, 2005, J MOL BIOL, V354, P927, DOI 10.1016/j.jmb.2005.09.093; Wu J, 2006, J BIOL CHEM, V281, P4042, DOI 10.1074/jbc.M512223200; Wu J, 2003, J BIOL CHEM, V278, P27525, DOI 10.1074/jbc.M304631200; Zhang S, 1998, J BIOL CHEM, V273, P6248, DOI 10.1074/jbc.273.11.6248	48	45	45	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10216	10224		10.1074/jbc.M110.209924	http://dx.doi.org/10.1074/jbc.M110.209924			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21282100	hybrid, Green Published			2022-12-27	WOS:000288547000038
J	Kruger, M; Linke, WA				Krueger, Martina; Linke, Wolfgang A.			The Giant Protein Titin: A Regulatory Node That Integrates Myocyte Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ALPHA-B-CRYSTALLIN; HUMAN DILATED CARDIOMYOPATHY; TISSUE-SPECIFIC EXPRESSION; M-LINE TITIN; PASSIVE STIFFNESS; SKELETAL-MUSCLE; CARDIAC MYOCYTES; THICK FILAMENT; KINASE DOMAIN; HEART-MUSCLE	Titin, the largest protein in the human body, is well known as a molecular spring in muscle cells and scaffold protein aiding myofibrillar assembly. However, recent evidence has established another important role for titin: that of a regulatory node integrating, and perhaps coordinating, diverse signaling pathways, particularly in cardiomyocytes. We review key findings within this emerging field, including those related to phosphorylation of the titin springs, and also discuss how titin participates in hypertrophic gene regulation and protein quality control.	[Krueger, Martina; Linke, Wolfgang A.] Ruhr Univ Bochum, Dept Cardiovasc Physiol, D-44780 Bochum, Germany	Ruhr University Bochum	Kruger, M (corresponding author), Ruhr Univ Bochum, Dept Cardiovasc Physiol, D-44780 Bochum, Germany.	martina.krueger@rub.de; wolfgang.linke@rub.de	Krüger, Martina/AAY-2064-2021; Linke, Wolfgang A/E-8662-2012; Krüger, Martina/H-8135-2013	Krüger, Martina/0000-0003-2446-5526; Linke, Wolfgang/0000-0003-0801-3773	German Research Foundation [Li 690/7-2, KR 3409/5-1]	German Research Foundation(German Research Foundation (DFG))	This work was supported by Grants Li 690/7-2 and KR 3409/5-1 from the German Research Foundation. This is the second article in the Thematic Minireview Series on Signaling in Cardiac Sarcomeres in Health and Disease. This minireview will be reprinted in the 2011 Minireview Compendium, which will be available in January, 2012.	Atkinson RA, 2001, NAT STRUCT BIOL, V8, P853, DOI 10.1038/nsb1001-853; Bang ML, 2001, CIRC RES, V89, P1065, DOI 10.1161/hh2301.100981; Barash IA, 2007, AM J PHYSIOL-CELL PH, V293, pC218, DOI 10.1152/ajpcell.00055.2007; Bartoo ML, 1997, AM J PHYSIOL-CELL PH, V273, pC266, DOI 10.1152/ajpcell.1997.273.1.C266; Bennett PM, 1996, J MOL BIOL, V259, P896, DOI 10.1006/jmbi.1996.0367; Bertz M, 2009, P NATL ACAD SCI USA, V106, P13307, DOI 10.1073/pnas.0902312106; Borbely A, 2009, CIRC RES, V104, P780, DOI 10.1161/CIRCRESAHA.108.193326; Bucher RM, 2010, J MOL BIOL, V401, P843, DOI 10.1016/j.jmb.2010.06.011; Bullard B, 2004, J BIOL CHEM, V279, P7917, DOI 10.1074/jbc.M307473200; Cavnar PJ, 2007, CELL MOTIL CYTOSKEL, V64, P418, DOI 10.1002/cm.20193; Cazorla O, 2001, CIRC RES, V88, P1028, DOI 10.1161/hh1001.090876; Centner T, 2001, J MOL BIOL, V306, P717, DOI 10.1006/jmbi.2001.4448; Coulis G, 2008, BIOCHEMISTRY-US, V47, P9174, DOI 10.1021/bi800315v; Ehler E, 2008, ADV EXP MED BIOL, V642, P1; Fernando P, 2009, J BIOL CHEM, V284, P27674, DOI 10.1074/jbc.M109.029538; Freiburg A, 2000, CIRC RES, V86, P1114; Fukuda N, 2005, J GEN PHYSIOL, V125, P257, DOI 10.1085/jgp.200409177; GAUTEL M, 1993, EMBO J, V12, P3827, DOI 10.1002/j.1460-2075.1993.tb06061.x; Gautel M, 1996, J CELL SCI, V109, P2747; Gautel M, 2008, ADV EXP MED BIOL, V642, P176; Golenhofen N, 2002, J MOL CELL CARDIOL, V34, P309, DOI 10.1006/jmcc.2001.1513; Goll CM, 1998, STRUCTURE, V6, P1291, DOI 10.1016/S0969-2126(98)00129-4; Greaser M, 2001, PROTEINS, V43, P145, DOI 10.1002/1097-0134(20010501)43:2<145::AID-PROT1026>3.0.CO;2-B; Greaser ML, 2008, J MOL CELL CARDIOL, V44, P983, DOI 10.1016/j.yjmcc.2008.02.272; Guo W, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/753675; Hayashi C, 2008, J BIOL CHEM, V283, P14801, DOI 10.1074/jbc.M708262200; Hidalgo C, 2009, CIRC RES, V105, P631, DOI 10.1161/CIRCRESAHA.109.198465; HOROWITS R, 1989, J CELL BIOL, V109, P2169, DOI 10.1083/jcb.109.5.2169; Houmeida A, 2008, J MOL BIOL, V384, P299, DOI 10.1016/j.jmb.2008.09.030; Hudson BD, 2010, J MOL CELL CARDIOL, V48, P972, DOI 10.1016/j.yjmcc.2009.12.006; Improta S, 1996, STRUCTURE, V4, P323, DOI 10.1016/S0969-2126(96)00036-6; Inagaki N, 2006, BIOCHEM BIOPH RES CO, V342, P379, DOI 10.1016/j.bbrc.2006.01.154; Knoll R, 2002, CELL, V111, P943, DOI 10.1016/S0092-8674(02)01226-6; Kolmerer B, 1996, J MOL BIOL, V256, P556, DOI 10.1006/jmbi.1996.0108; Kruger M, 2006, J MUSCLE RES CELL M, V27, P435, DOI 10.1007/s10974-006-9090-5; Kruger M, 2006, AM J PHYSIOL-HEART C, V291, pH496, DOI 10.1152/ajpheart.00114.2006; Kruger M, 2009, J MOL CELL CARDIOL, V46, P490, DOI 10.1016/j.yjmcc.2009.01.004; Kruger M, 2009, CIRC RES, V104, P87, DOI 10.1161/CIRCRESAHA.108.184408; Kulke M, 2001, CIRC RES, V89, P874, DOI 10.1161/hh2201.099453; LABEIT S, 1992, EMBO J, V11, P1711, DOI 10.1002/j.1460-2075.1992.tb05222.x; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; Lahmers S, 2004, CIRC RES, V94, P505, DOI 10.1161/01.RES.0000115522.52554.86; Lange S, 2005, SCIENCE, V308, P1599, DOI 10.1126/science.1110463; Lange S, 2002, J CELL SCI, V115, P4925, DOI 10.1242/jcs.00181; Lee EJ, 2010, J MOL CELL CARDIOL, V49, P449, DOI 10.1016/j.yjmcc.2010.05.006; Li HB, 2002, NATURE, V418, P998, DOI 10.1038/nature00938; Linke WA, 1997, BIOPHYS J, V73, P905, DOI 10.1016/S0006-3495(97)78123-2; Linke WA, 1999, J CELL BIOL, V146, P631, DOI 10.1083/jcb.146.3.631; Linke WA, 1996, J MOL BIOL, V261, P62, DOI 10.1006/jmbi.1996.0441; Linke WA, 2008, PFLUG ARCH EUR J PHY, V456, P101, DOI 10.1007/s00424-007-0389-x; Linke WA, 2008, CARDIOVASC RES, V77, P637, DOI 10.1016/j.cardiores.2007.03.029; Linke WA, 2010, PHYSIOLOGY, V25, P186, DOI 10.1152/physiol.00005.2010; Ma K, 2001, BIOCHEMISTRY-US, V40, P3427, DOI 10.1021/bi0022792; Makarenko I, 2004, CIRC RES, V95, P708, DOI 10.1161/01.RES.0000143901.37063.2f; Marino M, 2006, STRUCTURE, V14, P1437, DOI 10.1016/j.str.2006.07.009; MARUYAMA K, 1977, J BIOCHEM, V82, P339; Mayans O, 1998, NATURE, V395, P863, DOI 10.1038/27603; Mayans O, 2001, STRUCTURE, V9, P331, DOI 10.1016/S0969-2126(01)00591-3; McElhinny AS, 2002, J CELL BIOL, V157, P125, DOI 10.1083/jcb.200108089; Miller MK, 2003, J MOL BIOL, V333, P951, DOI 10.1016/j.jmb.2003.09.012; Minajeva A, 2001, BIOPHYS J, V80, P1442, DOI 10.1016/S0006-3495(01)76116-4; Mrosek M, 2007, FASEB J, V21, P1383, DOI 10.1096/fj.06-7644com; Mueller S, 2007, J MOL BIOL, V371, P469, DOI 10.1016/j.jmb.2007.05.055; Mues A, 1998, FEBS LETT, V428, P111, DOI 10.1016/S0014-5793(98)00501-8; Nagueh SF, 2004, CIRCULATION, V110, P155, DOI 10.1161/01.CIR.0000135591.37759.AF; Neagoe C, 2002, CIRCULATION, V106, P1333, DOI 10.1161/01.CIR.0000029803.93022.93; Opitz CA, 2004, CIRC RES, V94, P967, DOI 10.1161/01.RES.0000124301.48193.E1; Opitz CA, 2003, P NATL ACAD SCI USA, V100, P12688, DOI 10.1073/pnas.2133733100; Ottenheijm CAC, 2009, BIOPHYS J, V97, P2277, DOI 10.1016/j.bpj.2009.07.041; Pernigo S, 2010, P NATL ACAD SCI USA, V107, P2908, DOI 10.1073/pnas.0913736107; PFUHL M, 1995, STRUCTURE, V3, P391, DOI 10.1016/S0969-2126(01)00170-8; Pizon V, 2002, J CELL SCI, V115, P4469, DOI 10.1242/jcs.00131; Prado LG, 2005, J GEN PHYSIOL, V126, P461, DOI 10.1085/jgp.200509364; Preetha N, 2005, J MUSCLE RES CELL M, V26, P307, DOI 10.1007/s10974-005-9037-2; Puchner EM, 2008, P NATL ACAD SCI USA, V105, P13385, DOI 10.1073/pnas.0805034105; Sauer F, 2010, EMBO REP, V11, P534, DOI 10.1038/embor.2010.65; SEBESTYEN MG, 1995, J CELL SCI, V108, P3029; Sheikh F, 2008, J CLIN INVEST, V118, P3870, DOI 10.1172/JCI34472; Solaro RJ, 2008, J BIOL CHEM, V283, P26829, DOI 10.1074/jbc.R800037200; Sorimachi H, 1997, J MOL BIOL, V270, P688, DOI 10.1006/jmbi.1997.1145; Sotomayor M, 2007, SCIENCE, V316, P1144, DOI 10.1126/science.1137591; Stacklies W, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000306; Terui T, 2008, J GEN PHYSIOL, V131, P275, DOI 10.1085/jgp.200709895; Tian LF, 2006, BIOCHEM BIOPH RES CO, V345, P355, DOI 10.1016/j.bbrc.2006.04.108; Trombitas K, 1997, AM J PHYSIOL-CELL PH, V273, pC662, DOI 10.1152/ajpcell.1997.273.2.C662; Trombitas K, 1998, J CELL BIOL, V140, P853, DOI 10.1083/jcb.140.4.853; Tskhovrebova L, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/612482; Tskhovrebova L, 2010, J MOL BIOL, V397, P1092, DOI 10.1016/j.jmb.2010.01.073; Tucker NR, 2009, EXP CELL RES, V315, P3176, DOI 10.1016/j.yexcr.2009.06.030; Von Castelmur E, 2008, P NATL ACAD SCI USA, V105, P1186, DOI 10.1073/pnas.0707163105; WANG K, 1993, BIOPHYS J, V64, P1161, DOI 10.1016/S0006-3495(93)81482-6; Warren CM, 2004, MECH DEVELOP, V121, P1301, DOI 10.1016/j.mod.2004.07.003; Weinert S, 2006, J CELL BIOL, V173, P559, DOI 10.1083/jcb.200601014; Willis MS, 2009, CARDIOVASC RES, V81, P439, DOI 10.1093/cvr/cvn289; Witt SH, 2005, J MOL BIOL, V350, P713, DOI 10.1016/j.jmb.2005.05.021; Yamasaki R, 2002, CIRC RES, V90, P1181, DOI 10.1161/01.RES.0000021115.24712.99; Zhu Y, 2009, J BIOL CHEM, V284, P13914, DOI 10.1074/jbc.M809743200; Zoghbi ME, 2008, P NATL ACAD SCI USA, V105, P2386, DOI 10.1073/pnas.0708912105; Zou PJ, 2006, NATURE, V439, P229, DOI 10.1038/nature04343	99	104	106	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					9905	9912		10.1074/jbc.R110.173260	http://dx.doi.org/10.1074/jbc.R110.173260			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21257761	Green Published, hybrid			2022-12-27	WOS:000288547000003
J	Tang, ZZ; Sharma, S; Zheng, SK; Chawla, G; Nikolic, J; Black, DL				Tang, Zhen Zhi; Sharma, Shalini; Zheng, Sika; Chawla, Geetanjali; Nikolic, Julia; Black, Douglas L.			Regulation of the Mutually Exclusive Exons 8a and 8 in the CaV1.2 Calcium Channel Transcript by Polypyrimidine Tract-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINAL MUSCULAR-ATROPHY; CA2+ CHANNELS; ANTISENSE OLIGONUCLEOTIDES; FUNCTIONAL DIVERSITY; SPLICING REPRESSION; RNA; EXPRESSION; DISEASE; MOUSE; COMPLEX	CaV1.2 calcium channels play roles in diverse cellular processes such as gene regulation, muscle contraction, and membrane excitation and are diversified in their activity through extensive alternative splicing of the CaV1.2 mRNA. The mutually exclusive exons 8a and 8 encode alternate forms of transmembrane segment 6 (IS6) in channel domain 1. The human genetic disorder Timothy syndrome is caused by mutations in either of these two CaV1.2 exons, resulting in disrupted Ca2+ homeostasis and severe pleiotropic disease phenotypes. The tissue-specific pattern of exon 8/8a splicing leads to differences in symptoms between patients with exon 8 or 8a mutations. Elucidating the mechanisms controlling the exon 8/8a splicing choice will be important in understanding the spectrum of defects associated with the disease. We found that the polypyrimidine tract-binding protein (PTB) mediates a switch from exon 8 to 8a splicing. PTB and its neuronal homolog, nPTB, are widely studied splicing regulators controlling large sets of alternative exons. During neuronal development, PTB expression is down-regulated with a concurrent increase in nPTB expression. Exon 8a is largely repressed in embryonic mouse brain but is progressively induced during neuronal differentiation as PTB is depleted. This splicing repression is mediated by the direct binding of PTB to sequence elements upstream of exon 8a. The nPTB protein is a weaker repressor of exon 8a, resulting in a shift in exon choice when nPTB replaces PTB in cells. These results provide mechanistic understanding of how these two exons, important for human disease, are controlled.	[Tang, Zhen Zhi; Sharma, Shalini; Zheng, Sika; Chawla, Geetanjali; Black, Douglas L.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Nikolic, Julia; Black, Douglas L.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Black, DL (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA.	dougb@microbio.ucla.edu	Zheng, Sika/ABB-9203-2020; Chawla, Geetanjali/AAH-9493-2021	Zheng, Sika/0000-0002-0573-4981; Chawla, Geetanjali/0000-0003-0354-3716	National Institutes of Health Grant [RO1 GM49662]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049662] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM49662 (to D. L. B.).	Aartsma-Rus A, 2006, ANN NY ACAD SCI, V1082, P74, DOI 10.1196/annals.1348.058; Aartsma-Rus A, 2009, MOL THER, V17, P548, DOI 10.1038/mt.2008.205; Abernethy DR, 2002, J PHARMACOL EXP THER, V300, P724, DOI 10.1124/jpet.300.3.724; Amir-Ahmady B, 2005, RNA, V11, P699, DOI 10.1261/rna.2250405; Barrett CF, 2008, P NATL ACAD SCI USA, V105, P2157, DOI 10.1073/pnas.0710501105; BLACK DL, 1992, CELL, V69, P795, DOI 10.1016/0092-8674(92)90291-J; Boutz PL, 2007, GENE DEV, V21, P1636, DOI 10.1101/gad.1558107; Boutz PL, 2007, GENE DEV, V21, P71, DOI 10.1101/gad.1500707; Carafoli E, 1999, CALCIUM CELLULAR REG; Carstens RP, 2000, MOL CELL BIOL, V20, P7388, DOI 10.1128/MCB.20.19.7388-7400.2000; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Cheng XY, 2009, AM J PHYSIOL-HEART C, V297, pH680, DOI 10.1152/ajpheart.00109.2009; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; DELGATTO F, 1995, MOL CELL BIOL, V15, P4825; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Fairbrother W, 2008, BIOESSAYS, V30, P1, DOI 10.1002/bies.20696; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Hua YM, 2007, PLOS BIOL, V5, P729, DOI 10.1371/journal.pbio.0050073; Jearawiriyapaisarn N, 2008, MOL THER, V16, P1624, DOI 10.1038/mt.2008.120; Jones RB, 2001, J BIOL CHEM, V276, P4158, DOI 10.1074/jbc.M006151200; Jurkat-Rott K, 2004, J PHYSIOL-LONDON, V554, P609, DOI 10.1113/jphysiol.2003.052712; Khoo B, 2009, CURR OPIN MOL THER, V11, P108; Koschak A, 2001, J BIOL CHEM, V276, P22100, DOI 10.1074/jbc.M101469200; Lejeune F, 2005, CURR OPIN CELL BIOL, V17, P309, DOI 10.1016/j.ceb.2005.03.002; Letunic I, 2002, HUM MOL GENET, V11, P1561, DOI 10.1093/hmg/11.13.1561; Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237; Liao P, 2005, CARDIOVASC RES, V68, P197, DOI 10.1016/j.cardiores.2005.06.024; Liao P, 2010, PFLUG ARCH EUR J PHY, V460, P353, DOI 10.1007/s00424-009-0753-0; Liao P, 2009, PFLUG ARCH EUR J PHY, V458, P481, DOI 10.1007/s00424-009-0635-5; Lipscombe D, 2005, CURR OPIN NEUROBIOL, V15, P358, DOI 10.1016/j.conb.2005.04.002; Lipscombe D, 2002, MOL NEUROBIOL, V26, P21, DOI 10.1385/MN:26:1:021; Liu HY, 2002, RNA, V8, P137, DOI 10.1017/S1355838202015029; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Markovtsov V, 2000, MOL CELL BIOL, V20, P7463, DOI 10.1128/MCB.20.20.7463-7479.2000; Modafferi EF, 1999, RNA, V5, P687, DOI 10.1017/S1355838299990155; Modafferi EF, 1997, MOL CELL BIOL, V17, P6537, DOI 10.1128/MCB.17.11.6537; Modrek B, 2003, NAT GENET, V34, P177, DOI 10.1038/ng1159; Nyegaard M, 2010, MOL PSYCHIATR, V15, P119, DOI 10.1038/mp.2009.69; Oberstrass FC, 2005, SCIENCE, V309, P2054, DOI 10.1126/science.1114066; Rubin BY, 2008, NEUROMOL MED, V10, P148, DOI 10.1007/s12017-007-8019-5; Sharma S, 2005, MOL CELL, V19, P485, DOI 10.1016/j.molcel.2005.07.014; Singh NN, 2009, RNA BIOL, V6, P341, DOI 10.4161/rna.6.3.8723; Smith CWJ, 2005, CELL, V123, P1, DOI 10.1016/j.cell.2005.09.010; SMITH CWJ, 1989, CELL, V56, P749, DOI 10.1016/0092-8674(89)90678-8; SOLDATOV NM, 1992, P NATL ACAD SCI USA, V89, P4628, DOI 10.1073/pnas.89.10.4628; SOLDATOV NM, 1994, GENOMICS, V22, P77, DOI 10.1006/geno.1994.1347; Sorek R, 2003, GENOME RES, V13, P1631, DOI 10.1101/gr.1208803; Spellman R, 2006, TRENDS BIOCHEM SCI, V31, P73, DOI 10.1016/j.tibs.2005.12.003; Spellman R, 2007, MOL CELL, V27, P420, DOI 10.1016/j.molcel.2007.06.016; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Splawski I, 2005, P NATL ACAD SCI USA, V102, P8089, DOI 10.1073/pnas.0502506102; STEA A, 1995, HDB RECEPTORS CHANNE, P113; Striessnig J, 1999, CELL PHYSIOL BIOCHEM, V9, P242, DOI 10.1159/000016320; Sugnet CW, 2006, PLOS COMPUT BIOL, V2, P22, DOI 10.1371/journal.pcbi.0020004; Svasti S, 2009, P NATL ACAD SCI USA, V106, P1205, DOI 10.1073/pnas.0812436106; Tang ZZ, 2008, BBA-MOL CELL RES, V1783, P118, DOI 10.1016/j.bbamcr.2007.11.003; Tang ZZ, 2007, CELL CALCIUM, V41, P417, DOI 10.1016/j.ceca.2006.08.002; Tang ZZ, 2009, MOL CELL BIOL, V29, P4757, DOI 10.1128/MCB.00608-09; Tang ZZ, 2004, J BIOL CHEM, V279, P44335, DOI 10.1074/jbc.M407023200; Tazi J, 2009, BBA-MOL BASIS DIS, V1792, P14, DOI 10.1016/j.bbadis.2008.09.017; Thiel WH, 2008, CIRCULATION, V118, P2225, DOI 10.1161/CIRCULATIONAHA.108.788067; Tsien RW, 1999, CALCIUM AS A CELLULAR REGULATOR, P171; van Deutekom JC, 2007, NEW ENGL J MED, V357, P2677, DOI 10.1056/NEJMoa073108; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Welling A, 1997, CIRC RES, V81, P526, DOI 10.1161/01.RES.81.4.526; Wheeler TM, 2007, J CLIN INVEST, V117, P3952, DOI 10.1172/JCI33355; Williams JH, 2009, J NEUROSCI, V29, P7633, DOI 10.1523/JNEUROSCI.0950-09.2009; Wood MJA, 2010, BRAIN, V133, P957, DOI 10.1093/brain/awq002; Yeo GW, 2005, P NATL ACAD SCI USA, V102, P2850, DOI 10.1073/pnas.0409742102; Zuhlke RD, 1998, FEBS LETT, V427, P220, DOI 10.1016/S0014-5793(98)00425-6; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	72	46	47	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10007	10016		10.1074/jbc.M110.208116	http://dx.doi.org/10.1074/jbc.M110.208116			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21282112	Green Published, hybrid			2022-12-27	WOS:000288547000015
J	Wang, JY; Yeh, CL; Chou, HC; Yang, CH; Fu, YN; Chen, YT; Cheng, HW; Huang, CYF; Liu, HP; Huang, SF; Chen, YR				Wang, Jiz-Yuh; Yeh, Chi-Ling; Chou, Hsiao-Chin; Yang, Chi-Hwa; Fu, Yu-Ning; Chen, Ya-Ting; Cheng, Hui-Wen; Huang, Chi-Ying F.; Liu, Hui-Ping; Huang, Shiu-Feng; Chen, Yi-Rong			Vaccinia H1-related Phosphatase Is a Phosphatase of ErbB Receptors and Is Down-regulated in Non-small Cell Lung Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; DUAL-SPECIFICITY PHOSPHATASE; N-TERMINAL KINASE; MOLECULAR-CLONING; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; VHR; ACTIVATION; PATHWAY; GENE	Vaccinia H1-related phosphatase (VHR) is classified as a dual specificity phosphatase. Unlike typical dual specificity phosphatases, VHR lacks the MAPK-binding domain and shows poor activity against MAPKs. We found that EGF receptor (EGFR) was a direct substrate of VHR and that overexpression of VHR down-regulated EGFR phosphorylation, particularly at Tyr-992 residue. Expression ofVHRinhibited the activation of phospholipase C gamma and protein kinase C, both downstream effectors of Tyr-992 phosphorylation of EGFR. Decreasing VHR expression by RNA interference caused higher EGFR phosphorylation at Tyr-992. In addition to EGFR, VHR also directly dephosphorylated ErbB2. Consistent with these results, suppression of VHR augmented the foci formation ability of H1299 non-small cell lung cancer (NSCLC) cells, whereas overexpression of VHR suppressed cell growth in both two- and three-dimensional cultures. Expression of VHR also suppressed tumor formation in a mouse xenograft model. Furthermore, VHR expression was significantly lower in NSCLC tissues in comparison to that in normal lung tissues. Collectively, this study shows that down- regulation of VHR expression enhances the signaling of ErbB receptors and may be involved in NSCLC pathogenesis.	[Wang, Jiz-Yuh; Yeh, Chi-Ling; Chou, Hsiao-Chin; Yang, Chi-Hwa; Fu, Yu-Ning; Chen, Ya-Ting; Cheng, Hui-Wen; Huang, Shiu-Feng; Chen, Yi-Rong] Natl Hlth Res Inst, Div Mol & Genom Med, Zhunan 35053, Taiwan; [Huang, Chi-Ying F.] Natl Yang Ming Univ, Inst Clin Med, Taipei 11221, Taiwan; [Liu, Hui-Ping] BenQ Med Ctr, Dept Thorac Surg, Nanjing 210019, Peoples R China; [Liu, Hui-Ping] Chang Gung Mem Hosp, Dept Cardiovasc & Thorac Surg, Tao Yuan 33302, Taiwan; [Huang, Shiu-Feng] Chang Gung Mem Hosp, Dept Pathol, Tao Yuan 33302, Taiwan	National Health Research Institutes - Taiwan; National Yang Ming Chiao Tung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Chen, YR (corresponding author), 35 Keyan Rd, Zhunan 35053, Miaoli County, Taiwan.	yrchen@nhri.org.tw	Huang, Chi-Ying/AFL-7729-2022; Chen, Yi-Rong/E-3991-2010; Chen, Yi-Rong/CAF-2186-2022; Huang, Shiu-Feng Kathy/E-3977-2010; Huang, Chi-Ying/AAG-7672-2022; Chen, Yi-Rong/CAH-7991-2022	Huang, Chi-Ying/0000-0003-4898-4937; Chen, Yi-Rong/0000-0002-4307-3002; Chen, Yi-Rong/0000-0002-4307-3002; Huang, Chi-Ying/0000-0003-4898-4937; Chen, Yi-Rong/0000-0002-4307-3002	National Health Research Institutes [MG-098-PP-03, MG-099-PP-03]; Department of Health [DOH98-TD-G-111-026]; Taiwan National Science Council [97-2320-B-400-008-MY3]	National Health Research Institutes(National Health Research Institutes, Japan); Department of Health; Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by National Health Research Institutes Grants MG-098-PP-03 and MG-099-PP-03, Department of Health Grant DOH98-TD-G-111-026, and Taiwan National Science Council Grant 97-2320-B-400-008-MY3 (to Y.-R.C.).	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Alonso A, 2001, J BIOL CHEM, V276, P4766, DOI 10.1074/jbc.M006497200; Bokemeyer D, 1996, J BIOL CHEM, V271, P639, DOI 10.1074/jbc.271.2.639; Brondello JM, 1997, J BIOL CHEM, V272, P1368, DOI 10.1074/jbc.272.2.1368; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; Chen AJ, 2002, J BIOL CHEM, V277, P36592, DOI 10.1074/jbc.M200453200; Chen YR, 2002, J BIOL CHEM, V277, P39334, DOI 10.1074/jbc.M202070200; Grumont RJ, 1996, MOL CELL BIOL, V16, P2913; Hood KL, 2002, BIOCHEM BIOPH RES CO, V298, P545, DOI 10.1016/S0006-291X(02)02488-9; Hoyt R, 2007, J IMMUNOL, V179, P3402, DOI 10.4049/jimmunol.179.6.3402; ISHIBASHI T, 1992, P NATL ACAD SCI USA, V89, P12170, DOI 10.1073/pnas.89.24.12170; Li JP, 2010, J BIOL CHEM, V285, P5472, DOI 10.1074/jbc.M109.060186; Marti F, 2001, J IMMUNOL, V166, P197, DOI 10.4049/jimmunol.166.1.197; MISRAPRESS A, 1995, J BIOL CHEM, V270, P14587, DOI 10.1074/jbc.270.24.14587; Mourey RJ, 1996, J BIOL CHEM, V271, P3795; Muda M, 1997, J BIOL CHEM, V272, P5141, DOI 10.1074/jbc.272.8.5141; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Rahmouni S, 2006, NAT CELL BIOL, V8, P524, DOI 10.1038/ncb1398; ROHAN PJ, 1993, SCIENCE, V259, P1763, DOI 10.1126/science.7681221; ROTIN D, 1992, EMBO J, V11, P559, DOI 10.1002/j.1460-2075.1992.tb05087.x; Schumacher MA, 2002, BIOCHEMISTRY-US, V41, P3009, DOI 10.1021/bi015799l; SIERKE SL, 1993, BIOCHEM BIOPH RES CO, V191, P45, DOI 10.1006/bbrc.1993.1182; Smith A, 1997, CURR BIOL, V7, P893, DOI 10.1016/S0960-9822(06)00380-0; Stewart AE, 1999, NAT STRUCT BIOL, V6, P174; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Tanoue T, 1999, J BIOL CHEM, V274, P19949, DOI 10.1074/jbc.274.28.19949; Tanoue T, 2001, J BIOL CHEM, V276, P26629, DOI 10.1074/jbc.M101981200; Todd JL, 2002, ONCOGENE, V21, P2573, DOI 10.1038/sj.onc.1205344; Todd JL, 1999, J BIOL CHEM, V274, P13271, DOI 10.1074/jbc.274.19.13271; Wang JY, 2006, J NEUROCHEM, V98, P89, DOI 10.1111/j.1471-4159.2006.03852.x; WARD Y, 1994, NATURE, V367, P651, DOI 10.1038/367651a0; Yuvaniyama J, 1996, SCIENCE, V272, P1328, DOI 10.1126/science.272.5266.1328	32	32	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10177	10184		10.1074/jbc.M110.163295	http://dx.doi.org/10.1074/jbc.M110.163295			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21262974	Green Published, hybrid			2022-12-27	WOS:000288547000033
J	Watanabe, A; Tatematsu, M; Saeki, K; Shibata, S; Shime, H; Yoshimura, A; Obuse, C; Seya, T; Matsumoto, M				Watanabe, Ayako; Tatematsu, Megumi; Saeki, Kazuko; Shibata, Sachiko; Shime, Hiroaki; Yoshimura, Akihiko; Obuse, Chikashi; Seya, Tsukasa; Matsumoto, Misako			Raftlin Is Involved in the Nucleocapture Complex to Induce Poly(I:C)-mediated TLR3 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR-3; DOUBLE-STRANDED-RNA; TRIF-DEPENDENT PATHWAYS; HEPATITIS-C VIRUS; NF-KAPPA-B; RIG-I; ADAPTER PROTEIN; DENDRITIC CELLS; INTERFERON INDUCTION; LIPID RAFT	The double-stranded RNA analog, poly(I: C), extracellularly activates both the endosomal Toll-like receptor (TLR) 3 and the cytoplasmic RNA helicase, melanoma differentiation-associated gene 5, leading to the production of type I interferons (IFNs) and inflammatory cytokines. The mechanism by which extracellular poly(I: C) is delivered to TLR3-positive organelles and the cytoplasm remains to be elucidated. Here, we show that the cytoplasmic lipid raft protein, Raftlin, is essential for poly(I: C) cellular uptake in human myeloid dendritic cells and epithelial cells. When Raftlin was silenced, poly(I: C) failed to enter cells and induction of IFN-beta production was inhibited. In addition, cellular uptake of B-type oligodeoxynucleotide that shares its uptake receptor with poly(I: C) was suppressed in Raftlin knockdown cells. Upon poly(I: C) stimulation, Raftlin was translocated from the cytoplasm to the plasma membrane where it colocalized with poly(I: C), and thereafter moved to TLR3-positive endosomes. Thus, Raftlin cooperates with the uptake receptor to mediate cell entry of poly(I: C), which is critical for activation of TLR3.	[Watanabe, Ayako; Tatematsu, Megumi; Shime, Hiroaki; Seya, Tsukasa; Matsumoto, Misako] Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Saeki, Kazuko] Kyushu Univ, Grad Sch Med Sci, Dept Med Biochem, Fukuoka 8128582, Japan; [Shibata, Sachiko; Obuse, Chikashi] Hokkaido Univ, Grad Sch Life Sci, Div Mol Life Sci, Sapporo, Hokkaido 0010021, Japan; [Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo 1608582, Japan	Hokkaido University; Kyushu University; Hokkaido University; Keio University	Matsumoto, M (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0608638, Japan.	matumoto@pop.med.hokudai.ac.jp	美佐子, 松本/A-4497-2012; Obuse, Chikashi/F-5273-2011; Shime, Hiroaki/D-8721-2012; Seya, Tsukasa/A-4336-2012; Yoshimura, Akihiko/K-5515-2013; Shime, Hiroaki/P-6454-2019	Shime, Hiroaki/0000-0003-0209-5034	Ministry of Education, Science, and Culture; Ministry of Health, Labor, and Welfare of Japan; Akiyama Foundation; NorthTec Foundation; Yakult Foundation; MEXT; Grants-in-Aid for Scientific Research [22114008] Funding Source: KAKEN	Ministry of Education, Science, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Akiyama Foundation; NorthTec Foundation; Yakult Foundation; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid from the Ministry of Education, Science, and Culture, the Ministry of Health, Labor, and Welfare of Japan, and the Akiyama Foundation, NorthTec Foundation, Yakult Foundation, and the Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases, MEXT.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Ding CL, 2006, EUR J IMMUNOL, V36, P2013, DOI 10.1002/eji.200635850; Ebihara T, 2008, HEPATOLOGY, V48, P48, DOI 10.1002/hep.22337; Ebihara T, 2010, J EXP MED, V207, P2675, DOI 10.1084/jem.20091573; FIELD AK, 1967, P NATL ACAD SCI USA, V58, P1004, DOI 10.1073/pnas.58.3.1004; Funami K, 2007, J IMMUNOL, V179, P6867, DOI 10.4049/jimmunol.179.10.6867; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Itoh K, 2008, J IMMUNOL, V181, P5522, DOI 10.4049/jimmunol.181.8.5522; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Kumar H, 2008, J IMMUNOL, V180, P683, DOI 10.4049/jimmunol.180.2.683; Lee HK, 2006, IMMUNITY, V24, P153, DOI 10.1016/j.immuni.2005.12.012; Limmon GV, 2008, FASEB J, V22, P159, DOI 10.1096/fj.07-8348com; LINDENMANN J, 1957, BRIT J EXP PATHOL, V38, P551; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Matsumoto M, 2002, BIOCHEM BIOPH RES CO, V293, P1364, DOI 10.1016/S0006-291X(02)00380-7; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; Matsumoto M, 2008, ADV DRUG DELIVER REV, V60, P805, DOI 10.1016/j.addr.2007.11.005; McCartney S, 2009, J EXP MED, V206, P2967, DOI 10.1084/jem.20091181; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Miyake T, 2009, J IMMUNOL, V183, P2522, DOI 10.4049/jimmunol.0901500; NAGANO Y, 1954, CR SOC BIOL, V148, P1700; Obuse C, 2004, NAT CELL BIOL, V6, P1135, DOI 10.1038/ncb1187; Ohno H, 2006, J CELL SCI, V119, P3719, DOI 10.1242/jcs.03085; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Ranjith-Kumar CT, 2008, MOL CELL BIOL, V28, P4507, DOI 10.1128/MCB.00308-08; Saeki K, 2003, EMBO J, V22, P3015, DOI 10.1093/emboj/cdg293; Saeki K, 2009, J IMMUNOL, V182, P5929, DOI 10.4049/jimmunol.0802672; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851	35	61	62	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10702	10711		10.1074/jbc.M110.185793	http://dx.doi.org/10.1074/jbc.M110.185793			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21266579	Green Published, hybrid			2022-12-27	WOS:000288547000084
J	Watts, T; Khalimonchuk, O; Wolf, RZ; Turk, EM; Mohr, G; Winge, DR				Watts, Talina; Khalimonchuk, Oleh; Wolf, Rachel Z.; Turk, Edward M.; Mohr, Georg; Winge, Dennis R.			Mne1 Is a Novel Component of the Mitochondrial Splicing Apparatus Responsible for Processing of a COX1 Group I Intron in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; DEAD-BOX PROTEIN; SACCHAROMYCES-CEREVISIAE; RNA CHAPERONE; GENE; REQUIRES; LOCALIZATION; DEGRADOSOME; BIOGENESIS; EXPRESSION	Saccharomyces cerevisiae cells lacking Mne1 are deficient in intron splicing in the gene encoding the Cox1 subunit of cytochrome oxidase but contain wild-type levels of the bc(1) complex. Thus, Mne1 has no role in splicing of COB introns or expression of the COB gene. Northern experiments suggest that splicing of the COX1 aI5 beta intron is dependent on Mne1 in addition to the previously known Mrs1, Mss116, Pet54, and Suv3 factors. Processing of the aI5 beta intron is similarly impaired in mne1 Delta and mrs1 Delta cells and overexpression of Mrs1 partially restores the respiratory function of mne1 Delta cells. Mrs1 is known to function in the initial transesterification reaction of splicing. Mne1 is a mitochondrial matrix protein loosely associated with the inner membrane and is found in a high mass ribonucleoprotein complex specifically associated with the COX1 mRNA even within an intronless strain. Mne1 does not appear to have a secondary function in COX1 processing or translation, because disruption of MNE1 in cells containing intronless mtDNA does not lead to a respiratory growth defect. Thus, the primary defect in mne1 Delta cells is splicing of the aI5 beta intron in COX1.	[Watts, Talina; Khalimonchuk, Oleh; Winge, Dennis R.] Univ Utah, Hlth Sci Ctr, Dept Med, Salt Lake City, UT 84132 USA; [Watts, Talina; Khalimonchuk, Oleh; Winge, Dennis R.] Univ Utah, Hlth Sci Ctr, Dept Biochem, Salt Lake City, UT 84132 USA; [Wolf, Rachel Z.; Mohr, Georg] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Turk, Edward M.] Case Western Reserve Univ, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Texas System; University of Texas Austin; Case Western Reserve University	Winge, DR (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Med, Salt Lake City, UT 84132 USA.	dennis.winge@hsc.utah.edu	Khalimonchuk, Oleh/AAM-1194-2021	Khalimonchuk, Oleh/0000-0002-3972-8678; Mohr, Georg/0000-0002-6411-0685	National Institutes of Health [GM083292, GM037951]; American Heart Association [10POST4300044]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES003817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037951, R01GM083292, R37GM037951] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM083292 (to D. R. W.) and GM037951 (to Alan M. Lambowitz, University of Texas at Austin), and American Heart Association Grant 10POST4300044 (to O. K.).	Barrientos A, 2004, EMBO J, V23, P3472, DOI 10.1038/sj.emboj.7600358; Barrientos A, 2002, EMBO J, V21, P43, DOI 10.1093/emboj/21.1.43; Barrientos A, 2009, BBA-MOL CELL RES, V1793, P97, DOI 10.1016/j.bbamcr.2008.05.003; Barros MH, 2006, J BIOL CHEM, V281, P3743, DOI 10.1074/jbc.M510778200; Bifano AL, 2008, J MOL BIOL, V383, P667, DOI 10.1016/j.jmb.2008.08.070; BONITZ SG, 1980, J BIOL CHEM, V255, P1927; BOUSQUET I, 1990, CURR GENET, V18, P117, DOI 10.1007/BF00312599; Bullerwell CE, 2003, NUCLEIC ACIDS RES, V31, P759, DOI 10.1093/nar/gkg134; Capaldi RA, 1995, METHOD ENZYMOL, V260, P117, DOI 10.1016/0076-6879(95)60134-1; Carr HS, 2003, ACCOUNTS CHEM RES, V36, P309, DOI 10.1021/ar0200807; Chou JY, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000432; COSTANZO MC, 1989, GENETICS, V122, P297; DAUM G, 1982, J BIOL CHEM, V257, P3028; Del Campo M, 2007, MOL CELL, V28, P159, DOI 10.1016/j.molcel.2007.07.028; Diekert K, 2001, METHOD CELL BIOL, V65, P37, DOI 10.1016/S0091-679X(01)65003-9; Duncan CDS, 2010, BIOCHEMISTRY-US, V49, P5418, DOI 10.1021/bi100267g; Duncan CDS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008983; Dziembowski A, 2003, J BIOL CHEM, V278, P1603, DOI 10.1074/jbc.M208287200; Fontanesi F, 2008, IUBMB LIFE, V60, P557, DOI 10.1002/iub.86; Fontanesi F, 2006, AM J PHYSIOL-CELL PH, V291, pC1129, DOI 10.1152/ajpcell.00233.2006; Fontanesi F, 2010, MOL CELL BIOL, V30, P245, DOI 10.1128/MCB.00983-09; FUJIKI Y, 1982, J CELL BIOL, V93, P103, DOI 10.1083/jcb.93.1.103; Herbert Christopher J., 1992, Gene Expression, V2, P203; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Horng YC, 2005, J BIOL CHEM, V280, P34113, DOI 10.1074/jbc.M506801200; Huang HR, 2005, P NATL ACAD SCI USA, V102, P163, DOI 10.1073/pnas.0407896101; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Karunatilaka KS, 2010, NATURE, V467, P935, DOI 10.1038/nature09422; Kaspar BJ, 2008, NUCLEIC ACIDS RES, V36, P2958, DOI 10.1093/nar/gkn045; Khalimonchuk O, 2006, EUKARYOT CELL, V5, P997, DOI 10.1128/EC.00092-06; Khalimonchuk O, 2010, MOL CELL BIOL, V30, P1004, DOI 10.1128/MCB.00640-09; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; LABOUESSE M, 1990, MOL GEN GENET, V224, P209, DOI 10.1007/BF00271554; LAMBOWITZ AM, 1993, ANNU REV BIOCHEM, V62, P587, DOI 10.1146/annurev.bi.62.070193.003103; LAMBOWITZ AM, 1999, RNA WORLD, V2, P451; Lang BF, 2007, TRENDS GENET, V23, P119, DOI 10.1016/j.tig.2007.01.006; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Luban C, 2005, GENE, V354, P72, DOI 10.1016/j.gene.2005.03.023; Mohr S, 2002, CELL, V109, P769, DOI 10.1016/S0092-8674(02)00771-7; Moreno JI, 2009, CURR GENET, V55, P475, DOI 10.1007/s00294-009-0260-z; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; NYBERG TM, 2006, IN VIVO STUDIES YEAS, P190; Perez-Martinez X, 2003, EMBO J, V22, P5951, DOI 10.1093/emboj/cdg566; Pierrel F, 2007, EMBO J, V26, P4335, DOI 10.1038/sj.emboj.7601861; Sambrook J, 1989, MOL CLONING LABORATO; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; SERAPHIN B, 1988, EMBO J, V7, P1455, DOI 10.1002/j.1460-2075.1988.tb02963.x; SERAPHIN B, 1989, NATURE, V337, P84, DOI 10.1038/337084a0; SHIN J, 2010, FASEB J, V24; Signorovitch AY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030013; Turk EM, 2010, J BIOL CHEM, V285, P8585, DOI 10.1074/jbc.M109.090761; VALENCIK ML, 1989, EMBO J, V8, P3899, DOI 10.1002/j.1460-2075.1989.tb08569.x; Woodson SA, 2005, CURR OPIN STRUC BIOL, V15, P324, DOI 10.1016/j.sbi.2005.05.007; Yoshikawa S, 2000, J INORG BIOCHEM, V82, P1, DOI 10.1016/S0162-0134(00)00137-9	55	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10137	10146		10.1074/jbc.M110.205625	http://dx.doi.org/10.1074/jbc.M110.205625			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21257754	hybrid, Green Published			2022-12-27	WOS:000288547000028
J	Zhang, CL; Li, AM; Zhang, XC; Xiao, H				Zhang, Chengliang; Li, Aimin; Zhang, Xinchun; Xiao, Hua			A Novel TIP30 Protein Complex Regulates EGF Receptor Signaling and Endocytic Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-METASTASIS; EARLY ENDOSOMES; RAB5; EXPRESSION; INHIBITION; INTERACTS; FUSION	Activated epidermal growth factor receptor (EGFR) continues to signal in the early endosome, but how this signaling process is regulated is less well understood. Here we describe a protein complex consisting of TIP30, endophilin B1, and acyl-CoA synthetase long chain family member 4 (ACSL4) that interacts with Rab5a and regulates EGFR endocytosis and signaling. These proteins are required for the proper endocytic trafficking of EGF-EGFR. Knockdown of TIP30, ACSL4, endophilin B1, or Rab5a in human liver cancer cells or genetic knock-out of Tip30 in mouse primary hepatocytes results in the trapping of EGF-EGFR complexes in early endosomes, leading to delayed EGFR degradation and prolonged EGFR signaling. Furthermore, we show that Rab5a colocalizes with vacuolar (H+)-ATPases (V-ATPases) on transport vesicles. The TIP30 complex facilitates trafficking of Rab5a and V-ATPases to EEA1-positve endosomes in response to EGF. Together, these results suggest that this TIP30 complex regulates EGFR endocytosis by facilitating the transport of V-ATPases from trans-Golgi network to early endosomes.	[Zhang, Chengliang; Li, Aimin; Xiao, Hua] Michigan State Univ, Dept Biomed & Integrat Physiol, E Lansing, MI 48824 USA; [Zhang, Chengliang; Zhang, Xinchun] Michigan State Univ, Genet Program, E Lansing, MI 48824 USA; [Li, Aimin] So Med Univ, Dept Oncol, Nanfang Hosp, Guangzhou 510515, Guangdong, Peoples R China	Michigan State University; Michigan State University; Southern Medical University - China	Xiao, H (corresponding author), 3193 Biomed & Phys Sci Bldg, E Lansing, MI 48824 USA.	xiaoh@msu.edu	Zhang, Chengliang/E-6943-2016	Zhang, Chengliang/0000-0003-3798-4157; Zhang, Chengliang/0000-0001-6999-4670	National Institutes of Health [RO1 DK066110-01]; NIDDK [W81XWH-08-1-0377]; Department of Defense; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066110] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK066110-01 and W81XWH-08-1-0377 from the NIDDK (to H.X.). This work was also supported by a grant from the Department of Defense.	Authier F, 1999, FEBS LETT, V461, P25, DOI 10.1016/S0014-5793(99)01413-1; BACKER JM, 1990, J BIOL CHEM, V265, P14828; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Burke P, 2001, MOL BIOL CELL, V12, P1897, DOI 10.1091/mbc.12.6.1897; CARPENTER G, 1979, ANNU REV BIOCHEM, V48, P193, DOI 10.1146/annurev.bi.48.070179.001205; CARPENTER G, 1976, J CELL BIOL, V71, P159, DOI 10.1083/jcb.71.1.159; Carter RE, 1998, J BIOL CHEM, V273, P35000, DOI 10.1074/jbc.273.52.35000; Chen PI, 2009, J BIOL CHEM, V284, P30328, DOI 10.1074/jbc.M109.034546; CHIANG CM, 1995, SCIENCE, V267, P531, DOI 10.1126/science.7824954; CLAGUE MJ, 1994, J BIOL CHEM, V269, P21; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; HU CD, 2005, CURRENT PROTOCOLS PR; Ito M, 2003, CANCER RES, V63, P8763; Jiang C, 2004, J BIOL CHEM, V279, P27781, DOI 10.1074/jbc.M401809200; King FW, 2004, MOL CELL BIOL, V24, P7091, DOI 10.1128/MCB.24.16.7091-7101.2004; Krishnan MN, 2007, J VIROL, V81, P4881, DOI 10.1128/JVI.02210-06; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; Lawe DC, 2002, J BIOL CHEM, V277, P8611, DOI 10.1074/jbc.M109239200; Lee L W, 2004, Ann Acad Med Singap, V33, pS30; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; Polo S, 2006, CELL, V124, P897, DOI 10.1016/j.cell.2006.02.025; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rosenfeld JL, 2001, J CELL SCI, V114, P4499; SEGLEN PO, 1972, EXP CELL RES, V74, P450, DOI 10.1016/0014-4827(72)90400-4; Shtivelman E, 1997, ONCOGENE, V14, P2167, DOI 10.1038/sj.onc.1201059; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; STRINGER KF, 1990, NATURE, V345, P783, DOI 10.1038/345783a0; Takahashi Y, 2009, CELL DEATH DIFFER, V16, P947, DOI 10.1038/cdd.2009.19; Takahashi Y, 2008, AUTOPHAGY, V4, P121, DOI 10.4161/auto.5265; Tong X, 2009, AM J PATHOL, V174, P1931, DOI 10.2353/ajpath.2009.080846; Umebayashi K, 2008, MOL BIOL CELL, V19, P3454, DOI 10.1091/mbc.E07-10-0988; Wan J, 2008, J NEUROSCI, V28, P9002, DOI 10.1523/JNEUROSCI.0767-08.2008; Wang Y, 2002, MOL CELL BIOL, V22, P7279, DOI 10.1128/MCB.22.20.7279-7290.2002; Xiao H, 2000, EMBO J, V19, P956, DOI 10.1093/emboj/19.5.956; Xiao H, 1998, P NATL ACAD SCI USA, V95, P2146, DOI 10.1073/pnas.95.5.2146; YAMASHIRO DJ, 1984, CELL, V37, P789, DOI 10.1016/0092-8674(84)90414-8; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang CL, 2010, CANCER RES, V70, P10224, DOI 10.1158/0008-5472.CAN-10-3057; Zhao J, 2008, HEPATOLOGY, V48, P265, DOI 10.1002/hep.22280; Zhao J, 2007, HUM PATHOL, V38, P293, DOI 10.1016/j.humpath.2006.08.005	47	42	48	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9373	9381		10.1074/jbc.M110.207720	http://dx.doi.org/10.1074/jbc.M110.207720			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21252234	Green Published, hybrid			2022-12-27	WOS:000288247700066
J	Ohsakaya, S; Fujikawa, M; Hisabori, T; Yoshida, M				Ohsakaya, Shigenori; Fujikawa, Makoto; Hisabori, Toru; Yoshida, Masasuke			Knockdown of DAPIT (Diabetes-associated Protein in Insulin-sensitive Tissue) Results in Loss of ATP Synthase in Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE HEART-MITOCHONDRIA; RESOLUTION; F-1-ATPASE; ROTATION; DRIVEN; CELLS	It was found recently that a diabetes-associated protein in insulin-sensitive tissue (DAPIT) is associated with mitochondrial ATP synthase. Here, we report that the suppressed expression of DAPIT in DAPIT-knockdown HeLa cells causes loss of the population of ATP synthase in mitochondria. Consequently, DAPIT-knockdown cells show smaller mitochondrial ATP synthesis activity, slower growth in normal medium, and poorer viability in glucose-free medium than the control cells. The mRNA levels of alpha- and beta-subunits of ATP synthase remain unchanged by DAPIT knockdown. These results indicate a critical role of DAPIT in maintaining the ATP synthase population in mitochondria and raise an intriguing possibility of active role of DAPIT in cellular energy metabolism.	[Ohsakaya, Shigenori; Fujikawa, Makoto; Hisabori, Toru; Yoshida, Masasuke] Japan Sci & Technol Agcy, ATP Synth Regulat Project, Int Cooperat Res Project, Koto Ku, Tokyo 1350064, Japan; [Ohsakaya, Shigenori; Hisabori, Toru] Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Yoshida, Masasuke] Kyoto Sangyo Univ, Dept Mol Biosci, Kyoto 6038555, Japan	Japan Science & Technology Agency (JST); Tokyo Institute of Technology; Kyoto Sangyo University	Yoshida, M (corresponding author), Japan Sci & Technol Agcy, ATP Synth Regulat Project, Int Cooperat Res Project, Koto Ku, 2-3-6 Aomi, Tokyo 1350064, Japan.	masasuke.yoshida@cc.kyoto-su.ac.jp	Hisabori, Toru/E-5205-2014	Hisabori, Toru/0000-0003-2046-0277; Fujikawa, Makoto/0000-0002-8100-3718				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Carroll J, 2006, P NATL ACAD SCI USA, V103, P16170, DOI 10.1073/pnas.0607719103; Chen RM, 2007, FEBS LETT, V581, P3145, DOI 10.1016/j.febslet.2007.05.079; Duser MG, 2009, EMBO J, V28, P2689, DOI 10.1038/emboj.2009.213; Fujikawa M, 2010, BIOCHEM BIOPH RES CO, V401, P538, DOI 10.1016/j.bbrc.2010.09.089; Granhall C, 2006, GENETICS, V174, P1565, DOI 10.1534/genetics.106.062208; Havlickova V, 2010, BBA-BIOENERGETICS, V1797, P1124, DOI 10.1016/j.bbabio.2009.12.009; Ishiyama M, 1997, TALANTA, V44, P1299, DOI 10.1016/S0039-9140(97)00017-9; Junge W, 2009, NATURE, V459, P364, DOI 10.1038/nature08145; Kagawa Y, 2010, P JPN ACAD B-PHYS, V86, P667, DOI 10.2183/pjab.86.667; Ludlam A, 2009, J BIOL CHEM, V284, P17138, DOI 10.1074/jbc.M109.002568; Meyer B, 2007, MOL CELL PROTEOMICS, V6, P1690, DOI 10.1074/mcp.M700097-MCP200; Nakamoto RK, 2008, ARCH BIOCHEM BIOPHYS, V476, P43, DOI 10.1016/j.abb.2008.05.004; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Paivarinne H, 2001, ACTA DIABETOL, V38, P83; Pallotti F, 2007, METHOD CELL BIOL, V80, P3, DOI 10.1016/S0091-679X(06)80001-4; Rak M, 2009, BBA-MOL CELL RES, V1793, P108, DOI 10.1016/j.bbamcr.2008.07.001; von Ballmoos C, 2009, ANNU REV BIOCHEM, V78, P649, DOI 10.1146/annurev.biochem.78.081307.104803; Walker JE, 2006, BBA-BIOENERGETICS, V1757, P286, DOI 10.1016/j.bbabio.2006.01.001; Weber J, 2003, FEBS LETT, V545, P61, DOI 10.1016/S0014-5793(03)00394-6; Wittig I, 2008, BBA-BIOENERGETICS, V1777, P592, DOI 10.1016/j.bbabio.2008.04.027; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	25	50	51	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20292	20296		10.1074/jbc.M110.198523	http://dx.doi.org/10.1074/jbc.M110.198523			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21345788	Green Published, hybrid			2022-12-27	WOS:000291267600017
J	Tiso, M; Tejero, J; Basu, S; Azarov, I; Wang, XD; Simplaceanu, V; Frizzell, S; Jayaraman, T; Geary, L; Shapiro, C; Ho, C; Shiva, S; Kim-Shapiro, DB; Gladwin, MT				Tiso, Mauro; Tejero, Jesus; Basu, Swati; Azarov, Ivan; Wang, Xunde; Simplaceanu, Virgil; Frizzell, Sheila; Jayaraman, Thottala; Geary, Lisa; Shapiro, Calli; Ho, Chien; Shiva, Sruti; Kim-Shapiro, Daniel B.; Gladwin, Mark T.			Human Neuroglobin Functions as a Redox-regulated Nitrite Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING; MYOCARDIAL-ISCHEMIA; OXYGEN-AFFINITY; GLOBIN FAMILY; CYTOCHROME-C; BLOOD-CELLS; HEME; OXIDE; HEMOGLOBIN; CYTOGLOBIN	Neuroglobin is a highly conserved hemoprotein of uncertain physiological function that evolved from a common ancestor to hemoglobin and myoglobin. It possesses a six-coordinate heme geometry with proximal and distal histidines directly bound to the heme iron, although coordination of the sixth ligand is reversible. We show that deoxygenated human neuroglobin reacts with nitrite to form nitric oxide (NO). This reaction is regulated by redox-sensitive surface thiols, cysteine 55 and 46, which regulate the fraction of the five-coordinated heme, nitrite binding, and NO formation. Replacement of the distal histidine by leucine or glutamine leads to a stable five-coordinated geometry; these neuroglobin mutants reduce nitrite to NO similar to 2000 times faster than the wild type, whereas mutation of either Cys-55 or Cys-46 to alanine stabilizes the six-coordinate structure and slows the reaction. Using lentivirus expression systems, we show that the nitrite reductase activity of neuroglobin inhibits cellular respiration via NO binding to cytochrome c oxidase and confirm that the six-to-five-coordinate status of neuroglobin regulates intracellular hypoxic NO-signaling pathways. These studies suggest that neuroglobin may function as a physiological oxidative stress sensor and a post-translationally redox-regulated nitrite reductase that generates NO under six-to-five-coordinate heme pocket control. We hypothesize that the six-coordinate heme globin superfamily may subserve a function as primordial hypoxic and redox-regulated NO-signaling proteins.	[Tiso, Mauro; Tejero, Jesus; Frizzell, Sheila; Jayaraman, Thottala; Geary, Lisa; Shapiro, Calli; Shiva, Sruti; Gladwin, Mark T.] Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA 15213 USA; [Basu, Swati; Azarov, Ivan; Kim-Shapiro, Daniel B.] Wake Forest Univ, Dept Phys, Winston Salem, NC 27109 USA; [Simplaceanu, Virgil; Ho, Chien] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Wang, Xunde] NHLBI, NIH, Bethesda, MD 20892 USA; [Shiva, Sruti] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Wake Forest University; Carnegie Mellon University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gladwin, MT (corresponding author), Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA 15213 USA.	gladwinmt@upmc.edu	Tejero, Jesus/G-3953-2017; Ho, Chien/O-6112-2016; Kim-Shapiro, Daniel/HGA-2682-2022	Tejero, Jesus/0000-0003-3245-9978; Ho, Chien/0000-0002-4094-9232; Azarov, Ivan/0000-0002-9886-3298	National Institutes of Health [HL058091, GM084614, HL098032]; Institute for Transfusion Medicine, Hemophilia Center of Western Pennsylvania; American Heart Association [109SDG2150066]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL058091, R29HL058091, R01HL058091, R01HL098032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084614] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Transfusion Medicine, Hemophilia Center of Western Pennsylvania; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL058091 (to D. B. K.-S.), GM084614 (to C. H.), and HL098032 (to M. T. G.). This work was also supported by Institute for Transfusion Medicine, Hemophilia Center of Western Pennsylvania (to M. T. G. and S. S.), and American Heart Association Grant 109SDG2150066 (to S. S.). M. Tiso, M. T. Gladwin, and D. B. Kim-Shapiro are listed as co-inventors on a patent application entitled "Neuroglobin as a Six-to-Five-coordinate Regulated Nitrite Reductase."	Azarov I, 2005, J BIOL CHEM, V280, P39024, DOI 10.1074/jbc.M509045200; Basu S, 2008, J BIOL CHEM, V283, P32590, DOI 10.1074/jbc.M806934200; Basu S, 2007, NAT CHEM BIOL, V3, P785, DOI 10.1038/nchembio.2007.46; BIRAM D, 1993, BIOCHIM BIOPHYS ACTA, V1163, P67, DOI 10.1016/0167-4838(93)90280-5; BRANCACCIO A, 1994, J BIOL CHEM, V269, P13843; Brunori M, 2007, CELL MOL LIFE SCI, V64, P1259, DOI 10.1007/s00018-007-7090-2; Brunori M, 2004, BBA-BIOENERGETICS, V1655, P365, DOI 10.1016/j.bbabio.2003.06.008; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Burmester T, 2004, IUBMB LIFE, V56, P703, DOI 10.1080/15216540500037257; Burmester T, 2009, J EXP BIOL, V212, P1423, DOI 10.1242/jeb.000729; Capece L, 2009, PROTEINS, V75, P885, DOI 10.1002/prot.22297; Copeland DM, 2006, J INORG BIOCHEM, V100, P1413, DOI 10.1016/j.jinorgbio.2006.04.011; Crawford JH, 2006, BLOOD, V107, P566, DOI 10.1182/blood-2005-07-2668; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; DOYLE MP, 1981, J BIOL CHEM, V256, P2393; Du WH, 2003, J AM CHEM SOC, V125, P8080, DOI 10.1021/ja034584r; Garrocho-Villegas V, 2007, GENE, V398, P78, DOI 10.1016/j.gene.2007.01.035; Giuffre A, 2008, BIOCHEM BIOPH RES CO, V367, P893, DOI 10.1016/j.bbrc.2008.01.021; Gladwin MT, 2009, ACCOUNTS CHEM RES, V42, P157, DOI 10.1021/ar800089j; GRASSETTI DR, 1967, ARCH BIOCHEM BIOPHYS, V119, P41, DOI 10.1016/0003-9861(67)90426-2; Greenberg DA, 2008, CURR OPIN PHARMACOL, V8, P20, DOI 10.1016/j.coph.2007.09.003; Grubina R, 2008, J BIOL CHEM, V283, P3628, DOI 10.1074/jbc.M705222200; Grubina R, 2007, J BIOL CHEM, V282, P12916, DOI 10.1074/jbc.M700546200; Hamdane D, 2003, J BIOL CHEM, V278, P51713, DOI 10.1074/jbc.M309396200; Hamdane D, 2004, MICRON, V35, P59, DOI 10.1016/j.micron.2003.10.019; Hankeln T, 2005, J INORG BIOCHEM, V99, P110, DOI 10.1016/j.jinorgbio.2004.11.009; Hendgen-Cotta UB, 2008, P NATL ACAD SCI USA, V105, P10256, DOI 10.1073/pnas.0801336105; Hoshino M, 1996, J AM CHEM SOC, V118, P5702, DOI 10.1021/ja953311w; Huang Z, 2005, J CLIN INVEST, V115, P2099, DOI 10.1172/JCI24650; IKEDASAITO M, 1992, J BIOL CHEM, V267, P22843; Jung KH, 2010, BIOCHEM BIOPH RES CO, V403, P66, DOI 10.1016/j.bbrc.2010.10.116; Khan AA, 2006, P NATL ACAD SCI USA, V103, P17944, DOI 10.1073/pnas.0607497103; Kiger L, 2004, IUBMB LIFE, V56, P709, DOI 10.1080/15216540500037711; Kriegl JM, 2002, P NATL ACAD SCI USA, V99, P7992, DOI 10.1073/pnas.082244399; Liu JX, 2009, J NEUROSCI RES, V87, P164, DOI 10.1002/jnr.21826; Mason MG, 2006, P NATL ACAD SCI USA, V103, P708, DOI 10.1073/pnas.0506562103; Nadra AD, 2008, PROTEINS, V71, P695, DOI 10.1002/prot.21814; Nicolis S, 2007, BIOCHEM J, V407, P89, DOI 10.1042/BJ20070372; Nienhaus K, 2004, J BIOL CHEM, V279, P22944, DOI 10.1074/jbc.M401561200; Pesce A, 2003, STRUCTURE, V11, P1087, DOI 10.1016/S0969-2126(03)00166-7; Petersen MG, 2008, J INORG BIOCHEM, V102, P1777, DOI 10.1016/j.jinorgbio.2008.05.008; Presley TD, 2011, NITRIC OXIDE-BIOL CH, V24, P34, DOI 10.1016/j.niox.2010.10.002; Raychaudhuri S, 2010, APOPTOSIS, V15, P401, DOI 10.1007/s10495-009-0436-5; Salhany JM, 2008, BIOCHEMISTRY-US, V47, P6059, DOI 10.1021/bi8000819; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shiva S, 2007, CIRC RES, V100, P654, DOI 10.1161/01.RES.0000260171.52224.6b; Sun YJ, 2001, P NATL ACAD SCI USA, V98, P15306, DOI 10.1073/pnas.251466698; Uzan J, 2004, BIOPHYS J, V87, P1196, DOI 10.1529/biophysj.104.042168; Van Doorslaer S, 2003, J BIOL CHEM, V278, P4919, DOI 10.1074/jbc.M210617200; Wakasugi K, 2003, J BIOL CHEM, V278, P36505, DOI 10.1074/jbc.M305519200; Wang XY, 2008, STROKE, V39, P1869, DOI 10.1161/STROKEAHA.107.506022; Weiland TR, 2004, J AM CHEM SOC, V126, P11930, DOI 10.1021/ja046990w; Xu J, 2009, J INORG BIOCHEM, V103, P1693, DOI 10.1016/j.jinorgbio.2009.09.016; Yi J, 2008, BIOCHEMISTRY-US, V47, P8247, DOI 10.1021/bi801015c; Yi L, 2009, J BIOL CHEM, V284, P20556, DOI 10.1074/jbc.M109.015651	56	209	217	1	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18277	18289		10.1074/jbc.M110.159541	http://dx.doi.org/10.1074/jbc.M110.159541			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21296891	hybrid, Green Published			2022-12-27	WOS:000290585200088
J	Onoue, N; Yamashita, Y; Nagao, N; Goto, DB; Onouchi, H; Naito, S				Onoue, Noriyuki; Yamashita, Yui; Nagao, Nobuhiro; Goto, Derek B.; Onouchi, Hitoshi; Naito, Satoshi			S-Adenosyl-L-methionine Induces Compaction of Nascent Peptide Chain inside the Ribosomal Exit Tunnel upon Translation Arrest in the Arabidopsis CGS1 Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTATHIONINE GAMMA-SYNTHASE; MESSENGER-RNA DEGRADATION; TRYPTOPHAN INDUCTION; TRANSFERASE CENTER; ELONGATION ARREST; POSTTRANSCRIPTIONAL AUTOREGULATION; POLYPEPTIDE-CHAINS; STRUCTURAL BASIS; IN-VITRO; SITE	Expression of the Arabidopsis CGS1 gene, encoding the first committed enzyme of methionine biosynthesis, is feedback-regulated in response to S-adenosyl-L-methionine (AdoMet) at the mRNA level. This regulation is first preceded by temporal arrest of CGS1 translation elongation at the Ser-94 codon. AdoMet is specifically required for this translation arrest, although the mechanism by which AdoMet acts with the CGS1 nascent peptide remained elusive. We report here that the nascent peptide of CGS1 is induced to form a compact conformation within the exit tunnel of the arrested ribosome in an AdoMet-dependent manner. Cysteine residues introduced into CGS1 nascent peptide showed reduced ability to react with polyethyleneglycol maleimide in the presence of AdoMet, consistent with a shift into the ribosomal exit tunnel. Methylation protection and UV cross-link assays of 28 S rRNA revealed that induced compaction of nascent peptide is associated with specific changes in methylation protection and UV cross-link patterns in the exit tunnel wall. A 14-residue stretch of amino acid sequence, termed the MTO1 region, has been shown to act in cis for CGS1 translation arrest and mRNA degradation. This regulation is lost in the presence of mto1 mutations, which cause single amino acid alterations within MTO1. In this study, both the induced peptide compaction and exit tunnel change were found to be disrupted by mto1 mutations. These results suggest that the MTO1 region participates in the AdoMet-induced arrest of CGS1 translation by mediating changes of the nascent peptide and the exit tunnel wall.	[Onouchi, Hitoshi; Naito, Satoshi] Hokkaido Univ, Grad Sch Agr, Div Appl Biosci, Sapporo, Hokkaido 0608589, Japan; [Onoue, Noriyuki; Yamashita, Yui; Nagao, Nobuhiro; Naito, Satoshi] Hokkaido Univ, Grad Sch Life Sci, Div Life Sci, Sapporo, Hokkaido 0608589, Japan; [Goto, Derek B.] Hokkaido Univ, Creat Res Inst, Sapporo, Hokkaido 0010021, Japan; [Onouchi, Hitoshi] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Japan Science & Technology Agency (JST)	Naito, S (corresponding author), Hokkaido Univ, Grad Sch Agr, Div Appl Biosci, Sapporo, Hokkaido 0608589, Japan.	naito@abs.agr.hokudai.ac.jp	尾上, 典之/Q-8627-2019	ONOUE, Noriyuki/0000-0001-5765-4812; Naito, Satoshi/0000-0001-7006-5609	Japan Society for the Promotion of Science [20370016, 3032]; Ministry of Education, Culture, Sports, Science and Technology of Japan [22119006]; Japan Science and Technology Agency [PJ34085001]; Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grant-in-aid for Scientific Research (B) 20370016 (to S.N.), Grant-in-aid for JSPS Fellows 3032 (to N.O.) from the Japan Society for the Promotion of Science, Grant-in-aid for Scientific Research on Innovative Areas 22119006 (to S.N.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by Core Research for Evolutional Science and Technology PJ34085001 (to H.O.) from the Japan Science and Technology Agency.; Supported by the Japan Society for the Promotion of Science.	Armache JP, 2010, P NATL ACAD SCI USA, V107, P19748, DOI 10.1073/pnas.1009999107; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bhushan S, 2010, MOL CELL, V40, P138, DOI 10.1016/j.molcel.2010.09.009; Bhushan S, 2010, NAT STRUCT MOL BIOL, V17, P313, DOI 10.1038/nsmb.1756; BLOBEL G, 1970, J CELL BIOL, V45, P130, DOI 10.1083/jcb.45.1.130; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Chiba Y, 1999, SCIENCE, V286, P1371, DOI 10.1126/science.286.5443.1371; Chiba Y, 2003, P NATL ACAD SCI USA, V100, P10225, DOI 10.1073/pnas.1831512100; Cruz-Vera LR, 2006, P NATL ACAD SCI USA, V103, P3598, DOI 10.1073/pnas.0600082103; Cruz-Vera LR, 2005, MOL CELL, V19, P333, DOI 10.1016/j.molcel.2005.06.013; Cruz-Vera LR, 2008, J BACTERIOL, V190, P4791, DOI 10.1128/JB.00290-08; Cruz-Vera LR, 2007, J BACTERIOL, V189, P3140, DOI 10.1128/JB.01869-06; ERICKSON AH, 1983, METHOD ENZYMOL, V96, P38; Gong F, 2002, SCIENCE, V297, P1864, DOI 10.1126/science.1073997; Gong F, 2001, J BIOL CHEM, V276, P1974, DOI 10.1074/jbc.M008892200; Gong F, 2001, P NATL ACAD SCI USA, V98, P8997, DOI 10.1073/pnas.171299298; Hansen JL, 2002, MOL CELL, V10, P117, DOI 10.1016/S1097-2765(02)00570-1; Hansen JL, 2003, J MOL BIOL, V330, P1061, DOI 10.1016/S0022-2836(03)00668-5; Haraguchi Y, 2008, PLANT CELL PHYSIOL, V49, P314, DOI 10.1093/pcp/pcn005; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; INABA K, 1994, PLANT PHYSIOL, V104, P881, DOI 10.1104/pp.104.3.881; Janzen DM, 2002, MOL CELL BIOL, V22, P8562, DOI 10.1128/MCB.22.24.8562-8570.2002; Kim JS, 1996, PLANT MOL BIOL, V32, P1117, DOI 10.1007/BF00041395; Lambein I, 2003, PLANT CELL PHYSIOL, V44, P893, DOI 10.1093/pcp/pcg114; Lu JL, 2005, NAT STRUCT MOL BIOL, V12, P1123, DOI 10.1038/nsmb1021; Lu JL, 2005, BIOCHEMISTRY-US, V44, P8230, DOI 10.1021/bi050372q; Lu JL, 2001, BIOCHEMISTRY-US, V40, P13288, DOI 10.1021/bi0107647; MALKIN LI, 1967, J MOL BIOL, V26, P329, DOI 10.1016/0022-2836(67)90301-4; Matthews BF, 1999, BOOK SOIL P, P205; Menetret JF, 2000, MOL CELL, V6, P1219, DOI 10.1016/S1097-2765(00)00118-0; Mitra K, 2006, MOL CELL, V22, P533, DOI 10.1016/j.molcel.2006.05.003; MOAZED D, 1989, CELL, V57, P585, DOI 10.1016/0092-8674(89)90128-1; MOAZED D, 1986, CELL, V47, P985, DOI 10.1016/0092-8674(86)90813-5; Morgan DG, 2000, J MOL BIOL, V301, P301, DOI 10.1006/jmbi.2000.3947; Muto H, 2006, MOL CELL, V22, P545, DOI 10.1016/j.molcel.2006.03.033; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Nakatogawa H, 2001, MOL CELL, V7, P185, DOI 10.1016/S1097-2765(01)00166-6; Noah JW, 2003, BIOCHEMISTRY-US, V42, P14386, DOI 10.1021/bi035369q; Ominato K, 2002, J BIOL CHEM, V277, P36380, DOI 10.1074/jbc.M204645200; Onouchi H, 2005, GENE DEV, V19, P1799, DOI 10.1101/gad.1317105; Onouchi H, 2008, PLANT CELL PHYSIOL, V49, P549, DOI 10.1093/pcp/pcn028; Pogulis R J, 1996, Methods Mol Biol, V57, P167; PORSE BT, 1995, J MOL BIOL, V249, P1, DOI 10.1006/jmbi.1995.0276; Schaffitzel C, 2007, J STRUCT BIOL, V159, P302, DOI 10.1016/S1047-8477(07)00167-0; Schmeing TM, 2005, NATURE, V438, P520, DOI 10.1038/nature04152; Schmeing TM, 2005, MOL CELL, V20, P437, DOI 10.1016/j.molcel.2005.09.006; Seidelt B, 2009, SCIENCE, V326, P1412, DOI 10.1126/science.1177662; Spevak CC, 2010, J BIOL CHEM, V285, P40933, DOI 10.1074/jbc.M110.164152; Suzuki A, 2001, PLANT CELL PHYSIOL, V42, P1174, DOI 10.1093/pcp/pce146; Tu D, 2005, CELL, V121, P257, DOI 10.1016/j.cell.2005.02.005; Tu LW, 2010, J MOL BIOL, V396, P1346, DOI 10.1016/j.jmb.2009.12.059; UELAND PM, 1982, PHARMACOL REV, V34, P223; Vazquez-Laslop N, 2008, MOL CELL, V30, P190, DOI 10.1016/j.molcel.2008.02.026; Vazquez-Laslop N, 2010, EMBO J, V29, P3108, DOI 10.1038/emboj.2010.180; WOLIN SL, 1988, EMBO J, V7, P3559, DOI 10.1002/j.1460-2075.1988.tb03233.x; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; Woolhead CA, 2006, MOL CELL, V22, P587, DOI 10.1016/j.molcel.2006.05.021; Yang R, 2009, J BACTERIOL, V191, P3445, DOI 10.1128/JB.00096-09; Yap MN, 2009, MOL CELL, V34, P201, DOI 10.1016/j.molcel.2009.04.002	60	20	20	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14903	14912		10.1074/jbc.M110.211656	http://dx.doi.org/10.1074/jbc.M110.211656			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21335553	Green Published, hybrid			2022-12-27	WOS:000289788300020
J	Sanchez-Alavez, M; Osborn, O; Tabarean, IV; Holmberg, KH; Eberwine, J; Kahn, CR; Bartfai, T				Sanchez-Alavez, Manuel; Osborn, Olivia; Tabarean, Iustin V.; Holmberg, Kristina H.; Eberwine, James; Kahn, C. Ronald; Bartfai, Tamas			Insulin-like Growth Factor 1-mediated Hyperthermia Involves Anterior Hypothalamic Insulin Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-I RECEPTOR; IGF-I; BODY-TEMPERATURE; RAT-BRAIN; LIFE-SPAN; TRANSGENIC MICE; HUMAN LONGEVITY; CELL-GROWTH; RESISTANCE; PROTEIN	The objective is to investigate the role of insulin-like growth factor 1 (IGF-1) in the regulation of core body temperature. Sequencing cDNA libraries from individual warm-sensitive neurons from the preoptic area (POA) of the hypothalamus, a region involved in the central control of thermoregulation, identified neurons that express both IGF-1 receptor (IGF-1R) and insulin receptor transcripts. The effects of administration of IGF-1 into the POA was measured by radiotelemetry monitoring of core temperature, brown adipose tissue (BAT) temperature, metabolic assessment, and imaging of BAT by positron emission tomography of 2-[F-18]fluoro-2-deoxyglucose uptake combined with computed tomography. IGF-1 injection into the POA caused dose-dependent hyperthermia that could be blocked by pretreatment with the IGF-1R tyrosine kinase inhibitor, PQ401. The IGF-1-evoked hyperthermia involved activation of brown adipose tissue and was accompanied by a switch from glycolysis to fatty acid oxidation as a source of energy as shown by lowered respiratory exchange ratio. Transgenic mice that lack neuronal insulin receptor expression in the brain (NIRKO mice) were unable to mount the full hyperthermic response to IGF-1, suggesting that the IGF-1 mediated hyperthermia is partly dependent on expression of functional neuronal insulin receptors. These data indicate a novel thermoregulatory role for both IGF-1R and neuronal insulin receptors in IGF-1 activation of BAT and hyperthermia. These central effects of IGF-1 signaling may play a role in regulation of metabolic rate, aging, and the risk of developing type 2 diabetes.	[Osborn, Olivia] Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA; [Sanchez-Alavez, Manuel; Tabarean, Iustin V.; Bartfai, Tamas] Scripps Res Inst, Dept Mol & Integrat Neurosci, Harold Dorris Neurol Inst, La Jolla, CA 92037 USA; [Holmberg, Kristina H.] Pfizer Ltd, Expt Biol Sci, Sandwich CT13 9NJ, Kent, England; [Eberwine, James] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Kahn, C. Ronald] Joslin Diabet Ctr, Boston, MA 02215 USA; [Kahn, C. Ronald] Harvard Univ, Sch Med, Boston, MA 02215 USA	University of California System; University of California San Diego; Scripps Research Institute; Pfizer; University of Pennsylvania; Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School	Osborn, O (corresponding author), 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	oosborn@ucsd.edu; tbartfai@scripps.edu	osborn, olivia/R-1460-2018; Eberwine, James/B-2247-2010; Kahn, Ronald/AAY-2435-2021	osborn, olivia/0000-0003-0516-7937; Kahn, Ronald/0000-0002-7583-9228; Sanchez-Alavez, Manuel/0000-0002-8164-8452; Holmberg, Kristina/0000-0003-0760-3990	National Institutes of Health [R01NS043501, R01NS060799, DP1-OD-04117, DK31036]; The Harold L. Dorris Neurological Research Institute; The Skaggs Institute for Chemical Biology; The Ellison Medical Foundation; Commonwealth of Pennsylvania; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031036, R37DK031036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043501, R01NS060799] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD004117] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Harold L. Dorris Neurological Research Institute; The Skaggs Institute for Chemical Biology; The Ellison Medical Foundation(Lawrence Ellison Foundation); Commonwealth of Pennsylvania; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS043501 (to T.B.), R01NS060799 (to I.V.T.), DP1-OD-04117 (to J.E.), and DK31036 (to C.R.K.). This work was also supported by The Harold L. Dorris Neurological Research Institute, The Skaggs Institute for Chemical Biology, The Ellison Medical Foundation, and by Health Research Formula Funds from the Commonwealth of Pennsylvania. This is The Scripps Research Institute Manuscript 20540.	Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; Arai Y, 2001, J GERONTOL A-BIOL, V56, pM79, DOI 10.1093/gerona/56.2.M79; Bailyes EM, 1997, BIOCHEM J, V327, P209, DOI 10.1042/bj3270209; Barbieri M, 2008, EXP GERONTOL, V43, P74, DOI 10.1016/j.exger.2007.06.003; BASKIN DG, 1987, ANNU REV PHYSIOL, V49, P335, DOI 10.1146/annurev.ph.49.030187.002003; Belfiore A, 2007, CURR PHARM DESIGN, V13, P671, DOI 10.2174/138161207780249173; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Bonafe M, 2003, J CLIN ENDOCR METAB, V88, P3299, DOI 10.1210/jc.2002-021810; Bonafe M, 2009, MOL CELL ENDOCRINOL, V299, P118, DOI 10.1016/j.mce.2008.10.038; Boulant JA, 2000, CLIN INFECT DIS, V31, pS157, DOI 10.1086/317521; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Cardona-Gomez GP, 2001, BRAIN RES REV, V37, P320, DOI 10.1016/S0165-0173(01)00137-0; Clemmons DR, 2007, NAT REV DRUG DISCOV, V6, P821, DOI 10.1038/nrd2359; Conti B, 2006, SCIENCE, V314, P825, DOI 10.1126/science.1132191; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Daftary SS, 2004, J NEUROENDOCRINOL, V16, P160, DOI 10.1111/j.0953-8194.2004.01149.x; Delafontaine P, 1998, EUR HEART J, V19, pG18; DEMEYTS P, 1994, HORM RES, V42, P152, DOI 10.1159/000184188; EBERWINE J, 1992, P NATL ACAD SCI USA, V89, P3010, DOI 10.1073/pnas.89.7.3010; Fernandez AM, 2001, GENE DEV, V15, P1926, DOI 10.1101/gad.908001; Gable KL, 2006, MOL CANCER THER, V5, P1079, DOI 10.1158/1535-7163.MCT-05-0397; GarciaSegura LM, 1997, J NEUROCYTOL, V26, P479, DOI 10.1023/A:1018581407804; Hauck SJ, 2001, EXP BIOL MED, V226, P552; HAVRANKOVA J, 1978, P NATL ACAD SCI USA, V75, P5737, DOI 10.1073/pnas.75.11.5737; HAVRANKOVA J, 1979, J CLIN INVEST, V64, P636, DOI 10.1172/JCI109504; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Joshi RL, 1996, EMBO J, V15, P1542, DOI 10.1002/j.1460-2075.1996.tb00498.x; Kappeler L, 2008, PLOS BIOL, V6, P2144, DOI 10.1371/journal.pbio.0060254; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; KUZUYA H, 1993, DIABETES, V42, P696, DOI 10.2337/diabetes.42.5.696; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Louvi A, 1997, DEV BIOL, V189, P33, DOI 10.1006/dbio.1997.8666; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Lynch CD, 1999, NEUROBIOL AGING, V20, P191, DOI 10.1016/S0197-4580(99)00032-9; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; MARKS JL, 1991, MOL ENDOCRINOL, V5, P1158, DOI 10.1210/mend-5-8-1158; Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002; Morrison SF, 2008, EXP PHYSIOL, V93, P773, DOI 10.1113/expphysiol.2007.041848; Muzumdar RH, 2006, NEUROBIOL AGING, V27, P1308, DOI 10.1016/j.neurobiolaging.2005.07.007; Nakamura K, 2008, NAT NEUROSCI, V11, P62, DOI 10.1038/nn2027; Obici S, 2002, NAT NEUROSCI, V5, P566, DOI 10.1038/nn861; Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798; Olsson B, 2005, ENDOCRINOLOGY, V146, P920, DOI 10.1210/en.2004-1232; Paolisso G, 1997, J CLIN ENDOCR METAB, V82, P2204, DOI 10.1210/jc.82.7.2204; Rikke BA, 2003, MECH AGEING DEV, V124, P663, DOI 10.1016/S0047-6374(03)00003-4; Sanchez-Alavez M, 2010, DIABETES, V59, P43, DOI 10.2337/db09-1128; Sandhu MS, 2002, LANCET, V359, P1740, DOI 10.1016/S0140-6736(02)08655-5; Sonntag WE, 1999, NEUROSCIENCE, V88, P269, DOI 10.1016/S0306-4522(98)00192-4; Suh Y, 2008, P NATL ACAD SCI USA, V105, P3438, DOI 10.1073/pnas.0705467105; Vendola K, 1999, BIOL REPROD, V61, P353, DOI 10.1095/biolreprod61.2.353; WERTHER GA, 1989, J NEUROENDOCRINOL, V1, P369, DOI 10.1111/j.1365-2826.1989.tb00131.x; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0; Yang J, 2005, EXP GERONTOL, V40, P867, DOI 10.1016/j.exger.2005.08.001	54	30	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14983	14990		10.1074/jbc.M110.188540	http://dx.doi.org/10.1074/jbc.M110.188540			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21330367	Green Published, hybrid			2022-12-27	WOS:000289788300028
J	Wu, HX; Suzuki, T; Carey, B; Trapnell, BC; McCormack, FX				Wu, Huixing; Suzuki, Takuji; Carey, Brenna; Trapnell, Bruce C.; McCormack, Francis X.			Keratinocyte Growth Factor Augments Pulmonary Innate Immunity through Epithelium-driven, GM-CSF-dependent Paracrine Activation of Alveolar Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; INDUCED LUNG INJURY; SURFACTANT PROTEIN-A; II CELLS; PSEUDOMONAS-AERUGINOSA; GENE-EXPRESSION; DEFICIENT MICE; HOST-DEFENSE; RATS; PHAGOCYTOSIS	Keratinocyte growth factor (KGF) is an epithelial mitogen that has been reported to protect the lungs from a variety of insults. In this study, we tested the hypothesis that KGF augments pulmonary host defense. We found that a single dose of intrapulmonary KGF enhanced the clearance of Escherichia coli or Pseudomonas aeruginosa instilled into the lungs 24 h later. KGF augmented the recruitment, phagocytic activity, and oxidant responses of alveolar macrophages, including lipopolysaccharide-stimulated nitric oxide release and zymosan-induced superoxide production. Less robust alveolar macrophage recruitment and activation was observed in mice treated with intraperitoneal KGF. KGF treatment was associated with increased levels of MIP1 gamma, LIX, VCAM, IGFBP-6, and GM-CSF in the bronchoalveolar lavage fluid. Of these, only GM-CSF recapitulated in vitro the macrophage activation phenotype seen in the KGF-treated animals. The KGF-stimulated increase in GM-CSF levels in lung tissue and alveolar lining fluid arose from the epithelium, peaked within 1 h, and was associated with STAT5 phosphorylation in alveolar macrophages, consistent with epithelium-driven paracrine activation of macrophage signaling through the KGF receptor/GM-CSF/GM-CSF receptor/JAK-STAT axis. Enhanced bacterial clearance did not occur in response to KGF administration in GM-CSF-/- mice, or in mice treated with a neutralizing antibody to GM-CSF. We conclude that KGF enhances alveolar host defense through GM-CSF-stimulated macrophage activation. KGF administration may constitute a promising therapeutic strategy to augment innate immune defenses in refractory pulmonary infections.	[Wu, Huixing; McCormack, Francis X.] Univ Cincinnati, Childrens Hosp Med Ctr, Div Pulm & Crit Care Med, Dept Internal Med, Cincinnati, OH 45267 USA; [Suzuki, Takuji; Carey, Brenna; Trapnell, Bruce C.] Univ Cincinnati, Childrens Hosp Med Ctr, Div Pulm Biol, Dept Pediat, Cincinnati, OH 45267 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	McCormack, FX (corresponding author), POB 670564, Cincinnati, OH 45267 USA.	frank.mccormack@uc.edu	McCormack, Francis X./ABE-8398-2020	McCormack, Francis X./0000-0001-7168-9464	National Institutes of Health, NIAID [P01AI083222]; Department of Veteran Affairs; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI083222] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Department of Veteran Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant P01AI083222 from the NIAID (to F. X. M.) and a Veterans Affairs Merit grant from the Department of Veteran Affairs (to F. X. M.).	Anderson Robert N, 2005, Natl Vital Stat Rep, V53, P1; Ballinger MN, 2006, AM J RESP CELL MOL, V34, P766, DOI 10.1165/rcmb.2005-0246OC; Berclaz PY, 2002, BLOOD, V100, P4193, DOI 10.1182/blood-2002-04-1102; BRAUCHLE M, 1994, ONCOGENE, V9, P3199; Chang YS, 2006, AM J RESP CELL MOL, V35, P268, DOI 10.1165/rcmb.2006-0037OC; Chang YS, 2005, J LIPID RES, V46, P2624, DOI 10.1194/jlr.M500154-JLR200; Charafeddine L, 1999, AM J PHYSIOL-LUNG C, V276, pL105, DOI 10.1152/ajplung.1999.276.1.L105; CHEDID M, 1994, J BIOL CHEM, V269, P10753; Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933; DEFRANCIS CJ, 2005, NATL HOSP DISCHARGE; Deterding RR, 1997, P ASSOC AM PHYSICIAN, V109, P254; DRANOFF G, 1994, SCIENCE, V264, P713, DOI 10.1126/science.8171324; Erdag G, 2004, MOL THER, V10, P76, DOI 10.1016/j.ymthe.2004.04.013; Fehrenbach H, 2000, HISTOCHEM CELL BIOL, V114, P49; Franco-Montoya ML, 2009, AM J PHYSIOL-LUNG C, V297, pL965, DOI 10.1152/ajplung.00136.2009; Grenier A, 2002, BLOOD, V99, P2997, DOI 10.1182/blood.V99.8.2997; Kuzmenko AI, 2005, J BIOL CHEM, V280, P25913, DOI 10.1074/jbc.M411344200; LeVine AM, 1999, J CLIN INVEST, V103, P563, DOI 10.1172/JCI5212; Li CL, 2001, DEV DYNAM, V222, P471, DOI 10.1002/dvdy.1205; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; MANZKEINKE H, 1992, EUR J CELL BIOL, V57, P95; Mason RJ, 2003, J CLIN INVEST, V112, P244, DOI 10.1172/JCI200316793; Mason RJ, 2002, CHEST, V121, p77S, DOI 10.1378/chest.121.3_suppl.77S; Metcalf D, 1999, BLOOD, V93, P1579, DOI 10.1182/blood.V93.5.1579.405k01_1579_1585; Miceli R, 1999, J PHARMACOL EXP THER, V290, P464; Paine R, 2000, J IMMUNOL, V164, P2602, DOI 10.4049/jimmunol.164.5.2602; PANOS RJ, 1995, J CLIN INVEST, V96, P2026, DOI 10.1172/JCI118250; PETERS K, 1994, EMBO J, V13, P3296, DOI 10.1002/j.1460-2075.1994.tb06631.x; RUBIN JS, 1989, P NATL ACAD SCI USA, V86, P802, DOI 10.1073/pnas.86.3.802; Saeed FA, 1998, CLIN DIAGN LAB IMMUN, V5, P740, DOI 10.1128/CDLI.5.5.740-743.1998; Sanaie AR, 2002, J PERIODONTAL RES, V37, P66, DOI 10.1034/j.1600-0765.2002.t01-1-90770.x; Spielberger R, 2004, NEW ENGL J MED, V351, P2590, DOI 10.1056/NEJMoa040125; STANLEY E, 1994, P NATL ACAD SCI USA, V91, P5592, DOI 10.1073/pnas.91.12.5592; Takeoka M, 1997, AM J PHYSIOL-LUNG C, V272, pL1174, DOI 10.1152/ajplung.1997.272.6.L1174; Trapnell BC, 2002, ANNU REV PHYSIOL, V64, P775, DOI 10.1146/annurev.physiol.64.090601.113847; Viget NB, 2000, AM J PHYSIOL-LUNG C, V279, pL1199, DOI 10.1152/ajplung.2000.279.6.L1199; Whitsett JA, 2002, J CLIN INVEST, V109, P565, DOI 10.1172/JCI200215209; Wu HX, 2003, J CLIN INVEST, V111, P1589, DOI 10.1172/JCI200316889; Yano T, 1996, AM J RESP CELL MOL, V15, P433, DOI 10.1165/ajrcmb.15.4.8879176; Yi ES, 1996, AM J PATHOL, V149, P1963; Young LR, 2006, J IMMUNOL, V176, P4361, DOI 10.4049/jimmunol.176.7.4361	41	22	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14932	14940		10.1074/jbc.M110.182170	http://dx.doi.org/10.1074/jbc.M110.182170			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21343299	Green Published, hybrid			2022-12-27	WOS:000289788300023
J	Mant, A; Elliott, D; Eyers, PA; O'Kelly, IM				Mant, Alexandra; Elliott, David; Eyers, Patrick A.; O'Kelly, Ita M.			Protein Kinase A Is Central for Forward Transport of Two-pore Domain Potassium Channels K(2P)3.1 and K(2P)9.1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL S6 KINASE; K+ CHANNEL; BINDING; TASK-1; EXPRESSION; RSK; PHOSPHORYLATION; ANESTHETICS; SEQUENCE; SUBUNIT	Acid-sensitive two-pore domain potassium channels (K(2P)3.1 and K(2P)9.1) play key roles in both physiological and pathophysiological mechanisms, the most fundamental of which is control of resting membrane potential of cells in which they are expressed. These background "leak" channels are constitutively active once expressed at the plasma membrane, and hence tight control of their targeting and surface expression is fundamental to the regulation of K+ flux and cell excitability. The chaperone protein, 14-3-3, binds to a critical phosphorylated serine in the channel C termini of K(2P)3.1 and K(2P)9.1 (Ser(393) and Ser(373), respectively) and overcomes retention in the endoplasmic reticulum by beta COP. We sought to identify the kinase responsible for phosphorylation of the terminal serine in human and rat variants of K(2P)3.1 and K(2P)9.1. Adopting a bioinformatic approach, three candidate protein kinases were identified: cAMP-dependent protein kinase, ribosomal S6 kinase, and protein kinase C. In vitro phosphorylation assays were utilized to determine the ability of the candidate kinases to phosphorylate the channel C termini. Electrophysiological measurements of human K(2P)3.1 transiently expressed in HEK293 cells and cell surface assays of GFP-tagged K(2P)3.1 and K(2P)9.1 enabled the determination of the functional implications of phosphorylation by specific kinases. All of our findings support the conclusion that cAMP-dependent protein kinase is responsible for the phosphorylation of the terminal serine in both K(2P)3.1 and K(2P)9.1.	[Mant, Alexandra; O'Kelly, Ita M.] Univ Southampton, Southampton Gen Hosp, Div Human Genet, Ctr Human Dev Stem Cells & Regenerat, Southampton SO16 6YD, Hants, England; [Elliott, David] Univ Leeds, Inst Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; [Eyers, Patrick A.] Univ Sheffield, Inst Canc Studies, Sheffield S10 2RX, S Yorkshire, England	University of Southampton; University of Leeds; University of Sheffield	O'Kelly, IM (corresponding author), Univ Southampton, Southampton Gen Hosp, Div Human Genet, Ctr Human Dev Stem Cells & Regenerat, Duthie Bldg,Mail Point 808,Tremona Rd, Southampton SO16 6YD, Hants, England.	I.M.O'Kelly@southampton.ac.uk		Mant, Alexandra/0000-0001-7169-209X	Biotechnology and Biological Sciences Research Council [BB/E014453/2]; Biotechnology and Biological Sciences Research Council [BB/E014453/1] Funding Source: researchfish; Medical Research Council [G120/1030] Funding Source: researchfish; BBSRC [BB/E014453/1, BB/E014453/2] Funding Source: UKRI; MRC [G120/1030] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by Biotechnology and Biological Sciences Research Council Award BB/E014453/2 (to I.M.O.).	ALCORTA DA, 1989, MOL CELL BIOL, V9, P3850, DOI 10.1128/MCB.9.9.3850; Bayliss DA, 2008, TRENDS PHARMACOL SCI, V29, P566, DOI 10.1016/j.tips.2008.07.013; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Buckler KJ, 2000, J PHYSIOL-LONDON, V525, P135, DOI 10.1111/j.1469-7793.2000.00135.x; Coblitz B, 2006, FEBS LETT, V580, P1531, DOI 10.1016/j.febslet.2006.02.014; Czirjak G, 2000, MOL ENDOCRINOL, V14, P863, DOI 10.1210/me.14.6.863; Czirjak G, 2008, J BIOL CHEM, V283, P15672, DOI 10.1074/jbc.M800712200; Duprat F, 2007, TRENDS NEUROSCI, V30, P573, DOI 10.1016/j.tins.2007.08.003; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Gao XL, 2010, J BIOL CHEM, V285, P6970, DOI 10.1074/jbc.M109.083642; Girard C, 2002, EMBO J, V21, P4439, DOI 10.1093/emboj/cdf469; Kindler CH, 1999, ANESTHESIOLOGY, V90, P1092, DOI 10.1097/00000542-199904000-00024; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Lopes CMB, 2000, J BIOL CHEM, V275, P16969, DOI 10.1074/jbc.M001948200; Lu Z, 2008, CIRC RES, V103, P269, DOI 10.1161/CIRCRESAHA.107.166678; Medhurst AD, 2001, MOL BRAIN RES, V86, P101, DOI 10.1016/S0169-328X(00)00263-1; MOLLER DE, 1994, AM J PHYSIOL, V266, pC351, DOI 10.1152/ajpcell.1994.266.2.C351; Mrowiec T, 2006, BIOL CHEM, V387, P1227, DOI 10.1515/BC.2006.152; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; O'Kelly I, 2008, TRAFFIC, V9, P72, DOI 10.1111/j.1600-0854.2007.00663.x; Patel AJ, 1999, NAT NEUROSCI, V2, P422, DOI 10.1038/8084; Paul G, 2009, GENOMICS, V94, P287, DOI 10.1016/j.ygeno.2009.07.004; Rajan S, 2002, J PHYSIOL-LONDON, V545, P13, DOI 10.1113/jphysiol.2002.027052; Roberts NA, 2005, BRIT J PHARMACOL, V145, P477, DOI 10.1038/sj.bjp.0706210; Smith JA, 2005, CANCER RES, V65, P1027; Talley EM, 2000, NEURON, V25, P399, DOI 10.1016/S0896-6273(00)80903-4; Veale EL, 2007, MOL PHARMACOL, V71, P1666, DOI 10.1124/mol.106.033241; Zuzarte M, 2009, J PHYSIOL-LONDON, V587, P929, DOI 10.1113/jphysiol.2008.164756	29	18	18	4	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14110	14119		10.1074/jbc.M110.190702	http://dx.doi.org/10.1074/jbc.M110.190702			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21357689	Green Published, hybrid			2022-12-27	WOS:000289556200034
J	Nurmohamed, S; Vincent, HA; Titman, CM; Chandran, V; Pears, MR; Du, DJ; Griffin, JL; Callaghan, AJ; Luisi, BF				Nurmohamed, Salima; Vincent, Helen A.; Titman, Christopher M.; Chandran, Vidya; Pears, Michael R.; Du, Dijun; Griffin, Julian L.; Callaghan, Anastasia J.; Luisi, Ben F.			Polynucleotide Phosphorylase Activity May Be Modulated by Metabolites in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA DEGRADOSOME; MESSENGER-RNA; SALMONELLA-ENTERICA; GLYCOLYTIC-ENZYMES; RIBONUCLEASE-II; DECAY; VIRULENCE; RECONSTITUTION; MITOCHONDRIA; DEGRADATION	RNA turnover is an essential element of cellular homeostasis and response to environmental change. Whether the ribonucleases that mediate RNA turnover can respond to cellular metabolic status is an unresolved question. Here we present evidence that the Krebs cycle metabolite citrate affects the activity of Escherichia coli polynucleotide phosphorylase (PNPase) and, conversely, that cellular metabolism is affected widely by PNPase activity. An E. coli strain that requires PNPase for viability has suppressed growth in the presence of increased citrate concentration. Transcriptome analysis reveals a PNPase-mediated response to citrate, and PNPase deletion broadly impacts on the metabolome. In vitro, citrate directly binds and modulates PNPase activity, as predicted by crystallographic data. Binding of metal-chelated citrate in the active site at physiological concentrations appears to inhibit enzyme activity. However, metal-free citrate is bound at a vestigial active site, where it stimulates PNPase activity. Mutagenesis data confirmed a potential role of this vestigial site as an allosteric binding pocket that recognizes metal-free citrate. Collectively, these findings suggest that RNA degradative pathways communicate with central metabolism. This communication appears to be part of a feedback network that may contribute to global regulation of metabolism and cellular energy efficiency.	[Vincent, Helen A.; Callaghan, Anastasia J.] Univ Portsmouth, Inst Biomed & Biomol Sci, Sch Biol Sci, Biophys Lab, Portsmouth PO1 2DY, Hants, England; [Nurmohamed, Salima; Titman, Christopher M.; Chandran, Vidya; Pears, Michael R.; Du, Dijun; Griffin, Julian L.; Luisi, Ben F.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	University of Portsmouth; University of Cambridge	Callaghan, AJ (corresponding author), Univ Portsmouth, Inst Biomed & Biomol Sci, Sch Biol Sci, Biophys Lab, Portsmouth PO1 2DY, Hants, England.	Anastasia.Callaghan@port.ac.uk; bfl20@mole.bio.cam.ac.uk	Titman, Christopher M/M-2223-2013; Vincent, Helen/GZK-3422-2022	Titman, Christopher M/0000-0001-8698-8352; Darbari, Vidya/0000-0002-3387-5108	Wellcome Trust; Royal Society	Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London)	This work was supported by the Wellcome Trust (to B. F. L.) and Royal Society (to J.L.G. and A.J.C.).	Andrade JM, 2008, RNA, V14, P543, DOI 10.1261/rna.683308; Atherton HJ, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.18; Awano N, 2008, J BACTERIOL, V190, P5924, DOI 10.1128/JB.00500-08; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Bernstein JA, 2004, P NATL ACAD SCI USA, V101, P2758, DOI 10.1073/pnas.0308747101; Callaghan AJ, 2005, NATURE, V437, P1187, DOI 10.1038/nature04084; Callaghan AJ, 2004, J MOL BIOL, V340, P965, DOI 10.1016/j.jmb.2004.05.046; Carpousis AJ, 2007, ANNU REV MICROBIOL, V61, P71, DOI 10.1146/annurev.micro.61.080706.093440; Chandran V, 2006, J MOL BIOL, V358, P8, DOI 10.1016/j.jmb.2006.02.012; Cheng ZF, 2003, P NATL ACAD SCI USA, V100, P6388, DOI 10.1073/pnas.1231041100; Cheng ZF, 1998, J BIOL CHEM, V273, P14077, DOI 10.1074/jbc.273.23.14077; Clements MO, 2002, P NATL ACAD SCI USA, V99, P8784, DOI 10.1073/pnas.132047099; Commichau FM, 2009, MOL CELL PROTEOMICS, V8, P1350, DOI 10.1074/mcp.M800546-MCP200; Daran-Lapujade P, 2007, P NATL ACAD SCI USA, V104, P15753, DOI 10.1073/pnas.0707476104; Del Favero M, 2008, J BIOL CHEM, V283, P27355, DOI 10.1074/jbc.C800113200; Deutscher MP, 2006, NUCLEIC ACIDS RES, V34, P659, DOI 10.1093/nar/gkj472; DONOVAN WP, 1983, NUCLEIC ACIDS RES, V11, P265, DOI 10.1093/nar/11.2.265; DONOVAN WP, 1986, P NATL ACAD SCI USA, V83, P120, DOI 10.1073/pnas.83.1.120; Erce MA, 2009, BBA-PROTEINS PROTEOM, V1794, P1107, DOI 10.1016/j.bbapap.2009.03.016; Gatewood ML, 2010, J BACTERIOL, V192, P4275, DOI 10.1128/JB.00367-10; Hardiman T, 2007, J BIOTECHNOL, V132, P359, DOI 10.1016/j.jbiotec.2007.08.029; Hardwick SW, 2011, NUCLEIC ACIDS RES, V39, P1449, DOI 10.1093/nar/gkq928; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; Khemici V, 2004, MOL MICROBIOL, V54, P1422, DOI 10.1111/j.1365-2958.2004.04361.x; Khemici V, 2008, MOL MICROBIOL, V70, P799, DOI 10.1111/j.1365-2958.2008.06454.x; Le Belle JE, 2002, NMR BIOMED, V15, P37, DOI 10.1002/nbm.740; Leroy A, 2002, MOL MICROBIOL, V45, P1231, DOI 10.1046/j.1365-2958.2002.03104.x; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Lopez PJ, 1999, MOL MICROBIOL, V33, P188, DOI 10.1046/j.1365-2958.1999.01465.x; Marcaida MJ, 2006, TRENDS BIOCHEM SCI, V31, P359, DOI 10.1016/j.tibs.2006.05.005; Mohanty BK, 2006, NUCLEIC ACIDS RES, V34, P5695, DOI 10.1093/nar/gkl684; Mohanty BK, 2000, P NATL ACAD SCI USA, V97, P11966, DOI 10.1073/pnas.220295997; Mohanty BK, 2003, MOL MICROBIOL, V50, P645, DOI 10.1046/j.1365-2958.2003.03724.x; Morita T, 2004, MOL MICROBIOL, V54, P1063, DOI 10.1111/j.1365-2958.2004.04329.x; Nurmohamed S, 2009, J MOL BIOL, V389, P17, DOI 10.1016/j.jmb.2009.03.051; Pears MR, 2005, J BIOL CHEM, V280, P42508, DOI 10.1074/jbc.M507380200; Py B, 1996, NATURE, V381, P169, DOI 10.1038/381169a0; Schmid M, 2008, TRENDS BIOCHEM SCI, V33, P501, DOI 10.1016/j.tibs.2008.07.003; Schuster G, 2009, PROG MOL BIOL TRANSL, V85, P393, DOI 10.1016/S0079-6603(08)00810-6; Siculella L, 2010, MOL MICROBIOL, V77, P716, DOI 10.1111/j.1365-2958.2010.07240.x; Slornovic S, 2008, BBA-GENE REGUL MECH, V1779, P247, DOI 10.1016/j.bbagrm.2007.12.004; Stickney LM, 2005, J BACTERIOL, V187, P7214, DOI 10.1128/JB.187.21.7214-7221.2005; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Symmons MF, 2002, TRENDS BIOCHEM SCI, V27, P11, DOI 10.1016/S0968-0004(01)01999-5; Symmons MF, 2000, STRUCTURE, V8, P1215, DOI 10.1016/S0969-2126(00)00521-9; TUCKERMAN JR, 2011, J MOL BIOL IN PRESS; Viegas SC, 2007, NUCLEIC ACIDS RES, V35, P7651, DOI 10.1093/nar/gkm916; Wang G, 2010, CELL, V142, P456, DOI 10.1016/j.cell.2010.06.035; Worrall JAR, 2008, J MOL BIOL, V382, P870, DOI 10.1016/j.jmb.2008.07.059; Yang J, 2008, J BACTERIOL, V190, P3774, DOI 10.1128/JB.00147-08; Ygberg SE, 2006, INFECT IMMUN, V74, P1243, DOI 10.1128/IAI.74.2.1243-1254.2006	51	45	47	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14315	14323		10.1074/jbc.M110.200741	http://dx.doi.org/10.1074/jbc.M110.200741			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21324911	Green Published, hybrid			2022-12-27	WOS:000289556200054
J	Liu, Q; Siloto, RMP; Snyder, CL; Weselake, RJ				Liu, Qin; Siloto, Rodrigo M. P.; Snyder, Crystal L.; Weselake, Randall J.			Functional and Topological Analysis of Yeast Acyl-CoA:Diacylglycerol Acyltransferase 2, an Endoplasmic Reticulum Enzyme Essential for Triacylglycerol Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE PROTEIN TOPOLOGY; DIACYLGLYCEROL ACYLTRANSFERASE; MEMBRANE-PROTEINS; CHEMICAL-MODIFICATION; HEPATIC STEATOSIS; DGAT2; MICE; IDENTIFICATION; COA; SUPERFAMILY	Acyl-CoA:diacylglycerol acyltransferase (EC 2.3.1.20) is a membrane protein present mainly in the endoplasmic reticulum. It catalyzes the final and committed step in the biosynthesis of triacylglycerol, which is the principal repository of fatty acids for energy utilization and membrane formation. 'Iwo distinct family members of acyl-CoA:diacylglycerol acyltransferase, known as DGAT1 and DGAT2, have been characterized in different organisms, including mammals, fungi, and plants. In this study, we characterized the functional role and topological orientation of signature motifs in yeast (Saccharomyces cerevisiae) DGAT2 using mutagenesis in conjunction with chemical modification. Our data provide evidence that both the N and C termini are oriented toward the cytosol and have different catalytic roles. A highly conserved motif, (YFP131)-Y-129, and a hydrophilic segment exclusive to yeast DGAT2 reside in a long endoplasmic reticulum luminal loop following the first transmembrane domain and play an essential role in enzyme catalysis. In addition, the strongly conserved His(195) within the motif HPHG, which may play a role in the active site of DGAT2, is likely embedded in the membrane. These results indicate some similarities to the topology model of murine DGAT2 but also reveal striking differences suggesting that the topological organization of DGAT2 is not ubiquitously conserved.	[Weselake, Randall J.] Univ Alberta, Agr Lipid Biotechnol Program, Dept Agr Food & Nutr Sci, Agr Forestry Ctr 4 10, Edmonton, AB T6G 2P5, Canada	University of Alberta	Weselake, RJ (corresponding author), Univ Alberta, Agr Lipid Biotechnol Program, Dept Agr Food & Nutr Sci, Agr Forestry Ctr 4 10, Edmonton, AB T6G 2P5, Canada.	randall.weselake@ualberta.ca			Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs Program; Canada Foundation for Innovation; University of Alberta	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs Program(Canada Research Chairs); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); University of Alberta(University of Alberta)	This work was supported by Natural Sciences and Engineering Research Council of Canada, the Canada Research Chairs Program, the Canada Foundation for Innovation, and the University of Alberta.	Arai M, 2004, NUCLEIC ACIDS RES, V32, pW390, DOI 10.1093/nar/gkh380; Bogdanov M, 2005, METHODS, V36, P148, DOI 10.1016/j.ymeth.2004.11.002; Choi CS, 2007, J BIOL CHEM, V282, P22678, DOI 10.1074/jbc.M704213200; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Gilstring CF, 2000, J BIOL CHEM, V275, P31488, DOI 10.1074/jbc.M005047200; Guo ZY, 2005, J BIOL CHEM, V280, P37814, DOI 10.1074/jbc.M508384200; Han GS, 2004, J BIOL CHEM, V279, P53707, DOI 10.1074/jbc.M410014200; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Hofmann K., 1993, BIOL CHEM H-S, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kroon JTM, 2006, PHYTOCHEMISTRY, V67, P2541, DOI 10.1016/j.phytochem.2006.09.020; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LITTLE D, 1994, BIOCHEM J, V304, P951, DOI 10.1042/bj3040951; Liu Q, 2010, BIOCHEMISTRY-US, V49, P3237, DOI 10.1021/bi9020499; Liu Y, 2008, BBA-MOL CELL BIOL L, V1781, P97, DOI 10.1016/j.bbalip.2008.01.001; Lu JL, 2001, BIOCHEMISTRY-US, V40, P13288, DOI 10.1021/bi0107647; Lung SC, 2006, LIPIDS, V41, P1073, DOI 10.1007/s11745-006-5057-y; McFie PJ, 2010, J BIOL CHEM, V285, P37377, DOI 10.1074/jbc.M110.163691; NORMINGTON K, 1989, CELL, V57, P1223, DOI 10.1016/0092-8674(89)90059-7; Persson B, 2006, STRUCTURAL GENOMICS, P5; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Shockey JM, 2006, PLANT CELL, V18, P2294, DOI 10.1105/tpc.106.043695; Siloto RMP, 2009, LIPIDS, V44, P963, DOI 10.1007/s11745-009-3336-0; Siloto RMP, 2009, PLANT PHYSIOL BIOCH, V47, P456, DOI 10.1016/j.plaphy.2008.12.019; Snyder CL, 2009, NEW BIOTECHNOL, V26, P11, DOI 10.1016/j.nbt.2009.05.005; Stone SJ, 2009, J BIOL CHEM, V284, P5352, DOI 10.1074/jbc.M805768200; Stone SJ, 2006, J BIOL CHEM, V281, P40273, DOI 10.1074/jbc.M607986200; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Tamura N, 2001, J BIOL CHEM, V276, P20330, DOI 10.1074/jbc.M007993200; Turkish AR, 2005, J BIOL CHEM, V280, P14755, DOI 10.1074/jbc.M500025200; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; van Geest M, 2000, MICROBIOL MOL BIOL R, V64, P13, DOI 10.1128/MMBR.64.1.13-33.2000; Van Horn WD, 2009, SCIENCE, V324, P1726, DOI 10.1126/science.1171716; Wakimoto K, 2003, BIOCHEM BIOPH RES CO, V310, P296, DOI 10.1016/j.bbrc.2003.09.015; Wang Y, 2008, J BIOL CHEM, V283, P20696, DOI 10.1074/jbc.M803258200; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Yu XX, 2005, HEPATOLOGY, V42, P362, DOI 10.1002/hep.20783; Yuan Z, 2004, J COMPUT CHEM, V25, P632, DOI 10.1002/jcc.10411	41	72	80	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13115	13126		10.1074/jbc.M110.204412	http://dx.doi.org/10.1074/jbc.M110.204412			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21321129	Green Published, hybrid			2022-12-27	WOS:000289282200032
J	Xiong, L; Darwanto, A; Sharma, S; Herring, J; Hu, SY; Filippova, M; Filippov, V; Wang, YS; Chen, CS; Duerksen-Hughes, PJ; Sowers, LC; Zhang, KL				Xiong, Lei; Darwanto, Agus; Sharma, Seema; Herring, Jason; Hu, Shaoyan; Filippova, Maria; Filippov, Valery; Wang, Yinsheng; Chen, Chien-Shing; Duerksen-Hughes, Penelope J.; Sowers, Lawrence C.; Zhang, Kangling			Mass Spectrometric Studies on Epigenetic Interaction Networks in Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; MINICHROMOSOME MAINTENANCE PROTEIN; DNA-REPLICATION; HISTONE H2B; PAF1 COMPLEX; FATTY-ACID; HELICASE ACTIVITY; MAMMALIAN-CELLS; ADIPOSE-TISSUE; CANCER-CELLS	Arrest of cell differentiation is one of the leading causes of leukemia and other cancers. Induction of cell differentiation using pharmaceutical agents has been clinically attempted for the treatment of these cancers. Epigenetic regulation may be one of the underlying molecular mechanisms controlling cell proliferation or differentiation. Here, we report on the use of proteomics-based differential protein expression analysis in conjunction with quantification of histone modifications to decipher the interconnections among epigenetic modifications, their modifying enzymes or mediators, and changes in the associated pathways/networks that occur during cell differentiation. During phorbol-12-myristate 13-acetate-induced differentiation of U937 cells, fatty acid synthesis and its metabolic processing, the clathrin-coated pit endocytosis pathway, and the ubiquitin/26 S proteasome degradation pathways were up-regulated. In addition, global histone H3/H4 acetylation and H2B ubiquitination were down-regulated concomitantly with impaired chromatin remodeling machinery, RNA polymerase II complexes, and DNA replication. Differential protein expression analysis established the networks linking histone hypoacetylation to the down-regulated expression/activity of p300 and linking histone H2B ubiquitination to the RNA polymerase II-associated FACT-RTF1-PAF1 complex. Collectively, our approach has provided an unprecedentedly systemic set of insights into the role of epigenetic regulation in leukemia cell differentiation.	[Darwanto, Agus; Herring, Jason; Filippova, Maria; Filippov, Valery; Duerksen-Hughes, Penelope J.; Sowers, Lawrence C.; Zhang, Kangling] Loma Linda Univ, Sch Med, Dept Basic Sci, Loma Linda, CA 92350 USA; [Hu, Shaoyan; Chen, Chien-Shing] Loma Linda Univ, Sch Med, Div Med Oncol Hematol, Loma Linda, CA 92350 USA; [Xiong, Lei; Wang, Yinsheng] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA; [Sharma, Seema] Thermo Fisher Sci, Life Sci Mass Spectrometry, San Jose, CA 95134 USA	Loma Linda University; Loma Linda University; University of California System; University of California Riverside; Thermo Fisher Scientific	Zhang, KL (corresponding author), Loma Linda Univ, Sch Med, Dept Biochem, Loma Linda, CA 92350 USA.	kzhang@llu.edu	Sharma, Seema/GZL-2109-2022	Duerksen-Hughes, Penelope/0000-0002-0998-2157	National Institutes of Health [R01 DK082779, R01 CA84487, 1S10RR027643-01]; NATIONAL CANCER INSTITUTE [R01CA084487] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082779] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK082779 (to Y. W.), R01 CA84487 (to L. C. S.), and 1S10RR027643-01 (to K. Z.).	Adachi S, 2005, NUCLEIC ACIDS RES, V33, P3200, DOI 10.1093/nar/gki637; Agarwal MK, 2007, CANCER RES, V67, P116, DOI 10.1158/0008-5472.CAN-06-2835; Ait-Si-Ali S, 2000, ONCOGENE, V19, P2430, DOI 10.1038/sj.onc.1203562; Barman HK, 2008, BIOCHEM BIOPH RES CO, V373, P624, DOI 10.1016/j.bbrc.2008.06.100; Bluml S, 2009, BLOOD, V114, P5481, DOI 10.1182/blood-2008-11-191429; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Bourbon NA, 2001, AM J PHYSIOL-CELL PH, V280, pC1403, DOI 10.1152/ajpcell.2001.280.6.C1403; Brouillard F, 2003, J BIOL CHEM, V278, P39509, DOI 10.1074/jbc.M307123200; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Chmura SJ, 1996, CANCER RES, V56, P2711; CHONG JPJ, 1995, NATURE, V375, P418, DOI 10.1038/375418a0; Chong JPJ, 2000, P NATL ACAD SCI USA, V97, P1530, DOI 10.1073/pnas.030539597; Clarke DL, 2008, J IMMUNOL, V181, P3503, DOI 10.4049/jimmunol.181.5.3503; Collins N, 2002, NAT GENET, V32, P627, DOI 10.1038/ng1046; Darwanto A, 2010, J BIOL CHEM, V285, P21868, DOI 10.1074/jbc.M110.126813; Dasgupta U, 2009, P NATL ACAD SCI USA, V106, P20063, DOI 10.1073/pnas.0911028106; Donaldson JG, 2000, CURR OPIN CELL BIOL, V12, P475, DOI 10.1016/S0955-0674(00)00119-8; Dreyling MH, 1996, P NATL ACAD SCI USA, V93, P4804, DOI 10.1073/pnas.93.10.4804; Ecker J, 2010, P NATL ACAD SCI USA, V107, P7817, DOI 10.1073/pnas.0912059107; Falbo KB, 2009, MOL CELLS, V28, P149, DOI 10.1007/s10059-009-0127-7; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Follows GA, 2003, EMBO J, V22, P2798, DOI 10.1093/emboj/cdg250; HATTORI T, 1983, J CLIN INVEST, V72, P237, DOI 10.1172/JCI110962; Herring JL, 2009, CHEM RES TOXICOL, V22, P1060, DOI 10.1021/tx900027w; Horwitz GA, 2008, SCIENCE, V321, P1084, DOI 10.1126/science.1155544; HOUSEY GM, 1988, CELL, V52, P343, DOI 10.1016/S0092-8674(88)80027-8; Jin YT, 2004, J BIOL CHEM, V279, P20035, DOI 10.1074/jbc.M309916200; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kolak M, 2007, DIABETES, V56, P1960, DOI 10.2337/db07-0111; Kristjuhan A, 2002, MOL CELL, V10, P925, DOI 10.1016/S1097-2765(02)00647-0; Lee JK, 2001, P NATL ACAD SCI USA, V98, P54, DOI 10.1073/pnas.98.1.54; Lee JY, 1996, J BIOL CHEM, V271, P13169, DOI 10.1074/jbc.271.22.13169; Lee JY, 2003, J LEUKOCYTE BIOL, V73, P862, DOI 10.1189/jlb.1202618; Liu B, 2009, J BIOL CHEM, V284, P32288, DOI 10.1074/jbc.M109.045856; Makowski AM, 2001, J BIOL CHEM, V276, P43499, DOI 10.1074/jbc.C100549200; Mashek DG, 2006, J BIOL CHEM, V281, P945, DOI 10.1074/jbc.M507646200; Meyerholz A, 2005, TRAFFIC, V6, P1225, DOI 10.1111/j.1600-0854.2005.00355.x; Ng HH, 2003, J BIOL CHEM, V278, P33625, DOI 10.1074/jbc.C300270200; Nordick K, 2008, EUKARYOT CELL, V7, P1158, DOI 10.1128/EC.00434-07; Olefsky JM, 2008, CELL, V134, P914, DOI 10.1016/j.cell.2008.09.001; Olsen JV, 2009, MOL CELL PROTEOMICS, V8, P2759, DOI 10.1074/mcp.M900375-MCP200; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Planque Nathalie, 2006, Cell Commun Signal, V4, P7, DOI 10.1186/1478-811X-4-7; Plutzky J, 2009, NAT MED, V15, P618, DOI 10.1038/nm0609-618; Poizat C, 2000, MOL CELL BIOL, V20, P8643, DOI 10.1128/MCB.20.23.8643-8654.2000; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Rivenbark AG, 2007, SCIENCE, V318, P403, DOI 10.1126/science.1150321; Sandhoff K, 1998, ANN NY ACAD SCI, V845, P139, DOI 10.1111/j.1749-6632.1998.tb09667.x; Second TP, 2009, ANAL CHEM, V81, P7757, DOI 10.1021/ac901278y; Selth LA, 2010, ANNU REV BIOCHEM, V79, P271, DOI 10.1146/annurev.biochem.78.062807.091425; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Singh RP, 2009, CELL TRANSPLANT, V18, P1197, DOI 10.3727/096368909X12483162197204; Stopka T, 2000, LEUKEMIA, V14, P1247, DOI 10.1038/sj.leu.2401807; Takeda DY, 2005, ONCOGENE, V24, P2827, DOI 10.1038/sj.onc.1208616; Tasaki T, 2005, MOL CELL BIOL, V25, P7120, DOI 10.1128/MCB.25.16.7120-7136.2005; Tebar F, 1999, MOL BIOL CELL, V10, P2687, DOI 10.1091/mbc.10.8.2687; Wang N, 2010, ANAL CHEM, V82, P2262, DOI 10.1021/ac9023022; Warner MH, 2007, MOL CELL BIOL, V27, P6103, DOI 10.1128/MCB.00772-07; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; You ZY, 2008, J BIOL CHEM, V283, P24469, DOI 10.1074/jbc.M803212200; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025; Ziboh VA, 2000, AM J CLIN NUTR, V71, p361S, DOI 10.1093/ajcn/71.1.361s	63	22	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13657	13668		10.1074/jbc.M110.204800	http://dx.doi.org/10.1074/jbc.M110.204800			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21335548	hybrid, Green Published			2022-12-27	WOS:000289282200084
J	Xu, Y; Song, S; Moeller, A; Kim, N; Piao, S; Sim, SH; Kang, M; Yu, W; Cho, HS; Chang, I; Lee, K; Ha, NC				Xu, Yongbin; Song, Saemee; Moeller, Arne; Kim, Nahee; Piao, Shunfu; Sim, Se-Hoon; Kang, Mooseok; Yu, Wookyung; Cho, Hyun-Soo; Chang, Iksoo; Lee, Kangseok; Ha, Nam-Chul			Functional Implications of an Intermeshing Cogwheel-like Interaction between TolC and MacA in the Action of Macrolide-specific Efflux Pump MacAB-TolC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-FUSION PROTEIN; MULTIDRUG EFFLUX; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; PERIPLASMIC COMPONENT; ATPASE ACTIVITY; BACTERIAL; TRANSPORTER; RECONSTITUTION; MICROSCOPY	Macrolide-specific efflux pump MacAB-TolC has been identified in diverse Gram-negative bacteria including Escherichia coli. The inner membrane transporter MacB requires the outer membrane factor TolC and the periplasmic adaptor protein MacA to form a functional tripartite complex. In this study, we used a chimeric protein containing the tip region of the TolC a-barrel to investigate the role of the TolC alpha-barrel tip region with regard to its interaction with MacA. The chimeric protein formed a stable complex with MacA, and the complex formation was abolished by substitution at the functionally essential residues located at the MacA alpha-helical tip region. Electron microscopic study delineated that this complex was made by tip-to-tip interaction between the tip regions of the alpha-barrels of TolC and MacA, which correlated well with the TolC and MacA complex calculated by molecular dynamics. Taken together, our results demonstrate that the MacA hexamer interacts with TolC in a tip-to-tip manner, and implies the manner by which MacA induces opening of the TolC channel.	[Song, Saemee; Sim, Se-Hoon; Lee, Kangseok] Chung Ang Univ, Dept Life Sci, Program BK21, Res Ctr Biomol & Biosyst, Seoul 156756, South Korea; [Xu, Yongbin; Piao, Shunfu; Ha, Nam-Chul] Pusan Natl Univ, Res Inst Drug Dev, Dept Mfg Pharm, Pusan 609735, South Korea; [Moeller, Arne] Scripps Res Inst, La Jolla, CA 92037 USA; [Kim, Nahee; Cho, Hyun-Soo] Yonsei Univ, Coll Sci, Dept Biol, Seoul 120749, South Korea; [Kang, Mooseok; Yu, Wookyung; Chang, Iksoo] Pusan Natl Univ, Dept Phys, Ctr Proteome Biophys, Pusan 609735, South Korea	Chung Ang University; Pusan National University; Scripps Research Institute; Yonsei University; Pusan National University	Lee, K (corresponding author), Chung Ang Univ, Dept Life Sci, Program BK21, Res Ctr Biomol & Biosyst, Seoul 156756, South Korea.	kangseok@cau.ac.kr; hnc@pusan.ac.kr		Moeller, Arne/0000-0003-1101-5366; Yu, Wookyung/0000-0001-9835-930X	Korea Research Foundation [NRF-2010-0015298]; 21C Frontier Microbial Genomics and Application Center Program; Joint Center for Innovation in Membrane Protein Production for Structure Determination [RFA-RM-08-019]; Ministry of Education, Science & Technology, Republic of Korea [2008-0061984]; National Institutes of Health through the National Center for Research Resources [RR17573]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM073197] Funding Source: NIH RePORTER	Korea Research Foundation(National Research Foundation of Korea); 21C Frontier Microbial Genomics and Application Center Program(Ministry of Education, Science & Technology (MEST), Republic of Korea); Joint Center for Innovation in Membrane Protein Production for Structure Determination; Ministry of Education, Science & Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Institutes of Health through the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grants from the Korea Research Foundation (NRF-2010-0015298) (to N.-C. H.), and the 21C Frontier Microbial Genomics and Application Center Program (to K. L). This work was also supported by the Joint Center for Innovation in Membrane Protein Production for Structure Determination (Grant RFA-RM-08-019) (to A. M.), and the National Creative Research Initiatives (Center for Proteome Biophysics, Grant No. 2008-0061984) (to I. C.) from the Ministry of Education, Science & Technology, Republic of Korea.; We thank Erica Jacovetty for assistance with EM data collection. EM imaging was performed at the National Resource for Automated Molecular Microscopy, which is supported by the National Institutes of Health through the National Center for Research Resources P41 program (RR17573).	Akama H, 2004, J BIOL CHEM, V279, P25939, DOI 10.1074/jbc.C400164200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bavro VN, 2008, MOL CELL, V30, P114, DOI 10.1016/j.molcel.2008.02.015; DeLano WL, 2002, PYMOL USERS MANUAL; Fralick JA, 1996, J BACTERIOL, V178, P5803, DOI 10.1128/jb.178.19.5803-5805.1996; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Higgins MK, 2004, P NATL ACAD SCI USA, V101, P9994, DOI 10.1073/pnas.0400375101; Hirakata Y, 2002, J EXP MED, V196, P109, DOI 10.1084/jem.20020005; Kobayashi N, 2003, FEBS LETT, V546, P241, DOI 10.1016/S0014-5793(03)00579-9; Kobayashi N, 2001, J BACTERIOL, V183, P5639, DOI 10.1128/JB.183.19.5639-5644.2001; Koronakis V, 2004, ANNU REV BIOCHEM, V73, P467, DOI 10.1146/annurev.biochem.73.011303.074104; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Lewis K, 2000, CURR BIOL, V10, pR678, DOI 10.1016/S0960-9822(00)00682-5; Lin HT, 2009, J BIOL CHEM, V284, P1145, DOI 10.1074/jbc.M806964200; Lobedanz S, 2007, P NATL ACAD SCI USA, V104, P4612, DOI 10.1073/pnas.0610160104; Mikolosko J, 2006, STRUCTURE, V14, P577, DOI 10.1016/j.str.2005.11.015; Roseman AM, 2003, ULTRAMICROSCOPY, V94, P225, DOI 10.1016/S0304-3991(02)00333-9; Scheres SHW, 2005, J MOL BIOL, V348, P139, DOI 10.1016/j.jmb.2005.02.031; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Symmons MF, 2009, P NATL ACAD SCI USA, V106, P7173, DOI 10.1073/pnas.0900693106; Thanabalu T, 1998, EMBO J, V17, P6487, DOI 10.1093/emboj/17.22.6487; Tikhonova EB, 2007, MOL MICROBIOL, V63, P895, DOI 10.1111/j.1365-2958.2006.05549.x; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Xu YB, 2010, BIOCHEM BIOPH RES CO, V394, P962, DOI 10.1016/j.bbrc.2010.03.097; Yum SW, 2009, J MOL BIOL, V387, P1286, DOI 10.1016/j.jmb.2009.02.048; Zgurskaya HI, 2009, BBA-PROTEINS PROTEOM, V1794, P794, DOI 10.1016/j.bbapap.2008.10.010; Zgurskaya HI, 1999, P NATL ACAD SCI USA, V96, P7190, DOI 10.1073/pnas.96.13.7190	29	45	47	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13541	13549		10.1074/jbc.M110.202598	http://dx.doi.org/10.1074/jbc.M110.202598			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21325274	Green Published			2022-12-27	WOS:000289282200074
J	Pham, L; Kaiser, B; Romsa, A; Schwarz, T; Gopalakrishnan, R; Jensen, ED; Mansky, KC				Lan Pham; Kaiser, Bria; Romsa, Amanda; Schwarz, Toni; Gopalakrishnan, Raj; Jensen, Eric D.; Mansky, Kim C.			HDAC3 and HDAC7 Have Opposite Effects on Osteoclast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROPHTHALMIA TRANSCRIPTION FACTOR; HISTONE DEACETYLASE INHIBITORS; OSTEOBLAST DIFFERENTIATION; TRICHOSTATIN-A; FACTOR FAMILY; P38 MAPK; C-FOS; MITF; RUNX2; TARGET	Histone deacetylases (HDACs) are negative regulators of transcription. Endochondral bone formation including chondrocyte and osteoblast maturation is regulated by HDACs. Very little is known about the role HDACs play in osteoclast differentiation. It has been previously reported that HDAC inhibitors, trichostatin A and sodium butyrate, suppress osteoclast differentiation through multiple mechanisms. In this study, we report that suppression of HDAC3 expression similar to HDAC inhibitors inhibits osteoclast differentiation, whereas osteoclasts suppressed for HDAC7 expression had accelerated differentiation when compared with control cells. Mitf, a transcription factor, is necessary for osteoclast differentiation. We demonstrate that Mitf and HDAC7 interact in RAW 264 cells and osteoclasts. The transcriptional activity of Mitf is repressed by HDAC7. Lastly, we show that either the amino or the carboxyl terminus of HDAC7 is sufficient for transcriptional repression and that the repression of HDAC7 is insensitive to trichostatin A, indicating that HDAC7 represses Mitf at least in part by deacetylation-independent mechanism.	[Gopalakrishnan, Raj; Jensen, Eric D.] Univ Minnesota, Sch Dent, Dept Diagnost & Biol Sci, Minneapolis, MN 55455 USA; [Lan Pham; Kaiser, Bria; Romsa, Amanda; Schwarz, Toni; Mansky, Kim C.] Univ Minnesota, Sch Dent, Dept Dev & Surg Sci, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Jensen, ED (corresponding author), Univ Minnesota, Sch Dent, Dept Diagnost & Biol Sci, 16-108B Moos Tower,515 Delaware St SE, Minneapolis, MN 55455 USA.	jens0709@umn.edu; kmansky@umn.edu		Mansky, Kim/0000-0002-2826-5030; Schwarz, Toni/0000-0001-8694-2282	National Institutes of Health [R03 DE020117, R01 AR056642]; NIDCR [T32 DE007288]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE020117, T32DE007288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R03 DE020117 (to E. D. J.) and R01 AR056642 (to R. G.) and MinnCResT Grant T32 DE007288 from the NIDCR (to L. P.).	Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Bronisz A, 2006, MOL BIOL CELL, V17, P3897, DOI 10.1091/mbc.E06-05-0470; Dressel U, 2001, J BIOL CHEM, V276, P17007, DOI 10.1074/jbc.M101508200; Drummond DC, 2005, ANNU REV PHARMACOL, V45, P495, DOI 10.1146/annurev.pharmtox.45.120403.095825; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Fischle W, 2001, J BIOL CHEM, V276, P35826, DOI 10.1074/jbc.M104935200; Gottesfeld JM, 2009, FUTUR NEUROL, V4, P775, DOI 10.2217/FNL.09.55; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Halili MA, 2009, CURR TOP MED CHEM, V9, P309, DOI 10.2174/156802609788085250; Hayashi M, 2007, J CELL SCI, V120, P1350, DOI 10.1242/jcs.000067; HEMESATH TJ, 1994, GENE DEV, V8, P2770, DOI 10.1101/gad.8.22.2770; Hershey CL, 2004, BONE, V34, P689, DOI 10.1016/j.bone.2003.08.014; Hu R, 2007, MOL CELL BIOL, V27, P4018, DOI 10.1128/MCB.01839-06; Jensen ED, 2008, J BONE MINER RES, V23, P361, DOI 10.1359/JBMR.071104; Jeon EJ, 2006, J BIOL CHEM, V281, P16502, DOI 10.1074/jbc.M512494200; Kang JS, 2005, EMBO J, V24, P2543, DOI 10.1038/sj.emboj.7600729; Kao HY, 2000, GENE DEV, V14, P55; Kim HN, 2009, EUR J PHARMACOL, V623, P22, DOI 10.1016/j.ejphar.2009.09.025; Kim K, 2007, J IMMUNOL, V178, P5588, DOI 10.4049/jimmunol.178.9.5588; Lee HW, 2006, MOL ENDOCRINOL, V20, P2432, DOI 10.1210/me.2006-0061; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Mansky KC, 2002, J BIOL CHEM, V277, P11077, DOI 10.1074/jbc.M111696200; Mansky KC, 2002, J LEUKOCYTE BIOL, V71, P295; Matsuo K, 2000, NAT GENET, V24, P184, DOI 10.1038/72855; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Meadows NA, 2007, J BIOL CHEM, V282, P1891, DOI 10.1074/jbc.M608572200; Rahman MM, 2003, BLOOD, V101, P3451, DOI 10.1182/blood-2002-08-2622; Razidlo DF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011492; Routy JP, 2005, LANCET, V366, P523, DOI 10.1016/S0140-6736(05)67074-2; Schroeder TM, 2004, J BIOL CHEM, V279, P41998, DOI 10.1074/jbc.M403702200; Sengupta N, 2004, J CELL BIOCHEM, V93, P57, DOI 10.1002/jcb.20179; Sharma SM, 2007, J BIOL CHEM, V282, P15921, DOI 10.1074/jbc.M609723200; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Steingrimsson E, 2002, P NATL ACAD SCI USA, V99, P4477, DOI 10.1073/pnas.072071099; STEINGRIMSSON E, 1994, NAT GENET, V8, P256, DOI 10.1038/ng1194-256; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Tan JH, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-5; Vestergaard P, 2004, EPILEPSIA, V45, P1330, DOI 10.1111/j.0013-9580.2004.18804.x; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Weilbaecher KN, 2001, MOL CELL, V8, P749, DOI 10.1016/S1097-2765(01)00360-4; Westendorf JJ, 2006, J CELL BIOCHEM, V98, P54, DOI 10.1002/jcb.20805; Westendorf JJ, 2002, MOL CELL BIOL, V22, P7982, DOI 10.1128/MCB.22.22.7982-7992.2002; Yi T, 2007, EXP MOL MED, V39, P213, DOI 10.1038/emm.2007.24	45	63	65	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.216853	http://dx.doi.org/10.1074/jbc.M110.216853			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21324898	Green Published, hybrid			2022-12-27	WOS:000289077500020
J	Lim, S; Strahl, T; Thorner, J; Ames, JB				Lim, Sunghyuk; Strahl, Thomas; Thorner, Jeremy; Ames, James B.			Structure of a Ca2+-Myristoyl Switch Protein That Controls Activation of a Phosphatidylinositol 4-Kinase in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL CALCIUM SENSOR-1; PHOTORECEPTOR GUANYLYL CYCLASE; DOMINANT CONE DYSTROPHY; CRYSTAL-STRUCTURE; SACCHAROMYCES-CEREVISIAE; 3-DIMENSIONAL STRUCTURE; MOLECULAR-STRUCTURE; BOVINE NEUROCALCIN; BINDING PROPERTIES; RHODOPSIN KINASE	Neuronal calcium sensor (NCS) proteins transduce Ca2+ signals and are highly conserved from yeast to humans. We determined NMR structures of the NCS-1 homolog from fission yeast (Ncs1), which activates a phosphatidylinositol 4-kinase. Ncs1 contains an alpha-NH2-linked myristoyl group on a long N-terminal arm and four EF-hand motifs, three of which bind Ca2+, assembled into a compact structure. In Ca2+-free Ncs1, the N-terminal arm positions the fatty acyl chain inside a cavity near the C terminus. The C14 end of the myristate is surrounded by residues in the protein core, whereas its amide-linked (C1) end is flanked by residues at the protein surface. In Ca2+-bound Ncs1, the myristoyl group is extruded (Ca2+-myristoyl switch), exposing a prominent patch of hydrophobic residues that specifically contact phosphatidylinositol 4-kinase. The location of the buried myristate and structure of Ca2+-free Ncs1 are quite different from those in other NCS proteins. Thus, a unique remodeling of each NCS protein by its myristoyl group, and Ca2+-dependent unmasking of different residues, may explain how each family member recognizes distinct target proteins.	[Lim, Sunghyuk; Ames, James B.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Strahl, Thomas; Thorner, Jeremy] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94025 USA	University of California System; University of California Davis; University of California System; University of California Berkeley	Ames, JB (corresponding author), Univ Calif Davis, Dept Chem, 1 Shields Ave, Davis, CA 95616 USA.	ames@chem.ucdavis.edu	Strahl, Thomas/E-4315-2010; THORNER, Jeremy/O-6132-2019	THORNER, Jeremy/0000-0002-2583-500X	National Institutes of Health [EY012347]; NATIONAL EYE INSTITUTE [R01EY012347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021841] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant EY012347 (to J. B. A.).	Ames JB, 2006, J BIOL CHEM, V281, P37237, DOI 10.1074/jbc.M606913200; Ames JB, 2000, METHOD ENZYMOL, V316, P121; Ames JB, 2000, BIOCHEMISTRY-US, V39, P12149, DOI 10.1021/bi0012890; Ames JB, 2002, BIOCHEMISTRY-US, V41, P5776, DOI 10.1021/bi012153k; Ames JB, 1999, J BIOL CHEM, V274, P19329, DOI 10.1074/jbc.274.27.19329; Ames JB, 1996, CURR OPIN STRUC BIOL, V6, P432, DOI 10.1016/S0959-440X(96)80106-0; Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; BABU YS, 1988, J MOL BIOL, V204, P191, DOI 10.1016/0022-2836(88)90608-0; Badger J, 1999, PROTEINS, V35, P25, DOI 10.1002/(SICI)1097-0134(19990401)35:1<25::AID-PROT3>3.3.CO;2-M; Bourne Y, 2001, J BIOL CHEM, V276, P11949, DOI 10.1074/jbc.M009373200; Braunewell KH, 2009, CELL TISSUE RES, V335, P301, DOI 10.1007/s00441-008-0716-3; Braunewell KH, 1999, CELL TISSUE RES, V295, P1, DOI 10.1007/s004410051207; Burgoyne RD, 2004, TRENDS NEUROSCI, V27, P203, DOI 10.1016/j.tins.2004.01.010; Burgoyne RD, 2001, BIOCHEM J, V353, P1; CHEN CK, 1995, J BIOL CHEM, V270, P18060, DOI 10.1074/jbc.270.30.18060; Clore GM, 1997, NAT STRUCT BIOL, V4, P849; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DIZHOOR AM, 1995, J BIOL CHEM, V270, P25200, DOI 10.1074/jbc.270.42.25200; DIZHOOR AM, 1991, SCIENCE, V251, P915, DOI 10.1126/science.1672047; Erickson MA, 1998, P NATL ACAD SCI USA, V95, P6474, DOI 10.1073/pnas.95.11.6474; FLAHERTY KM, 1993, CELL, V75, P709, DOI 10.1016/0092-8674(93)90491-8; FLANAGAN CA, 1992, J BIOL CHEM, V267, P24117; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Gromada J, 2005, P NATL ACAD SCI USA, V102, P10303, DOI 10.1073/pnas.0504487102; Hamasaki-Katagiri N, 2004, J BIOL CHEM, V279, P12744, DOI 10.1074/jbc.M311895200; Hamasaki-Katagiri N, 2010, J BIOL CHEM, V285, P4405, DOI 10.1074/jbc.M109.058594; Hantschel O, 2003, CELL, V112, P845, DOI 10.1016/S0092-8674(03)00191-0; Hendricks KB, 1999, NAT CELL BIOL, V1, P234, DOI 10.1038/12058; HENDRICKS KB, 1999, THESIS U CALIFORNIA; HERZBERG O, 1988, J MOL BIOL, V203, P761, DOI 10.1016/0022-2836(88)90208-2; HIDAKA H, 1993, NEUROSCI RES, V16, P73, DOI 10.1016/0168-0102(93)90074-Z; Huttner IG, 2003, J BIOL CHEM, V278, P4862, DOI 10.1074/jbc.M207920200; Ikura M, 2006, P NATL ACAD SCI USA, V103, P1159, DOI 10.1073/pnas.0508640103; KAWAMURA S, 1993, NATURE, V362, P855, DOI 10.1038/362855a0; KOBAYASHI M, 1993, J BIOL CHEM, V268, P18898; LADANT D, 1995, J BIOL CHEM, V270, P3179; LEE W, 1994, FEBS LETT, V350, P87, DOI 10.1016/0014-5793(94)00740-3; Lim S, 2009, BIOMOL NMR ASSIGN, V3, P269, DOI 10.1007/s12104-009-9191-3; Lusin JD, 2008, BIOCHEMISTRY-US, V47, P2252, DOI 10.1021/bi7017267; Nahorski SR, 2003, TRENDS NEUROSCI, V26, P444, DOI 10.1016/S0166-2236(03)00178-4; O'Callaghan DW, 2004, J BIOL CHEM, V279, P14347, DOI 10.1074/jbc.M310152200; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; Park JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006179; Payne AM, 1998, HUM MOL GENET, V7, P273, DOI 10.1093/hmg/7.2.273; PONGS O, 1993, NEURON, V11, P15, DOI 10.1016/0896-6273(93)90267-U; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sokal I, 1998, MOL CELL, V2, P129, DOI 10.1016/S1097-2765(00)80121-5; Stephen R, 2007, STRUCTURE, V15, P1392, DOI 10.1016/j.str.2007.09.013; Stephen R, 2006, J MOL BIOL, V359, P266, DOI 10.1016/j.jmb.2006.03.042; Strahl T, 2005, J CELL BIOL, V171, P967, DOI 10.1083/jcb.200504104; Strahl T, 2003, J BIOL CHEM, V278, P49589, DOI 10.1074/jbc.M309017200; Strahl T, 2007, J BIOL CHEM, V282, P30949, DOI 10.1074/jbc.M705499200; TANAKA T, 1995, NATURE, V376, P444, DOI 10.1038/376444a0; Tang C, 2004, P NATL ACAD SCI USA, V101, P517, DOI 10.1073/pnas.0305665101; Tsujimoto T, 2002, SCIENCE, V295, P2276, DOI 10.1126/science.1068278; Tzingounis AV, 2007, NEURON, V53, P487, DOI 10.1016/j.neuron.2007.01.011; Valentine KG, 2010, STRUCTURE, V18, P9, DOI 10.1016/j.str.2009.11.010; Valentine KG, 2003, BIOCHEMISTRY-US, V42, P6333, DOI 10.1021/bi0206816; Vijay-Kumar S, 1999, NAT STRUCT BIOL, V6, P80; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758; Zhao CJ, 2009, CELL MOL NEUROBIOL, V29, P273, DOI 10.1007/s10571-008-9320-z; Zhao XH, 2001, J BIOL CHEM, V276, P40183, DOI 10.1074/jbc.M104048200; Zheng Q, 2005, J NEUROCHEM, V92, P442, DOI 10.1111/j.1471-4159.2004.02897.x; Zhou W, 2004, NEURON, V41, P573, DOI 10.1016/S0896-6273(04)00045-5; ZOZULYA S, 1992, P NATL ACAD SCI USA, V89, P11569, DOI 10.1073/pnas.89.23.11569	68	41	42	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.208868	http://dx.doi.org/10.1074/jbc.M110.208868			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21288895	Green Published, hybrid			2022-12-27	WOS:000289077500069
J	Ruprecht, J; Iwata, S; Rothery, RA; Weiner, JH; Maklashina, E; Cecchini, G				Ruprecht, Jonathan; Iwata, So; Rothery, Richard A.; Weiner, Joel H.; Maklashina, Elena; Cecchini, Gary			Perturbation of the Quinone-binding Site of Complex II Alters the Electronic Properties of the Proximal [3Fe-4S] Iron-Sulfur Cluster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI SUCCINATE-DEHYDROGENASE; ESCHERICHIA-COLI; FUMARATE REDUCTASE; UBIQUINONE OXIDOREDUCTASE; RESPIRATORY-CHAIN; MACROMOLECULAR STRUCTURES; CATALYTIC-ACTIVITY; LIGAND COMPLEXES; HEME-B; PROTEIN	Succinate-ubiquinone oxidoreductase (SQR) and menaquinol-fumarate oxidoreductase (QFR) from Escherichia coli are members of the complex II family of enzymes. SQR and QFR catalyze similar reactions with quinones; however, SQR preferentially reacts with higher potential ubiquinones, and QFR preferentially reacts with lower potential naphthoquinones. Both enzymes have a single functional quinone-binding site proximal to a [3Fe-4S] iron-sulfur cluster. A difference between SQR and QFR is that the redox potential of the [3Fe-4S] cluster in SQR is 140 mV higher than that found in QFR. This may reflect the character of the different quinones with which the two enzymes preferentially react. To investigate how the environment around the [3Fe-4S] cluster affects its redox properties and catalysis with quinones, a conserved amino acid proximal to the cluster was mutated in both enzymes. It was found that substitution of SdhB His-207 by threonine (as found in QFR) resulted in a 70-mV lowering of the redox potential of the cluster as measured by EPR. The converse substitution in QFR raised the redox potential of the cluster. X-ray structural analysis suggests that placing a charged residue near the [3Fe-4S] cluster is a primary reason for the alteration in redox potential with the hydrogen bonding environment having a lesser effect. Steady state enzyme kinetic characterization of the mutant enzymes shows that the redox properties of the [3Fe-4S] cluster have only a minor effect on catalysis.	[Maklashina, Elena; Cecchini, Gary] Vet Affairs Med Ctr, Div Mol Biol, San Francisco, CA 94121 USA; [Ruprecht, Jonathan; Iwata, So] Univ London Imperial Coll Sci Technol & Med, Membrane Prot Crystallog Grp, Mol Biosci Div, London SW7 2AZ, England; [Rothery, Richard A.; Weiner, Joel H.] Univ Alberta, Membrane Prot Res Grp, Dept Biochem, Sch Mol & Syst Med, Edmonton, AB T6G 2H7, Canada; [Maklashina, Elena; Cecchini, Gary] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Imperial College London; University of Alberta; University of California System; University of California San Francisco	Cecchini, G (corresponding author), Vet Affairs Med Ctr, Div Mol Biol, 4150 Clement St, San Francisco, CA 94121 USA.	Gary.Cecchini@ucsf.edu		Ruprecht, Jonathan/0000-0002-1838-7245; Rothery, Richard/0000-0003-3265-1783	National Institutes of Health [GM61606]; Department of Veterans Affairs, Office of Research and Development, Biomedical Laboratory Research Division; Biotechnology and Biological Sciences Research Council [B17935]; Exploratory Research for Advanced Technology (ERATO), Japan Science and Technology Agency; Canadian Institutes of Health Research [MOP89735]; Biotechnology and Biological Sciences Research Council [BB/C505116/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061606] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs, Office of Research and Development, Biomedical Laboratory Research Division; Biotechnology and Biological Sciences Research Council(US Department of Veterans AffairsUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Exploratory Research for Advanced Technology (ERATO), Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant GM61606. This work was also supported by the Department of Veterans Affairs, Office of Research and Development, Biomedical Laboratory Research Division; Biotechnology and Biological Sciences Research Council Grant B17935 with contributions from the Human Receptor Crystallography Project, Exploratory Research for Advanced Technology (ERATO), Japan Science and Technology Agency; and Canadian Institutes of Health Research Grant MOP89735.	ADMAN E, 1975, P NATL ACAD SCI USA, V72, P4854, DOI 10.1073/pnas.72.12.4854; Afonine PV, 2005, CCP4 NEWSL, V42; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; BREITER DR, 1991, J BIOL CHEM, V266, P18660; Cecchini G, 2003, ANNU REV BIOCHEM, V72, P77, DOI 10.1146/annurev.biochem.72.121801.161700; Cecchini G, 2002, BBA-BIOENERGETICS, V1553, P140, DOI 10.1016/S0005-2728(01)00238-9; Chen KS, 2002, NAT STRUCT BIOL, V9, P188, DOI 10.1038/nsb751; Cheng VWT, 2006, J BIOL CHEM, V281, P27662, DOI 10.1074/jbc.M604900200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans P. R., 1993, P CCP4 STUD WEEK DAT, P114; Evrard GX, 2007, ACTA CRYSTALLOGR D, V63, P108, DOI 10.1107/S0907444906023389; Hagerhall C, 1997, BBA-BIOENERGETICS, V1320, P107, DOI 10.1016/S0005-2728(97)00019-4; Hagerhall C, 1999, J BIOL CHEM, V274, P26157, DOI 10.1074/jbc.274.37.26157; Hastings SF, 1998, EUR J BIOCHEM, V255, P317, DOI 10.1046/j.1432-1327.1998.2550317.x; Horsefield R, 2006, J BIOL CHEM, V281, P7309, DOI 10.1074/jbc.M508173200; HOWLIN B, 1993, J APPL CRYSTALLOGR, V26, P622, DOI 10.1107/S0021889893002729; Huang LS, 2006, J BIOL CHEM, V281, P5965, DOI 10.1074/jbc.M511270200; Iverson TM, 1999, SCIENCE, V284, P1961, DOI 10.1126/science.284.5422.1961; Jang SB, 2000, BIOCHEMISTRY-US, V39, P641, DOI 10.1021/bi991694v; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kleywegt GJ, 2007, ACTA CRYSTALLOGR D, V63, P94, DOI [10.1107/S0907444906022657, 10.1107/S907444906022657]; KOWAL AT, 1995, BIOCHEMISTRY-US, V34, P12284, DOI 10.1021/bi00038a024; KURNIVKOV IV, 2006, HARLEM; Lancaster CRD, 2002, BBA-BIOENERGETICS, V1553, P1, DOI 10.1016/S0005-2728(01)00240-7; Lancaster CRD, 1999, NATURE, V402, P377, DOI 10.1038/46483; Maklashina E, 1998, J BACTERIOL, V180, P5989, DOI 10.1128/JB.180.22.5989-5996.1998; Maklashina E, 2006, J BIOL CHEM, V281, P11357, DOI 10.1074/jbc.M512544200; Maklashina E, 1999, ARCH BIOCHEM BIOPHYS, V369, P223, DOI 10.1006/abbi.1999.1359; Maklashina E, 2001, J BIOL CHEM, V276, P18968, DOI 10.1074/jbc.M011270200; Maklashina E, 2006, J BIOL CHEM, V281, P26655, DOI 10.1074/jbc.M602938200; MORNINGSTAR JE, 1985, J BIOL CHEM, V260, P3631; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OHNISHI T, 1976, J BIOL CHEM, V251, P2105; OHNISHI T, 1981, J BIOL CHEM, V256, P5577; Oyedotun KS, 2007, BBA-BIOENERGETICS, V1767, P1436, DOI 10.1016/j.bbabio.2007.09.008; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Rothery RA, 1996, BIOCHEMISTRY-US, V35, P3247, DOI 10.1021/bi951584y; Ruprecht J, 2009, J BIOL CHEM, V284, P29836, DOI 10.1074/jbc.M109.010058; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Stephens PJ, 1996, CHEM REV, V96, P2491, DOI 10.1021/cr950045w; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Tran QM, 2007, P NATL ACAD SCI USA, V104, P18007, DOI 10.1073/pnas.0707732104; Tran QM, 2006, J BIOL CHEM, V281, P32310, DOI 10.1074/jbc.M607476200; Unden G, 1997, BBA-BIOENERGETICS, V1320, P217, DOI 10.1016/S0005-2728(97)00034-0; WESTENBERG DJ, 1993, J BIOL CHEM, V268, P815; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605	50	24	24	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.209874	http://dx.doi.org/10.1074/jbc.M110.209874			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21310949	Green Published, hybrid			2022-12-27	WOS:000289077500086
J	Wu, YZ; Antony, S; Juhasz, A; Lu, JM; Ge, Y; Jiang, GJ; Roy, K; Doroshow, JH				Wu, Yongzhong; Antony, Smitha; Juhasz, Agnes; Lu, Jiamo; Ge, Yun; Jiang, Guojian; Roy, Krishnendu; Doroshow, James H.			Up-regulation and Sustained Activation of Stat1 Are Essential for Interferon-gamma (IFN-gamma)-induced Dual Oxidase 2 (Duox2) and Dual Oxidase A2 (DuoxA2) Expression in Human Pancreatic Cancer Cell Lines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY-TRACT EPITHELIUM; FAMILY NADPH OXIDASES; IFN-GAMMA; NOX FAMILY; SER-727 PHOSPHORYLATION; TYROSINE PHOSPHATASES; DUCTAL ADENOCARCINOMA; GENE-EXPRESSION; HOST-DEFENSE; TRANSCRIPTION	Dual oxidase 2 is a member of the NADPH oxidase (Nox) gene family that plays a critical role in the biosynthesis of thyroid hormone as well as in the inflammatory response of the upper airway mucosa and in wound healing, presumably through its ability to generate reactive oxygen species, including H2O2. The recently discovered overexpression of Duox2 in gastrointestinal malignancies, as well as our limited understanding of the regulation of Duox2 expression, led us to examine the effect of cytokines and growth factors on Duox2 in human tumor cells. We found that exposure of human pancreatic cancer cells to IFN-gamma (but not other agents) produced a profound up-regulation of the expression of Duox2, and its cognate maturation factor DuoxA2, but not other members of the Nox family. Furthermore, increased Duox2/DuoxA2 expression was closely associated with a significant increase in the production of both intracellular reactive oxygen species and extracellular H2O2. Examination of IFN-gamma-mediated signaling events demonstrated that in addition to the canonical Jak-Stat1 pathway, IFN-gamma activated the p38-MAPK pathway in pancreatic cancer cells, and both played an important role in the induction of Duox2 by IFN-gamma. Duox2 up-regulation following IFN-gamma exposure is also directly associated with the binding of Stat1 to elements of the Duox2 promoter. Our findings suggest that the pro-inflammatory cytokine IFN-gamma initiates a Duox2-mediated reactive oxygen cascade in human pancreatic cancer cells; reactive oxygen species production in this setting could contribute to the pathophysiologic characteristics of these tumors.	[Wu, Yongzhong; Antony, Smitha; Juhasz, Agnes; Lu, Jiamo; Ge, Yun; Jiang, Guojian; Doroshow, James H.] NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Roy, Krishnendu; Doroshow, James H.] NCI, Div Canc Treatment & Diag, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Doroshow, JH (corresponding author), NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bldg 31,Rm 3A-44,31 Ctr Dr, Bethesda, MD 20892 USA.	doroshoj@mail.nih.gov			NCI, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC011076] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by a NCI, National Institutes of Health, grant.	Alexandratou E, 2005, FREE RADICAL BIO MED, V39, P1119, DOI 10.1016/j.freeradbiomed.2005.06.006; Andrianifahanana M, 2007, ONCOGENE, V26, P7251, DOI 10.1038/sj.onc.1210532; Arbiser JL, 2002, P NATL ACAD SCI USA, V99, P715, DOI 10.1073/pnas.022630199; Arnold RS, 2001, P NATL ACAD SCI USA, V98, P5550, DOI 10.1073/pnas.101505898; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Brar SS, 2003, AM J PHYSIOL-CELL PH, V285, pC353, DOI 10.1152/ajpcell.00525.2002; Caillou B, 2001, J CLIN ENDOCR METAB, V86, P3351, DOI 10.1210/jc.86.7.3351; Chatterjee-Kishore M, 2000, EMBO J, V19, P4111, DOI 10.1093/emboj/19.15.4111; Chiera F, 2008, FREE RADICAL BIO MED, V44, P332, DOI 10.1016/j.freeradbiomed.2007.09.018; Dikalov S, 2007, HYPERTENSION, V49, P717, DOI 10.1161/01.HYP.0000258594.87211.6b; Edderkaoui M, 2005, AM J PHYSIOL-GASTR L, V289, pG1137, DOI 10.1152/ajpgi.00197.2005; El Hassani RA, 2005, AM J PHYSIOL-GASTR L, V288, pG933, DOI 10.1152/ajpgi.00198.2004; Esposito I, 2004, J CLIN PATHOL, V57, P630, DOI 10.1136/jcp.2003.014498; Farrow B, 2002, SURG ONCOL, V10, P153, DOI 10.1016/S0960-7404(02)00015-4; Fischer H, 2009, ANTIOXID REDOX SIGN, V11, P2453, DOI [10.1089/ars.2009.2558, 10.1089/ARS.2009.2558]; Gattas MV, 2009, FREE RADICAL BIO MED, V47, P1450, DOI 10.1016/j.freeradbiomed.2009.08.017; Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje; Gough DJ, 2008, CYTOKINE GROWTH F R, V19, P383, DOI 10.1016/j.cytogfr.2008.08.004; Grasberger H, 2006, J BIOL CHEM, V281, P18269, DOI 10.1074/jbc.C600095200; Greer JB, 2009, CURR OPIN PHARMACOL, V9, P411, DOI 10.1016/j.coph.2009.06.011; Ha EM, 2009, NAT IMMUNOL, V10, P949, DOI 10.1038/ni.1765; HANCOCK JT, 1987, BIOCHEM J, V242, P103, DOI 10.1042/bj2420103; Harper RW, 2006, FEBS LETT, V580, P5150, DOI 10.1016/j.febslet.2006.08.048; Harper RW, 2005, FEBS LETT, V579, P4911, DOI 10.1016/j.febslet.2005.08.002; Hill T, 2010, BIOCHEM BIOPH RES CO, V395, P270, DOI 10.1016/j.bbrc.2010.04.004; Juhasz A, 2009, FREE RADICAL RES, V43, P523, DOI 10.1080/10715760902918683; Kishimoto T, 2010, INT IMMUNOL, V22, P347, DOI 10.1093/intimm/dxq030; Kita H, 2006, J GASTROENTEROL, V41, P1053, DOI 10.1007/s00535-006-1894-y; Kovarik P, 1999, P NATL ACAD SCI USA, V96, P13956, DOI 10.1073/pnas.96.24.13956; Krause KH, 2004, JPN J INFECT DIS, V57, pS28; Kumatori A, 2002, J BIOL CHEM, V277, P9103, DOI 10.1074/jbc.M109803200; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P319, DOI 10.1016/j.freeradbiomed.2007.03.028; Lee JK, 2007, GASTROENTEROLOGY, V133, P1637, DOI 10.1053/j.gastro.2007.08.022; Leto TL, 2006, ANTIOXID REDOX SIGN, V8, P1549, DOI 10.1089/ars.2006.8.1549; Linderholm AL, 2010, AM J PHYSIOL-LUNG C, V299, pL215, DOI 10.1152/ajplung.00015.2010; Luxen S, 2008, CANCER RES, V68, P1037, DOI 10.1158/0008-5472.CAN-07-5782; Masamune A, 2008, AM J PHYSIOL-GASTR L, V294, pG99, DOI 10.1152/ajpgi.00272.2007; Matsuo Y, 2004, PANCREAS, V28, P344, DOI 10.1097/00006676-200404000-00025; Mochizuki T, 2006, ONCOGENE, V25, P3699, DOI 10.1038/sj.onc.1209406; Morand S, 2009, FASEB J, V23, P1205, DOI 10.1096/fj.08-120006; Nair JS, 2002, P NATL ACAD SCI USA, V99, P5971, DOI 10.1073/pnas.052159099; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Pandol S, 2009, CLIN GASTROENTEROL H, V7, pS44, DOI 10.1016/j.cgh.2009.07.039; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Ramsauer K, 2002, P NATL ACAD SCI USA, V99, P12859, DOI 10.1073/pnas.192264999; Saha B, 2010, CYTOKINE, V50, P1, DOI 10.1016/j.cyto.2009.11.021; Ushio-Fukai M, 2008, CANCER LETT, V266, P37, DOI 10.1016/j.canlet.2008.02.044; Valledor AF, 2008, J IMMUNOL, V180, P4523, DOI 10.4049/jimmunol.180.7.4523; Vaquero EC, 2004, J BIOL CHEM, V279, P34643, DOI 10.1074/jbc.M400078200; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Xia C, 2007, CANCER RES, V67, P10823, DOI 10.1158/0008-5472.CAN-07-0783; Yu JH, 2005, INT J BIOCHEM CELL B, V37, P1458, DOI 10.1016/j.biocel.2005.02.004	53	47	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.191031	http://dx.doi.org/10.1074/jbc.M110.191031			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21321110	Green Published, hybrid			2022-12-27	WOS:000289077500039
J	Chatterjee, S; Feinstein, SI; Dodia, C; Sorokina, E; Lien, YC; Nguyen, S; Debolt, K; Speicher, D; Fisher, AB				Chatterjee, Shampa; Feinstein, Sheldon I.; Dodia, Chandra; Sorokina, Elena; Lien, Yu-Chin; Su Nguyen; Debolt, Kris; Speicher, David; Fisher, Aron B.			Peroxiredoxin 6 Phosphorylation and Subsequent Phospholipase A(2) Activity Are Required for Agonist-mediated Activation of NADPH Oxidase in Mouse Pulmonary Microvascular Endothelium and Alveolar Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NORMOXIC LUNG ISCHEMIA; 1-CYS PEROXIREDOXIN; HUMAN NEUTROPHILS; PROTEIN-KINASE; GLUTATHIONE-PEROXIDASE; RESPIRATORY BURST; SHEAR-STRESS; MAP KINASES; CELLS; P67(PHOX)	Peroxiredoxin 6 (Prdx6), a bifunctional enzyme with glutathione peroxidase and phospholipase A2 (PLA(2)) activities, participates in the activation of NADPH oxidase 2 (NOX2) in neutrophils, but the mechanism for this effect is not known. We now demonstrate that Prdx6 is required for agonist-induced NOX2 activation in pulmonary microvascular endothelial cells (PMVEC) and that the effect requires the PLA(2) activity of Prdx6. Generation of reactive oxygen species (ROS) in response to angiotensin II (Ang II) or phorbol 12-myristate 13-acetate was markedly reduced in perfused lungs and isolated PMVEC from Prdx6 null mice. Rac1 and p47(phox), cytosolic components of NOX2, translocated to the endothelial cell membrane after Ang II treatment in wild-type but not Prdx6 null PMVEC. MJ33, an inhibitor of Prdx6 PLA(2) activity, blocked agonist-induced PLA(2) activity and ROS generation in PMVEC by > 80%, whereas inhibitors of other PLA(2)s were ineffective. Transfection of Prx6 null cells with wild-type and C47S mutant Prdx6, but not with mutants of the PLA(2) active site (S32A, H26A, and D140A), "rescued" Ang II-induced PLA(2) activity and ROS generation. Ang II treatment of wild-type cells resulted in phosphorylation of Prdx6 and its subsequent translocation from the cytosol to the cell membrane. Phosphorylation as well as PLA(2) activity and ROS generation were markedly reduced by the MAPK inhibitor, U0126. Thus, agonist-induced MAPK activation leads to Prdx6 phosphorylation and translocation to the cell membrane, where its PLA(2) activity facilitates assembly of the NOX2 complex and activation of the oxidase.	[Fisher, Aron B.] Univ Penn, Sch Med, Inst Environm Med, Med Ctr, Philadelphia, PA 19104 USA; [Speicher, David] Wistar Inst Anat & Biol, Ctr Syst & Computat Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; The Wistar Institute	Fisher, AB (corresponding author), Univ Penn, Sch Med, Inst Environm Med, Med Ctr, 1 John Morgan Bldg,3620 Hamilton Walk, Philadelphia, PA 19104 USA.	abf@mail.med.upenn.edu	NGUYEN, SU/S-5377-2016	Lien, Yu-Chin/0000-0002-2764-1794	National Institutes of Health [HL105509]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105509] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL105509. This work was presented in part at the 2010 Experimental Biology meeting in Anaheim, CA.	ACKERMANN EJ, 1995, J BIOL CHEM, V270, P445, DOI 10.1074/jbc.270.1.445; Akiba S, 1998, COMP BIOCHEM PHYS B, V120, P393, DOI 10.1016/S0305-0491(98)10046-9; Arguinzonis MIG, 2002, J BIOL CHEM, V277, P45604, DOI 10.1074/jbc.M202873200; Bostan M, 2003, J CELL MOL MED, V7, P57, DOI 10.1111/j.1582-4934.2003.tb00203.x; Chen JW, 2000, J BIOL CHEM, V275, P28421, DOI 10.1074/jbc.M005073200; DANA R, 1994, BIOCHEM J, V297, P217, DOI 10.1042/bj2970217; Dana R, 1998, J BIOL CHEM, V273, P441, DOI 10.1074/jbc.273.1.441; DUSI S, 1994, BIOCHEM J, V304, P243, DOI 10.1042/bj3040243; Fisher AB, 2005, J LIPID RES, V46, P1248, DOI 10.1194/jlr.M400499-JLR200; Fisher AB, 1996, J LIPID RES, V37, P1057; FISHER AB, 2011, ANTIOXID RE IN PRESS; FORMAN HJ, 1980, J BIOL CHEM, V255, P9879; Frey RS, 2009, ANTIOXID REDOX SIGN, V11, P791, DOI [10.1089/ars.2008.2220, 10.1089/ARS.2008.2220]; Gijon MA, 2000, J BIOL CHEM, V275, P20146, DOI 10.1074/jbc.M908941199; Hazan I, 1997, BIOCHEM J, V326, P867, DOI 10.1042/bj3260867; Kim TS, 1998, AM J PHYSIOL-LUNG C, V274, pL750, DOI 10.1152/ajplung.1998.274.5.L750; Lambeth JD, 2002, CURR OPIN HEMATOL, V9, P11, DOI 10.1097/00062752-200201000-00003; Lassegue B, 2010, ARTERIOSCL THROM VAS, V30, P653, DOI 10.1161/ATVBAHA.108.181610; Leavey PJ, 2002, J BIOL CHEM, V277, P45181, DOI 10.1074/jbc.M202869200; Liu G, 2010, FREE RADICAL BIO MED, V49, P1172, DOI 10.1016/j.freeradbiomed.2010.07.002; LU DJ, 1993, BLOOD CELLS, V19, P343; Manevich Y, 2002, P NATL ACAD SCI USA, V99, P11599, DOI 10.1073/pnas.182384499; Manevich Y, 2007, J LIPID RES, V48, P2306, DOI 10.1194/jlr.M700299-JLR200; Manevich Y, 2009, ARCH BIOCHEM BIOPHYS, V485, P139, DOI 10.1016/j.abb.2009.02.008; Milovanova T, 2006, AM J PHYSIOL-CELL PH, V290, pC66, DOI 10.1152/ajpcell.00094.2005; Milovanova T, 2008, BBA-MOL CELL RES, V1783, P1866, DOI 10.1016/j.bbamcr.2008.05.010; Mo YQ, 2003, FEBS LETT, V555, P192, DOI 10.1016/S0014-5793(03)01199-2; O'Donnell RW, 2003, ENDOTHELIUM-J ENDOTH, V10, P291, DOI 10.1080/10623320390272280; Pendyala S, 2009, ANTIOXID REDOX SIGN, V11, P841, DOI [10.1089/ars.2008.2231, 10.1089/ARS.2008.2231]; RAO GN, 1994, BIOCHEM J, V299, P197, DOI 10.1042/bj2990197; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rubin BB, 2005, J BIOL CHEM, V280, P7519, DOI 10.1074/jbc.M407438200; Shmelzer Z, 2003, J CELL BIOL, V162, P683, DOI 10.1083/jcb.200211056; Silliman CC, 2003, J LEUKOCYTE BIOL, V73, P511, DOI 10.1189/jlb.0402179; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Torres M, 1999, ARCH BIOCHEM BIOPHYS, V366, P231, DOI 10.1006/abbi.1999.1225; Wu Y, 2009, BIOCHEM J, V419, P669, DOI 10.1042/BJ20082061; Yu G, 2007, MICROCIRCULATION, V14, P125, DOI 10.1080/10739680601131218; Zhang QW, 2008, ANTIOXID REDOX SIGN, V10, P679, DOI 10.1089/ars.2007.1521; Zhang QW, 2005, AM J PHYSIOL-LUNG C, V289, pL954, DOI 10.1152/ajplung.00210.2005; Zhao XX, 2002, J BIOL CHEM, V277, P25385, DOI 10.1074/jbc.M203630200	41	98	105	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11696	11706		10.1074/jbc.M110.206623	http://dx.doi.org/10.1074/jbc.M110.206623			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21262967	hybrid, Green Published			2022-12-27	WOS:000288797100077
J	Matsumura, S; Shinoda, K; Yamada, M; Yokojima, S; Inoue, M; Ohnishi, T; Shimada, T; Kikuchi, K; Masui, D; Hashimoto, S; Sato, M; Ito, A; Akioka, M; Takagi, S; Nakamura, Y; Nemoto, K; Hasegawa, Y; Takamoto, H; Inoue, H; Nakamura, S; Nabeshima, Y; Teplow, DB; Kinjo, M; Hoshia, M				Matsumura, Satoko; Shinoda, Keiko; Yamada, Mayumi; Yokojima, Satoshi; Inoue, Masafumi; Ohnishi, Takayuki; Shimada, Tetsuya; Kikuchi, Kazuya; Masui, Dai; Hashimoto, Shigeki; Sato, Michio; Ito, Akane; Akioka, Manami; Takagi, Shinsuke; Nakamura, Yoshihiro; Nemoto, Kiyokazu; Hasegawa, Yutaka; Takamoto, Hisayoshi; Inoue, Haruo; Nakamura, Shinichiro; Nabeshima, Yo-ichi; Teplow, David B.; Kinjo, Masataka; Hoshia, Minako			Two Distinct Amyloid beta-Protein (A beta) Assembly Pathways Leading to Oligomers and Fibrils Identified by Combined Fluorescence Correlation Spectroscopy, Morphology, and Toxicity Analyses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; INTEGRAL-EQUATIONS; AGGREGATION; POLYMERIZATION; NEUROTOXICITY; MEMORY; NEURODEGENERATION; FIBRILLOGENESIS; INTERMEDIATE; PATHOGENESIS	Nonfibrillar assemblies of amyloid beta-protein (A beta) are considered to play primary roles in Alzheimer disease (AD). Elucidating the assembly pathways of these specific aggregates is essential for understanding disease pathogenesis and developing knowledge-based therapies. However, these assemblies cannot be monitored in vivo, and there has been no reliable in vitro monitoring method at low protein concentration. We have developed a highly sensitive in vitro monitoring method using fluorescence correlation spectroscopy (FCS) combined with transmission electron microscopy (TEM) and toxicity assays. Using A beta labeled at the N terminus or Lys(16), we uncovered two distinct assembly pathways. One leads to highly toxic 10-15-nm spherical A beta assemblies, termed amylospheroids (ASPDs). The other leads to fibrils. The first step in ASPD formation is trimerization. ASPDs of similar to 330 kDa in mass form from these trimers after 5 h of slow rotation. Up to at least 24 h, ASPDs remain the dominant structures in assembly reactions. Neurotoxicity studies reveal that the most toxic ASPDs are similar to 128 kDa (similar to 32-mers). In contrast, fibrillogenesis begins with dimer formation and then proceeds to formation of 15-40-nm spherical intermediates, from which fibrils originate after 15 h. Unlike ASPD formation, the Lys(16)-labeled peptide disturbed fibril formation because the A beta(16-20) region is critical for this final step. These differences in the assembly pathways clearly indicated that ASPDs are not fibril precursors. The method we have developed should facilitate identifying A beta assembly steps at which inhibition may be beneficial.	[Matsumura, Satoko; Yamada, Mayumi; Sato, Michio; Ito, Akane; Akioka, Manami; Hoshia, Minako] Mitsubishi Kagaku Inst Life Sci, Tokyo 1948511, Japan; [Shinoda, Keiko; Yokojima, Satoshi; Nakamura, Shinichiro] Mitsubishi Chem Grp Sci & Technol Res Ctr Inc, Yokohama, Kanagawa 2278502, Japan; [Inoue, Masafumi; Ohnishi, Takayuki; Nabeshima, Yo-ichi; Hoshia, Minako] Kyoto Univ, Kyoto 6068501, Japan; [Shimada, Tetsuya; Masui, Dai; Takagi, Shinsuke; Inoue, Haruo] Tokyo Metropolitan Univ, Tokyo 1920397, Japan; [Kikuchi, Kazuya] Osaka Univ, Suita, Osaka 5650871, Japan; [Hashimoto, Shigeki] Tokyo Univ Sci, Tokyo, Hokkaido 0493514, Japan; [Nakamura, Yoshihiro] Nagoya Inst Technol, Nagoya, Aichi 4668555, Japan; [Hasegawa, Yutaka; Takamoto, Hisayoshi] Hamamatsu Photon KK, Shizuoka 4380193, Japan; [Teplow, David B.] Univ Calif Los Angeles, Los Angeles, CA 90095 USA; [Kinjo, Masataka] Hokkaido Univ, Sapporo, Hokkaido 0010021, Japan	Mitsubishi Kagaku Institute of Life Sciences (MITILS); Kyoto University; Tokyo Metropolitan University; Osaka University; Tokyo University of Science; Nagoya Institute of Technology; Hamamatsu Photonics; University of California System; University of California Los Angeles; Hokkaido University	Hoshia, M (corresponding author), Sakyo Ku, Kyoto 6068501, Japan.	minhoshi@lmls.med.kyoto-u.ac.jp	Kikuchi, Kazuya/D-2370-2009; Takagi, Shinsuke/M-7035-2013; Kinjo, Masataka/F-5267-2011	Takagi, Shinsuke/0000-0001-7013-4942; Kinjo, Masataka/0000-0001-8889-8369; Yokojima, Satoshi/0000-0002-6555-0877	Ministry of Health, Labor and Welfare; Ministry of Education, Culture, Sports, Science, and Technology; New Energy and Industrial Technology Development Organization; Alzheimer's Drug Discovery and Biomarkers; Grants-in-Aid for Scientific Research [19058001] Funding Source: KAKEN	Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Alzheimer's Drug Discovery and Biomarkers; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Health, Labor and Welfare (Research on Nanotechnical Medical) (to M. H.), Special Coordination Funds for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science, and Technology (to K. K. and M. H.), the New Energy and Industrial Technology Development Organization (Translational Research Promotion Project) (to M. H.), and the Jim Easton Consortium for Alzheimer's Drug Discovery and Biomarkers (to D. B. T.).	Ashe KH, 2001, LEARN MEMORY, V8, P301, DOI 10.1101/lm.43701; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Bark N, 1999, BIOCHEM BIOPH RES CO, V260, P35, DOI 10.1006/bbrc.1999.0850; Bernstein SL, 2009, NAT CHEM, V1, P326, DOI [10.1038/NCHEM.247, 10.1038/nchem.247]; Bitan G, 2003, J BIOL CHEM, V278, P34882, DOI 10.1074/jbc.M300825200; Bjorling S, 1998, BIOCHEMISTRY-US, V37, P12971, DOI 10.1021/bi980694c; Chen YR, 2006, J BIOL CHEM, V281, P24414, DOI 10.1074/jbc.M602363200; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Deshpande A, 2006, J NEUROSCI, V26, P6011, DOI 10.1523/JNEUROSCI.1189-06.2006; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Gosch M, 2005, ADV DRUG DELIVER REV, V57, P169, DOI 10.1016/j.addr.2004.07.016; Grant MA, 2007, P NATL ACAD SCI USA, V104, P16522, DOI 10.1073/pnas.0705197104; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hepler RW, 2006, BIOCHEMISTRY-US, V45, P15157, DOI 10.1021/bi061850f; Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LEVINE H, 1995, NEUROBIOL AGING, V16, P755, DOI 10.1016/0197-4580(95)00052-G; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; Noguchi A, 2009, J BIOL CHEM, V284, P32895, DOI 10.1074/jbc.M109.000208; O'Nuallain B, 2010, J NEUROSCI, V30, P14411, DOI 10.1523/JNEUROSCI.3537-10.2010; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; PALMER AG, 1987, BIOPHYS J, V52, P257, DOI 10.1016/S0006-3495(87)83213-7; Perrin RJ, 2009, NATURE, V461, P916, DOI 10.1038/nature08538; Pitschke M, 1998, NAT MED, V4, P832, DOI 10.1038/nm0798-832; PODLISNY MB, 1995, J BIOL CHEM, V270, P9564, DOI 10.1074/jbc.270.16.9564; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P229, DOI 10.1016/0010-4655(82)90174-6; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P213, DOI 10.1016/0010-4655(82)90173-4; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Sandberg A, 2010, P NATL ACAD SCI USA, V107, P15595, DOI 10.1073/pnas.1001740107; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Sengupta P, 2003, BIOCHEMISTRY-US, V42, P10506, DOI 10.1021/bi0341410; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; Tjernberg LO, 1999, CHEM BIOL, V6, P53, DOI 10.1016/S1074-5521(99)80020-9; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x	48	83	85	2	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11555	11562		10.1074/jbc.M110.181313	http://dx.doi.org/10.1074/jbc.M110.181313			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21292768	Green Published, hybrid			2022-12-27	WOS:000288797100065
J	Bacolla, A; Wang, GL; Jain, A; Chuzhanova, NA; Cer, RZ; Collins, JR; Cooper, DN; Bohr, VA; Vasquez, KM				Bacolla, Albino; Wang, Guliang; Jain, Aklank; Chuzhanova, Nadia A.; Cer, Regina Z.; Collins, Jack R.; Cooper, David N.; Bohr, Vilhelm A.; Vasquez, Karen M.			Non-B DNA-forming Sequences and WRN Deficiency Independently Increase the Frequency of Base Substitution in Human Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WERNER-SYNDROME PROTEIN; SYNDROME RECQ HELICASE; HUMAN DHX9 HELICASE; GENETIC INSTABILITY; IN-VIVO; ELECTRON-TRANSFER; OXIDATIVE DAMAGE; REPLICATION FORK; AQUEOUS-SOLUTION; MAMMALIAN-CELLS	Although alternative DNA secondary structures (non-B DNA) can induce genomic rearrangements, their associated mutational spectra remain largely unknown. The helicase activity of WRN, which is absent in the human progeroid Werner syndrome, is thought to counteract this genomic instability. We determined non-B DNA-induced mutation frequencies and spectra in human U2OS osteosarcoma cells and assessed the role of WRN in isogenic knockdown (WRN-KD) cells using a supF gene mutation reporter system flanked by triplex-or Z-DNA-forming sequences. Although both non-B DNA and WRN-KD served to increase the mutation frequency, the increase afforded by WRN-KD was independent of DNA structure despite the fact that purified WRN helicase was found to resolve these structures in vitro. In U2OS cells, similar to 70% of mutations comprised single-base substitutions, mostly at G.C base-pairs, with the remaining similar to 30% being microdeletions. The number of mutations at G.C base-pairs in the context of NGNN/NNCN sequences correlated well with predicted free energies of base stacking and ionization potentials, suggesting a possible origin via oxidation reactions involving electron loss and subsequent electron transfer (hole migration) between neighboring bases. A set of similar to 40,000 somatic mutations at G.C base pairs identified in a lung cancer genome exhibited similar correlations, implying that hole migration may also be involved. We conclude that alternative DNA conformations, WRN deficiency and lung tumorigenesis may all serve to increase the mutation rate by promoting, through diverse pathways, oxidation reactions that perturb the electron orbitals of neighboring bases. It follows that such "hole migration" is likely to play a much more widespread role in mutagenesis than previously anticipated.	[Bacolla, Albino; Wang, Guliang; Jain, Aklank; Vasquez, Karen M.] Univ Texas MD Anderson Canc Ctr, Div Sci Pk Res, Dept Mol Carcinogenesis, Smithville, TX 78957 USA; [Chuzhanova, Nadia A.] Nottingham Trent Univ, Sch Sci & Technol, Nottingham NG11 8NS, England; [Cer, Regina Z.; Collins, Jack R.] NCI, Adv Biomed Comp Ctr, SAIC Frederick Inc, Frederick, MD 21702 USA; [Cooper, David N.] Cardiff Univ, Sch Med, Inst Med Genet, Cardiff CF14 4XN, S Glam, Wales; [Bohr, Vilhelm A.] NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA	University of Texas System; UTMD Anderson Cancer Center; Nottingham Trent University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Cardiff University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Vasquez, KM (corresponding author), 1400 Barbara Jordan Blvd,R1800, Austin, TX 78723 USA.	karen.vasquez@austin.utexas.edu	Jain, Aklank/AAM-5067-2021; Cooper, David N/H-4384-2011; Bacolla, Albino/N-3877-2013; Bohr, Vilhelm/AAP-5931-2020; Bacolla, Albino/AAP-1727-2020	Jain, Aklank/0000-0001-5539-3225; Cooper, David N/0000-0002-8943-8484; Bacolla, Albino/0000-0003-0206-8423; Bacolla, Albino/0000-0003-0206-8423; Chuzhanova, Nadia/0000-0002-4655-3618	National Institutes of Health [CA093729, HHSN261200800001E]; National Institute of Environmental Health Sciences Center [P30ES007784]; National Institute on Aging, National Institutes of Heath; National Institutes of Health through M.D. Anderson Cancer Center [CA016672]; NATIONAL CANCER INSTITUTE [R01CA093729, P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000721] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute on Aging, National Institutes of Heath(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health through M.D. Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants CA093729 (to K. M. V.) and HHSN261200800001E (to A. B.). This work was also supported by National Institute of Environmental Health Sciences Center Grant P30ES007784, by the Intramural Program of the National Institute on Aging, National Institutes of Heath, and by the National Institutes of Health through M.D. Anderson Cancer Center Support Grant CA016672.	Bacolla A, 2004, J BIOL CHEM, V279, P47411, DOI 10.1074/jbc.R400028200; Bacolla A, 2004, P NATL ACAD SCI USA, V101, P14162, DOI 10.1073/pnas.0405974101; Bacolla A, 2001, J BIOL CHEM, V276, P18597, DOI 10.1074/jbc.M100845200; Belotserkovskii BP, 2007, J BIOL CHEM, V282, P32433, DOI 10.1074/jbc.M704618200; Bergeron F, 2010, P NATL ACAD SCI USA, V107, P5528, DOI 10.1073/pnas.1000193107; Bohr VA, 2008, TRENDS BIOCHEM SCI, V33, P609, DOI 10.1016/j.tibs.2008.09.003; Brosh RM, 2001, J BIOL CHEM, V276, P3024, DOI 10.1074/jbc.M006784200; Brosh RM, 2006, METHOD ENZYMOL, V409, P52, DOI 10.1016/S0076-6879(05)09004-X; Bukowy Z, 2008, NUCLEIC ACIDS RES, V36, P4975, DOI 10.1093/nar/gkn468; Burrows CJ, 1998, CHEM REV, V98, P1109, DOI 10.1021/cr960421s; CANDEIAS LP, 1993, J AM CHEM SOC, V115, P2437, DOI 10.1021/ja00059a044; Chakraborty P, 2010, NUCLEIC ACIDS RES, V38, P4722, DOI 10.1093/nar/gkq240; Christensen LA, 2006, CANCER RES, V66, P4089, DOI 10.1158/0008-5472.CAN-05-4288; Chuzhanova N, 2009, HUM MUTAT, V30, P1189, DOI 10.1002/humu.21020; Compton SA, 2008, J BIOL CHEM, V283, P24478, DOI 10.1074/jbc.M803370200; Constantinou A, 2000, EMBO REP, V1, P80, DOI 10.1093/embo-reports/kvd004; Cooper David N, 2010, Hum Genomics, V4, P406; Das A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703343200; Deschenes F, 2005, HUM MOL GENET, V14, P3293, DOI 10.1093/hmg/ddi362; Dhillon KK, 2007, AGING CELL, V6, P53, DOI 10.1111/j.1474-9726.2006.00260.x; Ditlevson JV, 2008, NUCLEIC ACIDS RES, V36, P3163, DOI 10.1093/nar/gkn136; FRIEDMAN RA, 1995, BIOPHYS J, V69, P1528, DOI 10.1016/S0006-3495(95)80023-8; Friedrich K, 2010, HUM GENET, V128, P103, DOI 10.1007/s00439-010-0832-5; Fry M, 1999, J BIOL CHEM, V274, P12797, DOI 10.1074/jbc.274.18.12797; FUKUCHI K, 1989, P NATL ACAD SCI USA, V86, P5893, DOI 10.1073/pnas.86.15.5893; Gajecka M, 2008, GENOME RES, V18, P1733, DOI 10.1101/gr.077453.108; Gotter AL, 2004, HUM MOL GENET, V13, P103, DOI 10.1093/hmg/ddh004; Gotter AL, 2007, GENOME RES, V17, P470, DOI 10.1101/gr.6130907; Harrigan JA, 2006, NUCLEIC ACIDS RES, V34, P745, DOI 10.1093/nar/gkj475; Huang SR, 2006, HUM MUTAT, V27, P558, DOI 10.1002/humu.20337; Inagaki H, 2009, GENOME RES, V19, P191, DOI 10.1101/gr.079244.108; Jain A, 2010, BIOCHEMISTRY-US, V49, P6992, DOI 10.1021/bi100795m; Johnson JE, 2010, NUCLEIC ACIDS RES, V38, P1114, DOI 10.1093/nar/gkp1103; Kato T, 2006, SCIENCE, V311, P971, DOI 10.1126/science.1121452; Kino K, 2005, MUTAT RES-FUND MOL M, V571, P33, DOI 10.1016/j.mrfmmm.2004.10.010; Kolb J, 2009, CHROMOSOME RES, V17, P469, DOI 10.1007/s10577-009-9039-9; KRAEMER KH, 1989, MUTAT RES, V220, P61, DOI 10.1016/0165-1110(89)90011-0; Kyng KJ, 2003, P NATL ACAD SCI USA, V100, P12259, DOI 10.1073/pnas.2130723100; Kyoizumi S, 1998, HUM GENET, V103, P405, DOI 10.1007/s004390050841; Lau SS, 1996, ADV EXP MED BIOL, V387, P267; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Lewis FD, 2008, ANGEW CHEM INT EDIT, V47, P3798, DOI 10.1002/anie.200705903; London TBC, 2008, J BIOL CHEM, V283, P36132, DOI 10.1074/jbc.M808152200; Massip L, 2010, FASEB J, V24, P158, DOI 10.1096/fj.09-137133; Mirkin EV, 2007, MICROBIOL MOL BIOL R, V71, P13, DOI 10.1128/MMBR.00030-06; Moser MJ, 2000, CANCER RES, V60, P2492; Muftuoglu M, 2008, HUM GENET, V124, P369, DOI 10.1007/s00439-008-0562-0; Nyunoya T, 2009, AM J RESP CRIT CARE, V179, P279, DOI 10.1164/rccm.200802-320OC; Ozgenc A, 2005, MUTAT RES-FUND MOL M, V577, P237, DOI 10.1016/j.mrfmmm.2005.03.020; Popuri V, 2008, J BIOL CHEM, V283, P17766, DOI 10.1074/jbc.M709749200; Prince PR, 2001, GENE DEV, V15, P933, DOI 10.1101/gad.877001; Quemener S, 2010, HUM MUTAT, V31, P421, DOI 10.1002/humu.21196; Sambrook J, 2001, MOL CLONING LAB MANU; Senthilkumar K, 2005, J AM CHEM SOC, V127, P14894, DOI 10.1021/ja054257e; Shao FW, 2005, J AM CHEM SOC, V127, P17445, DOI 10.1021/ja0563399; Sidorova JM, 2008, DNA REPAIR, V7, P1776, DOI 10.1016/j.dnarep.2008.07.017; Stamatoyannopoulos JA, 2009, NAT GENET, V41, P393, DOI 10.1038/ng.363; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Stoltzfus A, 2008, MUTAT RES-FUND MOL M, V644, P71, DOI 10.1016/j.mrfmmm.2008.05.003; Sugiyama H, 1996, J AM CHEM SOC, V118, P7063, DOI 10.1021/ja9609821; Szekely AM, 2005, MOL CELL BIOL, V25, P10492, DOI 10.1128/MCB.25.23.10492-10506.2005; Turaga RVN, 2009, CELL CYCLE, V8, P2080, DOI 10.4161/cc.8.13.8925; Ungvari Z, 2008, AGE, V30, P121, DOI 10.1007/s11357-008-9059-y; Wang GL, 2006, P NATL ACAD SCI USA, V103, P2677, DOI 10.1073/pnas.0511084103; Wang GL, 2004, P NATL ACAD SCI USA, V101, P13448, DOI 10.1073/pnas.0405116101; Wang GL, 2009, MOL CARCINOGEN, V48, P286, DOI 10.1002/mc.20508; Wang GL, 2008, JNCI-J NATL CANCER I, V100, P1815, DOI 10.1093/jnci/djn385; Wells RD, 2005, NUCLEIC ACIDS RES, V33, P3785, DOI 10.1093/nar/gki697; Wojciechowska M, 2006, J BIOL CHEM, V281, P24531, DOI 10.1074/jbc.M603888200; Yokote K, 2008, J AM GERIATR SOC, V56, P1770, DOI 10.1111/j.1532-5415.2008.01817.x	70	25	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10017	10026		10.1074/jbc.M110.176636	http://dx.doi.org/10.1074/jbc.M110.176636			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21285356	Green Published, hybrid			2022-12-27	WOS:000288547000016
J	Chen, W; Li, L; Brod, T; Saeed, O; Thabet, S; Jansen, T; Dikalov, S; Weyand, C; Goronzy, J; Harrison, DG				Chen, Wei; Li, Li; Brod, Torben; Saeed, Omar; Thabet, Salim; Jansen, Thomas; Dikalov, Sergey; Weyand, Cornelia; Goronzy, Jorg; Harrison, David G.			Role of Increased Guanosine Triphosphate Cyclohydrolase-1 Expression and Tetrahydrobiopterin Levels upon T Cell Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; SHEAR-STRESS; IFN-GAMMA; SUPEROXIDE; GENERATION; PHOSPHORYLATION; DIFFERENTIATION; BIOSYNTHESIS; MECHANISM; OXIDATION	Tetrahydrobiopterin (BH4) is an essential co-factor for the nitric-oxide (NO) synthases, and in its absence these enzymes produce superoxide (O(2)radical anion) rather than NO. The rate-limiting enzyme for BH4 production is guanosine triphosphate cyclohydrolase-1 (GTPCH-1). Because endogenously produced NO affects T cell function, we sought to determine whether antigen stimulation affected T cell GTPCH-1 expression and ultimately BH4 levels. Resting T cells had minimal expression of inducible NOS (NOS2), endothelial NOS (NOS3), and GTPCH-1 protein and nearly undetectable levels of BH4. Anti-CD3 stimulation of T cells robustly stimulated the coordinated expression of NOS2, NOS3, and GTPCH-1 and markedly increased both GTPCH-1 activity and T cell BH4 levels. The newly expressed GTPCH-1 was phosphorylated on serine 72 and pharmacological inhibition of casein kinase II reduced GTPCH-1 phosphorylation and blunted the increase in T cell BH4. Inhibition of GTPCH-1 with diaminohydroxypyrimidine (1 mmol/liter) prevented T cell BH4 accumulation, reduced NO production, and increased T cell O(2)radical anion. production, due to both NOS2 and NOS3 uncoupling. GTPCH-1 inhibition also promoted TH2 polarization in memory CD4 cells. Ovalbumin immunization of mice transgenic for an ovalbumin receptor (OT-II mice) confirmed a marked increase in T cell BH4 in vivo. These studies identify a previously unidentified consequence of T cell activation, promoting BH4 levels, NO production, and modulating T cell cytokine production.	[Chen, Wei; Li, Li; Brod, Torben; Saeed, Omar; Thabet, Salim; Jansen, Thomas; Dikalov, Sergey; Harrison, David G.] Emory Univ, Sch Med, Div Cardiol, Atlanta, GA 30322 USA; [Chen, Wei; Li, Li; Brod, Torben; Saeed, Omar; Thabet, Salim; Jansen, Thomas; Dikalov, Sergey; Harrison, David G.] Emory Univ, Sch Med, Dept Med, Atlanta, GA 30322 USA; [Weyand, Cornelia; Goronzy, Jorg] Stanford Univ, Sch Med, Div Immunol, Palo Alto, CA 94304 USA; [Weyand, Cornelia; Goronzy, Jorg] Stanford Univ, Sch Med, Dept Med, Palo Alto, CA 94304 USA; [Harrison, David G.] Atlanta Vet Affairs Med Ctr, Decatur, GA 30033 USA	Emory University; Emory University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System	Harrison, DG (corresponding author), Vanderbilt Univ, Div Clin Pharmacol, 533 Robinson Res Bldg, Nashville, TN 37232 USA.	david.g.harrison@vanderbilt.edu	Li, Li/C-8981-2011; Weyand, Cornelia/AAH-3343-2021	Chen, Wei/0000-0002-3973-340X; Goronzy, Jorg/0000-0001-7670-1856; Dikalov, Sergey/0000-0003-2976-6184	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL058000, R01HL117913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044142, R56AI044142, R01AI108906] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042527] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL117913, P01 HL058000] Funding Source: Medline; NIAID NIH HHS [R01 AI044142, R01 AI108906, R56 AI044142] Funding Source: Medline; NIAMS NIH HHS [R01 AR042527] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Benbernou N, 1997, IMMUNOLOGY, V91, P361, DOI 10.1046/j.1365-2567.1997.00260.x; Brahmachari S, 2009, J IMMUNOL, V183, P2045, DOI 10.4049/jimmunol.0800276; CAI H, 2005, METHODS MOL MED, P293; Channon KM, 2004, TRENDS CARDIOVAS MED, V14, P323, DOI 10.1016/j.tcm.2004.10.003; Collins M, 2010, J LEUKOCYTE BIOL, V87, P691, DOI 10.1189/jlb.0409227; Collins M, 2010, MOL IMMUNOL, V47, P1665, DOI 10.1016/j.molimm.2010.03.009; Dikalov S, 2007, HYPERTENSION, V49, P717, DOI 10.1161/01.HYP.0000258594.87211.6b; Duan YL, 2010, AM J RESP CELL MOL, V42, P491, DOI 10.1165/rcmb.2008-0469OC; Feuerer M, 2006, J IMMUNOL, V176, P2857, DOI 10.4049/jimmunol.176.5.2857; GAL EM, 1978, NEUROCHEM RES, V3, P69, DOI 10.1007/BF00964361; GROSS SS, 1992, J BIOL CHEM, V267, P25722; HEINZEL B, 1992, BIOCHEM J, V281, P627, DOI 10.1042/bj2810627; Ibiza S, 2008, P NATL ACAD SCI USA, V105, P10507, DOI 10.1073/pnas.0711062105; Ibiza S, 2006, IMMUNITY, V24, P753, DOI 10.1016/j.immuni.2006.04.006; Jackson SH, 2004, NAT IMMUNOL, V5, P818, DOI 10.1038/ni1096; King MR, 2006, J IMMUNOL, V176, P2765, DOI 10.4049/jimmunol.176.5.2765; Landmesser U, 2003, J CLIN INVEST, V111, P1201, DOI 10.1172/JCI200314172; Lee KC, 2010, LEUKEMIA, V24, P896, DOI 10.1038/leu.2010.11; Li L, 2010, CIRC RES, V106, P328, DOI 10.1161/CIRCRESAHA.109.210658; Miller AA, 2000, BRIT J PHARMACOL, V131, P29, DOI 10.1038/sj.bjp.0703528; Murad F, 2006, NEW ENGL J MED, V355, P2003, DOI 10.1056/NEJMsa063904; Niedbala W, 2002, P NATL ACAD SCI USA, V99, P16186, DOI 10.1073/pnas.252464599; Niedbala W, 2007, P NATL ACAD SCI USA, V104, P15478, DOI 10.1073/pnas.0703725104; Patel KB, 2002, FREE RADICAL BIO MED, V32, P203, DOI 10.1016/S0891-5849(01)00777-8; POU S, 1992, J BIOL CHEM, V267, P24173; Sarno S, 2001, FEBS LETT, V496, P44, DOI 10.1016/S0014-5793(01)02404-8; Stuehr DJ, 1997, ANNU REV PHARMACOL, V37, P339, DOI 10.1146/annurev.pharmtox.37.1.339; Tai LK, 2002, ARTERIOSCL THROM VAS, V22, P1790, DOI 10.1161/01.ATV.0000034475.40227.40; Thony B, 2000, BIOCHEM J, V347, P1, DOI 10.1042/0264-6021:3470001; Toth M, 1997, PLACENTA, V18, P189, DOI 10.1016/S0143-4004(97)90092-8; Tzima E, 2001, EMBO J, V20, P4639, DOI 10.1093/emboj/20.17.4639; Vig M, 2004, J CLIN INVEST, V113, P1734, DOI 10.1172/JCI200420225; Wei CC, 2003, CHEM REV, V103, P2365, DOI 10.1021/cr0204350; Wei CC, 2008, J BIOL CHEM, V283, P11734, DOI 10.1074/jbc.M709250200; Wever RMF, 1997, BIOCHEM BIOPH RES CO, V237, P340, DOI 10.1006/bbrc.1997.7069; Widder JD, 2007, CIRC RES, V101, P830, DOI 10.1161/CIRCRESAHA.107.153809; Yoneyama T, 1998, J BIOL CHEM, V273, P20102, DOI 10.1074/jbc.273.32.20102; Zhu YQ, 2005, J AM CHEM SOC, V127, P858, DOI 10.1021/ja0445645	39	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					13846	13851		10.1074/jbc.M110.191023	http://dx.doi.org/10.1074/jbc.M110.191023			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21343293	hybrid, Green Published			2022-12-27	WOS:000289556200007
J	Hammerstein, AF; Jayasinghe, L; Bayley, H				Hammerstein, Anne F.; Jayasinghe, Lakmal; Bayley, Hagan			Subunit Dimers of alpha-Hemolysin Expand the Engineering Toolbox for Protein Nanopores	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BICOMPONENT TOXIN; PORE; CHANNEL; FORMS; CYCLODEXTRIN; RECEPTORS; ADAPTER; LUMEN	Staphylococcal alpha-hemolysin (alpha HL) forms a heptameric pore that features a 14-stranded transmembrane beta-barrel. We attempted to force the alpha HL pore to adopt novel stoichiometries by oligomerizing subunit dimers generated by in vitro transcription and translation of a tandem gene. However, in vitro transcription and translation also produced truncated proteins, monomers, that were preferentially incorporated into oligomers. These oligomers were shown to be functional heptamers by single-channel recording and had a similar mobility to wild-type heptamers in SDS-polyacrylamide gels. Purified full-length subunit dimers were then prepared by using His-tagged protein. Again, single-channel recording showed that oligomers made from these dimers are functional heptamers, implying that one or more subunits are excluded from the central pore. Therefore, the alpha HL pore resists all structures except those that possess seven subunits immediately surrounding the central axis. Although we were not able to change the stoichiometry of the central pore of alpha HL by the concatenation of subunits, we extended our findings to prepare pores containing one subunit dimer and five monomers and purified them by SDS-PAGE. Two half-chelating ligands were then installed at adjacent sites, one on each subunit of the dimer. Single-channel recording showed that pores formed from this construct formed complexes with divalent metal ions in a similar fashion to pores containing two half-chelating ligands on the same subunit, confirming that the oligomers had assembled with seven subunits around the central lumen. The ability to incorporate subunit dimers into alpha HL pores increases the range of structures that can be obtained from engineered protein nanopores.	[Hammerstein, Anne F.; Jayasinghe, Lakmal; Bayley, Hagan] Univ Oxford, Dept Chem, Oxford OX1 3TA, England	University of Oxford	Bayley, H (corresponding author), Univ Oxford, Dept Chem, Oxford OX1 3TA, England.	hagan.bayley@chem.ox.ac.uk		Bayley, Hagan/0000-0003-2499-6116	Medical Research Council; Medical Research Council [G0300122] Funding Source: researchfish; MRC [G0300122] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council.	Banerjee A, 2010, P NATL ACAD SCI USA, V107, P8165, DOI 10.1073/pnas.0914229107; Baumann SW, 2002, J BIOL CHEM, V277, P46020, DOI 10.1074/jbc.M207663200; Bayley H, 2001, NATURE, V413, P226, DOI 10.1038/35093038; Bayley H, 2004, MOL MEMBR BIOL, V21, P209, DOI 10.1080/09687680410001716853; Bayley Hagan, 2008, V12, P251; Bayley H, 2008, MOL BIOSYST, V4, P1191, DOI 10.1039/b808893d; Braha O, 1997, CHEM BIOL, V4, P497, DOI 10.1016/S1074-5521(97)90321-5; Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Cheley S, 1997, PROTEIN ENG, V10, P1433, DOI 10.1093/protein/10.12.1433; Czajkowsky DM, 1998, J MOL BIOL, V276, P325, DOI 10.1006/jmbi.1997.1535; DE S, 2011, P NATL ACAD IN PRESS; Deamer DW, 2002, ACCOUNTS CHEM RES, V35, P817, DOI 10.1021/ar000138m; Eroglu A, 2000, NAT BIOTECHNOL, V18, P163, DOI 10.1038/72608; Folgering JHA, 2005, PROTEIN SCI, V14, P2947, DOI 10.1110/ps.051679005; FREUND C, 1993, FEBS LETT, V320, P97, DOI 10.1016/0014-5793(93)80070-B; GOUAUX JE, 1994, P NATL ACAD SCI USA, V91, P12828, DOI 10.1073/pnas.91.26.12828; Gu LQ, 2001, J GEN PHYSIOL, V118, P481, DOI 10.1085/jgp.118.5.481; Hammerstein AF, 2010, ANGEW CHEM INT EDIT, V49, P5085, DOI 10.1002/anie.200906601; Howorka S, 1998, BIOTECHNIQUES, V25, P764, DOI 10.2144/98255bm03; Howorka S, 2009, CHEM SOC REV, V38, P2360, DOI 10.1039/b813796j; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; Jayasinghe L, 2006, J BIOL CHEM, V281, P2195, DOI 10.1074/jbc.M510841200; Jayasinghe L, 2005, PROTEIN SCI, V14, P2550, DOI 10.1110/ps.051648505; Kintzer AF, 2010, J MOL BIOL, V399, P741, DOI 10.1016/j.jmb.2010.04.041; Kintzer AF, 2009, J MOL BIOL, V392, P614, DOI 10.1016/j.jmb.2009.07.037; Maglia G, 2009, NAT NANOTECHNOL, V4, P437, DOI [10.1038/NNANO.2009.121, 10.1038/nnano.2009.121]; Majd S, 2010, CURR OPIN BIOTECH, V21, P439, DOI 10.1016/j.copbio.2010.05.002; Miles G, 2002, PROTEIN SCI, V11, P1813, DOI 10.1110/ps.0204002; Miles G, 2002, PROTEIN SCI, V11, P894, DOI 10.1110/ps.4360102; Miles G, 2001, BIOCHEMISTRY-US, V40, P8514, DOI 10.1021/bi010454o; Minier F, 2004, TRENDS PHARMACOL SCI, V25, P499, DOI 10.1016/j.tips.2004.07.005; Movileanu L, 2001, J GEN PHYSIOL, V117, P239, DOI 10.1085/jgp.117.3.239; Nicke A, 2003, MOL PHARMACOL, V63, P243, DOI 10.1124/mol.63.1.243; Panchal RG, 1996, NAT BIOTECHNOL, V14, P852, DOI 10.1038/nbt0796-852; RICHARD EA, 1990, SCIENCE, V247, P1208, DOI 10.1126/science.2156338; Sack JT, 2008, J GEN PHYSIOL, V131, P415, DOI 10.1085/jgp.200709939; Shin SH, 2007, ANGEW CHEM INT EDIT, V46, P7412, DOI 10.1002/anie.200700736; Siwy ZS, 2010, CHEM SOC REV, V39, P1115, DOI 10.1039/b909105j; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; WALKER B, 1995, CHEM BIOL, V2, P99, DOI 10.1016/1074-5521(95)90282-1; Wu HC, 2007, J AM CHEM SOC, V129, P16142, DOI 10.1021/ja0761840; Zhou Y, 2003, J NEUROSCI, V23, P9004	42	17	33	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14324	14334		10.1074/jbc.M111.218164	http://dx.doi.org/10.1074/jbc.M111.218164			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21324910	Green Published, hybrid			2022-12-27	WOS:000289556200055
J	Shen, Q; Bai, YC; Chang, KCN; Wang, YJ; Burris, TP; Freedman, LP; Thompson, CC; Nagpal, S				Shen, Qi; Bai, Yuchen; Chang, Ken C. N.; Wang, Yongjun; Burris, Thomas P.; Freedman, Leonard P.; Thompson, Catherine C.; Nagpal, Sunil			Liver X Receptor-Retinoid X Receptor (LXR-RXR) Heterodimer Cistrome Reveals Coordination of LXR and AP1 Signaling in Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDYLARGININE DEIMINASE; ATOPIC-DERMATITIS; EPIDERMAL DIFFERENTIATION; TRANSCRIPTION FACTORS; PERMEABILITY BARRIER; MURINE EPIDERMIS; GENE-EXPRESSION; BINDING; ACTIVATORS; PROMOTER	Liver X receptors (LXRs) play a critical role in regulating lipid synthesis and transport in numerous tissues. In the skin, activation of LXR induces keratinocyte differentiation and improves epidermal permeability barrier homeostasis. To elucidate the mechanism of LXR action in skin, we mapped its cistrome by identifying LXR beta-RXR alpha binding sites using ChIP-on-chip in normal human epidermal keratinocytes (NHEKs). The cistrome was integrated with transcription data to obtain a global view of LXR action in keratinocyte biology. Here, we identify 2035 LXR beta-RXR alpha binding sites containing 4794 LXR response elements in NHEKs and show the presence of consensus heterodimer active regions in genes involved in keratinocyte lipid transport/synthesis and terminal differentiation. Bioinformatics analysis of the cistrome revealed an enrichment of AP1 cis-regulatory motifs in the vicinity of the LXR beta-RXR alpha binding sites. Importantly, we have demonstrated a direct interaction between LXR and Jun/Fos, indicating that the cooperation between LXR and AP1 may orchestrate keratinocyte differentiation. Finally, we corroborated these results by genome-wide mapping of the c-Fos and c-Jun cistromes in NHEKs, demonstrating that 77% of all the LXR beta-RXR alpha binding regions show the presence of AP1 motifs at adjacent locations. Our findings provide new insight into the mechanism of LXR action in keratinocyte differentiation, lipid production and barrier formation, further strengthening the validation of LXR as a potential therapeutic target for skin disorders including skin aging, psoriasis, and atopic dermatitis.	[Shen, Qi; Bai, Yuchen; Chang, Ken C. N.; Freedman, Leonard P.; Thompson, Catherine C.; Nagpal, Sunil] Wyeth Res, Dept Womens Hlth & Musculoskeletal Biol, Nucl Receptors & Dermatol, Collegeville, PA 19426 USA; [Wang, Yongjun; Burris, Thomas P.] Scripps Res Inst, Jupiter, FL 33458 USA	Pfizer; Scripps Research Institute	Nagpal, S (corresponding author), Merck Res Labs, 770 Sumneytown Pike, West Point, PA 19486 USA.	sunil.nagpal@merck.com	Burris, Thomas/H-5078-2011; Burris, Thomas P/B-3886-2016	Burris, Thomas P/0000-0003-2922-4449				Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Chang KCN, 2008, MOL ENDOCRINOL, V22, P2407, DOI 10.1210/me.2008-0232; Chavanas S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003408; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Costet P, 2000, J BIOL CHEM, V275, P28240; Crish JF, 2008, J INVEST DERMATOL, V128, P530, DOI 10.1038/sj.jid.5701049; DiSepio D, 1999, DRUG DISCOV TODAY, V4, P222, DOI 10.1016/S1359-6446(99)01335-5; Elias Peter M, 2009, Clin Med Dermatol, V2, P1; Fleischmann A, 2000, GENE DEV, V14, P2695, DOI 10.1101/gad.187900; Fowler AJ, 2003, J INVEST DERMATOL, V120, P246, DOI 10.1046/j.1523-1747.2003.12033.x; Hanley K, 2000, J INVEST DERMATOL, V114, P545, DOI 10.1046/j.1523-1747.2000.00895.x; Ishida-Yamamoto A, 2000, J INVEST DERMATOL, V114, P701, DOI 10.1046/j.1523-1747.2000.00936.x; Jang SI, 1996, J BIOL CHEM, V271, P24105, DOI 10.1074/jbc.271.39.24105; Jang SI, 2002, J BIOL CHEM, V277, P42268, DOI 10.1074/jbc.M205593200; Ji XW, 2006, NUCLEIC ACIDS RES, V34, pW551, DOI 10.1093/nar/gkl322; Jiang YJ, 2008, J INVEST DERMATOL, V128, P104, DOI 10.1038/sj.jid.5700944; Jiang YJ, 2006, J LIPID RES, V47, P2248, DOI 10.1194/jlr.M600163-JLR200; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; Kennedy MA, 2001, J BIOL CHEM, V276, P39438, DOI 10.1074/jbc.M105863200; Komuves LG, 2002, J INVEST DERMATOL, V118, P25, DOI 10.1046/j.0022-202x.2001.01628.x; Laffitte BA, 2001, P NATL ACAD SCI USA, V98, P507, DOI 10.1073/pnas.021488798; Lefevre C, 2003, HUM MOL GENET, V12, P2369, DOI 10.1093/hmg/ddg235; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Li M, 2006, P NATL ACAD SCI USA, V103, P11736, DOI 10.1073/pnas.0604575103; Man MQ, 2006, J INVEST DERMATOL, V126, P386, DOI 10.1038/sj.jid.5700046; Massie CE, 2007, EMBO REP, V8, P871, DOI 10.1038/sj.embor.7401046; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Nakashima K, 2002, J BIOL CHEM, V277, P49562, DOI 10.1074/jbc.M208795200; Nemoto-Hasebe I, 2009, J INVEST DERMATOL, V129, P682, DOI 10.1038/jid.2008.280; Ohsawa T, 1999, J DERMATOL SCI, V19, P68, DOI 10.1016/S0923-1811(98)00051-6; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Rossi A, 1998, J INVEST DERMATOL, V110, P34, DOI 10.1046/j.1523-1747.1998.00071.x; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Schmuth M, 2004, J INVEST DERMATOL, V123, P41, DOI 10.1111/j.0022-202X.2004.22707.x; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Singh M, 2006, DERMATOL THER, V19, P297, DOI 10.1111/j.1529-8019.2006.00087.x; Strong CD, 2010, HUM MOL GENET, V19, P1453, DOI 10.1093/hmg/ddq019; Tarcsa E, 1996, J BIOL CHEM, V271, P30709, DOI 10.1074/jbc.271.48.30709; Yoshikawa T, 2001, MOL CELL BIOL, V21, P2991, DOI 10.1128/MCB.21.9.2991-3000.2001; Zenz R, 2005, NATURE, V437, P369, DOI 10.1038/nature03963; Zheng Y, 2005, J INVEST DERMATOL, V124, P867, DOI 10.1111/j.0022-202X.2005.23716.x; Zuo Y, 2008, J BIOL CHEM, V283, P36624, DOI 10.1074/jbc.M807377200	44	37	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14554	14563		10.1074/jbc.M110.165704	http://dx.doi.org/10.1074/jbc.M110.165704			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21349840	Green Published, hybrid			2022-12-27	WOS:000289556200075
J	Chen, Y; Yue, S; Xie, L; Pu, XH; Jin, T; Cheng, SY				Chen, Yan; Yue, Shen; Xie, Lu; Pu, Xiao-hong; Jin, Tian; Cheng, Steven Y.			Dual Phosphorylation of Suppressor of Fused (Sufu) by PKA and GSK3 beta Regulates Its Stability and Localization in the Primary Cilium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEDGEHOG SIGNAL-TRANSDUCTION; GLI; MOUSE; TRANSCRIPTION; ASSOCIATION; DROSOPHILA; PARADIGMS; MECHANISM	Suppressor of fused (Sufu) is an essential negative regulator of the sonic hedgehog (Shh) pathway, but little is known about how Sufu itself is normally regulated. Here, we report that Sufu is phosphorylated at Ser-342 and Ser-346 by GSK3 beta and cAMP-dependent protein kinase A (PKA), respectively, and phosphorylation at this dual site stabilizes Sufu against Shh signaling-induced degradation. We further show that localization of Sufu in the primary cilium is induced by Shh signaling and is required for the turnover of both phosphorylated and total Sufu. Perturbing Sufu phosphorylation with PKA inhibitors or replacing Ser-346 with alanine reduced the stay and replacing Ser-342 and Ser-346 with aspartic acid prolonged the stay of Sufu in the cilia. Finally, ciliary localization of Gli2/3 also required Smo and was similarly influenced by perturbations of PKA activity or mutations at the dual Sufu phosphorylation site. Thus, Shh likely induced trafficking of phospho-Sufu into the primary cilium in a complex with Gli2/3, and dephosphorylation triggered a retrograde export, allowing Sufu to be degraded by the ubiquitin-proteasome system.	[Chen, Yan; Yue, Shen; Xie, Lu; Pu, Xiao-hong; Cheng, Steven Y.] Nanjing Med Univ, Dept Dev Genet, Ctr Canc Res, Nanjing 210029, Jiangsu, Peoples R China; [Chen, Yan; Yue, Shen; Xie, Lu; Pu, Xiao-hong; Cheng, Steven Y.] Nanjing Med Univ, Ctr Regenerat Med, Nanjing 210029, Jiangsu, Peoples R China; [Jin, Tian] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA	Nanjing Medical University; Nanjing Medical University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Cheng, SY (corresponding author), Nanjing Med Univ, Dept Dev Genet, Ctr Canc Res, 140 Hanzhong Rd, Nanjing 210029, Jiangsu, Peoples R China.	sycheng@njmu.edu.cn			Chinese National Science Foundation [30771079]; Chinese Ministry of Science and Technology [2009CB918403]; University Research Grant [08NMUM010]; National Institutes of Health NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001156] Funding Source: NIH RePORTER	Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); University Research Grant; National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Chinese National Science Foundation Grant 30771079 (to S. Y. C.), 973 State Key Research Project of Chinese Ministry of Science and Technology Grant 2009CB918403 (to S. Y. C.), and University Research Grant 08NMUM010 (to S. Y.). This work was also supported in part by National Institutes of Health NIAID intramural fund (to T. J.).	Altaba ARI, 2008, CANCER CELL, V14, P281, DOI 10.1016/j.ccr.2008.09.007; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Chen MH, 2009, GENE DEV, V23, P1910, DOI 10.1101/gad.1794109; Cheng SY, 2008, ADV CANCER RES, V101, P29, DOI 10.1016/S0065-230X(08)00402-8; Cheng SY, 2002, P NATL ACAD SCI USA, V99, P5442, DOI 10.1073/pnas.082096999; Cooper AF, 2005, DEVELOPMENT, V132, P4407, DOI 10.1242/dev.02021; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Cortellino S, 2009, DEV BIOL, V325, P225, DOI 10.1016/j.ydbio.2008.10.020; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Ho KS, 2005, DEVELOPMENT, V132, P1401, DOI 10.1242/dev.01689; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Humke EW, 2010, GENE DEV, V24, P670, DOI 10.1101/gad.1902910; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; JACOB L, 2007, SCI STKE, pCM6, DOI DOI 10.1126/STKE.4072007CM6; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Kise Y, 2009, BIOCHEM BIOPH RES CO, V387, P569, DOI 10.1016/j.bbrc.2009.07.087; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Kovacs JJ, 2008, SCIENCE, V320, P1777, DOI 10.1126/science.1157983; Koyama E, 2007, DEVELOPMENT, V134, P2159, DOI 10.1242/dev.001586; Lum L, 2003, MOL CELL, V12, P1261, DOI 10.1016/S1097-2765(03)00426-X; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; Milenkovic L, 2009, J CELL BIOL, V187, P365, DOI 10.1083/jcb.200907126; Paces-Fessy M, 2004, BIOCHEM J, V378, P353, DOI 10.1042/BJ20030786; Pazour GJ, 2003, CURR OPIN CELL BIOL, V15, P105, DOI 10.1016/S0955-0674(02)00012-1; Pearse RV, 1999, DEV BIOL, V212, P323, DOI 10.1006/dbio.1999.9335; Rohatgi R, 2007, NAT CELL BIOL, V9, P1005, DOI 10.1038/ncb435; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Ruiz i Altaba A, 2007, TRENDS CELL BIOL, V17, P438, DOI 10.1016/j.tcb.2007.06.007; Silverman MA, 2009, TRENDS CELL BIOL, V19, P306, DOI 10.1016/j.tcb.2009.04.002; Subach FV, 2009, NAT METHODS, V6, P153, DOI [10.1038/nmeth.1298, 10.1038/NMETH.1298]; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Tempe D, 2006, MOL CELL BIOL, V26, P4316, DOI 10.1128/MCB.02183-05; Varjosalo M, 2006, DEV CELL, V10, P177, DOI 10.1016/j.devcel.2005.12.014; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang CB, 2010, DEVELOPMENT, V137, P2001, DOI 10.1242/dev.052126; Wang Y, 2007, CURR OPIN CELL BIOL, V19, P159, DOI 10.1016/j.ceb.2007.02.005; Wilson CW, 2010, DEVELOPMENT, V137, P2079, DOI 10.1242/dev.045021; Wilson CW, 2009, NATURE, V459, P98, DOI 10.1038/nature07883; Yue S, 2009, ONCOGENE, V28, P492, DOI 10.1038/onc.2008.403	42	80	88	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13502	13511		10.1074/jbc.M110.217604	http://dx.doi.org/10.1074/jbc.M110.217604			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21317289	Green Published, hybrid			2022-12-27	WOS:000289282200070
J	Kortenoeven, MLA; van den Brandi, M; Wetzels, JFM; Deen, PMT				Kortenoeven, Marleen L. A.; van den Brandi, Michiel; Wetzels, Jack F. M.; Deen, Peter M. T.			Hypotonicity-induced Reduction of Aquaporin-2 Transcription in mpkCCD Cells Is Independent of the Tonicity Responsive Element, Vasopressin, and cAMP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUCT PRINCIPAL CELLS; NEPHROGENIC DIABETES-INSIPIDUS; MEDULLARY COLLECTING DUCT; NITRIC-OXIDE; WATER CHANNEL; CONCENTRATING MECHANISM; INDUCED ANTIDIURESIS; ESSENTIAL REGULATOR; BINDING PROTEIN; GENE-EXPRESSION	The syndrome of inappropriate antidiuretic hormone secretion is characterized by excessive water uptake and hyponatremia. The extent of hyponatremia, however, is less than anticipated, which is ascribed to a defense mechanism, the vasopressin-escape, and is suggested to involve a tonicity-determined down-regulation of the water channel aquaporin-2 (AQP2). The underlying mechanism, however, is poorly understood. To study this, we used the mouse cortical collecting duct (mpkCCD) cell line. MpkCCD cells, transfected with an AQP2-promoter luciferase construct showed a reduced and increased AQP2 abundance and transcription following culture in hypotonic and hypertonic medium, respectively. This depended on tonicity rather than osmolality and occurred independently of the vasopressin analog dDAVP, cAMP levels, or protein kinase A activity. Although prostaglandins and nitric oxide reduced AQP2 abundance, inhibition of their synthesis did not influence tonicity-induced AQP2 transcription. Also, cells in which the cAMP or tonicity-responsive element (CRE/TonE) in the AQP2-promoter were mutated showed a similar response to hypotonicity. Instead, the tonicity-responsive elements were pin-pointed to nucleotides -283 to -252 and -157 to -126 bp. In conclusion, our data indicate that hypotonicity reduces AQP2 abundance and transcription, which occurs independently of vasopressin, cAMP, and the known TonE and CRE in the AQP2-promoter. Increased prostaglandin and nitric oxide, as found in vivo, may contribute to reduced AQP2 in vasopressin-escape, but do not mediate the effect of hypotonicity on AQP2 transcription. Our data suggest that two novel segments (-283 to -252 and -157 to -126 bp) in the AQP2-promoter mediate the hypotonicity-induced AQP2 down-regulation during vasopressin-escape.	[Kortenoeven, Marleen L. A.; van den Brandi, Michiel; Deen, Peter M. T.] Radboud Univ Nijmegen, Med Ctr, Dept Physiol, NL-6500 HB Nijmegen, Netherlands; [Wetzels, Jack F. M.] Radboud Univ Nijmegen, Med Ctr, Dept Nephrol, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Deen, PMT (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Physiol, 286 Physiol,POB 9101, NL-6500 HB Nijmegen, Netherlands.	p.deen@fysiol.umcn.nl	van den Brand, Michiel/E-2900-2016; Deen, Peter MT/B-9854-2013; Deen, P.M.T./H-8023-2014; Wetzels, Jack F.M./A-1720-2014; Kortenoeven, Marleen/B-8565-2014	van den Brand, Michiel/0000-0001-8871-6254; Deen, Peter MT/0000-0002-7868-4655; Deen, P.M.T./0000-0002-7868-4655; Wetzels, Jack F.M./0000-0002-0650-6921; Kortenoeven, Marleen/0000-0001-9962-8276	Radboud University Nijmegen Medical Centre [2004.55]; Netherlands Organization for Scientific Research (NWO) [865.07.002]	Radboud University Nijmegen Medical Centre; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by a grant from the Radboud University Nijmegen Medical Centre (2004.55) and a VICI grant of the Netherlands Organization for Scientific Research (NWO, 865.07.002) (to P. M. T. D.).	Arreche N, 2008, VASC PHARMACOL, V49, P19, DOI 10.1016/j.vph.2008.04.001; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen SC, 2002, J BIOL CHEM, V277, P32498, DOI 10.1074/jbc.M202321200; DEEN PMT, 1994, SCIENCE, V264, P92, DOI 10.1126/science.8140421; Deen PMT, 1997, PFLUG ARCH EUR J PHY, V433, P780, DOI 10.1007/s004240050345; Ecelbarger CA, 1997, J CLIN INVEST, V99, P1852, DOI 10.1172/JCI119352; Fluhmann B, 1998, MOL CELL ENDOCRINOL, V139, P89, DOI 10.1016/S0303-7207(98)00070-7; Furuno M, 1996, AM J PHYSIOL-RENAL, V271, pF854, DOI 10.1152/ajprenal.1996.271.4.F854; GROSS PA, 1983, CIRC RES, V53, P794, DOI 10.1161/01.RES.53.6.794; Hao CM, 2000, J CLIN INVEST, V106, P973, DOI 10.1172/JCI9956; Hasler U, 2005, J AM SOC NEPHROL, V16, P1571, DOI 10.1681/ASN.2004110930; Hasler U, 2002, J BIOL CHEM, V277, P10379, DOI 10.1074/jbc.M111880200; Hasler U, 2006, J AM SOC NEPHROL, V17, P1521, DOI 10.1681/ASN.2005121317; HEBERT RL, 1990, AM J PHYSIOL, V259, pF318, DOI 10.1152/ajprenal.1990.259.2.F318; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Hozawa S, 1996, AM J PHYSIOL-CELL PH, V270, pC1695, DOI 10.1152/ajpcell.1996.270.6.C1695; Jeon US, 2006, ACTA PHYSIOL, V187, P241, DOI 10.1111/j.1748-1716.2006.01551.x; Jun DW, 2010, DIGEST DIS SCI, V55, P1296, DOI 10.1007/s10620-009-0852-y; Kamsteeg EJ, 1999, EMBO J, V18, P2394, DOI 10.1093/emboj/18.9.2394; Kasono K, 2005, NEPHROL DIAL TRANSPL, V20, P509, DOI 10.1093/ndt/gfh677; Knepper MA, 1997, AM J PHYSIOL-RENAL, V272, pF3, DOI 10.1152/ajprenal.1997.272.1.F3; Lam AKM, 2004, J BIOL CHEM, V279, P48048, DOI 10.1074/jbc.M407224200; LEVINSKY NG, 1959, AM J PHYSIOL, V196, P451, DOI 10.1152/ajplegacy.1959.196.2.451; Li CL, 2006, J AM SOC NEPHROL, V17, P1657, DOI 10.1681/ASN.2005121381; Li SZ, 2007, AM J PHYSIOL-CELL PH, V292, pC1606, DOI 10.1152/ajpcell.00588.2005; Li YD, 2006, J AM SOC NEPHROL, V17, P1063, DOI 10.1681/ASN.2005080884; Liu J, 2009, PLACENTA, V30, P66, DOI 10.1016/j.placenta.2008.10.009; Lopez-Rodriguez C, 2004, P NATL ACAD SCI USA, V101, P2392, DOI 10.1073/pnas.0308703100; Matsumura Y, 1997, J AM SOC NEPHROL, V8, P861; Murase T, 2003, AM J PHYSIOL-REG I, V284, pR354, DOI 10.1152/ajpregu.00065.2002; NADLER SP, 1992, AM J PHYSIOL, V262, pF229, DOI 10.1152/ajprenal.1992.262.2.F229; Nemeth ZH, 2002, AM J PATHOL, V161, P987, DOI 10.1016/S0002-9440(10)64259-9; Neuhofer W, 2002, J PHYSIOL-LONDON, V543, P147, DOI 10.1113/jphysiol.2002.021931; Quinn PG, 2002, PROG NUCLEIC ACID RE, V72, P269, DOI 10.1016/S0079-6603(02)72072-2; SCHRIER RW, 1979, AM J PHYSIOL, V236, pF321, DOI 10.1152/ajprenal.1979.236.4.F321; Sheen MR, 2009, KIDNEY INT, V75, P518, DOI 10.1038/ki.2008.601; VALTIN H, 1987, KIDNEY INT, V31, P634, DOI 10.1038/ki.1987.45; Yasui M, 1997, AM J PHYSIOL-RENAL, V272, pF443, DOI 10.1152/ajprenal.1997.272.4.F443	38	13	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13002	13010		10.1074/jbc.M110.207878	http://dx.doi.org/10.1074/jbc.M110.207878			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21324903	Green Published, hybrid			2022-12-27	WOS:000289282200020
J	Lingaraju, GM; Davis, CA; Setser, JW; Samson, LD; Drennan, CL				Lingaraju, Gondichatnahalli M.; Davis, C. Ainsley; Setser, Jeremy W.; Samson, Leona D.; Drennan, Catherine L.			Structural Basis for the Inhibition of Human Alkyladenine DNA Glycosylase (AAG) by 3,N-4-Ethenocytosine-containing DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCISION-REPAIR ENZYMES; MICROSATELLITE INSTABILITY; DAMAGE; MUTAGENESIS; ADDUCT	Reactive oxygen and nitrogen species, generated by neutrophils and macrophages in chronically inflamed tissues, readily damage DNA, producing a variety of potentially genotoxic etheno base lesions; such inflammation-related DNA damage is now known to contribute to carcinogenesis. Although the human alkyladenine DNA glycosylase (AAG) can specifically bind DNA containing either 1,N-6-ethenoadenine (epsilon A) lesions or 3,N-4-ethenocytosine (epsilon C) lesions, it can only excise epsilon A lesions. AAG binds very tightly to DNA containing epsilon C lesions, forming an abortive protein-DNA complex; such binding not only shields epsilon C from repair by other enzymes but also inhibits AAG from acting on other DNA lesions. To understand the structural basis for inhibition, we have characterized the binding of AAG to DNA containing epsilon C lesions and have solved a crystal structure of AAG bound to a DNA duplex containing the epsilon C lesion. This study provides the first structure of a DNA glycosylase in complex with an inhibitory base lesion that is induced endogenously and that is also induced upon exposure to environmental agents such as vinyl chloride. We identify the primary cause of inhibition as a failure to activate the nucleotide base as an efficient leaving group and demonstrate that the higher binding affinity of AAG for epsilon C versus epsilon A is achieved through formation of an additional hydrogen bond between Asn-169 in the active site pocket and the O-2 of epsilon C. This structure provides the basis for the design of AAG inhibitors currently being sought as an adjuvant for cancer chemotherapy.	[Lingaraju, Gondichatnahalli M.; Samson, Leona D.; Drennan, Catherine L.] MIT, Ctr Environm Hlth Sci, Cambridge, MA 02139 USA; [Lingaraju, Gondichatnahalli M.; Samson, Leona D.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Davis, C. Ainsley; Setser, Jeremy W.; Drennan, Catherine L.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Samson, Leona D.; Drennan, Catherine L.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Samson, Leona D.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Drennan, Catherine L.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Drennan, CL (corresponding author), 77 Massachusetts Ave, Cambridge, MA 02193 USA.	Isamson@mit.edu; cdrennan@mit.edu	Classen, Scott/AAY-8176-2020		National Institutes of Health [P30-ES002109, GM65337, GM65337-03S2, CA055042, CA092584]; Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy [DE-AC02-05CH11231]; Repligen Koch Institute for Integrated Cancer Research; NATIONAL CANCER INSTITUTE [P01CA092584, R01CA055042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065337] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy(United States Department of Energy (DOE)); Repligen Koch Institute for Integrated Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P30-ES002109 (to C. L D. and L D. S.), GM65337 (to C. L D.), GM65337-03S2 (to C. A. D.), and CA055042 and CA092584 (to L D. S.).; The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under Contract Number DE-AC02-05CH11231.; Supported by a Repligen Koch Institute for Integrated Cancer Research Graduate Fellowship.	Adhikari S, 2006, J BIOL CHEM, V281, P29525, DOI 10.1074/jbc.M602673200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bartsch H, 2002, CANCER DETECT PREV, V26, P308, DOI 10.1016/S0361-090X(02)00093-4; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Connor EE, 2002, CHEM BIOL, V9, P1033, DOI 10.1016/S1074-5521(02)00215-6; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Gros L, 2003, MUTAT RES-FUND MOL M, V531, P219, DOI 10.1016/j.mrfmmm.2003.07.008; Gros L, 2004, J BIOL CHEM, V279, P17723, DOI 10.1074/jbc.M314010200; Hofseth LJ, 2003, J CLIN INVEST, V112, P1887, DOI 10.1172/JCI200319757; Klapacz J, 2010, MOL CELL, V37, P843, DOI 10.1016/j.molcel.2010.01.038; Lau AY, 1998, CELL, V95, P249, DOI 10.1016/S0092-8674(00)81755-9; Lau AY, 2000, P NATL ACAD SCI USA, V97, P13573, DOI 10.1073/pnas.97.25.13573; Lee CYI, 2009, BIOCHEMISTRY-US, V48, P1850, DOI 10.1021/bi8018898; Levine RL, 2000, CANCER RES, V60, P4098; Margison GP, 2007, DNA REPAIR, V6, P1222, DOI 10.1016/j.dnarep.2007.03.014; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miao F, 2000, J BIOL CHEM, V275, P28433, DOI 10.1074/jbc.M001064200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nair U, 2007, FREE RADICAL BIO MED, V43, P1109, DOI 10.1016/j.freeradbiomed.2007.07.012; O'Brien PJ, 2004, J BIOL CHEM, V279, P9750, DOI 10.1074/jbc.M312232200; O'Brien PJ, 2003, BIOCHEMISTRY-US, V42, P12418, DOI 10.1021/bi035177v; SAMSON L, 1991, P NATL ACAD SCI USA, V88, P9127, DOI 10.1073/pnas.88.20.9127; Tubbs JL, 2009, NATURE, V459, P808, DOI 10.1038/nature08076; Wang P, 2006, TOXICOL LETT, V166, P237, DOI 10.1016/j.toxlet.2006.06.647; Wiseman H, 1996, BIOCHEM J, V313, P17, DOI 10.1042/bj3130017; Wyatt MD, 1999, BIOESSAYS, V21, P668, DOI 10.1002/(SICI)1521-1878(199908)21:8<668::AID-BIES6>3.3.CO;2-4; Zharkov DO, 2008, CELL MOL LIFE SCI, V65, P1544, DOI 10.1007/s00018-008-7543-2	27	27	27	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13205	13213		10.1074/jbc.M110.192435	http://dx.doi.org/10.1074/jbc.M110.192435			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21349833	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000289282200041
J	Matsumoto, A; Onoyama, I; Sunabori, T; Kageyama, R; Okano, H; Nakayama, KI				Matsumoto, Akinobu; Onoyama, Ichiro; Sunabori, Takehiko; Kageyama, Ryoichiro; Okano, Hideyuki; Nakayama, Keiichi I.			Fbxw7-dependent Degradation of Notch Is Required for Control of "Stemness" and Neuronal-Glial Differentiation in Neural Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOOP-HELIX GENES; UBIQUITIN LIGASE; CYCLIN-E; TUMOR-SUPPRESSOR; MIND BOMB; C-MYC; PROTEOLYSIS; ACTIVATION; PATHWAY; GLIOGENESIS	Control of the growth and differentiation of neural stem cells is fundamental to brain development and is largely dependent on the Notch signaling pathway. The mechanism by which the activity of Notch is regulated during brain development has remained unclear, however. Fbxw7 (also known as Fbw7, SEL-10, hCdc4, or hAgo) is the F-box protein subunit of an Skp1-Cul1-F-box protein (SCF)-type ubiquitin ligase complex that plays a central role in the degradation of Notch family members. We now show that mice with brain-specific deletion of Fbxw7 (Nestin-Cre/Fbxw7(F/F) mice) die shortly after birth with morphological abnormalities of the brain and the absence of suckling behavior. The maintenance of neural stern cells was sustained in association with the accumulation of Notch! and Notch3, as well as up-regulation of Notch target genes in the mutant mice. Astrogenesis was also enhanced in the mutant mice in vivo, and the differentiation of neural progenitor cells was skewed toward astrocytes rather than neurons in vitro, with the latter effect being reversed by treatment of the cells with a pharmacological inhibitor of the Notch signaling pathway. Our results thus implicate Fbxw7 as a key regulator of the maintenance and differentiation of neural stein cells in the brain.	[Matsumoto, Akinobu; Onoyama, Ichiro; Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, Fukuoka 8128582, Japan; [Matsumoto, Akinobu; Onoyama, Ichiro; Kageyama, Ryoichiro; Nakayama, Keiichi I.] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Sunabori, Takehiko; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 1608582, Japan; [Kageyama, Ryoichiro] Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan	Kyushu University; Japan Science & Technology Agency (JST); Keio University; Kyoto University	Nakayama, KI (corresponding author), Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	nakayak1@bioreg.kyushu-u.ac.jp	Matsumoto, Akinobu/GPF-4945-2022; Okano, Hideyuki/I-7584-2019	Matsumoto, Akinobu/0000-0002-4077-3935	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Cau E, 2000, DEVELOPMENT, V127, P2323; Chan YM, 1998, CELL, V94, P423, DOI 10.1016/S0092-8674(00)81583-4; Chastagner P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002735; delaPompa J, 1997, DEVELOPMENT, V124, P1139; Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Handler M, 2000, DEVELOPMENT, V127, P2593; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Hoeck JD, 2010, NAT NEUROSCI, V13, P1365, DOI 10.1038/nn.2644; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Justice NJ, 2002, CURR OPIN NEUROBIOL, V12, P64, DOI 10.1016/S0959-4388(02)00291-X; Kageyama R, 2009, CURR OPIN CELL BIOL, V21, P733, DOI 10.1016/j.ceb.2009.08.009; Kalyani A, 1997, DEV BIOL, V186, P202, DOI 10.1006/dbio.1997.8592; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Kopan R, 2000, GENE DEV, V14, P2799, DOI 10.1101/gad.836900; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Lee JE, 1997, CURR OPIN NEUROBIOL, V7, P13, DOI 10.1016/S0959-4388(97)80115-8; Lutolf S, 2002, DEVELOPMENT, V129, P373; Mao JH, 2008, SCIENCE, V321, P1499, DOI 10.1126/science.1162981; Masuda K, 2010, ONCOGENE, V29, P1798, DOI 10.1038/onc.2009.469; Matsuoka S, 2008, GENE DEV, V22, P986, DOI 10.1101/gad.1621808; McGill MA, 2003, J BIOL CHEM, V278, P23196, DOI 10.1074/jbc.M302827200; Melino G, 2008, CELL DEATH DIFFER, V15, P1103, DOI 10.1038/cdd.2008.60; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Onoyama I, 2007, J EXP MED, V204, P2875, DOI 10.1084/jem.20062299; Pavlopoulos E, 2001, DEV CELL, V1, P807, DOI 10.1016/S1534-5807(01)00093-4; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Robey E, 1997, CURR OPIN GENET DEV, V7, P551, DOI 10.1016/S0959-437X(97)80085-8; Satow T, 2001, J NEUROSCI, V21, P1265; Schuurmans C, 2002, CURR OPIN NEUROBIOL, V12, P26, DOI 10.1016/S0959-4388(02)00286-6; Selkoe DJ, 2000, CURR OPIN NEUROBIOL, V10, P50, DOI 10.1016/S0959-4388(99)00054-9; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Yoon KJ, 2008, NEURON, V58, P519, DOI 10.1016/j.neuron.2008.03.018	49	83	89	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13754	13764		10.1074/jbc.M110.194936	http://dx.doi.org/10.1074/jbc.M110.194936			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21349854	Green Published, hybrid			2022-12-27	WOS:000289282200093
J	Ho, HA; Kapadia, R; Al-Tahan, S; Ahmad, S; Ganesan, AK				Ho, Hsiang; Kapadia, Rubina; Al-Tahan, Sejad; Ahmad, Safoora; Ganesan, Anand K.			WIPI1 Coordinates Melanogenic Gene Transcription and Melanosome Formation via TORC1 Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-B; PHOSPHATIDYLINOSITOL 3,5-BISPHOSPHATE; SACCHAROMYCES-CEREVISIAE; MAMMALIAN AUTOPHAGY; SKIN PIGMENTATION; PUNCTA-FORMATION; TRANSPORT; MELANOCYTES; COMPLEX; MOUSE	Recent studies implicate a role for WD repeat domain, phosphoinositide- interacting 1 (WIPI1) in the biogenesis of melanosomes, cell type-specific lysosome-related organelles. In this study, we determined that WIPI1, an ATG18 homologue that is shown to localize to both autophagosomes and early endosomes, inhibited mammalian target of rapamycin (MTOR) signaling, leading to increased transcription of melanogenic enzymes and the formation of mature melanosomes. WIPI1 suppressed the target of rapamycin complex 1 (TORC1) activity, resulting in glycogen synthase kinase 3 beta inhibition, beta-Catenin stabilization, and increased transcription of microphthalmia transcription factor and its target genes. WIPI1-depleted cells accumulated stage I melanosomes but lacked stage III-IV melanosomes. Inhibition of TORC1 by rapamycin treatment resulted in the accumulation of stage IV melanosomes but not autophagosomes, whereas starvation resulted in the formation of autophagosomes but not melanin accumulation. Taken together, our studies define a distinct role for WIPI1 and TORC1 signaling in controlling the transcription of melanogenic enzymes and melanosome maturation, a process that is distinct from starvation-induced autophagy.	[Ho, Hsiang; Ganesan, Anand K.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Kapadia, Rubina; Al-Tahan, Sejad; Ahmad, Safoora; Ganesan, Anand K.] Univ Calif Irvine, Dept Dermatol, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Ganesan, AK (corresponding author), Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA.	aganesan@uci.edu			National Institutes of Health [1RO3AR057150, 1K08AR056001]; Biomedical Technology Resource Grant [P41-RR01192]; Dermatology Foundation; Joanna M. Nicolay Melanoma Foundation; graduate fellowship in alternatives in scientific research; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR057150, K08AR056001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biomedical Technology Resource Grant; Dermatology Foundation; Joanna M. Nicolay Melanoma Foundation; graduate fellowship in alternatives in scientific research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1RO3AR057150 and 1K08AR056001 (to A. K. G.) and by Biomedical Technology Resource Grant P41-RR01192 (for the microscopy studies at the University of California, Irvine. This work was also supported by a Dermatology Foundation research grant.; Supported by a Joanna M. Nicolay Melanoma Foundation research scholar award and a graduate fellowship in alternatives in scientific research.	Barth H, 2001, FEBS LETT, V508, P23, DOI 10.1016/S0014-5793(01)03016-2; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Bellei B, 2008, CELL SIGNAL, V20, P1750, DOI 10.1016/j.cellsig.2008.06.001; Burgdorf S, 2004, J BIOL CHEM, V279, P17524, DOI 10.1074/jbc.M313703200; Busca R, 1996, J BIOL CHEM, V271, P31824, DOI 10.1074/jbc.271.50.31824; Cheli Y, 2010, PIGM CELL MELANOMA R, V23, P27, DOI 10.1111/j.1755-148X.2009.00653.x; Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200; Chow CY, 2007, NATURE, V448, P68, DOI 10.1038/nature05876; Costin GE, 2007, FASEB J, V21, P976, DOI 10.1096/fj.06-6649rev; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09; Double KL, 2006, J NEURAL TRANSM, V113, P751, DOI 10.1007/s00702-006-0450-5; Dove SK, 2004, EMBO J, V23, P1922, DOI 10.1038/sj.emboj.7600203; Du JY, 2003, AM J PATHOL, V163, P333, DOI 10.1016/S0002-9440(10)63657-7; Efe JA, 2007, MOL BIOL CELL, V18, P4232, DOI 10.1091/mbc.E07-04-0301; El-Mofty MA, 2007, DERMATOL CLIN, V25, P401, DOI 10.1016/j.det.2007.04.003; Eskelinen Eeva-Liisa, 2006, Molecular Aspects of Medicine, V27, P495, DOI 10.1016/j.mam.2006.08.005; Ferguson CJ, 2010, AUTOPHAGY, V6, P170, DOI 10.4161/auto.6.1.10626; Flinn RJ, 2010, MOL BIOL CELL, V21, P833, DOI 10.1091/mbc.E09-09-0756; Ganesan AK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000298; Gao C, 2010, NAT CELL BIOL, V12, P781, DOI 10.1038/ncb2082; Gautam R, 2006, TRAFFIC, V7, P779, DOI 10.1111/j.1600-0854.2006.00431.x; Georgakopoulos T, 2001, YEAST, V18, P1155, DOI 10.1002/yea.764; Guan J, 2001, MOL BIOL CELL, V12, P3821, DOI 10.1091/mbc.12.12.3821; Hajduch E, 2001, FEBS LETT, V492, P199, DOI 10.1016/S0014-5793(01)02242-6; Hearing VJ, 2005, J DERMATOL SCI, V37, P3, DOI 10.1016/j.jdermsci.2004.08.014; Hoashi T, 2005, J BIOL CHEM, V280, P14006, DOI 10.1074/jbc.M413692200; Hu DN, 2008, PHOTOCHEM PHOTOBIOL, V84, P639, DOI 10.1111/j.1751-1097.2008.00316.x; Hurbain I, 2008, P NATL ACAD SCI USA, V105, P19726, DOI 10.1073/pnas.0803488105; Jeffries TR, 2004, MOL BIOL CELL, V15, P2652, DOI 10.1091/mbc.E03-10-0732; Jin N, 2008, EMBO J, V27, P3221, DOI 10.1038/emboj.2008.248; Kim JH, 2008, J INVEST DERMATOL, V128, P1227, DOI 10.1038/sj.jid.5701177; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Matsunaga K, 2009, AUTOPHAGY, V5, P876, DOI 10.4161/auto.9098; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Michell RH, 2006, TRENDS BIOCHEM SCI, V31, P52, DOI 10.1016/j.tibs.2005.11.013; Mills IG, 1999, MOL MEMBR BIOL, V16, P73, DOI 10.1080/096876899294788; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Nicolaus BJR, 2005, MED HYPOTHESES, V65, P791, DOI 10.1016/j.mehy.2005.04.011; Ohguchi K, 2005, J CELL PHYSIOL, V205, P444, DOI 10.1002/jcp.20421; Oka M, 2000, J INVEST DERMATOL, V115, P699, DOI 10.1046/j.1523-1747.2000.00095.x; Passeron T, 2005, CLIN DERMATOL, V23, P56, DOI 10.1016/j.clindermatol.2004.09.013; Proikas-Cezanne T, 2007, FEBS LETT, V581, P3396, DOI 10.1016/j.febslet.2007.06.040; Proikas-Cezanne T, 2009, METHOD ENZYMOL, V452, P247, DOI 10.1016/S0076-6879(08)03616-1; Rabinovich A, 2008, GENOME RES, V18, P1763, DOI 10.1101/gr.080622.108; Raposo G, 2001, J CELL BIOL, V152, P809, DOI 10.1083/jcb.152.4.809; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Reggiori F, 2004, DEV CELL, V6, P79, DOI 10.1016/S1534-5807(03)00402-7; Roxrud I, 2010, BIOL CELL, V102, P293, DOI 10.1042/BC20090161; Saito H, 2002, J BIOL CHEM, V277, P28787, DOI 10.1074/jbc.M203719200; Salopek TG, 1996, JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, VOL 1, NO 2, APRIL 1996, P195; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sbrissa D, 2007, J BIOL CHEM, V282, P23878, DOI 10.1074/jbc.M611678200; SHIBATA K, 1992, J BIOL CHEM, V267, P20584; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Sturm RA, 2009, HUM MOL GENET, V18, pR9, DOI 10.1093/hmg/ddp003; Tachibana M, 1999, PIGM CELL RES, V12, P344, DOI 10.1111/j.1600-0749.1999.tb00518.x; Takeda K, 2000, J BIOL CHEM, V275, P14013, DOI 10.1074/jbc.C000113200; Theos AC, 2005, PIGM CELL RES, V18, P322, DOI 10.1111/j.1600-0749.2005.00269.x; Truschel ST, 2009, TRAFFIC, V10, P1318, DOI 10.1111/j.1600-0854.2009.00955.x; Verheyen EM, 2010, DEV DYNAM, V239, P34, DOI 10.1002/dvdy.22019; Wasmeier C, 2008, J CELL SCI, V121, P3995, DOI 10.1242/jcs.040667; Weiss P, 2009, BIOCHEM J, V424, P89, DOI 10.1042/BJ20090957; Yamaguchi Y, 2009, BIOFACTORS, V35, P193, DOI 10.1002/biof.29; Zhang HH, 2006, MOL CELL, V24, P185, DOI 10.1016/j.molcel.2006.09.019; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	69	59	66	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.200543	http://dx.doi.org/10.1074/jbc.M110.200543			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21317285	Green Published, hybrid			2022-12-27	WOS:000289077500064
J	Lee, CH; Pan, YJ; Huang, YT; Liu, TH; Hsu, SH; Lee, CH; Chen, YW; Lin, SM; Huang, LK; Pan, RL				Lee, Chien-Hsien; Pan, Yih-Jiuan; Huang, Yun-Tzu; Liu, Tseng-Huang; Hsu, Shen-Hsing; Lee, Ching-Hung; Chen, Yen-Wei; Lin, Shih-Ming; Huang, Lin-Kun; Pan, Rong-Long			Identification of Essential Lysines Involved in Substrate Binding of Vacuolar H+-Pyrophosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INORGANIC PYROPHOSPHATASE; RHODOSPIRILLUM-RUBRUM; ESCHERICHIA-COLI; INHIBITION; RESIDUES; PPASE; YEAST; SITE; INACTIVATION; ARABIDOPSIS	H+-translocating pyrophosphatase (H+-PPase; EC 3.6.1.1) drives proton transport against an electrochemical potential gradient by hydrolyzing pyrophosphate (PPi) and is found in various endomembranes of higher plants, bacteria, and some protists. H+-PPase contains seven highly conserved lysines. We examined the functional roles of these lysines, which are, for the most part, found in the cytosolic regions of mung bean H+-PPase by site-directed mutagenesis. Construction of mutants that each had a cytosolic and highly conserved lysine substituted with an alanine resulted in dramatic drops in the PPi hydrolytic activity. The effects caused by ions on the activities of WT and mutant H+-PPases suggest that Lys-730 may be in close proximity to the Mg2+-binding site, and the great resistance of the K694A and K695A mutants to fluoride inhibition suggests that these lysines are present in the active site. The modifier fluorescein 5`-isothiocyanate (FITC) labeled a lysine at the H+-PPase active site but did not inhibit the hydrolytic activities of K250A, K250N, K250T, and K250S, which suggested that Lys-250 is essential for substrate binding and may be involved in proton translocation. Analysis of tryptic digests indicated that Lys-711 and Lys-717 help maintain the conformation of the active site. Proteolytic evidence also demonstrated that Lys-250 is the primary target of trypsin and confirmed its crucial role in H+-PPase hydrolysis.	Natl Tsing Hua Univ, Coll Life Sci, Dept Life Sci, Hsinchu 30043, Taiwan; Natl Tsing Hua Univ, Coll Life Sci, Inst Bioinformat & Struct Biol, Hsinchu 30043, Taiwan	National Tsing Hua University; National Tsing Hua University	Pan, RL (corresponding author), Natl Tsing Hua Univ, Coll Life Sci, Dept Life Sci, Hsinchu 30013, Taiwan.	rlpan@life.nthu.edu.tw			National Science Council, Taiwan [NSC 98-2627-M-007-002, NSC 98-2627-M-007-001, NSC 97-2311-B-007-003-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council, Taiwan, Grants NSC 98-2627-M-007-002, NSC 98-2627-M-007-001, and NSC 97-2311-B-007-003-MY3 (to R.-L. P.).	Baltscheffsky M, 1999, FEBS LETT, V457, P525, DOI 10.1016/S0014-5793(99)00914-X; BARIK S, 1995, MOL BIOTECHNOL, V3, P1, DOI 10.1007/BF02821329; BAYKOV AA, 1993, FEBS LETT, V327, P199, DOI 10.1016/0014-5793(93)80169-U; Belogurov GA, 2002, J BIOL CHEM, V277, P22209, DOI 10.1074/jbc.M202951200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; Drozdowicz YM, 2001, TRENDS PLANT SCI, V6, P206, DOI 10.1016/S1360-1385(01)01923-9; Fabrichniy IP, 2007, J BIOL CHEM, V282, P1422, DOI 10.1074/jbc.M513161200; Fraichard A, 1996, BIOCHIMIE, V78, P259, DOI 10.1016/0300-9084(96)82189-4; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Guo SL, 2006, PLANT MOL BIOL, V60, P41, DOI 10.1007/s11103-005-2417-6; Hsiao YY, 2007, BBA-BIOENERGETICS, V1767, P965, DOI 10.1016/j.bbabio.2007.04.007; Hsiao YY, 2004, BBA-BIOENERGETICS, V1608, P190, DOI 10.1016/j.bbabio.2004.01.001; Hsiao YY, 2002, J PROTEIN CHEM, V21, P51, DOI 10.1023/A:1014183100021; Hsu SH, 2009, BOT STUD, V50, P291; Huang YT, 2010, J BIOL CHEM, V285, P23655, DOI 10.1074/jbc.M110.134916; KIM EJ, 1994, P NATL ACAD SCI USA, V91, P6128, DOI 10.1073/pnas.91.13.6128; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li JS, 2005, SCIENCE, V310, P121, DOI 10.1126/science.1115711; Maeshima M, 2000, BBA-BIOMEMBRANES, V1465, P37, DOI 10.1016/S0005-2736(00)00130-9; MAESHIMA M, 1991, EUR J BIOCHEM, V196, P11, DOI 10.1111/j.1432-1033.1991.tb15779.x; Malinen AM, 2004, J BIOL CHEM, V279, P26811, DOI 10.1074/jbc.M404154200; Mimura H, 2004, J BIOL CHEM, V279, P35106, DOI 10.1074/jbc.M406264200; Nakanishi Y, 2001, J BIOL CHEM, V276, P7654, DOI 10.1074/jbc.M009743200; Park S, 2005, P NATL ACAD SCI USA, V102, P18830, DOI 10.1073/pnas.0509512102; REA PA, 1993, ANNU REV PLANT PHYS, V44, P157, DOI 10.1146/annurev.pp.44.060193.001105; REA PA, 1992, PLANT PHYSIOL, V100, P1706, DOI 10.1104/pp.100.4.1706; Samygina VR, 2007, J MOL BIOL, V366, P1305, DOI 10.1016/j.jmb.2006.11.082; SATO MH, 1991, FEBS LETT, V290, P177, DOI 10.1016/0014-5793(91)81254-6; Serrano A, 2004, J BIOENERG BIOMEMBR, V36, P127, DOI 10.1023/B:JOBB.0000019604.49875.b3; TAKESHIGE K, 1988, PLANT CELL PHYSIOL, V29, P649; WU JJ, 1991, FEBS LETT, V283, P57, DOI 10.1016/0014-5793(91)80552-E; Yang SJ, 2000, BBA-BIOENERGETICS, V1460, P375, DOI 10.1016/S0005-2728(00)00203-6; Yang SJ, 1999, BIOCHEM J, V342, P641, DOI 10.1042/0264-6021:3420641; Zhen RG, 1997, J BIOL CHEM, V272, P22340, DOI 10.1074/jbc.272.35.22340	35	13	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.190215	http://dx.doi.org/10.1074/jbc.M110.190215			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21292767	Green Published, hybrid			2022-12-27	WOS:000289077500010
J	Takahashi, M; Koi, M; Balaguer, F; Boland, CR; Goel, A				Takahashi, Masanobu; Koi, Minoru; Balaguer, Francesc; Boland, C. Richard; Goel, Ajay			MSH3 Mediates Sensitization of Colorectal Cancer Cells to Cisplatin, Oxaliplatin, and a Poly(ADP-ribose) Polymerase Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERSTRAND CROSS-LINKS; MISMATCH-REPAIR SYSTEM; MICROSATELLITE-INSTABILITY; COLON-CANCER; ADJUVANT THERAPY; MUTANT-CELLS; DNA ADDUCTS; FLUOROURACIL; RECOGNITION; CARCINOMA	The MSH3 gene is one of the DNA mismatch repair (MMR) genes that has undergone somatic mutation frequently in MMR-deficient cancers. MSH3, together with MSH2, forms the MutS beta heteroduplex, which interacts with interstrand cross-links (ICLs) induced by drugs such as cisplatin and psoralen. However, the precise role of MSH3 in mediating the cytotoxic effects of ICL-inducing agents remains poorly understood. In this study, we first examined the effects of MSH3 deficiency on cytotoxicity caused by cisplatin and oxaliplatin, another ICL-inducing platinum drug. Using isogenic HCT116-derived clones in which MSH3 expression is controlled by shRNA expression in a Tet-off system, we discovered that MSH3 deficiency sensitized cells to both cisplatin and oxaliplatin at clinically relevant doses. Interestingly, siRNA-induced down-regulation of the MLH1 protein did not affect MSH3-dependent toxicity of these drugs, indicating that this process does not require participation of the canonical MMR pathway. Furthermore, MSH3-deficient cells maintained higher levels of phosphorylated histone H2AX and 53BP1 after oxaliplatin treatment in comparison with MSH3-proficient cells, suggesting that MSH3 plays an important role in repairing DNA double strand breaks (DSBs). This role of MSH3 was further supported by our findings that MSH3-deficient cells were sensitive to olaparib, a poly(ADP-ribose) polymerase inhibitor. Moreover, the combination of oxaliplatin and olaparib exhibited a synergistic effect compared with either treatment individually. Collectively, our results provide novel evidence that MSH3 deficiency contributes to the cytotoxicity of platinum drugs through deficient DSB repair. These data lay the foundation for the development of effective prediction and treatments for cancers with MSH3 deficiency.	[Koi, Minoru] Baylor Univ, Med Ctr, Charles A Sammons Canc Ctr,Dept Internal Med, Gastrointestinal Canc Res Lab,Div Gastroenterol, Dallas, TX 75246 USA; Baylor Univ, Med Ctr, Baylor Res Inst, Dallas, TX 75246 USA	Baylor University; Baylor University Medical Center; Baylor Scott & White Health; Baylor University; Baylor University Medical Center	Koi, M (corresponding author), Baylor Univ, Med Ctr, Charles A Sammons Canc Ctr,Dept Internal Med, Gastrointestinal Canc Res Lab,Div Gastroenterol, Dallas, TX 75246 USA.	minoruk@baylorhealth.edu; rickbo@baylorhealth.edu; ajay.goel@baylorhealth.edu	Koi, Minoru/C-3489-2012; Balaguer, Francesc/GPX-7801-2022; BALAGUER, FRANCESC/G-2389-2016; Koi, Minoru/G-9197-2014	Balaguer, Francesc/0000-0002-0206-0539; Goel, Ajay/0000-0003-1396-6341	NCI, National Institutes of Health [R01 CA72851, CA129286]; Baylor Research Institute; Cell Science Research Foundation; Charles Sammons Cancer Center; NATIONAL CANCER INSTITUTE [R01CA072851, R01CA129286] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Baylor Research Institute; Cell Science Research Foundation(Cell Science Research Foundation, Japan); Charles Sammons Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by NCI, National Institutes of Health Grants R01 CA72851 and CA129286. This work was also supported by funds from the Baylor Research Institute (to C. R. B. and A.G.).; Supported by a grant from the Cell Science Research Foundation.; Supported by funds from an institutional grant from Charles Sammons Cancer Center.	Abuin A, 2000, MOL CELL BIOL, V20, P149, DOI 10.1128/MCB.20.1.149-157.2000; Bertagnolli MM, 2009, J CLIN ONCOL, V27, P1814, DOI 10.1200/JCO.2008.18.2071; Black D, 2006, J CLIN ONCOL, V24, P1745, DOI 10.1200/JCO.2005.04.1574; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Chaney SG, 2005, CRIT REV ONCOL HEMAT, V53, P3, DOI 10.1016/j.critrevonc.2004.08.008; de Wind N, 1999, NAT GENET, V23, P359, DOI 10.1038/15544; Duckett DR, 1996, P NATL ACAD SCI USA, V93, P6443, DOI 10.1073/pnas.93.13.6443; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Haugen AC, 2008, CANCER RES, V68, P8465, DOI 10.1158/0008-5472.CAN-08-0002; HAWN MT, 1995, CANCER RES, V55, P3721; Hendriks YMC, 2006, CA-CANCER J CLIN, V56, P213, DOI 10.3322/canjclin.56.4.213; Hewish M, 2010, NAT REV CLIN ONCOL, V7, P197, DOI 10.1038/nrclinonc.2010.18; Hinz JM, 2010, ENVIRON MOL MUTAGEN, V51, P582, DOI 10.1002/em.20577; Hong Z, 2008, J CELL SCI, V121, P3146, DOI 10.1242/jcs.026393; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Kohonen-Corish MRJ, 2005, J CLIN ONCOL, V23, P2318, DOI 10.1200/JCO.2005.00.109; KOI M, 1994, CANCER RES, V54, P4308; Kucherlapati MH, 2010, GASTROENTEROLOGY, V138, P993, DOI 10.1053/j.gastro.2009.11.009; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; McEllin B, 2010, CANCER RES, V70, P5457, DOI 10.1158/0008-5472.CAN-09-4295; Mendes-Pereira AM, 2009, EMBO MOL MED, V1, P315, DOI 10.1002/emmm.200900041; Miquel C, 2007, ONCOGENE, V26, P5919, DOI 10.1038/sj.onc.1210419; Nehme A, 1999, BRIT J CANCER, V79, P1104, DOI 10.1038/sj.bjc.6690176; Pal T, 2008, CLIN CANCER RES, V14, P6847, DOI 10.1158/1078-0432.CCR-08-1387; Plaschke J, 2004, CANCER RES, V64, P864, DOI 10.1158/0008-5472.CAN-03-2807; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Reynolds MF, 2009, CANCER RES, V69, P1071, DOI 10.1158/0008-5472.CAN-08-2306; Ribic CM, 2003, NEW ENGL J MED, V349, P247, DOI 10.1056/NEJMoa022289; Rodriguez R, 2008, CLIN CANCER RES, V14, P5476, DOI 10.1158/1078-0432.CCR-08-0274; Sargent DJ, 2010, J CLIN ONCOL, V28, P3219, DOI 10.1200/JCO.2009.27.1825; Tejpar S, 2009, J CLIN ONCOL, V27; Vaisman A, 1998, CANCER RES, V58, P3579; Vasquez KM, 2010, ENVIRON MOL MUTAGEN, V51, P527, DOI 10.1002/em.20557; Vilar E, 2008, BRIT J CANCER, V99, P1607, DOI 10.1038/sj.bjc.6604691; Wright CM, 2005, GUT, V54, P103, DOI 10.1136/gut.2003.034579; Wu Q, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000189; Zhang NX, 2007, DNA REPAIR, V6, P1670, DOI 10.1016/j.dnarep.2007.06.002; Zhang NX, 2002, MOL CELL BIOL, V22, P2388, DOI 10.1128/MCB.22.7.2388-2397.2002; Zhao JH, 2009, NUCLEIC ACIDS RES, V37, P4420, DOI 10.1093/nar/gkp399; Zhu GY, 2009, BIOCHEMISTRY-US, V48, P4916, DOI 10.1021/bi900389b	42	62	63	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.198804	http://dx.doi.org/10.1074/jbc.M110.198804			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21285347	hybrid, Green Published			2022-12-27	WOS:000289077500031
J	Chen, CXJ; Soto, I; Guo, YL; Liu, YA				Chen, Celia X. -J.; Soto, Ileana; Guo, Ya-Lan; Liu, Yuan			Control of Secondary Granule Release in Neutrophils by Ral GTPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIVO PROTEIN TRANSDUCTION; PHOSPHOINOSITIDE 3-KINASE; TYROSINE KINASES; RAP2 PROTEINS; SIRP-ALPHA; ACTIVATION; TRANSMIGRATION; RECEPTOR; ADHESION; MIGRATION	Neutrophil (polymorphonuclear leukocyte; PMN) inflammatory functions, including cell adhesion, diapedesis, and phagocytosis, are dependent on the mobilization and release of various intracellular granules/vesicles. In this study, we found that treating PMN with damnacanthal, a Ras family GTPase inhibitor, resulted in a specific release of secondary granules but not primary or tertiary granules and caused dysregulation of PMN chemotactic transmigration and cell surface protein interactions. Analysis of the activities of Ras members identified Ral GTPase as a key regulator during PMN activation and degranulation. In particular, Ral was active in freshly isolated PMN, whereas chemoattractant stimulation induced a quick deactivation of Ral that correlated with PMN degranulation. Overexpression of a constitutively active Ral (Ral23V) in PMN inhibited chemoattractant-induced secondary granule release. By subcellular fractionation, we found that Ral, which was associated with the plasma membrane under the resting condition, was redistributed to secondary granules after chemoattractant stimulation. Blockage of cell endocytosis appeared to inhibit Ral translocation intracellularly. In conclusion, these results demonstrate that Ral is a critical regulator in PMN that specifically controls secondary granule release during PMN response to chemoattractant stimulation.	[Chen, Celia X. -J.; Soto, Ileana; Guo, Ya-Lan; Liu, Yuan] Georgia State Univ, Dept Biol, Program Cell & Mol Biol & Physiol, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University	Liu, YA (corresponding author), Georgia State Univ, Dept Biol, Program Cell & Mol Biol & Physiol, POB 4010, Atlanta, GA 30303 USA.	yliu@gsu.edu		Mauldin, Ileana/0000-0002-9318-8342	National Institutes of Health [AI073622]; American Heart Association [0565251B]; American Cancer Society [RSG-09-193-01-LIB]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI073622] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health R21 Grant AI073622. This study was also supported in part by Beginning Grant-in-aid 0565251B from the American Heart Association and Research Scholar Grant RSG-09-193-01-LIB from the American Cancer Society.	Abdel-Latif D, 2004, BLOOD, V104, P832, DOI 10.1182/blood-2003-07-2624; Balasubramanian N, 2010, CURR BIOL, V20, P75, DOI 10.1016/j.cub.2009.11.016; Benmerah A, 1998, J CELL BIOL, V140, P1055, DOI 10.1083/jcb.140.5.1055; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; Borregaard N, 2007, TRENDS IMMUNOL, V28, P340, DOI 10.1016/j.it.2007.06.002; Brumelll JH, 1996, J BIOL CHEM, V271, P1455, DOI 10.1074/jbc.271.3.1455; Bruyninckx WJ, 2001, BLOOD, V97, P3251, DOI 10.1182/blood.V97.10.3251; Brymora A, 2001, J BIOL CHEM, V276, P29792, DOI 10.1074/jbc.C100320200; Butterfield TA, 2006, J ATHL TRAINING, V41, P457; Choi M, 2003, BLOOD, V102, P2259, DOI 10.1182/blood-2002-09-2960; Cicchetti G, 2002, CRIT REV ORAL BIOL M, V13, P220, DOI 10.1177/154411130201300302; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; de Vries HE, 2002, J IMMUNOL, V168, P5832, DOI 10.4049/jimmunol.168.11.5832; FALTYNEK CR, 1995, BIOCHEMISTRY-US, V34, P12404, DOI 10.1021/bi00038a038; Faurschou M, 2003, MICROBES INFECT, V5, P1317, DOI 10.1016/j.micinf.2003.09.008; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; Gao XP, 2007, J BIOL CHEM, V282, P6116, DOI 10.1074/jbc.M610248200; Hinoi T, 1996, J BIOL CHEM, V271, P19710, DOI 10.1074/jbc.271.33.19710; HIRAMATSU T, 1993, CANCER LETT, V73, P161, DOI 10.1016/0304-3835(93)90259-C; Hiwasa T, 1997, NEUROSCI LETT, V238, P115, DOI 10.1016/S0304-3940(97)00861-6; Joliot A, 2004, NAT CELL BIOL, V6, P189, DOI 10.1038/ncb0304-189; Jullien-Flores V, 2000, J CELL SCI, V113, P2837; JULLIENFLORES V, 1995, J BIOL CHEM, V270, P22473, DOI 10.1074/jbc.270.38.22473; Kawai M, 2003, HYPERTENSION, V41, P956, DOI 10.1161/01.HYP.0000063884.36641.63; Kelly M, 2007, J ALLERGY CLIN IMMUN, V120, P3, DOI 10.1016/j.jaci.2007.05.017; Kobayashi SD, 2003, MICROBES INFECT, V5, P1337, DOI 10.1016/j.micinf.2003.09.013; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Liu Y, 2002, J BIOL CHEM, V277, P10028, DOI 10.1074/jbc.M109720200; Liu Y, 2004, J IMMUNOL, V172, P7, DOI 10.4049/jimmunol.172.1.7; Liu Y, 2000, J CELL SCI, V113, P2363; Liu Y, 2005, J BIOL CHEM, V280, P36132, DOI 10.1074/jbc.M506419200; Liu Y, 2001, J BIOL CHEM, V276, P40156, DOI 10.1074/jbc.M104138200; Liu Y, 2007, J MOL BIOL, V365, P680, DOI 10.1016/j.jmb.2006.09.079; M'Rabet L, 1999, J BIOL CHEM, V274, P21847, DOI 10.1074/jbc.274.31.21847; Macaluso M, 2002, J CELL PHYSIOL, V192, P125, DOI 10.1002/jcp.10109; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Makino A, 2005, AM J PHYSIOL-CELL PH, V288, pC863, DOI 10.1152/ajpcell.00358.2004; MARIDONNEAUPARINI I, 1992, J BIOL CHEM, V267, P6396; Mayadas TN, 2005, TRENDS IMMUNOL, V26, P388, DOI 10.1016/j.it.2005.05.002; Mocsai A, 2000, J IMMUNOL, V164, P4321, DOI 10.4049/jimmunol.164.8.4321; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; MOLLINEDO F, 1993, FEBS LETT, V326, P209, DOI 10.1016/0014-5793(93)81792-X; Nourshargh S, 2005, TRENDS IMMUNOL, V26, P157, DOI 10.1016/j.it.2005.01.006; Oxford G, 2003, CANCER LETT, V189, P117, DOI 10.1016/S0304-3835(02)00510-4; Parkos CA, 1997, AM J PHYSIOL-GASTR L, V273, pG763, DOI 10.1152/ajpgi.1997.273.4.G763; Parkos CA, 1996, J CELL BIOL, V132, P437, DOI 10.1083/jcb.132.3.437; Polzin A, 2002, MOL CELL BIOL, V22, P1714, DOI 10.1128/MCB.22.6.1714-1722.2002; SANDVIG K, 1987, J CELL BIOL, V105, P679, DOI 10.1083/jcb.105.2.679; SANDVIG K, 1988, J CELL BIOCHEM, V36, P73, DOI 10.1002/jcb.240360108; Schwarze SR, 2000, TRENDS CELL BIOL, V10, P290, DOI 10.1016/S0962-8924(00)01771-2; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Schwarze SR, 2000, TRENDS PHARMACOL SCI, V21, P45, DOI 10.1016/S0165-6147(99)01429-7; van Bergen En Henegouwen P. M., 2009, CELL COMMUN SIGNAL, V7, P24; Vitale N, 2005, J BIOL CHEM, V280, P29921, DOI 10.1074/jbc.M413748200; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Wolfe BL, 2007, TRAFFIC, V8, P462, DOI 10.1111/j.1600-0854.2007.00551.x; Wolthuis RMF, 1998, MOL CELL BIOL, V18, P2486, DOI 10.1128/MCB.18.5.2486; Zen K, 2006, J IMMUNOL METHODS, V309, P86, DOI 10.1016/j.jim.2005.11.014; Zen K, 2008, IMMUNOBIOLOGY, V213, P13, DOI 10.1016/j.imbio.2007.07.001	59	9	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11724	11733		10.1074/jbc.M110.154203	http://dx.doi.org/10.1074/jbc.M110.154203			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21282111	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000288797100080
J	Cheng, E; Haque, A; Rimmer, MA; Hussein, ITM; Sheema, S; Little, A; Mir, MA				Cheng, Erdong; Haque, Absarul; Rimmer, Mary Ashley; Hussein, Islam T. M.; Sheema, Sheema; Little, Alex; Mir, Mohammad A.			Characterization of the Interaction between Hantavirus Nucleocapsid Protein (N) and Ribosomal Protein S19 (RPS19)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-INDUCED ACTIVATION; SIN NOMBRE HANTAVIRUS; VIRAL-RNA PANHANDLE; HARE BUNYAVIRUS S; MESSENGER-RNA; 5 ENDS; P-PROTEINS; VIRUS; BINDING; GENOME	Hantaviruses, members of the Bunyaviridae family, are negative-stranded emerging RNA viruses and category A pathogens that cause serious illness when transmitted to humans through aerosolized excreta of infected rodent hosts. Hantaviruses have evolved a novel translation initiation mechanism, operated by nucleocapsid protein (N), which preferentially facilitates the translation of viral mRNAs. N binds to the ribosomal protein S19 (RPS19), a structural component of the 40 S ribosomal subunit. In addition, N also binds to both the viral mRNA 5' cap and a highly conserved triplet repeat sequence of the viral mRNA 5' UTR. The simultaneous binding of N at both the terminal cap and the 5' UTR favors ribosome loading on viral transcripts during translation initiation. We characterized the binding between N and RPS19 and demonstrate the role of the N-RPS19 interaction in N-mediated translation initiation mechanism. We show that N specifically binds to RPS19 with high affinity and a binding stoichiometry of 1:1. The N-RPS19 interaction is an enthalpy-driven process. RPS19 undergoes a conformational change after binding to N. Using T7 RNA polymerase, we synthesized the hantavirus S segment mRNA, which matches the transcript generated by the viral RNA-dependent RNA polymerase in cells. We show that the N-RPS19 interaction plays a critical role in the translation of this mRNA both in cells and rabbit reticulocyte lysates. Our results demonstrate that the N-mediated translation initiation mechanism, which lures the host translation machinery for the preferential translation of viral transcripts, primarily depends on the N-RPS19 interaction. We suggest that the N-RPS19 interaction is a novel target to shut down the N-mediated translation strategy and hence virus replication in cells.	[Cheng, Erdong; Haque, Absarul; Rimmer, Mary Ashley; Hussein, Islam T. M.; Sheema, Sheema; Little, Alex; Mir, Mohammad A.] Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center	Mir, MA (corresponding author), Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, 4022 Orr Major,3901 Rainbow Blvd, Kansas City, KS 66103 USA.	mmir@kumc.edu	HAQUE, ABSARUL/H-9610-2012	Mir, Sheema/0000-0001-7279-8734	National Institutes of Health [RAI083672Z, P20 RR016443]; Centers of Biomedical Research Excellence grant; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083672] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers of Biomedical Research Excellence grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants RAI083672Z and P20 RR016443, a Centers of Biomedical Research Excellence grant (to the Department of Microbiology, Molecular Genetics, and Immunology, Kansas University Medical Center).	Alfadhli A, 2002, J BIOL CHEM, V277, P27103, DOI 10.1074/jbc.M203395200; Alfadhli A, 2001, J VIROL, V75, P2019, DOI 10.1128/JVI.75.4.2019-2023.2001; Balvay L, 2009, BBA-GENE REGUL MECH, V1789, P542, DOI 10.1016/j.bbagrm.2009.07.005; Battisti AJ, 2011, J VIROL, V85, P835, DOI 10.1128/JVI.01847-10; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; BISHOP DHL, 1983, NUCLEIC ACIDS RES, V11, P6409, DOI 10.1093/nar/11.18.6409; Blakqori G, 2003, J GEN VIROL, V84, P1207, DOI 10.1099/vir.0.18876-0; Botten J, 2000, P NATL ACAD SCI USA, V97, P10578, DOI 10.1073/pnas.180197197; Botten J, 2003, J VIROL, V77, P1540, DOI 10.1128/JVI.77.2.1540-1550.2002; BOULOY M, 1990, VIROLOGY, V175, P50, DOI 10.1016/0042-6822(90)90185-T; BRAAM J, 1983, CELL, V34, P609; Bridgen A, 1996, P NATL ACAD SCI USA, V93, P15400, DOI 10.1073/pnas.93.26.15400; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; CATON AJ, 1980, NUCLEIC ACIDS RES, V8, P2591, DOI 10.1093/nar/8.12.2591; Das S, 2005, J INORG BIOCHEM, V99, P707, DOI 10.1016/j.jinorgbio.2004.11.027; DHAR R, 1980, CELL, V21, P495, DOI 10.1016/0092-8674(80)90486-9; Draptchinskaia N, 1999, NAT GENET, V21, P169, DOI 10.1038/5951; ESHITA Y, 1985, J VIROL, V55, P681, DOI 10.1128/JVI.55.3.681-689.1985; Gale M, 2000, MICROBIOL MOL BIOL R, V64, P239, DOI 10.1128/MMBR.64.2.239-280.2000; GARCIN D, 1995, J VIROL, V69, P5754, DOI 10.1128/JVI.69.9.5754-5762.1995; GOTT P, 1993, VIROLOGY, V194, P332, DOI 10.1006/viro.1993.1263; Haque A, 2010, J VIROL, V84, P12450, DOI 10.1128/JVI.01388-10; HELLEN CUT, 1994, J VIROL, V68, P6312, DOI 10.1128/JVI.68.10.6312-6322.1994; Hemmings-Mieszczak M, 1998, RNA, V4, P101; Ikegami T, 2005, J VIROL, V79, P5606, DOI 10.1128/JVI.79.9.5606-5615.2005; JIN H, 1993, J GEN VIROL, V74, P2293, DOI 10.1099/0022-1317-74-10-2293; Jonsson CB, 2001, CURR TOP MICROBIOL, V256, P15; Jonsson CB, 2001, PROTEIN EXPRES PURIF, V23, P134, DOI 10.1006/prep.2001.1489; Kohl A, 2004, J VIROL, V78, P5679, DOI 10.1128/JVI.78.11.5679-5685.2004; Lakowitcz J.R, 1999, PRINCIPLES FLUORESCE, P237, DOI DOI 10.1007/978-1-4757-3061-6_8; Mir MA, 2006, J VIROL, V80, P11283, DOI 10.1128/JVI.00820-06; Mir MA, 2008, P NATL ACAD SCI USA, V105, P19294, DOI 10.1073/pnas.0807211105; Mir MA, 2006, RNA, V12, P272, DOI 10.1261/rna.2101906; Mir MA, 2005, J VIROL, V79, P1824, DOI 10.1128/JVI.79.3.1824-1835.2005; Mir MA, 2004, J VIROL, V78, P8281, DOI 10.1128/jvi.78.15.8281-8288.2004; Mir MA, 2001, BIOCHEMISTRY-US, V40, P11578, DOI 10.1021/bi010731r; Mir MA, 2010, J VIROL, V84, P8937, DOI 10.1128/JVI.02720-09; Mir MA, 2010, J BIOL CHEM, V285, P11357, DOI 10.1074/jbc.M110.102459; Mir MA, 2008, EMBO J, V27, P3129, DOI 10.1038/emboj.2008.228; OBIJESKI JF, 1976, J VIROL, V19, P985, DOI 10.1128/JVI.19.3.985-997.1976; Osborne JC, 2000, J VIROL, V74, P9946, DOI 10.1128/JVI.74.21.9946-9952.2000; Padmanabhan U, 2001, J BIOL CHEM, V276, P43635, DOI 10.1074/jbc.M107531200; PATTERSON JL, 1984, J VIROL, V52, P215, DOI 10.1128/JVI.52.1.215-222.1984; PATTERSON JL, 1984, J VIROL, V49, P680, DOI 10.1128/JVI.49.3.680-685.1984; PETTERSSON RF, 1975, J VIROL, V15, P386, DOI 10.1128/JVI.15.2.386-392.1975; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; RAJU R, 1987, J VIROL, V61, P667, DOI 10.1128/JVI.61.3.667-672.1987; RAJU R, 1986, VIRUS RES, V5, P1, DOI 10.1016/0168-1702(86)90061-4; RAJU R, 1989, J VIROL, V63, P122, DOI 10.1128/JVI.63.1.122-128.1989; RAJU R, 1990, VIROLOGY, V174, P53, DOI 10.1016/0042-6822(90)90053-T; Schmaljohn C, 2001, FIELDS VIROLOGY, P1581; Schmaljohn C. M., 1996, MOL BIOL HANTAVIRUSE, P1; Severson W, 2005, J VIROL, V79, P10032, DOI 10.1128/JVI.79.15.10032-10039.2005; Severson W, 1999, J BIOL CHEM, V274, P33732, DOI 10.1074/jbc.274.47.33732; Severson WE, 2001, J VIROL, V75, P2646, DOI 10.1128/JVI.75.6.2646-2652.2001; SIMONS JF, 1991, J VIROL, V65, P4741, DOI 10.1128/JVI.65.9.4741-4748.1991; Taylor DJ, 2009, STRUCTURE, V17, P1591, DOI 10.1016/j.str.2009.09.015; Taylor SL, 2009, ANN NY ACAD SCI, V1171, pE86, DOI 10.1111/j.1749-6632.2009.05049.x; Taylor SL, 2009, J VIROL, V83, P1271, DOI 10.1128/JVI.00986-08; ULMANEN I, 1981, P NATL ACAD SCI-BIOL, V78, P7355, DOI 10.1073/pnas.78.12.7355; WANG JL, 1971, J BIOL CHEM, V246, P1185; WIMMER E, 1993, ANNU REV GENET, V27, P353, DOI 10.1146/annurev.ge.27.120193.002033	62	32	32	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11814	11824		10.1074/jbc.M110.210179	http://dx.doi.org/10.1074/jbc.M110.210179			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21296889	Green Published, hybrid			2022-12-27	WOS:000288797100088
J	Khrapunovich-Baine, M; Menon, V; Yang, CPH; Northcote, PT; Miller, JH; Angeletti, RH; Fiser, A; Horwitz, SB; Xiao, H				Khrapunovich-Baine, Marina; Menon, Vilas; Yang, Chia-Ping Huang; Northcote, Peter T.; Miller, John H.; Angeletti, Ruth Hogue; Fiser, Andras; Horwitz, Susan Band; Xiao, Hui			Hallmarks of Molecular Action of Microtubule Stabilizing Agents EFFECTS OF EPOTHILONE B, IXABEPILONE, PELORUSIDE A, AND LAULIMALIDE ON MICROTUBULE CONFORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							III BETA-TUBULIN; TAXOID SITE; ELECTRON CRYSTALLOGRAPHY; CELLS RESISTANT; BINDING AGENTS; CANCER-CELLS; BOVINE BRAIN; IN-VITRO; PACLITAXEL; DYNAMICS	Microtubule stabilizing agents (MSAs) comprise a class of drugs that bind to microtubule (MT) polymers and stabilize them against disassembly. Several of these agents are currently in clinical use as anticancer drugs, whereas others are in various stages of development. Nonetheless, there is insufficient knowledge about the molecular modes of their action. Recent studies from our laboratory utilizing hydrogen-deuterium exchange in combination with mass spectrometry (MS) provide new information on the conformational effects of Taxol and discodermolide on microtubules isolated from chicken erythrocytes (CET). We report here a comprehensive analysis of the effects of epothilone B, ixabepilone (IXEMPRA (TM)), laulimalide, and peloruside A on CET conformation. The results of our comparative hydrogen-deuterium exchange MS studies indicate that all MSAs have significant conformational effects on the C-terminal H12 helix of alpha-tubulin, which is a likely molecular mechanism for the previously observed modulations of MT interactions with microtubule-associated and motor proteins. More importantly, the major mode of MT stabilization by MSAs is the tightening of the longitudinal interactions between two adjacent alpha beta-tubulin heterodimers at the interdimer interface. In contrast to previous observations reported with bovine brain tubulin, the lateral interactions between the adjacent protofilaments in CET are particularly strongly stabilized by peloruside A and laulimalide, drugs that bind outside the taxane site. This not only highlights the significance of tubulin isotype composition in modulating drug effects on MT conformation and stability but also provides a potential explanation for the synergy observed when combinations of taxane and alternative site binding drugs are used.	[Khrapunovich-Baine, Marina; Yang, Chia-Ping Huang; Horwitz, Susan Band] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; [Menon, Vilas; Fiser, Andras] Albert Einstein Coll Med, Dept Syst & Computat Biol, Bronx, NY 10461 USA; [Angeletti, Ruth Hogue; Xiao, Hui] Albert Einstein Coll Med, Lab Macromol Anal & Prote, Bronx, NY 10461 USA; [Northcote, Peter T.; Miller, John H.] Victoria Univ Wellington, Ctr Biodiscovery, Wellington 6012, New Zealand	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Victoria University Wellington	Horwitz, SB (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA.	susan.horwitz@einstein.yu.edu	Baine, Marina/GPC-8924-2022; Menon, Vilas/AAG-4109-2021	Baine, Marina/0000-0003-4939-6491; Menon, Vilas/0000-0002-4096-8601	National Institutes of Health [CA124898 (NCI)]; National Foundation for Cancer Research; PhRMA Foundation; NATIONAL CANCER INSTITUTE [R01CA124898] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019891, S10RR019352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096041, T32GM007288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Foundation for Cancer Research; PhRMA Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA124898 (NCI) (to S. B. H.). This work was also supported by the National Foundation for Cancer Research (to S. B. H.).; Supported by a predoctoral fellowship in pharmacology/toxicology from the PhRMA Foundation.	Al-Bassam J, 2002, J CELL BIOL, V157, P1187, DOI 10.1083/jcb.200201048; BANERJEE A, 1992, J BIOL CHEM, V267, P5625; BANERJEE A, 1990, J BIOL CHEM, V265, P1794; Bennett MJ, 2009, BIOCHEMISTRY-US, V48, P4858, DOI 10.1021/bi900200q; Bode CJ, 2002, BIOCHEMISTRY-US, V41, P3870, DOI 10.1021/bi0121611; BOLLAG DM, 1995, CANCER RES, V55, P2325; Clark EA, 2006, MOL PHARMACEUT, V3, P457, DOI 10.1021/mp060016h; Derry WB, 1997, BIOCHEMISTRY-US, V36, P3554, DOI 10.1021/bi962724m; Field JJ, 2009, J MED CHEM, V52, P7328, DOI 10.1021/jm901249g; Gaitanos TN, 2004, CANCER RES, V64, P5063, DOI 10.1158/0008-5472.CAN-04-0771; Ganesh T, 2004, P NATL ACAD SCI USA, V101, P10006, DOI 10.1073/pnas.0403459101; Gapud EJ, 2004, MOL PHARMACOL, V66, P113, DOI 10.1124/mol.66.1.113; Geney R, 2005, CHEM BIOL, V12, P339, DOI 10.1016/j.chembiol.2005.01.004; Giannakakou P, 2000, P NATL ACAD SCI USA, V97, P2904, DOI 10.1073/pnas.040546297; Giannakakou P, 1997, J BIOL CHEM, V272, P17118, DOI 10.1074/jbc.272.27.17118; Hamel E, 2006, MOL PHARMACOL, V70, P1555, DOI 10.1124/mol.106.027847; Huzil JT, 2008, J MOL BIOL, V378, P1016, DOI 10.1016/j.jmb.2008.03.026; HYMAN AA, 1992, MOL BIOL CELL, V3, P1155, DOI 10.1091/mbc.3.10.1155; Kar S, 2003, FEBS LETT, V539, P34, DOI 10.1016/S0014-5793(03)00181-9; Katsetos CD, 2003, CELL MOTIL CYTOSKEL, V55, P77, DOI 10.1002/cm.10116; Katsetos CD, 2009, J CELL PHYSIOL, V221, P505, DOI 10.1002/jcp.21870; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Khrapunovich-Baine M, 2009, BIOCHEMISTRY-US, V48, P11664, DOI 10.1021/bi901351q; Kowalski RJ, 1997, J BIOL CHEM, V272, P2534; Lee KM, 2007, HISTOPATHOLOGY, V51, P539, DOI 10.1111/j.1365-2559.2007.02792.x; Li YK, 2000, BIOCHEMISTRY-US, V39, P281, DOI 10.1021/bi991936r; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; LU Q, 1994, J BIOL CHEM, V269, P2041; LU Q, 1993, CELL STRUCT FUNCT, V18, P173, DOI 10.1247/csf.18.173; Makrides V, 2004, P NATL ACAD SCI USA, V101, P6746, DOI 10.1073/pnas.0400992101; Mizuno N, 2004, EMBO J, V23, P2459, DOI 10.1038/sj.emboj.7600240; MURPHY DB, 1983, J BIOL CHEM, V258, P8357; Nettles JH, 2004, SCIENCE, V305, P866, DOI 10.1126/science.1099190; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Nogales E, 2006, CURR OPIN STRUC BIOL, V16, P221, DOI 10.1016/j.sbi.2006.03.005; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; Orr GA, 2003, ONCOGENE, V22, P7280, DOI 10.1038/sj.onc.1206934; PANDA D, 1994, P NATL ACAD SCI USA, V91, P11358, DOI 10.1073/pnas.91.24.11358; Pineda O, 2004, BIOORG MED CHEM LETT, V14, P4825, DOI 10.1016/j.bmcl.2004.07.053; Pryor DE, 2002, BIOCHEMISTRY-US, V41, P9109, DOI 10.1021/bi020211b; Rowinsky EK, 1997, ANNU REV MED, V48, P353; RUDIGER M, 1993, EUR J BIOCHEM, V218, P107, DOI 10.1111/j.1432-1033.1993.tb18357.x; Rusan NM, 2001, MOL BIOL CELL, V12, P971, DOI 10.1091/mbc.12.4.971; Seve P, 2008, LANCET ONCOL, V9, P168, DOI 10.1016/S1470-2045(08)70029-9; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Uchimura S, 2006, EMBO J, V25, P5932, DOI 10.1038/sj.emboj.7601442; Uchimura S, 2010, EMBO J, V29, P1167, DOI 10.1038/emboj.2010.25; West LM, 2000, J ORG CHEM, V65, P445, DOI 10.1021/jo991296y; Wilmes A, 2007, MOL PHARM, V4, P269, DOI 10.1021/mp060101p; Xia SJ, 2006, BIOCHEMISTRY-US, V45, P11762, DOI 10.1021/bi060497a; Xiao H, 2006, P NATL ACAD SCI USA, V103, P10166, DOI 10.1073/pnas.0603704103	52	54	55	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11765	11778		10.1074/jbc.M110.162214	http://dx.doi.org/10.1074/jbc.M110.162214			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21245138	Green Published, hybrid			2022-12-27	WOS:000288797100084
J	Lemke, CT; Goudreau, N; Zhao, SP; Hucke, O; Thibeault, D; Llinas-Brunet, M; White, PW				Lemke, Christopher T.; Goudreau, Nathalie; Zhao, Songping; Hucke, Oliver; Thibeault, Diane; Llinas-Brunet, Montse; White, Peter W.			Combined X-ray, NMR, and Kinetic Analyses Reveal Uncommon Binding Characteristics of the Hepatitis C Virus NS3-NS4A Protease Inhibitor BI 201335	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NS3 PROTEASE; SERINE-PROTEASE; ACTIVE-SITE; CRYSTAL-STRUCTURE; HCV INFECTION; HYDROGEN-BOND; COFACTOR; PEPTIDE; POTENT; DOMAIN	Hepatitis C virus infection, a major cause of liver disease worldwide, is curable, but currently approved therapies have suboptimal efficacy. Supplementing these therapies with direct-acting antiviral agents has the potential to considerably improve treatment prospects for hepatitis C virus-infected patients. The critical role played by the viral NS3 protease makes it an attractive target, and despite its shallow, solvent-exposed active site, several potent NS3 protease inhibitors are currently in the clinic. BI 201335, which is progressing through Phase IIb trials, contains a unique C-terminal carboxylic acid that binds noncovalently to the active site and a bromo-quinoline substitution on its proline residue that provides significant potency. In this work we have used stopped flow kinetics, x-ray crystallography, and NMR to characterize these distinctive features. Key findings include: slow association and dissociation rates within a single-step binding mechanism; the critical involvement of water molecules in acid binding; and protein side chain rearrangements, a bromine-oxygen halogen bond, and profound pK(a) changes within the catalytic triad associated with binding of the bromoquinoline moiety.	[Lemke, Christopher T.; Goudreau, Nathalie; Zhao, Songping; Hucke, Oliver; Thibeault, Diane; Llinas-Brunet, Montse; White, Peter W.] Boehringer Ingelheim Canada Ltd, Res & Dev, Laval, PQ H7S 2G5, Canada	Boehringer Ingelheim	Lemke, CT (corresponding author), Boehringer Ingelheim Canada Ltd, Res & Dev, 2100 Cunard St, Laval, PQ H7S 2G5, Canada.	christopher.lemke@boehringer-ingelheim.com						Auffinger P, 2004, P NATL ACAD SCI USA, V101, P16789, DOI 10.1073/pnas.0407607101; Barbato G, 1999, J MOL BIOL, V289, P371, DOI 10.1006/jmbi.1999.2745; BARTENSCHLAGER R, 1995, J VIROL, V69, P7519, DOI 10.1128/JVI.69.12.7519-7528.1995; BONDI A, 1964, J PHYS CHEM-US, V68, P441, DOI 10.1021/j100785a001; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Butkiewicz N, 2000, J VIROL, V74, P4291, DOI 10.1128/JVI.74.9.4291-4301.2000; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Cummings MD, 2010, ANGEW CHEM INT EDIT, V49, P1652, DOI 10.1002/anie.200906696; Dahl G, 2009, BIOCHEMISTRY-US, V48, P11592, DOI 10.1021/bi9016928; DeSantis G, 1998, J AM CHEM SOC, V120, P8582, DOI 10.1021/ja980072e; Di Marco S, 2000, J BIOL CHEM, V275, P7152, DOI 10.1074/jbc.275.10.7152; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gallinari P, 1998, J VIROL, V72, P6758, DOI 10.1128/JVI.72.8.6758-6769.1998; Gallo M, 2009, J MOL BIOL, V385, P1142, DOI 10.1016/j.jmb.2008.11.017; Gentile I, 2009, CURR MED CHEM, V16, P1115, DOI 10.2174/092986709787581789; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Goudreau N, 2005, EXPERT OPIN INV DRUG, V14, P1129, DOI 10.1517/13543784.14.9.1129; Goudreau N, 2004, J MED CHEM, V47, P123, DOI 10.1021/jm0303002; Harris TK, 2002, IUBMB LIFE, V53, P85, DOI 10.1080/15216540211468; Hinrichsen H, 2004, GASTROENTEROLOGY, V127, P1347, DOI 10.1053/j.gastro.2004.08.002; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Kim JL, 1996, CELL, V87, P343, DOI 10.1016/S0092-8674(00)81351-3; Kronenberger B, 2009, ANN HEPATOL, V8, P103, DOI 10.1016/S1665-2681(19)31786-7; Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Llinas-Brunet M, 2000, BIOORG MED CHEM LETT, V10, P2267, DOI 10.1016/S0960-894X(00)00465-0; Llinas-Brunet M, 1998, BIOORG MED CHEM LETT, V8, P2719, DOI 10.1016/S0960-894X(98)00480-6; Llinas-Brunet M, 2004, J MED CHEM, V47, P6584, DOI 10.1021/jm0494523; Llinas-Brunet M, 2010, J MED CHEM, V53, P6466, DOI 10.1021/jm100690x; Lu YX, 2009, J MED CHEM, V52, P2854, DOI 10.1021/jm9000133; Markley JL, 1996, BIOCHEMISTRY-US, V35, P11092, DOI 10.1021/bi961366k; Mederacke I, 2009, CURR OPIN INVEST DR, V10, P181; PELTON JG, 1993, PROTEIN SCI, V2, P543; Rajagopalan R, 2009, BIOCHEMISTRY-US, V48, P2559, DOI 10.1021/bi900038p; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Stranzl GR, 2004, J BIOL CHEM, V279, P3699, DOI 10.1074/jbc.M306814200; Thibeault D, 2009, BIOCHEMISTRY-US, V48, P744, DOI 10.1021/bi801931e; Tsantrizos Y. S., 2003, ANGEW CHEM INT EDIT, V42, P1356; Urbani A, 1998, J BIOL CHEM, V273, P18760, DOI 10.1074/jbc.273.30.18760; Voth AR, 2007, CURR TOP MED CHEM, V7, P1336; WALTER J, 1983, H-S Z PHYSIOL CHEM, V364, P949, DOI 10.1515/bchm2.1983.364.2.949; White PW, 2010, ANTIMICROB AGENTS CH, V54, P4611, DOI 10.1128/AAC.00787-10	43	40	43	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11434	11443		10.1074/jbc.M110.211417	http://dx.doi.org/10.1074/jbc.M110.211417			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21270126	Green Published, hybrid			2022-12-27	WOS:000288797100055
J	Smith, M; Mallin, DR; Simon, JA; Courey, AJ				Smith, Matthew; Mallin, Daniel R.; Simon, Jeffrey A.; Courey, Albert J.			Small Ubiquitin-like Modifier (SUMO) Conjugation Impedes Transcriptional Silencing by the Polycomb Group Repressor Sex Comb on Midleg	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYL-LYSINE-BINDING; GROUP PROTEIN COMPLEX; HOX GENE; METHYLTRANSFERASE ACTIVITY; FINGER PROTEIN; PCG PROTEINS; RING FINGER; DNA-BINDING; DROSOPHILA; SUMOYLATION	The Drosophila protein Sex Comb on Midleg (Scm) is a member of the Polycomb group (PcG), a set of transcriptional repressors that maintain silencing of homeotic genes during development. Recent findings have identified PcG proteins both as targets for modification by the small ubiquitin-like modifier (SUMO) protein and as catalytic components of the SUMO conjugation pathway. We have found that the SUMO-conjugating enzyme Ubc9 binds to Scm and that this interaction, which requires the Scm C-terminal sterile alpha motif (SAM) domain, is crucial for the efficient sumoylation of Scm. Scm is associated with the major Polycomb response element (PRE) of the homeotic gene Ultrabithorax (Ubx), and efficient PRE recruitment requires an intact Scm SAM domain. Global reduction of sumoylation augments binding of Scm to the PRE. This is likely to be a direct effect of Scm sumoylation because mutations in the SUMO acceptor sites in Scm enhance its recruitment to the PRE, whereas translational fusion of SUMO to the Scm N terminus interferes with this recruitment. In the metathorax, Ubx expression promotes haltere formation and suppresses wing development. When SUMO levels are reduced, we observe decreased expression of Ubx and partial haltere-to-wing transformation phenotypes. These observations suggest that SUMO negatively regulates Scm function by impeding its recruitment to the Ubx major PRE.	[Smith, Matthew; Courey, Albert J.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Mallin, Daniel R.; Simon, Jeffrey A.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	University of California System; University of California Los Angeles; University of Minnesota System; University of Minnesota Twin Cities	Courey, AJ (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, POB 951569,607 Charles E Young,Dr E, Los Angeles, CA 90095 USA.	courey@chem.ucla.edu			National Institutes of Health [GM63596, GM49850]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049850, R01GM063596] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM63596 (to A. J. C.) and GM49850 (to J. A. S.).	Bhaskar V, 2000, J BIOL CHEM, V275, P4033, DOI 10.1074/jbc.275.6.4033; Bhaskar V, 2002, MOL CELL BIOL, V22, P492, DOI 10.1128/MCB.22.2.492-504.2002; Bornemann D, 1996, DEVELOPMENT, V122, P1621; Bornemann D, 1998, GENETICS, V150, P675; BREEN TR, 1986, DEV BIOL, V118, P442, DOI 10.1016/0012-1606(86)90015-1; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Deng ZY, 2007, MOL CELL BIOL, V27, P3780, DOI 10.1128/MCB.01761-06; Dubnicoff T, 1997, GENE DEV, V11, P2952, DOI 10.1101/gad.11.22.2952; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Grimm C, 2007, EMBO REP, V8, P1031, DOI 10.1038/sj.embor.7401085; Grimm C, 2009, EMBO J, V28, P1965, DOI 10.1038/emboj.2009.147; Gutierrez L, 2003, DEVELOPMENT, V130, P343, DOI 10.1242/dev.00222; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Kang XL, 2010, MOL CELL, V38, P191, DOI 10.1016/j.molcel.2010.03.005; Kim CA, 2005, J BIOL CHEM, V280, P27769, DOI 10.1074/jbc.M503055200; Klymenko T, 2006, GENE DEV, V20, P1110, DOI 10.1101/gad.377406; MCKEON J, 1994, MOL GEN GENET, V244, P474, DOI 10.1007/BF00583898; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nayak A, 2009, J BIOL CHEM, V284, P10935, DOI 10.1074/jbc.M900465200; Negre N, 2006, PLOS BIOL, V4, P917, DOI 10.1371/journal.pbio.0040170; Ng J, 2000, MOL CELL BIOL, V20, P3069, DOI 10.1128/MCB.20.9.3069-3078.2000; Nie MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005905; Oktaba K, 2008, DEV CELL, V15, P877, DOI 10.1016/j.devcel.2008.10.005; PELEGRI F, 1994, GENETICS, V136, P1341; Peterson AJ, 2004, GENETICS, V167, P1225, DOI 10.1534/genetics.104.027474; Peterson AJ, 1997, MOL CELL BIOL, V17, P6683, DOI 10.1128/MCB.17.11.6683; Ratnaparkhi GS, 2008, DEV COMP IMMUNOL, V32, P1290, DOI 10.1016/j.dci.2008.04.006; Riising EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002704; Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723; Roscic A, 2006, MOL CELL, V24, P77, DOI 10.1016/j.molcel.2006.08.004; Roseman RR, 2001, GENETICS, V158, P291; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Saurin AJ, 2001, NATURE, V412, P655, DOI 10.1038/35088096; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Smith M, 2004, J BIOL CHEM, V279, P43805, DOI 10.1074/jbc.M404942200; Wang L, 2004, MOL CELL, V14, P637, DOI 10.1016/j.molcel.2004.05.009; Wang LJ, 2010, MOL CELL BIOL, V30, P2584, DOI 10.1128/MCB.01451-09; Xue Y, 2006, NUCLEIC ACIDS RES, V34, pW254, DOI 10.1093/nar/gkl207; Zhang H, 2004, NAT GENET, V36, P507, DOI 10.1038/ng1336; Zhang J, 2008, J BIOL CHEM, V283, P7464, DOI 10.1074/jbc.M707122200	45	26	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11391	11400		10.1074/jbc.M110.214569	http://dx.doi.org/10.1074/jbc.M110.214569			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21278366	hybrid, Green Published			2022-12-27	WOS:000288797100051
J	Ternes, P; Wobbe, T; Schwarz, M; Albrecht, S; Feussner, K; Riezman, I; Cregg, JM; Heinz, E; Riezman, H; Feussner, I; Warnecke, D				Ternes, Philipp; Wobbe, Tobias; Schwarz, Marnie; Albrecht, Sandra; Feussner, Kirstin; Riezman, Isabelle; Cregg, James M.; Heinz, Ernst; Riezman, Howard; Feussner, Ivo; Warnecke, Dirk			Two Pathways of Sphingolipid Biosynthesis Are Separated in the Yeast Pichia pastoris	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CERAMIDE SYNTHASES; GLUCOSYLCERAMIDE SYNTHASE; GROWTH-INHIBITION; GENE; PLANTS; IDENTIFICATION; PATHOGENICITY; AUREOBASIDIN; DESATURASE	Although the yeast Saccharomyces cerevisiae has only one sphingolipid class with a head group based on phosphoinositol, the yeast Pichia pastoris as well as many other fungi have a second class, glucosylceramide, which has a glucose head group. These two sphingolipid classes are in addition distinguished by a characteristic structure of their ceramide backbones. Here, we investigate the mechanisms controlling substrate entry into the glucosylceramide branch of the pathway. By a combination of enzymatic in vitro studies and lipid analysis of genetically engineered yeast strains, we show that the ceramide synthase Bar1p occupies a key branching point in sphingolipid biosynthesis in P. pastoris. By preferring dihydroxy sphingoid bases and C-16/C-18 acyl-coenzyme A as substrates, Bar1p produces a structurally well defined group of ceramide species, which is the exclusive precursor for glucosylceramide biosynthesis. Correlating with the absence of glucosylceramide in this yeast, a gene encoding Bar1p is missing in S. cerevisiae. We could not successfully investigate the second ceramide synthase in P. pastoris that is orthologous to S. cerevisiae Lag1p/Lac1p. By analyzing the ceramide and glucosylceramide species in a collection of P. pastoris knock-out strains in which individual genes encoding enzymes involved in glucosylceramide biosynthesis were systematically deleted, we show that the ceramide species produced by Bar1p have to be modified by two additional enzymes, sphingolipid Delta 4-desaturase and fatty acid alpha-hydroxylase, before the final addition of the glucose head group by the glucosylceramide synthase. Together, this set of four enzymes specifically defines the pathway leading to glucosylceramide biosynthesis.	[Ternes, Philipp; Schwarz, Marnie; Feussner, Ivo] Univ Gottingen, Albrecht von Haller Inst Plant Sci, Dept Plant Biochem, D-37077 Gottingen, Germany; [Wobbe, Tobias; Albrecht, Sandra; Heinz, Ernst; Warnecke, Dirk] Univ Hamburg, Biozentrum Klein Flottbek, D-22609 Hamburg, Germany; [Feussner, Kirstin] Univ Gottingen, Dept Mol Microbiol & Genet, D-37077 Gottingen, Germany; [Riezman, Isabelle; Riezman, Howard] Univ Geneva, Dept Biochem, CH-1211 Geneva 4, Switzerland; [Cregg, James M.] Keck Grad Inst Appl Life Sci, Claremont, CA 91711 USA	University of Gottingen; University of Hamburg; University of Gottingen; University of Geneva; Claremont Colleges; Keck Graduate Institute; Keck Graduate Institute of Applied Life Sciences	Ternes, P (corresponding author), Gottinger Expt Lab Junge Leute eV, XLAB, Justus von Liebig Weg 8, D-37077 Gottingen, Germany.	pternes@xlab-goettingen.de; warnecke@botanik.uni-hamburg.de	Feussner, Ivo/H-9320-2013	Feussner, Ivo/0000-0002-9888-7003; Riezman, Howard/0000-0003-4680-9422; Ternes, Philipp/0000-0003-0886-5474	Deutsche Forschungsgemeinschaft [TE 491/3-1, SFB470]; Swiss National Science Foundation; SystemsX.ch	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SystemsX.ch	This work was supported in part by Deutsche Forschungsgemeinschaft Grants TE 491/3-1 (to P. T.) and SFB470 (to S. A. and T. W.) and by the Swiss National Science Foundation and SystemsX.ch (evaluated by the Swiss National Science Foundation) (to H. R.).	BLIGH EG, 1959, CAN J MED SCI, V37, P911, DOI DOI 10.1139/O59-099; Cerantola V, 2007, BIOCHEM J, V401, P205, DOI 10.1042/BJ20061128; Cerantola V, 2009, MOL MICROBIOL, V71, P1523, DOI 10.1111/j.1365-2958.2009.06628.x; Chalfant C., 2010, SPHINGOLIPIDS SIGNAL; Cheng JJ, 2001, MOL CELL BIOL, V21, P6198, DOI 10.1128/MCB.21.18.6198-6209.2001; De Schutter K, 2009, NAT BIOTECHNOL, V27, P561, DOI 10.1038/nbt.1544; Dickson RC, 1999, BBA-GEN SUBJECTS, V1426, P347, DOI 10.1016/S0304-4165(98)00135-4; Dickson RC, 2008, J LIPID RES, V49, P909, DOI 10.1194/jlr.R800003-JLR200; DMELLO NP, 1994, J BIOL CHEM, V269, P15451; Ejsing CS, 2006, J MASS SPECTROM, V41, P372, DOI 10.1002/jms.997; Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200; FOLCH J, 1957, J BIOL CHEM, V226, P497; Garton S, 2003, FEBS LETT, V538, P192, DOI 10.1016/S0014-5793(03)00163-7; GOULD SJ, 1992, YEAST, V8, P613, DOI 10.1002/yea.320080805; Grilley MM, 1998, J BIOL CHEM, V273, P11062, DOI 10.1074/jbc.273.18.11062; Guan XL, 2006, YEAST, V23, P465, DOI 10.1002/yea.1362; Guillas I, 2001, EMBO J, V20, P2655, DOI 10.1093/emboj/20.11.2655; Haak D, 1997, J BIOL CHEM, V272, P29704, DOI 10.1074/jbc.272.47.29704; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; HEIDLER SA, 1995, ANTIMICROB AGENTS CH, V39, P2765, DOI 10.1128/AAC.39.12.2765; HIRSCHBERG K, 1993, BIOCHEM J, V290, P751, DOI 10.1042/bj2900751; Kageyama-Yahara N, 2006, BIOCHEM J, V398, P585, DOI 10.1042/BJ20060697; Lahiri S, 2007, FEBS LETT, V581, P5289, DOI 10.1016/j.febslet.2007.10.018; Leipelt M, 2001, J BIOL CHEM, V276, P33621, DOI 10.1074/jbc.M104952200; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Li SJ, 2007, GENETICS, V176, P243, DOI 10.1534/genetics.106.068239; Li SJ, 2006, MOL BIOL CELL, V17, P1218, DOI 10.1091/mbc.E05-06-0533; Luberto C, 2001, GENE DEV, V15, P201, DOI 10.1101/gad.856001; Marsh D, 2010, BBA-BIOMEMBRANES, V1798, P40, DOI 10.1016/j.bbamem.2009.10.010; Mattanovich D, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-29; Menuz V, 2009, SCIENCE, V324, P381, DOI 10.1126/science.1168532; Michaelson LV, 2009, PLANT PHYSIOL, V149, P487, DOI 10.1104/pp.108.129411; Nagiec MM, 1997, J BIOL CHEM, V272, P9809, DOI 10.1074/jbc.272.15.9809; Noble SM, 2010, NAT GENET, V42, P590, DOI 10.1038/ng.605; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Oura T, 2008, MICROBIOL-SGM, V154, P3795, DOI 10.1099/mic.0.2008/018788-0; Oura T, 2010, MICROBIOL-SGM, V156, P1234, DOI 10.1099/mic.0.033985-0; Pata MO, 2010, NEW PHYTOL, V185, P611, DOI 10.1111/j.1469-8137.2009.03123.x; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Ramamoorthy V, 2007, MOL MICROBIOL, V66, P771, DOI 10.1111/j.1365-2958.2007.05955.x; Ramamoorthy V, 2009, EUKARYOT CELL, V8, P217, DOI 10.1128/EC.00255-08; Rittershaus PC, 2006, J CLIN INVEST, V116, P1651, DOI 10.1172/JCI27890; Sakaki T, 2001, YEAST, V18, P679, DOI 10.1002/yea.720; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schorling S, 2001, MOL BIOL CELL, V12, P3417, DOI 10.1091/mbc.12.11.3417; Sperling P, 2000, BIOCHEM SOC T, V28, P638, DOI 10.1042/BST0280638; Sperling P, 1998, J BIOL CHEM, V273, P28590, DOI 10.1074/jbc.273.44.28590; Takakuwa N, 2008, FEMS YEAST RES, V8, P839, DOI 10.1111/j.1567-1364.2008.00407.x; Tani M, 2010, J BIOCHEM, V148, P565, DOI 10.1093/jb/mvq090; Ternes P, 2006, J BIOL CHEM, V281, P5582, DOI 10.1074/jbc.M512864200; Ternes P, 2002, J BIOL CHEM, V277, P25512, DOI 10.1074/jbc.M202947200; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Warnecke D, 2003, CELL MOL LIFE SCI, V60, P919, DOI 10.1007/s00018-003-2243-4; Wennekes T, 2009, ANGEW CHEM INT EDIT, V48, P8848, DOI 10.1002/anie.200902620; Zauner S, 2010, ADV EXP MED BIOL, V688, P249	55	53	58	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11401	11414		10.1074/jbc.M110.193094	http://dx.doi.org/10.1074/jbc.M110.193094			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21303904	hybrid, Green Published			2022-12-27	WOS:000288797100052
J	Mayer, SI; Muller, I; Mannebach, S; Endo, T; Thiel, G				Mayer, Sabine I.; Mueller, Isabelle; Mannebach, Stefanie; Endo, Takeshi; Thiel, Gerald			Signal Transduction of Pregnenolone Sulfate in Insulinoma Cells ACTIVATION OF EGR-1 EXPRESSION INVOLVING TRPM3, VOLTAGE-GATED CALCIUM CHANNELS, ERK, AND TERNARY COMPLEX FACTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; EPIDERMAL-GROWTH-FACTOR; FINGER TRANSCRIPTION FACTOR; ACTIVATED PROTEIN-KINASES; TETRADECANOYLPHORBOL ACETATE; BIOLOGICAL-ACTIVITY; GENE-TRANSCRIPTION; SYNAPSIN-I; SYNAPTIC-TRANSMISSION; INDUCED PROLIFERATION	The neurosteroid pregnenolone sulfate acts on the nervous system by modifying neurotransmission and receptor functions, thus influencing synaptic strength, neuronal survival, and neurogenesis. Here we show that pregnenolone sulfate induces a signaling cascade in insulinoma cells leading to enhanced expression of the zinc finger transcription factor Egr-1 and Egr-1-responsive target genes. Pharmacological and genetic experiments revealed that influx of Ca2+ ions via transient receptor potential M3 and voltage-gated Ca2+ channels, elevation of the cytosolic Ca2+ level, and activation of ERK are essential for connecting pregnenolone sulfate stimulation with enhanced Egr-1 biosynthesis. Expression of a dominant-negative mutant of Elk-1, a key regulator of gene transcription driven by a serum response element, attenuated Egr-1 expression following stimulation, indicating that Elk-1 or related ternary complex factors connect the transcription of the Egr-1 gene with the pregnenolone sulfate-induced intracellular signaling cascade elicited by the initial influx of Ca2+. The newly synthesized Egr-1 was biologically active and bound under physiological conditions to the regulatory regions of the Pdx-1, Synapsin I, and Chromogranin B genes. Pdx-1 is a major regulator of insulin gene transcription. Accordingly, elevated insulin promoter activity and increased mRNA levels of insulin could be detected in pregnenolone sulfate-stimulated insulinoma cells. Likewise, the biosynthesis of synapsin I, a synaptic vesicle protein that is found at secretory granules in insulinoma cells, was stimulated in pregnenolone sulfate-treated INS-1 cells. Together, these data show that pregnenolone sulfate induces a signaling cascade in insulinoma cells that is very similar to the signaling cascade induced by glucose in beta-cells.	[Mayer, Sabine I.; Mueller, Isabelle; Thiel, Gerald] Univ Saarland, Med Ctr, Dept Med Biochem & Mol Biol, D-66421 Homburg, Germany; [Mannebach, Stefanie] Univ Saarland, Med Ctr, Dept Expt & Clin Pharmacol & Toxicol, D-66421 Homburg, Germany; [Endo, Takeshi] Chiba Univ, Grad Sch Sci, Dept Biol, Chiba 2638522, Japan	Saarland University; Saarland University; Chiba University	Thiel, G (corresponding author), Univ Saarland, Med Ctr, Dept Med Biochem & Mol Biol, Bldg 44, D-66421 Homburg, Germany.	gerald.thiel@uks.eu	Mayer, Sabine/GXH-4352-2022; Tuluc, Petronel/C-2527-2011		Deutsche Forschungsgemeinschaft [SFB 530/C14]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 530/C14.	Akk G, 2001, J PHYSIOL-LONDON, V532, P673, DOI 10.1111/j.1469-7793.2001.0673e.x; Amemiya-Kudo M, 2005, J BIOL CHEM, V280, P34577, DOI 10.1074/jbc.M506718200; Arnette D, 2003, J BIOL CHEM, V278, P32517, DOI 10.1074/jbc.M301174200; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Bauer I, 2005, ARCH BIOCHEM BIOPHYS, V438, P36, DOI 10.1016/j.abb.2005.03.016; Bauer I, 2007, J CELL BIOCHEM, V100, P242, DOI 10.1002/jcb.21075; Baulieu EE, 1998, PSYCHONEUROENDOCRINO, V23, P963, DOI 10.1016/S0306-4530(98)00071-7; Benes C, 1999, BIOCHEM J, V340, P219, DOI 10.1042/0264-6021:3400219; Bernal-Mizrachi E, 2000, J BIOL CHEM, V275, P25681, DOI 10.1074/jbc.M003424200; Bernal-Mizrachi E, 2001, AM J PHYSIOL-ENDOC M, V281, pE1286, DOI 10.1152/ajpendo.2001.281.6.E1286; Brissova M, 2002, J BIOL CHEM, V277, P11225, DOI 10.1074/jbc.M111272200; Charalampopoulos I, 2008, TRENDS ENDOCRIN MET, V19, P300, DOI 10.1016/j.tem.2008.07.004; Chen L, 2005, J NEUROPHYSIOL, V94, P4131, DOI 10.1152/jn.00755.2004; Chen L, 2010, HIPPOCAMPUS, V20, P499, DOI 10.1002/hipo.20649; Compagnone NA, 2000, FRONT NEUROENDOCRIN, V21, P1, DOI 10.1006/frne.1999.0188; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Ekici M, 2008, NEUROCHEM INT, V53, P165, DOI 10.1016/j.neuint.2008.07.006; FRODIN M, 1995, J BIOL CHEM, V270, P7882, DOI 10.1074/jbc.270.14.7882; Gibbs TT, 2006, PHARMACOL BIOCHEM BE, V84, P555, DOI 10.1016/j.pbb.2006.07.031; Giordano T, 2008, DIABETOLOGIA, V51, P997, DOI 10.1007/s00125-008-0980-5; Glombik MM, 1999, EMBO J, V18, P1059, DOI 10.1093/emboj/18.4.1059; Groot M, 2000, EUR J CELL BIOL, V79, P924, DOI 10.1078/0171-9335-00126; Hige T, 2006, EUR J NEUROSCI, V24, P1955, DOI 10.1111/j.1460-9568.2006.05080.x; Hohl M, 2005, EUR J NEUROSCI, V22, P2216, DOI 10.1111/j.1460-9568.2005.04404.x; Horak M, 2006, NEUROSCIENCE, V137, P93, DOI 10.1016/j.neuroscience.2005.08.058; Josefsen K, 1999, DIABETOLOGIA, V42, P195, DOI 10.1007/s001250051139; Kaufmann K, 2001, J NEUROL SCI, V189, P83, DOI 10.1016/S0022-510X(01)00562-7; Kaufmann K, 2001, BIOL CHEM, V382, P1077, DOI 10.1515/BC.2001.135; Kaufmann K, 2002, J CELL BIOCHEM, V85, P381, DOI 10.1002/jcb.10145; Kobayashi T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006311; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Matsumoto K, 1999, J BIOL CHEM, V274, P2053, DOI 10.1074/jbc.274.4.2053; Mayer SI, 2009, J CELL SCI, V122, P3340, DOI 10.1242/jcs.048272; Mayer SI, 2009, EUR J CELL BIOL, V88, P19, DOI 10.1016/j.ejcb.2008.07.002; Mayer SI, 2008, J CELL BIOCHEM, V105, P1267, DOI 10.1002/jcb.21927; Mayer SI, 2008, ENDOCRINOLOGY, V149, P6311, DOI 10.1210/en.2008-0251; Mayo W, 2001, HORM BEHAV, V40, P215, DOI 10.1006/hbeh.2001.1677; Nakajima-Nagata N, 2004, BIOCHEM BIOPH RES CO, V318, P631, DOI 10.1016/j.bbrc.2004.04.071; Rossler OG, 2008, ARCH BIOCHEM BIOPHYS, V470, P93, DOI 10.1016/j.abb.2007.11.008; Rossler OG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-40; Rossler O.G., 2006, TRANSCRIPTION FACTOR, P379; RUSSO MW, 1995, P NATL ACAD SCI USA, V92, P6873, DOI 10.1073/pnas.92.15.6873; Satin LS, 2000, ENDOCRINE, V13, P251, DOI 10.1385/ENDO:13:3:251; Spohn D, 2010, MOL PHARMACOL, V78, P865, DOI 10.1124/mol.110.067637; Stefano L, 2006, J NEUROCHEM, V97, P92, DOI 10.1111/j.1471-4159.2006.03749.x; Sugimoto T, 1997, J BIOL CHEM, V272, P29415, DOI 10.1074/jbc.272.47.29415; Svaren J, 1996, MOL CELL BIOL, V16, P3545; Thiel G, 1998, J BIOL CHEM, V273, P26891, DOI 10.1074/jbc.273.41.26891; THIEL G, 1994, J BIOL CHEM, V269, P15294; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; Thiel G, 2000, BBA-GENE STRUCT EXPR, V1493, P289, DOI 10.1016/S0167-4781(00)00207-4; Tian JM, 1999, J BIOL CHEM, V274, P15173, DOI 10.1074/jbc.274.21.15173; Trus M, 2007, BIOCHEMISTRY-US, V46, P14461, DOI 10.1021/bi7016816; Wagner TFJ, 2008, NAT CELL BIOL, V10, P1421, DOI 10.1038/ncb1801; Yang M, 2010, MOL CELL ENDOCRINOL, V315, P308, DOI 10.1016/j.mce.2009.09.033; Yokoyama T, 2007, J CELL BIOL, V177, P781, DOI 10.1083/jcb.200703195	56	57	58	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10084	10096		10.1074/jbc.M110.202697	http://dx.doi.org/10.1074/jbc.M110.202697			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21257751	Green Published, hybrid			2022-12-27	WOS:000288547000023
J	Ozawa, D; Kaji, Y; Yagi, H; Sakurai, K; Kawakami, T; Naiki, H; Goto, Y				Ozawa, Daisaku; Kaji, Yuichi; Yagi, Hisashi; Sakurai, Kazumasa; Kawakami, Toru; Naiki, Hironobu; Goto, Yuji			Destruction of Amyloid Fibrils of Keratoepithelin Peptides by Laser Irradiation Coupled with Amyloid-specific Thioflavin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-BETA; IN-VITRO; INHIBITORS; GROWTH; PROPAGATION; MUTATIONS; THERAPY	Mutations in keratoepithelin are associated with blinding ocular diseases, including lattice corneal dystrophy type 1 and granular corneal dystrophy type 2. These diseases are characterized by deposits of amyloid fibrils and/or granular non-amyloid aggregates in the cornea. Removing the deposits in the cornea is important for treatment. Previously, we reported the destruction of amyloid fibrils of beta(2)-microglobulin K3 fragments and amyloid beta by laser irradiation coupled with the binding of an amyloid-specific thioflavin T. Here, we studied the effects of this combination on the amyloid fibrils of two 22-residue fragments of keratoepithelin. The direct observation of individual amyloid fibrils was performed in real time using total internal reflection fluorescence microscopy. Both types of amyloid fibrils were broken up by the laser irradiation, dependent on the laser power. The results suggest the laser-induced destruction of amyloid fibrils to be a useful strategy for the treatment of these corneal dystrophies.	[Ozawa, Daisaku; Yagi, Hisashi; Sakurai, Kazumasa; Kawakami, Toru; Goto, Yuji] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Kaji, Yuichi] Univ Tsukuba, Inst Clin Med, Dept Ophthalmol, Ibaraki 3058575, Japan; [Naiki, Hironobu] Univ Fukui, Dept Pathol Sci, Fac Med Sci, Matsuoka, Fukui 9101193, Japan	Osaka University; University of Tsukuba; University of Fukui	Goto, Y (corresponding author), Yamadaoka 3-2, Suita, Osaka 5650871, Japan.	ygoto@protein.osaka-u.ac.jp	Naiki, Hironobu/G-5599-2014		Japanese Ministry of Education, Culture, Sports, and Science and Technology; Japan Society for the Promotion of Science	Japanese Ministry of Education, Culture, Sports, and Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-aid from the Japanese Ministry of Education, Culture, Sports, and Science and Technology and by a Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science (to H. Y.).	Agon VV, 2006, FREE RADICAL BIO MED, V40, P698, DOI 10.1016/j.freeradbiomed.2005.09.039; Augustin AJ, 2006, OPHTHALMOLOGY, V113, P14, DOI 10.1016/j.ophtha.2005.09.002; Ban T, 2004, J MOL BIOL, V344, P757, DOI 10.1016/j.jmb.2004.09.078; Ban T, 2003, J BIOL CHEM, V278, P16462, DOI 10.1074/jbc.C300049200; Ban T, 2006, J BIOL CHEM, V281, P33677, DOI 10.1074/jbc.M606072200; Ban T, 2006, ACCOUNTS CHEM RES, V39, P663, DOI 10.1021/ar050074l; Biancalana M, 2009, J MOL BIOL, V385, P1052, DOI 10.1016/j.jmb.2008.11.006; Buytaert E, 2007, BBA-REV CANCER, V1776, P86, DOI 10.1016/j.bbcan.2007.07.001; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Davies MJ, 2004, PHOTOCH PHOTOBIO SCI, V3, P17, DOI 10.1039/b307576c; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Esteras-Chopo A, 2008, J MOL BIOL, V383, P266, DOI 10.1016/j.jmb.2008.07.076; Giuliano EA, 2007, VET OPHTHALMOL, V10, P337, DOI 10.1111/j.1463-5224.2007.00578.x; Korvatska E, 2000, J BIOL CHEM, V275, P11465, DOI 10.1074/jbc.275.15.11465; Korvatska E, 1998, AM J HUM GENET, V62, P320, DOI 10.1086/301720; Levine H, 2007, AMYLOID, V14, P185, DOI 10.1080/13506120701461020; Miller SR, 2004, LAB INVEST, V84, P545, DOI 10.1038/labinvest.3700059; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Ohhashi Y, 2004, J BIOL CHEM, V279, P10814, DOI 10.1074/jbc.M310334200; Ozawa D, 2009, J BIOL CHEM, V284, P1009, DOI 10.1074/jbc.M805118200; Schmitt-Bernard CF, 2002, EUR J BIOCHEM, V269, P5149, DOI 10.1046/j.1432-1033.2002.03205.x; Schmitt-Bernard CF, 2000, BIOCHEM BIOPH RES CO, V273, P649, DOI 10.1006/bbrc.2000.2955; Sekijima Y, 2008, CURR PHARM DESIGN, V14, P3219, DOI 10.2174/138161208786404155; Stoppini M, 2004, PHARMACOL RES, V50, P419, DOI 10.1016/j.phrs.2003.12.025; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Walsh DM, 2005, J NEUROSCI, V25, P2455, DOI 10.1523/JNEUROSCI.4391-04.2005; Yagi H, 2007, BIOCHEMISTRY-US, V46, P15009, DOI 10.1021/bi701842n; Yagi H, 2010, J BIOL CHEM, V285, P19660, DOI 10.1074/jbc.M109.076505; Yuan C, 2007, FEBS LETT, V581, P241, DOI 10.1016/j.febslet.2006.12.019	30	15	17	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10856	10863		10.1074/jbc.M111.222901	http://dx.doi.org/10.1074/jbc.M111.222901			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21300800	Green Published, hybrid			2022-12-27	WOS:000288547000099
J	Recchia, AG; De Francesco, EM; Vivacqua, A; Sisci, D; Panno, ML; Ando, S; Maggiolini, M				Recchia, Anna Grazia; De Francesco, Ernestina Marianna; Vivacqua, Adele; Sisci, Diego; Panno, Maria Luisa; Ando, Sebastiano; Maggiolini, Marcello			The G Protein-coupled Receptor 30 Is Up-regulated by Hypoxia-inducible Factor-1 alpha (HIF-1 alpha) in Breast Cancer Cells and Cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE GROWTH-FACTOR; MITOCHONDRIAL COMPLEX-III; ESTROGEN-RECEPTOR; INDUCED APOPTOSIS; TRANSCRIPTIONAL RESPONSE; FACTOR CTGF/CCN2; FACTOR 1-ALPHA; FREE-RADICALS; TUMOR-GROWTH; FACTOR-I	GPR30, also known as GPER, has been suggested to mediate rapid effects induced by estrogens in diverse normal and cancer tissues. Hypoxia is a common feature of solid tumors involved in apoptosis, cell survival, and proliferation. The response to low oxygen environment is mainly mediated by the hypoxia-inducible factor named HIF-1 alpha, which activates signaling pathways leading to adaptive mechanisms in tumor cells. Here, we demonstrate that the hypoxia induces HIF-1 alpha expression, which in turn mediates the up-regulation of GPER and its downstream target CTGF in estrogen receptor-negative SkBr3 breast cancer cells and in HL-1 cardiomyocytes. Moreover, we show that HIF-1 alpha-responsive elements located within the promoter region of GPER are involved in hypoxia-dependent transcription of GPER, which requires the ROS-induced activation of EGFR/ERK signaling in both SkBr3 and HL-1 and cells. Interestingly, the apoptotic response to hypoxia was prevented by estrogens through GPER in SkBr3 cells. Taken together, our data suggest that the hypoxia-induced expression of GPER may be included among the mechanisms involved in the anti-apoptotic effects elicited by estrogens, particularly in a low oxygen microenvironment.	[Recchia, Anna Grazia; De Francesco, Ernestina Marianna; Vivacqua, Adele; Sisci, Diego; Maggiolini, Marcello] Univ Calabria, Dept Pharmacobiol, I-87030 Cosenza, Italy; [Panno, Maria Luisa; Ando, Sebastiano] Univ Calabria, Dept Cell Biol, I-87030 Cosenza, Italy	University of Calabria; University of Calabria	Maggiolini, M (corresponding author), Univ Calabria, Dept Pharmacobiol, I-87030 Cosenza, Italy.	marcellomaggiolini@yahoo.it	vivacqua, adele/I-2771-2015; /AAD-9701-2019; Maggiolini, Marcello/Z-4729-2019; Recchia, Anna Grazia/ABA-5228-2020	vivacqua, adele/0000-0001-5333-8396; /0000-0001-6577-1541; Recchia, Anna Grazia/0000-0001-5748-2002; Maggiolini, Marcello/0000-0002-7485-854X	Associazione Italiana per la Ricerca sul Cancro [8925/2009]; Ministero dell'Universita e Ricerca Scientifica e Tecnologica [2008PK2WCW/2008]	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Universita e Ricerca Scientifica e Tecnologica(Ministry of Education, Universities and Research (MIUR))	This work was supported by Associazione Italiana per la Ricerca sul Cancro Project 8925/2009 and Ministero dell'Universita e Ricerca Scientifica e Tecnologica Cofin Project Prot. 2008PK2WCW/2008.	Albanito L, 2008, ENDOCRINOLOGY, V149, P3799, DOI 10.1210/en.2008-0117; Arias-Pulido H, 2010, BREAST CANCER RES TR, V123, P51, DOI 10.1007/s10549-009-0631-7; Bai ZL, 2009, ARCH PHARM, V342, P133, DOI 10.1002/ardp.200800174; Balhuizen A, 2010, MOL CELL ENDOCRINOL, V320, P16, DOI 10.1016/j.mce.2010.01.030; Bell EL, 2007, J CELL BIOL, V177, P1029, DOI 10.1083/jcb.200609074; Bennewith KL, 2009, CANCER RES, V69, P775, DOI 10.1158/0008-5472.CAN-08-0987; Brahimi-Horn MC, 2007, J MOL MED-JMM, V85, P1301, DOI 10.1007/s00109-007-0281-3; Calzada MJ, 2007, CLIN TRANSL ONCOL, V9, P278, DOI 10.1007/s12094-007-0055-y; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chaqour B, 2006, J BIOL CHEM, V281, P20608, DOI 10.1074/jbc.M600214200; Chen J, 2003, AM J PATHOL, V162, P1283, DOI 10.1016/S0002-9440(10)63924-7; Chu CY, 2008, J BIOMED SCI, V15, P675, DOI 10.1007/s11373-008-9264-9; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Croci S, 2004, CANCER RES, V64, P1730, DOI 10.1158/0008-5472.CAN-3502-02; Davoli A, 2010, CANCER CHEMOTH PHARM, V65, P611, DOI 10.1007/s00280-009-1208-1; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; Filardo EJ, 2006, CLIN CANCER RES, V12, P6359, DOI 10.1158/1078-0432.CCR-06-0860; Galanis A, 2008, CANCER LETT, V266, P12, DOI 10.1016/j.canlet.2008.02.028; Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004; Generali D, 2009, J CLIN ONCOL, V27, P227, DOI 10.1200/JCO.2007.13.7083; Gerstner B, 2009, J NEUROSCI RES, V87, P2078, DOI 10.1002/jnr.22023; GOLDBERG MA, 1988, SCIENCE, V242, P1412, DOI 10.1126/science.2849206; Goonewardene TI, 2002, MICROSC RES TECHNIQ, V59, P41, DOI 10.1002/jemt.10175; Greijer AE, 2004, J CLIN PATHOL, V57, P1009, DOI 10.1136/jcp.2003.015032; Guo M, 2006, APOPTOSIS, V11, P67, DOI 10.1007/s10495-005-3085-3; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Higgins DF, 2004, AM J PHYSIOL-RENAL, V287, pF1223, DOI 10.1152/ajprenal.00245.2004; Hong KH, 2006, CLIN EXP IMMUNOL, V146, P362, DOI 10.1111/j.1365-2249.2006.03199.x; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Kizaka-Kondoh S, 2009, ADV DRUG DELIVER REV, V61, P623, DOI 10.1016/j.addr.2009.01.006; Knowlden JM, 2003, ENDOCRINOLOGY, V144, P1032, DOI 10.1210/en.2002-220620; Koledova Vera V, 2007, Expert Rev Cardiovasc Ther, V5, P777; Krick S, 2005, AM J RESP CELL MOL, V32, P395, DOI 10.1165/rcmb.2004-0314OC; Kurebayashi J, 2001, JPN J CANCER RES, V92, P1093, DOI 10.1111/j.1349-7006.2001.tb01064.x; Kurokawa H, 2003, CLIN CANCER RES, V9, p511S; Lander HM, 1997, FASEB J, V11, P118, DOI 10.1096/fasebj.11.2.9039953; Lee M, 2009, ADV DRUG DELIVER REV, V61, P842, DOI 10.1016/j.addr.2009.04.017; Lendahl U, 2009, NAT REV GENET, V10, P821, DOI 10.1038/nrg2665; Liu SH, 2009, ISLETS, V1, P273, DOI 10.4161/isl.1.3.9781; Madeo A, 2010, ONCOGENE, V29, P978, DOI 10.1038/onc.2009.400; Madeo A, 2010, CANCER RES, V70, P6036, DOI 10.1158/0008-5472.CAN-10-0408; Maggiolini M, 2004, J BIOL CHEM, V279, P27008, DOI 10.1074/jbc.M403588200; Maggiolini M, 2010, J ENDOCRINOL, V204, P105, DOI 10.1677/JOE-09-0242; Malhotra R, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-9; Nicholson RI, 2002, ANN NY ACAD SCI, V963, P104, DOI 10.1111/j.1749-6632.2002.tb04101.x; Olde B, 2009, TRENDS ENDOCRIN MET, V20, P409, DOI 10.1016/j.tem.2009.04.006; Pandey DP, 2009, EMBO J, V28, P523, DOI 10.1038/emboj.2008.304; Patten RD, 2006, TRENDS CARDIOVAS MED, V16, P69, DOI 10.1016/j.tcm.2006.01.002; Piret JP, 2002, BIOCHEM PHARMACOL, V64, P889, DOI 10.1016/S0006-2952(02)01155-3; Poon E, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001173; Prossnitz ER, 2009, MOL CELL ENDOCRINOL, V308, P1, DOI 10.1016/j.mce.2009.04.005; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Rimon E, 2008, ENDOCRINOLOGY, V149, P2952, DOI 10.1210/en.2007-1099; Risbridger GP, 2010, NAT REV CANCER, V10, P205, DOI 10.1038/nrc2795; Ruan K, 2009, J CELL BIOCHEM, V107, P1053, DOI 10.1002/jcb.22214; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 2004, PHYSIOLOGY, V19, P176, DOI 10.1152/physiol.00001.2004; SEMENZA GL, 2009, SYST BIOL MED, V2, P336; Smith HO, 2009, GYNECOL ONCOL, V114, P465, DOI 10.1016/j.ygyno.2009.05.015; Smith HO, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2007.01.004; Stice JP, 2009, FUTUR CARDIOL, V5, P93, DOI 10.2217/14796678.5.1.93; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; Vivacqua A, 2009, MOL ENDOCRINOL, V23, P1815, DOI 10.1210/me.2009-0120; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; Xing DQ, 2009, ARTERIOSCL THROM VAS, V29, P289, DOI 10.1161/ATVBAHA.108.182279; Yi JM, 2009, BIOCHEM BIOPH RES CO, V378, P842, DOI 10.1016/j.bbrc.2008.11.142; Zhao LQ, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-24; Zhao ZQ, 2004, CURR OPIN PHARMACOL, V4, P159, DOI 10.1016/j.coph.2003.10.010; Zhong H, 1999, CANCER RES, V59, P5830	71	85	88	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10773	10782		10.1074/jbc.M110.172247	http://dx.doi.org/10.1074/jbc.M110.172247			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21266576	Green Published, hybrid			2022-12-27	WOS:000288547000091
J	Verhalen, B; Wilkens, S				Verhalen, Brandy; Wilkens, Stephan			P-glycoprotein Retains Drug-stimulated ATPase Activity upon Covalent Linkage of the Two Nucleotide Binding Domains at Their C-terminal Ends	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE CROSS-LINKING; ABC TRANSPORTER; MULTIDRUG-RESISTANCE; MALTOSE TRANSPORTER; ELECTRON-MICROSCOPY; ALTERNATING ACCESS; CATALYTIC CYCLE; MOLECULAR-BASIS; SITE; INTERMEDIATE	P-glycoprotein (Pgp), a member of the ABC transporter family, functions as an ATP hydrolysis-driven efflux pump to rid the cell of toxic organic compounds, including a variety of drugs used in anti-cancer chemotherapy. We have recently obtained EM projection images of lipid-bound Pgp without nucleotide and transport substrate that showed the two halves of the transporter separated by a central cavity (Lee, J. Y., Urbatsch, I. L., Senior, A. E., and Wilkens, S. (2002) J. Biol. Chem. 277, 4012540131). Addition of nucleotide and/or substrate lead to a close association of the two halves of the transporter, thereby closing the central cavity (Lee, J. Y., Urbatsch, I. L., Senior, A. E., and Wilkens, S. (2008) J. Biol. Chem. 283, 5769-5779). Here, we used cysteine-mediated disulfide cross-linking to further delineate the structural rearrangements of the two nucleotide binding domains (NBD1 and NBD2) that take place during catalysis. Cysteines introduced at or near the C-terminal ends of NBD1 and NBD2 allowed for spontaneous disulfide cross-linking under nonreducing conditions. For mutant A627C/S1276C, disulfide formation was with high efficiency and cross-linked Pgp retained 30-68% drug-stimulated ATPase activity compared with reduced or cysteine-less Pgp. Two other cysteine pairs (K615C/S1276C and A627C/K1260C) also formed a disulfide but to a lesser extent, and the cross-linked form of these two mutants had lower drug-stimulated ATPase activity. The data suggest that the C-terminal ends of the two NBDs of Pgp are not required to undergo significant motion with respect to one another during the catalytic cycle.	[Verhalen, Brandy; Wilkens, Stephan] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Wilkens, S (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA.	wilkenss@upstate.edu			National Institutes of Health [CA100246, GM058600]; NATIONAL CANCER INSTITUTE [R01CA100246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA100246 and GM058600 (to S. W.).	Al-Shawi MK, 2005, J BIOENERG BIOMEMBR, V37, P489, DOI 10.1007/s10863-005-9497-5; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Beaudet L, 1998, METHOD ENZYMOL, V292, P397; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dean M, 2001, J LIPID RES, V42, P1007; Delannoy S, 2005, BIOCHEMISTRY-US, V44, P14010, DOI 10.1021/bi0512445; Gottesman MM, 2006, FEBS LETT, V580, P998, DOI 10.1016/j.febslet.2005.12.060; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee JY, 2002, J BIOL CHEM, V277, P40125, DOI 10.1074/jbc.M206871200; Lee JY, 2008, J BIOL CHEM, V283, P5769, DOI 10.1074/jbc.M707028200; Lerner-Marmarosh N, 1999, J BIOL CHEM, V274, P34711, DOI 10.1074/jbc.274.49.34711; Liu RH, 1996, BIOCHEMISTRY-US, V35, P11865, DOI 10.1021/bi960823u; Loo TW, 2010, BIOCHEM BIOPH RES CO, V395, P436, DOI 10.1016/j.bbrc.2010.04.057; Loo TW, 2003, J BIOL CHEM, V278, P1575, DOI 10.1074/jbc.M211307200; Loo TW, 2002, J BIOL CHEM, V277, P41303, DOI 10.1074/jbc.C200484200; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Rosenberg MF, 2001, EMBO J, V20, P5615, DOI 10.1093/emboj/20.20.5615; Samanta S, 2003, J BIOL CHEM, V278, P35265, DOI 10.1074/jbc.M301171200; Sauna ZE, 2007, BIOCHEMISTRY-US, V46, P13787, DOI 10.1021/bi701385t; Senior AE, 1995, FEBS LETT, V377, P285, DOI 10.1016/0014-5793(95)01345-8; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416.9.1.105; Siarheyeva A, 2010, J BIOL CHEM, V285, P7575, DOI 10.1074/jbc.M109.047290; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Tombline G, 2006, ARCH BIOCHEM BIOPHYS, V445, P124, DOI 10.1016/j.abb.2005.11.004; Urbatsch IL, 2003, J BIOL CHEM, V278, P23171, DOI 10.1074/jbc.M301957200; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; Urbatsch IL, 2001, J BIOL CHEM, V276, P26980, DOI 10.1074/jbc.M010829200; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104	33	34	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10476	10482		10.1074/jbc.M110.193151	http://dx.doi.org/10.1074/jbc.M110.193151			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21278250	hybrid, Green Published			2022-12-27	WOS:000288547000064
J	Kresge, N; Simoni, RD; Hill, RL				Kresge, Nicole; Simoni, Robert D.; Hill, Robert L.			The Process of Reversible Phosphorylation: the Work of Edmond H. Fischer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							CYCLIC ADENINE RIBONUCLEOTIDE; TISSUE PARTICLES; PROTEIN-KINASE; MUSCLE; ACTIVATION							Kresge, Nicole/0000-0003-1551-6627				AHN NG, 1991, J BIOL CHEM, V266, P4220; Cori CF, 1928, J BIOL CHEM, V79, P321; CORI GERTY T., 1938, JOUR BIOL CHEM, V124, P543; Cori GT, 1939, J BIOL CHEM, V127, P771; Cori GT, 1943, J BIOL CHEM, V151, P31; DAVIE EW, 1955, J BIOL CHEM, V212, P515; FISCHER E, 1993, NOBEL PRIZES 1992; Green AA, 1943, J BIOL CHEM, V151, P21; RALL TW, 1958, J BIOL CHEM, V232, P1065; SCHWERT GW, 1948, J BIOL CHEM, V172, P221; SUTHERLAND EW, 1958, J BIOL CHEM, V232, P1077; WALSH DA, 1968, J BIOL CHEM, V243, P3763	12	2	2	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3							e1	10.1074/jbc.O110.000242	http://dx.doi.org/10.1074/jbc.O110.000242			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21294299	hybrid, Green Published			2022-12-27	WOS:000286191500001
J	Chen, H; Liu, LH; Ma, BY; Ma, TM; Hou, JJ; Xie, GM; Wu, W; Yang, FQ; Chen, YG				Chen, Hua; Liu, Linhua; Ma, Benyu; Ma, Ting Martin; Hou, Jun-Jie; Xie, Guo-Ming; Wu, Wei; Yang, Fu-Quan; Chen, Ye-Guang			Protein Kinase A-mediated 14-3-3 Association Impedes Human Dapper1 to Promote Dishevelled Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; COLORECTAL-CANCER; WNT PATHWAY; PHOSPHORYLATION; ACTIVATION; GENE; CYCLOOXYGENASE-2; BINDING; MICE; OVEREXPRESSION	Wnt signaling regulates embryo development and tissue homeostasis, and its deregulation leads to an array of diseases, including cancer. Dapper1 has been shown to be a key negative regulator of Wnt signaling. However, its function and regulation remain poorly understood. In this study, we report that 14-3-3 beta interacts with human Dapper1 (hDpr1). The interaction is dependent on protein kinase A (PKA)-mediated phosphorylation of hDpr1 at Ser-237 and Ser-827. 14-3-3 beta binding attenuates the ability of hDpr1 to promote Dishevelled (Dvl) degradation, thus enhancing Wnt signaling. We further provide evidence that PKA-mediated Dpr1 phosphorylation may contribute to growth and tumor formation of colon cancer Caco2 cells. Finally, we show that cyclooxygenase-2 expression and PKA activation are positively correlated with Dvl protein levels in colon cancer samples. Together, our findings establish a novel layer of regulation of Wnt signaling by PKA via the 14-3-3-Dpr1-Dvl axis.	[Chen, Hua; Liu, Linhua; Ma, Benyu; Ma, Ting Martin; Xie, Guo-Ming; Chen, Ye-Guang] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Chen, Hua; Liu, Linhua; Ma, Benyu; Ma, Ting Martin; Xie, Guo-Ming; Wu, Wei; Chen, Ye-Guang] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Hou, Jun-Jie; Yang, Fu-Quan] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China	Tsinghua University; Tsinghua University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Chen, YG (corresponding author), Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	ygchen@tsinghua.edu.cn	Chen, Ye-Guang/L-6998-2019		National Natural Science Foundation of China [30930050, 30921004]; 973 Program [2006CB943401, 2010CB833706, 2010CB833703]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grants 30930050 and 30921004 and the 973 Program Grants 2006CB943401 and 2010CB833706 (to Y.-G.C.) and 2010CB833703 (to F.-Q.Y.).	Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Castellone MD, 2006, CANCER RES, V66, P11085, DOI 10.1158/0008-5472.CAN-06-2233; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chan DW, 2006, GASTROENTEROLOGY, V131, P1218, DOI 10.1053/j.gastro.2006.07.020; Cheyette BNR, 2002, DEV CELL, V2, P449, DOI 10.1016/S1534-5807(02)00140-5; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Coblitz B, 2006, FEBS LETT, V580, P1531, DOI 10.1016/j.febslet.2006.02.014; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Fisher DA, 2006, DEV DYNAM, V235, P2620, DOI 10.1002/dvdy.20917; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Fujino H, 2002, J BIOL CHEM, V277, P2614, DOI 10.1074/jbc.M109440200; Gan XQ, 2008, J CELL BIOL, V180, P1087, DOI 10.1083/jcb.200710050; Gao C, 2010, NAT CELL BIOL, V12, P781, DOI 10.1038/ncb2082; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Gao X, 2008, J BIOL CHEM, V283, P35679, DOI 10.1074/jbc.M804088200; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; Gloy J, 2002, NAT CELL BIOL, V4, P351, DOI 10.1038/ncb784; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; Hermeking H, 2003, NAT REV CANCER, V3, P931, DOI 10.1038/nrc1230; Hino S, 2005, MOL CELL BIOL, V25, P9063, DOI 10.1128/MCB.25.20.9063-9072.2005; Ilyas M, 1997, P NATL ACAD SCI USA, V94, P10330, DOI 10.1073/pnas.94.19.10330; Itoh K, 2005, J BIOL, V4; Jiang X, 2008, CANCER CELL, V13, P529, DOI 10.1016/j.ccr.2008.04.019; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Li FQ, 2008, J CELL BIOL, V181, P1141, DOI 10.1083/jcb.200709091; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Malbon CC, 2006, CURR TOP DEV BIOL, V72, P153, DOI 10.1016/S0070-2153(05)72002-0; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Masters SC, 2001, J BIOL CHEM, V276, P45193, DOI 10.1074/jbc.M105971200; Meng FW, 2008, J CELL SCI, V121, P2904, DOI 10.1242/jcs.032417; Mizutani K, 2005, TUMORI J, V91, P546, DOI 10.1177/030089160509100616; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; Phelps RA, 2009, CELL CYCLE, V8, P2549, DOI 10.4161/cc.8.16.9278; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Sinicrope FA, 2004, CANCER METAST REV, V23, P63, DOI 10.1023/A:1025863029529; Steinbach G, 2000, NEW ENGL J MED, V342, P1946, DOI 10.1056/NEJM200006293422603; Su Y, 2007, FASEB J, V21, P682, DOI 10.1096/fj.06-6246com; Suriben R, 2009, NAT GENET, V41, P977, DOI 10.1038/ng.435; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Teran E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005522; Tian Q, 2004, P NATL ACAD SCI USA, V101, P15370, DOI 10.1073/pnas.0406499101; Tzivion G, 1998, NATURE, V394, P88, DOI 10.1038/27938; Uematsu K, 2003, ONCOGENE, V22, P7218, DOI 10.1038/sj.onc.1206817; Uematsu K, 2003, CANCER RES, V63, P4547; Waxman JS, 2004, DEVELOPMENT, V131, P5909, DOI 10.1242/dev.01520; Wen J, 2010, J BIOL CHEM, V285, P11023, DOI 10.1074/jbc.M109.085381; Wharton KA, 2003, DEV BIOL, V253, P1, DOI 10.1006/dbio.2002.0869; Willert K, 1997, EMBO J, V16, P3089, DOI 10.1093/emboj/16.11.3089; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Yau TO, 2005, ONCOGENE, V24, P1607, DOI 10.1038/sj.onc.1208340; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhang L, 2006, J BIOL CHEM, V281, P8607, DOI 10.1074/jbc.M600274200; Zhang LX, 2004, SCIENCE, V306, P114, DOI 10.1126/science.1100569	59	15	16	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14870	14880		10.1074/jbc.M110.211607	http://dx.doi.org/10.1074/jbc.M110.211607			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21262972	hybrid, Green Published			2022-12-27	WOS:000289788300017
J	Mizrachy-Schwartz, S; Cohen, N; Klein, S; Kravchenko-Balasha, N; Levitzki, A				Mizrachy-Schwartz, Sarit; Cohen, Noam; Klein, Shoshana; Kravchenko-Balasha, Nataly; Levitzki, Alexander			Up-regulation of AMP-activated Protein Kinase in Cancer Cell Lines Is Mediated through c-Src Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELLS; PHOSPHOLIPASE-C; PHOSPHOINOSITIDE 3-KINASE; TYROSINE PHOSPHORYLATION; MAMMALIAN TARGET; GROWTH; HYPOXIA; ENERGY; INVASION; RECEPTOR	We report that the activation level of AMP-dependent protein kinase AMPK is elevated in cancer cell lines as a hallmark of their transformed state. In OVCAR3 and A431 cells, c-Src signals through protein kinase C alpha, phospholipase C gamma, and LKB1 to AMPK. AMPK controls internal ribosome entry site (IRES) dependent translation in these cells. We suggest that AMPK activation via PKC might be a general mechanism to regulate IRES-dependent translation in cancer cells.	[Mizrachy-Schwartz, Sarit; Cohen, Noam; Klein, Shoshana; Kravchenko-Balasha, Nataly; Levitzki, Alexander] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, Unit Cellular Signaling, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Levitzki, A (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, Unit Cellular Signaling, Safra Campus, IL-91904 Jerusalem, Israel.	levitzki@vms.huji.ac.il	Kravchenko-Balasha, Nataly/D-7683-2016	Kravchenko-Balasha, Nataly/0000-0001-6943-7479	Deutsches Krebsforschungszentrum; Israel Ministry of Science and Technology	Deutsches Krebsforschungszentrum; Israel Ministry of Science and Technology(Ministry of Science, Technology and Space (MOST), Israel)	This work was supported by the Cooperation Program in Cancer Research of the Deutsches Krebsforschungszentrum and the Israel Ministry of Science and Technology.	Ashrafian H, 2006, LANCET, V367, P618, DOI 10.1016/S0140-6736(06)68228-7; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310; Dutil EM, 1998, CURR BIOL, V8, P1366, DOI 10.1016/S0960-9822(98)00017-7; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Karni R, 2002, J BIOL CHEM, V277, P42919, DOI 10.1074/jbc.M206141200; Kassis J, 1999, CLIN CANCER RES, V5, P2251; Kayali AG, 1998, J BIOL CHEM, V273, P13808, DOI 10.1074/jbc.273.22.13808; Kim EK, 2004, J BIOL CHEM, V279, P19970, DOI 10.1074/jbc.M402165200; KIM HK, 1991, CELL, V65, P435, DOI 10.1016/0092-8674(91)90461-7; Lang KJD, 2002, MOL BIOL CELL, V13, P1792, DOI 10.1091/mbc.02-02-0017; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Lee M, 2003, J BIOL CHEM, V278, P39653, DOI 10.1074/jbc.M306104200; LIN PH, 1995, ONCOGENE, V10, P401; Longo M, 2004, BONE, V34, P100, DOI 10.1016/j.bone.2003.09.007; Martin GS, 2004, ONCOGENE, V23, P7910, DOI 10.1038/sj.onc.1208077; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; Martiny-Baron G, 2007, PHARMACOL RES, V55, P477, DOI 10.1016/j.phrs.2007.04.001; Mizrachy-Schwartz S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000628; Nozawa H, 2008, CLIN CANCER RES, V14, P4336, DOI 10.1158/1078-0432.CCR-07-4857; OSHEROV N, 1994, EUR J BIOCHEM, V225, P1047, DOI 10.1111/j.1432-1033.1994.1047b.x; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Shah K, 2005, MOL BIOL CELL, V16, P5418, DOI 10.1091/mbc.e05-03-0263; Stoneley M, 1998, ONCOGENE, V16, P423, DOI 10.1038/sj.onc.1201763; Tan M, 2006, ONCOGENE, V25, P3286, DOI 10.1038/sj.onc.1209361; Taniyama Y, 2003, MOL CELL BIOL, V23, P8019, DOI 10.1128/MCB.23.22.8019-8029.2003; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Wang J, 2009, ARTERIOSCL THROM VAS, V29, P202, DOI 10.1161/ATVBAHA.108.174391; Wiener JR, 2003, GYNECOL ONCOL, V88, P73, DOI 10.1006/gyno.2002.6851; Xie Z, 2008, CIRCULATION, V117, P952, DOI 10.1161/CIRCULATIONAHA.107.744490; Xie ZL, 2006, J BIOL CHEM, V281, P6366, DOI 10.1074/jbc.M511178200; Yang KJ, 2008, J BIOL CHEM, V283, P1480, DOI 10.1074/jbc.M706361200; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Zor T, 1996, ANAL BIOCHEM, V236, P302, DOI 10.1006/abio.1996.0171; Zou MH, 2004, J BIOL CHEM, V279, P43940, DOI 10.1074/jbc.M404421200; Zou MH, 2003, J BIOL CHEM, V278, P34003, DOI 10.1074/jbc.M300215200	43	32	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15268	15277		10.1074/jbc.M110.211813	http://dx.doi.org/10.1074/jbc.M110.211813			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21245141	Green Published, hybrid			2022-12-27	WOS:000289788300058
J	Mohan, SK; Yu, C				Mohan, Sepuru K.; Yu, Chin			The IL1 alpha-S100A13 Heterotetrameric Complex Structure A COMPONENT IN THE NON-CLASSICAL PATHWAY FOR INTERLEUKIN 1 alpha SECRETION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; RHEUMATOID-ARTHRITIS; MAMMALIAN-CELLS; PLASMA-MEMBRANE; FUNCTIONAL-ROLE; CHEMICAL-SHIFT; EXPORT ROUTES; HEAT-SHOCK; PROTEIN; S100A13	Interleukin 1 alpha (IL1 alpha) plays an important role in several key biological functions, such as angiogenesis, cell proliferation, and tumor growth in several types of cancer. IL1 alpha is a potent cytokine that induces a wide spectrum of immunological and inflammatory activities. The biological effects of IL1 alpha are mediated through the activation of transmembrane receptors (IL1Rs) and therefore require the release of the protein into the extracellular space. IL1 alpha is exported through a non-classical release pathway involving the formation of a specific multiprotein complex, which includes IL1 alpha and S100A13. Because IL1 alpha plays an important role in cell proliferation and angiogenesis, inhibiting the formation of the IL1 alpha-S100A13 complex would be an effective strategy to inhibit a wide range of cancers. To understand the molecular events in the IL1 alpha release pathway, we studied the structure of the IL1 alpha-S100A13 tetrameric complex, which is the key complex formed during the non-classical pathway of IL1 alpha release.	[Mohan, Sepuru K.; Yu, Chin] Natl Tsing Hua Univ, Dept Chem, Hsinchu 30013, Taiwan	National Tsing Hua University	Yu, C (corresponding author), Natl Tsing Hua Univ, Dept Chem, Hsinchu 30013, Taiwan.	cyu.nthu@gmail.com	Sepuru, Krishna Mohan/K-5321-2014	Sepuru, Krishna Mohan/0000-0002-3675-6294	National Science Council of Taiwan [98-2113-M-007-018-MY2]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council of Taiwan Grant 98-2113-M-007-018-MY2.	Ababou A, 2007, J BIOL CHEM, V282, P9204, DOI 10.1074/jbc.M610899200; Bevers EM, 1999, BBA-MOL CELL BIOL L, V1439, P317, DOI 10.1016/S1388-1981(99)00110-9; Bhattacharya S, 2003, STRUCTURE, V11, P738, DOI 10.1016/S0969-2126(03)00132-1; Blobel G, 2000, CHEMBIOCHEM, V1, P87; Breeze AL, 2000, PROG NUCL MAG RES SP, V36, P323, DOI 10.1016/S0079-6565(00)00020-0; Bujak M, 2009, ARCH IMMUNOL THER EX, V57, P165, DOI 10.1007/s00005-009-0024-y; Carreira CM, 2001, CANCER RES, V61, P8079; Chang HK, 2010, BIOMOL NMR ASSIGN, V4, P59, DOI 10.1007/s12104-010-9207-z; Chang YG, 2006, PROTEIN SCI, V15, P1248, DOI 10.1110/ps.051995006; Combarros O, 2007, J NEUROL, V254, P115, DOI 10.1007/s00415-006-0291-z; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dayer JM, 2003, RHEUMATOLOGY, V42, P3, DOI 10.1093/rheumatology/keg326; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Diaz AR, 2008, J BIOL CHEM, V283, P2962, DOI 10.1074/jbc.M709032200; Dinarello C A, 1998, Int Rev Immunol, V16, P457, DOI 10.3109/08830189809043005; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; DINARELLO CA, 1994, FASEB J, V8, P1314, DOI 10.1096/fasebj.8.15.8001745; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Elaraj DM, 2006, CLIN CANCER RES, V12, P1088, DOI 10.1158/1078-0432.CCR-05-1603; Fischer K, 2006, BLOOD, V108, P4094, DOI 10.1182/blood-2006-03-011742; Garrett DS, 1997, BIOCHEMISTRY-US, V36, P4393, DOI 10.1021/bi970221q; Goddard D., 2008, SPARKY 3; GRAVES BJ, 1990, BIOCHEMISTRY-US, V29, P2679, DOI 10.1021/bi00463a009; GRZESIEK S, 1993, J MAGN RESON SER B, V102, P103, DOI 10.1006/jmrb.1993.1069; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Hall DA, 2001, P NATL ACAD SCI USA, V98, P9521, DOI 10.1073/pnas.171168898; Hayrabedyan S, 2005, J REPROD IMMUNOL, V67, P87, DOI 10.1016/j.jri.2005.07.001; Hubbard S. J., 1993, NACCESS; JACKSON A, 1992, P NATL ACAD SCI USA, V89, P10691, DOI 10.1073/pnas.89.22.10691; KATHIR KM, 2007, BIOCHIM BIOPHYS ACTA, V12, P3080; Kawaguchi Y, 2006, P NATL ACAD SCI USA, V103, P14501, DOI 10.1073/pnas.0603545103; KAY LE, 1994, J MAGN RESON SER A, V109, P129, DOI 10.1006/jmra.1994.1145; Landriscina M, 2001, J BIOL CHEM, V276, P25549, DOI 10.1074/jbc.M102925200; Landriscina M, 2006, J NEURO-ONCOL, V80, P251, DOI 10.1007/s11060-006-9189-y; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Maini RN, 2000, ANNU REV MED, V51, P207, DOI 10.1146/annurev.med.51.1.207; Mandinova A, 2003, J CELL SCI, V116, P2687, DOI 10.1242/jcs.00471; Matsunaga H, 2010, CELL DEATH DIFFER, V17, P1760, DOI 10.1038/cdd.2010.52; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; PASCAL SM, 1994, J MAGN RESON SER B, V103, P197, DOI 10.1006/jmrb.1994.1031; Pierce A, 2008, EUR J CANCER, V44, P151, DOI 10.1016/j.ejca.2007.10.017; Pierce MM, 1999, METHODS, V19, P213, DOI 10.1006/meth.1999.0852; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Pomorski T, 2001, SEMIN CELL DEV BIOL, V12, P139, DOI 10.1006/scdb.2000.0231; Prudovsky I, 2003, J CELL SCI, V116, P4871, DOI 10.1242/jcs.00872; Prudovsky I, 2008, J CELL BIOCHEM, V103, P1327, DOI 10.1002/jcb.21513; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; Rani SG, 2010, BIOCHEMISTRY-US, V49, P2585, DOI 10.1021/bi9019077; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Shin JT, 1996, BBA-MOL CELL RES, V1312, P27, DOI 10.1016/0167-4889(96)00013-4; Shishibori T, 1999, BIOCHEM J, V338, P583, DOI 10.1042/0264-6021:3380583; Sivaraja V, 2006, BIOPHYS J, V91, P1832, DOI [10.1529/biophysj.105.079988, 10.1529/biophysj.106.079988]; Soldi R, 2007, EXP CELL RES, V313, P3308, DOI 10.1016/j.yexcr.2007.05.031; Sparvero LJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-17; Tarantini F, 2001, J BIOL CHEM, V276, P5147, DOI 10.1074/jbc.C000714200; Wang AJ, 1996, CURR OPIN BIOTECH, V7, P403, DOI 10.1016/S0958-1669(96)80115-7; Williams C, 2007, STRUCTURE, V15, P1065, DOI 10.1016/j.str.2007.07.007; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033	60	23	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14608	14617		10.1074/jbc.M110.201954	http://dx.doi.org/10.1074/jbc.M110.201954			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21270123	hybrid, Green Published			2022-12-27	WOS:000289556200080
J	Nishi, K; Ono, T; Nakamura, T; Fukunaga, N; Izumi, M; Watanabe, H; Suenaga, A; Maruyama, T; Yamagata, Y; Curry, S; Otagiri, M				Nishi, Koji; Ono, Tomomi; Nakamura, Teruya; Fukunaga, Naoko; Izumi, Miyoko; Watanabe, Hiroshi; Suenaga, Ayaka; Maruyama, Toru; Yamagata, Yuriko; Curry, Stephen; Otagiri, Masaki			Structural Insights into Differences in Drug-binding Selectivity between Two Forms of Human alpha(1)-Acid Glycoprotein Genetic Variants, the A and F1*S Forms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ALPHA-1-ACID GLYCOPROTEIN; HIGH-AFFINITY BINDING; MOLECULAR-GRAPHICS; CARBOHYDRATE UNITS; SITE; PROTEIN; SYSTEM; UCN-01; MOIETIES; ACID	Human alpha(1)-acid glycoprotein (hAGP) in serum functions as a carrier of basic drugs. In most individuals, hAGP exists as a mixture of two genetic variants, the F1*S and A variants, which bind drugs with different selectivities. We prepared a mutant of the A variant, C149R, and showed that its drug-binding properties were indistinguishable from those of the wild type. In this study, we determined the crystal structures of this mutant hAGP alone and complexed with disopyramide (DSP), amitriptyline (AMT), and the nonspecific drug chlorpromazine (CPZ). The crystal structures revealed that the drug-binding pocket on the A variant is located within an eight-stranded beta-barrel, similar to that found in the F1*S variant and other lipocalin family proteins. However, the binding region of the A variant is narrower than that of the F1*S variant. In the crystal structures of complexes with DSP and AMT, the two aromatic rings of each drug interact with Phe-49 and Phe-112 at the bottom of the binding pocket. Although the structure of CPZ is similar to those of DSP and AMT, its fused aromatic ring system, which is extended in length by the addition of a chlorine atom, appears to dictate an alternative mode of binding, which explains its nonselective binding to the F1*S and A variant hAGPs. Modeling experiments based on the co-crystal structures suggest that, in complexes of DSP, AMT, or CPZ with the F1*S variant, Phe-114 sterically hinders interactions with DSP and AMT, but not CPZ.	[Nishi, Koji; Ono, Tomomi; Fukunaga, Naoko; Izumi, Miyoko; Watanabe, Hiroshi; Suenaga, Ayaka; Maruyama, Toru; Otagiri, Masaki] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Kumamoto 8620973, Japan; [Nakamura, Teruya; Yamagata, Yuriko] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Biol Struct, Kumamoto 8620973, Japan; [Watanabe, Hiroshi; Maruyama, Toru] Kumamoto Univ, Grad Sch Pharmaceut Sci, Ctr Clin Pharmaceut Sci, Kumamoto 8620973, Japan; [Nishi, Koji] Keio Univ, Sch Med, Dept Clin Pharmacokinet & Pharmacodynam, Tokyo 1608582, Japan; [Curry, Stephen] Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Biophys Sect, Shinjuku Ku, London SW7 2AZ, England; [Otagiri, Masaki] Sojo Univ, Fac Pharmaceut Sci, Kumamoto 8600822, Japan	Kumamoto University; Kumamoto University; Kumamoto University; Keio University; Imperial College London; Sojo University	Otagiri, M (corresponding author), Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	otagirim@ph.sojo-u.ac.jp		Curry, Stephen/0000-0002-0552-8870; Nakamura, Teruya/0000-0003-2013-3057	Japan Society for the Promotion of Science [21390161]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grant-in-aid for Scientific Research KAKENHI 21390161 from the Japan Society for the Promotion of Science.	Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Budai L, 2009, ANAL BIOANAL CHEM, V393, P991, DOI 10.1007/s00216-008-2518-6; Chuang VTG, 2005, BBA-GEN SUBJECTS, V1725, P385, DOI 10.1016/j.bbagen.2005.05.021; Delano WL., 2002, PYMOL MOL GRAPHICS S; Eap C B, 1989, Prog Clin Biol Res, V300, P111; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EVANS PR, 1997, JOINT CCP4 ESF EACMB; FRIEDMAN ML, 1986, BIOCHEM J, V236, P149, DOI 10.1042/bj2360149; Fuse E, 1998, CANCER RES, V58, P3248; Gambacorti-Passerini C, 2003, CLIN CANCER RES, V9, P625; Hochepied T, 2003, CYTOKINE GROWTH F R, V14, P25, DOI 10.1016/S1359-6101(02)00054-0; Holladay JW, 2001, DRUG METAB DISPOS, V29, P299; IMAMURA H, 1993, BIOL PHARM BULL, V16, P926; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Katsuki M, 2005, J BIOL CHEM, V280, P1384, DOI 10.1074/jbc.M411076200; Katsuki M, 2004, PHARM RES-DORDR, V21, P1648, DOI 10.1023/B:PHAM.0000041461.93787.6b; Kishino S, 2001, EUR J CLIN PHARMACOL, V57, P583, DOI 10.1007/s002280100354; Kopecky V, 2003, BIOCHEM BIOPH RES CO, V300, P41, DOI 10.1016/S0006-291X(02)02765-1; KREMER JMH, 1988, PHARMACOL REV, V40, P1; KUTE T, 1976, BIOCHIM BIOPHYS ACTA, V420, P195, DOI 10.1016/0005-2795(76)90358-5; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 1992, JOINT CCP4 ESF EACMB; MARUYAMA T, 1990, CHEM PHARM BULL, V38, P1688; Nishi K, 2010, DRUG METAB PHARMACOK, V25, P200, DOI 10.2133/dmpk.25.200; Nishi K, 2009, J PHARM SCI-US, V98, P4316, DOI 10.1002/jps.21697; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; SCHMID K, 1978, FED PROC, V37, P1298; SCHMID K, 1977, BIOCHIM BIOPHYS ACTA, V492, P291, DOI 10.1016/0005-2795(77)90080-0; Schonfeld DL, 2008, J MOL BIOL, V384, P393, DOI 10.1016/j.jmb.2008.09.020; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; YOSHIMA H, 1981, J BIOL CHEM, V256, P8476; YUASA I, 1993, VOX SANG, V64, P47, DOI 10.1111/j.1423-0410.1993.tb02514.x	34	64	65	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14427	14434		10.1074/jbc.M110.208926	http://dx.doi.org/10.1074/jbc.M110.208926			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21349832	hybrid, Green Published			2022-12-27	WOS:000289556200064
J	Shrivastava, AN; Triller, A; Sieghart, W; Sarto-Jackson, I				Shrivastava, Amulya Nidhi; Triller, Antoine; Sieghart, Werner; Sarto-Jackson, Isabella			Regulation of GABA(A) Receptor Dynamics by Interaction with Purinergic P2X(2) Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; CROSS-TALK; IMMUNOCYTOCHEMICAL DISTRIBUTION; MEMBRANE-RECEPTORS; INFLAMMATORY PAIN; LATERAL DIFFUSION; GLYCINE RECEPTORS; TNP-ATP; SUBUNITS; NEURONS	gamma-Aminobutyric acid type A receptors (GABA(A)Rs) in the spinal cord are evolving as an important target for drug development against pain. Purinergic P2X(2) receptors (P2X(2)Rs) are also expressed in spinal cord neurons and are known to cross-talk with GABA(A)Rs. Here, we investigated a possible "dynamic" interaction between GABAARs and P2X(2)Rs using co-immuno-precipitation and fluorescence resonance energy transfer (FRET) studies in human embryonic kidney (HEK) 293 cells along with co-localization and single particle tracking studies in spinal cord neurons. Our results suggest that a significant proportion of P2X(2)Rs forms a transient complex with GABA(A)Rs inside the cell, thus stabilizing these receptors and using them for co-trafficking to the cell surface, where P2X(2)Rs and GABA(A)Rs are primarily located extra-synaptically. Furthermore, agonist-induced activation of P2X(2)Rs results in a Ca2+ dependent as well as an apparently Ca2+-independent increase in the mobility and an enhanced degradation of GABA(A)Rs, whereas P2X(2)Rs are stabilized and form larger clusters. Antagonist-induced blocking of P2XRs results in co-stabilization of this receptor complex at the cell surface. These results suggest a novel mechanism where association of P2X(2)Rs and GABA(A)Rs could be used for specific targeting to neuronal membranes, thus providing an extrasynaptic receptor reserve that could regulate the excitability of neurons. We further conclude that blocking the excitatory activity of excessively released ATP under diseased state by P2XR antagonists could simultaneously enhance synaptic inhibition mediated by GABA(A)Rs.	[Shrivastava, Amulya Nidhi; Sieghart, Werner; Sarto-Jackson, Isabella] Med Univ Vienna, Ctr Brain Res, Dept Biochem & Mol Biol, A-1090 Vienna, Austria; [Shrivastava, Amulya Nidhi; Triller, Antoine] Ecole Normale Super, Inst Biol, F-75005 Paris, France; [Shrivastava, Amulya Nidhi; Triller, Antoine] INSERM, U1024, F-75005 Paris, France; [Shrivastava, Amulya Nidhi; Triller, Antoine] CNRS, UMR8197, F-75005 Paris, France	Medical University of Vienna; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Sarto-Jackson, I (corresponding author), Med Univ Vienna, Ctr Brain Res, Dept Biochem & Mol Biol, Spitalgasse 4, A-1090 Vienna, Austria.	isabella.sarto-jackson@meduniwien.ac.at	Sieghart, Werner/A-4877-2013	Sieghart, Werner/0000-0002-0443-0302; Shrivastava, Amulya Nidhi/0000-0002-1322-8018; TRILLER, Antoine/0000-0002-7530-1233	Medical University of Vienna; INSERM, Ecole Normale Superieure; Pierre-Gilles de Gennes Foundation	Medical University of Vienna; INSERM, Ecole Normale Superieure(Institut National de la Sante et de la Recherche Medicale (Inserm)); Pierre-Gilles de Gennes Foundation	This work was supported by the International Ph.D. Program "Cell Communication in Health and Disease" of the Medical University of Vienna and the Austrian Science Fund, INSERM, Ecole Normale Superieure, and a grant from the Pierre-Gilles de Gennes Foundation.	Alcor D, 2009, EUR J NEUROSCI, V30, P987, DOI 10.1111/j.1460-9568.2009.06927.x; Bannai H, 2006, NAT PROTOC, V1, P2628, DOI 10.1038/nprot.2006.429; Bannai H, 2009, NEURON, V62, P670, DOI 10.1016/j.neuron.2009.04.023; Bardoni R, 1997, J NEUROSCI, V17, P5297; Bartholomaeus I, 2008, J BIOL CHEM, V283, P10978, DOI 10.1074/jbc.M800622200; BLEEHEN T, 1977, PAIN, V3, P367, DOI 10.1016/0304-3959(77)90066-5; Bobanovic LK, 2002, J NEUROSCI, V22, P4814, DOI 10.1523/JNEUROSCI.22-12-04814.2002; Bogdanov Y, 2006, EMBO J, V25, P4381, DOI 10.1038/sj.emboj.7601309; Bonneau S, 2005, IEEE T IMAGE PROCESS, V14, P1384, DOI 10.1109/TIP.2005.852794; Boue-Grabot E, 2004, J BIOL CHEM, V279, P52517, DOI 10.1074/jbc.M410223200; Boue-Grabot E, 2004, J BIOL CHEM, V279, P6967, DOI 10.1074/jbc.M307772200; Boue-Grabot E, 2003, J NEUROSCI, V23, P1246, DOI 10.1523/JNEUROSCI.23-04-01246.2003; Burnstock G, 2004, INT REV CYTOL, V240, P31, DOI 10.1016/S0074-7696(04)40002-3; Charrier C, 2006, J NEUROSCI, V26, P8502, DOI 10.1523/JNEUROSCI.1758-06.2006; Charrier C, 2010, NAT NEUROSCI, V13, P1388, DOI 10.1038/nn.2645; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; Choquet D, 2003, NAT REV NEUROSCI, V4, P251, DOI 10.1038/nrn1077; Collo G, 1996, J NEUROSCI, V16, P2495; Decker DA, 2009, AM J PHYSIOL-GASTR L, V296, pG1267, DOI 10.1152/ajpgi.00048.2009; Ding YN, 2000, J AUTONOM NERV SYST, V81, P289, DOI 10.1016/S0165-1838(00)00131-4; Ehrensperger MV, 2007, BIOPHYS J, V92, P3706, DOI 10.1529/biophysj.106.095596; Feige JN, 2005, MICROSC RES TECHNIQ, V68, P51, DOI 10.1002/jemt.20215; Feige JN, 2005, J BIOL CHEM, V280, P17880, DOI 10.1074/jbc.M500786200; Gever JR, 2006, PFLUG ARCH EUR J PHY, V452, P513, DOI 10.1007/s00424-006-0070-9; Guerlet G, 2008, BIOCHEM BIOPH RES CO, V375, P405, DOI 10.1016/j.bbrc.2008.08.030; Harvey RJ, 2004, SCIENCE, V304, P884, DOI 10.1126/science.1094925; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Holcman D, 2006, BIOPHYS J, V91, P2405, DOI 10.1529/biophysj.106.081935; Honore P, 2002, PAIN, V96, P99, DOI 10.1016/S0304-3959(01)00434-1; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Jarvis MF, 2001, BRIT J PHARMACOL, V132, P259, DOI 10.1038/sj.bjp.0703793; Jo YH, 1999, NAT NEUROSCI, V2, P241, DOI 10.1038/6344; Karanjia R, 2006, EUR J NEUROSCI, V23, P3259, DOI 10.1111/j.1460-9568.2006.04861.x; Khakh BS, 2000, NATURE, V406, P405, DOI 10.1038/35019066; Khakh BS, 2005, J NEUROSCI, V25, P6911, DOI 10.1523/JNEUROSCI.0561-05.2005; Khakh BS, 2001, P NATL ACAD SCI USA, V98, P5288, DOI 10.1073/pnas.081089198; Klausberger T, 2000, J BIOL CHEM, V275, P8921, DOI 10.1074/jbc.275.12.8921; Knabl J, 2008, NATURE, V451, P330, DOI 10.1038/nature06493; Koles L, 2008, N-S ARCH PHARMACOL, V377, P1, DOI 10.1007/s00210-007-0222-2; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Labrakakis C, 2003, J PHYSIOL-LONDON, V549, P131, DOI 10.1113/jphysiol.2002.031963; Levi S, 2008, NEURON, V59, P261, DOI 10.1016/j.neuron.2008.05.030; Machado P, 2011, J NEUROSCI, V31, P3, DOI 10.1523/JNEUROSCI.2533-10.2011; Masin M, 2006, J BIOL CHEM, V281, P4100, DOI 10.1074/jbc.M507735200; Meier J, 2001, NAT NEUROSCI, V4, P253, DOI 10.1038/85099; Milan-Lobo L, 2009, MOL PHARMACOL, V76, P1196, DOI 10.1124/mol.109.059139; Moss SJ, 2001, NAT REV NEUROSCI, V2, P240, DOI 10.1038/35067500; Nakagawa T, 2007, NEUROSCIENCE, V147, P445, DOI 10.1016/j.neuroscience.2007.03.045; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Renner M, 2009, J NEUROSCI, V29, P2926, DOI 10.1523/JNEUROSCI.4445-08.2009; Rubio ME, 2001, J NEUROSCI, V21, P641, DOI 10.1523/JNEUROSCI.21-02-00641.2001; Sarto I, 2002, J BIOL CHEM, V277, P30656, DOI 10.1074/jbc.M203597200; Sarto-Jackson I, 2006, J NEUROCHEM, V96, P983, DOI 10.1111/j.1471-4159.2005.03626.x; Sarto-Jackson I, 2007, J BIOL CHEM, V282, P4354, DOI 10.1074/jbc.M609676200; Schicker K, 2009, BBA-MOL CELL RES, V1793, P325, DOI 10.1016/j.bbamcr.2008.09.014; SIEGHART W, 1995, PHARMACOL REV, V47, P181; Sokolova E, 2001, J NEUROSCI, V21, P4958, DOI 10.1523/JNEUROSCI.21-14-04958.2001; Souslova V, 2000, NATURE, V407, P1015, DOI 10.1038/35039526; Sperk G, 1997, NEUROSCIENCE, V80, P987, DOI 10.1016/S0306-4522(97)00146-2; Todd AJ, 1996, J NEUROSCI, V16, P974; Toulme E, 2007, J NEUROCHEM, V102, P1357, DOI 10.1111/j.1471-4159.2007.04640.x; Tretter V, 1997, J NEUROSCI, V17, P2728; Triller A, 2005, TRENDS NEUROSCI, V28, P133, DOI 10.1016/j.tins.2005.01.001; Triller A, 2008, NEURON, V59, P359, DOI 10.1016/j.neuron.2008.06.022; Trujillo CA, 2006, BIOCHEMISTRY-US, V45, P224, DOI 10.1021/bi051517w; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wirkner K, 2007, MOL NEUROBIOL, V36, P165, DOI 10.1007/s12035-007-0033-y; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Zeilhofer HU, 2008, NEUROSCI LETT, V437, P170, DOI 10.1016/j.neulet.2008.03.056; Zeilhofer HU, 2009, TRENDS PHARMACOL SCI, V30, P397, DOI 10.1016/j.tips.2009.05.007; ZEZULA J, 1991, FEBS LETT, V284, P15, DOI 10.1016/0014-5793(91)80750-W; Zhou XP, 1998, J PHYSIOL-LONDON, V513, P685, DOI 10.1111/j.1469-7793.1998.685ba.x	74	31	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14455	14468		10.1074/jbc.M110.165282	http://dx.doi.org/10.1074/jbc.M110.165282			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21343285	Green Published, hybrid			2022-12-27	WOS:000289556200067
J	Azoulay-Alfaguter, I; Yaffe, Y; Licht-Murava, A; Urbanska, M; Jaworski, J; Pietrokovski, S; Hirschberg, K; Eldar-Finkelman, H				Azoulay-Alfaguter, Inbar; Yaffe, Yakey; Licht-Murava, Avital; Urbanska, Malgorzata; Jaworski, Jacek; Pietrokovski, Shmuel; Hirschberg, Koret; Eldar-Finkelman, Hagit			Distinct Molecular Regulation of Glycogen Synthase Kinase-3 alpha Isozyme Controlled by Its N-terminal Region FUNCTIONAL ROLE IN CALCIUM/CALPAIN SIGNALING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; MAP KINASE; CYCLIN D1; SUBSTRATE-SPECIFICITY; ALZHEIMERS-DISEASE; BINDING-PROTEIN; CALPAIN; PHOSPHORYLATION; GSK-3; TARGET	Glycogen synthase kinase-3 (GSK-3) is expressed as two isozymes alpha and beta. They share high similarity in their catalytic domains but differ in their N- and C-terminal regions, with GSK-3 alpha having an extended glycine-rich N terminus. Here, we undertook live cell imaging combined with molecular and bioinformatic studies to understand the distinct functions of the GSK-3 isozymes focusing on GSK-3 alpha N-terminal region. We found that unlike GSK-3 beta, which shuttles between the nucleus and cytoplasm, GSK-3 alpha was excluded from the nucleus. Deletion of the N-terminal region of GSK-3 alpha resulted in nuclear localization, and treatment with leptomycin B resulted in GSK-3 alpha accumulation in the nucleus. GSK-3 alpha rapidly accumulated in the nucleus in response to calcium or serum deprivation, and accumulation was strongly inhibited by the calpain inhibitor calpeptin. This nuclear accumulation was not mediated by cleavage of the N-terminal region or phosphorylation of GSK-3 alpha. Rather, we show that calcium-induced GSK-3 alpha nuclear accumulation was governed by GSK-3 alpha binding with as yet unknown calpain-sensitive protein or proteins; this binding was mediated by the N-terminal region. Bioinformatic and experimental analyses indicated that nuclear exclusion of GSK-3 alpha was likely an exclusive characteristic of mammalian GSK-3 alpha. Finally, we show that nuclear localization of GSK-3 alpha reduced the nuclear pool of beta-catenin and its target cyclin D1. Taken together, these data suggest that the N-terminal region of GSK-3 alpha is responsible for its nuclear exclusion and that binding with a calcium/calpain-sensitive product enables GSK-3 alpha nuclear retention. We further uncovered a novel link between calcium and nuclear GSK-3 alpha-mediated inhibition of the canonical Wnt/beta-catenin pathway.	[Eldar-Finkelman, Hagit] Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel; [Yaffe, Yakey; Hirschberg, Koret] Tel Aviv Univ, Sackler Sch Med, Dept Pathol, IL-69978 Tel Aviv, Israel; [Urbanska, Malgorzata; Jaworski, Jacek] Int Inst Mol & Cell Biol, PL-02109 Warsaw, Poland; [Pietrokovski, Shmuel] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Weizmann Institute of Science	Eldar-Finkelman, H (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel.	heldar@post.tau.ac.il		Pietrokovski, Shmuel/0000-0001-8573-5863; Urbanska, Malgorzata/0000-0001-9521-0366; Yaffe, Yakey/0000-0003-4518-191X; Eldar-Finkelman, Hagit/0000-0002-8460-9686	European Union [223276]; Israeli Academy of Sciences [341/10]	European Union(European Commission); Israeli Academy of Sciences	This work was supported by Seventh Framework Program (FP7) European Union Grant 223276 "NeuroGSK3" and Israeli Academy of Sciences Grant 341/10.	Abe K, 2007, NEURON, V53, P387, DOI 10.1016/j.neuron.2007.01.016; Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Adachi M, 1999, EMBO J, V18, P5347, DOI 10.1093/emboj/18.19.5347; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Bendetz-Nezer S, 2007, J BIOL CHEM, V282, P25114, DOI 10.1074/jbc.M703120200; Benetti R, 2005, J BIOL CHEM, V280, P22070, DOI 10.1074/jbc.M501810200; Bertipaglia I., 2007, V45, P29; Bienz M, 2005, CURR BIOL, V15, pR64, DOI 10.1016/j.cub.2004.12.058; Bijur GN, 2000, J BIOL CHEM, V275, P7583, DOI 10.1074/jbc.275.11.7583; Bijur GN, 2003, NEUROREPORT, V14, P2415, DOI 10.1097/00001756-200312190-00025; Caspi M, 2008, ONCOGENE, V27, P3546, DOI 10.1038/sj.onc.1211026; Cho J, 2009, J BIOL CHEM, V284, P36647, DOI 10.1074/jbc.M109.019109; Chong ZZ, 2005, PROG NEUROBIOL, V75, P207, DOI 10.1016/j.pneurobio.2005.02.004; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; DASH PK, 1991, P NATL ACAD SCI USA, V88, P5061, DOI 10.1073/pnas.88.11.5061; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Dieterich DC, 2008, PLOS BIOL, V6, P286, DOI 10.1371/journal.pbio.0060034; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Dukhovny A, 2008, J CELL SCI, V121, P865, DOI 10.1242/jcs.019463; Eldar-Finkelman H, 2002, TRENDS MOL MED, V8, P126, DOI 10.1016/S1471-4914(01)02266-3; Force T, 2009, J BIOL CHEM, V284, P9643, DOI 10.1074/jbc.R800077200; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Franca-Koh J, 2002, J BIOL CHEM, V277, P43844, DOI 10.1074/jbc.M207265200; Frith MC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000071; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Goni-Oliver P, 2007, J BIOL CHEM, V282, P22406, DOI 10.1074/jbc.M702793200; Goni-Oliver P, 2009, J ALZHEIMERS DIS, V18, P843, DOI 10.3233/JAD-2009-1190; Goslin K., 1991, CULTURING NERVE CELL, P251; Gould TD, 2004, J CLIN PSYCHIAT, V65, P10; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; HENIKOFF S, 1995, GENE-COMBIS, V163, pGC17, DOI 10.1016/0378-1119(95)00486-P; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Huang HC, 2006, CURR DRUG TARGETS, V7, P1389, DOI 10.2174/1389450110607011389; HUGHES K, 1993, EMBO J, V12, P803, DOI 10.1002/j.1460-2075.1993.tb05715.x; Johnson GVW, 2006, J ALZHEIMERS DIS, V9, P243; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Jordan BA, 2009, TRENDS NEUROSCI, V32, P392, DOI 10.1016/j.tins.2009.04.001; Kerkela R, 2008, J CLIN INVEST, V118, P3609, DOI 10.1172/JCI36245; Kestler HA, 2008, PHILOS T R SOC B, V363, P1333, DOI 10.1098/rstb.2007.2251; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; Kim WY, 2006, NEURON, V52, P981, DOI 10.1016/j.neuron.2006.10.031; Kindler S, 2009, J BIOL CHEM, V284, P25431, DOI 10.1074/jbc.M109.022137; Lai KO, 2008, P NATL ACAD SCI USA, V105, P17175, DOI 10.1073/pnas.0803906105; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Li G, 2002, P NATL ACAD SCI USA, V99, P13254, DOI 10.1073/pnas.202355799; Liang MH, 2006, J BIOL CHEM, V281, P30479, DOI 10.1074/jbc.M607468200; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; MacAulay K, 2007, CELL METAB, V6, P329, DOI 10.1016/j.cmet.2007.08.013; Meares GP, 2007, J BIOL CHEM, V282, P16989, DOI 10.1074/jbc.M700610200; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Muntane G, 2008, NEUROSCIENCE, V152, P913, DOI 10.1016/j.neuroscience.2008.01.030; Patel S, 2008, MOL CELL BIOL, V28, P6314, DOI 10.1128/MCB.00763-08; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; PEIFER M, 1994, DEV BIOL, V166, P543, DOI 10.1006/dbio.1994.1336; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Proepper C, 2007, EMBO J, V26, P1397, DOI 10.1038/sj.emboj.7601569; Raman M, 2003, CURR BIOL, V13, pR886, DOI 10.1016/j.cub.2003.10.053; Rowe MK, 2007, NEUROSCI BIOBEHAV R, V31, P920, DOI 10.1016/j.neubiorev.2007.03.002; Schloesser RJ, 2008, NEUROPSYCHOPHARMACOL, V33, P110, DOI 10.1038/sj.npp.1301575; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; SUTHERLAND C, 1994, FEBS LETT, V338, P37, DOI 10.1016/0014-5793(94)80112-6; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; WANG QM, 1994, BIOCHEMISTRY-US, V33, P143, DOI 10.1021/bi00167a018; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011	72	39	39	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13470	13480		10.1074/jbc.M110.127969	http://dx.doi.org/10.1074/jbc.M110.127969			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21266584	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000289282200067
J	Jones, JC; Temple, BRS; Jones, AM; Dohlman, HG				Jones, Janice C.; Temple, Brenda R. S.; Jones, Alan M.; Dohlman, Henrik G.			Functional Reconstitution of an Atypical G Protein Heterotrimer and Regulator of G Protein Signaling Protein (RGS1) from Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SUBUNIT; CRYSTAL-STRUCTURE; BETA-SUBUNIT; ALPHA; GTP; DISSOCIATE; MG-2+	It has long been known that animal heterotrimeric G alpha beta gamma proteins are activated by cell-surface receptors that promote GTP binding to the G alpha subunit and dissociation of the heterotrimer. In contrast, the G alpha protein from Arabidopsis thaliana (AtGPA1) can activate itself without a receptor or other exchange factor. It is unknown how AtGPA1 is regulated by G beta gamma and the RGS (($) under bar regulator of ($) under barG protein ($) under bar signaling) protein AtRGS1, which is comprised of an RGS domain fused to a receptor-like domain. To better understand the cycle of G protein activation and inactivation in plants, we purified and reconstituted AtGPA1, full-length AtRGS1, and two putative G beta gamma dimers. We show that the Arabidopsis G alpha protein binds to its cognate G beta gamma dimer directly and in a nucleotide-dependent manner. Although animal G beta gamma dimers inhibit GTP binding to the G alpha subunit, AtGPA1 retains fast activation in the presence of its cognate G beta gamma dimer. We show further that the full-length AtRGS1 protein accelerates GTP hydrolysis and thereby counteracts the fast nucleotide exchange rate of AtGPA1 Finally, we show that AtGPA1 is less stable in complex with GDP than in complex with cap or the G beta gamma dimer. Molecular dynamics simulations and biophysical studies reveal that altered stability is likely due to increased dynamic motion in the N-terminal alpha-helix and Switch II of AtGPA1 Thus, despite profound differences in the mechanisms of activation, the Arabidopsis G protein is readily inactivated by its cognate RGS protein and forms a stable, GDP-bound, heterotrimeric complex similar to that found in animals.	[Jones, Alan M.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Jones, Alan M.; Dohlman, Henrik G.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Jones, Janice C.; Temple, Brenda R. S.; Dohlman, Henrik G.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Temple, Brenda R. S.] Univ N Carolina, RL Juliano Struct Bioinformat Core Facil, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Jones, AM (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.	alan_jones@unc.edu; henrik_dohlman@med.unc.edu		Dohlman, Henrik/0000-0003-2443-0729	National Institutes of Health [GM080739, GM082892, GM065989]; NIGMS; Department of Energy [DE-FG02-05er1 5671]; National Science Foundation [MCB-0723515, MCB-0718202]; Ruth Kirchstein F32; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065989, R01GM080739, R01GM082892] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Ruth Kirchstein F32(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM080739 and GM082892 (to H. G. D.) and GM065989 (to A. M. J.) from the NIGMS. This work was also supported by Department of Energy Grant DE-FG02-05er1 5671 and National Science Foundation Grants MCB-0723515 and MCB-0718202 (to A. M. J.).; Supported by a Ruth Kirchstein F32 postdoctoral award.	Adjobo-Hermans MJW, 2006, J CELL SCI, V119, P5087, DOI 10.1242/jcs.03284; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Chen JG, 2004, METHOD ENZYMOL, V389, P338; Chen JG, 2003, SCIENCE, V301, P1728, DOI 10.1126/science.1087790; Digby GJ, 2006, P NATL ACAD SCI USA, V103, P17789, DOI 10.1073/pnas.0607116103; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P762; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P757; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P752; Isom DG, 2011, PROTEINS, V79, P1034, DOI 10.1002/prot.22932; Isom DG, 2010, P NATL ACAD SCI USA, V107, P4908, DOI 10.1073/pnas.0910421107; Johnston CA, 2007, P NATL ACAD SCI USA, V104, P17317, DOI 10.1073/pnas.0704751104; Jones JC, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001446; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Mason MG, 2001, BBA-GENE STRUCT EXPR, V1520, P147, DOI 10.1016/S0167-4781(01)00262-7; Mason MG, 2000, P NATL ACAD SCI USA, V97, P14784, DOI 10.1073/pnas.97.26.14784; NEAL SE, 1990, P NATL ACAD SCI USA, V87, P3562, DOI 10.1073/pnas.87.9.3562; Posner BA, 1998, J BIOL CHEM, V273, P21752, DOI 10.1074/jbc.273.34.21752; Ryan MM, 2007, MOL BIOL CELL, V18, P1928, DOI 10.1091/mbc.E06-11-1024; Temple BRS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000962; Teotico DG, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000111; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Trusov Y, 2008, PLANT PHYSIOL, V147, P636, DOI 10.1104/pp.108.117655; Ullah H, 2003, PLANT CELL, V15, P393, DOI 10.1105/tpc.006148; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Wang SY, 2008, J BIOL CHEM, V283, P13913, DOI 10.1074/jbc.M801376200; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; WEISS CA, 1994, P NATL ACAD SCI USA, V91, P9554, DOI 10.1073/pnas.91.20.9554; Willard FS, 2004, METHOD ENZYMOL, V389, P320	31	46	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13143	13150		10.1074/jbc.M110.190355	http://dx.doi.org/10.1074/jbc.M110.190355			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21325279	hybrid, Green Published			2022-12-27	WOS:000289282200035
J	Vicari, D; Foy, KC; Liotta, EM; Kaumaya, PTP				Vicari, Daniele; Foy, Kevin C.; Liotta, Eric M.; Kaumaya, Pravin T. P.			Engineered Conformation-dependent VEGF Peptide Mimics Are Effective in Inhibiting VEGF Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-GROWTH-FACTOR; RECEPTOR TYROSINE KINASES; BREAST-CANCER PATIENTS; IN-VITRO; CRYSTAL-STRUCTURE; NEUTRALIZING ANTIBODIES; ANGIOGENESIS INHIBITORS; ANGSTROM RESOLUTION; CIRCULAR-DICHROISM; TUMOR ANGIOGENESIS	Angiogenesis, or formation of new blood vessels, is crucial to cancer tumor growth. Tumor growth, progression, and metastasis are critically influenced by the production of the pro-angiogenic vascular endothelial growth factor (VEGF). Promising anti-angiogenic drugs are currently available; however, their susceptibilities to drug resistance and long term toxicity are serious impediments to their use, thus requiring the development of new therapeutic approaches for safe and effective angiogenic inhibitors. In this work, peptides were designed to mimic the VEGF-binding site to its receptor VEGFR-2. The VEGF conformational peptide mimic, VEGT-P3(CYC), included two artificial cysteine residues, which upon cyclization constrained the peptide in a loop native-like conformation to better mimic the anti-parallel structure of VEGF. The engineered cyclic VEGF mimic peptide demonstrated the highest affinity to VEGTR-2 by surface plasmon resonance assay. The VEGF peptide mimics were evaluated as inhibitors in several in vitro assays in which VEGF-dependent signaling pathways were observed. All VEGF mimics inhibited VEGFR-2 phosphorylation with VEGF-P3(CYC) showing the highest inhibitory effects when compared with unstructured peptides. Additionally, we show in several arigiogenic in vitro assays that all the VEGF mimics inhibited endothelial cell proliferation, migration, and network formation with the conformational VEGT-P3 (CYC) being the best. The VEGT-P3(CYC) also caused a significant delay in tumor development in a transgenic model of VEGF(+/-)Neu2-5(+/-). These results indicate that the structure-based design is important for the development of this peptidomimetic and for its anti-angiogenic effects.	[Vicari, Daniele; Foy, Kevin C.; Kaumaya, Pravin T. P.] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Vicari, Daniele; Foy, Kevin C.; Kaumaya, Pravin T. P.] Ohio State Univ, Dept Obstet & Gynecol, Columbus, OH 43210 USA; [Liotta, Eric M.] Ohio State Univ, Sch Biomed Sci, Columbus, OH 43210 USA; [Kaumaya, Pravin T. P.] Ohio State Univ, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Kaumaya, PTP (corresponding author), Ohio State Univ, Dept Microbiol, Ste 316 Med Res Facil,420 W 12th Ave, Columbus, OH 43210 USA.	Kaumaya.1@osu.edu	Kaumaya, Pravin T. P/E-3354-2011					Ahmed SI, 2004, J CHEMOTHERAPY, V16, P59, DOI 10.1179/joc.2004.16.Supplement-1.59; Allen SD, 2005, J PEPT RES, V65, P591, DOI 10.1111/j.1399-3011.2005.00256.x; Allen SD, 2007, J IMMUNOL, V179, P472, DOI 10.4049/jimmunol.179.1.472; Anghelina M, 2004, STEM CELLS DEV, V13, P665, DOI 10.1089/scd.2004.13.665; Anghelina M, 2006, AM J PATHOL, V168, P529, DOI 10.2353/ajpath.2006.050255; Backer MV, 2001, J CONTROL RELEASE, V74, P349, DOI 10.1016/S0168-3659(01)00346-7; Benjamin LE, 1997, P NATL ACAD SCI USA, V94, P8761, DOI 10.1073/pnas.94.16.8761; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bergers G, 2001, NAT BIOTECHNOL, V19, P20, DOI 10.1038/83457; Binetruy-Tournaire R, 2000, EMBO J, V19, P1525, DOI 10.1093/emboj/19.7.1525; Boguslawski G, 2004, J BIOL CHEM, V279, P5716, DOI 10.1074/jbc.M308625200; Boldicke T, 2001, STEM CELLS, V19, P24, DOI 10.1634/stemcells.19-1-24; Brown KJ, 1996, LAB INVEST, V75, P539; BUSH CA, 1978, BIOCHEMISTRY-US, V17, P4951, DOI 10.1021/bi00616a015; Butenas S, 2006, J THROMB HAEMOST, V4, P2411, DOI 10.1111/j.1538-7836.2006.02226.x; Carmeliet P, 2005, ONCOLOGY-BASEL, V69, P4, DOI 10.1159/000088478; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Dakappagari NK, 2005, J BIOL CHEM, V280, P54, DOI 10.1074/jbc.M411020200; Dakappagari NK, 2000, CANCER RES, V60, P3782; Dakappagari NK, 2003, J IMMUNOL, V170, P4242, DOI 10.4049/jimmunol.170.8.4242; Dancey JE, 2006, NAT REV DRUG DISCOV, V5, P649, DOI 10.1038/nrd2089; Dass CR, 2006, PEPTIDES, V27, P3479, DOI 10.1016/j.peptides.2006.08.016; Deininger Michael, 2005, J Natl Compr Canc Netw, V3, P757; Drevs J, 2000, CANCER RES, V60, P4819; Ercil NE, 2005, PSYCHOPHARMACOLOGY, V180, P279, DOI 10.1007/s00213-005-2166-x; Fairbrother WJ, 1998, STRUCT FOLD DES, V6, P637, DOI 10.1016/S0969-2126(98)00065-3; Farrara N, 2000, CURR OPIN BIOTECH, V11, P617, DOI 10.1016/S0958-1669(00)00153-1; Fear G, 2007, PHARMACOL THERAPEUT, V113, P354, DOI 10.1016/j.pharmthera.2006.09.001; Ferrara N, 2005, BIOCHEM BIOPH RES CO, V333, P328, DOI 10.1016/j.bbrc.2005.05.132; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Folkman J, 1992, Semin Cancer Biol, V3, P65; Fuh G, 2006, J BIOL CHEM, V281, P6625, DOI 10.1074/jbc.M507783200; Fuh G, 1998, J BIOL CHEM, V273, P11197, DOI 10.1074/jbc.273.18.11197; Gampel A, 2006, BLOOD, V108, P2624, DOI 10.1182/blood-2005-12-007484; Garrett JT, 2007, J IMMUNOL, V178, P7120, DOI 10.4049/jimmunol.178.11.7120; Gong Y, 2007, LANCET ONCOL, V8, P203, DOI 10.1016/S1470-2045(07)70042-6; Grove AD, 2002, CLIN CANCER RES, V8, P3019; Herley MT, 1999, BIOCHEM BIOPH RES CO, V262, P731, DOI 10.1006/bbrc.1999.1282; Hiratsuka S, 2001, CANCER RES, V61, P1207; Jain RK, 2002, SEMIN ONCOL, V29, P3, DOI 10.1053/sonc.2002.37265; Joppa MA, 2005, PEPTIDES, V26, P2294, DOI 10.1016/j.peptides.2005.03.002; Kanno S, 2000, ONCOGENE, V19, P2138, DOI 10.1038/sj.onc.1203533; Kaumaya Pravin T. P., 1993, Journal of Molecular Recognition, V6, P81, DOI 10.1002/jmr.300060206; KAUMAYA PTP, 1992, J BIOL CHEM, V267, P6338; Kerbel R, 2002, NAT REV CANCER, V2, P727, DOI 10.1038/nrc905; Keyt BA, 1996, J BIOL CHEM, V271, P5638, DOI 10.1074/jbc.271.10.5638; Konecny GE, 2004, CLIN CANCER RES, V10, P1706, DOI 10.1158/1078-0432.CCR-0951-3; Kostopoulos I, 2006, BREAST CANCER RES TR, V96, P251, DOI 10.1007/s10549-005-9062-2; Kremer C, 1997, CANCER RES, V57, P3852; Ladner RC, 2004, DRUG DISCOV TODAY, V9, P525, DOI 10.1016/S1359-6446(04)03104-6; Lee J, 1996, P NATL ACAD SCI USA, V93, P1988, DOI 10.1073/pnas.93.5.1988; Lei HT, 2002, J BIOL CHEM, V277, P43137, DOI 10.1074/jbc.M203103200; LENDER A, 1993, INT J PEPT PROT RES, V42, P509; Li B, 2006, FASEB J, V20, P1495, DOI 10.1096/fj.05-5137fje; Lu D, 2003, J BIOL CHEM, V278, P43496, DOI 10.1074/jbc.M307742200; Mac Gabhann F, 2007, BIOPHYS CHEM, V128, P125, DOI 10.1016/j.bpc.2007.03.010; Milkiewicz M, 2006, INT J BIOCHEM CELL B, V38, P333, DOI 10.1016/j.biocel.2005.10.006; Moldovan L, 2005, EXP SUPPL, V94, P127; Morabito A, 2006, ONCOLOGIST, V11, P753, DOI 10.1634/theoncologist.11-7-753; Muller YA, 1997, STRUCTURE, V5, P1325, DOI 10.1016/S0969-2126(97)00284-0; Muller YA, 1997, P NATL ACAD SCI USA, V94, P7192, DOI 10.1073/pnas.94.14.7192; Muller YA, 1998, STRUCTURE, V6, P1153, DOI 10.1016/S0969-2126(98)00116-6; Neagoe PE, 2005, J BIOL CHEM, V280, P9904, DOI 10.1074/jbc.M412017200; Ng IOL, 2001, AM J CLIN PATHOL, V116, P838; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; PERCZEL A, 1993, INT J PEPT PROT RES, V41, P223; Perona Rosario, 2006, Clin Transl Oncol, V8, P77, DOI 10.1007/s12094-006-0162-1; Petit AMV, 1997, AM J PATHOL, V151, P1523; Schramm R, 2003, TRANSPLANTATION, V75, P239, DOI 10.1097/01.TP.0000040869.19883.4A; Sebolt-Leopold JS, 2006, NATURE, V441, P457, DOI 10.1038/nature04874; Sepp-Lorenzino L, 2004, CANCER RES, V64, P751, DOI 10.1158/0008-5472.CAN-03-2871; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; Shibuya M, 2006, J BIOCHEM MOL BIOL, V39, P469; Shor Audrey C, 2008, Cancer Control, V15, P47; Sundaram R, 2004, J BIOL CHEM, V279, P24141, DOI 10.1074/jbc.M313210200; Sundaram R, 2002, BIOPOLYMERS, V66, P200, DOI 10.1002/bip.10258; Takahashi H, 2005, CLIN SCI, V109, P227, DOI 10.1042/CS20040370; Verhoef C, 2006, CURR PHARM DESIGN, V12, P2623, DOI 10.2174/138161206777698756; Weigand Melanie, 2005, Angiogenesis, V8, P197, DOI 10.1007/s10456-005-9010-0; Wen XF, 2006, ONCOGENE, V25, P6986, DOI 10.1038/sj.onc.1209685; White FC, 1995, GROWTH FACTORS, V12, P289, DOI 10.3109/08977199509028967; Wiesmann C, 1998, BIOCHEMISTRY-US, V37, P17765, DOI 10.1021/bi9819327; Witte L, 1998, CANCER METAST REV, V17, P155, DOI 10.1023/A:1006094117427; Wood JM, 2000, MEDICINA-BUENOS AIRE, V60, P41; Wu LW, 2000, J BIOL CHEM, V275, P5096, DOI 10.1074/jbc.275.7.5096; Yang SY, 2002, ARTERIOSCL THROM VAS, V22, P1797, DOI 10.1161/01.ATV.0000038995.31179.24; Yoo PS, 2006, WORLD J GASTROENTERO, V12, P4937, DOI 10.3748/wjg.v12.i31.4937; Zhang Wei, 2002, Angiogenesis, V5, P35, DOI 10.1023/A:1021540120521; Zilberberg L, 2003, J BIOL CHEM, V278, P35564, DOI 10.1074/jbc.M304435200	89	54	59	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13612	13625		10.1074/jbc.M110.216812	http://dx.doi.org/10.1074/jbc.M110.216812			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21321115	Green Published, hybrid			2022-12-27	WOS:000289282200080
J	Wang, LP; Ota, N; Romanova, EV; Sweedler, JV				Wang, Liping; Ota, Nobutoshi; Romanova, Elena V.; Sweedler, Jonathan V.			A Novel Pyridoxal 5 '-Phosphate-dependent Amino Acid Racemase in the Aplysia californica Central Nervous System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-ASPARTIC ACID; INDUCED FLUORESCENCE DETECTION; MOLLUSK SCAPHARCA-BROUGHTONII; D-SERINE; CAPILLARY-ELECTROPHORESIS; NEURAL SAMPLES; RAT-BRAIN; D-ALANINE; GLUTAMATE; NEUROTRANSMISSION	D-Aspartate (D-Asp) is found in specific neurons, transported to neuronal terminals and released in a stimulation-dependent manner. Because D-Asp formation is not well understood, determining its function has proved challenging. Significant levels of D-Asp are present in the cerebral ganglion of the F- and C-clusters of the invertebrate Aplysia californica, and D-Asp appears to be involved in cell-cell communication in this system. Here, we describe a novel protein, DAR1, from A. californica that can convert aspartate and serine to their other chiral form in a pyridoxal 5'-phosphate (PLP)-dependent manner. DAR1 has a predicted length of 325 amino acids and is 55% identical to the bivalve aspartate racemase, EC 5.1.1.13, and 41% identical to the mammalian serine racemase, EC 5.1.1.18. However, it is only 14% identical to the recently reported mammalian aspartate racemase, DR, which is closely related to glutamate-oxaloacetate transaminase, EC 2.6.1.1. Using whole-mount immunohistochemistry staining of the A. californica central nervous system, we localized DAR1-like immunoreactivity to the medial region of the cerebral ganglion where the F- and C-clusters are situated. The biochemical and functional similarities between DAR1 and other animal serine and aspartate racemases make it valuable for examining PEP-dependent racemases, promising to increase our knowledge of enzyme regulation and ultimately, D-serine and D-Asp signaling pathways.	[Ota, Nobutoshi; Romanova, Elena V.; Sweedler, Jonathan V.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Wang, Liping; Sweedler, Jonathan V.] Univ Illinois, Neurosci Program, Urbana, IL 61801 USA; [Romanova, Elena V.; Sweedler, Jonathan V.] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA; [Wang, Liping] Univ Illinois, Immunol Resource Ctr, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Sweedler, JV (corresponding author), Univ Illinois, Dept Chem, 600 S Mathews Ave,63-5, Urbana, IL 61801 USA.	jsweedle@illinois.edu	Sweedler, Jonathan V/A-9405-2009	Sweedler, Jonathan V/0000-0003-3107-9922; Romanova, Elena/0000-0002-2040-3312	NINDS, National Institutes of Health [NS031609]; National Science Foundation (NSF) [CHE-04-00768, CHE-05-26692]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031609, R29NS031609] Funding Source: NIH RePORTER	NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by Award No. NS031609 from the NINDS, National Institutes of Health, and by Award Nos, CHE-04-00768 and CHE-05-26692 from the National Science Foundation (NSF).	Abe K, 2006, J BIOCHEM, V139, P235, DOI 10.1093/jb/mvj028; D'Aniello A, 2007, BRAIN RES REV, V53, P215, DOI 10.1016/j.brainresrev.2006.08.005; D'Aniello S, 2005, BIOCHEM J, V386, P331, DOI 10.1042/BJ20041070; Errico F, 2008, J NEUROSCI, V28, P10404, DOI 10.1523/JNEUROSCI.1618-08.2008; Errico F, 2009, REV NEUROSCIENCE, V20, P429; Fujisawa Y, 1999, J NEUROSCI, V19, P9618; Habl G, 2009, J NEURAL TRANSM, V116, P1657, DOI 10.1007/s00702-009-0312-z; HASHIMOTO A, 1993, NEUROSCI LETT, V152, P33, DOI 10.1016/0304-3940(93)90476-2; Kim PM, 2010, P NATL ACAD SCI USA, V107, P3175, DOI 10.1073/pnas.0914706107; Kirschner DL, 2007, ANAL CHEM, V79, P736, DOI 10.1021/ac061725+; Labrie V, 2009, HUM MOL GENET, V18, P3227, DOI 10.1093/hmg/ddp261; Lapainis T, 2008, J CHROMATOGR A, V1184, P144, DOI 10.1016/j.chroma.2007.10.098; LEWELLYNSMITH IJ, 1985, J HISTOCHEM CYTOCHEM, V33, P857; Mangas A, 2007, NEUROSCIENCE, V144, P654, DOI 10.1016/j.neuroscience.2006.09.045; Miao H, 2006, J NEUROCHEM, V97, P595, DOI 10.1111/j.1471-4159.2006.03791.x; Miao H, 2006, J CHROMATOGR A, V1106, P56, DOI 10.1016/j.chroma.2005.09.037; Morikawa A, 2003, ANAL BIOCHEM, V312, P66, DOI 10.1016/S0003-2697(02)00432-3; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; NEIDLE A, 1990, LIFE SCI, V46, P1517, DOI 10.1016/0024-3205(90)90424-P; Neidle A, 2002, NEUROCHEM RES, V27, P1719, DOI 10.1023/A:1021607715824; Paez X, 2001, BIOPHARM DRUG DISPOS, V22, P273, DOI 10.1002/bdd.277; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Quan Z, 2003, ELECTROPHORESIS, V24, P1092, DOI 10.1002/elps.200390127; Sakai K, 1998, BRAIN RES, V808, P65, DOI 10.1016/S0006-8993(98)00599-X; Scanlan C, 2010, J NEUROCHEM, V115, P1234, DOI 10.1111/j.1471-4159.2010.07020.x; SCHELL MJ, 1995, P NATL ACAD SCI USA, V92, P3948, DOI 10.1073/pnas.92.9.3948; Shibata K, 2003, COMP BIOCHEM PHYS B, V134, P713, DOI 10.1016/S1096-4959(03)00031-9; Shibata K, 2003, COMP BIOCHEM PHYS B, V134, P307, DOI 10.1016/S1096-4959(02)00267-1; Spinelli P, 2006, J CELL PHYSIOL, V206, P672, DOI 10.1002/jcp.20513; Topo E, 2010, AMINO ACIDS, V38, P1561, DOI 10.1007/s00726-009-0369-x; UEDA T, 1992, J CHROMATOGR, V593, P265, DOI 10.1016/0021-9673(92)80295-6; Verrall L, 2007, EUR J NEUROSCI, V26, P1657, DOI 10.1111/j.1460-9568.2007.05769.x; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P13409, DOI 10.1073/pnas.96.23.13409; Wolosker H, 2008, FEBS J, V275, P3514, DOI 10.1111/j.1742-4658.2008.06515.x; Yamashita T, 2004, EUR J BIOCHEM, V271, P4798, DOI 10.1111/j.1432-1033.2004.04445.x; Yoshimura T, 2008, FEBS J, V275, P3527, DOI 10.1111/j.1742-4658.2008.06516.x; Zaar K, 2002, J COMP NEUROL, V450, P272, DOI 10.1002/cne.10320; Zhao SL, 2005, TALANTA, V67, P212, DOI 10.1016/j.talanta.2005.02.032	38	24	24	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13765	13774		10.1074/jbc.M110.178228	http://dx.doi.org/10.1074/jbc.M110.178228			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21343289	hybrid, Green Published			2022-12-27	WOS:000289282200094
J	Shivaraju, M; Camahort, R; Mattingly, M; Gerton, JL				Shivaraju, Manjunatha; Camahort, Raymond; Mattingly, Mark; Gerton, Jennifer L.			Scm3 Is a Centromeric Nucleosome Assembly Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE KINETOCHORE; E3 UBIQUITIN LIGASE; HISTONE H3 VARIANT; CENP-A; BUDDING YEAST; STRUCTURAL DETERMINANTS; TARGETING DOMAIN; DNA-SYNTHESIS; COILED-COILS; CHROMATIN	The Cse4 nucleosome at each budding yeast centromere must be faithfully assembled each cell cycle to specify the site of kinetochore assembly and microtubule attachment for chromosome segregation. Although Scm3 is required for the localization of the centromeric H3 histone variant Cse4 to centromeres, its role in nucleosome assembly has not been tested. We demonstrate that Scm3 is able to mediate the assembly of Cse4 nucleosomes in vitro, but not H3 nucleosomes, as measured by a supercoiling assay. Localization of Cse4 to centromeres and the assembly activity depend on an evolutionarily conserved core motif in Scm3, but localization of the CBF3 subunit Ndc10 to centromeres does not depend on this motif. The centromere targeting domain of Cse4 is sufficient for Scm3 nucleosome assembly activity. Assembly does not depend on centromeric sequence. We propose that Scm3 plays an active role in centromeric nucleosome assembly.	Stowers Inst Med Res, Kansas City, MO 64110 USA; [Shivaraju, Manjunatha] Open Univ, Milton Keynes MK7 6BJ, Bucks, England; [Gerton, Jennifer L.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; Open University - UK; University of Kansas; University of Kansas Medical Center	Gerton, JL (corresponding author), 1000 E 50th St, Kansas City, MO 64110 USA.	jeg@stowers.org		Shivaraju, Manjunatha/0000-0001-6346-6279	National Institutes of Health [R01GM080477]; Stowers Institute for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080477] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stowers Institute for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM080477. This work was also supported by the Stowers Institute for Medical Research.	Andrews AJ, 2010, MOL CELL, V37, P834, DOI 10.1016/j.molcel.2010.01.037; Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Black BE, 2007, MOL CELL, V25, P309, DOI 10.1016/j.molcel.2006.12.018; Bloom K, 2006, CURR BIOL, V16, pR276, DOI 10.1016/j.cub.2006.03.054; Bogerd HP, 1996, MOL CELL BIOL, V16, P4207; BROWN MT, 1993, J CELL BIOL, V123, P387, DOI 10.1083/jcb.123.2.387; Camahort R, 2007, MOL CELL, V26, P853, DOI 10.1016/j.molcel.2007.05.013; Camahort R, 2009, MOL CELL, V35, P794, DOI 10.1016/j.molcel.2009.07.022; Chen YH, 2000, MOL CELL BIOL, V20, P7037, DOI 10.1128/MCB.20.18.7037-7048.2000; Dalal Y, 2007, PLOS BIOL, V5, P1798, DOI 10.1371/journal.pbio.0050218; De Koning L, 2007, NAT STRUCT MOL BIOL, V14, P997, DOI 10.1038/nsmb1318; DOHENY KF, 1993, CELL, V73, P761, DOI 10.1016/0092-8674(93)90255-O; Espelin CW, 1997, J CELL BIOL, V139, P1383, DOI 10.1083/jcb.139.6.1383; Espelin CW, 2003, MOL BIOL CELL, V14, P4557, DOI 10.1091/mbc.E02-08-0533; FITZGERALDHAYES M, 1982, CELL, V29, P235, DOI 10.1016/0092-8674(82)90108-8; Foltz DR, 2009, CELL, V137, P472, DOI 10.1016/j.cell.2009.02.039; Fraschini R, 2001, MOL GENET GENOMICS, V266, P115, DOI 10.1007/s004380100533; Furuyama S, 2007, P NATL ACAD SCI USA, V104, P14706, DOI 10.1073/pnas.0706985104; Furuyama T, 2009, CELL, V138, P104, DOI 10.1016/j.cell.2009.04.049; GOH PY, 1993, J CELL BIOL, V121, P503, DOI 10.1083/jcb.121.3.503; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Hewawasam G, 2010, MOL CELL, V40, P444, DOI 10.1016/j.molcel.2010.10.014; Huang CC, 2011, MOL CELL BIOL, V31, P1030, DOI 10.1128/MCB.01191-10; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; Jans DA, 2000, BIOESSAYS, V22, P532, DOI 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O; Keith KC, 1999, MOL CELL BIOL, V19, P6130; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Li B, 2005, P NATL ACAD SCI USA, V102, P18385, DOI 10.1073/pnas.0507975102; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luk E, 2007, MOL CELL, V25, P357, DOI 10.1016/j.molcel.2006.12.015; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; McAinsh AD, 2003, ANNU REV CELL DEV BI, V19, P519, DOI 10.1146/annurev.cellbio.19.111301.155607; Meluh PB, 1998, CELL, V94, P607, DOI 10.1016/S0092-8674(00)81602-5; Meraldi P, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r23; Mizuguchi G, 2007, CELL, V129, P1153, DOI 10.1016/j.cell.2007.04.026; NG R, 1987, MOL CELL BIOL, V7, P4522, DOI 10.1128/MCB.7.12.4522; Parry DAD, 2008, J STRUCT BIOL, V163, P258, DOI 10.1016/j.jsb.2008.01.016; Pearson CG, 2004, CURR BIOL, V14, P1962, DOI 10.1016/j.cub.2004.09.086; Pinto I, 2000, EMBO J, V19, P1598, DOI 10.1093/emboj/19.7.1598; Ranjitkar P, 2010, MOL CELL, V40, P455, DOI 10.1016/j.molcel.2010.09.025; Ray-Gallet D, 2002, MOL CELL, V9, P1091, DOI 10.1016/S1097-2765(02)00526-9; Rodrigo-Brenni MC, 2004, MOL BIOL CELL, V15, P3366, DOI 10.1091/mbc.E03-12-0887; Sambrook J, 2001, MOL CLONING LAB MANU; Sekulic N, 2010, NATURE, V467, P347, DOI 10.1038/nature09323; Shuaib M, 2010, P NATL ACAD SCI USA, V107, P1349, DOI 10.1073/pnas.0913709107; Stoler S, 2007, P NATL ACAD SCI USA, V104, P10571, DOI 10.1073/pnas.0703178104; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Visnapuu ML, 2009, NAT STRUCT MOL BIOL, V16, P1056, DOI 10.1038/nsmb.1655; Weber SA, 2004, PLOS BIOL, V2, P1340, DOI 10.1371/journal.pbio.0020260; Williams JS, 2009, MOL CELL, V33, P287, DOI 10.1016/j.molcel.2009.01.017; Yoda K, 2000, P NATL ACAD SCI USA, V97, P7266, DOI 10.1073/pnas.130189697	52	41	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.183640	http://dx.doi.org/10.1074/jbc.M110.183640			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21317428	hybrid, Green Published			2022-12-27	WOS:000289077500015
J	Boeda, B; Knowles, PP; Briggs, DC; Murray-Rust, J; Soriano, E; Garvalov, BK; McDonald, NQ; Way, M				Boeda, Batiste; Knowles, Phillip P.; Briggs, David C.; Murray-Rust, Judith; Soriano, Erika; Garvalov, Boyan K.; McDonald, Neil Q.; Way, Michael			Molecular Recognition of the Tes LIM2-3 Domains by the Actin-related Protein Arp7A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR ACTIN; ACROSOME; ACROPLAXOME; EVOLUTION; REGION; GENES; PLATE	Actin-related proteins (Arps) are a highly conserved family of proteins that have extensive sequence and structural similarity to actin. All characterized Arps are components of large multimeric complexes associated with chromatin or the cytoskeleton. In addition, the human genome encodes five conserved but largely uncharacterized "orphan" Arps, which appear to be mostly testis-specific. Here we show that Arp7A, which has 43% sequence identity with beta-actin, forms a complex with the cytoskeletal proteins Tes and Mena in the subacrosomal layer of round spermatids. The N-terminal 65-residue extension to the actin-like fold of Arp7A interacts directly with Tes. The crystal structure of the 1-65(Arp7A).LIM2-3(Tes).EVH1(Mena) complex reveals that residues 28-49 of Arp7A contact the LIM2-3 domains of Tes. Two alanine residues from Arp7A that occupy equivalent apolar pockets in both LIM domains as well as an intervening GPAK linker that binds the LIM2-3 junction are critical for the Arp7A-Tes interaction. Equivalent occupied apolar pockets are also seen in the tandem LIM domain structures of LMO4 and Lhx3 bound to unrelated ligands. Our results indicate that apolar pocket interactions are a common feature of tandem LIM domain interactions, but ligand specificity is principally determined by the linker sequence.	[Knowles, Phillip P.; Briggs, David C.; Murray-Rust, Judith; Soriano, Erika; McDonald, Neil Q.] London Res Inst, Canc Res UK, Struct Biol Lab, London WC2A 3LY, England; [Boeda, Batiste; Way, Michael] London Res Inst, Cell Motil Lab, London WC2A 3LY, England; [Briggs, David C.] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; [Garvalov, Boyan K.] Univ Giessen, Inst Neuropathol, D-35392 Giessen, Germany; [Boeda, Batiste] Inst Pasteur, CNRS 2582, Cell Polar & Migrat Grp, F-75724 Paris, France; [McDonald, Neil Q.] UCL, Inst Struct & Mol Biol, London WC1E 7HX, England; [McDonald, Neil Q.] Birkbeck Coll, London WC1E 7HX, England	Cancer Research UK; University of Manchester; Justus Liebig University Giessen; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of London; Birkbeck University London; University College London; University of London; Birkbeck University London	McDonald, NQ (corresponding author), London Res Inst, Canc Res UK, Struct Biol Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England.	neil.mcdonald@cancer.org.uk; michael.way@cancer.org.uk	Garvalov, Boyan K./AAF-6414-2020; BOEDA, Batiste/L-7217-2018	Garvalov, Boyan K./0000-0003-0013-9064; Soriano, Erika V./0000-0002-2972-9386; Boeda, Batiste/0000-0002-0806-8582; Way, Michael/0000-0001-7207-2722; Briggs, David/0000-0002-9793-7339	Cancer Research UK [10747] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Behnen M, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-34; Bhati M, 2008, EMBO J, V27, P2018, DOI 10.1038/emboj.2008.123; Blessing CA, 2004, TRENDS CELL BIOL, V14, P435, DOI 10.1016/j.tcb.2004.07.009; Boeda B, 2007, MOL CELL, V28, P1071, DOI 10.1016/j.molcel.2007.10.033; Chadwick BP, 1999, GENOMICS, V58, P302, DOI 10.1006/geno.1999.5848; Chen MM, 2007, CURR OPIN CELL BIOL, V19, P326, DOI 10.1016/j.ceb.2007.04.009; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Coutts AS, 2003, J CELL SCI, V116, P897, DOI 10.1242/jcs.00278; Deane JE, 2004, EMBO J, V23, P3589, DOI 10.1038/sj.emboj.7600376; DeLano W.L, PYMOL MOL GRAPHICS S; Derman AI, 2009, MOL MICROBIOL, V73, P534, DOI 10.1111/j.1365-2958.2009.06771.x; Drusco A, 2005, P NATL ACAD SCI USA, V102, P10947, DOI 10.1073/pnas.0504934102; El Omari K, 2011, BLOOD, V117, P2146, DOI 10.1182/blood-2010-07-293357; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erickson HP, 2007, BIOESSAYS, V29, P668, DOI 10.1002/bies.20601; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Goodson HV, 2002, J CELL SCI, V115, P2619; Hara Y, 2008, FEBS LETT, V582, P2998, DOI 10.1016/j.febslet.2008.07.058; Heid HW, 2002, EXP CELL RES, V279, P177, DOI 10.1006/excr.2002.5603; Hisano M, 2003, MOL REPROD DEV, V65, P148, DOI 10.1002/mrd.10276; Hyenne V, 2007, REPRODUCTION, V133, P563, DOI 10.1530/REP-06-0271; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Kierszenbaum Abraham L, 2007, Soc Reprod Fertil Suppl, V65, P33; Kierszenbaum AL, 2003, CYTOGENET GENOME RES, V103, P337, DOI 10.1159/000076822; Kierszenbaum AL, 2003, MOL BIOL CELL, V14, P4628, DOI 10.1091/mbc.E03-04-0226; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Meagher RB, 2009, INT REV CEL MOL BIO, V277, P157, DOI 10.1016/S1937-6448(09)77005-4; Michie KA, 2006, ANNU REV BIOCHEM, V75, P467, DOI 10.1146/annurev.biochem.75.103004.142452; Moreno RD, 2006, MOL REPROD DEV, V73, P1430, DOI 10.1002/mrd.20581; Mueller W, 2007, ONCOGENE, V26, P583, DOI 10.1038/sj.onc.1209805; Muller J, 2005, MOL BIOL CELL, V16, P5736, DOI 10.1091/mbc.E05-06-0508; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Rietdorf J, 2001, NAT CELL BIOL, V3, P992, DOI 10.1038/ncb1101-992; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Shih YL, 2006, MICROBIOL MOL BIOL R, V70, P729, DOI 10.1128/MMBR.00017-06; Tanaka H, 2003, BIOL REPROD, V69, P475, DOI 10.1095/biolreprod.103.015867; Tatarelli C, 2000, GENOMICS, V68, P1, DOI 10.1006/geno.2000.6272; Tobias ES, 2001, ONCOGENE, V20, P2844, DOI 10.1038/sj.onc.1204433; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766	42	27	36	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11543	11554		10.1074/jbc.M110.171264	http://dx.doi.org/10.1074/jbc.M110.171264			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21278383	hybrid, Green Published			2022-12-27	WOS:000288797100064
J	Pylypenko, O; Song, L; Squires, G; Liu, XY; Zong, AB; Houdusse, A; Sweeney, HL				Pylypenko, Olena; Song, Lin; Squires, Gaelle; Liu, Xiaoyan; Zong, Alan B.; Houdusse, Anne; Sweeney, H. Lee			Role of Insert-1 of Myosin VI in Modulating Nucleotide Affinity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPERTROPHIC CARDIOMYOPATHY; KINETIC MECHANISM; ACTIN-FILAMENTS; BINDING; MOTOR; SUBFRAGMENT-1; PROCESSIVITY; STROKE; ATPASE; SITES	Myosin VI is unique in its directionality among myosin superfamily members and also displays a slow and strain-dependent rate of ATP binding that allows for gating between its heads. In this study we demonstrate that leucine 310 is positioned by a class VI-specific insert, insert-1, so as to account for the selective hindrance of ATP versus ADP binding. Mutation of leucine 310 to glycine removes all influence of insert-1 on ATP binding. Furthermore, by analyzing myosin VI structures with either leucine 310 substituted to a glycine or complete removal of insert-1, we conclude that nucleotides may initially bind to myosin by their purine rings before docking their phosphate moieties. Otherwise, insert-1 could not exert a differential influence on ATP versus ADP binding.	[Pylypenko, Olena; Squires, Gaelle; Houdusse, Anne] CNRS, Inst Curie, UMR144, F-75248 Paris 05, France; [Song, Lin; Liu, Xiaoyan; Zong, Alan B.; Sweeney, H. Lee] Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; University of Pennsylvania	Houdusse, A (corresponding author), CNRS, Inst Curie, UMR144, 26 Rue Ulm, F-75248 Paris 05, France.	Anne.Houdusse@curie.fr	Sweeney, H Lee/F-1862-2010	Pylypenko, Olena/0000-0001-7073-5238	National Institutes of Health [DC009100]; CNRS; ANR Blanche [BLAN07-3_193368]; ACI BCMS; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009100] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR Blanche(French National Research Agency (ANR)); ACI BCMS; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grant DC009100 (to H. L. S.). This work was also supported by CNRS (to A. H.), ANR Blanche BLAN07-3_193368 (to A. H.), and ACI BCMS (to A. H.).	Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; De la Cruz EM, 2000, BIOPHYS J, V79, P1524, DOI 10.1016/S0006-3495(00)76403-4; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; De la Cruz EM, 2001, J BIOL CHEM, V276, P32373, DOI 10.1074/jbc.M104136200; Diederichs K, 2003, ACTA CRYSTALLOGR D, V59, P903, DOI 10.1107/S0907444903006516; GEEVES MA, 1988, BIOCHEM J, V256, P41, DOI 10.1042/bj2560041; Havndrup O, 2003, CARDIOVASC RES, V57, P347, DOI 10.1016/S0008-6363(02)00711-3; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; LUMB KJ, 1994, BIOCHEMISTRY-US, V33, P7361, DOI 10.1021/bi00189a042; Menetrey J, 2005, NATURE, V435, P779, DOI 10.1038/nature03592; Menetrey J, 2008, EMBO J, V27, P244, DOI 10.1038/sj.emboj.7601937; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Miller BM, 2007, J MOL BIOL, V368, P1051, DOI 10.1016/j.jmb.2007.02.042; Nishikawa S, 2002, BIOCHEM BIOPH RES CO, V290, P311, DOI 10.1006/bbrc.2001.6142; Park H, 2006, MOL CELL, V21, P331, DOI 10.1016/j.molcel.2005.12.015; Phichith D, 2009, P NATL ACAD SCI USA, V106, P17320, DOI 10.1073/pnas.0909748106; Purcell TJ, 2005, P NATL ACAD SCI USA, V102, P13873, DOI 10.1073/pnas.0506441102; Reifenberger JG, 2009, P NATL ACAD SCI USA, V106, P18255, DOI 10.1073/pnas.0900005106; Risal D, 2004, P NATL ACAD SCI USA, V101, P8930, DOI 10.1073/pnas.0403002101; Rock RS, 2001, P NATL ACAD SCI USA, V98, P13655, DOI 10.1073/pnas.191512398; Rosenfeld SS, 2005, J BIOL CHEM, V280, P6072, DOI 10.1074/jbc.M412717200; Rosenfeld SS, 2004, J BIOL CHEM, V279, P40100, DOI 10.1074/jbc.M402583200; Sweeney HL, 2007, EMBO J, V26, P2682, DOI 10.1038/sj.emboj.7601720; Sweeney HL, 2007, CURR OPIN CELL BIOL, V19, P57, DOI 10.1016/j.ceb.2006.12.005; Sweeney HL, 1998, J BIOL CHEM, V273, P6262, DOI 10.1074/jbc.273.11.6262; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Van Driest SL, 2004, J AM COLL CARDIOL, V44, P602, DOI 10.1016/j.jacc.2004.04.039; Veigel C, 2005, NAT CELL BIOL, V7, P861, DOI 10.1038/ncb1287; Veigel C, 2002, NAT CELL BIOL, V4, P59, DOI 10.1038/ncb732; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835	31	13	13	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11716	11723		10.1074/jbc.M110.200626	http://dx.doi.org/10.1074/jbc.M110.200626			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21278381	Green Published, hybrid			2022-12-27	WOS:000288797100079
J	Xu, M; Wang, WF; Frontera, JR; Neely, MC; Lu, JH; Aires, D; Hsu, FF; Turk, J; Swerdlow, RH; Carlson, SE; Zhu, H				Xu, Ming; Wang, WenFang; Frontera, Jennifer R.; Neely, Melanie C.; Lu, Jianghua; Aires, Daniel; Hsu, Fong-Fu; Turk, John; Swerdlow, Russell H.; Carlson, Susan E.; Zhu, Hao			Ncb5or Deficiency Increases Fatty Acid Catabolism and Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEAROYL-COA DESATURASE; INDUCED GENE-EXPRESSION; LIPOTOXIC CELL-DEATH; ENDOPLASMIC-RETICULUM; CONGENITAL METHEMOGLOBINEMIA; CYTOCHROME-B5 REDUCTASE; GENERALIZED DEFICIENCY; TRIGLYCERIDE SYNTHESIS; 3T3-L1 PREADIPOCYTES; MENTAL-RETARDATION	The endoplasmic reticulum-associated NADH cytochrome b(5) oxidoreductase (Ncb5or) is widely distributed in animal tissues. Ncb5or(-/-) mice develop diabetes at age 7 weeks and have increased susceptibility to the diabetogenic oxidant streptozotocin. Ncb5or deficiency also results in lipoatrophy and increased hepatocyte sensitivity to cytotoxic effects of saturated fatty acids. Here we investigate the mechanisms of these phenomena in prediabetic Ncb5or(-/-) mice and find that, despite increased rates of fatty acid uptake and synthesis and higher stearoyl-CoA desaturase (SCD) expression, Ncb5or(-/-) liver accumulates less triacylglycerol (TAG) than wild type (WT). Increased fatty acid catabolism and oxidative stress are evident in Ncb5or(-/-) hepatocytes and reflect increased mitochondrial content, peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha) expression, fatty acid oxidation rates, oxidative stress response gene expression, and oxidized glutathione content. Ncb5or(-/-) hepatocytes readily incorporate exogenous fatty acids into TAG but accumulate more free fatty acids (FFA) and have greater palmitate-induced oxidative stress responses and cell death than WT, all of which are alleviated by co-incubation with oleate via TAG channeling. A high fat diet rich in palmitate and oleate stimulates both lipogenesis and fatty acid catabolism in Ncb5or(-/-) liver, resulting in TAG levels similar to WT but increased intracellular FFA accumulation. Hepatic SCD-specific activity is lower in Ncb5or(-/-) than in WT mice, although Ncb5or(-/-) liver has a greater increase in Scd1 mRNA and protein levels. Together, these findings suggest that increased FFA accumulation and catabolism and oxidative stress are major consequences of Ncb5or deficiency in liver.	[Zhu, Hao] Univ Kansas, Med Ctr, Dept Clin Lab Sci, Kansas City, KS 66160 USA; [Xu, Ming; Wang, WenFang; Zhu, Hao] Univ Kansas, Med Ctr, Dept Phys Therapy & Rehabil Sci, Kansas City, KS 66160 USA; [Neely, Melanie C.; Carlson, Susan E.] Univ Kansas, Med Ctr, Dept Nutr & Dietet, Kansas City, KS 66160 USA; [Wang, WenFang; Frontera, Jennifer R.; Aires, Daniel] Univ Kansas, Med Ctr, Dept Internal Med, Div Dermatol, Kansas City, KS 66160 USA; [Lu, Jianghua; Swerdlow, Russell H.] Univ Kansas, Med Ctr, Dept Neurol, Kansas City, KS 66160 USA; [Swerdlow, Russell H.; Zhu, Hao] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA; [Wang, WenFang] Univ Kansas, Med Ctr, Dept Pathol, Kansas City, KS 66160 USA; [Hsu, Fong-Fu; Turk, John] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; Washington University (WUSTL)	Zhu, H (corresponding author), 3901 Rainbow Blvd,MSN 4048G Eaton, Kansas City, KS 66160 USA.	hzhu@kumc.edu	Xu, Ming/AAR-1681-2021; Xu, Ming/L-4044-2019	Xu, Ming/0000-0002-4477-939X; xu, ming/0000-0002-3920-8947; Hsu, Fong-Fu/0000-0001-5368-0183	National Institutes of Health [RO1-DK067355, R01-HD047315, RO1-AG022407, R37-DK34388, P41-RR00954, P60-DK20579, P30-DK56341]; NICHD, National Institutes of Health [HD02528]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD002528, R01HD047315] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067355, P30DK056341, P60DK020579, R37DK034388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG022407, P30AG035982] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-DK067355 (to H. Franklin Bunn and H. Z.) and in part by R01-HD047315 (to S. E. C.), RO1-AG022407 (to R. H. S.), R37-DK34388, P41-RR00954, P60-DK20579, and P30-DK56341 (to J. T.). Core facilities at the University of Kansas Medical Center were supported by NICHD, National Institutes of Health Grant HD02528.	Andersen G, 2004, DIABETES, V53, P2992, DOI 10.2337/diabetes.53.11.2992; Askari B, 2007, DIABETES, V56, P1143, DOI 10.2337/db06-0267; Back SH, 2009, CELL METAB, V10, P13, DOI 10.1016/j.cmet.2009.06.002; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Borradaile NM, 2006, MOL BIOL CELL, V17, P770, DOI 10.1091/mbc.E05-08-0742; Bu SY, 2010, J LIPID RES, V51, P3270, DOI 10.1194/jlr.M009407; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Cho HP, 1999, J BIOL CHEM, V274, P471, DOI 10.1074/jbc.274.1.471; Cho HP, 1999, J BIOL CHEM, V274, P37335, DOI 10.1074/jbc.274.52.37335; Coggan M, 2002, BIOCHEM J, V366, P323, DOI 10.1042/bj20011878; Deng B, 2010, J BIOL CHEM, V285, P30181, DOI 10.1074/jbc.M110.120329; Djouadi F, 2003, MOL GENET METAB, V78, P112, DOI 10.1016/S1096-7192(03)00017-9; Durgan DJ, 2006, AM J PHYSIOL-HEART C, V290, pH2480, DOI 10.1152/ajpheart.01344.2005; Ellis JM, 2010, CELL METAB, V12, P53, DOI 10.1016/j.cmet.2010.05.012; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Feldstein AE, 2004, HEPATOLOGY, V40, P185, DOI 10.1002/hep.20283; Finn RD, 2008, J BIOL CHEM, V283, P31385, DOI 10.1074/jbc.M803496200; Flowers JB, 2007, DIABETES, V56, P1228, DOI 10.2337/db06-1142; FOLCH J, 1957, J BIOL CHEM, V226, P497; Garcia-Ranea JA, 2002, FEBS LETT, V529, P162, DOI 10.1016/S0014-5793(02)03321-5; Gardner AM, 2010, J BIOL CHEM, V285, P23850, DOI 10.1074/jbc.M110.132340; Goren MA, 2008, PROTEIN EXPRES PURIF, V62, P171, DOI 10.1016/j.pep.2008.08.002; Hammond LE, 2005, J BIOL CHEM, V280, P25629, DOI 10.1074/jbc.M503181200; HIRONO H, 1984, LIPIDS, V19, P60, DOI 10.1007/BF02534610; HIRONO H, 1983, TOHOKU J EXP MED, V140, P391, DOI 10.1620/tjem.140.391; HUANG IY, 1981, J BIOCHEM-TOKYO, V89, P1839, DOI 10.1093/oxfordjournals.jbchem.a133385; JAESCHKE H, 1990, METHOD ENZYMOL, V186, P752; KAESTNER KH, 1989, J BIOL CHEM, V264, P14755; KAGEYAMA H, 1988, CANCER RES, V48, P4795; Kim ND, 2006, TOXICOL SCI, V90, P586, DOI 10.1093/toxsci/kfj111; KIRCHGESSNER TG, 1987, J BIOL CHEM, V262, P8463; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Larade K, 2007, BIOCHEM J, V404, P467, DOI 10.1042/BJ20061859; Li ZZ, 2009, J BIOL CHEM, V284, P5637, DOI 10.1074/jbc.M807616200; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Man WC, 2006, J LIPID RES, V47, P1928, DOI 10.1194/jlr.M600172-JLR200; Mashek DG, 2006, J LIPID RES, V47, P2004, DOI 10.1194/jlr.M600150-JLR200; MITCHELL AG, 1995, J BIOL CHEM, V270, P29766; Miyazaki M, 2001, J BIOL CHEM, V276, P39455, DOI 10.1074/jbc.M106442200; Miyazaki M, 2001, J LIPID RES, V42, P1018; Miyazaki M, 2000, J BIOL CHEM, V275, P30132, DOI 10.1074/jbc.M005488200; Miyazaki M, 2007, CELL METAB, V6, P484, DOI 10.1016/j.cmet.2007.10.014; MORRISON WR, 1964, J LIPID RES, V5, P600; Nagle CA, 2008, J LIPID RES, V49, P823, DOI 10.1194/jlr.M700592-JLR200; NTAMBI JM, 1988, J BIOL CHEM, V263, P17291; PAULAUSKIS JD, 1988, J BIOL CHEM, V263, P7049; Pigeon C, 2001, BBA-MOL BASIS DIS, V1535, P275, DOI 10.1016/S0925-4439(01)00024-2; RAO GA, 1980, LIPIDS, V15, P55, DOI 10.1007/BF02534119; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; SHANKLIN J, 1994, BIOCHEMISTRY-US, V33, P12787, DOI 10.1021/bi00209a009; STRITTMATTER P, 1988, J BIOL CHEM, V263, P2532; STRITTMATTER P, 1974, P NATL ACAD SCI USA, V71, P4565, DOI 10.1073/pnas.71.11.4565; STUKEY JE, 1990, J BIOL CHEM, V265, P20144; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Wolins NE, 2003, J BIOL CHEM, V278, P37713, DOI 10.1074/jbc.M304025200; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xie JX, 2004, P NATL ACAD SCI USA, V101, P10750, DOI 10.1073/pnas.0404044101; Zhang L, 2010, J PROTEOME RES, V9, P458, DOI 10.1021/pr900818g; Zhang YZ, 2010, J LIPID RES, V51, P53, DOI 10.1194/jlr.M900146-JLR200; Zhu H, 2004, J BIOL CHEM, V279, P30316, DOI 10.1074/jbc.M402664200; Zhu H, 1999, P NATL ACAD SCI USA, V96, P14742, DOI 10.1073/pnas.96.26.14742	65	26	27	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11141	11154		10.1074/jbc.M110.196543	http://dx.doi.org/10.1074/jbc.M110.196543			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21300801	Green Published, hybrid			2022-12-27	WOS:000288797100025
J	Chen, CH; Huang, PH; Chu, PC; Chen, MC; Chou, CC; Wang, DS; Kulp, SK; Teng, CM; Wang, QB; Chen, CS				Chen, Chun-Han; Huang, Po-Hsien; Chu, Po-Chen; Chen, Mei-Chuan; Chou, Chih-Chien; Wang, Dasheng; Kulp, Samuel K.; Teng, Che-Ming; Wang, Qianben; Chen, Ching-Shih			Energy Restriction-mimetic Agents Induce Apoptosis in Prostate Cancer Cells in Part through Epigenetic Activation of KLF6 Tumor Suppressor Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KRUPPEL-LIKE FACTOR-6; TRANSCRIPTION FACTOR; ANDROGEN RECEPTOR; UP-REGULATION; TARGET; SP1; THIAZOLIDINEDIONES; METABOLISM; CARCINOMA; PROMOTER	Although energy restriction has been recognized as an important target for cancer prevention, the mechanism by which energy restriction-mimetic agents (ERMAs) mediate apoptosis remains unclear. By using a novel thiazolidinedione-derived ERMA, CG-12 (Wei, S., Kulp, S. K., and Chen, C. S. (2010) J. Biol. Chem. 285, 9780-9791), vis-a-vis 2-deoxyglucose and glucose deprivation, we obtain evidence that epigenetic activation of the tumor suppressor gene Kruppel-like factor 6 (KLF6) plays a role in ERMA-induced apoptosis in LNCaP prostate cancer cells. KLF6 regulates the expression of many proapoptotic genes, and shRNA-mediated KLF6 knockdown abrogated the ability of ERMAs to induce apoptosis. Chromatin immunoprecipitation analysis indicates that this KLF6 transcriptional activation was associated with increased histone H3 acetylation and histone H3 lysine 4 trimethylation occupancy at the promoter region. Several lines of evidence demonstrate that the enhancing effect of ERMAs on these active histone marks was mediated through transcriptional repression of histone deacetylases and H3 lysine 4 demethylases by down-regulating Sp1 expression. First, putative Sp1-binding elements are present in the promoters of the affected histone-modifying enzymes, and luciferase reporter assays indicate that site-directed mutagenesis of these Sp1 binding sites significantly diminished the promoter activities. Second, shRNA-mediated knockdown of Sp1 mimicked the repressive effect of energy restriction on these histone-modifying enzymes. Third, ectopic Sp1 expression protected cells from the repressive effect of CG-12 on these histone-modifying enzymes, thereby abolishing the activation of KLF6 expression. Together, these findings underscore the intricate relationship between energy restriction and epigenetic regulation of tumor suppressor gene expression, which has therapeutic relevance to foster novel strategies for prostate cancer therapy.	[Chen, Chun-Han; Huang, Po-Hsien; Chu, Po-Chen; Chen, Mei-Chuan; Chou, Chih-Chien; Wang, Dasheng; Kulp, Samuel K.; Chen, Ching-Shih] Ohio State Univ, Coll Pharm, Div Med Chem, Columbus, OH 43210 USA; [Wang, Qianben] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Chen, Chun-Han; Chen, Mei-Chuan; Teng, Che-Ming] Natl Taiwan Univ, Coll Med, Dept Pharmacol, Taipei 10051, Taiwan	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; National Taiwan University	Chen, CS (corresponding author), Ohio State Univ, Coll Pharm, Div Med Chem, 336 Parks Hall,500 W 12th Ave, Columbus, OH 43210 USA.	chen.844@osu.edu	Wang, Qianben/E-4267-2011	TENG, CHE-MING/0000-0002-9719-7334	National Institutes of Health [CA112250]; Department of Defense [W81XWH-09-0198]; NATIONAL CANCER INSTITUTE [R01CA112250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported, in whole or in part, by National Institutes of Health Grant CA112250 and Department of Defense Prostate Cancer Research Program Grant W81XWH-09-0198.	Bott SRJ, 2005, PROSTATE CANCER P D, V8, P321, DOI 10.1038/sj.pcan.4500822; Britschgi A, 2008, ONCOGENE, V27, P5706, DOI 10.1038/onc.2008.179; Camacho-Vanegas O, 2007, INT J CANCER, V121, P1390, DOI 10.1002/ijc.22809; Catteau A, 2004, INT J ONCOL, V25, P5; Chen CS, 2003, AM J PATHOL, V162, P1349, DOI 10.1016/S0002-9440(10)63930-2; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Difeo A, 2006, ONCOGENE, V25, P6026, DOI 10.1038/sj.onc.1209611; Difeo A, 2009, DRUG RESIST UPDATE, V12, P1, DOI 10.1016/j.drup.2008.11.001; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Gehrau RC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008929; Huang XW, 2008, J BIOL CHEM, V283, P29795, DOI 10.1074/jbc.M802515200; Ito G, 2004, CANCER RES, V64, P3838, DOI 10.1158/0008-5472.CAN-04-0185; Ke XS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004687; Kelloff G, 2005, CLIN CANCER RES, V11, P2785, DOI 10.1158/1078-0432.CCR-04-2626; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Kremer-Tal S, 2007, J HEPATOL, V46, P645, DOI 10.1016/j.jhep.2006.10.012; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Liu F, 2006, MOL BIOL CELL, V17, P585, DOI 10.1091/mbc.E05-08-0775; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Narla G, 2001, SCIENCE, V294, P2563, DOI 10.1126/science.1066326; Osthus RC, 2000, J BIOL CHEM, V275, P21797, DOI 10.1074/jbc.C000023200; Reeves HL, 2004, GASTROENTEROLOGY, V126, P1090, DOI 10.1053/j.gastro.2004.01.005; Safe S, 2005, EUR J CANCER, V41, P2438, DOI 10.1016/j.ejca.2005.08.006; Sangodkar J, 2009, EUR J CANCER, V45, P666, DOI 10.1016/j.ejca.2008.11.009; Schuettengruber B, 2003, MOL CELL BIOL, V23, P6993, DOI 10.1128/MCB.23.19.6993-7004.2003; Singletary K, 2008, CANCER EPIDEM BIOMAR, V17, P1596, DOI 10.1158/1055-9965.EPI-07-2917; Solomon SS, 2008, LIFE SCI, V83, P305, DOI 10.1016/j.lfs.2008.06.024; Teixeira MS, 2007, INT J CANCER, V121, P1976, DOI 10.1002/ijc.22926; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Weake VM, 2010, NAT REV GENET, V11, P426, DOI 10.1038/nrg2781; Wei SO, 2010, J BIOL CHEM, V285, P9780, DOI 10.1074/jbc.M109.065466; Wei S, 2009, MOL PHARMACOL, V76, P47, DOI 10.1124/mol.109.055376; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; Yamashita K, 2002, CANCER CELL, V2, P485, DOI 10.1016/S1535-6108(02)00215-5; Yang J, 2008, J MED CHEM, V51, P2100, DOI 10.1021/jm701212m	38	16	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					9968	9976		10.1074/jbc.M110.203240	http://dx.doi.org/10.1074/jbc.M110.203240			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21282102	hybrid, Green Published			2022-12-27	WOS:000288547000011
J	Telford, JC; Yeung, JHF; Xu, GG; Kiefel, MJ; Watts, AG; Hader, S; Chan, J; Bennet, AJ; Moore, MM; Taylor, GL				Telford, Judith C.; Yeung, Juliana H. F.; Xu, Guogang; Kiefel, Milton J.; Watts, Andrew G.; Hader, Stefan; Chan, Jefferson; Bennet, Andrew J.; Moore, Margo M.; Taylor, Garry L.			The Aspergillus fumigatus Sialidase Is a 3-Deoxy-D-glycero-D-galacto-2-nonulosonic Acid Hydrolase (KDNase) STRUCTURAL AND MECHANISTIC INSIGHTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEAMINATED NEURAMINIC ACID; POLY(ALPHA 2,8-DEAMINONEURAMINIC ACID); VIBRIO-CHOLERAE NEURAMINIDASE; EXTRACELLULAR-MATRIX PROTEINS; CRYSTAL-STRUCTURE; TRANS-SIALIDASE; STREPTOCOCCUS-PNEUMONIAE; DEAMINONEURAMINIC ACID; BACTERIAL SIALIDASE; VIRUS NEURAMINIDASE	Aspergillus fumigatus is a filamentous fungus that can cause severe respiratory disease in immunocompromised individuals. A putative sialidase from A. fumigatus was recently cloned and shown to be relatively poor in cleaving N-acetylneuraminic acid (Neu5Ac) in comparison with bacterial sialidases. Here we present the first crystal structure of a fungal sialidase. When the apo structure was compared with bacterial sialidase structures, the active site of the Aspergillus enzyme suggested that Neu5Ac would be a poor substrate because of a smaller pocket that normally accommodates the acetamido group of Neu5Ac in sialidases. A sialic acid with a hydroxyl in place of an acetamido group is 2-keto-3-deoxynononic acid (KDN). We show that KDN is the preferred substrate for the A. fumigatus sialidase and that A. fumigatus can utilize KDN as a sole carbon source. A 1.45-angstrom resolution crystal structure of the enzyme in complex with KDN reveals KDN in the active site in a boat conformation and nearby a second binding site occupied by KDN in a chair conformation, suggesting that polyKDN may be a natural substrate. The enzyme is not inhibited by the sialidase transition state analog 2-deoxy-2,3-dehydro-N-acetylneuraminic acid (Neu5Ac2en) but is inhibited by the related 2,3-didehydro-2,3dideoxy-D-glycero-D-galacto-nonulosonic acid that we show bound to the enzyme in a 1.84-angstrom resolution crystal structure. Using a fluorinated KDN substrate, we present a 1.5-angstrom resolution structure of a covalently bound catalytic intermediate. The A. fumigatus sialidase is therefore a KDNase with a similar catalytic mechanism to Neu5Ac exosialidases, and this study represents the first structure of a KDNase.	[Telford, Judith C.; Xu, Guogang; Taylor, Garry L.] Univ St Andrews, St Andrews KY16 9ST, Fife, Scotland; [Yeung, Juliana H. F.; Moore, Margo M.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Chan, Jefferson; Bennet, Andrew J.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada; [Kiefel, Milton J.] Griffith Univ, Inst Glyc, Griffith, Qld 9726, Australia; [Watts, Andrew G.; Hader, Stefan] Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England	University of St Andrews; Simon Fraser University; Simon Fraser University; Griffith University; University of Bath	Taylor, GL (corresponding author), Univ St Andrews, Biomed Sci Res Complex, St Andrews KY16 9ST, Fife, Scotland.	glt2@st-andrews.ac.uk	Taylor, Garry/G-3017-2014; Kiefel, Milton/O-4740-2019; Xu, Guogang/AAN-9289-2020; Kiefel, Milton/A-6509-2015; Watts, Andrew/D-2802-2014	Kiefel, Milton/0000-0003-1030-1440; Xu, Guogang/0000-0002-6380-3500; Watts, Andrew/0000-0003-4299-2717; Chan, Jefferson/0000-0003-4139-4379	Scottish Structural Proteomics Facility at St. Andrews; Biotechnology and Biological Sciences Research Council; Wellcome Trust; Scottish Funding Council; Queensland International Fellowship; Natural Sciences and Engineering Research Council of Canada	Scottish Structural Proteomics Facility at St. Andrews; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Scottish Funding Council; Queensland International Fellowship; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported in part by the Scottish Structural Proteomics Facility at St. Andrews and funds from the Biotechnology and Biological Sciences Research Council, the Wellcome Trust, and the Scottish Funding Council (to G. L. T.).; Supported by the Biotechnology and Biological Sciences Research Council.; Recipient of a Queensland International Fellowship.; Supported by the Natural Sciences and Engineering Research Council of Canada.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Amaya MF, 2004, STRUCTURE, V12, P775, DOI 10.1016/j.str.2004.02.036; [Anonymous], PYMOL MOL GRAPH SYST; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Boraston AB, 2007, BIOCHEMISTRY-US, V46, P11352, DOI 10.1021/bi701317g; BURMEISTER WP, 1993, STRUCTURE, V1, P19, DOI 10.1016/0969-2126(93)90005-2; Buschiazzo A, 2000, EMBO J, V19, P16, DOI 10.1093/emboj/19.1.16; Buschiazzo A, 2002, MOL CELL, V10, P757, DOI 10.1016/S1097-2765(02)00680-9; Chavas LMG, 2005, J BIOL CHEM, V280, P469, DOI 10.1074/jbc.M411506200; Crennell S, 2000, NAT STRUCT BIOL, V7, P1068; CRENNELL S, 1994, STRUCTURE, V2, P535, DOI 10.1016/S0969-2126(00)00053-8; CRENNELL SJ, 1993, P NATL ACAD SCI USA, V90, P9852, DOI 10.1073/pnas.90.21.9852; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GASKELL A, 1995, STRUCTURE, V3, P1197, DOI 10.1016/S0969-2126(01)00255-6; Inoue S, 1996, J BIOL CHEM, V271, P24341, DOI 10.1074/jbc.271.40.24341; Inoue S, 1998, J BIOL CHEM, V273, P27199, DOI 10.1074/jbc.273.42.27199; Inoue S, 2006, GLYCOCONJUGATE J, V23, P277, DOI 10.1007/s10719-006-6484-y; KANAMORI A, 1994, HISTOCHEMISTRY, V101, P333, DOI 10.1007/BF00268994; KITAJIMA K, 1994, J BIOL CHEM, V269, P21415; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Luo Y, 1998, STRUCTURE, V6, P521, DOI 10.1016/S0969-2126(98)00053-7; Moustafa I, 2004, J BIOL CHEM, V279, P40819, DOI 10.1074/jbc.M404965200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NADANO D, 1986, J BIOL CHEM, V261, P1550; Newstead SL, 2008, J BIOL CHEM, V283, P9080, DOI 10.1074/jbc.M710247200; Nishino S, 1996, J BIOL CHEM, V271, P2909, DOI 10.1074/jbc.271.6.2909; Qu BX, 1996, P NATL ACAD SCI USA, V93, P8995, DOI 10.1073/pnas.93.17.8995; Schulz EC, 2010, J MOL BIOL, V397, P341, DOI 10.1016/j.jmb.2010.01.028; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SONG Y, 1993, GLYCOBIOLOGY, V3, P31, DOI 10.1093/glycob/3.1.31; Sun XL, 2000, CARBOHYD RES, V323, P1; Taylor G, 1996, CURR OPIN STRUC BIOL, V6, P830, DOI 10.1016/S0959-440X(96)80014-5; Terada T, 1997, J BIOL CHEM, V272, P5452, DOI 10.1074/jbc.272.9.5452; Terada T, 1996, EUR J BIOCHEM, V236, P852, DOI 10.1111/j.1432-1033.1996.00852.x; Thobhani S, 2003, J AM CHEM SOC, V125, P7154, DOI 10.1021/ja029759w; Tiralongo J, 2009, MICROBIOL-SGM, V155, P3100, DOI 10.1099/mic.0.026997-0; VARGHESE JN, 1983, NATURE, V303, P35, DOI 10.1038/303035a0; Varki A., 2009, ESSENTIALS GLYCOBIOL; Warwas ML, 2010, GLYCOCONJUGATE J, V27, P533, DOI 10.1007/s10719-010-9299-9; Wasylnka JA, 2001, MICROBIOL-UK, V147, P869, DOI 10.1099/00221287-147-4-869; Wasylnka JA, 2000, INFECT IMMUN, V68, P3377, DOI 10.1128/IAI.68.6.3377-3384.2000; Watson JN, 2003, BIOCHEMISTRY-US, V42, P12682, DOI 10.1021/bi035396g; Watts AG, 2006, J BIOL CHEM, V281, P4149, DOI 10.1074/jbc.M510677200; Xu GG, 2008, ACTA CRYSTALLOGR F, V64, P772, DOI 10.1107/S1744309108024044; Xu GG, 2009, J MOL BIOL, V386, P828, DOI 10.1016/j.jmb.2008.12.084; Xu GG, 2008, J MOL BIOL, V384, P436, DOI 10.1016/j.jmb.2008.09.032; Ziak M, 1996, P NATL ACAD SCI USA, V93, P2759, DOI 10.1073/pnas.93.7.2759	50	22	43	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10783	10792		10.1074/jbc.M110.207043	http://dx.doi.org/10.1074/jbc.M110.207043			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21247893	hybrid, Green Submitted, Green Published			2022-12-27	WOS:000288547000092
J	Nielsen, MM; Suits, MDL; Yang, M; Barry, CS; Martinez-Fleites, C; Tailford, LE; Flint, JE; Dumon, C; Davis, BG; Gilbert, HJ; Davies, GJ				Nielsen, Morten M.; Suits, Michael D. L.; Yang, Min; Barry, Conor S.; Martinez-Fleites, Carlos; Tailford, Louise E.; Flint, James E.; Dumon, Claire; Davis, Benjamin G.; Gilbert, Harry J.; Davies, Gideon J.			Substrate and Metal Ion Promiscuity in Mannosylglycerate Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; BLOOD-GROUP; GLYCOSYLTRANSFERASE; INSIGHT; COMPLEX; DONOR	The enzymatic transfer of the sugar mannose from activated sugar donors is central to the synthesis of a wide range of biologically significant polysaccharides and glycoconjugates. In addition to their importance in cellular biology, mannosyltransferases also provide model systems with which to study catalytic mechanisms of glycosyl transfer. Mannosylglycerate synthase (MGS) catalyzes the synthesis of alpha-mannosyl-D-glycerate using GDP-mannose as the preferred donor species, a reaction that occurs with a net retention of anomeric configuration. Past work has shown that the Rhodothermus marinus MGS, classified as a GT78 glycosyltransferase, displays a GT-A fold and performs catalysis in a metal ion-dependent manner. MGS shows very unusual metal ion dependences with Mg2+ and Ca2+ and, to a lesser extent, Mn2+, Ni2+, and Co2+, thus facilitating catalysis. Here, we probe these dependences through kinetic and calorimetric analyses of wild-type and site-directed variants of the enzyme. Mutation of residues that interact with the guanine base of GDP are correlated with a higher k(cat) value, whereas substitution of His-217, a key component of the metal coordination site, results in a change in metal specificity to Mn2+. Structural analyses of MGS complexes not only provide insight into metal coordination but also how lactate can function as an alternative acceptor to glycerate. These studies highlight the role of flexible loops in the active center and the subsequent coordination of the divalent metal ion as key factors in MGS catalysis and metal ion dependence. Furthermore, Tyr-220, located on a flexible loop whose conformation is likely influenced by metal binding, also plays a critical role in substrate binding.	[Nielsen, Morten M.; Tailford, Louise E.; Flint, James E.; Dumon, Claire; Gilbert, Harry J.] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Suits, Michael D. L.; Martinez-Fleites, Carlos; Davies, Gideon J.] Univ York, Dept Chem, York Struct Biol Lab, York YO10 5DD, N Yorkshire, England; [Yang, Min; Barry, Conor S.; Davis, Benjamin G.] Univ Oxford, Chem Res Lab, Dept Chem, Oxford OX1 3TA, England; [Gilbert, Harry J.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	Newcastle University - UK; University of York - UK; University of Oxford; University System of Georgia; University of Georgia	Gilbert, HJ (corresponding author), Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	h.j.gilbert@ncl.ac.uk; davies@ysbl.york.ac.uk	Davis, Benjamin G/C-5281-2011; Davies, Gideon J/A-9042-2011; Claire, Dumon/AAI-2553-2021	Davis, Benjamin G/0000-0002-5056-407X; Davies, Gideon J/0000-0002-7343-776X; Claire, Dumon/0000-0003-4925-7336; Flint, James/0000-0003-2923-7813	Biotechnology and Biological Sciences Research Council of the United Kingdom; European Molecular Biology Laboratory; Royal Society; Biotechnology and Biological Sciences Research Council [BB/E000568/1, BB/E001696/1, EGA17763, BB/C510824/1, BB/E004350/1, BBS/E/F/00044452] Funding Source: researchfish; Engineering and Physical Sciences Research Council [GR/T26542/01, EP/D023343/1, EP/G026688/1, EP/I500200/1, EP/D023335/1, EP/E000614/1] Funding Source: researchfish; BBSRC [BB/E004350/1, BB/E000568/1, BBS/E/F/00044452, BB/E001696/1] Funding Source: UKRI; EPSRC [EP/I500200/1, EP/G026688/1, EP/E000614/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Molecular Biology Laboratory; Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported in part by Biotechnology and Biological Sciences Research Council of the United Kingdom.; Recipient of a European Molecular Biology Laboratory long term fellowship.; Recipient of a Royal Society Wolfson research merit award.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boix E, 2002, J BIOL CHEM, V277, P28310, DOI 10.1074/jbc.M202631200; Borges N, 2002, EXTREMOPHILES, V6, P209, DOI 10.1007/s007920100236; Bourne Y, 2001, CURR OPIN STRUC BIOL, V11, P593, DOI 10.1016/S0959-440X(00)00253-0; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cornish-Bowden A, 2012, FUNDAMENTALS ENZYME, V4th; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Davis BG, 2000, J CHEM SOC PERK T 1, P2137, DOI 10.1039/a809774g; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Errey JC, 2010, ANGEW CHEM INT EDIT, V49, P1234, DOI 10.1002/anie.200905096; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Flint J, 2005, NAT STRUCT MOL BIOL, V12, P608, DOI 10.1038/nsmb950; Fulton Z, 2008, J BIOL CHEM, V283, P27881, DOI 10.1074/jbc.M801853200; Gastinel LN, 2001, EMBO J, V20, P638, DOI 10.1093/emboj/20.4.638; Goldschmidt L, 2007, PROTEIN SCI, V16, P1569, DOI 10.1110/ps.072914007; Goncalves S, 2010, J BIOL CHEM, V285, P17857, DOI 10.1074/jbc.M109.095976; GOSSELIN S, 1994, ANAL BIOCHEM, V220, P92, DOI 10.1006/abio.1994.1303; Igura M, 2008, EMBO J, V27, P234, DOI 10.1038/sj.emboj.7601940; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; LEWIS ES, 1952, J AM CHEM SOC, V74, P308, DOI 10.1021/ja01122a005; Maita N, 2010, J BIOL CHEM, V285, P4941, DOI 10.1074/jbc.M109.081752; Martins LO, 1999, J BIOL CHEM, V274, P35407, DOI 10.1074/jbc.274.50.35407; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pais TM, 2009, J MOL BIOL, V394, P237, DOI 10.1016/j.jmb.2009.09.012; Parodi AJ, 2000, ANNU REV BIOCHEM, V69, P69, DOI 10.1146/annurev.biochem.69.1.69; Persson K, 2001, NAT STRUCT BIOL, V8, P166, DOI 10.1038/84168; Ramakrishnan B, 2004, BIOCHEMISTRY-US, V43, P12513, DOI 10.1021/bi049007+; Seto NOL, 1997, J BIOL CHEM, V272, P14133, DOI 10.1074/jbc.272.22.14133; Yang M, 2005, CHEMBIOCHEM, V6, P346, DOI 10.1002/cbic.200400100	33	27	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15155	15164		10.1074/jbc.M110.199844	http://dx.doi.org/10.1074/jbc.M110.199844			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21288903	Green Published, hybrid			2022-12-27	WOS:000289788300047
J	el Azzouzi, H; Leptidis, S; Bourajjaj, M; Armand, AS; van der Nagel, R; van Bilsen, M; Martins, PAD; De Windt, LJ				el Azzouzi, Hamid; Leptidis, Stefanos; Bourajjaj, Meriem; Armand, Anne-Sophie; van der Nagel, Roel; van Bilsen, Marc; Martins, Paula A. Da Costa; De Windt, Leon J.			Peroxisome Proliferator-activated Receptor (PPAR) Gene Profiling Uncovers Insulin-like Growth Factor-1 as a PPAR alpha Target Gene in Cardioprotection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED HEART-FAILURE; CARDIAC-HYPERTROPHY; PRESSURE-OVERLOAD; CONTRACTILE DYSFUNCTION; MYOCARDIAL-ISCHEMIA; OXIDATIVE STRESS; EXPRESSION; DELTA; GAMMA; MICE	Peroxisome proliferator-activated receptors (PPARs) are members of the nuclear receptor family of ligand-activated transcription factors and consist of the three isoforms, PPAR alpha, PPAR beta/delta, and PPAR gamma. Considerable evidence indicates the importance of PPARs in cardiovascular lipid homeostasis and diabetes, yet the isoform-dependent cardiac target genes remain unknown. Here, we constructed murine ventricular clones allowing stable expression of siRNAs to achieve specifically knockdown for each of the PPAR isoforms. By combining gene profiling and computational peroxisome proliferator response element analysis following PPAR isoform activation in normal versus PPAR isoform-deficient cardiomyocyte-like cells, we have, for the first time, determined PPAR isoform-specific endogenous target genes in the heart. Electromobility shift and chromatin immunoprecipitation assays demonstrated the existence of an evolutionary conserved peroxisome proliferator response element consensus-binding site in an insulin-like growth factor-1 (igf-1) enhancer. In line, Wy-14643-mediated PPAR alpha activation in the wild-type mouse heart resulted in up-regulation of igf-1 transcript abundance and provided protection against cardiomyocyte apoptosis following ischemia/reperfusion or biomechanical stress. Taken together, these data confirm igf-1 as an in vivo target of PPAR alpha and the involvement of a PPAR alpha/IGF-1 signaling pathway in the protection of cardiomyocytes under ischemic and hemodynamic loading conditions.	[el Azzouzi, Hamid; Leptidis, Stefanos; Martins, Paula A. Da Costa; De Windt, Leon J.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Cardiol, NL-6200 MD Maastricht, Netherlands; [van Bilsen, Marc] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Physiol, NL-6200 MD Maastricht, Netherlands; [el Azzouzi, Hamid; Leptidis, Stefanos; Bourajjaj, Meriem; Armand, Anne-Sophie; van der Nagel, Roel] Royal Netherlands Acad Sci, Interuniv Cardiol Inst Netherlands, NL-3584 CS Utrecht, Netherlands; [el Azzouzi, Hamid; Leptidis, Stefanos; Bourajjaj, Meriem; Armand, Anne-Sophie; van der Nagel, Roel] Royal Netherlands Acad Sci, Hubrecht Inst, NL-3584 CS Utrecht, Netherlands	Maastricht University; Maastricht University; Interuniversity Cardiology Institute of the Netherlands; Utrecht University; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	De Windt, LJ (corresponding author), Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Cardiol, NL-6200 MD Maastricht, Netherlands.	l.dewindt@maastrichtuniversity.nl	Leptidis, Stefanos/D-1455-2016; van Bilsen, Marc/E-8342-2016; de Windt, Leon/AAO-6395-2020	Leptidis, Stefanos/0000-0003-0172-4193; de Windt, Leon/0000-0002-7793-2856; el Azzouzi, Hamid/0000-0003-1242-9691	The Netherlands Organization for Health Research and Development (ZonMW) [912-04-054, 912-04-017]; VIDI [917-863-72]; The Netherlands Heart Foundation [NHS2007B167]; European Union [LSHM-CT-2005-018833/EUGeneHeart]	The Netherlands Organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); VIDI(Netherlands Organization for Scientific Research (NWO)); The Netherlands Heart Foundation(Netherlands Heart Foundation); European Union(European Commission)	This work was supported by The Netherlands Organization for Health Research and Development (ZonMW) Grants 912-04-054 and 912-04-017 and VIDI Award 917-863-72, The Netherlands Heart Foundation Grant NHS2007B167, and the European Union Contract LSHM-CT-2005-018833/EUGeneHeart (to L. J. D. W.).	Baldan A, 2004, NUCLEIC ACIDS RES, V32, P4742, DOI 10.1093/nar/gkh806; Barak Y, 2002, P NATL ACAD SCI USA, V99, P303, DOI 10.1073/pnas.012610299; Bourajjaj M, 2008, J BIOL CHEM, V283, P22295, DOI 10.1074/jbc.M801296200; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Brun RP, 1996, GENE DEV, V10, P974, DOI 10.1101/gad.10.8.974; Bubikat A, 2005, J BIOL CHEM, V280, P21594, DOI 10.1074/jbc.m501103200; BUERKE M, 1995, P NATL ACAD SCI USA, V92, P8031, DOI 10.1073/pnas.92.17.8031; BUERKE M, 1995, CIRCULATION, V91, P393, DOI 10.1161/01.CIR.91.2.393; Burkart EM, 2007, J CLIN INVEST, V117, P3930, DOI 10.1172/JCI32578; Cheng LH, 2004, NAT MED, V10, P1245, DOI 10.1038/nm1116; Chevillotte E, 2001, J BIOL CHEM, V276, P10853, DOI 10.1074/jbc.M008010200; Ding GL, 2007, CARDIOVASC RES, V76, P269, DOI 10.1016/j.cardiores.2007.06.027; Diwan A, 2007, PHYSIOLOGY, V22, P56, DOI 10.1152/physiol.00033.2006; Dolcet X, 1999, J NEUROCHEM, V73, P521, DOI 10.1046/j.1471-4159.1999.0730521.x; Finck BN, 2003, P NATL ACAD SCI USA, V100, P1226, DOI 10.1073/pnas.0336724100; Finck BN, 2002, J CLIN INVEST, V109, P121, DOI 10.1172/JCI200214080; Gilde AJ, 2003, CIRC RES, V92, P518, DOI 10.1161/01.RES.0000060700.55247.7C; Griendling KK, 2003, CIRCULATION, V108, P2034, DOI 10.1161/01.CIR.0000093661.90582.c4; Guerre-Millo M, 2001, DIABETES, V50, P2809, DOI 10.2337/diabetes.50.12.2809; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Hirota H, 1999, CELL, V97, P189, DOI 10.1016/S0092-8674(00)80729-1; Keen HL, 2004, PHYSIOL GENOMICS, V18, P33, DOI 10.1152/physiolgenomics.00027.2004; Labinskyy V, 2007, J PHARMACOL EXP THER, V321, P165, DOI 10.1124/jpet.106.116871; Lemay DG, 2006, J LIPID RES, V47, P1583, DOI 10.1194/jlr.M500504-JLR200; Li BS, 1999, CIRC RES, V84, P1007, DOI 10.1161/01.RES.84.9.1007; Madrazo JA, 2008, J MOL CELL CARDIOL, V44, P968, DOI 10.1016/j.yjmcc.2008.03.021; Martins PAD, 2010, NAT CELL BIOL, V12, P1220, DOI 10.1038/ncb2126; Marx N, 1999, CIRCULATION, V99, P3125, DOI 10.1161/01.CIR.99.24.3125; Morgan EE, 2006, AM J PHYSIOL-HEART C, V290, pH1899, DOI 10.1152/ajpheart.01014.2005; Peters JM, 2000, MOL CELL BIOL, V20, P5119, DOI 10.1128/MCB.20.14.5119-5128.2000; Rybkin II, 2003, J BIOL CHEM, V278, P15927, DOI 10.1074/jbc.M213102200; Sadoshima J, 2002, J CLIN INVEST, V110, P271, DOI 10.1172/JCI200214938; Seimandi M, 2005, ANAL BIOCHEM, V344, P8, DOI 10.1016/j.ab.2005.06.010; Smeets PJH, 2007, ACTA PHYSIOL, V191, P171, DOI 10.1111/j.1748-1716.2007.01752.x; Tamura Kotaro, 2006, Journal of Toxicological Sciences, V31, P471, DOI 10.2131/jts.31.471; Teunissen BEJ, 2007, CARDIOVASC RES, V75, P519, DOI 10.1016/j.cardiores.2007.04.026; van Bilsen M, 2009, CARDIOVASC RES, V81, P420, DOI 10.1093/cvr/cvn282; van Empel VPM, 2005, CIRC RES, V96, pE92, DOI 10.1161/01.RES.0000172081.30327.28; van Empel VPM, 2005, CARDIOVASC RES, V67, P21, DOI 10.1016/j.cardiores.2005.04.012; van Oort RJ, 2006, CIRCULATION, V114, P298, DOI 10.1161/CIRCULATIONAHA.105.608968; van Rooij E, 2002, J BIOL CHEM, V277, P48617, DOI 10.1074/jbc.M206532200; Wang L, 1998, CIRC RES, V83, P516, DOI 10.1161/01.RES.83.5.516; Yeh CH, 2005, J CARDIOVASC PHARM, V45, P301, DOI 10.1097/01.fjc.0000155385.41479.b3; Young ME, 2001, J BIOL CHEM, V276, P44390, DOI 10.1074/jbc.M103826200; Yue TL, 2003, CIRCULATION, V108, P2393, DOI 10.1161/01.CIR.0000093187.42015.6C; Zhang D, 2000, NAT MED, V6, P556, DOI 10.1038/75037; ZHU YJ, 1993, J BIOL CHEM, V268, P26817	47	24	24	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14598	14607		10.1074/jbc.M111.220525	http://dx.doi.org/10.1074/jbc.M111.220525			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21245137	Green Published, hybrid			2022-12-27	WOS:000289556200079
J	Ong, EBB; Watanabe, N; Saito, A; Futamura, Y; Abd El Galil, KH; Koito, A; Najimudin, N; Osada, H				Ong, Eugene Boon Beng; Watanabe, Nobumoto; Saito, Akiko; Futamura, Yushi; Abd El Galil, Khaled Hussein; Koito, Atsushi; Najimudin, Nazalan; Osada, Hiroyuki			Vipirinin, a Coumarin-based HIV-1 Vpr Inhibitor, Interacts with a Hydrophobic Region of VPR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; REGULATORY PROTEIN VPR; PROTEASOMAL DEGRADATION; GENOTOXIC AGENTS; UBIQUITIN LIGASE; HIGH-THROUGHPUT; CELL-GROWTH; TRANSCRIPTION; REPLICATION; MACROPHAGES	The human immunodeficiency virus 1 (HIV-1) viral protein R (Vpr) is an accessory protein that has been shown to have multiple roles in HIV-1 pathogenesis. By screening chemical libraries in the RIKEN Natural Products Depository, we identified a 3-phenyl coumarin-based compound that inhibited the cell cycle arrest activity of Vpr in yeast and Vpr-dependent viral infection of human macrophages. We determined its minimal pharmacophore through a structure-activity relationship study and produced more potent derivatives. We detected direct binding, and by assaying a panel of Vpr mutants, we found the hydrophobic region about residues Glu-25 and Gln-65 to be potentially involved in the binding of the inhibitor. Our findings exposed a targeting site on Vpr and delineated a convenient approach to explore other targeting sites on the protein using small molecule inhibitors as bioprobes.	[Ong, Eugene Boon Beng; Watanabe, Nobumoto; Saito, Akiko; Futamura, Yushi; Osada, Hiroyuki] RIKEN Adv Sci Inst, Chem Biol Core Facil, Dept Biol Chem, Wako, Saitama 3510198, Japan; [Ong, Eugene Boon Beng; Watanabe, Nobumoto; Najimudin, Nazalan; Osada, Hiroyuki] Univ Sains Malaysia, Sch Biol Sci, George Town 11800, Malaysia; [Abd El Galil, Khaled Hussein; Koito, Atsushi] Kumamoto Univ, Dept Retrovirol & Self Def, Fac Life Sci, Kumamoto 8608556, Japan	RIKEN; Universiti Sains Malaysia; Kumamoto University	Watanabe, N (corresponding author), 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	nwatanab@riken.jp; hisyo@riken.jp	Osada, Hiroyuki/N-4305-2014; Najimudin, Nazalan/A-8368-2011; Beng, Eugene Ong Boon/A-2774-2015; Saito, Akiko/AAF-9531-2019; Watanabe, Nobumoto/N-6959-2015; Osada, Hiroyuki/AAY-6254-2020; Najimudin, Nazalan/B-2952-2011; Futamura, Yushi/C-7615-2017	Beng, Eugene Ong Boon/0000-0001-6259-9029; Watanabe, Nobumoto/0000-0002-2130-1334; Futamura, Yushi/0000-0002-4224-6944	RIKEN; Ministry of Education, Culture, Sports, Science, and Technology of Japan	RIKEN; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by the Chemical Biology Project of RIKEN and grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. E. B. O. is pursuing this work as a RIKEN Asia Program Associate.	Amini S, 2004, J BIOL CHEM, V279, P46046, DOI 10.1074/jbc.M403792200; Andersen JL, 2005, CURR HIV RES, V3, P43, DOI 10.2174/1570162052772988; Baetz K, 2004, P NATL ACAD SCI USA, V101, P4525, DOI 10.1073/pnas.0307122101; Barberis Alcide, 2005, Drug Discov Today Technol, V2, P187, DOI 10.1016/j.ddtec.2005.05.022; Belzile JP, 2007, PLOS PATHOG, V3, P882, DOI 10.1371/journal.ppat.0030085; Belzile JP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001080; Belzile JP, 2010, J VIROL, V84, P3320, DOI 10.1128/JVI.02590-09; Bourbigot S, 2005, BIOCHEM J, V387, P333, DOI 10.1042/BJ20041759; Budavari S., 2001, MERCK INDEX ENCY CHE, V13th; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; DeHart JL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-57; DeLano W.L, PYMOL MOL GRAPHICS S; Eckstein DA, 2001, J EXP MED, V194, P1407, DOI 10.1084/jem.194.10.1407; FELMEIST.A, 1972, J PHARM SCI-US, V61, P151, DOI 10.1002/jps.2600610202; Fritz JV, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-87; Fujino Y, 2000, CHEM PHARM BULL, V48, P298; Henklein P, 2000, J BIOL CHEM, V275, P32016, DOI 10.1074/jbc.M004044200; Hoshino S, 2010, J LEUKOCYTE BIOL, V87, P1133, DOI 10.1189/jlb.0809547; Jacquot G, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-84; Kamata M, 2006, BIOCHEM BIOPH RES CO, V348, P1101, DOI 10.1016/j.bbrc.2006.07.158; Kanoh N, 2005, ANGEW CHEM INT EDIT, V44, P3559, DOI 10.1002/anie.200462370; Kawatani M, 2008, P NATL ACAD SCI USA, V105, P11691, DOI 10.1073/pnas.0712239105; Kino T, 2002, J VIROL, V76, P9724, DOI 10.1128/JVI.76.19.9724-9734.2002; Kostova I, 2006, BIOINORG CHEM APPL, V2006, DOI [10.1155/BCA/2006/68274, 10.1155/BCA/2006/25651]; Le Rouzic E, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-11; Le Rouzic E, 2008, J BIOL CHEM, V283, P21686, DOI 10.1074/jbc.M710298200; Le Rouzic E, 2007, CELL CYCLE, V6, P182, DOI 10.4161/cc.6.2.3732; Leroux FR, 2008, BEILSTEIN J ORG CHEM, V4, DOI 10.3762/bjoc.4.13; Li G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-59; MACREADIE IG, 1995, P NATL ACAD SCI USA, V92, P2770, DOI 10.1073/pnas.92.7.2770; Morellet N, 2003, J MOL BIOL, V327, P215, DOI 10.1016/S0022-2836(03)00060-3; Morellet N, 2009, CURR HIV RES, V7, P184, DOI 10.2174/157016209787581490; Pandey RC, 2009, CURR HIV RES, V7, P114, DOI 10.2174/157016209787581508; PAROLIN C, 1990, FEMS MICROBIOL LETT, V68, P341, DOI 10.1016/S0378-1097(05)80065-5; Richter SN, 2009, CURR MED CHEM, V16, P267, DOI 10.2174/092986709787002646; Subbramanian RA, 1998, J EXP MED, V187, P1103, DOI 10.1084/jem.187.7.1103; Thotala D, 2004, VIROLOGY, V328, P89, DOI 10.1016/j.virol.2004.07.013; Tomiki T, 2006, J COMPUT AIDED CHEM, V7, P157; Toussaint M, 2006, NAT PROTOC, V1, P1922, DOI 10.1038/nprot.2006.304; Toussaint M, 2006, MUTAT RES-GEN TOX EN, V606, P92, DOI 10.1016/j.mrgentox.2006.03.006; Tristem M, 1998, VIROLOGY, V240, P232, DOI 10.1006/viro.1997.8929; Vanitharani R, 2001, VIROLOGY, V289, P334, DOI 10.1006/viro.2001.1153; WANG LL, 1995, J BIOL CHEM, V270, P25564, DOI 10.1074/jbc.270.43.25564; Watanabe N, 2006, FEBS LETT, V580, P2598, DOI 10.1016/j.febslet.2006.04.007; Xiao Y, 2008, VIROLOGY, V372, P384, DOI 10.1016/j.virol.2007.10.036; Zhang SG, 1998, GENE, V212, P157, DOI 10.1016/S0378-1119(98)00178-4; Zhao H, 1997, J MED CHEM, V40, P242, DOI 10.1021/jm960450v; Zhao RY, 2011, J NEUROIMMUNE PHARM; Zhao YQ, 2000, FRONT BIOSCI-LANDMRK, V5, pD905, DOI 10.2741/zhao	49	80	83	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14049	14056		10.1074/jbc.M110.185397	http://dx.doi.org/10.1074/jbc.M110.185397			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21357691	Green Published, hybrid			2022-12-27	WOS:000289556200027
J	Roth, DM; Moseley, GW; Pouton, CW; Jans, DA				Roth, Daniela Martino; Moseley, Gregory W.; Pouton, Colin W.; Jans, David A.			Mechanism of Microtubule-facilitated "Fast Track" Nuclear Import	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-RELATED PROTEIN; DYNEIN LIGHT-CHAIN; GREEN FLUORESCENT PROTEIN; TARGETING SIGNAL; NUCLEOCYTOPLASMIC FLUX; LOCALIZATION SEQUENCE; CELLS; BINDING; KINASE; LC8	Although the microtubule (MT) cytoskeleton has been shown to facilitate nuclear import of specific cancer-regulatory proteins including p53, retinoblastoma protein, and parathyroid hormone-related protein (PTHrP), the MT association sequences (MTASs) responsible and the nature of the interplay between MT-dependent and conventional importin (IMP)-dependent nuclear translocation are unknown. Here we used site-directed mutagenesis, live cell imaging, and direct IMP and MT binding assays to map the MTAS of PTHrP for the first time, finding that it is within a short modular region (residues 82-108) that overlaps with the IMP beta 1-recognized nuclear localization signal (residues 66-108) of PTHrP. Importantly, fluorescence recovery after photobleaching experiments indicated that disruption of the MT network or mutation of the MTAS of PTHrP decreases the rate of nuclear import by 2-fold. Moreover, MTAS functions depend on mutual exclusivity of binding of PTHrP to MTs and IMP beta 1 such that, following MT-dependent trafficking toward the nucleus, perinuclear PTHrP can be displaced from MTs by IMP beta 1 prior to import into the nucleus. This is the first molecular definition of an MTAS that facilitates protein nuclear import as well as the first delineation of the mechanism whereby cargo is transferred directly from the cytoskeleton to the cellular nuclear import apparatus. The results have broad significance with respect to fundamental processes regulating cell physiology/transformation.	[Roth, Daniela Martino; Moseley, Gregory W.; Jans, David A.] Monash Univ, Dept Biochem & Mol Biol, Nucl Signalling Lab, Clayton, Vic 3800, Australia; [Pouton, Colin W.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia	Monash University; Monash University	Jans, DA (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Nucl Signalling Lab, Box 13D, Clayton, Vic 3800, Australia.	david.jans@monash.edu	Pouton, Colin W/M-2049-2016	Pouton, Colin W/0000-0003-0224-3308; Jans, David/0000-0001-5115-4745; Moseley, Gregory/0000-0003-4516-3906	National Health and Medical Research Council, Australia [333013/384109, 384107]	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council, Australia (Fellowship 333013/384109 and Project Grant 384107).	Alonso C, 2001, J VIROL, V75, P9819, DOI 10.1128/JVI.75.20.9819-9827.2001; Alvisi G, 2005, TRAFFIC, V6, P1002, DOI 10.1111/j.1600-0854.2005.00331.x; Alvisi G, 2009, J VIROL, V83, P9567, DOI 10.1128/JVI.00669-09; AXELROD D, 1976, P NATL ACAD SCI USA, V73, P4594, DOI 10.1073/pnas.73.12.4594; Baliga BC, 2003, J BIOL CHEM, V278, P4899, DOI 10.1074/jbc.M211512200; Campbell EA, 2003, ADV DRUG DELIVER REV, V55, P761, DOI 10.1016/S0169-409X(03)00049-8; CHI NC, 1995, J CELL BIOL, V130, P265, DOI 10.1083/jcb.130.2.265; Davis FJ, 2005, AM J PHYSIOL-HEART C, V288, pH1477, DOI 10.1152/ajpheart.00789.2004; Espindola FS, 2000, CELL MOTIL CYTOSKEL, V47, P269, DOI 10.1002/1097-0169(200012)47:4<269::AID-CM2>3.3.CO;2-7; Ghildyal R, 2005, BIOCHEMISTRY-US, V44, P12887, DOI 10.1021/bi050701e; Giannakakou P, 2000, NAT CELL BIOL, V2, P709, DOI 10.1038/35036335; Glover DJ, 2005, NAT REV GENET, V6, P299, DOI 10.1038/nrg1577; Harley VR, 2003, P NATL ACAD SCI USA, V100, P7045, DOI 10.1073/pnas.1137864100; HENDERSON JE, 1995, MOL CELL BIOL, V15, P4064; Hubner S, 1997, J BIOL CHEM, V272, P17191, DOI 10.1074/jbc.272.27.17191; Jans DA, 2000, BIOCHEM BIOPH RES CO, V270, P1055, DOI 10.1006/bbrc.2000.2559; Kartsogiannis V, 1997, BONE, V21, P385, DOI 10.1016/S8756-3282(97)00180-4; Keminer O, 1999, BIOPHYS J, V77, P217, DOI 10.1016/S0006-3495(99)76883-9; King SM, 1996, J BIOL CHEM, V271, P19358, DOI 10.1074/jbc.271.32.19358; Lam MHC, 2002, MOL ENDOCRINOL, V16, P390, DOI 10.1210/me.16.2.390; Lam MHC, 2001, BIOCHEM BIOPH RES CO, V282, P629, DOI 10.1006/bbrc.2001.4607; Lam MHC, 2001, TRAFFIC, V2, P812, DOI 10.1034/j.1600-0854.2001.21110.x; Lam MHC, 1999, J BIOL CHEM, V274, P18559, DOI 10.1074/jbc.274.26.18559; Lam MHC, 1999, J BIOL CHEM, V274, P7391, DOI 10.1074/jbc.274.11.7391; LANG I, 1986, J CELL BIOL, V102, P1183, DOI 10.1083/jcb.102.4.1183; Liang SH, 1999, ONCOGENE, V18, P2163, DOI 10.1038/sj.onc.1202350; Lixin R, 2001, BIOCHEM BIOPH RES CO, V284, P185, DOI 10.1006/bbrc.2001.4953; Lo KWH, 2005, J BIOL CHEM, V280, P8172, DOI 10.1074/jbc.M411408200; Ma XY, 2007, BIOCHEMISTRY-US, V46, P7153, DOI 10.1021/bi700101n; Malki S, 2005, EXP CELL RES, V309, P468, DOI 10.1016/j.yexcr.2005.07.005; Martinez-Moreno M, 2003, FEBS LETT, V544, P262, DOI 10.1016/S0014-5793(03)00516-7; Massfelder T, 1997, P NATL ACAD SCI USA, V94, P13630, DOI 10.1073/pnas.94.25.13630; Moseley GW, 2007, MOL BIOL CELL, V18, P3204, DOI 10.1091/mbc.E07-01-0030; Moseley GW, 2009, J CELL SCI, V122, P3652, DOI 10.1242/jcs.045542; MOSELEY JM, 1995, CRIT REV CL LAB SCI, V32, P299, DOI 10.3109/10408369509084687; Mueller S, 2002, J BIOL CHEM, V277, P7897, DOI 10.1074/jbc.M111937200; Partikian A, 1998, J CELL BIOL, V140, P821, DOI 10.1083/jcb.140.4.821; PETERS R, 1974, BIOCHIM BIOPHYS ACTA, V367, P282, DOI 10.1016/0005-2736(74)90085-6; Phung-Koskas T, 2005, J BIOL CHEM, V280, P1123, DOI 10.1074/jbc.M409918200; Poisson N, 2001, J GEN VIROL, V82, P2691, DOI 10.1099/0022-1317-82-11-2691; Poon IH, 2005, CANCER RES, V65, P7059, DOI 10.1158/0008-5472.CAN-05-1370; Pouton CW, 2007, ADV DRUG DELIVER REV, V59, P698, DOI 10.1016/j.addr.2007.06.010; Raux H, 2000, J VIROL, V74, P10212, DOI 10.1128/JVI.74.21.10212-10216.2000; Rodriguez-Crespo I, 2001, FEBS LETT, V503, P135, DOI 10.1016/S0014-5793(01)02718-1; Roth DM, 2009, J CELL BIOCHEM, V107, P1160, DOI 10.1002/jcb.22218; Roth DM, 2007, TRAFFIC, V8, P673, DOI 10.1111/j.1600-0854.2007.00564.x; ROTH DM, 2009, NUCL TRANSPORT, P154; Sepulveda VAT, 2002, ENDOCRINOLOGY, V143, P596, DOI 10.1210/en.143.2.596; Sorg G, 1999, BIOTECHNIQUES, V26, P858, DOI 10.2144/99265bm12; Sugai M, 2003, BIOCHEM BIOPH RES CO, V311, P24, DOI 10.1016/j.bbrc.2003.09.157; Sunn KL, 2005, BIOCHEM J, V388, P509, DOI 10.1042/BJ20042040; Wagstaff KM, 2006, ANAL BIOCHEM, V348, P49, DOI 10.1016/j.ab.2005.10.029; Wagstaff KM, 2005, J FLUORESC, V15, P469, DOI 10.1007/s10895-005-2819-5; Whittaker GR, 2003, ADV DRUG DELIVER REV, V55, P733, DOI 10.1016/S0169-409X(03)00051-6; Whittaker GR, 2000, ANNU REV CELL DEV BI, V16, P627, DOI 10.1146/annurev.cellbio.16.1.627; Wysolmerski JJ, 1998, DEVELOPMENT, V125, P1285; Xiao CY, 1997, J BIOL CHEM, V272, P22191, DOI 10.1074/jbc.272.35.22191; ZACKSENHAUS E, 1993, MOL CELL BIOL, V13, P4588, DOI 10.1128/MCB.13.8.4588	58	36	41	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14335	14351		10.1074/jbc.M110.210302	http://dx.doi.org/10.1074/jbc.M110.210302			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21339293	hybrid, Green Published			2022-12-27	WOS:000289556200056
J	Wei, JQ; Wang, WW; Chopra, I; Li, HF; Dougherty, CJ; Adi, J; Adi, N; Wang, HL; Webster, KA				Wei, Jianqin; Wang, Weiwen; Chopra, Ines; Li, Hui Fang; Dougherty, Christopher J.; Adi, Jennipher; Adi, Nikhil; Wang, Huilan; Webster, Keith A.			c-Jun N-terminal Kinase (JNK-1) Confers Protection against Brief but Not Extended Ischemia during Acute Myocardial Infarction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; FREE-RADICAL GENERATION; REPERFUSION INJURY; CELL-DEATH; NH2-TERMINAL KINASE; CARDIAC MYOCYTES; IN-VIVO; SUPPRESSES APOPTOSIS; SIGNALING PATHWAY; ACTIVATION	Brief periods of ischemia do not damage the heart and can actually protect against reperfusion injury caused by extended ischemia. It is not known what causes the transition from protection to irreversible damage as ischemia progresses. c-Jun N-terminal kinase-1 (JNK-1) is a stress-regulated kinase that is activated by reactive oxygen and thought to promote injury during severe acute myocardial infarction. Because some reports suggest that JNK-1 can also be protective, we hypothesized that the function of JNK-1 depends on the metabolic state of the heart at the time of reperfusion, a condition that changes progressively with duration of ischemia. Mice treated with JNK-1 inhibitors or transgenic mice wherein the JNK-1 gene was ablated were subjected to 5 or 20 min of ischemia followed by reperfusion. When JNK-1 was inactive, ischemia of only 5 min duration caused massive apoptosis, infarction, and negative remodeling that was equivalent to or greater than extended ischemia. Conversely, when ischemia was extended JNK-1 inactivation was protective. Mechanisms of the JNK-1 switch in function were investigated in vivo and in cultured cardiac myocytes. In vitro there was a comparable switch in the function of JNK-1 from protective when ATP levels were maintained during hypoxia to injurious when reoxygenation followed glucose and ATP depletion. Both apoptotic and necrotic death pathways were affected and responded reciprocally to JNK-1 inhibitors. JNK-1 differentially regulated Akt phosphorylation of the regulatory sites Ser-473 and Thr-450 and the catalytic Thr-308 site in vivo. The studies define a novel role for JNK-1 as a conditional survival kinase that protects the heart against brief but not protracted ischemia.	[Wei, Jianqin; Wang, Weiwen; Chopra, Ines; Li, Hui Fang; Dougherty, Christopher J.; Adi, Jennipher; Adi, Nikhil; Wang, Huilan; Webster, Keith A.] Univ Miami, Dept Mol & Cellular Pharmacol, Vasc Biol Inst, Miller Sch Med, Miami, FL 33136 USA	University of Miami	Webster, KA (corresponding author), Univ Miami, Dept Mol & Cellular Pharmacol, Vasc Biol Inst, Miller Sch Med, Miami, FL 33136 USA.	kwebster@med.miami.edu		Wang, Weiwen/0000-0002-2468-5222; Webster, Keith A/0000-0002-6431-3642	National Institutes of Health [HL44578, HL92499]; Florida Heart Research Institute; Agatston Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044578, R01HL092499, R29HL044578] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Heart Research Institute; Agatston Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL44578 and HL92499 (to K.A.W.). This work was also supported by grants from the Florida Heart Research Institute and the Agatston Research Institute.	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bak MI, 1998, AM J PHYSIOL-CELL PH, V274, pC992, DOI 10.1152/ajpcell.1998.274.4.C992; Barbagelata A, 2007, J ELECTROCARDIOL, V40, P257, DOI 10.1016/j.jelectrocard.2007.01.007; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bishopric Nanette H., 2001, Current Opinion in Pharmacology, V1, P141, DOI 10.1016/S1471-4892(01)00032-7; BOLLI R, 1988, J CLIN INVEST, V82, P476, DOI 10.1172/JCI113621; Botker HE, 2010, LANCET, V375, P727, DOI 10.1016/S0140-6736(09)62001-8; Buja LM, 2010, CARDIOVASC PATHOL, V19, P29, DOI 10.1016/j.carpath.2008.10.001; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; Depre C, 2007, HEART FAIL REV, V12, P307, DOI 10.1007/s10741-007-9040-3; Donovan N, 2002, J BIOL CHEM, V277, P40944, DOI 10.1074/jbc.M206113200; Dougherty CJ, 2002, BIOCHEM J, V362, P561, DOI 10.1042/0264-6021:3620561; Duplain H, 2006, ADV EXP MED BIOL, V588, P157; Ferrandi C, 2004, BRIT J PHARMACOL, V142, P953, DOI 10.1038/sj.bjp.0705873; Frazier DP, 2007, AM J PHYSIOL-HEART C, V292, pH1675, DOI 10.1152/ajpheart.01132.2006; Guan QH, 2006, BRAIN RES, V1092, P36, DOI 10.1016/j.brainres.2006.03.086; Gustafsson AB, 2008, CARDIOVASC RES, V77, P334, DOI 10.1093/cvr/cvm005; Halestrap AP, 2010, BIOCHEM SOC T, V38, P841, DOI 10.1042/BST0380841; Hausenloy DJ, 2008, NEW ENGL J MED, V359, P518, DOI 10.1056/NEJMe0803746; Hausenloy DJ, 2007, PHARMACOL THERAPEUT, V116, P173, DOI 10.1016/j.pharmthera.2007.06.005; Hausenloy DJ, 2006, CARDIOVASC RES, V70, P240, DOI 10.1016/j.cardiores.2006.01.017; Heyndrickx GR, 2006, SEMIN CARDIOTHORAC V, V10, P236, DOI 10.1177/1089253206291137; Hoole SP, 2009, CIRCULATION, V119, P820, DOI 10.1161/CIRCULATIONAHA.108.809723; Hreniuk D, 2001, MOL PHARMACOL, V59, P867, DOI 10.1124/mol.59.4.867; Imahashi K, 2004, CIRC RES, V95, P734, DOI 10.1161/01.RES.0000143898.67182.4c; Johnson GL, 2007, BBA-MOL CELL RES, V1773, P1341, DOI 10.1016/j.bbamcr.2006.12.009; Juhaszova M, 2004, J CLIN INVEST, V113, P1535, DOI 10.1172/JCI200419906; Kaiser RA, 2005, J BIOL CHEM, V280, P32602, DOI 10.1074/jbc.M500684200; KINGSLEY PB, 1991, AM J PHYSIOL, V261, pH469, DOI 10.1152/ajpheart.1991.261.2.H469; Kloner RA, 2001, CIRCULATION, V104, P3158, DOI 10.1161/hc5001.100039; Kubasiak LA, 2002, P NATL ACAD SCI USA, V99, P12825, DOI 10.1073/pnas.202474099; KUPPUSAMY P, 1994, P NATL ACAD SCI USA, V91, P3388, DOI 10.1073/pnas.91.8.3388; Leung AWC, 2008, BBA-BIOENERGETICS, V1777, P946, DOI 10.1016/j.bbabio.2008.03.009; Liang QR, 2003, EMBO J, V22, P5079, DOI 10.1093/emboj/cdg474; Marone R, 2008, BBA-PROTEINS PROTEOM, V1784, P159, DOI 10.1016/j.bbapap.2007.10.003; Milano G, 2007, AM J PHYSIOL-HEART C, V292, pH1828, DOI 10.1152/ajpheart.01117.2006; Miller BR, 2009, NAT NEUROSCI, V12, P387, DOI 10.1038/nn.2290; Mocanu MM, 2007, BRIT J PHARMACOL, V150, P833, DOI 10.1038/sj.bjp.0707155; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; Sadoshima J, 2002, J CLIN INVEST, V110, P271, DOI 10.1172/JCI200214938; Shao ZL, 2006, CIRC RES, V98, P111, DOI 10.1161/01.RES.0000197781.20524.b9; Sunayama J, 2005, J CELL BIOL, V170, P295, DOI 10.1083/jcb.200409117; Tian R, 2001, CIRCULATION, V103, P2961, DOI 10.1161/01.CIR.103.24.2961; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Tran TH, 2007, J BIOL CHEM, V282, P20340, DOI 10.1074/jbc.M702210200; Tsuruta F, 2004, EMBO J, V23, P1889, DOI 10.1038/sj.emboj.7600194; Wang CH, 2007, J BIOL CHEM, V282, P7991, DOI 10.1074/jbc.M700098200; Webster KA, 1999, J CLIN INVEST, V104, P239; Webster KA, 2007, TRENDS PHARMACOL SCI, V28, P492, DOI 10.1016/j.tips.2007.07.004; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Yamashita K, 2001, CIRC RES, V88, P609, DOI 10.1161/01.RES.88.6.609; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Yu CF, 2004, MOL CELL, V13, P329, DOI 10.1016/S1097-2765(04)00028-0; Yung HW, 2003, J NEUROCHEM, V86, P1281, DOI 10.1046/j.1471-4159.2003.01946.x; Zhao Y, 2007, MOL CELL BIOL, V27, P4328, DOI 10.1128/MCB.00153-07; ZWEIER JL, 1989, J BIOL CHEM, V264, P18890	61	33	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					13995	14006		10.1074/jbc.M110.211334	http://dx.doi.org/10.1074/jbc.M110.211334			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21324895	Green Published, hybrid			2022-12-27	WOS:000289556200022
J	Winbanks, CE; Wang, B; Beyer, C; Koh, P; White, L; Kantharidis, P; Gregorevic, P				Winbanks, Catherine E.; Wang, Bo; Beyer, Claudia; Koh, Phillip; White, Lloyd; Kantharidis, Phillip; Gregorevic, Paul			TGF-beta Regulates miR-206 and miR-29 to Control Myogenic Differentiation through Regulation of HDAC4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFORMING-GROWTH-FACTOR; HISTONE DEACETYLASES; SKELETAL MYOGENESIS; NUCLEAR EXPORT; MUSCLE; TRANSCRIPTION; EXPRESSION; PROMOTES; FAMILY; REPRESSION	MicroRNAs (miRs) are emerging as prominent players in the regulation of many biological processes, including myogenic commitment and skeletal muscle formation. Members of the TGF-beta family can influence the proliferation and myogenic differentiation of cells, although it is presently not clear what role miRNAs play in the TGF-beta-mediated control of myogenic differentiation. Here, we demonstrate in the myogenic C2C12 cell line, and in primary muscle cells, that miR-206 and miR-29-two miRs that act on transcriptional events implicated in muscle differentiation are down-regulated by TGF-beta. We further demonstrate that TGF-beta treatment of myogenic cells is associated with increased expression of histone deacetylase 4 (HDAC4), a key inhibitor of muscle differentiation that has been identified as a target for regulation by miR-206 and miR-29. We confirmed that increased expression of miR-206 and miR-29 resulted in the translational repression of HDAC4 in the presence or absence of TGF-beta via interaction with the HDAC4 3'-untranslated region. Importantly, we found that miR-206 and miR-29 can attenuate the inhibitory actions of TGF-beta on myogenic differentiation. Furthermore, we present evidence that the mechanism by which miR-206 and miR-29 can inhibit the TGF-beta-mediated up-regulation of HDAC4 is via the inhibition of Smad3 expression, a transducer of TGF-beta signaling. These findings identify a novel mechanism of interaction between TGF-beta and miR-206 and -29 in the regulation of myogenic differentiation through HDAC4.	[Winbanks, Catherine E.; Beyer, Claudia; White, Lloyd; Gregorevic, Paul] Baker IDI Heart & Diabet Inst, Div Metab & Obes, Melbourne, Vic 8008, Australia; [Wang, Bo; Koh, Phillip; Kantharidis, Phillip] Baker IDI Heart & Diabet Inst, Div Diabet Complicat, Melbourne, Vic 8008, Australia; [Gregorevic, Paul] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Gregorevic, Paul] Univ Washington, Dept Neurol, Sch Med, Seattle, WA 98104 USA; [Gregorevic, Paul] Univ Melbourne, Dept Physiol, Melbourne, Vic 3000, Australia	Baker Heart and Diabetes Institute; Baker Heart and Diabetes Institute; Monash University; University of Washington; University of Washington Seattle; University of Melbourne	Gregorevic, P (corresponding author), POB 6492,St Kilda Rd, Central, Vic 8008, Australia.	paul.gregorevic@bakeridi.edu.au	Gregorevic, Paul/AAH-6040-2021; White, Lloyd J/L-7163-2013	Gregorevic, Paul/0000-0002-7418-8945; White, Lloyd J/0000-0003-0775-4975				Bakkar N, 2010, PHYSIOL REV, V90, P495, DOI 10.1152/physrev.00040.2009; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Di Padova M, 2007, J BIOL CHEM, V282, P37650, DOI 10.1074/jbc.M707309200; Fischle W, 1999, J BIOL CHEM, V274, P11713, DOI 10.1074/jbc.274.17.11713; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Guo WC, 2009, AM J PHYSIOL-LUNG C, V297, pL864, DOI 10.1152/ajplung.00128.2009; Hendrickson DG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002126; Ishikawa F, 2010, ONCOGENE, V29, P909, DOI 10.1038/onc.2009.387; Kang JS, 2005, EMBO J, V24, P2543, DOI 10.1038/sj.emboj.7600729; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kollias HD, 2006, MOL CELL BIOL, V26, P6248, DOI 10.1128/MCB.00384-06; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; Lin EA, 2009, J BIOL CHEM, V284, P11326, DOI 10.1074/jbc.M807709200; Liu D, 2004, EMBO J, V23, P1557, DOI 10.1038/sj.emboj.7600179; Liu D, 2001, GENE DEV, V15, P2950, DOI 10.1101/gad.925901; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Mal A, 2003, P NATL ACAD SCI USA, V100, P1735, DOI 10.1073/pnas.0437843100; Martello G, 2007, NATURE, V449, P183, DOI 10.1038/nature06100; MARTIN JF, 1992, J BIOL CHEM, V267, P10956; MASSAGUE J, 1986, P NATL ACAD SCI USA, V83, P8206, DOI 10.1073/pnas.83.21.8206; Massague J, 2000, GENE DEV, V14, P627; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2001, MOL CELL BIOL, V21, P6312, DOI 10.1128/MCB.21.18.6312-6321.2001; Nakasa T, 2010, J CELL MOL MED, V14, P2495, DOI 10.1111/j.1582-4934.2009.00898.x; OLSON EN, 1990, GENE DEV, V4, P1454, DOI 10.1101/gad.4.9.1454; Pei M, 2009, DIFFERENTIATION, V78, P260, DOI 10.1016/j.diff.2009.08.001; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Rosenberg MI, 2006, J CELL BIOL, V175, P77, DOI 10.1083/jcb.200603039; SANDLER MA, 1994, J BIOL CHEM, V269, P21500; Sato MM, 2009, BIOCHEM BIOPH RES CO, V383, P125, DOI 10.1016/j.bbrc.2009.03.142; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sun Q, 2008, NUCLEIC ACIDS RES, V36, P2690, DOI 10.1093/nar/gkn032; Sun YT, 2010, J CELL BIOL, V189, P1157, DOI 10.1083/jcb.200912093; Sweetman D, 2008, DEV BIOL, V321, P491, DOI 10.1016/j.ydbio.2008.06.019; Taulli R, 2009, J CLIN INVEST, V119, P2366, DOI 10.1172/JCI38075; Trendelenburg AU, 2009, AM J PHYSIOL-CELL PH, V296, pC1258, DOI 10.1152/ajpcell.00105.2009; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Wang SL, 2010, CANCER SCI, V101, P1108, DOI 10.1111/j.1349-7006.2010.01512.x; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545	48	211	225	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					13805	13814		10.1074/jbc.M110.192625	http://dx.doi.org/10.1074/jbc.M110.192625			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21324893	Green Published, hybrid			2022-12-27	WOS:000289556200003
J	Emara, M; Royer, PJ; Abbas, Z; Sewell, HF; Mohamed, GG; Singh, S; Peel, S; Fox, J; Shakib, F; Martinez-Pomares, L; Ghaemmaghamit, AM				Emara, Mohamed; Royer, Pierre-Joseph; Abbas, Zaigham; Sewell, Herb F.; Mohamed, Gihan Gebriel; Singh, Sonali; Peel, Samantha; Fox, Jane; Shakib, Farouk; Martinez-Pomares, Luisa; Ghaemmaghamit, Amir M.			Recognition of the Major Cat Allergen Fel d 1 through the Cysteine-rich Domain of the Mannose Receptor Determines Its Allergenicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TYPE LECTINS; DENDRITIC CELLS; D-I; LIGAND-BINDING; MONOCLONAL-ANTIBODIES; INDOOR ALLERGENS; IGE; EXPRESSION; ASTHMA; IGG2A	Dendritic cells are professional antigen-presenting cells that are specialized in antigen uptake and presentation. Allergy to cat has increased substantially in recent years and has been shown to be positively associated with asthma. We have recently shown that the mannose receptor (MR), a C-type lectin expressed by dendritic cells, recognizes various glycoallergens from diverse sources and is involved in promoting allergic responses to a major house dust mite allergen in vitro. Here we investigated the potential role of MR in allergic responses to Fel d 1, a major cat allergen. Eel d 1 binding to MR was confirmed by ELBA. Using blocking, gene silencing (siRNA) experiments, and MR knock-out (MR-/-) cells, we have demonstrated that MR plays a major role in internalization of Fel d 1 by human and mouse antigen-presenting cells. Intriguingly, unlike other glycoallergens, recognition of Fel d 1 by MR is mediated by the cysteine-rich domain, which correlates with the presence of sulfated carbohydrates in natural Fel d 1. WT and MR-/- mice were used to study the role of MR in allergic sensitization to Eel d 1 in vivo. MR-/- mice sensitized with cat dander extract and Eel d 1 produced significantly lower levels of total IgE, Eel d 1-specific-IgE and IgG1, the hallmarks of allergic response, compared with WT mice. Our data show for the first time that Fel d 1 is a novel ligand of the cysteine-rich domain of MR and that MR is likely to play a pivotal role in allergic sensitization to airborne allergens in vivo.	[Martinez-Pomares, Luisa] Univ Nottingham, Queens Med Ctr, Div Immunol, Sch Mol Med Sci, Nottingham NG7 2UH, England; [Peel, Samantha; Fox, Jane] Univ Nottingham, Queens Med Ctr, Div Therapeut & Mol Med, Nottingham NG7 2UH, England; [Singh, Sonali; Shakib, Farouk; Ghaemmaghamit, Amir M.] Univ Nottingham, Queens Med Ctr, Nottingham Resp Biomed Res Unit, Nottingham NG7 2UH, England	University of Nottingham; University of Nottingham; University of Nottingham	Martinez-Pomares, L (corresponding author), Univ Nottingham, Queens Med Ctr, Div Immunol, Sch Mol Med Sci, Nottingham NG7 2UH, England.	luisa.m@nottingham.ac.uk; amg@nottingham.ac.uk	Royer, Pierre-Joseph/D-4768-2015; Ghaemmaghami, Amir/AAP-2968-2020; Emara, Mohamed M./C-8220-2013	Royer, Pierre-Joseph/0000-0001-5534-7982; Ghaemmaghami, Amir/0000-0003-3160-8759; Emara, Mohamed M./0000-0001-7708-9435; Singh, Sonali/0000-0003-0600-9084; Martinez-Pomares, Luisa/0000-0002-2331-127X	Asthma UK [06/001]; Knut and Alice Wallenberg Foundation	Asthma UK; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported in part by Asthma UK Research Grant 06/001.; We thank the Proteomics Center at Sahlgrenska Academy (funded by a grant from the Knut and Alice Wallenberg Foundation) (University of Gothenburg) for technical assistance with regard to Glycan analysis and Nanoflow LC-MS/MS Fourier Transform Ion Cyclotron Resonance experiments.	Adedoyin J, 2007, J ALLERGY CLIN IMMUN, V119, P640, DOI 10.1016/j.jaci.2006.11.637; Adel-Patient K, 2000, J IMMUNOL METHODS, V235, P21, DOI 10.1016/S0022-1759(99)00210-0; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Cambi A, 2003, CURR OPIN CELL BIOL, V15, P539, DOI 10.1016/j.ceb.2003.08.004; Cambi A, 2005, CELL MICROBIOL, V7, P481, DOI 10.1111/j.1462-5822.2005.00506.x; Campbell JD, 2009, J EXP MED, V206, P1535, DOI 10.1084/jem.20082901; Carlsohn E, 2006, MOL CELL PROTEOMICS, V5, pS53; CHAPMAN MD, 1988, J IMMUNOL, V140, P812; Custovic A, 1998, THORAX, V53, P33, DOI 10.1136/thx.53.1.33; DEGROOT H, 1988, J ALLERGY CLIN IMMUN, V82, P778, DOI 10.1016/0091-6749(88)90079-6; Deslee G, 2002, J ALLERGY CLIN IMMUN, V110, P763, DOI 10.1067/mai.2002.129121; DUTFORT OA, 1991, MOL IMMUNOL, V28, P301; East L, 2002, BBA-GEN SUBJECTS, V1572, P364, DOI 10.1016/S0304-4165(02)00319-7; Engering AJ, 1997, ADV EXP MED BIOL, V417, P183; Fiete DJ, 1998, P NATL ACAD SCI USA, V95, P2089, DOI 10.1073/pnas.95.5.2089; GELBER LE, 1993, AM REV RESPIR DIS, V147, P573, DOI 10.1164/ajrccm/147.3.573; Gijzen K, 2006, CURR PROTEIN PEPT SC, V7, P283, DOI 10.2174/138920306778018016; Glovsky M Michael, 2007, Methods Mol Biol, V378, P205, DOI 10.1007/978-1-59745-323-3_15; GRIFFITH IJ, 1992, GENE, V113, P263, DOI 10.1016/0378-1119(92)90405-E; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Hamilton RG, 2010, IMMUNOL RES, V47, P273, DOI 10.1007/s12026-009-8160-3; HARRIS N, 1992, BLOOD, V80, P2363; Horlock C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r30; Ichikawa K, 1999, CLIN EXP ALLERGY, V29, P754; INABA K, 2009, CURR PROTOC IMMUNOL, V86; Kaiser L, 2003, J BIOL CHEM, V278, P37730, DOI 10.1074/jbc.M304740200; Karn RC, 2003, BIOCHEMISTRY-US, V42, P7162, DOI 10.1021/bi027424l; Kato M, 2000, INT IMMUNOL, V12, P1511, DOI 10.1093/intimm/12.11.1511; KLEINETEBBE J, 1993, INT ARCH ALLERGY IMM, V100, P256, DOI 10.1159/000236421; Kristensen AK, 1997, BIOL CHEM, V378, P899; Lee SJ, 2002, SCIENCE, V295, P1898, DOI 10.1126/science.1069540; Leteux C, 2000, J EXP MED, V191, P1117, DOI 10.1084/jem.191.7.1117; Liam CK, 2002, RESPIROLOGY, V7, P345, DOI 10.1046/j.1440-1843.2002.00409.x; LOWENSTEIN H, 1985, ALLERGY, V40, P430, DOI 10.1111/j.1398-9995.1985.tb02682.x; Martinez-Pomares L, 2006, EUR J IMMUNOL, V36, P1074, DOI 10.1002/eji.200535685; Martinez-Pomares Luisa, 2009, V531, P103, DOI 10.1007/978-1-59745-396-7_8; McGreal EP, 2005, CURR OPIN IMMUNOL, V17, P18, DOI 10.1016/j.coi.2004.12.001; MOUNTFORD AP, 1994, PARASITE IMMUNOL, V16, P521, DOI 10.1111/j.1365-3024.1994.tb00306.x; MULLIN NP, 1994, J BIOL CHEM, V269, P28405; Napper CE, 2006, BIOCHEM J, V395, P579, DOI 10.1042/BJ20052027; Niggemann B, 2008, PEDIAT ALLERG IMM-UK, V19, P325, DOI 10.1111/j.1399-3038.2007.00651.x; Ormstad H, 2003, TOXICOLOGY, V188, P309, DOI 10.1016/S0300-483X(03)00078-7; Peiser L, 2000, INFECT IMMUN, V68, P1953, DOI 10.1128/IAI.68.4.1953-1963.2000; Platts-Mills TAE, 1997, J ALLERGY CLIN IMMUN, V100, pS2, DOI 10.1016/S0091-6749(97)70292-6; PONTOW SE, 1992, INT REV CYTOL, V137B, P221; Roost HP, 1999, J ALLERGY CLIN IMMUN, V104, P941, DOI 10.1016/S0091-6749(99)70072-2; Royer PJ, 2010, J IMMUNOL, V185, P1522, DOI 10.4049/jimmunol.1000774; SARSFIELD JK, 1976, ARCH DIS CHILD, V51, P186, DOI 10.1136/adc.51.3.186; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9; Syme RM, 2002, INFECT IMMUN, V70, P5972, DOI 10.1128/IAI.70.11.5972-5981.2002; TAYLOR ME, 1992, J BIOL CHEM, V267, P1719; Taylor PR, 2005, TRENDS IMMUNOL, V26, P104, DOI 10.1016/j.it.2004.12.001; Terada T, 2006, CLIN IMMUNOL, V120, P45, DOI 10.1016/j.clim.2005.12.010; VANMILLIGEN FJ, 1994, J ALLERGY CLIN IMMUN, V93, P34, DOI 10.1016/0091-6749(94)90230-5; Wachholz Petra A, 2005, J Immunotoxicol, V1, P189, DOI 10.1080/15476910490919140	57	50	53	2	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13033	13040		10.1074/jbc.M111.220657	http://dx.doi.org/10.1074/jbc.M111.220657			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21335554	hybrid, Green Published			2022-12-27	WOS:000289282200023
J	Huang, CJ; Ferfoglia, F; Raleff, F; Kramer, A				Huang, Ching-Jung; Ferfoglia, Fabio; Raleff, Flore; Kraemer, Angela			Interaction Domains and Nuclear Targeting Signals in Subunits of the U2 Small Nuclear Ribonucleoprotein Particle-associated Splicing Factor SF3a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CELL-NUCLEUS; BRANCH SITE; YEAST PRP9; IN-VIVO; SNRNP; PROTEINS; RNA; SPLICEOSOME; COMPLEX	Human splicing factor SF3a is a component of the mature U2 small nuclear ribonucleoprotein particle (snRNP) and its three subunits of 60, 66, and 120 kDa are essential for splicing in vitro and in vivo. The SF3a heterotrimer forms in the cytoplasm and enters the nucleus independently of the U2 snRNP. Here, we have analyzed domains required for in vitro interactions between the SF3a subunits. Our results indicate that the SF3a66-SF3a120 interaction is mediated by a 27-amino acid region in SF3a120 C-terminal to the second suppressor-of-white-apricot and prp21/spp91 domain and amino acids 108 210 of SF3a66. Neither of these sequences contains known structural motifs, suggesting that the interaction domains are novel. Moreover, an similar to 100-amino acid region, including the SURP2 domain of SF3a120 but extending into neighboring regions, is sufficient for binding to SF3a60. Analysis of determinants for nuclear import of SF3a demonstrates that SF3a120 provides the major nuclear localization signal and SF3a60 contributes to nuclear import.	[Huang, Ching-Jung; Ferfoglia, Fabio; Raleff, Flore; Kraemer, Angela] Univ Geneva, Fac Sci, Dept Cell Biol, CH-1211 Geneva 4, Switzerland	University of Geneva	Kramer, A (corresponding author), Univ Geneva, Dept Cell Biol Sci 3, 30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.	angela.kraemer@unige.ch			Swiss National Science Foundation [3100-068239]; European Science Foundation [ERAS-CT-2003-980409]; European Commission [EURASNET-LSHG-CT-2005-518238]; Fondation MEDIC; Canton of Geneva	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Science Foundation(European Science Foundation (ESF)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Fondation MEDIC; Canton of Geneva	This work was supported by grants from the Swiss National Science Foundation (3100-068239), the European Science Foundation EUROCORES Programme EuroDYNA (ERAS-CT-2003-980409), the European Commission (EURASNET-LSHG-CT-2005-518238), the Fondation MEDIC, and the Canton of Geneva (to A. K.).	BEHRENS SE, 1993, P NATL ACAD SCI USA, V90, P8229, DOI 10.1073/pnas.90.17.8229; BENNETT M, 1993, SCIENCE, V262, P105, DOI 10.1126/science.8211113; Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; BROSI R, 1993, SCIENCE, V262, P102, DOI 10.1126/science.8211112; BROSI R, 1993, J BIOL CHEM, V268, P17640; CHIARA MD, 1994, P NATL ACAD SCI USA, V91, P6403, DOI 10.1073/pnas.91.14.6403; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gozani O, 1998, MOL CELL BIOL, V18, P4752, DOI 10.1128/MCB.18.8.4752; Gozani O, 1996, GENE DEV, V10, P233, DOI 10.1101/gad.10.2.233; Handwerger KE, 2006, TRENDS CELL BIOL, V16, P19, DOI 10.1016/j.tcb.2005.11.005; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; KRAMER A, 1994, NUCLEIC ACIDS RES, V22, P5223, DOI 10.1093/nar/22.24.5223; KRAMER A, 1995, RNA, V1, P260; Kramer A, 2005, BIOCHEM SOC T, V33, P439; Kuwasako K, 2006, STRUCTURE, V14, P1677, DOI 10.1016/j.str.2006.09.009; LEGRAIN P, 1993, SCIENCE, V262, P108, DOI 10.1126/science.8211114; Matera AG, 2006, CURR OPIN CELL BIOL, V18, P317, DOI 10.1016/j.ceb.2006.03.005; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nesic D, 2004, J CELL SCI, V117, P4423, DOI 10.1242/jcs.01308; Nesic D, 2001, MOL CELL BIOL, V21, P6406, DOI 10.1128/MCB.21.19.6406-6417.2001; Rain JC, 1996, RNA, V2, P535; SCHAPPERT K, 1991, MOL GEN GENET, V226, P277, DOI 10.1007/BF00273613; SPECTOR DL, 1991, EMBO J, V10, P3467, DOI 10.1002/j.1460-2075.1991.tb04911.x; Tanackovic G, 2005, MOL BIOL CELL, V16, P1366, DOI 10.1091/mbc.E04-11-1034; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Will CL, 2001, CURR OPIN CELL BIOL, V13, P290, DOI 10.1016/S0955-0674(00)00211-8; Will CL, 2001, EMBO J, V20, P4536, DOI 10.1093/emboj/20.16.4536; WILL CL, 2006, RNA WORLD, V3, P369; Xu DR, 2010, CURR OPIN STRUC BIOL, V20, P782, DOI 10.1016/j.sbi.2010.09.008	31	9	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13106	13114		10.1074/jbc.M110.201491	http://dx.doi.org/10.1074/jbc.M110.201491			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21349847	Green Published, hybrid			2022-12-27	WOS:000289282200031
J	Kim, MJ; Woo, SJ; Yoon, CH; Lee, JS; An, S; Choi, YH; Hwang, SG; Yoon, G; Lee, SJ				Kim, Min-Jung; Woo, Soo-Jung; Yoon, Chang-Hwan; Lee, Jae-Seong; An, Sungkwan; Choi, Yung-Hyun; Hwang, Sang-Gu; Yoon, Gyesoon; Lee, Su-Jae			Involvement of Autophagy in Oncogenic K-Ras-induced Malignant Cell Transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-MECHANISM; UP-REGULATION; DEATH; CANCER; SURVIVAL; APOPTOSIS; GENES; ACTIVATION; HEALTH; TUMORIGENESIS	Autophagy has recently been implicated in both the prevention and progression of cancer. However, the molecular basis for the relationship between autophagy induction and the initial acquisition of malignancy is currently unknown. Here, we provide the first evidence that autophagy is essential for oncogenic K-Ras (K-Ras(V12))-induced malignant cell transformation. Retroviral expression of K-Ras(V12) induced autophagic vacuole formation and malignant transformation in human breast epithelial cells. Interestingly, pharmacological inhibition of autophagy completely blocked K-Ras(V12)-induced, anchorage-independent cell growth on soft agar. Both mRNA and protein levels of ATG5 and ATG7 (autophagy-specific genes 5 and 7, respectively) were increased in cells overexpressing K-Ras(V12), Targeted suppression of ATG5 or ATG7 expression by short hairpin (sh) RNA inhibited cell growth on soft agar and tumor formation in nude mice. Moreover, inhibition of reactive oxygen species (ROS) with antioxidants clearly attenuated K-Ras(V12)-induced ATG5 and ATG7 induction, autophagy, and malignant cell transformation. MAPK pathway components were activated in cells overexpressing K-Ras(V12), and inhibition of JNK blunted induction of ATG5 and ATG7 and subsequent autophagy. In addition, pretreatment with antioxidants completely inhibited K-Ras(V12)-induced JNK activation. Our results provide novel evidence that autophagy is critically involved in malignant transformation by oncogenic K-Ras and show that reactive oxygen species-mediated INK activation plays a causal role in autophagy induction through up-regulation of ATG5 and ATG7.	[Kim, Min-Jung; Woo, Soo-Jung; Yoon, Chang-Hwan; Lee, Jae-Seong; Lee, Su-Jae] Hanyang Univ, Dept Chem, Seoul 133791, South Korea; [Kim, Min-Jung; Woo, Soo-Jung; Yoon, Chang-Hwan; Lee, Jae-Seong; Lee, Su-Jae] Hanyang Univ, Res Inst Nat Sci, Seoul 133791, South Korea; [An, Sungkwan] Konkuk Univ, Dept Microbiol Engn, Seoul 143701, South Korea; [Choi, Yung-Hyun] Dong Eui Univ, Dept Biochem, Coll Oriental Med, Pusan 614052, South Korea; [Hwang, Sang-Gu] Korea Inst Radiol & Med Sci, Div Radiat Canc Biol, Seoul 139706, South Korea; [Yoon, Gyesoon] Ajou Univ, Dept Biochem & Mol Biol, Sch Med, Suwon 443721, South Korea	Hanyang University; Hanyang University; Konkuk University; Dong-Eui University; Korea Institute of Radiological & Medical Sciences; Ajou University	Lee, SJ (corresponding author), Hanyang Univ, Dept Chem, 17 Haengdang Dong, Seoul 133791, South Korea.	sj0420@hanyang.ac.kr	Yoon, Changhwan/AAK-7842-2021; Lee, Jae-Seong/H-6013-2015	Yoon, Changhwan/0000-0002-8420-9818; Lee, Jae-Seong/0000-0003-0944-5172	Korea Science and Engineering Foundation (KOSEF); Ministry of Education, Science and Technology (MEST), Korean government [2009-0081812]; Basic Atomic Energy Research Institute (BAERI)	Korea Science and Engineering Foundation (KOSEF)(Korea Science and Engineering Foundation); Ministry of Education, Science and Technology (MEST), Korean government(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Basic Atomic Energy Research Institute (BAERI)	This work was supported by the Korea Science and Engineering Foundation (KOSEF) and Ministry of Education, Science and Technology (MEST), Korean government, through its National Nuclear Technology Program (2009-0081812) and the Program of Basic Atomic Energy Research Institute (BAERI).	Alexandrova AY, 2006, EXP CELL RES, V312, P2066, DOI 10.1016/j.yexcr.2006.03.004; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Botti J, 2006, AUTOPHAGY, V2, P67, DOI 10.4161/auto.2.2.2458; Castagnola P, 2005, BBA-REV CANCER, V1756, P115, DOI 10.1016/j.bbcan.2005.06.003; Chen N, 2009, BBA-MOL CELL RES, V1793, P1516, DOI 10.1016/j.bbamcr.2008.12.013; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Delgado MA, 2009, CELL DEATH DIFFER, V16, P976, DOI 10.1038/cdd.2009.40; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Dunn William A. Jr., 1994, Trends in Cell Biology, V4, P139, DOI 10.1016/0962-8924(94)90069-8; Furuta S, 2004, ONCOGENE, V23, P3898, DOI 10.1038/sj.onc.1207539; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; KARNOUB AE, 2008, NAT REV, V9, P531; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Konstantinopoulos PA, 2007, NAT REV DRUG DISCOV, V6, P540, DOI 10.1038/nrd2221; Kopnin PB, 2007, CANCER RES, V67, P4671, DOI 10.1158/0008-5472.CAN-06-2466; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Mathew R, 2007, AUTOPHAGY, V3, P502, DOI 10.4161/auto.4605; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Ng G, 2005, MOL CARCINOGEN, V43, P183, DOI 10.1002/mc.20097; Noguchi T, 2008, J BIOL CHEM, V283, P7657, DOI 10.1074/jbc.M708402200; Reggiori F, 2005, CURR OPIN CELL BIOL, V17, P415, DOI 10.1016/j.ceb.2005.06.007; Rockwell P, 2004, CELL SIGNAL, V16, P343, DOI 10.1016/j.cellsig.2003.08.006; Sahu RP, 2009, CARCINOGENESIS, V30, P1744, DOI 10.1093/carcin/bgp157; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Stromhaug PE, 2001, TRAFFIC, V2, P524, DOI 10.1034/j.1600-0854.2001.20802.x; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Todde V, 2009, BBA-MOL BASIS DIS, V1792, P3, DOI 10.1016/j.bbadis.2008.10.016; Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777; Wang CW, 2003, MOL MED, V9, P65, DOI 10.1007/BF03402040; Yang CS, 2008, CELL MICROBIOL, V10, P741, DOI 10.1111/j.1462-5822.2007.01081.x; Yang YP, 2005, ACTA PHARMACOL SIN, V26, P1421, DOI 10.1111/j.1745-7254.2005.00235.x; Yoo BH, 2010, J BIOL CHEM, V285, P5438, DOI 10.1074/jbc.M109.046789; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yu L, 2006, P NATL ACAD SCI USA, V103, P4952, DOI 10.1073/pnas.0511288103	50	165	175	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					12924	12932		10.1074/jbc.M110.138958	http://dx.doi.org/10.1074/jbc.M110.138958			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21300795	hybrid, Green Published			2022-12-27	WOS:000289282200012
J	Sonder, SU; Saret, S; Tang, W; Sturdevant, DE; Porcella, SF; Siebenlist, U				Sonder, Soren Ulrik; Saret, Sun; Tang, Wanhu; Sturdevant, Dan E.; Porcella, Stephen F.; Siebenlist, Ulrich			IL-17-induced NF-kappa B Activation via CIKS/Act1 PHYSIOLOGIC SIGNIFICANCE AND SIGNALING MECHANISMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILIZATION; ADAPTER PROTEIN CIKS/ACT1; EPITHELIAL-CELLS; GENE-EXPRESSION; NUCLEAR-PROTEIN; TNF-ALPHA; IL-17; RECEPTOR; ACT1; INTERLEUKIN-17	Interleukin-17 (IL-17) is essential in host defense against extracellular bacteria and fungi, especially at mucosal sites, but it also contributes significantly to inflammatory and autoimmune disease pathologies. Binding of IL-17 to its receptor leads to recruitment of adaptor protein CIKS/Act1 via heterotypic association of their respective SEFIR domains and activation of transcription factor NF-kappa B; it is not known whether CIKS and/or NE-kappa B are required for all gene induction events. Here we report that CIKS is essential for all IL-17-induced immediate-early genes in primary mouse embryo fibroblasts, whereas NF-kappa B is profoundly involved. We also identify a novel subdomain in the N terminus of CIKS that is essential for IL-17-mediated NF-kappa B activation. This domain is both necessary and sufficient for interaction between CIKS and TRAF6, an adaptor required for NF-kappa B activation. The ability of decoy peptides to block this interaction may provide a new therapeutic strategy for intervention in IL-17-driven autoimmune and inflammatory diseases.	[Sonder, Soren Ulrik; Saret, Sun; Tang, Wanhu; Siebenlist, Ulrich] NIA1D, Immunoregulat Lab, NIH, Rockville, MD 20852 USA; [Sturdevant, Dan E.; Porcella, Stephen F.] NIAID, Genom Unit, Res Technol Sect, Rocky Mt Labs,NIH, Hamilton, MT 59840 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Siebenlist, U (corresponding author), Bldg 10,Rm 11B15A, Bethesda, MD 20892 USA.	usiebenlist@niaid.nih.gov			National Institutes of Health NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001096, ZICAI001052] Funding Source: NIH RePORTER	National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the National Institutes of Health intramural research program of NIAID.	Andoh A, 2002, BBA-MOL CELL RES, V1591, P69, DOI 10.1016/S0167-4889(02)00250-1; Annunziato F, 2009, NAT REV RHEUMATOL, V5, P325, DOI 10.1038/nrrheum.2009.80; Awane M, 1999, J IMMUNOL, V162, P5337; Barlow JL, 2009, BIOFACTORS, V35, P178, DOI 10.1002/biof.24; Bren GD, 2001, ONCOGENE, V20, P7722, DOI 10.1038/sj.onc.1204868; Chang SH, 2006, J BIOL CHEM, V281, P35603, DOI 10.1074/jbc.C600256200; Claudio E, 2009, J IMMUNOL, V182, P1617, DOI 10.4049/jimmunol.182.3.1617; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; Dong C, 2006, NAT REV IMMUNOL, V6, P329, DOI 10.1038/nri1807; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Gaffen SL, 2008, CYTOKINE, V43, P402, DOI 10.1016/j.cyto.2008.07.017; Hartupee J, 2007, J IMMUNOL, V179, P4135, DOI 10.4049/jimmunol.179.6.4135; Hartupee J, 2009, J IMMUNOL, V182, P1660, DOI 10.4049/jimmunol.182.3.1660; Heinemann S, 2006, J BIOL CHEM, V281, P8565, DOI 10.1074/jbc.M510891200; Hoffmann A, 2003, EMBO J, V22, P5530, DOI 10.1093/emboj/cdg534; Huang F, 2007, J IMMUNOL, V179, P6504, DOI 10.4049/jimmunol.179.10.6504; Kanamori M, 2002, FEBS LETT, V532, P241, DOI 10.1016/S0014-5793(02)03688-8; Kang ZZ, 2010, IMMUNITY, V32, P414, DOI 10.1016/j.immuni.2010.03.004; Kao CY, 2004, J IMMUNOL, V173, P3482, DOI 10.4049/jimmunol.173.5.3482; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leonardi A, 2000, J BIOL CHEM, V275, P271, DOI 10.1074/jbc.275.1.271; Leonardi A, 2000, P NATL ACAD SCI USA, V97, P10494, DOI 10.1073/pnas.190245697; Li M, 2007, P NATL ACAD SCI USA, V104, P9469, DOI 10.1073/pnas.0702159104; Li XX, 2008, CYTOKINE, V41, P105, DOI 10.1016/j.cyto.2007.09.015; Li XX, 2000, P NATL ACAD SCI USA, V97, P10489, DOI 10.1073/pnas.160265197; Liu CN, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000382; Mauro C, 2003, BIOCHEM BIOPH RES CO, V309, P84, DOI 10.1016/S0006-291X(03)01532-8; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Neumann M, 2007, FASEB J, V21, P2642, DOI 10.1096/fj.06-7615rev; Novatchkova M, 2003, TRENDS BIOCHEM SCI, V28, P226, DOI 10.1016/S0968-0004(03)00067-7; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Pisitkun P, 2010, ARTHRITIS RHEUM-US, V62, P3334, DOI 10.1002/art.27653; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Schluns KS, 1997, J IMMUNOL, V158, P2704; Shea PR, 2010, P NATL ACAD SCI USA, V107, P4693, DOI 10.1073/pnas.0906384107; Shen F, 2005, J LEUKOCYTE BIOL, V77, P388, DOI 10.1189/jlb.0904490; Shen F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000066; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Sparna T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-226; Swaidani S, 2009, J IMMUNOL, V182, P1631, DOI 10.4049/jimmunol.182.3.1631; UEDA A, 1994, J IMMUNOL, V153, P2052; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Xu S, 2010, CELL MOL IMMUNOL, V7, P164, DOI 10.1038/cmi.2010.21; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yamazaki S, 2008, J BIOL CHEM, V283, P32404, DOI 10.1074/jbc.M802148200; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888	49	100	102	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					12881	12890		10.1074/jbc.M110.199547	http://dx.doi.org/10.1074/jbc.M110.199547			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21335551	hybrid, Green Published			2022-12-27	WOS:000289282200008
J	Lambert, S; Drews, A; Rizun, O; Wagner, TFJ; Lis, A; Mannebach, S; Plant, S; Portz, M; Meissner, M; Philipp, SE; Oberwinkler, J				Lambert, Sachar; Drews, Anna; Rizun, Oleksandr; Wagner, Thomas F. J.; Lis, Annette; Mannebach, Stefanie; Plant, Sandra; Portz, Melanie; Meissner, Marcel; Philipp, Stephan E.; Oberwinkler, Johannes			Transient Receptor Potential Melastatin 1 (TRPM1) Is an Ion-conducting Plasma Membrane Channel Inhibited by Zinc Ions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STATIONARY NIGHT BLINDNESS; PANCREATIC BETA-CELLS; RETINAL BIPOLAR CELLS; GENE-EXPRESSION; MGLUR6; TRANSMISSION; SELECTIVITY; MELANOMA; DISRUPTION; PERMEATION	TRPM1 is the founding member of the melastatin subgroup of transient receptor potential (TRP) proteins, but it has not yet been firmly established that TRPM1 proteins form ion channels. Consequently, the biophysical and pharmacological properties of these proteins are largely unknown. Here we show that heterologous expression of TRPM1 proteins induces ionic conductances that can be activated by extracellular steroid application. However the current amplitudes observed were too small to enable a reliable biophysical characterization. We overcame this limitation by modifying TRPM1 channels in several independent ways that increased the similarity to the closely related TRPM3 channels. The resulting constructs produced considerably larger currents after overexpression. We also demonstrate that unmodified TRPM1 and TRPM3 proteins form functional heteromultimeric channels. With these approaches, we measured the divalent permeability profile and found that channels containing the pore of TRPM1 are inhibited by extracellular zinc ions at physiological concentrations, in contrast to channels containing only the pore of TRPM3. Applying these findings to pancreatic beta cells, we found that TRPM1 proteins do not play a major role in steroid-activated currents of these cells. The inhibition of TRPM1 by zinc ions is primarily due to a short stretch of seven amino acids present only in the pore region of TRPM1 but not of TRPM3. Combined, our data demonstrate that TRPM1 proteins are bona fide ion-conducting plasma membrane channels. Their distinct biophysical properties allow a reliable identification of endogenous TRPM1-mediated currents.	[Lambert, Sachar; Drews, Anna; Rizun, Oleksandr; Wagner, Thomas F. J.; Lis, Annette; Mannebach, Stefanie; Plant, Sandra; Portz, Melanie; Meissner, Marcel; Philipp, Stephan E.; Oberwinkler, Johannes] Univ Saarland, D-66421 Homburg, Germany	Saarland University	Oberwinkler, J (corresponding author), Univ Klinikum Saarlandes, Gebaude 46, D-66421 Homburg, Germany.	johannes.oberwinkler@uniklinikum-saarland.de	Philipp, Stephan/AAR-7519-2020	Oberwinkler, Johannes/0000-0002-8541-3626; Philipp, Stephan/0000-0003-1959-9167	Deutsche Forschungsgemeinschaft [GK 1326, SFB 530, SFB 894]; HOMFOR; Forschungskommission der Universitat des Saarlandes	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); HOMFOR; Forschungskommission der Universitat des Saarlandes	This work was supported by Deutsche Forschungsgemeinschaft (GK 1326, SFB 530, SFB 894 and Emmy Noether-program), HOMFOR, and Forschungskommission der Universitat des Saarlandes.	Amiri H, 2003, CELL CALCIUM, V33, P463, DOI 10.1016/S0143-4160(03)00061-7; Audo I, 2009, AM J HUM GENET, V85, P720, DOI 10.1016/j.ajhg.2009.10.013; Bellone RR, 2008, GENETICS, V179, P1861, DOI 10.1534/genetics.108.088807; Braman J, 1996, Methods Mol Biol, V57, P31; Carlson JA, 2005, J AM ACAD DERMATOL, V52, P743, DOI 10.1016/j.jaad.2004.08.034; Chu XP, 2004, J NEUROSCI, V24, P8678, DOI 10.1523/JNEUROSCI.2844-04.2004; Chubanov V, 2004, P NATL ACAD SCI USA, V101, P2894, DOI 10.1073/pnas.0305252101; Duncan LM, 1998, CANCER RES, V58, P1515; Duncan LM, 2001, J CLIN ONCOL, V19, P568, DOI 10.1200/JCO.2001.19.2.568; Erickson LA, 2009, MODERN PATHOL, V22, P969, DOI 10.1038/modpathol.2009.56; Frederickson CJ, 2006, J NEUROSCI METH, V154, P19, DOI 10.1016/j.jneumeth.2005.11.014; Frederickson CJ, 2006, EXP NEUROL, V198, P285, DOI 10.1016/j.expneurol.2005.08.030; Georgiev P, 2010, CELL METAB, V12, P386, DOI 10.1016/j.cmet.2010.08.012; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Jeong SW, 2003, NEUROREPORT, V14, P1537, DOI 10.1097/00001756-200308060-00028; Kim DS, 2008, J COMP NEUROL, V507, P1795, DOI 10.1002/cne.21639; Kim DS, 2008, J NEUROSCI, V28, P7748, DOI 10.1523/JNEUROSCI.0397-08.2008; Koike C, 2010, P NATL ACAD SCI USA, V107, P332, DOI 10.1073/pnas.0912730107; Komatsu K, 2005, J AM CHEM SOC, V127, P10197, DOI 10.1021/ja050301e; Lee N, 2003, J BIOL CHEM, V278, P20890, DOI 10.1074/jbc.M211232200; Li M, 2006, J GEN PHYSIOL, V127, P525, DOI 10.1085/jgp.200609502; Li Y, 2001, J NEUROPHYSIOL, V86, P2597, DOI 10.1152/jn.2001.86.5.2597; Li Z, 2009, AM J HUM GENET, V85, P711, DOI 10.1016/j.ajhg.2009.10.003; Lis A, 2005, N-S ARCH PHARMACOL, V371, P315, DOI 10.1007/s00210-005-1050-x; MASU M, 1995, CELL, V80, P757, DOI 10.1016/0092-8674(95)90354-2; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; Mony L, 2009, BRIT J PHARMACOL, V157, P1301, DOI 10.1111/j.1476-5381.2009.00304.x; Morgans CW, 2009, P NATL ACAD SCI USA, V106, P19174, DOI 10.1073/pnas.0908711106; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; NAKAJIMA Y, 1993, J BIOL CHEM, V268, P11868; Nakajima Y, 2009, J BIOCHEM, V145, P811, DOI 10.1093/jb/mvp038; Nakamura M, 2010, MOL VIS, V16, P425; NAWY S, 1991, NEURON, V7, P677, DOI 10.1016/0896-6273(91)90380-I; NAWY S, 1990, NATURE, V346, P269, DOI 10.1038/346269a0; Oancea E, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000146; Oberwinkler J., 2007, V179, P253; Oberwinkler J, 2005, J BIOL CHEM, V280, P22540, DOI 10.1074/jbc.M503092200; Okawa H, 2010, J GEN PHYSIOL, V136, P443, DOI 10.1085/jgp.201010477; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Paoletti P, 2009, NEUROSCIENCE, V158, P126, DOI 10.1016/j.neuroscience.2008.01.061; Paoletti P, 1997, J NEUROSCI, V17, P5711; Philipp S, 2003, J BIOL CHEM, V278, P26629, DOI 10.1074/jbc.M304044200; Redenti S, 2005, VISION RES, V45, P3520, DOI 10.1016/j.visres.2005.07.039; Redenti S, 2007, EXP EYE RES, V85, P580, DOI 10.1016/j.exer.2007.07.017; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sampath AP, 2004, NEURON, V41, P431, DOI 10.1016/S0896-6273(04)00005-4; Schaefer M, 2005, PFLUG ARCH EUR J PHY, V451, P35, DOI 10.1007/s00424-005-1467-6; Shen Y, 2009, J NEUROSCI, V29, P6088, DOI 10.1523/JNEUROSCI.0132-09.2009; Snellman J, 2008, PROG RETIN EYE RES, V27, P450, DOI 10.1016/j.preteyeres.2008.03.003; van Genderen MM, 2009, AM J HUM GENET, V85, P730, DOI 10.1016/j.ajhg.2009.10.012; Voets T, 2004, J BIOL CHEM, V279, P19, DOI 10.1074/jbc.M311201200; Voets T, 2003, CELL CALCIUM, V33, P299, DOI 10.1016/S0143-4160(03)00044-7; Vogt K, 2000, NEURON, V26, P187, DOI 10.1016/S0896-6273(00)81149-6; Wagner TFJ, 2010, PFLUG ARCH EUR J PHY, V460, P755, DOI 10.1007/s00424-010-0838-9; Wagner TFJ, 2008, NAT CELL BIOL, V10, P1421, DOI 10.1038/ncb1801; Warnat J, 1999, J PHYSIOL-LONDON, V518, P631, DOI 10.1111/j.1469-7793.1999.0631p.x; Xu XZS, 2001, P NATL ACAD SCI USA, V98, P10692, DOI 10.1073/pnas.191360198	57	54	54	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.202945	http://dx.doi.org/10.1074/jbc.M110.202945			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21278253	Green Published, hybrid			2022-12-27	WOS:000289077500037
J	Narita, H; Yamamoto, Y; Suzuki, M; Miyazaki, N; Yoshida, A; Kawai, K; Iwasaki, K; Nakagawa, A; Takai, Y; Sakisaka, T				Narita, Hirotaka; Yamamoto, Yasunori; Suzuki, Mamoru; Miyazaki, Naoyuki; Yoshida, Asuka; Kawai, Katsuhisa; Iwasaki, Kenji; Nakagawa, Atsushi; Takai, Yoshimi; Sakisaka, Toshiaki			Crystal Structure of the cis-Dimer of Nectin-1 IMPLICATIONS FOR THE ARCHITECTURE OF CELL-CELL JUNCTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HERPES-SIMPLEX VIRUS; IMMUNOGLOBULIN-LIKE LOOP; ADHESION MOLECULE; ADHERENS JUNCTIONS; POLIOVIRUS RECEPTOR; CLEFT LIP/PALATE; V-DOMAIN; CADHERIN; AFADIN; PROTEIN	In multicellular organisms, cells are interconnected by cell adhesion molecules. Nectins are immunoglobulin (Ig)-like cell adhesion molecules that mediate homotypic and heterotypic cell-cell adhesion, playing key roles in tissue organization. To mediate cell-cell adhesion, nectin molecules dimerize in cis on the surface of the same cell, followed by trans-dimerization of the cis-dimers between the neighboring cells. Previous cell biological studies deduced that the first Ig-like domain of nectin and the second Ig-like domain are involved in trans-dimerization and cis-dimerization, respectively. However, to understand better the steps involved in nectin adhesion, the structural basis for the dimerization of nectin must be determined. In this study, we determined the first crystal structure of the entire extracellular region of nectin-1. In the crystal, nectin-1 formed a V-shaped homophilic dimer through the first Ig-like domain. Structure-based site-directed mutagenesis of the first Ig-like domain identified four essential residues that are involved in the homophilic dimerization. Upon mutating the four residues, nectin-1 significantly decreased cis-dimerization on the surface of cultured cells and abolished the homophilic and heterophilic adhesion activities. These results indicate that, in contrast with the previous notion, our structure represents a cis-dimer. Thus, our findings clearly reveal the structural basis for the cis-dimerization of nectins through the first Ig-like domains.	[Yamamoto, Yasunori; Yoshida, Asuka; Kawai, Katsuhisa; Sakisaka, Toshiaki] Kobe Univ, Div Membrane Dynam, Dept Physiol & Cell Biol, Grad Sch Med, Kobe, Hyogo 6500017, Japan; [Narita, Hirotaka; Suzuki, Mamoru; Nakagawa, Atsushi] Osaka Univ, Lab Supramol Crystallog, Res Ctr Struct & Funct Prote, Inst Prot Res, Suita, Osaka 5650871, Japan; [Miyazaki, Naoyuki; Iwasaki, Kenji] Osaka Univ, Lab Prot Synth & Express, Res Ctr Struct & Funct Prote, Inst Prot Res, Suita, Osaka 5650871, Japan; [Takai, Yoshimi] Kobe Univ, Div Mol & Cellular Biol, Dept Biochem & Mol Biol, Grad Sch Med, Kobe, Hyogo 6500017, Japan	Kobe University; Osaka University; Osaka University; Kobe University	Sakisaka, T (corresponding author), Kobe Univ, Div Membrane Dynam, Dept Physiol & Cell Biol, Grad Sch Med, Kobe, Hyogo 6500017, Japan.	sakisaka@med.kobe-u.ac.jp	Nakagawa, Atsushi/M-5731-2019; Suzuki, Mamoru/G-6576-2016; Miyazaki, Naoyuki/D-7435-2012; Nakagawa, Atsushi/D-4329-2009; Miyazaki, Naoyuki/P-3436-2018	Nakagawa, Atsushi/0000-0002-1700-7861; Suzuki, Mamoru/0000-0001-7071-5093; Miyazaki, Naoyuki/0000-0002-4880-7300; Nakagawa, Atsushi/0000-0002-1700-7861; Miyazaki, Naoyuki/0000-0002-4880-7300; Narita, Hirotaka/0000-0003-4604-9523	Ministry of Education, Culture, Sports, Science, and Technology, Japan	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for the National Project on Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Avila JR, 2006, AM J MED GENET A, V140A, P2562, DOI 10.1002/ajmg.a.31367; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng CY, 2002, PHYSIOL REV, V82, P825, DOI 10.1152/physrev.00009.2002; DeLano W.L, PYMOL MOL GRAPHICS S; Dong XH, 2006, J BIOL CHEM, V281, P10610, DOI 10.1074/jbc.M513459200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Geraghty RJ, 1998, SCIENCE, V280, P1618, DOI 10.1126/science.280.5369.1618; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; Honda T, 2003, BIOCHEM BIOPH RES CO, V306, P104, DOI 10.1016/S0006-291X(03)00919-7; Honda T, 2003, GENES CELLS, V8, P51, DOI 10.1046/j.1365-2443.2003.00616.x; HONIG MG, 1986, J CELL BIOL, V103, P171, DOI 10.1083/jcb.103.1.171; Ikeda W, 2003, J BIOL CHEM, V278, P28167, DOI 10.1074/jbc.M303586200; Koch AW, 1997, BIOCHEMISTRY-US, V36, P7697, DOI 10.1021/bi9705624; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krummenacher C, 2005, EMBO J, V24, P4144, DOI 10.1038/sj.emboj.7600875; Krummenacher C, 2002, J VIROL, V76, P2424, DOI 10.1128/JVI.76.5.2424-2433.2002; LOPEZ M, 1995, GENE, V155, P261, DOI 10.1016/0378-1119(94)00842-G; Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517; Martinez WM, 2002, J VIROL, V76, P7255, DOI 10.1128/JVI.76.14.7255-7262.2002; McRorie D. K., 1993, SELF ASS SYSTEMS ANA; Miyahara M, 2000, J BIOL CHEM, V275, P613, DOI 10.1074/jbc.275.1.613; Mizoguchi A, 2002, J CELL BIOL, V156, P555, DOI 10.1083/jcb.200103113; Momose Y, 2002, BIOCHEM BIOPH RES CO, V293, P45, DOI 10.1016/S0006-291X(02)00183-3; Okabe N, 2004, DEV BIOL, V273, P244, DOI 10.1016/j.ydbio.2004.05.034; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ozaki-Kuroda K, 2002, CURR BIOL, V12, P1145, DOI 10.1016/S0960-9822(02)00922-3; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Russell L. D., 1990, HISTOLOGICAL HISTOPA; Sakisaka T, 2004, CURR OPIN CELL BIOL, V16, P513, DOI 10.1016/j.ceb.2004.07.007; Sakisaka T, 2001, J VIROL, V75, P4734, DOI 10.1128/JVI.75.10.4734-4743.2001; Sakisaka T, 2007, CURR OPIN CELL BIOL, V19, P593, DOI 10.1016/j.ceb.2007.09.007; Satoh-Horikawa K, 2000, J BIOL CHEM, V275, P10291, DOI 10.1074/jbc.275.14.10291; Scapoli L, 2006, ANN HUM GENET, V70, P410, DOI 10.1111/j.1469-1809.2005.00237.x; Shapiro L, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003053; Sozen MA, 2001, NAT GENET, V29, P141, DOI 10.1038/ng740; SPACEK J, 1974, J ANAT, V117, P487; Stafford WF, 2004, BIOPHYS CHEM, V108, P231, DOI 10.1016/j.bpc.2003.10.028; Struyf F, 2002, J VIROL, V76, P12940, DOI 10.1128/JVI.76.24.12940-12950.2002; Suzuki K, 2000, NAT GENET, V25, P427, DOI 10.1038/78119; Takahashi K, 1999, J CELL BIOL, V145, P539, DOI 10.1083/jcb.145.3.539; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Tsukasaki Y, 2007, J MOL BIOL, V367, P996, DOI 10.1016/j.jmb.2006.12.022; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119; Yasumi M, 2003, BIOCHEM BIOPH RES CO, V302, P61, DOI 10.1016/S0006-291X(03)00106-2; Zhang P, 2008, P NATL ACAD SCI USA, V105, P18284, DOI 10.1073/pnas.0807848105	50	39	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.197368	http://dx.doi.org/10.1074/jbc.M110.197368			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21325282	Green Published, hybrid			2022-12-27	WOS:000289077500077
J	Page, AN; George, NP; Marceau, AH; Cox, MM; Keck, JL				Page, Asher N.; George, Nicholas P.; Marceau, Aimee H.; Cox, Michael M.; Keck, James L.			Structure and Biochemical Activities of Escherichia coli MgsA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STALLED REPLICATION FORKS; SINGLE-STRANDED-DNA; POLYMERASE-III HOLOENZYME; ENHANCER-BINDING PROTEIN; CLAMP-LOADER COMPLEX; AAA PLUS ATPASES; RECA PROTEIN; ATP HYDROLYSIS; CHROMOSOME SEGREGATION; PHYSICAL INTERACTION	Bacterial "maintenance of genome stability protein A" (MgsA) and related eukaryotic enzymes play important roles in cellular responses to stalled DNA replication processes. Sequence information identifies MgsA enzymes as members of the clamp loader clade of AAA(+) proteins, but structural information defining the family has been limited. Here, the x-ray crystal structure of Escherichia coli MgsA is described, revealing a homotetrameric arrangement for the protein that distinguishes it from other clamp loader clade AAA(+) proteins. Each MgsA protomer is composed of three elements as follows: ATP-binding and helical lid domains (conserved among AAA(+) proteins) and a tetramerization domain. Although the tetramerization domains bury the greatest amount of surface area in the MgsA oligomer, each of the domains participates in oligomerization to form a highly intertwined quaternary structure. Phosphate is bound at each AAA(+) ATP-binding site, but the active sites do not appear to be in a catalytically competent conformation due to displacement of Arg finger residues. E. coli MgsA is also shown to form a complex with the single-stranded DNA-binding protein through co-purification and biochemical studies. MgsA DNA-dependent ATPase activity is inhibited by single-stranded DNA-binding protein. Together, these structural and biochemical observations provide insights into the mechanisms of MgsA family AAA(+) proteins.	[George, Nicholas P.; Marceau, Aimee H.; Keck, James L.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53706 USA; [Page, Asher N.; Cox, Michael M.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Keck, JL (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53706 USA.	jlkeck@wisc.edu		Keck, James/0000-0002-5961-0220	National Institutes of Health from NIGMS [GM32335, GM068061]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068061, U01GM032335, R01GM032335] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM32335 from NIGMS (to M. M. C.) and Grant GM068061 (to J. L. K.).	Ammelburg M, 2006, J STRUCT BIOL, V156, P2, DOI 10.1016/j.jsb.2006.05.002; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Barre FX, 2001, P NATL ACAD SCI USA, V98, P8189, DOI 10.1073/pnas.111008998; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Bish RA, 2007, J BIOL CHEM, V282, P23184, DOI 10.1074/jbc.M701042200; Bowman GD, 2005, FEBS LETT, V579, P863, DOI 10.1016/j.febslet.2004.11.038; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Brunger AT, 2003, FEBS LETT, V555, P126, DOI 10.1016/S0014-5793(03)01107-4; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Costes A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001238; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Cox MM, 2002, MUTAT RES-FUND MOL M, V510, P107, DOI 10.1016/S0027-5107(02)00256-7; Crosetto N, 2008, J BIOL CHEM, V283, P35173, DOI 10.1074/jbc.M803219200; Davey MJ, 2002, NAT REV MOL CELL BIO, V3, P826, DOI 10.1038/nrm949; Duderstadt KE, 2008, CRIT REV BIOCHEM MOL, V43, P163, DOI [10.1080/10409230802058296, 10.1080/10409230802058296 ]; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erzberger JP, 2006, NAT STRUCT MOL BIOL, V13, P676, DOI 10.1038/nsmb1115; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; Guenther B, 1997, CELL, V91, P335, DOI 10.1016/S0092-8674(00)80417-1; Guo CX, 2006, MOL CELL BIOL, V26, P8892, DOI 10.1128/MCB.01118-06; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Haracska L, 2004, MOL CELL BIOL, V24, P4267, DOI 10.1128/MCB.24.10.4267-4274.2004; Haruta N, 2003, J BIOL CHEM, V278, P52710, DOI 10.1074/jbc.M308563200; Hishida T, 2004, GENE DEV, V18, P1886, DOI 10.1101/gad.1223804; Hishida T, 2001, P NATL ACAD SCI USA, V98, P8283, DOI 10.1073/pnas.121009098; Hishida T, 2006, MOL CELL BIOL, V26, P5509, DOI 10.1128/MCB.00307-06; Hobbs MD, 2007, J BIOL CHEM, V282, P11058, DOI 10.1074/jbc.M611007200; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Jeruzalmi D, 2001, CELL, V106, P429, DOI 10.1016/S0092-8674(01)00463-9; Karata K, 1999, J BIOL CHEM, V274, P26225, DOI 10.1074/jbc.274.37.26225; Kazmirski SL, 2004, P NATL ACAD SCI USA, V101, P16750, DOI 10.1073/pnas.0407904101; KELMAN Z, 1995, ANNU REV BIOCHEM, V64, P171, DOI 10.1146/annurev.bi.64.070195.001131; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Kozlov AG, 2010, J BIOL CHEM, V285, P17246, DOI 10.1074/jbc.M110.118273; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Lau IF, 2003, MOL MICROBIOL, V49, P731, DOI 10.1046/j.1365-2958.2003.03640.x; Laue T, 1992, ULTRACENTRIFUGATION, P90; LAUE TM, 1995, METHOD ENZYMOL, V259, P61; Lestini R, 2007, EMBO J, V26, P3804, DOI 10.1038/sj.emboj.7601804; Lew CM, 2002, J BIOL CHEM, V277, P41517, DOI 10.1074/jbc.M206912200; LINDSLEY JE, 1990, J BIOL CHEM, V265, P9043; LOHMAN TM, 1985, J BIOL CHEM, V260, P3594; Lu D, 2008, P NATL ACAD SCI USA, V105, P9169, DOI 10.1073/pnas.0800741105; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Marians KJ, 2000, TRENDS BIOCHEM SCI, V25, P185, DOI 10.1016/S0968-0004(00)01565-6; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MERTENS N, 1995, BIO-TECHNOL, V13, P175, DOI 10.1038/nbt0295-175; Michel B, 2004, P NATL ACAD SCI USA, V101, P12783, DOI 10.1073/pnas.0401586101; MORRICAL SW, 1986, BIOCHEMISTRY-US, V25, P1482, DOI 10.1021/bi00355a003; Nakajima S, 2006, J BIOL CHEM, V281, P34687, DOI 10.1074/jbc.M605545200; NEUENDORF SK, 1986, J BIOL CHEM, V261, P8276; Neuwald AF, 1999, GENOME RES, V9, P27; Nishida S, 2002, J BIOL CHEM, V277, P14986, DOI 10.1074/jbc.M108303200; O'Donnell M, 2006, CURR OPIN STRUC BIOL, V16, P35, DOI 10.1016/j.sbi.2005.12.004; O'Donnell M, 2006, J BIOL CHEM, V281, P10653, DOI 10.1074/jbc.R500028200; Ogura T, 2004, J STRUCT BIOL, V146, P106, DOI 10.1016/j.jsb.2003.11.008; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rombel I, 1999, J BACTERIOL, V181, P4628, DOI 10.1128/JB.181.15.4628-4638.1999; Shan Q, 1996, J BIOL CHEM, V271, P5712, DOI 10.1074/jbc.271.10.5712; Shereda RD, 2009, J MOL BIOL, V386, P612, DOI 10.1016/j.jmb.2008.12.065; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; Sherratt DJ, 2004, PHILOS T R SOC B, V359, P61, DOI 10.1098/rstb.2003.1365; Shibata T, 2005, GENES CELLS, V10, P181, DOI 10.1111/j.1365-2443.2005.00831.x; Steel GJ, 2000, MOL BIOL CELL, V11, P1345, DOI 10.1091/mbc.11.4.1345; STORY RM, 1992, NATURE, V355, P374, DOI 10.1038/355374a0; Tsurimoto T, 2005, GENES CELLS, V10, P13, DOI 10.1111/j.1365-2443.2004.00812.x; Turner J, 1999, EMBO J, V18, P771, DOI 10.1093/emboj/18.3.771; Vandewiele D, 2002, MUTAT RES-FUND MOL M, V499, P85, DOI 10.1016/S0027-5107(01)00268-8; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wang J, 2001, STRUCTURE, V9, P177, DOI 10.1016/S0969-2126(01)00570-6; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Watts FZ, 2006, DNA REPAIR, V5, P399, DOI 10.1016/j.dnarep.2005.11.002; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yao NY, 2006, J BIOL CHEM, V281, P17528, DOI 10.1074/jbc.M601273200; Yoshimura A, 2009, GENES GENET SYST, V84, P171, DOI 10.1266/ggs.84.171	81	22	22	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.210187	http://dx.doi.org/10.1074/jbc.M110.210187			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21297161	hybrid, Green Published			2022-12-27	WOS:000289077500022
J	Heller, C; Weisser, T; Mueller-Schickert, A; Rufer, E; Hoh, A; Leonhardt, RM; Knittler, MR				Heller, Corina; Weisser, Tanja; Mueller-Schickert, Antje; Rufer, Elke; Hoh, Alexander; Leonhardt, Ralf M.; Knittler, Michael R.			Identification of Key Amino Acid Residues That Determine the Ability of High Risk HPV16-E7 to Dysregulate Major Histocompatibility Complex Class I Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-I; NF-KAPPA-B; HUMAN-PAPILLOMAVIRUS TYPE-6; HISTONE DEACETYLASE; DOWN-REGULATION; E7 ONCOPROTEIN; CHROMATIN REPRESSION; IMMUNE EVASION; PROTEIN; TRANSCRIPTION	High risk human Papillomavirus (HPV) types are the major causative agents of cervical cancer. Reduced expression of major histocompatibility complex class I (MHC I) on HPV-infected cells might be responsible for insufficient T cell response and contribute to HPV-associated malignancy. The viral gene product required for subversion of MHC I synthesis is the E7 oncoprotein. Although it has been suggested that high and low risk HPVs diverge in their ability to dysregulate MHC I expression, it is not known what sequence determinants of HPV-E7 are responsible for this important functional difference. To investigate this, we analyzed the capability to affect MHC I of a set of chimeric E7 variants containing sequence elements from either high risk HPV16 or low risk HPV11. HPV16-E7, but not HPV11-E7, causes significant diminution of mRNA synthesis and surface presentation of MHC I, which depend on histone deacetylase activity. Our experiments demonstrate that the C-terminal region within the zinc finger domain of HPV-E7 is responsible for the contrasting effects of HPV11- and HPV16-E7 on MHC I. By using different loss- and gain-of-function mutants of HPV11- and HPV16-E7, we identify for the first time a residue variation at position 88 that is highly critical for HPV16-E7-mediated suppression of MHC I. Furthermore, our studies suggest that residues at position 78, 80, and 88 build a minimal functional unit within HPV16-E7 required for binding and histone deacetylase recruitment to the MHC I promoter. Taken together, our data provide new insights into how high risk HPV16-E7 dysregulates MHC I for immune evasion.	[Heller, Corina; Weisser, Tanja; Rufer, Elke; Hoh, Alexander; Knittler, Michael R.] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Inst Immunol, D-72076 Tubingen, Germany; [Mueller-Schickert, Antje] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Leonhardt, Ralf M.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06519 USA	Friedrich Loeffler Institute; University of Michigan System; University of Michigan; Yale University	Knittler, MR (corresponding author), Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Inst Immunol, Paul Ehrlich Str 28, D-72076 Tubingen, Germany.	michael.knittler@fli.bund.de		Leonhardt, Ralf Max/0000-0001-6673-8217	Friedrich-Loeffler-Institut; Cancer Research Institute	Friedrich-Loeffler-Institut; Cancer Research Institute	This work was supported by the Friedrich-Loeffler-Institut.; Supported by a fellowship from the Cancer Research Institute.	ANDROPHY EJ, 1987, EMBO J, V6, P989, DOI 10.1002/j.1460-2075.1987.tb04849.x; Antinore MJ, 1996, EMBO J, V15, P1950, DOI 10.1002/j.1460-2075.1996.tb00546.x; ARENDS MJ, 1993, HUM PATHOL, V24, P432, DOI 10.1016/0046-8177(93)90093-V; Armstrong DJ, 1997, VIROLOGY, V239, P238, DOI 10.1006/viro.1997.8885; Ashrafi GH, 2006, VIRUS RES, V120, P208, DOI 10.1016/j.virusres.2006.02.005; Ashrafi GH, 2005, INT J CANCER, V113, P276, DOI 10.1002/ijc.20558; Bonagura VR, 2004, HUM IMMUNOL, V65, P773, DOI 10.1016/j.humimm.2004.05.014; Bottley G, 2008, ONCOGENE, V27, P1794, DOI 10.1038/sj.onc.1210798; Brehm A, 1999, EMBO J, V18, P2449, DOI 10.1093/emboj/18.9.2449; Brodsky FM, 1999, IMMUNOL REV, V168, P199, DOI 10.1111/j.1600-065X.1999.tb01294.x; Burger RA, 1996, JNCI-J NATL CANCER I, V88, P1361, DOI 10.1093/jnci/88.19.1361; Chen SL, 1996, J VIROL, V70, P3502, DOI 10.1128/JVI.70.6.3502-3508.1996; CHEN SL, 1990, J VIROL, V64, P3226, DOI 10.1128/JVI.64.7.3226-3233.1990; COX JT, 1995, BAILLIERE CLIN OB GY, V9, P1, DOI 10.1016/S0950-3552(05)80357-8; Mora-Garcia MD, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-55; DEJONG WW, 1978, BIOCHEM BIOPH RES CO, V82, P532, DOI 10.1016/0006-291X(78)90907-5; Duensing A, 2008, VIROLOGY, V372, P157, DOI 10.1016/j.virol.2007.10.030; Dulat HJ, 2001, EUR J IMMUNOL, V31, P2217, DOI 10.1002/1521-4141(200107)31:7<2217::AID-IMMU2217>3.0.CO;2-E; Elliott T, 1997, IMMUNOL TODAY, V18, P375, DOI 10.1016/S0167-5699(97)01097-9; Garcia MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006422; Garcia-Lora A, 2003, J CELL PHYSIOL, V195, P346, DOI 10.1002/jcp.10290; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Georgopoulos NT, 2000, ONCOGENE, V19, P4930, DOI 10.1038/sj.onc.1203860; GISSMANN L, 1982, J VIROL, V44, P393, DOI 10.1128/JVI.44.1.393-400.1982; GREENFIELD I, 1991, P NATL ACAD SCI USA, V88, P11217, DOI 10.1073/pnas.88.24.11217; Guan H, 2008, J VIROL, V82, P40, DOI 10.1128/JVI.01579-07; HEEMELS MT, 1995, ANNU REV BIOCHEM, V64, P463, DOI 10.1146/annurev.bi.64.070195.002335; Hewitt EW, 2003, IMMUNOLOGY, V110, P163, DOI 10.1046/j.1365-2567.2003.01738.x; Hiraiwa A, 1996, VIRUS GENES, V12, P27, DOI 10.1007/BF00369998; Hobbs CGL, 2006, CLIN EXP IMMUNOL, V145, P365, DOI 10.1111/j.1365-2249.2006.03125.x; HOWCROFT TK, 1993, EMBO J, V12, P3163, DOI 10.1002/j.1460-2075.1993.tb05985.x; Hwang SG, 2002, J BIOL CHEM, V277, P2923, DOI 10.1074/jbc.M109113200; Imamura T, 2006, J PEPT SCI, V12, P403, DOI 10.1002/psc.741; Kanodia S, 2007, CURR CANCER DRUG TAR, V7, P79, DOI 10.2174/156800907780006869; Karre K, 1997, IMMUNOL REV, V155, P5, DOI 10.1111/j.1600-065X.1997.tb00935.x; KEATING PJ, 1995, BRIT J CANCER, V72, P405, DOI 10.1038/bjc.1995.346; Koopman LA, 2000, J EXP MED, V191, P961, DOI 10.1084/jem.191.6.961; Li H, 2006, BIOCHEM BIOPH RES CO, V349, P1315, DOI 10.1016/j.bbrc.2006.08.182; Li H, 2009, BIOCHEM BIOPH RES CO, V388, P383, DOI 10.1016/j.bbrc.2009.08.019; Li JW, 2002, GENE DEV, V16, P687, DOI 10.1101/gad.962502; Liu X, 2006, J BIOL CHEM, V281, P578, DOI 10.1074/jbc.M508455200; LUTZ PM, 1987, IMMUNOGENETICS, V25, P228, DOI 10.1007/BF00404692; Massimi P, 1997, VIROLOGY, V227, P255, DOI 10.1006/viro.1996.8315; MEYER TH, 1994, FEBS LETT, V351, P443, DOI 10.1016/0014-5793(94)00908-2; MUNGER K, 1991, J VIROL, V65, P3943; NISHIDA M, 1995, MOL CARCINOGEN, V13, P157, DOI 10.1002/mc.2940130305; O'Brien PM, 2003, TRENDS MICROBIOL, V11, P300, DOI 10.1016/S0966-842X(03)00145-8; Ohlenschlager O, 2006, ONCOGENE, V25, P5953, DOI 10.1038/sj.onc.1209584; Orlando Valerio, 2002, Genes and Development, V16, P2039, DOI 10.1101/gad.1017402; Park JS, 2000, J BIOL CHEM, V275, P6764, DOI 10.1074/jbc.275.10.6764; Peaper DR, 2008, P NATL ACAD SCI USA, V105, P10477, DOI 10.1073/pnas.0805044105; PHELPS WC, 1988, CELL, V53, P539, DOI 10.1016/0092-8674(88)90570-3; Schapiro F, 2000, J CELL BIOL, V148, P305, DOI 10.1083/jcb.148.2.305; Spitkovsky D, 2002, J BIOL CHEM, V277, P25576, DOI 10.1074/jbc.M201884200; Stern PL, 1996, ADV CANCER RES, V69, P175, DOI 10.1016/S0065-230X(08)60863-5; STRAIGHT SW, 1995, J VIROL, V69, P3185, DOI 10.1128/JVI.69.5.3185-3192.1995; Suprynowicz FA, 2008, ONCOGENE, V27, P1071, DOI 10.1038/sj.onc.1210725; Vambutas A, 2004, J INFECT DIS, V189, P871, DOI 10.1086/381764; Vambutas A, 2001, CLIN IMMUNOL, V101, P94, DOI 10.1006/clim.2001.5094; VANENDERT PM, 1994, IMMUNITY, V1, P491, DOI 10.1016/1074-7613(94)90091-4; Vanhaecke T, 2004, BIOCHEM PHARMACOL, V68, P753, DOI 10.1016/j.bcp.2004.05.022; WILCZYNSKI SP, 1988, HUM PATHOL, V19, P697, DOI 10.1016/S0046-8177(88)80176-X; Williams DB, 1996, TRENDS CELL BIOL, V6, P267, DOI 10.1016/0962-8924(96)10020-9; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Zhang WH, 2001, J BIOL CHEM, V276, P40373, DOI 10.1074/jbc.C100505200; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4; Zhao BW, 2006, VIROLOGY, V352, P338, DOI 10.1016/j.virol.2006.04.036; zur Hausen H, 2000, JNCI-J NATL CANCER I, V92, P690, DOI 10.1093/jnci/92.9.690	68	23	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					10983	10997		10.1074/jbc.M110.199190	http://dx.doi.org/10.1074/jbc.M110.199190			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21321113	Green Published, hybrid			2022-12-27	WOS:000288797100010
J	Finigan, JH; Faress, JA; Wilkinson, E; Mishra, RS; Nethery, DE; Wyler, D; Shatat, M; Ware, LB; Matthay, MA; Mason, R; Silver, RF; Kern, JA				Finigan, James H.; Faress, Jihane A.; Wilkinson, Emily; Mishra, Rangnath S.; Nethery, David E.; Wyler, David; Shatat, Mohammad; Ware, Lorraine B.; Matthay, Michael A.; Mason, Robert; Silver, Richard F.; Kern, Jeffrey A.			Neuregulin-1-Human Epidermal Receptor-2 Signaling Is a Central Regulator of Pulmonary Epithelial Permeability and Acute Lung Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY-DISTRESS-SYNDROME; GROWTH-FACTOR RECEPTOR; CANCER CELL-LINES; EGF RECEPTOR; IN-VITRO; ALVEOLAR EPITHELIUM; CYSTIC-FIBROSIS; MICE LACKING; FACTOR-ALPHA; INTERLEUKIN-1	The mechanisms behind the loss of epithelial barrier function leading to alveolar flooding in acute lung injury (ALI) are incompletely understood. We hypothesized that the tyrosine kinase receptor human epidermal growth factor receptor-2 (HER2) would be activated in an inflammatory setting and participate in ALI. Interleukin-1 beta (IL-1 beta) exposure resulted in HER2 activation in human epithelial cells and markedly increased conductance across a monolayer of airway epithelial cells. Upon HER2 blockade, conductance changes were significantly decreased. Mechanistic studies revealed that HER2 trans-activation by IL-1 beta required a disintegrin and metalloprotease 17 (ADAM17)-dependent shedding of the ligand neuregulin-1 (NRG-1). In murine models of ALI, NRG-1-HER2 signaling was activated, and ADAM17 blockade resulted in decreased NRG-1 shedding, HER2 activation, and lung injury in vivo. Finally, NRG-1 was detectable and elevated in pulmonary edema fluid from patients with ALI. These results suggest that the ADAM17-NRG-1-HER2 axis modulates the alveolar epithelial barrier and contributes to the pathophysiology of ALI.	[Finigan, James H.; Mason, Robert; Kern, Jeffrey A.] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA; [Finigan, James H.; Faress, Jihane A.; Wilkinson, Emily; Mishra, Rangnath S.; Nethery, David E.; Wyler, David; Shatat, Mohammad; Silver, Richard F.] Case Western Reserve Univ, Dept Internal Med, Div Pulm Crit Care & Sleep Med, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Finigan, James H.; Faress, Jihane A.; Wilkinson, Emily; Mishra, Rangnath S.; Nethery, David E.; Wyler, David; Shatat, Mohammad; Silver, Richard F.] Case Western Reserve Univ, Louis Stokes Cleveland Vet Affairs Med Ctr, Cleveland, OH 44106 USA; [Ware, Lorraine B.] Vanderbilt Univ, Div Allergy Pulm & Crit Care Med, Dept Med, Sch Med, Nashville, TN 37232 USA; [Matthay, Michael A.] Univ Calif San Francisco, Res Inst, Dept Med, San Francisco, CA 94143 USA; [Matthay, Michael A.] Univ Calif San Francisco, Res Inst, Dept Anesthesia, San Francisco, CA 94143 USA	National Jewish Health; Case Western Reserve University; Case Western Reserve University Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Vanderbilt University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Finigan, JH (corresponding author), Natl Jewish Hlth, Dept Med, 1400 Jackson St,K736A, Denver, CO 80206 USA.	FiniganJ@NJHealth.org	Ware, Lorraine/AAJ-9307-2021	Ware, Lorraine/0000-0002-9429-4702; Kern, Jeffrey/0000-0001-9709-9622; Shatat, Mohammad/0000-0002-8715-6889	National Institutes of Health [HL075422, K08 HL086668, HL029891, HL51856, HL51854, HL081332, HL103836]; Veterans Affairs merit award; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL103836, R01HL051854, K08HL086668, R37HL051856, R01HL029891, R01HL051856, R01HL075422, U01HL081332, R37HL029891] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs merit award(US Department of Veterans Affairs); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL075422 (to J.A.K.), K08 HL086668 (to J.H.F.), HL029891 (to R.S.M.), HL51856 (to M.A.M.), HL51854 (to M.A.M.), HL081332 (to L.B.W.), and HL103836 (to L.B.W.). This work was also supported by Veterans Affairs merit awards (to J.A.K. and R.F.S.) and an American Heart Association established investigator award (to L.B.W.).	Bhandari V, 2006, NAT MED, V12, P1286, DOI 10.1038/nm1494; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blobel CR, 2009, EXP CELL RES, V315, P671, DOI 10.1016/j.yexcr.2008.10.011; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Burden-Gulley SM, 1999, J CELL BIOL, V144, P1323, DOI 10.1083/jcb.144.6.1323; Carpenter G, 1999, J CELL BIOL, V146, P697, DOI 10.1083/jcb.146.4.697; Faress JA, 2007, J APPL PHYSIOL, V103, P2077, DOI 10.1152/japplphysiol.00239.2007; Frank JA, 2008, THORAX, V63, P147, DOI 10.1136/thx.2007.079608; Ganter MT, 2008, CIRC RES, V102, P804, DOI 10.1161/CIRCRESAHA.107.161067; Gasse P, 2007, J CLIN INVEST, V117, P3786, DOI 10.1172/JCI32285; Gollamudi M, 2004, LUNG CANCER, V43, P135, DOI 10.1016/j.lungcan.2003.08.027; GORIN AB, 1979, J APPL PHYSIOL, V47, P1315, DOI 10.1152/jappl.1979.47.6.1315; Goto Y, 2000, AM J RESP CELL MOL, V23, P712, DOI 10.1165/ajrcmb.23.6.4031; HOLMES WE, 1992, SCIENCE, V256, P1205, DOI 10.1126/science.256.5060.1205; Hoshino T, 2009, AM J RESP CELL MOL, V41, P661, DOI 10.1165/rcmb.2008-0182OC; HUDSON LD, 1995, AM J RESP CRIT CARE, V151, P293, DOI 10.1164/ajrccm.151.2.7842182; INOUE S, 1976, J ULTRA MOL STRUCT R, V56, P215, DOI 10.1016/S0022-5320(76)80167-0; Iwamoto R, 2003, P NATL ACAD SCI USA, V100, P3221, DOI 10.1073/pnas.0537588100; Jackson LF, 2003, EMBO J, V22, P2704, DOI 10.1093/emboj/cdg264; KERN JA, 1992, AM J RESP CELL MOL, V6, P359, DOI 10.1165/ajrcmb/6.4.359; Kolb M, 2001, J CLIN INVEST, V107, P1529, DOI 10.1172/JCI12568; LUETTEKE NC, 1993, CELL GROWTH DIFFER, V4, P203; MANN GB, 1993, CELL, V73, P249, DOI 10.1016/0092-8674(93)90227-H; Mato N, 2009, EUR RESPIR J, V33, P1415, DOI 10.1183/09031936.00084307; MATTHAY MA, 1994, CHEST, V105, pS67, DOI 10.1378/chest.105.3_Supplement.67S; MIETTINEN PJ, 1995, NATURE, V376, P337, DOI 10.1038/376337a0; Modelska K, 1999, AM J RESP CRIT CARE, V160, P1450, DOI 10.1164/ajrccm.160.5.9901096; Nethery DE, 2005, J APPL PHYSIOL, V99, P298, DOI 10.1152/japplphysiol.01360.2004; Ohtsu H, 2006, AM J PHYSIOL-CELL PH, V291, pC1, DOI 10.1152/ajpcell.00620.2005; Olman MA, 2004, J IMMUNOL, V172, P2668, DOI 10.4049/jimmunol.172.4.2668; Ortiz LA, 2007, P NATL ACAD SCI USA, V104, P11002, DOI 10.1073/pnas.0704421104; Park WY, 2001, AM J RESP CRIT CARE, V164, P1896, DOI 10.1164/ajrccm.164.10.2104013; Patel AS, 1998, ONCOGENE, V16, P3227, DOI 10.1038/sj.onc.1201850; Patel NV, 2000, AM J RESP CELL MOL, V22, P432, DOI 10.1165/ajrcmb.22.4.3854; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; PITTET JF, 1995, AM J RESP CRIT CARE, V151, P1093; Pugin J, 1996, AM J RESP CRIT CARE, V153, P1850, DOI 10.1164/ajrccm.153.6.8665045; Qiu Y, 1998, NATURE, V393, P83, DOI 10.1038/30012; Roupie E, 1999, INTENS CARE MED, V25, P920, DOI 10.1007/s001340050983; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Shah BH, 2004, MOL ENDOCRINOL, V18, P2035, DOI 10.1210/me.2003-0476; Shimabukuro DW, 2003, CRIT CARE MED, V31, pS524, DOI 10.1097/01.CCM.0000081437.06466.B3; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; SILER TM, 1989, EXP LUNG RES, V15, P881, DOI 10.3109/01902148909069633; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLIWKOWSKI MX, 1994, J BIOL CHEM, V269, P14661; SOBONYA RE, 1986, AM REV RESPIR DIS, V134, P290; Sternlicht MD, 2005, DEVELOPMENT, V132, P3923, DOI 10.1242/dev.01966; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Vermeer PD, 2003, NATURE, V422, P322, DOI 10.1038/nature01440; Wang JR, 2007, AM J RESP CELL MOL, V36, P661, DOI 10.1165/rcmb.2006-0410OC; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Ware LB, 2001, AM J RESP CRIT CARE, V163, P1376, DOI 10.1164/ajrccm.163.6.2004035; Wheeler AP, 1999, NEW ENGL J MED, V340, P207, DOI 10.1056/NEJM199901213400307; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zabner J, 2003, AM J PHYSIOL-LUNG C, V284, pL844, DOI 10.1152/ajplung.00355.2002	59	36	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10660	10670		10.1074/jbc.M110.208041	http://dx.doi.org/10.1074/jbc.M110.208041			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21247898	Green Published, hybrid			2022-12-27	WOS:000288547000080
J	Liebminger, E; Veit, C; Pabst, M; Batoux, M; Zipfel, C; Altmann, F; Mach, L; Strasser, R				Liebminger, Eva; Veit, Christiane; Pabst, Martin; Batoux, Martine; Zipfel, Cyril; Altmann, Friedrich; Mach, Lukas; Strasser, Richard			beta-N-Acetylhexosaminidases HEXO1 and HEXO3 Are Responsible for the Formation of Paucimannosidic N-Glycans in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORE ALPHA-1,3-LINKED FUCOSE; LC-ESI-MS; LINKED OLIGOSACCHARIDES; MONOCLONAL-ANTIBODY; PLANT IMMUNITY; RECEPTOR EFR; GLYCOSYLATION; CELLS; EXPRESSION; XYLOSE	Most plant glycoproteins contain substantial amounts of paucimannosidic N-glycans instead of their direct biosynthetic precursors, complex N-glycans with terminal N-acetylglucosamine residues. We now demonstrate that two beta-N-acetylhexosaminidases (HEXO1 and HEXO3) residing in different subcellular compartments jointly account for the formation of paucimannosidic N-glycans in Arabidopsis thaliana. Total N-glycan analysis of hexo knock-out plants revealed that HEXO1 and HEXO3 contribute equally to the production of paucimannosidic N-glycans in roots, whereas N-glycan processing in leaves depends more heavily on HEXO3 than on HEXO1. Because hexo1 hexo3 double mutants do not display any obvious phenotype even upon exposure to different forms of abiotic or biotic stress, it should be feasible to improve the quality of glycoprotein therapeutics produced in plants by down-regulation of endogenous beta-N-acetylhexosaminidase activities.	[Liebminger, Eva; Veit, Christiane; Mach, Lukas; Strasser, Richard] Univ Nat Resources & Life Sci, Dept Appl Genet & Cell Biol, A-1190 Vienna, Austria; [Pabst, Martin; Altmann, Friedrich] Univ Nat Resources & Life Sci, Dept Chem, A-1190 Vienna, Austria; [Batoux, Martine; Zipfel, Cyril] Sainsbury Lab, Norwich NR4 7UH, Norfolk, England	University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Strasser, R (corresponding author), Univ Nat Resources & Life Sci, Dept Appl Genet & Cell Biol, A-1190 Vienna, Austria.	richard.strasser@boku.ac.at	Strasser, Richard/AAD-2916-2020; ZIPFEL, CYRIL/ABD-5076-2021; ZIPFEL, CYRIL B/D-7103-2011; Pabst, Martin/GOH-1766-2022	ZIPFEL, CYRIL/0000-0003-4935-8583; ZIPFEL, CYRIL B/0000-0003-4935-8583; Pabst, Martin/0000-0001-9897-0723; Strasser, Richard/0000-0001-8764-6530; Altmann, Friedrich/0000-0002-0112-7877; Mach, Lukas/0000-0001-9013-5408	Austrian Science Fund [P19092, P20817]; Gatsby Charitable Foundation; BBSRC [BB/E024874/1] Funding Source: UKRI; Austrian Science Fund (FWF) [P 20817] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/E024874/1] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Gatsby Charitable Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Austrian Science Fund Grants P19092 and P20817. Research in the Zipfel laboratory is supported by the Gatsby Charitable Foundation.	ALTMANN F, 1995, J BIOL CHEM, V270, P17344, DOI 10.1074/jbc.270.29.17344; Bakker H, 2001, P NATL ACAD SCI USA, V98, P2899, DOI 10.1073/pnas.031419998; Boudart G, 2005, PROTEOMICS, V5, P212, DOI 10.1002/pmic.200400882; Butaye KMJ, 2004, PLANT J, V39, P440, DOI 10.1111/j.1365-313X.2004.02144.x; Castilho A, 2010, J BIOL CHEM, V285, P15923, DOI 10.1074/jbc.M109.088401; Chinchilla D, 2006, PLANT CELL, V18, P465, DOI 10.1105/tpc.105.036574; Cox KM, 2006, NAT BIOTECHNOL, V24, P1591, DOI 10.1038/nbt1260; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; Dirnberger D, 2001, EUR J BIOCHEM, V268, P4570, DOI 10.1046/j.1432-1327.2001.02384.x; Fitchette-Laine AC, 1997, PLANT J, V12, P1411, DOI 10.1046/j.1365-313x.1997.12061411.x; Forthal DN, 2010, J IMMUNOL, V185, P6876, DOI 10.4049/jimmunol.1002600; Frey AD, 2009, PLANT BIOTECHNOL J, V7, P33, DOI 10.1111/j.1467-7652.2008.00370.x; Haweker H, 2010, J BIOL CHEM, V285, P4629, DOI 10.1074/jbc.M109.063073; Hartweck LM, 2002, GENETICS, V161, P1279; Jin CS, 2006, GLYCOBIOLOGY, V16, P349, DOI 10.1093/glycob/cwj071; Kang JS, 2008, P NATL ACAD SCI USA, V105, P5933, DOI 10.1073/pnas.0800237105; Karg SR, 2010, J BIOTECHNOL, V146, P54, DOI 10.1016/j.jbiotec.2010.01.005; Kobae Y, 2006, BIOSCI BIOTECH BIOCH, V70, P980, DOI 10.1271/bbb.70.980; Koprivova A, 2004, PLANT BIOTECHNOL J, V2, P517, DOI 10.1111/j.1467-7652.2004.00100.x; Lerouge P, 1998, PLANT MOL BIOL, V38, P31, DOI 10.1023/A:1006012005654; Liebminger E, 2009, PLANT CELL, V21, P3850, DOI 10.1105/tpc.109.072363; Lu X, 2009, P NATL ACAD SCI USA, V106, P22522, DOI 10.1073/pnas.0907711106; Nekrasov V, 2009, EMBO J, V28, P3428, DOI 10.1038/emboj.2009.262; Pabst M, 2007, ANAL CHEM, V79, P5051, DOI 10.1021/ac070363i; Palacpac NQ, 1999, P NATL ACAD SCI USA, V96, P4692, DOI 10.1073/pnas.96.8.4692; Rouwendal GJA, 2007, GLYCOBIOLOGY, V17, P334, DOI 10.1093/glycob/cwl078; Schoberer J, 2009, TRAFFIC, V10, P101, DOI 10.1111/j.1600-0854.2008.00841.x; Stadlmann J, 2008, PROTEOMICS, V8, P2858, DOI 10.1002/pmic.200700968; Strasser R, 1999, GLYCOCONJUGATE J, V16, P787, DOI 10.1023/A:1007127815012; Strasser R, 2004, FEBS LETT, V561, P132, DOI 10.1016/S0014-5793(04)00150-4; Strasser R, 2008, PLANT BIOTECHNOL J, V6, P392, DOI 10.1111/j.1467-7652.2008.00330.x; Strasser R, 2007, PLANT PHYSIOL, V145, P5, DOI 10.1104/pp.107.101162; Strasser R, 2009, J BIOL CHEM, V284, P20479, DOI 10.1074/jbc.M109.014126; STURM A, 1991, EUR J BIOCHEM, V199, P169, DOI 10.1111/j.1432-1033.1991.tb16106.x; Suga S, 2001, PLANTA, V212, P294, DOI 10.1007/s004250000396; TAKAHASHI N, 1986, BIOCHEMISTRY-US, V25, P388, DOI 10.1021/bi00350a018; Thornton TM, 1999, TRENDS PLANT SCI, V4, P424, DOI 10.1016/S1360-1385(99)01485-5; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wilson IBH, 2001, GLYCOBIOLOGY, V11, P261, DOI 10.1093/glycob/11.4.261; Zeleny R, 2006, PLANTA, V224, P222, DOI 10.1007/s00425-005-0206-8; Zhu KY, 1996, PLANT PHYSIOL, V110, P195, DOI 10.1104/pp.110.1.195; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	42	57	62	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10793	10802		10.1074/jbc.M110.178020	http://dx.doi.org/10.1074/jbc.M110.178020			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21252225	Green Published, hybrid			2022-12-27	WOS:000288547000093
J	Chen, XP; Zhao, YF; Guo, ZM; Zhou, LC; Okoro, EU; Yang, H				Chen, Xinping; Zhao, Yanfeng; Guo, Zhongmao; Zhou, Lichun; Okoro, Emmanuel U.; Yang, Hong			Transcriptional Regulation of ATP-binding Cassette Transporter A1 Expression by a Novel Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-C-ZETA; CHOLESTEROL EFFLUX; X-RECEPTOR; TANGIER-DISEASE; IN-VITRO; GENE; INHIBITOR; 3-KINASE; ABCA1; ATHEROSCLEROSIS	ATP-binding cassette transporter A1 (ABCA1) is a membrane- bound protein that regulates the efflux of cholesterol derived from internalized lipoproteins. Using a mouse macrophage cell line, this report studied the impact of low-density lipoproteins (LDL) on ABCA1 expression and the signaling pathway responsible for lipoprotein-induced ABCA1 expression. Our data demonstrated that treatment of macrophages with LDL increased ABCA1 mRNA and protein levels 4.3- and 3.5-fold, respectively. LDL also induced an similar to 2-fold increase in macrophage surface expression of ABCA1 and a 14-fold-increase in apolipoprotein AI-mediated cholesterol efflux. In addition, LDL significantly increased the level of phosphorylated specificity protein 1 (Sp1) and the amount of Sp1 bound to the ABCA1 promoter without alteration in total Sp1 protein level. Mutation of the Sp1 binding site in the ABCA1 promoter and inhibition of Sp1 DNA binding with mithramycin A suppressed the ABCA1 promoter activity and reduced the ABCA1 expression level induced by LDL. LDL treatment also elevated protein kinase C-zeta (PKC-zeta) phosphorylation and induced PKC-zeta binding with Sp1. Inhibition of PKC-zeta with kinase inhibitors or overexpression of kinase-dead PKC-zeta attenuated Sp1 phosphorylation and ABCA1 expression induced by LDL. These results demonstrate for the first time that activation of the PKC zeta-Sp1 signaling cascade is a mechanism for regulation of LDL-induced ABCA1 expression.	[Chen, Xinping; Guo, Zhongmao; Zhou, Lichun; Okoro, Emmanuel U.; Yang, Hong] Meharry Med Coll, Dept Physiol, Nashville, TN 37208 USA; [Zhao, Yanfeng] Wuhan Univ, Sch Basic Med Sci, Wuhan 430071, Peoples R China	Meharry Medical College; Wuhan University	Yang, H (corresponding author), Meharry Med Coll, Dept Physiol, Nashville, TN 37208 USA.	hyang@mmc.edu			National Institutes of Health [R01ES014471, R01HL089382, SC1HL101431, U54RR026140]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR026140] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [SC1HL101431, R01HL089382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014472] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported, in whole or in part, by National Institutes of Health Grants R01ES014471 and R01HL089382 (to Z. G.) and SC1HL101431 and U54RR026140 (to H. Y.).	BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Chen W, 2001, J BIOL CHEM, V276, P43564, DOI 10.1074/jbc.M107938200; CHISOLM GM, 1996, ATHEROSCLEROSIS CORO, P129; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Costet P, 2000, J BIOL CHEM, V275, P28240; Dove DE, 2005, ARTERIOSCL THROM VAS, V25, P128, DOI 10.1161/01.ATV.0000148323.94021.e5; Geeraert B, 2007, J THROMB HAEMOST, V5, P2529, DOI 10.1111/j.1538-7836.2007.02786.x; Guo M, 2000, BIOCHEM PHARMACOL, V60, P635, DOI 10.1016/S0006-2952(00)00379-8; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; Linton MF, 2003, INT J OBESITY, V27, pS35, DOI 10.1038/sj.ijo.0802498; Marampon F, 2009, MOL CANCER THER, V8, P543, DOI 10.1158/1535-7163.MCT-08-0570; Orso E, 2000, NAT GENET, V24, P192, DOI 10.1038/72869; Reamon-Buettner SM, 2008, CANCER RES, V68, P7587, DOI 10.1158/0008-5472.CAN-08-0967; Repa JJ, 2002, NAT MED, V8, P1243, DOI 10.1038/nm1102-1243; Shenoy NG, 2003, J IMMUNOL, V171, P3734, DOI 10.4049/jimmunol.171.7.3734; Singaraja RR, 2002, J CLIN INVEST, V110, P35, DOI 10.1172/JCI200215748; Tang TA, 2010, FREE RADICAL BIO MED, V49, P487, DOI 10.1016/j.freeradbiomed.2010.05.007; Thymiakou E, 2007, BIOCHEMISTRY-US, V46, P11473, DOI 10.1021/bi700994m; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Van Eck M, 2006, ARTERIOSCL THROM VAS, V26, P929, DOI 10.1161/01.ATV.0000208364.22732.16; Van Eck M, 2002, P NATL ACAD SCI USA, V99, P6298, DOI 10.1073/pnas.092327399; Wang N, 2003, ARTERIOSCL THROM VAS, V23, P1178, DOI 10.1161/01.ATV.0000075912.83860.26; Wang ZF, 2009, FREE RADICAL BIO MED, V47, P1221, DOI 10.1016/j.freeradbiomed.2009.08.001; Wu DF, 2007, J LIPID RES, V48, P2571, DOI 10.1194/jlr.M700217-JLR200; Yang H, 2003, FREE RADICAL BIO MED, V35, P266, DOI 10.1016/S0891-5849(03)00277-6; Yu JH, 1999, J BIOL CHEM, V274, P34327, DOI 10.1074/jbc.274.48.34327; Zhu Y, 2005, CARDIOVASC RES, V68, P425, DOI 10.1016/j.cardiores.2005.07.003	29	27	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8917	8923		10.1074/jbc.M110.214429	http://dx.doi.org/10.1074/jbc.M110.214429			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21257755	Green Published, hybrid			2022-12-27	WOS:000288247700023
J	El Moustaine, D; Perrier, V; Van Ba, IAT; Meersman, F; Ostapchenko, VG; Baskakov, IV; Lange, R; Torrent, J				El Moustaine, Driss; Perrier, Veronique; Van Ba, Isabelle Acquatella-Tran; Meersman, Filip; Ostapchenko, Valeriy G.; Baskakov, Ilia V.; Lange, Reinhard; Torrent, Joan			Amyloid Features and Neuronal Toxicity of Mature Prion Fibrils Are Highly Sensitive to High Pressure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREUTZFELDT-JAKOB-DISEASE; P COMPONENT SCINTIGRAPHY; PROTEINASE-K RESISTANCE; ALZHEIMERS-DISEASE; IN-VITRO; CRYOELECTRON MICROSCOPY; STRUCTURAL POLYMORPHISM; INDUCED DISSOCIATION; TRANSITION-STATE; ALPHA-SYNUCLEIN	Prion proteins (PrP) can aggregate into toxic and possibly infectious amyloid fibrils. This particular macrostructure confers on them an extreme and still unexplained stability. To provide mechanistic insights into this self-assembly process, we used high pressure as a thermodynamic tool for perturbing the structure of mature amyloid fibrils that were prepared from recombinant full-length mouse PrP. Application of high pressure led to irreversible loss of several specific amyloid features, such as thioflavin T and 8-anilino-1-naphthalene sulfonate binding, alteration of the characteristic proteinase K digestion pattern, and a significant decrease in the beta-sheet structure and cytotoxicity of amyloid fibrils. Partial disaggregation of the mature fibrils into monomeric soluble PrP was observed. The remaining amyloid fibrils underwent a change in secondary structure that led to morphologically different fibrils composed of a reduced number of proto-filaments. The kinetics of these reactions was studied by recording the pressure-induced dissociation of thioflavin T from the amyloid fibrils. Analysis of the pressure and temperature dependence of the relaxation rates revealed partly unstructured and hydrated kinetic transition states and highlighted the importance of collapsing and hydrating inter- and intramolecular cavities to overcome the high free energy barrier that stabilizes amyloid fibrils.	[Torrent, Joan] Univ Montpellier 2, INSERM U710, CC 105, F-34095 Montpellier 5, France; [El Moustaine, Driss; Perrier, Veronique; Van Ba, Isabelle Acquatella-Tran; Lange, Reinhard; Torrent, Joan] Ecole Prat Hautes Etud, F-75007 Paris, France; [Meersman, Filip] Katholieke Univ Leuven, Dept Chem, B-3001 Louvain, Belgium; [Ostapchenko, Valeriy G.; Baskakov, Ilia V.] Univ Maryland, Dept Anat & Neurobiol, Sch Med, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); KU Leuven; University System of Maryland; University of Maryland Baltimore	Torrent, J (corresponding author), Univ Montpellier 2, INSERM U710, CC 105, Pl Eugene Bataillon, F-34095 Montpellier 5, France.	joan.torrent@inserm.fr	Perrier, Veronique/AAK-3594-2020	TORRENT, Joan/0000-0002-6908-4084; Ostapchenko, Valeriy/0000-0002-3629-7702; perrier, veronique/0000-0002-6570-7504	National Institutes of Health [NS045585]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045585] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS045585 (to I. V. B.).	Aguzzi A, 2008, ANNU REV PATHOL-MECH, V3, P11, DOI 10.1146/annurev.pathmechdis.3.121806.154326; Akasaka K, 2007, BIOCHEMISTRY-US, V46, P10444, DOI 10.1021/bi700648b; Alvarez-Martinez MT, 2003, BBA-PROTEINS PROTEOM, V1645, P228, DOI 10.1016/S1570-9639(02)00536-8; BAUER HH, 1995, J STRUCT BIOL, V115, P1, DOI 10.1006/jsbi.1995.1024; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Bocharova OV, 2006, J BIOL CHEM, V281, P2373, DOI 10.1074/jbc.M510840200; Bocharova OV, 2005, PROTEIN SCI, V14, P1222, DOI 10.1110/ps.041186605; Breydo Leonid, 2008, V459, P105, DOI 10.1007/978-1-59745-234-2_8; Brown P, 2003, P NATL ACAD SCI USA, V100, P6093, DOI 10.1073/pnas.1031826100; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Calamai M, 2005, J MOL BIOL, V346, P603, DOI 10.1016/j.jmb.2004.11.067; Callahan NA, 2001, J BIOL CHEM, V276, P28022, DOI 10.1074/jbc.M103629200; Carulla N, 2005, NATURE, V436, P554, DOI 10.1038/nature03986; Chatani E, 2005, J MOL BIOL, V352, P941, DOI 10.1016/j.jmb.2005.07.043; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Cordeiro Y, 2004, J BIOL CHEM, V279, P32354, DOI 10.1074/jbc.M404295200; Dirix C, 2005, J MOL BIOL, V347, P903, DOI 10.1016/j.jmb.2005.01.073; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; El Moustaine D, 2008, FEBS J, V275, P2021, DOI 10.1111/j.1742-4658.2008.06356.x; Esler WP, 2000, BIOCHEMISTRY-US, V39, P6288, DOI 10.1021/bi992933h; Fandrich M, 2007, CELL MOL LIFE SCI, V64, P2066, DOI 10.1007/s00018-007-7110-2; Fandrich M, 2002, EMBO J, V21, P5682, DOI 10.1093/emboj/cdf573; Fandrich M, 2009, PRION, V3, P89; Fernandez-Busquets X, 2008, CURR MED CHEM, V15, P1336, DOI 10.2174/092986708784534938; Foguel D, 2003, P NATL ACAD SCI USA, V100, P9831, DOI 10.1073/pnas.1734009100; Font J, 2006, BIOPHYS J, V91, P2264, DOI 10.1529/biophysj.106.082552; Forst P, 2000, RHEOL ACTA, V39, P566, DOI 10.1007/s003970000114; Garcia AF, 2004, J GEN VIROL, V85, P261, DOI 10.1099/vir.0.19410-0; Gharibyan AL, 2007, J MOL BIOL, V365, P1337, DOI 10.1016/j.jmb.2006.10.101; Gobbi M, 2006, J BIOL CHEM, V281, P843, DOI 10.1074/jbc.M506164200; Goldsbury CS, 1997, J STRUCT BIOL, V119, P17, DOI 10.1006/jsbi.1997.3858; Grudzielanek S, 2006, J MOL BIOL, V356, P497, DOI 10.1016/j.jmb.2005.11.075; Harper JD, 1997, CHEM BIOL, V4, P951, DOI 10.1016/S1074-5521(97)90303-3; HAWKINS PN, 1993, ARTHRITIS RHEUM, V36, P842, DOI 10.1002/art.1780360616; HAWKINS PN, 1993, Q J MED, V86, P365; Heindl P, 2005, BRAZ J MED BIOL RES, V38, P1223, DOI 10.1590/S0100-879X2005000800010; James TL, 1997, P NATL ACAD SCI USA, V94, P10086, DOI 10.1073/pnas.94.19.10086; Jimenez JL, 1999, EMBO J, V18, P815, DOI 10.1093/emboj/18.4.815; Jimenez JL, 2002, P NATL ACAD SCI USA, V99, P9196, DOI 10.1073/pnas.142459399; Jimenez JL, 2001, J MOL BIOL, V311, P241, DOI 10.1006/jmbi.2001.4863; Kamatari YO, 2005, J MOL BIOL, V349, P916, DOI 10.1016/j.jmb.2005.04.010; Langkilde AE, 2009, FEBS LETT, V583, P2600, DOI 10.1016/j.febslet.2009.05.040; Latif ARA, 2007, BIOPHYS J, V92, P323, DOI 10.1529/biophysj.106.088120; Laurine E, 2003, J BIOL CHEM, V278, P51770, DOI 10.1074/jbc.M306767200; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Loksztejn A, 2009, BIOCHEMISTRY-US, V48, P4846, DOI 10.1021/bi900394b; MacPhee CE, 2000, J MOL BIOL, V297, P1203, DOI 10.1006/jmbi.2000.3600; Madine J, 2008, J AM CHEM SOC, V130, P14990, DOI 10.1021/ja802483d; MAGGIO JE, 1992, P NATL ACAD SCI USA, V89, P5462, DOI 10.1073/pnas.89.12.5462; Makarava N, 2010, ACTA NEUROPATHOL, V119, P177, DOI 10.1007/s00401-009-0633-x; Meersman F, 2006, BBA-PROTEINS PROTEOM, V1764, P452, DOI 10.1016/j.bbapap.2005.10.021; Meersman F, 2003, BIOPHYS CHEM, V104, P297, DOI 10.1016/S0301-4622(02)00385-X; Meinhardt J, 2009, J MOL BIOL, V386, P869, DOI 10.1016/j.jmb.2008.11.005; Merzel F, 2002, P NATL ACAD SCI USA, V99, P5378, DOI 10.1073/pnas.082335099; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Milhiet PE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013240; Mishra R, 2008, ANGEW CHEM INT EDIT, V47, P6518, DOI 10.1002/anie.200802027; Morel B, 2010, J PHYS CHEM B, V114, P4010, DOI 10.1021/jp9102993; Niraula TN, 2004, P NATL ACAD SCI USA, V101, P4089, DOI 10.1073/pnas.0305798101; Novitskaya V, 2006, J BIOL CHEM, V281, P13828, DOI 10.1074/jbc.M511174200; Novitskaya V, 2006, J BIOL CHEM, V281, P15536, DOI 10.1074/jbc.M601349200; Ostapchenko VG, 2010, J MOL BIOL, V400, P908, DOI 10.1016/j.jmb.2010.05.051; Pace CN, 2009, NAT STRUCT MOL BIOL, V16, P681, DOI 10.1038/nsmb0709-681; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Pedersen JS, 2006, J MOL BIOL, V355, P501, DOI 10.1016/j.jmb.2005.09.100; Pertinhez TA, 2001, FEBS LETT, V495, P184, DOI 10.1016/S0014-5793(01)02384-5; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Pieri L, 2006, J BIOL CHEM, V281, P15337, DOI 10.1074/jbc.M511647200; Rezaei H, 2000, EUR J BIOCHEM, V267, P2833, DOI 10.1046/j.1432-1033.2000.01347.x; Rydh A, 1998, EUR J NUCL MED, V25, P709; Silva JL, 2010, ACCOUNTS CHEM RES, V43, P271, DOI 10.1021/ar900179t; Silva JL, 2001, TRENDS BIOCHEM SCI, V26, P612, DOI 10.1016/S0968-0004(01)01949-1; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; Takeda T, 2008, BIOPHYS J, V95, P1758, DOI 10.1529/biophysj.108.131698; Tan SY, 1996, KIDNEY INT, V50, P282, DOI 10.1038/ki.1996.313; Torrent J, 2006, BBA-PROTEINS PROTEOM, V1764, P489, DOI 10.1016/j.bbapap.2006.01.002; Torrent J, 2005, PROTEIN SCI, V14, P956, DOI 10.1110/ps.04989405; Torrent J, 2004, BIOCHEMISTRY-US, V43, P7162, DOI 10.1021/bi049939d; Torrent J, 2003, BIOCHEMISTRY-US, V42, P1318, DOI 10.1021/bi0269916; VANELDIK R, 1989, CHEM REV, V89, P549, DOI 10.1021/cr00093a005; VIDUGIRIS GJA, 1995, BIOCHEMISTRY-US, V34, P4909, DOI 10.1021/bi00015a001; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Woenckhaus J, 2001, BIOPHYS J, V80, P1518, DOI 10.1016/S0006-3495(01)76124-3	84	18	18	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13448	13459		10.1074/jbc.M110.192872	http://dx.doi.org/10.1074/jbc.M110.192872			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21357423	Green Published, hybrid			2022-12-27	WOS:000289282200065
J	Jeyakunnar, M; Carlson, KE; Gunther, JR; Katzenellenbogen, JA				Jeyakunnar, M.; Carlson, Kathryn E.; Gunther, Jillian R.; Katzenellenbogen, John A.			Exploration of Dimensions of Estrogen Potency PARSING LIGAND BINDING AND COACTIVATOR BINDING AFFINITIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-ALPHA; TISSUE-SPECIFICITY; NUCLEAR RECEPTOR; PHARMACOLOGY; SELECTIVITY; ANTAGONISM; METABOLISM; GENISTEIN; BETA; KEY	The estrogen receptors, ER alpha and ER beta, are ligand-regulated transcription factors that control gene expression programs in target tissues. The molecular events underlying estrogen action involve minimally two steps, hormone binding to the ER ligand-binding domain followed by coactiyator recruitment to the ER.ligand complex; this ligand.receptor.coactivator triple complex then alters gene expression. Conceptually, the potency of an estrogen in activating a cellular response should reflect the affinities that characterize both steps involved in the assembly of the active ligand.receptor.coactivator complex. Thus, to better understand the molecular basis of estrogen potency, we developed a completely in vitro system (using radiometric and time-resolved FRET assays) to quantify independently three parameters: (a) the affinity of ligand binding to ER, (b) the affinity of coactivator binding to the ER.ligand complex, and (c) the potency of ligand recruitment of coactivator. We used this system to characterize the binding and potency of 12 estrogens with both ER alpha and ER beta. Some ligands showed good correlations between ligand binding affinity, coactivator binding affinity, and coactivator recruitment potency with both ERs, whereas others showed correlations with only one ER subtype or displayed discordant coactivator recruitment potencies. When ligands with low receptor binding affinity but high coactivator recruitment potencies to ER beta were evaluated in cell-based assays, elevation of cellular coactivator levels significantly and selectively improved their potency. Collectively, our results indicate that some low affinity estrogens may elicit greater cellular responses in those target cells that express higher levels of specific coactivators capable of binding to their ER complexes with high affinity.	[Jeyakunnar, M.; Carlson, Kathryn E.; Gunther, Jillian R.; Katzenellenbogen, John A.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Katzenellenbogen, JA (corresponding author), Univ Illinois, Dept Chem, 600 S Mathews Ave, Urbana, IL 61801 USA.	jkatzene@uiuc.edu			National Institutes of Health [R37 DK015556, P01 AG024387, P50 AT006268]; National Research Service Awards [F30 ES016484-01, T32 GM070421]; National Center for Complementary & Integrative Health [P50AT006268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK015556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F30ES016484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM070421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG024387] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Awards(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R37 DK015556, P01 AG024387, and P50 AT006268 (to J. A. K.). This work was also supported by National Research Service Awards F30 ES016484-01 and T32 GM070421 (to J. R. G.).	Barkhem T, 1998, MOL PHARMACOL, V54, P105, DOI 10.1124/mol.54.1.105; Berrodin TJ, 2009, MOL ENDOCRINOL, V23, P74, DOI 10.1210/me.2008-0366; Bhavnani BR, 2008, ENDOCRINOLOGY, V149, P4857, DOI 10.1210/en.2008-0304; Bramlett KS, 2001, MOL ENDOCRINOL, V15, P909, DOI 10.1210/me.15.6.909; Brawer Michael K, 2006, Rev Urol, V8 Suppl 2, pS35; Check J H, 2006, Clin Exp Obstet Gynecol, V33, P71; Check M L, 2004, Clin Exp Obstet Gynecol, V31, P299; Dai SY, 2008, P NATL ACAD SCI USA, V105, P7171, DOI 10.1073/pnas.0710802105; Dai SY, 2009, BIOCHEMISTRY-US, V48, P9668, DOI 10.1021/bi901149t; Escande A, 2006, BIOCHEM PHARMACOL, V71, P1459, DOI 10.1016/j.bcp.2006.02.002; Gee AC, 1999, MOL ENDOCRINOL, V13, P1912, DOI 10.1210/me.13.11.1912; Grow DR, 2002, OBSTET GYN CLIN N AM, V29, P425, DOI 10.1016/S0889-8545(02)00009-8; Gunther JR, 2009, J BIOMOL SCREEN, V14, P181, DOI 10.1177/1087057108329349; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Hsieh RW, 2008, STEROIDS, V73, P59, DOI 10.1016/j.steroids.2007.08.014; Iannone MA, 2004, MOL ENDOCRINOL, V18, P1064, DOI 10.1210/me.2003-0432; Jeyakumar M, 2008, BIOCHEMISTRY-US, V47, P7465, DOI 10.1021/bi800393u; KILBOURN MR, 1981, MOL PHARMACOL, V19, P388; Kim SH, 2005, MOL CELL PROTEOMICS, V4, P267, DOI 10.1074/mcp.M400192-MCP200; Kim SH, 2004, J AM CHEM SOC, V126, P4754, DOI 10.1021/ja039586q; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Lascombe I, 2000, ENVIRON HEALTH PERSP, V108, P621, DOI 10.2307/3434882; Liu JW, 2003, MOL ENDOCRINOL, V17, P346, DOI 10.1210/me.2002-0331; Marini H, 2007, ANN INTERN MED, V146, P839, DOI 10.7326/0003-4819-146-12-200706190-00005; MINUTOLO F, 2009, MED RES REV MED; Monroe DG, 2003, J ENDOCRINOL, V176, P349, DOI 10.1677/joe.0.1760349; Nettles KW, 2004, MOL CELL, V13, P317, DOI 10.1016/S1097-2765(04)00054-1; Ruggiero RJ, 2002, J MIDWIFERY WOM HEAL, V47, P130, DOI 10.1016/S1526-9523(02)00233-7; SASSON S, 1988, MOL ENDOCRINOL, V2, P307, DOI 10.1210/mend-2-4-307; Scherr DS, 2003, J UROLOGY, V170, P1703, DOI 10.1097/01.ju.0000077558.48257.3d; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Smith CL, 2004, ENDOCR REV, V25, P45, DOI 10.1210/er.2003-0023; Tamrazi A, 2005, MOL ENDOCRINOL, V19, P1516, DOI 10.1210/me.2004-0458; Tamrazi A, 2003, MOL ENDOCRINOL, V17, P2593, DOI 10.1210/me.2003-0239; Tamrazi A, 2002, MOL ENDOCRINOL, V16, P2706, DOI 10.1210/me.2002-0250; Walf AA, 2008, NEUROREPORT, V19, P789, DOI 10.1097/WNR.0b013e3282fe209c; Williamson-Hughes PS, 2006, MENOPAUSE, V13, P831, DOI 10.1097/01.gme.0000227330.49081.9e; Zhao Chunyan, 2008, Nucl Recept Signal, V6, pe003, DOI 10.1621/nrs.06003; Zhou HB, 2009, BIOORG MED CHEM LETT, V19, P108, DOI 10.1016/j.bmcl.2008.11.006	40	58	59	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					12971	12982		10.1074/jbc.M110.205112	http://dx.doi.org/10.1074/jbc.M110.205112			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21321128	Green Published, hybrid			2022-12-27	WOS:000289282200017
J	Marcello, MR; Jia, WT; Leary, JA; Moore, KL; Evans, JP				Marcello, Matthew R.; Jia, Weitao; Leary, Julie A.; Moore, Kevin L.; Evans, Janice P.			Lack of Tyrosylprotein Sulfotransferase-2 Activity Results in Altered Sperm-Egg Interactions and Loss of ADAM3 and ADAM6 in Epididymal Sperm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE O-SULFATION; ANGIOTENSIN-CONVERTING ENZYME; MAMMALIAN MEMBRANE BLOCK; AMINO-TERMINUS; P-SELECTIN; REPRODUCTIVE ADAMS; SECRETORY PATHWAY; MOLECULAR-CLONING; MALE-FERTILITY; PROTEIN IZUMO	Tyrosine O-sulfation is a post-translational modification catalyzed by two tyrosylprotein sulfotransferases (TPST-1 and TPST-2) in the trans-Golgi network. Tpst2-deficient mice have male infertility, sperm motility defects, and possible abnormalities in sperm-egg membrane interactions. Studies here show that compared with wild-type sperm, fewer Tpst2-null sperm bind to the egg membrane, but more of these bound sperm progress to membrane fusion. Similar outcomes were observed with wild-type sperm treated with the anti-sulfotyrosine antibody PSG2. The increased extent of sperm-egg fusion is not due to a failure of Tpst2-null sperm to trigger establishment of the egg membrane block to polyspermy. Anti-sulfotyrosine staining of sperm showed localization similar to that of IZUMO1, a sperm protein that is essential for gamete fusion, but we detected little to no tyrosine sulfation of IZUMO1 and found that IZUMO1 expression and localization were normal in Tpst2-null sperm. Turning to a discovery-driven approach, we used mass spectrometry to characterize sperm proteins that associated with PSG2. This identified ADAM6, a member of the A disintegrin and A metalloprotease (ADAM) family; members of this protein family are associated with multiple sperm functions. Subsequent studies revealed that Tpst2-null sperm lack ADAM6 and ADAM3. Loss of ADAM3 is strongly associated with male infertility and is observed in knockouts of male germ line-specific endoplasmic reticulum-resident chaperones, raising the possibility that TPST-2 may function in quality control in the secretory pathway. These data suggest that TPST-2-mediated tyrosine O-sulfation participates in regulating the sperm surface proteome or membrane order, ultimately affecting male fertility.	[Marcello, Matthew R.; Evans, Janice P.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA; [Jia, Weitao; Leary, Julie A.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Moore, Kevin L.] Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA; [Moore, Kevin L.] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK 73104 USA; [Moore, Kevin L.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California Davis; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Evans, JP (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, 615 N Wolfe St, Baltimore, MD 21205 USA.	jpevans@jhsph.edu	Evans, Janice/Q-8483-2019; Jia, W.T./E-7803-2012	Marcello, Matthew/0000-0001-7397-3282	National Institutes of Health [R01 HD037696, R01 HD045671, HD056022]; National Institute of Child Health and Human Development [T32 HD007276]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD056022] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007276, R01HD037696, R01HD045671] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HD037696 and R01 HD045671 (to J. P. E.) and HD056022 (to K. L M. and J. A. L.). For a portion of this work, M. R. M. was supported by a training grant from the National Institute of Child Health and Human Development (T32 HD007276).	Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; BAEUERLE PA, 1987, J CELL BIOL, V105, P2655, DOI 10.1083/jcb.105.6.2655; Beisswanger R, 1998, P NATL ACAD SCI USA, V95, P11134, DOI 10.1073/pnas.95.19.11134; BETTELHEIM FR, 1954, J AM CHEM SOC, V76, P2838, DOI 10.1021/ja01639a073; Borghei A, 2006, J BIOL CHEM, V281, P9423, DOI 10.1074/jbc.M513768200; Cha SW, 2009, CURR BIOL, V19, P1573, DOI 10.1016/j.cub.2009.07.062; Cho CH, 1998, SCIENCE, V281, P1857, DOI 10.1126/science.281.5384.1857; Choe H, 2009, METHOD ENZYMOL, V461, P147, DOI 10.1016/S0076-6879(09)05407-X; Colvin RA, 2006, MOL CELL BIOL, V26, P5838, DOI 10.1128/MCB.00556-06; Ensslin MA, 2003, CELL, V114, P405, DOI 10.1016/S0092-8674(03)00643-3; Farzan M, 1999, CELL, V96, P667, DOI 10.1016/S0092-8674(00)80577-2; Fujihara Y, 2010, J CELL SCI, V123, P1531, DOI 10.1242/jcs.067363; Gao JM, 2003, J BIOL CHEM, V278, P37902, DOI 10.1074/jbc.M306061200; Gardner AJ, 2006, REPROD FERT DEVELOP, V18, P53, DOI 10.1071/RD05122; Gardner AJ, 2007, J CELL PHYSIOL, V212, P275, DOI 10.1002/jcp.21046; Gardner AJ, 2007, REPRODUCTION, V133, P383, DOI 10.1530/REP-06-0304; Goettsch S, 2006, J MOL BIOL, V361, P436, DOI 10.1016/j.jmb.2006.06.023; Goldberg E, 2010, J ANDROL, V31, P86, DOI 10.2164/jandrol.109.008367; Gutierrez J, 2004, J BIOL CHEM, V279, P14726, DOI 10.1074/jbc.M309689200; Hagaman JR, 1998, P NATL ACAD SCI USA, V95, P2552, DOI 10.1073/pnas.95.5.2552; Han C, 2009, BIOL REPROD, V80, P1001, DOI 10.1095/biolreprod.108.073700; Hoffhines AJ, 2009, J BIOL CHEM, V284, P3096, DOI 10.1074/jbc.M808434200; HORTIN GL, 1989, P NATL ACAD SCI USA, V86, P1338, DOI 10.1073/pnas.86.4.1338; HUTTNER WB, 1982, NATURE, V299, P273, DOI 10.1038/299273a0; Ikawa M, 2001, DEV BIOL, V240, P254, DOI 10.1006/dbio.2001.0462; Ikawa M, 1997, NATURE, V387, P607, DOI 10.1038/42484; Ikawa M, 2011, J BIOL CHEM, V286, P5639, DOI 10.1074/jbc.M110.140152; Inoue N, 2005, NATURE, V434, P234, DOI 10.1038/nature03362; Inoue N, 2008, BIOCHEM BIOPH RES CO, V377, P910, DOI 10.1016/j.bbrc.2008.10.073; Kim E, 2005, P NATL ACAD SCI USA, V102, P18028, DOI 10.1073/pnas.0506825102; Kim T, 2006, BIOL REPROD, V74, P744, DOI 10.1095/biolreprod.105.048892; Komori R, 2009, P NATL ACAD SCI USA, V106, P15067, DOI 10.1073/pnas.0902801106; LEE RWH, 1983, J BIOL CHEM, V258, P1326; Moore KL, 2009, P NATL ACAD SCI USA, V106, P14741, DOI 10.1073/pnas.0908376106; Moore KL, 2003, J BIOL CHEM, V278, P24243, DOI 10.1074/jbc.R300008200; Nishimura H, 2004, J BIOL CHEM, V279, P34957, DOI 10.1074/jbc.M314249200; Nishimura H, 2001, DEV BIOL, V233, P204, DOI 10.1006/dbio.2001.0166; Nishimura H, 2007, J BIOL CHEM, V282, P17900, DOI 10.1074/jbc.M702268200; Odet F, 2008, BIOL REPROD, V79, P26, DOI 10.1095/biolreprod.108.068353; Ouyang YB, 1998, J BIOL CHEM, V273, P24770, DOI 10.1074/jbc.273.38.24770; Ouyang YB, 1998, P NATL ACAD SCI USA, V95, P2896, DOI 10.1073/pnas.95.6.2896; Ouyang YB, 2002, J BIOL CHEM, V277, P23781, DOI 10.1074/jbc.M202420200; PITTMAN DD, 1994, BIOCHEMISTRY-US, V33, P6952, DOI 10.1021/bi00188a026; PITTMAN DD, 1992, BIOCHEMISTRY-US, V31, P3315, DOI 10.1021/bi00128a003; POUYANI T, 1995, CELL, V83, P333, DOI 10.1016/0092-8674(95)90174-4; ROSA P, 1992, J BIOL CHEM, V267, P12227; SAKO D, 1995, CELL, V83, P323, DOI 10.1016/0092-8674(95)90173-6; Shamsadin R, 1999, BIOL REPROD, V61, P1445, DOI 10.1095/biolreprod61.6.1445; Sosnik J, 2009, J CELL SCI, V122, P2741, DOI 10.1242/jcs.047225; Stein KK, 2005, BIOL REPROD, V73, P1032, DOI 10.1095/biolreprod.105.040972; STONE SR, 1986, BIOCHEMISTRY-US, V25, P4622, DOI 10.1021/bi00364a025; Westmuckett AD, 2008, GEN COMP ENDOCR, V156, P145, DOI 10.1016/j.ygcen.2007.12.006; Whitten WK, 1971, ADV BIOSCI, V6, P129, DOI DOI 10.1016/B978-0-08-017571-3.50013-9; WILKINS PP, 1995, J BIOL CHEM, V270, P22677, DOI 10.1074/jbc.270.39.22677; Wortzman GB, 2005, MOL HUM REPROD, V11, P1, DOI 10.1093/molehr/gah125; Yamaguchi R, 2006, BIOL REPROD, V75, P760, DOI 10.1095/biolreprod.106.052977; Yamaguchi R, 2009, BIOL REPROD, V81, P142, DOI 10.1095/biolreprod.108.074021; Zhu GZ, 2009, MOL REPROD DEV, V76, P1106, DOI 10.1002/mrd.21076	58	39	54	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13060	13070		10.1074/jbc.M110.175463	http://dx.doi.org/10.1074/jbc.M110.175463			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21339297	Green Published, hybrid			2022-12-27	WOS:000289282200026
J	Moroni, M; Meyer, JO; Lahmann, C; Sivilotti, LG				Moroni, Mirko; Meyer, James O.; Lahmann, Carolina; Sivilotti, Lucia G.			In Glycine and GABA(A) Channels, Different Subunits Contribute Asymmetrically to Channel Conductance via Residues in the Extracellular Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; GATED ION CHANNELS; CYS-LOOP RECEPTORS; AMINO-ACIDS; TRANSMEMBRANE SEGMENT; STOICHIOMETRY; SELECTIVITY; DETERMINES; REGION; MUTATION	Single-channel conductance in Cys-loop channels is controlled by the nature of the amino acids in the narrowest parts of the ion conduction pathway, namely the second transmembrane domain (M2) and the intracellular helix. In cationic channels, such as Torpedo ACh nicotinic receptors, conductance is increased by negatively charged residues exposed to the extracellular vestibule. We now show that positively charged residues at the same loop 5 position boost also the conductance of anionic Cys-loop channels, such as glycine (alpha 1 and alpha 1 beta) and GABA(A) (alpha 1 beta 2 gamma 2) receptors. Charge reversal mutations here produce a greater decrease on outward conductance, but their effect strongly depends on which subunit carries the mutation. In the glycine alpha 1 beta receptor, replacing Lys with Glu in alpha 1 reduces single-channel conductance by 41%, but has no effect in the beta subunit. By expressing concatameric receptors with constrained stoichiometry, we show that this asymmetry is not explained by the subunit copy number. A similar pattern is observed in the alpha 1 beta 2 gamma 2 GABA(A) receptor, where only mutations in alpha 1 or beta 2 decreased conductance (to different extents). In both glycine and GABA receptors, the effect of mutations in different subunits does not sum linearly: mutations that had no detectable effect in isolation did enhance the effect of mutations carried by other subunits. As in the nicotinic receptor, charged residues in the extracellular vestibule of anionic Cys-loop channels influence elementary conductance. The size of this effect strongly depends on the direction of the ion flow and, unexpectedly, on the nature of the subunit that carries the residue.	[Moroni, Mirko; Meyer, James O.; Lahmann, Carolina; Sivilotti, Lucia G.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England	University of London; University College London	Sivilotti, LG (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, Med Sci Bldg,Gower St, London WC1E 6BT, England.	l.sivilotti@ucl.ac.uk	Sivilotti, Lucia/D-8919-2011; Moroni, Mirko/Q-1524-2018	Sivilotti, Lucia/0000-0003-2510-8424; 	MRC [G0400869]; Nuffield Science Bursary; Medical Research Council [G0400869] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Nuffield Science Bursary; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the MRC (Programme Grant G0400869, to L. G. S.) and by a Nuffield Science Bursary (to C. L.).	BEHE P, 1995, P ROY SOC B-BIOL SCI, V262, P205, DOI 10.1098/rspb.1995.0197; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; BORMANN J, 1993, EMBO J, V12, P3729, DOI 10.1002/j.1460-2075.1993.tb06050.x; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; Brams M, 2011, J BIOL CHEM, V286, P4420, DOI 10.1074/jbc.M110.188730; Burzomato V, 2003, RECEPTOR CHANNEL, V9, P353, DOI 10.3109/714041016; Carland JE, 2009, J BIOL CHEM, V284, P2023, DOI 10.1074/jbc.M806618200; Chang YC, 1996, J NEUROSCI, V16, P5415; COOPER E, 1991, NATURE, V350, P235, DOI 10.1038/350235a0; Dalziel JE, 2000, MOL PHARMACOL, V57, P875; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Gonzales EB, 2008, NEUROSCI LETT, V431, P184, DOI 10.1016/j.neulet.2007.11.039; Groot-Kormelink PJ, 2004, J GEN PHYSIOL, V123, P697, DOI 10.1085/jgp.200409042; Groot-Kormelink PJ, 2002, J NEUROSCI METH, V113, P207, DOI 10.1016/S0165-0270(01)00500-3; Groot-Kormelink PJ, 2001, BRIT J PHARMACOL, V134, P789, DOI 10.1038/sj.bjp.0704313; Grudzinska J, 2005, NEURON, V45, P727, DOI 10.1016/j.neuron.2005.01.028; Hansen SB, 2008, J BIOL CHEM, V283, P36066, DOI 10.1074/jbc.C800194200; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; IMOTO K, 1991, FEBS LETT, V289, P193, DOI 10.1016/0014-5793(91)81068-J; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Jensen ML, 2002, J BIOL CHEM, V277, P41438, DOI 10.1074/jbc.M205645200; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Keramidas A, 2004, PROG BIOPHYS MOL BIO, V86, P161, DOI 10.1016/j.pbiomolbio.2003.09.002; KIENKER P, 1994, BIOPHYS J, V66, P325, DOI 10.1016/S0006-3495(94)80781-7; KONNO T, 1991, P ROY SOC B-BIOL SCI, V244, P69, DOI 10.1098/rspb.1991.0053; KUHSE J, 1993, NEURON, V11, P1049, DOI 10.1016/0896-6273(93)90218-G; LANGOSCH D, 1988, P NATL ACAD SCI USA, V85, P7394, DOI 10.1073/pnas.85.19.7394; Liu DT, 1996, NEURON, V16, P983, DOI 10.1016/S0896-6273(00)80121-X; LIVESEY M, 2010, P BR PHARM SOC, V7, pP37; Meltzer RH, 2006, BIOPHYS J, V91, P1315, DOI 10.1529/biophysj.106.081448; Minier F, 2004, TRENDS PHARMACOL SCI, V25, P499, DOI 10.1016/j.tips.2004.07.005; Mortensen M, 2010, J PHYSIOL-LONDON, V588, P1251, DOI 10.1113/jphysiol.2009.182444; Premkumar LS, 1997, J GEN PHYSIOL, V110, P485, DOI 10.1085/jgp.110.5.485; Rayes D, 2009, J NEUROSCI, V29, P6022, DOI 10.1523/JNEUROSCI.0627-09.2009; Shan Q, 2003, J NEUROCHEM, V86, P498, DOI 10.1046/j.1471-4159.2003.01872.x; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; Song C, 2009, BBA-BIOMEMBRANES, V1788, P1466, DOI 10.1016/j.bbamem.2009.04.015; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; VILLARROEL A, 1992, P ROY SOC B-BIOL SCI, V249, P317, DOI 10.1098/rspb.1992.0121; VILLARROEL A, 1991, P ROY SOC B-BIOL SCI, V243, P69, DOI 10.1098/rspb.1991.0012; Wilkins ME, 2002, J NEUROSCI, V22, P5328; Zhou Y, 2003, J NEUROSCI, V23, P9004	42	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13414	13422		10.1074/jbc.M110.204610	http://dx.doi.org/10.1074/jbc.M110.204610			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21343294	hybrid, Green Published			2022-12-27	WOS:000289282200061
J	Su, JY; Schlicker, C; Forchhammer, K				Su, Jiyong; Schlicker, Christine; Forchhammer, Karl			A Third Metal Is Required for Catalytic Activity of the Signal-transducing Protein Phosphatase M tPphA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE/THREONINE PHOSPHATASE; P-II; 2C; DEPHOSPHORYLATION; CONFORMATION; RESOLUTION; RESIDUES; BINDING	Protein phosphatase M (PPM) regulates key signaling pathways in prokaryotes and eukaryotes. Novel structures of bacterial PPM members revealed three divalent metal ions in their catalytic centers. The function of metal 3 (M3) remained unclear. To reveal its function, we created variants of tPphA from Thermosynechococcus elongatus in all metal-coordinating residues, and multiple variants were created for the M3 coordinating Asp-119 residue. The structures of variants D119A and D193A were resolved, showing loss of M3 binding but unaffected binding of M1 and M2 in the catalytic center of D119A, with the nucleophilic water molecule in the correct place. The catalytic activity of this variant was highly impaired. This and further structure-function analyses showed that M3 is required for catalysis by providing a water molecule as a proton donor during catalysis. Mutation of the homologue Asp residue in human PP2C alpha also caused loss of function, suggesting a general requirement of M3 in PPM-catalyzed reactions.	[Su, Jiyong; Forchhammer, Karl] Univ Tubingen, Dept Organism Interact, Interfac Inst Microbiol & Infect Med, D-72076 Tubingen, Germany; [Schlicker, Christine] Ruhr Univ Bochum, Dept Biophys, D-44801 Bochum, Germany	Eberhard Karls University of Tubingen; Ruhr University Bochum	Forchhammer, K (corresponding author), Univ Tubingen, Dept Organism Interact, Interfac Inst Microbiol & Infect Med, Morgenstelle 28, D-72076 Tubingen, Germany.	karl.forchhammer@uni-tuebingen.de		Su, Jiyong/0000-0001-8406-1676	Deutsche Forschungsgemeinschaft [Fo195, GRK 685]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant Fo195 and GRK 685 "Infection Biology" and Prof. Dr. Eckhard Hofmann.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Arino J, 2011, EUKARYOT CELL, V10, P21, DOI 10.1128/EC.00249-10; Bellinzoni M, 2007, STRUCTURE, V15, P863, DOI 10.1016/j.str.2007.06.002; Conner SH, 2006, BIOCHEM J, V399, P427, DOI 10.1042/BJ20061077; Das AK, 1996, EMBO J, V15, P6798, DOI 10.1002/j.1460-2075.1996.tb01071.x; EKMAN P, 1993, ANAL BIOCHEM, V214, P138, DOI 10.1006/abio.1993.1468; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Irmler A, 1997, MOL MICROBIOL, V26, P81, DOI 10.1046/j.1365-2958.1997.5521918.x; Jackson MD, 2003, BIOCHEMISTRY-US, V42, P8513, DOI 10.1021/bi034074+; Lai SM, 2005, MICROBIOL-SGM, V151, P1159, DOI 10.1099/mic.0.27585-0; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; MACKINTOSH C, 1999, PROTEIN PHOSPHORYLAT, P153; Marley AE, 1996, BIOCHEM J, V320, P801, DOI 10.1042/bj3200801; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pullen KE, 2004, STRUCTURE, V12, P1947, DOI 10.1016/j.str.2004.09.008; Rantanen MK, 2007, FEBS J, V274, P3128, DOI 10.1111/j.1742-4658.2007.05845.x; Ruppert U, 2002, MOL MICROBIOL, V44, P855, DOI 10.1046/j.1365-2958.2002.02927.x; Schlicker C, 2008, J MOL BIOL, V376, P570, DOI 10.1016/j.jmb.2007.11.097; Shakir SM, 2010, J BACTERIOL, V192, P400, DOI 10.1128/JB.01221-09; Sugiura T, 2009, BIOMETALS, V22, P469, DOI 10.1007/s10534-009-9204-9; Treuner-Lange A, 2001, MOL MICROBIOL, V40, P126, DOI 10.1046/j.1365-2958.2001.02362.x; VANVELDHOVEN PP, 1987, ANAL BIOCHEM, V161, P45, DOI 10.1016/0003-2697(87)90649-X; Wehenkel A, 2007, J MOL BIOL, V374, P890, DOI 10.1016/j.jmb.2007.09.076	25	31	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13481	13488		10.1074/jbc.M109.036467	http://dx.doi.org/10.1074/jbc.M109.036467			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21310952	hybrid, Green Published			2022-12-27	WOS:000289282200068
J	Hu, YF; Zhang, XX; Shi, YM; Zhou, YF; Zhang, W; Su, XD; Xia, B; Zhao, JD; Jin, CW				Hu, Yunfei; Zhang, Xinxin; Shi, Yunming; Zhou, Yanfeng; Zhang, Wei; Su, Xiao-Dong; Xia, Bin; Zhao, Jindong; Jin, Changwen			Structures of Anabaena Calcium-binding Protein CcbP INSIGHTS INTO CA(2+) SIGNALING DURING HETEROCYST DIFFERENTIATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIPHTHERIA-TOXIN REPRESSOR; TORSION ANGLE DYNAMICS; EF-HAND PROTEINS; NMR EXPERIMENTS; NOE ASSIGNMENT; SH3 DOMAINS; HOMOLOGY; SRC; CYANOBACTERIA; PROGRAMS	Ca2+-binding proteins play pivotal roles in both eukaryotic and prokaryotic cells. CcbP from cyanobacterium Anabaena sp. strain PCC 7120 is a major Ca2+-binding protein involved in heterocyst differentiation, a process that forms specialized nitrogen-fixing cells. The three-dimensional structures of both Ca2+-free and Ca2+-bound forms of CcbP are essential for elucidating the Ca2+-signaling mechanism. However, CcbP shares low sequence identity with proteins of known structures, and its Ca2+-binding sites remain unknown. Here, we report the solution structures of CcbP in both Ca2+-free and Ca2+-bound forms determined by nuclear magnetic resonance spectroscopy. CcbP adopts an overall new fold and contains two Ca2+-binding sites with distinct Ca2+-binding abilities. Mutation of Asp(38) at the stronger Ca2+-binding site of CcbP abolished its ability to regulate heterocyst formation in vivo. Surprisingly, the beta-barrel subdomain of CcbP, which does not participate in Ca2+-binding, topologically resembles the Src homology 3 (SH3) domain and might act as a protein-protein interaction module. Our results provide the structural basis of the unique Ca2+ signaling mechanism during heterocyst differentiation.	[Hu, Yunfei; Zhang, Xinxin; Xia, Bin; Zhao, Jindong; Jin, Changwen] Peking Univ, Coll Life Sci, Beijing Nucl Magnet Resonance Ctr, Beijing 100871, Peoples R China; [Shi, Yunming; Zhang, Wei; Zhao, Jindong; Jin, Changwen] Peking Univ, State Key Lab Plant & Prot Engn, Beijing 100871, Peoples R China; [Xia, Bin; Zhao, Jindong] Peking Univ, Coll Chem & Mol Engn, Beijing 100871, Peoples R China; [Xia, Bin; Jin, Changwen] Peking Univ, Beijing Natl Lab Mol Sci, Beijing 100871, Peoples R China; [Zhao, Jindong] Chinese Acad Sci, Inst Hydrobiol, Wuhan 430072, Hubei, Peoples R China	Peking University; Peking University; Peking University; Chinese Academy of Sciences; Peking University; Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Zhao, JD (corresponding author), Peking Univ, Coll Life Sci, Beijing Nucl Magnet Resonance Ctr, Beijing 100871, Peoples R China.	jzhao@pku.edu.cn; changwen@pku.edu.cn	Zhou, Yanfeng/B-3792-2012; Zhang, Wei/P-1532-2015		National Natural Science Foundation [30325010, 30230040]; Ministry of Science and Technology of China [2006CB910203, 2006AA02A323]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by National Natural Science Foundation Grants 30325010 (to C. J.) and 30230040 (to J. Z.) and Grants 2006CB910203 and 2006AA02A323 from the Ministry of Science and Technology of China (to C. J.).	Adams DG, 2000, CURR OPIN MICROBIOL, V3, P618, DOI 10.1016/S1369-5274(00)00150-8; Beard NA, 2004, PROG BIOPHYS MOL BIO, V85, P33, DOI 10.1016/j.pbiomolbio.2003.07.001; Biekofsky RR, 1998, BIOCHEMISTRY-US, V37, P7617, DOI 10.1021/bi9800449; Bilwes AM, 1999, CELL, V96, P131, DOI 10.1016/S0092-8674(00)80966-6; Buikema WJ, 2001, P NATL ACAD SCI USA, V98, P2729, DOI 10.1073/pnas.051624898; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dominguez DC, 2004, MOL MICROBIOL, V54, P291, DOI 10.1111/j.1365-2958.2004.04276.x; Duggan BM, 2001, J BIOMOL NMR, V19, P321, DOI 10.1023/A:1011227824104; FALZONE CJ, 1994, BIOCHEMISTRY-US, V33, P6052, DOI 10.1021/bi00186a004; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Golden JW, 2003, CURR OPIN MICROBIOL, V6, P557, DOI 10.1016/j.mib.2003.10.004; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Griswold IJ, 2002, NAT STRUCT BIOL, V9, P121, DOI 10.1038/nsb753; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; LODISH H, 2000, MOL CELL BIOL, P579; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Mayer BJ, 2001, J CELL SCI, V114, P1253; Meeks JC, 2002, MICROBIOL MOL BIOL R, V66, P94, DOI 10.1128/MMBR.66.1.94-121.2002; Michiels J, 2002, TRENDS MICROBIOL, V10, P87, DOI 10.1016/S0966-842X(01)02284-3; Nekhai SA, 1997, BIOCHEM J, V325, P401, DOI 10.1042/bj3250401; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Norris V, 1996, J BACTERIOL, V178, P3677, DOI 10.1128/jb.178.13.3677-3682.1996; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Pearl FMG, 2003, NUCLEIC ACIDS RES, V31, P452, DOI 10.1093/nar/gkg062; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Qiu XY, 1996, BIOCHEMISTRY-US, V35, P12292, DOI 10.1021/bi960861d; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Shi YM, 2006, P NATL ACAD SCI USA, V103, P11334, DOI 10.1073/pnas.0602839103; Sparks AB, 1996, P NATL ACAD SCI USA, V93, P1540, DOI 10.1073/pnas.93.4.1540; Sudol M, 1998, ONCOGENE, V17, P1469, DOI 10.1038/sj.onc.1202182; Wang G, 1999, P NATL ACAD SCI USA, V96, P6119, DOI 10.1073/pnas.96.11.6119; Wolk CP, 2000, PROKARYOTIC DEVELOPMENT, P83; Wylie GP, 2005, BIOCHEMISTRY-US, V44, P40, DOI 10.1021/bi048035p; Zhang CC, 2006, MOL MICROBIOL, V59, P367, DOI 10.1111/j.1365-2958.2005.04979.x; Zhao YH, 2005, P NATL ACAD SCI USA, V102, P5744, DOI 10.1073/pnas.0501782102	48	18	18	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.201186	http://dx.doi.org/10.1074/jbc.M110.201186			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21330362	hybrid, Green Published			2022-12-27	WOS:000289077500052
J	Hwang, JY; Huang, WW; Arnold, LA; Huang, RL; Attia, RR; Connelly, M; Wichterman, J; Zhu, FY; Augustinaite, I; Austin, CP; Inglese, J; Johnson, RL; Guy, RK				Hwang, Jong Yeon; Huang, Wenwei; Arnold, Leggy A.; Huang, Ruili; Attia, Ramy R.; Connelly, Michele; Wichterman, Jennifer; Zhu, Fangyi; Augustinaite, Indre; Austin, Christopher P.; Inglese, James; Johnson, Ronald L.; Guy, R. Kiplin			Methylsulfonylnitrobenzoates, a New Class of Irreversible Inhibitors of the Interaction of the Thyroid Hormone Receptor and Its Obligate Coactivators That Functionally Antagonizes Thyroid Hormone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITORS; ESTROGEN-RECEPTOR; NUCLEAR RECEPTORS; LIGAND-BINDING; IN-VIVO; AMPHIBIAN METAMORPHOSIS; BIOLOGICAL EVALUATION; HIGH-THROUGHPUT; DRUG DISCOVERY; ION CHANNELS	Thyroid hormone receptors (TRs) are members of the nuclear hormone receptor (NR) superfamily and regulate development, growth, and metabolism. Upon binding thyroid hormone, TR undergoes a conformational change that allows the release of corepressors and the recruitment of coactivators, which in turn regulate target gene transcription. Although a number of TR antagonists have been developed, most are analogs of the endogenous hormone that inhibit ligand binding. In a screen for inhibitors that block the association of TR beta with steroid receptor coactivator 2 (SRC2), we identified a novel methylsulfonylnitrobenzoate (MSNB)-containing series that blocks this interaction at micromolar concentrations. Here we have studied a series of MSNB analogs and characterized their structure activity relationships. MSNB members do not displace thyroid hormone T-3 but instead act by direct displacement of SRC2. MSNB series members are selective for the TR over the androgen, vitamin D, and PPAR gamma NR members, and they antagonize thyroid hormone-activated transcription action in cells. The methylsulfonylnitro group is essential for TR beta antagonism. Side-chain alkylamine substituents showed better inhibitory activity than arylamine substituents. Mass spectrum analysis suggested that MSNB inhibitors bind irreversibly to Cys-298 within the AF-2 cleft of TR beta to disrupt SRC2 association.	[Hwang, Jong Yeon; Attia, Ramy R.; Connelly, Michele; Zhu, Fangyi; Augustinaite, Indre; Guy, R. Kiplin] St Jude Childrens Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA; [Huang, Wenwei; Huang, Ruili; Wichterman, Jennifer; Austin, Christopher P.; Inglese, James; Johnson, Ronald L.] NHGRI, NIH Chem Genom Ctr, NIH, Bethesda, MD 20892 USA; [Arnold, Leggy A.] Univ Wisconsin, Dept Chem & Biochem, Milwaukee, WI 53211 USA	St Jude Children's Research Hospital; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); NIH National Human Genome Research Institute (NHGRI); University of Wisconsin System; University of Wisconsin Milwaukee	Guy, RK (corresponding author), 262 Danny Thomas Pl,Mail Stop 1000, Memphis, TN 38105 USA.	kip.guy@stjude.org	Guy, Rodney/J-7107-2013; Huang, WW/GXH-0977-2022; Huang, Wenwei/AFO-1997-2022	Guy, Rodney/0000-0002-9638-2060; Arnold, Leggy/0000-0003-1411-1572	National Institutes of Health [DK58080]; NIH Roadmap for Medical Research; National Institutes of Health NHGRI; American Lebanese Syrian Associated Charities (ALSAC); St. Jude Children's Research Hospital (SJCRH); NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIBHG200319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058080, R55DK058080] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); St. Jude Children's Research Hospital (SJCRH); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK58080, the NIH Roadmap for Medical Research, and the National Institutes of Health NHGRI Intramural Research Program. This work was also supported by the American Lebanese Syrian Associated Charities (ALSAC) and the St. Jude Children's Research Hospital (SJCRH).	Alonso M, 2009, ENDOCRINOLOGY, V150, P3927, DOI 10.1210/en.2009-0093; Armstrong Clay M, 2003, Sci STKE, V2003, pre10, DOI 10.1126/stke.2003.188.re10; Armstrong CM, 1998, NEURON, V20, P371, DOI 10.1016/S0896-6273(00)80981-2; Arnold LA, 2005, J BIOL CHEM, V280, P43048, DOI 10.1074/jbc.M506693200; ARNOLD LA, 2006, SCI STKE 2003, pPL3; Arnold LA, 2007, J MED CHEM, V50, P5269, DOI 10.1021/jm070556y; Attia RR, 2010, J BIOL CHEM, V285, P2375, DOI 10.1074/jbc.M109.039081; Babaoglu K, 2008, J MED CHEM, V51, P2502, DOI 10.1021/jm701500e; Brent G A, 2000, Rev Endocr Metab Disord, V1, P27, DOI 10.1023/A:1010056202122; Bruhova I, 2008, MOL PHARMACOL, V74, P1033, DOI 10.1124/mol.108.049759; Chambon P, 2005, MOL ENDOCRINOL, V19, P1418, DOI 10.1210/me.2005-0125; Chang CY, 1999, MOL CELL BIOL, V19, P8226; Chen TS, 2008, CURR OPIN CHEM BIOL, V12, P418, DOI 10.1016/j.cbpa.2008.07.001; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; Coleman MD, 2002, ENVIRON TOXICOL PHAR, V12, P7, DOI 10.1016/S1382-6689(01)00123-5; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; Ding XF, 1998, MOL ENDOCRINOL, V12, P302, DOI 10.1210/me.12.2.302; Elbrecht A, 1999, J BIOL CHEM, V274, P7913, DOI 10.1074/jbc.274.12.7913; Escriva H, 2004, ESSAYS BIOCHEM, V40, P11, DOI 10.1042/bse0400011; Estebanez-Perpina E, 2007, MOL ENDOCRINOL, V21, P2919, DOI 10.1210/me.2007-0174; Feau C, 2009, ACS CHEM BIOL, V4, P834, DOI 10.1021/cb900143a; Feau C, 2009, J BIOMOL SCREEN, V14, P43, DOI 10.1177/1087057108326662; Feng WJ, 1998, SCIENCE, V280, P1747, DOI 10.1126/science.280.5370.1747; Fradet Yves, 2004, Expert Rev Anticancer Ther, V4, P37, DOI 10.1586/14737140.4.1.37; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Geistlinger TR, 2003, METHOD ENZYMOL, V364, P223; Gillies PS, 2000, DRUGS, V60, P333, DOI 10.2165/00003495-200060020-00009; Gilmer JF, 2005, EUR J PHARM SCI, V24, P315, DOI 10.1016/j.ejps.2004.11.006; Glickman JF, 2002, J BIOMOL SCREEN, V7, P3, DOI 10.1177/108705710200700102; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Grover GJ, 2004, ENDOCRINOLOGY, V145, P1656, DOI 10.1210/en.2003-0973; Gul M, 2005, ARZNEIMITTELFORSCH, V55, P332; Harvey CB, 2002, THYROID, V12, P441, DOI 10.1089/105072502760143791; Hille B, 1999, NAT MED, V5, P1105, DOI 10.1038/13415; Huang H, 2007, ONCOGENE, V26, P258, DOI 10.1038/sj.onc.1209788; Hwang JY, 2009, J MED CHEM, V52, P3892, DOI 10.1021/jm9002704; Jamieson C, 2006, J MED CHEM, V49, P5029, DOI 10.1021/jm060379l; Jeyakumar M, 1997, MOL ENDOCRINOL, V11, P755, DOI 10.1210/me.11.6.755; JOHNSON RL, 2011, J BIOMOL SC IN PRESS; Jordan VC, 2006, BRIT J PHARMACOL, V147, pS269, DOI 10.1038/sj.bjp.0706399; Kansra S, 2005, MOL CELL ENDOCRINOL, V239, P27, DOI 10.1016/j.mce.2005.04.008; Kojetin DJ, 2008, ENDOCR-RELAT CANCER, V15, P851, DOI 10.1677/ERC-07-0281; Kress E, 2009, MOL CELL ENDOCRINOL, V313, P36, DOI 10.1016/j.mce.2009.08.028; Lawrence JM, 2000, INT J CLIN PRACT, V54, P614; Leesnitzer LM, 2002, BIOCHEMISTRY-US, V41, P6640, DOI 10.1021/bi0159581; Li Y, 2008, J BIOL CHEM, V283, P19132, DOI 10.1074/jbc.M802040200; Lim W, 2002, J BIOL CHEM, V277, P35664, DOI 10.1074/jbc.M205608200; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; McInerney EM, 1998, GENE DEV, V12, P3357, DOI 10.1101/gad.12.21.3357; Meng CQ, 2001, BIOORG MED CHEM LETT, V11, P1823, DOI 10.1016/S0960-894X(01)00306-7; Mills NL, 2007, J BIOMOL SCREEN, V12, P946, DOI 10.1177/1087057107306128; Mohanty P, 2004, J CLIN ENDOCR METAB, V89, P2728, DOI 10.1210/jc.2003-032103; Moore JMR, 2004, J BIOL CHEM, V279, P27584, DOI 10.1074/jbc.M403453200; Moore JT, 2006, CHEMMEDCHEM, V1, P504, DOI 10.1002/cmdc.200600006; Morgan DL, 2001, INHAL TOXICOL, V13, P633, DOI 10.1080/08958370152409883; NERI R, 1972, ENDOCRINOLOGY, V91, P427, DOI 10.1210/endo-91-2-427; Nguyen NH, 2002, J MED CHEM, V45, P3310, DOI 10.1021/jm0201013; Oppenheimer JH, 1997, ENDOCR REV, V18, P462, DOI 10.1210/er.18.4.462; Parent AA, 2008, J MED CHEM, V51, P6512, DOI 10.1021/jm800698b; Park EA, 1997, BIOCHEM J, V322, P343, DOI 10.1042/bj3220343; Paul BD, 2007, J BIOL CHEM, V282, P7472, DOI 10.1074/jbc.M607589200; Rodriguez AL, 2004, J MED CHEM, V47, P600, DOI 10.1021/jm030404c; Rouleau N, 2003, J BIOMOL SCREEN, V8, P191, DOI 10.1177/1087057103252605; Savkur RS, 2004, J PEPT RES, V63, P207, DOI 10.1111/j.1399-3011.2004.00126.x; Schellhammer Paul F, 2004, Clin Prostate Cancer, V2, P213, DOI 10.3816/CGC.2004.n.002; Shah V, 2008, MOL CELL ENDOCRINOL, V296, P69, DOI 10.1016/j.mce.2008.09.016; Shearer BG, 2010, J MED CHEM, V53, P1857, DOI 10.1021/jm900464j; Stumvoll M, 2002, ANN MED, V34, P217, DOI 10.1080/713782132; Valadares NF, 2008, J STEROID BIOCHEM, V112, P205, DOI 10.1016/j.jsbmb.2008.10.006; Vanhooke JL, 2004, BIOCHEMISTRY-US, V43, P4101, DOI 10.1021/bi036056y; Wang HW, 2007, CLIN CANCER RES, V13, P2488, DOI 10.1158/1078-0432.CCR-06-1592; Wang Y, 2006, P NATL ACAD SCI USA, V103, P9908, DOI 10.1073/pnas.0510596103; Webb P, 2002, J STEROID BIOCHEM, V83, P59, DOI 10.1016/S0960-0760(02)00270-4; Williams GR, 2000, MOL CELL BIOL, V20, P8329, DOI 10.1128/MCB.20.22.8329-8342.2000; Xu JM, 2003, MOL ENDOCRINOL, V17, P1681, DOI 10.1210/me.2003-0116; YAOITA Y, 1990, GENE DEV, V4, P1917, DOI 10.1101/gad.4.11.1917; ZOLLNER H, 1973, BIOCHEM PHARMACOL, V22, P1171, DOI 10.1016/0006-2952(73)90234-7	78	28	30	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.200436	http://dx.doi.org/10.1074/jbc.M110.200436			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21321127	Green Published, hybrid			2022-12-27	WOS:000289077500003
J	Hwang, J; Kim, Y; Kang, HB; Jaroszewski, L; Deacon, AM; Lee, H; Choi, WC; Kim, KJ; Kim, CH; Kang, BS; Lee, JO; Oh, TK; Kim, JW; Wilson, IA; Kim, MH				Hwang, Jungwon; Kim, Yoonjeong; Kang, Ho Bum; Jaroszewski, Lukasz; Deacon, Ashley M.; Lee, Hwiseop; Choi, Won-Chan; Kim, Kyung-Jin; Kim, Cheol-Hee; Kang, Beom Sik; Lee, Jie-Oh; Oh, Tae-Kwang; Kim, Jae Wha; Wilson, Ian A.; Kim, Myung Hee			Crystal Structure of the Human N-Myc Downstream-regulated Gene 2 Protein Provides Insight into Its Role as a Tumor Suppressor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLON-CARCINOMA CELLS; BETA-CATENIN; METASTASIS SUPPRESSOR; COLORECTAL-CANCER; PROSTATE-CANCER; DOWN-REGULATION; C-MYC; NDRG2; EXPRESSION; DIFFERENTIATION	Considerable attention has recently been paid to the N-Myc downstream-regulated gene (NDRG) family because of its potential as a tumor suppressor in many human cancers. Primary amino acid sequence information suggests that the NDRG family proteins may belong to the alpha/beta-hydrolase (ABH) superfamily; however, their functional role has not yet been determined. Here, we present the crystal structures of the human and mouse NDRG2 proteins determined at 2.0 and 1.7 angstrom resolution, respectively. Both NDRG2 proteins show remarkable structural similarity to the ABH superfamily, despite limited sequence similarity. Structural analysis suggests that NDRG2 is a nonenzymatic member of the ABH superfamily, because it lacks the catalytic signature residues and has an occluded substrate-binding site. Several conserved structural features suggest NDRG may be involved in molecular interactions. Mutagenesis data based on the structural analysis support a crucial role for helix alpha 6 in the suppression of TCF/beta-catenin signaling in the tumorigenesis of human colorectal cancer, via a molecular interaction.	[Kang, Ho Bum; Kim, Jae Wha] Korea Res Inst Biosci & Biotechnol, Med Genom Res Ctr, Taejon 305806, South Korea; [Hwang, Jungwon; Kim, Yoonjeong; Lee, Hwiseop; Choi, Won-Chan; Oh, Tae-Kwang; Kim, Myung Hee] Korea Res Inst Biosci & Biotechnol, Div Biosyst Res, Taejon 305806, South Korea; [Hwang, Jungwon; Lee, Jie-Oh] Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea; [Kim, Yoonjeong; Kang, Beom Sik] Kyungpook Natl Univ, Sch Life Sci & Biotechnol, Taegu 702701, South Korea; [Jaroszewski, Lukasz] Sanford Burnham Med Res Inst, Program Bioinformat & Syst Biol, Joint Ctr Struct Genom, La Jolla, CA 92037 USA; [Deacon, Ashley M.] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Joint Ctr Struct Genom, Menlo Pk, CA 94025 USA; [Kim, Kyung-Jin] Pohang Univ Sci & Technol, Pohang Accelerator Lab, Pohang 790784, Kyungbuk, South Korea; [Kim, Cheol-Hee] Chungnam Natl Univ, Dept Biol, Taejon 305764, South Korea; [Kim, Cheol-Hee] Chungnam Natl Univ, GRAST, Taejon 305764, South Korea; [Wilson, Ian A.] Scripps Res Inst, Joint Ctr Struct Genom, La Jolla, CA 92037 USA; [Kim, Myung Hee] Univ Sci & Technol, Biosyst & Bioengn Program, Taejon 305333, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Advanced Institute of Science & Technology (KAIST); Kyungpook National University; Sanford Burnham Prebys Medical Discovery Institute; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Pohang University of Science & Technology (POSTECH); Chungnam National University; Chungnam National University; Scripps Research Institute	Kim, JW (corresponding author), Korea Res Inst Biosci & Biotechnol, Med Genom Res Ctr, Taejon 305806, South Korea.	wjkim@kribb.re.kr; wilson@scripps.edu; mhk8n@kribb.re.kr	Kim, Cheol-Hee/F-6278-2013; Lee, Jie-Oh/AAG-4302-2020; Lee, Jie-Oh/C-1581-2011	Lee, Jie-Oh/0000-0001-6519-6049; Kim, Cheol-Hee/0000-0002-3019-0699; Kim, Jae Wha/0000-0002-1507-2731	Ministry of Education, Science, and Technology; Ministry for Health, Welfare and Family Affairs, Republic of Korea [A090509]; National Institutes of Health, NIGMS Protein Structure Initiative [U54 GM074898]; National Science Foundation; University of California and Henry Wheeler; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health (NCRR Biomedical Technology Program and NIGMS); Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074898] Funding Source: NIH RePORTER	Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry for Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); National Institutes of Health, NIGMS Protein Structure Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); University of California and Henry Wheeler(University of California System); Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health (NCRR Biomedical Technology Program and NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)NIH National Center for Research Resources (NCRR)); Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the 21C Frontier Microbial Genomics and Applications Center Program (to M. H. K.) funded by the Ministry of Education, Science, and Technology and in part by Korea Healthcare Technology R&D Project Grant A090509 (to J. W. K.) funded by the Ministry for Health, Welfare and Family Affairs, Republic of Korea.; We thank Drs. Kyung-Jin Kim and Ghyung-Hwa Kim at Pohang Accelerator Laboratory for help with human NDRG2 data collection. We also thank all the members of the Joint Center for Structural Genomics for their general contributions to the mouse NDRG2 protein production and structure determination. The Joint Center for Structural Genomics is supported by the National Institutes of Health, NIGMS Protein Structure Initiative Grant U54 GM074898. Beamline 8.3.1 was funded by the National Science Foundation, University of California and Henry Wheeler. The Stanford Synchrotron Radiation Lightsource Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and the National Institutes of Health (NCRR Biomedical Technology Program and NIGMS). Portions of this work were carried out at the Stanford Synchrotron Radiation Lightsource, a national user facility operated by Stanford University on behalf of the United States Department of Energy, Office of Basic Energy Sciences. Portions of this work were carried out at the Advanced Light Source, which is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under Contract DE-AC02-05CH11231.	Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; Assamaki R, 2007, GENE CHROMOSOME CANC, V46, P564, DOI 10.1002/gcc.20439; Bandyopadhyay S, 2004, ONCOGENE, V23, P5675, DOI 10.1038/sj.onc.1207734; Bandyopadhyay S, 2003, CANCER RES, V63, P1731; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Burchfield JG, 2004, J BIOL CHEM, V279, P18623, DOI 10.1074/jbc.M401504200; Chakrabarty S, 2003, CANCER RES, V63, P67; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Elmi F, 2005, J BACTERIOL, V187, P8470, DOI 10.1128/JB.187.24.8470-8476.2005; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Furuta H, 2010, BIOCHEM BIOPH RES CO, V391, P1785, DOI 10.1016/j.bbrc.2009.12.156; Goldschmidt L, 2007, PROTEIN SCI, V16, P1569, DOI 10.1110/ps.072914007; Guang RJ, 2000, CANCER RES, V60, P749; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Henderson BR, 2002, EMBO REP, V3, P834, DOI 10.1093/embo-reports/kvf181; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hummerich L, 2006, ONCOGENE, V25, P111, DOI 10.1038/sj.onc.1209016; Kaneko T, 2005, PROTEIN SCI, V14, P558, DOI 10.1110/ps.041170005; Kim MH, 2008, PROTEINS, V70, P578, DOI 10.1002/prot.21680; Kim YJ, 2009, INT J CANCER, V124, P7, DOI 10.1002/ijc.23945; Kim YJ, 2009, CARCINOGENESIS, V30, P598, DOI 10.1093/carcin/bgp047; Kovacevic Z, 2006, CARCINOGENESIS, V27, P2355, DOI 10.1093/carcin/bgl146; Kwon SY, 2005, PLASMID, V53, P274, DOI 10.1016/j.plasmid.2004.11.006; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee DC, 2008, CANCER RES, V68, P4210, DOI 10.1158/0008-5472.CAN-07-5040; Lesley SA, 2002, P NATL ACAD SCI USA, V99, P11664, DOI 10.1073/pnas.142413399; LESLIE AGW, 1992, JOINT CCP4 ESF EACBM; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu JJ, 2006, J CELL PHYSIOL, V207, P287, DOI 10.1002/jcp.20589; Mariadason JM, 2001, CANCER RES, V61, P3465; Melotte V, 2009, JNCI-J NATL CANCER I, V101, P916, DOI 10.1093/jnci/djp131; Mitchelmore C, 2004, NEUROBIOL DIS, V16, P48, DOI 10.1016/j.nbd.2004.01.003; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; O'Connell BC, 2003, J BIOL CHEM, V278, P12563, DOI 10.1074/jbc.M210462200; Okuda T, 2004, MOL CELL BIOL, V24, P3949, DOI 10.1128/MCB.24.9.3949-3956.2004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park YJ, 2007, BIOCHEM BIOPH RES CO, V363, P361, DOI 10.1016/j.bbrc.2007.08.195; Rockman SP, 2001, J BIOL CHEM, V276, P45113, DOI 10.1074/jbc.M107742200; Rychlewski L, 2000, PROTEIN SCI, V9, P232, DOI 10.1110/ps.9.2.232; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; Santarsiero BD, 2002, J APPL CRYSTALLOGR, V35, P278, DOI 10.1107/S0021889802001474; Schilling SH, 2009, J BIOL CHEM, V284, P25160, DOI 10.1074/jbc.M109.012484; Shaw E, 2002, PROTEINS, V47, P163, DOI 10.1002/prot.10083; Shelton DN, 2006, CANCER RES, V66, P7571, DOI 10.1158/0008-5472.CAN-06-1067; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Todd AE, 2002, STRUCTURE, V10, P1435, DOI 10.1016/S0969-2126(02)00861-4; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vervoorts J, 2006, J BIOL CHEM, V281, P34725, DOI 10.1074/jbc.R600017200; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang LF, 2008, CELL PHYSIOL BIOCHEM, V21, P239, DOI 10.1159/000113765; Wang WQ, 2009, INT J CANCER, V124, P521, DOI 10.1002/ijc.23961; Yao LB, 2008, ACTA BIOCH BIOPH SIN, V40, P625, DOI 10.1111/j.1745-7270.2008.00434.x; Zelko I, 2001, MOL CELL BIOL, V21, P2838, DOI 10.1128/MCB.21.8.2838-2846.2001; Zhao HD, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-303	60	57	64	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14					12450	12460		10.1074/jbc.M110.170803	http://dx.doi.org/10.1074/jbc.M110.170803			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21247902	hybrid, Green Submitted, Green Published			2022-12-27	WOS:000289077500059
J	Jung, GH; Barylko, B; Lu, DM; Shu, HJ; Yin, H; Albanesi, JP				Jung, Gwanghyun; Barylko, Barbara; Lu, Dongmei; Shu, Hongjun; Yin, Helen; Albanesi, Joseph P.			Stabilization of Phosphatidylinositol 4-Kinase Type II beta by Interaction with Hsp90	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONES; PROTEIN; MEMBRANE; GELDANAMYCIN; KINASE; PROTEASOME; PHOSPHOINOSITIDES; DEGRADATION; ACTIVATION; COMPLEX	Mammalian cells express two isoforms of type II phosphatidylinositol 4-kinase: PI4KII alpha and PI4KII beta. PI4KII alpha exists almost exclusively as a constitutively active integral membrane protein because of its palmitoylation (Barylko, B., Gerber, S. H., Binns, D. D., Grichine, N., Khvotchev, M., Sudhof, T. C., and Albanesi, J. P. (2001) J. Biol. Chem. 276, 7705-7708). In contrast, PI4KII beta is distributed almost evenly between membranes and cytosol. Whereas the palmitoylated membrane-bound pool is catalytically active, the cytosolic kinase is inactive (Wei, Y. J., Sun, H. Q., Yamamoto, M., Wlodarski, P., Kunii, K., Martinez, M., Barylko, B., Albanesi, J. P., and Yin, H. L. (2002) J. Biol. Chem. 277, 46586-46593; Jung, G., Wang, J., Wlodarski, P., Barylko, B., Binns, D. D., Shu, H., Yin, H. L., and Albanesi, J. P. (2008) Biochem. J. 409, 501-509). In this study, we identify the molecular chaperone Hsp90 as a binding partner of PI4KII beta, but not of PI4KII alpha. Geldanamycin (GA), a specific Hsp90 inhibitor, disrupts the Hsp90-PI4KII beta interaction and destabilizes PI4KII beta, reducing its half-life by 40% and increasing its susceptibility to ubiquitylation and proteasomal degradation. Cytosolic PI4KII beta is much more sensitive to GA treatment than is the integrally membrane-associated species. Exposure to GA induces a partial redistribution of PI4KII beta from the cytosol to membranes and, with brief GA treatments, a corresponding increase in cellular phosphatidylinositol 4-kinase activity. Stimuli such as PDGF receptor activation that also induce recruitment of the kinase to membranes disrupt the Hsp90-PI4KII beta interaction to a similar extent as GA treatment. These results support a model wherein Hsp90 interacts predominantly with the cytosolic, inactive pool of PI4KII beta, shielding it from proteolytic degradation but also sequestering it to the cytosol until an extracellular stimulus triggers its translocation to the Golgi or plasma membrane and subsequent activation.	[Jung, Gwanghyun; Barylko, Barbara; Shu, Hongjun; Albanesi, Joseph P.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75239 USA; [Lu, Dongmei; Yin, Helen] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75239 USA; [Shu, Hongjun] Univ Cincinnati, Dept Mol Oncogenesis, Genome Res Inst, Cincinnati, OH 45237 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University System of Ohio; University of Cincinnati	Albanesi, JP (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Ln, Dallas, TX 75390 USA.	Joseph.Albanesi@UTSouthwestern.edu			National Institutes of Health [R01 GM075401, R01 GM066110]; American Heart Association Texas [0455005Y, 46259]; National Science Foundation [9982061]; Robert A. Welch Foundation [I-1200]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066110, R01GM075401] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Texas(American Heart Association); National Science Foundation(National Science Foundation (NSF)); Robert A. Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM075401 (to J. P. A.) and R01 GM066110 (to H. Y.). This work was also supported by American Heart Association Texas Affiliate Grants 0455005Y and 46259 (to J. P. A.), National Science Foundation Grant 9982061 (to B. B.), and Robert A. Welch Foundation Grant I-1200 (to H. Y.).	An WG, 2000, CELL GROWTH DIFFER, V11, P355; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Barylko B, 2001, J BIOL CHEM, V276, P7705, DOI 10.1074/jbc.C000861200; Barylko B, 2002, J BIOL CHEM, V277, P44366, DOI 10.1074/jbc.M203241200; Barylko B, 2009, J BIOL CHEM, V284, P9994, DOI 10.1074/jbc.M900724200; Caplan AJ, 2007, TRENDS CELL BIOL, V17, P87, DOI 10.1016/j.tcb.2006.12.002; Citri A, 2006, J BIOL CHEM, V281, P14361, DOI 10.1074/jbc.M512613200; De Matteis MA, 2004, NAT CELL BIOL, V6, P487, DOI 10.1038/ncb0604-487; De Matteis MA, 2002, CURR OPIN CELL BIOL, V14, P434, DOI 10.1016/S0955-0674(02)00357-5; Donze O, 2001, EMBO J, V20, P3771, DOI 10.1093/emboj/20.14.3771; Fernandis AZ, 2000, MOL IMMUNOL, V37, P273, DOI 10.1016/S0161-5890(00)00053-5; FLANAGAN CA, 1992, J BIOL CHEM, V267, P24117; Fujita N, 2002, J BIOL CHEM, V277, P10346, DOI 10.1074/jbc.M106736200; Gamper N, 2007, NAT REV NEUROSCI, V8, P921, DOI 10.1038/nrn2257; Grenert JP, 1997, J BIOL CHEM, V272, P23843, DOI 10.1074/jbc.272.38.23843; Haucke V, 2007, CURR OPIN CELL BIOL, V19, P426, DOI 10.1016/j.ceb.2007.06.003; Heilmeyer LMG, 2003, IUBMB LIFE, V55, P59, DOI 10.1080/1521654031000090896; Janmey PA, 2004, NAT REV MOL CELL BIO, V5, P658, DOI 10.1038/nrm1434; Jung G, 2008, BIOCHEM J, V409, P501, DOI 10.1042/BJ20070821; Koga F, 2006, P NATL ACAD SCI USA, V103, P11318, DOI 10.1073/pnas.0604705103; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mayer MP, 1999, CURR BIOL, V9, pR322, DOI 10.1016/S0960-9822(99)80203-6; Mimnaugh EG, 1996, J BIOL CHEM, V271, P22796, DOI 10.1074/jbc.271.37.22796; Minogue S, 2006, J CELL SCI, V119, P571, DOI 10.1242/jcs.02752; Nomura M, 2005, BIOCHEM BIOPH RES CO, V335, P900, DOI 10.1016/j.bbrc.2005.07.160; PETERSON GL, 1979, ANAL BIOCHEM, V100, P201, DOI 10.1016/0003-2697(79)90222-7; Pizarro-Cerda J, 2007, CELL MICROBIOL, V9, P2381, DOI 10.1111/j.1462-5822.2007.00967.x; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Roth MG, 2004, PHYSIOL REV, V84, P699, DOI 10.1152/physrev.00033.2003; Schulte TW, 1997, BIOCHEM BIOPH RES CO, V239, P655, DOI 10.1006/bbrc.1997.7527; Shay KP, 2005, MOL CANCER RES, V3, P170; Terasawa K, 2005, J BIOCHEM, V137, P443, DOI 10.1093/jb/mvi056; Toker A, 2002, CELL MOL LIFE SCI, V59, P761, DOI 10.1007/s00018-002-8465-z; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tucker DE, 2008, J LEUKOCYTE BIOL, V84, P798, DOI 10.1189/jlb.0308197; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Wei YJ, 2002, J BIOL CHEM, V277, P46586, DOI 10.1074/jbc.M206860200; Whitesell L, 1997, ONCOGENE, V14, P2809, DOI 10.1038/sj.onc.1201120; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492	44	18	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.178616	http://dx.doi.org/10.1074/jbc.M110.178616			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21330372	Green Published, hybrid			2022-12-27	WOS:000289077500088
J	Klein, RR; Bourdon, DM; Costales, CL; Wagner, CD; White, WL; Williams, JD; Hicks, SN; Sondek, J; Thakker, DR				Klein, Ryan R.; Bourdon, David M.; Costales, Chester L.; Wagner, Craig D.; White, Wendy L.; Williams, Jon D.; Hicks, Stephanie N.; Sondek, John; Thakker, Dhiren R.			Direct Activation of Human Phospholipase C by Its Well Known Inhibitor U73122	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIGHT JUNCTION PERMEABILITY; PROTEIN-KINASE-C; S-NITROSATION; PANCREATIC LIPASE; CRYSTAL-STRUCTURE; PHOSPHOINOSITIDE HYDROLYSIS; COVALENT MODIFICATION; GASTRIC LIPASE; IN-VIVO; CELLS	Phospholipase C (PLC) enzymes are an important family of regulatory proteins involved in numerous cellular functions, primarily through hydrolysis of the polar head group from inositol- containing membrane phospholipids. U73122 (1-(6-((17 beta-3- methoxyestra-1,3,5(10)-trien-17-yl) amino)hexyl)-1H-pyrrole- 2,5-dione), one of only a few small molecules reported to inhibit the activity of these enzymes, has been broadly applied as a pharmacological tool to implicate PLCs in diverse experimental phenotypes. The purpose of this study was to develop a better understanding of molecular interactions between U73122 and PLCs. Hence, the effects of U73122 on human PLC beta 3 (hPLC beta 3) were evaluated in a cell-free micellar system. Surprisingly, U73122 increased the activity of hPLC beta 3 in a concentration- and time-dependent manner; up to an 8-fold increase in enzyme activity was observed with an EC50 = 13.6 +/- 5 mu M. Activation of hPLC beta 3 by U73122 required covalent modification of cysteines as evidenced by the observation that enzyme activation was attenuated by thiol-containing nucleophiles, L-cysteine and glutathione. Mass spectrometric analysis confirmed covalent reaction with U73122 at eight cysteines, although maximum activation was achieved without complete alkylation; the modified residues were identified by LC/MS/MS peptide sequencing. Interestingly, U73122 (10 mu M) also activated hPLC gamma 1 (> 10-fold) and hPLC beta 2 (similar to 2-fold); PLC delta 1 was neither activated nor inhibited. Therefore, in contrast to its reported inhibitory potential, U73122 failed to inhibit several purified PLCs. Most of these PLCs were directly activated by U73122, and a simple mechanism for the activation is proposed. These results strongly suggest a need to re-evaluate the use of U73122 as a general inhibitor of PLC isozymes.	[Klein, Ryan R.; Costales, Chester L.; Thakker, Dhiren R.] Univ N Carolina, UNC Eshelman Sch Pharm, Div Mol Pharmaceut, Chapel Hill, NC 27599 USA; [Bourdon, David M.; Hicks, Stephanie N.; Sondek, John] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Klein, Ryan R.] GlaxoSmithKline Inc, Drug Metab & Pharmacokinet, Metab Pathways Ctr Excellence Drug Discovery, Res Triangle Pk, NC 27709 USA; [Wagner, Craig D.; White, Wendy L.; Williams, Jon D.] GlaxoSmithKline Inc, Mol Discovery Res, Computat & Struct Chem, Res Triangle Pk, NC 27709 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; GlaxoSmithKline; GlaxoSmithKline	Thakker, DR (corresponding author), Univ N Carolina, UNC Eshelman Sch Pharm, Div Mol Pharmaceut, CB 7355,Beard Hall, Chapel Hill, NC 27599 USA.	dhiren_thakker@unc.edu		Sondek, John/0000-0002-1127-8310	National Institutes of Health [R01-GM057391]; GlaxoSmithKline for dissertation research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062299, R01GM057391] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GlaxoSmithKline for dissertation research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM057391 (to J. S.).; Supported by GlaxoSmithKline for dissertation research.	Aloulou A, 2006, BBA-MOL CELL BIOL L, V1761, P995, DOI 10.1016/j.bbalip.2006.06.009; BALDA MS, 1991, J MEMBRANE BIOL, V122, P193, DOI 10.1007/BF01871420; Berg OG, 1998, BIOCHEMISTRY-US, V37, P6615, DOI 10.1021/bi972998p; BLEASDALE JE, 1989, ADV PROSTAG THROMB L, V19, P590; Burgdorf C, 2010, J CARDIOVASC PHARM, V55, P555, DOI 10.1097/FJC.0b013e3181d8bec5; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; Carvou N, 2007, CELL SIGNAL, V19, P42, DOI 10.1016/j.cellsig.2006.05.023; CEREIJIDO M, 1993, J CELL SCI, P127; Chen YJ, 2006, J BIOMED SCI, V13, P667, DOI 10.1007/s11373-006-9100-z; EGLOFF MP, 1995, PROTEIN SCI, V4, P44; Enyeart JJ, 2005, J BIOL CHEM, V280, P30814, DOI 10.1074/jbc.M504283200; Feisst C, 2005, MOL PHARMACOL, V67, P1751, DOI 10.1124/mol.105.011007; Fratti RA, 2007, J BIOL CHEM, V282, P14861, DOI 10.1074/jbc.M700971200; Gloyna W, 2005, REGUL PEPTIDES, V125, P179, DOI 10.1016/j.regpep.2004.08.023; GOLDSMITH EJ, 1989, SCIENCE, V245, P528, DOI 10.1126/science.2756432; Gresset A, 2010, J BIOL CHEM, V285, P35836, DOI 10.1074/jbc.M110.166512; Han S, 2005, J BIOL CHEM, V280, P38228, DOI 10.1074/jbc.M508130200; Hancock JF, 2005, BIOCHEM J, V389, P1, DOI 10.1042/BJ20050231; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; Handy DE, 2006, ARTERIOSCL THROM VAS, V26, P1207, DOI 10.1161/01.ATV.0000217632.98717.a0; Harden TK, 2006, ANNU REV PHARMACOL, V46, P355, DOI 10.1146/annurev.pharmtox.46.120604.141223; Hicks SN, 2008, MOL CELL, V31, P383, DOI 10.1016/j.molcel.2008.06.018; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Hong JH, 2006, J BIOL CHEM, V281, P13057, DOI 10.1074/jbc.M601726200; Horowitz LF, 2005, J GEN PHYSIOL, V126, P243, DOI 10.1085/jgp.200509309; Hou CF, 2004, J PHARMACOL EXP THER, V309, P697, DOI 10.1124/jpet.103.060574; Hughes SACF, 2000, N-S ARCH PHARMACOL, V362, P555; JAMES SR, 1995, J BIOL CHEM, V270, P11872, DOI 10.1074/jbc.270.20.11872; James SR, 1996, BIOCHEM J, V314, P917, DOI 10.1042/bj3140917; Jezyk MR, 2006, NAT STRUCT MOL BIOL, V13, P1135, DOI 10.1038/nsmb1175; Ji QS, 1997, P NATL ACAD SCI USA, V94, P2999, DOI 10.1073/pnas.94.7.2999; Jones NP, 2005, J CELL SCI, V118, P2695, DOI 10.1242/jcs.02374; Klose A, 2008, MOL PHARMACOL, V74, P1203, DOI 10.1124/mol.108.047837; Konorev EA, 2000, FREE RADICAL BIO MED, V28, P1671, DOI 10.1016/S0891-5849(00)00281-1; MacMillan D, 2010, BRIT J PHARMACOL, V160, P1295, DOI 10.1111/j.1476-5381.2010.00771.x; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Mariappan MM, 2005, J BIOL CHEM, V280, P28402, DOI 10.1074/jbc.M504861200; Miersch S, 2005, CLIN BIOCHEM, V38, P777, DOI 10.1016/j.clinbiochem.2005.05.014; Mitchell DA, 2005, NAT CHEM BIOL, V1, P154, DOI 10.1038/nchembio720; Nebigil CG, 1997, BIOCHEMISTRY-US, V36, P15949, DOI 10.1021/bi971721m; Ohki SY, 2003, J MOL BIOL, V326, P1539, DOI 10.1016/S0022-2836(03)00048-2; Ohki SY, 2001, J MOL BIOL, V314, P839, DOI 10.1006/jmbi.2001.5200; Pulcinelli FM, 1998, BIOCHEM PHARMACOL, V56, P1481, DOI 10.1016/S0006-2952(98)00146-4; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; RHEE SG, 1989, SCIENCE, V244, P546, DOI 10.1126/science.2541501; RHEE SG, 1992, J BIOL CHEM, V267, P12393; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; Roussel A, 2002, J BIOL CHEM, V277, P2266, DOI 10.1074/jbc.M109484200; Roussel A, 1999, J BIOL CHEM, V274, P16995, DOI 10.1074/jbc.274.24.16995; Saario SM, 2005, CHEM BIOL, V12, P649, DOI 10.1016/j.chembiol.2005.04.013; SMITH RJ, 1990, J PHARMACOL EXP THER, V253, P688; Suzuki Y, 2006, J BIOL CHEM, V281, P28499, DOI 10.1074/jbc.M604291200; Tannenbaum SR, 2005, NAT CHEM BIOL, V1, P126, DOI 10.1038/nchembio0805-126; Thomas A, 2005, J BIOL CHEM, V280, P40074, DOI 10.1074/jbc.M502123200; THOMPSON AK, 1991, J BIOL CHEM, V266, P23856; Van Itallie CM, 2005, J CELL SCI, V118, P1427, DOI 10.1242/jcs.01735; Wagner CD, 2007, J MASS SPECTROM, V42, P139, DOI 10.1002/jms.1174; Wang YH, 2007, AM J PHYSIOL-CELL PH, V292, pC1775, DOI 10.1152/ajpcell.00420.2006; Ward PD, 2003, J PHARMACOL EXP THER, V304, P689, DOI 10.1124/jpet.102.043638; Ward PD, 2002, J BIOL CHEM, V277, P35760, DOI 10.1074/jbc.M203134200; Wei YA, 2007, J BIOL CHEM, V282, P6455, DOI 10.1074/jbc.M607477200; Wilsher N, 2007, DRUG METAB DISPOS, V35, P1017, DOI 10.1124/dmd.106.014498; WINKLER FK, 1990, NATURE, V343, P771, DOI 10.1038/343771a0; Yang YQ, 2000, J LIPID RES, V41, P48; Yu CX, 2005, MOL PHARMACOL, V68, P847, DOI 10.1124/mol.104.010504	66	41	46	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.191783	http://dx.doi.org/10.1074/jbc.M110.191783			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21266572	Green Published, hybrid			2022-12-27	WOS:000289077500055
J	Ortega, E; Buey, RM; Sonnenberg, A; de Pereda, JM				Ortega, Esther; Buey, Ruben M.; Sonnenberg, Arnoud; de Pereda, Jose M.			The Structure of the Plakin Domain of Plectin Reveals a Non-canonical SH3 Domain Interacting with Its Fourth Spectrin Repeat	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-BINDING DOMAIN; INTEGRIN BETA-4 SUBUNIT; INTERMEDIATE-FILAMENTS; EPIDERMOLYSIS-BULLOSA; CRYSTAL-STRUCTURE; DIFFRACTION DATA; PROTEINS; ASSOCIATION; INSIGHTS; PROGRAM	Plectin belongs to the plakin family of cytoskeletal crosslinkers, which is part of the spectrin superfamily. Plakins contain an N-terminal conserved region, the plakin domain, which is formed by an array of spectrin repeats (SR) and a Src-homology 3 (SH3), and harbors binding sites for junctional proteins. We have combined x-ray crystallography and small angle x-ray scattering (SAXS) to elucidate the structure of the central region of the plakin domain of plectin, which corresponds to the SR3, SR4, SR5, and SH3 domains. The crystal structures of the SR3-SR4 and SR4-SR5-SH3 fragments were determined to 2.2 and 2.95 angstrom resolution, respectively. The SH3 of plectin presents major alterations as compared with canonical Pro-rich binding SH3 domains, suggesting that plectin does not recognize Pro-rich motifs. In addition, the SH3 binding site is partially occluded by an intramolecular contact with the SR4. Residues of this pseudo-binding site and the SR4/SH3 interface are conserved within the plakin family, suggesting that the structure of this part of the plectin molecule is similar to that of other plakins. We have created a model for the SR3-SR4-SR5-SH3 region, which agrees well with SAXS data in solution. The three SRs form a semi-flexible rod that is not altered by the presence of the SH3 domain, and it is similar to those found in spectrins. The flexibility of the plakin domain, in analogy with spectrins, might contribute to the role of plakins in maintaining the stability of tissues subject to mechanical stress.	[Ortega, Esther; Buey, Ruben M.; de Pereda, Jose M.] Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, E-37007 Salamanca, Spain; [Buey, Ruben M.] Paul Scherrer Inst, Lab Biomol Res, CH-5232 Villigen, Switzerland; [Sonnenberg, Arnoud] Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Netherlands Cancer Institute	de Pereda, JM (corresponding author), Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, Campus Unamuno, E-37007 Salamanca, Spain.	pereda@usal.es	Martinez-Buey, Ruben/K-4296-2014; de Pereda, Jose M/F-1733-2010; de Pereda, Jose M/AAE-5226-2022; Ortega, Esther/AAB-1836-2020	Martinez-Buey, Ruben/0000-0003-1263-0221; de Pereda, Jose M/0000-0002-8912-6739; de Pereda, Jose M/0000-0002-8912-6739; 	Spanish Ministry of Science and Innovation [BES-2007-16463]; European Regional Development Fund [BFU2006-01929, BFU2009-08389]; Netherlands Science Foundation; Dutch Cancer Society; FEBS; Juan de la Cierva Program	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development Fund(European Commission); Netherlands Science Foundation(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Society(KWF Kankerbestrijding); FEBS; Juan de la Cierva Program	This work was supported by the Spanish Ministry of Science and Innovation and the European Regional Development Fund (Grants BFU2006-01929 and BFU2009-08389, to J. M. dP.). This work was also supported by grants from the Netherlands Science Foundation and the Dutch Cancer Society (to A. S.).; Recipient of a fellowship from the Spanish Ministry of Science and Innovation (BES-2007-16463).; Recipient of an FEBS fellowship and a contract from the Juan de la Cierva Program.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Afonine PV, 2005, CCP4 NEWSL, V42; Alonso-Garcia N, 2009, ACTA CRYSTALLOGR D, V65, P858, DOI 10.1107/S0907444909018745; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baines AJ, 2003, CELL MOL BIOL LETT, V8, P195; Baines AJ, 2009, BIOCHEM SOC T, V37, P796, DOI 10.1042/BST0370796; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de la Torre JG, 2000, BIOPHYS J, V78, p401A; de Pereda JM, 2009, CELL ADHES MIGR, V3, P361, DOI 10.4161/cam.3.4.9525; de Pereda JM, 2009, EMBO J, V28, P1180, DOI 10.1038/emboj.2009.48; DeLano W.L, PYMOL MOL GRAPHICS S; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Eger A, 1997, J CELL SCI, V110, P1307; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FOISNER R, 1988, J CELL BIOL, V106, P723, DOI 10.1083/jcb.106.3.723; Fontao L, 2001, J CELL SCI, V114, P2065; Garcia-Alvarez B, 2003, STRUCTURE, V11, P615, DOI 10.1016/S0969-2126(03)00090-X; Grum VL, 1999, CELL, V98, P523, DOI 10.1016/S0092-8674(00)81980-7; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; HAZES B, 1988, PROTEIN ENG, V2, P119, DOI 10.1093/protein/2.2.119; HERRMANN H, 1987, J BIOL CHEM, V262, P1320; Hijikata T, 2008, J CELL SCI, V121, P2062, DOI 10.1242/jcs.021634; Ipsaro JJ, 2010, BLOOD, V115, P4093, DOI 10.1182/blood-2009-11-255604; Jefferson JJ, 2004, NAT REV MOL CELL BIO, V5, P542, DOI 10.1038/nrm1425; Jefferson JJ, 2007, J MOL BIOL, V366, P244, DOI 10.1016/j.jmb.2006.11.036; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kaneko T, 2008, FRONT BIOSCI-LANDMRK, V13, P4938, DOI 10.2741/3053; Ketema M, 2007, J CELL SCI, V120, P3384, DOI 10.1242/jcs.014191; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Koster J, 2004, MOL BIOL CELL, V15, P1211, DOI 10.1091/mbc.E03-09-0697; Koster J, 2003, J CELL SCI, V116, P387, DOI 10.1242/jcs.00241; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kusunoki H, 2004, STRUCTURE, V12, P645, DOI 10.1016/j.str.2004.02.022; Litjens SHM, 2006, TRENDS CELL BIOL, V16, P376, DOI 10.1016/j.tcb.2006.05.004; Litjens SHM, 2005, J BIOL CHEM, V280, P22270, DOI 10.1074/jbc.M411818200; Litjens SHM, 2003, MOL BIOL CELL, V14, P4039, DOI 10.1091/mbc.E03-05-0268; Lunter PC, 2002, BIOCHEM BIOPH RES CO, V296, P904, DOI 10.1016/S0006-291X(02)02007-7; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Musacchio A, 2003, ADV PROTEIN CHEM, V61, P211; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pascual J, 1997, BIOESSAYS, V19, P811, DOI 10.1002/bies.950190911; Pascual J, 1996, FEBS LETT, V383, P201, DOI 10.1016/0014-5793(96)00251-7; Pascual J, 1997, J MOL BIOL, V273, P740, DOI 10.1006/jmbi.1997.1344; Pfendner E, 2005, EXP DERMATOL, V14, P241, DOI 10.1111/j.0906-6705.2005.00324.x; Reipert S, 1999, EXP CELL RES, V252, P479, DOI 10.1006/excr.1999.4626; Rezniczek GA, 2007, J CELL BIOL, V176, P965, DOI 10.1083/jcb.200604179; Rezniczek GA, 2010, DERMATOL CLIN, V28, P33, DOI 10.1016/j.det.2009.10.004; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schroder R, 1999, EUR J CELL BIOL, V78, P288, DOI 10.1016/S0171-9335(99)80062-4; Schwarzenbacher R, 2004, ACTA CRYSTALLOGR D, V60, P1229, DOI 10.1107/S0907444904010145; SEIFERT GJ, 1992, EUR J CELL BIOL, V59, P138; Sevcik J, 2004, EUR J BIOCHEM, V271, P1873, DOI 10.1111/j.1432-1033.2004.04095.x; Sonnenberg A, 2007, EXP CELL RES, V313, P2189, DOI 10.1016/j.yexcr.2007.03.039; Sonnenberg A, 2007, J MOL BIOL, V368, P1379, DOI 10.1016/j.jmb.2007.02.090; Spurny R, 2007, J BIOL CHEM, V282, P8175, DOI 10.1074/jbc.M608473200; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svitkina TM, 1996, J CELL BIOL, V135, P991, DOI 10.1083/jcb.135.4.991; Toivola DM, 2010, TRENDS CELL BIOL, V20, P79, DOI 10.1016/j.tcb.2009.11.004; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VIRATA MLA, 1992, P NATL ACAD SCI USA, V89, P544, DOI 10.1073/pnas.89.2.544; Wilhelmsen K, 2005, J CELL BIOL, V171, P799, DOI 10.1083/jcb.200506083; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Ylanne J, 2001, STRUCTURE, V9, P597, DOI 10.1016/S0969-2126(01)00619-0; Zarrinpar Ali, 2003, Sci STKE, V2003, pRE8, DOI 10.1126/stke.2003.179.re8	67	37	37	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.197467	http://dx.doi.org/10.1074/jbc.M110.197467			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21288893	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000289077500057
J	Heyes, DJ; Levy, C; Sakuma, M; Robertson, DL; Scrutton, NS				Heyes, Derren J.; Levy, Colin; Sakuma, Michiyo; Robertson, David L.; Scrutton, Nigel S.			A Twin-track Approach Has Optimized Proton and Hydride Transfer by Dynamically Coupled Tunneling during the Evolution of Protochlorophyllide Oxidoreductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-DRIVEN ENZYME; CONFORMATIONAL-CHANGES; ACTIVATED ENZYME; PROTEIN DYNAMICS; SOLVENT; CATALYSIS; SITE; FLUCTUATIONS; MUTAGENESIS; ENZYMOLOGY	Protein dynamics are crucial for realizing the catalytic power of enzymes, but how enzymes have evolved to achieve catalysis is unknown. The light-activated enzyme protochlorophyllide oxidoreductase (POR) catalyzes sequential hydride and proton transfers in the photoexcited and ground states, respectively, and is an excellent system for relating the effects of motions to catalysis. Here, we have used the temperature dependence of isotope effects and solvent viscosity measurements to analyze the dynamics coupled to the hydride and proton transfer steps in three cyanobacterial PORs and a related plant enzyme. We have related the dynamic profiles of each enzyme to their evolutionary origin. Motions coupled to light-driven hydride transfer are conserved across all POR enzymes, but those linked to thermally activated proton transfer are variable. Cyanobacterial PORs require complex and solvent-coupled dynamic networks to optimize the proton donor-acceptor distance, but evolutionary pressures appear to have minimized such networks in plant PORs. POR from Gloeobacter violaceus has features of both the cyanobacterial and plant enzymes, suggesting that the dynamic properties have been optimized during the evolution of POR. We infer that the differing trajectories in optimizing a catalytic structure are related to the stringency of the chemistry catalyzed and define a functional adaptation in which active site chemistry is protected from the dynamic effects of distal mutations that might otherwise impact negatively on enzyme catalysis.	[Heyes, Derren J.; Levy, Colin; Sakuma, Michiyo; Scrutton, Nigel S.] Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester M1 7DM, Lancs, England; [Robertson, David L.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester; University of Manchester	Heyes, DJ (corresponding author), Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester M1 7DM, Lancs, England.	derren.heyes@manchester.ac.uk; nigel.scrutton@manchester.ac.uk		Levy, Colin/0000-0002-9724-310X; Heyes, Derren/0000-0002-7453-1571	Biotechnology and Biological Sciences Research Council, United Kingdom; Biotechnology and Biological Sciences Research Council [BB/D01963X/1] Funding Source: researchfish; BBSRC [BB/D01963X/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council, United Kingdom.	ANSARI A, 1992, SCIENCE, V256, P1796, DOI 10.1126/science.1615323; Bandaria JN, 2009, J AM CHEM SOC, V131, P10151, DOI 10.1021/ja902120t; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Durin G, 2009, BIOPHYS J, V96, P1902, DOI [10.1016/j.bpj.2008.10.065, 10.1016/j.bpj.200X.10.065]; Eisenmesser EZ, 2002, SCIENCE, V295, P1520, DOI 10.1126/science.1066176; Fenimore PW, 2004, P NATL ACAD SCI USA, V101, P14408, DOI 10.1073/pnas.0405573101; Fenimore PW, 2002, P NATL ACAD SCI USA, V99, P16047, DOI 10.1073/pnas.212637899; Garcia-Viloca M, 2004, SCIENCE, V303, P186, DOI 10.1126/science.1088172; Gupta RS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-24; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Heyes DJ, 2007, J BIOL CHEM, V282, P32015, DOI 10.1074/jbc.M706098200; Heyes DJ, 2006, J BIOL CHEM, V281, P26847, DOI 10.1074/jbc.M602943200; Heyes DJ, 2009, ANGEW CHEM INT EDIT, V48, P3850, DOI 10.1002/anie.200900086; Heyes DJ, 2009, J BIOL CHEM, V284, P3762, DOI 10.1074/jbc.M808548200; Heyes DJ, 2005, TRENDS BIOCHEM SCI, V30, P642, DOI 10.1016/j.tibs.2005.09.001; Johannissen LO, 2007, J PHYS CHEM B, V111, P2631, DOI 10.1021/jp066276w; Knapp MJ, 2002, J AM CHEM SOC, V124, P3865, DOI 10.1021/ja012205t; Knapp MJ, 2002, EUR J BIOCHEM, V269, P3113, DOI 10.1046/j.1432-1033.2002.03022.x; Kuznetsov AM, 1999, CAN J CHEM, V77, P1085, DOI 10.1139/cjc-77-5-6-1085; Lebedev N, 2001, BIOCHEMISTRY-US, V40, P12562, DOI 10.1021/bi0105025; Masgrau L, 2004, ARCH BIOCHEM BIOPHYS, V428, P41, DOI 10.1016/j.abb.2004.03.013; Masgrau L, 2006, SCIENCE, V312, P237, DOI 10.1126/science.1126002; Masuda T, 2004, PHOTOSYNTH RES, V81, P1, DOI 10.1023/B:PRES.0000028392.80354.7c; Nagel ZD, 2009, NAT CHEM BIOL, V5, P543, DOI 10.1038/nchembio.204; NELISSEN B, 1995, MOL BIOL EVOL, V12, P1166; Pisliakov AV, 2009, P NATL ACAD SCI USA, V106, P17359, DOI 10.1073/pnas.0909150106; Pudney CR, 2006, J AM CHEM SOC, V128, P14053, DOI 10.1021/ja0614619; Samuni U, 2007, J AM CHEM SOC, V129, P12756, DOI 10.1021/ja072342b; SUZUKI JY, 1995, P NATL ACAD SCI USA, V92, P3749, DOI 10.1073/pnas.92.9.3749; Sytina OA, 2008, NATURE, V456, P1001, DOI 10.1038/nature07354; Townley HE, 2001, PROTEINS, V44, P329, DOI 10.1002/prot.1098; Yahashiri A, 2008, CHEMPHYSCHEM, V9, P980, DOI 10.1002/cphc.200800067	34	22	22	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11849	11854		10.1074/jbc.M111.219626	http://dx.doi.org/10.1074/jbc.M111.219626			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21317291	Green Published, hybrid			2022-12-27	WOS:000288797100091
J	Yamamoto, K; Taketomi, Y; Isogai, Y; Miki, Y; Sato, H; Masuda, S; Nishito, Y; Morioka, K; Ishimoto, Y; Suzuki, N; Yokota, Y; Hanasaki, K; Ishikawa, Y; Ishii, T; Kobayashi, T; Fukami, K; Ikeda, K; Nakanishi, H; Taguchi, R; Murakamia, M				Yamamoto, Kei; Taketomi, Yoshitaka; Isogai, Yuki; Miki, Yoshimi; Sato, Hiroyasu; Masuda, Seiko; Nishito, Yasumasa; Morioka, Kiyokazu; Ishimoto, Yoshikazu; Suzuki, Noriko; Yokota, Yasunori; Hanasaki, Kohji; Ishikawa, Yukio; Ishii, Toshiharu; Kobayashi, Tetsuyuki; Fukami, Kiyoko; Ikeda, Kazutaka; Nakanishi, Hiroki; Taguchi, Ryo; Murakamia, Makoto			Hair Follicular Expression and Function of Group X Secreted Phospholipase A(2) in Mouse Skin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIATION-DEPENDENT REGULATION; PROSTAGLANDIN E-2 PRODUCTION; CYCLOOXYGENASE-2 OVEREXPRESSION; HUMAN KERATINOCYTES; ARACHIDONIC-ACID; STRATUM-CORNEUM; DEFICIENT MICE; EPIDERMAL DIFFERENTIATION; REGRESSION CATAGEN; MASS-SPECTROMETRY	Although perturbed lipid metabolism can often lead to skin abnormality, the role of phospholipase A(2) (PLA(2)) in skin homeostasis is poorly understood. In the present study we found that group X-secreted PLA(2) (sPLA(2)-X) was expressed in the outermost epithelium of hair follicles in synchrony with the anagen phase of hair cycling. Transgenic mice overexpressing sPLA(2)-X (PLA2G10-Tg) displayed alopecia, which was accompanied by hair follicle distortion with reduced expression of genes related to hair development, during a postnatal hair cycle. Additionally, the epidermis and sebaceous glands of PLA2G10-Tg skin were hyperplasic. Proteolytic activation of sPLA(2)-X in PLA2G10-Tg skin was accompanied by preferential hydrolysis of phosphatidylethanolamine species with polyunsaturated fatty acids as well as elevated production of some if not all eicosanoids. Importantly, the skin of Pla2g10-deficient mice had abnormal hair follicles with noticeable reduction in a subset of hair genes, a hypoplasic outer root sheath, a reduced number of melanin granules, and unexpected up-regulation of prostanoid synthesis. Collectively, our study highlights the spatiotemporal expression of sPLA(2)-X in hair follicles, the presence of skin-specific machinery leading to sPLA(2)-X activation, a functional link of sPLA(2)-X with hair follicle homeostasis, and compartmentalization of the prostanoid pathway in hair follicles and epidermis.	[Yamamoto, Kei; Taketomi, Yoshitaka; Isogai, Yuki; Miki, Yoshimi; Sato, Hiroyasu; Masuda, Seiko; Murakamia, Makoto] Tokyo Metropolitan Inst Med Sci, Lipid Metab Project, Setagaya Ku, Tokyo 1568506, Japan; [Nishito, Yasumasa] Tokyo Metropolitan Inst Med Sci, Core Technol & Res Ctr, Setagaya Ku, Tokyo 1568506, Japan; [Morioka, Kiyokazu] Tokyo Metropolitan Inst Med Sci, Electron Microscope Lab, Setagaya Ku, Tokyo 1568506, Japan; [Taketomi, Yoshitaka; Miki, Yoshimi; Sato, Hiroyasu; Masuda, Seiko] Showa Univ, Sch Pharmaceut Sci, Dept Hlth Chem, Shinagawa Ku, Tokyo 1428555, Japan; [Isogai, Yuki; Kobayashi, Tetsuyuki] Ochanomizu Univ, Fac Sci, Dept Biol, Bunkyo Ku, Tokyo 1128610, Japan; [Ishimoto, Yoshikazu; Suzuki, Noriko; Yokota, Yasunori; Hanasaki, Kohji] Shionogi & Co Ltd, Shionogi Res Labs, Osaka 5610825, Japan; [Ishikawa, Yukio; Ishii, Toshiharu] Toho Univ, Sch Med, Dept Pathol, Ohta Ku, Tokyo 1438540, Japan; [Fukami, Kiyoko] Tokyo Univ Pharm & Life Sci, Lab Genome & Biosignal, Hachioji, Tokyo 1920392, Japan; [Ikeda, Kazutaka; Nakanishi, Hiroki; Taguchi, Ryo] Univ Tokyo, Grad Sch Med, Dept Metabolome, Bunkyo Ku, Tokyo 1130033, Japan; [Ikeda, Kazutaka; Nakanishi, Hiroki; Taguchi, Ryo] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Murakamia, Makoto] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science; Showa University; Ochanomizu University; Shionogi & Company Limited; Tokyo University of Pharmacy & Life Sciences; University of Tokyo; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Murakamia, M (corresponding author), Tokyo Metropolitan Inst Med Sci, Lipid Metab Project, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	murakami-mk@igakuken.or.jp	Kobayashi, Tetsuyuki/AAH-2985-2020	Kobayashi, Tetsuyuki/0000-0002-9285-0859; Nakanishi, Hiroki/0000-0002-5108-1598	Ministry of Education, Science, Culture, Sports, and Technology of Japan; Japan Science and Technology Agency; Cosmetology Research; Nakatomi; Uehara Toray Foundation; Mitsubishi Science Foundation; Grants-in-Aid for Scientific Research [22116005] Funding Source: KAKEN	Ministry of Education, Science, Culture, Sports, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Cosmetology Research; Nakatomi; Uehara Toray Foundation; Mitsubishi Science Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in aid for Scientific Research (to M. M.) and for Young Investigators (to K. Y., Y. T., and H. S.) from the Ministry of Education, Science, Culture, Sports, and Technology of Japan, SHISEIDO Grants for Scientific Research (to K. Y.), PRESTO (to M. M.), and CREST (to R. T.) from the Japan Science and Technology Agency, and the Cosmetology Research, Nakatomi, Uehara Toray and Mitsubishi Science Foundations (to M. M.).	Alonso L, 2006, J CELL SCI, V119, P391, DOI 10.1242/jcs02793; Benavides F, 2002, AM J PATHOL, V161, P693, DOI 10.1016/S0002-9440(10)64225-3; Bezzine S, 2000, J BIOL CHEM, V275, P3179, DOI 10.1074/jbc.275.5.3179; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bol DK, 2002, CANCER RES, V62, P2516; Botchkarev VA, 1998, AM J PATHOL, V153, P785, DOI 10.1016/S0002-9440(10)65621-0; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Cho YM, 2003, J INVEST DERMATOL, V120, P715, DOI 10.1046/j.1523-1747.2003.12147.x; Colombe L, 2007, EXP DERMATOL, V16, P762, DOI 10.1111/j.1600-0625.2007.00586.x; Cordeddu V, 2009, NAT GENET, V41, P1022, DOI 10.1038/ng.425; Cupillard L, 1997, J BIOL CHEM, V272, P15745, DOI 10.1074/jbc.272.25.15745; Descargues P, 2005, NAT GENET, V37, P56, DOI 10.1038/ng1493; Eckl KM, 2005, HUM MUTAT, V26, P351, DOI 10.1002/humu.20236; Escoffier J, 2010, J CLIN INVEST, V120, P1415, DOI 10.1172/JCI40494; Fluhr JW, 2004, J INVEST DERMATOL, V122, P320, DOI 10.1046/j.0022-202X.2003.00204.x; Fluhr JW, 2001, J INVEST DERMATOL, V117, P44, DOI 10.1046/j.0022-202x.2001.01399.x; Foitzik K, 2000, FASEB J, V14, P752, DOI 10.1096/fasebj.14.5.752; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Fujioka D, 2008, CIRCULATION, V117, P2977, DOI 10.1161/CIRCULATIONAHA.107.743997; Glotzer DJ, 2008, DEV BIOL, V315, P459, DOI 10.1016/j.ydbio.2008.01.005; Grass DS, 1996, J CLIN INVEST, V97, P2233, DOI 10.1172/JCI118664; Gurrieri S, 2003, J INVEST DERMATOL, V121, P156, DOI 10.1046/j.1523-1747.2003.12315.x; Haas U, 2005, J INVEST DERMATOL, V124, P204, DOI 10.1111/j.0022-202X.2004.23513.x; Hanasaki K, 1999, J BIOL CHEM, V274, P34203, DOI 10.1074/jbc.274.48.34203; Hansen LA, 1997, AM J PATHOL, V150, P1959; Hansson L, 2002, J INVEST DERMATOL, V118, P444, DOI 10.1046/j.0022-202x.2001.01684.x; HEBERT JM, 1994, CELL, V78, P1017, DOI 10.1016/0092-8674(94)90276-3; Henderson WR, 2007, J EXP MED, V204, P865, DOI 10.1084/jem.20070029; Houjou T, 2004, RAPID COMMUN MASS SP, V18, P3123, DOI 10.1002/rcm.1737; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Ikeda K, 2010, RAPID COMMUN MASS SP, V24, P2957, DOI 10.1002/rcm.4716; Jong MC, 1998, J CLIN INVEST, V101, P145, DOI 10.1172/JCI791; Kang HY, 2004, BRIT J DERMATOL, V150, P462, DOI 10.1111/j.1365-2133.2004.05844.x; Karnik P, 2009, J INVEST DERMATOL, V129, P1243, DOI 10.1038/jid.2008.369; Kishibe M, 2007, J BIOL CHEM, V282, P5834, DOI 10.1074/jbc.M607998200; Klar J, 2009, AM J HUM GENET, V85, P248, DOI 10.1016/j.ajhg.2009.06.021; Klucky B, 2007, CANCER RES, V67, P8198, DOI 10.1158/0008-5472.CAN-07-0607; Kupper TS, 2004, NAT REV IMMUNOL, V4, P211, DOI 10.1038/nri1310; Lambeau G, 2008, ANNU REV BIOCHEM, V77, P495, DOI 10.1146/annurev.biochem.76.062405.154007; Lee JS, 2007, EXP DERMATOL, V16, P118, DOI 10.1111/j.1600-0625.2006.00521.x; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; Li N, 2010, P NATL ACAD SCI USA, V107, P3734, DOI 10.1073/pnas.0911377107; List K, 2003, J CELL BIOL, V163, P901, DOI 10.1083/jcb.200304161; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; MACPHEE M, 1995, CELL, V81, P957, DOI 10.1016/0092-8674(95)90015-2; MaoQiang M, 1996, J INVEST DERMATOL, V106, P57, DOI 10.1111/1523-1747.ep12327246; Masuda S, 2005, J BIOL CHEM, V280, P23203, DOI 10.1074/jbc.M500985200; Muller-Decker K, 2003, J INVEST DERMATOL, V121, P661, DOI 10.1046/j.1523-1747.2003.12473.x; Muller-Decker K, 2002, P NATL ACAD SCI USA, V99, P12483, DOI 10.1073/pnas.192323799; Murakami M, 2005, J BIOL CHEM, V280, P24987, DOI 10.1074/jbc.M502088200; Murakami M, 1999, J BIOL CHEM, V274, P31435, DOI 10.1074/jbc.274.44.31435; Murakami M, 2001, J BIOL CHEM, V276, P10083, DOI 10.1074/jbc.M007877200; Murakami M, 2010, BIOCHIMIE, V92, P561, DOI 10.1016/j.biochi.2010.03.015; Nakamura Y, 2003, EMBO J, V22, P2981, DOI 10.1093/emboj/cdg302; Nakamura Y, 2008, FASEB J, V22, P841, DOI 10.1096/fj.07-9239com; Neufang G, 2001, P NATL ACAD SCI USA, V98, P7629, DOI 10.1073/pnas.121574098; Ninomiya Y, 2007, J STEROID BIOCHEM, V103, P44, DOI 10.1016/j.jsbmb.2006.07.009; Ohtsuki M, 2006, J BIOL CHEM, V281, P36420, DOI 10.1074/jbc.M607975200; Pasternack SM, 2008, NAT GENET, V40, P329, DOI 10.1038/ng.84; Pena JC, 1999, EMBO J, V18, P3596, DOI 10.1093/emboj/18.13.3596; Rys-Sikora KE, 2003, J INVEST DERMATOL, V120, P86, DOI 10.1046/j.1523-1747.2003.12001.x; Sato H, 2010, J CLIN INVEST, V120, P1400, DOI 10.1172/JCI40493; Sato H, 2008, J BIOL CHEM, V283, P33483, DOI 10.1074/jbc.M804628200; Schadow A, 2001, J INVEST DERMATOL, V116, P31, DOI 10.1046/j.1523-1747.2001.00179.x; Scott GA, 2006, J INVEST DERMATOL, V126, P855, DOI 10.1038/sj.jid.5700180; Shridas P, 2010, ARTERIOSCL THROM VAS, V30, P2014, DOI 10.1161/ATVBAHA.110.210237; Shridas P, 2010, J BIOL CHEM, V285, P20031, DOI 10.1074/jbc.M109.090423; Sung YM, 2006, ONCOGENE, V25, P5507, DOI 10.1038/sj.onc.1209538; Taguchi R, 2005, J CHROMATOGR B, V823, P26, DOI 10.1016/j.jchromb.2005.06.005; Tong XM, 2006, GENE DEV, V20, P1353, DOI 10.1101/gad.1387406; Torii E, 2002, BIOCHEM BIOPH RES CO, V290, P696, DOI 10.1006/bbrc.2001.6256; Vauclair S, 2005, DEV BIOL, V284, P184, DOI 10.1016/j.ydbio.2005.05.018; Westerberg R, 2004, J BIOL CHEM, V279, P5621, DOI 10.1074/jbc.M310529200; Xu LH, 2006, CANCER RES, V66, P11859, DOI 10.1158/0008-5472.CAN-06-1445; Yu ZY, 2005, BBA-MOL CELL BIOL L, V1686, P238, DOI 10.1016/j.bbalip.2004.10.007; Yuhki M, 2004, DEVELOPMENT, V131, P1825, DOI 10.1242/dev.01079; Zack M, 2011, ATHEROSCLEROSIS, V214, P58, DOI 10.1016/j.atherosclerosis.2010.08.054; Zeeuwen PLJM, 2004, EUR J CELL BIOL, V83, P761, DOI 10.1078/0171-9335-00388; Zeeuwen PLJM, 2004, HUM MOL GENET, V13, P1069, DOI 10.1093/hmg/ddh115; Zheng Y, 1999, NAT GENET, V23, P268, DOI 10.1038/15446	81	24	24	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11616	11631		10.1074/jbc.M110.206714	http://dx.doi.org/10.1074/jbc.M110.206714			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21266583	hybrid, Green Published			2022-12-27	WOS:000288797100071
J	Frandsen, RJN; Schutt, C; Lund, BW; Staerk, D; Nielsen, J; Olsson, S; Giese, H				Frandsen, Rasmus J. N.; Schutt, Claes; Lund, Birgitte W.; Staerk, Dan; Nielsen, John; Olsson, Stefan; Giese, Henriette			Two Novel Classes of Enzymes Are Required for the Biosynthesis of Aurofusarin in Fusarium graminearum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; POLYKETIDE SYNTHASE GENES; FASCICLIN-LIKE PROTEIN; NIDULANS-WA-GENE; GIBBERELLA-ZEAE; SUBCELLULAR-LOCALIZATION; ASPERGILLUS-NIDULANS; FUNCTIONAL EXPRESSION; SCYTALONE DEHYDRATASE; FILAMENTOUS FUNGI	Previous studies have reported the functional characterization of 9 out of 11 genes found in the gene cluster responsible for biosynthesis of the polyketide pigment aurofusarin in Fusarium graminearum. Here we reanalyze the function of a putative aurofusarin pump (AurT) and the two remaining orphan genes, aurZ and aurS. Targeted gene replacement of aurZ resulted in the discovery that the compound YWA1, rather than nor-rubrofusarin, is the primary product of F. graminearum polyketide synthase 12 (FgPKS12). AurZ is the first representative of a novel class of dehydratases that act on hydroxylated gamma-pyrones. Replacement of the aurS gene resulted in accumulation of rubrofusarin, an intermediate that also accumulates when the GIP1, aurF, or aurO genes in the aurofusarin cluster are deleted. Based on the shared phenotype and predicted subcellular localization, we propose that AurS is a member of an extracellular enzyme complex (GIP1-AurF-AurO-AurS) responsible for converting rubrofusarin into aurofusarin. This implies that rubrofusarin, rather than aurofusarin, is pumped across the plasma membrane. Replacement of the putative aurofusarin pump aurT increased the rubrofusarin-to-aurofusarin ratio, supporting that rubrofusarin is normally pumped across the plasma membrane. These results provide functional information on two novel classes of proteins and their contribution to polyketide pigment biosynthesis.	[Frandsen, Rasmus J. N.] Tech Univ Denmark, Dept Syst Biol, Ctr Microbial Biotechnol, DK-2800 Lyngby, Denmark; [Frandsen, Rasmus J. N.; Olsson, Stefan] Univ Copenhagen, Dept Agr & Ecol, Fac Life Sci, DK-1870 Frederiksberg, Denmark; [Schutt, Claes; Lund, Birgitte W.; Staerk, Dan; Nielsen, John] Univ Copenhagen, Dept Basic Sci & Environm, Fac Life Sci, DK-1870 Frederiksberg, Denmark; [Giese, Henriette] Univ Aarhus, Fac Agr Sci, DK-8000 Aarhus, Denmark	Technical University of Denmark; University of Copenhagen; University of Copenhagen; Aarhus University	Frandsen, RJN (corresponding author), Tech Univ Denmark, Dept Syst Biol, Ctr Microbial Biotechnol, DK-2800 Lyngby, Denmark.	rasf@bio.dtu.dk	Staerk, Dan/X-6110-2018; Olsson, Stefan/H-2617-2014; Olsson, Stefan/I-5889-2019	Staerk, Dan/0000-0003-0074-298X; Olsson, Stefan/0000-0003-1931-9081; Olsson, Stefan/0000-0003-1931-9081; Frandsen, Rasmus John Normand/0000-0002-3799-6062; Giese, Henriette/0000-0002-5284-4155; Nielsen, John/0000-0002-2854-8188	Danish Ministry for Food, Agriculture and Fisheries; Danish Research Council for Technology and Production Sciences [274-06-0371]	Danish Ministry for Food, Agriculture and Fisheries; Danish Research Council for Technology and Production Sciences	This work was supported by a grant from the Danish Ministry for Food, Agriculture and Fisheries and by The Danish Research Council for Technology and Production Sciences (Grant 274-06-0371).	Adams MA, 2005, J BIOL CHEM, V280, P8358, DOI 10.1074/jbc.M412637200; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Bailey TL, 1994, P 2 INT C INT SYST M; Basarab GS, 1999, BIOCHEMISTRY-US, V38, P6012, DOI 10.1021/bi982952b; Bell AA, 2003, PEST MANAG SCI, V59, P736, DOI 10.1002/ps.713; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bills CE, 1931, J BIOL CHEM, V93, P775; Chatterjee S, 2001, CELL MOL LIFE SCI, V58, P1969, DOI 10.1007/PL00000831; Eisenhaber B, 2004, J MOL BIOL, V337, P243, DOI 10.1016/j.jmb.2004.01.025; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Engh I, 2007, FEMS MICROBIOL LETT, V275, P62, DOI 10.1111/j.1574-6968.2007.00867.x; Evers ME, 2004, ADV BIOCHEM ENG BIOT, V88, P111, DOI 10.1007/b99259; Frandsen RJN, 2006, MOL MICROBIOL, V61, P1069, DOI 10.1111/j.1365-2958.2006.05295.x; Frandsen RJN, 2010, EUKARYOT CELL, V9, P1225, DOI 10.1128/EC.00031-10; Gaffoor I, 2005, EUKARYOT CELL, V4, P1926, DOI 10.1128/EC.4.11.1926-1933.2005; Grocholski T, 2010, BIOCHEMISTRY-US, V49, P934, DOI 10.1021/bi901985b; Guldener U, 2006, NUCLEIC ACIDS RES, V34, pD436, DOI 10.1093/nar/gkj003; Hong SY, 2008, APPL ENVIRON MICROB, V74, P6385, DOI 10.1128/AEM.01185-08; Hong SY, 2009, MYCOL RES, V113, P591, DOI 10.1016/j.mycres.2009.01.013; Hoppert M, 2001, ARCH MICROBIOL, V176, P285, DOI 10.1007/s002030100324; HUBER O, 1994, EMBO J, V13, P4212, DOI 10.1002/j.1460-2075.1994.tb06741.x; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jordan DB, 2000, BIOCHEMISTRY-US, V39, P2276, DOI 10.1021/bi991839y; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kawamoto T, 1998, BBA-GENE STRUCT EXPR, V1395, P288, DOI 10.1016/S0167-4781(97)00172-3; Kim JE, 2000, J BIOL CHEM, V275, P30907, DOI 10.1074/jbc.M002752200; Kim JE, 2005, APPL ENVIRON MICROB, V71, P1701, DOI 10.1128/AEM.71.4.1701-1708.2005; Kim JE, 2008, PLANT PATHOLOGY J, V24, P8, DOI 10.5423/PPJ.2008.24.1.008; Kim YT, 2005, MOL MICROBIOL, V58, P1102, DOI 10.1111/j.1365-2958.2005.04884.x; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Langfelder K, 2003, FUNGAL GENET BIOL, V38, P143, DOI 10.1016/S1087-1845(02)00526-1; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee WC, 2008, J BIOL CHEM, V283, P30957, DOI 10.1074/jbc.M709486200; Lemieux M. Joanne, 2005, Journal of Structural and Functional Genomics, V6, P245, DOI 10.1007/s10969-005-9004-6; LENDENFELD T, 1993, J BIOL CHEM, V268, P665; Liu TB, 2009, J ZHEJIANG UNIV-SC B, V10, P434, DOI 10.1631/jzus.B0920017; Lysoe E, 2006, APPL ENVIRON MICROB, V72, P3924, DOI 10.1128/AEM.00963-05; Malz S, 2005, FUNGAL GENET BIOL, V42, P420, DOI 10.1016/j.fgb.2005.01.010; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Marin M, 2009, J BIOL CHEM, V284, P32709, DOI 10.1074/jbc.M109.024604; MAYORGA ME, 1990, GENETICS, V126, P73; Miyazaki Y, 2007, CURR GENET, V51, P367, DOI 10.1007/s00294-007-0133-2; Nielsen NJ, 2010, J AGR FOOD CHEM, V58, P5509, DOI 10.1021/jf903988f; Pain A, 2004, FUNGAL GENET BIOL, V41, P443, DOI 10.1016/j.fgb.2003.12.003; Pruess LM, 1932, J BIOL CHEM, V97, P483; Roze LV, 2011, FUNGAL GENET BIOL, V48, P35, DOI 10.1016/j.fgb.2010.05.006; Sato K, 2004, ARCH BIOCHEM BIOPHYS, V424, P1, DOI 10.1016/j.abb.2004.01.014; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Song ZS, 2004, CHEMBIOCHEM, V5, P1196, DOI 10.1002/cbic.200400138; STANDFORTH SP, 2006, NATURAL PRODUCT CHEM, P38; Thompson JE, 1998, ANAL BIOCHEM, V256, P1, DOI 10.1006/abio.1997.2489; Tobiasen C, 2007, CURR GENET, V51, P43, DOI 10.1007/s00294-006-0103-0; van de Kamp M, 1999, ANTON LEEUW INT J G, V75, P41, DOI 10.1023/A:1001775932202; Varga J, 2005, ACTA BIOL HUNG, V56, P375, DOI 10.1556/ABiol.56.2005.3-4.19; Watanabe A, 1999, TETRAHEDRON LETT, V40, P91, DOI 10.1016/S0040-4039(98)80027-0; Watanabe A, 2002, TETRAHEDRON LETT, V43, P843, DOI 10.1016/S0040-4039(01)02251-1; Zhu BG, 2007, BIOTECHNIQUES, V43, P356, DOI 10.2144/000112536	58	55	67	1	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10419	10428		10.1074/jbc.M110.179853	http://dx.doi.org/10.1074/jbc.M110.179853			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21296881	Green Published, hybrid			2022-12-27	WOS:000288547000058
J	Lin, MT; Shubin, AA; Samoilova, RI; Narasimhulu, KV; Baldansuren, A; Gennis, RB; Dikanov, SA				Lin, Myat T.; Shubin, Alexander A.; Samoilova, Rimma I.; Narasimhulu, Kuppala V.; Baldansuren, Amgalanbaatar; Gennis, Robert B.; Dikanov, Sergei A.			Exploring by Pulsed EPR the Electronic Structure of Ubisemiquinone Bound at the Q(H) Site of Cytochrome bo(3) from Escherichia coli with in Vivo C-13-Labeled Methyl and Methoxy Substituents	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-13-ENRICHED UBIQUINONE RADICALS; QUINONE-BINDING-SITES; CHROMOSOMAL GENES; REACTION CENTERS; FUNCTIONAL-ROLE; SPIN-RESONANCE; ESEEM SPECTRA; VITAMIN-K; SEMIQUINONE; OXIDASE	The cytochrome bo(3) ubiquinol oxidase from Escherichia coli resides in the bacterial cytoplasmic membrane and catalyzes the two-electron oxidation of ubiquinol-8 and four-electron reduction of O-2 to water. The one-electron reduced semiquinone forms transiently during the reaction, and the enzyme has been demonstrated to stabilize the semiquinone. The semiquinone is also formed in the D75E mutant, where the mutation has little influence on the catalytic activity, and in the D75H mutant, which is virtually inactive. In this work, wild-type cytochrome bo3 as well as the D75E and D75H mutant proteins were prepared with ubiquinone-8 C-13-labeled selectively at the methyl and two methoxy groups. This was accomplished by expressing the proteins in a methionine auxotroph in the presence of L-methionine with the side chain methyl group C-13-labeled. The C-13-labeled quinone isolated from cytochrome bo(3) was also used for the generation of model anion radicals in alcohol. Two-dimensional pulsed EPR and ENDOR were used for the study of the C-13 methyl and methoxy hyperfine couplings in the semiquinone generated in the three proteins indicated above and in the model system. The data were used to characterize the transferred unpaired spin densities on the methyl and methoxy substituents and the conformations of the methoxy groups. In the wild type and D75E mutant, the constraints on the configurations of the methoxy side chains are similar, but the D75H mutant appears to have altered methoxy configurations, which could be related to the perturbed electron distribution in the semiquinone and the loss of enzymatic activity.	[Lin, Myat T.; Baldansuren, Amgalanbaatar; Gennis, Robert B.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Narasimhulu, Kuppala V.; Dikanov, Sergei A.] Univ Illinois, Dept Vet Clin Med, Urbana, IL 61801 USA; [Shubin, Alexander A.] Russian Acad Sci, Boreskov Inst Catalysis, Novosibirsk 630090, Russia; [Samoilova, Rimma I.] Russian Acad Sci, Inst Chem Kinet & Combust, Novosibirsk 630090, Russia	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Boreskov Institute of Catalysis, Siberian Branch, Russian Academy of Sciences; Russian Academy of Sciences; Russian Academy of Sciences; Voevodsky Institute of Chemical Kinetics & Combustion SB RAS	Gennis, RB (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.	r-gennis@illinois.edu; dikanov@illinois.edu	Baldansuren, Amgalanbaatar/B-5555-2015; Shubin, Aleksandr A/E-9275-2012; Samoilova, Rimma Ivanovna/T-7956-2017	Baldansuren, Amgalanbaatar/0000-0001-8767-3731; Shubin, Aleksandr A/0000-0001-7920-3350; Samoilova, Rimma Ivanovna/0000-0002-1649-1487	National Institutes of Health [GM062954]; National Institutes of Health, NCRR [S10-RR15878]; Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Sciences, United States Department of Energy [DE-FG02-08ER15960, DE-FG02-87ER13716]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR015878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062954] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Sciences, United States Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM062954 (to S. A. D.) and National Institutes of Health, NCRR, Grant S10-RR15878 for instrumentation. This work was also supported by Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Sciences, United States Department of Energy Grants DE-FG02-08ER15960 (to S. A. D.) and DE-FG02-87ER13716 (to R. B. G.).	Abramson J, 2000, NAT STRUCT BIOL, V7, P910; Asher JR, 2008, THEOR CHEM ACC, V119, P477, DOI 10.1007/s00214-007-0408-1; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Boesch SE, 2009, CHEMPHYSCHEM, V10, P3187, DOI 10.1002/cphc.200900503; Burie JR, 1997, J PHYS CHEM B, V101, P6607, DOI 10.1021/jp970640x; Crofts AR, 2004, ANNU REV PHYSIOL, V66, P689, DOI 10.1146/annurev.physiol.66.032102.150251; DAS MR, 1970, J AM CHEM SOC, V92, P2258, DOI 10.1021/ja00711a011; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Derbise A, 2003, FEMS IMMUNOL MED MIC, V38, P113, DOI 10.1016/S0928-8244(03)00181-0; DIKANOV SA, 1995, J MAGN RESON SER A, V116, P125, DOI 10.1006/jmra.1995.1199; Fisher N, 2000, J MOL BIOL, V296, P1153, DOI 10.1006/jmbi.2000.3509; Frisch M. J., 2001, GAUSSIAN 98 REVISION; Grimaldi S, 2003, BIOCHEMISTRY-US, V42, P5632, DOI 10.1021/bi034010z; Gunner MR, 2008, J BIOENERG BIOMEMBR, V40, P509, DOI 10.1007/s10863-008-9179-1; Hellwig P, 2002, BIOCHEMISTRY-US, V41, P10675, DOI 10.1021/bi012146w; HOFER P, 1986, CHEM PHYS LETT, V132, P279, DOI 10.1016/0009-2614(86)80124-5; Horsefield R, 2006, J BIOL CHEM, V281, P7309, DOI 10.1074/jbc.M508173200; Hsu AY, 1996, BIOCHEMISTRY-US, V35, P9797, DOI 10.1021/bi9602932; INGLEDEW WJ, 1995, EUR J BIOCHEM, V227, P903, DOI 10.1111/j.1432-1033.1995.tb20217.x; JACKMAN LM, 1967, BIOCHIM BIOPHYS ACTA, V141, P1, DOI 10.1016/0304-4165(67)90239-5; KAGAN RM, 1994, ARCH BIOCHEM BIOPHYS, V310, P417, DOI 10.1006/abbi.1994.1187; Kern J, 2007, PHOTOSYNTH RES, V94, P183, DOI 10.1007/s11120-007-9201-1; KIRSTE B, 1987, MAGN RESON CHEM, V25, P166, DOI 10.1002/mrc.1260250216; Kobayashi K, 2000, BIOCHEMISTRY-US, V39, P15620, DOI 10.1021/bi0014094; Krivankova L, 1980, Methods Enzymol, V67, P111; Lin MT, 2008, J AM CHEM SOC, V130, P15768, DOI 10.1021/ja805906a; Lubitz W, 1999, APPL MAGN RESON, V17, P1, DOI 10.1007/BF03162067; MacMillan F, 1995, MAGN RESON CHEM, V33, pS81, DOI 10.1002/mrc.1260331314; MacMillan F, 2011, FARADAY DISCUSS, V148, P315, DOI 10.1039/c005149g; Mogi T, 1999, FEBS LETT, V457, P61, DOI 10.1016/S0014-5793(99)01007-8; MORTON JR, 1978, J MAGN RESON, V30, P577, DOI 10.1016/0022-2364(78)90284-6; O'Malley PJ, 1998, J PHYS CHEM A, V102, P248, DOI 10.1021/jp972467a; Ohnishi T, 2008, BIOFACTORS, V32, P13, DOI 10.1002/biof.5520320103; PERDEW JP, 1986, PHYS REV B, V33, P8800, DOI 10.1103/PhysRevB.33.8800; PRINCE RC, 1983, FEBS LETT, V160, P273, DOI 10.1016/0014-5793(83)80981-8; Puustinen A, 1996, P NATL ACAD SCI USA, V93, P1545, DOI 10.1073/pnas.93.4.1545; PUUSTINEN A, 1991, BIOCHEMISTRY-US, V30, P3936, DOI 10.1021/bi00230a019; ROBINSON HH, 1990, J AM CHEM SOC, V112, P4728, DOI 10.1021/ja00168a017; SAMOILOVA RI, 1995, J CHEM SOC PERK T 2, P2063, DOI 10.1039/p29950002063; SAMOILOVA RI, 1994, J CHEM SOC PERK T 2, P609, DOI 10.1039/p29940000609; Sato-Watanabe M, 1998, BIOCHEMISTRY-US, V37, P5356, DOI 10.1021/bi9727592; SATOWATANABE M, 1995, FEBS LETT, V374, P265, DOI 10.1016/0014-5793(95)01125-X; Schweiger A., 2001, PRINCIPLES PULSE ELE, P359; Srinivasan N, 2009, BBA-BIOENERGETICS, V1787, P1057, DOI 10.1016/j.bbabio.2009.04.010; Stoll S, 2005, J MAGN RESON, V177, P93, DOI 10.1016/j.jmr.2005.07.012; te Velde G, 2001, J COMPUT CHEM, V22, P931, DOI 10.1002/jcc.1056; vanLenthe E, 1996, J CHEM PHYS, V105, P6505, DOI 10.1063/1.472460; VANLENTHE E, 1993, J CHEM PHYS, V99, P4597, DOI 10.1063/1.466059; VANLENTHE E, 1994, J CHEM PHYS, V101, P9783, DOI 10.1063/1.467943; VANLIEMT WBS, 1994, RECL TRAV CHIM PAY B, V113, P153; VOSKO SH, 1980, CAN J PHYS, V58, P1200, DOI 10.1139/p80-159; Wraight CA, 2008, BBA-BIOENERGETICS, V1777, P631, DOI 10.1016/j.bbabio.2008.04.025; Yap LL, 2007, J BIOL CHEM, V282, P8777, DOI 10.1074/jbc.M611595200; Yap LL, 2006, J BIOL CHEM, V281, P16879, DOI 10.1074/jbc.M602544200; Yap LL, 2010, BBA-BIOENERGETICS, V1797, P1924, DOI 10.1016/j.bbabio.2010.04.011; YOUNG IG, 1971, J BACTERIOL, V105, P769, DOI 10.1128/JB.105.3.769-778.1971	56	19	19	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10105	10114		10.1074/jbc.M110.206821	http://dx.doi.org/10.1074/jbc.M110.206821			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21247900	hybrid, Green Published			2022-12-27	WOS:000288547000025
J	Boehm, M; Romero, E; Reisinger, V; Yu, JF; Komenda, J; Eichacker, LA; Dekker, JP; Nixon, PJ				Boehm, Marko; Romero, Elisabet; Reisinger, Veronika; Yu, Jianfeng; Komenda, Josef; Eichacker, Lutz A.; Dekker, Jan P.; Nixon, Peter J.			Investigating the Early Stages of Photosystem II Assembly in Synechocystis sp PCC 6803 ISOLATION OF CP47 AND CP43 COMPLEXES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENERGY CHLOROPHYLL STATES; ANTENNA PROTEIN COMPLEX; OXYGEN-EVOLVING CENTER; SP PCC-6803; CRYSTAL-STRUCTURE; SPECTROSCOPIC PROPERTIES; SYNECHOCOCCUS-ELONGATUS; ANGSTROM RESOLUTION; MANGANESE CLUSTER; CP43	Biochemical characterization of intermediates involved in the assembly of the oxygen-evolving Photosystem II (PSII) complex is hampered by their low abundance in the membrane. Using the cyanobacterium Synechocystis sp. PCC 6803, we describe here the isolation of the CP47 and CP43 subunits, which, during biogenesis, attach to a reaction center assembly complex containing D1, D2, and cytochrome b(559), with CP47 binding first. Our experimental approach involved a combination of His tagging, the use of a D1 deletion mutant that blocks PSII assembly at an early stage, and, in the case of CP47, the additional inactivation of the FtsH2 protease involved in degrading unassembled PSII proteins. Absorption spectroscopy and pigment analyses revealed that both CP47-His and CP43-His bind chlorophyll a and beta-carotene. A comparison of the low temperature absorption and fluorescence spectra in the Q(Y) region for CP47-His and CP43-His with those for CP47 and CP43 isolated by fragmentation of spinach PSII core complexes confirmed that the spectro-scopic properties are similar but not identical. The measured fluorescence quantum yield was generally lower for the proteins isolated from Synechocystis sp. PCC 6803, and a 1-3-nm blue shift and a 2-nm red shift of the 77 K emission maximum could be observed for CP47-His and CP43-His, respectively. Immunoblotting and mass spectrometry revealed the co-purification of PsbH, PsbL, and PsbT with CP47-His and of PsbK and Psb30/Ycf12 with CP43-His. Overall, our data support the view that CP47 and CP43 form preassembled pigment-protein complexes in vivo before their incorporation into the PSII complex.	[Nixon, Peter J.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England; [Romero, Elisabet; Dekker, Jan P.] Vrije Univ Amsterdam, Fac Sci, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands; [Reisinger, Veronika; Eichacker, Lutz A.] Univ Stavanger, Ctr Organelle Res CORE, N-4021 Stavanger, Norway; [Komenda, Josef] Acad Sci Czech Republ, Inst Microbiol, Trebon 37981, Czech Republic	Imperial College London; Vrije Universiteit Amsterdam; Universitetet i Stavanger; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Nixon, PJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Wolfson Biochem Bldg,S Kensington Campus, London SW7 2AZ, England.	p.nixon@imperial.ac.uk	Komenda, Josef/H-4083-2014	Komenda, Josef/0000-0003-4588-0382; Yu, Jianfeng/0000-0001-7174-3803; Romero, Elisabet/0000-0003-3630-1617; Nixon, Peter/0000-0003-1952-6937	Engineering and Physical Sciences Research Council (EPSRC) [EP/F002070X/1]; Czech Academy of Science Institutional Research Concept [AV0Z50200510, IAA400200801]; BBSRC [BB/F020554/1, BB/E006388/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F020554/1, BB/E006388/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Czech Academy of Science Institutional Research Concept; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Engineering and Physical Sciences Research Council (EPSRC) Grant EP/F002070X/1 and in part by Czech Academy of Science Institutional Research Concept AV0Z50200510 and Grant Project IAA400200801.	ALFONSO M, 1994, BIOCHEMISTRY-US, V33, P10494, DOI 10.1021/bi00200a034; Andronis C, 1998, PLANT PHYSIOL, V117, P515, DOI 10.1104/pp.117.2.515; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Boehm M, 2009, J BACTERIOL, V191, P6425, DOI 10.1128/JB.00644-09; Bricker TM, 1998, BBA-BIOENERGETICS, V1409, P50, DOI 10.1016/S0005-2728(98)00148-0; Bricker TM, 2002, PHOTOSYNTH RES, V72, P131, DOI 10.1023/A:1016128715865; Debus RJ, 2001, BIOCHEMISTRY-US, V40, P3690, DOI 10.1021/bi002394c; Dobakova M, 2007, PLANT PHYSIOL, V145, P1681, DOI 10.1104/pp.107.107805; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; GHANOTAKIS DF, 1989, BIOCHIM BIOPHYS ACTA, V974, P44, DOI 10.1016/S0005-2728(89)80164-1; Granvogl B, 2008, ANAL BIOCHEM, V383, P279, DOI 10.1016/j.ab.2008.08.038; Groot ML, 1999, BIOPHYS J, V77, P3328, DOI 10.1016/S0006-3495(99)77164-X; GROOT ML, 1995, BIOPHYS J, V68, P281, DOI 10.1016/S0006-3495(95)80186-4; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Hughes JL, 2006, BIOCHEMISTRY-US, V45, P12345, DOI 10.1021/bi0614683; Iwata S, 2004, CURR OPIN STRUC BIOL, V14, P447, DOI 10.1016/j.sbi.2004.07.002; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Komenda J, 2006, J BIOL CHEM, V281, P1145, DOI 10.1074/jbc.M503852200; Komenda J, 2005, PLANT CELL PHYSIOL, V46, P1477, DOI 10.1093/pcp/pci159; Komenda J, 2004, J BIOL CHEM, V279, P48620, DOI 10.1074/jbc.M405725200; KOMENDA J, 1995, BIOCHEMISTRY-US, V34, P9625, DOI 10.1021/bi00029a040; Krieger-Liszkay A, 2008, PHOTOSYNTH RES, V98, P551, DOI 10.1007/s11120-008-9349-3; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Manna P, 1997, EUR J BIOCHEM, V247, P666, DOI 10.1111/j.1432-1033.1997.00666.x; Muh F, 2008, PLANT PHYSIOL BIOCH, V46, P238, DOI 10.1016/j.plaphy.2008.01.003; Neupane B, 2010, J AM CHEM SOC, V132, P4214, DOI 10.1021/ja908510w; Nixon PJ, 2010, ANN BOT-LONDON, V106, P1, DOI 10.1093/aob/mcq059; NIXON PJ, 1995, J BIOL CHEM, V270, P14919, DOI 10.1074/jbc.270.25.14919; NIXON PJ, 1992, BIOCHEMISTRY-US, V31, P10859, DOI 10.1021/bi00159a029; Promnares K, 2006, J BIOL CHEM, V281, P32705, DOI 10.1074/jbc.M606360200; Reppert M, 2008, J PHYS CHEM B, V112, P9934, DOI 10.1021/jp8013749; Rokka A, 2005, BIOCHEM J, V388, P159, DOI 10.1042/BJ20042098; Schottkowski M, 2009, MOL PLANT, V2, P1289, DOI 10.1093/mp/ssp075; SHEN GZ, 1994, BIOCHEMISTRY-US, V33, P7379, DOI 10.1021/bi00189a044; Shen J.-R., 2010, 15 INT C PHOT BEIJ A; Sobotka R, 2005, J BIOL CHEM, V280, P31595, DOI 10.1074/jbc.M505976200; Sobotka R, 2008, J BIOL CHEM, V283, P25794, DOI 10.1074/jbc.M803787200; Sozer O, 2010, PLANT CELL PHYSIOL, V51, P823, DOI 10.1093/pcp/pcq031; Sugimoto I, 2003, J BIOL CHEM, V278, P45004, DOI 10.1074/jbc.M307537200; Sugiura M, 1999, PLANT CELL PHYSIOL, V40, P1219, DOI 10.1093/oxfordjournals.pcp.a029510; VANDORSSEN RJ, 1987, BIOCHIM BIOPHYS ACTA, V893, P267, DOI 10.1016/0005-2728(87)90048-X; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; Wydrzynski T. J., 2005, PHOTOSYSTEM; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	44	69	71	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14812	14819		10.1074/jbc.M110.207944	http://dx.doi.org/10.1074/jbc.M110.207944			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21339295	Green Published, hybrid			2022-12-27	WOS:000289788300011
J	Kansanen, E; Bonacci, G; Schopfer, FJ; Kuosmanen, SM; Tong, KI; Leinonen, H; Woodcock, SR; Yamamoto, M; Carlberg, C; Yla-Herttuala, S; Freeman, BA; Levonen, AL				Kansanen, Emilia; Bonacci, Gustavo; Schopfer, Francisco J.; Kuosmanen, Suvi M.; Tong, Kit I.; Leinonen, Hanna; Woodcock, Steven R.; Yamamoto, Masayuki; Carlberg, Carsten; Yla-Herttuala, Seppo; Freeman, Bruce A.; Levonen, Anna-Liisa			Electrophilic Nitro-fatty Acids Activate NRF2 by a KEAP1 Cysteine 151-independent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CUL3-BASED E3 LIGASE; OXIDATIVE STRESS; ENDOTHELIAL-CELLS; PHASE-2 RESPONSE; GENE-EXPRESSION; DEFENSE SYSTEM; SENSOR KEAP1; DLG MOTIFS; OLEIC ACID; PROTEIN	Nitro-fatty acids (NO2-FAs) are electrophilic signaling mediators formed in vivo via nitric oxide (NO)- and nitrite (NO2-)-dependent reactions. Nitro-fatty acids modulate signaling cascades via reversible covalent post-translational modification of nucleophilic amino acids in regulatory proteins and enzymes, thus altering downstream signaling events, such as Keap1-Nrf2-antioxidant response element (ARE)-regulated gene expression. In this study, we investigate the molecular mechanisms by which 9- and 10-nitro-octadec-9-enoic acid (OA-NO2) activate the transcription factor Nrf2, focusing on the post-translational modifications of cysteines in the Nrf2 inhibitor Keap1 by nitroalkylation and its downstream responses. Of the two regioisomers, 9-nitrooctadec-9-enoic acid was a more potent ARE inducer than 10-nitro-octadec-9-enoic acid. The most OA-NO2-reactive Cys residues in Keap1 were Cys(38), Cys(226), Cys(257), Cys(273), Cys(288), and Cys(489). Of these, Cys(273) and Cys(288) accounted for similar to 50% of OA-NO2 reactions in a cellular milieu. Notably, Cys(151) was among the least OA-NO2-reactive of the Keap1 Cys residues, with mutation of Cys(151) having no effect on net OA-NO2 reaction with Keap1 or on ARE activation. Unlike many other Nrf2-activating electrophiles, OA-NO2 enhanced rather than diminished the binding between Keap1 and the Cul3 subunit of the E3 ligase for Nrf2. OA-NO2 canthereforebe categorized as a Cys(151)-independent Nrf2 activator, which in turn can influence the pattern of gene expression and therapeutic actions of nitroalkenes.	[Bonacci, Gustavo; Schopfer, Francisco J.; Woodcock, Steven R.; Freeman, Bruce A.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Kansanen, Emilia; Leinonen, Hanna; Yla-Herttuala, Seppo; Levonen, Anna-Liisa] Univ Eastern Finland, Dept Biotechnol & Mol Med, AI Virtanen Inst Mol Sci, FIN-70211 Kuopio, Finland; [Kuosmanen, Suvi M.; Carlberg, Carsten] Univ Eastern Finland, Dept Biosci, FIN-70211 Kuopio, Finland; [Tong, Kit I.; Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Carlberg, Carsten] Univ Luxembourg, Life Sci Res Unit, L-1511 Luxembourg, Luxembourg	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Eastern Finland; University of Eastern Finland; Tohoku University; University of Luxembourg	Freeman, BA (corresponding author), Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA.	freerad@pitt.edu; anna-liisa.levonen@uef.fi	Linna-Kuosmanen, Suvi/P-4574-2018; Schopfer, Francisco Jose/AAE-8125-2020; Woodcock, Steven/AAE-9199-2020; Freeman, Bruce A/H-9342-2012; Carlberg, Carsten/C-9075-2011; Schopfer, Francisco/AAW-6505-2021; Yamamoto, Masayuki/A-4873-2010	Linna-Kuosmanen, Suvi/0000-0002-3278-2727; Schopfer, Francisco Jose/0000-0001-9526-695X; Carlberg, Carsten/0000-0003-2633-0684; Yamamoto, Masayuki/0000-0002-9073-9436; Yla-Herttuala, Seppo/0000-0001-7593-2708; Levonen, Anna-Liisa/0000-0002-6575-2137; Kansanen, Emilia/0000-0001-6029-8097	National Institutes of Health [HL58115, HL64937]; Finnish Cultural Foundation; Academy of Finland; Finnish Foundation for Cardiovascular Research; Sigrid Juselius Foundation; Finnish Cancer Organizations; American Diabetes Association; Complexa, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL058115, R01HL058115, R01HL064937] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Academy of Finland(Academy of Finland); Finnish Foundation for Cardiovascular Research; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cancer Organizations; American Diabetes Association(American Diabetes Association); Complexa, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL58115 and HL64937 (to B.A.F., G.B., and F.J.S.). This work was also supported by grants from the Finnish Cultural Foundation (to E.K. and A.-L.L.), the Academy of Finland (to C.C. and A.-L.L.), the Finnish Foundation for Cardiovascular Research, the Sigrid Juselius Foundation, the Finnish Cancer Organizations (to A.-L.L.), and the American Diabetes Association (to F.J.S.). B.A.F. acknowledges a financial interest in Complexa, Inc.	Baker PRS, 2005, J BIOL CHEM, V280, P42464, DOI 10.1074/jbc.M504212200; Copple IM, 2008, HEPATOLOGY, V48, P1292, DOI 10.1002/hep.22472; Cui T, 2006, J BIOL CHEM, V281, P35686, DOI 10.1074/jbc.M603357200; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Dinkova-Kostova AT, 2005, BIOCHEMISTRY-US, V44, P6889, DOI 10.1021/bi047434h; Eggler AL, 2009, BIOCHEM J, V422, P171, DOI 10.1042/BJ20090471; Eggler AL, 2005, P NATL ACAD SCI USA, V102, P10070, DOI 10.1073/pnas.0502402102; Freeman BA, 2008, J BIOL CHEM, V283, P15515, DOI 10.1074/jbc.R800004200; Gorczynski MJ, 2009, J MED CHEM, V52, P4631, DOI 10.1021/jm900326c; Hurttila H, 2008, GENE THER, V15, P1271, DOI 10.1038/gt.2008.75; Jyrkkanen HK, 2008, CIRC RES, V103, pE1, DOI 10.1161/CIRCRESAHA.108.176883; Kansanen E, 2009, J BIOL CHEM, V284, P33233, DOI 10.1074/jbc.M109.064873; Kansanen E, 2009, FREE RADICAL BIO MED, V47, P1310, DOI 10.1016/j.freeradbiomed.2009.06.030; Kelley EE, 2008, J BIOL CHEM, V283, P36176, DOI 10.1074/jbc.M802402200; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Kobayashi M, 2009, MOL CELL BIOL, V29, P493, DOI 10.1128/MCB.01080-08; Levonen AL, 2004, BIOCHEM J, V378, P373, DOI 10.1042/BJ20031049; Levonen AL, 2001, ARTERIOSCL THROM VAS, V21, P1846, DOI 10.1161/hq1101.098488; Li L, 2008, J BIOL CHEM, V283, P3248, DOI 10.1074/jbc.M708702200; Liebler DC, 2008, CHEM RES TOXICOL, V21, P117, DOI 10.1021/tx700235t; McMahon M, 2010, P NATL ACAD SCI USA, V107, P18838, DOI 10.1073/pnas.1007387107; Ogura T, 2010, P NATL ACAD SCI USA, V107, P2842, DOI 10.1073/pnas.0914036107; Rachakonda G, 2008, CHEM RES TOXICOL, V21, P705, DOI 10.1021/tx700302s; Rudolph TK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.290re7; Rudolph V, 2010, CARDIOVASC RES, V85, P155, DOI 10.1093/cvr/cvp275; Schopfer FJ, 2009, FREE RADICAL BIO MED, V46, P1250, DOI 10.1016/j.freeradbiomed.2008.12.025; Schopfer FJ, 2005, P NATL ACAD SCI USA, V102, P2340, DOI 10.1073/pnas.0408384102; Schopfer FJ, 2010, J BIOL CHEM, V285, P12321, DOI 10.1074/jbc.M109.091512; Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006; Tong KI, 2007, MOL CELL BIOL, V27, P7511, DOI 10.1128/MCB.00753-07; Villacorta L, 2007, AM J PHYSIOL-HEART C, V293, pH770, DOI 10.1152/ajpheart.00261.2007; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Wang XJ, 2008, TOXICOL APPL PHARM, V230, P383, DOI 10.1016/j.taap.2008.03.003; Wild AC, 1999, J BIOL CHEM, V274, P33627, DOI 10.1074/jbc.274.47.33627; Woodcock SR, 2006, ORG LETT, V8, P3931, DOI 10.1021/ol0613463; Yamamoto T, 2008, MOL CELL BIOL, V28, P2758, DOI 10.1128/MCB.01704-07; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang JF, 2010, CIRC RES, V107, P540, DOI 10.1161/CIRCRESAHA.110.218404; Zipper LM, 2002, J BIOL CHEM, V277, P36544, DOI 10.1074/jbc.M206530200	43	151	155	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14019	14027		10.1074/jbc.M110.190710	http://dx.doi.org/10.1074/jbc.M110.190710			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21357422	Green Published, hybrid			2022-12-27	WOS:000289556200024
J	Kovacic, PB; Chowdhury, HH; Velebit, J; Kreft, M; Jensen, J; Zorec, R				Kovacic, Petra Brina; Chowdhury, Helena H.; Velebit, Jelena; Kreft, Marko; Jensen, Jorgen; Zorec, Robert			New Insights into Cytosolic Glucose Levels during Differentiation of 3T3-L1 Fibroblasts into Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT ADIPOSE-CELLS; INSULIN-RESISTANCE; PHOSPHORYLATION STATE; PHORBOL ESTER; HEXOSE UPTAKE; TRANSPORT; MODULATION; RESPONSIVENESS; ISOPROTERENOL; STIMULATION	Cytosolic glucose concentration reflects the balance between glucose entry across the plasma membrane and cytosolic glucose utilization. In adipocytes, glucose utilization is considered very rapid, meaning that every glucose molecule entering the cytoplasm is quickly phosphorylated. Thus, the cytosolic free glucose concentration is considered to be negligible; however, it was never measured directly. In the present study, we monitored cytosolic glucose dynamics in 3T3-L1 fibroblasts and adipocytes by expressing a fluorescence resonance energy transfer (FRET)-based glucose nanosensor: fluorescent indicator protein FLIPglu-600 mu.. Specifically, we monitored cytosolic glucose responses by varying transmembrane glucose concentration gradient. The changes in cytosolic glucose concentration were detected in only 56% of 3T3-L1 fibroblasts and in 14% of 3T3-L1 adipocytes. In adipocytes, the resting cytosolic glucose concentration was reduced in comparison with the one recorded in fibroblasts. Membrane permeabilization increased cytosolic glucose concentration in adipocytes, and glycolytic inhibitor iodoacetate failed to increase cytosolic glucose concentration, indicating low adipocyte permeability for glucose at rest. We also examined the effects of insulin and adrenaline. Insulin significantly increased cytosolic glucose concentration in adipocytes by a factor of 3.6; however, we recorded no effect on delta ratio (Delta R) in fibroblasts. Adrenaline increased cytosolic glucose concentration in fibroblasts but not in adipocytes. However, in adipocytes in insulin-stimulated conditions, glucose clearance was significantly faster following adrenaline addition in comparison with controls (p < 0.001). Together, these results demonstrate that during differentiation, adipocytes develop more efficient mechanisms for maintaining low cytosolic glucose concentration, predominantly with reduced membrane permeability for glucose.	[Chowdhury, Helena H.; Kreft, Marko; Zorec, Robert] Univ Ljubljana, Fac Med, Inst Pathophysiol, Lab Neuroendocrinol Mol Cell Physiol, Ljubljana 1000, Slovenia; [Kovacic, Petra Brina; Chowdhury, Helena H.; Velebit, Jelena; Kreft, Marko; Zorec, Robert] Biomed Ctr, Ljubljana 1000, Slovenia; [Jensen, Jorgen] Norwegian Sch Sport Sci, Dept Phys Performance, N-0864 Oslo, Norway	University of Ljubljana; Norwegian School of Sport Sciences	Zorec, R (corresponding author), Univ Ljubljana, Fac Med, Inst Pathophysiol, Lab Neuroendocrinol Mol Cell Physiol, Zaloska 4, Ljubljana 1000, Slovenia.	robert.zorec@mf.uni-lj.si	Jensen, Jørgen/O-2245-2013; Chowdhury, Helena/ADV-0582-2022; Zorec, Robert/AAD-7180-2021	Chowdhury, Helena/0000-0001-8252-573X; Zorec, Robert/0000-0002-7478-3875	Ministry of Higher Education, Sciences and Technology of the Republic of Slovenia [P3 310 381]; European Commission [QLG1-CT2001/02233]	Ministry of Higher Education, Sciences and Technology of the Republic of Slovenia; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by Grant P3 310 381 from the Ministry of Higher Education, Sciences and Technology of the Republic of Slovenia, by a grant from the Ministry of Higher Education, Sciences and Technology of the Republic of Slovenia (to P. B. K.), and by European Commission GrowBeta Grant QLG1-CT2001/02233.	Aslesen R, 1998, AM J PHYSIOL-ENDOC M, V275, pE448, DOI 10.1152/ajpendo.1998.275.3.E448; Chen XL, 2005, J PROTEOME RES, V4, P570, DOI 10.1021/pr049772a; CUSHMAN SW, 1983, ADIPOCYTE OBESITY CE, P105; DEHERREROS AG, 1989, J BIOL CHEM, V264, P19994; Elmendorf JS, 1999, EXP CELL RES, V253, P55, DOI 10.1006/excr.1999.4675; Fehr M, 2003, J BIOL CHEM, V278, P19127, DOI 10.1074/jbc.M301333200; FLIER JS, 1983, ANNU REV MED, V34, P145, DOI 10.1146/annurev.me.34.020183.001045; FURLER SM, 1991, AM J PHYSIOL, V261, pE337, DOI 10.1152/ajpendo.1991.261.3.E337; GREEN H, 1976, CELL, V7, P105, DOI 10.1016/0092-8674(76)90260-9; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; GRUBER K, 1971, N-S ARCH PHARMAKOL, V271, P361, DOI 10.1007/BF00997125; HARRISON SA, 1991, P NATL ACAD SCI USA, V88, P7839, DOI 10.1073/pnas.88.17.7839; HOLMAN GD, 1990, J BIOL CHEM, V265, P18172; JAMES DE, 1989, NATURE, V338, P83, DOI 10.1038/338083a0; JENSEN J, 1995, BIOCHEM MOL BIOL INT, V35, P145; John SA, 2008, PFLUG ARCH EUR J PHY, V456, P307, DOI 10.1007/s00424-007-0395-z; JOOST HG, 1986, J BIOL CHEM, V261, P33; JOOST HG, 1987, J BIOL CHEM, V262, P11261; KAESTNER KH, 1989, P NATL ACAD SCI USA, V86, P3150, DOI 10.1073/pnas.86.9.3150; KAHN CR, 1978, METABOLISM, V27, P1893; KIRSCH DM, 1983, BIOCHEM J, V216, P737, DOI 10.1042/bj2160737; KLETZIEN RF, 1973, J BIOL CHEM, V248, P711; KURODA M, 1987, J BIOL CHEM, V262, P245; Lafontan M, 1995, OBES RES, V3, pS507, DOI 10.1002/j.1550-8528.1995.tb00220.x; Lefrere I, 2002, J BIOL CHEM, V277, P39169, DOI 10.1074/jbc.M205084200; Monjo M, 2005, AM J PHYSIOL-ENDOC M, V289, pE145, DOI 10.1152/ajpendo.00563.2004; Mulder AH, 2005, AM J PHYSIOL-ENDOC M, V289, pE627, DOI 10.1152/ajpendo.00079.2004; NISHIMURA H, 1991, P NATL ACAD SCI USA, V88, P11500, DOI 10.1073/pnas.88.24.11500; OLEFSKY JM, 1989, ENDOCRINOLOGY, P1369; Poulos SP, 2010, EXP BIOL MED, V235, P1185, DOI 10.1258/ebm.2010.010063; PURICH DL, 1971, J BIOL CHEM, V246, P3456; RESH MD, 1982, J BIOL CHEM, V257, P6978; ROSEN OM, 1978, J BIOL CHEM, V253, P7579; SMITH U, 1984, J BIOL CHEM, V259, P8758; TRAYHURN P, 2007, OBES BEW S, V1, P41; Webb J.L., 1966, ENZYMES METABOL INH, VIII, P1; WHITESELL RR, 1985, J BIOL CHEM, V260, P2894	37	14	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13370	13381		10.1074/jbc.M110.200980	http://dx.doi.org/10.1074/jbc.M110.200980			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21349852	Green Published, hybrid			2022-12-27	WOS:000289282200057
J	Meotti, FC; Jameson, GNL; Turner, R; Harwood, T; Stockwell, S; Rees, MD; Thomas, SR; Kettle, AJ				Meotti, Flavia C.; Jameson, Guy N. L.; Turner, Rufus; Harwood, Tim; Stockwell, Samantha; Rees, Martin D.; Thomas, Shane R.; Kettle, Anthony J.			Urate as a Physiological Substrate for Myeloperoxidase IMPLICATIONS FOR HYPERURICEMIA AND INFLAMMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; URIC-ACID OXIDATION; APOLIPOPROTEIN-A-I; CARDIOVASCULAR-DISEASE; HYPOCHLOROUS ACID; ENDOTHELIAL DYSFUNCTION; MYOCARDIAL-INFARCTION; CATALYZED OXIDATION; ANTIOXIDANT DEFENSE; LIPID-PEROXIDATION	Urate and myeloperoxidase (MPO) are associated with adverse outcomes in cardiovascular disease. In this study, we assessed whether urate is a likely physiological substrate for MPO and if the products of their interaction have the potential to exacerbate inflammation. Urate was readily oxidized by MPO and hydrogen peroxide to 5-hydroxyisourate, which decayed to predominantly allantoin. The redox intermediates of MPO were reduced by urate with rate constants of 4.6 x 10(5) M-1 s(-1) for compound land 1.7 x 10(4) M-1 s(-1) for compound II. Urate competed with chloride for oxidation by MPO and at hyperuricemic levels is expected to be a substantive substrate for the enzyme. Oxidation of urate promoted super-stoichiometric consumption of glutathione, which indicates that it is converted to a free radical intermediate. In combination with superoxide and hydrogen peroxide, MPO oxidized mate to a reactive hydroperoxide. This would form by addition of superoxide to the urate radical. Urate also enhanced MPO-dependent consumption of nitric oxide. In human plasma, stimulated neutrophils produced allantoin in a reaction dependent on the NADPH oxidase, MPO and superoxide. We propose that urate is a physiological substrate for MPO that is oxidized to the urate radical. The reactions of this radical with superoxide and nitric oxide provide a plausible link between urate and MPO in cardiovascular disease.	[Meotti, Flavia C.; Turner, Rufus; Harwood, Tim; Stockwell, Samantha; Kettle, Anthony J.] Univ Otago, Dept Pathol, Free Rad Res Grp, Christchurch, New Zealand; [Jameson, Guy N. L.] Univ Otago, Dept Chem, Dunedin, New Zealand; [Rees, Martin D.; Thomas, Shane R.] Univ New S Wales, Ctr Vasc Res, Sch Med Sci, Sydney, NSW, Australia	University of Otago; University of Otago; University of New South Wales Sydney	Kettle, AJ (corresponding author), Univ Otago, Dept Pathol, Free Rad Res Grp, POB 4345, Christchurch, New Zealand.	tony.kettle@otago.ac.nz	Jameson, Guy N. L./J-3258-2015; Meotti, Flavia/H-1621-2015; Meotti, Flavia/AAS-8804-2021; Harwood, Tim/H-3636-2012; Kettle, Anthony J/A-8520-2008	Jameson, Guy N. L./0000-0001-9416-699X; Meotti, Flavia/0000-0002-7217-3352; Kettle, Anthony J/0000-0002-8218-7766; Rees, Martin/0000-0002-3564-5736	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq-Brazil); Health Research Council of New Zealand; New Zealand Centre of Excellence for Growth and Development; National Health and Medical Research Council [568721]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq-Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Health Research Council of New Zealand(Health Research Council of New Zealand); New Zealand Centre of Excellence for Growth and Development; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq-Brazil), the Health Research Council of New Zealand, and the New Zealand Centre of Excellence for Growth and Development and in part by National Health and Medical Research Council Project Grant 568721 (to S. R. T. and A. J. K.).	Abu-Soud HM, 2000, J BIOL CHEM, V275, P37524, DOI 10.1074/jbc.275.48.37524; Agner K., 1941, ACTA PHYSIOL SCAND, V2, P1; Alderman MH, 2007, CIRCULATION, V116, P880, DOI 10.1161/CIRCULATIONAHA.107.728600; Allegra M, 2001, BIOCHEM BIOPH RES CO, V282, P380, DOI 10.1006/bbrc.2001.4582; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; ARUOMA OI, 1989, FEBS LETT, V244, P76, DOI 10.1016/0014-5793(89)81166-4; Baldus S, 2006, CIRCULATION, V113, P1871, DOI 10.1161/CIRCULATIONAHA.105.590083; BECKER BF, 1993, FREE RADICAL BIO MED, V14, P615, DOI 10.1016/0891-5849(93)90143-I; BEERS RF, 1952, J BIOL CHEM, V195, P133; Benzie IFF, 1996, REDOX REP, V2, P231, DOI 10.1080/13510002.1996.11747055; BOWRY VW, 1993, J AM CHEM SOC, V115, P6029, DOI 10.1021/ja00067a019; Brennan M, 2003, NEW ENGL J MED, V349, P1595, DOI 10.1056/NEJMoa035003; BUETTNER GR, 1993, ARCH BIOCHEM BIOPHYS, V300, P535, DOI 10.1006/abbi.1993.1074; CANELLAKIS ES, 1955, J BIOL CHEM, V213, P397; CHAPMAN AL, 2001, BIOCHEM J, V417, P773; Das AB, 2010, FREE RADICAL BIO MED, V48, P1540, DOI 10.1016/j.freeradbiomed.2010.02.039; DORNER RW, 1981, ANN RHEUM DIS, V40, P70, DOI 10.1136/ard.40.1.70; Dunford HB, 1999, BIOCHEM CELL BIOL, V77, P449, DOI 10.1139/bcb-77-5-449; Eiserich JP, 2002, SCIENCE, V296, P2391, DOI 10.1126/science.1106830; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Filipe P, 2002, EUR J BIOCHEM, V269, P5474, DOI 10.1046/j.1432-1033.2002.03245.x; FREI B, 1988, P NATL ACAD SCI USA, V85, P9748, DOI 10.1073/pnas.85.24.9748; Fridovich I., 1985, HDB METHODS OXYGEN R, P51; Furtmuller PG, 1998, BIOCHEMISTRY-US, V37, P17923, DOI 10.1021/bi9818772; Gaffo AL, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2761; GROOTVELD M, 1987, BIOCHEM J, V243, P803, DOI 10.1042/bj2430803; Hare JM, 2005, J CLIN INVEST, V115, P509, DOI 10.1172/JCI200524459; Harwood DT, 2006, BIOCHEM J, V399, P161, DOI 10.1042/BJ20060978; HAZELL LJ, 1993, BIOCHEM J, V290, P165, DOI 10.1042/bj2900165; HOOGLAND H, 1987, BIOCHIM BIOPHYS ACTA, V916, P76, DOI 10.1016/0167-4838(87)90212-3; Hsuanyu Y, 1999, ARCH BIOCHEM BIOPHYS, V368, P413, DOI 10.1006/abbi.1999.1328; KETTLE AJ, 1989, BIOCHEM J, V263, P823, DOI 10.1042/bj2630823; Kettle AJ, 2000, REDOX REP, V5, P179, DOI 10.1179/135100000101535726; KETTLE AJ, 1988, BIOCHEM J, V252, P529, DOI 10.1042/bj2520529; Kettle AJ, 1997, REDOX REP, V3, P3, DOI 10.1080/13510002.1997.11747085; KETTLE AJ, 1990, METHOD ENZYMOL, V300, P111; Kettle AJ, 2007, BIOCHEMISTRY-US, V46, P4888, DOI 10.1021/bi602587k; Kim SY, 2010, ARTHRIT CARE RES, V62, P170, DOI 10.1002/acr.20065; KITTRIDGE KJ, 1984, FEBS LETT, V170, P162, DOI 10.1016/0014-5793(84)81391-5; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; KLEBANOFF SJ, 1968, J BACTERIOL, V95, P2131, DOI 10.1128/JB.95.6.2131-2138.1968; Kono H, 2010, J CLIN INVEST, V120, P1939, DOI 10.1172/JCI40124; Kutzing MK, 2008, J PHARMACOL EXP THER, V324, P1, DOI 10.1124/jpet.107.129031; MAPLES KR, 1988, J BIOL CHEM, V263, P1709; MARQUEZ LA, 1994, J BIOL CHEM, V269, P7950; MARQUEZ LA, 1990, J BIOL CHEM, V265, P5666; Marquez LA, 1995, J BIOL CHEM, V270, P30434, DOI 10.1074/jbc.270.51.30434; MARQUEZ LA, 1990, J BIOL CHEM, V265, P6074; Marshall CJ, 2010, AM J CARDIOL, V106, P316, DOI 10.1016/j.amjcard.2010.03.028; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2010, IMMUNOL REV, V233, P218, DOI 10.1111/j.0105-2896.2009.00860.x; Meotti FC, 2008, FREE RADICAL BIO MED, V44, P109, DOI 10.1016/j.freeradbiomed.2007.09.017; Meuwese MC, 2007, J AM COLL CARDIOL, V50, P159, DOI 10.1016/j.jacc.2007.03.033; Mocatta TJ, 2007, J AM COLL CARDIOL, V49, P1993, DOI 10.1016/j.jacc.2007.02.040; MUNDAY R, 1989, BIOCHEM PHARMACOL, V38, P4349, DOI 10.1016/0006-2952(89)90641-2; Nagy P, 2009, J BIOL CHEM, V284, P14723, DOI 10.1074/jbc.M809396200; Nakagawa T, 2006, KIDNEY INT, V69, P1722, DOI 10.1038/sj.ki.5000391; Nicholls SJ, 2005, ARTERIOSCL THROM VAS, V25, P1102, DOI 10.1161/01.ATV.0000163262.83456.6d; Ogura Y, 2006, CELL, V126, P659, DOI 10.1016/j.cell.2006.08.002; PICHORNER H, 1995, ARCH BIOCHEM BIOPHYS, V323, P429, DOI 10.1006/abbi.1995.0064; Santos CXC, 1999, ARCH BIOCHEM BIOPHYS, V372, P285, DOI 10.1006/abbi.1999.1491; Santus R, 2001, FREE RADICAL RES, V35, P129, DOI 10.1080/10715760100300671; Shao BH, 2006, J BIOL CHEM, V281, P9001, DOI 10.1074/jbc.C600011200; SHI Y, 2010, CLIN INVESTIGATOR, V120, P1809; SIMIC MG, 1989, J AM CHEM SOC, V111, P5778, DOI 10.1021/ja00197a042; So A, 2010, J CLIN INVEST, V120, P1791, DOI 10.1172/JCI42344; Stevenson WS, 2010, P NATL ACAD SCI USA, V107, P16625, DOI 10.1073/pnas.1010390107; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; Sugiyama S, 2001, AM J PATHOL, V158, P879, DOI 10.1016/S0002-9440(10)64036-9; vanDalen CJ, 1997, BIOCHEM J, V327, P487; Viazzi F, 2005, HYPERTENSION, V45, P991, DOI 10.1161/01.HYP.0000161184.10873.ea; Vita JA, 2004, CIRCULATION, V110, P1134, DOI 10.1161/01.CIR.0000140262.20831.8F; VOLK KJ, 1990, J PHARMACEUT BIOMED, V8, P205, DOI 10.1016/0731-7085(90)80028-N; Winterbourn CC, 2004, BIOCHEM J, V381, P241, DOI 10.1042/BJ20040259; Winterbourn CC, 2003, BIOCHEM BIOPH RES CO, V305, P729, DOI 10.1016/S0006-291X(03)00810-6; WOLFF SP, 1994, METHOD ENZYMOL, V233, P182; Ximenes VF, 2010, BIOCHEM J, V425, P285, DOI 10.1042/BJ20090776; Ximenes VF, 2005, J BIOL CHEM, V280, P38160, DOI 10.1074/jbc.M506384200; Zhang CX, 2001, AM J PHYSIOL-HEART C, V281, pH1469, DOI 10.1152/ajpheart.2001.281.4.H1469; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109	80	96	101	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					12901	12911		10.1074/jbc.M110.172460	http://dx.doi.org/10.1074/jbc.M110.172460			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21266577	hybrid, Green Published			2022-12-27	WOS:000289282200010
J	Zheng, H; Chu, J; Zhang, YH; Loh, HH; Law, PY				Zheng, Hui; Chu, Ji; Zhang, Yuhan; Loh, Horace H.; Law, Ping-Yee			Modulating mu-Opioid Receptor Phosphorylation Switches Agonist-dependent Signaling as Reflected in PKC epsilon Activation and Dendritic Spine Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; BETA-ARRESTINS; LIPID RAFTS; KINASE-C; MORPHINE; INTERNALIZATION; DESENSITIZATION; TOLERANCE; MEMBRANE; BINDING	A new role of G protein-coupled receptor (GPCR) phosphorylation was demonstrated in the current studies by using the mu-opioid receptor (OPRM1) as a model. Morphine induces a low level of receptor phosphorylation and uses the PKC epsilon pathway to induce ERK phosphorylation and receptor desensitization, whereas etorphine, fentanyl, and [D-Ala(2), N-Me-Phe(4), Gly(5)-ol]-enkephalin (DAMGO) induce extensive receptor phosphorylation and use the beta-arrestin2 pathway. Blocking OPRM1 phosphorylation (by mutating Ser(363), Thr(370) and Ser(375) to Ala) enabled etorphine, fentanyl, and DAMGO to use the PKC epsilon pathway. This was not due to the decreased recruitment of beta-arrestin2 to the receptor signaling complex, because these agonists were unable to use the PKC epsilon pathway when beta-arrestin2 was absent. In addition, overexpressing G protein-coupled receptor kinase 2 (GRK2) decreased the ability of morphine to activate PKC epsilon, whereas overexpressing dominant-negative GRK2 enabled etorphine, fentanyl, and DAMGO to activate PKC epsilon. Furthermore, by overexpressing wild-type OPRM1 and a phosphorylation-deficient mutant in primary cultures of hippocampal neurons, we demonstrated that receptor phosphorylation contributes to the differential effects of agonists on dendritic spine stability. Phosphorylation blockage made etorphine, fentanyl, and DAMGO function as morphine in the primary cultures. Therefore, agonist-dependent phosphorylation of GPCR regulates the activation of the PKC pathway and the subsequent responses.	[Zheng, Hui; Chu, Ji; Zhang, Yuhan; Loh, Horace H.; Law, Ping-Yee] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA; [Zheng, Hui] Chinese Acad Sci, Stem Cell & Canc Biol Grp, S China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol,Guangzhou Inst Biomed & Hl, Guangzhou 510530, Guangdong, Peoples R China	University of Minnesota System; University of Minnesota Twin Cities; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Zheng, H (corresponding author), 6-120 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	zhenhui2055@hotmail.com		Law, Ping-Yee/0000-0002-5364-1093; Zheng, Hui/0000-0001-6801-0529	National Institutes of Health [DA007339, DA016674, DA000564, DA011806]; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA000513, R56DA000564, R01DA016674, K05DA070554, R01DA000564, R01DA007339, P50DA011806] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA007339, DA016674, DA000564, and DA011806.	Cen B, 2001, MOL PHARMACOL, V59, P758, DOI 10.1124/mol.59.4.758; Chae JH, 2004, MOL CELLS, V18, P271; CHAKRABARTI S, 1995, MOL BRAIN RES, V30, P269, DOI 10.1016/0169-328X(95)00014-J; Chu J, 2008, CELL SIGNAL, V20, P1616, DOI 10.1016/j.cellsig.2008.05.004; Chu J, 2010, CELL SIGNAL, V22, P684, DOI 10.1016/j.cellsig.2009.12.003; Debic HH, 2005, J NEUROSCI, V25, P7847, DOI 10.1523/JNEUROSCI.5045-04.2005; DeGraff JL, 2002, J BIOL CHEM, V277, P43247, DOI 10.1074/jbc.M207495200; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; El Kouhen R, 2001, J BIOL CHEM, V276, P12774, DOI 10.1074/jbc.M009571200; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Gaudilliere B, 2004, NEURON, V41, P229, DOI 10.1016/S0896-6273(03)00841-9; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Keith DE, 1996, J BIOL CHEM, V271, P19021, DOI 10.1074/jbc.271.32.19021; Kobayashi H, 2005, CELL SIGNAL, V17, P1248, DOI 10.1016/j.cellsig.2004.12.014; Koch T, 2005, MOL PHARMACOL, V67, P280, DOI 10.1124/mol.104.004994; Kozasa T, 1996, J BIOL CHEM, V271, P12562, DOI 10.1074/jbc.271.21.12562; Lan HX, 2009, MOL PHARMACOL, V75, P113, DOI 10.1124/mol.108.050534; Law PY, 2004, NEUROPHARMACOLOGY, V47, P300, DOI 10.1016/j.neuropharm.2004.07.013; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Li JL, 2003, J BIOL CHEM, V278, P30219, DOI 10.1074/jbc.M302385200; Liao D, 2005, P NATL ACAD SCI USA, V102, P1725, DOI 10.1073/pnas.0406797102; Liao D, 2007, MOL CELL NEUROSCI, V35, P456, DOI 10.1016/j.mcn.2007.04.007; Lin H, 2009, NEUROPSYCHOPHARMACOL, V34, P2097, DOI 10.1038/npp.2009.34; Macdonald JL, 2005, J LIPID RES, V46, P1061, DOI 10.1194/jlr.D400041-JLR200; Macey TA, 2005, J NEUROCHEM, V93, P128, DOI 10.1111/j.1471-4159.2004.02998.x; Metaye T, 2005, CELL SIGNAL, V17, P917, DOI 10.1016/j.cellsig.2005.01.002; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; ROERIG SC, 1992, MOL PHARMACOL, V41, P822; Smith FL, 2007, PAIN, V127, P129, DOI 10.1016/j.pain.2006.08.009; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; von Bohlen und Halbach O, 2007, CELL TISSUE RES, V329, P409, DOI 10.1007/s00441-007-0432-4; Wess J, 1997, FASEB J, V11, P346, DOI 10.1096/fasebj.11.5.9141501; Xu C, 2010, J CELL SCI, V123, P4259, DOI 10.1242/jcs.073742; Zhang J, 1998, P NATL ACAD SCI USA, V95, P7157, DOI 10.1073/pnas.95.12.7157; Zheng H, 2008, P NATL ACAD SCI USA, V105, P9421, DOI 10.1073/pnas.0802253105; Zheng H, 2008, MOL PHARMACOL, V73, P178, DOI 10.1124/mol.107.039842; Zheng H, 2010, J BIOL CHEM, V285, P21994, DOI 10.1074/jbc.M110.112607; Zheng H, 2010, J NEUROSCI, V30, P8102, DOI 10.1523/JNEUROSCI.6069-09.2010; Zheng H, 2010, IUBMB LIFE, V62, P112, DOI 10.1002/iub.293; Zheng H, 2010, MOL PHARMACOL, V77, P102, DOI 10.1124/mol.109.060848	42	35	38	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.177089	http://dx.doi.org/10.1074/jbc.M110.177089			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21292762	hybrid, Green Published			2022-12-27	WOS:000289077500083
J	Cortesio, CL; Boateng, LR; Piazza, TM; Bennin, DA; Huttenlocher, A				Cortesio, Christa L.; Boateng, Lindsy R.; Piazza, Timothy M.; Bennin, David A.; Huttenlocher, Anna			Calpain-mediated Proteolysis of Paxillin Negatively Regulates Focal Adhesion Dynamics and Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; MEMBRANE PROTRUSION; CYTOPLASMIC DOMAIN; ALPHA-PARVIN; LD MOTIFS; CLEAVAGE; INVASION; TRANSFORMATION; LOCALIZATION; ACTOPAXIN	The dynamic turnover of integrin-mediated adhesions is important for cell migration. Paxillin is an adaptor protein that localizes to focal adhesions and has been implicated in cell motility. We previously reported that calpain-mediated proteolysis of talin1 and focal adhesion kinase mediates adhesion disassembly in motile cells. To determine whether calpain-mediated paxillin proteolysis regulates focal adhesion dynamics and cell motility, we mapped the preferred calpain proteolytic site in paxillin. The cleavage site is between the paxillin LD1 and LD2 motifs and generates a C-terminal fragment that is similar in size to the alternative product paxillin delta. The calpain-generated proteolytic fragment, like paxillin delta, functions as a paxillin antagonist and impairs focal adhesion disassembly and migration. We generated mutant paxillin with a point mutation (S95G) that renders it partially resistant to calpain proteolysis. Paxillin-deficient cells that express paxillin S95G display increased turnover of zyxin-containing adhesions using time-lapse microscopy and also show increased migration. Moreover, cancer-associated somatic mutations in paxillin are common in the N-terminal region between the LD1 and LD2 motifs and confer partial calpain resistance. Taken together, these findings suggest a novel role for calpain-mediated proteolysis of paxillin as a negative regulator of focal adhesion dynamics and migration that may function to limit cancer cell invasion.	[Cortesio, Christa L.; Piazza, Timothy M.; Bennin, David A.; Huttenlocher, Anna] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA; [Cortesio, Christa L.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; [Boateng, Lindsy R.] Univ Wisconsin, Program Cellular & Mol Biol, Madison, WI 53706 USA; [Huttenlocher, Anna] Univ Wisconsin, Dept Pediat, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Huttenlocher, A (corresponding author), Univ Wisconsin, Dept Med Microbiol & Immunol, 1550 Linden Dr,4225 Microbial Sci Bldg, Madison, WI 53706 USA.	huttenlocher@wisc.edu			National Institutes of Health [R01 CA085862-08]; Department of Defense [BC073295]; NATIONAL CANCER INSTITUTE [R01CA085862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA085862-08 (to A. H.). This work was also supported by Department of Defense Pre-Doctoral Fellowship BC073295 (to C. L. C.).	Bhatt A, 2002, J CELL SCI, V115, P3415; Bougie JK, 2009, J NEUROCHEM, V109, P1129, DOI 10.1111/j.1471-4159.2009.06045.x; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Carragher NO, 1999, J CELL BIOL, V147, P619, DOI 10.1083/jcb.147.3.619; Carragher NO, 2004, NEOPLASIA, V6, P53, DOI 10.1016/S1476-5586(04)80053-8; Chan KT, 2010, J BIOL CHEM, V285, P11418, DOI 10.1074/jbc.M109.090746; Cortesio CL, 2008, J CELL BIOL, V180, P957, DOI 10.1083/jcb.200708048; Cortesio CL, 2010, MOL BIOL CELL, V21, P186, DOI 10.1091/mbc.E09-02-0106; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; DU XP, 1995, J BIOL CHEM, V270, P26146, DOI 10.1074/jbc.270.44.26146; Franco S, 2004, EXP CELL RES, V299, P179, DOI 10.1016/j.yexcr.2004.05.021; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; GLENNEY JR, 1989, J CELL BIOL, V108, P2401, DOI 10.1083/jcb.108.6.2401; Jagadeeswaran R, 2008, CANCER RES, V68, P132, DOI 10.1158/0008-5472.CAN-07-1998; Lakshmikuttyamma A, 2004, CANCER EPIDEM BIOMAR, V13, P1604; Libertini SJ, 2005, CANCER RES, V65, P10700, DOI 10.1158/0008-5472.CAN-05-1666; Lorenz S, 2008, STRUCTURE, V16, P1521, DOI 10.1016/j.str.2008.08.007; Mamoune A, 2003, CANCER RES, V63, P4632; Nikolopoulos SN, 2002, J BIOL CHEM, V277, P1568, DOI 10.1074/jbc.M108612200; Nikolopoulos SN, 2000, J CELL BIOL, V151, P1435, DOI 10.1083/jcb.151.7.1435; Nikolopoulos SN, 2001, J BIOL CHEM, V276, P23499, DOI 10.1074/jbc.M102163200; Perrin BJ, 2006, MOL BIOL CELL, V17, P239, DOI 10.1091/mbc.e05-06-0488; Petit V, 2000, J CELL BIOL, V148, P957, DOI 10.1083/jcb.148.5.957; Pfaff M, 1999, FEBS LETT, V460, P17, DOI 10.1016/S0014-5793(99)01250-8; RUOSLAHTI E, 1982, METHOD ENZYMOL, V82, P803; Sprague CR, 2008, J BIOL CHEM, V283, P9217, DOI 10.1074/jbc.M707436200; Tumbarello DA, 2005, J CELL SCI, V118, P4849, DOI 10.1242/jcs.02615; Wang XX, 2008, J BIOL CHEM, V283, P21113, DOI 10.1074/jbc.M801270200; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Xi XD, 2003, J CELL BIOL, V162, P329, DOI 10.1083/jcb.200303120	32	78	78	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					9998	10006		10.1074/jbc.M110.187294	http://dx.doi.org/10.1074/jbc.M110.187294			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21270128	hybrid, Green Published			2022-12-27	WOS:000288547000014
J	Jimenez, E; Zafra, F; Perez-Sen, R; Delicado, EG; Miras-Portugal, MT; Aragon, C; Lopez-Corcuera, B				Jimenez, Esperanza; Zafra, Francisco; Perez-Sen, Raquel; Delicado, Esmerilda G.; Teresa Miras-Portugal, Maria; Aragon, Carmen; Lopez-Corcuera, Beatriz			P2Y Purinergic Regulation of the Glycine Neurotransmitter Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULTURED CHROMAFFIN CELLS; NITRIC-OXIDE PRODUCTION; RAT SPINAL-CORD; NEUROPATHIC PAIN; CYCLIC-GMP; SYNAPTIC-TRANSMISSION; SEROTONIN TRANSPORTER; MOLECULAR-MECHANISMS; ADENOSINE TRANSPORT; RECEPTORS	The sodium-and chloride-coupled glycine neurotransmitter transporters (GLYTs) control the availability of glycine at glycine-mediated synapses. The mainly glial GLYT1 is the key regulator of the glycine levels in glycinergic and glutamatergic pathways, whereas the neuronal GLYT2 is involved in the recycling of synaptic glycine from the inhibitory synaptic cleft. In this study, we report that stimulation of P2Y purinergic receptors with 2-methylthioadenosine 5'-diphosphate in rat brainstem/spinal cord primary neuronal cultures and adult rat synaptosomes leads to the inhibition of GLYT2 and the stimulation of GLYT1 by a paracrine regulation. These effects are mainly mediated by the ADP-preferring subtypes P2Y(1) and P2Y(13) because the effects are partially reversed by the specific antagonists N-6-methyl-2'-deoxyadenosine-3',5'-bisphosphate and pyridoxal-5'-phosphate-6-azo(2chloro-5-nitrophenyl)-2,4-disulfonate and are totally blocked by suramin. P2Y(12) receptor is additionally involved in GLYT1 stimulation. Using pharmacological approaches and siRNA-mediated protein knockdown methodology, we elucidate the molecular mechanisms of GLYT regulation. Modulation takes place through a signaling cascade involving phospholipase C activation, inositol 1,4,5-trisphosphate production, intracellular Ca2+ mobilization, protein kinase C stimulation, nitric oxide formation, cyclic guanosine monophosphate production, and protein kinase G-I (PKG-I) activation. GLYT1 and GLYT2 are differentially sensitive to NO/cGMP/PKG-I both in brain-derived preparations and in heterologous systems expressing the recombinant transporters and P2Y(1) receptor. Sensitivity to 2-methylthioadenosine 5'-diphosphate by GLYT1 and GLYT2 was abolished by small interfering RNA (siRNA)-mediated knockdown of nitric-oxide synthase. Our data may help define the role of GLYTs in nociception and pain sensitization.	[Jimenez, Esperanza; Zafra, Francisco; Aragon, Carmen; Lopez-Corcuera, Beatriz] Univ Autonoma Madrid, Dept Mol Biol, E-28049 Madrid, Spain; [Jimenez, Esperanza; Zafra, Francisco; Aragon, Carmen; Lopez-Corcuera, Beatriz] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; [Jimenez, Esperanza; Zafra, Francisco; Aragon, Carmen; Lopez-Corcuera, Beatriz] ISCIII, Ctr Invest Biomed Red Enfermedades Raras, Madrid 28049, Spain; [Perez-Sen, Raquel; Delicado, Esmerilda G.; Teresa Miras-Portugal, Maria] Univ Complutense Madrid, Fac Vet, Dept Bioquim & Biol Mol, E-28040 Madrid, Spain	Autonomous University of Madrid; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Complutense University of Madrid	Lopez-Corcuera, B (corresponding author), Univ Autonoma Madrid, Dept Mol Biol, E-28049 Madrid, Spain.	blopez@cbm.uam.es	Aragon, Carmen/K-9783-2014; Corcuera, Beatriz López/D-5188-2009; Delicado, Esmerilda G./L-6992-2014; Miras-Portugal, Maria Teresa/L-7137-2014; Zafra, Francisco/A-6121-2008; Perez-Sen, Raquel/L-6975-2014	Aragon, Carmen/0000-0001-8287-9386; Corcuera, Beatriz López/0000-0002-0383-4241; Zafra, Francisco/0000-0003-3801-3109; Perez-Sen, Raquel/0000-0001-6213-3376; Pintor, Jesus/0000-0002-9191-7679	Spanish Direccion General de Ensenanza Superior e Investigacion Cientifica [BFU2005-05931/BMC, BIO2005-05786]; Ministerio de Ciencia e Innovacion [SAF2008-05436]; Comunidad Autonoma de Madrid [11/BCB/010, S-SAL-0253/2006]; Fundacion Ramon Areces; Ministerio de Educacion y Ciencia, Spain; European Regional Development Fund [BFU2007-30688-E/BFI]	Spanish Direccion General de Ensenanza Superior e Investigacion Cientifica; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Comunidad Autonoma de Madrid(Comunidad de Madrid); Fundacion Ramon Areces; Ministerio de Educacion y Ciencia, Spain(Spanish Government); European Regional Development Fund(European Commission)	This work was supported in part by the Spanish Direccion General de Ensenanza Superior e Investigacion Cientifica Grants BFU2005-05931/BMC and BIO2005-05786, Ministerio de Ciencia e Innovacion Grant SAF2008-05436, Comunidad Autonoma de Madrid Grants 11/BCB/010 and S-SAL-0253/2006, and by an institutional grant from the Fundacion Ramon Areces.; Member of the Network for Cooperative Research on Membrane Transport Proteins, co-funded by the Ministerio de Educacion y Ciencia, Spain, and the European Regional Development Fund Grant BFU2007-30688-E/BFI.	Abbracchio Maria P, 2006, Purinergic Signal, V2, P595, DOI 10.1007/s11302-006-9016-0; Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Abbracchio MP, 2003, TRENDS PHARMACOL SCI, V24, P52, DOI 10.1016/S0165-6147(02)00038-X; Ahmadi S, 2003, SCIENCE, V300, P2094, DOI 10.1126/science.1083970; Ando RD, 2010, BRIT J PHARMACOL, V159, P1106, DOI 10.1111/j.1476-5381.2009.00596.x; Aragon C, 2005, TRENDS PHARMACOL SCI, V26, P283, DOI 10.1016/j.tips.2005.04.007; Aragon C, 2003, EUR J PHARMACOL, V479, P249, DOI 10.1016/j.ejphar.2003.08.074; Atterbury-Thomas AE, 2008, NEUROSCI LETT, V435, P190, DOI 10.1016/j.neulet.2008.02.034; Bardoni R, 1997, J NEUROSCI, V17, P5297; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Borniquel S, 2010, MOL CELL BIOL, V30, P4035, DOI 10.1128/MCB.00175-10; Bradaia A, 2004, J PHYSIOL-LONDON, V559, P169, DOI 10.1113/jphysiol.2004.068858; Burnstock G, 2006, TRENDS PHARMACOL SCI, V27, P166, DOI 10.1016/j.tips.2006.01.005; Burnstock G, 2008, NAT REV DRUG DISCOV, V7, P575, DOI 10.1038/nrd2605; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Caulfield WL, 2001, J MED CHEM, V44, P2679, DOI 10.1021/jm0011272; Chanrion B, 2007, P NATL ACAD SCI USA, V104, P8119, DOI 10.1073/pnas.0610964104; Chhatriwala M, 2004, J PHARMACOL EXP THER, V311, P1038, DOI 10.1124/jpet.104.068650; Chizh BA, 2001, PHARMACOL REV, V53, P553; Choi RCY, 2008, J BIOL CHEM, V283, P11050, DOI 10.1074/jbc.M709266200; Csolle C, 2008, J NEUROCHEM, V106, P347, DOI 10.1111/j.1471-4159.2008.05391.x; Cubelos B, 2005, NEUROPHARMACOLOGY, V49, P935, DOI 10.1016/j.neuropharm.2005.07.021; Cubelos B, 2005, CEREB CORTEX, V15, P448, DOI 10.1093/cercor/bhh147; DELICADO EG, 1990, J NEUROCHEM, V54, P1941, DOI 10.1111/j.1471-4159.1990.tb04895.x; Ding YN, 2000, J AUTONOM NERV SYST, V81, P289, DOI 10.1016/S0165-1838(00)00131-4; Dohi T, 2009, PHARMACOL THERAPEUT, V123, P54, DOI 10.1016/j.pharmthera.2009.03.018; Ferrero R, 1999, BRIT J PHARMACOL, V127, P779, DOI 10.1038/sj.bjp.0702607; Florenzano F, 2008, PROG NEUROBIOL, V84, P40, DOI 10.1016/j.pneurobio.2007.10.004; Fornes A, 2004, J BIOL CHEM, V279, P22934, DOI 10.1074/jbc.M401337200; Fornes A, 2008, BIOCHEM J, V412, P495, DOI 10.1042/BJ20071018; Freire MAM, 2009, FRONT NEUROSCI-SWITZ, V3, P175, DOI 10.3389/neuro.01.024.2009; GARTHWAITE J, 1995, MOL PHARMACOL, V48, P184; Geerlings A, 2000, FEBS LETT, V470, P51, DOI 10.1016/S0014-5793(00)01297-7; Geerlings A, 2001, J BIOL CHEM, V276, P17584, DOI 10.1074/jbc.M010602200; Gerevich Zoltan, 2004, Purinergic Signal, V1, P3, DOI 10.1007/s11302-004-4740-9; Glynn MW, 2006, NAT PROTOC, V1, P1287, DOI 10.1038/nprot.2006.220; Gomeza J, 2003, NEURON, V40, P785, DOI 10.1016/S0896-6273(03)00672-X; Gomeza J, 2003, NEURON, V40, P797, DOI 10.1016/S0896-6273(03)00673-1; Haranishi Y, 2010, ANESTH ANALG, V110, P615, DOI 10.1213/ANE.0b013e3181c7ebbb; Harvey RJ, 2008, TRENDS GENET, V24, P439, DOI 10.1016/j.tig.2008.06.005; Hermanns H, 2008, NEUROSCI LETT, V445, P214, DOI 10.1016/j.neulet.2008.09.012; Howard A, 2010, J PHYSIOL-LONDON, V588, P995, DOI 10.1113/jphysiol.2009.186262; Hussl S, 2006, PFLUG ARCH EUR J PHY, V452, P538, DOI 10.1007/s00424-006-0063-8; Inoue K, 2007, PURINERG SIGNAL, V3, P135, DOI 10.1007/s11302-006-9045-8; Jacquet S, 2005, CELL MOL LIFE SCI, V62, P2508, DOI 10.1007/s00018-005-5194-0; Javitt DC, 2004, MOL PSYCHIATR, V9, P984, DOI 10.1038/sj.mp.4001551; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kanner BI, 2008, CHEM REV, V108, P1654, DOI 10.1021/cr078246a; Kittner H, 2003, NEUROPSYCHOPHARMACOL, V28, P435, DOI 10.1038/sj.npp.1300043; Lechner Stefan G, 2004, Purinergic Signal, V1, P31, DOI 10.1007/s11302-004-4746-3; Levine YC, 2007, J BIOL CHEM, V282, P20351, DOI 10.1074/jbc.M702182200; LIU QR, 1993, J BIOL CHEM, V268, P22802; Lopez-Corcuera B, 2001, BIOCHEM SOC T, V29, P742, DOI 10.1042/0300-5127:0290742; Malin SA, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-21; Marteau F, 2003, MOL PHARMACOL, V64, P104, DOI 10.1124/mol.64.1.104; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; Miclescu A, 2009, ACTA ANAESTH SCAND, V53, P1107, DOI 10.1111/j.1399-6576.2009.02054.x; Miras-Portugal MT, 2003, NEUROCHEM RES, V28, P1597, DOI 10.1023/A:1025690913206; Moore D, 2000, J COMP NEUROL, V421, P374, DOI 10.1002/(SICI)1096-9861(20000605)421:3<374::AID-CNE6>3.0.CO;2-Z; Morita K, 2008, J PHARMACOL EXP THER, V326, P633, DOI 10.1124/jpet.108.136267; Nishikawa Y, 2010, J PHARMACOL SCI, V112, P352, DOI 10.1254/jphs.09351FP; Nunez E, 2005, NEUROPHARMACOLOGY, V49, P922, DOI 10.1016/j.neuropharm.2005.07.010; Nunez E, 2009, TRAFFIC, V10, P829, DOI 10.1111/j.1600-0854.2009.00911.x; Ohnishi T, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-40; Ramamoorthy S, 2007, J BIOL CHEM, V282, P11639, DOI 10.1074/jbc.M611353200; REISER G, 1995, J NEUROCHEM, V64, P61; Ruan HZ, 2003, HISTOCHEM CELL BIOL, V120, P415, DOI 10.1007/s00418-003-0579-3; Schmidtko A, 2009, TRENDS NEUROSCI, V32, P339, DOI 10.1016/j.tins.2009.01.010; Selden NR, 2007, NEUROSCIENCE, V146, P1808, DOI 10.1016/j.neuroscience.2007.03.044; SEN RP, 1993, J NEUROCHEM, V60, P613, DOI 10.1111/j.1471-4159.1993.tb03192.x; SMITH KE, 1992, NEURON, V8, P927, DOI 10.1016/0896-6273(92)90207-T; Steiner JA, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-26; Tanabe M, 2008, ANESTHESIOLOGY, V108, P929, DOI 10.1097/ALN.0b013e31816c9044; Tsai G, 2004, P NATL ACAD SCI USA, V101, P8485, DOI 10.1073/pnas.0402662101; ZAFRA F, 1995, EUR J NEUROSCI, V7, P1342, DOI 10.1111/j.1460-9568.1995.tb01125.x; ZAFRA F, 1995, J NEUROSCI, V15, P3952; Zeilhofer HU, 2008, INT IMMUNOPHARMACOL, V8, P182, DOI 10.1016/j.intimp.2007.07.009; Zhou L, 2009, NITRIC OXIDE-BIOL CH, V20, P223, DOI 10.1016/j.niox.2009.03.001	78	37	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10712	10724		10.1074/jbc.M110.167056	http://dx.doi.org/10.1074/jbc.M110.167056			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21245148	hybrid, Green Published			2022-12-27	WOS:000288547000085
J	Kamm, KE; Stull, JT				Kamm, Kristine E.; Stull, James T.			Signaling to Myosin Regulatory Light Chain in Sarcomeres	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; SKELETAL-MUSCLE CONTRACTION; INTERACTING PROTEIN-KINASE; PHOSPHATASE-ASSOCIATED KINASE; PERFUSED RABBIT HEART; SMOOTH-MUSCLE; CA2+ SENSITIVITY; FORCE DEVELOPMENT; POSTACTIVATION POTENTIATION; CALCIUM SENSITIVITY	Myosin regulatory light chain (RLC) phosphorylation in skeletal and cardiac muscles modulates Ca2+-dependent troponin regulation of contraction. RLC is phosphorylated by a dedicated Ca2+-dependent myosin light chain kinase in fast skeletal muscle, where biochemical properties of RLC kinase and phosphatase converge to provide a biochemical memory for RLC phosphorylation and post-activation potentiation of force development. The recent identification of cardiac-specific myosin light chain kinase necessary for basal RLC phosphorylation and another potential RLC kinase (zipper-interacting protein kinase) provides opportunities for new approaches to study signaling pathways related to the physiological function of RLC phosphorylation and its importance in cardiac muscle disease.	[Kamm, Kristine E.; Stull, James T.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Stull, JT (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.	james.stull@utsouthwestern.edu			National Institutes of Health [HL080536, HL026043]; Moss Heart Fund; Fouad A. and Val Imm Bashour Distinguished Chair in Physiology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL026043, R01HL026043, R01HL080536] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Moss Heart Fund; Fouad A. and Val Imm Bashour Distinguished Chair in Physiology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL080536 and HL026043. This work was also supported by the Moss Heart Fund and the Fouad A. and Val Imm Bashour Distinguished Chair in Physiology. This is the seventh article in the Thematic Minireview Series on Signaling in Cardiac Sarcomeres in Health and Disease. This minireview will be reprinted in the 2011 Minireview Compendium, which will be available in January, 2012.	Abraham TP, 2009, CARDIOVASC RES, V82, P84, DOI 10.1093/cvr/cvp016; Adhikari BB, 1999, BIOCHEMISTRY-US, V38, P3127, DOI 10.1021/bi982553g; Barefield D, 2010, J MOL CELL CARDIOL, V48, P866, DOI 10.1016/j.yjmcc.2009.11.014; Baudry S, 2007, J APPL PHYSIOL, V103, P1318, DOI 10.1152/japplphysiol.00403.2007; Bialik S, 2006, ANNU REV BIOCHEM, V75, P189, DOI 10.1146/annurev.biochem.75.103004.142615; BLUMENTHAL DK, 1980, BIOCHEMISTRY-US, V19, P5608, DOI 10.1021/bi00565a023; BOWMAN BF, 1992, J BIOL CHEM, V267, P5346; Chan JY, 2008, CIRC RES, V102, P571, DOI 10.1161/CIRCRESAHA.107.161687; Chang AN, 2010, J BIOL CHEM, V285, P5122, DOI 10.1074/jbc.C109.076489; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; CLOSE R, 1968, J PHYSIOL-LONDON, V197, P461, DOI 10.1113/jphysiol.1968.sp008570; Colson BA, 2010, J PHYSIOL-LONDON, V588, P981, DOI 10.1113/jphysiol.2009.183897; Davis JS, 2002, BIOPHYS J, V83, P359, DOI 10.1016/S0006-3495(02)75175-8; Davis JS, 2001, CELL, V107, P631, DOI 10.1016/S0092-8674(01)00586-4; Dias FAL, 2006, J MOL CELL CARDIOL, V41, P330, DOI 10.1016/j.yjmcc.2006.05.012; Ding HL, 2009, J BIOL CHEM, V284, P15541, DOI 10.1074/jbc.M900888200; Ding PG, 2010, J BIOL CHEM, V285, P40819, DOI 10.1074/jbc.M110.160499; Endo A, 2004, J BIOL CHEM, V279, P42055, DOI 10.1074/jbc.M403676200; FITZSIMONS DP, 1989, J APPL PHYSIOL, V67, P2447, DOI 10.1152/jappl.1989.67.6.2447; Force T, 2010, CIRCULATION, V122, P1130, DOI 10.1161/CIRCULATIONAHA.110.950089; FREARSON N, 1976, NATURE, V264, P801, DOI 10.1038/264801a0; Gallagher PJ, 1997, J MUSCLE RES CELL M, V18, P1, DOI 10.1023/A:1018616814417; GAO ZH, 1995, J BIOL CHEM, V270, P10125, DOI 10.1074/jbc.270.17.10125; Grange RW, 1998, J APPL PHYSIOL, V84, P236, DOI 10.1152/jappl.1998.84.1.236; Graves PR, 2005, J BIOL CHEM, V280, P9363, DOI 10.1074/jbc.M412538200; Grimm M, 2005, CARDIOVASC RES, V65, P211, DOI 10.1016/j.cardiores.2004.09.019; Gu XH, 2010, CARDIOVASC RES, V88, P334, DOI 10.1093/cvr/cvq223; Hagerty L, 2007, J BIOL CHEM, V282, P4884, DOI 10.1074/jbc.M609990200; Hamdani N, 2008, CARDIOVASC RES, V77, P649, DOI 10.1093/cvr/cvm079; Haystead TAJ, 2005, CELL SIGNAL, V17, P1313, DOI 10.1016/j.cellsig.2005.05.008; He WQ, 2008, GASTROENTEROLOGY, V135, P610, DOI 10.1053/j.gastro.2008.05.032; Heller WT, 2003, BIOCHEMISTRY-US, V42, P10579, DOI 10.1021/bi0348664; HERRING BP, 1986, BIOCHEM J, V240, P205, DOI 10.1042/bj2400205; HIGH CW, 1980, AM J PHYSIOL, V239, pH756, DOI 10.1152/ajpheart.1980.239.6.H756; HOLROYDE MJ, 1979, BIOCHIM BIOPHYS ACTA, V587, P628, DOI 10.1016/0304-4165(79)90014-X; Huang J, 2008, J BIOL CHEM, V283, P19748, DOI 10.1074/jbc.M802605200; Ihara E, 2007, CAN J PHYSIOL PHARM, V85, P79, DOI 10.1139/Y06-103; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; Jabbour A, 2011, EUR J HEART FAIL, V13, P83, DOI 10.1093/eurjhf/hfq152; James J, 2011, J BIOL CHEM, V286, P9913, DOI 10.1074/jbc.R110.171801; JEACOCKE SA, 1980, BIOCHEM J, V188, P763, DOI 10.1042/bj1880763; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Kawai T, 1998, MOL CELL BIOL, V18, P1642, DOI 10.1128/MCB.18.3.1642; Kerrick WGL, 2009, FASEB J, V23, P855, DOI 10.1096/fj.08-118182; Kobayashi T, 2005, ANNU REV PHYSIOL, V67, P39, DOI 10.1146/annurev.physiol.67.040403.114025; Kockskamper J, 2008, PROG BIOPHYS MOL BIO, V97, P250, DOI 10.1016/j.pbiomolbio.2008.02.026; Krueger JK, 1998, BIOCHEMISTRY-US, V37, P13997, DOI 10.1021/bi981311d; Krueger JK, 1997, BIOCHEMISTRY-US, V36, P6017, DOI 10.1021/bi9702703; Krueger JK, 1998, BIOCHEMISTRY-US, V37, P17810, DOI 10.1021/bi981656w; Krueger JK, 2001, J BIOL CHEM, V276, P4535, DOI 10.1074/jbc.C000857200; Levine RJC, 1998, J STRUCT BIOL, V122, P149, DOI 10.1006/jsbi.1998.3980; Lowey S, 2010, J BIOL CHEM, V285, P16403, DOI 10.1074/jbc.R109.025551; MacDonald JA, 2001, P NATL ACAD SCI USA, V98, P2419, DOI 10.1073/pnas.041331498; MANNING DR, 1982, AM J PHYSIOL, V242, pC234, DOI 10.1152/ajpcell.1982.242.3.C234; MANNING DR, 1979, BIOCHEM BIOPH RES CO, V90, P164, DOI 10.1016/0006-291X(79)91604-8; Matsumura F, 2008, BIOCHEM BIOPH RES CO, V369, P149, DOI 10.1016/j.bbrc.2007.12.090; Mayans O, 1998, NATURE, V395, P863, DOI 10.1038/27603; METZGER JM, 1989, J GEN PHYSIOL, V93, P855, DOI 10.1085/jgp.93.5.855; Mirzapoiazova T, 2011, AM J RESP CELL MOL, V44, P40, DOI 10.1165/rcmb.2009-0197OC; Mizutani H, 2010, CIRC J, V74, P120, DOI 10.1253/circj.CJ-09-0462; MOORE RL, 1984, AM J PHYSIOL, V247, pC462, DOI 10.1152/ajpcell.1984.247.5.C462; MORANO I, 1995, ACTA PHYSIOL SCAND, V154, P343, DOI 10.1111/j.1748-1716.1995.tb09918.x; Morano I, 1999, J MOL MED-JMM, V77, P544, DOI 10.1007/s001099900031; MORANO I, 1988, BASIC RES CARDIOL, V83, P350, DOI 10.1007/BF02005820; Okamoto R, 2006, CELL SIGNAL, V18, P1408, DOI 10.1016/j.cellsig.2005.11.001; Olsson MC, 2004, AM J PHYSIOL-HEART C, V287, pH2712, DOI 10.1152/ajpheart.01067.2003; Padre RC, 2000, J BIOL CHEM, V275, P26665; Padre RC, 2000, FEBS LETT, V472, P148, DOI 10.1016/S0014-5793(00)01434-4; Persechini A, 2000, J BIOL CHEM, V275, P4199, DOI 10.1074/jbc.275.6.4199; ROBERTSON SP, 1981, BIOPHYS J, V34, P559, DOI 10.1016/S0006-3495(81)84868-0; Ryder JW, 2007, J BIOL CHEM, V282, P20447, DOI 10.1074/jbc.M702927200; Sale DG, 2002, EXERC SPORT SCI REV, V30, P138, DOI 10.1097/00003677-200207000-00008; Sanbe A, 1999, J BIOL CHEM, V274, P21085, DOI 10.1074/jbc.274.30.21085; Scruggs SB, 2009, J BIOL CHEM, V284, P5097, DOI 10.1074/jbc.M807414200; Seguchi O, 2007, J CLIN INVEST, V117, P2812, DOI 10.1172/JCI30804; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; SILVER PJ, 1986, J MOL CELL CARDIOL, V18, P31, DOI 10.1016/S0022-2828(86)80980-4; Smith IC, 2010, J MUSCLE RES CELL M, V31, P267, DOI 10.1007/s10974-010-9229-2; Solaro RJ, 2011, J BIOL CHEM, V286, P9935, DOI 10.1074/jbc.R110.197731; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Stelzer JE, 2006, J GEN PHYSIOL, V128, P261, DOI 10.1085/jgp.200609547; STULL JT, 1986, ENZYMES, P113; SWEENEY HL, 1993, AM J PHYSIOL, V264, pC1085, DOI 10.1152/ajpcell.1993.264.5.C1085; Szczesna D, 2002, J APPL PHYSIOL, V92, P1661, DOI 10.1152/japplphysiol.00858.2001; Szczesna D, 2001, J BIOL CHEM, V276, P7086, DOI 10.1074/jbc.M009823200; Szczesna-Cordary D, 2005, J CELL SCI, V118, P3675, DOI 10.1242/jcs.02492; Tardiff JC, 2005, HEART FAIL REV, V10, P237, DOI 10.1007/s10741-005-5253-5; van der Velden J, 2003, CARDIOVASC RES, V57, P37, DOI 10.1016/S0008-6363(02)00606-5; Vandenboom R, 1997, AM J PHYSIOL-REG I, V272, P1980; WESTWOOD SA, 1981, BIOCHEM J, V197, P185, DOI 10.1042/bj1970185; Yang YH, 1998, J STRUCT BIOL, V122, P139, DOI 10.1006/jsbi.1998.3979; Yu D, 2010, P NATL ACAD SCI USA, V107, P8237, DOI 10.1073/pnas.0908869107; Zhang WC, 2010, J BIOL CHEM, V285, P5522, DOI 10.1074/jbc.M109.062836; Zhi G, 2005, P NATL ACAD SCI USA, V102, P17519, DOI 10.1073/pnas.0506846102; Zoghbi ME, 2008, P NATL ACAD SCI USA, V105, P2386, DOI 10.1073/pnas.0708912105	95	66	68	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					9941	9947		10.1074/jbc.R110.198697	http://dx.doi.org/10.1074/jbc.R110.198697			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21257758	hybrid, Green Published			2022-12-27	WOS:000288547000008
J	Seymour, LM; Falconer, L; Deutscher, AT; Minion, FC; Padula, MP; Dixon, NE; Djordjevic, SP; Walker, MJ				Seymour, Lisa M.; Falconer, Linda; Deutscher, Ania T.; Minion, F. Chris; Padula, Matthew P.; Dixon, Nicholas E.; Djordjevic, Steven P.; Walker, Mark J.			Mhp107 Is a Member of the Multifunctional Adhesin Family of Mycoplasma hyopneumoniae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX PROTEINS; FIBRONECTIN-BINDING PROTEINS; ELONGATION-FACTOR TU; PLASMINOGEN-BINDING; STREPTOCOCCUS-PYOGENES; CILIUM ADHESIN; MAMMALIAN-CELLS; POTENTIAL ROLE; ALPHA-ENOLASE; ADHERENCE	Mycoplasma hyopneumoniae is the causative pathogen of porcine enzootic pneumonia, an economically significant disease that disrupts the mucociliary escalator in the swine respiratory tract. Expression of Mhp107, a P97 paralog encoded by the gene mhp107, was confirmed using ESI-MS/MS. To investigate the function of Mhp107, three recombinant proteins, F1(Mhp107), F2(Mhp107), and F3(Mhp107), spanning the N-terminal, central, and C-terminal regions of Mhp107 were constructed. Colonization of swine by M. hyopneumoniae requires adherence of the bacterium to ciliated cells of the respiratory tract. Recent studies have identified a number of M. hyopneumoniae adhesins that bind heparin, fibronectin, and plasminogen. F1(Mhp107) was found to bind porcine heparin (K-D similar to 90 nM) in a dose-dependent and saturable manner, whereas F3(Mhp107) bound fibronectin (K-D similar to 180 nM) at physiologically relevant concentrations. F1(Mhp107) also bound porcine plasminogen (K-D = 24 nM) in a dose-dependent and physiologically relevant manner. Microspheres coated with F3(Mhp107) mediate adherence to porcine kidney epithelial-like (PK15) cells, and all three recombinant proteins (F1(Mhp107)-F3(Mhp107)) bound swine respiratory cilia. Together, these findings indicate that Mhp107 is a member of the multifunctional M. hyopneumoniae adhesin family of surface proteins and contributes to both adherence to the host and pathogenesis.	[Seymour, Lisa M.; Deutscher, Ania T.; Walker, Mark J.] Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia; [Falconer, Linda; Deutscher, Ania T.; Djordjevic, Steven P.] Elizabeth Macarthur Agr Inst, Ind & Investment NSW, Menangle, NSW 2567, Australia; [Minion, F. Chris] Iowa State Univ, Dept Vet Microbiol & Prevent Med, Ames, IA 50011 USA; [Padula, Matthew P.; Djordjevic, Steven P.] Univ Sydney, Ithree Inst, Sydney, NSW 2006, Australia; [Dixon, Nicholas E.] Univ Wollongong, Sch Chem, Wollongong, NSW 2522, Australia; [Walker, Mark J.] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia; [Walker, Mark J.] Univ Queensland, Australian Infect Dis Res Ctr, St Lucia, Qld 4072, Australia	University of Wollongong; NSW Department of Primary Industries; Iowa State University; University of Sydney; University of Technology Sydney; University of Wollongong; University of Queensland; University of Queensland	Walker, MJ (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia.	mark.walker@uq.edu.au	djordjevic, steven/GNP-4000-2022; Djordjevic, Steven/A-2024-2013; Minion, Chris/A-2955-2015; Padula, Matthew P/R-6150-2016; Walker, Mark J./F-6940-2011; Dixon, Nicholas E/A-1226-2008	djordjevic, steven/0000-0001-9301-5372; Djordjevic, Steven/0000-0001-9301-5372; Minion, Chris/0000-0003-4876-8396; Padula, Matthew P/0000-0002-8283-0643; Dixon, Nicholas E/0000-0002-5958-6945; Deutscher, Ania/0000-0002-5917-9223; Walker, Mark/0000-0001-7423-2769	Australian Postgraduate Award; Australian Research Council [LP776771]	Australian Postgraduate Award(Australian Government); Australian Research Council(Australian Research Council)	This work was supported by the Australian Postgraduate Award (to L. M. S.) and an Australian Research Council Linkage Project grant (LP776771).	Adams C, 2005, INFECT IMMUN, V73, P7784, DOI 10.1128/IAI.73.11.7784-7787.2005; Andronicos NM, 1997, BBA-PROTEIN STRUCT M, V1337, P27, DOI 10.1016/S0167-4838(96)00146-X; Balasubramanian S, 2008, INFECT IMMUN, V76, P3116, DOI 10.1128/IAI.00173-08; Baseggio N, 1996, MICROBIOL-SGM, V142, P1429, DOI 10.1099/13500872-142-6-1429; BEREITER M, 1990, VET MICROBIOL, V25, P177, DOI 10.1016/0378-1135(90)90075-7; Bergmann S, 2004, INFECT IMMUN, V72, P2416, DOI 10.1128/IAI.72.4.2416-2419.2004; Burnett TA, 2006, MOL MICROBIOL, V60, P669, DOI 10.1111/j.1365-2958.2006.05139.x; Chaussee MS, 2000, INFECT IMMUN, V68, P3226, DOI 10.1128/IAI.68.6.3226-3232.2000; Cole Jason N., 2008, V425, P295, DOI 10.1007/978-1-60327-210-0_24; Coraux Christelle, 2008, Proc Am Thorac Soc, V5, P689, DOI 10.1513/pats.200801-010AW; Cork AJ, 2009, J BIOL CHEM, V284, P17129, DOI 10.1074/jbc.M109.004317; DALLO SF, 1991, MICROB PATHOGENESIS, V10, P475, DOI 10.1016/0882-4010(91)90113-O; Dallo SF, 2002, MOL MICROBIOL, V46, P1041, DOI 10.1046/j.1365-2958.2002.03207.x; Delvecchio A, 2002, EPIDEMIOL INFECT, V128, P391, DOI 10.1017/S0950268802006787; Deutscher AT, 2010, MOL MICROBIOL, V78, P444, DOI 10.1111/j.1365-2958.2010.07345.x; Djordjevic SP, 2004, INFECT IMMUN, V72, P2791, DOI 10.1128/IAI.72.5.2791-2802.2004; Dubreuil JD, 2002, MICROBIOL MOL BIOL R, V66, P617, DOI 10.1128/MMBR.66.4.617-629.2002; Duensing TD, 1999, INFECT IMMUN, V67, P4463, DOI 10.1128/IAI.67.9.4463-4468.1999; Dziewanowska K, 1999, INFECT IMMUN, V67, P4673, DOI 10.1128/IAI.67.9.4673-4678.1999; ERLINGER R, 1995, CELL TISSUE RES, V281, P473, DOI 10.1007/BF00417864; Giron JA, 1996, INFECT IMMUN, V64, P197; Hsu T, 1998, INFECT IMMUN, V66, P4762, DOI 10.1128/IAI.66.10.4762-4766.1998; Hsu T, 1998, GENE, V214, P13, DOI 10.1016/S0378-1119(98)00247-9; Hsu T, 1997, J BACTERIOL, V179, P1317, DOI 10.1128/jb.179.4.1317-1323.1997; JACKSON RL, 1991, PHYSIOL REV, V71, P481, DOI 10.1152/physrev.1991.71.2.481; Jenkins C, 2006, INFECT IMMUN, V74, P481, DOI 10.1128/IAI.74.1.481-487.2006; Joh D, 1999, MATRIX BIOL, V18, P211, DOI 10.1016/S0945-053X(99)00025-6; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; Madsen ML, 2007, J BACTERIOL, V189, P7977, DOI 10.1128/JB.01068-07; May M, 2006, INFECT IMMUN, V74, P1777, DOI 10.1128/IAI.74.3.1777-1785.2006; McKay FC, 2004, INFECT IMMUN, V72, P364, DOI 10.1128/IAI.72.1.364-370.2004; Minion FC, 2000, INFECT IMMUN, V68, P3056, DOI 10.1128/IAI.68.5.3056-3060.2000; Minion FC, 2002, FRONT BIOSCI-LANDMRK, V7, pD1410, DOI 10.2741/minion; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; Pancholi V, 2003, MICROB PATHOGENESIS, V35, P293, DOI 10.1016/j.micpath.2003.08.004; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; PLOW EF, 1995, FASEB J, V9, P939, DOI 10.1096/fasebj.9.10.7615163; Rabenstein DL, 2002, NAT PROD REP, V19, P312, DOI 10.1039/b100916h; Ramachandran V, 2004, J BACTERIOL, V186, P7601, DOI 10.1128/JB.186.22.7601-7609.2004; Razin S, 1999, BIOSCIENCE REP, V19, P367, DOI 10.1023/A:1020204020545; REDDY SP, 1995, J BACTERIOL, V177, P5943, DOI 10.1128/jb.177.20.5943-5951.1995; Sanderson-Smith M, 2006, J BIOL CHEM, V281, P3217, DOI 10.1074/jbc.M508758200; Sanderson-Smith ML, 2008, FASEB J, V22, P2715, DOI 10.1096/fj.07-105643; Sanderson-Smith ML, 2007, J BACTERIOL, V189, P1435, DOI 10.1128/JB.01218-06; Scarman AL, 1997, MICROBIOL-SGM, V143, P663, DOI 10.1099/00221287-143-2-663; Scarselli M, 2006, MOL MICROBIOL, V61, P631, DOI 10.1111/j.1365-2958.2006.05261.x; Secott TE, 2004, INFECT IMMUN, V72, P3724, DOI 10.1128/IAI.72.7.3724-3732.2004; Seymour LM, 2010, J BIOL CHEM, V285, P33971, DOI 10.1074/jbc.M110.104463; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Wilton JL, 1998, MICROBIOL-UK, V144, P1931, DOI 10.1099/00221287-144-7-1931; Wilton J, 2009, MOL MICROBIOL, V71, P566, DOI 10.1111/j.1365-2958.2008.06546.x; WISE KS, 1987, J BACTERIOL, V169, P5546, DOI 10.1128/jb.169.12.5546-5555.1987; Yavlovich A, 2001, INFECT IMMUN, V69, P1977, DOI 10.1128/IAI.69.4.1977-1982.2001; Yavlovich A, 2007, FEMS MICROBIOL LETT, V266, P158, DOI 10.1111/j.1574-6968.2006.00534.x; ZHANG QJ, 1994, INFECT IMMUN, V62, P1616, DOI 10.1128/IAI.62.5.1616-1622.1994; ZHANG QJ, 1995, INFECT IMMUN, V63, P1013, DOI 10.1128/IAI.63.3.1013-1019.1995; ZHANG QJ, 1994, INFECT IMMUN, V62, P4367, DOI 10.1128/IAI.62.10.4367-4373.1994; ZIELINSKI GC, 1990, AM J VET RES, V51, P339	59	40	46	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10097	10104		10.1074/jbc.M110.208140	http://dx.doi.org/10.1074/jbc.M110.208140			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21245147	Green Published, hybrid			2022-12-27	WOS:000288547000024
J	Sumandea, MP; Steinberg, SF				Sumandea, Marius P.; Steinberg, Susan F.			Redox Signaling and Cardiac Sarcomeres	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PROTEIN-KINASE-C; TROPONIN-I PHOSPHORYLATION; OXIDANT-INDUCED ACTIVATION; OXIDATIVE STRESS; REACTIVE OXYGEN; COOPERATIVE ACTIVATION; CARDIOVASCULAR-SYSTEM; VENTRICULAR MYOCYTES; CALCIUM SENSITIVITY; MEDIATED ACTIVATION	Oxidative stress is common in many clinically important cardiac disorders, including ischemia/reperfusion, diabetes, and hypertensive heart disease. Oxidative stress leads to derangements in pump function due to changes in the expression or function of proteins that regulate intracellular Ca2+ homeostasis. There is growing evidence that the cardiodepressant actions of reactive oxygen species (ROS) also are attributable to ROS-dependent signaling events in the sarcomere. This minireview focuses on myofilament protein post-translational modifications induced by ROS or ROS-activated signaling enzymes that regulate cardiac contractility.	[Sumandea, Marius P.] Univ Kentucky, Dept Physiol, Ctr Muscle Biol, Lexington, KY 40536 USA; [Steinberg, Susan F.] Columbia Univ, Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA	University of Kentucky; Columbia University	Sumandea, MP (corresponding author), Univ Kentucky, Dept Physiol, Ctr Muscle Biol, Lexington, KY 40536 USA.	mariussumandea@uky.edu			National Institutes of Health [AG032009, HL77860]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077860] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG032009] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG032009 and HL77860. This is the fourth article in the Thematic Minireview Series on Signaling in Cardiac Sarcomeres in Health and Disease. This minireview will be reprinted in the 2011 Minireview Compendium, which will be available in January, 2012.	Aikawa R, 1997, J CLIN INVEST, V100, P1813, DOI 10.1172/JCI119709; Ammendola A, 2001, J BIOL CHEM, V276, P24153, DOI 10.1074/jbc.M101530200; Avkiran M, 2008, CIRC RES, V102, P157, DOI 10.1161/CIRCRESAHA.107.168211; Avner BS, 2010, AM J PHYSIOL-HEART C, V299, pH723, DOI 10.1152/ajpheart.00050.2010; Bardswell SC, 2010, J BIOL CHEM, V285, P5674, DOI 10.1074/jbc.M109.066456; Barefield D, 2010, J MOL CELL CARDIOL, V48, P866, DOI 10.1016/j.yjmcc.2009.11.014; Biol AJ, 2007, J NEUROPATH EXP NEUR, V66, P711, DOI 10.1097/nen.0b013e3181256b4c; BLUMENTHAL DK, 1978, J BIOL CHEM, V253, P334; Borbely A, 2005, CARDIOVASC RES, V67, P225, DOI 10.1016/j.cardiores.2005.03.025; Brennan JP, 2006, J BIOL CHEM, V281, P21827, DOI 10.1074/jbc.M603952200; Burgoyne JR, 2007, SCIENCE, V317, P1393, DOI 10.1126/science.1144318; Buscemi N, 2002, CIRC RES, V91, P509, DOI 10.1161/01.RES.0000035246.27856.53; Canton M, 2006, EUR HEART J, V27, P875, DOI 10.1093/eurheartj/ehi751; Canton M, 2004, AM J PHYSIOL-HEART C, V286, pH870, DOI 10.1152/ajpheart.00714.2003; Chen FC, 2006, AM J PHYSIOL-CELL PH, V290, pC719, DOI 10.1152/ajpcell.00419.2005; Cicchillitti L, 2003, J BIOL CHEM, V278, P19509, DOI 10.1074/jbc.M300511200; CROSBIE RH, 1994, BIOPHYS J, V67, P1957, DOI 10.1016/S0006-3495(94)80678-2; Cuello F, 2007, CIRC RES, V100, P864, DOI 10.1161/01.RES.0000260809.15393.fa; Deshmukh PA, 2007, AM J PHYSIOL-HEART C, V292, pH792, DOI 10.1152/ajpheart.00225.2006; Doppler H, 2007, J BIOL CHEM, V282, P31873, DOI 10.1074/jbc.M703584200; Engel PL, 2009, J MOL CELL CARDIOL, V47, P359, DOI 10.1016/j.yjmcc.2009.04.016; Feil R, 2003, CIRC RES, V93, P907, DOI 10.1161/01.RES.0000100390.68771.CC; Gao WD, 1996, CIRCULATION, V94, P2597, DOI 10.1161/01.CIR.94.10.2597; Giannoni E, 2005, MOL CELL BIOL, V25, P6391, DOI 10.1128/MCB.25.15.6391-6403.2005; Gopalakrishna R, 2000, FREE RADICAL BIO MED, V28, P1349, DOI 10.1016/S0891-5849(00)00221-5; Grutzner A, 2009, BIOPHYS J, V97, P825, DOI 10.1016/j.bpj.2009.05.037; Haworth RS, 2004, CIRC RES, V95, P1091, DOI 10.1161/01.RES.0000149299.34793.3c; He XG, 2003, AM J PATHOL, V163, P243, DOI 10.1016/S0002-9440(10)63647-4; Hidalgo C, 2009, CIRC RES, V105, P631, DOI 10.1161/CIRCRESAHA.109.198465; Hirotani S, 2002, CIRCULATION, V105, P509, DOI 10.1161/hc0402.102863; Humphries KM, 2007, J BIOL CHEM, V282, P22072, DOI 10.1074/jbc.M702582200; Humphries KM, 2005, J BIOL CHEM, V280, P2750, DOI 10.1074/jbc.M410242200; Humphries KM, 2002, J BIOL CHEM, V277, P43505, DOI 10.1074/jbc.M207088200; Itoh S, 2005, J BIOL CHEM, V280, P24135, DOI 10.1074/jbc.M413015200; Kanski J, 2005, AM J PHYSIOL-HEART C, V288, pH371, DOI 10.1152/ajpheart.01030.2003; Ke YB, 2004, CIRC RES, V94, P194, DOI 10.1161/01.RES.0000111522.02730.56; Kemble DJ, 2009, P NATL ACAD SCI USA, V106, P5070, DOI 10.1073/pnas.0806117106; Kirk JA, 2009, CIRC RES, V105, P1232, DOI 10.1161/CIRCRESAHA.109.205427; Korichneva I, 2002, J BIOL CHEM, V277, P44327, DOI 10.1074/jbc.M205634200; Kruger M, 2009, CIRC RES, V104, P87, DOI 10.1161/CIRCRESAHA.108.184408; Lee DI, 2010, BASIC RES CARDIOL, V105, P337, DOI 10.1007/s00395-010-0084-5; LINCOLN TM, 1976, P NATL ACAD SCI USA, V73, P2559, DOI 10.1073/pnas.73.8.2559; Liu QH, 2003, AM J PHYSIOL-HEART C, V285, pH97, DOI 10.1152/ajpheart.00956.2002; Liu QH, 2006, MOL CELL BIOL, V26, P3785, DOI 10.1128/MCB.26.10.3785-3797.2006; Liu QH, 2009, CIRC RES, V105, P1110, DOI 10.1161/CIRCRESAHA.109.200741; Lu QW, 2010, J BIOL CHEM, V285, P11810, DOI 10.1074/jbc.M109.055657; Lukowski R, 2010, P NATL ACAD SCI USA, V107, P5646, DOI 10.1073/pnas.1001360107; Luo JZ, 2006, J MOL CELL CARDIOL, V40, P64, DOI 10.1016/j.yjmcc.2005.09.013; MACFARLANE NG, 1992, CIRC RES, V70, P1217, DOI 10.1161/01.RES.70.6.1217; Maloyan A, 2009, CIRC RES, V104, P1021, DOI 10.1161/CIRCRESAHA.108.193516; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Mihm MJ, 2003, BIOCHIMIE, V85, P587, DOI 10.1016/S0300-9084(03)00090-7; Namgaladze D, 2002, J BIOL CHEM, V277, P5962, DOI 10.1074/jbc.M111268200; Nicolaou P, 2009, J MOL CELL CARDIOL, V47, P365, DOI 10.1016/j.yjmcc.2009.05.010; NOLAND TA, 1989, J BIOL CHEM, V264, P20778; Ozgen N, 2009, MOL PHARMACOL, V76, P896, DOI 10.1124/mol.109.056473; Passarelli C, 2008, J MUSCLE RES CELL M, V29, P119, DOI 10.1007/s10974-008-9145-x; Pfleiderer P, 2009, J MUSCLE RES CELL M, V30, P67, DOI 10.1007/s10974-009-9176-y; Pham FH, 2000, CIRC RES, V86, P1252, DOI 10.1161/01.RES.86.12.1252; Rao VS, 2007, AM J PHYSIOL-HEART C, V293, pH654, DOI 10.1152/ajpheart.01314.2006; Robia SL, 2005, AM J PHYSIOL-HEART C, V289, pH1941, DOI 10.1152/ajpheart.01111.2004; Rybin VO, 2004, J BIOL CHEM, V279, P19350, DOI 10.1074/jbc.M311096200; Schulz R, 1997, AM J PHYSIOL-HEART C, V272, pH1212, DOI 10.1152/ajpheart.1997.272.3.H1212; Singal PK, 1998, CARDIOVASC RES, V40, P426, DOI 10.1016/S0008-6363(98)00244-2; Snook JH, 2008, FREE RADICAL BIO MED, V44, P14, DOI 10.1016/j.freeradbiomed.2007.09.004; Sommer D, 2002, ARCH BIOCHEM BIOPHYS, V404, P271, DOI 10.1016/S0003-9861(02)00242-4; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; Sumandea CA, 2011, J BIOL CHEM, V286, P530, DOI 10.1074/jbc.M110.148684; Sumandea MP, 2008, J BIOL CHEM, V283, P22680, DOI 10.1074/jbc.M802396200; Sumandea MP, 2009, BIOCHEMISTRY-US, V48, P7722, DOI 10.1021/bi900516n; Sumandea MP, 2003, J BIOL CHEM, V278, P35135, DOI 10.1074/jbc.M306325200; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Tiago T, 2006, BIOCHEMISTRY-US, V45, P3794, DOI 10.1021/bi0518500; Tobiume K, 1997, BIOCHEM BIOPH RES CO, V239, P905, DOI 10.1006/bbrc.1997.7580; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Vaage J, 1997, FREE RADICAL BIO MED, V22, P85, DOI 10.1016/S0891-5849(96)00278-X; Vahebi S, 2007, CIRC RES, V100, P408, DOI 10.1161/01.RES.0000258116.60404.ad; Waldron RT, 2000, J BIOL CHEM, V275, P17114, DOI 10.1074/jbc.M908959199; Waldron RT, 2004, J BIOL CHEM, V279, P27482, DOI 10.1074/jbc.M402875200; Wang H, 2006, J MOL CELL CARDIOL, V41, P823, DOI 10.1016/j.yjmcc.2006.08.016; Wang LG, 2008, J MOL CELL CARDIOL, V45, P787, DOI 10.1016/j.yjmcc.2008.08.010; Wilkins BJ, 2002, J PHYSIOL-LONDON, V541, P1, DOI 10.1113/jphysiol.2002.017129; WILLIAMS DL, 1982, EUR J BIOCHEM, V127, P495; Wu SC, 2007, J BIOL CHEM, V282, P30691, DOI 10.1074/jbc.M703670200; Xiao L, 2007, BIOCHEMISTRY-US, V46, P7054, DOI 10.1021/bi700467k; Yamaguchi O, 2004, J CLIN INVEST, V114, P937, DOI 10.1172/JCI200420317; Yamaguchi O, 2003, P NATL ACAD SCI USA, V100, P15883, DOI 10.1073/pnas.2136717100; Yamamoto S, 2003, J CLIN INVEST, V111, P1463, DOI 10.1172/JCI200317459; Yamasaki R, 2002, CIRC RES, V90, P1181, DOI 10.1161/01.RES.0000021115.24712.99; Yang F, 2008, BIOCHEM CELL BIOL, V86, P70, DOI [10.1139/O07-150, 10.1139/o07-150]; You B, 2009, BIOCHEM J, V418, P93, DOI 10.1042/BJ20081340; YTREHUS K, 1986, CARDIOVASC RES, V20, P597, DOI 10.1093/cvr/20.8.597; Yuasa K, 1999, J BIOL CHEM, V274, P37429, DOI 10.1074/jbc.274.52.37429; Zabrouskov V, 2008, MOL CELL PROTEOMICS, V7, P1838, DOI 10.1074/mcp.M700524-MCP200; Zhang W, 2005, J BIOL CHEM, V280, P19036, DOI 10.1074/jbc.M414674200; Zhou JB, 2009, MOL CELL BIOL, V29, P4167, DOI 10.1128/MCB.01067-08	96	51	53	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					9921	9927		10.1074/jbc.R110.175489	http://dx.doi.org/10.1074/jbc.R110.175489			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21257753	Green Published, hybrid			2022-12-27	WOS:000288547000005
J	Wu, Q; Chambliss, K; Umetani, M; Mineo, C; Shaul, PW				Wu, Qian; Chambliss, Ken; Umetani, Michihisa; Mineo, Chieko; Shaul, Philip W.			Non-nuclear Estrogen Receptor Signaling in the Endothelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							NITRIC-OXIDE SYNTHASE; PULMONARY-ARTERY ENDOTHELIUM; SMOOTH-MUSCLE-CELLS; PLASMA-MEMBRANE; GENE-EXPRESSION; CARDIOVASCULAR-SYSTEM; POSTMENOPAUSAL WOMEN; RAPID ACTIONS; ALPHA; ACTIVATION	In addition to the classical function of estrogen receptors (ER) as transcription factors, evidence continues to accumulate that they mediate non-nuclear processes in numerous cell types, including the endothelium, in which they activate endothelial NO synthase. Non-nuclear ER signaling entails unique post-translational modifications and protein-protein interactions of the receptor with adaptor molecules, kinases, and G proteins. Recent in vitro and in vivo studies in mice using an estrogen-dendrimer conjugate that is excluded from the nucleus indicate that non-nuclear ER activation underlies the migration and growth responses of endothelial cells to estrogen but not the growth responses of endometrial or breast cancer cells to the hormone. In this minireview, the features of ER alpha and protein-protein interactions that enable it to invoke extranuclear signaling in the endothelium and the consequences of that signaling are discussed.	[Wu, Qian; Chambliss, Ken; Umetani, Michihisa; Mineo, Chieko; Shaul, Philip W.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Div Pulm & Vasc Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Shaul, PW (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pediat, Div Pulm & Vasc Biol, Dallas, TX 75390 USA.	philip.shaul@utsouthwestern.edu	Umetani, Michi/AAP-3964-2020	Umetani, Michi/0000-0001-8474-7088	National Institutes of Health [HD030276, HL087564]; Lowe Foundation; Crystal Charity Ball Center for Pediatric Critical Care Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD030276] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087564] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lowe Foundation; Crystal Charity Ball Center for Pediatric Critical Care Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HD030276 and HL087564. This work was also supported by the Lowe Foundation and the Crystal Charity Ball Center for Pediatric Critical Care Research. This minireview will be reprinted in the 2011 Minireview Compendium, which will be available in January, 2012.	Acconcia F, 2004, BIOCHEM BIOPH RES CO, V316, P878, DOI 10.1016/j.bbrc.2004.02.129; Akishita M, 1998, BIOCHEM BIOPH RES CO, V251, P17, DOI 10.1006/bbrc.1998.9409; Barletta F, 2004, MOL ENDOCRINOL, V18, P1096, DOI 10.1210/me.2003-0335; Broughton BRS, 2010, AM J PHYSIOL-HEART C, V298, pH1055, DOI 10.1152/ajpheart.00878.2009; CaulinGlaser T, 1997, CIRC RES, V81, P885; Chambliss KL, 2010, J CLIN INVEST, V120, P2319, DOI 10.1172/JCI38291; Chambliss KL, 2000, CIRC RES, V87, pE44, DOI 10.1161/01.RES.87.11.e44; Chambliss KL, 2002, ENDOCR REV, V23, P665, DOI 10.1210/er.2001-0045; Chambliss KL, 2002, MOL ENDOCRINOL, V16, P938, DOI 10.1210/me.16.5.938; Chen DS, 2002, ONCOGENE, V21, P4921, DOI 10.1038/sj.onc.1205420; Chen Z, 1999, J CLIN INVEST, V103, P401, DOI 10.1172/JCI5347; Cheng JW, 2007, ENDOCRINOLOGY, V148, P4634, DOI 10.1210/en.2007-0148; Cheskis BJ, 2004, J CELL BIOCHEM, V93, P20, DOI 10.1002/jcb.20180; Figtree GA, 2003, CIRCULATION, V107, P120, DOI 10.1161/01.CIR.0000043805.11780.F5; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Florian M, 2004, STEROIDS, V69, P637, DOI 10.1016/j.steroids.2004.05.016; GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448; GILLIGAN DM, 1994, CIRCULATION, V89, P2545, DOI 10.1161/01.CIR.89.6.2545; Goetz RM, 1999, P NATL ACAD SCI USA, V96, P2788, DOI 10.1073/pnas.96.6.2788; Grasselli A, 2008, CIRC RES, V103, P34, DOI 10.1161/CIRCRESAHA.107.169037; Greif DM, 2002, BIOCHEMISTRY-US, V41, P15845, DOI 10.1021/bi026732g; Guo XM, 2005, J BIOL CHEM, V280, P19704, DOI 10.1074/jbc.M501244200; Haas E, 2009, CIRC RES, V104, P288, DOI 10.1161/CIRCRESAHA.108.190892; Harrington WR, 2006, MOL ENDOCRINOL, V20, P491, DOI 10.1210/me.2005-0186; Haynes MP, 2003, J BIOL CHEM, V278, P2118, DOI 10.1074/jbc.M210828200; Haynes MP, 2000, CIRC RES, V87, P677, DOI 10.1161/01.RES.87.8.677; Hodgin JB, 2002, ENDOCRINOLOGY, V143, P4495, DOI 10.1210/en.2002-220844; Ihionkhan CE, 2002, CIRC RES, V91, P814, DOI 10.1161/01.RES.0000038304.62046.4C; Isensee J, 2009, ENDOCRINOLOGY, V150, P1722, DOI 10.1210/en.2008-1488; Jun SS, 1998, J CLIN INVEST, V102, P176, DOI 10.1172/JCI2034; Kelly MJ, 2001, TRENDS ENDOCRIN MET, V12, P152, DOI 10.1016/S1043-2760(01)00377-0; Kumar P, 2007, MOL ENDOCRINOL, V21, P1370, DOI 10.1210/me.2006-0360; LantinHermoso RL, 1997, AM J PHYSIOL-LUNG C, V273, pL119, DOI 10.1152/ajplung.1997.273.1.L119; Le Lay S, 2005, BBA-MOL CELL RES, V1746, P322, DOI 10.1016/j.bbamcr.2005.06.001; Le Romancer M, 2008, MOL CELL, V31, P212, DOI 10.1016/j.molcel.2008.05.025; Levin ER, 2009, ENDOCRINOLOGY, V150, P1563, DOI 10.1210/en.2008-1759; Levin ER, 2005, MOL ENDOCRINOL, V19, P1951, DOI 10.1210/me.2004-0390; Li L, 2003, P NATL ACAD SCI USA, V100, P4807, DOI 10.1073/PNAS.0831079100; Li L, 2007, P NATL ACAD SCI USA, V104, P16468, DOI 10.1073/pnas.0704315104; Lu Q, 2003, J BIOL CHEM, V278, P4639, DOI 10.1074/jbc.M210949200; Manavathi B, 2006, P NATL ACAD SCI USA, V103, P15981, DOI 10.1073/pnas.0607445103; Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306; Mendelsohn ME, 2000, J STEROID BIOCHEM, V74, P337, DOI 10.1016/S0960-0760(00)00110-2; Mercier I, 2009, AM J PATHOL, V174, P1172, DOI 10.2353/ajpath.2009.080882; Migliaccio A, 2000, EMBO J, V19, P5406, DOI 10.1093/emboj/19.20.5406; Miller VM, 2002, VASC PHARMACOL, V38, P109, DOI 10.1016/S0306-3623(02)00134-9; Murata T, 2007, J BIOL CHEM, V282, P16631, DOI 10.1074/jbc.M607948200; Nickenig G, 2000, CIRCULATION, V102, P1828; Norman AW, 2004, NAT REV DRUG DISCOV, V3, P27, DOI 10.1038/nrd1283; Osborne CK, 2005, J CLIN ONCOL, V23, P1616, DOI 10.1200/JCO.2005.10.036; Pedram A, 2002, J BIOL CHEM, V277, P50768, DOI 10.1074/jbc.M210106200; Pedram A, 2007, J BIOL CHEM, V282, P22278, DOI 10.1074/jbc.M611877200; Pedram A, 2006, MOL ENDOCRINOL, V20, P1996, DOI 10.1210/me.2005-0525; Qing L, 2004, P NATL ACAD SCI USA, V101, P17126, DOI 10.1073/pnas.0407492101; Rahman A, 2009, ACTA PHYSIOL, V195, P231, DOI 10.1111/j.1748-1716.2008.01907.x; Razandi M, 2000, J BIOL CHEM, V275, P38540, DOI 10.1074/jbc.M007555200; Razandi M, 2003, MOL CELL BIOL, V23, P1633, DOI 10.1128/MCB.23.5.1633-1646.2003; REIS SE, 1994, CIRCULATION, V89, P52, DOI 10.1161/01.CIR.89.1.52; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Rogatsky I, 1999, J BIOL CHEM, V274, P22296, DOI 10.1074/jbc.274.32.22296; Rubio-Gayosso I, 2000, J CARDIOVASC PHARM, V36, P196, DOI 10.1097/00005344-200008000-00009; Sengupta K, 2004, MOL CANCER RES, V2, P150; Shaul PW, 2002, ANNU REV PHYSIOL, V64, P749, DOI 10.1146/annurev.physiol.64.081501.155952; Shaul PW, 1998, AM J PHYSIOL-LUNG C, V275, pL843, DOI 10.1152/ajplung.1998.275.5.L843; Shaul PW, 1996, J BIOL CHEM, V271, P6518, DOI 10.1074/jbc.271.11.6518; Simoncini T, 2000, NATURE, V407, P538, DOI 10.1038/35035131; Simoncini T, 2006, MOL ENDOCRINOL, V20, P1756, DOI 10.1210/me.2005-0259; Song RXD, 2002, MOL ENDOCRINOL, V16, P116, DOI 10.1210/me.16.1.116; Stefano GB, 2000, CIRCULATION, V101, P1594, DOI 10.1161/01.CIR.101.13.1594; Stevis PE, 1999, ENDOCRINOLOGY, V140, P5455, DOI 10.1210/en.140.11.5455; Temple JL, 2005, ENDOCRINOLOGY, V146, P558, DOI 10.1210/en.2004-1117; Walker HA, 2001, CIRCULATION, V103, P258, DOI 10.1161/01.CIR.103.2.258; Wingrove CS, 1998, BBA-MOL BASIS DIS, V1406, P169, DOI 10.1016/S0925-4439(97)00097-5; Wyckoff MH, 2001, J BIOL CHEM, V276, P27071, DOI 10.1074/jbc.M100312200	74	78	78	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14737	14743		10.1074/jbc.R110.191791	http://dx.doi.org/10.1074/jbc.R110.191791			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21343284	hybrid, Green Published			2022-12-27	WOS:000289788300002
J	Zhang, F; Liu, S; Yang, F; Zheng, J; Wang, KW				Zhang, Feng; Liu, Shuang; Yang, Fan; Zheng, Jie; Wang, KeWei			Identification of a Tetrameric Assembly Domain in the C Terminus of Heat-activated TRPV1 Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANKYRIN REPEAT DOMAIN; CAPSAICIN RECEPTOR; ION-CHANNEL; VANILLOID RECEPTOR-1; PHOSPHORYLATION; DETERMINANT; SENSITIVITY; SUBUNITS	Transient receptor potential (TRP) channels as cellular sensors are thought to function as tetramers. Yet, the molecular determinants governing channel multimerization remain largely elusive. Here we report the identification of a segment comprising 21 amino acids (residues 752-772 of mouse TRPV1) after the known TRP-like domain in the channel C terminus that functions as a tetrameric assembly domain (TAD). Purified recombinant C-terminal proteins of TRPV1-4, but not the N terminus, mediated the protein-protein interaction in an in vitro pulldown assay. Western blot analysis combined with electrophysiology and calcium imaging demonstrated that TAD exerted a robust dominant-negative effect on wild-type TRPV1. When fused with the membrane-tethered peptide Gap43, the TAD blocked the formation of stable homomultimers. Calcium imaging and current recordings showed that deletion of the TAD in a poreless TRPV1 mutant subunit suppressed its dominant-negative phenotype, confirming the involvement of the TAD in assembly of functional channels. Our findings suggest that the C-terminal TAD in TRPV1 channels functions as a domain that is conserved among TRPV1-4 and mediates a direct subunit-subunit interaction for tetrameric assembly.	[Zhang, Feng; Liu, Shuang; Wang, KeWei] Peking Univ, Hlth Sci Ctr, Dept Neurobiol, Neurosci Res Inst, Beijing 100191, Peoples R China; [Wang, KeWei] Peking Univ, Sch Pharmaceut Sci, Dept Mol & Cellular Pharmacol, Beijing 100191, Peoples R China; [Yang, Fan; Zheng, Jie] Univ Calif Davis, Dept Physiol & Membrane Biol, Davis, CA 95616 USA	Peking University; Peking University; University of California System; University of California Davis	Zheng, J (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Neurobiol, Neurosci Res Inst, 38 Xueyuan Rd, Beijing 100191, Peoples R China.	jzheng@ucdavis.edu; wangkw@bjmu.edu.cn	Yang, Fan/GYU-4249-2022; Yang, Fan/AAA-6904-2022; Zhang, Feng/R-3368-2016; Zhu, Ren-Yuan/V-8966-2019; Zhang, Feng/R-3019-2019; Yang, Fan/C-6586-2012; Yang, Fan/J-4562-2015	Yang, Fan/0000-0002-0520-5254; Zhu, Ren-Yuan/0000-0003-3091-7461; Yang, Fan/0000-0002-9406-7710; Yang, Fan/0000-0002-9406-7710	National Science Foundation of China [30630017, 30970919]; Ministry of Science Technology of China [2007CB512100]; Ministry of Education of China [B07001]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072377] Funding Source: NIH RePORTER	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science Technology of China(Ministry of Science and Technology, China); Ministry of Education of China(Ministry of Education, China); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Science Foundation of China Research Grants 30630017 and 30970919 (to K. W. W.), Ministry of Science Technology of China "973 Program" 2007CB512100, and Ministry of Education of China 111 Project China B07001.	Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Bhave G, 2003, P NATL ACAD SCI USA, V100, P12480, DOI 10.1073/pnas.2032100100; Caterina MJ, 2007, AM J PHYSIOL-REG I, V292, pR64, DOI 10.1152/ajpregu.00446.2006; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cheng W, 2007, J GEN PHYSIOL, V129, P191, DOI 10.1085/jgp.200709731; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; den Dekker E, 2003, CELL CALCIUM, V33, P497, DOI 10.1016/S0143-4160(03)00065-4; Dhaka A, 2009, J NEUROSCI, V29, P153, DOI 10.1523/JNEUROSCI.4901-08.2009; Garcia-Sanz N, 2004, J NEUROSCI, V24, P5307, DOI 10.1523/JNEUROSCI.0202-04.2004; Garcia-Sanz N, 2007, J NEUROSCI, V27, P11641, DOI 10.1523/JNEUROSCI.2457-07.2007; Gaudet R, 2008, MOL BIOSYST, V4, P372, DOI 10.1039/b801481g; Guler AD, 2002, J NEUROSCI, V22, P6408; Hellwig N, 2004, J BIOL CHEM, V279, P34553, DOI 10.1074/jbc.M402966200; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hoenderop JGJ, 2003, EMBO J, V22, P776, DOI 10.1093/emboj/cdg080; Jin XS, 2006, J BIOL CHEM, V281, P25006, DOI 10.1074/jbc.C600153200; Kedei N, 2001, J BIOL CHEM, V276, P28613, DOI 10.1074/jbc.M103272200; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; McCleverty CJ, 2006, PROTEIN SCI, V15, P2201, DOI 10.1110/ps.062357206; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Montell C, 2001, Sci STKE, V2001, pre1, DOI 10.1126/stke.2001.90.re1; Numazaki M, 2002, J BIOL CHEM, V277, P13375, DOI 10.1074/jbc.C200104200; Phelps CB, 2008, BIOCHEMISTRY-US, V47, P2476, DOI 10.1021/bi702109w; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Saito S, 2006, PHYSIOL GENOMICS, V27, P219, DOI 10.1152/physiolgenomics.00322.2005; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Vlachova V, 2003, J NEUROSCI, V23, P1340, DOI 10.1523/JNEUROSCI.23-04-01340.2003; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Wang HY, 2007, NAT NEUROSCI, V10, P32, DOI 10.1038/nn1822; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807	31	23	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15308	15316		10.1074/jbc.M111.223941	http://dx.doi.org/10.1074/jbc.M111.223941			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21357419	hybrid, Green Published			2022-12-27	WOS:000289788300062
J	Montpellier, C; Tews, BA; Poitrimole, J; Rocha-Perugini, V; D'Arienzo, V; Potel, J; Zhang, XA; Rubinstein, E; Dubuisson, J; Cocquerel, L				Montpellier, Claire; Tews, Birke Andrea; Poitrimole, Julien; Rocha-Perugini, Vera; D'Arienzo, Valentina; Potel, Julie; Zhang, Xin A.; Rubinstein, Eric; Dubuisson, Jean; Cocquerel, Laurence			Interacting Regions of CD81 and Two of Its Partners, EWI-2 and EWI-2wint, and Their Effect on Hepatitis C Virus Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TETRASPANIN-ENRICHED MICRODOMAINS; PROTEIN PALMITOYLATION; MEMBRANE-PROTEINS; MAJOR CD9; ASSOCIATION; CELLS; INTEGRIN; WEB; GLYCOPROTEIN; ORGANIZATION	CD81 is a tetraspanin protein that is involved in several essential cellular functions, as well as in the hepatitis C virus (HCV) infection. CD81 interacts with a high stoichiometry with its partner proteins EWI-2, EWI-2wint, and EWI-F. These latter proteins modify the functions of CD81 and can thereby potentially inhibit infection or modulate cell migration. Here, we characterized the cleavage of EWI-2 leading to the production of EWI-2wint, which has been shown to inhibit HCV infection. We determined the regions of EWI-2/EWI-2wint and CD81 that are important for their interaction and their functionality. More precisely, we identified a glycine zipper motif in the transmembrane domain of EWI-2/EWI-2wint that is essential for the interaction with CD81. In addition, we found that palmitoylation on two juxtamembranous cysteines in the cytosolic tail of EWI-2/EWI-2wint is required for their interaction with CD81 as well as with CD9, another tetraspanin. Thus, we have shown that palmitoylation of a tetraspanin partner protein can influence the interaction with a tetraspanin. We therefore propose that palmitoylation not only of tetraspanins, but also of their partner proteins is important in regulating the composition of complexes in tetraspanin networks. Finally, we identified the regions in CD81 that are necessary for its functionality in HCV entry and we demonstrated that EWI-2wint needs to interact with CD81 to exert its inhibitory effect on HCV infection.	[Montpellier, Claire; Tews, Birke Andrea; Poitrimole, Julien; Rocha-Perugini, Vera; D'Arienzo, Valentina; Potel, Julie; Dubuisson, Jean; Cocquerel, Laurence] Univ Lille Nord France, Ctr Infect & Immun Lille, Hepatitis Lab C, Pasteur Inst Lille,CNRS,UMR8204,INSERM,U1019, F-59021 Lille, France; [Rubinstein, Eric] INSERM, U1004, F-94807 Villejuif, France; [Zhang, Xin A.] Univ Tennessee, Hlth Sci Ctr, Vasc Biol Ctr, Memphis, TN 38163 USA; [Zhang, Xin A.] Univ Tennessee, Hlth Sci Ctr, Dept Med, Memphis, TN 38163 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Cocquerel, L (corresponding author), HCV Lab, Ctr Infect & Immun Lille, IBL 1, Rue Pr Calmette,BP447, F-59021 Lille, France.	laurence.cocquerel@ibl.fr	Rubinstein, Eric/B-4650-2019; Rocha-Perugini, Vera/D-6977-2014; Cocquerel, Laurence/P-1951-2016; Dubuisson, Jean/E-6813-2016	Rubinstein, Eric/0000-0001-7623-9665; Rocha-Perugini, Vera/0000-0002-1761-9884; Cocquerel, Laurence/0000-0002-2136-5178; MONTPELLIER, Claire/0000-0002-3112-8491; Tews, Birke Andrea/0000-0002-8647-0497; Dubuisson, Jean/0000-0003-1626-7693	"Agence Nationale de Recherches sur le Sida et les hepatites virales" (ANRS); Fondation pour la Recherche Medicale; Marie Curie Intra European Fellowship	"Agence Nationale de Recherches sur le Sida et les hepatites virales" (ANRS)(ANRSFrench National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Marie Curie Intra European Fellowship(European Commission)	This work was supported in part by the "Agence Nationale de Recherches sur le Sida et les hepatites virales" (ANRS) and the "Fondation pour la Recherche Medicale."; Supported by a Fellowship of the ANRS and a Marie Curie Intra European Fellowship within the 7th European Community Framework Programme.	Andre M, 2009, J PROTEOMICS, V73, P93, DOI 10.1016/j.jprot.2009.08.005; Bagot M, 1997, TISSUE ANTIGENS, V50, P439, DOI 10.1111/j.1399-0039.1997.tb02898.x; Berditchevski F, 2002, J BIOL CHEM, V277, P36991, DOI 10.1074/jbc.M205265200; Bijlmakers MJ, 2003, TRENDS CELL BIOL, V13, P32, DOI 10.1016/S0962-8924(02)00008-9; Charrin S, 2003, BIOCHEM J, V373, P409, DOI 10.1042/BJ20030343; Charrin S, 2001, J BIOL CHEM, V276, P14329, DOI 10.1074/jbc.M011297200; Charrin S, 2009, J BIOL CHEM, V284, P31572, DOI 10.1074/jbc.M109.057927; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Clark KL, 2004, J BIOL CHEM, V279, P19401, DOI 10.1074/jbc.M312626200; Clark KL, 2001, J IMMUNOL, V167, P5115, DOI 10.4049/jimmunol.167.9.5115; Cocquerel L, 1998, J VIROL, V72, P2183, DOI 10.1128/JVI.72.3.2183-2191.1998; Coller KE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000702; Delgrange D, 2007, J GEN VIROL, V88, P2495, DOI 10.1099/vir.0.82872-0; Dubuisson J, 2008, CELL MICROBIOL, V10, P821, DOI 10.1111/j.1462-5822.2007.01107.x; Flannery AR, 2010, J CELL BIOL, V191, P599, DOI 10.1083/jcb.201003021; Flint M, 1999, J VIROL, V73, P6782, DOI 10.1128/JVI.73.8.6782-6790.1999; GORDON VM, 1995, INFECT IMMUN, V63, P82, DOI 10.1128/IAI.63.1.82-87.1995; Gruda R, 2007, J IMMUNOL, V179, P3655, DOI 10.4049/jimmunol.179.6.3655; Harris HJ, 2008, J VIROL, V82, P5007, DOI 10.1128/JVI.02286-07; Harris HJ, 2010, J BIOL CHEM, V285, P21092, DOI 10.1074/jbc.M110.104836; Kim S, 2005, P NATL ACAD SCI USA, V102, P14278, DOI 10.1073/pnas.0501234102; Kitadokoro K, 2001, EMBO J, V20, P12, DOI 10.1093/emboj/20.1.12; Kolesnikova TV, 2004, BLOOD, V103, P3013, DOI 10.1182/blood-2003-07-2201; Krieger SE, 2010, HEPATOLOGY, V51, P1144, DOI 10.1002/hep.23445; LEMON SM, 2007, FIELDS VIROLOGY, P1253; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Mee CJ, 2009, J VIROL, V83, P6211, DOI 10.1128/JVI.00246-09; OREN R, 1990, MOL CELL BIOL, V10, P4007, DOI 10.1128/MCB.10.8.4007; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2009, EMBO REP, V10, P1220, DOI 10.1038/embor.2009.223; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; ROBBINS PW, 1984, J BIOL CHEM, V259, P7577; Rocha-Perugini V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001866; Rocha-Perugini V, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-111; Rubinstein E, 1996, EUR J IMMUNOL, V26, P2657, DOI 10.1002/eji.1830261117; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Sala-Valdes M, 2006, J BIOL CHEM, V281, P19665, DOI 10.1074/jbc.M602116200; Seigneuret M, 2006, BIOPHYS J, V90, P212, DOI 10.1529/biophysj.105.069666; Silvie O, 2003, NAT MED, V9, P93, DOI 10.1038/nm808; Silvie O, 2006, J CELL SCI, V119, P1992, DOI 10.1242/jcs.02911; Stipp CS, 2003, J CELL BIOL, V163, P1167, DOI 10.1083/jcb.200309113; Stipp CS, 2001, J BIOL CHEM, V276, P40545, DOI 10.1074/jbc.M107338200; Stipp CS, 2001, J BIOL CHEM, V276, P4853, DOI 10.1074/jbc.M009859200; Tham TN, 2010, INFECT IMMUN, V78, P204, DOI 10.1128/IAI.00661-09; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Yalaoui S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000010; Yang XH, 2006, J BIOL CHEM, V281, P12976, DOI 10.1074/jbc.M510617200; Yang XW, 2004, J CELL BIOL, V167, P1231, DOI 10.1083/jcb.200404100; Zhang J, 2004, J VIROL, V78, P1448, DOI 10.1128/JVI.78.3.1448-1455.2004; Zhang XA, 2003, CANCER RES, V63, P2665	52	43	45	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					13954	13965		10.1074/jbc.M111.220103	http://dx.doi.org/10.1074/jbc.M111.220103			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21343309	Green Published, hybrid			2022-12-27	WOS:000289556200018
J	Song, ES; Rodgers, DW; Hersh, LB				Song, Eun Suk; Rodgers, David W.; Hersh, Louis B.			Mixed Dimers of Insulin-degrading Enzyme Reveal a Cis Activation Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULYSIN; RECOGNITION; ATP	Insulin-degrading enzyme (IDE) exists primarily as a dimer being unique among the zinc metalloproteases in that it exhibits allosteric kinetics with small synthetic peptide substrates. In addition the IDE reaction rate is increased by small peptides that bind to a distal site within the substrate binding site. We have generated mixed dimers of IDE in which one or both subunits contain mutations that affect activity. The mutation Y609F in the distal part of the substrate binding site of the active subunit blocks allosteric activation regardless of the activity of the other subunit. This effect shows that substrate or small peptide activation occurs through a cis effect. A mixed dimer composed of one wild-type subunit and the other subunit containing a mutation that neither permits substrate binding nor catalysis (H112Q) exhibits the same turnover number per active subunit as wild-type IDE. In contrast, a mixed dimer in which one subunit contains the wild-type sequence and the other contains a mutation that permits substrate binding, but not catalysis (E111F), exhibits a decrease in turnover number. This indicates a negative trans effect of substrate binding at the active site. On the other hand, activation in trans is observed with extended substrates that occupy both the active and distal sites. Comparison of the binding of an amyloid beta peptide analog to wild-type IDE and to the Y609F mutant showed no difference in affinity, indicating that Y609 does not play a significant role in substrate binding at the distal site.	[Hersh, Louis B.] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Hersh, Louis B.] Univ Kentucky, Struct Biol Ctr, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky	Hersh, LB (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, B283 BBSRB,741 S Limestone St, Lexington, KY 40536 USA.	lhersh@uky.edu			National Institutes of Health [DA02243, NS38041, P20 RR020171]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038041, R56NS038041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA002243] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA02243, NS38041, and P20 RR020171.	Fakhrai-Rad H, 2000, HUM MOL GENET, V9, P2149, DOI 10.1093/hmg/9.14.2149; HARI J, 1987, ENDOCRINOLOGY, V120, P829, DOI 10.1210/endo-120-2-829; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Leissring MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010504; Malito E, 2008, BIOCHEMISTRY-US, V47, P12822, DOI 10.1021/bi801192h; Miller BC, 2003, P NATL ACAD SCI USA, V100, P6221, DOI 10.1073/pnas.1031520100; Parker MW, 2010, BIOCHEMISTRY-US, V49, P4068, DOI 10.1021/bi100327r; Safavi A, 1996, BIOCHEMISTRY-US, V35, P14318, DOI 10.1021/bi960582q; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; SHII K, 1986, P NATL ACAD SCI USA, V83, P4147, DOI 10.1073/pnas.83.12.4147; Song ES, 2004, J BIOL CHEM, V279, P54216, DOI 10.1074/jbc.M411177200; Song ES, 2003, J BIOL CHEM, V278, P49789, DOI 10.1074/jbc.M308983200; Song ES, 2001, J BIOL CHEM, V276, P1152, DOI 10.1074/jbc.M008702200; Song ES, 2005, J BIOL CHEM, V280, P17701, DOI 10.1074/jbc.M501896200; Song ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009719; Yao HB, 2006, ARCH BIOCHEM BIOPHYS, V451, P175, DOI 10.1016/j.abb.2006.04.011	16	12	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					13852	13858		10.1074/jbc.M110.191668	http://dx.doi.org/10.1074/jbc.M110.191668			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21343292	Green Published, hybrid			2022-12-27	WOS:000289556200008
J	Hu, N; Zhang, JL; Cui, WJ; Kong, GY; Zhang, SA; Yue, L; Bai, X; Zhang, Z; Zhang, WY; Zhang, XD; Ye, LH				Hu, Nan; Zhang, Jianli; Cui, Wenjing; Kong, Guangyao; Zhang, Shuai; Yue, Lin; Bai, Xiao; Zhang, Zhao; Zhang, Weiying; Zhang, Xiaodong; Ye, Lihong			miR-520b Regulates Migration of Breast Cancer Cells by Targeting Hepatitis B X-interacting Protein and Interleukin-8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; MICRORNA-21 TARGETS; UP-REGULATION; EXPRESSION; HBXIP; METASTASIS; INVASION; PROLIFERATION; SUPPRESSION; SURVIVIN	MicroRNAs play important roles in tumor metastasis. Recently, we reported that the level of miR-520b is inversely related to the metastatic potential of breast cancer cells. In this study, we investigated the role of miR-520b in breast cancer cell migration. We found that miR-520b suppressed the migration of breast cancer cells with high metastatic potential, including M DA-MB-231 and LM-MCF-7 cells, although the inhibition of miR-520b enhanced the migration of low metastatic potential MCF-7 cells. We further discovered that miR-520b directly targets the 3'-untranslated region (3'UTR) of either hepatitis B X-interacting protein (HBXIP) or interleukin-8 (IL-8), which has been reported to contribute to cell migration. Surprisingly, tissue array assays showed that 75% (38:49) and 94% (36:38) of breast cancer tissues and metastatic lymph tissues, respectively, were positive for HBXIP expression. Moreover, overexpression of HBXIP was able to promote the migration of MCF-7 cells. Interestingly, HBXIP was able to regulate IL-8 transcription by NF-kappa B, suggesting that the two target genes of miR-520b are functionally connected, In addition, we found that miR-520b could indirectly regulate IL-8 transcription by targeting HBXIP. Thus, we conclude that miR-520b is involved in regulating breast cancer cell migration by targeting HBXIP and IL-8 via a network in which HBXIP promotes migration by stimulating NF-kappa B-mediated IL-8 expression. These studies point to HBXIP as a potential therapeutic target for breast cancer.	[Kong, Guangyao; Zhang, Shuai; Zhang, Xiaodong] Nankai Univ, Coll Life Sci, Key Lab Mol Microbiol & Technol, Inst Mol Biol,Minist Educ,Dept Canc Res, Tianjin 300071, Peoples R China; [Hu, Nan; Zhang, Jianli; Cui, Wenjing; Yue, Lin; Bai, Xiao; Zhang, Zhao; Zhang, Weiying; Ye, Lihong] Nankai Univ, Coll Life Sci, Dept Biochem, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Zhang, XD (corresponding author), Nankai Univ, Coll Life Sci, Key Lab Mol Microbiol & Technol, Inst Mol Biol,Minist Educ,Dept Canc Res, Tianjin 300071, Peoples R China.	zhangxd@nankai.edu.cn; yelihong@nankai.edu.cn	Cui, Wenjing/HIR-1471-2022; Kong, Guangyao/L-2162-2013	Zhang, Shuai/0000-0003-0272-0856	National Basic Research Program of China 973 Program [2007CB914804, 2007CB914802, 2009CB521702]; Natural Scientific Foundation of China [30770826, 81071623]; Tianjin Natural Scientific Foundation [08JCZDJC20700]	National Basic Research Program of China 973 Program(National Basic Research Program of China); Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Natural Scientific Foundation	This work was supported in part by National Basic Research Program of China 973 Program Grants 2007CB914804, 2007CB914802, and 2009CB521702, Natural Scientific Foundation of China Grants 30770826 and 81071623, and Tianjin Natural Scientific Foundation Grant 08JCZDJC20700.	Ben-Baruch A, 2006, CANCER METAST REV, V25, P357, DOI 10.1007/s10555-006-9003-5; Bendrik C, 2009, J IMMUNOL, V182, P371, DOI 10.4049/jimmunol.182.1.371; Benoy IH, 2004, CLIN CANCER RES, V10, P7157, DOI 10.1158/1078-0432.CCR-04-0812; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Bhaumik D, 2008, ONCOGENE, V27, P5643, DOI 10.1038/onc.2008.171; Braunstein S, 2008, MOL CANCER RES, V6, P78, DOI 10.1158/1541-7786.MCR-07-0339; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chavey C, 2008, MOL PHARMACOL, V74, P1359, DOI 10.1124/mol.108.047332; Sempere MC, 2008, CLIN TRANSL ONCOL, V10, P143, DOI 10.1007/s12094-008-0171-3; Cui W, 2010, CANCER BIOL THER, V10, P232; Freund A, 2004, ONCOGENE, V23, P6105, DOI 10.1038/sj.onc.1207815; Gebeshuber CA, 2009, EMBO REP, V10, P400, DOI 10.1038/embor.2009.9; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Hurst DR, 2009, CANCER RES, V69, P1279, DOI 10.1158/0008-5472.CAN-08-3559; Kim SW, 2005, CANCER RES, V65, P8784, DOI 10.1158/0008-5472.CAN-04-4422; Lerebours F, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-41; Li Q, 2010, J GASTROEN HEPATOL, V25, P164, DOI 10.1111/j.1440-1746.2009.05971.x; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lin Y, 2004, INT J CANCER, V109, P507, DOI 10.1002/ijc.11724; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Martin D, 2009, J BIOL CHEM, V284, P6038, DOI 10.1074/jbc.C800207200; Marusawa H, 2003, EMBO J, V22, P2729, DOI 10.1093/emboj/cdg263; Matsuo Y, 2009, INT J CANCER, V124, P853, DOI 10.1002/ijc.24040; Melegari M, 1998, J VIROL, V72, P1737, DOI 10.1128/JVI.72.3.1737-1743.1998; Minczuk M, 2005, FEBS J, V272, P5008, DOI 10.1111/j.1742-4658.2005.04910.x; O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484; Pan YZ, 2009, DRUG METAB DISPOS, V37, P2112, DOI 10.1124/dmd.109.027680; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; Prasad S, 2010, MOL CELL BIOCHEM, V336, P25, DOI 10.1007/s11010-009-0267-2; Shan CL, 2010, CELL RES, V20, P563, DOI 10.1038/cr.2010.49; Shen HM, 2009, APOPTOSIS, V14, P348, DOI 10.1007/s10495-009-0315-0; Strum JC, 2009, MOL ENDOCRINOL, V23, P1876, DOI 10.1210/me.2009-0117; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Wang FZ, 2008, ACTA PHARMACOL SIN, V29, P83, DOI 10.1111/j.1745-7254.2008.00729.x; Wang FZ, 2007, ACTA PHARMACOL SIN, V28, P431, DOI 10.1111/j.1745-7254.2007.00531.x; Wang GF, 2008, FEBS LETT, V582, P3663, DOI 10.1016/j.febslet.2008.09.051; Wang YF, 2009, J BIOL CHEM, V284, P23094, DOI 10.1074/jbc.M109.012617; Wen YF, 2008, J BIOL CHEM, V283, P2793, DOI 10.1074/jbc.M708419200; Wu KM, 2008, P NATL ACAD SCI USA, V105, P6924, DOI 10.1073/pnas.0802085105; Yadav D, 2009, J IMMUNOL, V182, P39, DOI 10.4049/jimmunol.182.1.39; Yao C, 2007, INT J CANCER, V121, P1949, DOI 10.1002/ijc.22930; Ye Li-hong, 2006, Zhonghua Yi Xue Za Zhi, V86, P61; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang XD, 2005, J MED VIROL, V77, P374, DOI 10.1002/jmv.20466; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	46	95	105	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13714	13722		10.1074/jbc.M110.204131	http://dx.doi.org/10.1074/jbc.M110.204131			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21343296	Green Published, hybrid			2022-12-27	WOS:000289282200089
J	Dave, N; Guaita-Esteruelas, S; Gutarra, S; Frias, A; Beltran, M; Peiro, S; de Herreros, AG				Dave, Natlia; Guaita-Esteruelas, Sandra; Gutarra, Susana; Frias, Alex; Beltran, Manuel; Peiro, Sandra; Garcia de Herreros, Antonio			Functional Cooperation between Snail1 and Twist in the Regulation of ZEB1 Expression during Epithelial to Mesenchymal Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR SNAIL; CADHERIN GENE-EXPRESSION; BREAST-CANCER; MUSCLE DIFFERENTIATION; TUMOR-METASTASIS; MIR-200 FAMILY; TGF-BETA; CELLS; REPRESSOR; PROTEIN	Snail1 and Zeb1 are E-cadherin-transcriptional repressors induced during epithelial mesenchymal transition (EMT). In this article we have analyzed the factors controlling Zeb1 expression during EMT. In NMuMG cells treated with TGF-beta, Snail1 RNA and protein are induced 1 h after addition of the cytokine preceding Zeb1 up-regulation that requires 6-8 h. Zeb1 gene expression is caused by increased RNA levels but also by enhanced protein stability and is markedly dependent on Snail1 because depletion of this protein prevents Zeb1 protein and RNA up-regulation. In addition to Snail1, depletion of the Twist transcriptional factor retards Zeb1 stimulation by TGF-beta or decreases Zeb1 expression in other cellular models indicating that this factor is also required for Zeb1 expression. Accordingly, Snail1 and Twist cooperate in the induction of Zeb1: co-transfection of both cDNAs is required for the maximal expression of ZEB1 mRNA. Unexpectedly, the expression of Snail1 and Twist shows a mutual dependence although to a different extent; whereas Twist depletion retards Snail1 up-regulation by TGF-beta, Snail1 is necessary for the rapid increase in Twist protein and later up-regulation of Twist1 mRNA induced by the cytokine. Besides this effect on Twist, Snail1 also induces the nuclear translocation of Ets1, another factor required for Zeb1 expression. Both Twist and Ets1 bind to the ZEB1 promoter although to different elements: whereas Ets1 interacts with the proximal promoter, Twist does it with a 700-bp sequence upstream of the transcription start site. These results indicate that Snail1 controls Zeb1 expression at multiple levels and acts cooperatively with Twist in the ZEB1 gene transcription induction.	[Dave, Natlia; Guaita-Esteruelas, Sandra; Gutarra, Susana; Frias, Alex; Beltran, Manuel; Peiro, Sandra; Garcia de Herreros, Antonio] Hosp del Mar, Inst Municipal Invest Med, Programa Recerca Canc, E-08003 Barcelona, Spain; [Garcia de Herreros, Antonio] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona 08003, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University	de Herreros, AG (corresponding author), Hosp del Mar, Inst Municipal Invest Med, Programa Recerca Canc, Parc Recerca Biomed Barcelona,Doctor Aiguade 88, E-08003 Barcelona, Spain.	agarcia@imim.es	de Herreros, A Garcia/H-3104-2014	de Herreros, A Garcia/0000-0001-5270-0808; Peiro, Sandra/0000-0001-9519-3877; Frias, Alex/0000-0002-4857-7904	Ministerio de Ciencia y Tecnologia [SAF2006-00339]; La Fundacion Cientifica de la Asociacion Espanola contra el Cancer; La Fundacio La Marato de TV3 [081731]; Instituto Carlos III-Fondos FEDER (RTICCC) [C03710, RD06/0020/0040]; Generalitat de Catalunya [2009SGR867]; la Asociacion Espanola contra el Cancer	Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); La Fundacion Cientifica de la Asociacion Espanola contra el Cancer; La Fundacio La Marato de TV3; Instituto Carlos III-Fondos FEDER (RTICCC); Generalitat de Catalunya(Generalitat de Catalunya); la Asociacion Espanola contra el Cancer	This work was supported in part by Grant SAF2006-00339 from Ministerio de Ciencia y Tecnologia, grants from the La Fundacion Cientifica de la Asociacion Espanola contra el Cancer and La Fundacio La Marato de TV3 (081731) (to A. G. H.), Instituto Carlos III-Fondos FEDER (RTICCC, C03710, RD06/0020/0040), and Generalitat de Catalunya Grant 2009SGR867.; Supported by a postdoctoral contract from la Asociacion Espanola contra el Cancer.	Ansieau S, 2010, ONCOGENE, V29, P3173, DOI 10.1038/onc.2010.92; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Foubert E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2585; Franci C, 2006, ONCOGENE, V25, P5134, DOI 10.1038/sj.onc.1209519; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Grooteclaes ML, 2000, ONCOGENE, V19, P3823, DOI 10.1038/sj.onc.1203721; Guaita S, 2002, J BIOL CHEM, V277, P39209, DOI 10.1074/jbc.M206400200; Hajra KM, 2002, CANCER RES, V62, P1613; HEBROK M, 1994, DEV BIOL, V165, P537, DOI 10.1006/dbio.1994.1273; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Palmer HG, 2004, NAT MED, V10, P917, DOI 10.1038/nm1095; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Peiro S, 2006, NUCLEIC ACIDS RES, V34, P2077, DOI 10.1093/nar/gkl141; Perez-Moreno MA, 2001, J BIOL CHEM, V276, P27424, DOI 10.1074/jbc.M100827200; Pham CG, 2007, MOL CELL BIOL, V27, P3920, DOI 10.1128/MCB.01219-06; Postigo AA, 1997, EMBO J, V16, P3935, DOI 10.1093/emboj/16.13.3935; Shirakihara T, 2007, MOL BIOL CELL, V18, P3533, DOI 10.1091/mbc.E07-03-0249; Solanas G, 2008, J CELL SCI, V121, P2224, DOI 10.1242/jcs.021667; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Vesuna F, 2008, BIOCHEM BIOPH RES CO, V367, P235, DOI 10.1016/j.bbrc.2007.11.151; Vinas-Castells R, 2010, J BIOL CHEM, V285, P3794, DOI 10.1074/jbc.M109.065995; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099	30	194	201	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.168625	http://dx.doi.org/10.1074/jbc.M110.168625			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21317430	hybrid, Green Published			2022-12-27	WOS:000289077500016
J	Dennis, MK; Taneva, SG; Cornell, RB				Dennis, Melissa K.; Taneva, Svetla G.; Cornell, Rosemary B.			The Intrinsically Disordered Nuclear Localization Signal and Phosphorylation Segments Distinguish the Membrane Affinity of Two Cytidylyltransferase Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; HAMSTER OVARY CELLS; RAT-LIVER CTP; BINDING DOMAIN; CTPPHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; PHOSPHATIDYLCHOLINE BIOSYNTHESIS; INTRACELLULAR-LOCALIZATION; NEURITE OUTGROWTH; LIPID ACTIVATION; TERMINAL DOMAIN	Membrane phosphatidylcholine homeostasis is maintained in part by a sensing device in the key regulatory enzyme, CTP: phosphocholine cytidylyltransferase (CCT). CCT responds to decreases in membrane phosphatidylcholine content by reversible membrane binding and activation. Two prominent isoforms, CCT alpha and -beta(2), have nearly identical catalytic domains and very similar membrane binding amphipathic helical (M) domains but have divergent and structurally disordered N-terminal (N) and C-terminal phosphorylation (P) regions. We found that the binding affinity of purified CCT beta(2) for anionic membranes was weaker than CCT alpha by more than an order of magnitude. Using chimeric CCTs, insertion/deletion mutants, and truncated CCTs, we show that the stronger affinity of CCT alpha can be attributed in large part to the electrostatic membrane binding function of the polybasic nuclear localization signal (NLS) motif, present in the unstructured N-terminal segment of CCT alpha but lacking in CCT beta(2). The membrane partitioning of CCT beta(2) in cells enriched with the lipid activator, oleic acid, was also weaker than that of CCT alpha and was elevated by incorporation of the NLS motif. Thus, the polybasic NLS can function as a secondary membrane binding motif not only in vitro but in the context of cell membranes. A comparison of phosphorylated, dephosphorylated, and region P-truncated forms showed that the in vitro membrane affinity of CCT beta 2 is more sensitive than CCT alpha to phosphorylation status, which antagonizes membrane binding of both isoforms. These data provide a model wherein the primary membrane binding motif, an amphipathic helical domain, works in collaboration with other intrinsically disordered segments that modulate membrane binding strength. The NLS reinforces, whereas the phosphorylated tail antagonizes the attraction of domain M for anionic membranes.	[Dennis, Melissa K.; Taneva, Svetla G.; Cornell, Rosemary B.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Cornell, Rosemary B.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University; Simon Fraser University	Cornell, RB (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada.	cornell@sfu.ca			Canadian Institutes for Health Research	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a Canadian Institutes for Health Research operating grant (to R. B. C.).	Agassandian M, 2005, J BIOL CHEM, V280, P21577, DOI 10.1074/jbc.M412409200; Arnold RS, 1996, BIOCHEMISTRY-US, V35, P9917, DOI 10.1021/bi960397c; Arnold RS, 1997, BIOCHEMISTRY-US, V36, P6149, DOI 10.1021/bi970023z; Attard GS, 2000, P NATL ACAD SCI USA, V97, P9032, DOI 10.1073/pnas.160260697; Bogan MJ, 2005, J BIOL CHEM, V280, P19613, DOI 10.1074/jbc.M414028200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carter JM, 2003, J BIOL CHEM, V278, P44988, DOI 10.1074/jbc.M307336200; Carter JM, 2008, J BIOL CHEM, V283, P202, DOI 10.1074/jbc.M706531200; Celton-Morizur S, 2004, MOL CELL BIOL, V24, P10621, DOI 10.1128/MCB.24.24.10621-10635.2004; Chen BB, 2009, MOL CELL BIOL, V29, P3062, DOI 10.1128/MCB.01824-08; CORNELL RB, 1995, BIOCHEM J, V310, P699, DOI 10.1042/bj3100699; Cornell RB, 2000, TRENDS BIOCHEM SCI, V25, P441, DOI 10.1016/S0968-0004(00)01625-X; CRAIG L, 1994, J BIOL CHEM, V269, P3311; Cui Z, 1996, J BIOL CHEM, V271, P14668, DOI 10.1074/jbc.271.25.14668; Davies SMA, 2001, BIOCHEMISTRY-US, V40, P10522, DOI 10.1021/bi010904c; Dunne SJ, 1996, BIOCHEMISTRY-US, V35, P11975, DOI 10.1021/bi960821+; Fagone P, 2007, J BIOL CHEM, V282, P7591, DOI 10.1074/jbc.M608175200; Friesen JA, 1999, J BIOL CHEM, V274, P13384, DOI 10.1074/jbc.274.19.13384; Galea CA, 2009, J PROTEOME RES, V8, P211, DOI 10.1021/pr800308v; Garnier-Lhomme M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004255; Gehrig K, 2009, J LIPID RES, V50, P966, DOI 10.1194/jlr.M800632-JLR200; GROBLEWSKI GE, 1995, J BIOL CHEM, V270, P1437, DOI 10.1074/jbc.270.3.1437; HATCH GM, 1992, J BIOL CHEM, V267, P15751; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; HOUWELING M, 1994, J BIOL CHEM, V269, P7544; Houweling M, 1996, EUR J CELL BIOL, V69, P55; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; JACKOWSKI S, 1994, J BIOL CHEM, V269, P3858; Jackowski S, 2004, MOL CELL BIOL, V24, P4720, DOI 10.1128/MCB.24.11.4720-4733.2004; Johnson JE, 1997, BBA-BIOMEMBRANES, V1324, P273, DOI 10.1016/S0005-2736(96)00233-7; Johnson JE, 2003, J BIOL CHEM, V278, P514, DOI 10.1074/jbc.M206072200; Johnson JE, 1998, BIOCHEMISTRY-US, V37, P9509, DOI 10.1021/bi980340l; JONES MK, 1992, J LIPID RES, V33, P287; Karim M, 2003, BBA-MOL CELL BIOL L, V1633, P1, DOI 10.1016/S1388-1981(03)00067-2; Lagace TK, 2000, J BIOL CHEM, V275, P14367, DOI 10.1074/jbc.275.19.14367; Lee JY, 2009, J BIOL CHEM, V284, P33535, DOI 10.1074/jbc.M109.053363; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Lykidis A, 1998, J BIOL CHEM, V273, P14022, DOI 10.1074/jbc.273.22.14022; Lykidis A, 1999, J BIOL CHEM, V274, P26992, DOI 10.1074/jbc.274.38.26992; Lykidis A, 2001, BIOCHEMISTRY-US, V40, P494, DOI 10.1021/bi002140r; MACDONALD JIS, 1994, J BIOL CHEM, V269, P10529; MACDONALD JIS, 1995, BIOCHEM J, V312, P425, DOI 10.1042/bj3120425; Murray D, 1998, BIOCHEMISTRY-US, V37, P2145, DOI 10.1021/bi972012b; Nomikos M, 2007, J BIOL CHEM, V282, P16644, DOI 10.1074/jbc.M701072200; Northwood IC, 1999, J BIOL CHEM, V274, P26240, DOI 10.1074/jbc.274.37.26240; PELECH SL, 1982, J BIOL CHEM, V257, P4198; POEHLING HM, 1981, ELECTROPHORESIS, V2, P141, DOI 10.1002/elps.1150020304; Ren HM, 2010, MOL BIOL CELL, V21, P3171, DOI 10.1091/mbc.E10-01-0073; Ridsdale R, 2001, J BIOL CHEM, V276, P49148, DOI 10.1074/jbc.M103566200; Ridsdale R, 2010, AM J RESP CELL MOL, V43, P74, DOI 10.1165/rcmb.2009-0231OC; Ryan AJ, 2006, ARCH BIOCHEM BIOPHYS, V447, P23, DOI 10.1016/j.abb.2006.01.007; SANGHERA JS, 1989, J BIOL CHEM, V264, P1215; SHIRATORI Y, 1995, J BIOL CHEM, V270, P29894; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; SOHAL PS, 1990, J BIOL CHEM, V265, P11746; Taneva S, 2003, BIOCHEMISTRY-US, V42, P11768, DOI 10.1021/bi035234k; Taneva SG, 2005, BIOCHEMISTRY-US, V44, P9382, DOI 10.1021/bi050679p; Taneva S, 2008, J BIOL CHEM, V283, P28137, DOI 10.1074/jbc.M802595200; Tseu I, 2002, AM J RESP CELL MOL, V26, P506, DOI 10.1165/ajrcmb.26.4.4702; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Vance JE, 1998, TRENDS BIOCHEM SCI, V23, P423, DOI 10.1016/S0968-0004(98)01297-3; Veitch DP, 1998, EUR J BIOCHEM, V255, P227, DOI 10.1046/j.1432-1327.1998.2550227.x; Wang LM, 2005, MOL CELL BIOL, V25, P3357, DOI 10.1128/MCB.25.8.3357-3363.2005; WANG Y, 1995, J BIOL CHEM, V270, P18948, DOI 10.1074/jbc.270.32.18948; WANG YL, 1995, J BIOL CHEM, V270, P17843, DOI 10.1074/jbc.270.30.17843; WANG YL, 1993, J BIOL CHEM, V268, P5512; WANG YL, 1993, J BIOL CHEM, V268, P5899; WANG YL, 1995, J BIOL CHEM, V270, P354, DOI 10.1074/jbc.270.1.354; WATKINS JD, 1991, J BIOL CHEM, V266, P21113; WATKINS JD, 1992, J BIOL CHEM, V267, P5686; WEIBEL ER, 1969, J CELL BIOL, V42, P68, DOI 10.1083/jcb.42.1.68; Wieprecht M, 1996, J BIOL CHEM, V271, P9955, DOI 10.1074/jbc.271.17.9955; Winters MJ, 2005, MOL CELL, V20, P21, DOI 10.1016/j.molcel.2005.08.020; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Xie MT, 2004, J BIOL CHEM, V279, P28817, DOI 10.1074/jbc.M403311200; YANG W, 1995, J BIOL CHEM, V270, P23951, DOI 10.1074/jbc.270.41.23951; YANG W, 1995, J BIOL CHEM, V270, P16503, DOI 10.1074/jbc.270.28.16503; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Zhang DJ, 2000, J BIOL CHEM, V275, P35368, DOI 10.1074/jbc.M007099200	80	27	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.201715	http://dx.doi.org/10.1074/jbc.M110.201715			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21303909	Green Published, hybrid			2022-12-27	WOS:000289077500049
J	Norenberg, W; Hempel, C; Urban, N; Sobottka, H; Illes, P; Schaefer, M				Noerenberg, Wolfgang; Hempel, Christoph; Urban, Nicole; Sobottka, Helga; Illes, Peter; Schaefer, Michael			Clemastine Potentiates the Human P2X7 Receptor by Sensitizing It to Lower ATP Concentrations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR ATP; P2X(7) RECEPTORS; SINGLE-CHANNEL; DIVALENT-CATIONS; PATCH-CLAMP; PORE; MACROPHAGES; MODULATION; RELEASE; PERMEABILITY	P2X7 receptors have emerged as potential drug targets for the treatment of medical conditions such as e. g. rheumatoid arthritis and neuropathic pain. To assess the impact of pharmaceuticals on P2X7, we screened a compound library comprising approved or clinically tested drugs and identified several compounds that augment the ATP-triggered P2X7 activity in a stably transfected HEK293 cell line. Of these, clemastine markedly sensitized Ca2+ entry through P2X7 to lower ATP concentrations. Extracellularly but not intracellularly applied clemastine rapidly and reversibly augmented P2X7-mediated whole-cell currents evoked by non-saturating ATP concentrations. Clemastine also accelerated the ATP-induced pore formation and Yo-Pro-1 uptake, increased the fractional NMDG(+) permeability, and stabilized the open channel conformation of P2X7. Thus, clemastine is an extracellularly binding allosteric modulator of P2X7 that sensitizes P2X7 to lower ATP concentrations and facilitates its pore dilation. The activity of clemastine on native P2X7 receptors, Ca2+ entry, and whole-cell currents was confirmed in human monocyte-derived macrophages. Similar effects were observed in murine bone marrow-derived macrophages. Consistent with the data on recombinant P2X7, clemastine augmented the ATP-induced cation entry and Yo-Pro-1 uptake. In accordance with the observation that P2X7 controls the cytokine release from LPS-primed macrophages, we found that clemastine augmented the IL-1 beta release from LPS-primed human macrophages. Collectively, these data point to a sensitization of the recombinantly or natively expressed human P2X7 receptor toward its physiological activator, ATP, possibly leading to a modulation of macrophage-dependent immune responses.	[Noerenberg, Wolfgang; Hempel, Christoph; Urban, Nicole; Sobottka, Helga; Illes, Peter; Schaefer, Michael] Univ Leipzig, Rudolf Boehm Inst Pharmacol & Toxicol, D-04107 Leipzig, Germany	Leipzig University	Schaefer, M (corresponding author), Univ Leipzig, Rudolf Boehm Inst Pharmacol & Toxicol, Hartelstr 16-18, D-04107 Leipzig, Germany.	michael.schaefer@medizin.uni-leipzig.de	Norenberg, Wolfgang/A-1999-2008	Norenberg, Wolfgang/0000-0002-0086-3717	Deutsche Forschungsgemeinschaft [Forschergruppe 748]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by funding from the Deutsche Forschungsgemeinschaft within the framework of the Forschergruppe 748.	Acuna-Castillo C, 2007, J NEUROCHEM, V101, P17, DOI 10.1111/j.1471-4159.2006.04343.x; Adinolfi E, 2003, J BIOL CHEM, V278, P37344, DOI 10.1074/jbc.M301508200; Alloisio S, 2006, MOL PHARMACOL, V69, P1975, DOI 10.1124/mol.105.020164; Anderson CM, 2006, TRENDS NEUROSCI, V29, P257, DOI 10.1016/j.tins.2006.03.003; Biswas D, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-35; Chaumont S, 2008, P NATL ACAD SCI USA, V105, P12063, DOI 10.1073/pnas.0803008105; Chessell IP, 1997, BRIT J PHARMACOL, V121, P1429, DOI 10.1038/sj.bjp.0701278; Coutinho-Silva R, 1997, AM J PHYSIOL-CELL PH, V273, pC1793, DOI 10.1152/ajpcell.1997.273.6.C1793; Davies John Q, 2005, Methods Mol Biol, V290, P105; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Egan TM, 2006, PFLUG ARCH EUR J PHY, V452, P501, DOI 10.1007/s00424-006-0078-1; FENWICK EM, 1982, J PHYSIOL-LONDON, V331, P599, DOI 10.1113/jphysiol.1982.sp014394; Ferrari D, 2007, BRIT J PHARMACOL, V150, P445, DOI 10.1038/sj.bjp.0706994; Ferrari D, 1997, J IMMUNOL, V159, P1451; GALLIN EK, 1988, J MEMBRANE BIOL, V103, P55, DOI 10.1007/BF01871932; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Glas R, 2009, DIABETOLOGIA, V52, P1579, DOI 10.1007/s00125-009-1349-0; GomezHernandez JM, 1997, PFLUG ARCH EUR J PHY, V434, P661, DOI 10.1007/s004240050449; Grinius L, 2002, DRUG DEV IND PHARM, V28, P193, DOI 10.1081/DDC-120002452; Gu BJ, 2009, AM J PHYSIOL-CELL PH, V297, pC430, DOI 10.1152/ajpcell.00079.2009; Guile SD, 2009, J MED CHEM, V52, P3123, DOI 10.1021/jm801528x; Hong SY, 2009, J IMMUNOL, V183, P578, DOI 10.4049/jimmunol.0900120; Honore P, 2009, BEHAV BRAIN RES, V204, P77, DOI 10.1016/j.bbr.2009.05.018; Izumi Norimasa, 2008, Allergol Int, V57, P257, DOI 10.2332/allergolint.O-07-525; Jarvis MF, 2009, NEUROPHARMACOLOGY, V56, P208, DOI 10.1016/j.neuropharm.2008.06.067; Jiang B, 2002, MOL CELL BIOCHEM, V238, P69, DOI 10.1023/A:1019907104763; Jiang LH, 2005, AM J PHYSIOL-CELL PH, V289, pC1295, DOI 10.1152/ajpcell.00253.2005; Jiang LH, 2009, EUR BIOPHYS J BIOPHY, V38, P339, DOI 10.1007/s00249-008-0315-y; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Lees MP, 2010, J IMMUNOL, V184, P7040, DOI 10.4049/jimmunol.1000012; Lenz JC, 2002, J CELL BIOL, V159, P291, DOI 10.1083/jcb.200203048; Li MF, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1048; Lopez-Castejon G, 2010, J IMMUNOL, V185, P2611, DOI 10.4049/jimmunol.1000436; Ma WH, 2009, J PHARMACOL EXP THER, V328, P409, DOI 10.1124/jpet.108.146365; McGaraughty S, 2007, NEUROSCIENCE, V146, P1817, DOI 10.1016/j.neuroscience.2007.03.035; Michel AD, 2007, BRIT J PHARMACOL, V152, P523, DOI 10.1038/sj.bjp.0707417; PARVEZ M, 1991, ACTA CRYSTALLOGR C, V47, P613, DOI 10.1107/S010827019000796X; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Qin F, 2004, BIOPHYS J, V86, P1488, DOI 10.1016/S0006-3495(04)74217-4; Rassendren F, 1997, J BIOL CHEM, V272, P5482, DOI 10.1074/jbc.272.9.5482; Riedel T, 2007, BIOPHYS J, V93, P846, DOI 10.1529/biophysj.106.103614; Schachter J, 2008, J CELL SCI, V121, P3261, DOI 10.1242/jcs.029991; Schwarz N, 2009, PURINERG SIGNAL, V5, P139, DOI 10.1007/s11302-009-9135-5; Sim JA, 2007, BRIT J PHARMACOL, V152, P1283, DOI 10.1038/sj.bjp.0707504; Sperlagh B, 2006, PROG NEUROBIOL, V78, P327, DOI 10.1016/j.pneurobio.2006.03.007; Takenouchi T, 2009, CRIT REV IMMUNOL, V29, P335, DOI 10.1615/CritRevImmunol.v29.i4.40; Verkhratsky A, 2009, MOL NEUROBIOL, V39, P190, DOI 10.1007/s12035-009-8063-2; Virginio C, 1999, J PHYSIOL-LONDON, V519, P335, DOI 10.1111/j.1469-7793.1999.0335m.x; Virginio C, 1998, J PHYSIOL-LONDON, V510, P27, DOI 10.1111/j.1469-7793.1998.027bz.x; Virginio C, 1999, NAT NEUROSCI, V2, P315, DOI 10.1038/7225; Virginio C, 1997, NEUROPHARMACOLOGY, V36, P1285, DOI 10.1016/S0028-3908(97)00141-X; Ward JR, 2010, J BIOL CHEM, V285, P23145, DOI 10.1074/jbc.M109.072793; Wareham K, 2009, BRIT J PHARMACOL, V157, P1215, DOI 10.1111/j.1476-5381.2009.00287.x; White N, 2006, TRENDS PHARMACOL SCI, V27, P211, DOI 10.1016/j.tips.2006.02.004; Wilson HL, 2007, BRIT J PHARMACOL, V151, P96, DOI 10.1038/sj.bjp.0707213; Wilson HL, 2004, J IMMUNOL, V173, P1202, DOI 10.4049/jimmunol.173.2.1202; Yan ZH, 2010, J NEUROSCI, V30, P14213, DOI 10.1523/JNEUROSCI.2390-10.2010	57	56	56	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11067	11081		10.1074/jbc.M110.198879	http://dx.doi.org/10.1074/jbc.M110.198879			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21262970	Green Published, hybrid			2022-12-27	WOS:000288797100018
J	Matsumura, F; Yamakita, Y; Yamashiro, S				Matsumura, Fumio; Yamakita, Yoshihiko; Yamashiro, Shigeko			Myosin Phosphatase-targeting Subunit 1 Controls Chromatid Segregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLO-LIKE KINASES; PROTEIN PHOSPHATASE-1; MAMMALIAN-CELLS; MITOSIS; CDC20; POLO-LIKE-KINASE-1; CENTROSOME; DYNAMICS; DIVISION; COHESION	Myosin phosphatase is a heterotrimeric holoenzyme consisting of myosin phosphatase-targeting subunit 1 (MYPT1), a catalytic subunit of PP1C beta, and a 20-kDa subunit of an unknown function. We have previously reported that myosin phosphatase also controls mitosis, apparently by antagonizing polo-like kinase 1 (PLK1). Here we found that depletion of MYPT1 by siRNA led to precocious chromatid segregation when HeLa cells were arrested at metaphase by a proteasome inhibitor, MG132, or by Cdc20 depletion. Consistently, cyclin B1 and securin were not degraded, indicating that the chromatid segregation is independent of the anaphase-promoting complex/cyclosome. Precocious segregation induced by MYPT1 depletion requires PLK1 activity because a PLK1 inhibitor, BI-2536, blocked precocious segregation. Furthermore, the expression of an unphosphorylatable mutant of SA2 (SCC3 homologue 2), a subunit of the cohesin complex, prevented precocious chromatid segregation induced by MYPT1 depletion. It has been shown that SA2 at centromeres is protected from phosphorylation by PP2A phosphatase recruited by Shugoshin (Sgo1), whereas SA2 along chromosome arms is phosphorylated by PLK1, leading to SA2 dissociation at chromosome arms. Taken together, our results suggest that hyperactivation of PLK1 caused by MYPT1 reduction could override the counteracting PP2A phosphatase, resulting in precocious chromatid segregation. We propose that SA2 at the centromeres is protected by two phosphatases. One is PP2A directly dephosphorylating SA2, and the other is myosin phosphatase counteracting PLK1.	[Matsumura, Fumio; Yamakita, Yoshihiko; Yamashiro, Shigeko] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Matsumura, F (corresponding author), Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA.	Matsumura@biology.rutgers.edu	Yamakita, Yoshihiko/A-3003-2016	Yamashiro, Shigeko/0000-0001-7207-9406; Matsumura, Fumio/0000-0002-8204-153X	National Institutes of Health throughout the NCI [CA42742]; NATIONAL CANCER INSTITUTE [R01CA042742, R37CA042742] Funding Source: NIH RePORTER	National Institutes of Health throughout the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA42742 throughout the NCI (to F. M.).	Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Blagden SP, 2003, NAT CELL BIOL, V5, P505, DOI 10.1038/ncb0603-505; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Chevrier V, 2002, J CELL BIOL, V157, P807, DOI 10.1083/jcb.200203034; Cohen PTW, 2002, J CELL SCI, V115, P241; Dai Wei, 2003, Prog Cell Cycle Res, V5, P327; Gimenez-Abian JF, 2004, CURR BIOL, V14, P1187, DOI 10.1016/j.cub.2004.06.052; GIMENEZABIAN JF, 1995, J CELL BIOL, V131, P7, DOI 10.1083/jcb.131.1.7; Hartshorne DJ, 2004, J BIOL CHEM, V279, P37211, DOI 10.1074/jbc.R400018200; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Huang HC, 2009, CANCER CELL, V16, P347, DOI 10.1016/j.ccr.2009.08.020; Kallio MJ, 2002, J CELL BIOL, V158, P841, DOI 10.1083/jcb.200201135; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Lowery DM, 2005, ONCOGENE, V24, P248, DOI 10.1038/sj.onc.1208280; Lowery DM, 2007, EMBO J, V26, P2262, DOI 10.1038/sj.emboj.7601683; Malureanu L, 2010, J CELL BIOL, V191, P313, DOI 10.1083/jcb.201003090; McGuinness BE, 2005, PLOS BIOL, V3, P433, DOI 10.1371/journal.pbio.0030086; Okamoto R, 2005, TRANSGENIC RES, V14, P337, DOI 10.1007/s11248-005-3453-3; Peters U, 2006, NAT CHEM BIOL, V2, P618, DOI 10.1038/nchembio826; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Salic A, 2004, CELL, V118, P567, DOI 10.1016/j.cell.2004.08.016; Somlyo AV, 2004, J MUSCLE RES CELL M, V25, P241, DOI 10.1023/B:JURE.0000038362.84697.c0; Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797; Trinkle-Mulcahy L, 2006, J CELL BIOL, V172, P679, DOI 10.1083/jcb.200508154; Trinkle-Mulcahy L, 2006, CURR OPIN CELL BIOL, V18, P623, DOI 10.1016/j.ceb.2006.09.001; Vagnarelli P, 2006, NAT CELL BIOL, V8, P1133, DOI 10.1038/ncb1475; Wolthuis R, 2008, MOL CELL, V30, P290, DOI 10.1016/j.molcel.2008.02.027; Yamashiro S, 2008, DEV CELL, V14, P787, DOI 10.1016/j.devcel.2008.02.013; Zagorska A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000616	32	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10825	10833		10.1074/jbc.M110.169722	http://dx.doi.org/10.1074/jbc.M110.169722			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21252232	Green Published, hybrid			2022-12-27	WOS:000288547000096
J	Pinz, I; Tian, R; Belke, D; Swanson, E; Dillmann, W; Ingwall, JS				Pinz, Ilka; Tian, Rong; Belke, Darrell; Swanson, Eric; Dillmann, Wolfgang; Ingwall, Joanne S.			Compromised Myocardial Energetics in Hypertrophied Mouse Hearts Diminish the Beneficial Effect of Overexpressing SERCA2a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; ADENOVIRAL GENE-TRANSFER; RAT HEARTS; CONTRACTILE RESERVE; CARDIAC CONTRACTILITY; PRESSURE-OVERLOAD; FAILURE; ENERGY; MODEL; ARRHYTHMIAS	The sarcoplasmic reticulum calcium ATPase (SERCA) plays a central role in regulating intracellular Ca2+ homeostasis and myocardial contractility. Several studies show that improving Ca2+ handling in hypertrophied rodent hearts by increasing SERCA activity results in enhanced contractile function. This suggests that SERCA is a potential target for gene therapy in cardiac hypertrophy and failure. However, it raises the issue of increased energy cost resulting from a higher ATPase activity. In this study, we determined whether SERCA overexpression alters the energy cost of increasing myocardial contraction in mouse hearts with pressure-overload hypertrophy using P-31 NMR spectroscopy. We isolated and perfused mouse hearts from wild-type (WT) and transgenic (TG) mice overexpressing the cardiac isoform of SERCA (SERCA2a) 8 weeks after ascending aortic constriction (left ventricular hypertrophy (LVH)) or sham operation. We found that overexpressing SERCA2a enhances myocardial contraction and relaxation in normal mouse hearts during inotropic stimulation with isoproterenol. Energy consumption was proportionate to the increase in contractile function. Thus, increasing SERCA2a expression in the normal heart allows an enhanced inotropic response with no compromise in energy supply and demand. However, this advantage was not sustained in LVH hearts in which the energetic status was compromised. Although the overexpression of SERCA2a prevented the down-regulation of SERCA protein in LVH hearts, TG-LVH hearts showed no increase in inotropic response when compared with WT-LVH hearts. Our results suggest that energy supply may be a limiting factor for the benefit of SERCA overexpression in hypertrophied hearts. Thus, strategies combining energetic support with increasing SERCA activity may improve the therapeutic effectiveness for heart failure.	[Pinz, Ilka; Tian, Rong; Ingwall, Joanne S.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, NMR Lab Physiol Chem, Boston, MA 02115 USA; [Belke, Darrell; Swanson, Eric; Dillmann, Wolfgang] Univ Calif San Diego, Dept Med, Div Endocrine & Metab, La Jolla, CA 92093 USA	Harvard University; Brigham & Women's Hospital; University of California System; University of California San Diego	Pinz, I (corresponding author), Maine Med Ctr, Res Inst, 81 Res Dr, Scarborough, ME 04074 USA.	pinzi@mmc.org	Tian, Rui/E-5637-2011; Tian, Rong/ABH-1383-2020	Tian, Rong/0000-0002-3676-3830				Baker DL, 1998, CIRC RES, V83, P1205, DOI 10.1161/01.RES.83.12.1205; Bers DR, 1999, CARDIOVASC RES, V42, P339, DOI 10.1016/S0008-6363(99)00038-3; Chen Y, 2004, CIRCULATION, V109, P1898, DOI 10.1161/01.CIR.0000124230.60028.42; Chu GX, 1996, CIRC RES, V79, P1064, DOI 10.1161/01.RES.79.6.1064; del Monte F, 2004, P NATL ACAD SCI USA, V101, P5622, DOI 10.1073/pnas.0305778101; del Monte F, 2001, CIRCULATION, V104, P1424, DOI 10.1161/hc3601.095574; Dorn GW, 2004, CIRCULATION, V109, P150, DOI 10.1161/01.CIR.0000111581.15521.F5; EBERLI FR, 1992, CIRC RES, V70, P931, DOI 10.1161/01.RES.70.5.931; He HP, 1997, J CLIN INVEST, V100, P380, DOI 10.1172/JCI119544; Houser SR, 2003, CIRC RES, V92, P350, DOI 10.1161/01.RES.0000060027.40275.A6; Ingwall JS, 2004, CIRC RES, V95, P135, DOI 10.1161/01.RES.0000137170.41939.d9; Ito K, 2000, CIRC RES, V87, P588, DOI 10.1161/01.RES.87.7.588; Ito K, 2001, CIRC RES, V89, P422, DOI 10.1161/hh1701.095522; Javadpour MM, 2003, J CLIN INVEST, V112, P768, DOI 10.1172/JC1200315967; KAMMERMEIER H, 1987, BASIC RES CARDIOL, V82, P31; Minamisawa S, 1999, CELL, V99, P313, DOI 10.1016/S0092-8674(00)81662-1; Miyamoto MI, 2000, P NATL ACAD SCI USA, V97, P793, DOI 10.1073/pnas.97.2.793; Muller OJ, 2003, CARDIOVASC RES, V59, P380, DOI 10.1016/S0008-6363(03)00429-2; O'Donnell JM, 2008, AM J PHYSIOL-HEART C, V295, pH2483, DOI 10.1152/ajpheart.01023.2008; Pinz I, 2008, AM J PHYSIOL-HEART C, V294, pH1459, DOI 10.1152/ajpheart.00911.2007; Tian R, 1997, CIRCULATION, V96, P1313, DOI 10.1161/01.CIR.96.4.1313; Tian R, 1996, AM J PHYSIOL-HEART C, V270, pH1207, DOI 10.1152/ajpheart.1996.270.4.H1207; Tian R, 1998, AM J PHYSIOL-HEART C, V275, pH2064, DOI 10.1152/ajpheart.1998.275.6.H2064	23	30	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10163	10168		10.1074/jbc.M110.210757	http://dx.doi.org/10.1074/jbc.M110.210757			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21278384	hybrid, Green Published			2022-12-27	WOS:000288547000031
J	Tacke, RS; Tosello-Trampont, A; Nguyen, V; Mullins, DW; Hahn, YS				Tacke, Robert S.; Tosello-Trampont, Annie; Nguyen, Virginia; Mullins, David W.; Hahn, Young S.			Extracellular Hepatitis C Virus Core Protein Activates STAT3 in Human Monocytes/Macrophages/Dendritic Cells via an IL-6 Autocrine Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPPRESSOR-CELLS; DENDRITIC CELLS; IMMUNE-SYSTEM; T-CELLS; INFECTION; DIFFERENTIATION; INTERLEUKIN-6; CANCER; INFLAMMATION; MACROPHAGES	Hepatitis C virus (HCV) infection is highly efficient in the establishment of persistent infection, which leads to the development of chronic liver disease and hepatocellular carcinoma. Impaired T cell responses with reduced IFN-gamma production have been reported to be associated with persistent HCV infection. Extracellular HCV core is a viral factor known to cause HCV-induced T cell impairment via its suppressive effect on the activation and induction of pro-inflammatory responses by antigen-presenting cells (APCs). The activation of STAT proteins has been reported to regulate the inflammatory responses and differentiation of APCs. To further characterize the molecular basis for the regulation of APC function by extracellular HCV core, we examined the ability of extracellular HCV core to activate STAT family members(STAT1, -2, -3, -5, and -6). In this study, we report the activation of STAT3 on human monocytes, macrophages, and dendritic cells following treatment with extracellular HCV core as well as treatment with a gC1qR agonistic monoclonal antibody. Importantly, HCV core-induced STAT3 activation is dependent on the activation of the PI3K/Akt pathway. In addition, the production of multifunctional cytokine IL-6 is essential for HCV core-induced STAT3 activation. These results suggest that HCV core-induced STAT3 activation plays a critical role in the alteration of inflammatory responses by APCs, leading to impaired anti-viral T cell responses during HCV infection.	[Tacke, Robert S.; Tosello-Trampont, Annie; Nguyen, Virginia; Mullins, David W.; Hahn, Young S.] Univ Virginia, Beirne Carter Ctr Immunol Res, Charlottesville, VA 22908 USA; [Tacke, Robert S.; Mullins, David W.; Hahn, Young S.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Hahn, Young S.] Univ Virginia, Dept Pathol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia	Hahn, YS (corresponding author), UVA, Carter Immunol Ctr, POB 801386, Charlottesville, VA 22908 USA.	ysh5e@virginia.edu	Mullins, David/J-1085-2019	Mullins, David/0000-0002-2644-350X	National Institutes of Health [AI057591, U19AI066328, RO1 CA134799]; Training Fellowship [5T32AI00749611]; NATIONAL CANCER INSTITUTE [R01CA134799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057591, U19AI066328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK067629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Training Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants AI057591 and U19AI066328 (to Y. S. H.) and RO1 CA134799 (to D. W. M.), and by Training Fellowship 5T32AI00749611 (to R. S. T.).	Barrett S, 2003, J MED VIROL, V71, P212, DOI 10.1002/jmv.10472; Baruah P, 2009, BLOOD, V113, P3485, DOI 10.1182/blood-2008-06-164392; Bunt SK, 2006, J IMMUNOL, V176, P284, DOI 10.4049/jimmunol.176.1.284; Chalmin F, 2010, J CLIN INVEST, V120, P457, DOI 10.1172/JCI40483; Cheng FD, 2003, IMMUNITY, V19, P425, DOI 10.1016/S1074-7613(03)00232-2; Cheng PY, 2008, J EXP MED, V205, P2235, DOI 10.1084/jem.20080132; Cooper S, 1999, IMMUNITY, V10, P439, DOI 10.1016/S1074-7613(00)80044-8; Cussigh A, 2011, IMMUNOGENETICS, V63, P33, DOI 10.1007/s00251-010-0491-7; Dolganiuc A, 2006, J IMMUNOL, V177, P6758, DOI 10.4049/jimmunol.177.10.6758; Eisen-Vandervelde AL, 2004, J BIOL CHEM, V279, P43479, DOI 10.1074/jbc.M407640200; Fairweather D, 2009, J AUTOIMMUN, V33, P222, DOI 10.1016/j.jaut.2009.09.012; Faruqi TR, 2001, P NATL ACAD SCI USA, V98, P9014, DOI 10.1073/pnas.161281298; Fukao T, 2003, TRENDS IMMUNOL, V24, P358, DOI 10.1016/S1471-4906(03)00139-X; Gabrilovich DI, 2007, CANCER RES, V67, P425, DOI 10.1158/0008-5472.CAN-06-3037; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gerlach JT, 1999, GASTROENTEROLOGY, V117, P933, DOI 10.1016/S0016-5085(99)70353-7; HAHN YS, 2003, NATURE, V15, P946; Hirano T, 1998, Int Rev Immunol, V16, P249; Jing N, 2005, ANTI-CANCER DRUG, V16, P601, DOI 10.1097/00001813-200507000-00002; KANTO T, 1995, J HEPATOL, V22, P440, DOI 10.1016/0168-8278(95)80107-3; Kittlesen DJ, 2000, J CLIN INVEST, V106, P1239, DOI 10.1172/JCI10323; Kortylewski M, 2008, CURR OPIN IMMUNOL, V20, P228, DOI 10.1016/j.coi.2008.03.010; Lechner MG, 2010, J IMMUNOL, V185, P2273, DOI 10.4049/jimmunol.1000901; Logvinoff C, 2004, P NATL ACAD SCI USA, V101, P10149, DOI 10.1073/pnas.0403519101; Machida K, 2010, HEPATOLOGY, V52, P480, DOI 10.1002/hep.23697; Park SJ, 2004, J IMMUNOL, V173, P3844, DOI 10.4049/jimmunol.173.6.3844; Pickering M C, 2000, Adv Immunol, V76, P227; Poschke I, 2010, CANCER RES, V70, P4335, DOI 10.1158/0008-5472.CAN-09-3767; Ratta M, 2002, BLOOD, V100, P230, DOI 10.1182/blood.V100.1.230; Rehermann B, 1996, J CLIN INVEST, V98, P1432, DOI 10.1172/JCI118931; Sabile A, 1999, HEPATOLOGY, V30, P1064, DOI 10.1002/hep.510300429; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Sundstrom S, 2005, J VIROL, V79, P2230, DOI 10.1128/JVI.79.4.2230-2239.2005; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Waggoner SN, 2005, J IMMUNOL, V175, P4706, DOI 10.4049/jimmunol.175.7.4706; Waggoner SN, 2007, J LEUKOCYTE BIOL, V82, P1407, DOI 10.1189/jlb.0507268; Welte T, 2003, P NATL ACAD SCI USA, V100, P1879, DOI 10.1073/PNAS.0237137100; Yoshida T, 2002, J EXP MED, V196, P641, DOI 10.1084/jem.20012127; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	41	70	71	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10847	10855		10.1074/jbc.M110.217653	http://dx.doi.org/10.1074/jbc.M110.217653			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21282107	hybrid, Green Published			2022-12-27	WOS:000288547000098
J	Yashin, DV; Dukhanina, EA; Kabanova, OD; Romanova, EA; Lukyanova, TI; Tonevitskii, AG; Raynes, DA; Gnuchev, NV; Guerriero, V; Georgiev, GP; Sashchenko, LP				Yashin, Denis V.; Dukhanina, Elena A.; Kabanova, Olga D.; Romanova, Elena A.; Lukyanova, Tamara I.; Tonevitskii, Alexsander G.; Raynes, Deborah A.; Gnuchev, Nikolai V.; Guerriero, Vince; Georgiev, Georgii P.; Sashchenko, Lidia P.			The Heat Shock-binding Protein (HspBP1) Protects Cells against the Cytotoxic Action of the Tag7-Hsp70 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDOGLYCAN RECOGNITION PROTEIN; APOPTOSIS-INDUCING FACTOR; GRAM-POSITIVE BACTERIA; COCHAPERONE HSPBP1; HSP70 COCHAPERONE; INNATE IMMUNITY; HEAT-SHOCK-PROTEIN-70; TAG7; MECHANISM; LYMPHOCYTES	Heat shock-binding protein HspBP1 is a member of the Hsp70 co-chaperone family. The interaction between HspBP1 and the ATPase domain of the major heat shock protein Hsp70 up-regulates nucleotide exchange and reduces the affinity between Hsp70 and the peptide in its peptide-binding site. Previously we have shown that Tag7 (also known as peptidoglycan recognition protein PGRP-S), an innate immunity protein, interacts with Hsp70 to form a stable Tag7-Hsp70 complex with cytotoxic activity against some tumor cell lines. This complex can be produced in cytotoxic lymphocytes and released during interaction with tumor cells. Here the effect of HspBP1 on the cytotoxic activity of the Tag7-Hsp70 complex was examined. HspBP1 could bind not only to Hsp70, but also to Tag7. This interaction eliminated the cytotoxic activity of Tag7-Hsp70 complex and decreased the ATP concentration required to dissociate Tag7 from the peptide-binding site of Hsp70. Moreover, HspBP1 inhibited the cytotoxic activity of the Tag7-Hsp70 complex secreted by lymphocytes. HspBP1 was detected in cytotoxic CD8+ lymphocytes. This protein was released simultaneously with Tag7-Hsp70 during interaction of these lymphocytes with tumor cells. The simultaneous secretion of the cytotoxic complex with its inhibitor could be a mechanism protecting normal cells from the cytotoxic effect of this complex.	[Yashin, Denis V.; Dukhanina, Elena A.; Kabanova, Olga D.; Romanova, Elena A.; Lukyanova, Tamara I.; Gnuchev, Nikolai V.; Georgiev, Georgii P.; Sashchenko, Lidia P.] Russian Acad Sci, Inst Gene Biol, Moscow 119344, Russia; [Dukhanina, Elena A.] Russian Acad Sci, VA Engelhardt Mol Biol Inst, Moscow 119344, Russia; [Yashin, Denis V.] Univ Oslo, Ctr Med Studies, Moscow 119344, Russia; [Raynes, Deborah A.; Guerriero, Vince] Univ Arizona, Dept Anim Sci, Tucson, AZ 85721 USA; [Guerriero, Vince] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; [Tonevitskii, Alexsander G.] Moscow MV Lomonosov State Univ, GSP 1, Moscow 119991, Russia	Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; University of Arizona; University of Arizona; Lomonosov Moscow State University	Sashchenko, LP (corresponding author), Russian Acad Sci, Inst Gene Biol, Moscow 119344, Russia.	sashchenko@genebiology.ru		Lukyanova, Tamara/0000-0003-4193-2843	Russian Foundation for Basic Research; RAS; International Centre for Genetic Engineering and Biotechnology (ICGEB)	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); RAS(Russian Academy of SciencesRegione Sardegna); International Centre for Genetic Engineering and Biotechnology (ICGEB)	This work was supported by the Russian Foundation for Basic Research, RAS program for Molecular and Cellular Biology, and International Centre for Genetic Engineering and Biotechnology (ICGEB).	Alberti S, 2004, MOL BIOL CELL, V15, P4003, DOI 10.1091/mbc.E04-04-0293; Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Bukau B, 2000, CELL, V101, P119, DOI 10.1016/S0092-8674(00)80806-5; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; CHERTOV OY, 1994, IMMUNOL LETT, V42, P97, DOI 10.1016/0165-2478(94)90042-6; Cho JH, 2005, BLOOD, V106, P2551, DOI 10.1182/blood-2005-02-0530; DELUCAFLAHERTY C, 1990, CELL, V62, P875, DOI 10.1016/0092-8674(90)90263-E; Dukhanina E A, 2007, Dokl Biol Sci, V414, P246, DOI 10.1134/S0012496607030222; Dukhanina EA, 2009, P NATL ACAD SCI USA, V106, P13963, DOI 10.1073/pnas.0900116106; Dziarski R, 2003, BLOOD, V102, P689, DOI 10.1182/blood-2002-12-3853; Dziarski R, 2004, MOL IMMUNOL, V40, P877, DOI 10.1016/j.molimm.2003.10.011; Evdonin A, 2009, BIOL CELL, V101, P351, DOI 10.1042/BC20080069; Gabai VL, 1998, FEBS LETT, V438, P1, DOI 10.1016/S0014-5793(98)01242-3; Graner MW, 2009, CANCER SCI, V100, P1870, DOI 10.1111/j.1349-7006.2009.01269.x; GREENE LE, 1995, J BIOL CHEM, V270, P2967, DOI 10.1074/jbc.270.7.2967; Gross C, 2003, J BIOL CHEM, V278, P41173, DOI 10.1074/jbc.M302644200; Guan RJ, 2005, J MOL BIOL, V347, P683, DOI 10.1016/j.jmb.2005.01.070; Gurbuxani S, 2003, ONCOGENE, V22, P6669, DOI 10.1038/sj.onc.1206794; HERBERMAN RB, 1986, ANNU REV IMMUNOL, V4, P651, DOI 10.1146/annurev.iy.04.040186.003251; JIANG SB, 1989, J IMMUNOL, V143, P1453; Kang DW, 1998, P NATL ACAD SCI USA, V95, P10078, DOI 10.1073/pnas.95.17.10078; KARELIN AA, 1994, BIOCHEM MOL BIOL INT, V33, P73; Kiselev SL, 1998, J BIOL CHEM, V273, P18633, DOI 10.1074/jbc.273.29.18633; Kustikova OS, 1996, GENETIKA+, V32, P621; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; McLellan CA, 2003, J BIOL CHEM, V278, P19017, DOI 10.1074/jbc.M301109200; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Multhoff G, 2001, CELL STRESS CHAPERON, V6, P337, DOI 10.1379/1466-1268(2001)006<0337:AMHPSN>2.0.CO;2; Park HS, 2001, EMBO J, V20, P446, DOI 10.1093/emboj/20.3.446; Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839; Raynes DA, 1998, J BIOL CHEM, V273, P32883, DOI 10.1074/jbc.273.49.32883; Raynes DA, 2006, J IMMUNOASS IMMUNOCH, V27, P251, DOI 10.1080/15321810600734935; Sashchenko LP, 2004, J BIOL CHEM, V279, P2117, DOI 10.1074/jbc.M307513200; Shomura Y, 2005, MOL CELL, V17, P367, DOI 10.1016/j.molcel.2004.12.023; Tanimura S, 2007, J BIOL CHEM, V282, P35430, DOI 10.1074/jbc.M707547200; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492	37	15	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10258	10264		10.1074/jbc.M110.163436	http://dx.doi.org/10.1074/jbc.M110.163436			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21247889	hybrid, Green Published			2022-12-27	WOS:000288547000043
J	Joo, HS; Cheung, GYC; Otto, M				Joo, Hwang-Soo; Cheung, Gordon Y. C.; Otto, Michael			Antimicrobial Activity of Community-associated Methicillin-resistant Staphylococcus aureus Is Caused by Phenol-soluble Modulin Derivatives	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRULENCE DETERMINANTS; GENOME SEQUENCE; EPIDERMIDIS; EVOLUTION; PEPTIDES; AGR; IDENTIFICATION; BIOSYNTHESIS; REPLACEMENT; EXPRESSION	Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) are causing an ongoing pandemic of mostly skin and soft tissue infections. The success of CA-MRSA as pathogens is due to a combination of antibiotic resistance with high virulence. In addition, it has been speculated that CA-MRSA strains such as the epidemic U. S. clone USA300 have increased capacity to colonize human epithelia, owing to bacteriocin-based bacterial interference. We here analyzed the molecular basis of antimicrobial activity detected in S. aureus strains, including those of the USA300 lineage. In contrast to a previous hypothesis, we found that this activity is not due to expression of a lantibiotic-type bacteriocin, but proteolytically processed derivatives of the phenol-soluble modulin (PSM) peptides PSM alpha 1 and PSM alpha 2. Notably, processed PSM alpha 1 and PSM alpha 2 exhibited considerable activity against Streptococcus pyogenes, indicating a role of PSMs in the interference of S. aureus strains with the competing colonizing pathogen. Furthermore, by offering a competitive advantage during colonization of the human body, the characteristically high production of PSMs in USA300 and other CA-MRSA strains may thus contribute not only to virulence but also the exceptional capacity of those strains to sustainably spread in the population, which so far has remained poorly understood.	[Joo, Hwang-Soo; Cheung, Gordon Y. C.; Otto, Michael] NIAID, Lab Human Bacterial Pathogenesis, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Otto, M (corresponding author), 9000 Rockville Pike,Bldg 331W10, Bethesda, MD 20892 USA.	motto@niaid.nih.gov	Cheung, Yiu Chong/K-3565-2012	Otto, Michael/0000-0002-2222-4115; JOO, HWANG-SOO/0000-0003-4668-3225	NIAID, National Institutes of Health [ZIA AI000904-08]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000904] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the Intramural Research Program of the NIAID, National Institutes of Health (Grant ZIA AI000904-08).	[Anonymous], 1999, JAMA, V282, P1123; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; BEAUDET R, 1982, ANTIMICROB AGENTS CH, V22, P277, DOI 10.1128/AAC.22.2.277; Bierbaum G, 2009, CURR PHARM BIOTECHNO, V10, P2, DOI 10.2174/138920109787048616; Bruckner R, 1997, FEMS MICROBIOL LETT, V151, P1; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P88; Cogen AL, 2010, J INVEST DERMATOL, V130, P192, DOI 10.1038/jid.2009.243; Daly KM, 2010, J BACTERIOL, V192, P1131, DOI 10.1128/JB.01375-09; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2008, TRENDS MICROBIOL, V16, P361, DOI 10.1016/j.tim.2008.05.002; Diep BA, 2008, J INFECT DIS, V197, P1523, DOI 10.1086/587907; Donvito B, 1997, INFECT IMMUN, V65, P95, DOI 10.1128/IAI.65.1.95-100.1997; Dorschner RA, 2006, FASEB J, V20, P35, DOI 10.1096/fj.05-4406com; Fitzgerald JR, 2000, J APPL MICROBIOL, V88, P1028, DOI 10.1046/j.1365-2672.2000.01071.x; Francis JS, 2005, CLIN INFECT DIS, V40, P100, DOI 10.1086/427148; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Kobayashi SD, 2003, P NATL ACAD SCI USA, V100, P10948, DOI 10.1073/pnas.1833375100; Kocianova S, 2005, J CLIN INVEST, V115, P688, DOI 10.1172/JCI200523523; Kong KF, 2006, INT J MED MICROBIOL, V296, P133, DOI 10.1016/j.ijmm.2006.01.042; Li M, 2009, P NATL ACAD SCI USA, V106, P5883, DOI 10.1073/pnas.0900743106; MACK D, 1994, INFECT IMMUN, V62, P3244, DOI 10.1128/IAI.62.8.3244-3253.1994; Mehlin C, 1999, J EXP MED, V189, P907, DOI 10.1084/jem.189.6.907; Miller LG, 2005, NEW ENGL J MED, V352, P1445, DOI 10.1056/NEJMoa042683; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; OTTENWALDER B, 1995, APPL ENVIRON MICROB, V61, P3894; Otto M, 1998, FEMS MICROBIOL LETT, V166, P203, DOI 10.1016/S0378-1097(98)00333-4; Otto M, 2001, RES MICROBIOL, V152, P351, DOI 10.1016/S0923-2508(01)01206-2; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; PENG HL, 1988, J BACTERIOL, V170, P4365, DOI 10.1128/jb.170.9.4365-4372.1988; Peschel A, 1996, J BACTERIOL, V178, P531, DOI 10.1128/jb.178.2.531-536.1996; Queck SY, 2008, MOL CELL, V32, P150, DOI 10.1016/j.molcel.2008.08.005; Saris PEJ, 1996, ANTON LEEUW INT J G, V69, P151, DOI 10.1007/BF00399420; SCHNELL N, 1992, EUR J BIOCHEM, V204, P57, DOI 10.1111/j.1432-1033.1992.tb16605.x; SCHNELL N, 1989, FEMS MICROBIOL LETT, V58, P263, DOI 10.1016/0378-1097(89)90050-5; SCHNELL N, 1988, NATURE, V333, P276, DOI 10.1038/333276a0; Selva L, 2009, P NATL ACAD SCI USA, V106, P1234, DOI 10.1073/pnas.0809600106; Vuong C, 2004, CELL MICROBIOL, V6, P753, DOI 10.1111/j.1462-5822.2004.00401.x; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wang R, 2011, J CLIN INVEST, V121, P238, DOI 10.1172/JCI42520; Yao YF, 2005, J INFECT DIS, V191, P289, DOI 10.1086/426945	42	109	112	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8933	8940		10.1074/jbc.M111.221382	http://dx.doi.org/10.1074/jbc.M111.221382			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21278255	Green Published, hybrid			2022-12-27	WOS:000288247700025
J	Shimano, M; Ouchi, N; Nakamura, K; Oshima, Y; Higuchi, A; Pimentel, DR; Panse, KD; Lara-Pezzi, E; Lee, SJ; Sam, F; Walsh, K				Shimano, Masayuki; Ouchi, Noriyuki; Nakamura, Kazuto; Oshima, Yuichi; Higuchi, Akiko; Pimentel, David R.; Panse, Kalyani D.; Lara-Pezzi, Enrique; Lee, Se-Jin; Sam, Flora; Walsh, Kenneth			Cardiac Myocyte-specific Ablation of Follistatin-like 3 Attenuates Stress-induced Myocardial Hypertrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA SUPERFAMILY; GROWTH-FACTOR-BETA; HEART-FAILURE; ACTIVIN-A; MYOSTATIN; PROTEINS; BINDING; CARDIOMYOCYTES; ACTIVATION; APOPTOSIS	Transforming growth factor-beta family cytokines have diverse actions in the maintenance of cardiac homeostasis. Follistatinlike 3 (Fstl3) is an extracellular regulator of certain TGF-beta family members, including activin A. The aim of this study was to examine the role of Fstl3 in cardiac hypertrophy. Cardiac myocyte-specific Fstl3 knock-out (KO) mice and control mice were subjected to pressure overload induced by transverse aortic constriction (TAC). Cardiac hypertrophy was assessed by echocardiography and histological and biochemical methods. KO mice showed reduced cardiac hypertrophy, pulmonary congestion, concentric LV wall thickness, LV dilatation, and LV systolic dysfunction after TAC compared with control mice. KO mice displayed attenuated increases in cardiomyocyte cell surface area and interstitial fibrosis following pressure overload. Although activin A was similarly up-regulated in KO and control mice after TAC, a significant increase in Smad2 phosphorylation only occurred in KO mice. Knockdown of Fstl3 in cultured cardiomyocytes inhibited PE-induced cardiac hypertrophy. Conversely, adenovirus-mediated Fstl3 overexpression blocked the inhibitory action of activin A on hypertrophy and Smad2 activation. Transduction with Smad7, a negative regulator of Smad2 signaling, blocked the antihypertrophic actions of activin A stimulation or Fstl3 ablation. These findings identify Fstl3 as a stress-induced regulator of hypertrophy that controls myocyte size via regulation of Smad signaling.	[Shimano, Masayuki; Ouchi, Noriyuki; Nakamura, Kazuto; Oshima, Yuichi; Higuchi, Akiko; Pimentel, David R.; Lara-Pezzi, Enrique; Sam, Flora; Walsh, Kenneth] Boston Univ, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Panse, Kalyani D.] Univ London Imperial Coll Sci Technol & Med, Heart Sci Ctr, Harefield UB9 6JH, Middx, England; [Lara-Pezzi, Enrique] Ctr Nacl Invest Cardiovasc, Madrid 28029, Spain; [Lee, Se-Jin] Johns Hopkins Univ, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Boston University; Imperial College London; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Johns Hopkins University	Walsh, K (corresponding author), Boston Univ, Mol Cardiol Whitaker Cardiovasc Inst, Med Campus,700 Albany St,W611, Boston, MA 02118 USA.	kxwalsh@bu.edu	Lara-Pezzi, Enrique/E-2350-2015; OUCHI, Noriyuki/I-7306-2014	Lara-Pezzi, Enrique/0000-0002-2743-1033; Sam, Flora/0000-0001-8442-9362; Pimentel, David/0000-0002-0537-7195; Walsh, Kenneth/0000-0001-7580-2276	National Institutes of Health [AG015052, AG034972, HL068758, HL102874, DK089875, AR060636]; Banyu Life Science Foundation International; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL102874, P01HL068758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060636] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015052, R01AG034972, R37AG015052] Funding Source: NIH RePORTER; British Heart Foundation [PG/08/084/25827] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Banyu Life Science Foundation International(Banyu Life Science Foundation International); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); British Heart Foundation(British Heart Foundation)	This work was supported, in whole or in part, by National Institutes of Health Grants AG015052, AG034972, HL068758, HL102874, and DK089875 (to K. W.) and AR060636 (to S.-J. L.).; Supported by the Banyu Fellowship Program sponsored by Banyu Life Science Foundation International.	Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Attisano L, 1996, MOL CELL BIOL, V16, P1066; Bujak M, 2007, CARDIOVASC RES, V74, P184, DOI 10.1016/j.cardiores.2006.10.002; Chen YG, 2006, EXP BIOL MED, V231, P534; Divakaran V, 2009, CIRC-HEART FAIL, V2, P633, DOI 10.1161/CIRCHEARTFAILURE.108.823070; Florholmen G, 2006, J MOL CELL CARDIOL, V41, P689, DOI 10.1016/j.yjmcc.2006.07.009; Frost RJA, 2007, CIRCULATION, V116, P1768, DOI 10.1161/CIRCULATIONAHA.107.696468; Hayette S, 1998, ONCOGENE, V16, P2949, DOI 10.1038/sj.onc.1201807; Heger J, 2009, J CELL PHYSIOL, V220, P515, DOI 10.1002/jcp.21805; Heineke J, 2010, CIRCULATION, V121, P419, DOI 10.1161/CIRCULATIONAHA.109.882068; Hill JJ, 2002, J BIOL CHEM, V277, P40735, DOI 10.1074/jbc.M206379200; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Izumi M, 2001, J BIOL CHEM, V276, P31133, DOI 10.1074/jbc.M101463200; Lara-Pezzi E, 2008, ENDOCRINOLOGY, V149, P5822, DOI 10.1210/en.2008-0151; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Mahmoudabady M, 2008, J CARD FAIL, V14, P703, DOI 10.1016/j.cardfail.2008.05.003; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Molkentin JD, 2001, ANNU REV PHYSIOL, V63, P391, DOI 10.1146/annurev.physiol.63.1.391; Morissette MR, 2006, CIRC RES, V99, P15, DOI 10.1161/01.RES.0000231290.45676.d4; Mukherjee A, 2007, P NATL ACAD SCI USA, V104, P1348, DOI 10.1073/pnas.0607966104; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Oshima Y, 2009, CIRCULATION, V120, P1606, DOI 10.1161/CIRCULATIONAHA.109.872200; Pimentel DR, 2001, CIRC RES, V89, P453, DOI 10.1161/hh1701.096615; Schneyer A, 2004, MOL CELL ENDOCRINOL, V225, P25, DOI 10.1016/j.mce.2004.02.009; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shibata R, 2004, NAT MED, V10, P1384, DOI 10.1038/nm1137; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Sidis Y, 2006, ENDOCRINOLOGY, V147, P3586, DOI 10.1210/en.2006-0089; Stamler R, 2008, J BIOL CHEM, V283, P32831, DOI 10.1074/jbc.M801266200; Tortoriello DV, 2001, ENDOCRINOLOGY, V142, P3426, DOI 10.1210/en.142.8.3426; Tsuchida K, 2000, J BIOL CHEM, V275, P40788, DOI 10.1074/jbc.M006114200; Wang J, 2005, CIRC RES, V97, P821, DOI 10.1161/01.RES.0000185833.42544.06; Welt C, 2002, EXP BIOL MED, V227, P724, DOI 10.1177/153537020222700905; Xu J, 2006, CIRC RES, V98, P342, DOI 10.1161/01.RES.0000202804.84885.d0; Yndestad A, 2004, CIRCULATION, V109, P1379, DOI 10.1161/01.CIR.0000120704.97934.41	36	32	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9840	9848		10.1074/jbc.M110.197079	http://dx.doi.org/10.1074/jbc.M110.197079			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21245136	hybrid, Green Published			2022-12-27	WOS:000288247700107
J	D'Souza, KM; Malhotra, R; Philip, JL; Staron, ML; Theccanat, T; Jeevanandam, V; Akhter, SA				D'Souza, Karen M.; Malhotra, Ricky; Philip, Jennifer L.; Staron, Michelle L.; Theccanat, Tiju; Jeevanandam, Valluvan; Akhter, Shahab A.			G Protein-coupled Receptor Kinase-2 Is a Novel Regulator of Collagen Synthesis in Adult Human Cardiac Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOCARDIAL-INFARCTION; ADENYLYL-CYCLASE; HEART-FAILURE; GENE-THERAPY; OVEREXPRESSION; CARDIOMYOPATHY; INHIBITION; MECHANISMS; TARGET	Cardiac fibroblasts (CF) make up 60-70% of the total cell number in the heart and play a critical role in regulating normal myocardial function and in adverse remodeling following myocardial infarction and the transition to heart failure. Recent studies have shown that increased intracellular cAMP can inhibit CF transformation and collagen synthesis in adult rat CF; however, mechanisms by which cAMP production is regulated in CF have not been elucidated. We investigated the potential role of G protein-coupled receptor kinase-2 (GRK2) in modulating collagen synthesis by adult human CF isolated from normal and failing left ventricles. Baseline collagen synthesis was elevated in failing CF and was not inhibited by beta-agonist stimulation in contrast to normal controls. beta-adrenergic receptor (beta-AR) signaling was markedly uncoupled in the failing CF, and expression and activity of GRK2 were increased 3-fold. Overexpression of GRK2 in normal CF recapitulated a heart failure phenotype with minimal inhibition of collagen synthesis following beta-agonist stimulation. In contrast, knockdown of GRK2 expression in normal CF enhanced cAMP production and led to greater beta-agonist-mediated inhibition of basal and TGF beta-stimulated collagen synthesis versus control. Inhibition of GRK2 activity in failing CF by expression of the GRK2 inhibitor, GRK2ct, or siRNA-mediated knockdown restored beta-agonist-stimulated inhibition of collagen synthesis and decreased collagen synthesis in response to TGF beta stimulation. GRK2 appears to play a significant role in regulating collagen synthesis in adult human CF, and increased activity of this kinase may be an important mechanism of maladaptive ventricular remodeling as mediated by cardiac fibroblasts.	[D'Souza, Karen M.; Malhotra, Ricky; Philip, Jennifer L.; Staron, Michelle L.; Theccanat, Tiju; Jeevanandam, Valluvan; Akhter, Shahab A.] Univ Chicago, Med Ctr, Dept Surg, Sect Cardiac & Thorac Surg, Chicago, IL 60637 USA	University of Chicago; University of Chicago Medical Center	Akhter, SA (corresponding author), Univ Chicago, Med Ctr, Dept Surg, Sect Cardiac & Thorac Surg, 5841 S Maryland Ave,MC 5040, Chicago, IL 60637 USA.	sakhter@surgery.bsd.uchicago.edu			National Institutes of Health [HL081472]; Thoracic Surgery Foundation for Research and Education; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL081472] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thoracic Surgery Foundation for Research and Education; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL081472 (to S. A. A.). This work was also supported by the Thoracic Surgery Foundation for Research and Education (to S. A. A.).	BELTRAMI CA, 1994, CIRCULATION, V89, P151, DOI 10.1161/01.CIR.89.1.151; Brown RD, 2005, ANNU REV PHARMACOL, V45, P657, DOI 10.1146/annurev.pharmtox.45.120403.095802; Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020; Cleutjens JPM, 1999, CARDIOVASC RES, V44, P232, DOI 10.1016/S0008-6363(99)00212-6; Katz AM, 1995, EUR HEART J, V16, P110, DOI 10.1093/eurheartj/16.suppl_O.110; KOCH WJ, 1995, SCIENCE, V268, P1350, DOI 10.1126/science.7761854; Liu XQ, 2006, MOL PHARMACOL, V70, P1992, DOI 10.1124/mol.106.028951; Liu XQ, 2004, AM J PHYSIOL-CELL PH, V286, pC1089, DOI 10.1152/ajpcell.00461.2003; Penela P, 2006, CARDIOVASC RES, V69, P46, DOI 10.1016/j.cardiores.2005.09.011; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Pleger ST, 2007, J CARD FAIL, V13, P401, DOI 10.1016/j.cardfail.2007.01.003; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; Rengo G, 2009, CIRCULATION, V119, P89, DOI 10.1161/CIRCULATIONAHA.108.803999; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Squires CE, 2005, J MOL CELL CARDIOL, V39, P699, DOI 10.1016/j.yjmcc.2005.07.008; Sun Y, 2009, CARDIOVASC RES, V81, P482, DOI 10.1093/cvr/cvn333; Swaney JS, 2005, P NATL ACAD SCI USA, V102, P437, DOI 10.1073/pnas.0408704102; Swynghedauw B, 1999, PHYSIOL REV, V79, P215, DOI 10.1152/physrev.1999.79.1.215; Turner NA, 2003, CARDIOVASC RES, V57, P784, DOI 10.1016/S0008-6363(02)00729-0; UNGERER M, 1993, CIRCULATION, V87, P454, DOI 10.1161/01.CIR.87.2.454; van den Borne SWM, 2010, NAT REV CARDIOL, V7, P30, DOI 10.1038/nrcardio.2009.199; Yokoyama U, 2008, P NATL ACAD SCI USA, V105, P6386, DOI 10.1073/pnas.0801490105	22	28	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15507	15516		10.1074/jbc.M111.218263	http://dx.doi.org/10.1074/jbc.M111.218263			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21357420	Green Published, hybrid			2022-12-27	WOS:000289788300078
J	Hurley, JM; Cruz, JW; Ouyang, M; Woychik, NA				Hurley, Jennifer M.; Cruz, Jonathan W.; Ouyang, Ming; Woychik, Nancy A.			Bacterial Toxin RelE Mediates Frequent Codon-independent mRNA Cleavage from the 5 ' End of Coding Regions in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; RIBOSOMES; SITE	The enzymatic activity of the RelE bacterial toxin component of the Escherichia coli RelBE toxin-antitoxin system has been extensively studied in vitro and to a lesser extent in vivo. These earlier reports revealed that 1) RelE alone does not exhibit mRNA cleavage activity, 2) RelE mediates mRNA cleavage through its association with the ribosome, 3) RelE-mediated mRNA cleavage occurs at the ribosomal A site and, 4) Cleavage of mRNA by RelE exhibits high codon specificity. More specifically, RelE exhibits a preference for the stop codons UAG and UGA and sense codons CAG and UCG in vitro. In this study, we used a comprehensive primer extension approach to map the frequency and codon specificity of RelE cleavage activity in vivo. We found extensive cleavage at the beginning of the coding region of five transcripts, ompA, lpp, ompF, rpsA, and tufA. We then mapped RelE cleavage sites across one short transcript (lpp) and two long transcripts (ompF and ompA). RelE cut all of these transcripts frequently and efficiently within the first similar to 100 codons, only occasionally cut beyond this point, and rarely cut at sites in proximity to the 3' end. Among 196 RelE sites in these five transcripts, there was no preference for CAG or UCG sense codons. In fact, bioinformatic analysis of the RelE cleavage sites failed to identify any sequence preferences. These results suggest a model of RelE function distinct from those proposed previously, because RelE directed frequent codon-independent mRNA cleavage coincident with the commencement of translation elongation.	[Hurley, Jennifer M.; Cruz, Jonathan W.; Woychik, Nancy A.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, Piscataway, NJ 08854 USA; [Ouyang, Ming] Univ Louisville, Dept Comp Sci & Comp Engn, Louisville, KY 40292 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Louisville	Woychik, NA (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, 675 Hoes Lane, Piscataway, NJ 08854 USA.	nancy.woychik@umdnj.edu		Hurley, Jennifer/0000-0002-1085-9391	National Institutes of Health [AI07403]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007403] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health T32 Training Grant AI07403 (to J.M.H. and J.W.C.) awarded to S. Pestka.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Chen DQ, 2006, GENE THER MOL BIOL, V10A, P1; Christensen SK, 2003, MOL MICROBIOL, V48, P1389, DOI 10.1046/j.1365-2958.2003.03512.x; Durbin R., 1998, BIOL SEQUENCE ANAL P; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hurley JM, 2009, J BIOL CHEM, V284, P18605, DOI 10.1074/jbc.M109.008763; Li GY, 2009, J BIOL CHEM, V284, P14628, DOI 10.1074/jbc.M809656200; Neubauer C, 2009, CELL, V139, P1084, DOI 10.1016/j.cell.2009.11.015; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Prysak MH, 2009, MOL MICROBIOL, V71, P1071, DOI 10.1111/j.1365-2958.2008.06572.x; Zhang Y, 2009, J BIOL CHEM, V284, P6627, DOI 10.1074/jbc.M808779200	12	35	38	4	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14770	14778		10.1074/jbc.M110.108969	http://dx.doi.org/10.1074/jbc.M110.108969			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21324908	hybrid, Green Published			2022-12-27	WOS:000289788300006
J	McNulty, DE; Li, ZG; White, CD; Sacks, DB; Annan, RS				McNulty, Dean E.; Li, Zhigang; White, Colin D.; Sacks, David B.; Annan, Roland S.			MAPK Scaffold IQGAP1 Binds the EGF Receptor and Modulates Its Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; PROTEIN-KINASE-C; PHOSPHORYLATION-DEPENDENT MANNER; ACTIN-BINDING; INTEGRATES CA2+/CALMODULIN; CELL-PROLIFERATION; SMALL GTPASES; B-RAF; CALMODULIN; CDC42	Cellular responses produced by EGF are mediated through the receptor (EGFR) and by various enzymes and scaffolds. Recent studies document IQGAP1 as a scaffold for the MAPK cascade, binding directly to B-Raf, MEK, and ERK and regulating their activation in response to EGF. We previously showed that EGF is unable to activate B-Raf in cells lacking IQGAP1. However, the mechanism by which IQGAP1 links B-Raf to EGFR was unknown. Here we report that endogenous EGFR and IQGAP1 co-localize and co-immunoprecipitate in cells. EGF has no effect on the association, but Ca2+ attenuates binding. In vitro analysis demonstrated a direct association mediated through the IQ and kinase domains of IQGAP1 and EGFR, respectively. Calmodulin disrupts this interaction. Using a mass spectrometry-based assay, we show that EGF induces phosphorylation of IQGAP1 Ser(1443), a residue known to be phosphorylated by PKC. This phosphorylation is eliminated by pharmacological inhibition of either EGFR or PKC and transfection with small interfering RNA directed against the PKC alpha isoform. In IQGAP1-null cells, EGF-stimulated tyrosine phosphorylation of EGFR is severely attenuated. Normal levels of autophosphorylation are restored by reconstituting wild type IQGAP1 and enhanced by an IQGAP1 S1443D mutant. Collectively, these data demonstrate a functional interaction between IQGAP1 and EGFR and suggest that IQGAP1 modulates EGFR activation.	[McNulty, Dean E.; Annan, Roland S.] GlaxoSmithKline Inc, Prote & Biol Mass Spectrometry Lab, Collegeville, PA 19426 USA; [McNulty, Dean E.] UMDNJ Grad Sch Biomed Sci, Stratford, NJ 08084 USA; [Li, Zhigang; White, Colin D.; Sacks, David B.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Li, Zhigang; White, Colin D.; Sacks, David B.] Harvard Univ, Sch Med, Boston, MA 02115 USA	GlaxoSmithKline; Rutgers State University New Brunswick; Rutgers State University Medical Center; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Sacks, DB (corresponding author), NIH, DLM, 10 Ctr Dr,Bldg 10,Rm 2C427, Bethesda, MD 20892 USA.	sacksdb@mail.nih.gov; roland.s.annan@gsk.com		Sacks, David/0000-0003-3100-0735	National Institutes of Health [RO1-CA93645]; Department of Defense [BC087504 (FY08)]; NATIONAL CANCER INSTITUTE [R01CA093645] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL080017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CLINICAL CENTER	This work was supported, in whole or in part, by a grant from the National Institutes of Health Grant RO1-CA93645 (to D.B.S.). This work was also supported by the Department of Defense Breast Cancer Research Program Grant BC087504 (FY08) (to C.D.W.).	Bensenor LB, 2007, J CELL SCI, V120, P658, DOI 10.1242/jcs.03376; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Blagoev B, 2003, NAT BIOTECHNOL, V21, P315, DOI 10.1038/nbt790; Bourguignon LYW, 2005, J BIOL CHEM, V280, P11961, DOI 10.1074/jbc.M411985200; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; Briggs MW, 2003, FEBS LETT, V542, P7, DOI 10.1016/S0014-5793(03)00333-8; Briggs MW, 2002, J BIOL CHEM, V277, P7453, DOI 10.1074/jbc.M104315200; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Brown MD, 2008, J BIOL CHEM, V283, P35212, DOI 10.1074/jbc.M803477200; Carpenter G, 2000, BIOESSAYS, V22, P697, DOI 10.1002/1521-1878(200008)22:8<697::AID-BIES3>3.3.CO;2-T; Casar B, 2009, MOL CELL BIOL, V29, P1338, DOI 10.1128/MCB.01359-08; Chen P, 1996, MOL BIOL CELL, V7, P871, DOI 10.1091/mbc.7.6.871; Grohmanova K, 2004, J BIOL CHEM, V279, P48495, DOI 10.1074/jbc.M408113200; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; Hubbard SR, 2009, CELL, V137, P1181, DOI 10.1016/j.cell.2009.06.008; Jeong HW, 2007, J BIOL CHEM, V282, P20752, DOI 10.1074/jbc.M700487200; Johnson M, 2009, CELL SIGNAL, V21, P1471, DOI 10.1016/j.cellsig.2009.02.023; Joyal JL, 1997, J BIOL CHEM, V272, P15419, DOI 10.1074/jbc.272.24.15419; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Kortum RL, 2004, MOL CELL BIOL, V24, P4407, DOI 10.1128/MCB.24.10.4407-4416.2004; Kuroda S, 1996, J BIOL CHEM, V271, P23363, DOI 10.1074/jbc.271.38.23363; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Li ZG, 2005, J BIOL CHEM, V280, P13871, DOI 10.1074/jbc.M413482200; Li ZG, 2003, J BIOL CHEM, V278, P4347, DOI 10.1074/jbc.M208579200; Li ZG, 1999, J BIOL CHEM, V274, P37885, DOI 10.1074/jbc.274.53.37885; LIVNEH E, 1988, MOL CELL BIOL, V8, P2302, DOI 10.1128/MCB.8.6.2302; Lombardo CR, 1995, BIOCHEMISTRY-US, V34, P16456, DOI 10.1021/bi00050a029; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; LUND KA, 1990, J BIOL CHEM, V265, P20517; Mateer SC, 2002, J BIOL CHEM, V277, P12324, DOI 10.1074/jbc.M109535200; McCallum SJ, 1998, J BIOL CHEM, V273, P22537, DOI 10.1074/jbc.273.35.22537; McCormack AL, 1997, ANAL CHEM, V69, P767, DOI 10.1021/ac960799q; Mendelsohn J, 2000, ONCOGENE, V19, P6550, DOI 10.1038/sj.onc.1204082; Meyer RD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003848; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Morrison P, 1996, J BIOL CHEM, V271, P12891, DOI 10.1074/jbc.271.22.12891; Nuriya M, 2005, J NEUROCHEM, V95, P544, DOI 10.1111/j.1471-4159.2005.03410.x; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Ren JG, 2005, J BIOL CHEM, V280, P34548, DOI 10.1074/jbc.M507321200; Ren JG, 2008, J BIOL CHEM, V283, P22972, DOI 10.1074/jbc.M804626200; Ren JG, 2007, P NATL ACAD SCI USA, V104, P10465, DOI 10.1073/pnas.0611308104; Roy F, 2002, GENE DEV, V16, P427, DOI 10.1101/gad.962902; Roy M, 2005, MOL CELL BIOL, V25, P7940, DOI 10.1128/MCB.25.18.7940-7952.2005; Roy M, 2004, J BIOL CHEM, V279, P17329, DOI 10.1074/jbc.M308405200; Sanchez-Gonzalez P, 2010, FEBS J, V277, P327, DOI 10.1111/j.1742-4658.2009.07469.x; SATO KI, 1995, BIOCHEM BIOPH RES CO, V215, P1078, DOI 10.1006/bbrc.1995.2574; Schrick C, 2007, NEURON, V55, P786, DOI 10.1016/j.neuron.2007.07.034; Singh AB, 2005, CELL SIGNAL, V17, P1183, DOI 10.1016/j.cellsig.2005.03.026; SLATER SJ, 1994, J BIOL CHEM, V269, P17160; STOVER DR, 1995, J BIOL CHEM, V270, P15591, DOI 10.1074/jbc.270.26.15591; Utz I, 1996, ANTICANCER RES, V16, P289; Wang JB, 2009, J CELL SCI, V122, P2024, DOI 10.1242/jcs.044644; Wang XQ, 2007, CANCER RES, V67, P9986, DOI 10.1158/0008-5472.CAN-07-1300; Wang YP, 2008, INT J MOL MED, V22, P79; WELSH JB, 1991, J CELL BIOL, V114, P533, DOI 10.1083/jcb.114.3.533; White CD, 2009, FEBS LETT, V583, P1817, DOI 10.1016/j.febslet.2009.05.007; Yamaoka-Tojo M, 2004, CIRC RES, V95, P276, DOI 10.1161/01.RES.0000136522.58649.60; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhang HT, 2007, J CLIN INVEST, V117, P2051, DOI 10.1172/JCI32278	61	62	67	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15010	15021		10.1074/jbc.M111.227694	http://dx.doi.org/10.1074/jbc.M111.227694			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21349850	Green Published, hybrid			2022-12-27	WOS:000289788300031
J	Cabrera, JR; Bouzas-Rodriguez, J; Tauszig-Delamasure, S; Mehlen, P				Cabrera, Jorge R.; Bouzas-Rodriguez, Jimena; Tauszig-Delamasure, Servane; Mehlen, Patrick			RET Modulates Cell Adhesion via Its Cleavage by Caspase in Sympathetic Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASE; NEUROTROPHIC FACTOR; CADHERIN SUPERFAMILY; SURVIVAL FACTOR; GDNF FAMILY; APOPTOSIS; GANGLIA; REVEALS; GROWTH	RET is a tyrosine kinase receptor involved in numerous cellular mechanisms including proliferation, neuronal navigation, migration, and differentiation upon binding with glial cell derived neurotrophic factor family ligands. RET is an atypical tyrosine kinase receptor containing four cadherin domains in its extracellular part. Furthermore, it has been shown to act as a dependence receptor. Such a receptor is active in the absence of ligand, triggering apoptosis through a mechanism that requires receptor intracellular caspase cleavage. However, different data suggest that RET is not always associated with the cell death/survival balance but rather provides positional information. We demonstrate here that caspase cleavage of RET is involved in the regulation of adhesion in sympathetic neurons. The cleavage of RET generates an N-terminal truncated fragment that functions as a cadherin accessory protein, modifying cadherin environment and potentiating cadherin-mediated cell aggregation. Thus, the caspase cleavage of RET generates two RET fragments: one intracellular domain that can trigger cell death in apoptotic permissive settings, and one membrane-anchored ectodomain with cadherin accessory activity. We propose that this latter function may notably be important for the adequate development of the superior cervical ganglion.	[Cabrera, Jorge R.; Bouzas-Rodriguez, Jimena; Tauszig-Delamasure, Servane; Mehlen, Patrick] Univ Lyon, Apoptosis Canc & Dev Lab, Equipe Labellisee La Ligue, Ctr Cancerol Lyon,INSERM U1052,CNRS UMR586,Ctr Le, F-69008 Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm)	Mehlen, P (corresponding author), Univ Lyon, Apoptosis Canc & Dev Lab, Equipe Labellisee La Ligue, Ctr Cancerol Lyon,INSERM U1052,CNRS UMR586,Ctr Le, F-69008 Lyon, France.	mehlen@lyon.fnclcc.fr	Cabrera, Jorge Rubén/H-6310-2015; Tauszig-Delamasure, Servane/G-7192-2017; Tauszig-Delamasure, Servane/AAJ-6493-2020	Cabrera, Jorge Rubén/0000-0003-4481-0198; Tauszig-Delamasure, Servane/0000-0003-4926-0199; Tauszig-Delamasure, Servane/0000-0003-4926-0199	CNRS; Centre Leon Berard; Universite de Lyon; Ligue Contre le Cancer; Institut National du Cancer; Agence Nationale de la Recherche blanche; Specific Targeted Research Projects Hermione; Apoptosis Mechanisms in Cancer and AIDS; Fondation pour la Recherche Medicale; Consejo Nacional de Ciencia y Tecnologia	CNRS(Centre National de la Recherche Scientifique (CNRS)); Centre Leon Berard; Universite de Lyon; Ligue Contre le Cancer(Ligue nationale contre le cancer); Institut National du Cancer(Institut National du Cancer (INCA) France); Agence Nationale de la Recherche blanche(French National Research Agency (ANR)); Specific Targeted Research Projects Hermione; Apoptosis Mechanisms in Cancer and AIDS; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by an institutional grant from CNRS (to P. M.), the Centre Leon Berard (to P. M.), the Universite de Lyon (to P. M.) and from the Ligue Contre le Cancer (to P. M.), Institut National du Cancer (to P. M.), Agence Nationale de la Recherche blanche (to P. M.), Specific Targeted Research Projects Hermione (to P. M.), and Apoptosis Mechanisms in Cancer and AIDS (to P. M.).; Supported by the Fondation pour la Recherche Medicale.; Supported by Consejo Nacional de Ciencia y Tecnologia.	Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Anastasiadis PZ, 2007, BBA-MOL CELL RES, V1773, P34, DOI 10.1016/j.bbamcr.2006.08.040; Anders J, 2001, J BIOL CHEM, V276, P35808, DOI 10.1074/jbc.M104968200; Bordeaux MC, 2000, EMBO J, V19, P4056, DOI 10.1093/emboj/19.15.4056; Canibano C, 2007, EMBO J, V26, P2015, DOI 10.1038/sj.emboj.7601636; Dix MM, 2008, CELL, V134, P679, DOI 10.1016/j.cell.2008.06.038; Encinas M, 2008, CELL DEATH DIFFER, V15, P1510, DOI 10.1038/cdd.2008.76; Enomoto H, 2001, DEVELOPMENT, V128, P3963; Furne C, 2008, P NATL ACAD SCI USA, V105, P14465, DOI 10.1073/pnas.0803645105; Goldschneider D, 2010, ONCOGENE, V29, P1865, DOI 10.1038/onc.2010.13; Gould TW, 2008, J NEUROSCI, V28, P2131, DOI 10.1523/JNEUROSCI.5185-07.2008; Hulpiau P, 2009, INT J BIOCHEM CELL B, V41, P349, DOI 10.1016/j.biocel.2008.09.027; Kasemeier-Kulesa JC, 2006, DEVELOPMENT, V133, P4839, DOI 10.1242/dev.02662; Kjaer S, 2010, NAT STRUCT MOL BIOL, V17, P726, DOI 10.1038/nsmb.1808; Ledda F, 2007, NAT NEUROSCI, V10, P293, DOI 10.1038/nn1855; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Matsunaga E, 2004, NAT CELL BIOL, V6, P749, DOI 10.1038/ncb1157; MCCARTHY KD, 1976, BRAIN RES, V114, P391, DOI 10.1016/0006-8993(76)90962-8; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Mille F, 2009, NAT CELL BIOL, V11, P739, DOI 10.1038/ncb1880; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; Philippova M, 2009, CELL SIGNAL, V21, P1035, DOI 10.1016/j.cellsig.2009.01.035; Plaza-Menacho I, 2006, TRENDS GENET, V22, P627, DOI 10.1016/j.tig.2006.09.005; Schalm SS, 2010, P NATL ACAD SCI USA, V107, P13894, DOI 10.1073/pnas.1007182107; TAKAHASHI M, 1993, ONCOGENE, V8, P2925; Takeichi M., 2001, CURR PROTOC CELL BIO, V9; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; Thibert C, 2003, SCIENCE, V301, P843, DOI 10.1126/science.1085405; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; Trupp M, 1998, MOL CELL NEUROSCI, V11, P47, DOI 10.1006/mcne.1998.0667; Tsui CC, 2010, J NEUROSCI, V30, P5149, DOI 10.1523/JNEUROSCI.5246-09.2010; Yap AS, 1998, J CELL BIOL, V141, P779, DOI 10.1083/jcb.141.3.779	33	13	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14628	14638		10.1074/jbc.M110.195461	http://dx.doi.org/10.1074/jbc.M110.195461			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21357690	Green Published, hybrid			2022-12-27	WOS:000289556200082
J	Di Cairano, ES; Davalli, AM; Perego, L; Sala, S; Sacchi, VF; La Rosa, S; Finzi, G; Placidi, C; Capella, C; Conti, P; Centonze, VE; Casiraghi, F; Bertuzzi, F; Folli, F; Perego, C				Di Cairano, Eliana S.; Davalli, Alberto M.; Perego, Lucia; Sala, Silvia; Sacchi, V. Franca; La Rosa, Stefano; Finzi, Giovanna; Placidi, Claudia; Capella, Carlo; Conti, Paola; Centonze, Victoria E.; Casiraghi, Francesca; Bertuzzi, Federico; Folli, Franco; Perego, Carla			The Glial Glutamate Transporter 1 (GLT1) Is Expressed by Pancreatic beta-Cells and Prevents Glutamate-induced beta-Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-2 DIABETES-MELLITUS; STIMULATED INSULIN-SECRETION; METABOTROPIC GLUTAMATE; OXIDATIVE STRESS; GLUCAGON-SECRETION; ALPHA-CELLS; NUDE-MICE; ISLETS; LANGERHANS; RECEPTOR	Glutamate is the major excitatory neurotransmitter of the central nervous system (CNS) and may induce cytotoxicity through persistent activation of glutamate receptors and oxidative stress. Its extracellular concentration is maintained at physiological concentrations by high affinity glutamate transporters of the solute carrier 1 family (SLC1). Glutamate is also present in islet of Langerhans where it is secreted by the alpha-cells and acts as a signaling molecule to modulate hormone secretion. Whether glutamate plays a role in islet cell viability is presently unknown. We demonstrate that chronic exposure to glutamate exerts a cytotoxic effect in clonal beta-cell lines and human islet beta-cells but not in alpha-cells. In human islets, glutamate-induced beta-cell cytotoxicity was associated with increased oxidative stress and led to apoptosis and autophagy. We also provide evidence that the key regulator of extracellular islet glutamate concentration is the glial glutamate transporter 1 (GLT1). GLT1 localizes to the plasma membrane of beta-cells, modulates hormone secretion, and prevents glutamate-induced cytotoxicity as shown by the fact that its down-regulation induced beta-cell death, whereas GLT1 up-regulation promoted beta-cell survival. In conclusion, the present study identifies GLT1 as a new player in glutamate homeostasis and signaling in the islet of Langerhans and demonstrates that beta-cells critically depend on its activity to control extracellular glutamate levels and cellular integrity.	[Davalli, Alberto M.; Casiraghi, Francesca; Folli, Franco] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Diabet Div, San Antonio, TX 78229 USA; [Centonze, Victoria E.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Perego, Carla] Univ Milan, Dept Mol Sci Appl Biosyst, Lab Cell Physiol, I-20134 Milan, Italy; [Davalli, Alberto M.] Ist Sci San Raffaele, Diabet & Endocrinol Unit, Dept Internal Med, I-20132 Milan, Italy; [La Rosa, Stefano; Finzi, Giovanna; Placidi, Claudia; Capella, Carlo] Osped Circolo Varese, Dept Pathol, I-21100 Varese, Italy; [La Rosa, Stefano; Finzi, Giovanna; Placidi, Claudia; Capella, Carlo] Univ Insubria, Dept Human Morphol, I-21100 Varese, Italy; [Conti, Paola] Univ Milan, Dept Pharmaceut Sci P Pratesi, I-20133 Milan, Italy; [Bertuzzi, Federico] Osped Niguarda Ca Granda, I-20162 Milan, Italy	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Insubria; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda	Folli, F (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Diabet Div, San Antonio, TX 78229 USA.	folli@uthscsa.edu; carla.perego@unimi.it	Casiraghi, Francesca/GLS-0884-2022; La+Rosa, Stefano/AAF-3366-2022; folli, franco/J-2795-2018; La+Rosa, Stefano/AFH-8608-2022; Conti, Paola/D-1266-2011; Perego, Carla/L-6147-2015	La+Rosa, Stefano/0000-0003-1941-2403; folli, franco/0000-0001-9824-5222; La+Rosa, Stefano/0000-0003-1941-2403; Perego, Carla/0000-0003-3027-1779; Conti, Paola/0000-0003-2140-0567	University Research Program; National Institutes of Health [RO1 DK080148]; Universita degli Studi di Milano; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080148] Funding Source: NIH RePORTER	University Research Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Universita degli Studi di Milano; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by University Research Program 2008 (to C.P.) and National Institutes of Health Grant RO1 DK080148 (to F.F.). E.S.D.C., A.M.D., F.F., and C.P. are inventors in a Patent Cooperation Treaty application.; Supported in part by the Universita degli Studi di Milano postgraduate fellowship program.	ARRIZA JL, 1994, J NEUROSCI, V14, P5559; Bai LQ, 2003, AM J PHYSIOL-GASTR L, V284, pG808, DOI 10.1152/ajpgi.00333.2002; Bao YQ, 2009, J PROTEOME RES, V8, P1623, DOI 10.1021/pr800643w; Bertrand G, 2002, J BIOL CHEM, V277, P32883, DOI 10.1074/jbc.M205326200; BERTRAND G, 1993, EUR J PHARMACOL, V237, P45, DOI 10.1016/0014-2999(93)90091-U; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; BONNERWEIR S, 1982, DIABETES, V31, P883, DOI 10.2337/diabetes.31.10.883; Brice NL, 2002, DIABETOLOGIA, V45, P242, DOI 10.1007/s00125-001-0750-0; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cabrera O, 2008, CELL METAB, V7, P545, DOI 10.1016/j.cmet.2008.03.004; Cho JH, 2010, ENDOCRINOLOGY, V151, P1541, DOI 10.1210/en.2009-0362; CHOI DW, 1987, J NEUROSCI, V7, P357; CLARK A, 1988, DIABETES RES CLIN EX, V9, P151; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Davalli AM, 2008, CELL TRANSPLANT, V17, P1323, DOI 10.3727/096368908787648137; de Koning EJP, 2008, TRENDS PHARMACOL SCI, V29, P218, DOI 10.1016/j.tips.2008.02.001; DeFronzo RA, 2004, MED CLIN N AM, V88, P787, DOI 10.1016/j.mcna.2004.04.013; Donath MY, 2008, DIABETES CARE, V31, pS161, DOI 10.2337/dc08-s243; Dunning BE, 2007, ENDOCR REV, V28, P253, DOI 10.1210/er.2006-0026; Federici M, 2001, DIABETES, V50, P1290, DOI 10.2337/diabetes.50.6.1290; Finzi G, 2005, ULTRASTRUCT PATHOL, V29, P525, DOI 10.1080/01913120500323563; Funicello M, 2004, MOL PHARMACOL, V66, P522; Gammelsaeter R, 2009, BIOCHEM BIOPH RES CO, V381, P378, DOI 10.1016/j.bbrc.2009.02.062; Ganor Y, 2003, J IMMUNOL, V170, P4362, DOI 10.4049/jimmunol.170.8.4362; Graham TE, 2000, AM J PHYSIOL-ENDOC M, V278, pE83, DOI 10.1152/ajpendo.2000.278.1.E83; Guardado-Mendoza R, 2009, P NATL ACAD SCI USA, V106, P13992, DOI 10.1073/pnas.0906471106; Hayashi M, 2003, J BIOL CHEM, V278, P1966, DOI 10.1074/jbc.M206758200; Lee SG, 2008, J BIOL CHEM, V283, P13116, DOI 10.1074/jbc.M707697200; Maechler P, 1999, NATURE, V402, P685, DOI 10.1038/45280; MANFRAS BJ, 1994, BBA-BIOMEMBRANES, V1195, P185, DOI 10.1016/0005-2736(94)90026-4; Masini M, 2009, DIABETOLOGIA, V52, P1083, DOI 10.1007/s00125-009-1347-2; Matyja E, 2005, ULTRASTRUCT PATHOL, V29, P331, DOI 10.1080/01913120500214333; McDonald JW, 1998, NAT MED, V4, P291, DOI 10.1038/nm0398-291; MOLNAR E, 1995, FEBS LETT, V371, P253, DOI 10.1016/0014-5793(95)00890-L; Montero F, 2007, BIOCHIMIE, V89, P1366, DOI 10.1016/j.biochi.2007.05.008; Morley P, 2000, NEUROL RES, V22, P379, DOI 10.1080/01616412.2000.11740687; Muroyama A, 2004, DIABETES, V53, P1743, DOI 10.2337/diabetes.53.7.1743; MURPHY TH, 1989, NEURON, V2, P1547, DOI 10.1016/0896-6273(89)90043-3; Numazawa S, 2008, AM J PHYSIOL-CELL PH, V295, pC468, DOI 10.1152/ajpcell.00203.2008; Oresic M, 2008, J EXP MED, V205, P2975, DOI 10.1084/jem.20081800; Pacheco R, 2006, J IMMUNOL, V177, P6695, DOI 10.4049/jimmunol.177.10.6695; Perego C, 2000, J NEUROCHEM, V75, P1076, DOI 10.1046/j.1471-4159.2000.0751076.x; Pradhan AD, 2003, AM J MED, V114, P438, DOI 10.1016/S0002-9343(03)00061-5; REETZ A, 1991, EMBO J, V10, P1275, DOI 10.1002/j.1460-2075.1991.tb08069.x; RICORDI C, 1988, DIABETES, V37, P413, DOI 10.2337/diabetes.37.4.413; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Tan Shirlee, 2001, Current Topics in Medicinal Chemistry, V1, P497, DOI 10.2174/1568026013394741; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tong QC, 2002, AM J PHYSIOL-ENDOC M, V282, pE1324, DOI 10.1152/ajpendo.00460.2001; TURQUE N, 1994, MOL ENDOCRINOL, V8, P929, DOI 10.1210/me.8.7.929; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; Uehara S, 2004, DIABETES, V53, P998, DOI 10.2337/diabetes.53.4.998; Weaver CD, 1998, J BIOL CHEM, V273, P1647, DOI 10.1074/jbc.273.3.1647; Weaver CD, 1996, J BIOL CHEM, V271, P12977, DOI 10.1074/jbc.271.22.12977	56	43	45	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14007	14018		10.1074/jbc.M110.183517	http://dx.doi.org/10.1074/jbc.M110.183517			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21335552	Green Published, hybrid			2022-12-27	WOS:000289556200023
J	De la Mota-Peynado, A; Chernoff, J; Beeser, A				De la Mota-Peynado, Alina; Chernoff, Jonathan; Beeser, Alexander			Identification of the Atypical MAPK Erk3 as a Novel Substrate for p21-activated Kinase (Pak) Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASES; C-TERMINAL DOMAIN; LOOP PHOSPHORYLATION; SPECIFICITY; MECHANISM; PRAK/MK5; DOCKING; PATHWAY; DEFINES; TARGETS	The class I p21-activated kinases (Pak1-3) regulate many essential biological processes, including cytoskeletal rearrangement, cell cycle progression, apoptosis, and cellular transformation. Although many Pak substrates, including elements of MAPK signaling cascades, have been identified, it is likely that additional substrates remain to be discovered, Identification of such substrates, and determination of the consequences of their phosphorylation, is essential for a better understanding of class I Pak activity. To identify novel class I Pak substrates, we used recombinant Pak2 to screen high density protein microarrays. This approach identified the atypical MAPK Erk3 as a potential Pak2 substrate. Solution-based in vitro kinase assays using recombinant Erk3 confirmed the protein microarray results, and phospho-specific antisera identified serine 189, within the Erk3 activation loop, as a site directly phosphorylated by Pak2 in vitro. Erk3 protein is known to shuttle between the cytoplasm and the nucleus, and we showed that selective inhibition of class I Pak kinase activity in cells promoted increased nuclear accumulation of Erk3. Pak inhibition in cells additionally reduced the extent of Ser(189) phosphorylation and inhibited the formation of Erk3-Prak complexes. Collectively, our results identify the Erk3 protein as a novel class I Pak substrate and further suggest a role for Pak kinase activity in atypical MAP K signaling.	[De la Mota-Peynado, Alina; Beeser, Alexander] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA; [De la Mota-Peynado, Alina; Beeser, Alexander] Kansas State Univ, Mol Cellular & Dev Biol Program, Manhattan, KS 66506 USA; [Chernoff, Jonathan] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA	Kansas State University; Kansas State University; Fox Chase Cancer Center	Beeser, A (corresponding author), Kansas State Univ, Div Biol, 412-A Ackert Hall, Manhattan, KS 66506 USA.	albeeser@ksu.edu	Chernoff, Jonathan/I-7631-2014	Chernoff, Jonathan/0000-0002-4803-7836	National Institutes of Health [R01 CA58836]; Terry C. Johnson Center for Basic Cancer Research; NATIONAL CANCER INSTITUTE [R01CA058836] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Terry C. Johnson Center for Basic Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA58836 (to J. C.). This work was also supported by Terry C. Johnson Center for Basic Cancer Research (to A. B.).	Abe MK, 1999, MOL CELL BIOL, V19, P1301; Aberg E, 2009, J BIOL CHEM, V284, P19392, DOI 10.1074/jbc.M109.023283; Allen JD, 2009, BLOOD, V113, P2695, DOI 10.1182/blood-2008-06-160861; Bardwell AJ, 2009, J BIOL CHEM, V284, P13165, DOI 10.1074/jbc.M900080200; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Cheng M, 1996, J BIOL CHEM, V271, P8951, DOI 10.1074/jbc.271.15.8951; Cheng M, 1996, J BIOL CHEM, V271, P12057, DOI 10.1074/jbc.271.20.12057; Cotteret S, 2002, GENOME BIOL, V3; Coulombe P, 2007, BBA-MOL CELL RES, V1773, P1376, DOI 10.1016/j.bbamcr.2006.11.001; Deacon SW, 2008, CHEM BIOL, V15, P322, DOI 10.1016/j.chembiol.2008.03.005; Deleris P, 2008, J CELL PHYSIOL, V217, P778, DOI 10.1002/jcp.21560; Dummler B, 2009, CANCER METAST REV, V28, P51, DOI 10.1007/s10555-008-9168-1; Eblen ST, 2002, MOL CELL BIOL, V22, P6023, DOI 10.1128/MCB.22.17.6023-6033.2002; Feilner T, 2005, MOL CELL PROTEOMICS, V4, P1558, DOI 10.1074/mcp.M500007-MCP200; Hayashi ML, 2007, P NATL ACAD SCI USA, V104, P11489, DOI 10.1073/pnas.0705003104; Hofmann C, 2004, J CELL SCI, V117, P4343, DOI 10.1242/jcs.01392; Jakobi R, 2000, EUR J BIOCHEM, V267, P4414, DOI 10.1046/j.1432-1327.2000.01488.x; Julien C, 2003, J BIOL CHEM, V278, P42615, DOI 10.1074/jbc.M302724200; Kant S, 2006, J BIOL CHEM, V281, P35511, DOI 10.1074/jbc.M606693200; Krishna M, 2008, CELL MOL LIFE SCI, V65, P3525, DOI 10.1007/s00018-008-8170-7; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Mason CS, 1999, EMBO J, V18, P2137, DOI 10.1093/emboj/18.8.2137; Nguyen DG, 2006, J VIROL, V80, P130, DOI 10.1128/JVI.80.1.130-137.2006; Perander M, 2008, BIOCHEM J, V411, P613, DOI 10.1042/BJ20071369; REESER A, 2005, J BIOL CHEM, V280, P36609; Rennefahrt UEE, 2007, J BIOL CHEM, V282, P15667, DOI 10.1074/jbc.M700253200; Robinson MJ, 1996, J BIOL CHEM, V271, P29734, DOI 10.1074/jbc.271.47.29734; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Schnack C, 2008, PROTEOMICS, V8, P1980, DOI 10.1002/pmic.200701063; Seoh ML, 2003, FEBS LETT, V539, P131, DOI 10.1016/S0014-5793(03)00213-8; Seternes OM, 2004, EMBO J, V23, P4780, DOI 10.1038/sj.emboj.7600489; Szczepanowska J, 2009, ACTA BIOCHIM POL, V56, P225; Tanguay PL, 2010, BIOCHEM J, V428, P103, DOI 10.1042/BJ20091604; Xie XZ, 2005, CELL SIGNAL, V17, P461, DOI 10.1016/j.cellsig.2004.09.012	34	44	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13603	13611		10.1074/jbc.M110.181743	http://dx.doi.org/10.1074/jbc.M110.181743			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21317288	Green Published, hybrid			2022-12-27	WOS:000289282200079
J	Grossoehme, N; Kehl-Fie, TE; Ma, Z; Adams, KW; Cowart, DM; Scott, RA; Skaar, EP; Giedroc, DP				Grossoehme, Nicholas; Kehl-Fie, Thomas E.; Ma, Zhen; Adams, Keith W.; Cowart, Darin M.; Scott, Robert A.; Skaar, Eric P.; Giedroc, David P.			Control of Copper Resistance and Inorganic Sulfur Metabolism by Paralogous Regulators in Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI RCNR; MYCOBACTERIUM-TUBERCULOSIS; METHICILLIN-RESISTANT; METAL SELECTIVITY; BACILLUS-SUBTILIS; REPRESSOR CSOR; HOMEOSTASIS; TAURINE; PROTEIN; DEHYDROGENASE	All strains of Staphylococcus aureus encode a putative copper-sensitive operon repressor (CsoR) and one other CsoR-like protein of unknown function. We show here that NWMN_1991 encodes a bona fide Cu(I)-inducible CsoR of a genetically unlinked copA-copZ copper resistance operon in S. aureus strain Newman. In contrast, an unannotated open reading frame found between NWMN_0027 and NWMN_0026 (denoted NWMN_0026.5) encodes a CsoR-like regulator that represses expression of adjacent genes by binding specifically to a pair of canonical operator sites positioned in the NWMN_0027-0026.5 intergenic region. Inspection of these regulated genes suggests a role in assimilation of inorganic sulfur from thiosulfate and vectorial sulfur transfer, and we designate NWMN_0026.5 as CstR (CsoR-like sulfur transferase repressor). Expression analysis demonstrates that CsoR and CstR control their respective regulons in response to distinct stimuli with no overlap in vivo. Unlike CsoR, CstR does not form a stable complex with Cu(I); operator binding is instead inhibited by oxidation of the intersubunit cysteine pair to a mixture of disulfide and trisulfide linkages by a likely metabolite of thiosulfate assimilation, sulfite. CsoR is unreactive toward sulfite under the same conditions. We conclude that CsoR and CstR are paralogs in S. aureus that function in the same cytoplasm to control distinct physiological processes.	[Grossoehme, Nicholas; Ma, Zhen; Giedroc, David P.] Indiana Univ, Dept Chem, Bloomington, IN 47405 USA; [Kehl-Fie, Thomas E.; Adams, Keith W.; Skaar, Eric P.] Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37232 USA; [Cowart, Darin M.; Scott, Robert A.] Univ Georgia, Dept Chem, Athens, GA 30602 USA; [Cowart, Darin M.; Scott, Robert A.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	Indiana University System; Indiana University Bloomington; Vanderbilt University; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Skaar, EP (corresponding author), 1161 21st Ave S,A-5102 MCN, Nashville, TN 37232 USA.	eric.skaar@vanderbilt.edu; giedroc@indiana.edu	Ma, Zhen/A-7151-2012; Giedroc, David/A-8608-2018	Giedroc, David/0000-0002-2342-1620; Scott, Robert/0000-0003-2236-1336; Kehl-Fie, Thomas/0000-0001-8234-1113	National Institutes of Health [R01 GM042569]; Southeastern Regional Center of Excellence for Emerging Infections and Biodefense [U54 AI057157]; T32 HL094296; American Heart Association; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources;  [R01 GM042025]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL094296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042569, R01GM042025, R01GM097225] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Southeastern Regional Center of Excellence for Emerging Infections and Biodefense(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); T32 HL094296; American Heart Association(American Heart Association); Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM042569 (to D. P. G.), U54 AI057157 from the Southeastern Regional Center of Excellence for Emerging Infections and Biodefense (to E P. S.), and R01 GM042025 (to R. A. S.).; Supported by Grant T32 HL094296 to Vanderbilt University and a postdoctoral fellowship from the American Heart Association.; Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource operated by Stanford University on behalf of the United States Department of Energy, Office of Basic Energy Sciences, The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and the National Institutes of Health, National Center for Research Resources Biomedical Technology Program.	Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Baker J, 2010, APPL ENVIRON MICROB, V76, P150, DOI 10.1128/AEM.02268-09; BALL S, 1995, CAN J CHEM, V73, P716, DOI 10.1139/v95-091; Burns KE, 2005, J AM CHEM SOC, V127, P11602, DOI 10.1021/ja053476x; Changela A, 2003, SCIENCE, V301, P1383, DOI 10.1126/science.1085950; Cipollone R, 2007, IUBMB LIFE, V59, P51, DOI 10.1080/15216540701206859; Conrady DG, 2008, P NATL ACAD SCI USA, V105, P19456, DOI 10.1073/pnas.0807717105; Festa RA, 2011, MOL MICROBIOL, V79, P133, DOI 10.1111/j.1365-2958.2010.07431.x; Gaballa A, 2010, P NATL ACAD SCI USA, V107, P6482, DOI 10.1073/pnas.1000928107; GIEHL TJ, 1987, J GEN MICROBIOL, V133, P849; Grossoehme NE, 2009, J MOL BIOL, V394, P544, DOI 10.1016/j.jmb.2009.09.040; HELMANN JD, 2010, ANTIOXID RE IN PRESS; Herring CD, 2004, J BACTERIOL, V186, P6714, DOI 10.1128/JB.186.20.6714-6720.2004; Highlander SK, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-99; Hong JA, 2009, J MED CHEM, V52, P5485, DOI 10.1021/jm900728u; Iwig JS, 2008, J AM CHEM SOC, V130, P7592, DOI 10.1021/ja710067d; Iwig JS, 2009, J MOL BIOL, V393, P514, DOI 10.1016/j.jmb.2009.08.038; KAU LS, 1987, J AM CHEM SOC, V109, P6433, DOI 10.1021/ja00255a032; Kehl-Fie TE, 2009, J BACTERIOL, V191, P4976, DOI 10.1128/JB.00123-09; Krejcik Z, 2008, ARCH MICROBIOL, V190, P159, DOI 10.1007/s00203-008-0386-2; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Lithgow JK, 2004, J BACTERIOL, V186, P1579, DOI 10.1128/JB.186.6.1579-1590.2004; Liu T, 2008, BIOCHEMISTRY-US, V47, P10564, DOI 10.1021/bi801313y; Liu T, 2007, NAT CHEM BIOL, V3, P60, DOI 10.1038/nchembio844; Ma Z, 2009, J AM CHEM SOC, V131, P18044, DOI 10.1021/ja908372b; Ma Z, 2009, CHEM REV, V109, P4644, DOI 10.1021/cr900077w; Ma Z, 2009, BIOCHEMISTRY-US, V48, P3325, DOI 10.1021/bi900115w; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; Marcia M, 2009, P NATL ACAD SCI USA, V106, P9625, DOI 10.1073/pnas.0904165106; Moen AEF, 2010, FEMS IMMUNOL MED MIC, V58, P374, DOI 10.1111/j.1574-695X.2009.00649.x; Newton GL, 2009, NAT CHEM BIOL, V5, P625, DOI 10.1038/nchembio.189; Osman D, 2010, J BIOL CHEM, V285, P25259, DOI 10.1074/jbc.M110.145953; Osman D, 2008, ADV APPL MICROBIOL, V65, P217, DOI 10.1016/S0065-2164(08)00608-4; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Sakamoto K, 2010, MICROBIOL-SGM, V156, P1993, DOI 10.1099/mic.0.037382-0; Santo CE, 2010, APPL ENVIRON MICROB, V76, P1341, DOI 10.1128/AEM.01952-09; Shibata H, 2007, CAN J MICROBIOL, V53, P1091, DOI 10.1139/W07-077; Sitthisak S, 2007, MICROBIOL-SGM, V153, P4274, DOI 10.1099/mic.0.2007/009860-0; Smaldone GT, 2007, MICROBIOL-SGM, V153, P4123, DOI 10.1099/mic.0.2007/011742-0; Solioz M, 2003, FEMS MICROBIOL REV, V27, P183, DOI 10.1016/S0168-6445(03)00053-6; Soutourina O, 2009, MOL MICROBIOL, V73, P194, DOI 10.1111/j.1365-2958.2009.06760.x; Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907; Tottey S, 2005, ACCOUNTS CHEM RES, V38, P775, DOI 10.1021/ar0300118; Voyich JM, 2009, J INFECT DIS, V199, P1698, DOI 10.1086/598967; Waldron KJ, 2009, NAT REV MICROBIOL, V7, P25, DOI 10.1038/nrmicro2057; Ward SK, 2008, J BACTERIOL, V190, P2939, DOI 10.1128/JB.01847-07; Ward SK, 2010, MOL MICROBIOL, V77, P1096, DOI 10.1111/j.1365-2958.2010.07273.x; Weaver L, 2010, J APPL MICROBIOL, V109, P2200, DOI 10.1111/j.1365-2672.2010.04852.x; Weinitschke S, 2007, MICROBIOL-SGM, V153, P3055, DOI 10.1099/mic.0.2007/009845-0; White C, 2009, J BIOL CHEM, V284, P33949, DOI 10.1074/jbc.M109.070201; Wiethaus J, 2008, J BACTERIOL, V190, P487, DOI 10.1128/JB.01510-07; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415	53	74	74	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13522	13531		10.1074/jbc.M111.220012	http://dx.doi.org/10.1074/jbc.M111.220012			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21339296	Green Published, hybrid			2022-12-27	WOS:000289282200072
J	Konno, H; Isu, A; Kim, Y; Murakami-Fuse, T; Sugano, Y; Hisabori, T				Konno, Hiroki; Isu, Atsuko; Kim, Yusung; Murakami-Fuse, Tomoe; Sugano, Yasushi; Hisabori, Toru			Characterization of the Relationship between ADP- and epsilon-induced Inhibition in Cyanobacterial F-1-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLOROPLAST ATP SYNTHASE; ESCHERICHIA-COLI F1-ATPASE; NUCLEOTIDE-BINDING SITE; PROTON MOTIVE FORCE; C-TERMINAL DOMAIN; ADENOSINE-TRIPHOSPHATASE; CATALYTIC SITE; F-1 MOTOR; LAURYLDIMETHYLAMINE OXIDE; CONFORMATIONAL-CHANGES	The ATPase activity of chloroplast and bacterial F-1-ATPase is strongly inhibited by both the endogenous inhibitor epsilon and tightly bound ADP. Although the physiological significance of these inhibitory mechanisms is not very well known for the membrane-bound F0F1, these are very likely to be important in avoiding the futile ATP hydrolysis reaction and ensuring efficient ATP synthesis in vivo. In a previous study using the alpha(3)beta(3)gamma complex of F-1 obtained from the thermophilic cyanobacteria, Thermosynechococcus elongatus BP-1, we succeeded in determining the discrete stop position, similar to 80 degrees forward from the pause position for ATP binding, caused by epsilon-induced inhibition (epsilon-inhibition) during gamma rotation (Konno, H., Murakami-Fuse, T., RIM, F., Koyama, F., Ueoka-Nakanishi, H., Pack, C. G., Kinjo, M., and Hisabori, T. (2006) EMBO J. 25, 4596 4604). Because gamma in ADP-inhibited F-1 also pauses at the same position, ADP-induced inhibition (ADP-inhibition) was assumed to be linked to epsilon-inhibition. However, ADP-inhibition and epsilon-inhibition should be independent phenomena from each other because the ATPase core complex, alpha(3)beta(3)gamma, also lapses into the ADP-inhibition state. By way of thorough biophysical and biochemical analyses, we determined that the E subunit inhibition mechanism does not directly correlate with ADP-inhibition. We suggest here that the cyanobacterial ATP synthase epsilon subunit carries out an important regulatory role in acting as an independent "braking system" for the physiologically unfavorable ATP hydrolysis reaction.	[Konno, Hiroki; Isu, Atsuko; Kim, Yusung; Murakami-Fuse, Tomoe; Sugano, Yasushi; Hisabori, Toru] Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan	Tokyo Institute of Technology	Hisabori, T (corresponding author), Tokyo Inst Technol, Chem Resources Lab, Midori Ku, 4259-R1-8, Yokohama, Kanagawa 2268503, Japan.	thisabor@res.titech.ac.jp	; Hisabori, Toru/E-5205-2014	Sugano, Yasushi/0000-0001-8463-5131; Hisabori, Toru/0000-0003-2046-0277	Ministry of Education, Culture, Sports, Science, and Technology, Japan [18074002]	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-aid for Scientific Research 18074002 (to T. H) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan and by Management Expenses Grants for National Universities Corporations from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Aggeler R, 1996, J BIOL CHEM, V271, P13888, DOI 10.1074/jbc.271.23.13888; BARZVI D, 1982, J BIOENERG BIOMEMBR, V14, P467, DOI 10.1007/BF00743072; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; BRAGG PD, 1986, BIOCHIM BIOPHYS ACTA, V851, P385, DOI 10.1016/0005-2728(86)90075-7; Cipriano DJ, 2006, J BIOL CHEM, V281, P501, DOI 10.1074/jbc.M509986200; Digel JG, 1996, J BIOL CHEM, V271, P19976, DOI 10.1074/jbc.271.33.19976; DUNCAN TM, 1995, P NATL ACAD SCI USA, V92, P10964, DOI 10.1073/pnas.92.24.10964; DUNN SD, 1987, BIOCHEMISTRY-US, V26, P4488, DOI 10.1021/bi00388a047; DUNN SD, 1990, BIOCHEMISTRY-US, V29, P4335, DOI 10.1021/bi00470a011; FELDMAN RI, 1985, J BIOL CHEM, V260, P3088; Feniouk BA, 2007, J BIOL CHEM, V282, P764, DOI 10.1074/jbc.M606321200; GRESSER MJ, 1982, J BIOL CHEM, V257, P2030; Hirono-Hara Y, 2005, P NATL ACAD SCI USA, V102, P4288, DOI 10.1073/pnas.0406486102; Hirono-Hara Y, 2001, P NATL ACAD SCI USA, V98, P13649, DOI 10.1073/pnas.241365698; HISABORI T, 1992, J BIOL CHEM, V267, P4551; Hisabori T, 1997, EUR J BIOCHEM, V247, P1158, DOI 10.1111/j.1432-1033.1997.01158.x; Iino R, 2005, J BIOL CHEM, V280, P40130, DOI 10.1074/jbc.M506160200; Iino R, 2009, J BIOL CHEM, V284, P17457, DOI 10.1074/jbc.M109.003798; Jault JM, 1996, J BIOL CHEM, V271, P28818, DOI 10.1074/jbc.271.46.28818; Johnson EA, 2002, BIOCHEMISTRY-US, V41, P2446, DOI 10.1021/bi011939f; Kaibara C, 1996, J BIOL CHEM, V271, P2433, DOI 10.1074/jbc.271.5.2433; Kato-Yamada Y, 1999, J BIOL CHEM, V274, P33991, DOI 10.1074/jbc.274.48.33991; KOMATSUTAKAKI M, 1989, J BIOL CHEM, V264, P17750; Konno H, 2006, EMBO J, V25, P4596, DOI 10.1038/sj.emboj.7601348; KUKI M, 1988, J BIOL CHEM, V263, P17437; LANDT O, 1990, GENE, V96, P125, DOI 10.1016/0378-1119(90)90351-Q; LOTSCHER HR, 1984, BIOCHEMISTRY-US, V23, P4140, DOI 10.1021/bi00313a020; Masaike T, 2006, BIOCHEM BIOPH RES CO, V342, P800, DOI 10.1016/j.bbrc.2006.02.017; Matsui T, 1997, J BIOL CHEM, V272, P8215, DOI 10.1074/jbc.272.13.8215; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; MENDELHARTVIG J, 1991, BIOCHEMISTRY-US, V30, P1278, DOI 10.1021/bi00219a017; MINKOV IB, 1979, BIOCHEM BIOPH RES CO, V89, P1300, DOI 10.1016/0006-291X(79)92150-8; NELSON N, 1972, J BIOL CHEM, V247, P7657; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Nowak KF, 2004, BIOCHEMISTRY-US, V43, P3273, DOI 10.1021/bi035820d; Nowak KF, 2002, BIOCHEMISTRY-US, V41, P15130, DOI 10.1021/bi026594v; Peskova YB, 2000, BIOCHEMISTRY-US, V39, P11830, DOI 10.1021/bi0013694; RICHTER ML, 1984, J BIOL CHEM, V259, P7371; Sabbert D, 1996, NATURE, V381, P623, DOI 10.1038/381623a0; Saita E, 2010, J BIOL CHEM, V285, P11411, DOI 10.1074/jbc.M109.099143; Samra HS, 2006, J BIOL CHEM, V281, P31041, DOI 10.1074/jbc.M603315200; Seelert H, 2000, NATURE, V405, P418, DOI 10.1038/35013148; SENIOR AE, 1990, ANNU REV BIOPHYS BIO, V19, P7; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; Sielaff H, 2008, P NATL ACAD SCI USA, V105, P17760, DOI 10.1073/pnas.0807683105; Stiggall D L, 1979, Methods Enzymol, V55, P308; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Suzuki T, 2003, J BIOL CHEM, V278, P46840, DOI 10.1074/jbc.M307165200; Tsumuraya M, 2009, FEBS LETT, V583, P1121, DOI 10.1016/j.febslet.2009.02.038; Tsunoda SP, 2001, P NATL ACAD SCI USA, V98, P6560, DOI 10.1073/pnas.111128098; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; Yasuno T, 2009, BIOCHEM BIOPH RES CO, V390, P230, DOI 10.1016/j.bbrc.2009.09.092; YOSHIDA M, 1979, J BIOL CHEM, V254, P9525; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	57	17	17	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13423	13429		10.1074/jbc.M110.155986	http://dx.doi.org/10.1074/jbc.M110.155986			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21345803	Green Published, hybrid			2022-12-27	WOS:000289282200062
J	Liu, YT; Lee, SY; Neely, E; Nandar, W; Moyo, M; Simmons, Z; Connor, JR				Liu, Yiting; Lee, Sang Y.; Neely, Elizabeth; Nandar, Wint; Moyo, Mthabisi; Simmons, Zachary; Connor, James R.			Mutant HFE H63D Protein Is Associated with Prolonged Endoplasmic Reticulum Stress and Increased Neuronal Vulnerability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; HEMOCHROMATOSIS GENE HFE; PARKINSONS-DISEASE; ER STRESS; TRANSFERRIN RECEPTOR; ALZHEIMERS-DISEASE; NEURODEGENERATIVE DISEASES; CASPASE-3 ACTIVATION; IRON-METABOLISM; SPORADIC ALS	A specific polymorphism in the hemochromatosis (HFE) gene, H63D, is over-represented in neurodegenerative disorders such as amyotrophic lateral sclerosis and Alzheimer disease. Mutations of HFE are best known as being associated with cellular iron overload, but the mechanism by which HFE H63D might increase the risk of neuron degeneration is unclear. Here, using an inducible expression cell model developed from a human neuronal cell line SH-SY5Y, we reported that the presence of the HFE H63D protein activated the unfolded protein response (UPR). This response was followed by a persistent endoplasmic reticulum (ER) stress, as the signals of UPR sensors attenuated and followed by up-regulation of caspase-3 cleavage and activity. Our in vitro findings were recapitulated in a transgenic mouse model carrying Hfe H67D, the mouse equivalent of the human H63D mutation. In this model, UP R activation was detected in the lumbar spinal cord at 6 months then declined at 12 months in association with increased caspase-3 cleavage. Moreover, upon the prolonged ER stress, the number of cells expressing HFE H63D in early apoptosis was increased moderately. Cell proliferation was decreased without increased cell death. Additionally, despite increased iron level in cells carrying HFE H63D, it appeared that ER stress was not responsive to the change of cellular iron status. Overall, our studies indicate that the HFE H63D mutant protein is associated with prolonged ER stress and chronically increased neuronal vulnerability.	[Liu, Yiting; Lee, Sang Y.; Neely, Elizabeth; Nandar, Wint; Connor, James R.] Penn State Univ, Milton S Hershey Med Ctr, Dept Neurosurg, Hershey, PA 17033 USA; [Simmons, Zachary] Penn State Univ, Milton S Hershey Med Ctr, Dept Neurol, Hershey, PA 17033 USA; [Moyo, Mthabisi] Ave Maria Univ, Dept Biol, Ave Maria, FL 34142 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Liu, YT (corresponding author), Penn State Univ, Milton S Hershey Med Ctr, Dept Neurosurg, H110,500 Univ Dr, Hershey, PA 17033 USA.	yliu2@hmc.psu.edu		Lee, Sang/0000-0003-3911-8316; Moyo, Mthabisi/0000-0002-7321-9834	Paul and Harriett Campbell Fund; Zimmerman Family Love Fund; Judith & Jean Pape Adams Charitable Foundation	Paul and Harriett Campbell Fund; Zimmerman Family Love Fund; Judith & Jean Pape Adams Charitable Foundation	This work was supported by the Paul and Harriett Campbell Fund for ALS Research, the Zimmerman Family Love Fund, and the Judith & Jean Pape Adams Charitable Foundation.	Atkin JD, 2008, NEUROBIOL DIS, V30, P400, DOI 10.1016/j.nbd.2008.02.009; Atkin JD, 2006, J BIOL CHEM, V281, P30152, DOI 10.1074/jbc.M603393200; Bahram S, 1999, P NATL ACAD SCI USA, V96, P13312, DOI 10.1073/pnas.96.23.13312; Berlin D, 2004, NEUROBIOL AGING, V25, P465, DOI 10.1016/j.neurobiolaging.2003.06.008; Connor JR, 2006, J ALZHEIMERS DIS, V10, P267; de Almeida SF, 2007, J IMMUNOL, V178, P3612, DOI 10.4049/jimmunol.178.6.3612; de Almeida SF, 2007, J BIOL CHEM, V282, P27905, DOI 10.1074/jbc.M702672200; Dekker MCJ, 2003, NEUROSCI LETT, V348, P117, DOI 10.1016/S0304-3940(03)00713-4; Feder JN, 1998, P NATL ACAD SCI USA, V95, P1472, DOI 10.1073/pnas.95.4.1472; Gao JW, 2010, BLOOD, V115, P3374, DOI 10.1182/blood-2009-09-245209; Golub MS, 2005, NUTR NEUROSCI, V8, P239, DOI 10.1080/10284150500277685; Goodall EF, 2005, NEUROLOGY, V65, P934, DOI 10.1212/01.wnl.0000176032.94434.d4; Guerreiro RJ, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-24; HALL EC, 2009, NEUROBIOL AGING; Holmstrom P, 2003, J HEPATOL, V39, P308, DOI 10.1016/S0168-8278(03)00293-9; Hoozemans JJM, 2005, ACTA NEUROPATHOL, V110, P165, DOI 10.1007/s00401-005-1038-0; Langou K, 2010, J NEUROCHEM, V114, P795, DOI 10.1111/j.1471-4159.2010.06806.x; Lebron JA, 1999, J MOL BIOL, V294, P239, DOI 10.1006/jmbi.1999.3252; Lee SY, 2007, FASEB J, V21, P564, DOI 10.1096/fj.06-6397com; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; McLaughlin B, 2003, P NATL ACAD SCI USA, V100, P715, DOI 10.1073/pnas.0232966100; Mendes CS, 2009, EMBO J, V28, P1296, DOI 10.1038/emboj.2009.76; MITCHELL RM, 2009, NEUROBIOL IN PRESS; NANDAR W, 2010, AMYOTROPH LATERAL SC, V11, P54; Oates PS, 1997, AM J PHYSIOL-GASTR L, V273, pG636, DOI 10.1152/ajpgi.1997.273.3.G636; Oliveira SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006618; POWELL L, 2000, IRON METABOLISM HLTH; Price DL, 1999, NATURE, V399, pA3, DOI 10.1038/399a003; Restagno G, 2007, J NEUROL NEUROSUR PS, V78, P327, DOI 10.1136/jnnp.2006.092338; Ristic S, 2005, NEUROSCI LETT, V383, P301, DOI 10.1016/j.neulet.2005.04.045; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Ryu EJ, 2002, J NEUROSCI, V22, P10690; Sado M, 2009, BRAIN RES, V1257, P16, DOI 10.1016/j.brainres.2008.11.104; Saxena S, 2009, NAT NEUROSCI, V12, P627, DOI 10.1038/nn.2297; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Sutedja NA, 2007, ARCH NEUROL-CHICAGO, V64, P63, DOI 10.1001/archneur.64.1.63; Tomatsu S, 2003, P NATL ACAD SCI USA, V100, P15788, DOI 10.1073/pnas.2237037100; Vecchi C, 2009, SCIENCE, V325, P877, DOI 10.1126/science.1176639; WANG XM, 2004, J NEUROL SCI, V227, pU1511; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160; Yen AA, 2004, NEUROLOGY, V62, P1611, DOI 10.1212/01.WNL.0000123114.04644.CC; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Zhang Y, 2006, EMBO J, V25, P5896, DOI 10.1038/sj.emboj.7601445	46	41	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13161	13170		10.1074/jbc.M110.170944	http://dx.doi.org/10.1074/jbc.M110.170944			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21349849	Green Published, hybrid			2022-12-27	WOS:000289282200037
J	Sannai, P; Shuman, S				Sannai, Poulami; Shuman, Stewart			Functional Dissection of the DNA Interface of the Nucleotidyltransferase Domain of Chlorella Virus DNA Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTATIONAL ANALYSIS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; NICK RECOGNITION; ADENYLATE; ENZYME; SPECIFICITY; MECHANISM; FIDELITY; REPAIR	Chlorella virus DNA ligase (ChVLig) has pluripotent biological activity and an intrinsic nick-sensing function. ChVLig consists of three structural modules that envelop nicked DNA as a C-shaped protein clamp: a nucleotidyltransferase (NTase) domain and an 013 domain (these two are common to all DNA ligases) as well as a distinctive beta-hairpin latch module. The NTase domain, which performs the chemical steps of ligation, binds the major groove flanking the nick and the minor groove on the 3'-OH side of the nick. Here we performed a structure-guided mutational analysis of the NTase domain, surveying the effects of 35 mutations in 19 residues on ChVLig activity in vivo and in vitro, including biochemical tests of the composite nick sealing reaction and of the three component steps of the ligation pathway (ligase adenylylation, DNA adenylylation, and phosphodiester synthesis). The results highlight (i) key contacts by Thr-84 and Lys-173 to the template DNA strand phosphates at the outer margins of the DNA ligase footprint; (ii) essential contacts of Ser-41, Arg-42, Met-83, and Phe-75 with the 3'-OH strand at the nick; (iii) Arg-176 phosphate contacts at the nick and with ATP during ligase adenylylation; (iv) the role of Phe-44 in forming the protein clamp around the nicked DNA substrate; and (v) the importance of adenine-binding residue Phe-98 in all three steps of ligation. Kinetic analysis of single-turnover nick sealing by ChVLig-AMP underscored the importance of Phe-75-mediated distortion of the nick 3'-OH nucleoside in the catalysis of DNA 5'-adenylylation (step 2) and phosphodiester synthesis (step 3). Induced fit of the nicked DNA into a distorted conformation when bound within the ligase clamp may account for the nick-sensing capacity of ChVLig.	[Sannai, Poulami; Shuman, Stewart] Sloan Kettering Inst, Program Mol Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Shuman, S (corresponding author), Amer Canc Soc, Atlanta, GA 30329 USA.	s-shuman@ski.mskcc.org			National Institutes of Health [GM63611]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063611] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM63611.	Auesukaree C, 2004, J BIOL CHEM, V279, P17289, DOI 10.1074/jbc.M312202200; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Cotner-Gohara E, 2010, BIOCHEMISTRY-US, V49, P6165, DOI 10.1021/bi100503w; Crut A, 2008, P NATL ACAD SCI USA, V105, P6894, DOI 10.1073/pnas.0800113105; Deng JP, 2004, J MOL BIOL, V343, P601, DOI 10.1016/j.jmb.2004.08.041; El Omari K, 2006, J BIOL CHEM, V281, P1573, DOI 10.1074/jbc.M509658200; Ellenberger T, 2008, ANNU REV BIOCHEM, V77, P313, DOI 10.1146/annurev.biochem.77.061306.123941; Hakansson K, 1997, CELL, V89, P545, DOI 10.1016/S0092-8674(00)80236-6; Ho CK, 1997, J VIROL, V71, P1931, DOI 10.1128/JVI.71.3.1931-1937.1997; Mulet JM, 1999, MOL CELL BIOL, V19, P3328; Nair PA, 2007, NAT STRUCT MOL BIOL, V14, P770, DOI 10.1038/nsmb1266; Nandakumar J, 2007, MOL CELL, V26, P257, DOI 10.1016/j.molcel.2007.02.026; Odell M, 2000, MOL CELL, V6, P1183, DOI 10.1016/S1097-2765(00)00115-5; Odell M, 1999, J BIOL CHEM, V274, P14032, DOI 10.1074/jbc.274.20.14032; Odell M, 2003, NUCLEIC ACIDS RES, V31, P5090, DOI 10.1093/nar/gkg665; Pascal JM, 2004, NATURE, V432, P473, DOI 10.1038/nature03082; Piserchio A, 2010, J MOL BIOL, V395, P291, DOI 10.1016/j.jmb.2009.11.007; Shuman S, 1995, BIOCHEMISTRY-US, V34, P16138, DOI 10.1021/bi00049a029; Shuman S, 2004, CURR OPIN STRUC BIOL, V14, P757, DOI 10.1016/j.sbi.2004.10.006; Shuman S, 2009, J BIOL CHEM, V284, P17365, DOI 10.1074/jbc.R900017200; Simsek D, 2011, NATURE, V471, P245, DOI 10.1038/nature09794; Sriskanda V, 1998, NUCLEIC ACIDS RES, V26, P525, DOI 10.1093/nar/26.2.525; Sriskanda V, 1999, NUCLEIC ACIDS RES, V27, P3953, DOI 10.1093/nar/27.20.3953; Sriskanda V, 1998, NUCLEIC ACIDS RES, V26, P4618, DOI 10.1093/nar/26.20.4618; Sriskanda V, 2002, J BIOL CHEM, V277, P9661, DOI 10.1074/jbc.M110613200; Sriskanda V, 2002, NUCLEIC ACIDS RES, V30, P903, DOI 10.1093/nar/30.4.903; Sriskanda V, 1998, NUCLEIC ACIDS RES, V26, P3536, DOI 10.1093/nar/26.15.3536	27	9	9	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13314	13326		10.1074/jbc.M111.226191	http://dx.doi.org/10.1074/jbc.M111.226191			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21335605	hybrid, Green Published			2022-12-27	WOS:000289282200052
J	Takac, I; Schroder, K; Zhang, LL; Lardy, B; Anilkumar, N; Lambeth, JD; Shah, AM; Morel, F; Brandes, RP				Takac, Ina; Schroeder, Katrin; Zhang, Leilei; Lardy, Bernard; Anilkumar, Narayana; Lambeth, J. David; Shah, Ajay M.; Morel, Francoise; Brandes, Ralf P.			The E-loop Is Involved in Hydrogen Peroxide Formation by the NADPH Oxidase Nox4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN XANTHINE OXIDOREDUCTASE; SMOOTH-MUSCLE-CELLS; SUPEROXIDE-DISMUTASE; NAD(P)H OXIDASE; HOST-DEFENSE; DEHYDROGENASE; LOCALIZATION; REVEALS; HEME; ACTIVATION	In contrast to the NADPH oxidases Nox1 and Nox2, which generate superoxide (O-2(radical anion)), Nox4 produces hydrogen peroxide (H2O2). We constructed chimeric proteins and mutants to address the protein region that specifies which reactive oxygen species is produced. Reactive oxygen species were measured with luminol/horseradish peroxidase and Amplex Red for H2O2 versus L-012 and cytochrome c for O-2(radical anion). The third extracytosolic loop (E-loop) of Nox4 is 28 amino acids longer than that of Nox1 or Nox2. Deletion of E-loop amino acids only present in Nox4 or exchange of the two cysteines in these stretches switched Nox4 from H2O2 to O-2(radical anion) generation while preserving expression and intracellular localization. In the presence of an NO donor, the O-2(radical anion)-producing Nox4 mutants, but not wild-type Nox4, generated peroxynitrite, excluding artifacts of the detection system as the apparent origin of O-2(radical anion). In Cos7 cells, in which Nox4 partially localizes to the plasma membrane, an antibody directed against the E-loop decreased H2O2, but increased O-2(radical anion), formation by Nox4 without affecting Nox1-dependent O-2(radical anion) formation. The E-loop of Nox4 but not Nox1 and Nox2 contains a highly conserved histidine that could serve as a source for protons to accelerate spontaneous dismutation of superoxide to form H2O2. Mutation of this but not of four other conserved histidines also switched Nox4 from H2O2, to O-2(radical anion) formation, Thus, H2O2, formation is an intrinsic property of Nox4 that involves its E-loop. The structure of the E-loop may hinder O-2(radical anion) egress and/or provide a source for protons, allowing dismutation to form H2O2.	[Takac, Ina; Schroeder, Katrin; Brandes, Ralf P.] Goethe Univ Frankfurt, Inst Kardiovaskulare Physiol, D-60590 Frankfurt, Germany; [Zhang, Leilei; Lardy, Bernard; Morel, Francoise] Univ Grenoble 1, TIMC Imag UMR CNRS 5525, Grp Rech & Etud Proc Inflammatoire, F-38041 Grenoble 09, France; [Anilkumar, Narayana; Shah, Ajay M.] Kings Coll London, British Heart Fdn Ctr, Div Cardiovasc, London SE5 9NU, England; [Lambeth, J. David] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	Goethe University Frankfurt; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); University of London; King's College London; Emory University	Brandes, RP (corresponding author), Goethe Univ Frankfurt, Inst Kardiovaskulare Physiol, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	r.brandes@em.uni-frankfurt.de	Schröder, Katrin/E-6874-2013; Brandes, Ralf P/L-3058-2017	Schröder, Katrin/0000-0002-3099-526X; Brandes, Ralf P/0000-0002-8035-0048; Shah, Ajay/0000-0002-6547-0631	National Institutes of Health [R01 CA084138, R01 CA105116, P01 ES011163]; Leducq Foundation; British Heart Foundation; Deutsche Forschungsgemeinschaft [SFB815/TP1, SFB834/TPA2]; Excellence Cluster Cardio-pulmonary System (ECCPS); NATIONAL CANCER INSTITUTE [R01CA105116, R01CA084138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011163] Funding Source: NIH RePORTER; British Heart Foundation [RG/08/011/25922] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leducq Foundation(Leducq Foundation); British Heart Foundation(British Heart Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Cluster Cardio-pulmonary System (ECCPS)(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); British Heart Foundation(British Heart Foundation)	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA084138, R01 CA105116, and P01 ES011163 (to J. D. L.) and the Leducq Foundation and the British Heart Foundation (to A. M. S.). This work was also supported by grants from the Deutsche Forschungsgemeinschaft (SFB815/TP1 and SFB834/TPA2) and the Excellence Cluster Cardio-pulmonary System (ECCPS).	Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; Ameziane-El-Hassani R, 2005, J BIOL CHEM, V280, P30046, DOI 10.1074/jbc.M500516200; Anilkumar N, 2008, ARTERIOSCL THROM VAS, V28, P1347, DOI 10.1161/ATVBAHA.108.164277; Asai R, 2007, J BIOCHEM, V141, P525, DOI 10.1093/jb/mvm054; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Block K, 2009, P NATL ACAD SCI USA, V106, P14385, DOI 10.1073/pnas.0906805106; Chen K, 2008, J CELL BIOL, V181, P1129, DOI 10.1083/jcb.200709049; DeLeo FR, 2000, J BIOL CHEM, V275, P13986, DOI 10.1074/jbc.275.18.13986; Forteza R, 2005, AM J RESP CELL MOL, V32, P462, DOI 10.1165/rcmb.2004-0302OC; Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje; Geiszt M, 2000, P NATL ACAD SCI USA, V97, P8010, DOI 10.1073/pnas.130135897; Harris CM, 1997, J BIOL CHEM, V272, P8370, DOI 10.1074/jbc.272.13.8370; Helmcke I, 2009, ANTIOXID REDOX SIGN, V11, P1279, DOI [10.1089/ars.2008.2383, 10.1089/ARS.2008.2383]; Hilenski LL, 2004, ARTERIOSCL THROM VAS, V24, P677, DOI 10.1161/01.ATV.0000112024.13727.2c; Holliday GL, 2009, J MOL BIOL, V390, P560, DOI 10.1016/j.jmb.2009.05.015; KAWAHARA T, 2011, BIOCHEMISTR IN PRESS; Kuroda J, 2005, GENES CELLS, V10, P1139, DOI 10.1111/j.1365-2443.2005.00907.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leto TL, 2006, ANTIOXID REDOX SIGN, V8, P1549, DOI 10.1089/ars.2006.8.1549; Lyle AN, 2009, CIRC RES, V105, P249, DOI 10.1161/CIRCRESAHA.109.193722; MARKLUND S, 1976, J BIOL CHEM, V251, P7504; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Meitzler JL, 2009, J BIOL CHEM, V284, P18634, DOI 10.1074/jbc.M109.013581; Morand S, 2009, FASEB J, V23, P1205, DOI 10.1096/fj.08-120006; Nauseef WM, 2004, HISTOCHEM CELL BIOL, V122, P277, DOI 10.1007/s00418-004-0679-8; Nishino T, 2008, FEBS J, V275, P3278, DOI 10.1111/j.1742-4658.2008.06489.x; Nisimoto Y, 2010, BIOCHEMISTRY-US, V49, P2433, DOI 10.1021/bi9022285; Serrander L, 2007, BIOCHEM J, V406, P105, DOI 10.1042/BJ20061903; Strange RW, 2003, J MOL BIOL, V328, P877, DOI 10.1016/S0022-2836(03)00355-3; Vignais PV, 2002, CELL MOL LIFE SCI, V59, P1428, DOI 10.1007/s00018-002-8520-9; von Lohneysen K, 2010, MOL CELL BIOL, V30, P961, DOI 10.1128/MCB.01393-09; Von Lohneysen K, 2008, J BIOL CHEM, V283, P35273, DOI 10.1074/jbc.M804200200; Wu RF, 2010, MOL CELL BIOL, V30, P3553, DOI 10.1128/MCB.01445-09; Yu LX, 1998, P NATL ACAD SCI USA, V95, P7993, DOI 10.1073/pnas.95.14.7993; Zhang LL, 2011, BIOCHIMIE, V93, P457, DOI 10.1016/j.biochi.2010.11.001	35	379	388	1	52	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13304	13313		10.1074/jbc.M110.192138	http://dx.doi.org/10.1074/jbc.M110.192138			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21343298	hybrid, Green Published			2022-12-27	WOS:000289282200051
J	Bacik, JP; Whitworth, GE; Stubbs, KA; Yadav, AK; Martin, DR; Bailey-Elkin, BA; Vocadlo, DJ; Mark, BL				Bacik, John-Paul; Whitworth, Garrett E.; Stubbs, Keith A.; Yadav, Anuj K.; Martin, Dylan R.; Bailey-Elkin, Ben A.; Vocadlo, David J.; Mark, Brian L.			Molecular Basis of 1,6-Anhydro Bond Cleavage and Phosphoryl Transfer by Pseudomonas aeruginosa 1,6-Anhydro-N-acetylmuramic Acid Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-N-ACETYLGLUCOSAMINIDASE; ESCHERICHIA-COLI; SUBSTRATE-SPECIFICITY; LEVOGLUCOSAN KINASE; ASPERGILLUS-NIGER; PROVIDES INSIGHT; MUREIN; IDENTIFICATION; MECHANISM	Anhydro-N-acetylmuramic acid kinase (AnmK) catalyzes the ATP-dependent conversion of the Gram-negative peptidoglycan (PG) recycling intermediate 1,6-anhydro-N-acetylmuramic acid (anhMurNAc) to N-acetylmuramic acid-6-phosphate (MurNAc-6-P). Here we present crystal structures of Pseudomonas aeruginosa AnmK in complex with its natural substrate, anhMurNAc, and a product of the reaction, ADP. AnmK is homodimeric, with each subunit comprised of two subdomains that are separated by a deep active site cleft, which bears similarity to the ATPase core of proteins belonging to the hexokinase-hsp70-actin superfamily of proteins. The conversion of anhMurNAc to MurNAc-6-P involves both cleavage of the 1,6-anhydro ring of anhMurNAc along with addition of a phosphoryl group to O6 of the sugar, and thus represents an unusual enzymatic mechanism involving the formal addition of H3PO4 to anhMurNAc. The structural complexes and NMR analysis of the reaction suggest that a water molecule, activated by Asp-182, attacks the anomeric carbon of anhMurNAc, aiding cleavage of the 1,6-anhydro bond and facilitating the capture of the gamma phosphate of ATP by O6 via an in-line phosphoryl transfer. AnmK is active only against anhMurNAc and not the metabolically related 1,6-anhydro-N-acetylmuramyl peptides, suggesting that the cytosolic N-acetyl-anhydromuramyl-L-alanine amidase AmpD must first remove the stem peptide from these PG muropeptide catabolites before anhMurNAc can be acted upon by AnmK. Our studies provide the foundation for a mechanistic model for the dual activities of AnmK as a hydrolase and a kinase of an unusual heterocyclic monosaccharide.	[Bacik, John-Paul; Martin, Dylan R.; Bailey-Elkin, Ben A.; Mark, Brian L.] Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada; [Whitworth, Garrett E.; Stubbs, Keith A.; Yadav, Anuj K.; Vocadlo, David J.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada; [Stubbs, Keith A.] Univ Western Australia, Sch Biomed Biomol & Chem Sci, Dept Chem M313, Crawley, WA 6009, Australia	University of Manitoba; Simon Fraser University; University of Western Australia	Mark, BL (corresponding author), Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada.	brian_mark@umanitoba.ca	Stubbs, Keith/H-5909-2014; Vocadlo, David J/E-5508-2014	Vocadlo, David J/0000-0001-6897-5558; Mark, Brian/0000-0002-7344-1355; Bacik, John-Paul/0000-0001-9315-5332; Stubbs, Keith/0000-0001-6899-402X	Canadian Institutes of Health Research; Canadian Cystic Fibrosis Foundation; Manitoba Health Research Council (MHRC); NSERC; National Research Council; University of Saskatchewan	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cystic Fibrosis Foundation; Manitoba Health Research Council (MHRC); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Research Council; University of Saskatchewan	This work was funded by Canadian Institutes of Health Research and Canadian Cystic Fibrosis Foundation Grants (to B. L. M. and D. J. V.).; Supported by a postdoctoral fellowship from the Manitoba Health Research Council (MHRC).; Supported by a postgraduate scholarship (PGS-D) from NSERC.; We thank V. Larmour for technical assistance and S. Labiuk and the staff of the Canadian Light Source (CLS) beam-line 08ID-1 for assistance with data collection. The CLS is supported by the Natural Sciences and Engineering Research Council of Canada (NSERC), National Research Council, the Canadian Institutes of Health Research (CIHR), and the University of Saskatchewan. K. A. S. thanks the Australian Research Council.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Balcewich MD, 2010, J MOL BIOL, V400, P998, DOI 10.1016/j.jmb.2010.05.040; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng QM, 2000, J BACTERIOL, V182, P4836, DOI 10.1128/JB.182.17.4836-4840.2000; Davies GJ, 1998, BIOCHEMISTRY-US, V37, P11707, DOI 10.1021/bi981315i; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Ganguli ARS, 2005, TETRAHEDRON-ASYMMETR, V16, P411, DOI 10.1016/j.tetasy.2004.11.053; GOODELL EW, 1985, J BACTERIOL, V163, P305, DOI 10.1128/JB.163.1.305-310.1985; GOSSELIN S, 1994, ANAL BIOCHEM, V220, P92, DOI 10.1006/abio.1994.1303; Grueninger D, 2006, J MOL BIOL, V359, P787, DOI 10.1016/j.jmb.2006.04.013; Hawley J, 2002, EUR J ORG CHEM, V2002, P1925, DOI 10.1002/1099-0690(200206)2002:12<1925::AID-EJOC1925>3.0.CO;2-9; Hoffmann D, 2010, ENVIRON SCI TECHNOL, V44, P694, DOI 10.1021/es902476f; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jacobs C, 1997, CELL, V88, P823, DOI 10.1016/S0092-8674(00)81928-5; JACOBS C, 1994, EMBO J, V13, P4684, DOI 10.1002/j.1460-2075.1994.tb06792.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kubasch N, 2002, EUR J ORG CHEM, V2002, P2710, DOI 10.1002/1099-0690(200208)2002:16<2710::AID-EJOC2710>3.0.CO;2-8; Lee MJ, 2009, J AM CHEM SOC, V131, P8742, DOI 10.1021/ja9025566; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; LIVERMORE DM, 1995, CLIN MICROBIOL REV, V8, P557, DOI 10.1128/CMR.8.4.557; Matte A, 1998, STRUCT FOLD DES, V6, P413, DOI 10.1016/S0969-2126(98)00043-4; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishimasu H, 2007, J BIOL CHEM, V282, P9923, DOI 10.1074/jbc.M610678200; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; PAULSEN H, 1986, LIEBIGS ANN CHEM, P664; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; Sulzenbacher G, 1996, BIOCHEMISTRY-US, V35, P15280, DOI 10.1021/bi961946h; Tews I, 1996, NAT STRUCT BIOL, V3, P638, DOI 10.1038/nsb0796-638; Uehara T, 2006, J BACTERIOL, V188, P1660, DOI 10.1128/JB.188.4.1660-1662.2006; Uehara T, 2005, J BACTERIOL, V187, P3643, DOI 10.1128/JB.187.11.3643-3649.2005; VANBOECKEL CAA, 1983, RECL TRAV CHIM PAY B, V102, P415; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Votsch W, 2000, J BIOL CHEM, V275, P39032, DOI 10.1074/jbc.M004797200; Weihofen WA, 2006, J MOL BIOL, V364, P388, DOI 10.1016/j.jmb.2006.08.085; Xie HJ, 2005, FEMS MICROBIOL LETT, V251, P313, DOI 10.1016/j.femsle.2005.08.024; Zhuang XL, 2002, PROTEIN EXPRES PURIF, V26, P71, DOI 10.1016/S1046-5928(02)00501-6; Zhuang XL, 2001, BIORESOURCE TECHNOL, V79, P63, DOI 10.1016/S0960-8524(01)00023-2	42	21	21	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.198317	http://dx.doi.org/10.1074/jbc.M110.198317			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21288904	hybrid, Green Published			2022-12-27	WOS:000289077500042
J	Blackman, BE; Horner, K; Heidmann, J; Wang, D; Richter, W; Rich, TC; Conti, M				Blackman, Brigitte E.; Horner, Kathleen; Heidmann, Julia; Wang, Dan; Richter, Wito; Rich, Thomas C.; Conti, Marco			PDE4D and PDE4B Function in Distinct Subcellular Compartments in Mouse Embryonic Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASODILATOR-STIMULATED PHOSPHOPROTEIN; CAMP-SPECIFIC PHOSPHODIESTERASES; NUCLEOTIDE-GATED CHANNELS; PROTEIN-KINASE; BETA-ARRESTIN; BETA(2)-ADRENERGIC RECEPTORS; ADENYLYL-CYCLASE; CYCLIC-AMP; CROSS-TALK; ACTIVATION	Signaling through cAMP regulates most cellular functions. The spatiotemporal control of cAMP is, therefore, crucial for differential regulation of specific cellular targets. Here we investigated the consequences of PDE4B or PDE4D gene ablation on cAMP signaling at a subcellular level using mouse embryonic fibroblasts. PDE4B ablation had no effect on the global or bulk cytosol accumulation of cAMP but increased both basal and hormone-dependent cAMP in a near-membrane pool. Conversely, PDE4D ablation enhanced agonist-induced cAMP accumulation in the bulk cytosol as well as at the plasma membrane. Both PDE4B and PDE4D ablation significantly modified the time course and the level of isoproterenol-induced phosphorylation of vasodilator-stimulated phosphoprotein, a membrane cytoskeletal component. A second membrane response through Toll-like receptor signaling, however, was only affected by PDE4B ablation. PDE4D but not PDE4B ablation significantly prolonged cAMP-response element-binding protein-mediated transcription. These findings demonstrate that PDE4D and PDE4B have specialized functions in mouse embryonic fibroblasts with PDE4B controlling cAMP in a discrete subdomain near the plasma membrane.	[Blackman, Brigitte E.; Horner, Kathleen; Heidmann, Julia; Wang, Dan; Richter, Wito; Conti, Marco] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Ctr Reprod Sci, San Francisco, CA 94143 USA; [Rich, Thomas C.] Univ S Alabama, Coll Med, Dept Pharmacol, Mobile, AL 36688 USA; [Rich, Thomas C.] Univ S Alabama, Ctr Lung Biol, Mobile, AL 36688 USA	University of California System; University of California San Francisco; University of South Alabama; University of South Alabama	Conti, M (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Ctr Reprod Sci, 513 Parnassus Ave,Box 0556, San Francisco, CA 94143 USA.	ContiM@obgyn.ucsf.edu		Richter, Wito/0000-0001-5588-9060	National Institutes of Health [HL092788]; Leducq Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092788] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leducq Foundation(Leducq Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL092788. This work was also supported by a grant from the Leducq Foundation.	Abrahamsen H, 2004, J IMMUNOL, V173, P4847, DOI 10.4049/jimmunol.173.8.4847; An D, 2006, AM J PHYSIOL-HEART C, V291, pH1489, DOI 10.1152/ajpheart.00278.2006; Arp J, 2003, MOL CELL BIOL, V23, P8042, DOI 10.1128/MCB.23.22.8042-8057.2003; Aszodi A, 1999, EMBO J, V18, P37, DOI 10.1093/emboj/18.1.37; Baillie GS, 2003, P NATL ACAD SCI USA, V100, P940, DOI 10.1073/pnas.262787199; Barnes AP, 2005, J BIOL CHEM, V280, P7997, DOI 10.1074/jbc.M407521200; BEAVO JA, 1974, P NATL ACAD SCI USA, V71, P3580, DOI 10.1073/pnas.71.9.3580; Bolger GB, 2006, BIOCHEM J, V398, P23, DOI 10.1042/BJ20060423; Bruss MD, 2008, J BIOL CHEM, V283, P22430, DOI 10.1074/jbc.M803306200; Chen HJ, 2008, J BIOL CHEM, V283, P4439, DOI 10.1074/jbc.M709439200; Comerford KM, 2002, FASEB J, V16, P583, DOI 10.1096/fj.01-0739fje; Conti M, 2000, PROG NUCLEIC ACID RE, V63, P1; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Dodge KL, 2001, EMBO J, V20, P1921, DOI 10.1093/emboj/20.8.1921; HARPER JF, 1975, J CYCLIC NUCL PROT, V1, P207; Houslay MD, 2001, PROG NUCLEIC ACID RE, V69, P249, DOI 10.1016/S0079-6603(01)69049-4; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; Huston E, 2008, P NATL ACAD SCI USA, V105, P12791, DOI 10.1073/pnas.0805167105; Jin SLC, 1998, J BIOL CHEM, V273, P19672, DOI 10.1074/jbc.273.31.19672; Jin SLC, 1999, P NATL ACAD SCI USA, V96, P11998, DOI 10.1073/pnas.96.21.11998; Jin SLC, 2005, J IMMUNOL, V175, P1523, DOI 10.4049/jimmunol.175.3.1523; Jin SLC, 2002, P NATL ACAD SCI USA, V99, P7628, DOI 10.1073/pnas.122041599; Jurevicius J, 1996, P NATL ACAD SCI USA, V93, P295, DOI 10.1073/pnas.93.1.295; Krumins AM, 2006, J BIOL CHEM, V281, P10250, DOI 10.1074/jbc.M511551200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lynch MJ, 2005, J BIOL CHEM, V280, P33178, DOI 10.1074/jbc.M414316200; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Oliveira RF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011725; Padron A, 2007, MOL ENDOCRINOL, V21, P49, DOI 10.1210/me.2006-0075; Perry SJ, 2002, SCIENCE, V298, P834, DOI 10.1126/science.1074683; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Rich TC, 2000, J GEN PHYSIOL, V116, P147, DOI 10.1085/jgp.116.2.147; Rich TC, 2001, J GEN PHYSIOL, V118, P63, DOI 10.1085/jgp.118.1.63; Rich TC, 2001, P NATL ACAD SCI USA, V98, P13049, DOI 10.1073/pnas.221381398; Rich TC, 2007, AM J PHYSIOL-CELL PH, V292, pC319, DOI 10.1152/ajpcell.00121.2006; Richter W, 2002, J BIOL CHEM, V277, P40212, DOI 10.1074/jbc.M203585200; Richter W, 2008, EMBO J, V27, P384, DOI 10.1038/sj.emboj.7601968; Saucerman JJ, 2006, P NATL ACAD SCI USA, V103, P12923, DOI 10.1073/pnas.0600137103; Stefan E, 2007, J AM SOC NEPHROL, V18, P199, DOI 10.1681/ASN.2006020132; Tasken KA, 2001, J BIOL CHEM, V276, P21999, DOI 10.1074/jbc.C000911200; Terrin A, 2006, J CELL BIOL, V175, P441, DOI 10.1083/jcb.200605050; Verde I, 2001, J BIOL CHEM, V276, P11189, DOI 10.1074/jbc.M006546200; Wachten S, 2010, J CELL SCI, V123, P95, DOI 10.1242/jcs.058594; Willoughby D, 2007, J BIOL CHEM, V282, P34235, DOI 10.1074/jbc.M706765200; Willoughby D, 2006, EMBO J, V25, P2051, DOI 10.1038/sj.emboj.7601113; Zaccolo M, 2006, BIOCHEM SOC T, V34, P495, DOI 10.1042/BST0340495; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	48	41	42	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.203604	http://dx.doi.org/10.1074/jbc.M110.203604			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21288894	hybrid, Green Published			2022-12-27	WOS:000289077500071
J	Dai, JX; Zhao, L; Yang, HO; Guo, HZ; Fan, KX; Wang, HQ; Qian, WZ; Zhang, DP; Li, BH; Wang, H; Guo, YJ				Dai, Jianxing; Zhao, Lei; Yang, Haiou; Guo, Huaizu; Fan, Kexing; Wang, Huaqing; Qian, Weizhu; Zhang, Dapeng; Li, Bohua; Wang, Hao; Guo, Yajun			Identification of a Novel Functional Domain of Ricin Responsible for Its Potent Toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-CHAIN; AMINO-ACIDS; SITE; ANTIBODIES; MUTAGENESIS; MECHANISM; CATALYSIS; PROTEINS; GENETICS; LECTINS	Ribosome-inactivating proteins (RIPs) are toxic N-glycosidases that depurinate the universally conserved alpha-sarcin loop of large rRNAs. They have received attention in biological and biomedical research because of their unique biological activities toward animals and human cells as cell-killing agents. A better understanding of the depurination mechanism of RIPs could allow us to develop potent neutralizing antibodies and to design efficient immunotoxins for clinical use. Among these RIPs, ricin exhibited remarkable efficacy in depurination activity and highly conserved tertiary structure with other RIPs. It can be considered as a prototype to investigate the depurination mechanism of RIPs. In the present study, we successfully identified a novel functional domain responsible for controlling the depurination activity of ricin, which is located far from the enzymatic active site reported previously. Our study indicated that ricin A-chain mAbs binding to this domain (an alpha-helix comprising the residues 99-106) exhibited an unusual potent neutralizing ability against ricin in vivo. To further investigate the potential role of the alpha-helix in regulating the catalytic activity of ricin, ricin A-chain variants with different flexibility of the alpha-helix were rationally designed. Our data clearly demonstrated that the flexibility of the alpha-helix is responsible for controlling the depurination activity of ricin and determining the extent of protein synthesis inhibition, suggesting that the conserved alpha-helix might be considered as a potential target for the prevention and treatment of RIP poisoning.	[Dai, Jianxing; Zhao, Lei; Yang, Haiou; Fan, Kexing; Wang, Huaqing; Qian, Weizhu; Zhang, Dapeng; Li, Bohua; Wang, Hao; Guo, Yajun] Second Mil Med Univ, Int Joint Canc Inst, Shanghai 200433, Peoples R China; [Dai, Jianxing; Fan, Kexing; Wang, Huaqing; Qian, Weizhu; Zhang, Dapeng; Li, Bohua; Wang, Hao; Guo, Yajun] Natl Engn Res Ctr Antibody Med, State Key Lab Antibody Med & Targeting Therapy, Shanghai 201203, Peoples R China; [Dai, Jianxing; Fan, Kexing; Wang, Huaqing; Qian, Weizhu; Zhang, Dapeng; Li, Bohua; Wang, Hao; Guo, Yajun] Natl Engn Res Ctr Antibody Med, Shanghai Key Lab Cell Engn, Shanghai 201203, Peoples R China; [Yang, Haiou; Guo, Huaizu; Guo, Yajun] Shanghai Jiao Tong Univ, Minist Educ, Ctr Antibody Med, Sch Med, Shanghai 200025, Peoples R China; [Yang, Haiou; Guo, Huaizu; Guo, Yajun] Shanghai Jiao Tong Univ, Minist Educ, Ctr Antibody Med, Sch Pharm, Shanghai 200025, Peoples R China; [Guo, Yajun] Peoples Liberat Army Gen Hosp, Ctr Canc, Beijing 100853, Peoples R China	Naval Medical University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese People's Liberation Army General Hospital	Guo, YJ (corresponding author), Second Mil Med Univ, Int Joint Canc Inst, 800 Xiang Yin Rd, Shanghai 200433, Peoples R China.	yjguo@smmu.edu.cn	Yang, Haiou/U-6328-2019; Li, Bo/AAA-8968-2020	Li, Bo/0000-0002-7294-6888; Zhao, Lei/0000-0002-5884-2708	National Natural Science Foundation of China, Ministry of Science and Technology of China [973, 863]; National Key project for New Drug Creation and Manufacture, Shanghai Commission of Science and Technology [B905]; Program for Pujiang Scholar and Innovative Research Team in University	National Natural Science Foundation of China, Ministry of Science and Technology of China(Ministry of Science and Technology, ChinaNational Natural Science Foundation of China (NSFC)); National Key project for New Drug Creation and Manufacture, Shanghai Commission of Science and Technology(Shanghai Science & Technology Committee); Program for Pujiang Scholar and Innovative Research Team in University	This work was supported by Program Project Grants 973 and 863 from the National Natural Science Foundation of China, Ministry of Science and Technology of China, by Grant B905 from the National Key project for New Drug Creation and Manufacture, Shanghai Commission of Science and Technology, Shanghai Leading Academic Discipline Project, and by the Program for Pujiang Scholar and Innovative Research Team in University.	Bowler BE, 2007, MOL BIOSYST, V3, P88, DOI 10.1039/b611895j; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chang Q, 2002, INFECT IMMUN, V70, P4977, DOI 10.1128/IAI.70.9.4977-4986.2002; ContiFine BM, 1996, ANNU REV BIOPH BIOM, V25, P197; Daniel RM, 2003, ANNU REV BIOPH BIOM, V32, P69, DOI 10.1146/annurev.biophys.32.110601.142445; Day PJ, 1996, BIOCHEMISTRY-US, V35, P11098, DOI 10.1021/bi960880n; ENDO Y, 1987, J BIOL CHEM, V262, P5908; Hartley MR, 2004, MINI-REV MED CHEM, V4, P487, DOI 10.2174/1389557043403828; Ho MC, 2009, P NATL ACAD SCI USA, V106, P20276, DOI 10.1073/pnas.0911606106; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Karginov AV, 2010, NAT BIOTECHNOL, V28, P743, DOI 10.1038/nbt.1639; KIM Y, 1992, PROTEIN ENG, V5, P775, DOI 10.1093/protein/5.8.775; KIM YS, 1992, BIOCHEMISTRY-US, V31, P3294, DOI 10.1021/bi00127a035; Kitaoka Y, 1998, EUR J BIOCHEM, V257, P255, DOI 10.1046/j.1432-1327.1998.2570255.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Maddaloni M, 2004, J IMMUNOL, V172, P6221, DOI 10.4049/jimmunol.172.10.6221; MONTFORT W, 1987, J BIOL CHEM, V262, P5398; MORRIS KN, 1992, P NATL ACAD SCI USA, V89, P4869, DOI 10.1073/pnas.89.11.4869; Motto M, 2004, MINI-REV MED CHEM, V4, P493, DOI 10.2174/1389557043403873; OLSNES S, 1975, EUR J BIOCHEM, V60, P281, DOI 10.1111/j.1432-1033.1975.tb21001.x; Pace CN, 1996, FASEB J, V10, P75, DOI 10.1096/fasebj.10.1.8566551; Pace CN, 1995, METHOD ENZYMOL, V259, P538; Pan YP, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000878; READY MP, 1991, PROTEINS, V10, P270, DOI 10.1002/prot.340100311; Rose GD, 2006, P NATL ACAD SCI USA, V103, P16623, DOI 10.1073/pnas.0606843103; RUTENBER E, 1991, PROTEINS, V10, P240, DOI 10.1002/prot.340100308; Stirpe F, 2006, CELL MOL LIFE SCI, V63, P1850, DOI 10.1007/s00018-006-6078-7; Sturm MB, 2009, ANAL CHEM, V81, P2847, DOI 10.1021/ac8026433; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang YZ, 2008, BIOCHEM BIOPH RES CO, V372, P902, DOI 10.1016/j.bbrc.2008.05.152; Zavodszky P, 1998, P NATL ACAD SCI USA, V95, P7406, DOI 10.1073/pnas.95.13.7406; Zolla-Pazner S, 2010, NAT REV IMMUNOL, V10, P527, DOI 10.1038/nri2801	32	31	33	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.196584	http://dx.doi.org/10.1074/jbc.M110.196584			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21303906	Green Published, hybrid			2022-12-27	WOS:000289077500032
J	Hachani, A; Lossi, NS; Hamilton, A; Jones, C; Bleves, S; Albesa-Jove, D; Filloux, A				Hachani, Abderrahman; Lossi, Nadine S.; Hamilton, Alexander; Jones, Cerith; Bleves, Sophie; Albesa-Jove, David; Filloux, Alain			Type VI Secretion System in Pseudomonas aeruginosa SECRETION AND MULTIMERIZATION OF VgrG PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFECTION; GENES; PREDICTION; STRAIN	Pseudomonas aeruginosa is a Gram-negative bacterium causing chronic infections in cystic fibrosis patients. Such infections are associated with an active type VI secretion system (T6SS), which consists of about 15 conserved components, including the AAA(+) ATPase, ClpV. The T6SS secretes two categories of proteins, VgrG and Hcp. Hcp is structurally similar to a phage tail tube component, whereas VgrG proteins show similarity to the puncturing device at the tip of the phage tube. In P. aeruginosa, three T6SSs are known. The expression of H1-T6SS genes is controlled by the RetS sensor. Here, 10 vgrG genes were identified in the PAO1 genome, among which three are co-regulated with H1-T6SS, namely vgrG1a/b/c. Whereas VgrG1a and VgrG1c were secreted in a ClpV1-dependent manner, secretion of VgrG1b was ClpV1-independent. We show that VgrG1a and VgrG1c form multimers, which confirmed the VgrG model predicting trimers similar to the tail spike. We demonstrate that Hcp1 secretion requires either VgrG1a or VgrG1c, which may act independently to puncture the bacterial envelope and give Hcp1 access to the surface. VgrG1b is not required for Hcp1 secretion. Thus, VgrG1b does not require H1-T6SS for secretion nor does H1-T6SS require VgrG1b for its function. Finally, we show that VgrG proteins are required for secretion of a genuine H1-T6SS substrate, Tse3. Our results demonstrate that VgrG proteins are not only secreted components but are essential for secretion of other T6SS substrates. Overall, we emphasize variability in behavior of three P. aeruginosa VgrGs, suggesting that, although very similar, distinct VgrGs achieve specific functions.	[Hachani, Abderrahman; Lossi, Nadine S.; Hamilton, Alexander; Jones, Cerith; Albesa-Jove, David; Filloux, Alain] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, Ctr Mol Microbiol & Infect, London SW7 2AZ, England; [Hamilton, Alexander] Univ Groningen, Univ Ctr Pharm, NL-9713 AV Groningen, Netherlands; [Bleves, Sophie] Aix Marseille Univ, CNRS, Lab Ingn Syst Macromol, F-13402 Marseille 20, France	Imperial College London; University of Groningen; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Filloux, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, Ctr Mol Microbiol & Infect, London SW7 2AZ, England.	a.filloux@imperial.ac.uk	Hachani, Abderrahman/AAV-3320-2020; Bleves, SOPHIE/HII-4948-2022; Jones, Cerith/AAH-5992-2020; Hachani, Abderrahman/H-1801-2013; Albesa-Jové, David/O-3822-2019; Albesa-Jové, David/F-5683-2016	Hachani, Abderrahman/0000-0001-8032-2154; Albesa-Jové, David/0000-0003-2904-8203; Albesa-Jové, David/0000-0003-2904-8203; Jones, Cerith/0000-0001-6275-0235	Network of Excellence [LSHB-CT-2005512061-EPG]; Wellcome Trust [WT091939]; Medical Research Council [G0800171/ID86344]; Royal Society; MRC [G0800171] Funding Source: UKRI; Medical Research Council [G0800171] Funding Source: researchfish	Network of Excellence; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by Network of Excellence Grant "EuroPathoGenomics" LSHB-CT-2005512061-EPG and by Wellcome Trust Grant WT091939.; Supported by Medical Research Council Grant G0800171/ID86344.; Supported by the Royal Society, Wellcome Trust Grant WT091939 and Medical Research Council Grant G0800171/ID86344.	Arisaka F, 2003, INT J BIOCHEM CELL B, V35, P16, DOI 10.1016/S1357-2725(02)00098-5; Ballister ER, 2008, P NATL ACAD SCI USA, V105, P3733, DOI 10.1073/pnas.0712247105; Barker JR, 2009, MOL MICROBIOL, V74, P1459, DOI 10.1111/j.1365-2958.2009.06947.x; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Bladergroen MR, 2003, MOL PLANT MICROBE IN, V16, P53, DOI 10.1094/MPMI.2003.16.1.53; Bleves S, 2010, INT J MED MICROBIOL, V300, P534, DOI 10.1016/j.ijmm.2010.08.005; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Durand E., 2009, Infectious Disorders - Drug Targets, V9, P518; Filloux A, 2008, MICROBIOL-SGM, V154, P1570, DOI 10.1099/mic.0.2008/016840-0; Galan JE, 2009, CELL HOST MICROBE, V5, P571, DOI 10.1016/j.chom.2009.04.008; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; Goodman AL, 2009, GENE DEV, V23, P249, DOI 10.1101/gad.1739009; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; LaBaer J, 2004, GENOME RES, V14, P2190, DOI 10.1101/gr.2482804; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Llosa M, 2009, MOL MICROBIOL, V73, P141, DOI 10.1111/j.1365-2958.2009.06751.x; Ma AT, 2009, CELL HOST MICROBE, V5, P234, DOI 10.1016/j.chom.2009.02.005; McGhie EJ, 2009, CURR OPIN MICROBIOL, V12, P117, DOI 10.1016/j.mib.2008.12.001; Merrell DS, 2004, NATURE, V430, P250, DOI 10.1038/nature02760; Mesyanzhinov VV, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1190, DOI 10.1007/s10541-005-0064-9; Parsot C, 2009, CURR OPIN MICROBIOL, V12, P110, DOI 10.1016/j.mib.2008.12.002; Pell LG, 2009, P NATL ACAD SCI USA, V106, P4160, DOI 10.1073/pnas.0900044106; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Suarez G, 2010, J BACTERIOL, V192, P155, DOI 10.1128/JB.01260-09; Vasseur P, 2005, MICROBIOL-SGM, V151, P985, DOI 10.1099/mic.0.27410-0; Ventre I, 2006, P NATL ACAD SCI USA, V103, P171, DOI 10.1073/pnas.0507407103; Vincent F, 2010, ENVIRON MICROBIOL, V12, P1775, DOI 10.1111/j.1462-2920.2010.02264.x; Voulhoux R, 2000, J BACTERIOL, V182, P4051, DOI 10.1128/JB.182.14.4051-4058.2000; Winsor GL, 2009, NUCLEIC ACIDS RES, V37, pD483, DOI 10.1093/nar/gkn861	39	109	113	3	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.193045	http://dx.doi.org/10.1074/jbc.M110.193045			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21325275	Green Published, hybrid			2022-12-27	WOS:000289077500046
J	Kellenberger, C; Leone, P; Coquet, L; Jouenne, T; Reichhart, JM; Roussel, A				Kellenberger, Christine; Leone, Philippe; Coquet, Laurent; Jouenne, Thierry; Reichhart, Jean-Marc; Roussel, Alain			Structure-Function Analysis of Grass Clip Serine Protease Involved in Drosophila Toll Pathway Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROPHENOLOXIDASE ACTIVATION; CRYSTAL-STRUCTURE; TERNARY COMPLEX; CASCADE; INSECT; DOMAIN; PEPTIDOGLYCAN; PROTEINASE-2; SPECIFICITY; TRYPSINOGEN	Grass is a clip domain serine protease (SP) involved in a proteolytic cascade triggering the Toll pathway activation of Drosophila during an immune response. Epistasic studies position it downstream of the apical protease ModSP and upstream of the terminal protease Spaetzle-processing enzyme. Here, we report the crystal structure of Grass zymogen. We found that Grass displays a rather deep active site cleft comparable with that of proteases of coagulation and complement cascades. A key distinctive feature is the presence of an additional loop (75-loop) in the proximity of the activation site localized on a protruding loop. All biochemical attempts to hydrolyze the activation site of Grass failed, strongly suggesting restricted access to this region. The 75-loop is thus proposed to constitute an original mechanism to prevent spontaneous activation. A comparison of Grass with clip serine proteases of known function involved in analogous proteolytic cascades allowed us to define two groups, according to the presence of the 75-loop and the conformation of the clip domain. One group (devoid of the 75-loop) contains penultimate proteases whereas the other contains terminal proteases. Using this classification, Grass appears to be a terminal protease. This result is evaluated according to the genetic data documenting Grass function.	[Kellenberger, Christine; Roussel, Alain] Architecture & Fonct Macromol Biol UMR6098, F-13288 Marseille 09, France; [Leone, Philippe] Ctr Immunol Marseille Luminy, F-13288 Marseille 09, France; [Coquet, Laurent; Jouenne, Thierry] Fac Sci Rouen, Plateforme Prote IFRMP23, F-76821 Mont St Aignan, France; [Reichhart, Jean-Marc] Inst Biol Mol & Cellulaire, UPR 9022, F-67084 Strasbourg, France	UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Kellenberger, C (corresponding author), Architecture & Fonct Macromol Biol UMR6098, Parc Sci & Technol Luminy,Case 932,Ave Luminy, F-13288 Marseille 09, France.	Christine.Kellenberger@afmb.univ-mrs.fr	kellenberger, christine/AAV-9304-2020	jouenne, thierry/0000-0003-0994-9944; COQUET, Laurent/0000-0001-7778-7321	Centre National de la Recherche Scientifique; Agence Nationale de la Recherche	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by an Action Thematique et Incitative sur Programme of the Centre National de la Recherche Scientifique 2005-2009 (to A. R.) and by a grant from the Agence Nationale de la Recherche (to A. R. and J.-M. R.).	An CJ, 2009, J BIOL CHEM, V284, P19716, DOI 10.1074/jbc.M109.007112; BODE W, 1978, J MOL BIOL, V118, P99, DOI 10.1016/0022-2836(78)90246-2; BRICOGNE G, 1993, ACTA CRYSTALLOGR D, V49, P37, DOI 10.1107/S0907444992010400; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buchon N, 2009, P NATL ACAD SCI USA, V106, P12442, DOI 10.1073/pnas.0901924106; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Dissing M, 2001, EMBO J, V20, P2387, DOI 10.1093/emboj/20.10.2387; Dobo J, 2009, J IMMUNOL, V183, P1207, DOI 10.4049/jimmunol.0901141; El Chamy L, 2008, NAT IMMUNOL, V9, P1165, DOI 10.1038/ni.1643; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gorman MJ, 2007, J BIOL CHEM, V282, P11742, DOI 10.1074/jbc.M611243200; Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046; Han JF, 2000, P NATL ACAD SCI USA, V97, P9093, DOI 10.1073/pnas.97.16.9093; Huang RD, 2007, BIOCHEMISTRY-US, V46, P11431, DOI 10.1021/bi7010724; Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013; Jiang HB, 2000, INSECT BIOCHEM MOLEC, V30, P95, DOI 10.1016/S0965-1748(99)00113-7; Kambris Z, 2006, CURR BIOL, V16, P808, DOI 10.1016/j.cub.2006.03.020; Kan H, 2008, J BIOL CHEM, V283, P25316, DOI 10.1074/jbc.M804364200; KATSUMI Y, 1995, EUR J BIOCHEM, V228, P870, DOI 10.1111/j.1432-1033.1995.tb20334.x; Kim CH, 2008, J BIOL CHEM, V283, P7599, DOI 10.1074/jbc.M710216200; Kim MS, 2002, J BIOL CHEM, V277, P39999, DOI 10.1074/jbc.M205508200; Krem MM, 2002, TRENDS BIOCHEM SCI, V27, P67, DOI 10.1016/S0968-0004(01)02007-2; LeMosy EK, 1999, TRENDS CELL BIOL, V9, P102, DOI 10.1016/S0962-8924(98)01494-9; Leone P, 2008, ACTA CRYSTALLOGR D, V64, P1165, DOI 10.1107/S0907444908030400; Leone P, 2008, MOL IMMUNOL, V45, P2521, DOI 10.1016/j.molimm.2008.01.015; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li W, 2004, NAT STRUCT MOL BIOL, V11, P857, DOI 10.1038/nsmb811; Ligoxygakis P, 2002, SCIENCE, V297, P114, DOI 10.1126/science.1072391; Mishima Y, 2009, J BIOL CHEM, V284, P28687, DOI 10.1074/jbc.M109.034587; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Pasternak A, 2001, PROTEIN SCI, V10, P1331, DOI 10.1110/ps.44101; Piao S, 2005, EMBO J, V24, P4404, DOI 10.1038/sj.emboj.7600891; Piao SF, 2007, J BIOL CHEM, V282, P10783, DOI 10.1074/jbc.M611556200; Rezaie AR, 2005, THROMB HAEMOSTASIS, V93, P1047, DOI 10.1160/TH04-11-0730; Roussel A, 1991, SILICON GRAPHICS GEO, P86; Wang Y, 2008, INSECT BIOCHEM MOLEC, V38, P763, DOI 10.1016/j.ibmb.2008.04.008; Wang Y, 2007, INSECT BIOCHEM MOLEC, V37, P1015, DOI 10.1016/j.ibmb.2007.05.013	39	25	28	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.182741	http://dx.doi.org/10.1074/jbc.M110.182741			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21310954	Green Published, hybrid			2022-12-27	WOS:000289077500044
J	Holscher, M; Silter, M; Krull, S; von Ahlen, M; Hesse, A; Schwartz, P; Wielockx, B; Breier, G; Katschinski, DM; Zieseniss, A				Hoelscher, Marion; Silter, Monique; Krull, Sabine; von Ahlen, Melanie; Hesse, Amke; Schwartz, Peter; Wielockx, Ben; Breier, Georg; Katschinski, Doerthe M.; Zieseniss, Anke			Cardiomyocyte-specific Prolyl-4-hydroxylase Domain 2 Knock Out Protects from Acute Myocardial Ischemic Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE-FACTOR; PROLYL 4-HYDROXYLASES; REPERFUSION INJURY; HIF-ALPHA; FACTOR-I; HEART; HYDROXYLATION; PHD2; HYDROXYPROLINE; HYPERTROPHY	Prolylhydroxylase domain proteins (PHD) are cellular oxygen- sensing molecules that regulate the stability of the alpha-subunit of the transcription factor hypoxia inducible factor (HIF)-1. HIF-1 affects cardiac development as well as adaptation of the heart toward increased pressure overload or myocardial infarction. We have disrupted PHD2 in cardiomyocytes (cPhd(-/-)) using Phd2(flox/flox) mice in combination with MLCvCre mice, which resulted in HIF-1 alpha stabilization and activation of HIF target genes in the heart. Although cPhd2(-/-) mice showed no gross abnormalities in cardiac filament structure or function, we observed a significant increased cardiac capillary area in those mice. cPhd2(-/-) mice did not respond differently to increased mechanical load by transverse aortic constriction compared with their wild-type (wt) littermates. After ligation of the left anterior descending artery, however, the area at risk and area of necrosis were significantly smaller in the cPhd2(-/-) mice compared with Phd2 wt mice in line with the described pivotal role of HIF-1 alpha for tissue protection in case of myocardial infarction. This correlated with a decreased number of apoptotic cells in the infarcted myocardium in the cPhd2(-/-) mice and significantly improved cardiac function 3 weeks after myocardial infarction.	[Hoelscher, Marion; Silter, Monique; Krull, Sabine; von Ahlen, Melanie; Hesse, Amke; Katschinski, Doerthe M.; Zieseniss, Anke] Univ Gottingen, Dept Cardiovasc Physiol, Univ Med Gottingen, D-37073 Gottingen, Germany; [Schwartz, Peter] Univ Gottingen, Dept Anat & Embryol, Univ Med Gottingen, D-37073 Gottingen, Germany; [Wielockx, Ben; Breier, Georg] Tech Univ Dresden, Dept Pathol, D-01307 Dresden, Germany	University of Gottingen; University of Gottingen; Technische Universitat Dresden	Katschinski, DM (corresponding author), Univ Gottingen, Dept Cardiovasc Physiol, Univ Med Gottingen, Humboldtallee 23, D-37073 Gottingen, Germany.	katschinski@physiol.med.uni-goettingen.de	Wielockx, Ben/AAC-6854-2020; Breier, Georg/E-3580-2016	Wielockx, Ben/0000-0002-4923-2596; Breier, Georg/0000-0002-9467-780X	Kroner Fresenius Stiftung [P25/10//A12/10]; Deutsche Forschungsgemeinschaft [Ka1269/11-1, Br 1336/2-3, SFB 655 A8, Wi 3291/1-1]	Kroner Fresenius Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Kroner Fresenius Stiftung Grant P25/10//A12/10 (to A.Z.) and Deutsche Forschungsgemeinschaft Grants Ka1269/11-1 (to D.M.K.), Br 1336/2-3 and SFB 655 A8 (to G.B.), and Wi 3291/1-1 (to B.W.). The work was performed as collaborative project within the COST Action TD0901 "HypoxiaNet."	Adluri R. S., 2010, ANTIOXID RE IN PRESS; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Bekeredjian R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011693; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bohl S, 2009, AM J PHYSIOL-HEART C, V297, pH2054, DOI 10.1152/ajpheart.00836.2009; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Eckle T, 2008, CIRCULATION, V118, P166, DOI 10.1161/CIRCULATIONAHA.107.758516; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Huang M, 2008, CIRCULATION, V118, pS226, DOI 10.1161/CIRCULATIONAHA.107.760785; Huang Y, 2004, FASEB J, V18, P1138, DOI 10.1096/fj.04-1510fje; Hyvarinen J, 2010, J BIOL CHEM, V285, P13646, DOI 10.1074/jbc.M109.084855; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Katschinski DM, 2009, ACTA PHYSIOL, V195, P407, DOI 10.1111/j.1748-1716.2008.01952.x; Kido M, 2005, J AM COLL CARDIOL, V46, P2116, DOI 10.1016/j.jacc.2005.08.045; Krishnan J, 2008, CIRC RES, V103, P1139, DOI 10.1161/01.RES.0000338613.89841.c1; Krishnan J, 2009, CELL METAB, V9, P512, DOI 10.1016/j.cmet.2009.05.005; Lieb ME, 2002, BIOCHEM CELL BIOL, V80, P421, DOI 10.1139/O02-115; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Minamisawa S, 1999, J BIOL CHEM, V274, P10066, DOI 10.1074/jbc.274.15.10066; Minamishima YA, 2008, BLOOD, V111, P3236, DOI 10.1182/blood-2007-10-117812; Moslehi J, 2010, CIRCULATION, V122, P1004, DOI 10.1161/CIRCULATIONAHA.109.922427; Myllyharju J, 2009, CURR PHARM DESIGN, V15, P3878, DOI 10.2174/138161209789649457; Palazzuoli A, 2010, VASC HEALTH RISK MAN, V6, P411; Percy MJ, 2007, BLOOD, V110, P2193, DOI 10.1182/blood-2007-04-084434; Schofield CJ, 2005, BIOCHEM BIOPH RES CO, V338, P617, DOI 10.1016/j.bbrc.2005.08.111; Semenza GL, 2007, J BIOENERG BIOMEMBR, V39, P231, DOI 10.1007/s10863-007-9081-2; Silter M, 2010, PFLUG ARCH EUR J PHY, V459, P569, DOI 10.1007/s00424-009-0748-x; Stiehl DP, 2006, J BIOL CHEM, V281, P23482, DOI 10.1074/jbc.M601719200; Takeda K, 2008, BLOOD, V111, P3229, DOI 10.1182/blood-2007-09-114561; Takeda K, 2007, CIRCULATION, V116, P774, DOI 10.1161/CIRCULATIONAHA.107.701516; Takeda K, 2006, MOL CELL BIOL, V26, P8336, DOI 10.1128/MCB.00425-06; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Yan L, 2010, EXPERT OPIN THER PAT, V20, P1219, DOI 10.1517/13543776.2010.510836; Zhang YM, 2000, NAT BIOTECHNOL, V18, P1314, DOI 10.1038/82449; Zieseniss A, 2007, CELL TISSUE RES, V327, P583, DOI 10.1007/s00441-006-0322-1	41	63	67	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11185	11194		10.1074/jbc.M110.186809	http://dx.doi.org/10.1074/jbc.M110.186809			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21270129	Green Published, hybrid			2022-12-27	WOS:000288797100029
J	Ideo, H; Matsuzaka, T; Nonaka, T; Seko, A; Yamashita, K				Ideo, Hiroko; Matsuzaka, Tsutomu; Nonaka, Takamasa; Seko, Akira; Yamashita, Katsuko			Galectin-8-N-domain Recognition Mechanism for Sialylated and Sulfated Glycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL CARBOHYDRATE-RECOGNITION; RAY CRYSTAL-STRUCTURE; BINDING; GALECTINS; PROTEIN; LECTIN; DOMAIN; SPECIFICITY; REFINEMENT; MODULATOR	Galectin-8 has much higher affinity for 3'-O-sulfated or 3'-O-sialylated glycoconjugates and a Lewis X-containing glycan than for oligosaccharides terminating in Gal beta 1 -> 33/4GlcNAc, and this specificity is mainly attributed to the N-terminal carbohydrate recognition domain (N-domain, CRD) (Ideo, H., Seko, A., Ishizuka, I., and Yamashita, K. (2003) Glycobiology 13, 713-723). In this study, we elucidated the crystal structures of the human galectin-8-N-domain (-8N) in the absence or presence of 4 ligands. The apo molecule forms a dimer, which is different from the canonical 2-fold symmetric dimer observed for galectin- 1 and -2. In a galectin-8N-lactose complex, the lactose-recognizing amino acids are highly conserved among the galectins. However, Arg(45), Gln(47), Arg(59), and the long loop region between the S3 and S4 beta-strands are unique to galectin-8N. These amino acids directly or indirectly interact with the sulfate or sialic acid moieties of 3'-sialyl-and 3'-sulfolactose complexed with galectin- 8N. Furthermore, in the LNF-III-galectin-8N complex, van der Waals interactions occur between the alpha 1-3-branched fucose and galactose and between galactose and Tyr(141), and these interactions increase the affinity toward galectin-8N. Based on the findings of these x-ray crystallographic analyses, a mutagenesis study using surface plasmon resonance showed that Arg(45), Gln(47), and Arg(59) of galectin-8N are indispensable and coordinately contribute to the strong binding of galectins-8N to sialylated and sulfated oligosaccharides. Arg(59) is the most critical amino acid for binding in the S3-S4 loop region.	[Matsuzaka, Tsutomu; Nonaka, Takamasa] Iwate Med Univ, Sch Pharm, Yahaba, Iwate 0283694, Japan; [Ideo, Hiroko; Seko, Akira; Yamashita, Katsuko] Tokyo Inst Technol, Innovat Res Initiat, Yokohama, Kanagawa 2268503, Japan	Iwate Medical University; Tokyo Institute of Technology	Nonaka, T (corresponding author), 2-1-1 Nishitokuta, Yahaba, Iwate 0283694, Japan.	tnonaka@iwate-med.ac.jp; kyamashi@bio.titech.ac.jp			New Energy and Industrial Technology Development Organization (NEDO) in Japan	New Energy and Industrial Technology Development Organization (NEDO) in Japan(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported in part by the New Energy and Industrial Technology Development Organization (NEDO) in Japan.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Arbel-Goren R, 2005, J BIOL CHEM, V280, P19105, DOI 10.1074/jbc.M502060200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARONDES SH, 1994, J BIOL CHEM, V269, P20807; BRENNAN MJ, 1991, J BIOL CHEM, V266, P18827; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Carcamo C, 2006, EXP CELL RES, V312, P374, DOI 10.1016/j.yexcr.2005.10.025; Cooper DNW, 1999, GLYCOBIOLOGY, V9, P979, DOI 10.1093/glycob/9.10.979; DeLano W.L, PYMOL MOL GRAPHICS S; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Hadari YR, 1997, TRENDS GLYCOSCI GLYC, V9, P103, DOI 10.4052/tigg.9.103; HADARI YR, 1995, J BIOL CHEM, V270, P3447, DOI 10.1074/jbc.270.7.3447; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; HIRABAYASHI J, 1994, GLYCOCONJUGATE J, V11, P437, DOI 10.1007/BF00731280; Honke K, 2001, J BIOL CHEM, V276, P267, DOI 10.1074/jbc.M005666200; Ideo H, 2003, GLYCOBIOLOGY, V13, P713, DOI 10.1093/glycob/cwg094; Ideo H, 2002, GLYCOBIOLOGY, V12, P199, DOI 10.1093/glycob/12.3.199; Ideo H, 2007, J BIOL CHEM, V282, P21081, DOI 10.1074/jbc.M703770200; Ishizuka I, 1997, PROG LIPID RES, V36, P245, DOI 10.1016/S0163-7827(97)00011-8; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Leonidas DD, 1998, BIOCHEMISTRY-US, V37, P13930, DOI 10.1021/bi981056x; Levy Y, 2001, J BIOL CHEM, V276, P31285, DOI 10.1074/jbc.M100340200; LIAO DI, 1994, P NATL ACAD SCI USA, V91, P1428, DOI 10.1073/pnas.91.4.1428; LOBSANOV YD, 1993, J BIOL CHEM, V268, P27034; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagae M, 2006, J BIOL CHEM, V281, P35884, DOI 10.1074/jbc.M606648200; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Seetharaman J, 1998, J BIOL CHEM, V273, P13047, DOI 10.1074/jbc.273.21.13047; Seko A, 2005, GLYCOBIOLOGY, V15, P943, DOI 10.1093/glycob/cwi082; Seko A, 2002, JPN J CANCER RES, V93, P507, DOI 10.1111/j.1349-7006.2002.tb01285.x; Stowell SR, 2008, J BIOL CHEM, V283, P20547, DOI 10.1074/jbc.M802495200; Suzuki T, 1996, BIOCHEM J, V318, P389, DOI 10.1042/bj3180389; Swaminathan GJ, 1999, BIOCHEMISTRY-US, V38, P13837, DOI 10.1021/bi990756e; Teneberg S, 1997, J BIOL CHEM, V272, P19067, DOI 10.1074/jbc.272.30.19067; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vonrhein C., 2006, MACROMOLECULAR CRYST, V2, P215; Warren L, 1976, BIOL ROLES SIALIC AC, P103; Zick Y, 2002, GLYCOCONJUGATE J, V19, P517, DOI 10.1023/B:GLYC.0000014081.55445.af	41	91	93	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11346	11355		10.1074/jbc.M110.195925	http://dx.doi.org/10.1074/jbc.M110.195925			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21288902	hybrid, Green Published			2022-12-27	WOS:000288797100047
J	Park, JH; Smith, RJ; Shieh, SY; Roeder, RG				Park, Jeong Hyeon; Smith, Rebecca J.; Shieh, Sheau-Yann; Roeder, Robert G.			The GAS41-PP2C beta Complex Dephosphorylates p53 at Serine 366 and Regulates Its Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASES; DNA-DAMAGE; PHOSPHORYLATION; TRANSCRIPTION; DEGRADATION; CHROMATIN; PATHWAY; 2C; INHIBITION; APOPTOSIS	The p53 tumor suppressor is principally regulated by post-translational modifications and proteasome-dependent degradation. Various kinases have been shown to phosphorylate p53, but little is known about the counteracting phosphatases. We demonstrate here that the newly identified complex GAS41-PP2C beta, and not PP2C beta alone, is specifically required for dephosphorylation of serine 366 on p53. Ectopic expression of GAS41 and PP2C beta reduces UV radiation-induced p53 up-regulation, thereby increasing the cell survival upon genotoxic DNA damage. To our knowledge, the GAS41-PP2C beta complex is the first example in which substrate specificity of a PP2C family member is controlled by an associated regulatory subunit. Because GAS41 is frequently amplified in human gliomas, our finding illustrates a novel oncogenic mechanism of GAS41 by p53 dephosphorylation.	[Park, Jeong Hyeon; Smith, Rebecca J.] Massey Univ, Inst Mol Biosci, Palmerston North 4442, New Zealand; [Shieh, Sheau-Yann] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Roeder, Robert G.] Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10065 USA	Massey University; Academia Sinica - Taiwan; Rockefeller University	Park, JH (corresponding author), Massey Univ, Inst Mol Biosci, Palmerston North 4442, New Zealand.	J.Park@massey.ac.nz	Shieh, Sheau-Yann/N-9512-2018	Shieh, Sheau-Yann/0000-0002-5351-4430; Park, Jeong Hyeon/0000-0003-2294-6342; SMITH, REBECCA/0000-0002-1658-5635	National Institutes of Health [CA129325]; Massey University; NATIONAL CANCER INSTITUTE [R01CA129325] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massey University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA129325 (to R. G. R.) and by a Massey University Research Fund grant (to J. H. P.).	Bech-Otschir D, 2001, EMBO J, V20, P1630, DOI 10.1093/emboj/20.7.1630; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Chehab NH, 1999, P NATL ACAD SCI USA, V96, P13777, DOI 10.1073/pnas.96.24.13777; Doyon Y, 2004, MOL CELL BIOL, V24, P1884, DOI 10.1128/MCB.24.5.1884-1896.2004; Fischer U, 1997, HUM MOL GENET, V6, P1817, DOI 10.1093/hmg/6.11.1817; Hanada M, 2001, J BIOL CHEM, V276, P5753, DOI 10.1074/jbc.M007773200; Jin JY, 2005, J BIOL CHEM, V280, P41207, DOI 10.1074/jbc.M509128200; Katayama H, 2004, NAT GENET, V36, P55, DOI 10.1038/ng1279; Klumpp S, 2006, BIOCHEM SOC T, V34, P1370, DOI 10.1042/BST0341370; Klumpp S, 2003, NEUROCHEM INT, V42, P555, DOI 10.1016/S0197-0186(02)00174-2; Lammers T, 2007, CRIT REV BIOCHEM MOL, V42, P437, DOI 10.1080/10409230701693342; Le Guezennec X, 2010, TRENDS BIOCHEM SCI, V35, P109, DOI 10.1016/j.tibs.2009.09.005; Li HH, 2004, MOL CELL, V13, P867, DOI 10.1016/S1097-2765(04)00123-6; Llanos S, 2006, CELL CYCLE, V5, P1880, DOI 10.4161/cc.5.16.3140; Lotem J, 2004, P NATL ACAD SCI USA, V101, P16022, DOI 10.1073/pnas.0406966101; Moorhead GBG, 2007, NAT REV MOL CELL BIO, V8, P234, DOI 10.1038/nrm2126; Olsson A, 2007, CELL DEATH DIFFER, V14, P1561, DOI 10.1038/sj.cdd.4402196; Ou YH, 2005, MOL BIOL CELL, V16, P1684, DOI 10.1091/mbc.E04-08-0689; Park J, 2002, MOL CELL BIOL, V22, P1307, DOI 10.1128/MCB.22.5.1307-1316.2002; Park JH, 2006, MOL CELL BIOL, V26, P4006, DOI 10.1128/MCB.02185-05; Poyurovsky MV, 2006, GENE DEV, V20, P125, DOI 10.1101/gad.1397506; Prajapati S, 2004, J BIOL CHEM, V279, P1739, DOI 10.1074/jbc.M306273200; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Schulze JM, 2009, BIOCHEM CELL BIOL, V87, P65, DOI 10.1139/O08-111; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Sun WJ, 2009, CELL SIGNAL, V21, P95, DOI 10.1016/j.cellsig.2008.09.012; Tamura S, 2006, CANCER SCI, V97, P563, DOI 10.1111/j.1349-7006.2006.00219.x; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Xia YF, 2009, P NATL ACAD SCI USA, V106, P2629, DOI 10.1073/pnas.0812256106; Zeisig DT, 2005, ONCOGENE, V24, P5525, DOI 10.1038/sj.onc.1208699	32	22	23	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					10911	10917		10.1074/jbc.C110.210211	http://dx.doi.org/10.1074/jbc.C110.210211			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21317290	Green Published, hybrid			2022-12-27	WOS:000288797100003
J	Pontarin, G; Ferraro, P; Rampazzo, C; Kollberg, G; Holme, E; Reichard, P; Bianchi, V				Pontarin, Giovanna; Ferraro, Paola; Rampazzo, Chiara; Kollberg, Gittan; Holme, Elisabeth; Reichard, Peter; Bianchi, Vera			Deoxyribonucleotide Metabolism in Cycling and Resting Human Fibroblasts with a Missense Mutation in p53R2, a Subunit of Ribonucleotide Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL-DNA DEPLETION; NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY; THYMIDINE KINASE; RENAL-FAILURE; CANCER CELLS; DNTP POOLS; IN-VITRO; DAMAGE; GENE; REPAIR	Ribonucleotide reduction provides deoxynucleotides for nuclear and mitochondrial (mt) DNA replication and DNA repair. In cycling mammalian cells the reaction is catalyzed by two proteins, R1 and R2. A third protein, p53R2, with the same function as R2, occurs in minute amounts. In quiescent cells, p53R2 replaces the absent R2. In humans, genetic inactivation of p53R2 causes early death with mtDNA depletion, especially in muscle. We found that cycling fibroblasts from a patient with a lethal mutation in p53R2 contained a normal amount of mtDNA and showed normal growth, ribonucleotide reduction, and deoxynucleoside triphosphate (dNTP) pools. However, when made quiescent by prolonged serum starvation the mutant cells strongly down-regulated ribonucleotide reduction, decreased their dCTP and dGTP pools, and virtually abolished the catabolism of dCTP in substrate cycles. mtDNA was not affected. Also, nuclear DNA synthesis and the cell cycle-regulated enzymes R2 and thymidine kinase 1 decreased strongly, but the mutant cell populations retained unexpectedly larger amounts of the two enzymes than the controls. This difference was probably due to their slightly larger fraction of S phase cells and therefore not induced by the absence of p53R2 activity. We conclude that loss of p53R2 affects ribonucleotide reduction only in resting cells and leads to a decrease of dNTP catabolism by substrate cycles that counterweigh the loss of anabolic activity. We speculate that this compensatory mechanism suffices to maintain mtDNA in fibroblasts but not in muscle cells with a larger content of mtDNA necessary for their high energy requirements.	[Pontarin, Giovanna; Ferraro, Paola; Rampazzo, Chiara; Reichard, Peter; Bianchi, Vera] Univ Padua, Dept Biol, I-35131 Padua, Italy; [Kollberg, Gittan; Holme, Elisabeth] Sahlgrens Univ Hosp, Dept Clin Chem, SE-41345 Gothenburg, Sweden	University of Padua; Sahlgrenska University Hospital	Bianchi, V (corresponding author), Univ Padua, Dept Biol, I-35131 Padua, Italy.	vbianchi@bio.unipd.it			Italian Telethon [GGP09019]; Italian Association for Cancer Research [1091]; Fondazione Cariparo; University of Padova	Italian Telethon(Fondazione Telethon); Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Fondazione Cariparo(Fondazione Cariparo); University of Padova	This work was supported by Italian Telethon Grant GGP09019, Italian Association for Cancer Research Grant 1091, the Fondazione Cariparo, and the University of Padova Strategic Projects 2008 (to V. B.).	Acham-Roschitz B, 2009, MOL GENET METAB, V98, P300, DOI 10.1016/j.ymgme.2009.06.012; Andreu AL, 2009, MITOCHONDRION, V9, P242, DOI 10.1016/j.mito.2009.02.006; Bianchi V, 2003, J BIOL CHEM, V278, P46195, DOI 10.1074/jbc.R300032200; BJORKLUND S, 1990, BIOCHEMISTRY-US, V29, P5452; Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006; Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040; Chabes AL, 2004, J BIOL CHEM, V279, P10796, DOI 10.1074/jbc.M312482200; Chabes AL, 2003, P NATL ACAD SCI USA, V100, P3925, DOI 10.1073/pnas.0330774100; Chen YL, 2010, J BIOL CHEM, V285, P27327, DOI 10.1074/jbc.M110.137042; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Devlin HL, 2008, MOL CANCER RES, V6, P808, DOI 10.1158/1541-7786.MCR-07-2027; Evans DR, 2004, J BIOL CHEM, V279, P33035, DOI 10.1074/jbc.R400007200; Ferraro P, 2005, J BIOL CHEM, V280, P24472, DOI 10.1074/jbc.M502869200; Ferraro P, 2006, P NATL ACAD SCI USA, V103, P18586, DOI 10.1073/pnas.0609020103; Ferraro P, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1141; Gallinaro L, 2002, J BIOL CHEM, V277, P35080, DOI 10.1074/jbc.M203755200; Gazziola C, 2001, J BIOL CHEM, V276, P6185, DOI 10.1074/jbc.M007623200; Guittet O, 2001, J BIOL CHEM, V276, P40647, DOI 10.1074/jbc.M106088200; Hakansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200; Hofer A, 1998, J BIOL CHEM, V273, P34098, DOI 10.1074/jbc.273.51.34098; Hu CM, 2007, J BIOMED SCI, V14, P491, DOI 10.1007/s11373-007-9175-1; Kimura T, 2003, NAT GENET, V34, P440, DOI 10.1038/ng1212; Kollberg G, 2009, NEUROMUSCULAR DISORD, V19, P147, DOI 10.1016/j.nmd.2008.11.014; KOSHLAND DE, 1984, TRENDS BIOCHEM SCI, V9, P155, DOI 10.1016/0968-0004(84)90125-7; KUNZ BA, 1994, MUTAT RES-REV GENET, V318, P1, DOI 10.1016/0165-1110(94)90006-X; Lin ZP, 2007, BIOCHEM PHARMACOL, V73, P760, DOI 10.1016/j.bcp.2006.11.014; Lin ZP, 2004, J BIOL CHEM, V279, P27030, DOI 10.1074/jbc.M402056200; Nakano K, 2000, ONCOGENE, V19, P4283, DOI 10.1038/sj.onc.1203774; Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pontarin G, 2007, J BIOL CHEM, V282, P16820, DOI 10.1074/jbc.M701310200; Pontarin G, 2006, J BIOL CHEM, V281, P22720, DOI 10.1074/jbc.M604498200; Powell DR, 2005, PEDIATR NEPHROL, V20, P432, DOI 10.1007/s00467-004-1696-5; Rampazzo C, 2007, J BIOL CHEM, V282, P34758, DOI 10.1074/jbc.M705923200; Rampazzo C, 2010, MUTAT RES-GEN TOX EN, V703, P2, DOI 10.1016/j.mrgentox.2010.06.002; REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025; Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139; SHERMAN PA, 1989, ANAL BIOCHEM, V180, P222, DOI 10.1016/0003-2697(89)90420-X; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; Tsai MH, 2006, ONCOGENE, V25, P622, DOI 10.1038/sj.onc.1209082; Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009	42	26	26	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11132	11140		10.1074/jbc.M110.202283	http://dx.doi.org/10.1074/jbc.M110.202283			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21297166	Green Published, hybrid			2022-12-27	WOS:000288797100024
J	Pullen, L; Bolon, DN				Pullen, Lester; Bolon, Daniel N.			Enforced N-domain Proximity Stimulates Hsp90 ATPase Activity and Is Compatible with Function in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI HSP90; HEAT-SHOCK-PROTEIN; CRYSTAL-STRUCTURE; STEROID-RECEPTOR; MOLECULAR CLAMP; CHAPERONE; HYDROLYSIS; CYCLE; NUCLEOTIDE; BINDING	Hsp90 populates distinct open and closed conformations mediated by transient N-terminal dimerization. To investigate the mechanistic role of these large conformational changes, we designed Hsp90 with an N-terminal coiled-coil to clamp the termini together and enforce N-domain proximity. Biophysical analyses demonstrate that the coiled-coil effectively maintains N-domain proximity in the absence of ATP, a condition that favors the open state of Hsp90. Enforcing N-domain proximity results in increased ATPase activity, indicating that N-terminal dimerization is a rate-limiting step that is sped-up with the coiled-coil due to increased effective N-domain concentration. The relative difference in ATPase activity between coil-Hsp90 and wt was reduced in the presence of both an ATPase activating (Aha1) and an inhibiting (Sba1) co-chaperone. As both of these co-chaperones bind preferentially to N-terminally dimerized Hsp90, the buffering effect of these co-chaperones demonstrates the biochemical relevance of Hsp90 conformational properties in addition to N-terminal dimerization. Enforcing N-domain proximity is compatible with viability in yeast, underlining the mechanistic relevance of Hsp90 conformational changes that are less dramatic than the transition between fully open and closed.	[Pullen, Lester; Bolon, Daniel N.] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Bolon, DN (corresponding author), 364 Plantat St,UMMS LRB 922, Worcester, MA 01605 USA.	Dan.Bolon@umassmed.edu		Bolon, Daniel/0000-0001-5857-6676	National Institutes of Health [R01-GM083038-01A]; American Cancer Society [RSG-08-17301-GMC]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083038] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM083038-01A and by American Cancer Society Grant RSG-08-17301-GMC.	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; Cunningham CN, 2008, J BIOL CHEM, V283, P21170, DOI 10.1074/jbc.M800046200; Havranek JJ, 2003, NAT STRUCT BIOL, V10, P45, DOI 10.1038/nsb877; Hessling M, 2009, NAT STRUCT MOL BIOL, V16, P287, DOI 10.1038/nsmb.1565; Krukenberg KA, 2008, STRUCTURE, V16, P755, DOI 10.1016/j.str.2008.01.021; MARQUSEE S, 1989, P NATL ACAD SCI USA, V86, P5286, DOI 10.1073/pnas.86.14.5286; McLaughlin SH, 2006, J MOL BIOL, V356, P746, DOI 10.1016/j.jmb.2005.11.085; McLaughlin SH, 2004, J MOL BIOL, V344, P813, DOI 10.1016/j.jmb.2004.09.055; McLaughlin SH, 2002, J MOL BIOL, V315, P787, DOI 10.1006/jmbi.2001.5245; Meyer P, 2004, EMBO J, V23, P511, DOI 10.1038/sj.emboj.7600060; Mickler M, 2009, NAT STRUCT MOL BIOL, V16, P281, DOI 10.1038/nsmb.1557; NATHAN DF, 1995, MOL CELL BIOL, V15, P3917; NORBY JG, 1988, METHOD ENZYMOL, V156, P116; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Pearl LH, 2002, ADV PROTEIN CHEM, V59, P157; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Prodromou C, 1997, NAT STRUCT BIOL, V4, P477, DOI 10.1038/nsb0697-477; Retzlaff M, 2010, MOL CELL, V37, P344, DOI 10.1016/j.molcel.2010.01.006; Richter K, 2004, J MOL BIOL, V342, P1403, DOI 10.1016/j.jmb.2004.07.064; Richter K, 2002, J BIOL CHEM, V277, P44905, DOI 10.1074/jbc.M208457200; Richter K, 2001, J BIOL CHEM, V276, P33689, DOI 10.1074/jbc.M103832200; Shiau AK, 2006, CELL, V127, P329, DOI 10.1016/j.cell.2006.09.027; Southworth DR, 2008, MOL CELL, V32, P631, DOI 10.1016/j.molcel.2008.10.024; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; SVERGUN DI, 1991, J APPL CRYSTALLOGR, V24, P485, DOI 10.1107/S0021889891001280; Taldone T, 2009, BIOORGAN MED CHEM, V17, P2225, DOI 10.1016/j.bmc.2008.10.087; Wayne N, 2010, J BIOL CHEM, V285, P234, DOI 10.1074/jbc.M109.060129; Weikl T, 2000, J MOL BIOL, V303, P583, DOI 10.1006/jmbi.2000.4157; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716	33	28	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11091	11098		10.1074/jbc.M111.223131	http://dx.doi.org/10.1074/jbc.M111.223131			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21278257	Green Published, hybrid			2022-12-27	WOS:000288797100020
J	Stoll, KE; Brzovic, PS; Davis, TN; Klevit, RE				Stoll, Kate E.; Brzovic, Peter S.; Davis, Trisha N.; Klevit, Rachel E.			The Essential Ubc4/Ubc5 Function in Yeast Is HECT E3-dependent, and RING E3-dependent Pathways Require Only Monoubiquitin Transfer by Ubc4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-CONJUGATING ENZYMES; PROTEIN LIGASE; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; E2 ENZYMES; IN-VITRO; COMPLEX; MECHANISMS; DETERMINANTS; DEGRADATION	The ubiquitin (Ub)-conjugating enzymes Ubc4 and Ubc5 are involved in a variety of ubiquitination pathways in yeast, including Rsp5- and anaphase-promoting complex (APC)-mediated pathways. We have found the double deletion of UBC4 and UBC5 genes in yeast to be lethal. To investigate the essential pathway disrupted by the ubc4/ubc5 deletion, several point mutations were inserted in Ubc4. The Ubc4 active site mutation C86A and the E3-binding mutations A97D and F63A were both unable to rescue the lethal phenotype, indicating that an active E3/E2 similar to Ub complex is required for the essential function of Ubc4/Ubc5. A mutation that specifically eliminates RING E3-catalyzed isopeptide formation but not HECT E3 transthiolation (N78S-Ubc4) rescued the lethal phenotype. Thus, the essential redundant function performed by Ubc4 and Ubc5 in yeast is with a HECT-type E3, likely the only essential HECT in yeast, Rsp5. Our results also suggest that Ubc1 can weakly replace Ubc4 to transfer mono-Ub with APC, but Ubc4 cannot replace Ubc1 for poly-Ub chain extension on APC substrates. Finally, the backside Ub-binding mutant S23R-Ubc4 has no observable effect in yeast. Together, our results are consistent with a model in which Ubc4 and Ubc5 are 1) the primary E2s for Rsp5 in yeast and 2) act as monoubiquitinating E2s in RING E3-catalyzed pathways, in contrast to the processive human ortholog UbcH5.	[Stoll, Kate E.; Brzovic, Peter S.; Davis, Trisha N.; Klevit, Rachel E.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Stoll, Kate E.; Klevit, Rachel E.] Univ Washington, Biomol Struct & Design Program, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Klevit, RE (corresponding author), Univ Washington, Dept Biochem, POB 357350, Seattle, WA 98195 USA.	klevit@uw.edu	Davis, Trisha/F-8584-2010; Klevit, Rachel/AAI-7038-2021	Klevit, Rachel/0000-0002-3476-969X; Davis, Trisha/0000-0003-4797-3152	National Institutes of Health [R01 GM088055]; NIGMS [T32 GM008268]; National Science Foundation [MCB0615632]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008268, R01GM088055] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM088055 (to R.E.K.) and Molecular Biophysics Training Grant T32 GM008268 from NIGMS (to K.E.S.). This work was also supported by National Science Foundation Grant MCB0615632 (to R.E.K.).	Brzovic PS, 2003, P NATL ACAD SCI USA, V100, P5646, DOI 10.1073/pnas.0836054100; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; COOK WJ, 1993, BIOCHEMISTRY-US, V32, P13809, DOI 10.1021/bi00213a009; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gwizdek C, 2005, J BIOL CHEM, V280, P13401, DOI 10.1074/jbc.C500040200; Heiligenstein S, 2006, EMBO J, V25, P4717, DOI 10.1038/sj.emboj.7601350; HEIN C, 1995, MOL MICROBIOL, V18, P77, DOI 10.1111/j.1365-2958.1995.mmi_18010077.x; Hwang GW, 2008, LIFE SCI, V82, P1182, DOI 10.1016/j.lfs.2008.04.002; Kim HC, 2009, MOL CELL BIOL, V29, P3307, DOI 10.1128/MCB.00240-09; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Kus BM, 2004, PROTEINS, V54, P455, DOI 10.1002/prot.10620; Michelle C, 2009, J MOL EVOL, V68, P616, DOI 10.1007/s00239-009-9225-6; Mulder KW, 2007, GENETICS, V176, P181, DOI 10.1534/genetics.106.060640; Nuber U, 1999, J BIOL CHEM, V274, P7576, DOI 10.1074/jbc.274.11.7576; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; Panasenko OO, 2009, GENETICS, V181, P447, DOI 10.1534/genetics.108.095422; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Sakata E, 2010, STRUCTURE, V18, P138, DOI 10.1016/j.str.2009.11.007; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; Williams C, 2008, BIOCHEM BIOPH RES CO, V374, P620, DOI 10.1016/j.bbrc.2008.07.054; Wu PY, 2003, EMBO J, V22, P5241, DOI 10.1093/emboj/cdg501; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	27	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15165	15170		10.1074/jbc.M110.203968	http://dx.doi.org/10.1074/jbc.M110.203968			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21357418	hybrid, Green Published			2022-12-27	WOS:000289788300048
J	Choi, DH; Kim, YJ; Kim, YG; Joh, TH; Beal, MF; Kim, YS				Choi, Dong-Hee; Kim, Youn-Jung; Kim, Young-Gun; Joh, Tong H.; Beal, M. Flint; Kim, Yoon-Seong			Role of Matrix Metalloproteinase 3-mediated alpha-Synuclein Cleavage in Dopaminergic Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL PARKINSONS-DISEASE; TRANSGENIC MICE; LEWY BODIES; IN-VITRO; PATHOLOGICAL FORMS; SUBSTANTIA-NIGRA; AGGREGATION; DEMENTIA; MUTATION; MODEL	Evidence suggests that the C-terminal truncation of alpha-synuclein is equally important as aggregation of alpha-synuclein in Parkinson disease (PD). Our previous results showed that an endopeptidase, matrix metalloproteinase-3 (MMP3), was induced and activated in dopaminergic (DA) cells upon stress conditions. Here, we report that MMP3 cleaved alpha-synuclein in vitro and in vivo and that alpha-synuclein and MMP3 were co-localized in Lewy bodies (LB) in the postmortem brains of PD patients. Incubation of alpha-synuclein with the catalytic domain of MMP3 (cMMP3) resulted in generation of several peptides, and the peptide profiles of WT alpha-synuclein (WTsyn) and A53T mutant (A53Tsyn) were different. Combined analysis using mass spectrometry and N-terminal determination revealed that MMP3 generated C-terminally truncated peptides of amino acids 1-78, 1-91, and 1-93 and that A53Tsyn produced significantly higher quantities of these peptides. Similar sizes of peptides were detected in N27 DA cells under oxidative stress and RNA interference to knock down MMP3-attenuated peptide generation. Co-overexpression of cMMP3 with either WTsyn or A53Tsyn led to a reduction in Triton X-100-insoluble aggregates and an increase in protofibril-like small aggregates. In addition, overexpression of the 1-93-amino acid peptide in the substantia nigra led to DA neuronal loss without LB-like aggregate formation. The results strongly indicate that MMP3 digestion of alpha-synuclein in DA neurons plays a pivotal role in the progression of PD through modulation of alpha-synuclein in aggregation, LB formation, and neurotoxicity.	[Choi, Dong-Hee; Kim, Young-Gun; Joh, Tong H.; Beal, M. Flint; Kim, Yoon-Seong] Cornell Univ, Weill Med Coll, Neurol Neurosci Dept, New York, NY 10065 USA; [Choi, Dong-Hee] Konkuk Univ, Ctr Geriatr Neurosci Res, Inst Biomed Sci & Technol, Seoul 143701, South Korea; [Kim, Youn-Jung; Kim, Yoon-Seong] Kyung Hee Univ, Coll Nursing Sci, Seoul 130701, South Korea; [Kim, Yoon-Seong] Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, Orlando, FL 32827 USA	Cornell University; Konkuk University; Kyung Hee University; State University System of Florida; University of Central Florida	Kim, YS (corresponding author), 6900 Lake Nona Blvd, Orlando, FL 32827 USA.	yskim@mail.ucf.edu		Kim, Young-Gun/0000-0002-8982-5230	Michael J. Fox Foundation Community; Korean Government [KRF-E00081]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062827] Funding Source: NIH RePORTER	Michael J. Fox Foundation Community; Korean Government(Korean Government); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Michael J. Fox Foundation Community Fast Track 2005 and National Research Foundation of Korea Grant KRF-E00081 funded by the Korean Government.	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Baba M, 1998, AM J PATHOL, V152, P879; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Bjorklund A, 2000, BRAIN RES, V886, P82, DOI 10.1016/S0006-8993(00)02915-2; Campbell BCV, 2001, J NEUROCHEM, V76, P87, DOI 10.1046/j.1471-4159.2001.00021.x; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Choi DH, 2008, J NEUROCHEM, V106, P405, DOI 10.1111/j.1471-4159.2008.05399.x; CHOI DH, 2011, ANTIOXID REDOX SIGNA; Chung CY, 2009, J NEUROSCI, V29, P3365, DOI 10.1523/JNEUROSCI.5427-08.2009; da Costa CA, 2006, J BIOL CHEM, V281, P9824, DOI 10.1074/jbc.M513903200; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Ding TT, 2002, BIOCHEMISTRY-US, V41, P10209, DOI 10.1021/bi020139h; Eguchi T, 2008, MOL CELL BIOL, V28, P2391, DOI 10.1128/MCB.01288-07; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Flex A, 2006, J GERONTOL A-BIOL, V61, P1065, DOI 10.1093/gerona/61.10.1065; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Guo SZ, 2006, BRAIN RES, V1111, P222, DOI 10.1016/j.brainres.2006.06.041; Hsu LJ, 2000, AM J PATHOL, V157, P401, DOI 10.1016/S0002-9440(10)64553-1; Iwata A, 2003, HUM MOL GENET, V12, P2625, DOI 10.1093/hmg/ddg283; Kasai T, 2008, NEUROSCI LETT, V436, P52, DOI 10.1016/j.neulet.2008.02.057; Kim YS, 2007, FASEB J, V21, P179, DOI 10.1096/fj.06-5865com; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kwan JA, 2004, FASEB J, V18, P690, DOI 10.1096/fj.02-1202fje; Lee HJ, 2002, J BIOL CHEM, V277, P5411, DOI 10.1074/jbc.M105326200; Lee HJ, 2002, J BIOL CHEM, V277, P48976, DOI 10.1074/jbc.M208192200; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Levin J, 2009, EXP NEUROL, V215, P201, DOI 10.1016/j.expneurol.2008.10.010; Li WX, 2005, P NATL ACAD SCI USA, V102, P2162, DOI 10.1073/pnas.0406976102; Lindersson E, 2004, J BIOL CHEM, V279, P12924, DOI 10.1074/jbc.M306390200; Liu CW, 2005, J BIOL CHEM, V280, P22670, DOI 10.1074/jbc.M501508200; Lorenzl S, 2002, EXP NEUROL, V178, P13, DOI 10.1006/exnr.2002.8019; Mandel RJ, 2004, CURR OPIN MOL THER, V6, P482; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Michell AW, 2007, CELL TRANSPLANT, V16, P461, DOI 10.3727/000000007783464911; Mishizen-Eberz AJ, 2003, J NEUROCHEM, V86, P836, DOI 10.1046/j.1471-4159.2003.01878.x; O'Carroll SJ, 2000, BIOTECHNIQUES, V28, P408, DOI 10.2144/00283bm03; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Song DD, 2004, EXP NEUROL, V186, P158, DOI 10.1016/S0014-4886(03)00342-X; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; St Martin JL, 2007, J NEUROCHEM, V100, P1449, DOI 10.1111/j.1471-4159.2006.04310.x; Sung JY, 2005, J BIOL CHEM, V280, P25216, DOI 10.1074/jbc.M503341200; Thomas B, 2007, HUM MOL GENET, V16, pR183, DOI 10.1093/hmg/ddm159; Wakamatsu M, 2008, NEUROBIOL AGING, V29, P574, DOI 10.1016/j.neurobiolaging.2006.11.017; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	46	80	82	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14168	14177		10.1074/jbc.M111.222430	http://dx.doi.org/10.1074/jbc.M111.222430			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21330369	Green Published, hybrid			2022-12-27	WOS:000289556200040
J	Gehret, JJ; Gu, LC; Gerwick, WH; Wipf, P; Sherman, DH; Smith, JL				Gehret, Jennifer J.; Gu, Liangcai; Gerwick, William H.; Wipf, Peter; Sherman, David H.; Smith, Janet L.			Terminal Alkene Formation by the Thioesterase of Curacin A Biosynthesis STRUCTURE OF A DECARBOXYLATING THIOESTERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; NATURAL-PRODUCT; POLYKETIDE; DOMAIN; MACROLACTONIZATION; SURFACTIN; INSIGHTS; CLUSTER; PHENIX	Curacin A is a polyketide synthase (PKS)-non-ribosomal peptide synthetase-derived natural product with potent anticancer properties generated by the marine cyanobacterium Lyngbya majuscula. Type I modular PKS assembly lines typically employ a thioesterase (TE) domain to off-load carboxylic acid or macrolactone products from an adjacent acyl carrier protein (ACP) domain. In a striking departure from this scheme the curacin A PKS employs tandem sulfotransferase and TE domains to form a terminal alkene moiety. Sulfotransferase sulfonation of beta-hydroxy-acyl-ACP is followed by TE hydrolysis, decarboxylation, and sulfate elimination (Gu, L., Wang, B., Kulkarni, A., Gehret, J. J., Lloyd, K. R., Gerwick, L., Gerwick, W. H., Wipf, P., Hakansson, K., Smith, J. L., and Sherman, D. H. (2009) J. Am. Chem. Soc. 131, 16033-16035). With low sequence identity to other PKS TEs (< 15%), the curacin TE represents a new thioesterase subfamily. The 1.7-angstrom curacin TE crystal structure reveals how the familiar alpha/beta-hydrolase architecture is adapted to specificity for beta-sulfated substrates. A Ser-His-Glu catalytic triad is centered in an open active site cleft between the core domain and a lid subdomain. Unlike TEs from other PKSs, the lid is fixed in an open conformation on one side by dimer contacts of a protruding helix and on the other side by an arginine anchor from the lid into the core. Adjacent to the catalytic triad, another arginine residue is positioned to recognize the substrate beta-sulfate group. The essential features of the curacin TE are conserved in sequences of five other putative bacterial ACP-ST-TE tridomains. Formation of a sulfate leaving group as a biosynthetic strategy to facilitate acyl chain decarboxylation is of potential value as a route to hydrocarbon biofuels.	[Smith, Janet L.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Gu, Liangcai; Sherman, David H.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Gehret, Jennifer J.; Gu, Liangcai; Sherman, David H.; Smith, Janet L.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Gerwick, William H.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Wipf, Peter] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California San Diego; Scripps Institution of Oceanography; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Smith, JL (corresponding author), Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA.	JanetSmith@umich.edu	Gu, Liangcai/E-4600-2010; Wipf, Peter/AAG-1771-2021; Gu, Liangcai/U-6908-2019	Wipf, Peter/0000-0001-7693-5863; 	National Institutes of Health [R01 DK42303, R01 CA108874, U01 TW007404]; National Institutes of Health, National Institute of General Medical Sciences [Y1-GM-1104]; National Cancer Institute through United States Department of Energy [Y1-CO-1020]; FOGARTY INTERNATIONAL CENTER [U01TW007404] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA108874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076477] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute through United States Department of Energy; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK42303 (to J.L.S.), R01 CA108874 (to D.H.S., W.H.G., and P. W.), and U01 TW007404, and a Hans W. Vahlteich Professorship (to D.H.S.).; We thank Drs. Amol Kulkarni and Sarang Kulkarni for the synthesis of substrate analogs. Beamline 23ID-D is supported by the National Institutes of Health, National Institute of General Medical Sciences Grant Y1-GM-1104 and National Cancer Institute Grant Y1-CO-1020 through the GM/CA Collaborative Access Team at the APS, which is supported by the United States Department of Energy.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Akey DL, 2006, NAT CHEM BIOL, V2, P537, DOI 10.1038/nchembio824; Akey DL, 2010, STRUCTURE, V18, P94, DOI 10.1016/j.str.2009.10.018; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bruner SD, 2002, STRUCTURE, V10, P301, DOI 10.1016/S0969-2126(02)00716-5; Chang ZX, 2004, J NAT PROD, V67, P1356, DOI 10.1021/np0499261; Chapman E, 2004, ANGEW CHEM INT EDIT, V43, P3526, DOI 10.1002/anie.200300631; Claxton HB, 2009, J BIOL CHEM, V284, P5021, DOI 10.1074/jbc.M808604200; DeLano W.L, PYMOL MOL GRAPHICS S; DelProposto J, 2009, PROTEIN EXPRES PURIF, V63, P40, DOI 10.1016/j.pep.2008.08.011; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fischetti RF, 2009, J SYNCHROTRON RADIAT, V16, P217, DOI 10.1107/S0909049508040612; Fortman JL, 2008, TRENDS BIOTECHNOL, V26, P375, DOI 10.1016/j.tibtech.2008.03.008; Frueh DP, 2008, NATURE, V454, P903, DOI 10.1038/nature07162; Geders TW, 2007, J BIOL CHEM, V282, P35954, DOI 10.1074/jbc.M703921200; GERWICK WH, 1994, J ORG CHEM, V59, P1243, DOI 10.1021/jo00085a006; Giraldes JW, 2006, NAT CHEM BIOL, V2, P531, DOI 10.1038/nchembio822; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gu LC, 2007, SCIENCE, V318, P970, DOI 10.1126/science.1148790; Gu LC, 2009, J AM CHEM SOC, V131, P16033, DOI 10.1021/ja9071578; Gu LC, 2009, NATURE, V459, P731, DOI 10.1038/nature07870; Koglin A, 2008, NATURE, V454, P907, DOI 10.1038/nature07161; Metzger P, 2005, APPL MICROBIOL BIOT, V66, P486, DOI 10.1007/s00253-004-1779-z; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Roongsawang N, 2007, CHEMBIOCHEM, V8, P501, DOI 10.1002/cbic.200600465; Samel SA, 2006, J MOL BIOL, V359, P876, DOI 10.1016/j.jmb.2006.03.062; Sanchez C, 2001, CHEM BIOL, V8, P725, DOI 10.1016/S1074-5521(01)00047-3; Scaglione JB, 2010, ANGEW CHEM INT EDIT, V49, P5726, DOI 10.1002/anie.201000032; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tsai SC, 2001, P NATL ACAD SCI USA, V98, P14808, DOI 10.1073/pnas.011399198; Verdier-Pinard P, 1998, MOL PHARMACOL, V53, P62, DOI 10.1124/mol.53.1.62; YOUNG TC, 1986, NEW J CHEM, V10, P701; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	42	52	61	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14445	14454		10.1074/jbc.M110.214635	http://dx.doi.org/10.1074/jbc.M110.214635			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21357626	hybrid, Green Published, Green Accepted			2022-12-27	WOS:000289556200066
J	Hickman, DT; Lopez-Deber, MP; Ndao, DM; Silva, AB; Nand, D; Pihlgren, M; Giriens, V; Madani, R; St-Pierre, A; Karastaneva, H; Nagel-Steger, L; Willbold, D; Riesner, D; Nicolau, C; Baldus, M; Pfeifer, A; Muhs, A				Hickman, David T.; Lopez-Deber, Maria Pilar; Ndao, Dorin Mlaki; Silva, Alberto B.; Nand, Deepak; Pihlgren, Maria; Giriens, Valerie; Madani, Rime; St-Pierre, Annie; Karastaneva, Hristina; Nagel-Steger, Luitgard; Willbold, Dieter; Riesner, Detlev; Nicolau, Claude; Baldus, Marc; Pfeifer, Andrea; Muhs, Andreas			Sequence-independent Control of Peptide Conformation in Liposomal Vaccines for Targeting Protein Misfolding Diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOFLAVINE-T INTERACTION; BETA-SHEET STRUCTURES; ALZHEIMERS-DISEASE; COMMON MECHANISM; IMMUNE-RESPONSE; AMYLOID FIBRILS; PRION PROTEIN; ANTIBODIES; OLIGOMERS; VACCINATION	Synthetic peptide immunogens that mimic the conformation of a target epitope of pathological relevance offer the possibility to precisely control the immune response specificity. Here, we performed conformational analyses using a panel of peptides in order to investigate the key parameters controlling their conformation upon integration into liposomal bilayers. These revealed that the peptide lipidation pattern, the lipid anchor chain length, and the liposome surface charge all significantly alter peptide conformation. Peptide aggregation could also be modulated post-liposome assembly by the addition of distinct small molecule beta-sheet breakers. Immunization of both mice and monkeys with a model liposomal vaccine containing beta-sheet aggregated lipopeptide (Palm1-15) induced polyclonal IgG antibodies that specifically recognized beta-sheet multimers over monomer or non-pathological native protein. The rational design of liposome-bound peptide immunogens with defined conformation opens up the possibility to generate vaccines against a range of protein misfolding diseases, such as Alzheimer disease.	[Hickman, David T.; Lopez-Deber, Maria Pilar; Ndao, Dorin Mlaki; Silva, Alberto B.; Pihlgren, Maria; Giriens, Valerie; Madani, Rime; St-Pierre, Annie; Pfeifer, Andrea; Muhs, Andreas] AC Immune SA, PSE B, EPFL, CH-1015 Lausanne, Switzerland; [Nand, Deepak; Baldus, Marc] Univ Utrecht, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; [Karastaneva, Hristina; Nagel-Steger, Luitgard; Willbold, Dieter; Riesner, Detlev] Univ Dusseldorf, Inst Phys Biol, D-40225 Dusseldorf, Germany; [Willbold, Dieter] Forschungszentrum Julich, Inst Strukturbiol & Biophys ISB 3, D-52425 Julich, Germany; [Nicolau, Claude] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02115 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Utrecht University; Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; Tufts University	Muhs, A (corresponding author), AC Immune SA, PSE B, EPFL, CH-1015 Lausanne, Switzerland.	andreas.muhs@acimmune.com	Silva, Alberto B/H-3630-2011; Baldus, Marc/C-2737-2009; Willbold, Dieter/A-6280-2013; Nagel-Steger, Luitgard/H-6415-2013	Baldus, Marc/0000-0001-7068-5613; Willbold, Dieter/0000-0002-0065-7366; Nagel-Steger, Luitgard/0000-0001-5232-2149	Netherlands Organization for Scientific Research [700.26.121]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	Solid-state NMR studies were supported by Netherlands Organization for Scientific Research Grant 700.26.121. D.R. is a member of the Board of Directors and Scientific Advisory Board of AC Immune SA.	Bokvist M, 2004, J MOL BIOL, V335, P1039, DOI 10.1016/j.jmb.2003.11.046; Bosco DA, 2006, NAT CHEM BIOL, V2, P249, DOI 10.1038/nchembio782; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; BURDICK D, 1992, J BIOL CHEM, V267, P546; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; FIESER TM, 1987, P NATL ACAD SCI USA, V84, P8568, DOI 10.1073/pnas.84.23.8568; Gao JJ, 2009, P NATL ACAD SCI USA, V106, P3071, DOI 10.1073/pnas.0812952106; Groenning Minna, 2010, J Chem Biol, V3, P1, DOI 10.1007/s12154-009-0027-5; Hock C, 2002, NAT MED, V8, P1270, DOI 10.1038/nm783; House E, 2009, J ALZHEIMERS DIS, V18, P811, DOI 10.3233/JAD-2009-1235; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Jha S, 2009, J MOL BIOL, V389, P907, DOI 10.1016/j.jmb.2009.04.077; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; Laczko I, 1998, BIOCHEM BIOPH RES CO, V249, P213, DOI 10.1006/bbrc.1998.9109; Lambert MP, 2001, J NEUROCHEM, V79, P595, DOI 10.1046/j.1471-4159.2001.00592.x; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; LEVINE H, 1995, AMYLOID, V2, P1, DOI 10.3109/13506129509031881; LIEBMAN HA, 1985, P NATL ACAD SCI USA, V82, P3879, DOI 10.1073/pnas.82.11.3879; Lowik DWPM, 2003, ORG BIOMOL CHEM, V1, P1827, DOI 10.1039/b303749e; Lu SM, 2002, J BIOL CHEM, V277, P23515, DOI 10.1074/jbc.M201981200; Maezawa I, 2008, J NEUROCHEM, V104, P457, DOI 10.1111/j.1471-4159.2007.04972.x; Maji SK, 2009, J BIOL CHEM, V284, P23580, DOI 10.1074/jbc.M109.038133; Meier M, 2008, J AM CHEM SOC, V130, P1017, DOI 10.1021/ja077231r; Misumi S, 2006, J IMMUNOL, V176, P463, DOI 10.4049/jimmunol.176.1.463; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Muhs A, 2007, P NATL ACAD SCI USA, V104, P9810, DOI 10.1073/pnas.0703137104; Nicolau C, 2002, P NATL ACAD SCI USA, V99, P2332, DOI 10.1073/pnas.022627199; Noguchi A, 2009, J BIOL CHEM, V284, P32895, DOI 10.1074/jbc.M109.000208; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; Paramithiotis E, 2003, NAT MED, V9, P893, DOI 10.1038/nm883; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Pimentel TAPF, 2009, CHEM BIOL DRUG DES, V73, P53, DOI 10.1111/j.1747-0285.2008.00746.x; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Sarell CJ, 2009, BIOCHEMISTRY-US, V48, P4388, DOI 10.1021/bi900254n; Schmechel A, 2003, J BIOL CHEM, V278, P35317, DOI 10.1074/jbc.M303547200; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Su HP, 2007, VIROLOGY, V368, P331, DOI 10.1016/j.virol.2007.06.042; TOSI PF, 1995, BIOCHEM BIOPH RES CO, V212, P494, DOI 10.1006/bbrc.1995.1997; Villard V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000645; Wang YJ, 2002, PROTEIN SCI, V11, P852, DOI 10.1110/ps.3180102; Weaver-Feldhaus JM, 2005, PROTEIN ENG DES SEL, V18, P527, DOI 10.1093/protein/gzi060; Yokoyama T, 2001, J BIOL CHEM, V276, P11265, DOI 10.1074/jbc.M008734200; Zhang QH, 2004, P NATL ACAD SCI USA, V101, P4752, DOI 10.1073/pnas.0400924101	49	59	64	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					13966	13976		10.1074/jbc.M110.186338	http://dx.doi.org/10.1074/jbc.M110.186338			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21343310	Green Published, hybrid			2022-12-27	WOS:000289556200019
J	Ogata, N; Shinoda, Y; Wettschureck, N; Offermanns, S; Takeda, S; Nakamura, K; Segre, GV; Chung, U; Kawaguchi, H				Ogata, Naoshi; Shinoda, Yusuke; Wettschureck, Nina; Offermanns, Stefan; Takeda, Shu; Nakamura, Kozo; Segre, Gino V.; Chung, Ung-il; Kawaguchi, Hiroshi			G alpha(q) Signal in Osteoblasts Is Inhibitory to the Osteoanabolic Action of Parathyroid Hormone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; G-PROTEINS; BONE; RECEPTOR; EXPRESSION; PTH; ACTIVATION; SELECTIVITY; REGULATOR; KNOCKOUT	This study examined the role of the G alpha(q) signal constituted by G alpha(q) and G alpha(11) (encoded by Gn alpha(q) and Gn alpha(11), respectively), a major intracellular pathway of parathyroid hormone (PTH), in the PTH osteoanabolic action by the gain- and loss-of-function analyses. Transgenic mice with osteoblast-specific overexpression of the constitutively active Gn alpha(q) gene under the control of 2.3-kb type I collagen alpha 1 chain (Col1a1) promoter exhibited osteopenia with decreased bone formation parameters and did not respond to the daily PTH treatment. We then established osteoblast-specific Gn alpha(q) and Gn alpha(11) double-knock-out (cDKO) mice by crossing the 2.3-kb Col1a1 promoter-Cre recombinase transgenic mice and those with Gn alpha(q) gene flanked with loxP and global ablation of Gn alpha(11) (Col1a1-Cre(+/-);Gn alpha(fl/fl)(q);Gna(11)(-/-)) and found that the cDKO and single knock-out litterrnates of Gn alpha(q) or Gn alpha(11) exhibited normal bone volume and turnover under physiological conditions. With a daily injection of PTH, however, the cDKO mice, but not the single knock-out mice, showed higher bone volume and turnover than the wild-type littermates. Cultures of primary osteoblasts derived from cDKO and wild-type littermates confirmed enhancement of the PTH osteoanabolic action by the G alpha(q) signal deficiency in a cell-autonomous mechanism, in association with the membrane translocation of protein kinase C delta. This enhancement was reproduced by oyerexpression of regulator of G protein signaling-2, a G alpha(q) signal inhibitor, in osteoblastic MC3T3-E1 cells. Hence, the G alpha(q) signal plays an inhibitory role in the PTH osteoanabolic action, suggesting that its suppression may lead to a novel treatment in combination with PTH against osteoporosis.	[Kawaguchi, Hiroshi] Univ Tokyo, Fac Med, Dept Sensory & Motor Syst Med, Tokyo 1138655, Japan; [Ogata, Naoshi] Univ Tokyo, Dept Bone & Cartilage Regenerat Med, Tokyo 1138655, Japan; [Chung, Ung-il] Univ Tokyo, Ctr Dis Biol & Integrat Med, Tokyo 1138655, Japan; [Wettschureck, Nina; Offermanns, Stefan] Max Planck Inst Heart & Lung Res, Dept Pharmacol, D-61231 Bad Nauheim, Germany; [Takeda, Shu] Keio Univ, Sch Med, Dept Endocrinol & Metab, Tokyo 1608582, Japan; [Segre, Gino V.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA	University of Tokyo; University of Tokyo; University of Tokyo; Max Planck Society; Keio University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Kawaguchi, H (corresponding author), Univ Tokyo, Fac Med, Dept Sensory & Motor Syst Med, 7-3-1 Bunkyo, Tokyo 1138655, Japan.	kawaguchi-ort@h.u-tokyo.ac.jp	takeda, shu/B-5195-2012; Wettschureck, Nina/L-3651-2017; Offermanns, Stefan/L-3313-2017	Wettschureck, Nina/0000-0001-6858-1460; Offermanns, Stefan/0000-0001-8676-6805	Japanese Ministry of Education,Culture, Sports, Science, and Technology [21390416, 22659267, 22390286]	Japanese Ministry of Education,Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-aid for Scientific Research 21390416, 22659267, and 22390286 from the Japanese Ministry of Education,Culture, Sports, Science, and Technology.	ABOUSAMRA AB, 1992, P NATL ACAD SCI USA, V89, P2732, DOI 10.1073/pnas.89.7.2732; Bellido T., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P358; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Bikle DD, 2002, J BONE MINER RES, V17, P1570, DOI 10.1359/jbmr.2002.17.9.1570; Calvi LM, 2001, J CLIN INVEST, V107, P277, DOI 10.1172/JCI11296; CANALIS E, 1989, J CLIN INVEST, V83, P60, DOI 10.1172/JCI113885; Chang WZ, 2004, J BIOL CHEM, V279, P42438, DOI 10.1074/jbc.M405549200; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Datta NS, 2009, CELL SIGNAL, V21, P1245, DOI 10.1016/j.cellsig.2009.02.012; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; Dromey Jasmin R., 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P51, DOI 10.2174/187153008783928352; Gudermann T, 1996, ANNU REV PHARMACOL, V36, P429; Hao JM, 2006, J MOL CELL CARDIOL, V41, P51, DOI 10.1016/j.yjmcc.2006.04.003; Hodsman AB, 2005, ENDOCR REV, V26, P688, DOI 10.1210/er.2004-0006; Ishizuya T, 1997, J CLIN INVEST, V99, P2961, DOI 10.1172/JCI119491; JUPPNER H, 1991, SCIENCE, V254, P1024, DOI 10.1126/science.1658941; Kawano T, 2008, ENDOCRINOLOGY, V149, P4009, DOI 10.1210/en.2008-0034; Keller H, 2005, BONE, V37, P148, DOI 10.1016/j.bone.2005.03.018; Knopp E, 2005, ENDOCRINOLOGY, V146, P1983, DOI 10.1210/en.2004-0770; Kronenberg HM, 2010, ANN NY ACAD SCI, V1192, P327, DOI 10.1111/j.1749-6632.2009.05251.x; Lampasso JD, 2006, INT J MOL MED, V17, P1125; McCudden CR, 2005, CELL MOL LIFE SCI, V62, P551, DOI 10.1007/s00018-004-4462-3; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Offermanns S, 1997, NATURE, V389, P183, DOI 10.1038/38284; Offermanns S, 1998, EMBO J, V17, P4304, DOI 10.1093/emboj/17.15.4304; Ogata N, 2007, J BIOL CHEM, V282, P35757, DOI 10.1074/jbc.M611902200; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Partridge NC, 2006, ANN NY ACAD SCI, V1068, P187, DOI 10.1196/annals.1346.024; Qiu T, 2010, NAT CELL BIOL, V12, P224, DOI 10.1038/ncb2022; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Sakamoto A, 2005, J BIOL CHEM, V280, P21369, DOI 10.1074/jbc.M500346200; Shinoda Y, 2010, J CELL BIOCHEM, V109, P755, DOI 10.1002/jcb.22454; Spiegel AM, 1997, HORM RES, V47, P89, DOI 10.1159/000185441; Swarthout JT, 2002, GENE, V282, P1, DOI 10.1016/S0378-1119(01)00798-3; Taboubi S, 2010, MOL BIOL CELL, V21, P946, DOI 10.1091/mbc.E09-06-0497; Takimoto E, 2009, J CLIN INVEST, V119, P408, DOI 10.1172/JCI35620; Umayahara Y, 1999, J BIOL CHEM, V274, P10609, DOI 10.1074/jbc.274.15.10609; Weinstein LS, 2001, ENDOCR REV, V22, P675, DOI 10.1210/er.22.5.675; Wettschureck N, 2004, PHARMACOL THERAPEUT, V101, P75, DOI 10.1016/j.pharmthera.2003.10.005; Wettschureck N, 2001, NAT MED, V7, P1236, DOI 10.1038/nm1101-1236; Wettschureck N, 2007, MOL ENDOCRINOL, V21, P274, DOI 10.1210/me.2006-0110; Yamada T, 2006, NAT MED, V12, P665, DOI 10.1038/nm1409; Yamaguchi M, 2005, ENDOCRINOLOGY, V146, P2620, DOI 10.1210/en.2004-1511; Zou MX, 2006, CELL SIGNAL, V18, P1655, DOI 10.1016/j.cellsig.2006.01.012	45	18	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13733	13740		10.1074/jbc.M110.200196	http://dx.doi.org/10.1074/jbc.M110.200196			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21345793	Green Published, hybrid			2022-12-27	WOS:000289282200091
J	Butler, JS; Zurita-Lopez, CI; Clarke, SG; Bedford, MT; Dent, SYR				Butler, Jill S.; Zurita-Lopez, Cecilia I.; Clarke, Steven G.; Bedford, Mark T.; Dent, Sharon Y. R.			Protein-arginine Methyltransferase 1 (PRMT1) Methylates Ash2L, a Shared Component of Mammalian Histone H3K4 Methyltransferase Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; N-METHYLTRANSFERASE; IN-VIVO; SYMMETRIC DIMETHYLARGININE; TRANSCRIPTIONAL REGULATION; SUBSTRATE-SPECIFICITY; CELL-PROLIFERATION; DNA METHYLATION; GENE EZH2; MLL	Multiple enzymes and enzymatic complexes coordinately regulate the addition and removal of post-translational modifications on histone proteins. The oncoprotein Ash2L is a component of the mixed lineage leukemia (MLL) family members 1-4, Setd1A, and Setd1B mammalian histone H3K4 methyltransferase complexes and is essential to maintain global trimethylation of histone H3K4. However, regulation of these complexes at the level of expression and activity remains poorly understood. In this report, we demonstrate that Ash2L is methylated on arginine residues both in vitro and in cells. We found that both protein-arginine methyltransferases 1 and 5 methylate Arg-296 within Ash2L. These findings are the first to demonstrate that post-translational modifications occur on the Ash2L protein and provide a novel example of cross-talk between chromatin-modifying enzyme complexes.	[Butler, Jill S.; Bedford, Mark T.; Dent, Sharon Y. R.] Univ Texas MD Anderson Canc Ctr Sci Pk, Virginia Harris Cockrell Canc Res Ctr, Dept Mol Carcinogenesis, Smithville, TX 78957 USA; [Butler, Jill S.; Bedford, Mark T.; Dent, Sharon Y. R.] Univ Texas MD Anderson Canc Ctr, Ctr Canc Epigenet, Houston, TX 77030 USA; [Butler, Jill S.; Dent, Sharon Y. R.] Univ Texas MD Anderson Canc Ctr, Program Genes & Dev, Houston, TX 77030 USA; [Zurita-Lopez, Cecilia I.; Clarke, Steven G.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California Los Angeles	Dent, SYR (corresponding author), Univ Texas MD Anderson Canc Ctr Sci Pk, Virginia Harris Cockrell Canc Res Ctr, Dept Mol Carcinogenesis, POB 389, Smithville, TX 78957 USA.	sroth@mdanderson.org	Bedford, Mark T/E-7856-2011; Zurita-Lopez, Cecilia I./AAC-6509-2020; Dent, Sharon YR/F-1746-2011	Dent, Sharon YR/0000-0002-4824-3269; Napierala, Jill/0000-0002-5141-0822	National Institutes of Health [T32 CA00929930, T32 CA929931A1, GM026020, F31 GM078761]; Cancer Prevention Research Institute of Texas; Welch Foundation; NATIONAL CANCER INSTITUTE [R21CA092993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026020, F31GM078761, R37GM026020] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas; Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Training Grants T32 CA00929930 and T32 CA929931A1 (to J. S. B.) and Grants GM026020 (to S. G. C.) and F31 GM078761 (to C. I. Z.-L.). This work was also supported by the Cancer Prevention Research Institute of Texas and the Welch Foundation (to S. Y. R. D.).	Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Branscombe TL, 2001, J BIOL CHEM, V276, P32971, DOI 10.1074/jbc.M105412200; Cheng DH, 2007, MOL CELL, V25, P71, DOI 10.1016/j.molcel.2006.11.019; Cheung N, 2007, NAT CELL BIOL, V9, P1208, DOI 10.1038/ncb1642; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Cote J, 2005, J BIOL CHEM, V280, P28476, DOI 10.1074/jbc.M414328200; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Fabbrizio E, 2002, EMBO REP, V3, P641, DOI 10.1093/embo-reports/kvf136; Faber J, 2009, BLOOD, V113, P2375, DOI 10.1182/blood-2007-09-113597; Fisk JC, 2010, EUKARYOT CELL, V9, P866, DOI 10.1128/EC.00018-10; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Gary JD, 1996, J BIOL CHEM, V271, P12585, DOI 10.1074/jbc.271.21.12585; Hanson RD, 1999, P NATL ACAD SCI USA, V96, P14372, DOI 10.1073/pnas.96.25.14372; HARLOW E, 1999, USING ANTIBODIES LAB, P77; Huang SM, 2005, GENE DEV, V19, P1885, DOI 10.1101/gad.1333905; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Ikegawa S, 1999, CYTOGENET CELL GENET, V84, P167, DOI 10.1159/000015248; Kennison JA, 1995, ANNU REV GENET, V29, P289, DOI 10.1146/annurev.ge.29.120195.001445; Krause CD, 2007, PHARMACOL THERAPEUT, V113, P50, DOI 10.1016/j.pharmthera.2006.06.007; Kumar AR, 2004, BLOOD, V103, P1823, DOI 10.1182/blood-2003-07-2582; Kwak YT, 2003, MOL CELL, V11, P1055, DOI 10.1016/S1097-2765(03)00101-1; Lakowski TM, 2009, BIOCHEM J, V421, P253, DOI 10.1042/BJ20090268; Lamonica JM, 2006, BLOOD, V108, P3736, DOI 10.1182/blood-2006-07-032847; Latham JA, 2007, NAT STRUCT MOL BIOL, V14, P1017, DOI 10.1038/nsmb1307; Lee J, 2002, EMBO REP, V3, P268, DOI 10.1093/embo-reports/kvf052; Lee JH, 2007, J BIOL CHEM, V282, P13419, DOI 10.1074/jbc.M609809200; Lee JH, 2005, J BIOL CHEM, V280, P3656, DOI 10.1074/jbc.M405295200; Lee JH, 2005, J BIOL CHEM, V280, P41725, DOI 10.1074/jbc.M508312200; Lee YH, 2009, MOL ENDOCRINOL, V23, P425, DOI 10.1210/me.2008-0380; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; LIU Q, 1995, MOL CELL BIOL, V15, P2800; Luscher-Firzlaff J, 2008, CANCER RES, V68, P749, DOI 10.1158/0008-5472.CAN-07-3158; Makishima H, 2010, LEUKEMIA, V24, P1799, DOI 10.1038/leu.2010.167; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Miranda TB, 2004, J BIOL CHEM, V279, P22902, DOI 10.1074/jbc.M312904200; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Nikoloski G, 2010, NAT GENET, V42, P665, DOI 10.1038/ng.620; Nishioka K, 2003, METHODS, V31, P49, DOI 10.1016/S1046-2023(03)00087-2; Patel A, 2009, J BIOL CHEM, V284, P24242, DOI 10.1074/jbc.M109.014498; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Pawlak MR, 2000, MOL CELL BIOL, V20, P4859, DOI 10.1128/MCB.20.13.4859-4869.2000; Rampalli S, 2007, NAT STRUCT MOL BIOL, V14, P1150, DOI 10.1038/nsmb1316; SHEARN A, 1971, P NATL ACAD SCI USA, V68, P2594, DOI 10.1073/pnas.68.10.2594; Southall SM, 2009, MOL CELL, V33, P181, DOI 10.1016/j.molcel.2008.12.029; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Stoller JZ, 2010, EXP BIOL MED, V235, P569, DOI 10.1258/ebm.2010.009318; Strahl BD, 2001, CURR BIOL, V11, P996, DOI 10.1016/S0960-9822(01)00294-9; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Swiercz R, 2007, J BIOL CHEM, V282, P16917, DOI 10.1074/jbc.M609778200; Tan CC, 2008, P NATL ACAD SCI USA, V105, P7472, DOI 10.1073/pnas.0711896105; Tan CP, 2006, MOL CELL BIOL, V26, P7224, DOI 10.1128/MCB.00473-06; Tang J, 1998, J BIOL CHEM, V273, P16935, DOI 10.1074/jbc.273.27.16935; Tang J, 2000, J BIOL CHEM, V275, P7723, DOI 10.1074/jbc.275.11.7723; THIRMAN MJ, 1993, NEW ENGL J MED, V329, P909, DOI 10.1056/NEJM199309233291302; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Wang JH, 2001, J MOL MED, V79, P399, DOI 10.1007/s001090100222; Wang L, 2008, MOL CELL BIOL, V28, P6262, DOI 10.1128/MCB.00923-08; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09; Wooderchak WL, 2008, BIOCHEMISTRY-US, V47, P9456, DOI 10.1021/bi800984s; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Yu BD, 1998, P NATL ACAD SCI USA, V95, P10632, DOI 10.1073/pnas.95.18.10632; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; Yu ZB, 2009, MOL CELL BIOL, V29, P2982, DOI 10.1128/MCB.00042-09; Zeisig BB, 2004, MOL CELL BIOL, V24, P617, DOI 10.1128/MCB.24.2.617-628.2004; Zhao Q, 2009, NAT STRUCT MOL BIOL, V16, P304, DOI 10.1038/nsmb.1568; ZIEMINVANDERPOEL S, 1991, P NATL ACAD SCI USA, V88, P10735, DOI 10.1073/pnas.88.23.10735	68	24	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.202416	http://dx.doi.org/10.1074/jbc.M110.202416			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21285357	hybrid, Green Published			2022-12-27	WOS:000289077500038
J	Delgado-Olguin, P; Brand-Arzamendi, K; Scott, IC; Jungblut, B; Stainier, DY; Bruneau, BG; Recillas-Targa, F				Delgado-Olguin, Paul; Brand-Arzamendi, Koroboshka; Scott, Ian C.; Jungblut, Benno; Stainier, Didier Y.; Bruneau, Benoit G.; Recillas-Targa, Felix			CTCF Promotes Muscle Differentiation by Modulating the Activity of Myogenic Regulatory Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SARCOGLYCAN PROMOTER; DNA-BINDING; ZEBRAFISH GASTRULATION; EXTENSION MOVEMENTS; SKELETAL MYOGENESIS; GENE-EXPRESSION; DISTINCT ROLES; PROTEIN CTCF; HUMAN GENOME; MYOD	CTCF nuclear factor regulates many aspects of gene expression, largely as a transcriptional repressor or via insulator function. Its roles in cellular differentiation are not clear. Here we show an unexpected role for CTCF in myogenesis. Ctcf is expressed in myogenic structures during mouse and zebrafish development. Gain-and loss-of-function approaches in C2C12 cells revealed CTCF as a modulator of myogenesis by regulating muscle-specific gene expression. We addressed the functional connection between CTCF and myogenic regulatory factors (MRFs). CTCF enhances the myogenic potential of MyoD and myogenin and establishes direct interactions with MyoD, indicating that CTCF regulates MRF-mediated muscle differentiation. Indeed, CTCF modulates functional interactions between MyoD and myogenin in co-activation of muscle-specific gene expression and facilitates MyoD recruitment to a muscle-specific promoter. Finally, ctcf loss-of-function experiments in zebrafish embryos revealed a critical role of CTCF in myogenic development and linked CTCF to broader aspects of development via regulation of Wnt signaling. We conclude that CTCF modulates MRF functional interactions in the orchestration of myogenesis.	[Delgado-Olguin, Paul; Bruneau, Benoit G.] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Brand-Arzamendi, Koroboshka; Stainier, Didier Y.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Stainier, Didier Y.; Bruneau, Benoit G.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Delgado-Olguin, Paul; Recillas-Targa, Felix] Univ Nacl Autonoma Mexico, Dept Mol Genet, Inst Fisiol Celular, Mexico City 04510, DF, Mexico; [Bruneau, Benoit G.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Brand-Arzamendi, Koroboshka; Scott, Ian C.] Univ Toronto, Hosp Sick Children, Dept Mol & Med Genet, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Brand-Arzamendi, Koroboshka; Jungblut, Benno] Max Planck Inst Heart & Lung Res, D-61231 Bad Nauheim, Germany	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Universidad Nacional Autonoma de Mexico; University of California System; University of California San Francisco; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Max Planck Society	Bruneau, BG (corresponding author), Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, 1650 Owens St, San Francisco, CA 94158 USA.	bbruneau@gladstone.ucsf.edu; frecilla@ifc.unam.mx	Olguin, Paul Delgado/H-9293-2019	Olguin, Paul Delgado/0000-0002-5355-247X; Stainier, Didier/0000-0002-0382-0026; Bruneau, Benoit/0000-0002-0804-7597; Scott, Ian/0000-0001-6665-1410	National Institutes of Health [HL54737]; Direccion General de Asuntos del Personal Academico; Universidad Nacional Autonoma de Mexico [IX230104, IN209403, IN214407]; Consejo Nacional de Ciencia y Tecnologia [42653-Q, 58767]; Third World Academy of Sciences [01-055 RG/BIO/LA]; J. David Gladstone Institutes; California Institute of Regenerative Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054737] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direccion General de Asuntos del Personal Academico; Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Third World Academy of Sciences; J. David Gladstone Institutes(University of California System); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL54737 (to D. Y. S.). This work was also supported by Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico Grants IX230104, IN209403, and IN214407; Consejo Nacional de Ciencia y Tecnologia Grants 42653-Q and 58767; and Third World Academy of Sciences Grant 01-055 RG/BIO/LA (to F.R.-T.); and the J. David Gladstone Institutes (to B. G. B.).; Supported by the California Institute of Regenerative Medicine.	Anakwe K, 2003, DEVELOPMENT, V130, P3503, DOI 10.1242/dev.00538; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Bergstrom DA, 2002, MOL CELL, V9, P587, DOI 10.1016/S1097-2765(02)00481-1; BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; Borello U, 2006, DEVELOPMENT, V133, P3723, DOI 10.1242/dev.02517; Bruneau BG, 2001, MOL CELL BIOL, V21, P1730, DOI 10.1128/MCB.21.5.1730-1736.2001; Cao Y, 2006, EMBO J, V25, P502, DOI 10.1038/sj.emboj.7600958; Chao W, 2002, SCIENCE, V295, P345, DOI 10.1126/science.1065982; Cossu G, 1999, EMBO J, V18, P6867, DOI 10.1093/emboj/18.24.6867; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DAVIS RL, 1990, CELL, V60, P733, DOI 10.1016/0092-8674(90)90088-V; Delgado MD, 1999, FEBS LETT, V444, P5, DOI 10.1016/S0014-5793(99)00013-7; Delgado-Olguin P, 2004, BIOCHEM BIOPH RES CO, V319, P1032, DOI 10.1016/j.bbrc.2004.05.074; Delgado-Olguin P, 2008, BBA-GENE REGUL MECH, V1779, P74, DOI 10.1016/j.bbagrm.2007.09.002; Delgado-Olguin P, 2006, BBA-GENE STRUCT EXPR, V1759, P240, DOI 10.1016/j.bbaexp.2006.04.007; Dilworth FJ, 2004, P NATL ACAD SCI USA, V101, P11593, DOI 10.1073/pnas.0404192101; Donohoe ME, 2007, MOL CELL, V25, P43, DOI 10.1016/j.molcel.2006.11.017; Donohoe ME, 2009, NATURE, V460, P128, DOI 10.1038/nature08098; Fedoriw AM, 2004, SCIENCE, V303, P238, DOI 10.1126/science.1090934; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Geetha-Loganathan P, 2005, DEV BIOL, V288, P221, DOI 10.1016/j.ydbio.2005.09.035; Gros J, 2009, NATURE, V457, P589, DOI 10.1038/nature07564; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Heidt AB, 2007, MOL CELL BIOL, V27, P5910, DOI 10.1128/MCB.01700-06; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Kim CH, 2008, MOL CELL BIOL, V28, P2941, DOI 10.1128/MCB.01682-07; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; KLENOVA EM, 1993, MOL CELL BIOL, V13, P7612, DOI 10.1128/MCB.13.12.7612; LASSAR AB, 1991, CELL, V66, P305, DOI 10.1016/0092-8674(91)90620-E; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Mal A, 2003, P NATL ACAD SCI USA, V100, P1735, DOI 10.1073/pnas.0437843100; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; OTT MO, 1991, DEVELOPMENT, V111, P1097; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Parker MH, 2003, NAT REV GENET, V4, P497, DOI 10.1038/nrg1109; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Pugacheva EM, 2006, GENE, V375, P26, DOI 10.1016/j.gene.2006.01.036; Puri PL, 2000, J CELL PHYSIOL, V185, P155, DOI 10.1002/1097-4652(200011)185:2<155::AID-JCP1>3.0.CO;2-Z; Puri PL, 1997, MOL CELL, V1, P35, DOI 10.1016/S1097-2765(00)80005-2; Recillas-Targa F, 2006, J CELL MOL MED, V10, P554, DOI 10.1111/j.1582-4934.2006.tb00420.x; Ridgeway AG, 2000, J BIOL CHEM, V275, P32398, DOI 10.1074/jbc.M004349200; ROBERDS SL, 1994, CELL, V78, P625, DOI 10.1016/0092-8674(94)90527-4; Sartorelli V, 2005, CURR OPIN GENET DEV, V15, P528, DOI 10.1016/j.gde.2005.04.015; Seo J, 2010, J CELL BIOCHEM, V110, P1022, DOI 10.1002/jcb.22616; Soshnikova N, 2010, DEV CELL, V19, P819, DOI 10.1016/j.devcel.2010.11.009; Spicer DB, 1996, SCIENCE, V272, P1476, DOI 10.1126/science.272.5267.1476; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; STAINIER DYR, 1990, P NATL ACAD SCI USA, V87, P923, DOI 10.1073/pnas.87.3.923; Tajbakhsh S, 1998, DEVELOPMENT, V125, P4155; Tao QH, 2005, CELL, V120, P857, DOI 10.1016/j.cell.2005.01.013; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Wan LB, 2008, DEVELOPMENT, V135, P2729, DOI 10.1242/dev.024539; Weinberg ES, 1996, DEVELOPMENT, V122, P271; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Yin CY, 2007, DEV BIOL, V304, P141, DOI 10.1016/j.ydbio.2006.12.030; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2; Zlatanova J, 2009, J CELL SCI, V122, P1275, DOI 10.1242/jcs.039990	60	35	35	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.164574	http://dx.doi.org/10.1074/jbc.M110.164574			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21288905	Green Published, hybrid			2022-12-27	WOS:000289077500062
J	Schmid, AW; Condemi, E; Tuchscherer, G; Chiappe, D; Mutter, M; Vogel, H; Moniatte, M; Tsybin, YO				Schmid, Adrien W.; Condemi, Enrico; Tuchscherer, Gabriele; Chiappe, Diego; Mutter, Manfred; Vogel, Horst; Moniatte, Marc; Tsybin, Yury O.			Tissue Transglutaminase-mediated Glutamine Deamidation of beta-Amyloid Peptide Increases Peptide Solubility, Whereas Enzymatic Cross-linking and Peptide Fragmentation May Serve as Molecular Triggers for Rapid Peptide Aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE BRAIN; LONG-TERM POTENTIATION; ALPHA-SYNUCLEIN; ASPARAGINE DEAMIDATION; SYNAPTIC PLASTICITY; CEREBROSPINAL-FLUID; PARKINSONS-DISEASE; MASS-SPECTROMETRY; SER(26) RESIDUE; BINDING DOMAIN	Tissue transglutaminase (TGase) has been implicated in a number of cellular processes and disease states, where the enzymatic actions of TGase may serve in both, cell survival and apoptosis. To date, the precise functional properties of TGase in cell survival or cell death mechanisms still remain elusive. TGase-mediated cross-linking has been reported to account for the formation of insoluble lesions in conformational diseases. We report here that TGase induces intramolecular cross-linking of beta-amyloid peptide (A beta), resulting in structural changes of monomeric A beta. Using high resolution mass spectrometry (MS) of cross-linkedA beta peptides, we observed a shift in mass, which is, presumably associated with the loss of NH3 due to enzymatic transamidation activity and hence intramolecular peptide cross-linking. We have observed that a large population of A beta monomers contained an 0.984 Da increase in mass at a glutamine residue, indicating that glutamine 15 serves as an indispensable substrate in TGase-mediated deamidation to glutamate 15. We provide strong analytical evidence on TGase-mediated A beta peptide dimerization, through covalent intermolecular cross-linking and hence the formation of A beta(1-40) dimers. Our in depth analyses indicate that TGase-induced post-translational modifications of A beta peptide may serve as an important seed for aggregation.	[Schmid, Adrien W.; Chiappe, Diego; Moniatte, Marc] Ecole Polytech Fed Lausanne, Prote Core Facil, CH-1015 Lausanne, Switzerland; Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland; [Schmid, Adrien W.; Chiappe, Diego; Moniatte, Marc] Ecole Polytech Fed Lausanne, AI 0151, Stn 15, Prote Core Facil, CH-1015 Lausanne, Switzerland; [Condemi, Enrico; Tuchscherer, Gabriele; Vogel, Horst] Ecole Polytech Fed Lausanne, Stn 6, Lab Phys Chem Polymers & Membranes, CH-1015 Lausanne, Switzerland; [Mutter, Manfred] Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn, CH-1015 Lausanne, Switzerland; [Tsybin, Yury O.] Ecole Polytech Fed Lausanne, Biomol Mass Spectrometry Lab, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Schmid, AW (corresponding author), Ecole Polytech Fed Lausanne, AI 0151, Stn 15, Prote Core Facil, CH-1015 Lausanne, Switzerland.	adrien.schmid@epfl.ch	Vogel, Horst/AAJ-5490-2021; Schmid, Adrien/CAG-1527-2022; Tsybin, Yury/AAN-9764-2020; Tsybin, Yury O/A-2446-2011	Tsybin, Yury/0000-0001-7533-0774; Schmid, Adrien W./0000-0001-6671-7950; Moniatte, Marc/0000-0003-2235-4523	Biomedizin-Naturwissenschaft-Forschung (University of Bern, Switzerland); Ecole Polytechnique Federale Lausanne, Switzerland; Swiss National Science Foundation [200021-125147/1]; University of Bern, Switzerland	Biomedizin-Naturwissenschaft-Forschung (University of Bern, Switzerland); Ecole Polytechnique Federale Lausanne, Switzerland; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Bern, Switzerland	This work was supported by the Biomedizin-Naturwissenschaft-Forschung (University of Bern, Switzerland), Proteomics Core Facility (Ecole Polytechnique Federale Lausanne, Switzerland), Ecole Polytechnique Federale Lausanne, Switzerland, and Swiss National Science Foundation project Grant 200021-125147/1 (to Y. O. T.).; We are grateful to Dr. Manfredo Quadroni and Dr. Patrice Waridel (Protein Analysis Facility, University of Lausanne) for preliminary analyses on Orbitrap. We thank Romain Hamelin (PCF) for help with Scaffold and MASCOT profiling. We thank Prof. Dominic Walsh (Conway Institute, University College of Dublin) for critical review and discussion on the preliminary data and the BNF program at the University of Bern, Switzerland, for financial support.	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Andringa G, 2004, FASEB J, V18, P932, DOI 10.1096/fj.03-0829fje; Bonelli RM, 2002, NEUROBIOL DIS, V11, P106, DOI 10.1006/nbdi.2002.0535; Boros S, 2008, EXP EYE RES, V86, P383, DOI 10.1016/j.exer.2007.11.011; CHAN WC, 2000, FMOC SOLID PHASE PEP, P1; Chevallet M, 2006, NAT PROTOC, V1, P1852, DOI 10.1038/nprot.2006.288; Dorum S, 2009, J PROTEOME RES, V8, P1748, DOI 10.1021/pr800960n; DUDEK SM, 1994, BRAIN RES, V651, P129, DOI 10.1016/0006-8993(94)90688-2; Esposito C, 2005, FEBS J, V272, P615, DOI 10.1111/j.1742-4658.2004.04476.x; Fantini J, 2003, CELL MOL LIFE SCI, V60, P1027, DOI 10.1007/s00018-003-3003-1; Flaugh SL, 2006, J BIOL CHEM, V281, P30782, DOI 10.1074/jbc.M603882200; Fornelli L, 2011, CHEM-EUR J, V17, P486, DOI 10.1002/chem.201002483; Halverson RA, 2005, J NEUROSCI, V25, P1226, DOI 10.1523/JNEUROSCI.3263-04.2005; Hamaguchi T, 2009, AM J PATHOL, V175, P2557, DOI 10.2353/ajpath.2009.090417; Hartley DM, 2008, J BIOL CHEM, V283, P16790, DOI 10.1074/jbc.M802215200; Hebbar S, 2008, J LIPID RES, V49, P1077, DOI 10.1194/jlr.M700543-JLR200; IKURA K, 1993, FEBS LETT, V326, P109, DOI 10.1016/0014-5793(93)81772-R; Jeitner TM, 2009, J NEUROCHEM, V109, P160, DOI 10.1111/j.1471-4159.2009.05843.x; Johnson GVW, 1997, BRAIN RES, V751, P323, DOI 10.1016/S0006-8993(96)01431-X; Junn E, 2003, P NATL ACAD SCI USA, V100, P2047, DOI 10.1073/pnas.0438021100; Kaneko I, 2001, NEUROSCIENCE, V104, P1003, DOI 10.1016/S0306-4522(01)00155-5; Kim SY, 1999, J BIOL CHEM, V274, P30715, DOI 10.1074/jbc.274.43.30715; Klyubin I, 2008, J NEUROSCI, V28, P4231, DOI 10.1523/JNEUROSCI.5161-07.2008; Kubo T, 2003, J NEUROPATH EXP NEUR, V62, P248, DOI 10.1093/jnen/62.3.248; Lam HT, 2007, J PROTEOME RES, V6, P1666, DOI 10.1021/pr0606023; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li HY, 2010, BIOCHEMISTRY-US, V49, P6358, DOI 10.1021/bi100773g; Li XJ, 2010, ANAL CHEM, V82, P3606, DOI 10.1021/ac9028467; Maggio N, 2001, BRAIN RES BULL, V56, P173, DOI 10.1016/S0361-9230(01)00649-9; MILHAUD PG, 1980, BIOCHIM BIOPHYS ACTA, V630, P476, DOI 10.1016/0304-4165(80)90002-1; Mishizen-Eberz AJ, 2003, J NEUROCHEM, V86, P836, DOI 10.1046/j.1471-4159.2003.01878.x; Mishra S, 2007, J BIOL CHEM, V282, P18108, DOI 10.1074/jbc.M607413200; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Nemes Z, 2009, J BIOL CHEM, V284, P27252, DOI 10.1074/jbc.M109.033969; Nilsson MR, 2002, PROTEIN SCI, V11, P342, DOI 10.1110/ps.48702; O'Nuallain B, 2010, J NEUROSCI, V30, P14411, DOI 10.1523/JNEUROSCI.3537-10.2010; Oliverio S, 1997, MOL CELL BIOL, V17, P6040, DOI 10.1128/MCB.17.10.6040; Palmblad M, 2002, J BIOL CHEM, V277, P19506, DOI 10.1074/jbc.M112218200; Pittenauer E, 2006, J MASS SPECTROM, V41, P421, DOI 10.1002/jms.1032; Portelius E, 2006, NEUROSCI LETT, V409, P215, DOI 10.1016/j.neulet.2006.09.044; Portelius E, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-2; Robinson NE, 2001, P NATL ACAD SCI USA, V98, P944, DOI 10.1073/pnas.98.3.944; ROHER AE, 1993, J BIOL CHEM, V268, P3072; Saido TC, 1996, NEUROSCI LETT, V215, P173, DOI 10.1016/0304-3940(96)12970-0; Sandmeier E, 1999, BIOCHEM BIOPH RES CO, V261, P578, DOI 10.1006/bbrc.1999.1056; Schmid AW, 2008, BRAIN RES, V1197, P135, DOI 10.1016/j.brainres.2007.11.056; Schmid AW, 2009, J BIOL CHEM, V284, P13128, DOI 10.1074/jbc.M809067200; SELKOE DJ, 1982, P NATL ACAD SCI-BIOL, V79, P6070, DOI 10.1073/pnas.79.19.6070; Sergeant N, 2003, J NEUROCHEM, V85, P1581, DOI 10.1046/j.1471-4159.2003.01818.x; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shimmyo Y, 2008, J NEUROSCI RES, V86, P368, DOI 10.1002/jnr.21476; TOMIYAMA T, 1994, J BIOL CHEM, V269, P10205; Wakshlag JJ, 2006, PROTEIN J, V25, P83, DOI 10.1007/s10930-006-0009-1; Walsh DM, 2005, J NEUROSCI, V25, P2455, DOI 10.1523/JNEUROSCI.4391-04.2005; Wang DS, 2008, J ALZHEIMERS DIS, V13, P53; Wang R, 1996, J BIOL CHEM, V271, P31894, DOI 10.1074/jbc.271.50.31894; Warren CM, 2010, J PROTEOMICS, V73, P1551, DOI 10.1016/j.jprot.2010.03.016; Watanabe A, 1999, J BIOL CHEM, V274, P7368, DOI 10.1074/jbc.274.11.7368; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wilhelmus MMM, 2009, BRAIN PATHOL, V19, P612, DOI 10.1111/j.1750-3639.2008.00197.x; Yang HQ, 2010, ELECTROPHORESIS, V31, P1764, DOI 10.1002/elps.201000027; Zhang W, 1998, ACTA NEUROPATHOL, V96, P395, DOI 10.1007/s004010050910	64	32	34	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.176149	http://dx.doi.org/10.1074/jbc.M110.176149			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21300794	Green Published, hybrid			2022-12-27	WOS:000289077500033
J	Wang, RW; Zhong, XW; Meng, X; Koop, A; Tian, XX; Jones, PP; Fruen, BR; Wagenknecht, T; Liu, Z; Chen, SRW				Wang, Ruiwu; Zhong, Xiaowei; Meng, Xing; Koop, Andrea; Tian, Xixi; Jones, Peter P.; Fruen, Bradley R.; Wagenknecht, Terence; Liu, Zheng; Chen, S. R. Wayne			Localization of the Dantrolene-binding Sequence near the FK506-binding Protein-binding Site in the Three-dimensional Structure of the Ryanodine Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; CA2+ RELEASE CHANNELS; SKELETAL-MUSCLE; CRYOELECTRON MICROSCOPY; MALIGNANT HYPERTHERMIA; CALCIUM-RELEASE; PHOSPHORYLATION SITE; FKBP12.6 BINDING; DISEASE; MUTATIONS	Dantrolene is believed to stabilize interdomain interactions between the NH2-terminal and central regions of ryanodine receptors by binding to the NH2-terminal residues 590-609 in skeletal ryanodine receptor (RyR1) and residues 601-620 in cardiac ryanodine receptor (RyR2). To gain further insight into the structural basis of dantrolene action, we have attempted to localize the dantrolene-binding sequence in RyR1/RyR2 by using GFP as a structural marker and three-dimensional cryoEM. We inserted GFP into RyR2 after residues Arg-626 and Tyr-846 to generate GFP-RyR2 fusion proteins, RyR2(Arg-626-GFP) and RyR2(Tyr-846-GFP). Insertion of GFP after residue Arg-626 abolished the binding of a bulky GST-or cyan fluorescent protein-tagged FKBP12.6 but not the binding of a smaller, nontagged FKBP12.6, suggesting that residue Arg-626 and the dantrolene-binding sequence are located near the FKBP12.6-binding site. Using cryo-EM, we have mapped the three-dimensional location of Tyr-846-GFP to domain 9, which is also adjacent to the FKBP12.6-binding site. To further map the three-dimensional location of the dantrolene-binding sequence, we generated 10 FRET pairs based on four known three-dimensional locations (FKBP12.6, Ser-437-GFP, Tyr-846-GFP, and Ser-2367-GFP). Based on the FRET efficiencies of these FRET pairs and the corresponding distance relationships, we mapped the three-dimensional location of Arg-626-GFP or -cyan fluorescent protein, hence the dantrolene-binding sequence, to domain 9 near the FKBP12.6-binding site but distant to the central region around residue Ser-2367. An allosteric mechanism by which dantrolene stabilizes interdomain interactions between the NH2-terminal and central regions is proposed.	[Meng, Xing; Wagenknecht, Terence; Liu, Zheng; Chen, S. R. Wayne] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA; [Wang, Ruiwu; Zhong, Xiaowei; Koop, Andrea; Tian, Xixi; Jones, Peter P.; Chen, S. R. Wayne] Univ Calgary, Libin Cardiovasc Inst Alberta, Dept Physiol & Pharmacol, Calgary, AB T2N 4N1, Canada; [Wang, Ruiwu; Zhong, Xiaowei; Koop, Andrea; Tian, Xixi; Jones, Peter P.; Chen, S. R. Wayne] Univ Calgary, Libin Cardiovasc Inst Alberta, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Fruen, Bradley R.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Wagenknecht, Terence] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY 12201 USA	State University of New York (SUNY) System; Wadsworth Center; Libin Cardiovascular Institute Of Alberta; University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Minnesota System; University of Minnesota Twin Cities; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Liu, Z (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA.	liuz@wadsworth.org	Jones, Peter P/G-2618-2013	Liu, Zheng/0000-0001-6952-3406; Jones, Pete/0000-0001-7977-1737	National Institutes of Health [R01 HL075210, R01HL095541, R01AR040615, R01HL076433, P41RR01219]; Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada; Achievers in Medical Science Scholarship; Alberta Innovates-Health Solutions; Heart and Stroke Foundation of Alberta; Alberta Innovates [201001238] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001219] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076433, R01HL075210, R01HL095541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040615] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Achievers in Medical Science Scholarship; Alberta Innovates-Health Solutions; Heart and Stroke Foundation of Alberta; Alberta Innovates; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL075210 (to S. R. W. C.), R01HL095541 (to Z. L.), R01AR040615 (to T. W.), and R01HL076433 (to B. R. F.). This work was also supported by research grants from the Canadian Institutes of Health Research and the Heart and Stroke Foundation of Canada (to S. R. W. C.) and by National Institutes of Health Biotechnological Resource Grant P41RR01219.; Recipient of the Achievers in Medical Science Scholarship.; Recipient of the Alberta Innovates-Health Solutions Studentship Award.; Recipient of Alberta Innovates-Health Solutions and Heart and Stroke Foundation of Alberta Fellowship Awards. Present address: Dept. of Physiology, University of Otago, Dunedin 9054, New Zealand.	Benacquista BL, 2000, BIOPHYS J, V78, P1349, DOI 10.1016/S0006-3495(00)76689-6; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Cherednichenko G, 2008, MOL PHARMACOL, V73, P1203, DOI 10.1124/mol.107.043299; Cornea RL, 2010, J BIOL CHEM, V285, P19219, DOI 10.1074/jbc.M109.066944; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Frank J, 2006, 3 DIMENSIONAL ELECT, P71; George CH, 2007, J MOL CELL CARDIOL, V42, P34, DOI 10.1016/j.yjmcc.2006.08.115; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Ikemoto N, 2002, FRONT BIOSCI-LANDMRK, V7, pD671, DOI 10.2741/ikemoto; Inan S, 2010, ANESTH ANALG, V111, P1400, DOI 10.1213/ANE.0b013e3181f7181c; Jiang DW, 2005, CIRC RES, V97, P1173, DOI 10.1161/01.RES.0000192146.85173.4b; Jones PP, 2008, BIOCHEM J, V410, P261, DOI 10.1042/BJ20071257; Kobayashi S, 2005, J BIOL CHEM, V280, P6580, DOI 10.1074/jbc.M408375200; Kobayashi S, 2009, J AM COLL CARDIOL, V53, P1993, DOI 10.1016/j.jacc.2009.01.065; Krause T, 2004, ANAESTHESIA, V59, P364, DOI 10.1111/j.1365-2044.2004.03658.x; Li P, 2001, J GEN PHYSIOL, V118, P33, DOI 10.1085/jgp.118.1.33; Liu Z, 2005, J BIOL CHEM, V280, P37941, DOI 10.1074/jbc.M505714200; Liu Z, 2004, J MOL BIOL, V338, P533, DOI 10.1016/j.jmb.2004.03.011; Liu Z, 2002, J BIOL CHEM, V277, P46712, DOI 10.1074/jbc.M208124200; Liu Z, 2010, J CELL SCI, V123, P1775, DOI 10.1242/jcs.064071; MacLennan DH, 2000, EUR J BIOCHEM, V267, P5291, DOI 10.1046/j.1432-1327.2000.01566.x; Malhotra A, 1998, J MOL BIOL, V280, P103, DOI 10.1006/jmbi.1998.1859; Masumiya H, 2003, J BIOL CHEM, V278, P3786, DOI 10.1074/jbc.M210962200; Meng X, 2007, J BIOL CHEM, V282, P25929, DOI 10.1074/jbc.M704474200; Murayama T, 1999, J BIOL CHEM, V274, P17297, DOI 10.1074/jbc.274.24.17297; Palnitkar SS, 1999, J MED CHEM, V42, P1872, DOI 10.1021/jm9805079; Papadopoulos S, 2004, J BIOL CHEM, V279, P44046, DOI 10.1074/jbc.M405317200; Paul-Pletzer K, 2005, BIOCHEM J, V387, P905, DOI 10.1042/BJ20041336; Paul-Pletzer K, 2002, J BIOL CHEM, V277, P34918, DOI 10.1074/jbc.M205487200; Paul-Pletzer K, 2001, BIOCHEMISTRY-US, V40, P531, DOI 10.1021/bi001502s; PENCZEK PA, 1994, ULTRAMICROSCOPY, V53, P251, DOI 10.1016/0304-3991(94)90038-8; Priori SG, 2005, J CLIN INVEST, V115, P2033, DOI 10.1172/JCI25664; RADERMACHER M, 1994, J CELL BIOL, V127, P411, DOI 10.1083/jcb.127.2.411; Robinson R, 2006, HUM MUTAT, V27, P977, DOI 10.1002/humu.20356; Rosenberg H, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-21; Samso M, 2006, J MOL BIOL, V356, P917, DOI 10.1016/j.jmb.2005.12.023; Sharma MR, 2006, BIOPHYS J, V90, P164, DOI 10.1529/biophysj.105.063503; Sharma MR, 1998, J BIOL CHEM, V273, P18429, DOI 10.1074/jbc.273.29.18429; Sutko JL, 1996, PHYSIOL REV, V76, P1027, DOI 10.1152/physrev.1996.76.4.1027; Tung CC, 2010, NATURE, V468, P585, DOI 10.1038/nature09471; Uchinoumi H, 2010, CIRC RES, V106, DOI 10.1161/CIRCRESAHA.109.209312; Wagenknecht T, 1997, J BIOL CHEM, V272, P32463, DOI 10.1074/jbc.272.51.32463; Wang RW, 2007, J BIOL CHEM, V282, P17785, DOI 10.1074/jbc.M700660200; Wang RW, 2004, J BIOL CHEM, V279, P3635, DOI 10.1074/jbc.M311367200; Zhang J, 2003, J BIOL CHEM, V278, P14211, DOI 10.1074/jbc.M213164200; Zhao MC, 1999, J BIOL CHEM, V274, P25971, DOI 10.1074/jbc.274.37.25971; Zhao XL, 2006, J BIOL CHEM, V281, P33477, DOI 10.1074/jbc.M602306200	47	37	37	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.194316	http://dx.doi.org/10.1074/jbc.M110.194316			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21262961	Green Published, hybrid			2022-12-27	WOS:000289077500035
J	Palam, LR; Baird, TD; Wek, RC				Palam, Lakshmi Reddy; Baird, Thomas D.; Wek, Ronald C.			Phosphorylation of eIF2 Facilitates Ribosomal Bypass of an Inhibitory Upstream ORF to Enhance CHOP Translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; OPEN READING FRAMES; EUKARYOTIC INITIATION-FACTOR-2; OXIDATIVE STRESS; MAMMALIAN-CELLS; GENE-EXPRESSION; MESSENGER-RNAS; REINITIATION; TRANSCRIPTION	In response to different environmental stresses, phosphorylation of eukaryotic initiation factor-2 (eIF2) rapidly reduces protein synthesis, which lowers energy expenditure and facilitates reprogramming of gene expression to remediate stress damage. Central to the changes in gene expression, eIF2 phosphorylation also enhances translation of ATF4, a transcriptional activator of genes subject to the integrated stress response (ISR). The ISR increases the expression of genes important for alleviating stress or alternatively triggering apoptosis. One ISR target gene encodes the transcriptional regulator CHOP whose accumulation is critical for stress-induced apoptosis. In this study, we show that eIF2 phosphorylation induces preferential translation of CHOP by a mechanism involving a single upstream ORF (uORF) located in the 5'-leader of the CHOP mRNA. In the absence of stress and low eIF2 phosphorylation, translation of the uORF serves as a barrier that prevents translation of the downstream CHOP coding region. Enhanced eIF2 phosphorylation during stress facilitates ribosome bypass of the uORF due to its poor start site context, and instead it allows scanning ribosomes to translate CHOP. This new mechanism of translational control explains how expression of CHOP and the fate of cells are tightly linked to the levels of phosphorylated eIF2 and stress damage.	[Palam, Lakshmi Reddy; Baird, Thomas D.; Wek, Ronald C.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Wek, RC (corresponding author), Indiana Univ, Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	rwek@iupui.edu	palam, lakshmi reddy/H-4902-2015	Baird, Thomas/0000-0002-0280-9984	National Institutes of Health [GM49164, GM64350]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM049164, R01GM064350, R01GM049164] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM49164 and GM64350 (to R. C. W.).	ABASTADO JP, 1991, MOL CELL BIOL, V11, P486, DOI 10.1128/MCB.11.1.486; Chen YJ, 2010, NUCLEIC ACIDS RES, V38, P764, DOI 10.1093/nar/gkp1034; Connor JH, 2001, MOL CELL BIOL, V21, P6841, DOI 10.1128/MCB.21.20.6841-6850.2001; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Dey S, 2010, J BIOL CHEM, V285, P33165, DOI 10.1074/jbc.M110.167213; Do AND, 2009, PHYSIOL GENOMICS, V38, P328, DOI 10.1152/physiolgenomics.90396.2008; Gilbert WV, 2010, J BIOL CHEM, V285, P29033, DOI 10.1074/jbc.R110.150532; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hood HM, 2009, ANNU REV MICROBIOL, V63, P385, DOI 10.1146/annurev.micro.62.081307.162835; Ivanov IP, 2010, P NATL ACAD SCI USA, V107, P18056, DOI 10.1073/pnas.1009269107; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Jiang HY, 2003, MOL CELL BIOL, V23, P5651, DOI 10.1128/MCB.23.16.5651-5663.2003; Jousse C, 2001, NUCLEIC ACIDS RES, V29, P4341, DOI 10.1093/nar/29.21.4341; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; Kozak M, 2001, NUCLEIC ACIDS RES, V29, P5226, DOI 10.1093/nar/29.24.5226; KOZAK M, 1987, MOL CELL BIOL, V7, P3438, DOI 10.1128/MCB.7.10.3438; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Li G, 2009, J CELL BIOL, V186, P783, DOI 10.1083/jcb.200904060; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Pisarev AV, 2006, GENE DEV, V20, P624, DOI 10.1101/gad.1397906; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2007, TRENDS BIOCHEM SCI, V32, P469, DOI 10.1016/j.tibs.2007.09.003; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Spirin AS, 2009, BIOCHEMISTRY-US, V48, P10688, DOI 10.1021/bi901379a; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wek RC, 2009, CELL METAB, V10, P1, DOI 10.1016/j.cmet.2009.06.005; Zhou DH, 2008, J BIOL CHEM, V283, P7064, DOI 10.1074/jbc.M708530200	44	256	273	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					10939	10949		10.1074/jbc.M110.216093	http://dx.doi.org/10.1074/jbc.M110.216093			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21285359	Green Published, hybrid			2022-12-27	WOS:000288797100006
J	Arcipowski, KM; Stunz, LL; Graham, JP; Kraus, ZJ; Vanden Bush, TJ; Bishop, GA				Arcipowski, Kelly M.; Stunz, Laura L.; Graham, John P.; Kraus, Zachary J.; Vanden Bush, Tony J.; Bishop, Gail A.			Molecular Mechanisms of TNFR-associated Factor 6 (TRAF6) Utilization by the Oncogenic Viral Mimic of CD40, Latent Membrane Protein 1 (LMP1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPSTEIN-BARR-VIRUS; NF-KAPPA-B; SYSTEMIC-LUPUS-ERYTHEMATOSUS; HEART-TRANSPLANT PATIENTS; TERMINAL KINASE PATHWAY; BINDING-SITE; SIGNAL-TRANSDUCTION; CRITICAL MEDIATOR; RING DOMAIN; LYMPHOCYTES	Latent membrane protein 1 (LMP1), encoded by Epstein-Barr virus, is required for EBV-mediated B cell transformation and plays a significant role in the development of posttransplant B cell lymphomas. LMP1 has also been implicated in exacerbation of autoimmune diseases such as systemic lupus erythematosus. LMP1 is a constitutively active functional mimic of the tumor necrosis factor receptor superfamily member CD40, utilizing tumor necrosis factor receptor-associated factor (TRAF) adaptor proteins to induce signaling. However, LMP1-mediated B cell activation is amplified and sustained compared with CD40. We have previously shown that LMP1 and CD40 use TRAFs 1, 2, 3, and 5 differently. TRAF6 is important for CD40 signaling, but the role of TRAF6 in LMP1 signaling in B cells is not clear. Although TRAF6 binds directly to CD40, TRAF6 interaction with LMP1 in B cells has not been characterized. Here we tested the hypothesis that TRAF6 is a critical regulator of LMP1 signaling in B cells, either as part of a receptor-associated complex and/or as a cytoplasmic adaptor protein. Using TRAF6-deficient B cells, we determined that TRAF6 was critical for LMP1-mediated B cell activation. Although CD40-mediated TRAF6-dependent signaling does not require the TRAF6 receptor-binding domain, we found that LMP1 signaling required the presence of this domain. Furthermore, TRAF6 was recruited to the LMP1 signaling complex via the TRAF1/2/3/5 binding site within the cytoplasmic domain of LMP1.	[Arcipowski, Kelly M.; Bishop, Gail A.] Univ Iowa, Interdisciplinary Grad Program Mol & Cellular Bio, Iowa City, IA 52242 USA; [Graham, John P.; Kraus, Zachary J.; Bishop, Gail A.] Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA; [Stunz, Laura L.; Vanden Bush, Tony J.; Bishop, Gail A.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Bishop, Gail A.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Bishop, Gail A.] Vet Affairs Med Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Bishop, GA (corresponding author), Univ Iowa, Interdisciplinary Grad Program Mol & Cellular Bio, 2193B MERF,375 Newton Rd, Iowa City, IA 52242 USA.	gail-bishop@uiowa.edu		Bishop, Gail/0000-0002-1291-5078	National Institutes of Health [CA099997, T32AI007533-12]; American Heart Association; NATIONAL CANCER INSTITUTE [R01CA099997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007533] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Awards CA099997 (to G. A. B.) and T32AI007533-12 (to K. M. A.). K. M. A. was also supported by the American Heart Association.	Abou-Raya A, 2006, AUTOIMMUN REV, V5, P331, DOI 10.1016/j.autrev.2005.12.006; Bishop GA, 2004, NAT REV IMMUNOL, V4, P775, DOI 10.1038/nri1462; Bishop GA, 2002, J LEUKOCYTE BIOL, V72, P19; Bishop GA, 2002, MICROBES INFECT, V4, P853, DOI 10.1016/S1286-4579(02)01605-2; BISHOP GA, 1986, P NATL ACAD SCI USA, V83, P7410, DOI 10.1073/pnas.83.19.7410; Bishop GA, 2001, IMMUNOL RES, V24, P97, DOI 10.1385/IR:24:2:097; Bishop GA, 2007, ADV EXP MED BIOL, V597, P131; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Brown KD, 2001, J EXP MED, V193, P943, DOI 10.1084/jem.193.8.943; Busch LK, 1999, J IMMUNOL, V162, P2555; Busch LK, 2001, J IMMUNOL, V167, P5805, DOI 10.4049/jimmunol.167.10.5805; Eliopoulos AG, 2001, SEMIN CANCER BIOL, V11, P435, DOI 10.1006/scbi.2001.0410; Fries KL, 1999, VIROLOGY, V264, P159, DOI 10.1006/viro.1999.9980; Gautheron J, 2010, HUM MOL GENET, V19, P3138, DOI 10.1093/hmg/ddq222; Graham JP, 2010, IMMUNOL REV, V237, P226, DOI 10.1111/j.1600-065X.2010.00932.x; Graham JP, 2009, J IMMUNOL, V183, P2966, DOI 10.4049/jimmunol.0900442; Gross AJ, 2005, J IMMUNOL, V174, P6599, DOI 10.4049/jimmunol.174.11.6599; Hostager BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011380; Hostager BS, 2003, J BIOL CHEM, V278, P45382, DOI 10.1074/jbc.M306708200; Hostager BS, 1996, J IMMUNOL, V157, P1047; Hostager BS, 2000, J BIOL CHEM, V275, P15392, DOI 10.1074/jbc.M909520199; HU HM, 1994, J BIOL CHEM, V269, P30069; Ikeda O, 2009, FEBS LETT, V583, P1567, DOI 10.1016/j.febslet.2009.04.022; Jalukar SV, 2000, J IMMUNOL, V164, P623, DOI 10.4049/jimmunol.164.2.623; Kanamori M, 2002, FEBS LETT, V532, P241, DOI 10.1016/S0014-5793(02)03688-8; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; KAYE KM, 1993, P NATL ACAD SCI USA, V90, P9150, DOI 10.1073/pnas.90.19.9150; Kieser A, 2008, BIOL CHEM, V389, P1261, DOI 10.1515/BC.2008.144; KIM KJ, 1979, J IMMUNOL, V122, P549; Kobayashi T, 2004, MICROBES INFECT, V6, P1333, DOI 10.1016/j.micinf.2004.09.001; Kraus ZJ, 2009, P NATL ACAD SCI USA, V106, P17140, DOI 10.1073/pnas.0903786106; Kuppers R, 2003, NAT REV IMMUNOL, V3, P801, DOI 10.1038/nri1201; Luftig M, 2003, P NATL ACAD SCI USA, V100, P15595, DOI 10.1073/pnas.2136756100; Mainou BA, 2007, J VIROL, V81, P9680, DOI 10.1128/JVI.01001-07; Markin CJ, 2008, BIOCHEMISTRY-US, V47, P10010, DOI 10.1021/bi800252x; Mercier P, 2007, PROTEIN SCI, V16, P602, DOI 10.1110/ps.062358007; Nakano H, 1999, P NATL ACAD SCI USA, V96, P9803, DOI 10.1073/pnas.96.17.9803; Noels H, 2007, J BIOL CHEM, V282, P10180, DOI 10.1074/jbc.M611038200; Pai S, 2001, SEMIN CANCER BIOL, V11, P455, DOI 10.1006/scbi.2001.0412; Peters AL, 2010, J IMMUNOL, V185, P4053, DOI 10.4049/jimmunol.0904065; Poole BD, 2009, AUTOIMMUN REV, V8, P337, DOI 10.1016/j.autrev.2008.12.008; Pullen SS, 1999, J BIOL CHEM, V274, P14246, DOI 10.1074/jbc.274.20.14246; Rowland SL, 2007, J IMMUNOL, V179, P4645, DOI 10.4049/jimmunol.179.7.4645; Scheinfeld AG, 1997, AM J PATHOL, V151, P805; Schubert S, 2009, PEDIATR TRANSPLANT, V13, P54, DOI 10.1111/j.1399-3046.2008.00969.x; Schubert S, 2008, J HEART LUNG TRANSPL, V27, P100, DOI 10.1016/j.healun.2007.09.027; Schultheiss U, 2001, EMBO J, V20, P5678, DOI 10.1093/emboj/20.20.5678; Seliger B, 2008, TRENDS MOL MED, V14, P550, DOI 10.1016/j.molmed.2008.09.010; Stunz LL, 2004, IMMUNITY, V21, P255, DOI 10.1016/j.immuni.2004.07.008; Thorley-Lawson DA, 2001, NAT REV IMMUNOL, V1, P75, DOI 10.1038/35095584; Uchida J, 1999, SCIENCE, V286, P300, DOI 10.1126/science.286.5438.300; Wajant H, 2001, CELL SIGNAL, V13, P389, DOI 10.1016/S0898-6568(01)00160-7; Wan J, 2006, MOL CELL BIOL, V26, P448, DOI 10.1128/MCB.26.2.448-456.2006; Wan J, 2004, MOL CELL BIOL, V24, P192, DOI 10.1128/MCB.24.1.192-199.2004; Wu LM, 2006, J BIOL CHEM, V281, P2162, DOI 10.1074/jbc.M505903200; Wu SD, 2005, J BIOL CHEM, V280, P33620, DOI 10.1074/jbc.M502511200; Xie P, 2004, J IMMUNOL, V173, P5546, DOI 10.4049/jimmunol.173.9.5546; Xie P, 2004, J EXP MED, V199, P661, DOI 10.1084/jem.20031255; Xie P, 2006, J IMMUNOL, V176, P5388, DOI 10.4049/jimmunol.176.9.5388; Yin Q, 2009, NAT STRUCT MOL BIOL, V16, P658, DOI 10.1038/nsmb.1605; Yin QY, 2008, J BIOL CHEM, V283, P2654, DOI 10.1074/jbc.M708218200	62	31	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					9948	9955		10.1074/jbc.M110.185983	http://dx.doi.org/10.1074/jbc.M110.185983			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21262968	Green Published, hybrid			2022-12-27	WOS:000288547000009
J	Dammer, EB; Na, CH; Xu, P; Seyfried, NT; Duong, DM; Cheng, DM; Gearing, M; Rees, H; Lah, JJ; Levey, AI; Rush, J; Peng, JM				Dammer, Eric B.; Na, Chan Hyun; Xu, Ping; Seyfried, Nicholas T.; Duong, Duc M.; Cheng, Dongmei; Gearing, Marla; Rees, Howard; Lah, James J.; Levey, Allan I.; Rush, John; Peng, Junmin			Polyubiquitin Linkage Profiles in Three Models of Proteolytic Stress Suggest the Etiology of Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANAPHASE-PROMOTING COMPLEX; QUANTITATIVE PROTEOMICS; UBIQUITIN CHAINS; NEURODEGENERATIVE DISEASES; PROTEIN UBIQUITINATION; MASS-SPECTROMETRY; CELL-DEATH; AUTOPHAGY; DEGRADATION; REVEALS	Polyubiquitin chains on substrates are assembled through any of seven lysine residues or the N terminus of ubiquitin (Ub), generating diverse linkages in the chain structure. PolyUb linkages regulate the fate of modified substrates, but their abundance and function in mammalian cells are not well studied. We present a mass spectrometry-based method to measure polyUb linkages directly from total lysate of mammalian cells. In HEK293 cells, the level of polyUb linkages was found to be 52% (Lys(48)), 38% (Lys(63)), 8% (Lys(29)), 2% (Lys(11)), and 0.5% or less for linear, Lys(6), Lys(27), and Lys(33) linkages. Tissue specificity of these linkages was examined in mice fully labeled by heavy stable isotopes (i.e. SILAC mice). Moreover, we profiled the Ub linkages in brain tissues from patients of Alzheimer disease with or without concurrent Lewy body disease as well as three cellular models of proteolytic stress: proteasome deficiency, lysosome deficiency, and heat shock. The data support that polyUb chains linked through Lys(6), Lys(11), Lys(27), Lys(29), and Lys(48) mediate proteasomal degradation, whereas Lys(63) chains are preferentially involved in the lysosomal pathway. Mixed linkages, including Lys(48), may also contribute to lysosomal targeting, as both Lys(63) and Lys(48) linkages are colocalized in LC3-labeled autophagosomes. Interestingly, heat shock treatment augments Lys(11), Lys(48), and Lys(63) but not Lys(29) linkages, and this unique pattern is similar to that in the profiled neurodegenerative cases. We conclude that different polyUb linkages play distinct roles under the three proteolytic stress conditions, and protein folding capacity in the heat shock responsive pathway might be more affected in Alzheimer disease.	[Dammer, Eric B.; Na, Chan Hyun; Xu, Ping; Seyfried, Nicholas T.; Duong, Duc M.; Cheng, Dongmei; Peng, Junmin] Emory Univ, Sch Med, Dept Human Genet, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA; [Duong, Duc M.; Cheng, Dongmei; Peng, Junmin] Emory Univ, Sch Med, Emory Prote Serv Ctr, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA; [Gearing, Marla] Emory Univ, Sch Med, Dept Pathol, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA; [Rees, Howard; Lah, James J.; Levey, Allan I.] Emory Univ, Sch Med, Dept Neurol, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA; [Rush, John] Cell Signaling Technol Inc, Danvers, MA 01923 USA	Emory University; Emory University; Emory University; Emory University	Peng, JM (corresponding author), Emory Univ, Sch Med, Dept Human Genet, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA.	jpeng@emory.edu	Peng, Junmin/N-2614-2018; Levey, Allan/F-2104-2011; Dammer, Eric B/V-8652-2019	Peng, Junmin/0000-0003-0472-7648; Levey, Allan/0000-0002-3153-502X; Dammer, Eric B/0000-0003-2947-7606; Duong, Duc/0000-0001-5880-1888	National Institutes of Health [AG025688, NS055077, RR025822, NS007480]; American Cancer Society [RSG-09-181]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR025822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS055077, T32NS007480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG025688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG025688, NS055077, and RR025822 and Training Grant NS007480 (to E. B. D. and N. T. S.). This work was also supported by Research Scholar Grant RSG-09-181 from the American Cancer Society.	Bedford L, 2008, J NEUROSCI, V28, P8189, DOI 10.1523/JNEUROSCI.2218-08.2008; Bendall SC, 2008, MOL CELL PROTEOMICS, V7, P1587, DOI 10.1074/mcp.M800113-MCP200; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Cripps D, 2006, J BIOL CHEM, V281, P10825, DOI 10.1074/jbc.M512786200; FINLEY D, 1994, MOL CELL BIOL, V14, P5501, DOI 10.1128/MCB.14.8.5501; Finn PE, 2005, AUTOPHAGY, V1, P141, DOI 10.4161/auto.1.3.2000; Gitcho MA, 2009, J BIOL CHEM, V284, P12384, DOI 10.1074/jbc.M900992200; HAAS AL, 1987, J BIOL CHEM, V262, P345; Hammond TG, 1998, J MEMBRANE BIOL, V162, P157, DOI 10.1007/s002329900353; Hanna J, 2003, MOL CELL BIOL, V23, P9251, DOI 10.1128/MCB.23.24.9251-9261.2003; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Jones J, 2008, J PROTEOME RES, V7, P1274, DOI 10.1021/pr700749v; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Kirkpatrick DS, 2005, NAT CELL BIOL, V7, P750, DOI 10.1038/ncb0805-750; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kruger M, 2008, CELL, V134, P353, DOI 10.1016/j.cell.2008.05.033; Kundrat L, 2010, J MOL BIOL, V395, P587, DOI 10.1016/j.jmb.2009.11.017; Lia LJ, 2004, J BIOL CHEM, V279, P37061, DOI 10.1074/jbc.M403672200; Mallick P, 2007, NAT BIOTECHNOL, V25, P125, DOI 10.1038/nbt1275; Meierhofer D, 2008, J PROTEOME RES, V7, P4566, DOI 10.1021/pr800468j; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Paine S, 2009, NEUROSCI LETT, V460, P205, DOI 10.1016/j.neulet.2009.05.074; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pivtoraiko VN, 2010, J NEUROCHEM, V114, P1193, DOI 10.1111/j.1471-4159.2010.06838.x; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Ryu KY, 2006, ANAL BIOCHEM, V353, P153, DOI 10.1016/j.ab.2006.03.038; Seyfried NT, 2008, ANAL CHEM, V80, P4161, DOI 10.1021/ac702516a; Seyfried NT, 2010, MOL CELL PROTEOMICS, V9, P705, DOI 10.1074/mcp.M800390-MCP200; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Tan JMM, 2008, HUM MOL GENET, V17, P431, DOI 10.1093/hmg/ddm320; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Williamson A, 2009, P NATL ACAD SCI USA, V106, P18213, DOI 10.1073/pnas.0907887106; Wu T, 2010, P NATL ACAD SCI USA, V107, P1355, DOI 10.1073/pnas.0912802107; Xu P, 2006, ISRAEL J CHEM, V46, P171, DOI 10.1560/1JVL-J4EE-FVW4-MXRE; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yang JX, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002864; Zhao SK, 2010, P NATL ACAD SCI USA, V107, P7704, DOI 10.1073/pnas.0908764107	51	127	131	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10457	10465		10.1074/jbc.M110.149633	http://dx.doi.org/10.1074/jbc.M110.149633			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21278249	hybrid, Green Published			2022-12-27	WOS:000288547000062
J	Han, SI; Yasuda, K; Kataoka, K				Han, Song-iee; Yasuda, Kunio; Kataoka, Kohsuke			ATF2 Interacts with beta-Cell-enriched Transcription Factors, MafA, Pdx1, and Beta2, and Activates Insulin Gene Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; KEY REGULATOR; GLUCOSE; PROMOTER; EXPRESSION; PHOSPHORYLATION; DIFFERENTIATION; PROTEINS; GLUCAGON; INHIBIT	Pancreatic beta-cell-restricted expression of insulin is established through several critical cis-regulatory elements located in the insulin gene promoter region. The principal cis elements are A-boxes, E1, and C1/RIPE3b. The beta-cell-enriched transcription factors Pdx1 and Beta2 bind to the A-boxes and E1 element, respectively. A beta-cell-specific trans-acting factor binding to C1/RIPE3b (termed RIPE3b1 activator) was detected by electrophoretic mobility shift assay and has been identified as MafA, a member of the Maf family of basic leucine zipper (bZip) proteins. Here, ATF2, a member of the ATF/CREB family of basic leucine zipper proteins, was identified as a component of the RIPE3b1 activator. ATF2 alone was unable to bind to the C1/RIPE3b element but acquired binding capacity upon complex formation with MafA. ATF2 also interacted with Pdx1 and Beta2, and co-expression of ATF2, MafA, Pdx1, and Beta2 resulted in a synergistic activation of the insulin promoter. Immunohistochemical analysis of mouse pancreas tissue sections showed that ATF2 is enriched in islet endocrine cells, including beta-cells. RNAi-mediated knockdown of MafA or ATF2 in the MIN6 beta-cell line resulted in a significant decrease in endogenous levels of insulin mRNA. These data indicate that ATF2 is an essential component of the positive regulators of the insulin gene expression.	[Han, Song-iee; Yasuda, Kunio; Kataoka, Kohsuke] Nara Inst Sci & Technol, Mol & Dev Biol Lab, Grad Sch Biol Sci, Ikoma 6300192, Japan	Nara Institute of Science & Technology	Kataoka, K (corresponding author), Nara Inst Sci & Technol, Mol & Dev Biol Lab, Grad Sch Biol Sci, 8916-5 Takayama Cho, Ikoma 6300192, Japan.	kkataoka@bs.naist.jp			MEXT, Japan; Mitsubishi Foundation; Takeda Science Foundation; Japan Society for the Promotion of Science	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsubishi Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-Aid for Scientific Research on Priority Areas (DECODE), for Scientific Research (C), and for the Global COE Program in NAIST from MEXT, Japan, a grant from the Mitsubishi Foundation, and a grant from Takeda Science Foundation (to K. K.). This work was also supported by the Postdoctoral Fellowship for Foreign Researchers from the Japan Society for the Promotion of Science (to S. H.).	Abdelli S, 2007, DIABETOLOGIA, V50, P1660, DOI 10.1007/s00125-007-0704-2; Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Aramata S, 2005, BBA-GENE STRUCT EXPR, V1730, P41, DOI 10.1016/j.bbaexp.2005.05.009; Artner I, 2007, P NATL ACAD SCI USA, V104, P3853, DOI 10.1073/pnas.0700013104; Ban N, 2000, DIABETES, V49, P1142, DOI 10.2337/diabetes.49.7.1142; Bernardo AS, 2008, MOL CELL ENDOCRINOL, V294, P1, DOI 10.1016/j.mce.2008.07.006; Docherty HM, 2005, BIOCHEM J, V389, P813, DOI 10.1042/BJ20041891; Han S, 2007, MOL CELL BIOL, V27, P6593, DOI 10.1128/MCB.01573-06; Hay CW, 2007, BBA-GENE STRUCT EXPR, V1769, P79, DOI 10.1016/j.bbaexp.2007.01.005; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; IGARASHI K, 1994, NATURE, V367, P568, DOI 10.1038/367568a0; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kanai K, 2010, GENES CELLS, V15, P971, DOI 10.1111/j.1365-2443.2010.01431.x; Kaneto H, 2002, J BIOL CHEM, V277, P30010, DOI 10.1074/jbc.M202066200; Kaneto H, 2005, J BIOL CHEM, V280, P15047, DOI 10.1074/jbc.M412013200; Kataoka K, 2002, J BIOL CHEM, V277, P49903, DOI 10.1074/jbc.M206796200; Kataoka K, 2004, J MOL ENDOCRINOL, V32, P9, DOI 10.1677/jme.0.0320009; Kataoka K, 2001, J BIOL CHEM, V276, P819, DOI 10.1074/jbc.M007643200; Kemp DM, 2001, ENDOCRINOLOGY, V142, P1179, DOI 10.1210/en.142.3.1179; Marshak S, 1996, P NATL ACAD SCI USA, V93, P15057, DOI 10.1073/pnas.93.26.15057; Matsuoka T, 2003, MOL CELL BIOL, V23, P6049, DOI 10.1128/MCB.23.17.6049-6062.2003; NAYA FJ, 1995, GENE DEV, V9, P1009, DOI 10.1101/gad.9.8.1009; Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323; Offield MF, 1996, DEVELOPMENT, V122, P983; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; Olbrot M, 2002, P NATL ACAD SCI USA, V99, P6737, DOI 10.1073/pnas.102168499; PETERSEN HV, 1994, P NATL ACAD SCI USA, V91, P10465, DOI 10.1073/pnas.91.22.10465; SHARMA A, 1995, MOL ENDOCRINOL, V9, P1468, DOI 10.1210/me.9.11.1468; SHIEH SY, 1991, J BIOL CHEM, V266, P16708; Solinas G, 2006, P NATL ACAD SCI USA, V103, P16454, DOI 10.1073/pnas.0607626103; van Dam H, 2001, ONCOGENE, V20, P2453, DOI 10.1038/sj.onc.1204239; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005; Zhao L, 2005, J BIOL CHEM, V280, P11887, DOI 10.1074/jbc.M409475200	33	29	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10449	10456		10.1074/jbc.M110.209510	http://dx.doi.org/10.1074/jbc.M110.209510			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21278380	Green Published, hybrid			2022-12-27	WOS:000288547000061
J	Sharma, V; Freeze, HH				Sharma, Vandana; Freeze, Hudson H.			Mannose Efflux from the Cells A POTENTIAL SOURCE OF MANNOSE IN BLOOD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE POLYMANNOSE OLIGOSACCHARIDES; ENDOPLASMIC-RETICULUM; GLUCOSE-TRANSPORT; GLYCOPROTEIN-BIOSYNTHESIS; HEXOKINASE; METABOLISM; MEMBRANE; GLYCOGEN; CYTOSOL; PERMEABILITY	All mammals have 50-100 mu M mannose in their blood. However, the source of the dynamic pool of mannose in blood is unknown. Most of it is thought to be derived from glucose in the cells. We studied mannose uptake and release by various cell types. Interestingly, our results show that mannose taken up by the cells through transporters is handled differently from the mannose released within the cells due to glycan processing of protein-bound oligosaccharides. Although more than 95% of incoming mannose is catabolized, most of the mannose released by intracellular processing is expelled from the cells as free mannose predominantly via a nocodazole-sensitive sugar transporter. Under physiological conditions, incoming mannose is more accessible to hexokinase, whereas mannose released within the cells is protected from HK and therefore has a different fate. Our data also suggest that generation of free mannose due to the processing of glycoconjugates composed of glucose-derived mannose and its efflux from the cells can account for most of the mannose found in blood and its steady state maintenance.	[Sharma, Vandana; Freeze, Hudson H.] Sanford Childrens Hlth Res Ctr, Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Freeze, HH (corresponding author), Sanford Childrens Hlth Res Ctr, Sanford Burnham Med Res Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hudson@sanfordburnham.org		Freeze, Hudson/0000-0001-6316-0501	National Institutes of Health [R01GM55695, R01DK55615, R21HD062914]; Sanford Professorship; Rocket Williams Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD062914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055695] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sanford Professorship; Rocket Williams Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM55695, R01DK55615, and R21HD062914. This work was also supported by a Sanford Professorship (to H. H. F.) and by the Rocket Williams Fund.	Alton G, 1998, GLYCOBIOLOGY, V8, P285, DOI 10.1093/glycob/8.3.285; ANUMULA KR, 1983, J BIOL CHEM, V258, P5274; BUNN HF, 1981, SCIENCE, V213, P222, DOI 10.1126/science.12192669; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Davis JA, 2001, BBA-GEN SUBJECTS, V1528, P116, DOI 10.1016/S0304-4165(01)00183-0; DEERY WJ, 1981, BIOCHEMISTRY-US, V20, P2316, DOI 10.1021/bi00511a038; DeRossi C, 2006, J BIOL CHEM, V281, P5916, DOI 10.1074/jbc.M511982200; DROSE S, 1993, BIOCHEMISTRY-US, V32, P3902, DOI 10.1021/bi00066a008; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fehr M, 2005, MOL CELL BIOL, V25, P11102, DOI 10.1128/MCB.25.24.11102-11112.2005; FREEZE HH, 2010, CURRENT PROTOCOLS IM, pCH8; Gao NG, 2005, J BIOL CHEM, V280, P17901, DOI 10.1074/jbc.M500510200; Gomis RR, 2002, J BIOL CHEM, V277, P23246, DOI 10.1074/jbc.M111208200; Hardin CD, 1998, AM J PHYSIOL-CELL PH, V274, pC88, DOI 10.1152/ajpcell.1998.274.1.C88; HOEBEKE J, 1976, BIOCHEM BIOPH RES CO, V69, P319, DOI 10.1016/0006-291X(76)90524-6; HUBBARD SC, 1980, J BIOL CHEM, V255, P1782; Karaivanova VK, 2000, GLYCOBIOLOGY, V10, P727, DOI 10.1093/glycob/10.7.727; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; LYNCH RM, 1991, J CELL BIOL, V112, P385, DOI 10.1083/jcb.112.3.385; MALAISSE WJ, 1991, INT J BIOCHEM, V23, P1471, DOI 10.1016/0020-711X(91)90290-4; MANCINI GMS, 1990, J BIOL CHEM, V265, P12380; Marcolongo P, 1996, BIOCHEM BIOPH RES CO, V219, P916, DOI 10.1006/bbrc.1996.0333; Marieb E, 2007, HUMAN ANATOMY PHYSL, P317; MENDES P, 1995, ADV MOL CELL BIOL, V11, P1; Molero JC, 2001, J BIOL CHEM, V276, P43829, DOI 10.1074/jbc.M105452200; MOORE SEH, 1995, EMBO J, V14, P6034, DOI 10.1002/j.1460-2075.1995.tb00292.x; Ovadi J, 2000, INT REV CYTOL, V192, P255; Panneerselvam K, 1997, BIOCHEM MOL MED, V61, P161, DOI 10.1006/bmme.1997.2599; Panneerselvam K, 1996, J BIOL CHEM, V271, P9417, DOI 10.1074/jbc.271.16.9417; PEDLEY KC, 1993, BIOCHEM J, V291, P515, DOI 10.1042/bj2910515; Rauch MC, 2006, J CELL PHYSIOL, V207, P397, DOI 10.1002/jcp.20582; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; Shang J, 2004, J BIOL CHEM, V279, P12076, DOI 10.1074/jbc.M400431200; Stanley P, 2008, ESSENTIALS GLYCOBIOL, P101; Suzuki T, 2002, GLYCOBIOLOGY, V12, P803, DOI 10.1093/glycob/cwf095; Taguchi T, 2005, AM J PHYSIOL-ENDOC M, V288, pE534, DOI 10.1152/ajpendo.00451.2004; WOOD FC, 1963, J CLIN INVEST, V42, P1300, DOI 10.1172/JCI104814; WOOD RE, 1968, BIOCHIM BIOPHYS ACTA, V163, P171, DOI 10.1016/0005-2736(68)90095-3	38	31	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10193	10200		10.1074/jbc.M110.194241	http://dx.doi.org/10.1074/jbc.M110.194241			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21273394	Green Published, hybrid			2022-12-27	WOS:000288547000035
J	Kristiansen, GK; Andersen, MD				Kristiansen, Gunhild Klarskov; Andersen, Mette Dahl			Reversible Activation of Cellular Factor XIII by Calcium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGULATION-FACTOR-XIII; HUMAN-BLOOD PLATELETS; MALDI-TOF MS; CROSS-LINKING; TISSUE TRANSGLUTAMINASE; BINDING; FIBRINOGEN; THROMBIN; PEPTIDE; MOUSE	Factor XIII (FXIII) is a pro-transglutaminase found in the plasma as well as intracellularly in platelets and macrophages. Plasma FXIII is activated by thrombin cleavage (FXIIIa*) and acts in the final stages of blood coagulation cascade. In contrast, the function and activation of cellular FXIII are less characterized. Cellular FXIII relies on a conformational activation of the protein. The nonproteolytic activation of FXIII to FXIIIa degrees induced by Ca2+ alone is well known, but up until now it has been discussed under which conditions the process can be induced and whether it can be reversed. Here, we study the nature of the Ca2+ -induced FXIII activation. Previously used methods to evaluate FXIII activity detect both FXIIIa* and FXIIIa degrees because they rely on occurrence of enzyme activity or on active site Cys-314 solvent accessibility. Therefore, an analytical HPLC method was developed that separates zymogen recombinant FXIII (rFXIII) from rFXIIIa degrees. The data demonstrate that nonproteolytic activation and deactivation are highly dependent on Ca2+ concentration, buffer, and salt components. Moreover, it is established that Ca2+ activation of rFXIII is fully reversible, and only 2-5 mM CaCl2 is sufficient to retain full rFXIIIa degrees activity. However, below 2 mM CaCl2 the rFXIIIa degrees molecule deactivates. The deactivated molecule can subsequently undergo a new activation round. Furthermore, it is demonstrated that thermal stress of freeze-dried rFXIII can induce a new predisposed form that activates faster than nonstressed rFXIII.	[Kristiansen, Gunhild Klarskov] Novo Nordisk AS, Dept Prot Characterizat, DK-2760 Malov, Denmark; [Andersen, Mette Dahl] Novo Nordisk AS, Dept Prot Struct & Biophys, DK-2760 Malov, Denmark	Novo Nordisk; Novo Nordisk	Kristiansen, GK (corresponding author), Novo Nordisk AS, Dept Prot Characterizat, Novo Nordisk Pk, DK-2760 Malov, Denmark.	GKK@novonordisk.com						AbdAlla S, 2004, CELL, V119, P343, DOI 10.1016/j.cell.2004.10.006; Adany R, 2003, CELL MOL LIFE SCI, V60, P1049, DOI 10.1007/s00018-003-2178-9; Ahvazi B, 2003, J BIOL CHEM, V278, P23834, DOI 10.1074/jbc.M301162200; Ambrus A, 2001, J BIOMOL STRUCT DYN, V19, P59, DOI 10.1080/07391102.2001.10506720; ANDERSEN MD, 2002, EMBO J, V21, P2055; Ariens RAS, 2002, BLOOD, V100, P743, DOI 10.1182/blood.V100.3.743; ASIJEE GM, 1988, BIOCHIM BIOPHYS ACTA, V954, P303, DOI 10.1016/0167-4838(88)90085-4; Begg GE, 2006, P NATL ACAD SCI USA, V103, P19683, DOI 10.1073/pnas.0609283103; BISHOP PD, 1990, BIOCHEMISTRY-US, V29, P1861, DOI 10.1021/bi00459a028; Candi E, 2004, BIOCHEM J, V381, P313, DOI 10.1042/BJ20031474; CREDO RB, 1978, P NATL ACAD SCI USA, V75, P4234, DOI 10.1073/pnas.75.9.4234; DEBACKERROYER C, 1992, INT J BIOCHEM, V24, P91, DOI 10.1016/0020-711X(92)90234-R; Fox BA, 1999, J BIOL CHEM, V274, P4917, DOI 10.1074/jbc.274.8.4917; HORNYAK TJ, 1992, BIOCHEMISTRY-US, V31, P423, DOI 10.1021/bi00117a017; Iismaa SE, 2009, PHYSIOL REV, V89, P991, DOI 10.1152/physrev.00044.2008; KIM IG, 1993, J BIOL CHEM, V268, P12682; KIM SY, 1995, J BIOL CHEM, V270, P18026, DOI 10.1074/jbc.270.30.18026; Komaromi I, 2011, J THROMB HAEMOST, V9, P9, DOI 10.1111/j.1538-7836.2010.04070.x; Lee CH, 2002, AM J PHYSIOL-HEART C, V282, pH1571, DOI 10.1152/ajpheart.01035.2001; LEWIS BA, 1978, BIOCHEM J, V169, P397, DOI 10.1042/bj1690397; LI LW, 1995, CELL GROWTH DIFFER, V6, P1171; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; LOPACIUK S, 1976, THROMB RES, V8, P453, DOI 10.1016/0049-3848(76)90223-1; LORAND L, 1981, METHOD ENZYMOL, V80, P333; Lorand L, 2005, J THROMB HAEMOST, V3, P1337, DOI 10.1111/j.1538-7836.2005.01213.x; LORAND L, 1976, P NATL ACAD SCI USA, V73, P4479, DOI 10.1073/pnas.73.12.4479; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; LORAND L, 1980, MEMBRANE TRANSPORT E, P285; Lorand L, 2007, FASEB J, V21, P1627, DOI 10.1096/fj.07-0602ufm; MUSZBEK L, 1995, THROMB HAEMOSTASIS, V73, P702; MUSZBEK L, 1993, THROMB HAEMOSTASIS, V69, P282; Muszbek L, 1999, THROMB RES, V94, P271, DOI 10.1016/S0049-3848(99)00023-7; Muszbek L, 2007, J THROMB HAEMOST, V5, P181, DOI 10.1111/j.1538-7836.2006.02182.x; Muszbek L., 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P190, DOI 10.2174/187152508784871990; Nemes Z, 1999, J BIOL CHEM, V274, P11013, DOI 10.1074/jbc.274.16.11013; Oertel K, 2007, ANAL BIOCHEM, V367, P152, DOI 10.1016/j.ab.2007.05.011; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; POCH E, 1995, NEPHROL DIAL TRANSPL, V10, P366; POLGAR J, 1990, BIOCHEM J, V267, P557, DOI 10.1042/bj2670557; RINK TJ, 1990, ANNU REV PHYSIOL, V52, P431, DOI 10.1146/annurev.ph.52.030190.002243; Sabo TM, 2007, BIOCHEMISTRY-US, V46, P10089, DOI 10.1021/bi700579z; Serrano K, 2002, THROMB HAEMOSTASIS, V88, P315; SIEFRING GE, 1978, BIOCHEMISTRY-US, V17, P2598, DOI 10.1021/bi00606a022; SIXMA JJ, 1984, THROMB HAEMOSTASIS, V51, P388; Smethurst PA, 1996, BIOCHEM J, V313, P803, DOI 10.1042/bj3130803; Turner BT, 2002, BIOCHEMISTRY-US, V41, P7947, DOI 10.1021/bi025630n; Weiss MS, 1998, FEBS LETT, V423, P291, DOI 10.1016/S0014-5793(98)00098-2; YEE VC, 1995, THROMB RES, V78, P389, DOI 10.1016/0049-3848(95)00072-Y; YEE VC, 1994, P NATL ACAD SCI USA, V91, P7296, DOI 10.1073/pnas.91.15.7296	49	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9833	9839		10.1074/jbc.M110.174128	http://dx.doi.org/10.1074/jbc.M110.174128			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21245142	hybrid, Green Published			2022-12-27	WOS:000288247700106
J	Oelze, M; Knorr, M; Schell, R; Kamuf, J; Pautz, A; Art, J; Wenzel, P; Munzel, T; Kleinert, H; Daiber, A				Oelze, Matthias; Knorr, Maike; Schell, Richard; Kamuf, Jens; Pautz, Andrea; Art, Julia; Wenzel, Philip; Muenzel, Thomas; Kleinert, Hartmut; Daiber, Andreas			Regulation of Human Mitochondrial Aldehyde Dehydrogenase (ALDH-2) Activity by Electrophiles in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; ORGANIC NITRATES; MODEL SYSTEMS; NITROGLYCERIN; INHIBITION; BIOACTIVATION; DEFICIENCY; PEROXYNITRITE; TETRANITRATE	Recently, mitochondrial aldehyde dehydrogenase (ALDH-2) was reported to reduce ischemic damage in an experimental myocardial infarction model. ALDH-2 activity is redox-sensitive. Therefore, we here compared effects of various electrophiles (organic nitrates, reactive fatty acid metabolites, or oxidants) on the activity of ALDH-2 with special emphasis on organic nitrate-induced inactivation of the enzyme, the biochemical correlate of nitrate tolerance. Recombinant human ALDH-2 was overexpressed in Escherichia coli; activity was determined with an HPLC-based assay, and reactive oxygen and nitrogen species formation was determined by chemiluminescence, fluorescence, protein tyrosine nitration, and diaminonaphthalene nitrosation. The organic nitrate glyceryl trinitrate caused a severe concentration-dependent decrease in enzyme activity, whereas incubation with pentaerythritol tetranitrate had only minor effects. 4-Hydroxynonenal, an oxidized prostaglandin J(2), and 9- or 10-nitrooleate caused a significant inhibition of ALDH-2 activity, which was improved in the presence of Mg2+ and Ca2+. Hydrogen peroxide and NO generation caused only minor inhibition of ALDH-2 activity, whereas peroxynitrite generation or bolus additions lead to severe impairment of the enzymatic activity, which was prevented by the thioredoxin/ thioredoxin reductase (Trx/TrxR) system. In the presence of glyceryl trinitrate and to a lesser extent pentaerythritol tetranitrate, ALDH-2 may be switched to a peroxynitrite synthase. Electrophiles of different nature potently regulate the enzymatic activity of ALDH-2 and thereby may influence the resistance to ischemic damage in response to myocardial infarction. The Trx/TrxR system may play an important role in this process because it not only prevents inhibition of ALDH-2 but is also inhibited by the ALDH-2 substrate 4-hydroxynonenal.	[Daiber, Andreas] Johannes Gutenberg Univ Mainz, Univ Med, Med Klin 2, Lab Mol Kardiol, D-55101 Mainz, Germany; [Pautz, Andrea; Art, Julia; Kleinert, Hartmut] Johannes Gutenberg Univ Mainz, Inst Pharmakol, D-55101 Mainz, Germany	Johannes Gutenberg University of Mainz; University of Hamburg; University Medical Center Hamburg-Eppendorf; Johannes Gutenberg University of Mainz	Daiber, A (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med, Med Klin 2, Lab Mol Kardiol, Obere Zahlbacher Str 63, D-55101 Mainz, Germany.	andreas.daiber@bioredox.com	Wenzel, Philip/Z-1503-2019; Wenzel, Philip/HIA-0033-2022; Kleinert, Hartmut/M-2988-2018; Munzel, Thomas/A-2912-2014	Wenzel, Philip/0000-0002-5397-2781; Wenzel, Philip/0000-0002-5397-2781; Kleinert, Hartmut/0000-0003-2202-3548; Munzel, Thomas/0000-0001-5503-4150	Johannes Gutenberg University; Actavis Deutschland GmbH, Langenfeld, Germany; University Medical Center Mainz (MAIFOR)	Johannes Gutenberg University; Actavis Deutschland GmbH, Langenfeld, Germany; University Medical Center Mainz (MAIFOR)	This work was supported by generous financial support by the Johannes Gutenberg University and University Medical Center Mainz (MAIFOR and Forschungsfonds grants to A. D.). This paper contains results that are part of the doctoral thesis of R. S.; A. D. received honoraries and research support from Actavis Deutschland GmbH, Langenfeld, Germany (manufacturer of PETN).	Beretta M, 2008, J BIOL CHEM, V283, P17873, DOI [10.1074/jbc.M801182200, 10.1074/jbc.M804001200]; Budas GR, 2009, TRENDS CARDIOVAS MED, V19, P158, DOI 10.1016/j.tcm.2009.09.003; Chalmers S, 2003, J BIOL CHEM, V278, P19062, DOI 10.1074/jbc.M212661200; Chen CH, 2008, SCIENCE, V321, P1493, DOI 10.1126/science.1158554; Chen ZQ, 2005, P NATL ACAD SCI USA, V102, P12159, DOI 10.1073/pnas.0503723102; Chen ZQ, 2002, P NATL ACAD SCI USA, V99, P8306, DOI 10.1073/pnas.122225199; Daiber A, 2005, MOL PHARMACOL, V68, P579, DOI 10.1124/mol.105.011585; Daiber A, 2004, MOL PHARMACOL, V66, P1372, DOI 10.1124/mol.104.002600; Daiber A, 2004, FREE RADICAL RES, V38, P259, DOI 10.1080/10715760410001659773; Daiber A, 2004, FREE RADICAL BIO MED, V36, P101, DOI 10.1016/j.freeradbiomed.2003.10.012; Daiber A, 2003, NITRIC OXIDE-BIOL CH, V9, P44, DOI 10.1016/j.niox.2003.08.002; Daiber A, 2009, FREE RADICAL BIO MED, V47, P458, DOI 10.1016/j.freeradbiomed.2009.05.019; Doorn JA, 2006, CHEM RES TOXICOL, V19, P102, DOI 10.1021/tx0501839; Endo J, 2009, CIRC RES, V105, P1118, DOI 10.1161/CIRCRESAHA.109.206607; Fang JG, 2006, J AM CHEM SOC, V128, P1879, DOI 10.1021/ja057358l; Florang VR, 2007, NEUROTOXICOLOGY, V28, P76, DOI 10.1016/j.neuro.2006.07.018; GOEDDE HW, 1992, HUM GENET, V88, P344; Gori T, 2009, AM J CARDIOVASC DRUG, V9, P7, DOI 10.2165/00129784-200909010-00002; Hink U, 2003, J AM COLL CARDIOL, V42, P1826, DOI 10.1016/j.jacc.2003.07.009; HJELLE JJ, 1982, TOXICOL LETT, V14, P35, DOI 10.1016/0378-4274(82)90007-8; HJELLE JJ, 1983, TOXICOL APPL PHARM, V70, P57, DOI 10.1016/0041-008X(83)90179-5; Ma H, 2011, EUR HEART J, V32, P1025, DOI 10.1093/eurheartj/ehq253; Mackenzie IS, 2005, ARTERIOSCL THROM VAS, V25, P1891, DOI 10.1161/01.ATV.0000179599.71086.89; Munzel T, 2005, CIRC RES, V97, P618, DOI 10.1161/01.RES.0000184694.03262.6d; Nakamura Y, 1999, AM HEART J, V138, P577, DOI 10.1016/S0002-8703(99)70163-8; Nikitovic D, 1996, J BIOL CHEM, V271, P19180, DOI 10.1074/jbc.271.32.19180; Pautz A, 2009, PHYSIOL GENOMICS, V38, P176, DOI 10.1152/physiolgenomics.00035.2009; Sydow K, 2004, J CLIN INVEST, V113, P482, DOI 10.1172/JCI200419267; Wenzel P, 2007, BRIT J PHARMACOL, V150, P526, DOI 10.1038/sj.bjp.0707116; Wenzel P, 2008, CARDIOVASC RES, V80, P280, DOI 10.1093/cvr/cvn182; Wenzel P, 2008, BIOCHEM BIOPH RES CO, V367, P137, DOI 10.1016/j.bbrc.2007.12.089; Wenzel P, 2007, ARTERIOSCL THROM VAS, V27, P1729, DOI 10.1161/ATVBAHA.107.143909; Wenzel P, 2007, J BIOL CHEM, V282, P792, DOI 10.1074/jbc.M606477200; Wenzl MV, 2009, J BIOL CHEM, V284, P19878, DOI 10.1074/jbc.M109.005652; XIAO Q, 1995, J CLIN INVEST, V96, P2180, DOI 10.1172/JCI118272	35	33	33	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8893	8900		10.1074/jbc.M110.190017	http://dx.doi.org/10.1074/jbc.M110.190017			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21252222	hybrid, Green Published			2022-12-27	WOS:000288247700020
J	Jimenez, RM; Delwart, E; Luptak, A				Jimenez, Randi M.; Delwart, Eric; Luptak, Andrej			Structure-based Search Reveals Hammerhead Ribozymes in the Human Microbiome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELF-CLEAVING RIBOZYMES; HEPATITIS-DELTA-VIRUS; CATALYTIC DIVERSITY; MESSENGER-RNA; ACTIVE-SITE; CLEAVAGE; SEQUENCE; TRANSCRIPTS; SAMPLES; MOTIFS	Deep sequencing of viral or bacterial nucleic acids monitors the presence and diversity of microbes in select populations and locations. Metagenomic study of mammalian viromes can help trace paths of viral transmissions within or between species. High throughput sequencing of patient and untreated sewage microbiomes showed many sequences with no similarity to genomic sequences of known function or origin. To estimate the distribution of functional RNAs in these microbiomes, we used the hammerhead ribozyme (HHR) motif to search for sequences capable of assuming its three-way junction fold. Although only two of the three possible natural HHR topologies had been known, our analysis revealed highly active ribozymes that terminated in any of the three stems. The most abundant of these are type II HHRs, one of which is the fastest natural cis-acting HHR yet discovered. Altogether, 13 ribozymes were confirmed in vitro, but only one showed sequence similarity to previously described HHRs. Sequences surrounding the ribozymes do not generally show similarity to known genes, except in one case, where a ribozyme is immediately preceded by a bacterial RadC gene. We demonstrate that a structure-based search for a known functional RNA is a powerful tool for analysis of metagenomic datasets, complementing sequence alignments.	[Jimenez, Randi M.; Luptak, Andrej] Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92697 USA; [Luptak, Andrej] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA; [Luptak, Andrej] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Delwart, Eric] Univ Calif San Francisco, Blood Syst Res Inst, San Francisco, CA 94118 USA; [Delwart, Eric] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94118 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California San Francisco; Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco	Luptak, A (corresponding author), Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92697 USA.	aluptak@uci.edu		Delwart, Eric/0000-0002-6296-4484	National Institutes of Health [R01 GM094929, R01 HL083254]; University of California, Irvine; Pew Charitable Funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083254] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094929] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, Irvine(University of California System); Pew Charitable Funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM094929 (to A. L.) and R01 HL083254 (to E. D.). This work was also supported by the University of California, Irvine, startup funds and the Pew Charitable Funds (to A. L.).	Blinkova O, 2009, J CLIN MICROBIOL, V47, P3507, DOI 10.1128/JCM.01062-09; Bourdeau V, 1999, NUCLEIC ACIDS RES, V27, P4457, DOI 10.1093/nar/27.22.4457; Canny MD, 2007, BIOCHEMISTRY-US, V46, P3826, DOI 10.1021/bi062077r; Canny MD, 2004, J AM CHEM SOC, V126, P10848, DOI 10.1021/ja046848v; Cech TR, 2002, BIOCHEM SOC T, V30, P1162, DOI 10.1042/BST0301162; De la Pena M, 2003, EMBO J, V22, P5561, DOI 10.1093/emboj/cdg530; De la Pena M, 2001, J BIOL CHEM, V276, P34586, DOI 10.1074/jbc.M103867200; de la Pena M, 2010, RNA, V16, P1943, DOI 10.1261/rna.2130310; de la Pena M, 2010, EMBO REP, V11, P711, DOI 10.1038/embor.2010.100; Dufour D, 2009, NUCLEIC ACIDS RES, V37, P368, DOI 10.1093/nar/gkn918; Eickbush DG, 2010, MOL CELL BIOL, V30, P3142, DOI 10.1128/MCB.00300-10; EPSTEIN LM, 1987, COLD SPRING HARB SYM, V52, P261, DOI 10.1101/SQB.1987.052.01.031; Fedor MJ, 2005, NAT REV MOL CELL BIO, V6, P399, DOI 10.1038/nrm1647; Ferbeyre G, 2000, GENOME RES, V10, P1011, DOI 10.1101/gr.10.7.1011; Ferbeyre G, 1998, MOL CELL BIOL, V18, P3880, DOI 10.1128/MCB.18.7.3880; FORSTER AC, 1987, CELL, V50, P9, DOI 10.1016/0092-8674(87)90657-X; Gesteland R.F., 2006, RNA WORLD NATURE MOD, V3rd; HAMPEL A, 1989, BIOCHEMISTRY-US, V28, P4929, DOI 10.1021/bi00438a002; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Khvorova A, 2003, NAT STRUCT BIOL, V10, P708, DOI 10.1038/nsb959; Kore AR, 1998, NUCLEIC ACIDS RES, V26, P4116, DOI 10.1093/nar/26.18.4116; Li LL, 2010, J VIROL, V84, P6955, DOI 10.1128/JVI.00501-10; Martick M, 2008, NATURE, V454, P899, DOI 10.1038/nature07117; Martick M, 2006, CELL, V126, P309, DOI 10.1016/j.cell.2006.06.036; Menger M, 2000, NUCLEIC ACIDS RES, V28, P4428, DOI 10.1093/nar/28.22.4428; Nelson JA, 2006, MOL CELL, V23, P447, DOI 10.1016/j.molcel.2006.08.001; Nielsen H, 2005, SCIENCE, V309, P1584, DOI 10.1126/science.1113645; Nielsen H, 2009, RNA BIOL, V6, P375, DOI 10.4161/rna.6.4.9334; PRODY GA, 1986, SCIENCE, V231, P1577, DOI 10.1126/science.231.4745.1577; Riccitelli NJ, 2010, METHODS, V52, P133, DOI 10.1016/j.ymeth.2010.06.005; Rojas AA, 2000, NUCLEIC ACIDS RES, V28, P4037, DOI 10.1093/nar/28.20.4037; Roychowdhury-Saha M, 2006, RNA, V12, P1846, DOI 10.1261/rna.128906; Salehi-Ashtiani K, 2001, NATURE, V414, P82, DOI 10.1038/35102081; Salehi-Ashtiani K, 2006, SCIENCE, V313, P1788, DOI 10.1126/science.1129308; SAVILLE BJ, 1990, CELL, V61, P685, DOI 10.1016/0092-8674(90)90480-3; Scott WG, 2009, BBA-GENE REGUL MECH, V1789, P634, DOI 10.1016/j.bbagrm.2009.09.006; Seehafer C, 2011, RNA, V17, P21, DOI 10.1261/rna.2429911; SHARMEEN L, 1988, J VIROL, V62, P2674, DOI 10.1128/JVI.62.8.2674-2679.1988; Shepotitiovskaya IV, 2008, BIOCHEMISTRY-US, V47, P7034, DOI 10.1021/bi7025358; Sperschneider J, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq021; Symonds EM, 2009, APPL ENVIRON MICROB, V75, P1402, DOI 10.1128/AEM.01899-08; Tang J, 2000, P NATL ACAD SCI USA, V97, P5784, DOI 10.1073/pnas.97.11.5784; TUSCHL T, 1994, SCIENCE, V266, P785, DOI 10.1126/science.7973630; Victoria JG, 2010, J VIROL, V84, P6033, DOI 10.1128/JVI.02690-09; Victoria JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08; Webb CHT, 2009, SCIENCE, V326, P953, DOI 10.1126/science.1178084; Winkler WC, 2004, NATURE, V428, P281, DOI 10.1038/nature02362; WU HN, 1989, P NATL ACAD SCI USA, V86, P1831, DOI 10.1073/pnas.86.6.1831	48	38	39	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7737	7743		10.1074/jbc.C110.209288	http://dx.doi.org/10.1074/jbc.C110.209288			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21257745	Green Published, hybrid			2022-12-27	WOS:000288013300005
J	Chen, D; Vollmar, M; Rossi, MN; Phillips, C; Kraehenbuehl, R; Slade, D; Mehrotra, PV; von Delft, F; Crosthwaite, SK; Gileadi, O; Denu, JM; Ahel, I				Chen, Dawei; Vollmar, Melanie; Rossi, Marianna N.; Phillips, Claire; Kraehenbuehl, Rolf; Slade, Dea; Mehrotra, Pawan V.; von Delft, Frank; Crosthwaite, Susan K.; Gileadi, Opher; Denu, John M.; Ahel, Ivan			Identification of Macrodomain Proteins as Novel O-Acetyl-ADP-ribose Deacetylases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACRO DOMAIN; CHROMATIN; BINDING; GENE; MECHANISM; PRODUCT; FAMILY	Sirtuins are a family of protein lysine deacetylases, which regulate gene silencing, metabolism, life span, and chromatin structure. Sirtuins utilize NAD(+) to deacetylate proteins, yielding O-acetyl-ADP-ribose (OAADPr) as a reaction product. The macrodomain is a ubiquitous protein module known to bind ADP-ribose derivatives, which diverged through evolution to support many different protein functions and pathways. The observation that some sirtuins and macrodomains are physically linked as fusion proteins or genetically coupled through the same operon, provided a clue that their functions might be connected. Indeed, here we demonstrate that the product of the sirtuin reaction OAADPr is a substrate for several related macrodomain proteins: human MacroD1, human MacroD2, Escherichia colt YmdB, and the sirtuin-linked MacroD-like protein from Staphylococcus aureus. In addition, we show that the cell extracts derived from MacroD-deficient Neurospora crassa strain exhibit a major reduction in the ability to hydrolyze OAADPr. Our data support a novel function of macrodomains as OAADPr deacetylases and potential in vivo regulators of cellular OAADPr produced by NAD(+)-dependent deacetylation.	[Chen, Dawei; Denu, John M.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; [Chen, Dawei; Denu, John M.] Univ Wisconsin, Wisconsin Inst Discovery, Madison, WI 53706 USA; [Vollmar, Melanie; Phillips, Claire; von Delft, Frank; Gileadi, Opher] Univ Oxford, ORCRB, Struct Genom Consortium, Oxford OX3 7DQ, England; [Rossi, Marianna N.; Kraehenbuehl, Rolf; Slade, Dea; Mehrotra, Pawan V.; Ahel, Ivan] Univ Manchester, Paterson Inst Canc Res, DNA Damage Response Grp, Manchester M20 4BX, Lancs, England; [Slade, Dea] Univ Paris 05, INSERM, Fac Med, U1001, F-75015 Paris, France; [Crosthwaite, Susan K.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Oxford; Paterson Institute for Cancer Research; University of Manchester; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Manchester	Denu, JM (corresponding author), Univ Wisconsin, Dept Biomol Chem, 1300 Univ Ave, Madison, WI 53706 USA.	jmdenu@wisc.edu; IAhel@picr.man.ac.uk	Gileadi, Opher/F-1105-2013; Rossi, Marianna Nicoletta/S-5083-2019	Gileadi, Opher/0000-0001-6886-898X; Rossi, Marianna Nicoletta/0000-0003-4485-7738; Kraehenbuehl, Rolf/0000-0003-2578-5601; Vollmar, Melanie/0000-0002-9162-9159; Ahel, Ivan/0000-0002-9446-3756; von Delft, Frank/0000-0003-0378-0017; Slade, Dea/0000-0002-0052-5910	Canadian Institutes fin. Health Research [1097737]; Canadian Foundation for Innovation; Genome Canada through Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; National Institutes of Health [GM065386]; Cancer Research UK; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM059785, R01GM065386] Funding Source: NIH RePORTER	Canadian Institutes fin. Health Research; Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Structural Genomics Consortium (SGC) is a registered charity (number 1097737) that receives funds from the Canadian Institutes fin. Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust.; This work was supported, in whole or in part by National Institutes of Health Grant GM065386 to J. M. D.) and by Cancer Research UK (to I. A.).	Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Ahel I, 2008, NATURE, V451, P81, DOI 10.1038/nature06420; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Borra MT, 2002, J BIOL CHEM, V277, P12632, DOI 10.1074/jbc.M111830200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Comstock LR, 2007, ORG BIOMOL CHEM, V5, P3087, DOI 10.1039/b710231c; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Davis R.H., 1970, METHODS ENZYMOL, V17, P79, DOI [10.1016/0076-6879(71)17168-6, DOI 10.1016/0076-6879(71)17168-6]; Egloff MP, 2006, J VIROL, V80, P8493, DOI 10.1128/JVI.00713-06; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Garceau NY, 1997, CELL, V89, P469, DOI 10.1016/S0092-8674(00)80227-5; Garrity J, 2007, J BIOL CHEM, V282, P30239, DOI 10.1074/jbc.M704409200; Hallows WC, 2009, CELL, V137, P404, DOI 10.1016/j.cell.2009.04.036; Han WD, 2003, ENDOCR-RELAT CANCER, V10, P217, DOI 10.1677/erc.0.0100217; Hoff KG, 2005, NAT STRUCT MOL BIOL, V12, P560, DOI 10.1038/nsmb0705-560; Jackson AD, 2002, J BIOL CHEM, V277, P18535, DOI 10.1074/jbc.M200671200; Jackson MD, 2003, J BIOL CHEM, V278, P50985, DOI 10.1074/jbc.M306552200; Karras GI, 2005, EMBO J, V24, P1911, DOI 10.1038/sj.emboj.7600664; Kraus WL, 2009, NAT STRUCT MOL BIOL, V16, P904, DOI 10.1038/nsmb0909-904; Kumaran D, 2005, PROTEIN SCI, V14, P719, DOI 10.1110/ps.041132005; Kustatscher G, 2005, NAT STRUCT MOL BIOL, V12, P624, DOI 10.1038/nsmb956; Ladurner AG, 2003, MOL CELL, V12, P1, DOI 10.1016/S1097-2765(03)00284-3; Lee S, 2008, ANAL BIOCHEM, V383, P174, DOI 10.1016/j.ab.2008.08.033; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Maas NMC, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.049510; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neuvonen M, 2009, J MOL BIOL, V385, P212, DOI 10.1016/j.jmb.2008.10.045; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Ono T, 2006, P NATL ACAD SCI USA, V103, P16687, DOI 10.1073/pnas.0607911103; Rafty LA, 2002, J BIOL CHEM, V277, P47114, DOI 10.1074/jbc.M208997200; Savitsky P, 2010, J STRUCT BIOL, V172, P3, DOI 10.1016/j.jsb.2010.06.008; Smith BC, 2008, CHEM BIOL, V15, P1002, DOI 10.1016/j.chembiol.2008.09.009; Tada M, 2010, CANCER SCI, V101, P1261, DOI 10.1111/j.1349-7006.2010.01500.x; Tanner KG, 2000, P NATL ACAD SCI USA, V97, P14178, DOI 10.1073/pnas.250422697; Till S, 2009, FRONT BIOSCI-LANDMRK, V14, P3246, DOI 10.2741/3448; Timinszky G, 2009, NAT STRUCT MOL BIOL, V16, P923, DOI 10.1038/nsmb.1664; Tong L, 2010, BBA-PROTEINS PROTEOM, V1804, P1617, DOI 10.1016/j.bbapap.2010.02.007; Tong L, 2009, J BIOL CHEM, V284, P11256, DOI 10.1074/jbc.M809790200	40	122	128	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13261	13271		10.1074/jbc.M110.206771	http://dx.doi.org/10.1074/jbc.M110.206771			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21257746	Green Published, hybrid			2022-12-27	WOS:000289282200047
J	Guo, L; Mishra, G; Taylor, K; Wang, XM				Guo, Liang; Mishra, Girish; Taylor, Kyle; Wang, Xuemin			Phosphatidic Acid Binds and Stimulates Arabidopsis Sphingosine Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE DILUTION KINETICS; PLANT STRESS RESPONSES; PHOSPHOLIPASE D-ALPHA; PLASMA-MEMBRANE; PROTEIN; SPHINGOSINE-1-PHOSPHATE; EXPRESSION; THALIANA; LOCALIZATION; ACTIVATION	Phosphatidic acid (PA) and phytosphingosine-1-phosphate (phyto-S1P) have both been identified as lipid messengers mediating plant response to abscisic acid (ABA). To determine the relationship of these messengers, we investigated the direct interaction of PA with Arabidopsis sphingosine kinases (SPHKs) that phosphorylate phytosphingosine to generate phyto-S1P. Two unique SPHK cDNAs were cloned from the annotated At4g21540 locus of Arabidopsis, and the two transcripts are differentially expressed in Arabidopsis tissues. Both SPHKs are catalytically active, phosphorylating various long-chain sphingoid bases (LCBs) and are associated with the tonoplast. They both interact with PA as demonstrated by lipid-filter binding, liposome binding, and surface plasmon resonance (SPR). SPHK1 and SPHK2 exhibited strong binding to 18:1/18:1, 16:0/18:1, and 16:0/18:2 PA, but poor binding to 16:0/16:0, 8:0/8:0, 18:0/18:0, and 18:2/18:2 PA. Surface dilution kinetics analysis indicates that PA stimulates SPHK activity by increasing the specificity constant through decreasing K-m(B). The results show that the annotated At4g21540 locus is actually comprised of two separate SPHK genes. PA binds to both SPHKs, and the interaction promotes lipid substrate binding to the catalytic site of the enzyme. The PA-SPHK interaction depends on the PA molecular species. The data suggest that these two Arabidopsis SPHKs are molecular targets of PA, and the PA stimulation of SPHK is part of the signaling networks in Arabidopsis.	[Wang, Xuemin] Univ Missouri, Dept Biol, St Louis, MO 63121 USA; Univ Missouri, Donald Danforth Plant Sci Ctr, St Louis, MO 63121 USA	University of Missouri System; University of Missouri Saint Louis; Donald Danforth Plant Science Center; University of Missouri System; University of Missouri Saint Louis	Wang, XM (corresponding author), Univ Missouri, Dept Biol, 8001 Nat Bridge Rd, St Louis, MO 63121 USA.	wangxue@umsl.edu	Guo, Liang/AAW-4739-2021; Wang, Xuemin/M-2853-2013	Guo, Liang/0000-0001-7191-5062; wang, xuemin/0000-0002-6251-6745	National Science Foundation [IOS-0818740]; United States Department of Agriculture [2007-35318-18393]	National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture(United States Department of Agriculture (USDA))	This work was supported by National Science Foundation Grant IOS-0818740 and United States Department of Agriculture Grant 2007-35318-18393.	Anthony RG, 2004, EMBO J, V23, P572, DOI 10.1038/sj.emboj.7600068; Bargmann BO, 2006, CURR OPIN PLANT BIOL, V9, P515, DOI 10.1016/j.pbi.2006.07.011; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; Coursol S, 2005, PLANT PHYSIOL, V137, P724, DOI 10.1104/pp.104.055806; Coursol S, 2003, NATURE, V423, P651, DOI 10.1038/nature01643; Delon C, 2004, J BIOL CHEM, V279, P44763, DOI 10.1074/jbc.M405771200; DENNIS EA, 1973, ARCH BIOCHEM BIOPHYS, V158, P485, DOI 10.1016/0003-9861(73)90540-7; Fan L, 1999, PLANT PHYSIOL, V119, P1371, DOI 10.1104/pp.119.4.1371; Foster DA, 2009, BBA-MOL CELL BIOL L, V1791, P949, DOI 10.1016/j.bbalip.2009.02.009; Hong YY, 2008, PLANT CELL, V20, P803, DOI 10.1105/tpc.107.056390; Jaquinod M, 2007, MOL CELL PROTEOMICS, V6, P394, DOI 10.1074/mcp.M600250-MCP200; Johnson KR, 2002, J BIOL CHEM, V277, P35257, DOI 10.1074/jbc.M203033200; Kooijman EE, 2007, J BIOL CHEM, V282, P11356, DOI 10.1074/jbc.M609737200; Kooijman EE, 2009, BBA-MOL CELL BIOL L, V1791, P881, DOI 10.1016/j.bbalip.2009.04.001; Li MY, 2009, BBA-MOL CELL BIOL L, V1791, P927, DOI 10.1016/j.bbalip.2009.02.017; Liang H, 2003, GENE DEV, V17, P2636, DOI 10.1101/gad.1140503; Lu BB, 2009, J BIOL CHEM, V284, P17420, DOI 10.1074/jbc.M109.016014; Lynch DV, 2009, TRENDS PLANT SCI, V14, P463, DOI 10.1016/j.tplants.2009.06.008; Marion J, 2008, PLANT J, V56, P169, DOI 10.1111/j.1365-313X.2008.03596.x; Markham JE, 2007, RAPID COMMUN MASS SP, V21, P1304, DOI 10.1002/rcm.2962; Melendez AJ, 2002, SEMIN IMMUNOL, V14, P49, DOI 10.1006/smim.2001.0341; Michaelson LV, 2009, PLANT PHYSIOL, V149, P487, DOI 10.1104/pp.108.129411; Mishra G, 2006, SCIENCE, V312, P264, DOI 10.1126/science.1123769; Ng CKY, 2001, NATURE, V410, P596, DOI 10.1038/35069092; Nishiura H, 2000, BIOCHEM SOC T, V28, P747, DOI 10.1042/BST0280747; Olivera A, 1998, J BIOL CHEM, V273, P12576, DOI 10.1074/jbc.273.20.12576; Olivera A, 1996, J CELL BIOCHEM, V60, P529, DOI 10.1002/(SICI)1097-4644(19960315)60:4<529::AID-JCB9>3.0.CO;2-U; Qin CB, 2002, J BIOL CHEM, V277, P49685, DOI 10.1074/jbc.M209598200; Stevenson JM, 1998, J BIOL CHEM, V273, P22761, DOI 10.1074/jbc.273.35.22761; Testerink C, 2004, PLANT J, V39, P527, DOI 10.1111/j.1365-313X.2004.02152.x; Testerink C, 2005, TRENDS PLANT SCI, V10, P368, DOI 10.1016/j.tplants.2005.06.002; Testerink C, 2007, J EXP BOT, V58, P3905, DOI 10.1093/jxb/erm243; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Wang CX, 2001, PLANT PHYSIOL, V127, P1102, DOI 10.1104/pp.010444; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Wattenberg BW, 2006, J LIPID RES, V47, P1128, DOI 10.1194/jlr.R600003-JLR200; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; Worrall D, 2008, PLANT J, V56, P64, DOI 10.1111/j.1365-313X.2008.03579.x; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; YOSHIDA S, 1986, PLANT PHYSIOL, V82, P807, DOI 10.1104/pp.82.3.807; Zhang WH, 2004, P NATL ACAD SCI USA, V101, P9508, DOI 10.1073/pnas.0402112101; Zhang YB, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/17/175802	42	84	90	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13336	13345		10.1074/jbc.M110.190892	http://dx.doi.org/10.1074/jbc.M110.190892			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21330371	Green Published, hybrid			2022-12-27	WOS:000289282200054
J	Bergeron, MJ; Burzle, M; Kovacs, G; Simonin, A; Hediger, MA				Bergeron, Marc J.; Buerzle, Marc; Kovacs, Gergely; Simonin, Alexandre; Hediger, Matthias A.			Synthesis, Maturation, and Trafficking of Human Na+-Dicarboxylate Cotransporter NaDC1 Requires the Chaperone Activity of Cyclophilin B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS ISOMERASE ACTIVITY; ENDOPLASMIC-RETICULUM STRESS; RENAL TUBULAR-ACIDOSIS; CYCLOSPORINE-A; KIDNEY-TRANSPLANTATION; SURFACE EXPRESSION; PHENOTYPIC CHANGES; SECRETORY PATHWAY; HOMOLOG NINAA; PROTEIN	Renal excretion of citrate, an inhibitor of calcium stone formation, is controlled mainly by reabsorption via the apical Na+-dicarboxylate cotransporter NaDC1 (SLC13A2) in the proximal tubule. Recently, it has been shown that the protein phosphatase calcineurin inhibitors cyclosporin A (CsA) and FK-506 induce hypocitraturia, a risk factor for nephrolithiasis in kidney transplant patients, but apparently through urine acidification. This suggests that these agents up-regulate NaDC1 activity. Using the Xenopus laevis oocyte and HEK293 cell expression systems, we examined first the effect of both anti-calcineurins on NaDC1 activity and expression. While FK-506 had no effect, CsA reduced NaDC1-mediated citrate transport by lowering heterologous carrier expression (as well as endogenous carrier expression in HEK293 cells), indicating that calcineurin is not involved. Given that CsA also binds specifically to cyclophilins, we determined next whether such proteins could account for the observed changes by examining the effect of selected cyclophilin wild types and mutants on NaDC1 activity and cyclophilin-specific siRNA. Interestingly, our data show that the cyclophilin isoform B is likely responsible for down-regulation of carrier expression by CsA and that it does so via its chaperone activity on NaDC1 (by direct interaction) rather than its rotamase activity. We have thus identified for the first time a regulatory partner for NaDC1, and have gained novel mechanistic insight into the effect of CsA on renal citrate transport and kidney stone disease, as well as into the regulation of membrane transporters in general.	[Bergeron, Marc J.] Univ Laval Robert Giffard, Ctr Rech, Unite Neurobiol Cellulaire, Quebec City, PQ G1J 2G3, Canada; [Bergeron, Marc J.; Buerzle, Marc; Kovacs, Gergely; Simonin, Alexandre; Hediger, Matthias A.] Univ Bern, Inst Biochem & Mol Med, CH-3012 Bern, Switzerland; [Bergeron, Marc J.; Buerzle, Marc; Kovacs, Gergely; Simonin, Alexandre; Hediger, Matthias A.] Univ Bern, Swiss Natl Ctr Competence Res, NCCR TransCure, CH-3012 Bern, Switzerland	Laval University; University of Bern; University of Bern	Bergeron, MJ (corresponding author), Univ Laval Robert Giffard, Ctr Rech, Unite Neurobiol Cellulaire, 2601 Chemin Canardiere, Quebec City, PQ G1J 2G3, Canada.	marc.bergeron.2@ulaval.ca		Hediger, Matthias/0000-0003-1946-027X	Swiss National Foundation (SNF)	Swiss National Foundation (SNF)(Swiss National Science Foundation (SNSF))	This work was supported by a grant from The Swiss National Foundation (SNF) entitled "Calcium and Citrate Transporters in Renal Stone Disease."	Aruga S, 2000, KIDNEY INT, V58, P206, DOI 10.1046/j.1523-1755.2000.00155.x; BAKER EK, 1994, EMBO J, V13, P4886, DOI 10.1002/j.1460-2075.1994.tb06816.x; Bollo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011925; Bouvier N, 2009, AM J PHYSIOL-RENAL, V296, pF160, DOI 10.1152/ajprenal.90567.2008; Chen H, 1998, FEBS LETT, V422, P307, DOI 10.1016/S0014-5793(98)00028-3; COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; Elbaz B, 2008, MOL PHARMACOL, V73, P1254, DOI 10.1124/mol.107.041582; Fujiwara T, 2003, TRANSPL INT, V16, P108, DOI 10.1111/j.1432-2277.2003.tb00271.x; Galat A, 2003, CURR TOP MED CHEM, V3, P1315, DOI 10.2174/1568026033451862; Hamm LL, 2002, ENDOCRIN METAB CLIN, V31, P885, DOI 10.1016/S0889-8529(02)00031-2; HAMM LL, 1990, KIDNEY INT, V38, P728, DOI 10.1038/ki.1990.265; He Y, 2004, J NEPHROL, V17, P34; Heering P, 1996, NEPHRON, V74, P501, DOI 10.1159/000189443; Helekar SA, 1997, P NATL ACAD SCI USA, V94, P5432, DOI 10.1073/pnas.94.10.5432; Ho HTB, 2007, KIDNEY INT, V72, P63, DOI 10.1038/sj.ki.5002258; Hong F, 2004, BIOCHEM BIOPH RES CO, V316, P1073, DOI 10.1016/j.bbrc.2004.02.160; JENKINS AD, 1985, AM J PHYSIOL, V249, pF590, DOI 10.1152/ajprenal.1985.249.4.F590; Keven K, 2007, NEPHROL DIAL TRANSPL, V22, P906, DOI 10.1093/ndt/gfl714; Kimchi-Sarfaty C, 2002, J BIOL CHEM, V277, P2505, DOI 10.1074/jbc.M109154200; KINO T, 1987, J ANTIBIOT, V40, P1256, DOI 10.7164/antibiotics.40.1256; Long K, 2005, BIOORG MED CHEM LETT, V15, P3849, DOI 10.1016/j.bmcl.2005.05.120; Mochida S, 2007, NATURE, V449, P336, DOI 10.1038/nature06121; Okamoto N, 2007, INT J UROL, V14, P344, DOI 10.1111/j.1442-2042.2007.01554.x; Pajor A. M., 1996, AM J PHYSIOL, V270, pF642; Pallet N, 2008, AM J TRANSPLANT, V8, P2283, DOI 10.1111/j.1600-6143.2008.02396.x; PRICE ER, 1994, P NATL ACAD SCI USA, V91, P3931, DOI 10.1073/pnas.91.9.3931; PRICE ER, 1991, P NATL ACAD SCI USA, V88, P1903, DOI 10.1073/pnas.88.5.1903; Romero MF, 1998, METHOD ENZYMOL, V296, P17; Rosado JA, 2010, ARTERIOSCL THROM VAS, V30, P419, DOI 10.1161/ATVBAHA.109.194530; Rycyzyn MA, 2002, P NATL ACAD SCI USA, V99, P6790, DOI 10.1073/pnas.092160699; SHAW LM, 1990, CLIN CHEM, V36, P1841; Shiraishi S, 2000, NEUROSCI LETT, V293, P211, DOI 10.1016/S0304-3940(00)01513-5; Stapenhorst L, 2005, PEDIATR NEPHROL, V20, P652, DOI 10.1007/s00467-005-1831-y; Stumpf T, 2008, J BIOL CHEM, V283, P18086, DOI 10.1074/jbc.M801821200; Sune G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013930; TEGZESS AM, 1988, TRANSPLANT P, V20, P530; Tran TT, 2009, ADV EXP MED BIOL, V643, P503, DOI 10.1007/978-0-387-75681-3_52; Tran TT, 2000, J BIOL CHEM, V275, P35708, DOI 10.1074/jbc.M005636200; Wagner CA, 2000, CELL PHYSIOL BIOCHEM, V10, P1, DOI 10.1159/000016341; Wan L., 2009, ASN 42 ANN M SCI EXP; Watanabe S, 2005, AM J PHYSIOL-RENAL, V288, pF40, DOI 10.1152/ajprenal.00218.2004; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764	42	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11242	11253		10.1074/jbc.M110.171728	http://dx.doi.org/10.1074/jbc.M110.171728			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21257749	hybrid, Green Published			2022-12-27	WOS:000288797100036
J	Hoffman, HM; Brydges, SD				Hoffman, Hal M.; Brydges, Susannah D.			Genetic and Molecular Basis of Inflammasome-mediated Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							COLD AUTOINFLAMMATORY SYNDROME; ENCODING MEVALONATE KINASE; INNATE IMMUNE ACTIVATION; NLRP3 INFLAMMASOME; NALP3 INFLAMMASOME; CUTTING EDGE; ARTICULAR SYNDROME; IL-1-BETA RELEASE; CIAS1 MUTATIONS; CROHNS-DISEASE		[Hoffman, Hal M.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Brydges, Susannah D.] Univ Calif San Diego, Div Rheumatol Allergy & Immunol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Hoffman, HM (corresponding author), Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.	hahoffman@ucsd.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052430] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI052430] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abdul-Sater AA, 2009, J BIOL CHEM, V284, P26789, DOI 10.1074/jbc.M109.026823; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Akhter A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000361; Aksentijevich I, 2002, ARTHRITIS RHEUM-US, V46, P3340, DOI 10.1002/art.10688; Aksentijevich I, 1997, CELL, V90, P797; Aksentijevich I, 2007, ARTHRITIS RHEUM-US, V56, P1273, DOI 10.1002/art.22491; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Babelova A, 2009, J BIOL CHEM, V284, P24035, DOI 10.1074/jbc.M109.014266; Bernot A, 1997, NAT GENET, V17, P25; Brydges SD, 2009, IMMUNITY, V30, P875, DOI 10.1016/j.immuni.2009.05.005; Caicedo MS, 2009, J ORTHOP RES, V27, P847, DOI 10.1002/jor.20826; Carneiro LAM, 2009, CELL HOST MICROBE, V5, P123, DOI 10.1016/j.chom.2008.12.011; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Craven RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007446; Cruz AR, 2008, INFECT IMMUN, V76, P56, DOI 10.1128/IAI.01039-07; Delaloye J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000480; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Dostert C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006510; Drenth JPH, 1999, NAT GENET, V22, P178, DOI 10.1038/9696; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Duncan JA, 2009, J IMMUNOL, V182, P6460, DOI 10.4049/jimmunol.0802696; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Feldmann J, 2002, AM J HUM GENET, V71, P198, DOI 10.1086/341357; Feldmeyer L, 2007, CURR BIOL, V17, P1140, DOI 10.1016/j.cub.2007.05.074; Ferrari D, 1997, J IMMUNOL, V159, P1451; Franchi L, 2008, EUR J IMMUNOL, V38, P2085, DOI 10.1002/eji.200838549; Franchi L, 2009, J IMMUNOL, V183, P792, DOI 10.4049/jimmunol.0900173; Frenkel J, 2004, ARTHRITIS RHEUM, V50, P2719, DOI 10.1002/art.20295; Gasse P, 2009, AM J RESP CRIT CARE, V179, P903, DOI 10.1164/rccm.200808-1274OC; Gattorno M, 2007, ARTHRITIS RHEUM, V56, P3138, DOI 10.1002/art.22842; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Griffith JW, 2009, J IMMUNOL, V183, P5208, DOI 10.4049/jimmunol.0713552; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Harder J, 2009, J IMMUNOL, V183, P5823, DOI 10.4049/jimmunol.0900444; Hise AG, 2009, CELL HOST MICROBE, V5, P487, DOI 10.1016/j.chom.2009.05.002; Hitomi Y, 2009, J ALLERGY CLIN IMMUN, V124, P779, DOI 10.1016/j.jaci.2009.07.044; Hoffman HM, 2000, AM J HUM GENET, V66, P1693, DOI 10.1086/302874; Hoffman HM, 2004, LANCET, V364, P1779, DOI 10.1016/S0140-6736(04)17401-1; Hoffman HM, 2001, J ALLERGY CLIN IMMUN, V108, P615, DOI 10.1067/mai.2001.118790; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Houten SM, 1999, NAT GENET, V22, P175, DOI 10.1038/9691; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Jin Y, 2007, J INVEST DERMATOL, V127, P2558, DOI 10.1038/sj.jid.5700953; Jin Y, 2007, NEW ENGL J MED, V356, P1216, DOI 10.1056/NEJMoa061592; Joly S, 2009, J IMMUNOL, V183, P3578, DOI 10.4049/jimmunol.0901323; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Kim S, 2010, EUR J IMMUNOL, V40, P1545, DOI 10.1002/eji.201040425; Kool M, 2008, J IMMUNOL, V181, P3755, DOI 10.4049/jimmunol.181.6.3755; Kumar H, 2009, J IMMUNOL, V183, P8061, DOI 10.4049/jimmunol.0902477; Lamkanfi M, 2009, J BIOL CHEM, V284, P20574, DOI 10.1074/jbc.M109.023689; Latz E, 2010, CURR OPIN IMMUNOL, V22, P28, DOI 10.1016/j.coi.2009.12.004; Lev-Sagie A, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.10.039; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; Li HF, 2009, J IMMUNOL, V183, P1528, DOI 10.4049/jimmunol.0901080; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Macaluso F, 2007, EXP DERMATOL, V16, P692, DOI 10.1111/j.1600-0625.2007.00589.x; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; Mayor A, 2007, NAT IMMUNOL, V8, P497, DOI 10.1038/ni1459; McDermott MF, 1999, CELL, V97, P133, DOI 10.1016/S0092-8674(00)80721-7; Meng GX, 2009, IMMUNITY, V30, P860, DOI 10.1016/j.immuni.2009.04.012; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Mishra BB, 2010, CELL MICROBIOL, V12, P1046, DOI 10.1111/j.1462-5822.2010.01450.x; Omi T, 2006, EUR J HUM GENET, V14, P1295, DOI 10.1038/sj.ejhg.5201698; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Rosengren S, 2007, J ALLERGY CLIN IMMUN, V119, P991, DOI 10.1016/j.jaci.2006.12.649; Said-Sadier N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010008; Schoultz I, 2009, AM J GASTROENTEROL, V104, P1180, DOI 10.1038/ajg.2009.29; Shinkai K, 2008, CLIN EXP DERMATOL, V33, P1, DOI 10.1111/j.1365-2230.2007.02540.x; Shio MT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000559; Silveira TN, 2010, INFECT IMMUN, V78, P1403, DOI 10.1128/IAI.00905-09; Stack JH, 2005, J IMMUNOL, V175, P2630, DOI 10.4049/jimmunol.175.4.2630; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Toma C, 2010, J IMMUNOL, V184, P5287, DOI 10.4049/jimmunol.0903536; Touitou I, 2004, HUM MUTAT, V24, P194, DOI 10.1002/humu.20080; Villani AC, 2009, NAT GENET, V41, P71, DOI 10.1038/ng.285; Yamasaki K, 2009, J BIOL CHEM, V284, P12762, DOI 10.1074/jbc.M806084200; Yilmaz O, 2010, CELL MICROBIOL, V12, P188, DOI 10.1111/j.1462-5822.2009.01390.x; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	91	55	59	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					10889	10896		10.1074/jbc.R110.135491	http://dx.doi.org/10.1074/jbc.R110.135491			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21296874	Green Published, hybrid			2022-12-27	WOS:000288797100001
J	Tang, CH; Chen, CF; Chen, WM; Fong, YC				Tang, Chih-Hsin; Chen, Cheng-Fong; Chen, Wei-Ming; Fong, Yi-Chin			IL-6 Increases MMP-13 Expression and Motility in Human Chondrosarcoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOCRINE GROWTH-FACTOR; NF-KAPPA-B; IN-VITRO; MATRIX METALLOPROTEINASE-13; ALPHA-V-BETA-3 INTEGRIN; UP-REGULATION; CANCER CELLS; INTERLEUKIN-6; CARCINOMA; MIGRATION	Chondrosarcoma is a type of highly malignant tumor with a potent capacity to invade locally and cause distant metastasis. Chondrosarcoma shows a predilection for metastasis to the lungs. IL-6 is a multifunctional cytokine that is associated with the disease status and outcomes of cancers. However, the effect of IL-6 on the migration activity of human chondrosarcoma cells is mostly unknown. Here, we found that IL-6 increased the migration and expression of MMP-13 in human chondrosarcoma cells. We also found that human chondrosarcoma tissues had significant expression of IL-6, which was higher than that in normal cartilage. IL-6-mediated migration and MMP-13 up-regulation were attenuated by anti-IL-6 receptor antibody, Ras, Raf-1, and a MEK inhibitor. Activation of the Ras, Raf-1, MEK, ERK, and NF-kappa B signaling pathways after IL-6 treatment was demonstrated, and IL-6-induced MMP-13 expression and migration activity were inhibited by the specific inhibitor and mutant Ras, Raf-1, MEK, ERK, and NF-kappa B cascades. In addition, migration-prone sublines demonstrated that cells with increasing migration ability had greater expression of IL-6 and MMP-13. Taken together, these results indicate that IL-6 and IL-6 receptor interaction enhances migration of chondrosarcoma through an increase in MMP-13 production.	[Tang, Chih-Hsin] China Med Univ & Hosp, Sch Med, Dept Pharmacol, Taichung 404, Taiwan; [Tang, Chih-Hsin] China Med Univ & Hosp, Grad Inst Basic Med Sci, Taichung 404, Taiwan; [Chen, Cheng-Fong] Natl Yang Ming Univ, Dept Surg, Taipei 112, Taiwan; [Chen, Wei-Ming] Taipei Vet Gen Hosp, Dept Orthoped & Traumatol, Taipei 112, Taiwan; [Fong, Yi-Chin] China Med Univ, Sch Chinese Med, Taichung 404, Taiwan; [Fong, Yi-Chin] China Med Univ Hosp, Dept Orthoped Surg, Taichung 40447, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Tang, CH (corresponding author), China Med Univ, Sch Med, Dept Pharmacol, 91 Hsueh Shih Rd, Taichung 404, Taiwan.	chtang@mail.cmu.edu.tw; yichin.fong@mail.cmu.edu.tw	Tang, Chih Hsin/O-5212-2015	Tang, Chih Hsin/0000-0002-7113-8352; Chen, Cheng-Fong/0000-0002-2485-6159	National Science Council of Taiwan [NSC99-2320-B-039-003-MY3]; China Medical University Hospital [DMR-100-086]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); China Medical University Hospital	This work was supported by National Science Council of Taiwan Grant NSC99-2320-B-039-003-MY3 and China Medical University Hospital Grant DMR-100-086.	Ala-Aho R, 2005, BIOCHIMIE, V87, P273, DOI 10.1016/j.biochi.2004.12.009; BEREK JS, 1991, AM J OBSTET GYNECOL, V164, P1038, DOI 10.1016/0002-9378(91)90582-C; Blaine SA, 2001, J BIOL CHEM, V276, P42737, DOI 10.1074/jbc.M107773200; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; CHEN L, 1988, P NATL ACAD SCI USA, V85, P8037, DOI 10.1073/pnas.85.21.8037; Chiu YC, 2009, CARCINOGENESIS, V30, P1651, DOI 10.1093/carcin/bgp156; Chuang JY, 2009, J CELL PHYSIOL, V220, P418, DOI 10.1002/jcp.21783; Culig Z, 2005, J CELL BIOCHEM, V95, P497, DOI 10.1002/jcb.20477; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; EUSTACE D, 1993, GYNECOL ONCOL, V50, P15, DOI 10.1006/gyno.1993.1156; Fong YC, 2008, J CELL PHYSIOL, V217, P846, DOI 10.1002/jcp.21568; Fong YC, 2007, J ORTHOP RES, V25, P1106, DOI 10.1002/jor.20364; Friday BB, 2008, CLIN CANCER RES, V14, P342, DOI 10.1158/1078-0432.CCR-07-4790; Hou CH, 2009, BONE, V44, P233, DOI 10.1016/j.bone.2008.09.021; Hov H, 2009, EUR J HAEMATOL, V82, P277, DOI 10.1111/j.1600-0609.2009.01212.x; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kerkela E, 2003, EXP DERMATOL, V12, P109, DOI 10.1034/j.1600-0625.2003.120201.x; Lahsnig C, 2009, ONCOGENE, V28, P638, DOI 10.1038/onc.2008.418; Lee HW, 2002, J BIOL CHEM, V277, P32624, DOI 10.1074/jbc.M200353200; Leeman MF, 2002, CRIT REV BIOCHEM MOL, V37, P149, DOI 10.1080/10409230290771483; Li Y, 2008, CYTOKINE, V43, P165, DOI 10.1016/j.cyto.2008.05.007; LU C, 1993, J CELL BIOL, V120, P1281, DOI 10.1083/jcb.120.5.1281; Lu KW, 2008, ANTICANCER RES, V28, P1093; Madrid LV, 2001, J BIOL CHEM, V276, P18934, DOI 10.1074/jbc.M101103200; Marshall CJ, 1996, CURR OPIN CELL BIOL, V8, P197, DOI 10.1016/S0955-0674(96)80066-4; MIKI S, 1989, FEBS LETT, V250, P607, DOI 10.1016/0014-5793(89)80805-1; Okamoto M, 1997, CANCER RES, V57, P141; Okamoto M, 1997, ENDOCRINOLOGY, V138, P5071, DOI 10.1210/en.138.11.5071; Okamoto M, 1997, INT J CANCER, V72, P149, DOI 10.1002/(SICI)1097-0215(19970703)72:1<149::AID-IJC21>3.0.CO;2-D; Rose-John S, 2006, J LEUKOCYTE BIOL, V80, P227, DOI 10.1189/jlb.1105674; SATOH T, 1992, J BIOL CHEM, V267, P24149; Scully SP, 1999, BRAZ J MED BIOL RES, V32, P885, DOI 10.1590/S0100-879X1999000700013; Shi J, 2004, INFLAMM RES, V53, P377, DOI 10.1007/s00011-004-1271-3; Tan TW, 2009, J CELL BIOCHEM, V107, P345, DOI 10.1002/jcb.22132; Tan TW, 2009, CARCINOGENESIS, V30, P258, DOI 10.1093/carcin/bgn284; Terek RM, 1998, J ORTHOPAED RES, V16, P585, DOI 10.1002/jor.1100160510; Walter M, 2009, ONCOGENE, V28, P2745, DOI 10.1038/onc.2009.130; Whitmarsh AJ, 1998, TRENDS BIOCHEM SCI, V23, P481, DOI 10.1016/S0968-0004(98)01309-7; Woodhouse EC, 1997, CANCER-AM CANCER SOC, V80, P1529, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1529::AID-CNCR2>3.0.CO;2-F; Yuan J, 2005, J ORTHOP RES, V23, P1467, DOI 10.1016/j.orthres.2005.04.004; ZHANG XF, 1993, NATURE, V364, P308, DOI 10.1038/364308a0	41	41	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11056	11066		10.1074/jbc.M110.204081	http://dx.doi.org/10.1074/jbc.M110.204081			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21278254	Green Published, hybrid			2022-12-27	WOS:000288797100017
J	Bernatik, O; Ganji, RS; Dijksterhuis, JP; Konik, P; Cervenka, I; Polonio, T; Krejci, P; Schulte, G; Bryja, V				Bernatik, Ondrej; Ganji, Ranjani Sri; Dijksterhuis, Jacomijn P.; Konik, Peter; Cervenka, Igor; Polonio, Tilman; Krejci, Pavel; Schulte, Gunnar; Bryja, Vitezslav			Sequential Activation and Inactivation of Dishevelled in the Wnt/beta-Catenin Pathway by Casein Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ARRESTIN; I-EPSILON; WNT; PHOSPHORYLATION; PROTEINS; DVL; LRP6; AXIN; UBIQUITINATION; MECHANISM	Dishevelled (Dvl) is a key component in the Wnt/beta-catenin signaling pathway. Dvl can multimerize to form dynamic protein aggregates, which are required for the activation of downstream signaling. Upon pathway activation by Wnts, Dvl becomes phosphorylated to yield phosphorylated and shifted (PS) Dvl. Both activation of Dvl in Wnt/beta-catenin signaling and Wnt-induced PS-Dvl formation are dependent on casein kinase 1 (CK1) delta/epsilon activity. However, the overexpression of CK1 was shown to dissolve Dvl aggregates, and endogenous PS-Dvl forms irrespective of whether or not the activating Wnt triggers the Wnt/beta-catenin pathway. Using a combination of gain-of-function, loss-of-function, and domain mapping approaches, we attempted to solve this discrepancy regarding the role of CK1 epsilon in Dvl biology. We analyzed mutual interaction of CK1 delta/epsilon and two other Dvl kinases, CK2 and PAR1, in the Wnt/beta-catenin pathway. We show that CK2 acts as a constitutive kinase whose activity is required for the further action of CK1 epsilon. Furthermore, we demonstrate that the two consequences of CK1 epsilon phosphorylation are separated both spatially and functionally; first, CK1 epsilon-mediated induction of TCF/LEF-driven transcription (associated with dynamic recruitment of Axin1) is mediated via a PDZ-proline-rich region of Dvl. Second, CK1 epsilon-mediated formation of PS-Dvl is mediated by the Dvl3 C terminus. Furthermore, we demonstrate with several methods that PS-Dvl has decreased ability to polymerize with other Dvls and could, thus, act as the inactive signaling intermediate. We propose a multistep and multikinase model for Dvl activation in the Wnt/beta-catenin pathway that uncovers a built-in de-activation mechanism that is triggered by activating phosphorylation of Dvl by CK1 delta/epsilon.	[Bryja, Vitezslav] Masaryk Univ, Fac Sci, Inst Expt Biol, CS-61137 Brno, Czech Republic; [Dijksterhuis, Jacomijn P.; Polonio, Tilman; Schulte, Gunnar] Karolinska Inst, Sect Receptor Biol & Signaling, Dept Physiol & Pharmacol, SE-17177 Stockholm, Sweden; [Konik, Peter] Univ S Bohemia, Fac Sci, Ceske Budejovice 37005, Czech Republic; [Krejci, Pavel; Bryja, Vitezslav] ASCR, Dept Cytokinet, Inst Biophys, Brno 61265, Czech Republic; [Krejci, Pavel] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA	Masaryk University Brno; Karolinska Institutet; University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Cedars Sinai Medical Center	Bryja, V (corresponding author), Masaryk Univ, Fac Sci, Inst Expt Biol, CS-61137 Brno, Czech Republic.	bryja@sci.muni.cz	Krejčí, Pavel/I-4285-2014; Bryja, Vít?zslav/H-1925-2014; Bryja, Vítězslav/P-4217-2019; Ganji, Ranjani/AGD-5702-2022	Bryja, Vít?zslav/0000-0002-9136-5085; Bryja, Vítězslav/0000-0002-9136-5085; Dijksterhuis, Jacomijn/0000-0002-9214-6255; Bernatik, Ondrej/0000-0002-2188-332X; Krejci, Pavel/0000-0003-0618-9134; Schulte, Gunnar/0000-0002-2700-7013	Czech Science Foundation [301/09/0587, 204/09/H058, 204/09/0498, 204/09/J030]; Knut and Alice Wallenberg Foundation [KAW2008.0149]; Swedish Research Council [K2008-68P-20810-01-4, K2008-68X-20805-01-4]; Swedish Cancer Society [CAN 2008/539]; Swedish Foundation for International Cooperation in Research and Higher Education (STINT); Ministry of Education, Youth, and Sports of the Czech Republic [MSM0021622430]; Academy of Sciences of the Czech Republic [KJB501630801, AVOZ50040507, AVOZ50040702]; EMBO Installation grant	Czech Science Foundation(Grant Agency of the Czech Republic); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Foundation for International Cooperation in Research and Higher Education (STINT); Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); EMBO Installation grant	Supported by Czech Science Foundation Grant 301/09/0587.; Supported by Knut and Alice Wallenberg Foundation Grant KAW2008.0149, Swedish Research Council Grants K2008-68P-20810-01-4 and K2008-68X-20805-01-4, Swedish Cancer Society Grant CAN 2008/539, and The Swedish Foundation for International Cooperation in Research and Higher Education (STINT).; Supported by Ministry of Education, Youth, and Sports of the Czech Republic Grant MSM0021622430, Academy of Sciences of the Czech Republic Grants KJB501630801, AVOZ50040507, and AVOZ50040702, Czech Science Foundation Grants 204/09/H058, 204/09/0498, and 204/09/J030, and an EMBO Installation grant. To whom correspondence should be addressed: Institute of Experimental Biology, Faculty of Science, Masaryk University, Kotlarska 2, 61137 Brno, Czech Republic. Tel.: 420-549493291; Fax: 420-541211214; E-mail: bryja@sci.muni.cz.	Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Bryja V, 2007, J CELL SCI, V120, P586, DOI 10.1242/jcs.03368; Bryja V, 2007, P NATL ACAD SCI USA, V104, P6690, DOI 10.1073/pnas.0611356104; Bryja V, 2007, CELL SIGNAL, V19, P610, DOI 10.1016/j.cellsig.2006.08.011; Bryja V, 2008, EMBO REP, V9, P1244, DOI 10.1038/embor.2008.193; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cong F, 2004, MOL CELL BIOL, V24, P2000, DOI 10.1128/MCB.24.5.2000-2011.2004; Dominguez I, 2005, MOL CELL BIOCHEM, V274, P125, DOI 10.1007/s11010-005-3073-5; Foldynova-Trantirkova S, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2581; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Gao Y, 2006, J BIOL CHEM, V281, P18394, DOI 10.1074/jbc.M601112200; Gonzalez-Sancho JM, 2004, MOL CELL BIOL, V24, P4757, DOI 10.1128/MCB.24.11.4757-4768.2004; Itoh K, 2005, J BIOL, V4; Jenny A, 2005, NAT CELL BIOL, V7, P691, DOI 10.1038/ncb1271; Khan Z, 2007, MOL CELL BIOL, V27, P7291, DOI 10.1128/MCB.00773-07; Kishida M, 2001, J BIOL CHEM, V276, P33147, DOI 10.1074/jbc.M103555200; Kishida S, 1999, MOL CELL BIOL, V19, P4414; Klein TJ, 2006, CURR BIOL, V16, P1337, DOI 10.1016/j.cub.2006.06.030; Klimowski LK, 2006, FEBS J, V273, P4594, DOI 10.1111/j.1742-4658.2006.05462.x; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lee JS, 1999, J BIOL CHEM, V274, P21464, DOI 10.1074/jbc.274.30.21464; Lee YN, 2008, CELL SIGNAL, V20, P443, DOI 10.1016/j.cellsig.2007.11.005; Li L, 1999, J BIOL CHEM, V274, P129, DOI 10.1074/jbc.274.1.129; Malanchi I, 2009, CURR OPIN ONCOL, V21, P41, DOI 10.1097/CCO.0b013e32831d1faf; Malbon CC, 2006, CURR TOP DEV BIOL, V72, P153, DOI 10.1016/S0070-2153(05)72002-0; McKay RM, 2001, DEV BIOL, V235, P388, DOI 10.1006/dbio.2001.0308; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Ossipova O, 2005, DEV CELL, V8, P829, DOI 10.1016/j.devcel.2005.04.011; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Sakanaka C, 1999, P NATL ACAD SCI USA, V96, P12548, DOI 10.1073/pnas.96.22.12548; Schulte G, 2007, TRENDS PHARMACOL SCI, V28, P518, DOI 10.1016/j.tips.2007.09.001; Schwarz-Romond T, 2005, J CELL SCI, V118, P5269, DOI 10.1242/jcs.02646; Schwarz-Romond T, 2007, J CELL SCI, V120, P2402, DOI 10.1242/jcs.002956; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Smalley MJ, 2005, J CELL SCI, V118, P5279, DOI 10.1242/jcs.02647; Song DH, 2000, J BIOL CHEM, V275, P23790, DOI 10.1074/jbc.M909107199; Tauriello DVF, 2010, MOL CELL, V37, P607, DOI 10.1016/j.molcel.2010.01.035; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Wharton KA, 2003, DEV BIOL, V253, P1, DOI 10.1006/dbio.2002.0869; Willert K, 1997, EMBO J, V16, P3089, DOI 10.1093/emboj/16.11.3089; Witte F, 2010, FASEB J, V24, P2417, DOI 10.1096/fj.09-150615; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540	46	78	79	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10396	10410		10.1074/jbc.M110.169870	http://dx.doi.org/10.1074/jbc.M110.169870			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21285348	Green Published, hybrid			2022-12-27	WOS:000288547000056
J	Choubey, V; Safiulina, D; Vaarmann, A; Cagalinec, M; Wareski, P; Kuum, M; Zharkovsky, A; Kaasik, A				Choubey, Vinay; Safiulina, Dzhamilja; Vaarmann, Annika; Cagalinec, Michal; Wareski, Przemyslaw; Kuum, Malle; Zharkovsky, Alexander; Kaasik, Allen			Mutant A53T alpha-Synuclein Induces Neuronal Death by Increasing Mitochondrial Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; MOUSE MODEL; PARKINSONS; DEGRADATION; MITOPHAGY; INDUCTION; PROTEIN; FUSION; NEURODEGENERATION; DYSFUNCTION	Parkinson disease is characterized by the accumulation of aggregated alpha-synuclein as the major component of the Lewy bodies. alpha-Synuclein accumulation in turn leads to compensatory effects that may include the up-regulation of autophagy. Another common feature of Parkinson disease (PD) is mitochondrial dysfunction. Here, we provide evidence that the overactivation of autophagy may be a link that connects the intracellular accumulation of alpha-synuclein with mitochondrial dysfunction. We found that the activation of macroautophagy in primary cortical neurons that overexpress mutant A53T alpha-synuclein leads to massive mitochondrial destruction and loss, which is associated with a bioenergetic deficit and neuronal degeneration. No mitochondrial removal or net loss was observed when we suppressed the targeting of mitochondria to autophagosomes by silencing Parkin, overexpressing wild-type Mitofusin 2 and dominant negative Dynamin-related protein 1 or blocking autophagy by silencing autophagy-related genes. The inhibition of targeting mitochondria to autophagosomes or autophagy was also partially protective against mutant A53T alpha-synuclein-induced neuronal cell death. These data suggest that overactivated mitochondrial removal could be one of the contributing factors that leads to the mitochondrial loss observed in PD models.	[Choubey, Vinay; Safiulina, Dzhamilja; Vaarmann, Annika; Cagalinec, Michal; Wareski, Przemyslaw; Kuum, Malle; Zharkovsky, Alexander; Kaasik, Allen] Univ Tartu, Dept Pharmacol, EE-51014 Tartu, Estonia	University of Tartu	Kaasik, A (corresponding author), Ravila 19, EE-51014 Tartu, Estonia.	allen.kaasik@ut.ee	Kaasik, Allen/I-2738-2015; Safiulina, Dzamilja/I-7336-2015; Cagalinec, Michal/AAC-5087-2022; Choubey, Vinay/H-3170-2015; Vaarmann, Annika/AAH-7289-2021	Cagalinec, Michal/0000-0001-8044-8419; Choubey, Vinay/0000-0002-1953-5692; Vaarmann, Annika/0000-0003-0296-8325; Safiulina, Dzhamilja/0000-0002-4188-4207; Kaasik, Allen/0000-0002-4850-3198	Estonian Science Foundation [7991, 7175, 8125]; European Community; European Regional Development Fund	Estonian Science Foundation; European Community(European Commission); European Regional Development Fund(European Commission)	This work was supported by Grants 7991, 7175, and 8125 from the Estonian Science Foundation, the European Community (Projects BRAIN BIOENERGETICS and ESTBIOREG), and by the European Regional Development Fund.	Anglade P, 1997, HISTOL HISTOPATHOL, V12, P25; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Ayala A, 2007, FRONT BIOSCI-LANDMRK, V12, P986, DOI 10.2741/2119; Batulan Z, 2006, NEUROBIOL DIS, V24, P213, DOI 10.1016/j.nbd.2006.06.017; Bulina ME, 2006, NAT BIOTECHNOL, V24, P95, DOI 10.1038/nbt1175; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Canu N, 2005, J NEUROCHEM, V92, P1228, DOI 10.1111/j.1471-4159.2004.02956.x; Cheung ZH, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-29; Chu CT, 2007, AUTOPHAGY, V3, P663, DOI 10.4161/auto.4625; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; Fournier M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006629; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Henchcliffe C, 2008, NAT CLIN PRACT NEURO, V4, P600, DOI 10.1038/ncpneuro0924; Honda S, 2003, BIOCHEM BIOPH RES CO, V311, P424, DOI 10.1016/j.bbrc.2003.10.008; Iwata A, 2005, P NATL ACAD SCI USA, V102, P13135, DOI 10.1073/pnas.0505801102; Kaasik A, 2005, EUR J NEUROSCI, V22, P1023, DOI 10.1111/j.1460-9568.2005.04279.x; Kaasik A, 2007, EPILEPSIA, V48, P752, DOI 10.1111/j.1528-1167.2007.00985.x; Kamp F, 2010, EMBO J, V29, P3571, DOI 10.1038/emboj.2010.223; Kanki T, 2009, MOL BIOL CELL, V20, P4730, DOI 10.1091/mbc.E09-03-0225; Kim I, 2004, HEPATOLOGY, V40, p291A; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kirik D, 2002, J NEUROSCI, V22, P2780, DOI 10.1523/JNEUROSCI.22-07-02780.2002; Kissova I, 2004, J BIOL CHEM, V279, P39068, DOI 10.1074/jbc.M406960200; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Lee JA, 2009, J NEUROSCI, V29, P8506, DOI 10.1523/JNEUROSCI.0924-09.2009; Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3; Lo Bianco C, 2004, P NATL ACAD SCI USA, V101, P17510, DOI 10.1073/pnas.0405313101; Menzies FM, 2010, BRAIN, V133, P93, DOI 10.1093/brain/awp292; Moreau K, 2010, CURR OPIN CELL BIOL, V22, P206, DOI 10.1016/j.ceb.2009.12.002; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Nowikovsky K, 2007, CELL DEATH DIFFER, V14, P1647, DOI 10.1038/sj.cdd.4402167; Petrucelli L, 2002, NEURON, V36, P1007, DOI 10.1016/S0896-6273(02)01125-X; Priault M, 2005, CELL DEATH DIFFER, V12, P1613, DOI 10.1038/sj.cdd.4401697; Sahlin C, 2007, J NEUROCHEM, V101, P854, DOI 10.1111/j.1471-4159.2006.04443.x; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Spencer B, 2009, J NEUROSCI, V29, P13578, DOI 10.1523/JNEUROSCI.4390-09.2009; Stefanis L, 2001, J NEUROSCI, V21, P9549, DOI 10.1523/JNEUROSCI.21-24-09549.2001; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Vila M, 2008, J NEUROCHEM, V107, P317, DOI 10.1111/j.1471-4159.2008.05604.x; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; von Coelln R, 2006, J NEUROSCI, V26, P3685, DOI 10.1523/JNEUROSCI.0414-06.2006; Wang Y, 2009, EUR J NEUROSCI, V30, P2258, DOI 10.1111/j.1460-9568.2009.07025.x; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122; Xilouri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005515; YANG DS, 2008, ALZHEIMERS DEMENT, V4, pT223; Yang Q, 2009, SCIENCE, V323, P124, DOI 10.1126/science.1166088; Zhu JH, 2003, BRAIN PATHOL, V13, P473	55	192	195	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10814	10824		10.1074/jbc.M110.132514	http://dx.doi.org/10.1074/jbc.M110.132514			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21252228	Green Published, hybrid			2022-12-27	WOS:000288547000095
J	Kaur, S; Kuznetsova, SA; Pendrak, ML; Sipes, JM; Romeo, MJ; Li, ZQ; Zhang, LJ; Roberts, DD				Kaur, Sukhbir; Kuznetsova, Svetlana A.; Pendrak, Michael L.; Sipes, John M.; Romeo, Martin J.; Li, Zhuqing; Zhang, Lijuan; Roberts, David D.			Heparan Sulfate Modification of the Transmembrane Receptor CD47 Is Necessary for Inhibition of T Cell Receptor Signaling by Thrombospondin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRIN-ASSOCIATED PROTEIN; PRECURSOR-LIKE PROTEIN-2; HAMSTER OVARY CELL; C-TERMINAL DOMAIN; CHONDROITIN SULFATE; CYCLOPHILIN-B; NITRIC-OXIDE; ACTIVATION; PROTEOGLYCANS; ADHESION	Cell surface proteoglycans on T cells contribute to retroviral infection, binding of chemokines and other proteins, and are necessary for some T cell responses to the matricellular glycoprotein thrombospondin-1. The major cell surface proteoglycans expressed by primary T cells and Jurkat T cells have an apparent M-r > 200,000 and are modified with chondroitin sulfate and heparan sulfate chains. Thrombospondin-1 bound in a heparin-inhibitable manner to this proteoglycan and to a soluble form released into the medium. Based on mass spectrometry, knockdown, and immunochemical analyses, the proteoglycan contains two major core proteins as follows: amyloid precursor-like protein-2 (APLP2, apparent M-r 230,000) and CD47 (apparent M-r > 250,000). CD47 is a known thrombospondin-1 receptor but was not previously reported to be a proteoglycan. This proteoglycan isoform of CD47 is widely expressed on vascular cells. Mutagenesis identified glycosaminoglycan modification of CD47 at Ser(64) and Ser(79). Inhibition of T cell receptor signaling by thrombospondin-1 was lost in CD47-deficient T cells that express the proteoglycan isoform of APLP2, indicating that binding to APLP2 is not sufficient. Inhibition of CD69 induction was restored in CD47-deficient cells by re-expressing CD47 or an S79A mutant but not by the S64A mutant. Therefore, inhibition of T cell receptor signaling by thrombospondin-1 is mediated by CD47 and requires its modification at Ser(64).	[Kaur, Sukhbir; Kuznetsova, Svetlana A.; Pendrak, Michael L.; Sipes, John M.; Romeo, Martin J.; Li, Zhuqing; Roberts, David D.] NCI, Pathol Lab, Ctr Canc Res, NIH, Bethesda, MD 20982 USA; [Zhang, Lijuan] Ocean Univ China, Sch Med & Pharm, Qingdao 266003, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Ocean University of China	Roberts, DD (corresponding author), NIH, Bldg 10,Rm 2A33,10 Ctr Dr, Bethesda, MD 20892 USA.	droberts@helix.nih.gov	Roberts, David D./A-9699-2008; Kaur, Sukhbir/ADW-6023-2022	Roberts, David D./0000-0002-2481-2981; Kaur, Sukhbir/0000-0003-0513-6225; Romeo, Martin/0000-0001-7941-1862	NCI; NATIONAL CANCER INSTITUTE [ZIASC009174, ZIASC009172] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program of the NCI.	ADAMS JC, 1994, MOL BIOL CELL, V5, P423, DOI 10.1091/mbc.5.4.423; Adams JC, 2001, J CELL BIOL, V152, P1169, DOI 10.1083/jcb.152.6.1169; Adams JC, 2008, J CELL SCI, V121, P784, DOI 10.1242/jcs.021006; Alexopoulou AN, 2007, INT J BIOCHEM CELL B, V39, P505, DOI 10.1016/j.biocel.2006.10.014; Allain F, 2002, P NATL ACAD SCI USA, V99, P2714, DOI 10.1073/pnas.052284899; Asari A, 1996, OSTEOARTHR CARTILAGE, V4, P149, DOI 10.1016/S1063-4584(05)80324-3; Barazi HO, 2002, J BIOL CHEM, V277, P42859, DOI 10.1074/jbc.M206849200; Barazi HO, 2002, CANCER RES, V62, P1541; Bass MD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.264pe18; Billard MJ, 2008, IMMUNOL CELL BIOL, V86, P381, DOI 10.1038/sj.icb.7100165; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Bobardt MD, 2003, IMMUNITY, V18, P27, DOI 10.1016/S1074-7613(02)00504-6; BROWN E, 1990, J CELL BIOL, V111, P2785, DOI 10.1083/jcb.111.6.2785; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Carlson CB, 2008, CELL MOL LIFE SCI, V65, P672, DOI 10.1007/s00018-007-7484-1; CATERSON B, 1985, FED PROC, V44, P386; Chandrasekaran L, 2000, MOL BIOL CELL, V11, P2885, DOI 10.1091/mbc.11.9.2885; Chung JS, 2007, J IMMUNOL, V179, P5778, DOI 10.4049/jimmunol.179.9.5778; Cladera J, 2001, EMBO J, V20, P19, DOI 10.1093/emboj/20.1.19; Couchman JR, 2003, NAT REV MOL CELL BIO, V4, P926, DOI 10.1038/nrm1257; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; Deligny A, 2010, J BIOL CHEM, V285, P1701, DOI 10.1074/jbc.M109.018184; Esko JD, 1996, CURR OPIN STRUC BIOL, V6, P663, DOI 10.1016/S0959-440X(96)80034-0; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Floquet N, 2008, ARCH BIOCHEM BIOPHYS, V478, P103, DOI 10.1016/j.abb.2008.07.015; Frazier WA, 2010, NATURE SIGNALING GAT, DOI [10.1038/mp.a002870.01, DOI 10.1038/MP.A002870.01]; Gao AG, 1996, J BIOL CHEM, V271, P21, DOI 10.1074/jbc.271.1.21; Greenfield B, 1999, J BIOL CHEM, V274, P2511, DOI 10.1074/jbc.274.4.2511; Guo J, 1998, INVEST OPHTH VIS SCI, V39, P292; Hatherley D, 2008, MOL CELL, V31, P266, DOI 10.1016/j.molcel.2008.05.026; Isenberg JS, 2008, CELL MOL LIFE SCI, V65, P728, DOI 10.1007/s00018-007-7488-x; Isenberg JS, 2008, BLOOD, V111, P613, DOI 10.1182/blood-2007-06-098392; Isenberg JS, 2007, CIRC RES, V100, P712, DOI 10.1161/01.RES.0000259579.35787.4e; Isenberg JS, 2006, CARDIOVASC RES, V71, P785, DOI 10.1016/j.cardiores.2006.05.024; Isenberg JS, 2009, MATRIX BIOL, V28, P110, DOI 10.1016/j.matbio.2009.01.002; Isenberg JS, 2009, NAT REV CANCER, V9, P182, DOI 10.1038/nrc2561; Isenberg JS, 2009, J BIOL CHEM, V284, P1116, DOI 10.1074/jbc.M804860200; Isenberg JS, 2005, P NATL ACAD SCI USA, V102, P13141, DOI 10.1073/pnas.0502977102; Jury EC, 2007, J IMMUNOL, V179, P7975, DOI 10.4049/jimmunol.179.11.7975; Kalendar R., 2009, GENES GENOMES GENOMI, V3, P1; Khan AA, 2001, SCIENCE, V292, P1681, DOI 10.1126/science.1056594; Kirn-Safran C, 2009, CELL MOL LIFE SCI, V66, P3421, DOI 10.1007/s00018-009-0096-1; Lambert S, 2009, BLOOD, V113, P5176, DOI 10.1182/blood-2008-04-150342; Lebakken CS, 1996, J CELL BIOL, V132, P1209, DOI 10.1083/jcb.132.6.1209; Li XF, 1999, J BIOL CHEM, V274, P27249, DOI 10.1074/jbc.274.38.27249; Li ZQ, 2002, J CELL BIOL, V157, P509, DOI 10.1083/jcb.200109098; Li ZQ, 2001, J IMMUNOL, V166, P2427, DOI 10.4049/jimmunol.166.4.2427; LIDHOLT K, 1992, P NATL ACAD SCI USA, V89, P2267, DOI 10.1073/pnas.89.6.2267; Lu H., 2010, GLYCOBIOL INSIGHTS, V2010, P13; Maile LA, 2008, MOL ENDOCRINOL, V22, P1226, DOI 10.1210/me.2007-0552; Makatsori E, 2001, BIOMED CHROMATOGR, V15, P413, DOI 10.1002/bmc.91; MAWBY WJ, 1994, BIOCHEM J, V304, P525, DOI 10.1042/bj3040525; Maxhimer JB, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000139; Neto EH, 2007, BBA-MOL CELL RES, V1773, P176, DOI 10.1016/j.bbamcr.2006.09.026; Oravecz T, 1997, J IMMUNOL, V159, P4587; Pakula R, 2007, GLYCOBIOLOGY, V17, P492, DOI 10.1093/glycob/cwm009; Pan J, 2010, NAT BIOTECHNOL, V28, P203, DOI 10.1038/nbt0310-203; PANGALOS MN, 1995, J NEUROCHEM, V65, P762; Park PW, 2000, J BIOL CHEM, V275, P29923, DOI 10.1074/jbc.R000008200; Pinon JD, 2003, J VIROL, V77, P9922, DOI 10.1128/JVI.77.18.9922-9930.2003; Rebres RA, 2001, J BIOL CHEM, V276, P34607, DOI 10.1074/jbc.M106107200; Reinhold MI, 1999, INT IMMUNOL, V11, P707, DOI 10.1093/intimm/11.5.707; Roberts David D., 1994, Journal of Tissue Culture Methods, V16, P217, DOI 10.1007/BF01540654; ROBERTS DD, 1988, CANCER RES, V48, P6785; RODERIQUEZ G, 1995, J VIROL, V69, P2233, DOI 10.1128/JVI.69.4.2233-2239.1995; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Shintani Y, 2006, EMBO J, V25, P3045, DOI 10.1038/sj.emboj.7601188; Studelska DR, 2006, GLYCOBIOLOGY, V16, P65, DOI 10.1093/glycob/cwj037; Subramanian S, 2007, J BIOL CHEM, V282, P1805, DOI 10.1074/jbc.M603923200; SUN X, 1992, SEMIN THROMB HEMOST, V18, P243, DOI 10.1055/s-2007-1002430; THINAKARAN G, 1994, J BIOL CHEM, V269, P22099; Vanpouille C, 2007, J BIOL CHEM, V282, P24416, DOI 10.1074/jbc.M701835200; Watson K, 1999, J BIOL CHEM, V274, P21707, DOI 10.1074/jbc.274.31.21707; Weimann TK, 2003, EXP DERMATOL, V12, P204, DOI 10.1034/j.1600-0625.2003.00044.x; Wilson KE, 1999, J IMMUNOL, V163, P3621; Winzen U, 2003, J BIOL CHEM, V278, P30106, DOI 10.1074/jbc.M212676200; YABKOWITZ R, 1993, J IMMUNOL, V151, P149; Yu HN, 2000, ARCH BIOCHEM BIOPHYS, V374, P13, DOI 10.1006/abbi.1999.1597; ZHANG LJ, 1995, J BIOL CHEM, V270, P27127, DOI 10.1074/jbc.270.45.27127	79	57	62	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14991	15002		10.1074/jbc.M110.179663	http://dx.doi.org/10.1074/jbc.M110.179663			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21343308	hybrid, Green Published			2022-12-27	WOS:000289788300029
J	Hafner-Bratkovic, I; Bester, R; Pristovsek, P; Gaedtke, L; Veranic, P; Gaspersic, J; Mancek-Keber, M; Avbelj, M; Polymenidou, M; Julius, C; Aguzzi, A; Vorberg, I; Jerala, R				Hafner-Bratkovic, Iva; Bester, Romina; Pristovsek, Primoz; Gaedtke, Lars; Veranic, Peter; Gaspersic, Jernej; Mancek-Keber, Mateja; Avbelj, Matevz; Polymenidou, Magdalini; Julius, Christian; Aguzzi, Adriano; Vorberg, Ina; Jerala, Roman			Globular Domain of the Prion Protein Needs to Be Unlocked by Domain Swapping to Support Prion Protein Conversion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY; CREUTZFELDT-JAKOB-DISEASE; AMYLOID-LIKE FIBRILS; HYDROGEN/DEUTERIUM EXCHANGE; IN-VITRO; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; MAMMALIAN PRIONS; DISULFIDE BONDS; NMR STRUCTURE	Prion diseases are fatal transmissible neurodegenerative diseases affecting many mammalian species. The normal prion protein (PrP) converts into a pathological aggregated form, PrPSc, which is enriched in the beta-sheet structure. Although the high resolution structure of the normal PrP was determined, the structure of the converted form of PrP remains inaccessible to high resolution techniques. To map the PrP conversion process we introduced disulfide bridges into different positions within the globular domain of PrP, tethering selected secondary structure elements. The majority of tethered PrP mutants exhibited increased thermodynamic stability, nevertheless, they converted efficiently. Only the disulfides that tether subdomain B1-H1-B2 to subdomain H2-H3 prevented PrP conversion in vitro and in prion-infected cell cultures. Reduction of disulfides recovered the ability of these mutants to convert, demonstrating that the separation of subdomains is an essential step in conversion. Formation of disulfide-linked proteinase K-resistant dimers in fibrils composed of a pair of single cysteine mutants supports the model based on domain-swapped dimers as the building blocks of prion fibrils. In contrast to previously proposed structural models of PrPSc suggesting conversion of large secondary structural segments, we provide evidence for the conservation of secondary structural elements of the globular domain upon PrP conversion. Previous studies already showed that dimerization is the rate-limiting step in PrP conversion. We show that separation and swapping of subdomains of the globular domain is necessary for conversion. Therefore, we propose that the domain-swapped dimer of PrP precedes amyloid formation and represents a potential target for therapeutic intervention.	[Hafner-Bratkovic, Iva; Pristovsek, Primoz; Gaspersic, Jernej; Mancek-Keber, Mateja; Avbelj, Matevz; Jerala, Roman] Natl Inst Chem, Dept Biotechnol, SI-1000 Ljubljana, Slovenia; [Bester, Romina; Gaedtke, Lars; Vorberg, Ina] Tech Univ Munich, Inst Virol, D-81675 Munich, Germany; [Veranic, Peter] Univ Ljubljana, Sch Med, Inst Cell Biol, Ljubljana 1000, Slovenia; [Polymenidou, Magdalini; Julius, Christian; Aguzzi, Adriano] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; [Jerala, Roman] Univ Ljubljana, Fac Chem & Chem Technol, Ljubljana 1000, Slovenia; [Jerala, Roman] EN FIST Ctr Excellence, Ljubljana 1000, Slovenia	National Institute of Chemistry - Slovenia; Technical University of Munich; University of Ljubljana; University of Zurich; University Zurich Hospital; University of Ljubljana	Jerala, R (corresponding author), Natl Inst Chem, Dept Biotechnol, Hajdrihova 19, SI-1000 Ljubljana, Slovenia.	roman.jerala@ki.si	Aguzzi, Adriano/A-3351-2008; Veranic, Peter/I-6276-2015; Polymenidou, Magdalini/D-2254-2014; Jerala, Roman/H-9850-2015	Veranic, Peter/0000-0003-1999-9988; Pristovsek, Primoz/0000-0002-2304-1791; Jerala, Roman/0000-0002-6337-5251; Aguzzi, Adriano/0000-0002-0344-6708; Gaspersic, Jernej/0000-0003-2131-284X; Hafner Bratkovic, Iva/0000-0001-5635-931X	Slovenian Research Agency; EN-FIST Centre of Excellence; Sonderforschungsbereich [597 B14]; TSEUR; Novartis Research Foundation; Swiss National Foundation; European Union	Slovenian Research Agency(Slovenian Research Agency - Slovenia); EN-FIST Centre of Excellence; Sonderforschungsbereich(German Research Foundation (DFG)); TSEUR; Novartis Research Foundation; Swiss National Foundation(Swiss National Science Foundation (SNSF)); European Union(European Commission)	This work was supported by grants from the Slovenian Research Agency (to I. H.-B. and R. J.), EN-FIST Centre of Excellence (to R. J.), Sonderforschungsbereich 597 B14 (to I. V.), the 6th framework European Union project, TSEUR (to A. A., R. J., and I. V.), the Novartis Research Foundation (to A. A.), and the Swiss National Foundation (to A. A.).	BESTWICK RK, 1988, P NATL ACAD SCI USA, V85, P5404, DOI 10.1073/pnas.85.15.5404; Bocharova OV, 2005, PROTEIN SCI, V14, P1222, DOI 10.1110/ps.041186605; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; CAUGHEY B, 1993, J VIROL, V67, P643, DOI 10.1128/JVI.67.2.643-650.1993; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Colby DW, 2009, P NATL ACAD SCI USA, V106, P20417, DOI 10.1073/pnas.0910350106; Cordeiro Y, 2001, J BIOL CHEM, V276, P49400, DOI 10.1074/jbc.M106707200; Dani VS, 2003, PROTEIN ENG, V16, P187, DOI 10.1093/proeng/gzg024; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; DeMarco ML, 2007, BIOCHEMISTRY-US, V46, P3045, DOI 10.1021/bi0619066; DeMarco ML, 2006, BIOCHEMISTRY-US, V45, P15573, DOI 10.1021/bi0612723; DeMarco ML, 2004, P NATL ACAD SCI USA, V101, P2293, DOI 10.1073/pnas.0307178101; Eghiaian F, 2004, P NATL ACAD SCI USA, V101, P10254, DOI 10.1073/pnas.0400014101; Eghiaian F, 2007, P NATL ACAD SCI USA, V104, P7414, DOI 10.1073/pnas.0607745104; Ertmer A, 2004, J BIOL CHEM, V279, P41918, DOI 10.1074/jbc.M405652200; Gaspersic J, 2010, FEBS J, V277, P2038, DOI 10.1111/j.1742-4658.2010.07619.x; Glockshuber R, 1997, TRENDS BIOCHEM SCI, V22, P241, DOI 10.1016/S0968-0004(97)01070-0; Gossert AD, 2005, P NATL ACAD SCI USA, V102, P646, DOI 10.1073/pnas.0409008102; Guo ZF, 2006, P NATL ACAD SCI USA, V103, P8042, DOI 10.1073/pnas.0602607103; Hafner-Bratkovic I, 2008, J NEUROCHEM, V104, P1553, DOI 10.1111/j.1471-4159.2007.05105.x; Harris DA, 1999, CLIN MICROBIOL REV, V12, P429, DOI 10.1128/CMR.12.3.429; HUNTER N, 1993, J GEN VIROL, V74, P1025, DOI 10.1099/0022-1317-74-6-1025; Jackson GS, 1999, BBA-PROTEIN STRUCT M, V1431, P1, DOI 10.1016/S0167-4838(99)00038-2; Kaimann T, 2008, J MOL BIOL, V376, P582, DOI 10.1016/j.jmb.2007.11.035; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; Kanyo ZF, 1999, J MOL BIOL, V293, P855, DOI 10.1006/jmbi.1999.3193; Kim JI, 2010, J BIOL CHEM, V285, P14083, DOI 10.1074/jbc.C110.113464; Knaus KJ, 2001, NAT STRUCT BIOL, V8, P770, DOI 10.1038/nsb0901-770; KOCISKO DA, 1995, P NATL ACAD SCI USA, V92, P3923, DOI 10.1073/pnas.92.9.3923; Kuwahara C, 1999, NATURE, V400, P225, DOI 10.1038/22241; Lee S, 2010, EMBO J, V29, P251, DOI 10.1038/emboj.2009.333; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Lu XJ, 2007, P NATL ACAD SCI USA, V104, P1510, DOI 10.1073/pnas.0608447104; Luhrs TT, 2006, J MOL BIOL, V357, P833, DOI 10.1016/j.jmb.2006.01.016; Maas E, 2007, J BIOL CHEM, V282, P18702, DOI 10.1074/jbc.M701309200; Makarava N, 2008, J BIOL CHEM, V283, P15988, DOI 10.1074/jbc.M800562200; Makarava N, 2010, ACTA NEUROPATHOL, V119, P177, DOI 10.1007/s00401-009-0633-x; MANN R, 1983, CELL, V33, P153, DOI 10.1016/0092-8674(83)90344-6; MILLER AD, 1986, MOL CELL BIOL, V6, P2895, DOI 10.1128/MCB.6.8.2895; Nazabal A, 2009, J MASS SPECTROM, V44, P965, DOI 10.1002/jms.1572; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; Polymenidou M, 2005, LANCET NEUROL, V4, P805, DOI 10.1016/S1474-4422(05)70225-8; Polymenidou M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003872; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; ROGERS M, 1991, J IMMUNOL, V147, P3568; Sajnani G, 2008, J MOL BIOL, V382, P88, DOI 10.1016/j.jmb.2008.06.070; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sambashivan S, 2005, NATURE, V437, P266, DOI 10.1038/nature03916; Shindoh R, 2009, J VIROL, V83, P3852, DOI 10.1128/JVI.01740-08; Sigurdson CJ, 2009, P NATL ACAD SCI USA, V106, P304, DOI 10.1073/pnas.0810680105; Silva JL, 2008, TRENDS BIOCHEM SCI, V33, P132, DOI 10.1016/j.tibs.2007.11.003; Staniforth RA, 2001, EMBO J, V20, P4774, DOI 10.1093/emboj/20.17.4774; Stohr J, 2008, P NATL ACAD SCI USA, V105, P2409, DOI 10.1073/pnas.0712036105; Tattum MH, 2006, J MOL BIOL, V357, P975, DOI 10.1016/j.jmb.2006.01.052; TURK E, 1988, EUR J BIOCHEM, V176, P21, DOI 10.1111/j.1432-1033.1988.tb14246.x; Tycko R, 2010, BIOCHEMISTRY-US, V49, P9488, DOI 10.1021/bi1013134; Vakser IA, 1999, P NATL ACAD SCI USA, V96, P8477, DOI 10.1073/pnas.96.15.8477; Vieira TCRG, 2011, J AM CHEM SOC, V133, P334, DOI 10.1021/ja106725p; Vorberg I, 2004, J INFECT DIS, V189, P431, DOI 10.1086/381166; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Welker E, 2002, J BIOL CHEM, V277, P33477, DOI 10.1074/jbc.M204273200; Wille H, 2002, P NATL ACAD SCI USA, V99, P3563, DOI 10.1073/pnas.052703499; Wiltzius JJW, 2009, NAT STRUCT MOL BIOL, V16, P973, DOI 10.1038/nsmb.1643; Wuthrich K, 2001, ADV PROTEIN CHEM, V57, P55; Yamasaki M, 2008, NATURE, V455, P1255, DOI 10.1038/nature07394; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zahn R, 1997, FEBS LETT, V417, P400, DOI 10.1016/S0014-5793(97)01330-6	70	76	76	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.213926	http://dx.doi.org/10.1074/jbc.M110.213926			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21324909	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000289077500030
J	Nakano, N; Nishiyama, C; Yagita, H; Koyanagi, A; Ogawa, H; Okumura, K				Nakano, Nobuhiro; Nishiyama, Chiharu; Yagita, Hideo; Koyanagi, Akemi; Ogawa, Hideoki; Okumura, Ko			Notch1-mediated Signaling Induces MHC Class II Expression through Activation of Class II Transactivator Promoter III in Mast Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; TRANSCRIPTION FACTORS; HEMATOPOIETIC-CELLS; DENDRITIC CELLS; T-CELLS; PU.1; CIITA; NOTCH; DIFFERENTIATION; FATE	Mast cells constitutively express Notch1 and Notch2 on the cell surface. Notch ligand Dll1 (Delta-like (1) under bar) stimulation induces MHC class II expression in mast cells and renders them as antigen-presenting cells. However, nothing is known about the mechanism by which Notch signaling induces MHC class II expression in mast cells. MHC class II genes are regulated by the class II transactivator (CIITA). In mice, transcription of the CIITA gene is controlled by three cell type-specific promoters (pI, pIII, and pIV). Here, we show that CIITA expression induced by Dll1 stimulation in mouse bone marrow-derived mast cells (BMMCs) depends critically on the signal mediated by Notch1 and that the most dominant promoter in Notch signaling-mediated CIITA expression in BMMCs is pIII, which is a lymphoid lineage-specific promoter. ChIP assays indicated that Notch signaling increased the binding of the transcription factor PU.1 to CIITA pIII in BMMCs. The knockdown of PU.1 expression using a specific siRNA suppressed Notch signaling-mediated CIITA expression, suggesting that PU. 1 contributes to the expression of MHC class II induced by Notch signaling in mast cells. Furthermore, we show that a portion of freshly isolated splenic mast cells express MHC class II and that the most dominant promoter of CIITA in mast cells is pIII. These findings indicate that activation of CIITA pIII plays an important role in MHC class II expression in mast cells.	[Nakano, Nobuhiro] Juntendo Univ, Sch Med, Atopy Allergy Res Ctr, Bunkyo Ku, Tokyo 1138421, Japan; [Yagita, Hideo; Okumura, Ko] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 1138421, Japan; [Yagita, Hideo; Koyanagi, Akemi] Juntendo Univ, Sch Med, Biomed Res Ctr, Div Cell Biol, Tokyo 1138421, Japan	Juntendo University; Juntendo University; Juntendo University	Nakano, N (corresponding author), Juntendo Univ, Sch Med, Atopy Allergy Res Ctr, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	nbnakano@juntendo.ac.jp	Nishiyama, Chiharu/GPW-9372-2022	Nakano, Nobuhiro/0000-0002-5317-5950	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by a grant-in-aid for young scientists (to N. N.) and a grant-in-aid for scientific research (C) (to C. N.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by a grant from the Takeda Science Foundation (to N. N.).	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; CHANG CH, 1994, J EXP MED, V180, P1367, DOI 10.1084/jem.180.4.1367; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; Gurbuxani S, 2004, BLOOD, V103, P399, DOI 10.1182/blood-2003-05-1556; Hallgren J, 2007, IMMUNOL REV, V217, P8, DOI 10.1111/j.1600-065X.2007.00502.x; Holling TM, 2002, J IMMUNOL, V168, P763, DOI 10.4049/jimmunol.168.2.763; Ito T, 2005, J IMMUNOL, V174, P376, DOI 10.4049/jimmunol.174.1.376; Ito T, 2009, INT IMMUNOL, V21, P803, DOI 10.1093/intimm/dxp048; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Kambayashi T, 2009, J IMMUNOL, V182, P4686, DOI 10.4049/jimmunol.0803180; KIM KJ, 1979, J IMMUNOL, V122, P549; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kitamura Y, 2006, IMMUNOL ALLERGY CLIN, V26, P387, DOI 10.1016/j.iac.2006.05.004; Kumano K, 2001, BLOOD, V98, P3283, DOI 10.1182/blood.V98.12.3283; LeibundGut-Landmann S, 2004, EUR J IMMUNOL, V34, P1513, DOI 10.1002/eji.200424964; LeibundGut-Landmann S, 2004, NAT IMMUNOL, V5, P899, DOI 10.1038/ni1109; MacDonald AS, 2008, J EXP MED, V205, P13, DOI 10.1084/jem.20072665; Maeda K, 2006, BLOOD, V108, P262, DOI 10.1182/blood-2005-07-2878; Maeda K, 2010, J IMMUNOL, V185, P4252, DOI 10.4049/jimmunol.1001228; Moriyama Y, 2008, INT IMMUNOL, V20, P763, DOI 10.1093/intimm/dxn034; MuhlethalerMOttet A, 1997, EMBO J, V16, P2851, DOI 10.1093/emboj/16.10.2851; Nakano N, 2009, J ALLERGY CLIN IMMUN, V123, P74, DOI 10.1016/j.jaci.2008.10.040; NAKANO T, 1985, J EXP MED, V162, P1025, DOI 10.1084/jem.162.3.1025; Nerlov C, 2000, BLOOD, V95, P2543, DOI 10.1182/blood.V95.8.2543.008k19_2543_2551; Nishiyama C, 2006, BIOSCI BIOTECH BIOCH, V70, P1, DOI 10.1271/bbb.70.1; Nishiyama C, 2004, BIOCHEM BIOPH RES CO, V313, P516, DOI 10.1016/j.bbrc.2003.11.145; Niwa Y, 2008, BIOCHEM BIOPH RES CO, V375, P95, DOI 10.1016/j.bbrc.2008.07.129; Okayama Y, 2006, IMMUNOL RES, V34, P97, DOI 10.1385/IR:34:2:97; Ong CT, 2006, J BIOL CHEM, V281, P5106, DOI 10.1074/jbc.M506108200; Osborne BA, 2007, NAT REV IMMUNOL, V7, P64, DOI 10.1038/nri1998; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; Rekhtman N, 1999, GENE DEV, V13, P1398, DOI 10.1101/gad.13.11.1398; Sakata-Yanagimoto M, 2008, P NATL ACAD SCI USA, V105, P7839, DOI 10.1073/pnas.0801074105; Sakata-Yanagimoto M, 2011, BLOOD, V117, P128, DOI 10.1182/blood-2010-07-289611; Schroeder T, 2003, J IMMUNOL, V170, P5538, DOI 10.4049/jimmunol.170.11.5538; Shimizu K, 2000, MOL CELL BIOL, V20, P6913, DOI 10.1128/MCB.20.18.6913-6922.2000; Shimizu K, 2002, BIOCHEM BIOPH RES CO, V291, P775, DOI 10.1006/bbrc.2002.6528; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; Takagi A, 2006, BIOCHEM BIOPH RES CO, V347, P388, DOI 10.1016/j.bbrc.2006.05.215; Tsai FY, 1997, BLOOD, V89, P3636, DOI 10.1182/blood.V89.10.3636.3636_3636_3643; Tsuchiya S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-35; van der Stoep N, 2004, BLOOD, V104, P2849, DOI 10.1182/blood-2004-03-0790; Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705	44	17	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.138966	http://dx.doi.org/10.1074/jbc.M110.138966			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21321116	hybrid, Green Published			2022-12-27	WOS:000289077500018
J	Feng, YQ; Chelico, L				Feng, Yuqing; Chelico, Linda			Intensity of Deoxycytidine Deamination of HIV-1 Proviral DNA by the Retroviral Restriction Factor APOBEC3G Is Mediated by the Noncatalytic Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CYTIDINE DEAMINASE; VIRUS-LIKE PARTICLES; SINGLE-STRANDED-DNA; VIF PROTEIN; DRUG-RESISTANCE; ENZYME APOBEC3G; RNA; HYPERMUTATION; INFECTION; VIRIONS	APOBEC3G is a single-stranded (ss) DNA deaminase that restricts replication of HIV-1 by inducing viral genome mutagenesis through deamination of cytosine to uracil on HIV-1 cDNA. APOBEC3G has polydisperse oligomeric states and deaminates ssDNA processively through jumping and sliding. APOBEC3G has a catalytically inactive N-terminal CD1 domain that mediates processivity and an active C-terminal CD2 domain that catalyzes deaminations. Here, we assess the determinants of APOBEC3G deamination efficiency mediated by the CD1 domain by comparing native APOBEC3G and two CD1 mutants, a monomeric mutant (F126A/W127A) and a clinical mutant associated with high viral loads (H186R). Biochemical assays on ssDNA or partially dsDNA and with a reconstituted HIV replication system demonstrate that both mutants of Apo3G have altered DNA scanning properties in either jumping (F126A/W127A) or sliding (H186R), which results in decreased abilities to induce mutagenesis during reverse transcription. The data reveal a functionality for Apo3G oligomers in deamination and provide the first biochemical characterization of the clinical mutant H186R. The data demonstrate that the balance between the jumping and sliding of Apo3G is needed for efficient mutational inactivation of HIV-1.	[Feng, Yuqing; Chelico, Linda] Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK S7N 5E5, Canada	University of Saskatchewan	Chelico, L (corresponding author), Univ Saskatchewan, Dept Microbiol & Immunol, 107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.	linda.chelico@usask.ca		Feng, Yuqing/0000-0002-7156-1628; Chelico, Linda/0000-0003-4673-8978	Natural Sciences and Engineering Research Council of Canada; Saskatchewan Health Research Foundation; College of Medicine at the University of Saskatchewan; University of Saskatchewan; National Institutes of Health [ISI0RR023748-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023748] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Saskatchewan Health Research Foundation; College of Medicine at the University of Saskatchewan; University of Saskatchewan; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by a discovery grant from the Natural Sciences and Engineering Research Council of Canada, a new investigator establishment grant from the Saskatchewan Health Research Foundation, and tri-council recognition award from the College of Medicine at the University of Saskatchewan (to L. C.).; Supported by a University of Saskatchewan Summer Student Employment Program-Board of Governors' Scholarship.; We thank Dr. Brian Bandy for the use of the fluorometer, Jason Maley at the Saskatchewan Structural Sciences Centre for assistance with AFM, and Dr. Kerri Kobryn for critical review of the manuscript. The SEC-LX/UV/RI instrumentation was supported by National Institutes of Health Award ISI0RR023748-01.	Alce TM, 2004, J BIOL CHEM, V279, P34083, DOI 10.1074/jbc.C400235200; An P, 2004, J VIROL, V78, P11070, DOI 10.1128/JVI.78.20.11070-11076.2004; Bach D, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-54; Bogerd HP, 2008, RNA, V14, P1228, DOI 10.1261/rna.964708; Bransteitter R, 2004, J BIOL CHEM, V279, P51612, DOI 10.1074/jbc.M408135200; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Browne EP, 2009, VIROLOGY, V387, P313, DOI 10.1016/j.virol.2009.02.026; Bulliard Y, 2009, J VIROL, V83, P12611, DOI 10.1128/JVI.01491-09; Cen S, 2004, J BIOL CHEM, V279, P33177, DOI 10.1074/jbc.M402062200; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chelico L, 2008, J BIOL CHEM, V283, P13780, DOI 10.1074/jbc.M801004200; Chelico L, 2010, J BIOL CHEM, V285, P16195, DOI 10.1074/jbc.M110.107987; Chelico L, 2009, PHILOS T R SOC B, V364, P583, DOI 10.1098/rstb.2008.0195; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; COFFIN JM, 1997, RETROVIRUSES, P121; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Creighton S, 1995, METHOD ENZYMOL, V262, P232; Douaisi M, 2004, BIOCHEM BIOPH RES CO, V321, P566, DOI 10.1016/j.bbrc.2004.07.005; Folta-Stogniew E, 1999, J Biomol Tech, V10, P51; Gao F, 1996, J VIROL, V70, P1651, DOI 10.1128/JVI.70.3.1651-1667.1996; Gifford RJ, 2008, AIDS, V22, P717, DOI 10.1097/QAD.0b013e3282f5e07a; Hache G, 2005, J BIOL CHEM, V280, P10920, DOI 10.1074/jbc.M500382200; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; Harris RS, 2006, NAT STRUCT MOL BIOL, V13, P380, DOI 10.1038/nsmb0506-380; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Hu CL, 2010, J VIROL, V84, P11981, DOI 10.1128/JVI.00723-10; Hultquist JF, 2009, FUTURE VIROL, V4, P605, DOI 10.2217/FVL.09.59; Huthoff H, 2007, J VIROL, V81, P3807, DOI 10.1128/JVI.02795-06; Huthoff H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000330; Jern P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000367; Khan MA, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-48; Kim EY, 2010, J VIROL, V84, P10402, DOI 10.1128/JVI.01223-10; Kohli RM, 2009, J BIOL CHEM, V284, P22898, DOI 10.1074/jbc.M109.025536; LOEB DD, 1989, NATURE, V340, P397, DOI 10.1038/340397a0; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Mulder LCF, 2008, P NATL ACAD SCI USA, V105, P5501, DOI 10.1073/pnas.0710190105; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Nowarski R, 2008, NAT STRUCT MOL BIOL, V15, P1059, DOI 10.1038/nsmb.1495; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Pham P, 2008, J BIOL CHEM, V283, P17428, DOI 10.1074/jbc.M802121200; Pillai SK, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-26; Ratcliff GC, 2001, J AM CHEM SOC, V123, P5632, DOI 10.1021/ja005750n; Rausch JW, 2009, J BIOL CHEM, V284, P7047, DOI 10.1074/jbc.M807258200; Reddy K, 2010, AIDS, V24, P195, DOI 10.1097/QAD.0b013e3283353bba; Refsland EW, 2010, NUCLEIC ACIDS RES, V38, P4274, DOI 10.1093/nar/gkq174; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Sadler HA, 2010, J VIROL, V84, P7396, DOI 10.1128/JVI.00056-10; SCHATZ O, 1990, EMBO J, V9, P1171, DOI 10.1002/j.1460-2075.1990.tb08224.x; Shao W, 1997, P NATL ACAD SCI USA, V94, P2243, DOI 10.1073/pnas.94.6.2243; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Stanford NP, 2000, EMBO J, V19, P6546, DOI 10.1093/emboj/19.23.6546; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Strebel K, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-55; Suspene R, 2006, NUCLEIC ACIDS RES, V34, P4677, DOI 10.1093/nar/gkl555; Svarovskaia ES, 2004, J BIOL CHEM, V279, P35822, DOI 10.1074/jbc.M405761200; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; Wang T, 2007, J VIROL, V81, P13112, DOI 10.1128/JVI.00892-07; Wlodawer A, 1998, ANNU REV BIOPH BIOM, V27, P249, DOI 10.1146/annurev.biophys.27.1.249; WYATT PJ, 1993, ANAL CHIM ACTA, V272, P1, DOI 10.1016/0003-2670(93)80373-S; Xu HZ, 2007, VIROLOGY, V360, P247, DOI 10.1016/j.virol.2006.10.036; Yang Y, 2003, METHODS, V29, P175, DOI 10.1016/S1046-2023(02)00308-0; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhu P, 2003, P NATL ACAD SCI USA, V100, P15812, DOI 10.1073/pnas.2634931100	68	46	46	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11415	11426		10.1074/jbc.M110.199604	http://dx.doi.org/10.1074/jbc.M110.199604			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21300806	hybrid, Green Published			2022-12-27	WOS:000288797100053
J	Wang, Y; Wu, ZY; Li, D; Wang, DA; Wang, XM; Feng, XA; Xia, M				Wang, Yun; Wu, Zeyu; Li, Dan; Wang, Duan; Wang, Xiaoming; Feng, Xiang; Xia, Min			Involvement of Oxygen-regulated Protein 150 in AMP-activated Protein Kinase-mediated Alleviation of Lipid-induced Endoplasmic Reticulum Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FOXO1; OXIDATIVE-STRESS; CELL-DEATH; HEPATIC LIPOGENESIS; ER STRESS; APOPTOSIS; ORP150; ATHEROSCLEROSIS; METABOLISM; EXPRESSION	Hepatocytes show endoplasmic reticulum (ER) stress when exposed to lipotoxic stimuli such as hyperlipidemia. Recent work has revealed that AMP- activated protein kinase (AMPK) can mitigate ER stress. In this study we investigated the impact of AMPK on lipid-induced ER stress in hepatocytes and its underlying molecular mechanism. Treatment with 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), an AMPK agonist, or overexpression of a constitutively active AMPK significantly suppressed lipid-mediated ER stress, leading to marked protection against lipotoxic death. Incubation with AICAR and constitutively active AMPK overexpression induced the expression of an ER-associated chaperone, 150-kDa oxygen-regulated protein (ORP150), at both the mRNA and protein levels in hepatocytes. Forkhead box O1 (FOXO1) was identified as the critical transcription factor regulating ORP150 expression because silencing FOXO1 expression prevented the induction of ORP150 expression by AMPK. In contrast, overexpression of FOXO1-ADA promoted ORP150 expression in hepatocytes. FOXO1 bound directly to the ORP150 promoter, which was enhanced in the presence of AICAR. AMPK acts to activate FOXO1 by increasing its deacetylation and transcriptional activity via silent mating type information regulation 2 homolog 1 (SIRT1). Furthermore, AICAR infusion enhanced ORP150 expression, resulting in the marked amelioration of hepatic ER stress and apoptosis in C57BL/6J mice fed a high fat diet. Our results reveal a novel mechanism by which AMPK regulates ER homeostasis in hepatocytes and suggest that AMPK has a protective role against hypercholesterolemia-related liver damage.	[Wang, Yun; Li, Dan; Wang, Duan; Wang, Xiaoming; Feng, Xiang; Xia, Min] Sun Yat Sen Univ, Sch Publ Hlth, Dept Nutr, Guangzhou 510080, Guangdong, Peoples R China; [Wang, Yun; Li, Dan; Wang, Duan; Wang, Xiaoming; Feng, Xiang; Xia, Min] Sun Yat Sen Univ, Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou 510080, Guangdong, Peoples R China; [Wu, Zeyu] Guangdong Gen Hosp, Guangdong Acad Med Sci, Dept Surg Vasc Dis, Guangzhou 510080, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Guangdong Academy of Medical Sciences & Guangdong General Hospital	Xia, M (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Dept Nutr, No Campus,74 Zhongshan Rd 2, Guangzhou 510080, Guangdong, Peoples R China.	xiamin@mail.sysu.edu.cn			National Natural Science Foundation [81072301]; Guangdong Natural Science Foundation [9151012003000002]; Foundation for the Author of National Excellent Doctoral Dissertation of PR China [200978]; Sun Yat-Sen University [10ykzd04]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Foundation for the Author of National Excellent Doctoral Dissertation of PR China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Sun Yat-Sen University	This research was supported by grants from the National Natural Science Foundation (81072301), grants from the Guangdong Natural Science Foundation (9151012003000002), Foundation for the Author of National Excellent Doctoral Dissertation of PR China (200978), and the Fundamental Research Funds for the Central Universities of Sun Yat-Sen University (10ykzd04).	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Akao M, 2001, CIRC RES, V88, P1267, DOI 10.1161/hh1201.092094; Bando Y, 2000, AM J PHYSIOL-CELL PH, V278, pC1172, DOI 10.1152/ajpcell.2000.278.6.C1172; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Dong YZ, 2010, CIRCULATION, V121, P792, DOI 10.1161/CIRCULATIONAHA.109.900928; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; FERNANDESALNEMRI T, 1994, J BIOL CHEM, V269, P30761; Flamment M, 2010, CURR OPIN LIPIDOL, V21, P239, DOI 10.1097/MOL.0b013e3283395e5c; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hotamisligil GS, 2010, NAT MED, V16, P396, DOI 10.1038/nm0410-396; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kuwabara K, 1996, J BIOL CHEM, V271, P5025; Lai E, 2008, AM J PHYSIOL-ENDOC M, V294, pE540, DOI 10.1152/ajpendo.00478.2007; Lavu S, 2008, NAT REV DRUG DISCOV, V7, P841, DOI 10.1038/nrd2665; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Malhi H, 2010, PHYSIOL REV, V90, P1165, DOI 10.1152/physrev.00061.2009; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Matsuzaki H, 2005, P NATL ACAD SCI USA, V102, P11278, DOI 10.1073/pnas.0502738102; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nakae J, 2000, EMBO J, V19, P989, DOI 10.1093/emboj/19.5.989; Nakamura T, 2008, MOL CELL ENDOCRINOL, V281, P47, DOI 10.1016/j.mce.2007.10.007; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Ozawa K, 1999, J BIOL CHEM, V274, P6397, DOI 10.1074/jbc.274.10.6397; Park KG, 2008, HEPATOLOGY, V48, P1477, DOI 10.1002/hep.22496; Qin XM, 2008, HEPATOLOGY, V48, P432, DOI 10.1002/hep.22334; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2010, J CELL BIOL, V189, P783, DOI 10.1083/jcb.201003138; Sanson M, 2008, CELL DEATH DIFFER, V15, P1255, DOI 10.1038/cdd.2008.36; Sanson M, 2009, CIRC RES, V104, P328, DOI 10.1161/CIRCRESAHA.108.183749; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Tamatani M, 2001, NAT MED, V7, P317, DOI 10.1038/85463; Terai K, 2005, MOL CELL BIOL, V25, P9554, DOI 10.1128/MCB.25.21.9554-9575.2005; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Tsukamoto Y, 1996, J CLIN INVEST, V98, P1930, DOI 10.1172/JCI118994; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yang YH, 2005, EMBO J, V24, P1021, DOI 10.1038/sj.emboj.7600570; Yao PM, 2000, J BIOL CHEM, V275, P23807, DOI 10.1074/jbc.M002087200; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	47	51	57	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11119	11131		10.1074/jbc.M110.203323	http://dx.doi.org/10.1074/jbc.M110.203323			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21296878	hybrid, Green Published			2022-12-27	WOS:000288797100023
J	James, J; Robbins, J				James, Jeanne; Robbins, Jeffrey			Signaling and Myosin-binding Protein C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; UBIQUITIN-PROTEASOME SYSTEM; KINASE-A PHOSPHORYLATION; CARDIAC TROPONIN-I; SPLICE DONOR SITE; HEAVY-CHAIN GENE; MYBP-C; SKELETAL-MUSCLE; DILATED CARDIOMYOPATHY; MOLECULAR-BASIS	Myosin-binding protein C (MyBP-C) is a thick filament protein consisting of 1274 amino acid residues (149 kDa) that was identified by Starr and Offer over 30 years ago as a contaminant present in a preparation of purified myosin. Since then, numerous studies have defined the muscle-specific isoforms, the structure, and the importance of the proteins in normal striated muscle structure and function. Underlying the critical role the protein plays, it is now apparent that mutations in the cardiac isoform (cMyBP-C) are responsible for a substantial proportion (30-40%) of genotyped cases of familial hypertrophic cardiomyopathy. Although generally accepted that MyBP-C can interact with all three filament systems within the sarcomere (the thick, thin, and titin filaments), the exact nature of these interactions and the functional consequences of modified binding remain obscure. In addition to these structural considerations, cMyBP-C can serve as a point of convergence for signaling processes in the cardiomyocyte via post-translational modifications mediated by kinases that phosphorylate residues in the cardiac-specific isoform sequence. Thus, cMyBP-C is a critical nodal point that has both important structural and signaling roles and whose modifications are known to cause significant human cardiac disease.	[Robbins, Jeffrey] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; Cincinnati Childrens Hosp Med Ctr, Inst Heart, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Robbins, J (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA.	jeff.robbins@cchmc.org			National Institutes of Health [P01 HL69779, P01 HL059408, R01 HL087862, P01 HL077101]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL069779, P50HL077101, R01HL087862, P01HL059408] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 HL69779, P01 HL059408, R01 HL087862, and P01 HL077101 (to J. R.). This is the third article in the Thematic Minireview Series on Signaling in Cardiac Sarcomeres in Health and Disease. This minireview will be reprinted in the 2011 Minireview Compendium, which will be available in January, 2012.	ASGHAR A, 1985, CRC CR REV FOOD SCI, V22, P27, DOI 10.1080/10408398509527408; BAHLER M, 1985, J MOL BIOL, V186, P381, DOI 10.1016/0022-2836(85)90112-3; Bardswell SC, 2010, J BIOL CHEM, V285, P5674, DOI 10.1074/jbc.M109.066456; Barefield D, 2010, J MOL CELL CARDIOL, V48, P866, DOI 10.1016/j.yjmcc.2009.11.014; BENNETT P, 1985, J MOL BIOL, V184, P297, DOI 10.1016/0022-2836(85)90381-X; Brickson S, 2007, AM J PHYSIOL-HEART C, V292, pH1747, DOI 10.1152/ajpheart.01037.2006; CARRIER L, 1993, NAT GENET, V4, P311, DOI 10.1038/ng0793-311; Carrier L, 2010, CARDIOVASC RES, V85, P330, DOI 10.1093/cvr/cvp247; Chang AN, 2005, HEART FAIL REV, V10, P225, DOI 10.1007/s10741-005-5252-6; Colson BA, 2010, J PHYSIOL-LONDON, V588, P981, DOI 10.1113/jphysiol.2009.183897; Colucci WS, 2000, J CARD FAIL, V6, P1; Dalloz F, 2001, J MOL CELL CARDIOL, V33, P9, DOI 10.1006/jmcc.2000.1289; Decker RS, 2010, TRANSL RES, V155, P27, DOI 10.1016/j.trsl.2009.09.007; Decker RS, 2005, CIRCULATION, V111, P906, DOI 10.1161/01.CIR.0000155609.95618.75; Dellefave LM, 2009, CIRC-CARDIOVASC GENE, V2, P442, DOI 10.1161/CIRCGENETICS.109.861955; Dhandapany PS, 2009, NAT GENET, V41, P187, DOI 10.1038/ng.309; DHOOT GK, 1985, J MUSCLE RES CELL M, V6, P487, DOI 10.1007/BF00712585; DOETSCHMAN T, 1988, P NATL ACAD SCI USA, V85, P8583, DOI 10.1073/pnas.85.22.8583; El-Armouche A, 2006, CIRCULATION, V114, P670, DOI 10.1161/CIRCULATIONAHA.106.636845; ENGLAND PJ, 1984, ADV CYCLIC NUCL PROT, V17, P383; ENGLAND PJ, 1983, BIOCHEM SOC T, V11, P153, DOI 10.1042/bst0110153; Erdmann J, 2003, CLIN GENET, V64, P339, DOI 10.1034/j.1399-0004.2003.00151.x; Flashman E, 2008, FEBS LETT, V582, P434, DOI 10.1016/j.febslet.2008.01.004; Flashman E, 2004, CIRC RES, V94, P1279, DOI 10.1161/01.RES.0000127175.21818.C2; Flashman E, 2007, BIOCHEM J, V401, P97, DOI 10.1042/BJ20060500; Frank-Hansen R, 2008, EUR J HUM GENET, V16, P1062, DOI 10.1038/ejhg.2008.52; GAUTEL M, 1995, EMBO J, V14, P1952, DOI 10.1002/j.1460-2075.1995.tb07187.x; GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I; Granzier HL, 2006, CIRC RES, V99, P795, DOI 10.1161/01.RES.0000247031.56868.10; Harris SP, 2004, CIRC RES, V95, P930, DOI 10.1161/01.RES.0000147312.02673.56; Harris SP, 2002, CIRC RES, V90, P594, DOI 10.1161/01.RES.0000012222.70819.64; HARTZELL HC, 1984, J BIOL CHEM, V259, P5587; Hershberger RE, 2010, CIRC-CARDIOVASC GENE, V3, P155, DOI 10.1161/CIRCGENETICS.109.912345; Jacques AM, 2008, J MOL CELL CARDIOL, V45, P209, DOI 10.1016/j.yjmcc.2008.05.020; James J, 1997, AM J PHYSIOL-HEART C, V273, pH2105, DOI 10.1152/ajpheart.1997.273.5.H2105; JEACOCKE SA, 1980, FEBS LETT, V122, P129, DOI 10.1016/0014-5793(80)80418-2; Kimura A, 2010, J HUM GENET, V55, P81, DOI 10.1038/jhg.2009.138; Kubo T, 2005, J AM COLL CARDIOL, V46, P1737, DOI 10.1016/j.jacc.2005.05.087; Kulikovskaya I, 2003, J GEN PHYSIOL, V122, P761, DOI 10.1085/jgp.200308941; Kunst G, 2000, CIRC RES, V86, P51, DOI 10.1161/01.RES.86.1.51; Marian AJ, 2008, CURR OPIN CARDIOL, V23, P199, DOI 10.1097/HCO.0b013e3282fc27d9; Markwald RR, 2010, ANN NY ACAD SCI, V1188, P177, DOI 10.1111/j.1749-6632.2009.05098.x; Marston SB, 2009, J MUSCLE RES CELL M, V30, P93, DOI 10.1007/s10974-009-9184-y; McConnell BK, 1999, J CLIN INVEST, V104, P1235, DOI 10.1172/JCI7377; Michels M, 2009, JACC-CARDIOVASC IMAG, V2, P58, DOI 10.1016/j.jcmg.2008.08.003; Mohamed AS, 1998, ARCH BIOCHEM BIOPHYS, V358, P313, DOI 10.1006/abbi.1998.0857; MOLINA MI, 1987, J BIOL CHEM, V262, P6478; Moolman JA, 2000, CIRCULATION, V101, P1396, DOI 10.1161/01.CIR.101.12.1396; Moolman-Smook J, 2002, CIRC RES, V91, P704, DOI 10.1161/01.RES.0000036750.81083.83; MOOS C, 1981, J CELL BIOL, V90, P25, DOI 10.1083/jcb.90.1.25; MOOS C, 1980, BIOCHIM BIOPHYS ACTA, V632, P141, DOI 10.1016/0304-4165(80)90071-9; Morimoto S, 2008, CARDIOVASC RES, V77, P659, DOI 10.1093/cvr/cvm084; Nagayama T, 2007, CIRCULATION, V116, P2399, DOI 10.1161/CIRCULATIONAHA.107.706523; Nicol RL, 2000, ANNU REV GENOM HUM G, V1, P179, DOI 10.1146/annurev.genom.1.1.179; Nicolaou P, 2009, J MOL CELL CARDIOL, V47, P365, DOI 10.1016/j.yjmcc.2009.05.010; Niimura H, 1998, NEW ENGL J MED, V338, P1248, DOI 10.1056/NEJM199804303381802; OBINATA T, 1984, DEV BIOL, V105, P253, DOI 10.1016/0012-1606(84)90283-5; OBINATA T, 1984, DEV BIOL, V101, P116, DOI 10.1016/0012-1606(84)90122-2; OFFER G, 1972, COLD SPRING HARB SYM, V37, P87; Otey CA, 2009, CELL MOTIL CYTOSKEL, V66, P618, DOI 10.1002/cm.20385; Palmer BM, 2004, MOL CELL BIOCHEM, V263, P73, DOI 10.1023/B:MCBI.0000041849.60591.45; PALMITER RD, 1982, CELL, V29, P701, DOI 10.1016/0092-8674(82)90186-6; Richard P, 2003, CIRCULATION, V107, P2227, DOI 10.1161/01.CIR.0000066323.15244.54; Rottbauer W, 1997, J CLIN INVEST, V100, P475, DOI 10.1172/JCI119555; Sadayappan S, 2005, CIRC RES, V97, P1156, DOI 10.1161/01.RES.0000190605.79013.4d; Sadayappan S, 2008, FASEB J, V22, P1246, DOI 10.1096/fj.07-9458com; Sadayappan S, 2008, ANN NY ACAD SCI, V1123, P1, DOI 10.1196/annals.1420.002; Sadayappan S, 2006, P NATL ACAD SCI USA, V103, P16918, DOI 10.1073/pnas.0607069103; Sadayappan S, 2009, CIRCULATION, V119, P1253, DOI 10.1161/CIRCULATIONAHA.108.798983; Sarikas A, 2005, CARDIOVASC RES, V66, P33, DOI 10.1016/j.cardiores.2005.01.004; Shaffer JF, 2009, J MUSCLE RES CELL M, V30, P303, DOI 10.1007/s10974-010-9207-8; Shaffer JF, 2009, J BIOL CHEM, V284, P12318, DOI 10.1074/jbc.M808850200; SOLOMON SD, 1990, J CLIN INVEST, V86, P993, DOI 10.1172/JCI114802; Squire JM, 2003, J MOL BIOL, V331, P713, DOI 10.1016/S0022-2836(03)00781-2; STARR R, 1978, BIOCHEM J, V171, P813, DOI 10.1042/bj1710813; Stelzer JE, 2007, CIRC RES, V101, P503, DOI 10.1161/CIRCRESAHA.107.153650; TANIGAWA G, 1990, CELL, V62, P991, DOI 10.1016/0092-8674(90)90273-H; Tardiff JC, 2005, HEART FAIL REV, V10, P237, DOI 10.1007/s10741-005-5253-5; Tooze SA, 2010, IUBMB LIFE, V62, P503, DOI 10.1002/iub.334; van Dijk SJ, 2009, CIRCULATION, V119, P1473, DOI 10.1161/CIRCULATIONAHA.108.838672; Wang LB, 2010, ANN INTERN MED, V152, P513, DOI 10.7326/0003-4819-152-8-201004200-00008; Wang XJ, 2006, CIRC RES, V99, P1315, DOI 10.1161/01.RES.0000252342.61447.a2; WATKINS H, 1995, NAT GENET, V11, P434, DOI 10.1038/ng1295-434; WEBER FE, 1993, EUR J BIOCHEM, V216, P661, DOI 10.1111/j.1432-1033.1993.tb18186.x; Wexler R, 2009, AM FAM PHYSICIAN, V79, P778; Winegrad S, 2005, ADV EXP MED BIOL, V565, P269; Winegrad S, 2003, ADV EXP MED BIOL, V538, P31; YAMAMOTO K, 1983, J BIOL CHEM, V258, P8395; Yang QL, 1999, CIRC RES, V85, P841, DOI 10.1161/01.RES.85.9.841; Yang QL, 1998, J CLIN INVEST, V102, P1292, DOI 10.1172/JCI3880; Yuan C, 2008, AM J PHYSIOL-HEART C, V295, pH647, DOI 10.1152/ajpheart.00357.2008; Yuan C, 2006, PROTEOMICS, V6, P4176, DOI 10.1002/pmic.200500894	92	30	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					9913	9919		10.1074/jbc.R110.171801	http://dx.doi.org/10.1074/jbc.R110.171801			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21257752	hybrid, Green Published			2022-12-27	WOS:000288547000004
J	Martin, DC; Kim, H; Mackin, NA; Maldonado-Baez, L; Evangelista, CC; Beaudry, VG; Dudgeon, DD; Naiman, DQ; Erdman, SE; Cunningham, KW				Martin, D. Christian; Kim, Hyemin; Mackin, Nancy A.; Maldonado-Baez, Lymarie; Evangelista, Carlos C., Jr.; Beaudry, Veronica G.; Dudgeon, Drew D.; Naiman, Daniel Q.; Erdman, Scott E.; Cunningham, Kyle W.			New Regulators of a High Affinity Ca2+ Influx System Revealed through a Genome-wide Screen in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; GPI-ANCHORED PROTEINS; SACCHAROMYCES-CEREVISIAE; BIOACTIVE COMPOUNDS; INTERACTION NETWORK; MEMBRANE-PROTEINS; CALCIUM-CHANNEL; GENE-EXPRESSION; CALCINEURIN; HOMOLOG	The bakers' yeast Saccharomyces cerevisiae utilizes a high affinity Ca2+ influx system (HACS) to survive assaults by mating pheromones, tunicamycin, and azole-class antifungal agents. HACS consists of two known subunits, Cch1 and Mid1, that are homologous and analogous to the catalytic alpha-subunits and regulatory alpha 2 delta-subunits of mammalian voltage-gated calcium channels, respectively. To search for additional subunits and regulators of HACS, a collection of gene knock-out mutants was screened for abnormal uptake of Ca2+ after exposure to mating pheromone or to tunicamycin. The screen revealed that Ecm7 is required for HACS function in most conditions. Cycloheximide chase experiments showed that Ecm7 was stabilized by Mid1, and Mid1 was stabilized by Cch1 in non-signaling conditions, suggesting they all interact. Ecm7 is a member of the PMP-22/EMP/MP20/Claudin superfamily of transmembrane proteins that includes gamma-subunits of voltage-gated calcium channels. Eleven additional members of this superfamily were identified in yeast, but none was required for HACS activity in response to the stimuli. Remarkably, many dozens of genes involved in vesicle-mediated trafficking and protein secretion were required to prevent spontaneous activation of HACS. Taken together, the findings suggest that HACS and calcineurin monitor performance of the membrane trafficking system in yeasts and coordinate compensatory processes. Conservation of this quality control system in Candida glabrata suggests that many pathogenic species of fungi may utilize HACS and calcineurin to resist azoles and other compounds that target membrane biosynthesis.	[Martin, D. Christian; Maldonado-Baez, Lymarie; Evangelista, Carlos C., Jr.; Beaudry, Veronica G.; Dudgeon, Drew D.; Cunningham, Kyle W.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Naiman, Daniel Q.] Johns Hopkins Univ, Dept Appl Math & Stat, Baltimore, MD 21218 USA; [Mackin, Nancy A.; Erdman, Scott E.] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA	Johns Hopkins University; Johns Hopkins University; Syracuse University	Cunningham, KW (corresponding author), Johns Hopkins Univ, Dept Biol, 3400 N Charles St, Baltimore, MD 21218 USA.	kwc@jhu.edu	Naiman, Daniel Q/A-3304-2010	Naiman, Daniel Q/0000-0001-6504-9081	National Institutes of Health [GM053082, NS057023]; National Science Foundation [MCB-0131408]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS057023] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants GM053082 and NS057023 (to K. W. C.). This work was also supported by National Science Foundation Grant MCB-0131408 (to S. E. E.).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANTEBI A, 1992, MOL BIOL CELL, V3, P633, DOI 10.1091/mbc.3.6.633; Bonilla M, 2003, MOL BIOL CELL, V14, P4296, DOI 10.1091/mbc.E03-02-0113; Bonilla M, 2002, EMBO J, V21, P2343, DOI 10.1093/emboj/21.10.2343; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chen XH, 1996, J GEN PHYSIOL, V108, P363, DOI 10.1085/jgp.108.5.363; Chu PJ, 2001, GENE, V280, P37, DOI 10.1016/S0378-1119(01)00738-7; Conboy MJ, 2000, MOL BIOL CELL, V11, P2429, DOI 10.1091/mbc.11.7.2429; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Courchesne WE, 2003, MOL MICROBIOL, V47, P223, DOI 10.1046/j.1365-2958.2003.03291.x; CUNNINGHAM KW, 1994, J CELL BIOL, V124, P351, DOI 10.1083/jcb.124.3.351; Davies A, 2010, P NATL ACAD SCI USA, V107, P1654, DOI 10.1073/pnas.0908735107; de Mendoza A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-93; Dixon SJ, 2008, P NATL ACAD SCI USA, V105, P16653, DOI 10.1073/pnas.0806261105; DUNN T, 1994, J BIOL CHEM, V269, P7273; Erdman S, 1998, J CELL BIOL, V140, P461, DOI 10.1083/jcb.140.3.461; Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039; Fischer M, 1997, FEBS LETT, V419, P259, DOI 10.1016/S0014-5793(97)01466-X; FULLER RS, 1989, P NATL ACAD SCI USA, V86, P1434, DOI 10.1073/pnas.86.5.1434; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gordon JL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000485; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hong MP, 2010, J BIOL CHEM, V285, P10951, DOI 10.1074/jbc.M109.056218; IIDA H, 1990, J BIOL CHEM, V265, P13391; IIDA H, 1994, MOL CELL BIOL, V14, P8259, DOI 10.1128/MCB.14.12.8259; Iida K, 2004, FEBS LETT, V576, P291, DOI 10.1016/j.febslet.2004.09.021; Kaur R, 2004, ANTIMICROB AGENTS CH, V48, P1600, DOI 10.1128/AAC.48.5.1600-1613.2004; Kim H, 2003, J BIOL CHEM, V278, P10208, DOI 10.1074/jbc.M300163200; Lesage G, 2004, GENETICS, V167, P35, DOI 10.1534/genetics.167.1.35; Li WS, 1997, GENETICS, V145, P63; Liu M, 2006, EUKARYOT CELL, V5, P1788, DOI 10.1128/EC.00158-06; Locke EG, 2000, MOL CELL BIOL, V20, P6686, DOI 10.1128/MCB.20.18.6686-6694.2000; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lussier M, 1997, GENETICS, V147, P435; Matheos DP, 1997, GENE DEV, V11, P3445, DOI 10.1101/gad.11.24.3445; Miseta A, 1999, J BIOL CHEM, V274, P5939, DOI 10.1074/jbc.274.9.5939; Muend S, 2008, FEMS YEAST RES, V8, P425, DOI 10.1111/j.1567-1364.2008.00354.x; Muller EM, 2003, J BIOL CHEM, V278, P38461, DOI 10.1074/jbc.M304089200; Muller EM, 2001, GENETICS, V159, P1527; Paidhungat M, 1997, MOL CELL BIOL, V17, P6339, DOI 10.1128/MCB.17.11.6339; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; PENNY II, 1996, APPL STAT, V45, P73; Plaine A, 2008, FUNGAL GENET BIOL, V45, P1404, DOI 10.1016/j.fgb.2008.08.003; Rabitsch KP, 2001, CURR BIOL, V11, P1001, DOI 10.1016/S0960-9822(01)00274-3; Reedy J. L., 2010, Fungal Genetics and Biology, V47, P107, DOI 10.1016/j.fgb.2009.09.002; Rousseeuw PJ, 1999, TECHNOMETRICS, V41, P212, DOI 10.2307/1270566; Sen Gupta S, 2003, J BIOL CHEM, V278, P28831, DOI 10.1074/jbc.M303300200; Sherman F., 1986, METHODS YEAST GENETI; Stie J, 2008, EUKARYOT CELL, V7, P177, DOI 10.1128/EC.00326-07; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Treton B, 2000, MOL GEN GENET, V263, P505, DOI 10.1007/s004380051195; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Viladevall L, 2004, J BIOL CHEM, V279, P43614, DOI 10.1074/jbc.M403606200; WALLIS JW, 1989, CELL, V58, P409, DOI 10.1016/0092-8674(89)90855-6; Ward JM, 2001, BIOINFORMATICS, V17, P560, DOI 10.1093/bioinformatics/17.6.560; Yoshimoto H, 2002, J BIOL CHEM, V277, P31079, DOI 10.1074/jbc.M202718200; Young ME, 2002, MOL CELL BIOL, V22, P927, DOI 10.1128/MCB.22.3.927-934.2002	58	78	85	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10744	10754		10.1074/jbc.M110.177451	http://dx.doi.org/10.1074/jbc.M110.177451			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21252230	Green Published, hybrid			2022-12-27	WOS:000288547000088
J	Ko, YP; Liang, XW; Smith, CW; Degen, JL; Hook, M				Ko, Ya-Ping; Liang, Xiaowen; Smith, C. Wayne; Degen, Jay L.; Hoeoek, Magnus			Binding of Efb from Staphylococcus aureus to Fibrinogen Blocks Neutrophil Adherence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOTAXIS INHIBITORY PROTEIN; TRANSENDOTHELIAL MIGRATION; PLATELET-AGGREGATION; INTEGRIN ALPHA(M)BETA(2); VIRULENCE DETERMINANT; LEUKOCYTE ADHESION; DELAYS APOPTOSIS; IMMUNE EVASION; MICE LACKING; GAMMA-CHAIN	In addition to its pivotal role in hemostasis, fibrinogen (Fg) and provisional fibrin matrices play important roles in inflammation and regulate innate immune responses by interacting with leukocytes. Efb (the extracellular fibrinogen-binding protein) is a secreted Staphylococcus aureus protein that engages host Fg and complement C3. However, the molecular details underlying the Efb-Fg interaction and the biological relevance of this interaction have not been determined. In the present study, we characterize the interaction of Efb with Fg. We demonstrate that the Fg binding activity is located within the intrinsically disordered N-terminal half of Efb (Efb-N) and that the D fragment of Fg is the region that mediates Efb-N binding. More detailed studies of the Efb-N-Fg interactions using ELISA and surface plasmon resonance analyses revealed that Efb-N exhibits a much higher affinity for Fg than typically observed with Fg-binding MSCRAMMs(microbial surface components recognizing adhesive matrix molecules), and data obtained from ELISA analyses using truncated Efb-N constructs demonstrate that Efb-N contains two binding sites located within residues 30-67 and 68-98, respectively. Efb-N inhibits neutrophil adhesion to immobilized Fg by binding to Fg and blocking the interaction of the protein with the leukocyte integrin receptor, alpha(M)beta(2). A motif in the Fg gamma chain previously shown to be central to the alpha(M)beta(2) interaction was shown to be functionally distinguishable from the Efb-N binding site, suggesting that the Fg-Efb interaction indirectly impedes Fg engagement by alpha(M)beta(2). Taken together, these studies provide insights into how Efb interacts with Fg and suggest that Efb may support bacterial virulence at least in part by impeding Fg-driven leukocyte adhesion events.	[Ko, Ya-Ping; Liang, Xiaowen; Hoeoek, Magnus] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Infect & Inflammatory Dis, Houston, TX 77030 USA; [Smith, C. Wayne] Baylor Coll Med, Childrens Nutr Res Ctr, Dept Pediat, Leukocyte Lab, Houston, TX 77030 USA; [Degen, Jay L.] Childrens Hosp Res Fdn, Cincinnati, OH 45229 USA; [Degen, Jay L.] Univ Cincinnati, Coll Med, Cincinnati, OH 45229 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Baylor College of Medicine; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati	Hook, M (corresponding author), 2121 W Holcombe Blvd, Houston, TX 77030 USA.	mhook@ibt.tamhsc.edu		Liang, Xiaowen/0000-0002-6174-2951	National Institutes of Health [AI20624]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI020624, R01AI020624] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI20624 (to M. H.).	Adams RA, 2007, J EXP MED, V204, P571, DOI 10.1084/jem.20061931; ALTIERI DC, 1993, J BIOL CHEM, V268, P1847; BODEN MK, 1994, MOL MICROBIOL, V12, P599, DOI 10.1111/j.1365-2958.1994.tb01046.x; Burns AR, 2000, J CELL SCI, V113, P45; Chavakis T, 2005, THROMB HAEMOSTASIS, V94, P278, DOI 10.1160/TH05-05-0306; Cheng AG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001036; Cruz-Topete D, 2006, J PATHOL, V210, P325, DOI 10.1002/path.2060; Davis SL, 2001, J BIOL CHEM, V276, P27799, DOI 10.1074/jbc.M103873200; de Haas CJC, 2004, J EXP MED, V199, P687, DOI 10.1084/jem.20031636; Diekema DJ, 2001, CLIN INFECT DIS, V32, pS114, DOI 10.1086/320184; Drew AF, 2001, BLOOD, V97, P3691, DOI 10.1182/blood.V97.12.3691; EVERSE SJ, 1995, PROTEIN SCI, V4, P1013; Flick MJ, 2007, J CLIN INVEST, V117, P3224, DOI 10.1172/JCI30134; Flick MJ, 2004, J CLIN INVEST, V113, P1596, DOI 10.1172/JCI200420741; Forsyth CB, 2001, J EXP MED, V193, P1123, DOI 10.1084/jem.193.10.1123; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; Hammel M, 2007, NAT IMMUNOL, V8, P430, DOI 10.1038/ni1450; Herrick S, 1999, INT J BIOCHEM CELL B, V31, P741, DOI 10.1016/S1357-2725(99)00032-1; Herwald H, 2004, CELL, V116, P367, DOI 10.1016/S0092-8674(04)00057-1; Holmback K, 1996, EMBO J, V15, P5760, DOI 10.1002/j.1460-2075.1996.tb00962.x; Jongerius I, 2007, J EXP MED, V204, P2461, DOI 10.1084/jem.20070818; Josefsson E, 2001, J INFECT DIS, V184, P1572, DOI 10.1086/324430; KUENG W, 1989, ANAL BIOCHEM, V182, P16, DOI 10.1016/0003-2697(89)90710-0; Kuhns DB, 2001, J IMMUNOL, V167, P2869, DOI 10.4049/jimmunol.167.5.2869; LANGUINO LR, 1993, CELL, V73, P1423, DOI 10.1016/0092-8674(93)90367-Y; Lee JK, 2004, J EXP MED, V200, P1455, DOI 10.1084/jem.20041251; Lee LYL, 2004, J INFECT DIS, V190, P571, DOI 10.1086/422259; Lee LYL, 2004, J BIOL CHEM, V279, P50710, DOI 10.1074/jbc.M408570200; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; McArthur JD, 2006, MOL MICROBIOL, V59, P1, DOI 10.1111/j.1365-2958.2005.04967.x; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; Palma M, 1996, INFECT IMMUN, V64, P5284, DOI 10.1128/IAI.64.12.5284-5289.1996; Palma M, 1998, J BIOL CHEM, V273, P13177, DOI 10.1074/jbc.273.21.13177; Palma M, 2001, J BIOL CHEM, V276, P31691, DOI 10.1074/jbc.M104554200; Postma B, 2004, J IMMUNOL, V172, P6994, DOI 10.4049/jimmunol.172.11.6994; Ricklin D, 2008, J IMMUNOL, V181, P7463, DOI 10.4049/jimmunol.181.11.7463; Rivera J, 2007, THROMB HAEMOSTASIS, V98, P503, DOI 10.1160/TH07-03-0233; Rooijakkers SHM, 2005, NAT IMMUNOL, V6, P920, DOI 10.1038/ni1235; Rubel C, 2001, J IMMUNOL, V166, P2002, DOI 10.4049/jimmunol.166.3.2002; Rubel C, 2003, EUR J IMMUNOL, V33, P1429, DOI 10.1002/eji.200323512; Shannon O, 2005, THROMB HAEMOSTASIS, V93, P927, DOI 10.1160/TH04-08-0501; Shannon O, 2004, THROMB HAEMOSTASIS, V91, P779, DOI 10.1160/TH03-05-0287; SMITH CW, 1989, J CLIN INVEST, V83, P2008, DOI 10.1172/JCI114111; SMITH CW, 1979, J CLIN INVEST, V63, P221, DOI 10.1172/JCI109293; SMITH CW, 1988, J CLIN INVEST, V82, P1746, DOI 10.1172/JCI113788; Soehnlein O, 2008, EUR RESPIR J, V32, P405, DOI 10.1183/09031936.00173207; Solovjov DA, 2005, J BIOL CHEM, V280, P1336, DOI 10.1074/jbc.M406968200; Tuluc F, 2004, AM J PHYSIOL-CELL PH, V287, pC1264, DOI 10.1152/ajpcell.00177.2004; Ugarova TP, 1998, J BIOL CHEM, V273, P22519, DOI 10.1074/jbc.273.35.22519; Wade D, 1998, BIOCHEM BIOPH RES CO, V248, P690, DOI 10.1006/bbrc.1998.9028; Zhang L, 1999, CELL RES, V9, P171, DOI 10.1038/sj.cr.7290015	52	39	41	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9865	9874		10.1074/jbc.M110.199687	http://dx.doi.org/10.1074/jbc.M110.199687			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21247890	Green Published, hybrid			2022-12-27	WOS:000288247700110
J	Stergiou, C; Zisimopoulou, P; Tzartos, SJ				Stergiou, Christos; Zisimopoulou, Paraskevi; Tzartos, Socrates J.			Expression of Water-soluble, Ligand-binding Concatameric Extracellular Domains of the Human Neuronal Nicotinic Receptor alpha 4 and beta 2 Subunits in the Yeast Pichia pastoris GLYCOSYLATION IS NOT REQUIRED FOR LIGAND BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED ION-CHANNEL; X-RAY-STRUCTURE; ACETYLCHOLINE-RECEPTOR; CRYSTAL-STRUCTURE; HUMAN BRAIN; SUBTYPES; AGONIST; DESENSITIZATION; PHARMACOLOGY; BUNGAROTOXIN	Nicotinic acetylcholine receptors (nAChRs) are ligand-gated cation channels that are responsible for cell communication via the neurotransmitter acetylcholine. The predominant nAChR subtype in the mammalian brain with a high affinity for nicotine is composed of alpha 4 and beta 2 subunits. This nAChR subtype is responsible for addiction to nicotine and is thought to be implicated in Alzheimer and Parkinson diseases and therefore presents an important target for drug design. In an effort to obtain water-soluble, ligand-binding domains of the human alpha 4 beta 2 nAChR for structural studies, we expressed the extracellular domains (ECDs) of these subunits in the eukaryotic expression system Pichia pastoris. The wild-type ECDs and their mutants containing the more hydrophilic Cys-loop from the snail acetylcholine- binding protein (individually expressed or coexpressed) did not demonstrate any specific interaction with ligands. We then linked the mutated ECDs with the 24-amino acid peptide (AGS)(8) and observed that the beta 2-24-alpha 4 ECD concatamer, but not the alpha 4-24-beta 2 one, exhibited very satisfactory water solubility and ligand binding properties. The I-125-epibatidine and [H-3] nicotine bound to beta 2-24-alpha 4 with dissociation constants (K-d) of 0.38 and 19 nM, respectively, close to the published values for the intact alpha 4 beta 2 AChR. In addition, I-125-epibatidine binding was blocked by nicotine, cytisine, acetylcholine, and carbamylcholine with inhibition constants (K-i) of 20.64, 3.24, 242, and 2,254 nM, respectively. Interestingly, deglycosylation of the concatamer did not affect its ligand binding properties. Furthermore, the deglycosylated beta 2-24-alpha 4 ECD existed mainly in monomeric form, thus forming an appropriate material for structural studies and possibly for pharmacological evaluation of novel alpha 4 beta 2 nAChR-specific agonists.	[Stergiou, Christos; Zisimopoulou, Paraskevi; Tzartos, Socrates J.] Hellenic Pasteur Inst, Dept Biochem, GR-11521 Athens, Greece; [Stergiou, Christos; Tzartos, Socrates J.] Univ Patras, Dept Pharm, GR-26504 Patras, Greece	University of Patras	Tzartos, SJ (corresponding author), Hellenic Pasteur Inst, Dept Biochem, Vas Sofias Ave 127, GR-11521 Athens, Greece.	tzartos@pasteur.gr	Zisimopoulou, P/B-4105-2017		European Community [202088]	European Community(European Commission)	This work was supported by European Community Grant FP7 NeuroCypres under Contract 202088.	Arneric SP, 2007, BIOCHEM PHARMACOL, V74, P1092, DOI 10.1016/j.bcp.2007.06.033; Avramopoulou V, 2004, J BIOL CHEM, V279, P38287, DOI 10.1074/jbc.M402533200; Bencherif M, 1996, J PHARMACOL EXP THER, V279, P1413; Bisson WH, 2008, J MOL MODEL, V14, P891, DOI 10.1007/s00894-008-0340-x; Bitzopoulou K, 2008, BBA-PROTEINS PROTEOM, V1784, P1226, DOI 10.1016/j.bbapap.2008.04.023; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Breese CR, 2000, NEUROPSYCHOPHARMACOL, V23, P351, DOI 10.1016/S0893-133X(00)00121-4; Breese CR, 1997, J PHARMACOL EXP THER, V282, P7; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; BRUNS RF, 1983, ANAL BIOCHEM, V132, P74, DOI 10.1016/0003-2697(83)90427-X; Carbone AL, 2009, BRIT J PHARMACOL, V156, P970, DOI 10.1111/j.1476-5381.2008.00104.x; Chen Y, 2003, NEUROPHARMACOLOGY, V45, P334, DOI 10.1016/S0028-3908(03)00189-8; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; DENNIS M, 1988, BIOCHEMISTRY-US, V27, P2346, DOI 10.1021/bi00407a016; Galanti LM, 2008, VASC HEALTH RISK MAN, V4, P837, DOI 10.2147/VHRM.S3250; GALZI JL, 1995, NEUROPHARMACOLOGY, V34, P563, DOI 10.1016/0028-3908(95)00034-4; Gotti C, 2006, TRENDS PHARMACOL SCI, V27, P482, DOI 10.1016/j.tips.2006.07.004; Groot-Kormelink PJ, 2006, MOL PHARMACOL, V69, P558, DOI 10.1124/mol.105.019356; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; HUGANIR RL, 1990, NEURON, V5, P555, DOI 10.1016/0896-6273(90)90211-W; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Konstantakaki M, 2008, J MOL GRAPH MODEL, V26, P1333, DOI 10.1016/j.jmgm.2008.01.004; Kullmann DM, 2002, BRAIN, V125, P1177, DOI 10.1093/brain/awf130; Kuryatov A, 2011, MOL PHARMACOL, V79, P126, DOI 10.1124/mol.110.066159; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Marks MJ, 1996, J PHARMACOL EXP THER, V277, P1383; Moroni M, 2006, MOL PHARMACOL, V70, P755, DOI 10.1124/mol.106.023044; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; Paterson D, 2000, PROG NEUROBIOL, V61, P75, DOI 10.1016/S0301-0082(99)00045-3; Pedretti A, 2008, BIOCHEM BIOPH RES CO, V369, P648, DOI 10.1016/j.bbrc.2008.02.080; Perry DC, 2002, J NEUROCHEM, V82, P468, DOI 10.1046/j.1471-4159.2002.00951.x; Perry E, 2000, EUR J PHARMACOL, V393, P215, DOI 10.1016/S0014-2999(00)00064-9; Person AM, 2005, J BIOL CHEM, V280, P39990, DOI 10.1074/jbc.M505087200; Psaridi-Linardaki L, 2002, J BIOL CHEM, V277, P26980, DOI 10.1074/jbc.M110731200; Schrattenholz A, 1998, J BIOL CHEM, V273, P32393, DOI 10.1074/jbc.273.49.32393; Sharples CGV, 2002, J MED CHEM, V45, P3235, DOI 10.1021/jm020814l; Unwin N, 1998, J STRUCT BIOL, V121, P181, DOI 10.1006/jsbi.1997.3949; Wang DX, 1996, J NEUROSCI RES, V44, P350, DOI 10.1002/(SICI)1097-4547(19960515)44:4<350::AID-JNR6>3.0.CO;2-B; Whiteaker P, 2000, BRIT J PHARMACOL, V131, P729, DOI 10.1038/sj.bjp.0703616; Xiao YX, 2004, J PHARMACOL EXP THER, V310, P98, DOI 10.1124/jpet.104.066787; Zhou Y, 2003, J NEUROSCI, V23, P9004; Zouridakis M, 2009, BBA-PROTEINS PROTEOM, V1794, P355, DOI 10.1016/j.bbapap.2008.11.002	44	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8884	8892		10.1074/jbc.M110.171645	http://dx.doi.org/10.1074/jbc.M110.171645			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21252231	hybrid, Green Published			2022-12-27	WOS:000288247700019
J	Liu, QY; Chen, JW; Liu, L; Zhang, J; Wang, DF; Ma, L; He, YM; Liu, YL; Liu, ZS; Wu, JG				Liu, Quanyan; Chen, Jiwei; Liu, Li; Zhang, Jun; Wang, Dongfeng; Ma, Lu; He, Yueming; Liu, Yingle; Liu, Zhisu; Wu, Jianguo			The X Protein of Hepatitis B Virus Inhibits Apoptosis in Hepatoma Cells through Enhancing the Methionine Adenosyltransferase 2A Gene Expression and Reducing S-Adenosylmethionine Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; RAT HEPATOCYTES; MOLECULAR FUNCTIONS; GROWTH-FACTOR; MAT2A GENE; INDUCTION; PROLIFERATION; ACTIVATION; HYPOXIA; KINASE	The X protein (HBx) of hepatitis B virus (HBV) is involved in the development of hepatocellular carcinoma (HCC), and methionine adenosyltransferase 2A (MAT2A) promotes the growth of liver cancer cells through altering S-adenosylmethionine homeostasis. Thus, we speculated that a link between HBx and MAT2A may contribute to HCC development. In this study, the effects of HBx on MAT2A expression and cell apoptosis were investigated, and the molecular mechanism by which HBx and MAT2A regulate tumorigenesis was evaluated. Results from immunohistochemistry analyses of 37 pairs of HBV-associated liver cancer tissues/corresponding peritumor tissues showed that HBx and MAT2A are highly expressed in most liver tumor tissues. Our in vitro results revealed that HBx activates MAT2A expression in a dose-dependent manner in hepatoma cells, and such regulation requires the cis-regulatory elements NF-kappa B and CREB on the MAT2A gene promoter. Electrophoretic mobility shift assay (EMSA) and chromatin immunoprecipitation (ChIP) further demonstrated that HBx facilitates the binding of NF-kappa B and CREB to MAT2A gene promoter. In addition, overexpression of HBx or MAT2A inhibits cell apoptosis, whereas knockdown of MAT2A expression stimulates apoptosis in hepatoma cells. Furthermore, we demonstrated that HBx reduces MAT1A expression and AdoMet production but enhances MAT2 beta expression. Thus, we proposed that HBx activates MAT2A expression through NF-kappa B and CREB signaling pathways to reduce AdoMet production, inhibit hepatoma cell apoptosis, and perhaps enhance HCC development. These findings should provide new insights into our understanding how the molecular mechanisms underline the effects of HBV infection on the production of MAT2A and the development of HCC.	[Liu, Quanyan; Chen, Jiwei; Liu, Li; Zhang, Jun; Wang, Dongfeng; He, Yueming; Liu, Zhisu] Wuhan Univ, Dept Gen Surg, Digest Dis Res Ctr, Zhongnan Hosp, Wuhan 430071, Peoples R China; [Liu, Yingle; Wu, Jianguo] Wuhan Univ, State Key Lab Virol, Coll Life Sci, Zhongnan Hosp, Wuhan 430071, Peoples R China; [Liu, Yingle; Wu, Jianguo] Wuhan Univ, Chinese French Liver Dis Res Inst, Zhongnan Hosp, Wuhan 430071, Peoples R China; [Ma, Lu] Wuhan Univ, Sch Publ Hlth, Dept Epidemiol & Hyg Stat, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University; Wuhan University; Wuhan University	Liu, ZS (corresponding author), Wuhan Univ, Dept Gen Surg, Digest Dis Res Ctr, Zhongnan Hosp, Wuhan 430071, Peoples R China.	spss2005@126.com; jwu@whu.edu.cn		Wu, Jianguo/0000-0002-8326-2895; Liu, Quanyan/0000-0002-5353-0377	National Mega Project on Major Infectious Diseases Prevention and Treatment [2008ZX10002-009, 2009ZX10004-207]; National Mega Project on Major Drug Development [2009ZX09301-014, 2011ZX09401-302]; Major State Basic Research Development Program of China [2005CB522901]; National Science Foundation of China [30730001, 30872491]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0745]; Chinese Ministry of Education [204114208]; Department of Science and Technology of Hubei Province [2005ABC003]; Fundamental Research Funds for the Central Universities [1102001]; Specialized Research Fund for the Doctoral Program of Higher Education [20090141110033]	National Mega Project on Major Infectious Diseases Prevention and Treatment; National Mega Project on Major Drug Development; Major State Basic Research Development Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Chinese Ministry of Education(Ministry of Education, China); Department of Science and Technology of Hubei Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by National Mega Project on Major Infectious Diseases Prevention and Treatment Research Grants 2008ZX10002-009 and 2009ZX10004-207, National Mega Project on Major Drug Development Research Grants 2009ZX09301-014 and 2011ZX09401-302, Major State Basic Research Development Program of China Research Grant 2005CB522901, National Science Foundation of China Research Grants 30730001 and 30872491, Program for Changjiang Scholars and Innovative Research Team in University Research Grant IRT0745, Key Project of Chinese Ministry of Education Research Grant 204114208, Department of Science and Technology of Hubei Province Research Grant 2005ABC003, Fundamental Research Funds for the Central Universities Research Grant 1102001, and Specialized Research Fund for the Doctoral Program of Higher Education Research Grant 20090141110033.	Assrir N, 2010, FRONT BIOSCI-LANDMRK, V15, P12, DOI 10.2741/3602; Avila MA, 1998, GASTROENTEROLOGY, V114, P364, DOI 10.1016/S0016-5085(98)70489-5; Benhenda S, 2009, ADV CANCER RES, V103, P75, DOI 10.1016/S0065-230X(09)03004-8; Bouchard MJ, 2006, J VIROL, V80, P4406, DOI 10.1128/JVI.80.9.4406-4414.2006; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cai JX, 1996, HEPATOLOGY, V24, P1090; CANTONI GL, 1953, J BIOL CHEM, V204, P403; Chami M, 2003, J BIOL CHEM, V278, P31745, DOI 10.1074/jbc.M304202200; Chan DW, 2006, J PATHOL, V208, P372, DOI 10.1002/path.1901; Cheng ASL, 2007, CANCER LETT, V253, P43, DOI 10.1016/j.canlet.2007.01.004; Chiang PK, 1996, FASEB J, V10, P471, DOI 10.1096/fasebj.10.4.8647346; Clippinger AJ, 2009, J VIROL, V83, P4718, DOI 10.1128/JVI.02590-08; Corrales FJ, 2002, J NUTR, V132, p2377S, DOI 10.1093/jn/132.8.2377S; Cougot D, 2007, J BIOL CHEM, V282, P4277, DOI 10.1074/jbc.M606774200; Feitelson MA, 2007, CANCER LETT, V252, P157, DOI 10.1016/j.canlet.2006.11.010; Garcia-Trevijano ER, 2000, FASEB J, V14, P2511, DOI 10.1096/fj.00-0121com; Halim AB, 1999, J BIOL CHEM, V274, P29720, DOI 10.1074/jbc.274.42.29720; Latasa MU, 2001, FASEB J, V15, P1248, DOI 10.1096/fj.00-0556fjev1; Lee ATC, 2007, FRONT BIOSCI-LANDMRK, V12, P234, DOI 10.2741/2061; Liang XH, 2007, J IMMUNOL, V178, P503, DOI 10.4049/jimmunol.178.1.503; Liu QY, 2007, HEPATOL RES, V37, P376, DOI 10.1111/j.1872-034X.2007.00041.x; Liu XH, 2008, BIOCHEM BIOPH RES CO, V373, P643, DOI 10.1016/j.bbrc.2008.06.087; Loenen WAM, 2006, BIOCHEM SOC T, V34, P330, DOI 10.1042/BST0340330; Lu SC, 2000, AM J PHYSIOL-GASTR L, V279, pG178, DOI 10.1152/ajpgi.2000.279.1.G178; Lu SC, 2005, ALCOHOL, V35, P227, DOI 10.1016/j.alcohol.2005.03.011; Lu SC, 2008, J GASTROEN HEPATOL, V23, pS73, DOI 10.1111/j.1440-1746.2007.05289.x; Martinez-Chantar ML, 2003, J BIOL CHEM, V278, P19885, DOI 10.1074/jbc.M211554200; Mato JM, 2002, FASEB J, V16, P15, DOI 10.1096/fj.01-0401rev; Moon EJ, 2003, FASEB J, V17, P382, DOI 10.1096/fj.03-0153fje; Paneda C, 2002, HEPATOLOGY, V35, P1381, DOI 10.1053/jhep.2002.32538; Park Neung Hwa, 2007, Korean J Hepatol, V13, P320; Ramani K, 2008, HEPATOLOGY, V47, P521, DOI 10.1002/hep.22064; ROBINSON WS, 1994, ANNU REV MED, V45, P297; Roje S, 2006, PHYTOCHEMISTRY, V67, P1686, DOI 10.1016/j.phytochem.2006.04.019; Tang H, 2006, CANCER SCI, V97, P977, DOI 10.1111/j.1349-7006.2006.00299.x; Wang Q, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-72; Wang WH, 2004, MOL CELL BIOL, V24, P10352, DOI 10.1128/MCB.24.23.10352-10365.2004; Yang HP, 2008, GASTROENTEROLOGY, V134, P281, DOI 10.1053/j.gastro.2007.10.027; Yang HP, 2007, J CELL PHYSIOL, V210, P766, DOI 10.1002/jcp.20891; Yang HP, 2003, J BIOL CHEM, V278, P50887, DOI 10.1074/jbc.M307600200; Yang HP, 2001, FASEB J, V15, P1507, DOI 10.1096/fj.01-0040com; Ye LH, 2008, INTERVIROLOGY, V51, P50, DOI 10.1159/000120289; Ye L, 2007, J HUAZHONG U SCI-MED, V27, P167, DOI 10.1007/s11596-007-0215-x; Zhang JL, 2005, ARCH VIROL, V150, P721, DOI 10.1007/s00705-004-0446-0; Zhang XD, 2006, J LAB CLIN MED, V147, P58, DOI 10.1016/j.lab.2005.10.003	45	48	54	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17168	17180		10.1074/jbc.M110.167783	http://dx.doi.org/10.1074/jbc.M110.167783			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21247894	hybrid, Green Published			2022-12-27	WOS:000290301900066
J	Dar, I; Yosha, G; Elfassy, R; Galron, R; Wang, ZQ; Shiloh, Y; Barzilai, A				Dar, Inbal; Yosha, Galit; Elfassy, Ronen; Galron, Ronit; Wang, Zhao-Qi; Shiloh, Yosef; Barzilai, Ari			Investigation of the Functional Link between ATM and NBS1 in the DNA Damage Response in the Mouse Cerebellum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; TELANGIECTASIA-LIKE DISORDER; NIGRO-STRIATAL NEURONS; ATAXIA-TELANGIECTASIA; IONIZING-RADIATION; DEFICIENT MICE; OXIDATIVE STRESS; PURKINJE-CELLS; MRE11 COMPLEX; MUTANT MICE	Ataxia-telangiectasia (A-T) and Nijmegen breakage syndrome (NBS) are related genomic instability syndromes characterized by neurological deficits. The NBS1 protein that is defective in NBS is a component of the Mre11/RAD50/NBS1 (MRN) complex, which plays a major role in the early phase of the complex cellular response to double strand breaks (DSBs) in the DNA. Among others, Mre11/RAD50/NBS1 is required for timely activation of the protein kinase ATM (A-T, mutated), which is missing or inactivated in patients with A-T. Understanding the molecular pathology of A-T, primarily its cardinal symptom, cerebellar degeneration, requires investigation of the DSB response in cerebellar neurons, particularly Purkinje cells, which are the first to be lost in A-T patients. Cerebellar cultures derived from mice with different mutations in DNA damage response genes is a useful experimental system to study malfunctioning of the damage response in the nervous system. To clarify the interrelations between murine Nbs1 and Atm, we generated a mouse strain with specific disruption of the Nbs1 gene in the central nervous system on the background of general Atm deficiency (Nbs1-CNS-Delta//Atm(-/-)). This genotype exacerbated several features of both conditions and led to a markedly reduced life span, dramatic decline in the number of cerebellar granule neurons with considerable cerebellar disorganization, abolishment of the white matter, severe reduction in glial cell proliferation, and delayed DSB repair in cerebellar tissue. Combined loss of Nbs1 and Atm in the CNS significantly abrogated the DSB response compared with the single mutation genotypes. Importantly, the data indicate that Atm has cellular roles not regulated by Nbs1 in the murine cerebellum.	[Barzilai, Ari] Tel Aviv Univ, Fac Life Sci, Dept Neurobiol, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Shiloh, Yosef] Tel Aviv Univ, Dept Human Mol Genet & Biochem, David & Inez Myers Lab Canc Genet, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Wang, Zhao-Qi] Fritz Lipmann Inst eV, Leibniz Inst Age Res, D-07745 Jena, Germany; [Wang, Zhao-Qi] Univ Jena, D-07745 Jena, Germany	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Friedrich Schiller University of Jena	Barzilai, A (corresponding author), Tel Aviv Univ, Fac Life Sci, Dept Neurobiol, Sackler Sch Med, IL-69978 Tel Aviv, Israel.	barzilai@post.tau.ac.il			A-T Children's Project; Israel Science Foundation; U.S.-Israel Binational Science Foundation; German-Israeli Foundation; A-T Medical Research Foundation; Israel Cancer Research Fund; A-T Ease Foundation; Association for International Cancer Research, UK; Deutschen Forschungsgemeinschaft, Germany	A-T Children's Project; Israel Science Foundation(Israel Science Foundation); U.S.-Israel Binational Science Foundation(US-Israel Binational Science Foundation); German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); A-T Medical Research Foundation; Israel Cancer Research Fund; A-T Ease Foundation; Association for International Cancer Research, UK; Deutschen Forschungsgemeinschaft, Germany(German Research Foundation (DFG))	This work was supported by research grants from the A-T Children's Project, the Israel Science Foundation, and the U.S.-Israel Binational Science Foundation (to A. B. and Y. S.) and by The German-Israeli Foundation (to A. B., Z.-Q. W., and Y. S.). Work in the laboratory of Y. S. was supported by research grants from the A-T Medical Research Foundation, The Israel Cancer Research Fund, and the A-T Ease Foundation.; Supported by the Association for International Cancer Research, UK, and by the Deutschen Forschungsgemeinschaft, Germany.	Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Adams KE, 2006, ONCOGENE, V25, P3894, DOI 10.1038/sj.onc.1209426; Adelman CA, 2009, MOL CELL BIOL, V29, P483, DOI 10.1128/MCB.01525-08; Allen DR, 2001, GENE DEV, V15, P554, DOI 10.1101/gad.869001; Assaf Y, 2008, EXP NEUROL, V209, P181, DOI 10.1016/j.expneurol.2007.09.021; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; BAPTISTA CA, 1994, NEURON, V12, P243, DOI 10.1016/0896-6273(94)90268-2; Barlow C, 1999, P NATL ACAD SCI USA, V96, P9915, DOI 10.1073/pnas.96.17.9915; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Barzilai A, 2008, DNA REPAIR, V7, P1010, DOI 10.1016/j.dnarep.2008.03.005; Bassing CH, 2004, DNA REPAIR, V3, P781, DOI 10.1016/j.dnarep.2004.06.001; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Bekker-Jensen S, 2010, DNA REPAIR, V9, P1219, DOI 10.1016/j.dnarep.2010.09.010; Bensimon A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001034; Biton S, 2008, DNA REPAIR, V7, P1028, DOI 10.1016/j.dnarep.2008.03.006; Borghesani PR, 2000, P NATL ACAD SCI USA, V97, P3336, DOI 10.1073/pnas.050584897; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burdak-Rothkamm S, 2007, ONCOGENE, V26, P993, DOI 10.1038/sj.onc.1209863; Callen E, 2009, MOL CELL, V34, P285, DOI 10.1016/j.molcel.2009.04.025; Carson CT, 2003, EMBO J, V22, P6610, DOI 10.1093/emboj/cdg630; Chen P, 2003, J NEUROSCI, V23, P11453; Chiesa N, 2000, NEUROSCIENCE, V96, P575, DOI 10.1016/S0306-4522(99)00581-3; Chun HH, 2004, DNA REPAIR, V3, P1187, DOI 10.1016/j.dnarep.2004.04.010; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Damjanac M, 2007, BRAIN RES, V1128, P40, DOI 10.1016/j.brainres.2006.05.050; Deckbar D, 2007, J CELL BIOL, V176, P749, DOI 10.1083/jcb.200612047; Delia D, 2004, HUM MOL GENET, V13, P2155, DOI 10.1093/hmg/ddh221; Difilippantonio S, 2005, NAT CELL BIOL, V7, P675, DOI 10.1038/ncb1270; Digweed M, 2004, DNA REPAIR, V3, P1207, DOI 10.1016/j.dnarep.2004.03.004; Dupre A, 2008, NAT CHEM BIOL, V4, P119, DOI 10.1038/nchembio.63; Eilam R, 2003, NEUROSCIENCE, V121, P83, DOI 10.1016/S0306-4522(03)00322-1; Eilam R, 1998, P NATL ACAD SCI USA, V95, P12653, DOI 10.1073/pnas.95.21.12653; Elson A, 1996, P NATL ACAD SCI USA, V93, P13084, DOI 10.1073/pnas.93.23.13084; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Fernet M, 2005, HUM MOL GENET, V14, P307, DOI 10.1093/hmg/ddi027; Frappart PO, 2005, NAT MED, V11, P538, DOI 10.1038/nm1228; Friesner JD, 2005, MOL BIOL CELL, V16, P2566, DOI 10.1091/mbc.E04-10-0890; GALRON R, 2011, J MOL NEURO IN PRESS; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Gueven N, 2006, FREE RADICAL BIO MED, V41, P992, DOI 10.1016/j.freeradbiomed.2006.06.018; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Harlow E, 1988, ANTIBODIES LABORATOR, P471; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Helt CE, 2005, J BIOL CHEM, V280, P1186, DOI 10.1074/jbc.M410873200; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hurley PJ, 2007, CELL CYCLE, V6, P414, DOI 10.4161/cc.6.4.3886; Inamura N, 2000, J NEUROSCI RES, V60, P450, DOI 10.1002/(SICI)1097-4547(20000515)60:4<450::AID-JNR3>3.3.CO;2-G; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Kim JA, 2007, J CELL BIOL, V178, P209, DOI 10.1083/jcb.200612031; Kruhlak MJ, 2006, J CELL BIOL, V172, P823, DOI 10.1083/jcb.200510015; Kuljis RO, 1997, P NATL ACAD SCI USA, V94, P12688, DOI 10.1073/pnas.94.23.12688; Lavin MF, 2007, ONCOGENE, V26, P7749, DOI 10.1038/sj.onc.1210880; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Lavin MF, 2007, CELL CYCLE, V6, P931, DOI 10.4161/cc.6.8.4180; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lempiainen H, 2009, EMBO J, V28, P3067, DOI 10.1038/emboj.2009.281; Lopez-Contreras AJ, 2010, DNA REPAIR, V9, P1249, DOI 10.1016/j.dnarep.2010.09.012; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Lukas J, 2004, CELL, V118, P666, DOI 10.1016/j.cell.2004.09.006; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mladenov E, 2009, RADIAT RES, V171, P397, DOI 10.1667/RR1487.1; Mochan TA, 2004, DNA REPAIR, V3, P945, DOI 10.1016/j.dnarep.2004.03.017; Moreno-Herrero F, 2005, NATURE, V437, P440, DOI 10.1038/nature03927; Mount HTJ, 2004, J NEUROCHEM, V88, P1449, DOI 10.1046/j.1471-4159.2003.02278.x; Myers JS, 2006, J BIOL CHEM, V281, P9346, DOI 10.1074/jbc.M513265200; Noraberg J, 1999, BRAIN RES PROTOC, V3, P278, DOI 10.1016/S1385-299X(98)00050-6; Nutley BP, 2005, BRIT J CANCER, V93, P1011, DOI 10.1038/sj.bjc.6602823; Paull TT, 2005, CELL CYCLE, V4, P737, DOI 10.4161/cc.4.6.1715; Paulsen RD, 2007, DNA REPAIR, V6, P953, DOI 10.1016/j.dnarep.2007.02.015; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Shiotani B, 2009, MOL CELL, V33, P547, DOI 10.1016/j.molcel.2009.01.024; Shull ERP, 2009, GENE DEV, V23, P171, DOI 10.1101/gad.1746609; Smith J, 2010, ADV CANCER RES, V108, P73, DOI [10.1016/B978-0-12-380888-2.00003-0, 10.1016/S0065.230X(10)08002.4]; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Stiff T, 2005, EMBO J, V24, P199, DOI 10.1038/sj.emboj.7600504; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Stracker TH, 2004, DNA REPAIR, V3, P845, DOI 10.1016/j.dnarep.2004.03.014; Su TT, 2006, ANNU REV GENET, V40, P187, DOI 10.1146/annurev.genet.40.110405.090428; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; van den Bosch M, 2003, EMBO REP, V4, P844, DOI 10.1038/sj.embor.embor925; van Gent DC, 2007, ONCOGENE, V26, P7731, DOI 10.1038/sj.onc.1210871; Wang VY, 2001, NAT REV NEUROSCI, V2, P484, DOI 10.1038/35081558; Watters D, 1999, J BIOL CHEM, V274, P34277, DOI 10.1074/jbc.274.48.34277; Watters DJ, 2003, REDOX REP, V8, P23, DOI 10.1179/135100003125001206; Weterings E, 2007, J CELL BIOL, V179, P183, DOI 10.1083/jcb.200705106; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411	93	22	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15361	15376		10.1074/jbc.M110.204172	http://dx.doi.org/10.1074/jbc.M110.204172			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21300797	Green Published, hybrid			2022-12-27	WOS:000289788300067
J	Chen, R; Dioum, EM; Hogg, RT; Gerard, RD; Garcia, JA				Chen, Rui; Dioum, Elhadji M.; Hogg, Richard T.; Gerard, Robert D.; Garcia, Joseph A.			Hypoxia Increases Sirtuin 1 Expression in a Hypoxia-inducible Factor-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PROTEIN; FACTOR 2-ALPHA; TARGET GENE; NUCLEAR TRANSLOCATION; TRANSCRIPTION FACTORS; REGULATES EXPRESSION; VASCULAR DEVELOPMENT; DEACETYLASE SIRT1; FACTOR 1-ALPHA; HEART-FAILURE	Hypoxia-inducible factors (HIFs) are stress-responsive transcriptional regulators of cellular and physiological processes involved in oxygen metabolism. Although much is understood about the molecular machinery that confers HIF responsiveness to oxygen, far less is known about HIF isoform-specific mechanisms of regulation, despite the fact that HIF-1 and HIF-2 exhibit distinct biological roles. We recently determined that the stress-responsive genetic regulator sirtuin 1 (Sirt1) selectively augments HIF-2 signaling during hypoxia. However, the mechanism by which Sirt1 maintains activity during hypoxia is unknown. In this report, we demonstrate that Sirt1 gene expression increases in a HIF-dependent manner during hypoxia in Hep3B and in HT1080 cells. Impairment of HIF signaling affects Sirt1 deacetylase activity as decreased HIF-1 signaling results in the appearance of acetylated HIF-2 alpha, which is detected without pharmacological inhibition of Sirt1. We also find that Sirt1 augments HIF-2 mediated, but not HIF-1 mediated, transcriptional activation of the isolated Sirt1 promoter. These data in summary reveal a bidirectional link of HIF and Sirt1 signaling during hypoxia.	[Chen, Rui; Dioum, Elhadji M.; Garcia, Joseph A.] Vet Affairs N Texas Hlth Care Syst, Dept Med, Dallas, TX 75216 USA; [Chen, Rui; Dioum, Elhadji M.; Hogg, Richard T.; Gerard, Robert D.; Garcia, Joseph A.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Gerard, Robert D.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Garcia, JA (corresponding author), Vet Affairs N Texas Hlth Care Syst, Dept Med, 4600 S Lancaster Rd, Dallas, TX 75216 USA.	joseph.garcia@utsouthwestern.edu		Garcia, Joseph/0000-0002-5621-7538; Chen, Rui/0000-0002-7003-6602	American Heart Association; Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108104] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000446] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the American Heart Association and the Department of Veterans Affairs.	Aprelikova O, 2006, CANCER RES, V66, P5641, DOI 10.1158/0008-5472.CAN-05-3345; Baek JH, 2005, MOL CELL, V17, P503, DOI 10.1016/j.molcel.2005.01.011; Bracken CP, 2005, J BIOL CHEM, V280, P14240, DOI 10.1074/jbc.M409987200; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cai ZQ, 2003, CIRCULATION, V108, P79, DOI 10.1161/01.CIR.0000078635.89229.8A; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Chen L, 2007, J BIOL CHEM, V282, P12707, DOI 10.1074/jbc.M700423200; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Denu JM, 2003, TRENDS BIOCHEM SCI, V28, P41, DOI 10.1016/S0968-0004(02)00005-1; Ding K, 2005, INVEST OPHTH VIS SCI, V46, P1010, DOI 10.1167/iovs.04-0788; Dioum EM, 2008, INVEST OPHTH VIS SCI, V49, P2714, DOI 10.1167/iovs.07-1469; Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956; Duan LJ, 2005, CIRCULATION, V111, P2227, DOI 10.1161/01.CIR.0000163580.98098.A3; Elvert G, 2003, J BIOL CHEM, V278, P7520, DOI 10.1074/jbc.M211298200; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Ford J, 2008, CELL CYCLE, V7, P3091, DOI 10.4161/cc.7.19.6799; Gu YZ, 1998, GENE EXPRESSION, V7, P205; Guo XM, 2010, J BIOL CHEM, V285, P13223, DOI 10.1074/jbc.M110.102574; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Hisahara S, 2008, P NATL ACAD SCI USA, V105, P15599, DOI 10.1073/pnas.0800612105; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Huang Y, 2004, FASEB J, V18, P1138, DOI 10.1096/fj.04-1510fje; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kang H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006611; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Le Bras A, 2007, ONCOGENE, V26, P7480, DOI 10.1038/sj.onc.1210566; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Morita M, 2003, EMBO J, V22, P1134, DOI 10.1093/emboj/cdg117; Nasrin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008414; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; O'Rourke JF, 1999, J BIOL CHEM, V274, P2060, DOI 10.1074/jbc.274.4.2060; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Ohradanova A, 2008, BRIT J CANCER, V99, P1348, DOI 10.1038/sj.bjc.6604685; Oktay Y, 2007, J BIOL CHEM, V282, P11750, DOI 10.1074/jbc.M611133200; Peng J, 2000, P NATL ACAD SCI USA, V97, P8386, DOI 10.1073/pnas.140087397; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Scortegagna M, 2003, NAT GENET, V35, P331, DOI 10.1038/ng1266; Scortegagna M, 2003, BLOOD, V102, P1634, DOI 10.1182/blood-2003-02-0448; Seagroves TN, 2001, MOL CELL BIOL, V21, P3436, DOI 10.1128/MCB.21.10.3436-3444.2001; Semenza GL, 2000, GENE DEV, V14, P1983; Sugino T, 2010, FEBS LETT, V584, P2821, DOI 10.1016/j.febslet.2010.04.063; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Tanno M, 2010, J BIOL CHEM, V285, P8375, DOI 10.1074/jbc.M109.090266; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Tian H, 1998, GENE DEV, V12, P3320, DOI 10.1101/gad.12.21.3320; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Warnecke C, 2004, FASEB J, V18, P1462, DOI 10.1096/fj.04-1640fje; Yang JS, 2005, J BIOL CHEM, V280, P36047, DOI 10.1074/jbc.M501755200; Zelzer E, 1997, GENE DEV, V11, P2079, DOI 10.1101/gad.11.16.2079; Zhang QH, 2007, P NATL ACAD SCI USA, V104, P829, DOI 10.1073/pnas.0610590104; Zschoernig B, 2009, BIOCHEM BIOPH RES CO, V381, P372, DOI 10.1016/j.bbrc.2009.02.085	59	112	117	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					13869	13878		10.1074/jbc.M110.175414	http://dx.doi.org/10.1074/jbc.M110.175414			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21345792	Green Published, hybrid			2022-12-27	WOS:000289556200010
J	Shang, H; Han, XX; Shi, XL; Zuo, T; Goldin, M; Chen, D; Han, B; Sun, W; Wu, H; Wang, XQ; Zhang, LQ				Shang, Hong; Han, Xiaoxu; Shi, Xuanling; Zuo, Teng; Goldin, Mark; Chen, Dan; Han, Bing; Sun, Wei; Wu, Hao; Wang, Xinquan; Zhang, Linqi			Genetic and Neutralization Sensitivity of Diverse HIV-1 env Clones from Chronically Infected Patients in China	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODY; EPITOPE; GP120; SUBTYPE; GP41; GLYCOPROTEIN; SEROTYPES; VACCINE; BROAD	As HIV-1 continues to spread in China from traditional high risk populations to the general public, its genetic makeup has become increasingly complex. However, the impact of these genetic changes on the biological and neutralization sensitivity of the virus is unknown. The current study aims to characterize the genetic, biological, and neutralization sensitivity of HIV-1 identified in China between 2004 and 2007. Based on a total of 107 full-length envelope genes obtained directly from the infected patients, we found that those viruses fell into three major genetic groups: CRF01_AE, subtype B', and subtype C/CRF07_BC/CRF08_BC/B'C. Pseudotyped viruses built upon the viable env genes have demonstrated their substantial variability in mediating viral entry and in sensitivity to neutralization by subtype-specific plasma pools and broadly neutralizing monoclonal antibodies (bnmAb). Many viruses are resistant to one or more bnmAb, including those known to have high potency against diverse viruses from outside China. Sequence and structural analysis has revealed several mechanisms by which these resistant viruses escape recognition from bnmAb. We believe that these results will help us to better understand the impact of genetic diversity on the neutralizing sensitivity of the viruses and to facilitate the design of immunogens capable of eliciting antibodies with potency and breadth similar to those of bnmAb.	[Shang, Hong; Han, Xiaoxu] China Med Univ, Hosp 1, Minist Hlth, Dept Lab Med,Key Lab AIDS Immunol, Shenyang 110001, Peoples R China; [Shi, Xuanling; Zuo, Teng; Goldin, Mark; Chen, Dan; Han, Bing; Zhang, Linqi] Tsinghua Univ, Sch Med, Comprehens AIDS Res Ctr, Beijing 100084, Peoples R China; [Wang, Xinquan] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, Beijing 100084, Peoples R China; [Sun, Wei; Wu, Hao] Capital Univ Med Sci, YouAn Hosp, Dept Infect Dis, Beijing 100054, Peoples R China	China Medical University; Tsinghua University; Tsinghua University; Capital Medical University	Shang, H (corresponding author), China Med Univ, Hosp 1, Minist Hlth, Dept Lab Med,Key Lab AIDS Immunol, Shenyang 110001, Peoples R China.	hongshang100@hotmail.com; zhanglinqi@tsinghua.edu.cn	ZHANG, LIN/GYD-9123-2022		National Science and Technology Major Project [2008ZX10001-001, 007, 011, 2009ZX10004-016]; National Basic Research Program (973 Program) [2006CB504200]; National Outstanding Youth Award [30825035]; National Natural Science Funds [30800969, U0832604]; Tsinghua University Initiative; Tsinghua Yue-Yuen Medical Sciences Fund; Liaoning Province, Institution of Higher Education [[2008]90]	National Science and Technology Major Project; National Basic Research Program (973 Program)(National Basic Research Program of China); National Outstanding Youth Award; National Natural Science Funds(National Natural Science Foundation of China (NSFC)); Tsinghua University Initiative; Tsinghua Yue-Yuen Medical Sciences Fund; Liaoning Province, Institution of Higher Education	This work was supported by National Science and Technology Major Project Grants 2008ZX10001-001, 007, 011, and 2009ZX10004-016; National Basic Research Program (also called the 973 Program) Grant 2006CB504200; National Outstanding Youth Award 30825035; National Natural Science Funds Grant 30800969 and U0832604; the Tsinghua University Initiative Scientific Research Program; and the Tsinghua Yue-Yuen Medical Sciences Fund, and High-Level Scholar Program of Liaoning Province, Institution of Higher Education [2008]90.	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; BARBAS CF, 1992, P NATL ACAD SCI USA, V89, P9339, DOI 10.1073/pnas.89.19.9339; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Bures R, 2002, J VIROL, V76, P2233, DOI 10.1128/JVI.76.5.2233-2244.2002; Chong HH, 2008, JAIDS-J ACQ IMM DEF, V47, P535, DOI 10.1097/QAI.0b013e3181663967; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Gnanakaran S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000955; Han XX, 2010, JAIDS-J ACQ IMM DEF, V53, pS27, DOI 10.1097/QAI.0b013e3181c7d5bf; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hoxie JA, 2010, ANNU REV MED, V61, P135, DOI 10.1146/annurev.med.60.042507.164323; Kostrikis LG, 1996, J VIROL, V70, P445, DOI 10.1128/JVI.70.1.445-458.1996; Kuiken Carla, 2003, AIDS Reviews, V5, P52; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Lu L, 2008, NATURE, V455, P609, DOI 10.1038/455609a; Mascola JR, 1996, AIDS RES HUM RETROV, V12, P1319, DOI 10.1089/aid.1996.12.1319; MASCOLA JR, 1994, J INFECT DIS, V169, P48, DOI 10.1093/infdis/169.1.48; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Ministry of Health of the People's Republic of China, 2010, CHIN 2010 UNGASS COU; Moore JP, 1996, J VIROL, V70, P427, DOI 10.1128/JVI.70.1.427-444.1996; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Nie JH, 2010, JAIDS-J ACQ IMM DEF, V53, P440, DOI 10.1097/QAI.0b013e3181cb8300; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Rerks-Ngarm S, 2010, CURR OPIN HIV AIDS, V5, P435, DOI 10.1097/COH.0b013e32833c95c1; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Utachee P, 2010, J VIROL, V84, P4311, DOI 10.1128/JVI.02619-09; van Gils MJ, 2010, CURR HIV RES, V8, P579, DOI 10.2174/157016210794088254; Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833; Walker LM, 2010, CURR OPIN IMMUNOL, V22, P358, DOI 10.1016/j.coi.2010.02.012; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Weber J, 1996, J VIROL, V70, P7827, DOI 10.1128/JVI.70.11.7827-7832.1996; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wu XL, 2009, J VIROL, V83, P10892, DOI 10.1128/JVI.01142-09; Zhang LQ, 2004, J VIROL, V78, P13591, DOI 10.1128/JVI.78.24.13591-13599.2004; Zhang LQ, 1998, J VIROL, V72, P9307, DOI 10.1128/JVI.72.11.9307-9312.1998; Zhang Y, 2006, PLOS MED, V3, P2065, DOI 10.1371/journal.pmed.0030443; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zwick MB, 2005, J VIROL, V79, P1252, DOI 10.1128/JVI.79.2.1252-1261.2005	51	47	58	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14531	14541		10.1074/jbc.M111.224527	http://dx.doi.org/10.1074/jbc.M111.224527			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21325278	Green Published, hybrid			2022-12-27	WOS:000289556200073
J	Zou, G; Chen, YL; Dong, HP; Lim, CC; Yap, LJ; Yau, YH; Shochat, SG; Lescar, J; Shi, PY				Zou, Gang; Chen, Yen-Liang; Dong, Hongping; Lim, Chin Chin; Yap, Li Jian; Yau, Yin Hoe; Shochat, Susana Geifman; Lescar, Julien; Shi, Pei-Yong			Functional Analysis of Two Cavities in Flavivirus NS5 Polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT RNA-POLYMERASE; WEST-NILE-VIRUS; DENGUE VIRUS; CRYSTAL-STRUCTURE; NONSTRUCTURAL PROTEIN; ADENOSINE NUCLEOSIDE; HELICASE; DOMAIN; METHYLTRANSFERASE; IDENTIFICATION	Flavivirus NS5 protein encodes methyltransferase and RNA-dependent RNA polymerase (RdRp) activities. Structural analysis of flavivirus RdRp domains uncovered two conserved cavities (A and B). Both cavities are located in the thumb subdomains and represent potential targets for development of allosteric inhibitors. In this study, we used dengue virus as a model to analyze the function of the two RdRp cavities. Amino acids from both cavities were subjected to mutagenesis analysis in the context of genome-length RNA and recombinant NS5 protein; residues critical for viral replication were subjected to revertant analysis. For cavity A, we found that only one (Lys-756) of the seven selected amino acids is critical for viral replication. Alanine substitution of Lys-756 did not affect the RdRp activity, suggesting that this residue functions through a nonenzymatic mechanism. For cavity B, all four selected amino acids (Leu-328, Lys-330, Trp-859, and Ile-863) are critical for viral replication. Biochemical and revertant analyses showed that three of the four mutated residues (Leu-328, Trp-859, and Ile-863) function at the step of initiation of RNA synthesis, whereas the fourth residue (Lys-330) functions by interacting with the viral NS3 helicase domain. Collectively, our results have provided direct evidence for the hypothesis that cavity B, but not cavity A, from dengue virus NS5 polymerase could be a target for rational drug design.	[Zou, Gang; Chen, Yen-Liang; Dong, Hongping; Lim, Chin Chin; Shi, Pei-Yong] Novartis Inst Trop Dis, Singapore 138670, Singapore; [Yap, Li Jian; Yau, Yin Hoe; Shochat, Susana Geifman; Lescar, Julien] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Novartis; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Shi, PY (corresponding author), 10 Biopolis Rd,05-01 Chromos, Singapore 138670, Singapore.	pei_yong.shi@novartis.com	Hoe, YAU Yin/A-2817-2011; Zou, Gang/J-1833-2014	Hoe, YAU Yin/0000-0001-8136-2393; Zou, Gang/0000-0001-9607-7827				Ackermann M, 2001, J BIOL CHEM, V276, P39926, DOI 10.1074/jbc.M104248200; Ansarah-Sobrinho C, 2008, VIROLOGY, V381, P67, DOI 10.1016/j.virol.2008.08.021; Chen CJ, 1997, J VIROL, V71, P3466, DOI 10.1128/JVI.71.5.3466-3473.1997; Chen YL, 2010, ANTIMICROB AGENTS CH, V54, P3255, DOI 10.1128/AAC.00397-10; Chen YL, 2010, ANTIMICROB AGENTS CH, V54, P2932, DOI 10.1128/AAC.00140-10; Chinnaswamy S, 2008, J BIOL CHEM, V283, P20535, DOI 10.1074/jbc.M801490200; Deore RR, 2010, CURR MED CHEM, V17, P3806; Dong HP, 2008, J VIROL, V82, P4295, DOI 10.1128/JVI.02202-07; Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757; FALGOUT B, 1993, J VIROL, V67, P2034, DOI 10.1128/JVI.67.4.2034-2042.1993; Gubler D.J., 2007, FIELDS VIROLOGY, VVolume 1; Hsieh SC, 2011, VIROLOGY, V410, P170, DOI 10.1016/j.virol.2010.11.006; Johansson M, 2001, J GEN VIROL, V82, P735, DOI 10.1099/0022-1317-82-4-735; KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100; Lescar J, 2009, CURR OPIN STRUC BIOL, V19, P759, DOI 10.1016/j.sbi.2009.10.011; Lindenbach B., 2011, FIELDS VIROLOGY, V5th ed., P1101; Luo D, 2008, J VIROL, V82, P173, DOI 10.1128/JVI.01788-07; Malet H, 2008, ANTIVIR RES, V80, P23, DOI 10.1016/j.antiviral.2008.06.007; Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200; Niyomrattanakit P, 2011, J BIOMOL SCREEN, V16, P201, DOI 10.1177/1087057110389323; Niyomrattanakit P, 2010, J VIROL, V84, P5678, DOI 10.1128/JVI.02451-09; Paul AV, 1998, NATURE, V393, P280, DOI 10.1038/30529; Poh MK, 2009, ANTIVIR RES, V84, P260, DOI 10.1016/j.antiviral.2009.09.011; Qing M, 2010, ANTIVIR RES, V86, P163, DOI 10.1016/j.antiviral.2010.02.313; Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06; Schul W, 2007, J INFECT DIS, V195, P665, DOI 10.1086/511310; Shi PY, 2002, J VIROL, V76, P5847, DOI 10.1128/JVI.76.12.5847-5856.2002; Tan BH, 1996, VIROLOGY, V216, P317, DOI 10.1006/viro.1996.0067; Velthuis AJWT, 2010, NUCLEIC ACIDS RES, V38, P203, DOI 10.1093/nar/gkp904; WENGLER G, 1991, VIROLOGY, V184, P707, DOI 10.1016/0042-6822(91)90440-M; WENGLER G, 1993, VIROLOGY, V197, P265, DOI 10.1006/viro.1993.1587; Wu JH, 2005, J VIROL, V79, P10268, DOI 10.1128/JVI.79.16.10268-10277.2005; Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06; Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106; Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06	35	93	96	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14362	14372		10.1074/jbc.M110.214189	http://dx.doi.org/10.1074/jbc.M110.214189			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21349834	Green Published, hybrid			2022-12-27	WOS:000289556200058
J	Igura, M; Kohda, D				Igura, Mayumi; Kohda, Daisuke			Selective Control of Oligosaccharide Transfer Efficiency for the N-Glycosylation Sequon by a Point Mutation in Oligosaccharyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED PROTEIN GLYCOSYLATION; IMPORTANT DETERMINANT; CAMPYLOBACTER-JEJUNI; CONSENSUS SEQUENCE; ESCHERICHIA-COLI; AMINO-ACID; COMPLEX; OCCUPANCY; TOPOLOGY; POSITION	Asn-linked glycosylation is the most ubiquitous posttranslational protein modification in eukaryotes and archaea, and in some eubacteria. Oligosaccharyltransferase (OST) catalyzes the transfer of preassembled oligosaccharides on lipid carriers onto asparagine residues in polypeptide chains. Inefficient oligosaccharide transfer results in glycoprotein heterogeneity, which is particularly bothersome in pharmaceutical glycoprotein production. Amino acid variation at the X position of the Asn-X-Ser/Thr sequon is known to modulate the glycosylation efficiency. The best amino acid at X is valine, for an archaeal Pyrococcus furiosus OST. We performed a systematic alanine mutagenesis study of the archaeal OST to identify the essential and dispensable amino acid residues in the three catalytic motifs. We then investigated the effects of the dispensable mutations on the amino acid preference in the N-glycosylation sequon. One residue position was found to selectively affect the amino acid preference at the X position. This residue is located within the recently identified DXXKXXX(M/I) motif, suggesting the involvement of this motif in N-glycosylation sequon recognition. In applications, mutations at this position may facilitate the design of OST variants adapted to particular N-glycosylation sites to reduce the heterogeneity of glycan occupancy. In fact, a mutation at this position led to 9-fold higher activity relative to the wild-type enzyme, toward a peptide containing arginine at X in place of valine. This mutational approach is potentially applicable to eukaryotic and eubacterial OSTs for the production of homogenous glycoproteins in engineered mammalian and Escherichia coli cells.	[Igura, Mayumi; Kohda, Daisuke] Kyushu Univ, Med Inst Bioregulat, Div Struct Biol, Higashi Ku, Fukuoka 8128582, Japan	Kyushu University	Kohda, D (corresponding author), Kyushu Univ, Med Inst Bioregulat, Div Struct Biol, Higashi Ku, Maidashi 3-1-1, Fukuoka 8128582, Japan.	kohda@bioreg.kyushu-u.ac.jp	Kohda, Daisuke/I-4990-2019	Kohda, Daisuke/0000-0001-8234-3776	Scientific Research on Innovative Areas [21121003]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Mizutani Foundation [090036]	Scientific Research on Innovative Areas(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mizutani Foundation	This work was supported by Grant-in-aid for Scientific Research on Innovative Areas 21121003, the Targeted Proteins Research Program (TPRP) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, and Research Grant 090036 from the Mizutani Foundation for Glyco science.	Abu-Qarn M, 2008, CURR OPIN STRUC BIOL, V18, P544, DOI 10.1016/j.sbi.2008.06.010; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Bano-Polo M, 2011, PROTEIN SCI, V20, P179, DOI 10.1002/pro.551; BAUSE E, 1979, FEBS LETT, V108, P341, DOI 10.1016/0014-5793(79)80559-1; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; Chavan M, 2003, J BIOL CHEM, V278, P51441, DOI 10.1074/jbc.M310456200; Chen MM, 2007, BIOCHEMISTRY-US, V46, P5579, DOI 10.1021/bi602633n; Feldman MF, 2005, P NATL ACAD SCI USA, V102, P3016, DOI 10.1073/pnas.0500044102; GAVEL Y, 1990, PROTEIN ENG, V3, P433, DOI 10.1093/protein/3.5.433; Glover KJ, 2005, CHEM BIOL, V12, P1311, DOI 10.1016/j.chembiol.2005.10.004; Hese K, 2009, GLYCOBIOLOGY, V19, P160, DOI 10.1093/glycob/cwn118; IGURA M, 2011, GLYCOBIOLOG IN PRESS; Igura M, 2008, EMBO J, V27, P234, DOI 10.1038/sj.emboj.7601940; Jones J, 2005, BBA-GEN SUBJECTS, V1726, P121, DOI 10.1016/j.bbagen.2005.07.003; Kasturi L, 1997, BIOCHEM J, V323, P415, DOI 10.1042/bj3230415; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kim H, 2005, J BIOL CHEM, V280, P20261, DOI 10.1074/jbc.M412213200; Knauer R, 1999, BBA-GEN SUBJECTS, V1426, P259, DOI 10.1016/S0304-4165(98)00128-7; Kohda D, 2007, GLYCOBIOLOGY, V17, P1175, DOI 10.1093/glycob/cwm087; Li L, 2010, BIOCHEM BIOPH RES CO, V394, P1069, DOI 10.1016/j.bbrc.2010.03.126; Maita N, 2010, J BIOL CHEM, V285, P4941, DOI 10.1074/jbc.M109.081752; Mellquist JL, 1998, BIOCHEMISTRY-US, V37, P6833, DOI 10.1021/bi972217k; Nita-Lazar M, 2005, GLYCOBIOLOGY, V15, P361, DOI 10.1093/glycob/cwi019; Petrescu AJ, 2004, GLYCOBIOLOGY, V14, P103, DOI 10.1093/glycob/cwh008; PICARD V, 1995, BIOCHEMISTRY-US, V34, P8433, DOI 10.1021/bi00026a026; Schwarz F, 2010, NAT CHEM BIOL, V6, P264, DOI [10.1038/NCHEMBIO.314, 10.1038/nchembio.314]; ShakinEshleman SH, 1996, J BIOL CHEM, V271, P6363, DOI 10.1074/jbc.271.11.6363; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; WITTWER AJ, 1989, BIOCHEMISTRY-US, V28, P7662, DOI 10.1021/bi00445a022; Yan AX, 2005, J BIOL CHEM, V280, P3121, DOI 10.1074/jbc.R400036200; Yan G, 2002, J BIOL CHEM, V277, P47692, DOI 10.1074/jbc.M208136200; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012	32	14	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13255	13260		10.1074/jbc.M110.213900	http://dx.doi.org/10.1074/jbc.M110.213900			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21357684	Green Published, hybrid			2022-12-27	WOS:000289282200046
J	Vanhercke, T; Shrestha, P; Green, AG; Singh, SP				Vanhercke, Thomas; Shrestha, Pushkar; Green, Allan G.; Singh, Surinder P.			Mechanistic and Structural Insights into the Regioselectivity of an Acyl-CoA Fatty Acid Desaturase via Directed Molecular Evolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARRIER-PROTEIN DESATURASE; FUNCTIONAL-CHARACTERIZATION; ACHETA-DOMESTICUS; CRYSTAL-STRUCTURE; HOUSE CRICKET; DELTA-12-DESATURASE; GENE; DIVERSIFICATION; IDENTIFICATION; SPECIFICITY	Membrane-bound fatty acid desaturases and related enzymes play a pivotal role in the biosynthesis of unsaturated and various unusual fatty acids. Structural insights into the remarkable catalytic diversity and wide range of substrate specificities of this class of enzymes remain limited due to the lack of a crystal structure. To investigate the structural basis of the double bond positioning (regioselectivity) of the desaturation reaction in more detail, we relied on a combination of directed evolution in vitro and a powerful yeast complementation assay to screen for Delta x regioselectivity. After two selection rounds, variants of the bifunctional Delta 12/Delta 9-desaturase from the house cricket (Acheta domesticus) exhibited increased Delta 9-desaturation activity on shorter chain fatty acids. This change in specificity was the result of as few as three mutations, some of them near the putative active site. Subsequent analysis of individual substitutions revealed an important role of residue Phe-52 in facilitating Delta 9-desaturation of shorter chain acyl substrates and allowed for the redesign of the cricket Delta 12/Delta 9-desaturase into a 16:0-specific Delta 9-desaturase. Our results demonstrate that a minimal number of mutations can have a profound impact on the regiselectivity of acyl-CoA fatty acid desaturases and include the first biochemical data supporting the acyl-CoA acyl carrier specificity of a desaturase able to carry out Delta 12-desaturation.	[Vanhercke, Thomas; Shrestha, Pushkar; Green, Allan G.; Singh, Surinder P.] CSIRO Plant Ind, Canberra, ACT 2601, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Singh, SP (corresponding author), CSIRO Plant Ind, POB 1600, Canberra, ACT 2601, Australia.	Surinder.Singh@csiro.au	Green, Allan/AAM-6856-2021; singh, surinder/C-9528-2009; Vanhercke, Thomas/B-6647-2011; Shrestha, Pushkar/A-2728-2010; Green, Allan G/C-6572-2008	singh, surinder/0000-0003-4488-8147; Vanhercke, Thomas/0000-0003-1397-7622; Shrestha, Pushkar/0000-0001-9642-6636; Green, Allan/0000-0002-3248-2089	CSIRO Office of the Chief Executive Post-doctoral Fellowship Scheme	CSIRO Office of the Chief Executive Post-doctoral Fellowship Scheme	This work was supported by the CSIRO Office of the Chief Executive Post-doctoral Fellowship Scheme.	Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BORGESON CE, 1990, BIOCHIM BIOPHYS ACTA, V1047, P135, DOI 10.1016/0005-2760(90)90039-Z; Broadwater JA, 2002, J BIOL CHEM, V277, P15613, DOI 10.1074/jbc.M200231200; Broun P, 1998, SCIENCE, V282, P1315, DOI 10.1126/science.282.5392.1315; Cahoon EB, 2005, EUR J LIPID SCI TECH, V107, P239, DOI 10.1002/ejlt.200590020; Cahoon EB, 1997, P NATL ACAD SCI USA, V94, P4872, DOI 10.1073/pnas.94.10.4872; CRIPPS C, 1990, ARCH BIOCHEM BIOPHYS, V278, P46, DOI 10.1016/0003-9861(90)90229-R; Damude HG, 2006, P NATL ACAD SCI USA, V103, P9446, DOI 10.1073/pnas.0511079103; Domergue F, 2005, BIOCHEM J, V389, P483, DOI 10.1042/BJ20050111; Fang S, 2009, MOL BIOL EVOL, V26, P1447, DOI 10.1093/molbev/msp057; Gagne SJ, 2009, BIOCHEMISTRY-US, V48, P12298, DOI 10.1021/bi901605d; GOSTINCAR C, 2001, J MEMBR, V233, P63; Guy JE, 2007, J BIOL CHEM, V282, P19863, DOI 10.1074/jbc.M702520200; Guy JE, 2006, P NATL ACAD SCI USA, V103, P17220, DOI 10.1073/pnas.0607165103; Hashimoto K, 2008, J LIPID RES, V49, P183, DOI 10.1194/jlr.M700377-JLR200; Hoffmann M, 2008, J BIOL CHEM, V283, P22352, DOI 10.1074/jbc.M802377200; Hoffmann M, 2007, J BIOL CHEM, V282, P26666, DOI 10.1074/jbc.M705068200; Hofmann K., 1993, BIOL CHEM H-S, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Hongsthong A, 2004, APPL MICROBIOL BIOT, V66, P74, DOI 10.1007/s00253-004-1655-x; Jackel C, 2008, ANNU REV BIOPHYS, V37, P153, DOI 10.1146/annurev.biophys.37.032807.125832; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Libisch B, 2000, BIOCHEM BIOPH RES CO, V279, P779, DOI 10.1006/bbrc.2000.4023; Lindqvist Y, 1996, EMBO J, V15, P4081, DOI 10.1002/j.1460-2075.1996.tb00783.x; Man WC, 2006, J BIOL CHEM, V281, P1251, DOI 10.1074/jbc.M508733200; MCDONOUGH VM, 1992, J BIOL CHEM, V267, P5931; Meesapyodsuk D, 2000, BIOCHEMISTRY-US, V39, P11948, DOI 10.1021/bi000756a; Meesapyodsuk D, 2007, J BIOL CHEM, V282, P20191, DOI 10.1074/jbc.M702196200; Reetz MT, 2007, NAT PROTOC, V2, P891, DOI 10.1038/nprot.2007.72; Riddervold MH, 2002, INSECT BIOCHEM MOLEC, V32, P1731, DOI 10.1016/S0965-1748(02)00113-3; Roelofs WL, 2003, P NATL ACAD SCI USA, V100, P9179, DOI 10.1073/pnas.1233767100a; Sayanova O, 2006, J BIOL CHEM, V281, P36533, DOI 10.1074/jbc.M605158200; SHANKLIN J, 1991, P NATL ACAD SCI USA, V88, P2510, DOI 10.1073/pnas.88.6.2510; Shanklin J, 1998, ANNU REV PLANT PHYS, V49, P611, DOI 10.1146/annurev.arplant.49.1.611; SHANKLIN J, 2004, BIOCHEMISTRY-US, V33, P12787; Shanklin J, 2008, ADV PL BIOCH MOL BIO, V1, P29, DOI 10.1016/S1755-0408(07)01002-8; Shanklin J, 2009, J BIOL CHEM, V284, P18559, DOI 10.1074/jbc.R900009200; Sperling P, 2003, PROSTAG LEUKOTR ESS, V68, P73, DOI 10.1016/S0952-3278(02)00258-2; STUKEY JE, 1990, J BIOL CHEM, V265, P20144; Tracewell CA, 2009, CURR OPIN CHEM BIOL, V13, P3, DOI 10.1016/j.cbpa.2009.01.017; Turner NJ, 2009, NAT CHEM BIOL, V5, P568, DOI 10.1038/nchembio.203; Vanhercke T, 2005, ANAL BIOCHEM, V339, P9, DOI 10.1016/j.ab.2004.11.032; Whittle E, 2001, J BIOL CHEM, V276, P21500, DOI 10.1074/jbc.M102129200; Whittle EJ, 2008, P NATL ACAD SCI USA, V105, P14738, DOI 10.1073/pnas.0805645105; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Zhang S, 2007, FEBS LETT, V581, P315, DOI 10.1016/j.febslet.2006.12.031; Zhang XX, 2009, MOL BIOL REP, V36, P567, DOI 10.1007/s11033-008-9215-6; Zhou XR, 2008, INSECT MOL BIOL, V17, P667, DOI 10.1111/j.1365-2583.2008.00841.x	49	31	35	3	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					12860	12869		10.1074/jbc.M110.191098	http://dx.doi.org/10.1074/jbc.M110.191098			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21300802	Green Published, hybrid			2022-12-27	WOS:000289282200006
J	Houliston, RS; Vinogradov, E; Dzieciatkowska, M; Li, JJ; Michael, FS; Karwaski, MF; Brochu, D; Jarrell, HC; Parker, CT; Yuki, N; Mandrell, RE; Gilbert, M				Houliston, R. Scott; Vinogradov, Evgeny; Dzieciatkowska, Monika; Li, Jianjun; Michael, Frank St.; Karwaski, Marie-France; Brochu, Denis; Jarrell, Harold C.; Parker, Craig T.; Yuki, Nobuhiro; Mandrell, Robert E.; Gilbert, Michel			Lipooligosaccharide of Campylobacter jejuni SIMILARITY WITH MULTIPLE TYPES OF MAMMALIAN GLYCANS BEYOND GANGLIOSIDES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUILLAIN-BARRE-SYNDROME; CORE OLIGOSACCHARIDE REGIONS; GENUS-SPECIFIC EPITOPE; BACTERIAL LIPOPOLYSACCHARIDES; CHLAMYDIA LIPOPOLYSACCHARIDE; CAPILLARY-ELECTROPHORESIS; LIPO-OLIGOSACCHARIDES; HELICOBACTER-PYLORI; STRUCTURAL-ANALYSIS; GANGLIOSIDE MIMICS	Campylobacter jejuni is well known for synthesizing ganglioside mimics within the glycan component of its lipooligosaccharide (LOS), which have been implicated in triggering Guillain-Barre syndrome. We now confirm that this pathogen is capable of synthesizing a much broader spectrum of host glycolipid/glycoprotein mimics within its LOS. P blood group and paragloboside (lacto-N-neotetraose) antigen mimicry is exhibited by RM1221, a strain isolated from a poultry source. RM1503, a gastroenteritis-associated strain, expresses lacto-N-biose and sialyl-Lewis c units, the latter known as the pancreatic tumor-associated antigen, DU-PAN-2 (or LSTa). C. jejuni GC149, a Guillain-Barre ' syndrome-associated strain, expresses an unusual sialic acid-containing hybrid oligosaccharide with similarity to both ganglio and P-k antigens and can, through phase variation of its LOS biosynthesis genes, display GT1a or GD3 ganglioside mimics. We show that the sialyltransferase CstII and the galactosyltransferase CgtD are involved in the synthesis of multiple mimic types, with LOS structural diversity achieved through evolving allelic substrate specificity.	[Houliston, R. Scott; Vinogradov, Evgeny; Dzieciatkowska, Monika; Li, Jianjun; Michael, Frank St.; Karwaski, Marie-France; Brochu, Denis; Jarrell, Harold C.; Gilbert, Michel] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada; [Parker, Craig T.; Mandrell, Robert E.] ARS, USDA, Albany, CA 94710 USA; [Yuki, Nobuhiro] Natl Univ Singapore, Dept Microbiol, Singapore 117597, Singapore; [Yuki, Nobuhiro] Natl Univ Singapore, Dept Med, Singapore 117597, Singapore	National Research Council Canada; United States Department of Agriculture (USDA); National University of Singapore; National University of Singapore	Gilbert, M (corresponding author), Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada.	michel.gilbert@nrc-cnrc.gc.ca	Mandrell, Robert E/O-9814-2018; Yuki, Nobuhiro/H-3187-2012	Li, Jianjun/0000-0002-6531-3687; Parker, Craig/0000-0002-7719-8882; Gilbert, Michel/0000-0002-0204-4408; Vinogradov, Evgeny/0000-0002-5364-1376				ASPINALL GO, 1993, EUR J BIOCHEM, V213, P1029, DOI 10.1111/j.1432-1033.1993.tb17850.x; ASPINALL GO, 1993, EUR J BIOCHEM, V213, P1017, DOI 10.1111/j.1432-1033.1993.tb17849.x; Aspinall GO, 1996, BIOCHEMISTRY-US, V35, P2489, DOI 10.1021/bi951852s; ASPINALL GO, 1994, BIOCHEMISTRY-US, V33, P241, DOI 10.1021/bi00167a032; Bernatchez S, 2007, GLYCOBIOLOGY, V17, P1333, DOI 10.1093/glycob/cwm090; CHAN NWC, 1995, GLYCOBIOLOGY, V5, P683, DOI 10.1093/glycob/5.7.683; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Duus JO, 2000, CHEM REV, V100, P4589, DOI 10.1021/cr990302n; Dzieciatkowska M, 2007, BIOCHEMISTRY-US, V46, P14704, DOI 10.1021/bi701229k; Gilbert M, 2002, J BIOL CHEM, V277, P327, DOI 10.1074/jbc.M108452200; Gilbert M, 2000, J BIOL CHEM, V275, P3896, DOI 10.1074/jbc.275.6.3896; Gilbert M, 2008, CAMPYLOBACTER, 3RD EDITION, P483; Godschalk PCR, 2004, J CLIN INVEST, V114, P1659, DOI 10.1172/JCI200415707; Hobley P, 1996, MAGN RESON CHEM, V34, P755; HOLST O, 1993, EUR J BIOCHEM, V214, P703, DOI 10.1111/j.1432-1033.1993.tb17971.x; HOLST O, 1994, EUR J BIOCHEM, V222, P183, DOI 10.1111/j.1432-1033.1994.tb18856.x; Houliston RS, 2009, GLYCOBIOLOGY, V19, P153, DOI 10.1093/glycob/cwn117; Houliston RS, 2006, J BIOL CHEM, V281, P11480, DOI 10.1074/jbc.M512183200; JENNINGS HJ, 1983, CARBOHYD RES, V121, P233, DOI 10.1016/0008-6215(83)84020-8; Karlyshev AV, 2000, MOL MICROBIOL, V35, P529, DOI 10.1046/j.1365-2958.2000.01717.x; Koga M, 2006, J INFECT DIS, V193, P547, DOI 10.1086/499969; Li JJ, 2007, MASS SPECTROM REV, V26, P35, DOI 10.1002/mas.20105; Linton D, 2000, MOL MICROBIOL, V35, P1120, DOI 10.1046/j.1365-2958.2000.01780.x; MANDRELL RE, 1992, INFECT IMMUN, V60, P3017, DOI 10.1128/IAI.60.7.3017-3020.1992; MANDRELL RE, 1993, IMMUNOBIOLOGY, V187, P382, DOI 10.1016/S0171-2985(11)80352-9; MANDRELL RE, 1994, METHOD ENZYMOL, V236, P231; Moran AP, 1996, FEMS IMMUNOL MED MIC, V16, P105, DOI 10.1111/j.1574-695X.1996.tb00127.x; Parker CT, 2008, J BACTERIOL, V190, P5681, DOI 10.1128/JB.00254-08; Parker CT, 2005, J CLIN MICROBIOL, V43, P2771, DOI 10.1128/JCM.43.6.2771-2781.2005; Rinaldi S, 2008, CURR OPIN NEUROL, V21, P540, DOI 10.1097/WCO.0b013e32830b84b7; Wakarchuk Warren W, 2003, Methods Mol Biol, V213, P263; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; YUKI N, 1993, J EXP MED, V178, P1771, DOI 10.1084/jem.178.5.1771; Yuki N, 2010, METHODS MOL BIOL, V600, P51, DOI 10.1007/978-1-60761-454-8_4	34	42	43	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.181750	http://dx.doi.org/10.1074/jbc.M110.181750			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21257763	Green Published, hybrid			2022-12-27	WOS:000289077500050
J	Hu, R; Liu, W; Li, H; Yang, L; Chen, C; Xia, ZY; Guo, LJ; Xie, H; Zhou, HD; Wu, XP; Luo, XH				Hu, Rong; Liu, Wei; Li, Hui; Yang, Li; Chen, Chao; Xia, Zhu-Ying; Guo, Li-Juan; Xie, Hui; Zhou, Hou-De; Wu, Xian-Ping; Luo, Xiang-Hang			A Runx2/miR-3960/miR-2861 Regulatory Feedback Loop during Mouse Osteoblast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICRORNA GENES; EXPRESSION; TRANSCRIPTION	Our recent study showed that miR-2861 promotes osteoblast differentiation by targeting histone deacetylase 5, resulting in increased runt-related transcription factor 2 (Runx2) protein production. Here we identified another new microRNA (miRNA) (miR-3960) that played a regulatory role in osteoblast differentiation through a regulatory feedback loop with miR-2861. miR-3960 and miR-2861 were found clustered at the same loci. miR-3960 was transcribed during bone morphogenic protein 2 (BMP2)-induced osteogenesis of ST2 stromal cells. Overexpression of miR-3960 promoted BMP2-induced osteo-blastogenesis. However, the inhibition of miR-3960 expression attenuated the osteoblastogenesis. Homeobox A2 (Hoxa2), a repressor of Runx2 expression, was confirmed to be a target of miR-3960. Electrophoretic mobility shift assay and chromatin immunoprecipitation experiments confirmed that Runx2 bound to the promoter of the miR-3960/miR-2861 cluster. Furthermore, overexpression of Runx2 induced miR-3960/miR2861 transcription, and block of Runx2 expression attenuated BMP2-induced miR-3960/miR-2861 transcription. Here we report that miR-3960 and miR-2861, transcribed together from the same miRNA polycistron, both function in osteoblast differentiation through a novel Runx2/miR-3960/miR-2861 regulatory feedback loop. Our findings provide new insights into the roles of miRNAs in osteoblast differentiation.	[Hu, Rong; Liu, Wei; Li, Hui; Yang, Li; Chen, Chao; Xia, Zhu-Ying; Guo, Li-Juan; Xie, Hui; Zhou, Hou-De; Wu, Xian-Ping; Luo, Xiang-Hang] Cent S Univ, Xiangya Hosp 2, Inst Endocrinol & Metab, Changsha 410011, Hunan, Peoples R China	Central South University	Luo, XH (corresponding author), Cent S Univ, Xiangya Hosp 2, Inst Endocrinol & Metab, 139 Middle Renmin Rd, Changsha 410011, Hunan, Peoples R China.	xianghangluo@hotmail.com	Xie, Hui/AAF-8152-2020	Zhou, Hou-De/0000-0001-9131-4141	National Natural Science Foundation from China [30870925, 81070696, 81000122]	National Natural Science Foundation from China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation Grants 30870925, 81070696, and 81000122 from China.	Ambros V, 2007, DEVELOPMENT, V134, P1635, DOI 10.1242/dev.002006; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Gao JS, 2010, NUCLEIC ACIDS RES, V38, P2775, DOI 10.1093/nar/gkp1242; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hagen JW, 2008, CELL CYCLE, V7, P2327, DOI 10.4161/cc.6447; Kahai S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007535; Kanzler B, 1998, DEVELOPMENT, V125, P2587; Ko HY, 2009, FEBS J, V276, P4854, DOI 10.1111/j.1742-4658.2009.07185.x; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li H, 2009, J CLIN INVEST, V119, P3666, DOI 10.1172/JCI39832; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Mizuno Y, 2008, BIOCHEM BIOPH RES CO, V368, P267, DOI 10.1016/j.bbrc.2008.01.073; Mizuno Y, 2009, FEBS LETT, V583, P2263, DOI 10.1016/j.febslet.2009.06.006; Nakamura T, 2003, BRIT J CANCER, V88, P1101, DOI 10.1038/sj.bjc.6600869; OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304; Phimphilai M, 2006, J BONE MINER RES, V21, P637, DOI 10.1359/JBMR.060109; Ro S, 2007, RNA, V13, P1693, DOI 10.1261/rna.640307; Roca H, 2008, NUCLEIC ACIDS RES, V36, P1723, DOI 10.1093/nar/gkn022; Ryoo HM, 2006, GENE, V366, P51, DOI 10.1016/j.gene.2005.10.011; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Trang P, 2008, Oncogene, V27 Suppl 2, pS52, DOI 10.1038/onc.2009.353; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	32	189	215	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.176099	http://dx.doi.org/10.1074/jbc.M110.176099			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21324897	Green Published, hybrid			2022-12-27	WOS:000289077500047
J	Grishin, AM; Ajamian, E; Tao, LM; Zhang, LH; Menard, R; Cygler, M				Grishin, Andrey M.; Ajamian, Eunice; Tao, Limei; Zhang, Linhua; Menard, Robert; Cygler, Miroslaw			Structural and Functional Studies of the Escherichia coli Phenylacetyl-CoA Monooxygenase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLUENE/O-XYLENE MONOOXYGENASE; METHYLOCOCCUS-CAPSULATUS BATH; SOLUBLE METHANE MONOOXYGENASE; PSEUDOMONAS-STUTZERI OX1; MULTICOMPONENT MONOOXYGENASES; CRYSTAL-STRUCTURE; AROMATIC HYDROXYLATION; PHENOL HYDROXYLASE; PROTEIN COMPLEX; BACTERIAL	The utilization of phenylacetic acid (PA) in Escherichia coli occurs through a hybrid pathway that shows features of both aerobic and anaerobic metabolism. Oxygenation of the aromatic ring is performed by a multisubunit phenylacetyl-coenzyme A oxygenase complex that shares remote homology of two subunits to well studied bacterial multicomponent monooxygenases and was postulated to form a new bacterial multicomponent monooxygenase subfamily. We expressed the subunits PaaA, B, C, D, and E of the PA-CoA oxygenase and showed that PaaABC, PaaAC, and PaaBC form stable subcomplexes that can be purified. In vitro reconstitution of the oxygenase subunits showed that each of the PaaA, B, C, and E subunits are necessary for catalysis, whereas PaaD is not essential. We have determined the crystal structure of the PaaAC complex in a ligand-free form and with several CoA derivatives. We conclude that PaaAC forms a catalytic core with a monooxygenase fold with PaaA being the catalytic alpha subunit and PaaC, the structural beta subunit. PaaAC forms heterotetramers that are organized very differently from other known multisubunit monooxygenases and lacks their conservative network of hydrogen bonds between the di-iron center and protein surface, suggesting different association with the reductase and different mechanisms of electron transport. The PaaA structure shows adaptation of the common access route to the active site for binding a CoA-bound substrate. The enzyme-substrate complex shows the orientation of the aromatic ring, which is poised for oxygenation at the ortho-position, in accordance with the expected chemistry. The PACoA oxygenase complex serves as a paradigm for the new subfamily multicomponent monooxygenases comprising several hundred homologs.	[Tao, Limei; Zhang, Linhua; Menard, Robert; Cygler, Miroslaw] Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada; [Grishin, Andrey M.; Ajamian, Eunice; Cygler, Miroslaw] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada	National Research Council Canada; McGill University	Cygler, M (corresponding author), Natl Res Council Canada, Biotechnol Res Inst, 6100 Royalmount Ave, Montreal, PQ H4P 2R2, Canada.	mirek@bri.nrc.ca			National Sciences and Engineering Research Council of Canada; National Research Council; Canadian Institutes of Health Research [GSP-48370]; University of Saskatchewan	National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Research Council; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Saskatchewan	This work was supported in part by the National Sciences and Engineering Research Council of Canada, the National Research Council, the Canadian Institutes of Health Research, and the University of Saskatchewan. This work was supported by Grant GSP-48370 from Canadian Institutes of Health Research (to M. C.).	Bailey LJ, 2008, P NATL ACAD SCI USA, V105, P19194, DOI 10.1073/pnas.0807948105; Batie C. J., 1991, CHEM BIOCH FLAVOENZY, V3, P543; Borodina E, 2007, APPL ENVIRON MICROB, V73, P6460, DOI 10.1128/AEM.00823-07; Cafaro V, 2002, EUR J BIOCHEM, V269, P5689, DOI 10.1046/j.1432-1033.2002.03281.x; Cafaro V, 2004, APPL ENVIRON MICROB, V70, P2211, DOI 10.1128/AEM.70.4.2211-2219.2004; Cao B, 2009, APPL MICROBIOL BIOT, V85, P207, DOI 10.1007/s00253-009-2192-4; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez C, 2006, APPL ENVIRON MICROB, V72, P7422, DOI 10.1128/AEM.01550-06; Ferrandez A, 1998, J BIOL CHEM, V273, P25974, DOI 10.1074/jbc.273.40.25974; Fuchs G, 2008, ANN NY ACAD SCI, V1125, P82, DOI 10.1196/annals.1419.010; Gibson DT, 2000, CURR OPIN BIOTECH, V11, P236, DOI 10.1016/S0958-1669(00)00090-2; Grishin AM, 2010, ACTA CRYSTALLOGR F, V66, P1045, DOI 10.1107/S174430911002748X; Ismail W, 2003, EUR J BIOCHEM, V270, P3047, DOI 10.1046/j.1432-1033.2003.03683.x; JABRI E, 1995, SCIENCE, V268, P998, DOI 10.1126/science.7754395; Jaganaman S, 2007, PROTEIN EXPRES PURIF, V52, P273, DOI 10.1016/j.pep.2006.09.004; Leungsakul T, 2006, APPL ENVIRON MICROB, V72, P3933, DOI 10.1128/AEM.02966-05; Luengo JM, 2001, MOL MICROBIOL, V39, P1434, DOI 10.1046/j.1365-2958.2001.02344.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mitchell KH, 2003, P NATL ACAD SCI USA, V100, P3784, DOI 10.1073/pnas.0636619100; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Notomista E, 2003, J MOL EVOL, V56, P435, DOI 10.1007/s00239-002-2414-1; Notomista E, 2009, APPL ENVIRON MICROB, V75, P823, DOI 10.1128/AEM.01951-08; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pikus JD, 1997, BIOCHEMISTRY-US, V36, P9283, DOI 10.1021/bi971049t; REINER AM, 1971, BIOCHEMISTRY-US, V10, P2530, DOI 10.1021/bi00789a017; ROSENZWEIG AC, 1993, NATURE, V366, P537, DOI 10.1038/366537a0; Rosenzweig AC, 1997, PROTEINS, V29, P141, DOI 10.1002/(SICI)1097-0134(199710)29:2<141::AID-PROT2>3.3.CO;2-W; Sazinsky MH, 2006, ACCOUNTS CHEM RES, V39, P558, DOI 10.1021/ar030204v; Sazinsky MH, 2006, BIOCHEMISTRY-US, V45, P15392, DOI 10.1021/bi0618969; Sazinsky MH, 2004, J BIOL CHEM, V279, P30600, DOI 10.1074/jbc.M400710200; Sazinsky MH, 2004, BIOCHEMISTRY-US, V43, P16263, DOI 10.1021/bi048140z; TAGAWA K, 1962, NATURE, V195, P537, DOI 10.1038/195537a0; Teufel R, 2010, P NATL ACAD SCI USA, V107, P14390, DOI 10.1073/pnas.1005399107; Ullrich R, 2007, CELL MOL LIFE SCI, V64, P271, DOI 10.1007/s00018-007-6362-1; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766	36	34	41	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10735	10743		10.1074/jbc.M110.194423	http://dx.doi.org/10.1074/jbc.M110.194423			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21247899	Green Published, hybrid			2022-12-27	WOS:000288547000087
J	Soontharapirakkul, K; Promden, W; Yamada, N; Kageyama, H; Incharoensakdi, A; Iwamoto-Kihara, A; Takabe, T				Soontharapirakkul, Kanteera; Promden, Worrawat; Yamada, Nana; Kageyama, Hakuto; Incharoensakdi, Aran; Iwamoto-Kihara, Atsuko; Takabe, Teruhiro			Halotolerant Cyanobacterium Aphanothece halophytica Contains an Na+-dependent F1F0-ATP Synthase with a Potential Role in Salt-stress Tolerance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP SYNTHASE; FUNCTIONAL-CHARACTERIZATION; ESCHERICHIA-COLI; ION SPECIFICITY; PLASMA-MEMBRANE; H+-ATPASE; SUBUNITS; SEQUENCE; GENES; CHLOROPLASTS	Aphanothece halophytica is a halotolerant alkaliphilic cyanobacterium that can grow in media of up to 3.0 M NaCl and pH 11. Here, we show that in addition to a typical H+-ATP synthase, Aphanothece halophytica contains a putative F1F0-type Na+-ATP synthase (ApNa(+)-ATPase) operon (ApNa(+)-atp). The operon consists of nine genes organized in the order of putative subunits beta, epsilon, I, hypothetical protein, a, c, b, alpha, and gamma. Homologous operons could also be found in some cyanobacteria such as Synechococcus sp. PCC 7002 and Acaryochloris marina MBIC11017. The ApNa(+)-atp operon was isolated from the A. halophytica genome and transferred into an Escherichia coli mutant DK8 (Delta atp) deficient in ATP synthase. The inverted membrane vesicles of E. coli DK8 expressing ApNa(+)-ATPase exhibited Na+-dependent ATP hydrolysis activity, which was inhibited by monensin and tributyltin chloride, but not by the protonophore, carbonyl cyanide m-chlorophenyl hydrazone (CCCP). The Na+ ion protected the inhibition of ApNa(+)-ATPase by N,N'-dicyclohexylcarbodiimide. The ATP synthesis activity was also observed using the Na+-loaded inverted membrane vesicles. Expression of the ApNa(+)-atp operon in the heterologous cyanobacterium Synechococcus sp. PCC 7942 showed its localization in the cytoplasmic membrane fractions and increased tolerance to salt stress. These results indicate that A. halophytica has additional Na+-dependent F1F0-ATPase in the cytoplasmic membrane playing a potential role in salt-stress tolerance.	[Soontharapirakkul, Kanteera; Promden, Worrawat; Yamada, Nana; Kageyama, Hakuto; Takabe, Teruhiro] Meijo Univ, Grad Sch Environm & Human Sci, Nagoya, Aichi 4688502, Japan; [Soontharapirakkul, Kanteera; Incharoensakdi, Aran] Chulalongkorn Univ, Fac Sci, Bangkok 10330, Thailand; [Iwamoto-Kihara, Atsuko] Nagahama Inst Biosci & Technol, Fac Biosci, Shiga, Nagahama 5260829, Japan; [Takabe, Teruhiro] Meijo Univ, Res Inst, Nagoya, Aichi 4688502, Japan	Meijo University; Chulalongkorn University; Meijo University	Takabe, T (corresponding author), 1-01 Shiogamaguchi,Tenpaku Ku, Aichi 4688502, Japan.	takabe@meijo-u.ac.jp	Kageyama, Hakuto/M-7302-2019; Kageyama, Hakuto/L-6890-2019; PROMDEN, WORRAWAT/GSJ-0691-2022; Kageyama, Hakuto/AAX-1682-2020	Kageyama, Hakuto/0000-0002-7741-7408; PROMDEN, WORRAWAT/0000-0002-3846-8894; 	Ministry of Education, Science, and Culture of Japan; Salt Science Research Foundation; High-Technology Research Center of Meijo University; Royal Golden Jubilee Ph.D. program; 90th Anniversary of Chulalongkorn University Fund	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Salt Science Research Foundation; High-Technology Research Center of Meijo University; Royal Golden Jubilee Ph.D. program(Thailand Research Fund (TRF)); 90th Anniversary of Chulalongkorn University Fund(Chulalongkorn University)	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Science, and Culture of Japan; the Salt Science Research Foundation; and the High-Technology Research Center of Meijo University. This work was also supported by the Royal Golden Jubilee Ph.D. program and the 90th Anniversary of Chulalongkorn University Fund (Ratchadaphiseksomphote Endowment Fund) (to K. S.).	BALNOKIN YV, 1994, FEBS LETT, V343, P61, DOI 10.1016/0014-5793(94)80607-1; BERGER S, 1991, FEBS LETT, V286, P129, DOI 10.1016/0014-5793(91)80957-5; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; COZENS AL, 1987, J MOL BIOL, V194, P359, DOI 10.1016/0022-2836(87)90667-X; CURTIS SE, 1987, J BACTERIOL, V169, P80, DOI 10.1128/jb.169.1.80-86.1987; Ferguson SA, 2006, J BACTERIOL, V188, P5045, DOI 10.1128/JB.00128-06; Fukaya F, 2009, APPL ENVIRON MICROB, V75, P6626, DOI 10.1128/AEM.01387-09; KAIM G, 1992, EUR J BIOCHEM, V207, P463, DOI 10.1111/j.1432-1033.1992.tb17072.x; LILL H, 1991, PLANT MOL BIOL, V17, P641, DOI 10.1007/BF00037050; Meier T, 2003, BBA-GENE STRUCT EXPR, V1625, P221, DOI 10.1016/S0167-4781(02)00625-5; MIKI J, 1988, FEBS LETT, V232, P221, DOI 10.1016/0014-5793(88)80421-6; MORIYAMA Y, 1991, J BIOL CHEM, V266, P22141; OMATA T, 1995, PLANT CELL PHYSIOL, V36, P207, DOI 10.1093/oxfordjournals.pcp.a078751; Rahlfs S, 1999, J BIOL CHEM, V274, P33999, DOI 10.1074/jbc.274.48.33999; Shono M, 1996, PLANT CELL PHYSIOL, V37, P385, DOI 10.1093/oxfordjournals.pcp.a028957; Vollmar M, 2009, J BIOL CHEM, V284, P18228, DOI 10.1074/jbc.M109.006916; von Ballmoos C, 2009, ANNU REV BIOCHEM, V78, P649, DOI 10.1146/annurev.biochem.78.081307.104803; Waditee R, 2004, J BIOL CHEM, V279, P4330, DOI 10.1074/jbc.M310282200; Waditee R, 2003, J BIOL CHEM, V278, P4932, DOI 10.1074/jbc.M210970200; Waditee R, 2002, P NATL ACAD SCI USA, V99, P4109, DOI 10.1073/pnas.052576899; Waditee R, 2001, J BIOL CHEM, V276, P36931, DOI 10.1074/jbc.M103650200; Waditee R, 2007, J BIOL CHEM, V282, P34185, DOI 10.1074/jbc.M704939200; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wutipraditkul N, 2005, APPL ENVIRON MICROB, V71, P4176, DOI 10.1128/AEM.71.8.4176-4184.2005; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2	25	28	31	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10169	10176		10.1074/jbc.M110.208892	http://dx.doi.org/10.1074/jbc.M110.208892			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21262962	hybrid, Green Published			2022-12-27	WOS:000288547000032
J	Leonhardt, RM; Vigneron, N; Rahner, C; Cresswell, P				Leonhardt, Ralf M.; Vigneron, Nathalie; Rahner, Christoph; Cresswell, Peter			Proprotein Convertases Process Pmel17 during Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI NETWORK; BASIC-AMINO-ACIDS; SEQUENCE REQUIREMENTS; MELANOSOME BIOGENESIS; ENDOPLASMIC-RETICULUM; PROTEOLYTIC CLEAVAGE; PROPEPTIDE CLEAVAGE; SUBSTRATE CLEAVAGE; GAMMA-SECRETASE; SPLICE VARIANT	Pmel17 is a melanocyte/melanoma-specific protein that traffics to melanosomes where it forms a fibrillar matrix on which melanin gets deposited. Before being cleaved into smaller fibrillogenic fragments the protein undergoes processing by proprotein convertases, a class of serine proteases that typically recognize the canonical motif RX(R/K)R down arrow. The current model of Pmel17 maturation states that this processing step occurs in melanosomes, but in light of recent reports this issue has become controversial. We therefore addressed this question by thoroughly assessing the processing kinetics of either wild-type Pmel17 or a secreted soluble Pmel17 derivative. Our results demonstrate clearly that processing of Pmel17 occurs during secretion and that it does not require entry of the protein into the endocytic system. Strikingly, processing proceeds even in the presence of the secretion inhibitor monensin, suggesting that Pmel17 is an exceptionally good substrate. In line with this, we find that newly synthesized surface Pmel17 is already quantitatively cleaved. Moreover, we demonstrate that Pmel17 function is independent of the sequence identity of its unconventional proprotein convertase-cleavage motif that lacks arginine in P4 position. The data alter the current view of Pmel17 maturation and suggest that the multistep processing of Pmel17 begins with an early cleavage during secretion that primes the protein for later functional processing.	[Leonhardt, Ralf M.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06519 USA; [Cresswell, Peter] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06519 USA; [Rahner, Christoph; Cresswell, Peter] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06519 USA; [Vigneron, Nathalie] Catholic Univ Louvain, Ludwig Inst Canc Res, Brussels Branch, B-1200 Brussels, Belgium; [Vigneron, Nathalie] Catholic Univ Louvain, Cellular Genet Unit, de Duve Inst, B-1200 Brussels, Belgium	Yale University; Howard Hughes Medical Institute; Yale University; Yale University; Ludwig Institute for Cancer Research; Universite Catholique Louvain; Universite Catholique Louvain	Leonhardt, RM (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 300 Cedar St,TAC S669-670, New Haven, CT 06519 USA.	Ralf.Leonhardt@yale.edu		Leonhardt, Ralf Max/0000-0001-6673-8217	National Institutes of Health [R37-AI23081]; Howard Hughes Medical Institute; Yale SPORE in Skin Cancer [5P50 CA121974]; Cancer Research Institute; European Union; Fonds National de la Recherche Scientific (F.N.R.S.), Belgium; NATIONAL CANCER INSTITUTE [P50CA121974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI023081] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Yale SPORE in Skin Cancer; Cancer Research Institute; European Union(European Commission); Fonds National de la Recherche Scientific (F.N.R.S.), Belgium(Fonds de la Recherche Scientifique - FNRS); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R37-AI23081, the Howard Hughes Medical Institute, and Yale SPORE in Skin Cancer Grant 5P50 CA121974 (to P.C.).; Supported by a Cancer Research Institute Fellowship. To whom correspondence should be addressed: Dept. of Immunobiology, 300 Cedar St., TAC S669/670, New Haven, CT 06519-1612. Tel.: 203-785-5042; Fax: 203-785-4461; E-mail: Ralf.Leonhardt@yale.edu.; Supported by a Marie Curie Outgoing International Fellowship (OIF) from the European Union and the Fonds National de la Recherche Scientific (F.N.R.S.), Belgium.	ADEMA GJ, 1994, J BIOL CHEM, V269, P20126; Anders L, 2006, MOL CELL BIOL, V26, P3917, DOI 10.1128/MCB.26.10.3917-3934.2006; Anderson ED, 1997, EMBO J, V16, P1508, DOI 10.1093/emboj/16.7.1508; Barton GM, 2002, P NATL ACAD SCI USA, V99, P14943, DOI 10.1073/pnas.242594499; Basque J, 2008, CAN J PHYSIOL PHARM, V86, P606, DOI 10.1139/y08-063; Bass J, 2000, P NATL ACAD SCI USA, V97, P11905, DOI 10.1073/pnas.97.22.11905; Bennett BD, 2000, J BIOL CHEM, V275, P37712, DOI 10.1074/jbc.M005339200; Berson JF, 2003, J CELL BIOL, V161, P521, DOI 10.1083/jcb.200302072; Berson JF, 2001, MOL BIOL CELL, V12, P3451, DOI 10.1091/mbc.12.11.3451; Carrithers MD, 2009, J BIOL CHEM, V284, P8114, DOI 10.1074/jbc.M801892200; Chiamenti AM, 1996, MELANOMA RES, V6, P291, DOI 10.1097/00008390-199608000-00003; CREEMERS JWM, 1993, FEBS LETT, V336, P65, DOI 10.1016/0014-5793(93)81610-C; de Cicco RL, 2007, MOL CARCINOGEN, V46, P654, DOI 10.1002/mc.20331; DeBie I, 1996, J CELL BIOL, V135, P1261, DOI 10.1083/jcb.135.5.1261; ESCLAMADO RM, 1986, AM J SURG, V152, P376, DOI 10.1016/0002-9610(86)90308-9; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; GARTEN W, 1994, BIOCHIMIE, V76, P217, DOI 10.1016/0300-9084(94)90149-X; GOLDFINE ID, 1987, ENDOCR REV, V8, P235, DOI 10.1210/edrv-8-3-235; Harper DC, 2008, J BIOL CHEM, V283, P2307, DOI 10.1074/jbc.M708007200; Hoashi T, 2006, J BIOL CHEM, V281, P21198, DOI 10.1074/jbc.M601643200; Hoashi T, 2010, FASEB J, V24, P916, DOI 10.1096/fj.09-140921; Hurbain I, 2008, P NATL ACAD SCI USA, V105, P19726, DOI 10.1073/pnas.0803488105; Jean F, 1998, P NATL ACAD SCI USA, V95, P7293, DOI 10.1073/pnas.95.13.7293; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kummer MP, 2009, J BIOL CHEM, V284, P2296, DOI 10.1074/jbc.M808904200; Lee ZH, 1996, J INVEST DERMATOL, V106, P605, DOI 10.1111/1523-1747.ep12345163; Leighton M, 2003, J BIOL CHEM, V278, P18478, DOI 10.1074/jbc.M213021200; Leonhardt RM, 2010, J BIOL CHEM, V285, P16166, DOI 10.1074/jbc.M109.097725; Leonhardt RM, 2010, J IMMUNOL, V184, P2985, DOI 10.4049/jimmunol.0900308; Leonhardt RM, 2005, J IMMUNOL, V175, P5104, DOI 10.4049/jimmunol.175.8.5104; Lopez-Fraga M, 2001, EMBO REP, V2, P945, DOI 10.1093/embo-reports/kve198; Lum L, 1998, J BIOL CHEM, V273, P26236, DOI 10.1074/jbc.273.40.26236; Marcinkiewicz M, 1996, ACTA NEUROBIOL EXP, V56, P287; MARK MR, 1992, J BIOL CHEM, V267, P26166; Mayer G, 2008, J BIOL CHEM, V283, P2373, DOI 10.1074/jbc.M708763200; McGlinchey RP, 2009, P NATL ACAD SCI USA, V106, P13731, DOI 10.1073/pnas.0906509106; MEYER TH, 1994, FEBS LETT, V351, P443, DOI 10.1016/0014-5793(94)00908-2; MOLLENHAUER HH, 1990, BIOCHIM BIOPHYS ACTA, V1031, P225, DOI 10.1016/0304-4157(90)90008-Z; MOLLOY SS, 1994, EMBO J, V13, P18, DOI 10.1002/j.1460-2075.1994.tb06231.x; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; Nichols SE, 2003, J INVEST DERMATOL, V121, P821, DOI 10.1046/j.1523-1747.2003.12474.x; ODA K, 1991, BIOCHEM BIOPH RES CO, V179, P1181, DOI 10.1016/0006-291X(91)91696-A; Plonka PM, 2009, EXP DERMATOL, V18, P799, DOI 10.1111/j.1600-0625.2009.00912.x; QUEVEDO WC, 1981, PIGMENT CELL 1981 PH, P177; Raposo G, 2002, TRAFFIC, V3, P237, DOI 10.1034/j.1600-0854.2002.030401.x; Raposo G, 2001, J CELL BIOL, V152, P809, DOI 10.1083/jcb.152.4.809; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; REHEMTULLA A, 1992, BLOOD, V79, P2349; Remacle AG, 2008, J BIOL CHEM, V283, P20897, DOI 10.1074/jbc.M803762200; Rousselet E, 2011, J BIOL CHEM, V286, P2728, DOI 10.1074/jbc.M110.192344; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; Sadler JE, 2009, J THROMB HAEMOST, V7, P24, DOI 10.1111/j.1538-7836.2009.03375.x; Salvas A, 2005, FEBS LETT, V579, P5621, DOI 10.1016/j.febslet.2005.09.029; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; SONG LX, 1995, J NEUROCHEM, V65, P444; Theos AC, 2006, DEV CELL, V10, P343, DOI 10.1016/j.devcel.2006.01.012; Theos AC, 2005, PIGM CELL RES, V18, P322, DOI 10.1111/j.1600-0749.2005.00269.x; Theos AC, 2006, MOL BIOL CELL, V17, P3598, DOI 10.1091/mbc.E06-01-0081; Valencia JC, 2006, J CELL SCI, V119, P1080, DOI 10.1242/jcs.02804; Valencia JC, 2007, J BIOL CHEM, V282, P11266, DOI 10.1074/jbc.M608449200; VEY M, 1992, VIROLOGY, V188, P408, DOI 10.1016/0042-6822(92)90775-K; VEY M, 1994, J CELL BIOL, V127, P1829, DOI 10.1083/jcb.127.6.1829; Vigneron N, 2005, TISSUE ANTIGENS, V65, P156, DOI 10.1111/j.1399-0039.2005.00365.x; WATANABE T, 1993, FEBS LETT, V320, P215, DOI 10.1016/0014-5793(93)80589-M; Watt B, 2009, J BIOL CHEM, V284, P35543, DOI 10.1074/jbc.M109.047449; Wouters S, 1998, BIOCHEM J, V336, P311, DOI 10.1042/bj3360311; Yamaguchi Y, 2009, BIOFACTORS, V35, P193, DOI 10.1002/biof.29; Yasumoto K, 2004, J BIOL CHEM, V279, P28330, DOI 10.1074/jbc.M401269200; Zhu YJ, 2010, J BIOL CHEM, V285, P38283, DOI 10.1074/jbc.M110.170530	71	36	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9321	9337		10.1074/jbc.M110.168088	http://dx.doi.org/10.1074/jbc.M110.168088			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21247888	Green Published, hybrid			2022-12-27	WOS:000288247700062
J	Ebbes, M; Bleymuller, WM; Cernescu, M; Nolker, R; Brutschy, B; Niemann, HH				Ebbes, Maria; Bleymueller, Willem M.; Cernescu, Mihaela; Noelker, Rolf; Brutschy, Bernd; Niemann, Hartmut H.			Fold and Function of the InlB B-repeat	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INVASION PROTEIN-INLB; RECEPTOR TYROSINE KINASE; LEUCINE-RICH REPEAT; INTERNALIN MULTIGENE FAMILY; LASER MASS-SPECTROMETRY; LISTERIA-MONOCYTOGENES; MET RECEPTOR; SECONDARY-STRUCTURE; SURFACE PROTEIN; GW DOMAINS	Host cell invasion by the facultative intracellular pathogen Listeria monocytogenes requires the invasion protein InlB in many cell types. InlB consists of an N-terminal internalin domain that binds the host cell receptor tyrosine kinase Met and C-terminal GW domains that bind to glycosaminoglycans (GAGs). Met binding and activation is required for host cell invasion, while the interaction between GW domains and GAGs enhances this effect. Soluble InlB elicits the same cellular phenotypes as the natural Met ligand hepatocyte growth factor/scatter factor (HGF/SF), e. g. cell scatter. So far, little is known about the central part of InlB, the B-repeat. Here we present a structural and functional characterization of the InlB B-repeat. The crystal structure reveals a variation of the beta-grasp fold that is most similar to small ubiquitin-like modifiers (SUMOs). However, structural similarity also suggests a potential evolutionary relation to bacterial mucin-binding proteins. The B-repeat defines the prototype structure of a hitherto uncharacterized domain present in over a thousand bacterial proteins. Generally, this domain probably acts as a spacer or a receptor-binding domain in extracellular multi-domain proteins. In cellular assays the B-repeat acts synergistically with the internalin domain conferring to it the ability to stimulate cell motility. Thus, the B-repeat probably binds a further host cell receptor and thereby enhances signaling downstream of Met.	Univ Bielefeld, Dept Chem, D-33615 Bielefeld, Germany; [Cernescu, Mihaela; Brutschy, Bernd] Goethe Univ Frankfurt, Inst Phys & Theoret Chem, D-60438 Frankfurt, Germany	University of Bielefeld; Goethe University Frankfurt	Niemann, HH (corresponding author), Univ Bielefeld, Dept Chem, Postfach 10 01 31, D-33501 Bielefeld, Germany.	Hartmut.Niemann@uni-bielefeld.de	Niemann, Hartmut/F-7947-2011; Cernescu, Mihaela/G-8956-2012	Niemann, Hartmut/0000-0002-8582-0360; 	Deutsche Forschungsgemeinschaft [1150]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Priority Program 1150 "Signal Pathways to the Cytoskeleton and Bacterial Pathogenesis" of the Deutsche Forschungsgemeinschaft.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Allerberger F, 2010, CLIN MICROBIOL INFEC, V16, P16, DOI 10.1111/j.1469-0691.2009.03109.x; Banerjee M, 2004, MOL MICROBIOL, V52, P257, DOI 10.1111/j.1365-2958.2003.03968.x; Bierne H, 2007, MICROBES INFECT, V9, P1156, DOI 10.1016/j.micinf.2007.05.003; Bierne H, 2002, J CELL SCI, V115, P3357; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Braun L, 1999, MOL MICROBIOL, V34, P10, DOI 10.1046/j.1365-2958.1999.01560.x; Braun L, 1997, MOL MICROBIOL, V25, P285, DOI 10.1046/j.1365-2958.1997.4621825.x; Burroughs AM, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-4; Copp J, 2003, J BIOL CHEM, V278, P7783, DOI 10.1074/jbc.M211666200; Cossart P, 2008, MICROBES INFECT, V10, P1041, DOI 10.1016/j.micinf.2008.07.043; DELANO WL, 2002, WORLD WIDE WEB; DERRICK JP, 1992, NATURE, V359, P752, DOI 10.1038/359752a0; Dortet L, 2010, MICROBES INFECT, V12, P919, DOI 10.1016/j.micinf.2010.07.009; DRAMSI S, 1995, MOL MICROBIOL, V16, P251, DOI 10.1111/j.1365-2958.1995.tb02297.x; Dramsi S, 1997, INFECT IMMUN, V65, P1615, DOI 10.1128/IAI.65.5.1615-1625.1997; Eddy SR, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000069; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferraris DM, 2010, J MOL BIOL, V395, P522, DOI 10.1016/j.jmb.2009.10.074; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; GAILLARD JL, 1991, CELL, V65, P1127, DOI 10.1016/0092-8674(91)90009-N; Gilmour MW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-120; Graille M, 2001, STRUCTURE, V9, P679, DOI 10.1016/S0969-2126(01)00630-X; Guerrero SA, 2001, APPL MICROBIOL BIOT, V56, P718, DOI 10.1007/s002530100690; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jonquieres R, 2001, MOL MICROBIOL, V42, P955, DOI 10.1046/j.1365-2958.2001.02704.x; Jonquieres R, 1999, MOL MICROBIOL, V34, P902, DOI 10.1046/j.1365-2958.1999.01652.x; Jung C, 2009, MOL MICROBIOL, V72, P1196, DOI 10.1111/j.1365-2958.2009.06716.x; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; KRISSINEL E, 2005, COMPLIFE; Levy ED, 2008, NATURE, V453, P1262, DOI 10.1038/nature06942; Linden SK, 2008, ARCH MICROBIOL, V190, P101, DOI 10.1007/s00203-008-0358-6; Machner MP, 2003, MOL MICROBIOL, V48, P1525, DOI 10.1046/j.1365-2958.2003.03532.x; MacKenzie DA, 2009, J BIOL CHEM, V284, P32444, DOI 10.1074/jbc.M109.040907; Marino M, 2002, EMBO J, V21, P5623, DOI 10.1093/emboj/cdf558; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Morgner N, 2006, AUST J CHEM, V59, P109, DOI 10.1071/CH05285; Morgner N, 2008, BBA-BIOENERGETICS, V1777, P1384, DOI 10.1016/j.bbabio.2008.08.001; Morgner N, 2007, J AM SOC MASS SPECTR, V18, P1429, DOI 10.1016/j.jasms.2007.04.013; Mostowy S, 2009, CELL HOST MICROBE, V5, P510, DOI 10.1016/j.chom.2009.06.002; Niemann HH, 2008, J MOL BIOL, V377, P489, DOI 10.1016/j.jmb.2008.01.027; Niemann HH, 2007, CELL, V130, P235, DOI 10.1016/j.cell.2007.05.037; Niemann HH, 2011, EUR J CELL BIOL, V90, P972, DOI 10.1016/j.ejcb.2010.11.014; ORENGO CA, 1994, NATURE, V372, P631, DOI 10.1038/372631a0; Ortiz AR, 2002, PROTEIN SCI, V11, P2606, DOI 10.1110/ps.0215902; Overington J.P., 1992, CURR OPIN STRUC BIOL, V2, P394, DOI 10.1016/0959-440X(92)90231-U; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Perica T, 2010, CURR OPIN STRUC BIOL, V20, P367, DOI 10.1016/j.sbi.2010.03.007; Schubert WD, 2001, J MOL BIOL, V312, P783, DOI 10.1006/jmbi.2001.4989; Schulz GE, 2010, J MOL BIOL, V395, P834, DOI 10.1016/j.jmb.2009.10.044; Schuster-Bockler B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-7; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Shen Y, 2000, CELL, V103, P501, DOI 10.1016/S0092-8674(00)00141-0; Soding J, 2006, NUCLEIC ACIDS RES, V34, pW137, DOI 10.1093/nar/gkl130; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yee A, 2002, P NATL ACAD SCI USA, V99, P1825, DOI 10.1073/pnas.042684599	62	29	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15496	15506		10.1074/jbc.M110.189951	http://dx.doi.org/10.1074/jbc.M110.189951			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21345802	Green Published, hybrid			2022-12-27	WOS:000289788300077
J	Yin, X; Johns, SC; Lawrence, R; Xu, D; Reddi, K; Bishop, JR; Varner, JA; Fuster, MM				Yin, Xin; Johns, Scott C.; Lawrence, Roger; Xu, Ding; Reddi, Krisanavane; Bishop, Joseph R.; Varner, Judith A.; Fuster, Mark M.			Lymphatic Endothelial Heparan Sulfate Deficiency Results in Altered Growth Responses to Vascular Endothelial Growth Factor-C (VEGF-C)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR LYMPHANGIOGENESIS; N-SULFOTRANSFERASE; BASEMENT-MEMBRANE; TRANSGENIC MICE; ANGIOGENESIS; BINDING; RECEPTOR; DISEASE; CELLS; ANGIOPOIETIN-1	Growth and remodeling of lymphatic vasculature occur during development and during various pathologic states. A major stimulus for this process is the unique lymphatic vascular endothelial growth factor-C (VEGF-C). Other endothelial growth factors, such as fibroblast growth factor-2 (FGF-2) or VEGF-A, may also contribute. Heparan sulfate is a linear sulfated polysaccharide that facilitates binding and action of some vascular growth factors such as FGF-2 and VEGF-A. However, a direct role for heparan sulfate in lymphatic endothelial growth and sprouting responses, including those mediated by VEGF-C, remains to be examined. We demonstrate that VEGF-C binds to heparan sulfate purified from primary lymphatic endothelia, and activation of lymphatic endothelial Erk1/2 in response to VEGF-C is reduced by interference with heparin or pretreatment of cells with heparinase, which destroys heparan sulfate. Such treatment also inhibited phosphorylation of the major VEGF-C receptor VEGFR-3 upon VEGF-C stimulation. Silencing lymphatic heparan sulfate chain biosynthesis inhibited VEGF-C-mediated Erk1/2 activation and abrogated VEGFR-3 receptor-dependent binding of VEGF-C to the lymphatic endothelial surface. These findings prompted targeting of lymphatic N-deacetylase/N-sulfotransferase-1 (Ndst1), a major sulfate-modifying heparan sulfate biosynthetic enzyme. VEGF-C-mediated Erk1/2 phosphorylation was inhibited in Ndst1-silenced lymphatic endothelia, and scratch-assay responses to VEGF-C and FGF-2 were reduced in Ndst1-deficient cells. In addition, lymphatic Ndst1 deficiency abrogated cell-based growth and proliferation responses to VEGF-C. In other studies, lymphatic endothelia cultured ex vivo from Ndst1 gene-targeted mice demonstrated reduced VEGF-C-and FGF-2-mediated sprouting in collagen matrix. Lymphatic heparan sulfate may represent a novel molecular target for therapeutic intervention.	[Yin, Xin; Johns, Scott C.; Fuster, Mark M.] Vet Affairs San Diego Healthcare Syst, Med Serv, San Diego, CA 92161 USA; [Yin, Xin; Johns, Scott C.; Fuster, Mark M.] Vet Affairs San Diego Healthcare Syst, Res Serv, San Diego, CA 92161 USA; [Yin, Xin; Johns, Scott C.; Reddi, Krisanavane; Fuster, Mark M.] Univ Calif San Diego, Dept Med, Div Pulm & Crit Care, La Jolla, CA 92037 USA; [Lawrence, Roger; Xu, Ding; Bishop, Joseph R.] Univ Calif San Diego, Dept Cellular & Mol Med, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; [Varner, Judith A.; Fuster, Mark M.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Fuster, MM (corresponding author), Univ Calif San Diego, Dept Med, 3350 La Jolla Village Dr, San Diego, CA 92161 USA.	mfuster@ucsd.edu	Xu, Ding/B-2493-2009	Xu, Ding/0000-0001-9380-2712; Varner, Judith/0000-0002-9251-0600	Veterans Affairs; American Cancer Society [RSG-08-153-01-CSM]; Uniting Against Lung Cancer Foundation; National Institutes of Health [P01-HL57345-11]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057345] Funding Source: NIH RePORTER	Veterans Affairs(US Department of Veterans Affairs); American Cancer Society(American Cancer Society); Uniting Against Lung Cancer Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Veterans Affairs Career Development Program, American Cancer Society Grant RSG-08-153-01-CSM, and Uniting Against Lung Cancer Foundation (to M. M. F.). This work was also supported in part by National Institutes of Health Grant P01-HL57345-11 (to Dr. Jeffrey D. Esko).	Aikawa J, 2001, J BIOL CHEM, V276, P5876, DOI 10.1074/jbc.M009606200; Albuquerque RJC, 2009, NAT MED, V15, P1023, DOI 10.1038/nm.2018; Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; BAME KJ, 1989, J BIOL CHEM, V264, P8059; Chang LK, 2004, P NATL ACAD SCI USA, V101, P11658, DOI 10.1073/pnas.0404272101; Cohen-Kaplan V, 2008, INT J CANCER, V123, P2566, DOI 10.1002/ijc.23898; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; FOLKMAN J, 1988, AM J PATHOL, V130, P393; Fuster MM, 2007, J CELL BIOL, V177, P539, DOI 10.1083/jcb.200610086; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Iozzo RV, 2009, MOL CELLS, V27, P503, DOI 10.1007/s10059-009-0069-0; Jakobsson L, 2006, DEV CELL, V10, P625, DOI 10.1016/j.devcel.2006.03.009; Joukov V, 1997, EMBO J, V16, P3898, DOI 10.1093/emboj/16.13.3898; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Kreuger J, 2006, ARTERIOSCL THROM VAS, V26, P1073, DOI 10.1161/01.ATV.0000217610.58032.b7; Kreuger J, 2003, METHOD ENZYMOL, V363, P327; Lawrence R, 2004, GLYCOBIOLOGY, V14, P467, DOI 10.1093/glycob/cwh057; Lawrence R, 2008, J BIOL CHEM, V283, P33674, DOI 10.1074/jbc.M804288200; Liersch R, 2007, THROMB HAEMOSTASIS, V98, P304, DOI 10.1160/TH07-04-0238; Longley RL, 1999, J CELL SCI, V112, P3421; Makinen T, 2001, EMBO J, V20, P4762, DOI 10.1093/emboj/20.17.4762; Mancardi S, 1999, EXP CELL RES, V246, P368, DOI 10.1006/excr.1998.4270; Morisada T, 2005, BLOOD, V105, P4649, DOI 10.1182/blood-2004-08-3382; Nagy JA, 2002, J EXP MED, V196, P1497, DOI 10.1084/jem.20021244; Ono K, 1999, GLYCOBIOLOGY, V9, P705, DOI 10.1093/glycob/9.7.705; Shin WS, 2008, ANN NY ACAD SCI, V1131, P50, DOI 10.1196/annals.1413.005; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Stacker SA, 1999, J BIOL CHEM, V274, P32127, DOI 10.1074/jbc.274.45.32127; Veikkola T, 2001, EMBO J, V20, P1223, DOI 10.1093/emboj/20.6.1223; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; WATSON JV, 1987, CYTOMETRY, V8, P1, DOI 10.1002/cyto.990080101; Wissmann C, 2006, CLIN CANCER RES, V12, P6865, DOI 10.1158/1078-0432.CCR-06-1800; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W	33	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14952	14962		10.1074/jbc.M110.206664	http://dx.doi.org/10.1074/jbc.M110.206664			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21343305	Green Published, hybrid			2022-12-27	WOS:000289788300025
J	Hall, BS; Bot, C; Wilkinson, SR				Hall, Belinda S.; Bot, Christopher; Wilkinson, Shane R.			Nifurtimox Activation by Trypanosomal Type I Nitroreductases Generates Cytotoxic Nitrile Metabolites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; TRYPANOTHIONE REDUCTASE; NITROHETEROCYCLIC DRUGS; NITROAROMATIC COMPOUNDS; CATALYTIC PROPERTIES; CHAGAS-DISEASE; FREE-RADICALS; CRUZI; RESISTANCE; BENZNIDAZOLE	The prodrug nifurtimox has been used for more than 40 years to treat Chagas disease and forms part of a recently approved combinational therapy that targets West African trypanosomiasis. Despite this, its mode of action is poorly understood, Detection of reactive oxygen and nitrogen intermediates in nifurtimox-treated extracts led to the proposal that this drug induces oxidative stress in the target cell. Here, we outline an alternative mechanism involving reductive activation by a eukaryotic type I nitroreductase. Several enzymes proposed to metabolize nifurtimox, including prostaglandin F2 alpha synthase and cytochrome P450 reductase, were overexpressed in bloodstream-form Trypanosoma brucei. Only cells with elevated levels of the nitroreductase displayed altered susceptibility to this nitrofuran, implying a key role in drug action. Reduction of nifurtimox by this enzyme was shown to be insensitive to oxygen and yields a product characterized by LC/MS as an unsaturated open-chain nitrite. This metabolite was shown to inhibit both parasite and mammalian cell growth at equivalent concentrations, in marked contrast to the parental prodrug. These experiments indicate that the basis for the selectivity of nifurtimox against T. brucei lies in the expression of a parasite-encoded type I nitroreductase.	[Hall, Belinda S.; Bot, Christopher; Wilkinson, Shane R.] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England	University of London; Queen Mary University London	Wilkinson, SR (corresponding author), Mile End Rd, London E1 4NS, England.	s.r.wilkinson@qmul.ac.uk	Hall, Belinda/AGU-6214-2022; Bot, Christopher/E-9811-2011	Bot, Christopher/0000-0001-6225-4047; Hall, Belinda/0000-0002-3753-1978	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust.	Alsford S, 2005, MOL BIOCHEM PARASIT, V144, P142, DOI 10.1016/j.molbiopara.2005.08.009; Baker N, 2011, MOL BIOCHEM PARASIT, V176, P55, DOI 10.1016/j.molbiopara.2010.11.010; BECKETT AH, 1959, J MED PHARMACEUT CH, V1, P155, DOI 10.1021/jm50003a003; Bern C, 2009, CLIN INFECT DIS, V49, pE52, DOI 10.1086/605091; Blumenstiel K, 1999, BIOCHEM PHARMACOL, V58, P1791, DOI 10.1016/S0006-2952(99)00264-6; Boiani M, 2010, BIOCHEM PHARMACOL, V79, P1736, DOI 10.1016/j.bcp.2010.02.009; BOLAND MP, 1991, BIOCHEM PHARMACOL, V41, P867, DOI 10.1016/0006-2952(91)90190-G; Bot C, 2010, ANTIMICROB AGENTS CH, V54, P4246, DOI 10.1128/AAC.00800-10; Brun R, 2010, LANCET, V375, P148, DOI 10.1016/S0140-6736(09)60829-1; Cenas N, 2006, J BIOL CHEM, V281, P5593, DOI 10.1074/jbc.M511972200; DOCAMPO R, 1979, ARCH BIOCHEM BIOPHYS, V197, P317, DOI 10.1016/0003-9861(79)90251-0; DOCAMPO R, 1981, J BIOL CHEM, V256, P930; FILALIMOUHIM A, 1991, J CHIM PHYS PCB, V88, P937, DOI 10.1051/jcp/1991880937; Gascon J, 2010, ACTA TROP, V115, P22, DOI 10.1016/j.actatropica.2009.07.019; GAUTRET P, 2009, EURO SURVEILL, V14; GAVIN JJ, 1966, ARCH BIOCHEM BIOPHYS, V113, P399, DOI 10.1016/0003-9861(66)90205-0; GOIJMAN SG, 1985, BIOCHEM PHARMACOL, V34, P1331, DOI 10.1016/0006-2952(85)90514-3; GOIJMAN SG, 1985, BIOCHEM PHARMACOL, V34, P1457, DOI 10.1016/0006-2952(85)90684-7; Hall BS, 2010, ANTIMICROB AGENTS CH, V54, P1193, DOI 10.1128/AAC.01213-09; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Jaiswal AK, 2000, FREE RADICAL BIO MED, V29, P254, DOI 10.1016/S0891-5849(00)00306-3; JOCKERSSCHERUBL MC, 1989, EUR J BIOCHEM, V180, P267, DOI 10.1111/j.1432-1033.1989.tb14643.x; KELLY JM, 1993, EUR J BIOCHEM, V218, P29, DOI 10.1111/j.1432-1033.1993.tb18348.x; Kubata BK, 2002, J EXP MED, V196, P1241, DOI 10.1084/jem.20020885; MASON RP, 1975, BIOCHEM BIOPH RES CO, V67, P1267, DOI 10.1016/0006-291X(75)90163-1; MASON RP, 1975, BIOCHEMISTRY-US, V14, P1626, DOI 10.1021/bi00679a013; Maya JD, 1997, MOL BIOCHEM PARASIT, V86, P101, DOI 10.1016/S0166-6851(97)90010-4; MCCALLA DR, 1978, J BACTERIOL, V133, P10, DOI 10.1128/JB.133.1.10-16.1978; MCCALLA DR, 1971, CANCER RES, V31, P2184; MORENO SNJ, 1984, J BIOL CHEM, V259, P6298; Nivinskas H, 2001, ARCH BIOCHEM BIOPHYS, V385, P170, DOI 10.1006/abbi.2000.2127; Olry A, 2007, PLANT J, V51, P331, DOI 10.1111/j.1365-313X.2007.03140.x; PETERSON FJ, 1979, J BIOL CHEM, V254, P4009; Portal P, 2008, MOL BIOCHEM PARASIT, V160, P42, DOI 10.1016/j.molbiopara.2008.03.007; Prathalingham SR, 2007, ANTIMICROB AGENTS CH, V51, P755, DOI 10.1128/AAC.01360-06; Priotto G, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010039; Priotto G, 2009, LANCET, V374, P56, DOI 10.1016/S0140-6736(09)61117-X; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; SASTRY SS, 1984, MOL GEN GENET, V196, P379, DOI 10.1007/BF00328076; Schoneck R, 1997, EUR J BIOCHEM, V243, P739, DOI 10.1111/j.1432-1033.1997.00739.x; Sholler GLS, 2006, J PEDIAT HEMATOL ONC, V28, P693, DOI 10.1097/01.mph.0000212994.56812.f2; Sholler GLS, 2009, J PEDIAT HEMATOL ONC, V31, P187, DOI 10.1097/MPH.0b013e3181984d91; STREETER AJ, 1988, PHARMACEUT RES, V5, P434, DOI 10.1023/A:1015988401601; SWAMINATHAN S, 1984, CANCER RES, V44, P2331; SWAMINATHAN S, 1982, CANCER RES, V42, P4479; Viode C, 1999, BIOCHEM PHARMACOL, V57, P549, DOI 10.1016/S0006-2952(98)00324-4; Whiteway J, 1998, J BACTERIOL, V180, P5529, DOI 10.1128/JB.180.21.5529-5539.1998; Wilkinson SR, 2008, P NATL ACAD SCI USA, V105, P5022, DOI 10.1073/pnas.0711014105; Wilkinson SR, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001252; Wu KB, 1997, ARCH BIOCHEM BIOPHYS, V347, P221, DOI 10.1006/abbi.1997.0344; XU WY, 1994, ANAL CHEM, V66, P4133, DOI 10.1021/ac00095a004	51	173	176	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13088	13095		10.1074/jbc.M111.230847	http://dx.doi.org/10.1074/jbc.M111.230847			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21345801	Green Published, hybrid			2022-12-27	WOS:000289282200029
J	Mandal, P; Pratt, BT; Barnes, M; McMullen, MR; Nagy, LE				Mandal, Palash; Pratt, Brian T.; Barnes, Mark; McMullen, Megan R.; Nagy, Laura E.			Molecular Mechanism for Adiponectin-dependent M2 Macrophage Polarization LINK BETWEEN THE METABOLIC AND INNATE IMMUNE ACTIVITY OF FULL-LENGTH ADIPONECTIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALCOHOLIC LIVER-DISEASE; RAT KUPFFER CELLS; FATTY LIVER; ALTERNATIVE ACTIVATION; OXIDATIVE STRESS; TERM TREATMENT; TNF-ALPHA; ETHANOL; INJURY; PROGRESSION	The anti-inflammatory effects of globular adiponectin (gAcrp) are mediated by IL-10/heme oxygenase 1 (HO-1)-dependent pathways. Although full-length (flAcrp) adiponectin also suppresses LPS-induced pro-inflammatory signaling, its signaling mechanisms are not yet understood. The aim of this study was to examine the differential mechanisms by which gAcrp and flAcrp suppress pro-inflammatory signaling in macrophages. Chronic ethanol feeding increased LPS-stimulated TNF-alpha expression by Kupffer cells, associated with a shift to an M1 macrophage polarization. Both gAcrp and flAcrp suppressed TNF-alpha expression in Kupffer cells; however, only the effect of gAcrp was dependent on IL-10. Similarly, inhibition of HO-1 activity or siRNA knockdown of HO-1 in RAW264.7 macrophages only partially attenuated the suppressive effects of flAcrp on MyD88-dependent and -independent cytokine signatures. Instead, flAcrp, acting via the adiponectin R2 receptor, potently shifted the polarization of Kupffer cells and RAW264.7 macrophages to an M2 phenotype. gAcrp, acting via the adiponectin R1 receptor, was much less effective at eliciting an M2 pattern of gene expression. M2 polarization was also partially dependent on AMP-activated kinase. flAcrp polarized RAW264.7 macrophages to an M2 phenotype in an IL-4/STAT6-dependent mechanism. flAcrp also increased the expression of genes involved in oxidative phosphorylation in RAW264.7 macrophages, similar to the effect of flAcrp on hepatocytes. In summary, these data demonstrate that gAcrp and flAcrp utilize differential signaling strategies to decrease the sensitivity of macrophages to activation by TLR4 ligands, with flAcrp utilizing an IL-4/STAT6-dependent mechanism to shift macrophage polarization to the M2/anti-inflammatory phenotype.	[Mandal, Palash; Pratt, Brian T.; McMullen, Megan R.; Nagy, Laura E.] Cleveland Clin, Dept Pathobiol, Cleveland, OH 44195 USA; [Nagy, Laura E.] Cleveland Clin, Dept Gastroenterol, Cleveland, OH 44195 USA; [Barnes, Mark; Nagy, Laura E.] Case Western Reserve Univ, Dept Mol Med, Cleveland, OH 44120 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University	Mandal, P (corresponding author), Cleveland Clin Fdn, Lerner Res Inst NE 40, 9500 Euclid Ave, Cleveland, OH 44195 USA.	len2@case.edu	MANDAL, PALASH/I-5238-2019	MANDAL, PALASH/0000-0001-6612-3773	National Institutes of Health [RO1AA011975, R37AA011876]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA011876, R01AA011975] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1AA011975 and R37AA011876 (to L. E. N.).	Balmer ML, 2010, CLIN SCI, V119, P431, DOI 10.1042/CS20100008; Berg AH, 2002, TRENDS ENDOCRIN MET, V13, P84, DOI 10.1016/S1043-2760(01)00524-0; Chaitidis P, 2005, CYTOKINE, V30, P366, DOI 10.1016/j.cyto.2005.02.004; Cohen JI, 2010, GASTROENTEROLOGY, V139, P664, DOI 10.1053/j.gastro.2010.04.041; Folco EJ, 2009, J BIOL CHEM, V284, P25569, DOI 10.1074/jbc.M109.019786; Fukushima J, 2009, HEPATOL RES, V39, P724, DOI 10.1111/j.1872-034X.2009.00509.x; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Hritz I, 2008, HEPATOLOGY, V48, P1224, DOI 10.1002/hep.22470; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Lovren F, 2010, AM J PHYSIOL-HEART C, V299, pH656, DOI 10.1152/ajpheart.00115.2010; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Mandal P, 2010, J IMMUNOL, V185, P4928, DOI 10.4049/jimmunol.1002060; Mandal P, 2010, HEPATOLOGY, V51, P1420, DOI 10.1002/hep.23427; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; McVicker BL, 2007, WORLD J GASTROENTERO, V13, P4960, DOI 10.3748/wjg.v13.i37.4960; Nagy LE, 2003, EXP BIOL MED, V228, P882, DOI 10.1177/153537020322800803; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Ohashi K, 2010, J BIOL CHEM, V285, P6153, DOI 10.1074/jbc.M109.088708; Okamoto Y, 2008, CIRC RES, V102, P218, DOI 10.1161/CIRCRESAHA.107.164988; Pang MY, 2009, J HEPATOL, V50, P1192, DOI 10.1016/j.jhep.2009.01.021; Park PH, 2007, J BIOL CHEM, V282, P21695, DOI 10.1074/jbc.M701419200; Pouliot P, 2005, CLIN EXP ALLERGY, V35, P804, DOI 10.1111/j.1365-2222.2005.02246.x; Rao R, 2009, HEPATOLOGY, V50, P638, DOI 10.1002/hep.23009; Rogers CQ, 2008, IUBMB LIFE, V60, P790, DOI 10.1002/iub.124; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Schaffaler A, 2010, TRENDS IMMUNOL, V31, P228, DOI 10.1016/j.it.2010.03.001; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Shen Z, 2010, AM J PHYSIOL-GASTR L, V298, pG364, DOI 10.1152/ajpgi.00456.2009; Steinberg GR, 2009, FRONT BIOSCI-LANDMRK, V14, P1902, DOI 10.2741/3350; Stout RD, 2004, J LEUKOCYTE BIOL, V76, P509, DOI 10.1189/jlb.0504272; Thakur V, 2006, AM J PHYSIOL-GASTR L, V290, pG998, DOI 10.1152/ajpgi.00553.2005; Thurman RG, 1998, AM J PHYSIOL-GASTR L, V275, pG605, DOI 10.1152/ajpgi.1998.275.4.G605; Tilg H, 2000, NEW ENGL J MED, V343, P1467, DOI 10.1056/NEJM200011163432007; Vidali M, 2008, TRENDS MOL MED, V14, P63, DOI 10.1016/j.molmed.2007.12.005; Waki H, 2005, ENDOCRINOLOGY, V146, P790, DOI 10.1210/en.2004-1096; Wulster-Radcliffe MC, 2004, BIOCHEM BIOPH RES CO, V316, P924, DOI 10.1016/j.bbrc.2004.02.130; Xu AM, 2003, J CLIN INVEST, V112, P91, DOI 10.1172/JCI200317797; Yamaguchi N, 2005, FEBS LETT, V579, P6821, DOI 10.1016/j.febslet.2005.11.019; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yokota T, 2000, BLOOD, V96, P1723, DOI 10.1182/blood.V96.5.1723; Zhao XJ, 2008, J IMMUNOL, V181, P3049, DOI 10.4049/jimmunol.181.5.3049	44	183	195	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13460	13469		10.1074/jbc.M110.204644	http://dx.doi.org/10.1074/jbc.M110.204644			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21357416	Green Published, hybrid			2022-12-27	WOS:000289282200066
J	Nagamatsu, G; Kosaka, T; Kawasumi, M; Kinoshita, T; Takubo, K; Akiyama, H; Sudo, T; Kobayashi, T; Oya, M; Suda, T				Nagamatsu, Go; Kosaka, Takeo; Kawasumi, Miyuri; Kinoshita, Taisuke; Takubo, Keiyo; Akiyama, Hideo; Sudo, Tetsuo; Kobayashi, Takashi; Oya, Mototsugu; Suda, Toshio			A Germ Cell-specific Gene, Prmt5, Works in Somatic Cell Reprogramming	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLURIPOTENT STEM-CELLS; ARGININE METHYLATION; MOUSE; GENERATION; INDUCTION; HISTONE; EXPRESSION; DYNAMICS; LINEAGE; PRDM14	Germ cells possess the unique ability to acquire totipotency during development in vivo as well as give rise to pluripotent stem cells under the appropriate conditions in vitro. Recent studies in which somatic cells were experimentally converted into pluripotent stem cells revealed that genes expressed in primordial germ cells (PGCs), such as Oct3/4, Sox2, and Lin28, are involved in this reprogramming. These findings suggest that PGCs may be useful for identifying factors that successfully and efficiently reprogram somatic cells into toti- and/or pluripotent stem cells. Here, we show that Blimp-1, Prdm14, and Prmt5, each of which is crucial for PGC development, have the potential to reprogram somatic cells into pluripotent stem cells. Among them, Prmt5 exhibited remarkable reprogramming of mouse embryonic fibroblasts into which Prmt5, Klf4, and Oct3/4 were introduced. The resulting cells exhibited pluripotent gene expression, teratoma formation, and germline transmission in chimeric mice, all of which were indistinguishable from those induced with embryonic stem cells. These data indicate that some of the factors that play essential roles in germ cell development are also active in somatic cell reprogramming.	[Nagamatsu, Go] Keio Univ, Sch Med, Dept Cell Differentiat, Sakaguchi Lab,Shinjuku Ku, Tokyo 1608582, Japan; [Kosaka, Takeo; Oya, Mototsugu] Keio Univ, Sch Med, Dept Urol, Tokyo 1608582, Japan; [Kawasumi, Miyuri; Kobayashi, Takashi] Keio Univ, Sch Med, Ctr Integrated Med Res, Tokyo 1608582, Japan; [Nagamatsu, Go] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama 3320012, Japan; [Akiyama, Hideo; Sudo, Tetsuo] Toray New Frontiers Res Labs, Kanagawa 2488555, Japan	Keio University; Keio University; Keio University; Japan Science & Technology Agency (JST)	Nagamatsu, G (corresponding author), Keio Univ, Sch Med, Dept Cell Differentiat, Sakaguchi Lab,Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan.	gonag@sc.itc.keio.ac.jp; sudato@sc.itc.keio.ac.jp	Oya, Mototsugu/K-8592-2013; Suda, Toshio/H-6761-2013; Takubo, Keiyo/AAX-5546-2020	Suda, Toshio/0000-0001-7540-1771; Takubo, Keiyo/0000-0002-1736-7592	Japan Science and Technology Agency; Project for Realization of Regenerative Medicine; MEXT; Keio University; PREST	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Project for Realization of Regenerative Medicine(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Keio University; PREST	This work was supported by PREST of the Japan Science and Technology Agency and Grant-in-Aid for Young Scientists (B) and a Grant-in-aid for Scientific Research (KAKENHI) on Innovative Areas, "Regulatory Mechanism of Gamate Stem Cells." This work was also supported in part by a grant from the Project for Realization of Regenerative Medicine, and support for the core institutes for iPS cell research was provided by MEXT, a Grant-in-aid for the Global Century COE Program from MEXT to Keio University, and the Keio University Medical Science Fund.	Ancelin K, 2006, NAT CELL BIOL, V8, P623, DOI 10.1038/ncb1413; Durcova-Hills G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003531; Fujino RS, 2006, MOL ENDOCRINOL, V20, P904, DOI 10.1210/me.2005-0423; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Horikawa K, 2006, IMMUNOLOGY, V118, P497, DOI 10.1111/j.1365-2567.2006.02382.x; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Jansson M, 2008, NAT CELL BIOL, V10, P1431, DOI 10.1038/ncb1802; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Lacroix M, 2008, EMBO REP, V9, P452, DOI 10.1038/embor.2008.45; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mise N, 2008, GENES CELLS, V13, P863, DOI 10.1111/j.1365-2443.2008.01211.x; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pal S, 2007, J CELL PHYSIOL, V213, P306, DOI 10.1002/jcp.21180; Saitou M, 2009, CURR OPIN GENET DEV, V19, P386, DOI 10.1016/j.gde.2009.06.003; Seki Y, 2007, DEVELOPMENT, V134, P2627, DOI 10.1242/dev.005611; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanaka SS, 2000, GENE DEV, V14, P841; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Tsuneyoshi N, 2008, BIOCHEM BIOPH RES CO, V367, P899, DOI 10.1016/j.bbrc.2007.12.189; West JA, 2009, NATURE, V460, P909, DOI 10.1038/nature08210; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; YUAN X, 2011, STEM CELLS IN PRESS; Zhao Q, 2009, NAT STRUCT MOL BIOL, V16, P304, DOI 10.1038/nsmb.1568; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002	33	50	53	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10641	10648		10.1074/jbc.M110.216390	http://dx.doi.org/10.1074/jbc.M110.216390			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21270127	Green Published, hybrid			2022-12-27	WOS:000288547000078
J	Portbury, AL; Willis, MS; Patterson, C				Portbury, Andrea L.; Willis, Monte S.; Patterson, Cam			Tearin' Up My Heart: Proteolysis in the Cardiac Sarcomere	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							UBIQUITIN-PROTEASOME PATHWAY; MUSCLE PROTEIN-DEGRADATION; RING FINGER 1; SKELETAL-MUSCLE; MYOFIBRILLAR PROTEINS; IN-VIVO; COORDINATE ACTIVATION; LYSOSOMAL ALTERATIONS; REOXYGENATED HEARTS; SOLEUS MUSCLE	Proteolysis within the cardiac sarcomere is a constantly evolving area of research. Three major pathways of proteolysis have been identified as being active within the cardiac sarcomere, namely the ubiquitin-proteasome system, autophagy, and the calpain system. The role of ubiquitin-proteasome system-mediated proteolysis in cardiovascular health and disease has been known for some time; however, it is now apparent that other proteolytic systems also aid in the stabilization of cardiac sarcomere structure and function. This minireview focuses on the individual as well as cooperative involvement of each of these three major pathways of proteolysis within the cardiac sarcomere.	[Portbury, Andrea L.; Willis, Monte S.; Patterson, Cam] Univ N Carolina, Sch Med, McAllister Heart Inst, Chapel Hill, NC 27599 USA; [Willis, Monte S.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Patterson, Cam] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Patterson, Cam] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Patterson, Cam] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Patterson, C (corresponding author), Univ N Carolina, Sch Med, McAllister Heart Inst, Chapel Hill, NC 27599 USA.	cpatters@med.unc.edu	Willis, Monte S/J-9994-2015	Willis, Monte S/0000-0002-0769-5816	National Institutes of Health [GM61728, HL65619]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL065619, R01HL065619, R01HL104129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061728] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM61728 and HL65619 (to C. P.). This is the fifth article in the Thematic Minireview Series on Signaling in Cardiac Sarcomeres in Health and Disease. This minireview will be reprinted in the 2011 Minireview Compendium, which will be available in January, 2012.	Bailey JL, 1996, J CLIN INVEST, V97, P1447, DOI 10.1172/JCI118566; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; BARACOS VE, 1995, AM J PHYSIOL-ENDOC M, V268, pE996, DOI 10.1152/ajpendo.1995.268.5.E996; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bondareva L A, 2008, Bioorg Khim, V34, P295; Centner T, 2001, J MOL BIOL, V306, P717, DOI 10.1006/jmbi.2001.4448; Chen ZY, 2008, CARDIOVASC RES, V79, P97, DOI 10.1093/cvr/cvn073; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; CONG JY, 1989, J BIOL CHEM, V264, P10096; Dear TN, 2001, GENE, V274, P245, DOI 10.1016/S0378-1119(01)00599-6; DECKER RS, 1980, AM J PATHOL, V98, P445; DECKER RS, 1980, AM J PATHOL, V98, P425; Depre C, 2006, CIRCULATION, V114, P1821, DOI 10.1161/CIRCULATIONAHA.106.637827; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Dosenko VE, 2006, AUTOPHAGY, V2, P305, DOI 10.4161/auto.2946; Du J, 2004, J CLIN INVEST, V113, P115, DOI 10.1172/JCI200418330; Duguez S, 2003, AM J PHYSIOL-ENDOC M, V285, pE206, DOI 10.1152/ajpendo.00331.2002; Eble DM, 1999, CELL TISSUE RES, V296, P541, DOI 10.1007/s004410051315; Feasson L, 2002, J PHYSIOL-LONDON, V543, P297, DOI 10.1113/jphysiol.2002.018689; Fielitz J, 2007, J CLIN INVEST, V117, P2486, DOI 10.1172/JCI32827; Fielitz J, 2007, P NATL ACAD SCI USA, V104, P4377, DOI 10.1073/pnas.0611726104; Galvez AS, 2007, CIRC RES, V100, P1071, DOI 10.1161/01.RES.0000261938.28365.11; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Gustafsson AB, 2008, J MOL CELL CARDIOL, V44, P654, DOI 10.1016/j.yjmcc.2008.01.010; Gustafsson AB, 2009, CIRC RES, V104, P150, DOI 10.1161/CIRCRESAHA.108.187427; Hamacher-Brady A, 2006, J BIOL CHEM, V281, P29776, DOI 10.1074/jbc.M603783200; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hasselgren PO, 2001, ANN SURG, V233, P9, DOI 10.1097/00000658-200101000-00003; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Huang J, 1998, P NATL ACAD SCI USA, V95, P12100, DOI 10.1073/pnas.95.21.12100; JONES TL, 1983, AM J PHYSIOL, V245, pH294, DOI 10.1152/ajpheart.1983.245.2.H294; Ke L, 2008, J MOL CELL CARDIOL, V45, P685, DOI 10.1016/j.yjmcc.2008.08.012; Kedar V, 2004, P NATL ACAD SCI USA, V101, P18135, DOI 10.1073/pnas.0404341102; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Komatsu M, 2010, GENES CELLS, V15, P923, DOI 10.1111/j.1365-2443.2010.01433.x; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Kramerova I, 2005, HUM MOL GENET, V14, P2125, DOI 10.1093/hmg/ddi217; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lee SW, 2004, J AM SOC NEPHROL, V15, P1537, DOI 10.1097/01.ASN.0000127211.86206.E1; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li HH, 2004, J CLIN INVEST, V114, P1058, DOI 10.1172/JCl200422220; Li HH, 2007, J CLIN INVEST, V117, P3211, DOI 10.1172/JCI31757; Lim CC, 2004, J BIOL CHEM, V279, P8290, DOI 10.1074/jbc.M308033200; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; McElhinny AS, 2004, J CELL SCI, V117, P3175, DOI 10.1242/jcs.01158; MEDINA R, 1991, BIOMED BIOCHIM ACTA, V50, P347; MITCH WE, 1994, J CLIN INVEST, V93, P2127, DOI 10.1172/JCI117208; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Ord J M, 1983, Adv Myocardiol, V4, P195; Ordway GA, 2000, J APPL PHYSIOL, V88, P1134, DOI 10.1152/jappl.2000.88.3.1134; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Price SR, 1996, J CLIN INVEST, V98, P1703, DOI 10.1172/JCI118968; Razeghi P, 2003, CIRCULATION, V108, P2536, DOI 10.1161/01.CIR.0000096481.45105.13; Rodriguez JE, 2009, CURR HYPERTENS REP, V11, P396, DOI 10.1007/s11906-009-0069-7; Rottbauer W, 2006, CIRC RES, V99, P323, DOI 10.1161/01.RES.0000234807.16034.fe; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Solomon V, 1996, J BIOL CHEM, V271, P26690, DOI 10.1074/jbc.271.43.26690; Spencer JA, 2000, J CELL BIOL, V150, P771, DOI 10.1083/jcb.150.4.771; Sybers H D, 1976, Recent Adv Stud Cardiac Struct Metab, V12, P453; Taillandier D, 2003, INT J BIOCHEM CELL B, V35, P665, DOI 10.1016/S1357-2725(03)00004-9; Taillandier D, 1996, BIOCHEM J, V316, P65, DOI 10.1042/bj3160065; Taneike M, 2010, AUTOPHAGY, V6, P600, DOI 10.4161/auto.6.5.11947; Tannous P, 2008, CIRCULATION, V117, P3070, DOI 10.1161/CIRCULATIONAHA.107.763870; Tidball JG, 2002, J PHYSIOL-LONDON, V545, P819, DOI 10.1113/jphysiol.2002.024935; Valentim L, 2006, J MOL CELL CARDIOL, V40, P846, DOI 10.1016/j.yjmcc.2006.03.428; WHIPPLE G, 1991, J ANIM SCI, V69, P4449, DOI 10.2527/1991.69114449x; Wildenthal K, 1985, Prog Clin Biol Res, V180, P511; Willis MS, 2007, CIRC RES, V100, P456, DOI 10.1161/01.RES.0000259559.48597.32; Willis MS, 2006, J MOL CELL CARDIOL, V41, P567, DOI 10.1016/j.yjmcc.2006.07.015; Willis MS, 2009, AM J PHYSIOL-HEART C, V296, pH997, DOI 10.1152/ajpheart.00660.2008; Witt CC, 2008, EMBO J, V27, P350, DOI 10.1038/sj.emboj.7601952; Witt SH, 2005, J MOL BIOL, V350, P713, DOI 10.1016/j.jmb.2005.05.021; Yan L, 2005, P NATL ACAD SCI USA, V102, P13807, DOI 10.1073/pnas.0506843102; Zhao JH, 2008, AUTOPHAGY, V4, P378, DOI 10.4161/auto.5633; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	80	66	66	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					9929	9934		10.1074/jbc.R110.170571	http://dx.doi.org/10.1074/jbc.R110.170571			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21257759	hybrid, Green Published			2022-12-27	WOS:000288547000006
J	Ram, S; Lewis, LA; Agarwal, S				Ram, Sanjay; Lewis, Lisa A.; Agarwal, Sarika			Meningococcal Group W-135 and Y Capsular Polysaccharides Paradoxically Enhance Activation of the Alternative Pathway of Complement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-H BINDING; B NEISSERIA-MENINGITIDIS; SIALIC-ACID; SERUM RESISTANCE; SEROGROUP-B; NULL LOCUS; CRYPTOCOCCUS-NEOFORMANS; PATHOGENIC NEISSERIAE; BACTERICIDAL ACTIVITY; PROPERDIN DEFICIENCY	Although capsular polysaccharide (CPS) is critical for meningococcal virulence, the molecular basis of alternative complement pathway (AP) regulation by meningococcal CPSs remains unclear. Using serum with only the AP active, the ability of strains to generate C3a (a measure of C3 activation) and subsequently deposit C3 fragments on bacteria was studied in encapsulated group A, B, C, W-135, and Y strains and their isogenic unencapsulated mutants. To eliminate confounding AP regulation by membrane-bound factor H(fH; AP inhibitor) and lipooligosaccharide sialic acid, the meningococcal fH ligands (fHbp and NspA) and lipooligosaccharide sialylation were deleted in all strains. Group A CPS expression did not affect C3a generation or C3 deposition. C3a generated by encapsulated and unencapsulated group B and C strains was similar, but CPS expression was associated with reduced C3 deposition, suggesting that these CPSs blocked C3 deposition on membrane targets. Paradoxically, encapsulated W-135 and Y strains (including the wild-type parent strains) enhanced C3 activation and showed marked C3 deposition as early as 10 min; at this time point C3 was barely activated by the unencapsulated mutants. W-135 and Y CPSs themselves served as a site for C3 deposition; this observation was confirmed using immobilized purified CPSs. Purified CPSs bound to unencapsulated meningococci, simulated findings with naturally encapsulated strains. These data highlight the heterogeneity of AP activation on the various meningococcal serogroups that may contribute to differences in their pathogenic mechanisms.	[Ram, Sanjay] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Ram, S (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Lazare Res Bldg,Rm 322,364 Plantat St, Worcester, MA 01605 USA.	sanjay.ram@umassmed.edu			National Institutes of Health [AI054544, AI 084048, AI32725]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI084048, R01AI032725, R56AI032725, R37AI032725, R01AI054544] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI054544, AI 084048, and AI32725.	Alper C. A., 1970, NEW ENGL J MED, V282, P350; Austen K F, 1979, Adv Exp Med Biol, V120B, P3; BARBA GMR, 1994, CLIN IMMUNOL IMMUNOP, V72, P83, DOI 10.1006/clin.1994.1110; Biesma DH, 2001, J CLIN INVEST, V108, P233, DOI 10.1172/JCI12023; CARLONE GM, 1992, J CLIN MICROBIOL, V30, P154, DOI 10.1128/JCM.30.1.154-159.1992; Claus H, 2004, MOL MICROBIOL, V51, P227, DOI 10.1046/j.1365-2958.2003.03819.x; CZOP JK, 1985, J IMMUNOL, V135, P3388; DENSEN P, 1987, NEW ENGL J MED, V316, P922, DOI 10.1056/NEJM198704093161506; Edwards JL, 2002, CELL MICROBIOL, V4, P585, DOI 10.1046/j.1462-5822.2002.00212.x; EDWARDS MS, 1982, J IMMUNOL, V128, P1278; EDWARDS MS, 1980, J EXP MED, V151, P1275, DOI 10.1084/jem.151.5.1275; ELLISON RT, 1983, NEW ENGL J MED, V308, P913, DOI 10.1056/NEJM198304213081601; Estabrook MM, 1997, INFECT IMMUN, V65, P4436, DOI 10.1128/IAI.65.11.4436-4444.1997; FEARON DT, 1978, P NATL ACAD SCI USA, V75, P1971, DOI 10.1073/pnas.75.4.1971; FIGUEROA J, 1993, IMMUNOL RES, V12, P295, DOI 10.1007/BF02918259; FIGUEROA JE, 1991, CLIN MICROBIOL REV, V4, P359, DOI 10.1128/CMR.4.3.359-395.1991; FIJEN CAP, 1989, LANCET, V2, P585; Fijen CAP, 1999, CLIN INFECT DIS, V28, P98, DOI 10.1086/515075; Findlow H, 2007, J INFECT DIS, V195, P1071, DOI 10.1086/512084; FRASCH CE, 1985, REV INFECT DIS, V7, P504; Frosch M., 2006, HDB MENINGOCOCCAL DI, P145, DOI DOI 10.1002/3527608508.CH8; Gudlavalleti SK, 2004, J BIOL CHEM, V279, P42765, DOI 10.1074/jbc.M313552200; Hoang LMN, 2005, CLIN INFECT DIS, V40, pE38, DOI 10.1086/427875; IIDA K, 1987, IMMUNOLOGY, V62, P413; INGWER I, 1978, J LAB CLIN MED, V92, P211; JARVIS GA, 1987, INFECT IMMUN, V55, P174, DOI 10.1128/IAI.55.1.174-180.1987; JARVIS GA, 1994, INFECT IMMUN, V62, P1755, DOI 10.1128/IAI.62.5.1755-1760.1994; Uria MJ, 2008, J EXP MED, V205, P1423, DOI 10.1084/jem.20072577; KOZEL TR, 1991, INFECT IMMUN, V59, P3101, DOI 10.1128/IAI.59.9.3101-3110.1991; KOZEL TR, 1977, INFECT IMMUN, V16, P99, DOI 10.1128/IAI.16.1.99-106.1977; Law SKA, 1997, PROTEIN SCI, V6, P263; LEHNER PJ, 1992, LANCET, V340, P1379, DOI 10.1016/0140-6736(92)92561-S; Lewis LA, 2008, INFECT IMMUN, V76, P339, DOI 10.1128/IAI.00613-07; Lewis LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001027; Lewis LA, 2009, INFECT IMMUN, V77, P1112, DOI 10.1128/IAI.01280-08; LIM D, 1976, J PEDIATR-US, V89, P42, DOI 10.1016/S0022-3476(76)80924-9; Madico G, 2007, J IMMUNOL, V178, P4489, DOI 10.4049/jimmunol.178.7.4489; Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501; McQuillen DP, 1999, J INFECT DIS, V179, P124, DOI 10.1086/314545; MORRIS JT, 1992, SOUTHERN MED J, V85, P1030, DOI 10.1097/00007611-199210000-00027; PANGBURN MK, 1978, P NATL ACAD SCI USA, V75, P2416, DOI 10.1073/pnas.75.5.2416; PANGBURN MK, 1983, J IMMUNOL, V131, P1930; PETERSEN BH, 1976, J CLIN INVEST, V57, P283, DOI 10.1172/JCI108279; Ram S, 2003, J BIOL CHEM, V278, P50853, DOI 10.1074/jbc.M308364200; Reis ES, 2006, SCAND J IMMUNOL, V63, P155, DOI 10.1111/j.1365-3083.2006.01729.x; ROSEN MS, 1988, ARCH INTERN MED, V148, P1441, DOI 10.1001/archinte.148.6.1441; Sacchi CT, 1998, CLIN DIAGN LAB IMMUN, V5, P845, DOI 10.1128/CDLI.5.6.845-855.1998; SAHU A, 1995, MOL IMMUNOL, V32, P711, DOI 10.1016/0161-5890(95)98933-F; Schneider MC, 2006, J IMMUNOL, V176, P7566, DOI 10.4049/jimmunol.176.12.7566; Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769; Selander B, 2000, J CLIN IMMUNOL, V20, P138, DOI 10.1023/A:1006638631581; Severi E, 2007, MICROBIOL-SGM, V153, P2817, DOI 10.1099/mic.0.2007/009480-0; Shaughnessy J, 2009, INFECT IMMUN, V77, P2094, DOI 10.1128/IAI.01561-08; SIM E, 1981, FEBS LETT, V132, P55, DOI 10.1016/0014-5793(81)80426-7; SIM RB, 1981, BIOCHEM J, V193, P115, DOI 10.1042/bj1930115; SODERSTROM C, 1989, SCAND J INFECT DIS, V21, P259, DOI 10.3109/00365548909035695; Taylor Clare M., 2005, V12, P55, DOI 10.1159/000081689; van Deuren M, 2000, CLIN MICROBIOL REV, V13, P144, DOI 10.1128/CMR.13.1.144-166.2000; VARKI A, 1980, J EXP MED, V152, P532, DOI 10.1084/jem.152.3.532; VENKATESH YP, 1988, MOL IMMUNOL, V25, P821, DOI 10.1016/0161-5890(88)90118-6; VENKATESH YP, 1984, J IMMUNOL, V132, P1435; Vogel U, 1997, INFECT IMMUN, V65, P4022, DOI 10.1128/IAI.65.10.4022-4029.1997; Vogel U, 2004, J CLIN MICROBIOL, V42, P2898, DOI 10.1128/JCM.42.7.2898-2901.2004; Vogel U, 1996, MED MICROBIOL IMMUN, V185, P81, DOI 10.1007/s004300050018; Vogel U, 1998, J CLIN MICROBIOL, V36, P2465, DOI 10.1128/JCM.36.9.2465-2470.1998; Vogel U, 1999, INFECT IMMUN, V67, P954, DOI 10.1128/IAI.67.2.954-957.1999; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406	67	23	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8297	8307		10.1074/jbc.M110.184838	http://dx.doi.org/10.1074/jbc.M110.184838			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21245150	hybrid, Green Published			2022-12-27	WOS:000288013300059
J	Kretner, B; Fukumori, A; Gutsmiedl, A; Page, RM; Luebbers, T; Galley, G; Baumann, K; Haass, C; Steiner, H				Kretner, Benedikt; Fukumori, Akio; Gutsmiedl, Amelie; Page, Richard M.; Luebbers, Thomas; Galley, Guido; Baumann, Karlheinz; Haass, Christian; Steiner, Harald			Attenuated A beta(42) Responses to Low Potency gamma-Secretase Modulators Can Be Overcome for Many Pathogenic Presenilin Mutants by Second-generation Compounds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ALZHEIMERS-DISEASE; AMYLOID DEPOSITION; TRANSGENIC MICE; MOUSE MODEL; GXGD-MOTIF; A-BETA-42; GENERATION; MUTATIONS; INHIBITORS	Sequential processing of the beta-amyloid precursor protein by beta- and gamma-secretase generates the amyloid beta-peptide (A beta), which is widely believed to play a causative role in Alzheimer disease. Selective lowering of the pathogenic 42-amino acid variant of A beta by gamma-secretase modulators (GSMs) is a promising therapeutic strategy. Here we report that mutations in presenilin (PS), the catalytic subunit of gamma-secretase, display differential responses to non-steroidal anti-inflammatory drug (NSAID)-type GSMs and more potent second-generation compounds. Although many pathogenic PS mutations resisted lowering of A beta(42) generation by the NSAID sulindac sulfide, the potent NSAID-like second-generation compound GSM-1 was capable of lowering A beta(42) for many but not all mutants. We further found that mutations at homologous positions in PS1 and PS2 can elicit differential A beta(42) responses to GSM-1, suggesting that a positive GSM-1 response depends on the spatial environment in gamma-secretase. The aggressive pathogenic PS1 L166P mutation was one of the few pathogenic mutations that resisted GSM-1, and Leu166 was identified as a critical residue with respect to the A beta(42)-lowering response of GSM-1. Finally, we found that GSM-1-responsive and -resistant PS mutants behave very similarly toward other potent second-generation compounds of different structural classes than GSM-1. Taken together, our data show that a positive A beta(42) response for PS mutants depends both on the particular mutation and the GSM used and that attenuated A beta(42) responses to low potency GSMs can be overcome for many PS mutants by second generation GSMs.	[Kretner, Benedikt; Fukumori, Akio; Gutsmiedl, Amelie; Page, Richard M.; Haass, Christian; Steiner, Harald] Univ Munich, DZNE German Ctr Neurodegenerat Dis, D-80336 Munich, Germany; [Kretner, Benedikt; Fukumori, Akio; Gutsmiedl, Amelie; Page, Richard M.; Haass, Christian; Steiner, Harald] Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany; [Luebbers, Thomas; Galley, Guido; Baumann, Karlheinz] F Hoffmann La Roche Ltd, Preclin CNS Res, Div Pharmaceut, CH-4070 Basel, Switzerland	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; University of Munich; Roche Holding	Steiner, H (corresponding author), Univ Munich, DZNE German Ctr Neurodegenerat Dis, Schillerstr 44, D-80336 Munich, Germany.	harald.steiner@med.uni-muenchen.de			Deutsche Forschungsgemeinschaft (Collaborative Research Center) [SFB596]; Bundesministerium fur Bildung und Forschung; Ludwig-Maximilians-University Munich; Center for Integrated Protein Science Munich; Elitenetzwerk Bayern; LMUexcellent	Deutsche Forschungsgemeinschaft (Collaborative Research Center)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Ludwig-Maximilians-University Munich; Center for Integrated Protein Science Munich; Elitenetzwerk Bayern; LMUexcellent	This work was supported by the Deutsche Forschungsgemeinschaft (Collaborative Research Center (SFB596) "Molecular Mechanisms of Neurodegeneration" (to H. S. and C. H.), the Bundesministerium fur Bildung und Forschung ("Degenerative Dementias: Target Identification, Validation, and Translation into Treatment Strategies"; to C. H. and H. S.), the FoFoLe program of the Ludwig-Maximilians-University Munich (to B. K. and H. S.), and the Center for Integrated Protein Science Munich.; Supported by the Elitenetzwerk Bayern.; Supported by a LMUexcellent program research professorship.	Beel AJ, 2009, BIOCHEMISTRY-US, V48, P11837, DOI 10.1021/bi901839d; Beher D, 2004, J BIOL CHEM, V279, P43419, DOI 10.1074/jbc.M404937200; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; Czirr E, 2008, J BIOL CHEM, V283, P17049, DOI 10.1074/jbc.M802912200; Czirr E, 2007, J BIOL CHEM, V282, P24504, DOI 10.1074/jbc.M700618200; Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Kounnas MZ, 2010, NEURON, V67, P769, DOI 10.1016/j.neuron.2010.08.018; Kukar T, 2005, NAT MED, V11, P545, DOI 10.1038/nm1235; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Lleo A, 2004, NAT MED, V10, P1065, DOI 10.1038/nm1112; Moehlmann T, 2002, P NATL ACAD SCI USA, V99, P8025, DOI 10.1073/pnas.112686799; Moliaka YK, 2004, FEBS LETT, V557, P185, DOI 10.1016/S0014-5793(03)01489-3; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Nakaya Y, 2005, J BIOL CHEM, V280, P19070, DOI 10.1074/jbc.M501130200; Page RM, 2010, J BIOL CHEM, V285, P17798, DOI 10.1074/jbc.M110.103283; Perez-Revuelta BI, 2010, J NEUROCHEM, V112, P940, DOI 10.1111/j.1471-4159.2009.06510.x; Portelius E, 2010, J ALZHEIMERS DIS, V21, P1005, DOI 10.3233/JAD-2010-100573; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Richards JG, 2003, J NEUROSCI, V23, P8989; Richter L, 2010, P NATL ACAD SCI USA, V107, P14597, DOI 10.1073/pnas.1003026107; Shirotani K, 2007, NEUROBIOL DIS, V27, P102, DOI 10.1016/j.nbd.2007.04.011; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Steiner H, 2002, J BIOL CHEM, V277, P39062, DOI 10.1074/jbc.C200469200; Steiner H, 2008, J BIOL CHEM, V283, P29627, DOI 10.1074/jbc.R800010200; Steiner H, 2008, CURR ALZHEIMER RES, V5, P147, DOI 10.2174/156720508783954677; Takahashi Y, 2003, J BIOL CHEM, V278, P18664, DOI 10.1074/jbc.M301619200; Tolia A, 2009, SEMIN CELL DEV BIOL, V20, P211, DOI 10.1016/j.semcdb.2008.10.007; Tomita T, 2009, EXPERT REV NEUROTHER, V9, P661, DOI [10.1586/ern.09.24, 10.1586/ERN.09.24]; Wang J, 2006, J NEUROCHEM, V96, P218, DOI 10.1111/j.1471-4159.2005.03548.x; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Weggen S, 2003, J BIOL CHEM, V278, P31831, DOI 10.1074/jbc.M303592200; Yamasaki A, 2006, J NEUROSCI, V26, P3821, DOI 10.1523/JNEUROSCI.5354-05.2006	35	35	35	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15240	15251		10.1074/jbc.M110.213587	http://dx.doi.org/10.1074/jbc.M110.213587			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21357415	hybrid, Green Published			2022-12-27	WOS:000289788300055
J	Pashkov, V; Huang, J; Parameswara, VK; Kedzierski, W; Kurrasch, DM; Tall, GG; Esser, V; Gerard, RD; Uyeda, K; Towle, HC; Wilkie, TM				Pashkov, Victor; Huang, Jie; Parameswara, Vinay K.; Kedzierski, Wojciech; Kurrasch, Deborah M.; Tall, Gregory G.; Esser, Victoria; Gerard, Robert D.; Uyeda, Kosaku; Towle, Howard C.; Wilkie, Thomas M.			Regulator of G Protein Signaling (RGS16) Inhibits Hepatic Fatty Acid Oxidation in a Carbohydrate Response Element-binding Protein (ChREBP)-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEINS; N-TERMINAL DOMAIN; TRANSCRIPTION FACTOR; GENE-EXPRESSION; ALPHA SUBUNITS; RECEPTOR GENE; PPAR-ALPHA; GLUCOSE; RAT; MOUSE	Gprotein-coupled receptor (GPCR) pathways control glucose and fatty acid metabolism and the onset of obesity and diabetes. Regulators of G protein signaling (RGS) are GTPase-activating proteins (GAPs) for G(i) and G(q) alpha-subunits that control the intensity and duration of GPCR signaling. Herein we determined the role of Rgs16 in GPCR regulation of liver metabolism. Rgs16 is expressed during the last few hours of the daily fast in periportal hepatocytes, the oxygen-rich zone of the liver where lipolysis and gluconeogenesis predominate. Rgs16 knock-out mice had elevated expression of fatty acid oxidation genes in liver, higher rates of fatty acid oxidation in liver extracts, and higher plasma beta-ketone levels compared with wild type mice. By contrast, transgenic mice that overexpressed RGS16 protein specifically in liver exhibited reciprocal phenotypes as well as low blood glucose levels compared with wild type littermates and fatty liver after overnight fasting. The transcription factor carbohydrate response element-binding protein (ChREBP), which induces fatty acid synthesis genes in response to high carbohydrate feeding, was unexpectedly required during fasting for maximal Rgs16 transcription in liver and in cultured primary hepatocytes during gluconeogenesis. Thus, RGS16 provides a signaling mechanism for glucose production to inhibit GPCR-stimulated fatty acid oxidation in hepatocytes.	[Pashkov, Victor; Huang, Jie; Kedzierski, Wojciech; Kurrasch, Deborah M.; Tall, Gregory G.; Wilkie, Thomas M.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Parameswara, Vinay K.; Esser, Victoria] Univ Texas SW Med Ctr Dallas, Dept Internal Med Digest & Liver Dis, Dallas, TX 75390 USA; [Gerard, Robert D.] Univ Texas SW Med Ctr Dallas, Dept Internal Med Cardiol & Mol Biol, Dallas, TX 75390 USA; [Uyeda, Kosaku] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Towle, Howard C.] Univ Minnesota, Minneapolis, MN 55455 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Minnesota System; University of Minnesota Twin Cities	Wilkie, TM (corresponding author), 6001 Forest Pk Rd, Dallas, TX 75390 USA.	Thomas.Wilkie@UTSouthwestern.edu	Kurrasch, Deborah M/E-4506-2019	Kurrasch, Deborah M/0000-0002-9945-287X; Wilkie, Thomas/0000-0002-9357-637X	National Institutes of Health [GM61395, PAR-98-057, HL072551]; Welch Foundation [I-1382]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL072551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088242, R01GM061395] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM61395 and PAR-98-057 (to T.M.W.) and HL072551 (to D.K.O.). This work was also supported by Welch Foundation Grant I-1382 (to T.M.W.).	Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Bernstein LS, 2004, J BIOL CHEM, V279, P21248, DOI 10.1074/jbc.M312407200; Bernstein LS, 2000, J BIOL CHEM, V275, P18520, DOI 10.1074/jbc.M000618200; Brown MS, 1998, NUTR REV, V56, pS1; DIETZEL C, 1987, MOL CELL BIOL, V7, P4169, DOI 10.1128/MCB.7.12.4169; Dohlman HG, 1996, MOL CELL BIOL, V16, P5194; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HATTORI M, 1990, DNA CELL BIOL, V9, P777, DOI 10.1089/dna.1990.9.777; Heximer SP, 2001, J BIOL CHEM, V276, P14195, DOI 10.1074/jbc.M009942200; Horton JD, 1999, J CLIN INVEST, V103, P1067, DOI 10.1172/JCI6246; Hotta Y, 2009, ENDOCRINOLOGY, V150, P4625, DOI 10.1210/en.2009-0119; Hsueh YP, 2007, MOL BIOL CELL, V18, P3237, DOI 10.1091/mbc.E07-02-0133; Huang Jie, 2006, Comp Hepatol, V5, P8, DOI 10.1186/1476-5926-5-8; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Iizuka K, 2009, FEBS LETT, V583, P2882, DOI 10.1016/j.febslet.2009.07.053; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; JUNGERMANN K, 1989, PHYSIOL REV, V69, P708, DOI 10.1152/physrev.1989.69.3.708; Kabashima T, 2003, P NATL ACAD SCI USA, V100, P5107, DOI 10.1073/pnas.0730817100; Kalaany NY, 2005, CELL METAB, V1, P231, DOI 10.1016/j.cmet.2005.03.001; Kurrasch DM, 2004, METHOD ENZYMOL, V389, P3; Kuwata H, 2007, KOBE J MED SCI, V53, P275; Lamartina S, 2002, HUM GENE THER, V13, P199, DOI 10.1089/10430340252769734; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; LONG CS, 1982, NEUROLOGY, V32, P663, DOI 10.1212/WNL.32.6.663; Longuet C, 2008, CELL METAB, V8, P359, DOI 10.1016/j.cmet.2008.09.008; Luo X, 2001, MOL CELL, V7, P651, DOI 10.1016/S1097-2765(01)00211-8; Ma L, 2006, J BIOL CHEM, V281, P28721, DOI 10.1074/jbc.M601576200; MCGARRY JD, 1978, BIOCHIM BIOPHYS ACTA, V530, P305, DOI 10.1016/0005-2760(78)90150-9; Muallem S, 1999, CELL CALCIUM, V26, P173, DOI 10.1054/ceca.1999.0077; Ou-Yang YS, 2003, BIOSCIENCE REP, V23, P213, DOI 10.1023/B:BIRE.0000007694.71158.02; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Saitoh O, 2002, P NATL ACAD SCI USA, V99, P10138, DOI 10.1073/pnas.152085999; Sierra DA, 2002, GENOMICS, V79, P177, DOI 10.1006/geno.2002.6693; Srinivasa SP, 1998, P NATL ACAD SCI USA, V95, P5584, DOI 10.1073/pnas.95.10.5584; Srivastava RAK, 2000, NUCLEIC ACID PROTOCOLS HANDBOOK, P207; TONNAER JADM, 1986, BRAIN RES, V370, P200, DOI 10.1016/0006-8993(86)91125-X; TONTONOZ P, 1993, MOL CELL BIOL, V13, P4753, DOI 10.1128/MCB.13.8.4753; Towle HC, 2001, P NATL ACAD SCI USA, V98, P13476, DOI 10.1073/pnas.251530798; Veech RL, 2003, P NATL ACAD SCI USA, V100, P5578, DOI 10.1073/pnas.1132039100; Verrill C, 2002, J PHARMACOL TOX MET, V48, P103, DOI 10.1016/S1056-8719(03)00042-X; Villasenor A, 2010, DIS MODEL MECH, V3, P567, DOI 10.1242/dmm.003210; Xu X, 1999, J BIOL CHEM, V274, P3549, DOI 10.1074/jbc.274.6.3549; Xu X, 1998, J BIOL CHEM, V273, P27275, DOI 10.1074/jbc.273.42.27275; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zeng WZ, 1998, J BIOL CHEM, V273, P34687, DOI 10.1074/jbc.273.52.34687	50	43	44	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15116	15125		10.1074/jbc.M110.216234	http://dx.doi.org/10.1074/jbc.M110.216234			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21357625	hybrid, Green Published			2022-12-27	WOS:000289788300042
J	Jovanovic, M; Burrows, PC; Bose, D; Camara, B; Wiesler, S; Zhang, XD; Wigneshweraraj, S; Weinzierl, ROJ; Buck, M				Jovanovic, Milija; Burrows, Patricia C.; Bose, Daniel; Camara, Beatriz; Wiesler, Simone; Zhang, Xiaodong; Wigneshweraraj, Sivaramesh; Weinzierl, Robert O. J.; Buck, Martin			Activity Map of the Escherichia coli RNA Polymerase Bridge Helix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II ELONGATION COMPLEX; STRUCTURAL BASIS; TRANSCRIPTION INHIBITION; ALLOSTERIC CONTROL; TRIGGER LOOP; CRYSTAL-STRUCTURE; BETA-SUBUNIT; CATALYSIS; SITE; ACTIVATION	Transcription, the synthesis of RNA from a DNA template, is performed by multisubunit RNA polymerases (RNAPs) in all cellular organisms. The bridge helix (BH) is a distinct feature of all multisubunit RNAPs and makes direct interactions with several active site-associated mobile features implicated in the nucleotide addition cycle and RNA and DNA binding. Because the BH has been captured in both kinked and straight conformations in different crystals structures of RNAP, recently supported by molecular dynamics studies, it has been proposed that cycling between these conformations is an integral part of the nucleotide addition cycle. To further evaluate the role of the BH, we conducted systematic alanine scanning mutagenesis of the Escherichia coli RNAP BH to determine its contributions to activities required for transcription. Combining our data with an atomic model of E. coli RNAP, we suggest that alterations in the interactions between the BH and (i) the trigger loop, (ii) fork loop 2, and (iii) switch 2 can help explain the observed changes in RNAP functionality associated with some of the BH variants. Additionally, we show that extensive defects in E. coli RNAP functionality depend upon a single previously not studied lysine residue (Lys-781) that is strictly conserved in all bacteria. It appears that direct interactions made by the BH with other conserved features of RNAP are lost in some of the E. coli alanine substitution variants, which we infer results in conformational changes in RNAP that modify RNAP functionality.	[Jovanovic, Milija; Burrows, Patricia C.; Wiesler, Simone; Weinzierl, Robert O. J.; Buck, Martin] Univ London Imperial Coll Sci Technol & Med, Div Biol, London SW7 2AZ, England; [Bose, Daniel; Zhang, Xiaodong] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London SW7 2AZ, England; [Camara, Beatriz; Wigneshweraraj, Sivaramesh] Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Microbiol, London SW7 2AZ, England; [Camara, Beatriz; Wigneshweraraj, Sivaramesh] Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol & Infect, London SW7 2AZ, England	Imperial College London; Imperial College London; Imperial College London; Imperial College London	Burrows, PC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Biol, London SW7 2AZ, England.	pcb1@imperial.ac.uk; m.buck@imperial.ac.uk	Bose, Daniel/AAI-2775-2020	Bose, Daniel/0000-0002-0276-6486; Wigneshweraraj, Sivaramesh/0000-0002-1418-4029; Zhang, Xiaodong/0000-0001-9786-7038; Camara, Beatriz/0000-0001-5227-7499	Wellcome Trust [084599/Z/07/Z]; Biotechnology and Biological Sciences Research Council [BB/E00975/1, BB/E023703/1]; Biotechnology and Biological Sciences Research Council [BB/J002828/1, BB/D00862X/1] Funding Source: researchfish; Medical Research Council [G0501703] Funding Source: researchfish; BBSRC [BB/J002828/1, BB/E023703/1, BB/D00862X/1] Funding Source: UKRI; MRC [G0501703] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Wellcome Trust Grant 084599/Z/07/Z and Biotechnology and Biological Sciences Research Council Grant BB/E00975/1 (to M. B.) and by Biotechnology and Biological Sciences Research Council David Phillips Fellowship BB/E023703/1 (to S. W.).	Artsimovitch I, 2003, SCIENCE, V302, P650, DOI 10.1126/science.1087526; Belogurov GA, 2007, MOL CELL, V26, P117, DOI 10.1016/j.molcel.2007.02.021; Belogurov GA, 2009, NATURE, V457, P332, DOI 10.1038/nature07510; BORUKHOV S, 1992, P NATL ACAD SCI USA, V89, P8899, DOI 10.1073/pnas.89.19.8899; BORUKHOV S, 1993, CELL, V72, P459, DOI 10.1016/0092-8674(93)90121-6; Brueckner F, 2008, NAT STRUCT MOL BIOL, V15, P811, DOI 10.1038/nsmb.1458; Burrows PC, 2010, P NATL ACAD SCI USA, V107, P9376, DOI 10.1073/pnas.1001188107; Burrows PC, 2009, J MOL BIOL, V387, P306, DOI 10.1016/j.jmb.2009.01.052; Camara B, 2010, P NATL ACAD SCI USA, V107, P2247, DOI 10.1073/pnas.0907908107; Christie GE, 1996, J BACTERIOL, V178, P6991, DOI 10.1128/jb.178.23.6991-6993.1996; Cramer P, 2002, CURR OPIN STRUC BIOL, V12, P89, DOI 10.1016/S0959-440X(02)00294-4; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Cramer P, 2009, CURR OPIN STRUC BIOL, V19, P680, DOI 10.1016/j.sbi.2009.10.013; de Sousa MM, 2011, J THEOR BIOL, V271, P136, DOI 10.1016/j.jtbi.2010.11.028; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Hein PP, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-141; Joly N, 2008, J BIOL CHEM, V283, P13725, DOI 10.1074/jbc.M800801200; Joly N, 2007, MOL MICROBIOL, V66, P583, DOI 10.1111/j.1365-2958.2007.05901.x; Kaplan CD, 2008, MOL CELL, V30, P547, DOI 10.1016/j.molcel.2008.04.023; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; Lane WJ, 2010, J MOL BIOL, V395, P686, DOI 10.1016/j.jmb.2009.10.063; Lane WJ, 2010, J MOL BIOL, V395, P671, DOI 10.1016/j.jmb.2009.10.062; Majovski RC, 2005, J BIOL CHEM, V280, P34917, DOI 10.1074/jbc.M502932200; Miropolskaya N, 2009, P NATL ACAD SCI USA, V106, P18942, DOI 10.1073/pnas.0905402106; Mukhopadhyay J, 2008, CELL, V135, P295, DOI 10.1016/j.cell.2008.09.033; Nickels BE, 2004, CELL, V118, P281, DOI 10.1016/j.cell.2004.07.021; Nudler E, 2009, ANNU REV BIOCHEM, V78, P335, DOI 10.1146/annurev.biochem.76.052705.164655; Opalka N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000483; Rutherford ST, 2009, GENE DEV, V23, P236, DOI 10.1101/gad.1745409; Seibold SA, 2010, BBA-GENE REGUL MECH, V1799, P575, DOI 10.1016/j.bbagrm.2010.05.002; Svetlov V, 2007, NUCLEIC ACIDS RES, V35, P5694, DOI 10.1093/nar/gkm600; Svetlov V, 2009, CURR OPIN STRUC BIOL, V19, P701, DOI 10.1016/j.sbi.2009.10.002; Tan Lin, 2008, J Biol, V7, P40, DOI 10.1186/jbiol98; Temiakov D, 2005, MOL CELL, V19, P655, DOI 10.1016/j.molcel.2005.07.020; Tupin A, 2010, EMBO J, V29, P2527, DOI 10.1038/emboj.2010.135; Tuske S, 2005, CELL, V122, P541, DOI 10.1016/j.cell.2005.07.017; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Vassylyev DG, 2005, NAT STRUCT MOL BIOL, V12, P1086, DOI 10.1038/nsmb1015; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; WEDEL A, 1990, SCIENCE, V248, P486, DOI 10.1126/science.1970441; Weinzierl ROJ, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-134; Weinzierl ROJ, 2010, BIOCHEM SOC T, V38, P428, DOI 10.1042/BST0380428; Werner F, 2008, TRENDS MICROBIOL, V16, P247, DOI 10.1016/j.tim.2008.03.008; Wigneshweraraj SR, 2003, METHOD ENZYMOL, V370, P646; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9; Zhang JW, 2010, NAT STRUCT MOL BIOL, V17, P99, DOI 10.1038/nsmb.1732	49	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14469	14479		10.1074/jbc.M110.212902	http://dx.doi.org/10.1074/jbc.M110.212902			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21357417	hybrid, Green Published			2022-12-27	WOS:000289556200068
J	Goh, WI; Sudhaharan, T; Lim, KB; Sem, KP; Lau, CL; Ahmed, S				Goh, Wah Ing; Sudhaharan, Thankiah; Lim, Kim Buay; Sem, Kai Ping; Lau, Chew Ling; Ahmed, Sohail			Rif-mDia1 Interaction Is Involved in Filopodium Formation Independent of Cdc42 and Rac Effectors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-BUNDLING ACTIVITY; GTPASE RIF; MIGRATING CELLS; MEMBRANE; FORMINS; COMPLEX; MDIA1; CYTOSKELETON; WAVE; REORGANIZATION	Filopodia are cellular protrusions important for axon guidance, embryonic development, and wound healing. The Rho GTPase Cdc42 is the best studied inducer of filopodium formation, and several of its effectors and their interacting partners have been linked to the process. These include IRSp53, N-WASP, Mena, and Eps8. The Rho GTPase, Rif, also drives filopodium formation. The signaling pathway by which Rif induces filopodia is poorly understood, with mDia2 being the only protein implicated to date. It is thus not clear how distinct the Rif-driven pathway for filopodium formation is from the one mediated by Cdc42. In this study, we characterize the dynamics of Rif-induced filopodia by time lapse imaging of live neuronal cells and show that Rif drives filopodium formation via an independent pathway that does not involve the Cdc42 effectors N-WASP and IRSp53, the IRSp53 binding partner Mena, or the Rac effectors WAVE1 and WAVE2. Rif formed filopodia in the absence of N-WASP or Mena and when IRSp53, WAVE1, or WAVE2 was knocked down by RNAi. Rif-mediated filopodial protrusion was instead reduced by silencing mDial expression or overexpressing a dominant negative mutant of mDial. mDial on its own was able to form filopodia. Data from acceptor photobleaching FRET studies of protein-protein interaction demonstrate that Rif interacts directly with mDia1 in filopodia but not with mDia2. Taken together, these results suggest a novel pathway for filopodia formation via Rif and mDial.	[Goh, Wah Ing; Sudhaharan, Thankiah; Lim, Kim Buay; Sem, Kai Ping; Lau, Chew Ling; Ahmed, Sohail] Inst Med Biol, Singapore 138648, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)	Ahmed, S (corresponding author), Inst Med Biol, 8A Biomed Grove, Singapore 138648, Singapore.	sohail.ahmed@imb.a-star.edu.sg		Goh, Wah Ing/0000-0001-6594-0640				Ahn SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003917; Arakawa Y, 2003, J CELL BIOL, V161, P381, DOI 10.1083/jcb.200210149; Beli P, 2008, NAT CELL BIOL, V10, P849, DOI 10.1038/ncb1745; Berger CN, 2009, CELL MICROBIOL, V11, P309, DOI 10.1111/j.1462-5822.2008.01254.x; Biyasheva A, 2004, J CELL SCI, V117, P837, DOI 10.1242/jcs.00921; Bu WY, 2009, J BIOL CHEM, V284, P11622, DOI 10.1074/jbc.M805940200; Carlier MF, 1999, CHEM BIOL, V6, pR235, DOI 10.1016/S1074-5521(99)80107-0; Carramusa L, 2007, J CELL SCI, V120, P3870, DOI 10.1242/jcs.014365; Copeland JW, 2002, MOL BIOL CELL, V13, P4088, DOI 10.1091/mbc.02-06-0092; Danson CM, 2007, J CELL SCI, V120, P4144, DOI 10.1242/jcs.013714; Disanza A, 2006, NAT CELL BIOL, V8, P1337, DOI 10.1038/ncb1502; Dixit R, 2008, NEUROSCI LETT, V440, P113, DOI 10.1016/j.neulet.2008.05.031; Eisenmann KM, 2007, J BIOL CHEM, V282, P25152, DOI 10.1074/jbc.M703243200; Ellis S, 2000, CURR BIOL, V10, P1387, DOI 10.1016/S0960-9822(00)00777-6; Faix J, 2006, DEV CELL, V10, P693, DOI 10.1016/j.devcel.2006.05.001; Fan LF, 2010, J CELL SCI, V123, P1247, DOI 10.1242/jcs.061754; Fernandez-Borja M, 2005, J CELL SCI, V118, P2661, DOI 10.1242/jcs.02384; Fujiwara T, 2000, BIOCHEM BIOPH RES CO, V271, P626, DOI 10.1006/bbrc.2000.2671; Gad AKB, 2010, CELL SIGNAL, V22, P183, DOI 10.1016/j.cellsig.2009.10.001; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Govind S, 2001, J CELL BIOL, V152, P579, DOI 10.1083/jcb.152.3.579; Guerrier S, 2009, CELL, V138, P990, DOI 10.1016/j.cell.2009.06.047; Harris ES, 2006, J BIOL CHEM, V281, P14383, DOI 10.1074/jbc.M510923200; He LS, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni057; Hotulainen P, 2009, J CELL BIOL, V185, P323, DOI 10.1083/jcb.200809046; Ishizaki T, 2001, NAT CELL BIOL, V3, P8; Kashiwagi H, 2005, J THROMB HAEMOST, V3, P361, DOI 10.1111/j.1538-7836.2004.01082.x; Kim HJ, 2006, J NEUROSCI, V26, P5849, DOI 10.1523/JNEUROSCI.4921-05.2006; Kovar DR, 2006, CURR OPIN CELL BIOL, V18, P11, DOI 10.1016/J.CEB.2005.12.011; Krugmann S, 2001, CURR BIOL, V11, P1645, DOI 10.1016/S0960-9822(01)00506-1; Lim KB, 2008, J BIOL CHEM, V283, P20454, DOI 10.1074/jbc.M710185200; Lizarraga F, 2009, CANCER RES, V69, P2792, DOI 10.1158/0008-5472.CAN-08-3709; Loitto VM, 2007, EXP CELL RES, V313, P1295, DOI 10.1016/j.yexcr.2007.01.023; Machesky LM, 2008, FEBS LETT, V582, P2102, DOI 10.1016/j.febslet.2008.03.039; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; McCroskery S, 2006, MOL CELL NEUROSCI, V33, P15, DOI 10.1016/j.mcn.2006.06.004; Mellor H, 2010, BBA-MOL CELL RES, V1803, P191, DOI 10.1016/j.bbamcr.2008.12.018; Miyashita M, 2004, MOL BIOL CELL, V15, P3950, DOI 10.1091/mbc.E04-01-0019; Nakagawa H, 2003, J CELL SCI, V116, P2577, DOI 10.1242/jcs.00462; Obermeier A, 1998, EMBO J, V17, P4328, DOI 10.1093/emboj/17.15.4328; Pellegrin S, 2005, CURR BIOL, V15, P129, DOI 10.1016/j.cub.2005.01.011; Peng J, 2003, CURR BIOL, V13, P534, DOI 10.1016/S0960-9822(03)00170-2; Radha V, 2007, EXP CELL RES, V313, P2476, DOI 10.1016/j.yexcr.2007.03.019; Ramalingam N, 2010, EUR J CELL BIOL, V89, P723, DOI 10.1016/j.ejcb.2010.06.001; Robles E, 2005, J NEUROSCI, V25, P7669, DOI 10.1523/JNEUROSCI.2680-05.2005; Sarmiento C, 2008, J CELL BIOL, V180, P1245, DOI 10.1083/jcb.200708123; Schirenbeck A, 2006, P NATL ACAD SCI USA, V103, P7694, DOI 10.1073/pnas.0511243103; Sigal YJ, 2007, J CELL SCI, V120, P340, DOI 10.1242/jcs.03335; Soderling SH, 2007, J NEUROSCI, V27, P355, DOI 10.1523/JNEUROSCI.3209-06.2006; Steffen A, 2006, MOL BIOL CELL, V17, P2581, DOI 10.1091/mbc.E05-11-1088; Sudhaharan T, 2009, J BIOL CHEM, V284, P13602, DOI 10.1074/jbc.M900894200; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tokuo H, 2004, BIOCHEM BIOPH RES CO, V319, P214, DOI 10.1016/j.bbrc.2004.04.167; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160; Wood W, 2002, INT J BIOCHEM CELL B, V34, P726, DOI 10.1016/S1357-2725(01)00172-8; Woodring PJ, 2004, J CELL BIOL, V165, P493, DOI 10.1083/jcb.200312171; Xie Y, 2008, J CELL SCI, V121, P514, DOI 10.1242/jcs.013557; Yamana N, 2006, MOL CELL BIOL, V26, P6844, DOI 10.1128/MCB.00283-06; Yang C, 2007, PLOS BIOL, V5, P2624, DOI 10.1371/journal.pbio.0050317; Yang CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005678; Yang L, 2006, MOL BIOL CELL, V17, P4675, DOI 10.1091/mbc.E06-05-0466; Young KG, 2010, BBA-MOL CELL RES, V1803, P183, DOI 10.1016/j.bbamcr.2008.09.017; Zaoui K, 2008, J CELL BIOL, V183, P401, DOI 10.1083/jcb.200805107	66	32	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13681	13694		10.1074/jbc.M110.182683	http://dx.doi.org/10.1074/jbc.M110.182683			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21339294	Green Published, hybrid			2022-12-27	WOS:000289282200086
J	Ikonomov, OC; Sbrissa, D; Delvecchio, K; Xie, YF; Jin, JP; Rappolee, D; Shisheva, A				Ikonomov, Ognian C.; Sbrissa, Diego; Delvecchio, Khortnal; Xie, Yufen; Jin, Jian-Ping; Rappolee, Daniel; Shisheva, Assia			The Phosphoinositide Kinase PIKfyve Is Vital in Early Embryonic Development PREIMPLANTATION LETHALITY OF PIKfyve(-/-) EMBRYOS BUT NORMALITY OF PIKfyve(+/-) MICE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3,5-BISPHOSPHATE; MAMMALIAN ORTHOLOG; VACUOLE FUNCTION; LIPID KINASE; 5-PHOSPHATE; EXPRESSION; FAB1P; 3-PHOSPHATASE; TRAFFICKING; METABOLISM	Gene mutations in the phosphoinositide-metabolizing enzymes are linked to various human diseases. In mammals, PIKfyve synthesizes PtdIns(3,5)P-2 and PtdIns5P lipids that regulate endosomal trafficking and responses to extracellular stimuli. The consequence of pikfyve gene ablation in mammals is unknown. To clarify the importance of PIKfyve and PIKfyve lipid products, in this study, we have characterized the first mouse model with global deletion of the pikfyve gene using the Cre-loxP approach. We report that nearly all PIKfyve(KO/KO) mutant embryos died before the 32-64-cell stage. Cultured fibroblasts derived from PIKfyve(flox/flox) embryos and rendered pikfyve-null by Cre recombinase expression displayed severely reduced DNA synthesis, consistent with impaired cell division causing early embryo lethality. The heterozygous PIKfyve(WT/KO) mice were born at the expected Mendelian ratio and developed into adulthood. PIKfyve(WT/KO) mice were ostensibly normal by several other in vivo, ex vivo, and in vitro criteria despite the fact that their levels of the PIKfyve protein and in vitro enzymatic activity in cells and tissues were 50-55% lower than those of wild-type mice. Consistently, steady-state levels of the PIKfyve products PtdIns(3,5)P-2 and PtdIns5P selectively decreased, but this reduction (35-40%) was 10-15% less than that expected based on PIKfyve protein reduction. The nonlinear decrease of the PIKfyve protein versus PIKfyve lipid products, the potential mechanism(s) discussed herein, may explain how one functional allele in PIKfyve(WT/KO) mice is able to support the demands for PtdIns(3,5)P-2/PtdIns5P synthesis during life. Our data also shed light on the known human disorder linked to PIKFYVE mutations.	[Ikonomov, Ognian C.; Sbrissa, Diego; Delvecchio, Khortnal; Jin, Jian-Ping; Rappolee, Daniel; Shisheva, Assia] Wayne State Univ, Dept Physiol, Sch Med, Detroit, MI 48201 USA; [Xie, Yufen; Rappolee, Daniel] Wayne State Univ, Dept Obstet & Gynecol, Sch Med, Detroit, MI 48201 USA	Wayne State University; Wayne State University	Shisheva, A (corresponding author), Wayne State Univ, Dept Physiol, Sch Med, 540 E Canfield, Detroit, MI 48201 USA.	ashishev@med.wayne.edu	Jin, Jian-Ping/AAD-1149-2020	Delvecchio, Khortnal/0000-0002-5441-5709; Jin, JP/0000-0001-9932-1063	National Institutes of Health [DK58058]; Wayne State University (WSU); WSU School of Medicine Research Offices; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058058] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wayne State University (WSU); WSU School of Medicine Research Offices; American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK58058 (to A. S.). This work was also supported by Wayne State University (WSU) and the WSU School of Medicine Research Offices and the American Diabetes Association (to A. S.).	Balla T, 2006, J ENDOCRINOL, V188, P135, DOI 10.1677/joe.1.06595; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Best MD, 2010, NAT PROD REP, V27, P1403, DOI 10.1039/b923844c; Cooke FT, 1998, CURR BIOL, V8, P1219, DOI 10.1016/S0960-9822(07)00513-1; de Lartigue J, 2009, TRAFFIC, V10, P883, DOI 10.1111/j.1600-0854.2009.00915.x; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Gary JD, 1998, J CELL BIOL, V143, P65, DOI 10.1083/jcb.143.1.65; Ikonomov OC, 2003, MOL BIOL CELL, V14, P4581, DOI 10.1091/mbc.E03-04-0222; Ikonomov OC, 2002, ENDOCRINOLOGY, V143, P4742, DOI 10.1210/en.2002-220615; Ikonomov OC, 2006, AM J PHYSIOL-CELL PH, V291, pC393, DOI 10.1152/ajpcell.00019.2006; Ikonomov OC, 2010, J BIOL CHEM, V285, P26760, DOI 10.1074/jbc.C110.154658; Ikonomov OC, 2009, J BIOL CHEM, V284, P35794, DOI 10.1074/jbc.M109.037515; Ikonomov OC, 2009, J BIOL CHEM, V284, P3750, DOI 10.1074/jbc.M806539200; Jefferies HBJ, 2008, EMBO REP, V9, P164, DOI 10.1038/sj.embor.7401155; Ko MSH, 2000, DEVELOPMENT, V127, P1737; Li SL, 2005, AM J HUM GENET, V77, P54, DOI 10.1086/431346; Majerus PW, 2009, J LIPID RES, V50, pS249, DOI 10.1194/jlr.R800072-JLR200; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Michell RH, 2006, TRENDS BIOCHEM SCI, V31, P52, DOI 10.1016/j.tibs.2005.11.013; Miki H, 2001, MOL CELL BIOL, V21, P2521, DOI 10.1128/MCB.21.7.2521-2532.2001; Nicot AS, 2006, MOL BIOL CELL, V17, P3062, DOI 10.1091/mbc.e05-12-1120; Ooms LM, 2009, BIOCHEM J, V419, P29, DOI 10.1042/BJ20081673; RAPPOLEE DA, 2011, INT REV CEL MOL BIO, V287, P43; Roberts HF, 2005, FEBS LETT, V579, P2868, DOI 10.1016/j.febslet.2005.04.027; Rusten TE, 2006, MOL BIOL CELL, V17, P3989, DOI 10.1091/mbc.E06-03-0239; Rutherford AC, 2006, J CELL SCI, V119, P3944, DOI 10.1242/jcs.03153; Sagona AP, 2010, NAT CELL BIOL, V12, P362, DOI 10.1038/ncb2036; Sbrissa D, 1999, J BIOL CHEM, V274, P21589, DOI 10.1074/jbc.274.31.21589; Sbrissa D, 2004, MOL CELL BIOL, V24, P10437, DOI 10.1128/MCB.24.23.10437-10447.2004; Sbrissa D, 2004, ENDOCRINOLOGY, V145, P4853, DOI 10.1210/en.2004-0489; Sbrissa D, 2002, J BIOL CHEM, V277, P47276, DOI 10.1074/jbc.M207576200; Sbrissa D, 2002, J BIOL CHEM, V277, P6073, DOI 10.1074/jbc.M110194200; Sbrissa D, 2007, J BIOL CHEM, V282, P23878, DOI 10.1074/jbc.M611678200; Sbrissa D, 2008, J MOL BIOL, V384, P766, DOI 10.1016/j.jmb.2008.10.009; Shisheva A, 2008, CELL BIOL INT, V32, P591, DOI 10.1016/j.cellbi.2008.01.006; Tolias KF, 1998, J BIOL CHEM, V273, P18040, DOI 10.1074/jbc.273.29.18040; Tronchere H, 2004, J BIOL CHEM, V279, P7304, DOI 10.1074/jbc.M311071200; Vicinanza M, 2008, CELL MOL LIFE SCI, V65, P2833, DOI 10.1007/s00018-008-8353-2; Walker DM, 2001, CURR BIOL, V11, P1600, DOI 10.1016/S0960-9822(01)00501-2; Wang QT, 2004, DEV CELL, V6, P133, DOI 10.1016/S1534-5807(03)00404-0; Wang YC, 2005, FERTIL STERIL, V83, P1144, DOI 10.1016/j.fertnstert.2004.08.038; Whiteford CC, 1996, BIOCHEM J, V319, P851, DOI 10.1042/bj3190851; Whitley P, 2009, PLANT PHYSIOL, V151, P1812, DOI 10.1104/pp.109.146159; YAMAMOTO A, 1995, MOL BIOL CELL, V6, P525, DOI 10.1091/mbc.6.5.525; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P17518, DOI 10.1073/pnas.0702275104	45	94	99	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13404	13413		10.1074/jbc.M111.222364	http://dx.doi.org/10.1074/jbc.M111.222364			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21349843	hybrid, Green Published			2022-12-27	WOS:000289282200060
J	Mazzone, A; Bernard, CE; Strege, PR; Beyder, A; Galietta, LJV; Pasricha, PJ; Rae, JL; Parkman, HP; Linden, DR; Szurszewski, JH; Ordog, T; Gibbons, SJ; Farrugia, G				Mazzone, Amelia; Bernard, Cheryl E.; Strege, Peter R.; Beyder, Arthur; Galietta, Luis J. V.; Pasricha, Pankaj J.; Rae, James L.; Parkman, Henry P.; Linden, David R.; Szurszewski, Joseph H.; Oerdoeg, Tamas; Gibbons, Simon J.; Farrugia, Gianrico			Altered Expression of Ano1 Variants in Human Diabetic Gastroparesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-ACTIVATED CL-CONDUCTANCE; NEURONAL NITRIC-OXIDE; INTERSTITIAL-CELLS; GASTROINTESTINAL-TRACT; CARBON-MONOXIDE; SMOOTH-MUSCLE; CAJAL; CHANNEL; RECEPTOR; DISEASE	Diabetes affects many organs including the stomach. Altered number and function of interstitial cells of Cajal (ICC), the gastrointestinal pacemaker cells, underlie a number of gastrointestinal motility disorders, including diabetic gastroparesis. In the muscle layers, ICC selectively express Ano1, thought to underlie classical Ca2+-activated Cl- currents. Mice homozygous for Ano1 knock-out exhibit abnormal ICC function and motility. Several transcripts for Ano1 are generated by alternative splicing of four exons. Here, we report expression levels of transcripts encoded by alternative splicing of Ano1 gene in gastric muscles of patients with diabetic gastroparesis and nondiabetic control tissues. Expression of mRNA from two alternatively transcribed exons are significantly different between patients and controls. Furthermore, patients with diabetic gastroparesis express mRNA for a previously unknown variant of Ano1. The 5' end of this novel variant lacks exons 1 and 2 and part of exon 3. Expression of this variant in HEK cells produces a decreased density of Ca2+-activated Cl- currents that exhibit slower kinetics compared with the full-length Ano1. These results identify important changes in expression and splicing of Ano1 in patients with diabetic gastroparesis that alter the electrophysiological properties of the channel. Changes in Ano1 expression in ICC may directly contribute to diabetic gastroparesis.	[Mazzone, Amelia; Bernard, Cheryl E.; Strege, Peter R.; Beyder, Arthur; Rae, James L.; Linden, David R.; Szurszewski, Joseph H.; Oerdoeg, Tamas; Gibbons, Simon J.; Farrugia, Gianrico] Mayo Clin, Div Gastroenterol & Hepatol, Dept Physiol & Biomed Engn, Enter Neurosci Program,Coll Med, Rochester, MN 55905 USA; [Galietta, Luis J. V.] Ist Giannina Gaslini, Mol Genet Lab, I-16147 Genoa, Italy; [Pasricha, Pankaj J.] Stanford Univ, Sch Med, Dept Med, Div Gastroenterol, Stanford, CA 94305 USA; [Parkman, Henry P.] Temple Univ, Sch Med, Dept Med, Philadelphia, PA 19140 USA	Mayo Clinic; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Genoa; IRCCS Istituto Giannina Gaslini; Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Farrugia, G (corresponding author), Mayo Clin, Div Gastroenterol & Hepatol, Dept Physiol & Biomed Engn, Enter Neurosci Program,Coll Med, 200 1st St SW, Rochester, MN 55905 USA.	farrugia.gianrico@mayo.edu	Galietta, Luis JV/HCG-8692-2022; yang, xiao-jun/B-1927-2009	Harrington, Jon/0000-0003-1293-5201; MAZZONE, Amelia/0000-0001-6236-6962; Gibbons, Simon/0000-0001-5311-5993; Galietta, Luis/0000-0001-8686-3461; Strege, Peter/0000-0003-4571-2207	National Institutes of Health [DK57061, DK52766, DK84567, DK73983, DK74008]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK074008, U01DK074035, R01DK052766, U24DK074008, R01DK057061, U01DK073983, P30DK084567] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK57061, DK52766, DK84567, DK73983, and DK74008.	Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Castrignano T, 2008, BIOINFORMATICS, V24, P1300, DOI 10.1093/bioinformatics/btn113; Cheng TH, 2007, MOL CELL BIOL, V27, P111, DOI 10.1128/MCB.00235-06; Choi KM, 2007, NEUROGASTROENT MOTIL, V19, P585, DOI 10.1111/j.1365-2982.2007.00936.x; Courtois S, 2002, ONCOGENE, V21, P6722, DOI 10.1038/sj.onc.1205874; Espinosa I, 2008, AM J SURG PATHOL, V32, P210, DOI 10.1097/PAS.0b013e3181238cec; Farrugia G, 2008, NEUROGASTROENT MOTIL, V20, P54, DOI 10.1111/j.1365-2982.2008.01109.x; Farrugia G, 1999, MICROSC RES TECHNIQ, V47, P321, DOI 10.1002/(SICI)1097-0029(19991201)47:5<321::AID-JEMT3>3.0.CO;2-J; Ferrera L, 2009, J BIOL CHEM, V284, P33360, DOI 10.1074/jbc.M109.046607; Gibbons SJ, 2004, J PHYSIOL-LONDON, V556, P325, DOI 10.1113/jphysiol.2003.056556; Gomez-Pinilla PJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1370, DOI 10.1152/ajpgi.00074.2009; He CL, 2001, GASTROENTEROLOGY, V121, P427, DOI 10.1053/gast.2001.26264; Hwang SJ, 2009, J PHYSIOL-LONDON, V587, P4887, DOI 10.1113/jphysiol.2009.176198; Iwasaki H, 2006, J GASTROENTEROL, V41, P1076, DOI 10.1007/s00535-006-1909-8; Kraichely RE, 2007, NEUROGASTROENT MOTIL, V19, P245, DOI 10.1111/j.1365-2982.2006.00880.x; Kunzelmann K, 2007, PFLUG ARCH EUR J PHY, V454, P879, DOI 10.1007/s00424-007-0245-z; Lareau LF, 2004, CURR OPIN STRUC BIOL, V14, P273, DOI 10.1016/j.sbi.2004.05.002; Large WA, 1996, AM J PHYSIOL-CELL PH, V271, pC435; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Liu F, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-8; Liu S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009482; Miller SM, 2008, NEUROGASTROENT MOTIL, V20, P349, DOI 10.1111/j.1365-2982.2007.01040.x; Ordog T, 2000, DIABETES, V49, P1731, DOI 10.2337/diabetes.49.10.1731; Pasricha PJ, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-21; Pedersen AG, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P226; Reisert J, 2003, J GEN PHYSIOL, V122, P349, DOI 10.1085/jgp.200308888; Sanders KM, 2006, ANNU REV PHYSIOL, V68, P307, DOI 10.1146/annurev.physiol.68.040504.094718; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Tian YM, 2011, FASEB J, V25, P1058, DOI 10.1096/fj.10-166884; Ward AJ, 2010, J PATHOL, V220, P152, DOI 10.1002/path.2649; Ward SM, 2006, J PHYSIOL-LONDON, V576, P675, DOI 10.1113/jphysiol.2006.117390; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yudt MR, 2002, MOL ENDOCRINOL, V16, P1719, DOI 10.1210/me.2002-0106; Zhu MH, 2009, J PHYSIOL-LONDON, V587, P4905, DOI 10.1113/jphysiol.2009.176206	34	83	85	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13393	13403		10.1074/jbc.M110.196089	http://dx.doi.org/10.1074/jbc.M110.196089			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21349842	Green Published, hybrid			2022-12-27	WOS:000289282200059
J	Ruiz, PA; Jarai, G				Ruiz, Pedro A.; Jarai, Gabor			Collagen I Induces Discoidin Domain Receptor (DDR) 1 Expression through DDR2 and a JAK2-ERK1/2-mediated Mechanism in Primary Human Lung Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX-METALLOPROTEINASE EXPRESSION; TO-MESENCHYMAL TRANSITION; HEPATIC STELLATE CELLS; EXTRACELLULAR-MATRIX; STROMELYSIN-2 MMP-10; TYROSINE KINASES; BETA(1) INTEGRIN; GROWTH-FACTORS; 2 ACTIVATION; MIGRATION	Discoidin domain receptors (DDRs) DDR1 and DDR2 are receptor tyrosine kinases with the unique ability among receptor tyrosine kinases to respond to collagen. Several signaling molecules have been implicated in DDR signaling, including Shp-2, Src, and MAPK pathways, but a detailed understanding of these pathways and their transcriptional targets is still lacking. Similarly, the regulation of the expression of DDRs is poorly characterized with only a few inflammatory mediators, such as lipopolysaccharide and interleukin-1 beta identified as playing a role in DDR1 expression. DDRs have been reported to induce the expression of various genes including matrix metalloproteinases and bone morphogenetic proteins, but the regulatory mechanisms underlying DDR-induced gene expression remain to be determined. The aim of the present work was to elucidate the molecular mechanisms implicated in the expression of DDRs and to identify DDR-induced signaling pathways and target genes. Our data show that collagen I induces the expression of DDR1 in a dose- and time-dependent manner in primary human lung fibroblasts. Furthermore, activation of DDR2, JAK2, and ERK1/2 MAPK signaling pathways was essential for collagen I-induced DDR1 and matrix metalloproteinase 10 expression. Finally, inhibition of the ERK1/2 pathway abrogated DDR1 expression by blocking the recruitment of the transcription factor polyoma enhancer A-binding protein 3 to the DDR1 promoter. Our data provide new insights into the molecular mechanisms of collagen I-induced DDR1 expression and demonstrate an important role for ERK1/2 activation and the recruitment of polyoma enhancer-A binding protein 3 to the DDR1 promoter.	[Ruiz, Pedro A.; Jarai, Gabor] Novartis Inst Biomed Res, Resp Dis Area, Horsham RH12 5AB, W Sussex, England	Novartis	Jarai, G (corresponding author), Novartis Inst Biomed Res, Resp Dis Area, Wirnblehurst Rd, Horsham RH12 5AB, W Sussex, England.	gabor.jarai@novartis.com		Ruiz-Castro, Pedro Antonio/0000-0001-7528-1474	Novartis Institutes for Biomedical Research	Novartis Institutes for Biomedical Research	This work was supported by the Postdoctoral Program of the Novartis Institutes for Biomedical Research.	ALVES F, 1995, ONCOGENE, V10, P609; Avivi-Green C, 2006, AM J RESP CRIT CARE, V174, P420, DOI 10.1164/rccm.200603-333OC; Balduino A, 2005, CELL TISSUE RES, V319, P255, DOI 10.1007/s00441-004-1006-3; Benbow U, 1997, MATRIX BIOL, V15, P519, DOI 10.1016/S0945-053X(97)90026-3; Chen SC, 2008, BIOCHEM BIOPH RES CO, V374, P662, DOI 10.1016/j.bbrc.2008.07.092; Chin GS, 2001, PLAST RECONSTR SURG, V107, P769, DOI 10.1097/00006534-200103000-00018; Choi M, 2008, TOXICOL LETT, V182, P97, DOI 10.1016/j.toxlet.2008.08.019; Crawford HC, 1996, ENZYME PROTEIN, V49, P20, DOI 10.1159/000468614; Curran S, 2000, EUR J CANCER, V36, P1621, DOI 10.1016/S0959-8049(00)00156-8; Das S, 2006, CANCER RES, V66, P8123, DOI 10.1158/0008-5472.CAN-06-1215; Day E, 2008, EUR J PHARMACOL, V599, P44, DOI 10.1016/j.ejphar.2008.10.014; Faraci E, 2003, MATRIX BIOL, V22, P373, DOI 10.1016/S0945-053X(03)00053-2; Faraci-Orf E, 2006, J CELL BIOCHEM, V97, P109, DOI 10.1002/jcb.20618; Ferri N, 2004, AM J PATHOL, V164, P1575, DOI 10.1016/S0002-9440(10)63716-9; Gilles C, 1998, CANCER RES, V58, P5529; Goetze S, 2001, ATHEROSCLEROSIS, V159, P93, DOI 10.1016/S0021-9150(01)00497-X; Gum R, 1997, ONCOGENE, V14, P1481, DOI 10.1038/sj.onc.1200973; Henry MT, 2002, EUR RESPIR J, V20, P1220, DOI 10.1183/09031936.02.00022302; Hou GP, 2002, CIRC RES, V90, P1147, DOI 10.1161/01.RES.0000022166.74073.F8; Ikeda K, 2002, J BIOL CHEM, V277, P19206, DOI 10.1074/jbc.M201078200; Kamohara H, 2001, FASEB J, V15, P2724, DOI 10.1096/fj.01-0359fje; Kerkela E, 2001, BRIT J CANCER, V84, P659, DOI 10.1054/bjoc.2000.1634; Koo DHH, 2006, FEBS LETT, V580, P15, DOI 10.1016/j.febslet.2005.11.035; Krampert M, 2004, MOL BIOL CELL, V15, P5242, DOI 10.1091/mbc.E04-02-0109; Labrador JP, 2001, EMBO REP, V2, P446, DOI 10.1093/embo-reports/kve094; Lakka SS, 2002, ONCOGENE, V21, P5601, DOI 10.1038/sj.onc.1205646; Lloyd GM, 1997, J EXP MED, V185, P1371, DOI 10.1084/jem.185.7.1371; Madlener M, 1996, BIOCHEM J, V320, P659, DOI 10.1042/bj3200659; McKeown S, 2009, EUR RESPIR J, V33, P77, DOI 10.1183/09031936.00060708; Morrissey J, 2002, J AM SOC NEPHROL, V13, pS14; Myllarniemi M, 2008, AM J RESP CRIT CARE, V177, P321, DOI 10.1164/rccm.200706-945OC; Nelson AR, 2000, J CLIN ONCOL, V18, P1135, DOI 10.1200/JCO.2000.18.5.1135; Olaso E, 2002, J BIOL CHEM, V277, P3606, DOI 10.1074/jbc.M107571200; Olaso E, 2001, J CLIN INVEST, V108, P1369, DOI 10.1172/JCI12373; Ongusaha PP, 2003, EMBO J, V22, P1289, DOI 10.1093/emboj/cdg129; Schnabl B, 2005, BIOCHEM BIOPH RES CO, V335, P87, DOI 10.1016/j.bbrc.2005.07.043; Selman M, 2008, PLOS MED, V5, P373, DOI 10.1371/journal.pmed.0050062; SELTZER JL, 1994, EXP CELL RES, V213, P365, DOI 10.1006/excr.1994.1211; Shin M, 2002, BBA-MOL CELL RES, V1589, P311, DOI 10.1016/S0167-4889(02)00195-7; Shintani Y, 2008, J CELL BIOL, V180, P1277, DOI 10.1083/jcb.200708137; Shintani Y, 2008, AM J RESP CELL MOL, V38, P95, DOI 10.1165/rcmb.2007-0071OC; Shrivastava A, 1997, MOL CELL, V1, P25, DOI 10.1016/S1097-2765(00)80004-0; SMITH RE, 1995, J LEUKOCYTE BIOL, V57, P782, DOI 10.1002/jlb.57.5.782; Su J, 2009, MOL CELL BIOCHEM, V330, P141, DOI 10.1007/s11010-009-0127-0; Theret N, 1999, HEPATOLOGY, V30, P462, DOI 10.1002/hep.510300236; Vogel W, 2000, J BIOL CHEM, V275, P5779, DOI 10.1074/jbc.275.8.5779; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Vogel WF, 2006, CELL SIGNAL, V18, P1108, DOI 10.1016/j.cellsig.2006.02.012; Wahab NA, 2006, NEPHRON EXP NEPHROL, V104, pE129, DOI 10.1159/000094963; Walker JL, 2005, CANCER METAST REV, V24, P383, DOI 10.1007/s10555-005-5130-7; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Wilkins JA, 1996, J BIOL CHEM, V271, P3046, DOI 10.1074/jbc.271.6.3046; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yan CH, 2007, J CELL PHYSIOL, V211, P19, DOI 10.1002/jcp.20948; Yang K, 2005, J BIOL CHEM, V280, P39058, DOI 10.1074/jbc.M506921200; Yoshimura T, 2005, IMMUNOL RES, V31, P219, DOI 10.1385/IR:31:3:219	57	48	50	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					12912	12923		10.1074/jbc.M110.143693	http://dx.doi.org/10.1074/jbc.M110.143693			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21335558	Green Published, hybrid			2022-12-27	WOS:000289282200011
J	Joly, N; Buck, M				Joly, Nicolas; Buck, Martin			Single Chain Forms of the Enhancer Binding Protein PspF Provide Insights into Geometric Requirements for Gene Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AAA PLUS PROTEIN; ESCHERICHIA-COLI; RNA-POLYMERASE; TRANSCRIPTIONAL ACTIVATION; SIGMA(54) SIGMA(N); STRUCTURAL BASIS; DNA-REPLICATION; ATP-HYDROLYSIS; PROMOTER DNA; PORE LOOPS	Genetic information in the DNA is accessed by the molecular machine RNA polymerase following a highly conserved process, invariably involving the transition between double-stranded and single-stranded DNA states. In the case of the bacterial enhancer-dependent RNA polymerase (which is essential for adaptive responses and bacterial pathogenesis), the DNA melting event depends on specialized hexameric AAA+ ATPase activators. Involvement of such factors in transcription was demonstrated 25 years ago, but why these activators need to be hexameric, whether all the subunits operate identically, what is the contribution of each of the six subunits within the hexamer (structural, functional, or both), and how many active subunits are required for transcription activation remain open questions. Using engineered single-chain polypeptides covalently linking two or three subunits of the activator (allowing the subunit distribution within a hexamer to be fixed), we now show that (i) individual subunits have differential contributions to the activities of the oligomer and (ii) only a fraction of the subunits within the hexameric ATPase is directly required for gene activation. We establish that nucleotide-dependent coordination across three subunits of the hexameric bacterial enhancer binding proteins (bEBPs) is necessary for engagement and remodeling of the closed complex (RPc). Outcomes revealed features of bEBP, distinguishing their mode of action from fully processive AAA+ proteins or from simple bimodal switches. We now propose that the hexamer functions with asymmetric organization, potentially involving a split planar (open ring) or spiral character.	Univ Paris Diderot, Inst Jacques Monod, CNRS UMR 7592, F-75205 Paris 13, France; [Joly, Nicolas; Buck, Martin] Univ London Imperial Coll Sci Technol & Med, Div Biol, London SW7 2AZ, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Imperial College London	Joly, N (corresponding author), Univ Paris Diderot, Inst Jacques Monod, CNRS UMR 7592, Batiment Buffon,15 Rue Helene Brion, F-75205 Paris 13, France.	joly@ijm.univ-paris-diderot.fr; m.buck@imperial.ac.uk	Joly, Nicolas/H-6851-2018	Joly, Nicolas/0000-0003-2731-3827	Biotechnology and Biological Sciences Research Council [BB/G001278/1]; BBSRC [BB/G001278/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant BB/G001278/1.	Barry ER, 2009, P NATL ACAD SCI USA, V106, P1051, DOI 10.1073/pnas.0809192106; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Bordes P, 2003, P NATL ACAD SCI USA, V100, P2278, DOI 10.1073/pnas.0537525100; Bose D, 2008, MOL CELL, V32, P337, DOI 10.1016/j.molcel.2008.09.015; Buck M, 2000, J BACTERIOL, V182, P4129, DOI 10.1128/JB.182.15.4129-4136.2000; BUCK M, 1992, NATURE, V358, P422, DOI 10.1038/358422a0; Burrows PC, 2010, P NATL ACAD SCI USA, V107, P9376, DOI 10.1073/pnas.1001188107; Cannon WV, 2000, NAT STRUCT BIOL, V7, P594; Chaney M, 2001, GENE DEV, V15, P2282, DOI 10.1101/gad.205501; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Hoskins JR, 2009, P NATL ACAD SCI USA, V106, P22233, DOI 10.1073/pnas.0911937106; Ishihama A, 2000, ANNU REV MICROBIOL, V54, P499, DOI 10.1146/annurev.micro.54.1.499; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Joly N, 2006, J BIOL CHEM, V281, P34997, DOI 10.1074/jbc.M606628200; Joly N, 2010, J BIOL CHEM, V285, P15178, DOI 10.1074/jbc.M110.103150; Jovanovic G, 1997, MOL MICROBIOL, V25, P473, DOI 10.1046/j.1365-2958.1997.4791844.x; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Martin A, 2008, MOL CELL, V29, P441, DOI 10.1016/j.molcel.2008.02.002; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P139, DOI 10.1038/nsmb.1380; MERRICK MJ, 1993, MOL MICROBIOL, V10, P903, DOI 10.1111/j.1365-2958.1993.tb00961.x; Model P, 1997, MOL MICROBIOL, V24, P255, DOI 10.1046/j.1365-2958.1997.3481712.x; Moreau MJ, 2007, MOL CELL, V28, P304, DOI 10.1016/j.molcel.2007.08.013; Mott ML, 2008, CELL, V135, P623, DOI 10.1016/j.cell.2008.09.058; Neuwald AF, 1999, GENOME RES, V9, P27; NORBY JG, 1988, METHOD ENZYMOL, V156, P116; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Ogura T, 2008, BIOCHEM SOC T, V36, P68, DOI 10.1042/BST0360068; Rappas M, 2006, J MOL BIOL, V357, P481, DOI 10.1016/j.jmb.2005.12.052; Rappas M, 2005, SCIENCE, V307, P1972, DOI 10.1126/science.1105932; Roberts AJ, 2009, CELL, V136, P485, DOI 10.1016/j.cell.2008.11.049; Schumacher J, 2006, J STRUCT BIOL, V156, P190, DOI 10.1016/j.jsb.2006.01.006; Schwacha A, 2001, MOL CELL, V8, P1093, DOI 10.1016/S1097-2765(01)00389-6; Thomsen ND, 2009, CELL, V139, P523, DOI 10.1016/j.cell.2009.08.043; Tucker PA, 2007, CURR OPIN STRUC BIOL, V17, P641, DOI 10.1016/j.sbi.2007.09.012; Wigneshweplaraj SR, 2005, PROG NUCLEIC ACID RE, V79, P339, DOI 10.1016/S0079-6603(04)79007-8; Zhang X, 2002, MOL MICROBIOL, V45, P895, DOI 10.1046/j.1365-2958.2002.03065.x	41	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.203554	http://dx.doi.org/10.1074/jbc.M110.203554			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21300807	hybrid, Green Published			2022-12-27	WOS:000289077500084
J	Oloo, EO; Yethon, JA; Ochs, MM; Carpick, B; Oomen, R				Oloo, Eliud O.; Yethon, Jeremy A.; Ochs, Martina M.; Carpick, Bruce; Oomen, Raymond			Structure-guided Antigen Engineering Yields Pneumolysin Mutants Suitable for Vaccination against Pneumococcal Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLESTEROL-DEPENDENT CYTOLYSINS; STREPTOCOCCUS-PNEUMONIAE; PROTEIN CONFORMATION; MOLECULAR-DYNAMICS; TOXIN PNEUMOLYSIN; MEMBRANE-PROTEINS; PORE FORMATION; VACCINES; STABILIZATION; IMMUNIZATION	Pneumolysin (PLY) is a cholesterol-binding, pore-forming protein toxin. It is an important virulence factor of Streptococcus pneumoniae and a key vaccine target against pneumococcal disease. We report a systematic structure-driven approach that solves a long-standing problem for vaccine development in this field: detoxification of PLY with retention of its antigenic integrity. Using three conformational restraint techniques, we rationally designed variants of PLY that lack hemolytic activity and yet induce neutralizing antibodies against the wild-type toxin. These results represent a key milestone toward a broad-spectrum protein-based pneumococcal vaccine and illustrate the value of structural knowledge in formulating effective strategies for antigen optimization.	[Oloo, Eliud O.; Yethon, Jeremy A.; Ochs, Martina M.; Carpick, Bruce; Oomen, Raymond] Sanofi Pasteur, Toronto, ON M2R 3T4, Canada	Sanofi-Aventis	Oloo, EO (corresponding author), Sanofi Pasteur, 38 Sidney St, Cambridge, MA 02139 USA.	eliud.oloo@sanofipasteur.com						ALEXANDER JE, 1994, INFECT IMMUN, V62, P5683, DOI 10.1128/IAI.62.12.5683-5688.1994; [Anonymous], 2003, Weekly Epidemiological Record, V78, P110; Ash WL, 2004, BBA-BIOMEMBRANES, V1666, P158, DOI 10.1016/j.bbamem.2004.04.012; Berman HM, 2009, NUCLEIC ACIDS RES, V37, pD365, DOI 10.1093/nar/gkn790; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BERRY AM, 1995, INFECT IMMUN, V63, P1969, DOI 10.1128/IAI.63.5.1969-1974.1995; Black S, 2008, VACCINES, P531; Choi EJ, 2006, PROTEIN ENG DES SEL, V19, P285, DOI 10.1093/protein/gzl007; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Del Giudice G, 1999, SCHWEIZ MED WSCHR, V129, P1744; Dill KA, 2008, ANNU REV BIOPHYS, V37, P289, DOI 10.1146/annurev.biophys.37.092707.153558; Dormitzer PR, 2008, TRENDS BIOTECHNOL, V26, P659, DOI 10.1016/j.tibtech.2008.08.002; Douek DC, 2006, CELL, V124, P677, DOI 10.1016/j.cell.2006.02.005; FELDMAN C, 1991, AM J RESP CELL MOL, V5, P416, DOI 10.1165/ajrcmb/5.5.416; FERRANTE A, 1984, INFECT IMMUN, V46, P585, DOI 10.1128/IAI.46.2.585-589.1984; GIANNINI G, 1984, NUCLEIC ACIDS RES, V12, P4063, DOI 10.1093/nar/12.10.4063; Gilbert RJC, 2002, CELL MOL LIFE SCI, V59, P832, DOI 10.1007/s00018-002-8471-1; Hadders MA, 2007, SCIENCE, V317, P1552, DOI 10.1126/science.1147103; Hotze EM, 2001, J BIOL CHEM, V276, P8261, DOI 10.1074/jbc.M009865200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kirkham LAS, 2006, INFECT IMMUN, V74, P586, DOI 10.1128/IAI.74.1.586-593.2006; Korchev YE, 1998, BIOCHEM J, V329, P571; Lindahl E, 2008, CURR OPIN STRUC BIOL, V18, P425, DOI 10.1016/j.sbi.2008.02.003; LOCK RA, 1988, MICROB PATHOGENESIS, V5, P461, DOI 10.1016/0882-4010(88)90007-1; MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H; MITCHELL TJ, 1990, NUCLEIC ACIDS RES, V18, P4010, DOI 10.1093/nar/18.13.4010; Nollmann M, 2004, BIOPHYS J, V86, P3141, DOI 10.1016/S0006-3495(04)74362-3; Paton James C., 2008, P421; PATON JC, 1983, INFECT IMMUN, V40, P548, DOI 10.1128/IAI.40.2.548-552.1983; PATON JC, 1983, INFECT IMMUN, V41, P1212, DOI 10.1128/IAI.41.3.1212-1216.1983; Paton JC, 1996, TRENDS MICROBIOL, V4, P103, DOI 10.1016/0966-842X(96)81526-5; Pletz MW, 2008, INT J ANTIMICROB AG, V32, P199, DOI 10.1016/j.ijantimicag.2008.01.021; Polekhina G, 2005, P NATL ACAD SCI USA, V102, P600, DOI 10.1073/pnas.0403229101; Ramachandran R, 2004, NAT STRUCT MOL BIOL, V11, P697, DOI 10.1038/nsmb793; RAPPUOLI R, 1994, VACCINE, V12, P579, DOI 10.1016/0264-410X(94)90259-3; Reiter Y, 1995, PROTEIN ENG, V8, P1323, DOI 10.1093/protein/8.12.1323; Rosado CJ, 2007, SCIENCE, V317, P1548, DOI 10.1126/science.1144706; Rossjohn J, 1997, CELL, V89, P685, DOI 10.1016/S0092-8674(00)80251-2; Rossjohn J, 2007, J MOL BIOL, V367, P1227, DOI 10.1016/j.jmb.2007.01.042; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; SAUNDERS FK, 1989, INFECT IMMUN, V57, P2547, DOI 10.1128/IAI.57.8.2547-2552.1989; Schueler-Furman O, 2005, SCIENCE, V310, P638, DOI 10.1126/science.1112160; SOWDHAMINI R, 1989, PROTEIN ENG, V3, P95, DOI 10.1093/protein/3.2.95; Tilley SJ, 2005, CELL, V121, P247, DOI 10.1016/j.cell.2005.02.033; Vieille C, 1996, Biotechnol Annu Rev, V2, P1, DOI 10.1016/S1387-2656(08)70006-1; Walz T, 2005, MOL CELL, V18, P393, DOI 10.1016/j.molcel.2005.04.018; Wriggers W, 1997, PROTEINS, V29, P1	47	26	30	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.191148	http://dx.doi.org/10.1074/jbc.M110.191148			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21296887	Green Published, hybrid			2022-12-27	WOS:000289077500028
J	Tu, QS; Zhang, J; Dong, LQ; Saunders, E; Luo, E; Tang, JA; Chen, JK				Tu, Qisheng; Zhang, Jin; Dong, Lily Q.; Saunders, Eileen; Luo, En; Tang, Jean; Chen, Jake			Adiponectin Inhibits Osteoclastogenesis and Bone Resorption via APPL1-mediated Suppression of Akt1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-2 DIABETES-MELLITUS; BODY-MASS INDEX; MINERAL DENSITY; ADIPOSE-TISSUE; PERIODONTAL-DISEASE; INSULIN-RESISTANCE; PLASMA-CONCENTRATIONS; SIGNALING PATHWAY; IN-VIVO; OBESITY	Adiponectin is an adipokine playing an important role in regulating energy homeostasis and insulin sensitivity. However, the effect of adiponectin on bone metabolism shows contradictory results according to different research studies. In this study femurs were isolated from genetically double-labeled mBSP9.0Luc/beta-ACT-EGFP transgenic mice and were transplanted into adiponectin knock-out mice or wild type mice to investigate the effect of temporary exposure to adiponectin deficiency on bone growth and metabolism. We found that the growth of bone explants in adiponectin knock-out mice was significantly retarded. Histological analysis, microcomputed tomography analysis, and tartrate-resistant acid phosphatase staining revealed reduced trabecular bone volume, decreased cortical bone, and increased osteoclast number in bone explants in adiponectin knock-out mice. We then found that adiponectin inhibits RANKL-induced osteoclastogenesis from RAW264.7 cells and down-regulates RANKL-enhanced expressions of osteoclastogenic regulators including NFAT2, TRAF6, cathepsin K, and tartrate-resistant acid phosphatase. Adiponectin also increases osteoclast apoptosis and decreases survival/proliferation of osteoclast precursor cells. Using siRNA specifically targeting APPL1, the first identified adaptor protein of adiponectin signaling, we found that the inhibitory effect of adiponectin on osteoclasts was induced by APPL1-mediated down-regulation of Akt1 activity. In addition, overexpression of Akt1 successfully reversed adiponectin- induced inhibition in RANKL-stimulated osteoclast differentiation. In conclusion, adiponectin is important in maintaining the balance of energy metabolism, inflammatory responses, and bone formation.	[Tu, Qisheng; Zhang, Jin; Saunders, Eileen; Luo, En; Tang, Jean; Chen, Jake] Tufts Univ, Sch Dent Med, Dept Gen Dent, Div Oral Biol, Boston, MA 02111 USA; [Zhang, Jin] Shandong Univ, Sch Dent, Jinan 250012, Shandong, Peoples R China; [Dong, Lily Q.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol Cellular & Struct Biol, San Antonio, TX 78229 USA; [Dong, Lily Q.] Univ Texas Hlth Sci Ctr San Antonio, Barshop Ctr Longev & Aging Studies, San Antonio, TX 78229 USA	Tufts University; Shandong University; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Chen, JK (corresponding author), Tufts Univ, Sch Dent Med, Dept Gen Dent, Div Oral Biol, Boston, MA 02111 USA.	jk.chen@tufts.edu		Luo, En/0000-0002-7447-1097; Tu, Qisheng/0000-0003-0639-8761; Chen, Jake/0000-0001-8829-7504	National Institutes of Health [DE14537, DE16710]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014537, R01DE016710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080344] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant Grants DE14537 and DE16710 (to J. C.)	Adachi M, 2008, HEPATOLOGY, V47, P677, DOI 10.1002/hep.21991; Araneta MRG, 2009, J BONE MINER RES, V24, P2016, DOI [10.1359/JBMR.090519, 10.1359/jbmr.090519]; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cyert MS, 2001, J BIOL CHEM, V276, P20805, DOI 10.1074/jbc.R100012200; Dacquin R, 2004, J CELL BIOL, V164, P509, DOI 10.1083/jcb.200312135; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Ealey KN, 2008, EXP BIOL MED, V233, P1546, DOI 10.3181/0806-RM-192; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Friedman JM, 2000, NATURE, V404, P632, DOI 10.1038/35007504; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Goulding A, 2005, J BONE MINER RES, V20, P2090, DOI 10.1359/JBMR.050820; Hanada M, 2004, BBA-PROTEINS PROTEOM, V1697, P3, DOI 10.1016/j.bbapap.2003.11.009; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167; Hirotani H, 2004, J BIOL CHEM, V279, P13984, DOI 10.1074/jbc.M213067200; Hotta K, 2001, DIABETES, V50, P1126, DOI 10.2337/diabetes.50.5.1126; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Hsu YH, 2006, AM J CLIN NUTR, V83, P146; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Kanazawa I, 2010, METABOLISM, V59, P1252, DOI 10.1016/j.metabol.2009.11.017; Kumada M, 2004, CIRCULATION, V109, P2046, DOI 10.1161/01.CIR.0000127953.98131.ED; Lee HW, 2009, STEM CELLS, V27, P2254, DOI 10.1002/stem.144; Lenchik L, 2003, BONE, V33, P646, DOI 10.1016/S8756-3282(03)00237-0; Li S, 2008, J CELL PHYSIOL, V215, P204, DOI 10.1002/jcp.21302; Luo XH, 2006, J BONE MINER RES, V21, P1648, DOI 10.1359/JBMR.060707; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; NELSON RG, 1990, DIABETES CARE, V13, P836, DOI 10.2337/diacare.13.8.836; Oh KW, 2005, CLIN ENDOCRINOL, V63, P131, DOI 10.1111/j.1365-2265.2005.02312.x; Oshima K, 2005, BIOCHEM BIOPH RES CO, V331, P520, DOI 10.1016/j.bbrc.2005.03.210; Pischon N, 2007, J DENT RES, V86, P400, DOI 10.1177/154405910708600503; Preshaw PM, 2007, PERIODONTOL 2000, V45, P138, DOI 10.1111/j.1600-0757.2007.00221.x; Ravn P, 1999, J BONE MINER RES, V14, P1622, DOI 10.1359/jbmr.1999.14.9.1622; Saito M, 2006, OSTEOPOROSIS INT, V17, P1514, DOI 10.1007/s00198-006-0155-5; Saito T, 1998, NEW ENGL J MED, V339, P482, DOI 10.1056/NEJM199808133390717; Shapiro L, 1998, CURR BIOL, V8, P335, DOI 10.1016/S0960-9822(98)70133-2; Shinoda Y, 2006, J CELL BIOCHEM, V99, P196, DOI 10.1002/jcb.20890; Shishodia S, 2006, ONCOGENE, V25, P1463, DOI 10.1038/sj.onc.1209194; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Stolk RP, 1996, BONE, V18, P545, DOI 10.1016/8756-3282(96)00079-8; Sugatani T, 2005, J BIOL CHEM, V280, P3583, DOI 10.1074/jbc.M410480200; Tanaka H, 2004, J STEROID BIOCHEM, V89-90, P343, DOI 10.1016/j.jsbmb.2004.03.021; Tu Q, 2008, J CELL PHYSIOL, V217, P40, DOI 10.1002/jcp.21472; Tu QS, 2009, J CELL PHYSIOL, V218, P135, DOI 10.1002/jcp.21576; Tu QS, 2004, BIOCHEM BIOPH RES CO, V316, P461, DOI 10.1016/j.bbrc.2004.02.068; Valverde P, 2005, J BONE MINER RES, V20, P1669, DOI 10.1359/JBMR.050511; Valverde P, 2008, J BONE MINER RES, V23, P1775, DOI 10.1359/JBMR.080605; Vondracek Sheryl F, 2009, Int J Chron Obstruct Pulmon Dis, V4, P267; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Williams GA, 2009, ENDOCRINOLOGY, V150, P3603, DOI 10.1210/en.2008-1639; Wulster-Radcliffe MC, 2004, BIOCHEM BIOPH RES CO, V316, P924, DOI 10.1016/j.bbrc.2004.02.130; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yamaguchi N, 2008, FEBS LETT, V582, P451, DOI 10.1016/j.febslet.2007.12.037; Yamaguchi N, 2007, FEMS IMMUNOL MED MIC, V49, P28, DOI 10.1111/j.1574-695X.2006.00164.x; Yang ZZ, 2003, J BIOL CHEM, V278, P32124, DOI 10.1074/jbc.M302847200; Yano A, 2008, P NATL ACAD SCI USA, V105, P15541, DOI 10.1073/pnas.0805354105; Yokota T, 2000, BLOOD, V96, P1723, DOI 10.1182/blood.V96.5.1723; Zhao LJ, 2007, J CLIN ENDOCR METAB, V92, P1640, DOI 10.1210/jc.2006-0572; Zillikens MC, 2010, CALCIFIED TISSUE INT, V86, P116, DOI 10.1007/s00223-009-9319-6	64	90	95	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.152405	http://dx.doi.org/10.1074/jbc.M110.152405			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21300805	Green Published, hybrid			2022-12-27	WOS:000289077500067
J	Jimenez, M; Martos, A; Vicente, M; Rivas, G				Jimenez, Mercedes; Martos, Ariadna; Vicente, Miguel; Rivas, German			Reconstitution and Organization of Escherichia coli Proto-ring Elements (FtsZ and FtsA) inside Giant Unilamellar Vesicles Obtained from Bacterial Inner Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DIVISION PROTEIN; PHYSIOLOGICAL CONDITIONS; AMPHITROPIC PROTEINS; NATIVE MEMBRANES; LIPID MIXTURES; ZIPA; DYNAMICS; TUBULIN; ACTIN; MICROSCOPY	We have incorporated, for the first time, FtsZ and FtsA (the soluble proto-ring proteins from Escherichia coli) into bacterial giant unilamellar inner membrane vesicles (GUIMVs). Inside the vesicles, the structural organization and spatial distribution of fluorescently labeled FtsZ and FtsA were determined by confocal microscopy. We found that, in the presence of GDP, FtsZ was homogeneously distributed in the lumen of the vesicle. In the presence of GTP analogs, FtsZ assembled inside the GUIMVs, forming a web of dense spots and fibers. Whereas isolated FtsA was found adsorbed to the inner face of GUIMVs, the addition of FtsZ together with GTP analogs resulted in its dislodgement and its association with the FtsZ fibers in the lumen, suggesting that the FtsA-membrane interaction can be modulated by FtsZ polymers. The use of this novel in vitro system to probe interactions between divisome components will help to determine the biological implications of these findings.	[Jimenez, Mercedes; Martos, Ariadna; Rivas, German] CSIC, Ctr Invest Biol, Chem & Phys Biol Programme, Madrid 28040, Spain; [Vicente, Miguel] CSIC, Ctr Nacl Biotecnol, E-28049 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Jimenez, M (corresponding author), CSIC, Ctr Invest Biol, Chem & Phys Biol Programme, Madrid 28040, Spain.	enoe@cib.csic.es; grivas@cib.csic.es	Rivas, German/AFL-7528-2022; Rivas, German/AAG-7458-2022; Jimenez Sarmiento, Mercedes/K-2691-2014	Rivas, German/0000-0003-3450-7478; Rivas, German/0000-0003-3450-7478; Jimenez Sarmiento, Mercedes/0000-0003-2006-1903	European Commission [HEALTH-F3-2009-223431]; Ministerio de Ciencia e Innovacion Plan Nacional (Spain) [BIO2008-04478-C03-00]; Comunidad de Madrid COMBACT [S-BIO-0260/2006]	European Commission(European CommissionEuropean Commission Joint Research Centre); Ministerio de Ciencia e Innovacion Plan Nacional (Spain); Comunidad de Madrid COMBACT(Comunidad de Madrid)	This work was supported in part by European Commission DIVINOCELL FP7 HEALTH-F3-2009-223431, Ministerio de Ciencia e Innovacion Plan Nacional BIO2008-04478-C03-00 (Spain), and Comunidad de Madrid COMBACT S-BIO-0260/2006 (to G. R. and M. V.).	ALTENDORF KH, 1974, J BACTERIOL, V117, P888, DOI 10.1128/JB.117.2.888-899.1974; Beuria TK, 2009, J BIOL CHEM, V284, P14079, DOI 10.1074/jbc.M808872200; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; BURN P, 1988, TRENDS BIOCHEM SCI, V13, P79, DOI 10.1016/0968-0004(88)90043-6; de Boer PAJ, 2010, CURR OPIN MICROBIOL, V13, P730, DOI 10.1016/j.mib.2010.09.015; Den Blaauwen T, 1999, J BACTERIOL, V181, P5167, DOI 10.1128/JB.181.17.5167-5175.1999; DEVRIJE T, 1987, BIOCHIM BIOPHYS ACTA, V900, P63, DOI 10.1016/0005-2736(87)90278-1; Dominak LM, 2008, LANGMUIR, V24, P13565, DOI 10.1021/la8028403; Erickson HP, 1996, P NATL ACAD SCI USA, V93, P519, DOI 10.1073/pnas.93.1.519; Errington J, 2003, MICROBIOL MOL BIOL R, V67, P52, DOI 10.1128/MMBR.67.1.52-65.2003; Geissler B, 2003, P NATL ACAD SCI USA, V100, P4197, DOI 10.1073/pnas.0635003100; Geissler B, 2007, MICROBIOL-SGM, V153, P814, DOI 10.1099/mic.0.2006/001834-0; Goehring NW, 2005, CURR BIOL, V15, pR514, DOI 10.1016/j.cub.2005.06.038; Gonzalez JM, 2003, J BIOL CHEM, V278, P37664, DOI 10.1074/jbc.M305230200; Gonzalez JM, 2005, P NATL ACAD SCI USA, V102, P1895, DOI 10.1073/pnas.0409517102; Hale CA, 1997, CELL, V88, P175, DOI 10.1016/S0092-8674(00)81838-3; Holtje JV, 2001, BIOCHIMIE, V83, P103, DOI 10.1016/S0300-9084(00)01226-8; Johnson JE, 1999, MOL MEMBR BIOL, V16, P217, DOI 10.1080/096876899294544; JONES CA, 1984, EMBO J, V3, P1181, DOI 10.1002/j.1460-2075.1984.tb01948.x; Meleard P, 2009, METHOD ENZYMOL, V465, P161, DOI 10.1016/S0076-6879(09)65009-6; Mingorance J, 2005, J BIOL CHEM, V280, P20909, DOI 10.1074/jbc.M503059200; Mingorance J, 2010, TRENDS MICROBIOL, V18, P348, DOI 10.1016/j.tim.2010.06.001; Montes LR, 2007, BIOPHYS J, V93, P3548, DOI 10.1529/biophysj.107.116228; MUKHERJEE A, 1993, P NATL ACAD SCI USA, V90, P1053, DOI 10.1073/pnas.90.3.1053; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; Oliva MA, 2003, J BIOL CHEM, V278, P33562, DOI 10.1074/jbc.M303798200; OSBORN MJ, 1972, J BIOL CHEM, V247, P3962; Pichoff S, 2005, MOL MICROBIOL, V55, P1722, DOI 10.1111/j.1365-2958.2005.04522.x; Pichoff S, 2002, EMBO J, V21, P685, DOI 10.1093/emboj/21.4.685; PLA J, 1991, MOL MICROBIOL, V5, P1681, DOI 10.1111/j.1365-2958.1991.tb01915.x; PLA J, 1990, J BACTERIOL, V172, P5097, DOI 10.1128/jb.172.9.5097-5102.1990; Pott T, 2008, CHEM PHYS LIPIDS, V154, P115, DOI 10.1016/j.chemphyslip.2008.03.008; Record MT, 1998, TRENDS BIOCHEM SCI, V23, P190, DOI 10.1016/S0968-0004(98)01207-9; Rico AI, 2004, MOL MICROBIOL, V53, P1359, DOI 10.1111/j.1365-2958.2004.04245.x; Rivas G, 2000, J BIOL CHEM, V275, P11740, DOI 10.1074/jbc.275.16.11740; Rueda S, 2003, J BACTERIOL, V185, P3344, DOI 10.1128/JB.185.11.3344-3351.2003; Sambrook J., 2002, MOL CLONING LAB MANU; SANCHEZ M, 1994, EMBO J, V13, P4919, DOI 10.1002/j.1460-2075.1994.tb06819.x; Stricker J, 2002, P NATL ACAD SCI USA, V99, P3171, DOI 10.1073/pnas.052595099; Vicente M, 2006, J BACTERIOL, V188, P19, DOI 10.1128/JB.188.1.19-27.2006; Vicente M, 2006, MOL MICROBIOL, V61, P5, DOI 10.1111/j.1365-2958.2006.05233.x; Yim L, 2000, J BACTERIOL, V182, P6366, DOI 10.1128/JB.182.22.6366-6373.2000; ZIMMERMAN SB, 1991, J MOL BIOL, V222, P599, DOI 10.1016/0022-2836(91)90499-V	43	29	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11236	11241		10.1074/jbc.M110.194365	http://dx.doi.org/10.1074/jbc.M110.194365			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21257762	Green Published, hybrid			2022-12-27	WOS:000288797100035
J	Chou, TF; Deshaies, RJ				Chou, Tsui-Fen; Deshaies, Raymond J.			Quantitative Cell-based Protein Degradation Assays to Identify and Classify Drugs That Target the Ubiquitin-Proteasome System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-NITROSTYRENE DERIVATIVES; AAA-ATPASE CDC48/P97; ELEVATED EXPRESSION; P97; INHIBITORS; ER; RECOGNITION; PROGNOSIS; COMPLEX; APOPTOSIS	We have generated a set of dual-reporter human cell lines and devised a chase protocol to quantify proteasomal degradation of a ubiquitin fusion degradation (UFD) substrate, a ubiquitin ligase CRL2(VHL) substrate, and a ubiquitin-independent substrate. Well characterized inhibitors that target different aspects of the ubiquitin-proteasome system can be distinguished by their distinctive patterns of substrate stabilization, enabling assignment of test compounds as inhibitors of the proteasome, ubiquitin chain formation or perception, CRL activity, or the UFD-p97 pathway. We confirmed that degradation of the UFD but not the CRL2(VHL) or ubiquitin-independent substrates depends on p97 activity. We optimized our suite of assays to establish conditions suitable for high-throughput screening and then validated their performance by screening against 160 cell-permeable protein kinase inhibitors. This screen identified Syk inhibitor III as an irreversible p97/vasolin containing protein inhibitor (IC50 = 1.7 mu M) that acts through Cys-522 within the D2 ATPase domain. Our work establishes a high-throughput screening-compatible pipeline for identification and classification of small molecules, cDNAs, or siRNAs that target components of the ubiquitin-proteasome system.	[Chou, Tsui-Fen; Deshaies, Raymond J.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Deshaies, Raymond J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Chou, TF (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	tfchou@caltech.edu; deshaies@caltech.edu	Deshaies, Raymond/B-8354-2014	Deshaies, Raymond/0000-0002-3671-9354	National Institutes of Health [R03 MH085687]; Howard Hughes Medical Institute; Multiple Myeloma Research Foundation; Weston Havens Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH085687] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Multiple Myeloma Research Foundation; Weston Havens Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant R03 MH085687. This work was also supported by the Howard Hughes Medical Institute.; Supported by a 2008 Fellows Grant Program Award from the Multiple Myeloma Research Foundation, the Howard Hughes Medical Institute, and the Weston Havens Foundation. To whom correspondence may be addressed. E-mail: tfchou@caltech.edu.	Aghajan M, 2010, NAT BIOTECHNOL, V28, P738, DOI 10.1038/nbt.1645; Alvarez-Castelao B, 2009, J BIOL CHEM, V284, P28253, DOI 10.1074/jbc.M109.004101; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Beskow A, 2009, J MOL BIOL, V394, P732, DOI 10.1016/j.jmb.2009.09.050; Boyault C, 2007, GENE DEV, V21, P2172, DOI 10.1101/gad.436407; Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210; Cao K, 2003, CELL, V115, P355, DOI 10.1016/S0092-8674(03)00815-8; Chou TF, 2011, P NATL ACAD SCI USA, V108, P4834, DOI 10.1073/pnas.1015312108; Colson Kathleen, 2004, Clin J Oncol Nurs, V8, P473, DOI 10.1188/04.CJON.473-480; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Ding WX, 2007, APOPTOSIS, V12, P2233, DOI 10.1007/s10495-007-0142-0; Eldridge AG, 2010, CELL DEATH DIFFER, V17, P4, DOI 10.1038/cdd.2009.82; Elofsson M, 1999, CHEM BIOL, V6, P811, DOI 10.1016/S1074-5521(99)80128-8; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Golbik R, 1999, BIOL CHEM, V380, P1049, DOI 10.1515/BC.1999.131; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Janiesch PC, 2007, NAT CELL BIOL, V9, P379, DOI 10.1038/ncb1554; Ju JS, 2008, J BIOL CHEM, V283, P30289, DOI 10.1074/jbc.M805517200; Kane RC, 2003, ONCOLOGIST, V8, P508, DOI 10.1634/theoncologist.8-6-508; Kimbrel EA, 2009, MOL IMAGING, V8, P140, DOI 10.2310/7290.2009.00007; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Milhazes N, 2006, BIOORGAN MED CHEM, V14, P4078, DOI 10.1016/j.bmc.2006.02.006; Muller JMM, 2007, BIOCHEM BIOPH RES CO, V354, P459, DOI 10.1016/j.bbrc.2006.12.206; Nawrocki ST, 2005, CANCER RES, V65, P11510, DOI 10.1158/0008-5472.CAN-05-2394; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Noguchi M, 2005, J BIOL CHEM, V280, P41332, DOI 10.1074/jbc.M509700200; Ohh M, 2002, EMBO REP, V3, P177, DOI 10.1093/embo-reports/kvf028; Patel S, 2008, EXPERT OPIN INV DRUG, V17, P1865, DOI 10.1517/13543780802493366 ; RABOUILLE C, 1995, CELL, V82, P905, DOI 10.1016/0092-8674(95)90270-8; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Tsujimoto Y, 2004, CLIN CANCER RES, V10, P3007, DOI 10.1158/1078-0432.CCR-03-0191; Wang QY, 2008, J BIOL CHEM, V283, P7445, DOI 10.1074/jbc.M708347200; Wang WY, 2007, BIOCHEM PHARMACOL, V74, P601, DOI 10.1016/j.bcp.2007.06.001; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Yamamoto S, 2004, CLIN CANCER RES, V10, P5558, DOI 10.1158/1078-0432.CCR-0723-03; Yamamoto S, 2004, ANN SURG ONCOL, V11, P697, DOI 10.1245/ASO.2004.10.018; Yamamoto S, 2003, J CLIN ONCOL, V21, P447, DOI 10.1200/JCO.2003.06.068; Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang MS, 2003, EMBO J, V22, P1488, DOI 10.1093/emboj/cdg158	49	49	51	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16546	16554		10.1074/jbc.M110.215319	http://dx.doi.org/10.1074/jbc.M110.215319			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21343295	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000290301900003
J	Wands, AM; Wang, N; Lum, JK; Hsieh, J; Fierke, CA; Mapp, AK				Wands, Amberlyn M.; Wang, Ningkun; Lum, Jenifer K.; Hsieh, John; Fierke, Carol A.; Mapp, Anna K.			Transient-state Kinetic Analysis of Transcriptional Activator center dot DNA Complexes Interacting with a Key Coactivator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; TERMINAL TRANSACTIVATION DOMAIN; IN-VIVO; STRUCTURAL BASIS; CROSS-LINKING; PROTEIN; MEDIATOR; BINDING; RECOGNITION; MECHANISM	Several lines of evidence suggest that the prototypical amphipathic transcriptional activators Gal4, Gcn4, and VP16 interact with the key coactivator Med15 (Gal11) during transcription initiation despite little sequence homology. Recent cross-linking data further reveal that at least two of the activators utilize the same binding surface within Med15 for transcriptional activation. To determine whether these three activators use a shared binding mechanism for Med15 recruitment, we characterized the thermodynamics and kinetics of Med15 center dot activator center dot DNA complex formation by fluorescence titration and stopped-flow techniques. Combination of each activator center dot DNA complex with Med15 produced biphasic time courses. This is consistent with a minimum two-step binding mechanism composed of a bimolecular association step limited by diffusion, followed by a conformational change in the Med15 center dot activator center dot DNA complex. Furthermore, the equilibrium constant for the conformational change (K-2) correlates with the ability of an activator to stimulate transcription. VP16, the most potent of the activators, has the largest K-2 value, whereas Gcn4, the least potent, has the smallest value. This correlation is consistent with a model in which transcriptional activation is regulated at least in part by the rearrangement of the Med15 center dot activator center dot DNA ternary complex. These results are the first detailed kinetic characterization of the transcriptional activation machinery and provide a framework for the future design of potent transcriptional activators.	[Wands, Amberlyn M.; Hsieh, John; Fierke, Carol A.; Mapp, Anna K.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Lum, Jenifer K.; Mapp, Anna K.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA; [Fierke, Carol A.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Wang, Ningkun; Fierke, Carol A.; Mapp, Anna K.] Univ Michigan, Program Chem Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Fierke, CA (corresponding author), Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.	fierke@umich.edu; amapp@umich.edu	, Dr Anna Mapp/GPX-8261-2022	Wang, Ningkun/0000-0003-3545-5323	National Institutes of Health [GM65330, GM55387]; Novartis Young Investigator Award; Pharmaceutical Sciences Training Program Training Grant [GM7767]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007767, R01GM065330, R01GM055387] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis Young Investigator Award; Pharmaceutical Sciences Training Program Training Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM65330 (to A. K. M.) and GM55387 (to C. A. F.). This work was supported by a Novartis Young Investigator Award (to A. K. M.) and by Pharmaceutical Sciences Training Program Training Grant GM7767 (to A. M. W. and N. W.).	Ansari AZ, 1998, P NATL ACAD SCI USA, V95, P13543, DOI 10.1073/pnas.95.23.13543; Archer CT, 2010, NUCLEIC ACIDS RES, V38, P789, DOI 10.1093/nar/gkp1066; CHANG J, 1995, J BIOL CHEM, V270, P25014, DOI 10.1074/jbc.270.42.25014; Chen X, 2002, MOL BIOL CELL, V13, P1929, DOI 10.1091/mbc.02-02-0023; Dames SA, 2002, P NATL ACAD SCI USA, V99, P5271, DOI 10.1073/pnas.082121399; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; Davis JA, 2002, MOL CELL, V10, P409, DOI 10.1016/S1097-2765(02)00598-1; Demchenko AP, 2001, J MOL RECOGNIT, V14, P42, DOI 10.1002/1099-1352(200101/02)14:1<42::AID-JMR518>3.0.CO;2-8; DONALDSON L, 1992, J BIOL CHEM, V267, P1411; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7; Ferreira ME, 2005, J BIOL CHEM, V280, P21779, DOI 10.1074/jbc.M502627200; Fishburn J, 2005, MOL CELL, V18, P369, DOI 10.1016/j.molcel.2005.03.029; Hall DB, 2002, J BIOL CHEM, V277, P46043, DOI 10.1074/jbc.M208911200; Hermann S, 2001, J BIOL CHEM, V276, P40127, DOI 10.1074/jbc.M103793200; Hidalgo P, 2001, GENE DEV, V15, P1007, DOI 10.1101/gad.873901; Hong MQ, 2008, STRUCTURE, V16, P1019, DOI 10.1016/j.str.2008.03.015; Hsieh J, 2009, RNA, V15, P1565, DOI 10.1261/rna.1639409; Jeong CJ, 2001, BIOCHEMISTRY-US, V40, P9421, DOI 10.1021/bi010011k; Johnson K. A., 1992, ENZYMES, V20, P1, DOI DOI 10.1016/S1874-6047(08)60019-0; JOHNSON KA, 1986, METHOD ENZYMOL, V134, P677; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Kim DH, 2009, BMB REP, V42, P411, DOI 10.5483/BMBRep.2009.42.7.411; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Lee LW, 2010, J BIOL CHEM, V285, P11033, DOI 10.1074/jbc.R109.075044; Liang SD, 1996, MOL CELL BIOL, V16, P3773; LOHMAN TM, 1992, METHOD ENZYMOL, V212, P424; MA J, 1987, CELL, V51, P113, DOI 10.1016/0092-8674(87)90015-8; Majmudar CY, 2009, ANGEW CHEM INT EDIT, V48, P7021, DOI 10.1002/anie.200902669; Mapp AK, 2007, ACS CHEM BIOL, V2, P62, DOI 10.1021/cb600463w; NORTHRUP SH, 1992, P NATL ACAD SCI USA, V89, P3338, DOI 10.1073/pnas.89.8.3338; Paal K, 1997, NUCLEIC ACIDS RES, V25, P1050, DOI 10.1093/nar/25.5.1050; Park JM, 2000, MOL CELL BIOL, V20, P8709, DOI 10.1128/MCB.20.23.8709-8719.2000; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; PTASHNE M, 2002, GENES SIGNALS; Rea AM, 2009, BIOCHEMISTRY-US, V48, P7556, DOI 10.1021/bi900805s; Reeves WM, 2005, MOL CELL BIOL, V25, P9092, DOI 10.1128/MCB.25.20.9092-9102.2005; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Thoden JB, 2008, J BIOL CHEM, V283, P30266, DOI 10.1074/jbc.M805200200; Uesugi M, 1997, SCIENCE, V277, P1310, DOI 10.1126/science.277.5330.1310; Volkman HM, 2005, J AM CHEM SOC, V127, P4649, DOI 10.1021/ja042761y; Wells M, 2008, P NATL ACAD SCI USA, V105, P5762, DOI 10.1073/pnas.0801353105; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Wu YB, 1996, EMBO J, V15, P3951, DOI 10.1002/j.1460-2075.1996.tb00769.x; Wu ZQ, 2003, J AM CHEM SOC, V125, P12390, DOI 10.1021/ja036685v; Zhang F, 2004, MOL CELL BIOL, V24, P6871, DOI 10.1128/mcb.24.15.6871-6886.2004	49	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.207589	http://dx.doi.org/10.1074/jbc.M110.207589			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21317429	Green Published, hybrid			2022-12-27	WOS:000290022800063
J	Kar, P; Nelson, C; Parekh, AB				Kar, Pulak; Nelson, Charmaine; Parekh, Anant B.			Selective Activation of the Transcription Factor NFAT1 by Calcium Microdomains near Ca2+ Release-activated Ca2+ (CRAC) Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-LYMPHOCYTES; GENE-EXPRESSION; HIPPOCAMPAL-NEURONS; MAST-CELLS; CALCINEURIN; CALMODULIN; INACTIVATION; OSCILLATIONS; MECHANISM; MESSENGER	NFATs are a family of Ca2+-dependent transcription factors that play a central role in the morphogenesis, development, and physiological activities of numerous distinct cell types and organ systems. Here, we visualize NFAT1 movement in and out of the nucleus in response to transient activation of store-operated Ca2+ release-activated Ca2+(CRAC) channels in nonexcitable cells. We show that NFAT migration is exquisitely sensitive to Ca2+ microdomains near open CRAC channels. Another Ca2+-permeable ion channel (TRPC3) was ineffective in driving NFAT1 to the nucleus. NFAT1 movement is temporally dissociated from the time course of the Ca2+ signal and remains within the nucleus for 10 times longer than the duration of the trigger Ca2+ signal. Kinetic analyses of each step linking CRAC channel activation to NFAT1 nuclear residency reveals that the rate-limiting step is transcription factor exit from the nucleus. The slow deactivation of NFAT provides a mechanism whereby Ca2+-dependent responses can be sustained despite the termination of the initial Ca2+ signal and helps explain how gene expression in nonexcitable cells can continue after the primary stimulus has been removed.	[Kar, Pulak; Nelson, Charmaine; Parekh, Anant B.] Univ Oxford, Dept Physiol, Oxford OX1 3PT, England	University of Oxford	Parekh, AB (corresponding author), Univ Oxford, Dept Physiol, Sherrington Bldg,Parks Rd, Oxford OX1 3PT, England.	anant.parekh@dpag.ox.ac.uk			Medical Research Council (United Kingdom); British Heart Foundation; MRC [G1000813] Funding Source: UKRI; Medical Research Council [G1000813] Funding Source: researchfish	Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council (United Kingdom) and the British Heart Foundation Centre of Excellence award.	Bautista DM, 2004, J PHYSIOL-LONDON, V556, P805, DOI 10.1113/jphysiol.2003.060004; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bird GS, 2005, J PHYSIOL-LONDON, V562, P697, DOI 10.1113/jphysiol.2004.077289; Chang WC, 2004, J BIOL CHEM, V279, P29994, DOI 10.1074/jbc.M403969200; Chang WC, 2008, J BIOL CHEM, V283, P4622, DOI 10.1074/jbc.M705002200; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Di Capite J, 2009, CURR BIOL, V19, P853, DOI 10.1016/j.cub.2009.03.063; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Gilabert JA, 2000, EMBO J, V19, P6401, DOI 10.1093/emboj/19.23.6401; Glitsch MD, 2002, J PHYSIOL-LONDON, V539, P93, DOI 10.1113/jphysiol.2001.012826; Glitsch MD, 2002, EMBO J, V21, P6744, DOI 10.1093/emboj/cdf675; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Higazi DR, 2009, MOL CELL, V33, P472, DOI 10.1016/j.molcel.2009.02.005; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Hoth M, 2000, P NATL ACAD SCI USA, V97, P10607, DOI 10.1073/pnas.180143997; Kim MS, 2009, J NEUROSCI, V29, P12101, DOI 10.1523/JNEUROSCI.3384-09.2009; Kummerow C, 2009, IMMUNOL REV, V231, P132, DOI 10.1111/j.1600-065X.2009.00811.x; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Li WH, 1998, NATURE, V392, P936, DOI 10.1038/31965; Mullins FM, 2009, P NATL ACAD SCI USA, V106, P15495, DOI 10.1073/pnas.0906781106; NEGULESCU PA, 1994, P NATL ACAD SCI USA, V91, P2873, DOI 10.1073/pnas.91.7.2873; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Ng SW, 2008, J BIOL CHEM, V283, P31348, DOI 10.1074/jbc.M804942200; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; Parekh AB, 2000, P NATL ACAD SCI USA, V97, P12933, DOI 10.1073/pnas.97.24.12933; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Parekh AB, 2008, J PHYSIOL-LONDON, V586, P3043, DOI 10.1113/jphysiol.2008.153460; Parekh AB, 2008, CELL CALCIUM, V44, P6, DOI 10.1016/j.ceca.2007.12.006; Petersen OH, 2008, ANNU REV PHYSIOL, V70, P273, DOI 10.1146/annurev.physiol.70.113006.100618; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; SHAW KTY, 1995, P NATL ACAD SCI USA, V92, P11205, DOI 10.1073/pnas.92.24.11205; Tomida T, 2003, EMBO J, V22, P3825, DOI 10.1093/emboj/cdg381; Trebak M, 2003, J BIOL CHEM, V278, P16244, DOI 10.1074/jbc.M300544200	39	92	92	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14795	14803		10.1074/jbc.M111.220582	http://dx.doi.org/10.1074/jbc.M111.220582			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21325277	hybrid, Green Published			2022-12-27	WOS:000289788300009
J	Turner, EC; Kavanagh, DJ; Mulvaney, EP; McLean, C; Wikstrom, K; Reid, HM; Kinsella, BT				Turner, Elizebeth C.; Kavanagh, David J.; Mulvaney, Eamon P.; McLean, Caitriona; Wikstroem, Katarina; Reid, Helen M.; Kinsella, B. Therese			RETRACTED: Identification of an Interaction between the TP alpha and TP beta Isoforms of the Human Thromboxane A(2) Receptor with Protein Kinase C-related Kinase (PRK) 1 IMPLICATIONS FOR PROSTATE CANCER (Retracted article. See vol. 293, pg. 12286, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							HUMAN-ERYTHROLEUKEMIA-CELLS; SMOOTH-MUSCLE; NITRIC-OXIDE; HUMAN THROMBOXANE-A(2)-RECEPTOR; HOMOLOGOUS DESENSITIZATION; MEDIATED DESENSITIZATION; INDEPENDENT MODULATION; NEGATIVE REGULATION; COUPLED RECEPTORS; RHO-KINASE	In humans, thromboxane (TX) A(2) signals through the TP alpha and TP beta isoforms of the TXA(2) receptor or TP. Here, the RhoA effector protein kinase C-related kinase (PRK) 1 was identified as an interactant of both TP alpha and TP beta involving common and unique sequences within their respective C-terminal (C)-tail domains and the kinase domain of PRK1 (PRK1(640-942)). Although the interaction with PRK1 is constitutive, agonist activation of TP alpha/TP beta did not regulate the complex per se but enhanced PRK1 activation leading to phosphorylation of its general substrate histone H1 in vitro. Altered PRK1 and TP expression and signaling are increasingly implicated in certain neoplasms, particularly in androgen-associated prostate carcinomas. Agonist activation of TP alpha/TP beta led to phosphorylation of histone H3 at Thr(11) (H3 Thr(11)), a previously recognized specific marker of androgen-induced chromatin remodeling, in the prostate LNCaP and PC-3 cell lines but not in primary vascular smooth muscle or endothelial cells. Moreover, this effect was augmented by dihydrotestosterone in androgen-responsive LNCaP but not in nonresponsive PC-3 cells. Furthermore, PRK1 was confirmed to constitutively interact with TP alpha/TP beta in both LNCaP and PC-3 cells, and targeted disruption of PRK1 impaired TP alpha/TP beta -mediated H3 Thr(11) phosphorylation in, and cell migration of, both prostate cell types. Collectively, considering the role of TXA(2) as a potent mediator of RhoA signaling, the identification of PRK1 as a bona fide interactant of TP alpha/TP beta, and leading to H3 Thr(11) phosphorylation to regulate cell migration, has broad functional significance such as within the vasculature and in neoplasms in which both PRK1 and the TPs are increasingly implicated.	[Turner, Elizebeth C.; Kavanagh, David J.; Mulvaney, Eamon P.; McLean, Caitriona; Wikstroem, Katarina; Reid, Helen M.; Kinsella, B. Therese] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Sch Biomol & Biomed Sci, Dublin 4, Ireland	University College Dublin	Kinsella, BT (corresponding author), Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Sch Biomol & Biomed Sci, Dublin 4, Ireland.	Therese.Kinsella@UCD.IE		Kinsella, B. Therese/0000-0003-3072-941X; Mulvaney, Eamon/0000-0003-3661-2116	Science Foundation of Ireland [05/IN.1/B19]; Health Research Board of Ireland [RP/2008/33]	Science Foundation of Ireland(Science Foundation Ireland); Health Research Board of Ireland	This work was supported by Science Foundation of Ireland Grant 05/IN.1/B19 and by Health Research Board of Ireland Grant RP/2008/33.	Amano M, 1996, SCIENCE, V271, P648, DOI 10.1126/science.271.5249.648; Coyle AT, 2006, BIOCHEM PHARMACOL, V71, P1308, DOI 10.1016/j.bcp.2006.01.011; Coyle AT, 2005, FEBS J, V272, P4754, DOI 10.1111/j.1742-4658.2005.04890.x; Coyle AT, 2005, FEBS J, V272, P1036, DOI 10.1111/j.1742-4658.2004.04538.x; Coyle AT, 2002, EUR J BIOCHEM, V269, P4058, DOI 10.1046/j.1432-1033.2002.03098.x; Dassesse T, 2006, EUR UROL, V50, P1021, DOI 10.1016/j.eururo.2006.01.036; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Deaton RA, 2005, J BIOL CHEM, V280, P31172, DOI 10.1074/jbc.M504774200; Flynn P, 1998, J BIOL CHEM, V273, P2698, DOI 10.1074/jbc.273.5.2698; Fukata Y, 2001, TRENDS PHARMACOL SCI, V22, P32, DOI 10.1016/S0165-6147(00)01596-0; Galgano MT, 2009, HUM PATHOL, V40, P1434, DOI 10.1016/j.humpath.2009.02.008; Gannon AM, 2008, J LIPID RES, V49, P2590, DOI 10.1194/jlr.M800256-JLR200; Gannon AM, 2009, J CELL MOL MED, V13, P4571, DOI 10.1111/j.1582-4934.2008.00599.x; Gannon AM, 2009, J MOL BIOL, V394, P29, DOI 10.1016/j.jmb.2009.09.007; Gotoh Y, 2004, BIOCHEM BIOPH RES CO, V314, P688, DOI 10.1016/j.bbrc.2003.12.148; Hamelin E, 2005, J BIOL CHEM, V280, P36195, DOI 10.1074/jbc.M503438200; Harrison BC, 2010, FEBS LETT, V584, P1103, DOI 10.1016/j.febslet.2010.02.057; Helley-Hickie LP, 2004, BRIT J PHARMACOL, V142, P203, DOI 10.1038/sj.bjp.0705695; Jackson SP, 2003, J THROMB HAEMOST, V1, P1602, DOI 10.1046/j.1538-7836.2003.00267.x; Kaneko Y, 2006, HYPERTENS RES, V29, P665, DOI 10.1291/hypres.29.665; Kato T, 2008, GENES CELLS, V13, P509, DOI 10.1111/j.1365-2443.2008.01182.x; Katragadda M, 2004, BBA-BIOMEMBRANES, V1663, P74, DOI 10.1016/j.bbamem.2004.01.012; Kelley-Hickie LP, 2007, BBA-MOL CELL RES, V1773, P970, DOI 10.1016/j.bbamcr.2007.03.012; Kelley-Hickie LP, 2006, BBA-MOL CELL BIOL L, V1761, P1114, DOI 10.1016/j.bbalip.2006.07.012; Kinsella BT, 2001, BIOCHEM SOC T, V29, P641, DOI 10.1042/BST0290641; Kobayashi T, 2004, J CLIN INVEST, V114, P784, DOI 10.1172/JCI200421446; Li XL, 2007, ARCH BIOCHEM BIOPHYS, V467, P20, DOI 10.1016/j.abb.2007.08.005; Matsuzawa K, 1997, BIOCHEM BIOPH RES CO, V234, P621, DOI 10.1006/bbrc.1997.6669; Metzger E, 2003, EMBO J, V22, P270, DOI 10.1093/emboj/cdg023; Metzger E, 2008, NAT CELL BIOL, V10, P53, DOI 10.1038/ncb1668; Metzger E, 2010, NATURE, V464, P792, DOI 10.1038/nature08839; Miggin SM, 1998, BBA-GEN SUBJECTS, V1425, P543, DOI 10.1016/S0304-4165(98)00109-3; Mukai H, 2006, METHOD ENZYMOL, V406, P234, DOI 10.1016/S0076-6879(06)06017-4; Mukai H, 2003, J BIOCHEM, V133, P17, DOI 10.1093/jb/mvg019; Nakahata Norimichi, 2009, Folia Pharmacologica Japonica, V134, P259; Nie DT, 2008, CANCER RES, V68, P115, DOI 10.1158/0008-5472.CAN-07-1018; Offermanns S, 2006, CIRC RES, V99, P1293, DOI 10.1161/01.RES.0000251742.71301.16; Reid HM, 2011, CELL SIGNAL, V23, P700, DOI 10.1016/j.cellsig.2010.12.003; Reid HM, 2010, J BIOL CHEM, V285, P18709, DOI 10.1074/jbc.M110.106476; Reid HM, 2009, BRIT J PHARMACOL, V158, P830, DOI 10.1111/j.1476-5381.2009.00351.x; Reid HM, 2003, J BIOL CHEM, V278, P51190, DOI 10.1074/jbc.M309314200; RIEDER CL, 1992, J CELL SCI, V102, P387; Ritter SL, 2009, NAT REV MOL CELL BIO, V10, P819, DOI 10.1038/nrm2803; Rochdi MD, 2004, J BIOL CHEM, V279, P18981, DOI 10.1074/jbc.M312621200; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Sasaki M, 2007, PROSTAG OTH LIPID M, V83, P237, DOI 10.1016/j.prostaglandins.2006.12.001; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Shibata H, 1996, FEBS LETT, V385, P221, DOI 10.1016/0014-5793(96)00385-7; Somlyo AP, 2000, J PHYSIOL-LONDON, V522, P177, DOI 10.1111/j.1469-7793.2000.t01-2-00177.x; Su C, 2007, CELL CYCLE, V6, P739, DOI 10.4161/cc.6.6.3985; Tokue SI, 2009, PROSTAG OTH LIPID M, V89, P8, DOI 10.1016/j.prostaglandins.2009.02.001; Torbett NE, 2003, J BIOL CHEM, V278, P32344, DOI 10.1074/jbc.M303532200; Walsh MT, 2000, J BIOL CHEM, V275, P20412, DOI 10.1074/jbc.M907881199; Wikstrom K, 2008, CELL SIGNAL, V20, P1497, DOI 10.1016/j.cellsig.2008.04.006; Yoshinaga C, 1999, J BIOCHEM, V126, P475, DOI 10.1093/oxfordjournals.jbchem.a022476; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702	57	24	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15440	15457		10.1074/jbc.M110.181180	http://dx.doi.org/10.1074/jbc.M110.181180			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21357687	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000289788300073
J	Ouedraogo, JP; Hagen, S; Spielvogel, A; Engelhardt, S; Meyer, V				Ouedraogo, Jean Paul; Hagen, Silke; Spielvogel, Anja; Engelhardt, Susanne; Meyer, Vera			Survival Strategies of Yeast and Filamentous Fungi against the Antifungal Protein AFP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL INTEGRITY; HOST-PATHOGEN INTERACTIONS; SACCHAROMYCES-CEREVISIAE; ASPERGILLUS-GIGANTEUS; CHITIN SYNTHESIS; PLASMA-MEMBRANE; CALCOFLUOR WHITE; BASIC CONCEPTS; NIGER; PATHWAY	The activities of signaling pathways are critical for fungi to survive antifungal attack and to maintain cell integrity. However, little is known about how fungi respond to antifungals, particularly if these interact with multiple cellular targets. The antifungal protein AFP is a very potent inhibitor of chitin synthesis and membrane integrity in filamentous fungi and has so far not been reported to interfere with the viability of yeast strains. With the hypothesis that the susceptibility of fungi toward AFP is not merely dependent on the presence of an AFP-specific target at the cell surface but relies also on the cell's capacity to counteract AFP, we used a genetic approach to decipher defense strategies of the naturally AFP-resistant strain Saccharomyces cerevisiae. The screening of selected strains from the yeast genomic deletion collection for AFP-sensitive phenotypes revealed that a concerted action of calcium signaling, TOR signaling, cAMP-protein kinase A signaling, and cell wall integrity signaling is likely to safeguard S. cerevisiae against AFP. Our studies uncovered that the yeast cell wall gets fortified with chitin to defend against AFP and that this response is largely dependent on calcium/Crz1p signaling. Most importantly, we observed that stimulation of chitin synthesis is characteristic for AFP-resistant fungi but not for AFP-sensitive fungi, suggesting that this response is a successful strategy to protect against AFP. We finally propose the adoption of the damage-response framework of microbial pathogenesis for the interactions of antimicrobial proteins and microorganisms in order to comprehensively understand the outcome of an antifungal attack.	[Hagen, Silke; Spielvogel, Anja; Engelhardt, Susanne; Meyer, Vera] Berlin Univ Technol, Inst Biotechnol, Dept Appl & Mol Microbiol, D-13355 Berlin, Germany; [Ouedraogo, Jean Paul; Meyer, Vera] Leiden Univ, Inst Biol, Dept Mol Microbiol & Biotechnol, NL-2333 BE Leiden, Netherlands	Technical University of Berlin; Leiden University; Leiden University - Excl LUMC	Meyer, V (corresponding author), Berlin Univ Technol, Inst Biotechnol, Dept Appl & Mol Microbiol, Gustav Meyer Allee 25, D-13355 Berlin, Germany.	vera.meyer@tu-berlin.de		Meyer, Vera/0000-0002-2298-2258; Ouedraogo, Jean-Paul/0000-0002-9735-6235; Spielvogel, Anja/0000-0001-9345-6821	Federal Ministry of Economics and Technology (AiF) [13305N]; German Academic Exchange Service	Federal Ministry of Economics and Technology (AiF)(Federal Ministry for Economic Affairs and Energy (BMWi)); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by Federal Ministry of Economics and Technology (AiF) Grant 13305N) and by a grant from the German Academic Exchange Service (to J.P.O.).	Aerts AM, 2008, CELL MOL LIFE SCI, V65, P2069, DOI 10.1007/s00018-008-8035-0; Aronova S, 2007, MOL BIOL CELL, V18, P2779, DOI 10.1091/mbc.E07-03-0274; Barakat H, 2010, APPL MICROBIOL BIOT, V87, P617, DOI 10.1007/s00253-010-2508-4; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Bennett JW, 1991, MORE GENE MANIPULATI; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Binder U, 2010, EUKARYOT CELL, V9, P1374, DOI 10.1128/EC.00050-10; Brachmann CB, 1998, YEAST, V14, P115; CABIB E, 1992, J GEN MICROBIOL, V138, P97, DOI 10.1099/00221287-138-1-97; CAMPOSOLIVAS R, 1995, BIOCHEMISTRY-US, V34, P3009, DOI 10.1021/bi00009a032; Carvalho NDSP, 2010, APPL MICROBIOL BIOT, V87, P1463, DOI 10.1007/s00253-010-2588-1; Casadevall A, 2003, NAT REV MICROBIOL, V1, P17, DOI 10.1038/nrmicro732; Casadevall A, 1999, INFECT IMMUN, V67, P3703, DOI 10.1128/IAI.67.8.3703-3713.1999; Casadevall A, 2000, INFECT IMMUN, V68, P6511, DOI 10.1128/IAI.68.12.6511-6518.2000; Chang YY, 2009, BIOCHEM SOC T, V37, P232, DOI 10.1042/BST0370232; Chopra R, 1999, APPL ENVIRON MICROB, V65, P2267; Damveld RA, 2005, MOL MICROBIOL, V58, P305, DOI 10.1111/j.1365-2958.2005.04827.x; del Pozo AM, 2002, J BIOL CHEM, V277, P46179, DOI 10.1074/jbc.M207472200; Fortwendel JR, 2009, ANTIMICROB AGENTS CH, V53, P476, DOI 10.1128/AAC.01154-08; FRANTZ S, 2005, BIOCHIM BIOPHYS ACTA, V437, P11; Fuchs BB, 2009, EUKARYOT CELL, V8, P1616, DOI 10.1128/EC.00193-09; Fujioka T, 2007, EUKARYOT CELL, V6, P1497, DOI 10.1128/EC.00281-06; Grossmann G, 2008, J CELL BIOL, V183, P1075, DOI 10.1083/jcb.200806035; Hagen S, 2007, APPL ENVIRON MICROB, V73, P2128, DOI 10.1128/AEM.02497-06; HERMAN PK, 1990, MOL CELL BIOL, V10, P6742, DOI 10.1128/MCB.10.12.6742; Inoki K, 2005, MICROBIOL MOL BIOL R, V69, P79, DOI 10.1128/MMBR.69.1.79-100.2005; Leiter E, 2005, ANTIMICROB AGENTS CH, V49, P2445, DOI 10.1128/AAC.49.6.2445-2453.2005; Lesage G, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-8; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Madrid MP, 2003, MOL MICROBIOL, V47, P257, DOI 10.1046/j.1365-2958.2003.03299.x; Meyer V, 2002, MOL GENET GENOMICS, V266, P747, DOI 10.1007/s00438-001-0609-6; MEYER V, 2011, APPL ENV MI IN PRESS; Meyer V, 2008, APPL MICROBIOL BIOT, V78, P17, DOI 10.1007/s00253-007-1291-3; Meyer V, 2007, J BIOL CHEM, V282, P32935, DOI 10.1074/jbc.M705856200; Meyer V, 2007, J BIOTECHNOL, V128, P770, DOI 10.1016/j.jbiotec.2006.12.021; Meyer V, 2010, MANUAL OF INDUSTRIAL MICROBIOLOGY AND BIOTECHNOLOGY, THIRD EDITION, P318; Ohdate T, 2010, GENES CELLS, V15, P59, DOI 10.1111/j.1365-2443.2009.01365.x; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; Plaine A, 2008, FUNGAL GENET BIOL, V45, P1404, DOI 10.1016/j.fgb.2008.08.003; Popolo L, 1997, J BACTERIOL, V179, P463, DOI 10.1128/jb.179.2.463-469.1997; Ram AFJ, 2004, MICROBIOL-SGM, V150, P3315, DOI 10.1099/mic.0.27249-0; Ram AFJ, 2006, NAT PROTOC, V1, P2253, DOI 10.1038/nprot.2006.397; Rodicio R, 2010, YEAST, V27, P531, DOI 10.1002/yea.1785; RONCERO C, 1988, J BACTERIOL, V170, P1945, DOI 10.1128/jb.170.4.1945-1949.1988; Roncero C, 2002, CURR GENET, V41, P367, DOI 10.1007/s00294-002-0318-7; Sambrook J, 2001, MOL CLONING LAB MANU; Sanz M, 2004, MICROBIOL-SGM, V150, P3229, DOI 10.1099/mic.0.27352-0; Slessareva JE, 2006, CELL, V126, P191, DOI 10.1016/j.cell.2006.04.045; Strahl T, 2007, BBA-MOL CELL BIOL L, V1771, P353, DOI 10.1016/j.bbalip.2007.01.015; Tamaki H, 2007, J BIOSCI BIOENG, V104, P245, DOI 10.1263/jbb.104.245; Theis T, 2005, RES MICROBIOL, V156, P47, DOI 10.1016/j.resmic.2004.08.006; Theis T, 2003, ANTIMICROB AGENTS CH, V47, P588, DOI 10.1128/AAC.47.2.588-593.2003; TRACEY MV, 1955, MOD METHOD PLANT, V2, P264; VANGORCOM RFM, 1988, NUCLEIC ACIDS RES, V16, P9052, DOI 10.1093/nar/16.18.9052; Walker LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000040; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Yang L, 2004, EUKARYOT CELL, V3, P1359, DOI 10.1128/EC.3.5.1359-1362.2004; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang NN, 2006, MOL BIOL CELL, V17, P3409, DOI 10.1091/mbc.E06-03-0177; Ziman M, 1998, MOL BIOL CELL, V9, P1565, DOI 10.1091/mbc.9.6.1565; Ziman M, 1996, MOL BIOL CELL, V7, P1909, DOI 10.1091/mbc.7.12.1909; Zurita-Martinez SA, 2007, GENETICS, V176, P2139, DOI 10.1534/genetics.107.072835	63	44	44	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					13859	13868		10.1074/jbc.M110.203588	http://dx.doi.org/10.1074/jbc.M110.203588			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21343301	Green Published, hybrid			2022-12-27	WOS:000289556200009
J	Qu, XX; Carbe, C; Tao, CQ; Powers, A; Lawrence, R; van Kuppevelt, TH; Cardoso, WV; Grobe, K; Esko, JD; Zhang, X				Qu, Xiuxia; Carbe, Christian; Tao, Chenqi; Powers, Andrea; Lawrence, Roger; van Kuppevelt, Toin H.; Cardoso, Wellington V.; Grobe, Kay; Esko, Jeffrey D.; Zhang, Xin			Lacrimal Gland Development and Fgf10-Fgfr2b Signaling Are Controlled by 2-O- and 6-O-sulfated Heparan Sulfate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-SITES; FGF; MICE; OLIGOSACCHARIDES; PROTEOGLYCANS; ANTIBODIES; PROTEINS; COMPLEX; ROLES; MOUSE	Heparan sulfate, an extensively sulfated glycosaminoglycan abundant on cell surface proteoglycans, regulates intercellular signaling through its binding to various growth factors and receptors. In the lacrimal gland, branching morphogenesis depends on the interaction of heparan sulfate with Fgf10-Fgfr2b. To address if lacrimal gland development and FGF signaling depends on 2-O-sulfation of uronic acids and 6-O-sulfation of glucosamine residues, we genetically ablated heparan sulfate 2-O and 6-O sulfotransferases (Hs2st, Hs6st1, and Hs6st2) in developing lacrimal gland. Using a panel of phage display antibodies, we confirmed that these mutations disrupted 2-O and/or 6-O but not N-sulfation of heparan sulfate. The Hs6st mutants exhibited significant lacrimal gland hypoplasia and a strong genetic interaction with Fgf10, demonstrating the importance of heparan sulfate 6-O sulfation in lacrimal gland FGF signaling. Altering Hs2st caused a much less severe phenotype, but the Hs2st;Hs6st double mutants completely abolished lacrimal gland development, suggesting that both 2-O and 6-O sulfation of heparan sulfate contribute to FGF signaling. Combined Hs2st; Hs6st deficiency synergistically disrupted the formation of Fgf10-Fgfr2b-heparan sulfate complex on the cell surface and prevented lacrimal gland induction by Fgf10 in explant cultures. Importantly, the Hs2st;Hs6st double mutants abrogated FGF downstream ERK signaling. Therefore, Fgf10-Fgfr2b signaling during lacrimal gland development is sensitive to the content or arrangement of O-sulfate groups in heparan sulfate. To our knowledge, this is the first study to show that simultaneous deletion of Hs2st and Hs6st exhibits profound FGF signaling defects in mammalian development.	[Qu, Xiuxia; Carbe, Christian; Tao, Chenqi; Powers, Andrea; Zhang, Xin] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [van Kuppevelt, Toin H.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life, Dept Biochem, NL-6500 HB Nijmegen, Netherlands; [Cardoso, Wellington V.] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA; [Grobe, Kay] Univ Munster, D-48149 Munster, Germany; [Lawrence, Roger; Esko, Jeffrey D.] Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Indiana University System; Indiana University Bloomington; Radboud University Nijmegen; Boston University; University of Munster; University of California System; University of California San Diego	Zhang, X (corresponding author), Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA.	xz4@iupui.edu	van Kuppevelt, A.H.M.S.M./L-4463-2015; Grobe, Kay/F-2399-2011	Cardoso, Wellington/0000-0002-2550-3697	National Institutes of Health [EY018868, GM33063, GM93131]; Ralph W. and Grace M. Showalter Research Trust; NATIONAL EYE INSTITUTE [R01EY018868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093131, R37GM033063, R01GM033063] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ralph W. and Grace M. Showalter Research Trust; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY018868 (to X.Z.) and GM33063 and GM93131 (to J.D.E.). This work was also supported by the Ralph W. and Grace M. Showalter Research Trust Fund (to X.Z.).	Allen BL, 2003, J CELL BIOL, V163, P637, DOI 10.1083/jcb.200307053; Ashery-Padan R, 2000, GENE DEV, V14, P2701, DOI 10.1101/gad.184000; Ashikari-Hada S, 2004, J BIOL CHEM, V279, P12346, DOI 10.1074/jbc.M313523200; Bullock SL, 1998, GENE DEV, V12, P1894, DOI 10.1101/gad.12.12.1894; Bulow HE, 2006, ANNU REV CELL DEV BI, V22, P375, DOI 10.1146/annurev.cellbio.22.010605.093433; Cai ZG, 2010, J NEUROSCI, V30, P4110, DOI 10.1523/JNEUROSCI.4364-09.2010; Dennissen MABA, 2002, J BIOL CHEM, V277, P10982, DOI 10.1074/jbc.M104852200; Entesarian M, 2005, NAT GENET, V37, P125, DOI 10.1038/ng1507; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Govindarajan V, 2000, DEV BIOL, V225, P188, DOI 10.1006/dbio.2000.9812; Guimond SE, 1999, CURR BIOL, V9, P1343, DOI 10.1016/S0960-9822(00)80060-3; Habuchi H, 2007, J BIOL CHEM, V282, P15578, DOI 10.1074/jbc.M607434200; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; Izvolsky KI, 2008, GENESIS, V46, P8, DOI 10.1002/dvg.20355; Jastrebova N, 2006, J BIOL CHEM, V281, P26884, DOI 10.1074/jbc.M600806200; Jastrebova N, 2010, J BIOL CHEM, V285, P26842, DOI 10.1074/jbc.M109.093542; JAT PS, 1986, MOL CELL BIOL, V6, P1204, DOI 10.1128/MCB.6.4.1204; Jenniskens GJ, 2000, J NEUROSCI, V20, P4099; Kamimura K, 2006, J CELL BIOL, V174, P773, DOI 10.1083/jcb.200603129; Kreuger J, 2005, BIOCHEM J, V389, P145, DOI 10.1042/BJ20042129; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Lawrence R, 2008, J BIOL CHEM, V283, P33674, DOI 10.1074/jbc.M804288200; Lawrence R, 2008, NAT METHODS, V5, P291, DOI 10.1038/nmeth0408-291; Li JP, 2003, J BIOL CHEM, V278, P28363, DOI 10.1074/jbc.C300219200; Li Y, 2007, J IMMUNOL, V179, P8322, DOI 10.4049/jimmunol.179.12.8322; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Lindahl U, 2009, INT REV CEL MOL BIO, V276, P105, DOI 10.1016/S1937-6448(09)76003-4; Makarenkova HP, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000304; Makarenkova HP, 2000, DEVELOPMENT, V127, P2563; Merry CLR, 2001, J BIOL CHEM, V276, P35429, DOI 10.1074/jbc.M100379200; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; Nagai N, 2007, J BIOL CHEM, V282, P14942, DOI 10.1074/jbc.M610691200; Ori A, 2008, FRONT BIOSCI-LANDMRK, V13, P4309, DOI 10.2741/3007; Ornitz DM, 2000, BIOESSAYS, V22, P108, DOI 10.1002/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M; Ostrovsky O, 2002, J BIOL CHEM, V277, P2444, DOI 10.1074/jbc.M108540200; Pan Y, 2008, DEVELOPMENT, V135, P301, DOI 10.1242/dev.014829; Pan Y, 2006, DEVELOPMENT, V133, P4933, DOI 10.1242/dev.02679; Pan Y, 2010, DEVELOPMENT, V137, P1085, DOI 10.1242/dev.042820; Patel VN, 2008, J BIOL CHEM, V283, P9308, DOI 10.1074/jbc.M709995200; Pratt T, 2006, J NEUROSCI, V26, P6911, DOI 10.1523/JNEUROSCI.0505-06.2006; Pye DA, 1998, J BIOL CHEM, V273, P22936, DOI 10.1074/jbc.273.36.22936; Sedita J, 2004, DEV DYNAM, V231, P782, DOI 10.1002/dvdy.20173; Selleck SB, 2000, TRENDS GENET, V16, P206, DOI 10.1016/S0168-9525(00)01997-1; Stanford KI, 2010, J BIOL CHEM, V285, P286, DOI 10.1074/jbc.M109.063701; Sugaya N, 2008, J BIOL CHEM, V283, P10366, DOI 10.1074/jbc.M705948200; van Kuppevelt TH, 1998, J BIOL CHEM, V273, P12960, DOI 10.1074/jbc.273.21.12960; Wu ZLL, 2003, J BIOL CHEM, V278, P17121, DOI 10.1074/jbc.M212590200	47	60	60	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14435	14444		10.1074/jbc.M111.225003	http://dx.doi.org/10.1074/jbc.M111.225003			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21357686	hybrid, Green Published			2022-12-27	WOS:000289556200065
J	Akhtart, K; Broekelnnann, TJ; Song, HW; Turk, J; Brett, TJ; Mecham, RP; Adair-Kirk, TL				Akhtart, Kamal; Broekelnnann, Thomas J.; Song, Haowei; Turk, John; Brett, Tom J.; Mecham, Robert P.; Adair-Kirk, Tracy L.			Oxidative Modifications of the C-terminal Domain of Tropoelastin Prevent Cell Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPRAVALVULAR AORTIC-STENOSIS; SMOOTH-MUSCLE-CELLS; EXTRACELLULAR-MATRIX; ELASTIN GENE; VASCULAR MORPHOGENESIS; SUPEROXIDE DISMUTASE; CUTIS LAXA; DISEASE; EXPRESSION; INTEGRIN	Tropoelastin (TE), the soluble monomer of elastin, is synthesized by elastogenic cells, such as chondrocytes, fibroblasts, and smooth muscle cells (SMCs). The C-terminal domain of TE interacts with cell receptors, and these interactions play critical roles in elastic fiber assembly. We recently found that oxidation of TE prevents elastic fiber assembly. Here, we examined the effects of oxidation of TE on cell interactions. We found that SMCs bind to TE through heparan sulfate (HS), whereas fetal lung fibroblasts (WI-38 cells) bind through integrin a,alpha(v)beta(3) and HS. In addition, we found that oxidation of TE by peroxynitrite (ONOO-) prevented binding of SMCs and WI-38 cells and other elastogenic cells, human dermal fibroblasts and fetal bovine chondrocytes. Because the C-terminal domain of TE has binding sites for both HS and integrin, we examined the effects of oxidation of a synthetic peptide derived from the C-terminal 25 amino acids of TE (CT-25) on cell binding. The CT-25 peptide contains the only two Cys residues in TE juxtaposed to a cluster of positively charged residues (RKRK) that are important for cell binding. ONOO- treatment of the CT-25 peptide prevented cell binding, whereas reduction of the CT-25 peptide had no effect. Mass spectrometric and circular dichroism spectroscopic analyses showed that ONOO- treatment modified both Cys residues in the CT-25 peptide to sulfonic acid derivatives, without altering the secondary structure. These data suggest that the mechanism by which ONOO- prevents cell binding to TE is by introducing negatively charged sulfonic acid residues near the positively charged cluster.	[Akhtart, Kamal; Song, Haowei; Turk, John; Brett, Tom J.; Mecham, Robert P.; Adair-Kirk, Tracy L.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Broekelnnann, Thomas J.; Mecham, Robert P.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Adair-Kirk, TL (corresponding author), 660 S Euclid Ave,Box 8052, St Louis, MO 63110 USA.	tkirk@dom.wustl.edu	Brett, Thomas/AAC-9147-2019	Brett, Thomas/0000-0002-6871-6676	National Institutes of Health [PO1HL29594]; NHLBI [HL53325]; USPHS [R37-DK34388, P41-RR00954, P60-DK20579, P30-DK56341]; Alpha-1 Foundation; Alan A. and Edith L. Wolff Charitable Trust/Barnes-Jewish Hospital Foundation; American Lung Association; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053325, P01HL029594, R37HL053325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK034388, P60DK020579, P30DK056341] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Alpha-1 Foundation; Alan A. and Edith L. Wolff Charitable Trust/Barnes-Jewish Hospital Foundation; American Lung Association; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1HL29594 and HL53325 from NHLBI and Grants R37-DK34388, P41-RR00954, P60-DK20579, and P30-DK56341 from USPHS. This work was also supported by Alpha-1 Foundation, Alan A. and Edith L. Wolff Charitable Trust/Barnes-Jewish Hospital Foundation, and American Lung Association.	Akhtar K, 2010, J BIOL CHEM, V285, P37396, DOI 10.1074/jbc.M110.126789; Alvarez B, 2003, AMINO ACIDS, V25, P295, DOI 10.1007/s00726-003-0018-8; Araki E, 2009, MOL BIOL CELL, V20, P3012, DOI 10.1091/mbc.E08-09-0977; Assoian RK, 1996, J CLIN INVEST, V98, P2436, DOI 10.1172/JCI119059; Baranek T, 2007, J IMMUNOL, V179, P6184, DOI 10.4049/jimmunol.179.9.6184; Bass MD, 2008, J CELL BIOL, V181, P1013, DOI 10.1083/jcb.200711129; Bax DV, 2009, J BIOL CHEM, V284, P28616, DOI 10.1074/jbc.M109.017525; Broekelmann TJ, 2005, J BIOL CHEM, V280, P40939, DOI 10.1074/jbc.M507309200; Brooke BS, 2003, TRENDS CELL BIOL, V13, P51, DOI 10.1016/S0962-8924(02)00007-7; BROWN PL, 1992, BIOCHEM BIOPH RES CO, V186, P549, DOI 10.1016/S0006-291X(05)80843-5; Chen YR, 2002, J BIOL CHEM, V277, P29781, DOI 10.1074/jbc.M200709200; CURRAN ME, 1993, CELL, V73, P159, DOI 10.1016/0092-8674(93)90168-P; Debret R, 2006, J INVEST DERMATOL, V126, P1860, DOI 10.1038/sj.jid.5700337; Deslee G, 2009, EUR RESPIR J, V34, P324, DOI 10.1183/09031936.00123008; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11; Fearon IM, 2009, J MOL CELL CARDIOL, V47, P372, DOI 10.1016/j.yjmcc.2009.05.013; Floquet N, 2005, MATRIX BIOL, V24, P271, DOI 10.1016/j.matbio.2005.03.002; HINEK A, 1988, SCIENCE, V239, P1539, DOI 10.1126/science.2832941; Karnik SK, 2003, DEVELOPMENT, V130, P411, DOI 10.1242/dev.00223; Kelleher CM, 2005, AM J RESP CELL MOL, V33, P355, DOI 10.1165/rcmb.2005-0206OC; Kozel BA, 2006, J CELL PHYSIOL, V207, P87, DOI 10.1002/jcp.20546; Kozel BA, 2003, J BIOL CHEM, V278, P18491, DOI 10.1074/jbc.M212715200; Krettek A, 2003, ARTERIOSCL THROM VAS, V23, P582, DOI 10.1161/01.ATV.0000064372.78561.A5; LANDEGREN U, 1984, J IMMUNOL METHODS, V67, P379, DOI 10.1016/0022-1759(84)90477-0; Li DY, 1997, HUM MOL GENET, V6, P1021, DOI 10.1093/hmg/6.7.1021; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Madamanchi NR, 2005, ARTERIOSCL THROM VAS, V25, P950, DOI 10.1161/01.ATV.0000161050.77646.68; Maeda I, 2007, J BIOCHEM, V142, P627, DOI 10.1093/jb/mvm170; Avalos AM, 2009, J CELL SCI, V122, P3462, DOI 10.1242/jcs.034827; MECHAM RP, 1989, BIOCHEMISTRY-US, V28, P3716, DOI 10.1021/bi00435a014; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; OLSEN DR, 1988, J BIOL CHEM, V263, P6465; OOYAMA T, 1987, ARTERIOSCLEROSIS, V7, P593, DOI 10.1161/01.ATV.7.6.593; Pierce RA, 1997, AM J PHYSIOL-LUNG C, V272, pL452, DOI 10.1152/ajplung.1997.272.3.L452; PYTELA R, 1987, METHOD ENZYMOL, V144, P475; RAINES EW, 1993, BRIT HEART J, V69, pS30; Reynolds LE, 2005, NAT MED, V11, P167, DOI 10.1038/nm1165; Rodgers UR, 2004, BIOCHIMIE, V86, P173, DOI 10.1016/j.biochi.2004.03.002; RONGIOLETTI F, 1995, DERMATOLOGY, V191, P19, DOI 10.1159/000246478; SENIOR RM, 1984, J CELL BIOL, V99, P870, DOI 10.1083/jcb.99.3.870; Singh Uma, 2006, Pathophysiology, V13, P129, DOI 10.1016/j.pathophys.2006.05.002; Song HW, 2010, J BIOL CHEM, V285, P33843, DOI 10.1074/jbc.M110.153197; Stiebellehner L, 2003, AM J PHYSIOL-LUNG C, V285, pL819, DOI 10.1152/ajplung.00062.2003; Verzijl N, 2000, BIOCHEM J, V350, P381, DOI 10.1042/0264-6021:3500381; Verzijl N, 2000, J BIOL CHEM, V275, P39027, DOI 10.1074/jbc.M006700200; Wagenseil Jessica E., 2007, Birth Defects Research, V81, P229, DOI 10.1002/bdrc.20111; Waller JM, 2006, SKIN RES TECHNOL, V12, P145, DOI 10.1111/j.0909-752X.2006.00146.x; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; Williamson MR, 2007, BIOMATERIALS, V28, P5307, DOI 10.1016/j.biomaterials.2007.08.019; Yamakura F, 1998, J BIOL CHEM, V273, P14085, DOI 10.1074/jbc.273.23.14085; Yao HW, 2010, P NATL ACAD SCI USA, V107, P15571, DOI 10.1073/pnas.1007625107; Yoneda A, 2003, MATRIX BIOL, V22, P25, DOI 10.1016/S0945-053X(03)00010-6; ZAMBRUNO G, 1995, J CELL BIOL, V129, P853, DOI 10.1083/jcb.129.3.853; Zhang MC, 1999, J BIOL CHEM, V274, P981, DOI 10.1074/jbc.274.2.981	55	18	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13574	13582		10.1074/jbc.M110.192088	http://dx.doi.org/10.1074/jbc.M110.192088			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21321118	Green Published, hybrid			2022-12-27	WOS:000289282200077
J	Lawan, A; Al-Harthi, S; Cadalbert, L; McCluskey, AG; Shweash, M; Grassia, G; Grant, A; Boyd, M; Currie, S; Plevin, R				Lawan, Ahmed; Al-Harthi, Sameer; Cadalbert, Laurence; McCluskey, Anthony G.; Shweash, Muhannad; Grassia, Gianluca; Grant, Anne; Boyd, Marie; Currie, Susan; Plevin, Robin			Deletion of the Dual Specific Phosphatase-4 (DUSP-4) Gene Reveals an Essential Non-redundant Role for MAP Kinase Phosphatase-2 (MKP-2) in Proliferation and Cell Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL-KINASE; PROTECTS ENDOTHELIAL-CELLS; DOUBLE-STRAND BREAKS; SIGNALING PATHWAYS; OXIDATIVE STRESS; EXPRESSION; APOPTOSIS; ACTIVATION; JNK; CANCER	Mitogen-activated protein kinase phosphatase-2 (MKP-2) is a type 1 nuclear dual specific phosphatase (DUSP) implicated in a number of cancers. We examined the role of MKP-2 in the regulation of MAP kinase phosphorylation, cell proliferation, and survival responses in mouse embryonic fibroblasts (MEFs) derived from a novel MKP-2 (DUSP-4) deletion mouse. We show that serum and PDGF induced ERK-dependent MKP-2 expression in wild type METs but not in MKP-2(-/-) MEFs. PDGF stimulation of sustained ERK phosphorylation was enhanced in MKP-2(-/-) MEFs, whereas anisomycin-induced JNK was only marginally increased. However, marked effects upon cell growth parameters were observed. Cellular proliferation rates were significantly reduced in MKP-2(-/-) MEFs and associated with a significant increase in cell doubling time. Infection with adenoviral MKP-2 reversed the decrease in proliferation. Cell cycle analysis revealed a block in G(2)/M phase transition associated with cyclin B accumulation and enhanced cdc2 phosphorylation. MEFs from MKP-2(-/-) mice also showed enhanced apoptosis when stimulated with anisomycin correlated with increased caspase-3 cleavage and gamma H2AX phosphorylation. Increased apoptosis was reversed by adenoviral MKP-2 infection and correlated with selective inhibition of JNK signaling. Collectively, these data demonstrate for the first time a critical non-redundant role fir MKP-2 in regulating cell cycle progression and apoptosis.	[Lawan, Ahmed; Al-Harthi, Sameer; Cadalbert, Laurence; McCluskey, Anthony G.; Shweash, Muhannad; Grassia, Gianluca; Grant, Anne; Boyd, Marie; Currie, Susan; Plevin, Robin] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow G4 0NR, Lanark, Scotland	University of Strathclyde	Plevin, R (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, 27 Taylor St, Glasgow G4 0NR, Lanark, Scotland.	r.plevin@strath.ac.uk	Shweash, Muhannad/E-1741-2019; Alharthi, Sameer/J-7710-2012; Grassia, Gianluca/H-7677-2019	Shweash, Muhannad/0000-0003-4373-9465; Grassia, Gianluca/0000-0001-7846-5594; Currie, Susan/0000-0002-4237-4428; Cadalbert, Laurence/0000-0003-1333-2146; Plevin, Robin/0000-0002-7849-1220; Boyd, Marie/0000-0003-4120-2218	Nigerian Government; University of Strathclyde; government of Saudi Arabia	Nigerian Government; University of Strathclyde; government of Saudi Arabia	This work was supported by a studentship from the Nigerian Government and the University of Strathclyde (to A. L.) and a scholarship from government of Saudi Arabia (to S. A.).	Al-Mutairi MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001192; Albrecht EA, 2009, INFLAMM RES, V58, P30, DOI 10.1007/s00011-008-8156-9; Arnoldussen YJ, 2009, MOL CELL ENDOCRINOL, V309, P1, DOI 10.1016/j.mce.2009.05.019; Brondello JM, 1997, J BIOL CHEM, V272, P1368, DOI 10.1074/jbc.272.2.1368; Cadalbert L, 2005, CELL SIGNAL, V17, P1254, DOI 10.1016/j.cellsig.2005.01.003; Cadalbert LC, 2010, CELL SIGNAL, V22, P357, DOI 10.1016/j.cellsig.2009.10.002; Chitale D, 2009, ONCOGENE, V28, P2773, DOI 10.1038/onc.2009.135; Chu YF, 1996, J BIOL CHEM, V271, P6497, DOI 10.1074/jbc.271.11.6497; Dadakhujaev S, 2009, AUTOPHAGY, V5, P103, DOI 10.4161/auto.5.1.7276; Daniel S, 2004, BLOOD, V104, P2376, DOI 10.1182/blood-2003-02-0635; de Feraudy S, 2010, P NATL ACAD SCI USA, V107, P6870, DOI 10.1073/pnas.1002175107; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Farooq A, 2004, CELL SIGNAL, V16, P769, DOI 10.1016/j.cellsig.2003.12.008; Hasegawa T, 2008, ONCOGENE, V27, P5684, DOI 10.1038/onc.2008.182; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Ianzini F, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-11; Innocente SA, 1999, P NATL ACAD SCI USA, V96, P2147, DOI 10.1073/pnas.96.5.2147; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kamada S, 2005, J BIOL CHEM, V280, P857, DOI 10.1074/jbc.C400538200; Keyse SM, 2008, CANCER METAST REV, V27, P253, DOI 10.1007/s10555-008-9123-1; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Lang R, 2006, J IMMUNOL, V177, P7497, DOI 10.4049/jimmunol.177.11.7497; Li MX, 2003, J BIOL CHEM, V278, P41059, DOI 10.1074/jbc.M307149200; Lu CR, 2006, MOL CELL, V23, P121, DOI 10.1016/j.molcel.2006.05.023; Meszaros JG, 2000, AM J PHYSIOL-CELL PH, V278, pC154, DOI 10.1152/ajpcell.2000.278.1.C154; MISRAPRESS A, 1995, J BIOL CHEM, V270, P14587, DOI 10.1074/jbc.270.24.14587; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Ohneseit PA, 2005, RADIOTHER ONCOL, V75, P237, DOI 10.1016/j.radonc.2005.03.025; Osto E, 2008, CIRCULATION, V118, P2073, DOI 10.1161/CIRCULATIONAHA.108.765032; Ramesh S, 2008, EMBO REP, V9, P990, DOI 10.1038/embor.2008.158; Robinson CJM, 2001, CELL SIGNAL, V13, P29, DOI 10.1016/S0898-6568(00)00121-2; Rosini P, 2004, J BIOL CHEM, V279, P14016, DOI 10.1074/jbc.M305356200; Shen WH, 2006, CANCER RES, V66, P6033, DOI 10.1158/0008-5472.CAN-05-3878; Sieben NLG, 2005, J CLIN ONCOL, V23, P7257, DOI 10.1200/JCO.2005.02.2541; Sloss CM, 2005, CELL SIGNAL, V17, P709, DOI 10.1016/j.cellsig.2004.10.010; Suzuki T, 2003, HYPERTENSION, V42, P342, DOI 10.1161/01.HYP.0000084602.06114.AD; Teng CH, 2007, J BIOL CHEM, V282, P28395, DOI 10.1074/jbc.M705142200; Tresini M, 2007, J BIOL CHEM, V282, P4136, DOI 10.1074/jbc.M604955200; Wang JL, 2007, J BIOL CHEM, V282, P18521, DOI 10.1074/jbc.M610538200; Wu JJ, 2006, CELL METAB, V4, P61, DOI 10.1016/j.cmet.2006.05.010; Wu JJ, 2005, J BIOL CHEM, V280, P16461, DOI 10.1074/jbc.M501762200; Yip-Schneider MT, 2001, BIOCHEM BIOPH RES CO, V280, P992, DOI 10.1006/bbrc.2001.4243; Yokoyama A, 1997, BIOCHEM BIOPH RES CO, V239, P746, DOI 10.1006/bbrc.1997.7547; Yoshimura K, 2005, NAT MED, V11, P1330, DOI 10.1038/nm1335	45	44	44	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					12933	12943		10.1074/jbc.M110.181370	http://dx.doi.org/10.1074/jbc.M110.181370			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21317287	Green Published, hybrid			2022-12-27	WOS:000289282200013
J	Scholz, C; Parcej, D; Ejsing, CS; Robenek, H; Urbatsch, IL; Tampe, R				Schoelz, Christian; Parcej, David; Ejsing, Christer S.; Robenek, Horst; Urbatsch, Ina L.; Tampe, Robert			Specific Lipids Modulate the Transporter Associated with Antigen Processing (TAP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABC TRANSPORTER; PICHIA-PASTORIS; ATP HYDROLYSIS; PEPTIDE-BINDING; P-GLYCOPROTEIN; MOLECULAR-MECHANISM; NUCLEOTIDE-BINDING; PROTEIN; PURIFICATION; INHIBITION	The transporter associated with antigen processing (TAP) plays a key role in adaptive immunity by translocating proteasomal degradation products from the cytosol into the endoplasmic reticulum lumen for subsequent loading onto major histocompatibility (MHC) class I molecules. For functional and structural analysis of this ATP-binding cassette complex, we established the overexpression of TAP in the methylotrophic yeast Pichia pastoris. Screening of optimal solubilization and purification conditions allowed the isolation of the heterodimeric transport complex, yielding 30 mg of TAP/liter of culture. Detailed analysis of TAP function in the membrane, solubilized, purified, and reconstituted states revealed a direct influence of the native lipid environment on activity. TAP-associated phospholipids, essential for function, were profiled by liquid chromatography Fourier transform mass spectrometry. The antigen translocation activity is stimulated by phosphatidylinositol and -ethanolamine, whereas cholesterol has a negative effect on TAP activity.	[Schoelz, Christian; Parcej, David; Tampe, Robert] Goethe Univ Frankfurt, Inst Biochem, D-60438 Frankfurt, Germany; [Ejsing, Christer S.] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark; [Robenek, Horst] Leibniz Inst Arterioskleroseforsch, D-48149 Munster, Germany; [Urbatsch, Ina L.] Texas Tech Univ, Hlth Sci Ctr, Dept Biochem & Cell Biol, Lubbock, TX 79430 USA	Goethe University Frankfurt; University of Southern Denmark; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Tampe, R (corresponding author), Goethe Univ Frankfurt, Inst Biochem, Max von Laue Str 9, D-60438 Frankfurt, Germany.	tampe@em.uni-frankfurt.de	Schölz, Christian/K-2855-2014; Ejsing, Christer S/R-5922-2016; Parcej, David/AAW-7306-2020; Tampé, Robert/H-2953-2015	Schölz, Christian/0000-0002-1633-2072; Tampé, Robert/0000-0002-0403-2160; Ejsing, Christer S./0000-0003-4963-0276	German Research Foundation [SFB 807, TA157/7, AB149/1]; United States Department of Defense [W81XWH-05-1-0316]; Danish Council for independent Resarch [DOK1155860]; Lundbeckfonden [R45-A4342]; European Commission	German Research Foundation(German Research Foundation (DFG)); United States Department of Defense(United States Department of Defense); Danish Council for independent Resarch; Lundbeckfonden(Lundbeckfonden); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the German Research Foundation (SFB 807 Transport and Communication across Biological Membranes, Grants TA157/7 and AB149/1 to R. T.), the United States Department of Defense (Grant W81XWH-05-1-0316 to I. L U.), the Danish Council for independent Resarch (Grant DOK1155860 to C. S. E.), the Lundbeckfonden (Grant R45-A4342 to C. S. E.), and the European Drug Initiative on Channels and Transporters (EDICT to R. T.) funded by the European Commission Seventh Framework Program.	ABACIOGLU YH, 1994, AIDS RES HUM RETROV, V10, P371, DOI 10.1089/aid.1994.10.371; Ahn K, 1996, EMBO J, V15, P3247, DOI 10.1002/j.1460-2075.1996.tb00689.x; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; ANDROLEWICZ MJ, 1994, P NATL ACAD SCI USA, V91, P12716, DOI 10.1073/pnas.91.26.12716; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Brierley RA, 1997, US Patent, Patent No. [5, 612,198, 5612198]; Burgdorf S, 2008, NAT IMMUNOL, V9, P558, DOI 10.1038/ni.1601; Chen M, 2003, J BIOL CHEM, V278, P29686, DOI 10.1074/jbc.M302757200; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chloupkova M, 2007, BIOCHEMISTRY-US, V46, P7992, DOI 10.1021/bi700020m; Cogan EB, 1999, ANAL BIOCHEM, V271, P29, DOI 10.1006/abio.1999.4100; CREGG JM, 1993, BIO-TECHNOL, V11, P905, DOI 10.1038/nbt0893-905; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Davidson AL, 2007, TRENDS MICROBIOL, V15, P448, DOI 10.1016/j.tim.2007.09.005; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Gaudet R, 2001, EMBO J, V20, P4964, DOI 10.1093/emboj/20.17.4964; Ghanem E, 2010, J CELL SCI, V123, P4271, DOI 10.1242/jcs.060632; Gorbulev S, 2001, P NATL ACAD SCI USA, V98, P3732, DOI 10.1073/pnas.061467898; Herget M, 2007, J BIOL CHEM, V282, P3871, DOI 10.1074/jbc.M608480200; Herget M, 2009, J BIOL CHEM, V284, P33740, DOI 10.1074/jbc.M109.047779; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Johnson BJH, 2010, BIOCHEMISTRY-US, V49, P3403, DOI 10.1021/bi902064g; Keusekotten K, 2006, J BIOL CHEM, V281, P17545, DOI 10.1074/jbc.M602360200; Kyritsis C, 2001, J BIOL CHEM, V276, P48031, DOI 10.1074/jbc.M108528200; Lerner-Marmarosh N, 1999, J BIOL CHEM, V274, P34711, DOI 10.1074/jbc.274.49.34711; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Marsh D, 2007, BIOPHYS J, V93, P3884, DOI 10.1529/biophysj.107.107938; MEYER TH, 1994, FEBS LETT, V351, P443, DOI 10.1016/0014-5793(94)00908-2; MOOR H, 1963, J CELL BIOL, V17, P609, DOI 10.1083/jcb.17.3.609; Oancea G, 2009, P NATL ACAD SCI USA, V106, P5551, DOI 10.1073/pnas.0811260106; Oswald C, 2008, J STRUCT BIOL, V162, P85, DOI 10.1016/j.jsb.2007.11.006; Parcej D, 2010, NAT CHEM BIOL, V6, P572, DOI [10.1038/NCHEMBIO.410, 10.1038/nchembio.410]; Procko E, 2009, FASEB J, V23, P1287, DOI 10.1096/fj.08-121855; Procko E, 2006, MOL CELL, V24, P51, DOI 10.1016/j.molcel.2006.07.034; Qu Q, 2003, BIOCHEMISTRY-US, V42, P1170, DOI 10.1021/bi026555j; RAETZ CRH, 1990, J BIOL CHEM, V265, P1235; Reich-Slotky R, 2000, J BACTERIOL, V182, P993, DOI 10.1128/JB.182.4.993-1000.2000; Schrodt S, 2006, J BIOL CHEM, V281, P6455, DOI 10.1074/jbc.M509784200; SCORER CA, 1994, BIO-TECHNOL, V12, P181, DOI 10.1038/nbt0294-181; Shaikh SR, 2006, CHEM PHYS LIPIDS, V144, P1, DOI 10.1016/j.chemphyslip.2006.06.017; STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9; Storch CH, 2007, J PHARMACOL EXP THER, V323, P257, DOI 10.1124/jpet.107.122994; Takahashi K, 2006, J BIOL CHEM, V281, P10760, DOI 10.1074/jbc.M513783200; UEBEL S, 1995, J BIOL CHEM, V270, P18512, DOI 10.1074/jbc.270.31.18512; Urlinger S, 1997, EUR J BIOCHEM, V245, P266, DOI 10.1111/j.1432-1033.1997.00266.x; Valiyaveetil FI, 2002, BIOCHEMISTRY-US, V41, P10771, DOI 10.1021/bi026215y; van den Brink-van der Laan E, 2004, BIOCHEMISTRY-US, V43, P4240, DOI 10.1021/bi036129d; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; VANENDERT PM, 1994, IMMUNITY, V1, P491, DOI 10.1016/1074-7613(94)90091-4; Wang J, 2006, J BIOL CHEM, V281, P27894, DOI 10.1074/jbc.M605603200; Wang ZL, 2006, BIOCHEMISTRY-US, V45, P9929, DOI 10.1021/bi0608055; Watanabe J, 1996, J ELECTRON MICROSC, V45, P171, DOI 10.1093/oxfordjournals.jmicro.a023429; Zhang W., 2000, BIOTECHNOL BIOPROC E, V5, P275, DOI DOI 10.1007/BF02942184; Zhang WH, 2000, BIOTECHNOL BIOENG, V70, P1, DOI 10.1002/1097-0290(20001005)70:1<1::AID-BIT1>3.0.CO;2-Y	54	23	23	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13346	13356		10.1074/jbc.M110.216416	http://dx.doi.org/10.1074/jbc.M110.216416			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21357424	Green Published, hybrid			2022-12-27	WOS:000289282200055
J	Tang, XY; Sun, ZZ; Runne, C; Madsen, J; Domann, F; Henry, M; Lin, F; Chen, S				Tang, Xiaoyun; Sun, Zhizeng; Runne, Caitlin; Madsen, Joshua; Domann, Frederick; Henry, Michael; Lin, Fang; Chen, Songhai			A Critical Role of G beta gamma in Tumorigenesis and Metastasis of Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOKINE RECEPTOR CXCR4; PROTEIN-COUPLED RECEPTORS; CELL-MIGRATION; TUMOR-GROWTH; LYSOPHOSPHATIDIC ACID; SIGNAL-TRANSDUCTION; THROMBIN; TARGETS; DISSEMINATION; ANGIOGENESIS	A growing body of evidence indicates that G protein-coupled receptors (GPCRs) are involved in breast tumor progression and that targeting GPCRs may be a novel adjuvant strategy in cancer treatment. However, due to the redundant role of multiple GPCRs in tumor development, it may be necessary to target a common signaling component downstream of these receptors to achieve maximum efficacy. GPCRs transmit signals through heterotrimeric G proteins composed of G alpha and G beta gamma subunits. Here we evaluated the role of G beta gamma in breast tumor growth and metastasis both in vitro and in vivo. Our data show that blocking G beta gamma signaling with G alpha(t) or small molecule inhibitors blocked serum-induced breast tumor cell proliferation as well as tumor cell migration induced by various GPCRs in vitro. Moreover, induced expression of G alpha(t) in MDA-MB-231 cells inhibited primary tumor formation and retarded growth of existing breast tumors in nude mice. Blocking G beta gamma signaling also dramatically reduced the incidence of spontaneous lung metastasis from primary tumors and decreased tumor formation in the experimental lung metastasis model. Additional studies indicate that G beta gamma signaling may also play a role in the generation of a tumor microenvironment permissive for tumor progression, because the inhibition of G beta gamma signaling attenuated leukocyte infiltration and angiogenesis in primary breast tumors. Taken together, our data demonstrate a critical role of G beta gamma signaling in promoting breast tumor growth and metastasis and suggest that targeting G beta gamma may represent a novel therapeutic approach for breast cancer.	[Tang, Xiaoyun; Sun, Zhizeng; Runne, Caitlin; Chen, Songhai] Univ Iowa, Dept Pharmacol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Madsen, Joshua; Domann, Frederick] Univ Iowa, Dept Radiat Oncol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Henry, Michael] Univ Iowa, Dept Mol Physiol & Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Henry, Michael] Univ Iowa, Dept Pathol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Lin, Fang] Univ Iowa, Dept Anat & Cell Biol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Chen, Songhai] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa	Chen, S (corresponding author), Bowen Sci Bldg,Rm 2-452,51 Newton Rd, Iowa City, IA 52242 USA.	songhai-chen@uiowa.edu		Lin, Fang/0000-0003-2179-7031; Domann, Frederick/0000-0002-0489-2179; Sun, Zhizeng/0000-0002-0033-5885; Henry, Michael/0000-0002-7871-245X; chen, songhai/0000-0001-7316-7125	National Institutes of Health, NCI [R01CA115438]; American Cancer Society [IRG-77-004-31]; NATIONAL CANCER INSTITUTE [R01CA115438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067795] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grant R01CA115438. The work was also supported by American Cancer Society Grant IRG-77-004-31 (to S. C.).	Ali S, 2007, CANCER METAST REV, V26, P401, DOI 10.1007/s10555-007-9073-z; Ayoub MA, 2009, J BIOL CHEM, V284, P29136, DOI 10.1074/jbc.M109.042333; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Bonacci TM, 2006, SCIENCE, V312, P443, DOI 10.1126/science.1120378; Bookout AL, 2003, J BIOL CHEM, V278, P37569, DOI 10.1074/jbc.M306276200; Cabioglu N, 2005, CLIN EXP METASTAS, V22, P39, DOI 10.1007/s10585-005-3222-y; Cabioglu N, 2005, CLIN CANCER RES, V11, P5686, DOI 10.1158/1078-0432.CCR-05-0014; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chen SH, 2008, MOL BIOL CELL, V19, P3909, DOI 10.1091/mbc.E08-04-0433; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; COUGHLIN SS, 2009, CANCER, V33, P318; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Drake JM, 2005, CLIN EXP METASTAS, V22, P674, DOI 10.1007/s10585-006-9011-4; Even-Ram S, 1998, NAT MED, V4, P909, DOI 10.1038/nm0898-909; Holland JD, 2006, CANCER RES, V66, P4117, DOI 10.1158/0008-5472.CAN-05-1631; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kelly P, 2006, P NATL ACAD SCI USA, V103, P8173, DOI 10.1073/pnas.0510254103; Kirui JK, 2010, J PHARMACOL EXP THER, V333, P393, DOI 10.1124/jpet.109.164814; Lee BC, 2004, MOL CANCER RES, V2, P327; Lee TH, 2003, J BIOL CHEM, V278, P5277, DOI 10.1074/jbc.M210063200; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liebmann C, 2004, CURR PHARM DESIGN, V10, P1937, DOI 10.2174/1381612043384367; Liu SY, 2009, CELL CYCLE, V8, P3695, DOI 10.4161/cc.8.22.9937; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; McLaughlin JN, 2005, J BIOL CHEM, V280, P25048, DOI 10.1074/jbc.M414090200; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Nierodzik ML, 2006, CANCER CELL, V10, P355, DOI 10.1016/j.ccr.2006.10.002; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Panupinthu N, 2010, BRIT J CANCER, V102, P941, DOI 10.1038/sj.bjc.6605588; Park CC, 2006, CANCER RES, V66, P1526, DOI 10.1158/0008-5472.CAN-05-3071; Prevost GP, 2006, CANCER RES, V66, P9227, DOI 10.1158/0008-5472.CAN-05-4205; Price JT, 1999, CANCER RES, V59, P5475; Roland J, 2003, BLOOD, V101, P399, DOI 10.1182/blood-2002-03-0978; Ruffell B, 2010, CYTOKINE GROWTH F R, V21, P3, DOI 10.1016/j.cytogfr.2009.11.002; Schmid BC, 2004, BREAST CANCER RES TR, V84, P247, DOI 10.1023/B:BREA.0000019962.18922.87; Shi GX, 2007, J EXP MED, V204, P2705, DOI 10.1084/jem.20071267; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; Soh UJK, 2010, BRIT J PHARMACOL, V160, P191, DOI 10.1111/j.1476-5381.2010.00705.x; STEPHENS L, 1994, CELL, V77, P83, DOI 10.1016/0092-8674(94)90237-2; Taborga M, 2007, MINI-REV MED CHEM, V7, P245, DOI 10.2174/138955707780059826; Tan WF, 2006, J BIOL CHEM, V281, P39542, DOI 10.1074/jbc.M609062200; UI M, 1990, ADV SEC MESS PHOSPH, V24, P63; Weigelt B, 2008, SEMIN CANCER BIOL, V18, P311, DOI 10.1016/j.semcancer.2008.03.013; WEST RE, 1985, J BIOL CHEM, V260, P4428; Weydert CJ, 2009, CANCER BIOL THER, V8, P720, DOI 10.4161/cbt.8.8.7922; Wu XS, 2009, CURR PHARM DESIGN, V15, P742, DOI 10.2174/138161209787582165; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019	55	35	35	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13244	13254		10.1074/jbc.M110.206615	http://dx.doi.org/10.1074/jbc.M110.206615			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21349837	hybrid, Green Published			2022-12-27	WOS:000289282200045
J	von Holleben, M; Gohla, A; Janssen, KP; Iritani, BM; Beer-Hammer, S				von Holleben, Max; Gohla, Antje; Janssen, Klaus-Peter; Iritani, Brian M.; Beer-Hammer, Sandra			Immunoinhibitory Adapter Protein Src Homology Domain 3 Lymphocyte Protein 2 (SLy2) Regulates Actin Dynamics and B Cell Spreading	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; SIGNAL-TRANSDUCTION; IMMUNE SYNAPSE; RHO-GTPASES; ACTIVATION; CYTOSKELETON; CORTACTIN; COMPLEX; SH3; HACS1	Appropriate B cell activation is essential for adaptive immunity. In contrast to the molecular mechanisms that regulate positive signaling in immune responses, the counterbalancing negative regulatory pathways remain insufficiently understood. The Src homology domain 3 (SH3)-containing adapter protein SH3 lymphocyte protein 2 (SLy2, also known as hematopoietic adapter-containing SH3 and sterile alpha-motif (SAM) domains 1; HACS1) is strongly up-regulated upon B cell activation and functions as an endogenous immunoinhibitor in vivo, but the underlying molecular mechanisms of SLy2 function have been elusive. We have generated transgenic mice overexpressing SLy2 in B and T cells and have studied the biological effects of elevated SLy2 levels in Jurkat and HeLa cells. Our results demonstrate that SLy2 induces Rac1-dependent membrane ruffle formation and regulates cell spreading and polarization and that the SLy2 SH3 domain is essential for these effects. Using immunoprecipitation and confocal microscopy, we provide evidence that the actin nucleation-promoting factor cortactin is an SH3 domain-directed interaction partner of SLy2. Consistent with an important role of SLy2 for actin cytoskeletal reorganization, we further show that SLy2-transgenic B cells are severely defective in cell spreading. Together, our findings extend our mechanistic understanding of the immunoinhibitory roles of SLy2 in vivo and suggest that the physiological up-regulation of SLy2 observed upon B cell activation functions to counteract excessive B cell spreading.	[von Holleben, Max; Beer-Hammer, Sandra] Univ Dusseldorf, Inst Med Microbiol & Hosp Hyg, D-40225 Dusseldorf, Germany; [Gohla, Antje] Univ Dusseldorf, Inst Biochem & Mol Biol 2, D-40225 Dusseldorf, Germany; [Gohla, Antje] Univ Wurzburg, Deutsch Forsch Gemeinschaft Res Ctr Expt Biomed, Inst Pharmacol & Toxicol, D-97078 Wurzburg, Germany; [Gohla, Antje] Univ Wurzburg, Deutsch Forsch Gemeinschaft Res Ctr Expt Biomed, Rudolf Virchow Ctr, D-97078 Wurzburg, Germany; [Janssen, Klaus-Peter] Tech Univ Munich, Klinikum Rechts Isar, Dept Surg, D-81675 Munich, Germany; [Iritani, Brian M.] Univ Washington, Sch Med, Dept Comparat Med, Seattle, WA 98195 USA; [Beer-Hammer, Sandra] Univ Tubingen, Inst Expt & Clin Pharmacol & Toxicol, Eberhard Karls Univ Hosp & Clin, Dept Pharmacol & Expt Therapy, D-72074 Tubingen, Germany; [Beer-Hammer, Sandra] Univ Tubingen, Interfac Ctr Pharmacogen & Pharmaceut Res, D-72074 Tubingen, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; University of Wurzburg; University of Wurzburg; Technical University of Munich; University of Washington; University of Washington Seattle; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen	Beer-Hammer, S (corresponding author), Univ Tubingen, Inst Expt & Clin Pharmacol & Toxicol, Eberhard Karls Univ Hosp & Clin, Dept Pharmacol & Expt Therapy, Wilhelmstr 56, D-72074 Tubingen, Germany.	sandra.beer-hammer@uni-tuebingen.de	Beer-Hammer, Sandra/C-7442-2014	Beer-Hammer, Sandra/0000-0001-6049-0257; Iritani, Brian/0000-0003-1903-7850; Gohla, Antje/0000-0002-7442-1487	Deutsche Forschungsgemeinschaft [BE 2813/1-1, 2813/1-2, SFB 728, FOR729, SFB 688, SFB 456]; Forschungskommission of the Heinrich Heine University Duesseldorf; Karls-Eberhard-University Tubingen; NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR024462] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Forschungskommission of the Heinrich Heine University Duesseldorf; Karls-Eberhard-University Tubingen; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by Grants BE 2813/1-1 and 2813/1-2 (to S. B.), SFB 728, FOR729, and SFB 688 (to A. G.), and SFB 456 (to K.-P. J.) from Deutsche Forschungsgemeinschaft and Forschungskommission of the Heinrich Heine University Duesseldorf and Karls-Eberhard-University Tubingen (to S. B.-H.).	Arana E, 2008, IMMUNITY, V28, P88, DOI 10.1016/j.immuni.2007.12.003; Batista FD, 2010, IMMUNOL REV, V237, P191, DOI 10.1111/j.1600-065X.2010.00943.x; Beer S, 2001, BBA-GENE STRUCT EXPR, V1520, P89, DOI 10.1016/S0167-4781(01)00242-1; Billadeau DD, 2006, TRAFFIC, V7, P1451, DOI 10.1111/j.1600-0854.2006.00491.x; Brandt S, 2010, INT J BIOCHEM CELL B, V42, P1472, DOI 10.1016/j.biocel.2010.05.004; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Butler B, 2008, NAT IMMUNOL, V9, P887, DOI 10.1038/ni.1630; Claudio J, 2001, ONCOGENE, V20, P5373, DOI 10.1038/sj.onc.1204698; Cosen-Binker LI, 2006, PHYSIOLOGY, V21, P352, DOI 10.1152/physiol.00012.2006; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; Fleire SJ, 2006, SCIENCE, V312, P738, DOI 10.1126/science.1123940; Gomez TS, 2006, IMMUNITY, V24, P741, DOI 10.1016/j.immuni.2006.03.022; Haas AK, 2007, J CELL SCI, V120, P2997, DOI 10.1242/jcs.014225; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Harwood NE, 2008, IMMUNITY, V28, P609, DOI 10.1016/j.immuni.2008.04.007; HIDAKA M, 1991, BIOCHEM BIOPH RES CO, V180, P1490, DOI 10.1016/S0006-291X(05)81364-6; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Iritani BM, 1997, EMBO J, V16, P7019, DOI 10.1093/emboj/16.23.7019; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; Lai FPL, 2009, MOL BIOL CELL, V20, P3209, DOI 10.1091/mbc.E08-12-1180; Lanzetti L, 2004, NATURE, V429, P309, DOI 10.1038/nature02542; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Mitelman F, 1997, NAT GENET, V15, P417, DOI 10.1038/ng0497supp-417; Nolz JC, 2006, CURR BIOL, V16, P24, DOI 10.1016/j.cub.2005.11.036; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Rimkus C, 2006, BRIT J CANCER, V95, P1419, DOI 10.1038/sj.bjc.6603452; Shaw AS, 2009, NAT REV IMMUNOL, V9, P47, DOI 10.1038/nri2473; Vicente-Manzanares M, 2004, NAT REV IMMUNOL, V4, P110, DOI 10.1038/nri1268; Wang DY, 2010, FASEB J, V24, P947, DOI 10.1096/fj.09-140806; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; Zeller C, 2003, ONCOGENE, V22, P2972, DOI 10.1038/sj.onc.1206474; Zhu YX, 2004, J EXP MED, V200, P737, DOI 10.1084/jem.20031816	34	21	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13489	13501		10.1074/jbc.M110.155184	http://dx.doi.org/10.1074/jbc.M110.155184			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21296879	hybrid, Green Published			2022-12-27	WOS:000289282200069
J	Yuga, M; Gomi, K; Klionsky, DJ; Shintani, T				Yuga, Masaki; Gomi, Katsuya; Klionsky, Daniel J.; Shintani, Takahiro			Aspartyl Aminopeptidase Is Imported from the Cytoplasm to the Vacuole by Selective Autophagy in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGETING PATHWAY; ALPHA-MANNOSIDASE; BUDDING YEAST; TRANSPORT; PROTEIN; MECHANISM; UBIQUITIN; MEMBRANE; RECEPTOR; MUTANTS	Macroautophagy is a catabolic process by which cytosolic components are sequestered by double membrane vesicles called autophagosomes and sorted to the lysosomes/vacuoles to be degraded. Saccharomyces cerevisiae has adapted this mechanism for constitutive transport of the specific vacuolar hydrolases aminopeptidase I (Ape1) and alpha-mannosidase (Ams1); this process is called the cytoplasm to vacuole targeting (Cvt) pathway. The precursor form of Ape1 self-assembles into an aggregate-like structure in the cytosol that is then recognized by Atg19 in a propeptide-dependent manner. The interaction between Atg19 and autophagosome-forming machineries allows selective packaging of the Ape1-Atg19 complex by the autophagosome-like Cvt vesicle. Amsl also forms oligomers and utilizes the Ape1 transport system by interacting with Atg19. Although the mechanism of selective transport of the Cvt cargoes has been well studied, it is unclear whether proteins other than Ape1 and Ams1 are transported via the Cvt pathway. We describe here that aspartyl aminopeptidase (Yhr113w/Ape4) is the third Cvt cargo, which is similar in primary structure and subunit organization to Ape1. Ape4 has no propeptide, and it does not self-assemble into aggregates. However, it binds to Atg19 in a site distinct from the Ape1- and Ams1-binding sites, allowing it to "piggyback" on the Ape1 transport system. In growing conditions, a small portion of Ape4 localizes in the vacuole, but its vacuolar transport is accelerated by nutrient starvation, and it stably resides in the vacuole lumen. We propose that the cytosolic Ape4 is redistributed to the vacuole when yeast cells need more active vacuolar degradation.	[Shintani, Takahiro] Tohoku Univ, Grad Sch Agr Sci, Dept Bioind Informat & Genom, Aoba Ku, Sendai, Miyagi 9818555, Japan; [Klionsky, Daniel J.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Klionsky, Daniel J.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Klionsky, Daniel J.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	Tohoku University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Shintani, T (corresponding author), Tohoku Univ, Grad Sch Agr Sci, Dept Bioind Informat & Genom, Aoba Ku, 1-1 Tsutsumidori Amamiyamachi, Sendai, Miyagi 9818555, Japan.	shintani@biochem.tohoku.ac.jp	SHINTANI, Takahiro/ABE-1267-2020	Shintani, Takahiro/0000-0001-6630-5892	Sapporo Bioscience Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053396] Funding Source: NIH RePORTER	Sapporo Bioscience Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Sapporo Bioscience Foundation (to T. S.).	Amberg DC, 2005, METHODS YEAST GENETI, P199; Andrei-Selmer C, 2001, J BIOL CHEM, V276, P11606, DOI 10.1074/jbc.M003846200; Baba M, 1997, J CELL BIOL, V139, P1687, DOI 10.1083/jcb.139.7.1687; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Cheong H, 2008, METHOD ENZYMOL, V451, P1, DOI 10.1016/S0076-6879(08)03201-1; ENENKEL C, 1993, J BIOL CHEM, V268, P7036; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; He CC, 2006, J CELL BIOL, V175, P925, DOI 10.1083/jcb.200606084; He CC, 2008, MOL BIOL CELL, V19, P5506, DOI 10.1091/mbc.E08-05-0544; Hirayama H, 2010, J BIOL CHEM, V285, P12390, DOI 10.1074/jbc.M109.082081; Hutchins MU, 2001, J BIOL CHEM, V276, P20491, DOI 10.1074/jbc.M101150200; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; James P, 1996, GENETICS, V144, P1425; Kageyama T, 2009, BIOCHEM BIOPH RES CO, V378, P551, DOI 10.1016/j.bbrc.2008.11.084; Kanki T, 2008, J BIOL CHEM, V283, P32386, DOI 10.1074/jbc.M802403200; Kim J, 1997, J CELL BIOL, V137, P609, DOI 10.1083/jcb.137.3.609; Kim J, 2001, J CELL BIOL, V153, P381, DOI 10.1083/jcb.153.2.381; Kim J, 2001, J CELL BIOL, V152, P51, DOI 10.1083/jcb.152.1.51; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; KLIONSKY DJ, 1992, J CELL BIOL, V119, P287, DOI 10.1083/jcb.119.2.287; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Meijer WH, 2007, AUTOPHAGY, V3, P106, DOI 10.4161/auto.3595; METZ G, 1976, BIOCHIM BIOPHYS ACTA, V429, P933, DOI 10.1016/0005-2744(76)90338-7; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; Reggiori F, 2004, DEV CELL, V6, P79, DOI 10.1016/S1534-5807(03)00402-7; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Scott SV, 1997, J CELL BIOL, V138, P37, DOI 10.1083/jcb.138.1.37; Scott SV, 2001, MOL CELL, V7, P1131, DOI 10.1016/S1097-2765(01)00263-5; Shintani T, 2004, J BIOL CHEM, V279, P29889, DOI 10.1074/jbc.M404399200; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Shintani T, 2001, J BIOL CHEM, V276, P30452, DOI 10.1074/jbc.M102346200; Shintani T, 2008, METHOD ENZYMOL, V451, P43, DOI 10.1016/S0076-6879(08)03204-7; Suzuki K, 2002, DEV CELL, V3, P815, DOI 10.1016/S1534-5807(02)00359-3; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Suzuki K, 2010, J BIOL CHEM, V285, P30019, DOI 10.1074/jbc.M110.143511; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Watanabe Y, 2010, J BIOL CHEM, V285, P30026, DOI 10.1074/jbc.M110.143545; Wilk S, 1998, J BIOL CHEM, V273, P15961, DOI 10.1074/jbc.273.26.15961; YASUHARA T, 1994, J BIOL CHEM, V269, P13644; Yokoyama R, 2006, FEBS J, V273, P192, DOI 10.1111/j.1742-4658.2005.05057.x; YOSHIHISA T, 1990, J BIOL CHEM, V265, P22418; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	46	60	63	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13704	13713		10.1074/jbc.M110.173906	http://dx.doi.org/10.1074/jbc.M110.173906			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21343297	Green Published, hybrid			2022-12-27	WOS:000289282200088
J	Ramstedt, M; Nakao, R; Wai, SN; Uhlin, BE; Boily, JF				Ramstedt, Madeleine; Nakao, Ryoma; Wai, Sun Nyunt; Uhlin, Bernt Eric; Boily, Jean-Francois			Monitoring Surface Chemical Changes in the Bacterial Cell Wall MULTIVARIATE ANALYSIS OF CRYO-X-RAY PHOTOELECTRON SPECTROSCOPY DATA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-AERUGINOSA; OUTER-MEMBRANE; ESCHERICHIA-COLI; XPS ANALYSIS; LIPOPOLYSACCHARIDE; SALMONELLA; ENVELOPE	Gram-negative bacteria can alter the composition of the lipopolysaccharide (LPS) layer of the outer membrane as a response to different growth conditions and external stimuli. These alterations can, for example, promote attachment to surfaces and biofilm formation. The changes occur in the outermost layer of the cell and may consequently influence interactions between bacterial cells and surrounding host tissue, as well as other surfaces. Microscopic analyses, fractionation of bacterial cells, or other traditional microbiological assays have previously been used to study these alterations. These methods can, however, be time consuming and do not always give detailed chemical information about the bacterial cell surface. We here present an analytical method that provides chemical information on the outermost portion of bacterial cells with respect to protein, peptidoglycan, lipid, and polysaccharide content. The method involves cryo-x-ray photoelectron spectroscopy analyses of the outermost portion (within similar to 10 nm of the surface) of intact bacterial cells followed by a multivariate curve resolution analysis of carbon spectra. It can be used as a tool for characterizing and monitoring variations in the chemical composition of bacterial cell walls or of isolated outer membrane vesicles, variations that result from e. g. mutations or external stimuli. The method enabled us to predict accurately the alterations in polysaccharide content and surface chemistries of a set of well characterized Escherichia coli LPS mutants. The described approach may moreover be applied to monitor surface chemical composition of other biological samples.	[Ramstedt, Madeleine; Boily, Jean-Francois] Umea Univ, Dept Chem, SE-90187 Umea, Sweden; [Nakao, Ryoma; Wai, Sun Nyunt; Uhlin, Bernt Eric] Umea Univ, Dept Mol Biol, SE-90187 Umea, Sweden; [Nakao, Ryoma; Wai, Sun Nyunt; Uhlin, Bernt Eric] Umea Univ, Lab Mol Infect Med Sweden, SE-90187 Umea, Sweden; [Nakao, Ryoma] Natl Inst Infect Dis, Dept Bacteriol, Tokyo 1628640, Japan	Umea University; Umea University; Umea University; National Institute of Infectious Diseases (NIID)	Ramstedt, M (corresponding author), Umea Univ, Dept Chem, SE-90187 Umea, Sweden.	madeleine.ramstedt@chem.umu.se	Uhlin, Bernt Eric/AAO-6292-2021; Ramstedt, Madeleine/E-7852-2011	Uhlin, Bernt Eric/0000-0002-2991-8072; Ramstedt, Madeleine/0000-0003-2646-8501; Wai, Sun Nyunt/0000-0003-4793-4671	Curth Nilsson Foundation for Scientific Research; Swedish Research Council; Wallenberg and Kempe foundations	Curth Nilsson Foundation for Scientific Research; Swedish Research Council(Swedish Research CouncilEuropean Commission); Wallenberg and Kempe foundations	Supported by the Curth Nilsson Foundation for Scientific Research. To whom correspondence should be addressed: Dept. of Chemistry, Umea University, SE-90187 Umea, Sweden. Tel.: 46-90-786-6328; Fax: 46-90-786-7655; E-mail: madeleine.ramstedt@chem.umu.se.; Supported by the Swedish Research Council.; Supported by the Swedish Research Council as well as the Wallenberg and Kempe foundations.	Ahimou F, 2007, J COLLOID INTERF SCI, V309, P49, DOI 10.1016/j.jcis.2007.01.055; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BIELIG H, 2011, INFECT IMMU IN PRESS; Briggs D., 1992, HIGH RESOLUTION XPS; COSTERTON JW, 1974, BACTERIOL REV, V38, P87, DOI 10.1128/MMBR.38.1.87-110.1974; DEPETRIS S, 1967, J ULTRA MOL STRUCT R, V19, P45, DOI 10.1016/S0022-5320(67)80059-5; Dufrene YF, 1997, J BACTERIOL, V179, P1023, DOI 10.1128/jb.179.4.1023-1028.1997; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Flemming CA, 1999, BIOFOULING, V13, P213; GOLUB GH, 1970, NUMER MATH, V14, P403, DOI 10.1007/BF02163027; HANCOCK IC, 1991, MICROBIAL CELL SURFA, P23; HOCHELLA MF, 1988, REV MINERAL, V18, P573; Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912; Jaumot J, 2005, CHEMOMETR INTELL LAB, V76, P101, DOI 10.1016/j.chemolab.2004.12.007; KADURUGAMUWA JL, 1993, ANTIMICROB AGENTS CH, V37, P715, DOI 10.1128/AAC.37.4.715; KOPLOW J, 1974, J BACTERIOL, V117, P527, DOI 10.1128/JB.117.2.527-543.1974; Leone L, 2006, SURF INTERFACE ANAL, V38, P202, DOI 10.1002/sia.2184; LIU D, 1994, MICROBIOL-UK, V140, P49, DOI 10.1099/13500872-140-1-49; MEKALANOS JJ, 1983, CELL, V35, P253, DOI 10.1016/0092-8674(83)90228-3; Metzler D. E, 2001, BIOCH CHEM REACTIONS, V2; Ohl ME, 2001, ANNU REV MED, V52, P259, DOI 10.1146/annurev.med.52.1.259; Ramstedt M, 2002, SURF INTERFACE ANAL, V34, P632, DOI 10.1002/sia.1376; Rouxhet PG, 2008, SURF INTERFACE ANAL, V40, P718, DOI 10.1002/sia.2779; Sabra W, 2003, MICROBIOL-SGM, V149, P2789, DOI 10.1099/mic.0.26443-0; Saka K, 2005, DNA RES, V12, P63, DOI 10.1093/dnares/12.1.63; Shroll RM, 2002, BIOPOLYMERS, V65, P395, DOI 10.1002/bip.10279; SMIT J, 1975, J BACTERIOL, V124, P942, DOI 10.1128/JB.124.2.942-958.1975; Strauss J, 2009, J MOL RECOGNIT, V22, P347, DOI 10.1002/jmr.955; van der Mei HC, 2000, SURF SCI REP, V39, P3; Yao X, 1999, J BACTERIOL, V181, P6865, DOI 10.1128/JB.181.22.6865-6875.1999	30	36	38	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.209536	http://dx.doi.org/10.1074/jbc.M110.209536			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21330374	Green Published, hybrid			2022-12-27	WOS:000289077500053
J	Fu, YX; Chang, ACY; Fournier, M; Chang, L; Niessen, K; Karsan, A				Fu, YangXin; Chang, Alex Chia Yu; Fournier, Michele; Chang, Linda; Niessen, Kyle; Karsan, Aly			RUNX3 Maintains the Mesenchymal Phenotype after Termination of the Notch Signal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL HEART-DEFECTS; RBP-J-KAPPA; CARDIAC DEVELOPMENT; VASCULAR DEVELOPMENT; ENDOTHELIAL-CELLS; TRANSITION; DIFFERENTIATION; ACTIVATION; PATHWAY; GENE	Notch is a critical mediator of endothelial-to-mesenchymal transition (EndMT) during cardiac cushion development. Slug, a transcriptional repressor that is a Notch target, is an important Notch effector of EndMT in the cardiac cushion. Here, we report that the runt-related transcription factor RUNX3 is a novel direct Notch target in the endothelium. Ectopic expression of RUNX3 in endothelium induces Slug expression and EndMT independent of Notch activation. Interestingly, RUNX3 physically interacts with CSL, the Notch-interacting partner in the nucleus, and induces Slug in a CSL-dependent, but Notch-independent manner. Although RUNX3 may not be required for the initial induction of Slug and EndMT by Notch, because RUNX3 has a much longer half-life than Slug, it sustains the expression of Slug thereby maintaining the mesenchymal phenotype. CSL binds to the Runx3 promoter in the atrioventricular canal in vivo, and inhibition of Notch reduces RUNX3 expression in the cardiac cushion of embryonic hearts. Taken together, our results suggest that induction of RUNX3 may be a mechanism to maintain Notch-transformed mesenchymal cells during heart development.	[Fu, YangXin; Fournier, Michele; Karsan, Aly] Univ British Columbia, British Columbia Canc Res Ctr, Vancouver, BC V5Z 1L3, Canada; [Fu, YangXin; Chang, Alex Chia Yu; Chang, Linda; Niessen, Kyle; Karsan, Aly] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1L3, Canada	British Columbia Cancer Agency; University of British Columbia; University of British Columbia	Karsan, A (corresponding author), Univ British Columbia, British Columbia Canc Res Ctr, 675W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	akarsan@bccrc.ca	Karsan, Aly/K-2067-2015	Chang, Alex Chia Yu/0000-0001-9441-4033	Canadian Institutes of Health Research; Heart and Stroke Foundation of British Columbia and Yukon; Genome Canada; Genome British Columbia; Michael Smith Foundation for Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of British Columbia and Yukon; Genome Canada(Genome Canada); Genome British Columbia; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This work was supported by grants from the Canadian Institutes of Health Research, the Heart and Stroke Foundation of British Columbia and Yukon, Genome Canada, and Genome British Columbia.; Supported by a Doctoral Research Award from the Michael Smith Foundation for Health Research.	Armstrong EJ, 2004, CIRC RES, V95, P459, DOI 10.1161/01.RES.0000141146.95728.da; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Blyth K, 2005, NAT REV CANCER, V5, P376, DOI 10.1038/nrc1607; Brennan K, 2002, BIOESSAYS, V24, P405, DOI 10.1002/bies.10089; Burns CE, 2005, GENE DEV, V19, P2331, DOI 10.1101/gad.1337005; Del Monte G, 2007, DEV DYNAM, V236, P2594, DOI 10.1002/dvdy.21246; Donovan J, 2002, CURR BIOL, V12, P1605, DOI 10.1016/S0960-9822(02)01149-1; Engin FZ, 2008, NAT MED, V14, P299, DOI 10.1038/nm1712; Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004; Fischer A, 2007, CIRC RES, V100, P856, DOI 10.1161/01.RES.0000260913.95642.3b; Fu YX, 2009, J BIOL CHEM, V284, P19452, DOI 10.1074/jbc.M109.011833; Gao J, 2010, EXP CELL RES, V316, P149, DOI 10.1016/j.yexcr.2009.09.025; Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940; High FA, 2008, NAT REV GENET, V9, P49, DOI 10.1038/nrg2279; High FA, 2007, J CLIN INVEST, V117, P353, DOI 10.1172/JCI30070; Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Ito Y, 2004, ONCOGENE, V23, P4198, DOI 10.1038/sj.onc.1207755; Ito Y, 2008, ADV CANCER RES, V99, P33, DOI 10.1016/S0065-230X(07)99002-8; Joutel A, 2000, J CLIN INVEST, V105, P597, DOI 10.1172/JCI8047; Leong KG, 2007, J EXP MED, V204, P2935, DOI 10.1084/jem.20071082; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; MacKenzie F, 2004, BLOOD, V104, P1760, DOI 10.1182/blood-2003-12-4244; Mailhos C, 2001, DIFFERENTIATION, V69, P135, DOI 10.1046/j.1432-0436.2001.690207.x; Nakagawa M, 2006, BLOOD, V108, P3329, DOI 10.1182/blood-2006-04-019570; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Niessen K, 2008, CIRC RES, V102, P1169, DOI 10.1161/CIRCRESAHA.108.174318; Niessen K, 2008, J CELL BIOL, V182, P315, DOI 10.1083/jcb.200710067; Nigam V, 2009, J MOL CELL CARDIOL, V47, P828, DOI 10.1016/j.yjmcc.2009.08.008; Noseda M, 2004, CIRC RES, V94, P910, DOI 10.1161/01.RES.0000124300.76171.C9; Noseda M, 2006, CIRC RES, V98, P1468, DOI 10.1161/01.RES.0000229683.81357.26; O'Neil J, 2007, J EXP MED, V204, P1813, DOI 10.1084/jem.20070876; Oberg C, 2001, J BIOL CHEM, V276, P35847, DOI 10.1074/jbc.M103992200; OKA C, 1995, DEVELOPMENT, V121, P3291; Sarao R, 1998, TRANSGENIC RES, V7, P421, DOI 10.1023/A:1008837410485; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; Tsunematsu R, 2004, J BIOL CHEM, V279, P9417, DOI 10.1074/jbc.M312337200; Uyttendaele H, 1996, DEVELOPMENT, V122, P2251; Van de Walle I, 2009, BLOOD, V113, P2988, DOI 10.1182/blood-2008-06-164871; Wederell ED, 2008, NUCLEIC ACIDS RES, V36, P4549, DOI 10.1093/nar/gkn382; Wu GY, 2001, MOL CELL BIOL, V21, P7403, DOI 10.1128/MCB.21.21.7403-7415.2001; Wu L, 2002, MOL CELL BIOL, V22, P7688, DOI 10.1128/MCB.22.21.7688-7700.2002; Zeisberg EM, 2007, CANCER RES, V67, P10123, DOI 10.1158/0008-5472.CAN-07-3127; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613	46	30	32	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11803	11813		10.1074/jbc.M111.222331	http://dx.doi.org/10.1074/jbc.M111.222331			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21288908	Green Published, hybrid			2022-12-27	WOS:000288797100087
J	Gaborit, N; Larbouret, C; Vallaghe, J; Peyrusson, F; Bascoul-Mollevi, C; Crapez, E; Azria, D; Chardes, T; Poul, MA; Mathis, G; Bazin, H; Pelegrin, A				Gaborit, Nadege; Larbouret, Christel; Vallaghe, Julie; Peyrusson, Frederic; Bascoul-Mollevi, Caroline; Crapez, Evelyne; Azria, David; Chardes, Thierry; Poul, Marie-Alix; Mathis, Gerard; Bazin, Herve; Pelegrin, Andre			Time-resolved Fluorescence Resonance Energy Transfer (TR-FRET) to Analyze the Disruption of EGFR/HER2 Dimers A NEW METHOD TO EVALUATE THE EFFICIENCY OF TARGETED THERAPY USING MONOCLONAL ANTIBODIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; BREAST-CANCER CELLS; FACTOR RECEPTOR; QUANTITATIVE-ANALYSIS; EXTRACELLULAR DOMAIN; ERBB RECEPTORS; OVARIAN-CANCER; EGF RECEPTOR; LUNG-CANCER; DIMERIZATION	In oncology, simultaneous inhibition of epidermal growth factor receptor (EGFR) and HER2 by monoclonal antibodies (mAbs) is an efficient therapeutic strategy but the underlying mechanisms are not fully understood. Here, we describe a time-resolved fluorescence resonance energy transfer (TR-FRET) method to quantify EGFR/HER2 heterodimers on cell surface to shed some light on the mechanism of such therapies. First, we tested this antibody-based TR-FRET assay in NIH/3T3 cell lines that express EGFR and/or HER2 and in various tumor cell lines. Then, we used the antibody-based TR-FRET assay to evaluate in vitro the effect of different targeted therapies on EGFR/HER2 heterodimers in the ovarian carcinoma cell line SKOV-3. A simultaneous incubation with Cetuximab (anti-EGFR) and Trastuzumab (anti-HER2) disturbed EGFR/HER2 heterodimers resulting in a 72% reduction. Cetuximab, Trastuzumab or Pertuzumab (antiHER2) alone induced a 48, 44, or 24% reduction, respectively. In contrast, the tyrosine kinase inhibitors Erlotinib and Lapatinib had very little effect on EGFR/HER2 dimers concentration. In vivo, the combination of Cetuximab and Trastuzumab showed a better therapeutic effect (median survival and percentage of tumor-free mice) than the single mAbs. These results suggest a correlation between the extent of the mAb-induced EGFR/HER2 heterodimer reduction and the efficacy of such mAbs in targeted therapies. In conclusion, quantifying EGFR/HER2 heterodimers using our antibody-based TR-FRET assay may represent a useful method to predict the efficacy and explain the mechanisms of action of therapeutic mAbs, in addition to other commonly used techniques that focus on antibody-dependent cellular cytotoxicity, phosphorylation, and cell proliferation.	[Gaborit, Nadege; Larbouret, Christel; Azria, David; Chardes, Thierry; Poul, Marie-Alix; Pelegrin, Andre] Univ Montpellier 1, IRCM, INSERM, CRLC Val dAurelle Paul Lamarque,U896, F-34298 Montpellier, France; [Vallaghe, Julie; Peyrusson, Frederic; Mathis, Gerard; Bazin, Herve] Cisbio, Res Dept, F-30204 Bagnols Sur Ceze, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM)	Pelegrin, A (corresponding author), Univ Montpellier 1, IRCM, INSERM, CRLC Val dAurelle Paul Lamarque,U896, F-34298 Montpellier, France.	andre.pelegrin@inserm.fr	Pèlegrin, André/J-3167-2016; Gaborit, Nadège A/O-7825-2017; Chardès, Thierry/B-5420-2019; Mollevi, Caroline/AAA-6839-2019	Chardès, Thierry/0000-0002-1836-7439; Mollevi, Caroline/0000-0003-4827-3684; Peyrusson, Frederic/0000-0002-5544-8916; Crapez, evelyne/0000-0002-8261-3470; Pelegrin, Andre/0000-0001-9254-2648	Agence Nationale de la Recherche [ANR-07-RIB-003/Dim-HER]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This project was supported by Agence Nationale de la Recherche Grant ANR-07-RIB-003/Dim-HER.	Adams CW, 2006, CANCER IMMUNOL IMMUN, V55, P717, DOI 10.1007/s00262-005-0058-x; Agus DB, 2002, CANCER CELL, V2, P127, DOI 10.1016/S1535-6108(02)00097-1; Arteaga CL, 1997, J BIOL CHEM, V272, P23247, DOI 10.1074/jbc.272.37.23247; Barros FFT, 2010, HISTOPATHOLOGY, V56, P560, DOI 10.1111/j.1365-2559.2010.03494.x; Brandt BH, 1999, FASEB J, V13, P1939, DOI 10.1096/fasebj.13.14.1939; Bublil EM, 2010, FASEB J, V24, P4744, DOI 10.1096/fj.10-166199; Burgess AW, 2008, GROWTH FACTORS, V26, P263, DOI 10.1080/08977190802312844; Cai Z, 2008, ONCOGENE, V27, P3870, DOI 10.1038/onc.2008.13; Cappuzzo F, 2003, J CLIN ONCOL, V21, P2658, DOI 10.1200/JCO.2003.01.039; Chen XM, 2000, BIOCHEM BIOPH RES CO, V277, P757, DOI 10.1006/bbrc.2000.3731; Chung KY, 2005, J CLIN ONCOL, V23, P1803, DOI 10.1200/JCO.2005.08.037; Clayton AHA, 2005, J BIOL CHEM, V280, P30392, DOI 10.1074/jbc.M504770200; De Pas T, 2004, J CLIN ONCOL, V22, P4966, DOI 10.1200/JCO.2004.01.195; Diermeier-Daucher S, 2008, ANN NY ACAD SCI, V1130, P280, DOI 10.1196/annals.1430.003; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; Frolov A, 2007, CANCER BIOL THER, V6, P548, DOI 10.4161/cbt.6.4.3849; Furuuchi K, 2007, J IMMUNOL, V178, P1021, DOI 10.4049/jimmunol.178.2.1021; Gajadhar A, 2010, BIOTECHNIQUES, V48, P145, DOI 10.2144/000113354; Gan HK, 2007, J BIOL CHEM, V282, P2840, DOI 10.1074/jbc.M605136200; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Goldstein NS, 2001, CANCER, V92, P1331, DOI 10.1002/1097-0142(20010901)92:5<1331::AID-CNCR1455>3.0.CO;2-M; Harris M, 2004, LANCET ONCOL, V5, P292, DOI 10.1016/S1470-2045(04)01467-6; HARWERTH IM, 1992, J BIOL CHEM, V267, P15160; Hendriks BS, 2003, CANCER RES, V63, P1130; Hughes JB, 2009, MOL CANCER THER, V8, P1885, DOI 10.1158/1535-7163.MCT-09-0291; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jain A, 2010, CANCER RES, V70, P1989, DOI 10.1158/0008-5472.CAN-09-3326; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Khan IH, 2010, ASSAY DRUG DEV TECHN, V8, P27, DOI 10.1089/adt.2009.0208; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kristjansdottir K, 2010, EXPERT OPIN BIOL TH, V10, P243, DOI 10.1517/14712590903514090; Lafky JM, 2008, BBA-REV CANCER, V1785, P232, DOI 10.1016/j.bbcan.2008.01.001; Larbouret C, 2010, ANN ONCOL, V21, P98, DOI 10.1093/annonc/mdp496; Larbouret C, 2007, CLIN CANCER RES, V13, P3356, DOI 10.1158/1078-0432.CCR-06-2302; LAX I, 1988, MOL CELL BIOL, V8, P1831, DOI 10.1128/MCB.8.4.1831; Maurel D, 2004, ANAL BIOCHEM, V329, P253, DOI 10.1016/j.ab.2004.02.013; Mullen P, 2007, MOL CANCER THER, V6, P93, DOI 10.1158/1535-7163.MCT-06-0401; Nahta R, 2004, CANCER RES, V64, P2343, DOI 10.1158/0008-5472.CAN-03-3856; Normanno N, 2003, J CELL PHYSIOL, V194, P13, DOI 10.1002/jcp.10194; Patel D, 2009, INT J ONCOL, V34, P25, DOI 10.3892/ijo_00000125; Scartozzi M, 2004, J CLIN ONCOL, V22, P4772, DOI 10.1200/JCO.2004.00.117; Schmitz KR, 2009, EXP CELL RES, V315, P659, DOI 10.1016/j.yexcr.2008.10.008; Shi YN, 2009, DIAGN MOL PATHOL, V18, P11, DOI 10.1097/PDM.0b013e31818cbdb2; Suo Z, 2002, J PATHOL, V196, P17, DOI 10.1002/path.1003; Takai N, 2005, CANCER-AM CANCER SOC, V104, P2701, DOI 10.1002/cncr.21533; Wang ZX, 1999, MOL BIOL CELL, V10, P1621, DOI 10.1091/mbc.10.5.1621; Wilkinson JC, 2002, BIOCHEMISTRY-US, V41, P8, DOI 10.1021/bi015839l; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhang K, 1996, J BIOL CHEM, V271, P3884	51	42	53	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11337	11345		10.1074/jbc.M111.223503	http://dx.doi.org/10.1074/jbc.M111.223503			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21282108	hybrid, Green Published, Green Submitted			2022-12-27	WOS:000288797100046
J	Gan, XQ; Wang, JY; Su, B; Wu, DQ				Gan, Xiaoqing; Wang, Jiyong; Su, Bing; Wu, Dianqing			Evidence for Direct Activation of mTORC2 Kinase Activity by Phosphatidylinositol 3,4,5-Trisphosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PARTNER; MOTIF PHOSPHORYLATION; ACTIN CYTOSKELETON; MAMMALIAN TARGET; TOR COMPLEXES; SIGNAL RELAY; RICTOR; GROWTH; RAPTOR; IDENTIFICATION	mTORC2 (mammalian target of rapamycin complex 2) plays important roles in signal transduction by regulating an array of downstream effectors, including protein kinase AKT. However, its regulation by upstream regulators remains poorly characterized. Although phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P-3) is known to regulate the phosphorylation of AKT Ser(473), the hydrophobic motif (HM) site, by mTORC2, it is not clear whether PtdIns(3,4,5)P-3 can directly regulate mTORC2 kinase activity. Here, we used two membrane-docked AKT mutant proteins, one with and the other without the pleckstrin homology (PH) domain, as substrates for mTORC2 to dissect the roles of PtdIns(3,4,5)P-3 in AKT HM phosphorylation in cultured cells and in vitro kinase assays. In HEK293T cells, insulin and constitutively active mutants of small GTPase H-Ras and PI3K could induce HM phosphorylation of both AKT mutants, which was blocked by the PI3K inhibitor LY294002. Importantly, PtdIns(3,4,5)P-3 was able to stimulate the phosphorylation of both AKT mutants by immunoprecipitated mTOR2 complexes in an in vitro kinase assay. In both in vivo and in vitro assays, the AKT mutant containing the PH domain appeared to be a better substrate than the one without the PH domain. Therefore, these results suggest that PtdIns(3,4,5)P-3 can regulate HM phosphorylation by mTORC2 via multiple mechanisms. One of the mechanisms is to directly stimulate the kinase activity of mTORC2.	[Gan, Xiaoqing; Wang, Jiyong; Su, Bing; Wu, Dianqing] Yale Univ, Sch Med, Program Vasc Biol & Therapeut, New Haven, CT 06520 USA; [Gan, Xiaoqing; Wang, Jiyong; Wu, Dianqing] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Su, Bing] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Wu, DQ (corresponding author), Yale Univ, Sch Med, Program Vasc Biol & Therapeut, New Haven, CT 06520 USA.	dan.wu@yale.edu			National Institutes of Health [HL070694, CA132317, CA139395]; NATIONAL CANCER INSTITUTE [R01CA132317, R01CA139395] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080706, P01HL070694, R01HL108430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054597] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL070694, CA132317, and CA139395 (to D. W.).	Bondeva T, 1998, SCIENCE, V282, P293, DOI 10.1126/science.282.5387.293; Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014; Fonseca BD, 2007, J BIOL CHEM, V282, P24514, DOI 10.1074/jbc.M704406200; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hayashi T, 2007, GENES CELLS, V12, P1357, DOI 10.1111/j.1365-2443.2007.01141.x; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2008, BIOCHEM J, V410, P19, DOI 10.1042/BJ20071518; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kovacina KS, 2003, J BIOL CHEM, V278, P10189, DOI 10.1074/jbc.M210837200; Lee S, 2005, MOL BIOL CELL, V16, P4572, DOI 10.1091/mbc.E05-04-0342; Lee S, 1999, MOL BIOL CELL, V10, P2829, DOI 10.1091/mbc.10.9.2829; Li WQ, 2004, J BIOL CHEM, V279, P37398, DOI 10.1074/jbc.M405730200; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Milburn CC, 2003, BIOCHEM J, V375, P531, DOI 10.1042/BJ20031229; Pearce LR, 2007, BIOCHEM J, V405, P513, DOI 10.1042/BJ20070540; Polak P, 2009, CURR OPIN CELL BIOL, V21, P209, DOI 10.1016/j.ceb.2009.01.024; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schmidt A, 1996, P NATL ACAD SCI USA, V93, P13780, DOI 10.1073/pnas.93.24.13780; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Wabnitz GH, 2006, J IMMUNOL, V176, P1668, DOI 10.4049/jimmunol.176.3.1668; Woo SY, 2007, J BIOL CHEM, V282, P25604, DOI 10.1074/jbc.M704343200; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206	34	144	152	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					10998	11002		10.1074/jbc.M110.195016	http://dx.doi.org/10.1074/jbc.M110.195016			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21310961	hybrid, Green Published			2022-12-27	WOS:000288797100011
J	Lalmansingh, AS; Urekar, CJ; Reddi, PP				Lalmansingh, Avin S.; Urekar, Craig J.; Reddi, Prabhakara P.			TDP-43 Is a Transcriptional Repressor THE TESTIS-SPECIFIC MOUSE acrv1 GENE IS A TDP-43 TARGET IN VIVO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR FACTOR TDP-43; DNA-BINDING PROTEIN; SPERMATID-SPECIFIC TRANSCRIPTION; AMYOTROPHIC-LATERAL-SCLEROSIS; TRANSFECTED DNA; CFTR EXON-9; SP-10 GENE; PROMOTER; CHROMATIN; DISEASE	TDP-43 is an evolutionarily conserved ubiquitously expressed DNA/RNA-binding protein. Although recent studies have shown its association with a variety of neurodegenerative disorders, the function of TDP-43 remains poorly understood. Here we address TDP-43 function using spermatogenesis as a model system. We previously showed that TDP-43 binds to the testis-specific mouse acrv1 gene promoter in vitro via two GTGTGT-motifs and that mutation of these motifs led to premature transcription in spermatocytes of an otherwise round spermatid-specific promoter. The present study tested the hypothesis that TDP-43 represses acrv1 gene transcription in spermatocytes. Plasmid chromatin immunoprecipitation demonstrated that TDP-43 binds to the acrv1 promoter through GTGTGT motifs in vivo. Reporter gene assays showed that TDP-43 represses acrv1 core promoter-driven transcription via the N-terminal RRM1 domain in a histone deacetylase-independent manner. Consistent with repressor role, ChIP on physiologically isolated germ cells confirmed that TDP-43 occupies the endogenous acrv1 promoter in spermatocytes. Surprisingly, however, TDP-43 remains at the promoter in round spermatids, which express acrv1 mRNA. We show that RNA binding-defective TDP-43, but not splice variant isoforms, relieve repressor function. Transitioning from repressive to active histone marks has little effect on TDP-43 occupancy. Finally, we found that RNA polymerase II is recruited but paused at the acrv1 promoter in spermatocytes. Because mutation of TDP-43 sites caused premature transcription in spermatocytes in vivo, TDP-43 may be involved in pausing RNAPII at the acrv1 promoter in spermatocytes. Overall, our study shows that TDP-43 is a transcriptional repressor and that it regulates spatiotemporal expression of the acrv1 gene during spermatogenesis.	[Reddi, Prabhakara P.] Univ Virginia, Sch Med, Dept Pathol, Charlottesville, VA 22908 USA	University of Virginia	Reddi, PP (corresponding author), Univ Virginia, Sch Med, Dept Pathol, POB 800904, Charlottesville, VA 22908 USA.	ppr5s@virginia.edu	Reddi, Prabhakara/AAY-8092-2020	Reddi, Prabhakara/0000-0003-4891-8964	National Institutes of Health [R01HD36239, 5T32HD007382]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036239, T32HD007382] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HD36239 (to P. P. R.).; Received support from National Institutes of Health Training Grant 5T32HD007382 awarded to the Center for Research in Reproduction, University of Virginia.	Abhyankar MM, 2007, J BIOL CHEM, V282, P36143, DOI 10.1074/jbc.M705811200; Acharya KK, 2006, DEV BIOL, V295, P781, DOI 10.1016/j.ydbio.2006.04.443; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2004, AM J HUM GENET, V74, P1322, DOI 10.1086/420978; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727; Buratti E, 2010, FEBS J, V277, P2268, DOI 10.1111/j.1742-4658.2010.07643.x; CEREGHINI S, 1984, EMBO J, V3, P1243, DOI 10.1002/j.1460-2075.1984.tb01959.x; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; De Leeuw F, 2007, EXP CELL RES, V313, P4130, DOI 10.1016/j.yexcr.2007.09.017; Hatchell EC, 2006, MOL CELL, V22, P657, DOI 10.1016/j.molcel.2006.05.024; Hebbar PB, 2008, J BIOL CHEM, V283, P4595, DOI 10.1074/jbc.M709121200; Hu SH, 2009, CELL, V139, P610, DOI 10.1016/j.cell.2009.08.037; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kraemer BC, 2010, ACTA NEUROPATHOL, V119, P409, DOI 10.1007/s00401-010-0659-0; Lalmansingh AS, 2008, ENDOCRINOLOGY, V149, P346, DOI 10.1210/en.2007-0372; Miyake T, 2000, J BIOL CHEM, V275, P40169, DOI 10.1074/jbc.M007138200; Narita T, 2003, MOL CELL BIOL, V23, P1863, DOI 10.1128/MCB.23.6.1863-1873.2003; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Newberry EP, 1999, BIOCHEMISTRY-US, V38, P10678, DOI 10.1021/bi990967j; Ooi L, 2006, J BIOL CHEM, V281, P38974, DOI 10.1074/jbc.M605370200; Otto SJ, 2007, J NEUROSCI, V27, P6729, DOI 10.1523/JNEUROSCI.0091-07.2007; Reddi PP, 1999, BIOL REPROD, V61, P1256, DOI 10.1095/biolreprod61.5.1256; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Sephton CF, 2010, J BIOL CHEM, V285, P6826, DOI 10.1074/jbc.M109.061846; Voigt A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012247; Volkening K, 2009, BRAIN RES, V1305, P168, DOI 10.1016/j.brainres.2009.09.105; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Wang Yanming, 2004, Novartis Found Symp, V259, P3; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3; Wells J, 2002, METHODS, V26, P48, DOI 10.1016/S1046-2023(02)00007-5; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Wu LS, 2010, GENESIS, V48, P56, DOI 10.1002/dvg.20584; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106	38	49	50	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					10970	10982		10.1074/jbc.M110.166587	http://dx.doi.org/10.1074/jbc.M110.166587			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21252238	Green Published, hybrid			2022-12-27	WOS:000288797100009
J	Sato, H; Isogai, Y; Masuda, S; Taketomi, Y; Miki, Y; Kamei, D; Hara, S; Kobayashi, T; Ishikawa, Y; Ishii, T; Ikeda, K; Taguchi, R; Ishimoto, Y; Suzuki, N; Yokota, Y; Hanasaki, K; Suzuki-Yamamoto, T; Yamamoto, K; Murakami, M				Sato, Hiroyasu; Isogai, Yuki; Masuda, Seiko; Taketomi, Yoshitaka; Miki, Yoshimi; Kamei, Daisuke; Hara, Shuntaro; Kobayashi, Tetsuyuki; Ishikawa, Yukio; Ishii, Toshiharu; Ikeda, Kazutaka; Taguchi, Ryo; Ishimoto, Yoshikazu; Suzuki, Noriko; Yokota, Yasunori; Hanasaki, Kohji; Suzuki-Yamamoto, Toshiko; Yamamoto, Kei; Murakami, Makoto			Physiological Roles of Group X-secreted Phospholipase A(2) in Reproduction, Gastrointestinal Phospholipid Digestion, and Neuronal Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIET-INDUCED OBESITY; FOAM CELL-FORMATION; MICE LACKING; GROUP-V; LYSOPHOSPHATIDIC ACID; GROUP-II; INFLAMMATORY HYPERALGESIA; PAIN HYPERSENSITIVITY; STAPHYLOCOCCUS-AUREUS; EMBRYO IMPLANTATION	Although the secreted phospholipase A(2) (sPLA(2)) family has been generally thought to participate in pathologic events such as inflammation and atherosclerosis, relatively high and constitutive expression of group X sPLA(2) (sPLA(2)-X) in restricted sites such as reproductive organs, the gastrointestinal tract, and peripheral neurons raises a question as to the roles played by this enzyme in the physiology of reproduction, digestion, and the nervous system. Herein we used mice with gene disruption or transgenic overexpression of sPLA(2)-X to clarify the homeostatic functions of this enzyme at these locations. Our results suggest that sPLA(2)-X regulates 1) the fertility of spermatozoa, not oocytes, beyond the step of flagellar motility, 2) gastrointestinal phospholipid digestion, perturbation of which is eventually linked to delayed onset of a lean phenotype with reduced adiposity, decreased plasma leptin, and improved muscle insulin tolerance, and 3) neuritogenesis of dorsal root ganglia and the duration of peripheral pain nociception. Thus, besides its inflammatory action proposed previously, sPLA(2)-X participates in physiologic processes including male fertility, gastrointestinal phospholipid digestion linked to adiposity, and neuronal outgrowth and sensing.	[Sato, Hiroyasu; Isogai, Yuki; Masuda, Seiko; Taketomi, Yoshitaka; Miki, Yoshimi; Yamamoto, Kei; Murakami, Makoto] Tokyo Metropolitan Inst Med Sci, Lipid Metab Project, Setagaya Ku, Tokyo 1568506, Japan; [Sato, Hiroyasu; Masuda, Seiko; Taketomi, Yoshitaka; Miki, Yoshimi; Kamei, Daisuke; Hara, Shuntaro] Showa Univ, Sch Pharceut Sci, Dept Hlth Chem, Shinagawa Ku, Tokyo 1428555, Japan; [Isogai, Yuki; Kobayashi, Tetsuyuki] Ochanomizu Univ, Fac Sci, Dept Biol, Bunkyo Ku, Tokyo 1128610, Japan; [Ishikawa, Yukio; Ishii, Toshiharu] Toho Univ, Sch Med, Dept Pathol, Ohta Ku, Tokyo 1438540, Japan; [Ikeda, Kazutaka; Taguchi, Ryo] Univ Tokyo, Grad Sch Med, Dept Metabolome, Bunkyo Ku, Tokyo 1130033, Japan; [Ishimoto, Yoshikazu; Suzuki, Noriko; Yokota, Yasunori; Hanasaki, Kohji] Shionogi & Co Ltd, Shionogi Res Labs, Osaka 5610825, Japan; [Ikeda, Kazutaka; Suzuki-Yamamoto, Toshiko] Okayama Prefectural Univ, Fac Hlth & Welf Sci, Dept Neutrit Sci, Okayama 7191197, Japan; [Taguchi, Ryo] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Murakami, Makoto] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Tokyo Metropolitan Institute of Medical Science; Showa University; Ochanomizu University; University of Tokyo; Shionogi & Company Limited; Okayama Prefectural University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Murakami, M (corresponding author), Tokyo Metropolitan Inst Med Sci, Lipid Metab Project, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	murakami-mk@igakuken.or.jp	Kobayashi, Tetsuyuki/AAH-2985-2020	Kobayashi, Tetsuyuki/0000-0002-9285-0859	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Science and Technology Agency; Mitsubishi Science Foundation; Uehara Science Foundation; Toray Science Foundation; Grants-in-Aid for Scientific Research [22116005] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Mitsubishi Science Foundation; Uehara Science Foundation(Uehara Memorial Foundation); Toray Science Foundation(Toray Industries, Inc.); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in aid for Scientific Research and for Young Scientists from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, PRESTO and CREST from the Japan Science and Technology Agency, Mitsubishi Science Foundation, the Uehara Science Foundation, and the Toray Science Foundation.	Balestrieri B, 2009, J IMMUNOL, V182, P4891, DOI 10.4049/jimmunol.0803776; Boilard E, 2010, EMBO MOL MED, V2, P172, DOI 10.1002/emmm.201000072; Bostrom MA, 2007, ARTERIOSCL THROM VAS, V27, P600, DOI 10.1161/01.ATV.0000257133.60884.44; CAREY MC, 1983, ANNU REV PHYSIOL, V45, P651, DOI 10.1146/annurev.ph.45.030183.003251; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Cupillard L, 1997, J BIOL CHEM, V272, P15745, DOI 10.1074/jbc.272.25.15745; Darios F, 2006, NATURE, V440, P813, DOI 10.1038/nature04598; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; Eerola LI, 2006, BBA-MOL CELL BIOL L, V1761, P745, DOI 10.1016/j.bbalip.2006.04.002; Eguchi N, 1999, P NATL ACAD SCI USA, V96, P726, DOI 10.1073/pnas.96.2.726; Escoffier J, 2010, J CLIN INVEST, V120, P1415, DOI 10.1172/JCI40494; Fujioka D, 2008, CIRCULATION, V117, P2977, DOI 10.1161/CIRCULATIONAHA.107.743997; Gilham D, 2007, J BIOL CHEM, V282, P24642, DOI 10.1074/jbc.M702530200; Greer JM, 2002, NEURON, V33, P23, DOI 10.1016/S0896-6273(01)00564-5; Hamaguchi K, 2003, BBA-MOL CELL BIOL L, V1635, P37, DOI 10.1016/j.bbalip.2003.10.004; Hanasaki K, 2002, J BIOL CHEM, V277, P29116, DOI 10.1074/jbc.M202867200; Hanlon DW, 1997, NEURON, V18, P439, DOI 10.1016/S0896-6273(00)81244-1; Henderson WR, 2007, J EXP MED, V204, P865, DOI 10.1084/jem.20070029; Hizaki H, 1999, P NATL ACAD SCI USA, V96, P10501, DOI 10.1073/pnas.96.18.10501; Hobson SA, 2006, J NEUROCHEM, V99, P1000, DOI 10.1111/j.1471-4159.2006.04143.x; Holmes FE, 2000, P NATL ACAD SCI USA, V97, P11563, DOI 10.1073/pnas.210221897; Holstege JC, 2008, P NATL ACAD SCI USA, V105, P6338, DOI 10.1073/pnas.0802176105; Huggins KW, 2002, AM J PHYSIOL-ENDOC M, V283, pE994, DOI 10.1152/ajpendo.00110.2002; Hui DY, 2009, BRIT J PHARMACOL, V157, P1263, DOI 10.1111/j.1476-5381.2009.00308.x; IKEDA I, 1987, BIOCHIM BIOPHYS ACTA, V921, P245; Ikeno Y, 2005, J BIOL CHEM, V280, P28044, DOI 10.1074/jbc.M503343200; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Ito S, 2001, NEUROSCI RES, V41, P299, DOI 10.1016/S0168-0102(01)00289-9; Ivandic B, 1999, ARTERIOSCL THROM VAS, V19, P1284, DOI 10.1161/01.ATV.19.5.1284; Jacobson L, 1999, ENDOCRINOLOGY, V140, P310, DOI 10.1210/en.140.1.310; Ji RR, 1999, NAT NEUROSCI, V2, P1114, DOI 10.1038/16040; Jimenez-Andrade JM, 2004, PAIN, V110, P10, DOI 10.1016/j.pain.2004.02.032; Kamei D, 2004, J BIOL CHEM, V279, P33684, DOI 10.1074/jbc.M400199200; Kerr BJ, 2001, PAIN, V93, P267, DOI 10.1016/S0304-3959(01)00326-8; Kim DH, 2008, NEUROSCIENCE, V154, P1077, DOI 10.1016/j.neuroscience.2008.04.033; Koduri RS, 2002, J BIOL CHEM, V277, P5849, DOI 10.1074/jbc.M109699200; Kubagawa HM, 2006, NAT CELL BIOL, V8, P1143, DOI 10.1038/ncb1476; Kudo I, 2002, PROSTAG OTH LIPID M, V68-9, P3, DOI 10.1016/S0090-6980(02)00020-5; Labonte ED, 2006, DIABETES, V55, P935, DOI 10.2337/diabetes.55.04.06.db05-1286; Labonte ED, 2010, FASEB J, V24, P2516, DOI 10.1096/fj.09-144436; Laine VJO, 1999, J IMMUNOL, V162, P7402; Lambeau G, 2008, ANNU REV BIOCHEM, V77, P495, DOI 10.1146/annurev.biochem.76.062405.154007; Li X, 2010, FASEB J, V24, P4313, DOI 10.1096/fj.10-154716; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Ma L, 2010, J PHARMACOL EXP THER, V333, P540, DOI 10.1124/jpet.109.164830; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Masuda S, 2005, J BIOL CHEM, V280, P23203, DOI 10.1074/jbc.M500985200; Masuda S, 2005, BIOCHEM J, V387, P27, DOI 10.1042/BJ20041307; Masuda S, 2004, BBA-MOL CELL BIOL L, V1686, P61, DOI 10.1016/j.bbalip.2004.08.017; Minami T, 1997, BRIT J PHARMACOL, V122, P605, DOI 10.1038/sj.bjp.0701421; Miyado K, 2008, P NATL ACAD SCI USA, V105, P12921, DOI 10.1073/pnas.0710608105; Munoz NM, 2007, J IMMUNOL, V179, P4800, DOI 10.4049/jimmunol.179.7.4800; Murakami M, 2001, J BIOL CHEM, V276, P10083, DOI 10.1074/jbc.M007877200; Murata T, 1997, NATURE, V388, P678, DOI 10.1038/41780; Nakano H, 2001, BRIT J PHARMACOL, V133, P438, DOI 10.1038/sj.bjp.0704092; O'Meara G, 2000, P NATL ACAD SCI USA, V97, P11569, DOI 10.1073/pnas.210254597; Ohtsuki M, 2006, J BIOL CHEM, V281, P36420, DOI 10.1074/jbc.M607975200; Olefsky JM, 2008, CELL, V134, P914, DOI 10.1016/j.cell.2008.09.001; Pietilainen KH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000218; Reinold H, 2005, J CLIN INVEST, V115, P673; Richmond BL, 2001, GASTROENTEROLOGY, V120, P1193, DOI 10.1053/gast.2001.23254; Riffo MS, 1997, J EXP ZOOL, V279, P81, DOI 10.1002/(SICI)1097-010X(19970901)279:1<81::AID-JEZ8>3.3.CO;2-V; Rigoni M, 2005, SCIENCE, V310, P1678, DOI 10.1126/science.1120640; Satake Y, 2004, J BIOL CHEM, V279, P16488, DOI 10.1074/jbc.M313748200; Sato H, 2010, J CLIN INVEST, V120, P1400, DOI 10.1172/JCI40493; Sato H, 2009, BIOCHEM J, V421, P17, DOI 10.1042/BJ20082429; Sato H, 2008, J BIOL CHEM, V283, P33483, DOI 10.1074/jbc.M804628200; Shi TJS, 2006, EUR J NEUROSCI, V23, P627, DOI 10.1111/j.1460-9568.2006.04593.x; Shridas P, 2010, J BIOL CHEM, V285, P20031, DOI 10.1074/jbc.M109.090423; Song H, 2002, DEVELOPMENT, V129, P2879; Stock JL, 2001, J CLIN INVEST, V107, P325, DOI 10.1172/JCI6749; Sugimoto Y, 1997, SCIENCE, V277, P681, DOI 10.1126/science.277.5326.681; Surrel F, 2009, MOL PHARMACOL, V76, P778, DOI 10.1124/mol.108.053371; Svensson CI, 2005, NEUROSCIENCE, V133, P543, DOI 10.1016/j.neuroscience.2005.01.024; Unger RH, 2001, FASEB J, V15, P312, DOI 10.1096/fj.00-0590; van den Akker E, 1999, MECH DEVELOP, V89, P103, DOI 10.1016/S0925-4773(99)00212-9; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Weinrauch Y, 1996, J CLIN INVEST, V97, P250, DOI 10.1172/JCI118399; Yamamoto K., J BIOL CHEM, V286; Ye XQ, 2005, NATURE, V435, P104, DOI 10.1038/nature03505; Yen CLE, 2009, NAT MED, V15, P442, DOI 10.1038/nm.1937; Yoshikawa K, 2006, J BIOL CHEM, V281, P14663, DOI 10.1074/jbc.M511089200; Young SC, 1999, BIOCHEM J, V339, P615, DOI 10.1042/0264-6021:3390615; Zack M, 2011, ATHEROSCLEROSIS, V214, P58, DOI 10.1016/j.atherosclerosis.2010.08.054; Zhou LJ, 2008, EXP NEUROL, V212, P507, DOI 10.1016/j.expneurol.2008.04.034	86	37	38	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11632	11648		10.1074/jbc.M110.206755	http://dx.doi.org/10.1074/jbc.M110.206755			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21266581	hybrid, Green Published			2022-12-27	WOS:000288797100072
J	Burkhardt, J; Vonck, J; Averhoff, B				Burkhardt, Janin; Vonck, Janet; Averhoff, Beate			Structure and Function of PilQ, a Secretin of the DNA Transporter from the Thermophilic Bacterium Thermus thermophilus HB27	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; ENTEROPATHOGENIC ESCHERICHIA-COLI; TRANSMISSION ELECTRON-MICROSCOPY; NATURAL GENETIC-TRANSFORMATION; OUTER-MEMBRANE COMPONENTS; FILAMENTOUS PHAGE-PIV; HIGH-MOLECULAR-MASS; N-TERMINAL DOMAIN; NEISSERIA-MENINGITIDIS; PSEUDOMONAS-AERUGINOSA	Secretins are a family of large bacterial outer membrane protein complexes mediating the transport of complex structures, such as type IV pili, DNA and filamentous phage, or various proteins, such as extracellular enzymes and pathogenicity determinants. PilQ of the thermophilic bacterium Thermus thermophilus HB27 is a member of the secretin family required for natural transformation. Here we report the isolation, structural, and functional analyses of a unique PilQ from T. thermophilus. Native PAGE, gel filtration chromatography, and electrophoretic mobility shift analyses indicated that PilQ forms a macromolecular homopolymeric complex that binds dsDNA. Electron microscopy showed that the PilQ complex is 15 nm wide and 34 nm long and consists of an extraordinary stable "cone" and "cup" structure and five ring structures with a large central channel. Moreover, the electron microscopic images together with secondary structure analyses combined with structural data of type II protein secretion system and type III protein secretion system secretins suggest that the individual rings are formed by conserved domains of alternating alpha-helices and alpha-sheets. The unprecedented length of the PilQ complex correlated well with the distance between the inner and outer membrane of T. thermophilus. Indeed, PilQ was found immunologically in both membranes, indicating that the PilQ complex spans the entire cell periphery of T. thermophilus. This is consistent with the hypothesis that PilQ accommodates a PilA4 comprising pseudopilus mediating DNA transport across the outer membrane and periplasmic space in a single-step process.	[Burkhardt, Janin; Averhoff, Beate] Goethe Univ Frankfurt, Inst Mol Biosci, D-60438 Frankfurt, Germany; [Vonck, Janet] Max Planck Inst Biophys, Dept Biol Struct, D-60438 Frankfurt, Germany	Goethe University Frankfurt; Max Planck Society	Averhoff, B (corresponding author), Goethe Univ Frankfurt, Inst Mol Biosci, Max von Laue Str 9, D-60438 Frankfurt, Germany.	Averhoff@bio.uni-frankfurt.de		Averhoff, Beate/0000-0003-1460-3649; Vonck, Janet/0000-0001-5659-8863				Assalkhou R, 2007, MICROBIOL-SGM, V153, P1593, DOI 10.1099/mic.0.2006/004200-0; Averhoff B, 2004, J BIOENERG BIOMEMBR, V36, P25, DOI 10.1023/B:JOBB.0000019595.66733.fa; Averhoff B, 2009, FEMS MICROBIOL REV, V33, P611, DOI 10.1111/j.1574-6976.2008.00160.x; Bayan N, 2006, MOL MICROBIOL, V60, P1, DOI 10.1111/j.1365-2958.2006.05084.x; Bitter W, 1998, MOL MICROBIOL, V27, P209, DOI 10.1046/j.1365-2958.1998.00677.x; Bitter W, 2007, J BACTERIOL, V189, P2967, DOI 10.1128/JB.01583-06; Bose N, 2005, J BACTERIOL, V187, P2225, DOI 10.1128/JB.187.7.2225-2232.2005; Bouley J, 2001, J MOL BIOL, V308, P205, DOI 10.1006/jmbi.2001.4594; Brok R, 1999, J MOL BIOL, V294, P1169, DOI 10.1006/jmbi.1999.3340; Burghout P, 2004, J BACTERIOL, V186, P4645, DOI 10.1128/JB.186.14.4645-4654.2004; CASTON JR, 1988, FEMS MICROBIOL LETT, V51, P225, DOI 10.1111/j.1574-6968.1988.tb03001.x; Chami M, 2005, J BIOL CHEM, V280, P37732, DOI 10.1074/jbc.M504463200; Chen I, 2005, SCIENCE, V310, P1456, DOI 10.1126/science.1114021; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; Chen I, 2006, J BIOL CHEM, V281, P21720, DOI 10.1074/jbc.M604071200; Clock SA, 2008, J BACTERIOL, V190, P980, DOI 10.1128/JB.01347-07; Collins RF, 2005, J BIOL CHEM, V280, P18923, DOI 10.1074/jbc.M411603200; Collins RF, 2004, J BIOL CHEM, V279, P39750, DOI 10.1074/jbc.M405971200; Collins RF, 2003, J BACTERIOL, V185, P2611, DOI 10.1128/JB.185.8.2611-2617.2003; Collins RF, 2001, J BACTERIOL, V183, P3825, DOI 10.1128/JB.183.13.3825-3832.2001; Daefler S, 1997, MOL MICROBIOL, V24, P465, DOI 10.1046/j.1365-2958.1997.3531727.x; Daniel A, 2006, MICROBIOL-SGM, V152, P2405, DOI 10.1099/mic.0.28860-0; DENFERT C, 1989, J BIOL CHEM, V264, P17462; Drake SL, 1997, MOL MICROBIOL, V23, P657, DOI 10.1046/j.1365-2958.1997.2511618.x; FARALDO MM, 1992, J BACTERIOL, V174, P7458, DOI 10.1128/jb.174.22.7458-7462.1992; FERNANDEZHERRERO LA, 1995, J BACTERIOL, V177, P5460, DOI 10.1128/jb.177.19.5460-5466.1995; Friedrich A, 2001, APPL ENVIRON MICROB, V67, P3140, DOI 10.1128/AEM.67.7.3140-3148.2001; Friedrich A, 2003, APPL ENVIRON MICROB, V69, P3695, DOI 10.1128/AEM.69.7.3695-3700.2003; Friedrich A, 2002, APPL ENVIRON MICROB, V68, P745, DOI 10.1128/AEM.68.2.745-755.2002; Fussenegger M, 1997, GENE, V192, P125, DOI 10.1016/S0378-1119(97)00038-3; GENIN S, 1994, MOL GEN GENET, V243, P112, DOI 10.1007/BF00283883; Graupner S, 2000, J BACTERIOL, V182, P2184, DOI 10.1128/JB.182.8.2184-2190.2000; Guilvout I, 1999, J BACTERIOL, V181, P7212, DOI 10.1128/JB.181.23.7212-7220.1999; HANCOCK REW, 1978, J BACTERIOL, V136, P381, DOI 10.1128/JB.136.1.381-390.1978; Hardie KR, 1996, EMBO J, V15, P978, DOI 10.1002/j.1460-2075.1996.tb00434.x; Helm RA, 2007, J BACTERIOL, V189, P3198, DOI 10.1128/JB.01833-06; HOBBS M, 1993, MOL MICROBIOL, V10, P233, DOI 10.1111/j.1365-2958.1993.tb01949.x; Johnsborg O, 2007, RES MICROBIOL, V158, P767, DOI 10.1016/j.resmic.2007.09.004; Koomey M, 1998, APMIS, V106, P56; Korotkov KV, 2006, J MOL BIOL, V363, P311, DOI 10.1016/j.jmb.2006.08.037; Korotkov KV, 2009, STRUCTURE, V17, P255, DOI 10.1016/j.str.2008.11.011; Koster M, 1997, MOL MICROBIOL, V26, P789, DOI 10.1046/j.1365-2958.1997.6141981.x; Koster M, 2000, INT J MED MICROBIOL, V290, P325; KOYAMA Y, 1986, J BACTERIOL, V166, P338, DOI 10.1128/jb.166.1.338-340.1986; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Maier B, 2004, P NATL ACAD SCI USA, V101, P10961, DOI 10.1073/pnas.0402305101; Maier B, 2002, P NATL ACAD SCI USA, V99, P16012, DOI 10.1073/pnas.242523299; Maier E, 2001, J BACTERIOL, V183, P800, DOI 10.1128/JB.183.2.800-803.2001; Nouwen N, 2000, EMBO J, V19, P2229, DOI 10.1093/emboj/19.10.2229; Nouwen N, 1999, P NATL ACAD SCI USA, V96, P8173, DOI 10.1073/pnas.96.14.8173; Opalka N, 2003, J MOL BIOL, V325, P461, DOI 10.1016/S0022-2836(02)01246-9; Ramer SW, 1996, J BACTERIOL, V178, P6555, DOI 10.1128/jb.178.22.6555-6563.1996; Reichow SL, 2010, NAT STRUCT MOL BIOL, V17, P1226, DOI 10.1038/nsmb.1910; Rose I, 2011, EXTREMOPHILES, V15, P191, DOI 10.1007/s00792-010-0343-2; Rumszauer J, 2006, FEBS J, V273, P3261, DOI 10.1111/j.1742-4658.2006.05335.x; RUSSEL M, 1993, J BACTERIOL, V175, P3998, DOI 10.1128/JB.175.13.3998-4007.1993; Schmidt SA, 2001, J BACTERIOL, V183, P4848, DOI 10.1128/JB.183.16.4848-4859.2001; Schwarzenlander C, 2009, ENVIRON MICROBIOL, V11, P801, DOI 10.1111/j.1462-2920.2008.01801.x; SEIFERT HS, 1990, J BACTERIOL, V172, P40, DOI 10.1128/JB.172.1.40-46.1990; Shevchik VE, 1997, EMBO J, V16, P3007, DOI 10.1093/emboj/16.11.3007; Spagnuolo J, 2010, MOL MICROBIOL, V76, P133, DOI 10.1111/j.1365-2958.2010.07085.x; Spreter T, 2009, NAT STRUCT MOL BIOL, V16, P468, DOI 10.1038/nsmb.1603; Thanassi DG, 2002, J MOL MICROB BIOTECH, V4, P11; Tonjum T, 1997, GENE, V192, P155, DOI 10.1016/S0378-1119(97)00018-8; TONJUM T, 1995, MOL MICROBIOL, V16, P451, DOI 10.1111/j.1365-2958.1995.tb02410.x; van Schaik EJ, 2005, J BACTERIOL, V187, P1455, DOI 10.1128/JB.187.4.1455-1464.2005; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62	69	48	48	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					9977	9984		10.1074/jbc.M110.212688	http://dx.doi.org/10.1074/jbc.M110.212688			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21285351	Green Published, hybrid			2022-12-27	WOS:000288547000012
J	Daly, NL; Callaghan, B; Clark, RJ; Nevin, ST; Adams, DJ; Craik, DJ				Daly, Norelle L.; Callaghan, Brid; Clark, Richard J.; Nevin, Simon T.; Adams, David J.; Craik, David J.			Structure and Activity of alpha-Conotoxin PeIA at Nicotinic Acetylcholine Receptor Subtypes and GABA(B) Receptor-coupled N-type Calcium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT SENSORY NEURONS; NEUROPATHIC PAIN; ALPHA-9-ALPHA-10; VC1.1; INHIBITION; RGIA; ANTAGONISTS; MODULATION; DISCOVERY; PEPTIDES	alpha-Conotoxins are peptides from cone snails that target the nicotinic acetylcholine receptor (nAChR). RgIA and Vc1.1 have analgesic activity in animal pain models. Both peptides target the alpha 9 alpha 10 nAChR and inhibit N-type calcium channels via GABA(B) receptor activation, but the mechanism of action of analgesic activity is unknown. PeIA has previously been shown to inhibit the alpha 9 alpha 10 and alpha 3 beta 2 nAChRs. In this study, we have determined the structure of PeIA and shown that it is also a potent inhibitor of N-type calcium channels via GABA(B) receptor activation. The characteristic alpha-conotoxin fold is present in PeIA, but it has a different distribution of surface-exposed hydrophobic and charged residues compared with Vc1.1. Thus, the surface residue distribution, rather than the overall fold, appears to be responsible for the 50-fold increase in selectivity at the alpha 3 beta 2 nAChR by PeIA relative to Vc1.1. In contrast to their difference in potency at the nAChR, the equipotent activity of PeIA and Vc1.1 at the GABA(B) receptor suggests that the GABA(B) receptor is more tolerant to changes in surface residues than is the nAChR. The conserved Asp-Pro-Arg motif of Vc1.1 and RgIA, which is crucial for potency at the alpha 9 alpha 10 nAChR, is not required for activity at GABAB receptor/N-type calcium channels because PeIA has a His-Pro-Ala motif in the equivalent position. This study shows that different structure-activity relationships are associated with the targeting of the GABA(B) receptor versus nAChRs. Furthermore, there is probably a much more diverse range of conotoxins that target the GABA(B) receptor than currently realized.	[Daly, Norelle L.; Clark, Richard J.; Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Nevin, Simon T.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Callaghan, Brid; Adams, David J.] RMIT Univ, Hlth Innovat Res Inst, Melbourne, Vic 3083, Australia	University of Queensland; University of Queensland; Royal Melbourne Institute of Technology (RMIT)	Daly, NL (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	n.daly@imb.uq.edu.au	Adams, David/J-9125-2014; Daly, Norelle L/D-4302-2013; Clark, Richard J/G-8848-2012; Adams, David John/K-3578-2019; Nevin, Simon/B-2663-2014; Craik, David/B-1695-2010; Callaghan, Brid/N-1764-2019	Adams, David/0000-0002-7030-2288; Daly, Norelle L/0000-0002-4697-6602; Clark, Richard J/0000-0002-6807-5426; Adams, David John/0000-0002-7030-2288; Craik, David/0000-0003-0007-6796; Callaghan, Brid/0000-0001-7251-8851	Australian Research Council [DP0986281]; National Health and Medical Research Council [APP456074]	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Australian Research Council Grant DP0986281 and National Health and Medical Research Council Grant APP456074.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Callaghan B, 2008, J NEUROSCI, V28, P10943, DOI 10.1523/JNEUROSCI.3594-08.2008; Callaghan B, 2010, CHANNELS, V4, P51, DOI 10.4161/chan.4.1.10281; CAMPBELL V, 1993, J PHYSIOL-LONDON, V470, P1; Clark RJ, 2006, J BIOL CHEM, V281, P23254, DOI 10.1074/jbc.M604550200; Clark RJ, 2010, ANGEW CHEM INT EDIT, V49, P6545, DOI 10.1002/anie.201000620; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; DOLPHIN AC, 1987, J PHYSIOL-LONDON, V386, P1; Dutton JL, 2001, CURR MED CHEM, V8, P327, DOI 10.2174/0929867013373453; Dwoskin LP, 2009, NEUROPSYCHOPHARMACOL, V34, P244, DOI 10.1038/npp.2008.157; Ellison M, 2006, BIOCHEMISTRY-US, V45, P1511, DOI 10.1021/bi0520129; Ellison M, 2008, J MOL BIOL, V377, P1216, DOI 10.1016/j.jmb.2008.01.082; Gotti C, 2006, CURR PHARM DESIGN, V12, P407, DOI 10.2174/138161206775474486; Halai R, 2009, J BIOL CHEM, V284, P20275, DOI 10.1074/jbc.M109.015339; Hu SH, 1997, BIOCHEMISTRY-US, V36, P11323, DOI 10.1021/bi9713052; Klimis H, 2011, PAIN, V152, P259, DOI 10.1016/j.pain.2010.09.007; Lewis RJ, 2000, J BIOL CHEM, V275, P35335, DOI 10.1074/jbc.M002252200; Livett BG, 2006, TOXICON, V48, P810, DOI 10.1016/j.toxicon.2006.07.023; Luo SL, 2010, J BIOL CHEM, V285, P12355, DOI 10.1074/jbc.M109.079012; McIntosh JM, 2009, BIOCHEM PHARMACOL, V78, P693, DOI 10.1016/j.bcp.2009.05.020; McIntosh JM, 2000, EUR J PHARMACOL, V393, P205, DOI 10.1016/S0014-2999(99)00887-0; McIntosh JM, 2005, J BIOL CHEM, V280, P30107, DOI 10.1074/jbc.M504102200; Millard EL, 2004, EUR J BIOCHEM, V271, P2320, DOI 10.1111/j.1432-1033.2004.04148.x; Millard EL, 2009, J BIOL CHEM, V284, P4944, DOI 10.1074/jbc.M804950200; Nevin ST, 2007, MOL PHARMACOL, V72, P1406, DOI 10.1124/mol.107.040568; Olivera BM, 2008, CHANNELS, V2, P143, DOI 10.4161/chan.2.2.6276; Satkunanathan N, 2005, BRAIN RES, V1059, P149, DOI 10.1016/j.brainres.2005.08.009; TATEBAYASHI H, 1992, J PHYSIOL-LONDON, V447, P391, DOI 10.1113/jphysiol.1992.sp019008; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Towers S, 2000, EUR J NEUROSCI, V12, P3201, DOI 10.1046/j.1460-9568.2000.00237.x; Vincler M, 2007, EXPERT OPIN THER TAR, V11, P891, DOI 10.1517/14728222.11.7.891; Vincler M, 2006, P NATL ACAD SCI USA, V103, P17880, DOI 10.1073/pnas.0608715103; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471	33	38	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10233	10237		10.1074/jbc.M110.196170	http://dx.doi.org/10.1074/jbc.M110.196170			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21252227	Green Published, hybrid			2022-12-27	WOS:000288547000040
J	Solaro, RJ; Kobayashi, T				Solaro, R. John; Kobayashi, Tomoyoshi			Protein Phosphorylation and Signal Transduction in Cardiac Thin Filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							TROPONIN-I PHOSPHORYLATION; N-TERMINAL EXTENSION; KINASE-A PHOSPHORYLATION; ORDERED PHOSPHORYLATION; SARCOMERIC PROTEINS; REGULATORY DOMAIN; MASS-SPECTROMETRY; CALCIUM-BINDING; CROSS-LINKING; HEART-MUSCLE	Homeostasis of cardiac function requires significant adjustments in sarcomeric protein phosphorylation. The existence of unique peptides in cardiac sarcomeres, which are substrates for a multitude of kinases, strongly supports this concept (1). We focus here on the troponin complex of the thin filaments, which contain two major proteins that participate in these phosphoryl group transfer reactions: the inhibitory protein (cardiac troponin (cTn)(2) I) and the tropomyosin (Tm)-binding protein (cTnT). We describe the relatively new understanding of the molecular mechanisms of thin filament-based control of the heartbeat and how these mechanisms are altered by phosphorylation. We discuss new concepts regarding the relation between the beat of the heart and the location of thin filament proteins and their long-and short-range interactions. We also discuss elucidation of mechanisms by which these phosphorylations exacerbate or ameliorate effects of mutations in the myofilament proteins that are linked to familial cardiomyopathies.	[Solaro, R. John] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA; Univ Illinois, Cardiovasc Res Ctr, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Solaro, RJ (corresponding author), Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA.	solarorj@uic.edu			National Institutes of Health [HL 62426, HL 64035, HL 22231, HL 082923]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082923, R01HL064035, P01HL062426, R37HL022231, R01HL022231] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL 62426, HL 64035, and HL 22231 (to R. J. S.) and HL 082923 (to T. K.). This is the sixth article in the Thematic Minireview Series on Signaling in Cardiac Sarcomeres in Health and Disease. This minireview will be reprinted in the 2011 Minireview Compendium, which will be available in January, 2012.	Abbott MB, 2000, J BIOL CHEM, V275, P20610, DOI 10.1074/jbc.M909252199; Ayaz-Guner S, 2009, BIOCHEMISTRY-US, V48, P8161, DOI 10.1021/bi900739f; Baryshnikova OK, 2008, J MOL BIOL, V375, P735, DOI 10.1016/j.jmb.2007.10.062; Biesiadecki BJ, 2007, CIRC RES, V100, P1486, DOI 10.1161/01.RES.0000267744.92677.7f; BREMEL RD, 1972, NATURE-NEW BIOL, V238, P97, DOI 10.1038/newbio238097a0; Burkart EM, 2003, J BIOL CHEM, V278, P11265, DOI 10.1074/jbc.M210712200; Davis JP, 2007, BIOPHYS J, V92, P3195, DOI 10.1529/biophysj.106.095406; Deng Y, 2001, BIOCHEMISTRY-US, V40, P14593, DOI 10.1021/bi0115232; Finley N, 1999, FEBS LETT, V453, P107, DOI 10.1016/S0014-5793(99)00693-6; Fukuda N, 2008, J PHYSIOL SCI, V58, P151, DOI 10.2170/physiolsci.RV005408; Galinska-Rakoczy A, 2008, J MOL BIOL, V379, P929, DOI 10.1016/j.jmb.2008.04.062; Gaponenko V, 1999, J BIOL CHEM, V274, P16681, DOI 10.1074/jbc.274.24.16681; Howarth JW, 2007, J MOL BIOL, V373, P706, DOI 10.1016/j.jmb.2007.08.035; Hunlich M, 2005, J MOL CELL CARDIOL, V38, P119, DOI 10.1016/j.yjmcc.2004.10.005; Jideama NM, 2006, INT J BIOL SCI, V2, P1; Ke YB, 2008, PROG BIOPHYS MOL BIO, V98, P238, DOI 10.1016/j.pbiomolbio.2009.01.007; Keane NE, 1997, EUR J BIOCHEM, V248, P329, DOI 10.1111/j.1432-1033.1997.00329.x; Kentish JC, 2001, CIRC RES, V88, P1059, DOI 10.1161/hh1001.091640; KING MM, 1981, BIOCHEMISTRY-US, V20, P4387, DOI 10.1021/bi00518a024; Kobayashi T, 2005, ANNU REV PHYSIOL, V67, P39, DOI 10.1146/annurev.physiol.67.040403.114025; Kobayashi T, 2009, J BIOL CHEM, V284, P20052, DOI 10.1074/jbc.M109.001396; Kowlessur D, 2010, J BIOL CHEM, V285, P2686, DOI 10.1074/jbc.M109.062349; Kozaili JM, 2010, J BIOL CHEM, V285, P38034, DOI 10.1074/jbc.M110.165753; Lehman W, 2009, J MOL BIOL, V388, P673, DOI 10.1016/j.jmb.2009.03.060; Li MX, 1999, BIOCHEMISTRY-US, V38, P8289, DOI 10.1021/bi9901679; Lindhout DA, 2002, BIOCHEMISTRY-US, V41, P7267, DOI 10.1021/bi020100c; Lu QW, 2010, J BIOL CHEM, V285, P11810, DOI 10.1074/jbc.M109.055657; MAKEEVA V F, 1989, Biokhimiya, V54, P1434; MITTMANN K, 1992, FEBS LETT, V302, P133, DOI 10.1016/0014-5793(92)80423-E; Moss RL, 2004, CIRC RES, V94, P1290, DOI 10.1161/01.RES.0000127125.61647.4F; Mudalige WAKA, 2009, J MOL BIOL, V389, P575, DOI 10.1016/j.jmb.2009.04.027; Noland TA, 1996, BIOCHEMISTRY-US, V35, P14923, DOI 10.1021/bi9616357; PAN BS, 1990, J MOL CELL CARDIOL, V22, P1117, DOI 10.1016/0022-2828(90)90075-D; PAN BS, 1987, J BIOL CHEM, V262, P7839; Pfleiderer P, 2009, J MUSCLE RES CELL M, V30, P67, DOI 10.1007/s10974-009-9176-y; Pirani A, 2005, J MOL BIOL, V346, P761, DOI 10.1016/j.jmb.2004.12.013; QUIRK PG, 1995, FEBS LETT, V370, P175, DOI 10.1016/0014-5793(95)00812-N; ROBERTSON SP, 1982, J BIOL CHEM, V257, P260; Sadayappan S, 2008, FASEB J, V22, P1246, DOI 10.1096/fj.07-9458com; Schmidtmann A, 2005, FEBS J, V272, P6087, DOI 10.1111/j.1742-4658.2005.05001.x; Sfichi-Duke L, 2010, J MOL CELL CARDIOL, V48, P934, DOI 10.1016/j.yjmcc.2010.01.005; Sheehan KA, 2007, AM J PHYSIOL-REG I, V293, pR963, DOI 10.1152/ajpregu.00253.2007; Solaro RJ, 2008, J BIOL CHEM, V283, P26829, DOI 10.1074/jbc.R800037200; Solaro RJ, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/105648; Solaro RJ, 2010, J MOL CELL CARDIOL, V48, P810, DOI 10.1016/j.yjmcc.2010.02.014; Spyracopoulos L, 1997, BIOCHEMISTRY-US, V36, P12138, DOI 10.1021/bi971223d; Stelzer JE, 2007, CIRC RES, V101, P503, DOI 10.1161/CIRCRESAHA.107.153650; Sumandea MP, 2008, J BIOL CHEM, V283, P22680, DOI 10.1074/jbc.M802396200; Sumandea MP, 2009, BIOCHEMISTRY-US, V48, P7722, DOI 10.1021/bi900516n; Sumandea MP, 2003, J BIOL CHEM, V278, P35135, DOI 10.1074/jbc.M306325200; Sun YB, 2010, J MOL CELL CARDIOL, V48, P859, DOI 10.1016/j.yjmcc.2009.11.019; Sun YB, 2009, J PHYSIOL-LONDON, V587, P155, DOI 10.1113/jphysiol.2008.164707; SWIDEREK K, 1990, EUR J BIOCHEM, V190, P575, DOI 10.1111/j.1432-1033.1990.tb15612.x; Swindle N, 2010, BIOCHEMISTRY-US, V49, P4813, DOI 10.1021/bi100400h; Tachampa K, 2007, CIRC RES, V101, P1081, DOI 10.1161/CIRCRESAHA.107.165258; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Takimoto E, 2004, CIRC RES, V94, P496, DOI 10.1161/01.RES.0000117307.57798.F5; Tobacman LS, 1996, ANNU REV PHYSIOL, V58, P447, DOI 10.1146/annurev.physiol.58.1.447; TOBACMAN LS, 1990, J BIOL CHEM, V265, P931; Tobacman LS, 2002, J BIOL CHEM, V277, P27636, DOI 10.1074/jbc.M201768200; VANEERD JP, 1975, BIOCHEM BIOPH RES CO, V64, P122, DOI 10.1016/0006-291X(75)90227-2; Vibert P, 1997, J MOL BIOL, V266, P8, DOI 10.1006/jmbi.1996.0800; VILLARPALASI C, 1981, J BIOL CHEM, V256, P7409; Wang H, 2006, J MOL CELL CARDIOL, V41, P823, DOI 10.1016/j.yjmcc.2006.08.016; Ward DG, 2004, BIOCHEMISTRY-US, V43, P5772, DOI 10.1021/bi036310m; Ward DG, 2004, BIOCHEMISTRY-US, V43, P4020, DOI 10.1021/bi036128l; Ward DG, 2003, BIOCHEMISTRY-US, V42, P10324, DOI 10.1021/bi034495r; Ward DG, 2002, J BIOL CHEM, V277, P41795, DOI 10.1074/jbc.M206744200; Warren CM, 2009, J BIOL CHEM, V284, P14258, DOI 10.1074/jbc.M807621200; Westfall MV, 2005, J BIOL CHEM, V280, P41324, DOI 10.1074/jbc.M506043200; Wu SC, 2007, J BIOL CHEM, V282, P30691, DOI 10.1074/jbc.M703670200; Yang F, 2008, BIOCHEM CELL BIOL, V86, P70, DOI [10.1139/O07-150, 10.1139/o07-150]; Yasuda SI, 2007, CIRC RES, V101, P377, DOI 10.1161/CIRCRESAHA.106.145557; Yin XK, 2010, MOL CELL PROTEOMICS, V9, P497, DOI 10.1074/mcp.M900275-MCP200; Zabrouskov V, 2008, MOL CELL PROTEOMICS, V7, P1838, DOI 10.1074/mcp.M700524-MCP200; Zhang JA, 2010, J AM SOC MASS SPECTR, V21, P940, DOI 10.1016/j.jasms.2010.02.005; Zhang R, 1995, J BIOL CHEM, V270, P30773, DOI 10.1074/jbc.270.51.30773	77	83	83	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					9935	9940		10.1074/jbc.R110.197731	http://dx.doi.org/10.1074/jbc.R110.197731			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21257760	Green Published, hybrid			2022-12-27	WOS:000288547000007
J	Mitra, S; Lee, JS; Cantrell, M; Van den Berg, CL				Mitra, Shreya; Lee, Ju-Seog; Cantrell, Michael; Van den Berg, Carla Lynn			c-Jun N-terminal Kinase 2 (JNK2) Enhances Cell Migration through Epidermal Growth Factor Substrate 8 (EPS8)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; FACTOR RECEPTOR; BREAST-CANCER; NH2-TERMINAL KINASE; PANCREATIC-CANCER; DORSAL RUFFLES; EXPRESSION; RAC; MOTILITY; TRANSFORMATION	Membrane-bound receptors induce biochemical signals to remodel the actin cytoskeleton and mediate cell motility. In association with receptor tyrosine kinases, several downstream mitogen-induced kinases facilitate cell migration. Here, we show a role for c-Jun N-terminal kinase 2 (JNK2) in promoting mammary cancer cell migration through inhibition of epidermal growth factor substrate 8 (EPS8) expression, a key regulator of EGF receptor (R) signaling and trafficking. Using jnk2(-/-) mice, we found that EPS8 expression is higher in polyoma middle T antigen (PyVMT)jnk2(-/-) mammary tumors and jnk2(-/-) mammary glands compared with the respective jnk2(-/-) controls. The inverse relationship between the jnk2 and eps8 expression was also associated with cancer progression in that patients with basal-type breast tumors expressing high jnk2 and low eps8 experienced poor disease-free survival. In mammary tumor cell lines, the absence of jnk2 greatly reduces cell migration that is rescued by EPS8 knockdown. Subsequent studies show that JNK2 enhances formation of the EPS8-Abi-1-Sos-1 complex to augment EGFR activation of Akt and ERK, whereas the absence of JNK2 promotes ESP8/RN-Tre association to inhibit endocytotic trafficking of the EGFR. Together, these studies unveil a critical role for JNK2 and EPS8 in receptor tyrosine kinase signaling and trafficking to convey distinctly different effects on cell migration.	[Mitra, Shreya; Van den Berg, Carla Lynn] Univ Texas Austin, Coll Pharm, Div Pharmacol Toxicol, Austin, TX 78712 USA; [Mitra, Shreya; Van den Berg, Carla Lynn] Univ Texas Austin, Ctr Mol & Cellular Toxicol, Austin, TX 78712 USA; [Cantrell, Michael] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Mitra, Shreya; Lee, Ju-Seog] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Div Canc Med, Houston, TX 77054 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; UTMD Anderson Cancer Center	Van den Berg, CL (corresponding author), Univ Texas Austin, Coll Pharm, Div Pharmacol Toxicol, Austin, TX 78712 USA.	cvandenberg@mail.utexas.edu	Lee, Ju-Seog/X-1786-2018	Lee, Ju-Seog/0000-0002-5666-9753	National Institutes of Health [CA 100238]; NATIONAL CANCER INSTITUTE [R01CA100238] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA 100238 (to C. L. V. D. B.).	Almeida EAC, 2000, J CELL BIOL, V149, P741, DOI 10.1083/jcb.149.3.741; Antonyak MA, 1998, J BIOL CHEM, V273, P2817, DOI 10.1074/jbc.273.5.2817; Barr RK, 2002, J BIOL CHEM, V277, P10987, DOI 10.1074/jbc.M107565200; Barr RK, 2001, INT J BIOCHEM CELL B, V33, P1047, DOI 10.1016/S1357-2725(01)00093-0; Behrens A, 2000, ONCOGENE, V19, P2657, DOI 10.1038/sj.onc.1203603; Bogoyevitch MA, 2006, BIOESSAYS, V28, P923, DOI 10.1002/bies.20458; Bost F, 1999, MOL CELL BIOL, V19, P1938; Chen NY, 2001, CANCER RES, V61, P3908; Chen PL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010443; Cory GOC, 2002, NATURE, V418, P732, DOI 10.1038/418732a; Croce A, 2004, NAT CELL BIOL, V6, P1173, DOI 10.1038/ncb1198; Disanza A, 2004, NAT CELL BIOL, V6, P1180, DOI 10.1038/ncb1199; Disanza A, 2006, NAT CELL BIOL, V8, P1337, DOI 10.1038/ncb1502; Disanza A, 2009, MOL ONCOL, V3, P280, DOI 10.1016/j.molonc.2009.05.008; Dreskin SC, 2001, J IMMUNOL, V166, P5646, DOI 10.4049/jimmunol.166.9.5646; FAZIOLI F, 1993, EMBO J, V12, P3799, DOI 10.1002/j.1460-2075.1993.tb06058.x; Gallo R, 1997, ONCOGENE, V15, P1929, DOI 10.1038/sj.onc.1201344; Goicoechea S, 2006, J CELL SCI, V119, P3316, DOI 10.1242/jcs.03076; Gould GW, 2009, NAT REV MOL CELL BIO, V10, P287, DOI 10.1038/nrm2652; Griffith OL, 2006, J CLIN ONCOL, V24, P5043, DOI 10.1200/JCO.2006.06.7330; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Huang CY, 2009, BIOCHEM PHARMACOL, V77, P794, DOI 10.1016/j.bcp.2008.11.014; Innocenti M, 2003, J CELL BIOL, V160, P17, DOI 10.1083/jcb.200206079; Innocenti M, 2002, J CELL BIOL, V156, P125, DOI 10.1083/jcb.200108035; Inobe M, 1999, BIOCHEM BIOPH RES CO, V266, P216, DOI 10.1006/bbrc.1999.1782; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Joslin EJ, 2007, J CELL SCI, V120, P3688, DOI 10.1242/jcs.010488; Kawada K, 2009, MOL CELL BIOL, V29, P4508, DOI 10.1128/MCB.00015-09; Lanzetti L, 2000, NATURE, V408, P374, DOI 10.1038/35042605; Lanzetti L, 2004, NATURE, V429, P309, DOI 10.1038/nature02542; Lelekakis M, 1999, CLIN EXP METASTAS, V17, P163, DOI 10.1023/A:1006689719505; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Liu PS, 2010, ONCOGENE, V29, P3977, DOI 10.1038/onc.2010.144; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Loi S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-239; Maa MC, 2007, J BIOL CHEM, V282, P19399, DOI 10.1074/jbc.M610280200; Matoskova B, 1996, ONCOGENE, V12, P2679; MATOSKOVA B, 1995, MOL CELL BIOL, V15, P3805; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Mouneimne G, 2004, J CELL BIOL, V166, P697, DOI 10.1083/jcb.200405156; Offenhauser N, 2004, MOL BIOL CELL, V15, P91, DOI 10.1091/mbc.E03-06-0427; Orth JD, 2006, CANCER RES, V66, P11094, DOI 10.1158/0008-5472.CAN-06-3397; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Ridley AJ, 2001, J CELL SCI, V114, P2713; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sabapathy K, 1999, MECH DEVELOP, V89, P115, DOI 10.1016/S0925-4773(99)00213-0; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; Scita G, 2001, J CELL BIOL, V154, P1031, DOI 10.1083/jcb.200103146; Shintani Y, 2006, MOL BIOL CELL, V17, P2963, DOI 10.1091/mbc.E05-12-1123; Sorkin A, 2001, BIOCHEM SOC T, V29, P480, DOI 10.1042/BST0290480; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Tang J, 2003, BIOCHEM BIOPH RES CO, V312, P930, DOI 10.1016/j.bbrc.2003.11.016; Teranishi F, 2009, CANCER SCI, V100, P770, DOI 10.1111/j.1349-7006.2009.01084.x; Tomshine JC, 2009, J BIOL CHEM, V284, P26331, DOI 10.1074/jbc.M109.033514; Tong C, 2007, AM J PATHOL, V171, P297, DOI 10.2353/ajpath.2007.061036; Tsuiki H, 2003, CANCER RES, V63, P250; Wang X, 2010, HUM PATHOL, V41, P401, DOI 10.1016/j.humpath.2009.08.018; Webster MA, 1998, MOL CELL BIOL, V18, P2344, DOI 10.1128/MCB.18.4.2344; Welsch T, 2007, CANCER LETT, V255, P205, DOI 10.1016/j.canlet.2007.04.008; Weston CR, 2003, GENE DEV, V17, P1271, DOI 10.1101/gad.1087303; Xia Y, 2004, TRENDS CELL BIOL, V14, P94, DOI 10.1016/j.tcb.2003.12.005; Xu M, 2009, ENDOCRINOLOGY, V150, P2064, DOI 10.1210/en.2008-1265; Yamazaki T, 2002, J CELL SCI, V115, P1791; YANG SS, 1995, J BIOL CHEM, V270, P18212, DOI 10.1074/jbc.270.31.18212; Yao J, 2006, CANCER RES, V66, P4065, DOI 10.1158/0008-5472.CAN-05-4083	68	22	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15287	15297		10.1074/jbc.M109.094441	http://dx.doi.org/10.1074/jbc.M109.094441			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21357683	hybrid, Green Published			2022-12-27	WOS:000289788300060
J	Wollert, T; Patel, A; Lee, YL; Provance, DW; Vought, VE; Cosgrove, MS; Mercer, JA; Langford, GM				Woellert, Torsten; Patel, Anamika; Lee, Ying-Lung; Provance, D. William, Jr.; Vought, Valarie E.; Cosgrove, Michael S.; Mercer, John A.; Langford, George M.			Myosin5a Tail Associates Directly with Rab3A-containing Compartments in Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN RAB3A; SYNAPTIC VESICLES; MELANOSOME TRANSPORT; SECRETORY GRANULES; AXONAL-TRANSPORT; PURKINJE-CELLS; ACTIVE ZONE; F-ACTIN; VA; IDENTIFICATION	Myosin-Va (Myo5a) is a motor protein associated with synaptic vesicles (SVs) but the mechanism by which it interacts has not yet been identified. A potential class of binding partners are Rab GTPases and Rab3A is known to associate with SVs and is involved in SV trafficking. We performed experiments to determine whether Rab3A interacts with Myo5a and whether it is required for transport of neuronal vesicles. In vitro motility assays performed with axoplasm from the squid giant axon showed a requirement for a Rab GTPase in Myo5a-dependent vesicle transport. Furthermore, mouse recombinant Myo5a tail revealed that it associated with Rab3A in rat brain synaptosomal preparations in vitro and the association was confirmed by immunofluorescence imaging of primary neurons isolated from the frontal cortex of mouse brains. Synaptosomal Rab3A was retained on recombinant GST-tagged Myo5a tail affinity columns in a GTP-dependent manner. Finally, the direct interaction of Myo5a and Rab3A was determined by sedimentation velocity analytical ultracentrifugation using recombinant mouse Myo5a tail and human Rab3A. When both proteins were incubated in the presence of 1 mM GTP gamma S, Myo5a tail and Rab3A formed a complex and a direct interaction was observed. Further analysis revealed that GTP-bound Rab3A interacts with both the monomeric and dimeric species of the Myo5a tail. However, the interaction between Myo5a tail and nucleotide-free Rab3A did not occur. Thus, our results show that Myo5a and Rab3A are direct binding partners and interact on SVs and that the Myo5a/Rab3A complex is involved in transport of neuronal vesicles.	[Woellert, Torsten; Patel, Anamika; Vought, Valarie E.; Cosgrove, Michael S.; Langford, George M.] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA; [Woellert, Torsten; Lee, Ying-Lung; Langford, George M.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Woellert, Torsten; Langford, George M.] Marine Biol Lab, Woods Hole, MA 02543 USA; [Provance, D. William, Jr.; Mercer, John A.] McLaughlin Res Inst, Great Falls, MT 59405 USA	Syracuse University; Dartmouth College; Marine Biological Laboratory - Woods Hole; McLaughlin Research Institute for Biomedical Sciences, Inc.	Langford, GM (corresponding author), Syracuse Univ, Dept Biol, 107 Coll Pl, Syracuse, NY 13244 USA.	glangfor@syr.edu	Provance, David W/D-5294-2013; Idn, Inct/J-8385-2013	Provance, David W/0000-0002-9824-0672; Woellert, Torsten/0000-0002-3814-9623; Mercer, John/0000-0003-0307-4438; Langford, George/0000-0001-9737-2182	National Institutes of Health [CA140522, GM066901, TW007220]; NSF [MCB-0517303]; FOGARTY INTERNATIONAL CENTER [R03TW007220] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA140522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066901] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA140522 (to M. S. C.), GM066901, and TW007220 (to J. A. M. and D. W. P.) and NSF Grant MCB-0517303 (to G. M. L.).	Bahadoran P, 2001, J CELL BIOL, V152, P843, DOI 10.1083/jcb.152.4.843; Bridgman PC, 1999, J CELL BIOL, V146, P1045, DOI 10.1083/jcb.146.5.1045; BRONDYK WH, 1995, MOL CELL BIOL, V15, P1137; Brown JR, 2004, J NEUROBIOL, V58, P175, DOI 10.1002/neu.10317; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; CHIN GJ, 1992, BRAIN RES, V571, P89, DOI 10.1016/0006-8993(92)90512-8; Chou JH, 2000, J BIOL CHEM, V275, P9433, DOI 10.1074/jbc.275.13.9433; Correia SS, 2008, NAT NEUROSCI, V11, P457, DOI 10.1038/nn2063; DekkerOhno K, 1996, BRAIN RES, V714, P226, DOI 10.1016/0006-8993(95)01560-4; Desnos C, 2007, J NEUROSCI, V27, P10636, DOI 10.1523/JNEUROSCI.1228-07.2007; Desnos C, 2007, BIOL CELL, V99, P411, DOI 10.1042/BC20070021; Eichler TW, 2006, BIOCHEM SOC T, V34, P671, DOI 10.1042/BST0340671; Evans LL, 1998, J CELL SCI, V111, P2055; FISCHER V, 1991, NATURE, V349, P79; GEPPERT M, 1994, NATURE, V369, P493, DOI 10.1038/369493a0; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; Giovedi S, 2004, J BIOL CHEM, V279, P43760, DOI 10.1074/jbc.M403293200; Gramowski A, 2006, EUR J NEUROSCI, V24, P455, DOI 10.1111/j.1460-9568.2006.04892.x; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Hales CM, 2002, J BIOL CHEM, V277, P50415, DOI 10.1074/jbc.M209270200; Huang JD, 1999, NATURE, V397, P267, DOI 10.1038/16722; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; JAHN R, 1994, ANNU REV NEUROSCI, V17, P219, DOI 10.1146/annurev.ne.17.030194.001251; Jordan BA, 2004, MOL CELL PROTEOMICS, V3, P857, DOI 10.1074/mcp.M400045-MCP200; Jordens I, 2005, TRAFFIC, V6, P1070, DOI 10.1111/j.1600-0854.2005.00336.x; LANDIS DMD, 1988, NEURON, V1, P201, DOI 10.1016/0896-6273(88)90140-7; Lapierre LA, 2001, MOL BIOL CELL, V12, P1843, DOI 10.1091/mbc.12.6.1843; Leenders AGM, 2001, MOL BIOL CELL, V12, P3095, DOI 10.1091/mbc.12.10.3095; Li XD, 2005, J BIOL CHEM, V280, P17815, DOI 10.1074/jbc.M413295200; Libby RT, 2004, J CELL SCI, V117, P4509, DOI 10.1242/jcs.01316; Lise MF, 2006, J BIOL CHEM, V281, P3669, DOI 10.1074/jbc.M511725200; MANI F, 1994, BRAZ J MED BIOL RES, V27, P2639; Matesic LE, 2001, P NATL ACAD SCI USA, V98, P10238, DOI 10.1073/pnas.181336698; MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0; MORRIS RL, 1995, J CELL BIOL, V131, P1315, DOI 10.1083/jcb.131.5.1315; Patel A, 2008, J BIOL CHEM, V283, P32162, DOI 10.1074/jbc.M806317200; Patel A, 2009, J BIOL CHEM, V284, P24242, DOI 10.1074/jbc.M109.014498; Pathak D, 2010, J NEUROSCI, V30, P8984, DOI 10.1523/JNEUROSCI.1621-10.2010; Prekeris R, 1997, J CELL BIOL, V137, P1589, DOI 10.1083/jcb.137.7.1589; Provance DW, 2002, TRAFFIC, V3, P124, DOI 10.1034/j.1600-0854.2002.030205.x; Rodriguez OC, 2002, J CELL SCI, V115, P991; Roland JT, 2007, MOL BIOL CELL, V18, P2828, DOI 10.1091/mbc.E07-02-0169; Roland JT, 2009, J BIOL CHEM, V284, P1213, DOI 10.1074/jbc.M805957200; Rose SD, 2003, J NEUROCHEM, V85, P287, DOI 10.1046/j.1471-4159.2003.01649.x; Rudolf R, 2003, J CELL SCI, V116, P1339, DOI 10.1242/jcs.00317; Schlamp CL, 1996, EXP EYE RES, V63, P613, DOI 10.1006/exer.1996.0155; Schluter OM, 2004, J NEUROSCI, V24, P6629, DOI 10.1523/JNEUROSCI.1610-04.2004; Schluter OM, 2002, J BIOL CHEM, V277, P40919, DOI 10.1074/jbc.M203704200; Schluter OM, 1999, J NEUROSCI, V19, P5834, DOI 10.1523/JNEUROSCI.19-14-05834.1999; Schnell E, 2001, J NEUROPHYSIOL, V85, P1498, DOI 10.1152/jn.2001.85.4.1498; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; STAHL B, 1994, J BIOL CHEM, V269, P24770; Stahl B, 1996, EMBO J, V15, P1799, DOI 10.1002/j.1460-2075.1996.tb00529.x; Star EN, 2005, J PHYSIOL-LONDON, V569, P103, DOI 10.1113/jphysiol.2005.092528; Tabb JS, 1998, J CELL SCI, V111, P3221; Takagishi Y, 1996, NEUROSCI LETT, V215, P169, DOI 10.1016/S0304-3940(96)12967-0; Trybus KM, 2008, CELL MOL LIFE SCI, V65, P1378, DOI 10.1007/s00018-008-7507-6; Turner KM, 1999, TRENDS NEUROSCI, V22, P459, DOI 10.1016/S0166-2236(99)01436-8; VONMOLLARD GF, 1990, P NATL ACAD SCI USA, V87, P1988, DOI 10.1073/pnas.87.5.1988; VONMOLLARD GF, 1994, TRENDS BIOCHEM SCI, V19, P164, DOI 10.1016/0968-0004(94)90278-X; Walikonis RS, 2000, J NEUROSCI, V20, P4069; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Waselle L, 2003, MOL BIOL CELL, V14, P4103, DOI 10.1091/mbc.E03-01-0022; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760	65	24	25	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14352	14361		10.1074/jbc.M110.187286	http://dx.doi.org/10.1074/jbc.M110.187286			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21349835	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000289556200057
J	Chung, H; Suh, EK; Han, IO; Oh, ES				Chung, Heesung; Suh, Eun-Kyung; Han, Inn-Oc; Oh, Eok-Soo			Keratinocyte-derived Laminin-332 Promotes Adhesion and Migration in Melanocytes and Melanoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; BAND ULTRAVIOLET-B; CELL-MIGRATION; BASEMENT-MEMBRANE; INTEGRIN RECEPTORS; ALPHA-3-BETA-1; EXPRESSION; INVASION; MATRIX; GAMMA-2-CHAIN	Melanocytes are highly motile cells that play an integral role in basic skin physiological processes such as wound healing and proper skin pigmentation. It has been postulated that surrounding keratinocytes contribute to melanocyte migration, but underlying mechanisms remain rather vague so far. In this study, we set out to analyze the specific potential contribution of keratinocyte components to melanocytes and melanoma cell migration-related processes. Our studies revealed that A375 human melanoma cell attachment, spreading, and migration are interestingly better supported by HaCaT keratinocyte extracellular matrix (ECM) than by self-derived A375 ECM. Moreover, HaCaT ECM caused increased integrin alpha 6 expression, adhesion-mediated focal adhesion kinase phosphorylation, and focal adhesion formations. Similar effects were confirmed in human melanocytes. Furthermore, we found that keratinocyte-derived soluble factors did not appear to significantly contribute to these processes. Specific extrinsic factors that promoted melanoma migration were attributed to keratinocyte-derived laminin-332, whereas alternative ECM component such as laminin-111 and fibronectin functions appeared to have insignificant contributions. Taken together, these studies implicate extrinsic laminin-332 in promoting the high mobility property and perhaps invasiveness inherently characteristic of, and that are the menace of, melanocytes and melanomas, respectively.	[Chung, Heesung; Suh, Eun-Kyung; Oh, Eok-Soo] Ewha Womans Univ, Dept Life Sci, Div Life & Pharmaceut Sci, Seoul 120750, South Korea; [Chung, Heesung; Suh, Eun-Kyung; Oh, Eok-Soo] Ewha Womans Univ, Ctr Cell Signaling & Drug Discovery Res, Seoul 120750, South Korea; [Han, Inn-Oc] Inha Univ, Coll Med, Dept Physiol & Biophys, Inchon 402751, South Korea	Ewha Womans University; Ewha Womans University; Inha University	Oh, ES (corresponding author), Ewha Womans Univ, Dept Life Sci, Div Life & Pharmaceut Sci, Seoul 120750, South Korea.	OhES@ewha.ac.kr			Ministry of Education, Science and Technology [2009-0071381]	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Basic Science Research Program through the National Research Foundation of Korea funded by Ministry of Education, Science and Technology Grant 2009-0071381 (to E.-S.O.).	CARTER WG, 1991, CELL, V65, P599, DOI 10.1016/0092-8674(91)90092-D; D'Alessio S, 2008, J CELL SCI, V121, P3922, DOI 10.1242/jcs.037549; Danen EHJ, 1996, EUR J CELL BIOL, V70, P69; DiPersio CM, 2000, J CELL SCI, V113, P3051; ECKERT RL, 1989, ENVIRON HEALTH PERSP, V80, P109, DOI 10.2307/3430736; Eves P, 2003, CLIN EXP METASTAS, V20, P685, DOI 10.1023/B:CLIN.0000006824.41376.b0; Eves P, 2003, BRIT J CANCER, V89, P2004, DOI 10.1038/sj.bjc.6601349; Fitsialos G, 2008, J CELL SCI, V121, P2992, DOI 10.1242/jcs.029256; Frank DE, 2004, J CELL SCI, V117, P1351, DOI 10.1242/jcs.01003; Gilles C, 2001, J CELL SCI, V114, P2967; Haass NK, 2004, J MOL HISTOL, V35, P309; Haass NK, 2005, PIGM CELL RES, V18, P150, DOI 10.1111/j.1600-0749.2005.00235.x; Hintermann E, 2004, MATRIX BIOL, V23, P75, DOI 10.1016/j.matbio.2004.03.001; Hirobe T, 2005, PIGM CELL RES, V18, P2, DOI 10.1111/j.1600-0749.2004.00198.x; Hoogduijn MJ, 2004, EXP CELL RES, V294, P60, DOI 10.1016/j.yexcr.2003.11.007; Joshi PG, 2007, PIGM CELL RES, V20, P380, DOI 10.1111/j.1600-0749.2007.00397.x; Koshikawa N, 2000, J CELL BIOL, V148, P615, DOI 10.1083/jcb.148.3.615; Leng J, 1999, J BIOL CHEM, V274, P37855, DOI 10.1074/jbc.274.53.37855; Li YH, 2006, INT J MOL MED, V18, P713; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Miyazaki K, 2006, CANCER SCI, V97, P91, DOI 10.1111/j.1349-7006.2006.00150.x; O'Toole EA, 2001, CLIN EXP DERMATOL, V26, P525, DOI 10.1046/j.1365-2230.2001.00891.x; Ogawa T, 2007, MOL BIOL CELL, V18, P1621, DOI 10.1091/mbc.E06-09-0806; Ogura Y, 2008, BRIT J DERMATOL, V159, P49, DOI 10.1111/j.1365-2133.2008.08576.x; OIKAWA Y, 2010, EXP CELL RE IN PRESS; Pirila E, 2003, BIOCHEM BIOPH RES CO, V303, P1012, DOI 10.1016/S0006-291X(03)00452-2; Rodeck U, 1997, J CELL SCI, V110, P113; ROUSSELLE P, 1991, J CELL BIOL, V114, P567, DOI 10.1083/jcb.114.3.567; Scherschun L, 2001, J AM ACAD DERMATOL, V44, P999, DOI 10.1067/mjd.2001.114752; Scott GA, 1999, EXP DERMATOL, V8, P212, DOI 10.1111/j.1600-0625.1999.tb00373.x; Tsuji T, 2002, CLIN EXP METASTAS, V19, P127, DOI 10.1023/A:1014573204062; WAYNER EA, 1993, J CELL BIOL, V121, P1141, DOI 10.1083/jcb.121.5.1141; ZAMBRUNO G, 1993, J CELL SCI, V105, P179; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4; Zhu N, 2004, BRIT J CANCER, V90, P1457, DOI 10.1038/sj.bjc.6601698; Zhu NW, 2002, J INVEST DERMATOL, V119, P1165, DOI 10.1046/j.1523-1747.2002.19516.x	37	36	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13438	13447		10.1074/jbc.M110.166751	http://dx.doi.org/10.1074/jbc.M110.166751			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21349841	hybrid, Green Published			2022-12-27	WOS:000289282200064
J	Fortian, A; Gonzalez, E; Castano, D; Falcon-Perez, JM; Millet, O				Fortian, Arola; Gonzalez, Esperanza; Castano, David; Falcon-Perez, Juan M.; Millet, Oscar			Intracellular Rescue of the Uroporphyrinogen III Synthase Activity in Enzymes Carrying the Hotspot Mutation C73R	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL ERYTHROPOIETIC PORPHYRIA; BONE-MARROW-TRANSPLANTATION; PROTEIN; PHENOTYPE; GENE; DISEASE; IDENTIFICATION; GENOTYPE	A single mutation (C73R) in the enzyme uroporphyrinogen III synthase (UROIIIS) is responsible for more than one-third of all of the reported cases of the rare autosomal disease congenital erythropoietic porphyria (CEP). CEP patients carrying this hotspot mutation develop a severe phenotype of the disease, including reduced life expectancy. Here, we have investigated the molecular basis for the functional deficit in the mutant enzyme both in vitro and in cellular systems. We show that a Cys in position 73 is not essential for the catalytic activity of the enzyme but its mutation to Arg speeds up the process of irreversible unfolding and aggregation. In the mammalian cell milieu, the mutant protein levels decrease to below the detection limit, whereas wild type UROIIIS can be detected easily. The disparate response is not produced by differences at the level of transcription, and the results with cultured cells and in vitro are consistent with a model where the protein becomes very unstable upon mutation and triggers a degradation mechanism via the proteasome. Mutant protein levels can be restored upon cell treatment with the proteasome inhibitor MG132. The intracellularly recovered C73R-UROIIIS protein shows enzymatic activity, paving the way for a new line of therapeutic intervention in CEP patients.	[Fortian, Arola; Castano, David; Millet, Oscar] Ctr Invest Cooperat Biociencias, Struct Biol Unit, Derio 48160, Vizcaya, Spain; [Gonzalez, Esperanza; Falcon-Perez, Juan M.] Ctr Invest Cooperat Biociencias, Metabol Unit, Derio 48160, Vizcaya, Spain		Millet, O (corresponding author), CICbioGUNE, Bizkaia Technol Pk,Bldg 800, Derio 48160, Spain.	omillet@cicbiogune.es	Falcon-Perez, Juan M/F-5920-2011; González, Esperanza/H-5450-2015; González, Esperanza/AAK-4097-2020; Millet, Oscar/F-9696-2011	González, Esperanza/0000-0002-3831-4596; González, Esperanza/0000-0002-3831-4596; Millet, Oscar/0000-0001-8748-4105; Falcon-Perez, Juan M/0000-0003-3133-0670; , Arola/0000-0002-6848-2953	Department of Industry, Tourism; Trade of the Basque government; Innovation Technology Department of Bizkaia County; Ministerio de Ciencia y Tecnologia [CTQ2006-09101/BQU, CTQ2009-10353/BQU]; Fundacion Ramon Areces	Department of Industry, Tourism; Trade of the Basque government; Innovation Technology Department of Bizkaia County; Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Ramon Areces	This work was supported by the Department of Industry, Tourism, and Trade of the Basque government (Etortek Research Programs 2005/2007), the Innovation Technology Department of Bizkaia County, the Ministerio de Ciencia y Tecnologia (CTQ2006-09101/BQU and CTQ2009-10353/BQU), The Fundacion Ramon Areces, and the Ramon y Cajal program (to J. M. F. P.).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Battersby AR, 2000, NAT PROD REP, V17, P507, DOI 10.1039/b002635m; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Bishop DF, 2006, AM J HUM GENET, V78, P645, DOI 10.1086/502667; Brown CR, 1996, CELL STRESS CHAPERON, V1, P117, DOI 10.1379/1466-1268(1996)001<0117:CCCTMP>2.3.CO;2; Conn PM, 2007, PHARMACOL REV, V59, P225, DOI 10.1124/pr.59.3.2; Cunha L, 2008, PROTEINS, V71, P855, DOI 10.1002/prot.21755; Dsnick RJ, 2002, BRIT J HAEMATOL, V117, P779, DOI 10.1046/j.1365-2141.2002.03557.x; Duncan RF, 2005, FEBS J, V272, P5244, DOI 10.1111/j.1742-4658.2005.04921.x; Dupuis-Girod S, 2005, EUR J PEDIATR, V164, P104, DOI 10.1007/s00431-004-1575-x; Falcon-Perez JM, 2007, EXP CELL RES, V313, P1473, DOI 10.1016/j.yexcr.2007.02.006; Fontanellas A, 1996, EUR J HUM GENET, V4, P274; Fortian A, 2009, BIOCHEMISTRY-US, V48, P454, DOI 10.1021/bi801731q; Frank J, 1998, ANN HUM GENET, V62, P225, DOI 10.1046/j.1469-1809.1998.6230225.x; Ged C, 2009, CELL MOL BIOL, V55, P53, DOI 10.1170/T838; HART GJ, 1985, BIOCHEM J, V232, P151, DOI 10.1042/bj2320151; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Knecht E, 2009, CELL MOL LIFE SCI, V66, P2427, DOI 10.1007/s00018-009-0030-6; Lagarde C, 1998, ANN DERMATOL VENER, V125, P114; Mathews MAA, 2001, EMBO J, V20, P5832, DOI 10.1093/emboj/20.21.5832; Puertollano R, 1999, MOL BIOL CELL, V10, P3435, DOI 10.1091/mbc.10.10.3435; Ruggeri B, 2009, ADV PHARMACOL, V57, P91, DOI 10.1016/S1054-3589(08)57003-7; Schenkein D, 2002, CLIN LYMPHOMA, V3, P49, DOI 10.3816/CLM.2002.n.011; Schubert HL, 2008, BIOCHEMISTRY-US, V47, P8648, DOI 10.1021/bi800635y; Schubert HL, 2002, BIOCHEM SOC T, V30, P595, DOI 10.1042/bst0300595; ShoolinginJordan PM, 1997, METHOD ENZYMOL, V281, P327; Tadeo X, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000257; Tezcan I, 1998, BLOOD, V92, P4053, DOI 10.1182/blood.V92.11.4053.423k38_4053_4058; To-Figueras J, 2007, BLOOD CELL MOL DIS, V38, P242, DOI 10.1016/j.bcmd.2006.12.001; TSAI SF, 1987, ANAL BIOCHEM, V166, P120, DOI 10.1016/0003-2697(87)90554-9; XU WM, 1995, J CLIN INVEST, V95, P905, DOI 10.1172/JCI117742	31	16	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13127	13133		10.1074/jbc.M110.205849	http://dx.doi.org/10.1074/jbc.M110.205849			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21343304	Green Published, hybrid			2022-12-27	WOS:000289282200033
J	Cardarelli, F; Serresi, M; Albanese, A; Bizzarri, R; Beltram, F				Cardarelli, Francesco; Serresi, Michela; Albanese, Alberto; Bizzarri, Ranieri; Beltram, Fabio			Quantitative Analysis of Tat Peptide Binding to Import Carriers Reveals Unconventional Nuclear Transport Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ARGININE-RICH MOTIF; NUCLEOCYTOPLASMIC TRANSPORT; LOCALIZATION SIGNALS; ALPHA; PROTEIN; RECOGNITION; BETA; RNA; SEQUENCE	A detailed study of nuclear import mediated by the HIV-1 Tat peptide ((47)YGRKKRRQRRR(57), Tat(RRR)) is reported. Fluorescence-based measurements, calibration of protein concentrations, and binding assays are exploited to address the physicochemical mechanisms of Tat peptide recognition by the classical importin alpha (Imp alpha) and importin beta (Imp beta) receptors both in vitro and in intact cells. We show that TatRRR is an unconventional nuclear localization sequence that binds directly to both Imp alpha and Imp beta carriers in the absence of competitors (in vitro), whereas this property is silenced in the actual cellular environment. In the latter case, Imp alpha/beta-dependent nuclear import can be successfully restored by replacing the "RRR" stretch with "GGG". We apply a recently developed method to determine quantitatively Tat(GGG) affinity for each receptor. Based on these results, we can rationalize previous controversial reports on the Tat peptide and provide coherent guidelines for the design of novel intracellular targeting sequences.	[Cardarelli, Francesco; Serresi, Michela; Bizzarri, Ranieri; Beltram, Fabio] IIT, NEST, Ctr Nanotechnol Innovat, I-56127 Pisa, Italy; [Albanese, Alberto; Bizzarri, Ranieri; Beltram, Fabio] CNR, Scuola Normale Super, Ist Nanosci, I-56127 Pisa, Italy	Istituto Italiano di Tecnologia - IIT; Consiglio Nazionale delle Ricerche (CNR); Istituto Nanoscienze (NANO-CNR); Scuola Normale Superiore di Pisa	Cardarelli, F (corresponding author), IIT, NEST, Ctr Nanotechnol Innovat, Piazza San Silvestro 12, I-56127 Pisa, Italy.	francesco.cardarelli@iit.it; m.serresi@sns.it	Bizzarri, Ranieri/H-1779-2011; Beltram, Fabio/L-9486-2019; Bizzarri, Ranieri/ABH-8343-2020; Beltram, Fabio/F-2920-2013	Bizzarri, Ranieri/0000-0002-8222-2672; Beltram, Fabio/0000-0002-6081-436X; Beltram, Fabio/0000-0002-6081-436X				Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; BERKHOUT B, 1989, CELL, V59, P273, DOI 10.1016/0092-8674(89)90289-4; Brady J, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-69; Brooks H, 2005, ADV DRUG DELIVER REV, V57, P559, DOI 10.1016/j.addr.2004.12.001; CALNAN BJ, 1991, GENE DEV, V5, P201, DOI 10.1101/gad.5.2.201; Cardarelli F, 2008, TRAFFIC, V9, P528, DOI 10.1111/j.1600-0854.2007.00696.x; Cardarelli F, 2007, MOL THER, V15, P1313, DOI 10.1038/sj.mt.6300172; Cardarelli F, 2009, J BIOL CHEM, V284, P36638, DOI 10.1074/jbc.M109.036699; Ciciarello M, 2004, J CELL SCI, V117, P6511, DOI 10.1242/jcs.01569; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; DELLING U, 1991, P NATL ACAD SCI USA, V88, P6234, DOI 10.1073/pnas.88.14.6234; Efthymiadis A, 1998, J BIOL CHEM, V273, P1623, DOI 10.1074/jbc.273.3.1623; Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230; Fanara P, 2000, J BIOL CHEM, V275, P21218, DOI 10.1074/jbc.M002217200; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; GORLICH D, 1995, CURR BIOL, V5, P383, DOI 10.1016/S0960-9822(95)00079-0; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Miyamoto Y, 2002, EMBO J, V21, P5833, DOI 10.1093/emboj/cdf569; Percipalle P, 1999, J MOL BIOL, V292, P263, DOI 10.1006/jmbi.1999.3077; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Serresi M, 2009, ANAL BIOANAL CHEM, V393, P1123, DOI 10.1007/s00216-008-2489-7; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Stauber RH, 1998, VIROLOGY, V252, P126, DOI 10.1006/viro.1998.9400; Truant R, 1999, MOL CELL BIOL, V19, P1210; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; WEEKS KM, 1991, CELL, V66, P577, DOI 10.1016/0092-8674(81)90020-9; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Yang SNY, 2010, J BIOL CHEM, V285, P19935, DOI 10.1074/jbc.M109.079574	29	19	22	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.203083	http://dx.doi.org/10.1074/jbc.M110.203083			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21321119	hybrid, Green Published			2022-12-27	WOS:000289077500043
J	Sato, Y; Endo, H; Okuyama, H; Takeda, T; Iwahashi, H; Imagawa, A; Yamagata, K; Shimomura, I; Inoue, M				Sato, Yoshifumi; Endo, Hiroko; Okuyama, Hiroaki; Takeda, Takaaki; Iwahashi, Hiromi; Imagawa, Akihisa; Yamagata, Kazuya; Shimomura, Iichiro; Inoue, Masahiro			Cellular Hypoxia of Pancreatic beta-Cells Due to High Levels of Oxygen Consumption for Insulin Secretion in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; ENDOPLASMIC-RETICULUM; INTRACELLULAR OXYGEN; GLUCOSE; METABOLISM; SYSTEM; LINE; STABILIZATION; HIF-2-ALPHA; RESPIRATION	Cellular oxygen consumption is a determinant of intracellular oxygen levels. Because of the high demand of mitochondrial respiration during insulin secretion, pancreatic beta-cells consume large amounts of oxygen in a short time period. We examined the effect of insulin secretion on cellular oxygen tension in vitro. We confirmed that Western blotting of pimonidazole adduct was more sensitive than immunostaining for detection of cellular hypoxia in vitro and in vivo. The islets of the diabetic mice but not those of normal mice were hypoxic, especially when a high dose of glucose was loaded. In MIN6 cells, a pancreatic beta-cell line, pimonidazole adduct formation and stabilization of hypoxia-inducible factor- 1 alpha (HIF-1 alpha) were detected under mildly hypoxic conditions. Inhibition of respiration rescued the cells from becoming hypoxic. Glucose stimulation decreased cellular oxygen levels in parallel with increased insulin secretion and mitochondrial respiration. The cellular hypoxia by glucose stimulation was also observed in the isolated islets from mice. The MIN6 cells overexpressing HIF-1 alpha were resistant to becoming hypoxic after glucose stimulation. Thus, glucose-stimulated beta-cells can become hypoxic by oxygen consumption, especially when the oxygen supply is impaired.	[Sato, Yoshifumi; Endo, Hiroko; Okuyama, Hiroaki; Takeda, Takaaki; Inoue, Masahiro] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Biochem, Higashinari Ku, Osaka 5378511, Japan; [Sato, Yoshifumi; Iwahashi, Hiromi; Imagawa, Akihisa; Shimomura, Iichiro] Osaka Univ, Grad Sch Med, Dept Metab Med, Osaka, Japan; [Yamagata, Kazuya] Kumamoto Univ, Fac Life Sci, Dept Med Biochem, Kumamoto 8608556, Japan	Osaka Medical Center for Cancer & Cardiovascular Diseases; Osaka University; Kumamoto University	Inoue, M (corresponding author), Osaka Med Ctr Canc & Cardiovasc Dis, Dept Biochem, Higashinari Ku, 1-3-3 Nakamichi, Osaka 5378511, Japan.	inoue-ma2@mc.pref.osaka.jp	Sato, Yoshifumi/GYQ-7230-2022	Sato, Yoshifumi/0000-0003-0697-1476	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a grant-in-aid for scientific research from the Japan Society for the Promotion of Science.	Aragones J, 2008, NAT GENET, V40, P170, DOI 10.1038/ng.2007.62; Arteel GE, 1998, EUR J BIOCHEM, V253, P743, DOI 10.1046/j.1432-1327.1998.2530743.x; Bracken CP, 2006, J BIOL CHEM, V281, P22575, DOI 10.1074/jbc.M600288200; Brown ST, 2008, AM J PHYSIOL-CELL PH, V294, pC1305, DOI 10.1152/ajpcell.00007.2008; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Cantley J, 2009, J CLIN INVEST, V119, P125, DOI 10.1172/JCI26934; Cheng K, 2010, J CLIN INVEST, V120, P2171, DOI 10.1172/JCI35846; Daunt M, 2006, ENDOCRINOLOGY, V147, P1527, DOI 10.1210/en.2005-0873; Doege K, 2005, BLOOD, V106, P2311, DOI 10.1182/blood-2005-03-1138; Echevarria M, 2007, J BIOL CHEM, V282, P30207, DOI 10.1074/jbc.M702639200; Eliasson L, 2008, J PHYSIOL-LONDON, V586, P3313, DOI 10.1113/jphysiol.2008.155317; Endo H, 2007, CANCER RES, V67, P8095, DOI 10.1158/0008-5472.CAN-06-3389; Fukui K, 2005, CELL METAB, V2, P373, DOI 10.1016/j.cmet.2005.11.003; Gilbert M, 2008, J BIOL CHEM, V283, P24334, DOI 10.1074/jbc.M802097200; GROSS MW, 1995, INT J CANCER, V61, P567, DOI 10.1002/ijc.2910610422; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; Guppy M, 1997, J CELL PHYSIOL, V170, P1, DOI 10.1002/(SICI)1097-4652(199701)170:1<1::AID-JCP1>3.0.CO;2-S; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Hagen T, 2003, SCIENCE, V302, P1975, DOI 10.1126/science.1088805; He FQ, 2008, CANCER RES, V68, P8597, DOI 10.1158/0008-5472.CAN-08-0677; Hochachka P. W., 2002, BIOCH ADAPTATION; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Ivanov II, 2004, BIOCHEM BIOPH RES CO, V322, P746, DOI 10.1016/j.bbrc.2004.07.187; Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132; JANSSON L, 1986, AM J PHYSIOL, V251, pE644, DOI 10.1152/ajpendo.1986.251.6.E644; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Li XQ, 2006, DIABETES, V55, P2965, DOI 10.2337/db06-0733; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; Miao G, 2006, AM J TRANSPLANT, V6, P2636, DOI 10.1111/j.1600-6143.2006.01541.x; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Mukai M, 2005, CANCER RES, V65, P9121, DOI 10.1158/0008-5472.CAN-04-4344; O'Hagan KA, 2009, P NATL ACAD SCI USA, V106, P2188, DOI 10.1073/pnas.0808801106; Okuyama H, 2006, J BIOL CHEM, V281, P15554, DOI 10.1074/jbc.M602003200; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Poitout V, 1996, DIABETES METAB, V22, P7; Puri S, 2009, DIABETES, V58, P433, DOI 10.2337/db08-0749; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; Semenza GL, 2000, GENE DEV, V14, P1983; Semenza GL, 2007, SCIENCE, V318, P62, DOI 10.1126/science.1147949; Soejima A, 1996, J BIOL CHEM, V271, P26194, DOI 10.1074/jbc.271.42.26194; Wang WJ, 2005, J ENDOCRINOL, V185, P445, DOI 10.1677/joe.1.06092; Wiederkehr A, 2006, ENDOCRINOLOGY, V147, P2643, DOI 10.1210/en.2006-0057; Zehetner J, 2008, GENE DEV, V22, P3135, DOI 10.1101/gad.496908; Zhdanov AV, 2008, J BIOL CHEM, V283, P5650, DOI 10.1074/jbc.M706439200	44	113	114	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.194738	http://dx.doi.org/10.1074/jbc.M110.194738			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21296882	Green Published, hybrid			2022-12-27	WOS:000289077500065
J	Zahedi, B; Goo, HJ; Beaulieu, N; Tazmini, G; Kay, RJ; Cornell, RB				Zahedi, Bari; Goo, Hyun-Jung; Beaulieu, Nadine; Tazmini, Ghazaleh; Kay, Robert J.; Cornell, Rosemary B.			Phosphoinositide 3-Kinase Regulates Plasma Membrane Targeting of the Ras-specific Exchange Factor RasGRP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-CELL ANTIGEN; PLECKSTRIN HOMOLOGY DOMAIN; BRUTONS TYROSINE KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHOLIPID-MEMBRANES; DIFFERENTIAL ROLES; BINDING PROPERTIES; AROMATIC RESIDUES; C1 DOMAINS; DIACYLGLYCEROL	Receptor-induced targeting of exchange factors to specific cellular membranes is the predominant mechanism for initiating and compartmentalizing signal transduction by Ras GTPases. The exchange factor RasGRP1 has a C1 domain that binds the lipid diacylglycerol and thus can potentially mediate membrane localization in response to receptors that are coupled to diacylglycerol-generating phospholipase Cs. However, the C1 domain is insufficient for targeting RasGRP1 to the plasma membrane. We found that a basic/hydrophobic cluster of amino acids within the plasma membrane-targeting domain of RasGRP1 is instead responsible for plasma membrane targeting. This basic/hydrophobic cluster binds directly to phospholipid vesicles containing phosphoinositides via electrostatic interactions with polyanionic phosphoinositide headgroups and insertion of a tryptophan into the lipid bilayer. B cell antigen receptor ligation and other stimuli induce plasma membrane targeting of RasGRP1 by activating the phosphoinositide 3-kinase signaling pathway, which generates phosphoinositides within the plasma membrane. Direct detection of phosphoinositides by the basic/hydrophobic cluster of RasGRP1 provides a novel mechanism for coupling and co-compartmentalizing phosphoinositide 3-kinase and Ras signaling and, in coordination with diacylglycerol detection by the C1 domain, gives RasGRP1 the potential to serve as an integrator of converging signals from the phosphoinositide 3-kinase and phospholipase C pathways.	[Zahedi, Bari; Goo, Hyun-Jung; Beaulieu, Nadine; Tazmini, Ghazaleh; Kay, Robert J.] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Zahedi, Bari; Goo, Hyun-Jung; Beaulieu, Nadine; Tazmini, Ghazaleh; Kay, Robert J.] Univ British Columbia, Dept Med Genet, Vancouver, BC V5Z 1L3, Canada; [Cornell, Rosemary B.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	British Columbia Cancer Agency; University of British Columbia; Simon Fraser University	Kay, RJ (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, 601 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	rkay@bccrc.ca; cornell@sfu.ca			Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Canadian Institutes of Health Research (to R. B. C. and R. J. K.).	Arbuzova A, 2000, BBA-BIOMEMBRANES, V1464, P35, DOI 10.1016/S0005-2736(99)00243-6; Bae YS, 2003, MOL PHARMACOL, V63, P1043, DOI 10.1124/mol.63.5.1043; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Beaulieu N, 2007, MOL BIOL CELL, V18, P3156, DOI 10.1091/mbc.E06-10-0932; Bilancio A, 2006, BLOOD, V107, P642, DOI 10.1182/blood-2005-07-3041; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; Buday L, 2008, BBA-REV CANCER, V1786, P178, DOI 10.1016/j.bbcan.2008.05.001; Caesar CEB, 2006, BIOCHEMISTRY-US, V45, P7682, DOI 10.1021/bi052095t; Caloca MJ, 2003, J BIOL CHEM, V278, P33465, DOI 10.1074/jbc.M302807200; Caloca MJ, 2003, EMBO J, V22, P3326, DOI 10.1093/emboj/cdg316; Carrasco S, 2004, MOL BIOL CELL, V15, P2932, DOI 10.1091/mbc.E03-11-0844; Castellano E, 2010, CURR TOP MICROBIOL, V346, P143, DOI 10.1007/82_2010_56; Cheung SMS, 2007, CELL SIGNAL, V19, P902, DOI 10.1016/j.cellsig.2006.10.013; Cho WW, 2001, ANAL BIOCHEM, V296, P153, DOI 10.1006/abio.2001.5225; Cornell RB, 2006, CURR PROTEIN PEPT SC, V7, P539, DOI 10.2174/138920306779025675; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Gambhir A, 2004, BIOPHYS J, V86, P2188, DOI 10.1016/S0006-3495(04)74278-2; GOLD MR, 1994, J IMMUNOL, V152, P42; Golebiewska U, 2008, MOL BIOL CELL, V19, P1663, DOI 10.1091/mbc.E07-12-1208; Groves JT, 2010, NAT STRUCT MOL BIOL, V17, P659, DOI 10.1038/nsmb.1844; Gureasko J, 2008, NAT STRUCT MOL BIOL, V15, P452, DOI 10.1038/nsmb.1418; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hyun T, 2000, BLOOD, V96, P3560, DOI 10.1182/blood.V96.10.3560.h8003560_3560_3568; Janmey PA, 2004, NAT REV MOL CELL BIO, V5, P658, DOI 10.1038/nrm1434; Johnson JE, 1998, BIOCHEMISTRY-US, V37, P9509, DOI 10.1021/bi980340l; Johnson JE, 2007, BIOCHEM J, V406, P223, DOI 10.1042/BJ20070294; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Klinger MB, 2005, ONCOGENE, V24, P2695, DOI 10.1038/sj.onc.1208334; Kool J, 2009, NAT REV CANCER, V9, P389, DOI 10.1038/nrc2647; LAKOWICZ JR, 2006, PRINCIPLES FLUORESCE, pCH8, DOI DOI 10.1007/978-0-387-46312-4; Layer K, 2003, IMMUNITY, V19, P243, DOI 10.1016/S1074-7613(03)00209-7; Lazaridis T, 2005, PROTEINS, V58, P518, DOI 10.1002/prot.20358; LEMMON MA, 1995, P NATL ACAD SCI USA, V92, P10472, DOI 10.1073/pnas.92.23.10472; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Lorenzo PS, 2000, MOL PHARMACOL, V57, P840; Maass K, 2009, J CELL SCI, V122, P625, DOI 10.1242/jcs.036012; Manna D, 2008, J BIOL CHEM, V283, P26047, DOI 10.1074/jbc.M802617200; Marshall AJ, 2002, MOL CELL BIOL, V22, P5479, DOI 10.1128/MCB.22.15.5479-5491.2002; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Mor A, 2007, NAT CELL BIOL, V9, P713, DOI 10.1038/ncb1592; Mulgrew-Nesbitt A, 2006, BBA-MOL CELL BIOL L, V1761, P812, DOI 10.1016/j.bbalip.2006.07.002; Murray D, 1998, BIOCHEMISTRY-US, V37, P2145, DOI 10.1021/bi972012b; Narayan K, 2006, METHODS, V39, P122, DOI 10.1016/j.ymeth.2006.05.006; Nomikos M, 2007, J BIOL CHEM, V282, P16644, DOI 10.1074/jbc.M701072200; Oki-Idouchi CE, 2007, CANCER RES, V67, P276, DOI 10.1158/0008-5472.CAN-06-3080; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Perez de Castro I, 2004, MOL CELL BIOL, V24, P3485, DOI 10.1128/MCB.24.8.3485-3496.2004; Priatel JJ, 2006, J IMMUNOL, V177, P1470, DOI 10.4049/jimmunol.177.3.1470; Qin SF, 2000, P NATL ACAD SCI USA, V97, P7118, DOI 10.1073/pnas.130198197; Roose JP, 2005, MOL CELL BIOL, V25, P4426, DOI 10.1128/MCB.25.11.4426-4441.2005; Sanjuan MA, 2003, J IMMUNOL, V170, P2877, DOI 10.4049/jimmunol.170.6.2877; Skwarek LC, 2007, DEV CELL, V13, P783, DOI 10.1016/j.devcel.2007.10.020; Stahelin RV, 2001, BIOCHEMISTRY-US, V40, P4672, DOI 10.1021/bi0020325; Stone JC, 2006, BIOCHEM SOC T, V34, P858, DOI 10.1042/BST0340858; Sweede M, 2008, BIOCHEMISTRY-US, V47, P13524, DOI 10.1021/bi801037h; Takahashi S, 2007, MOL BIOL CELL, V18, P4945, DOI 10.1091/mbc.E07-07-0676; Tazmini G, 2009, BBA-MOL CELL RES, V1793, P447, DOI 10.1016/j.bbamcr.2008.12.019; Tognon CE, 1998, MOL CELL BIOL, V18, P6995, DOI 10.1128/MCB.18.12.6995; Varnai P, 1999, J BIOL CHEM, V274, P10983, DOI 10.1074/jbc.274.16.10983; Varnai P, 2008, METHODS, V46, P167, DOI 10.1016/j.ymeth.2008.09.019; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002; Watt SA, 2004, BIOCHEM J, V377, P653, DOI 10.1042/BJ20031397; WHITEHEAD I, 1995, MOL CELL BIOL, V15, P704; Zha YY, 2006, NAT IMMUNOL, V7, P1166, DOI 10.1038/ni1394; Zhang WY, 2003, J BIOL CHEM, V278, P21459, DOI 10.1074/jbc.M301652200; Zugaza JL, 2004, ONCOGENE, V23, P5823, DOI 10.1038/sj.onc.1207768	72	14	15	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.189605	http://dx.doi.org/10.1074/jbc.M110.189605			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21285350	hybrid, Green Published			2022-12-27	WOS:000289077500082
J	Amako, Y; Syed, GH; Siddiqui, A				Amako, Yutaka; Syed, Gulam H.; Siddiqui, Aleem			Protein Kinase D Negatively Regulates Hepatitis C Virus Secretion through Phosphorylation of Oxysterol-binding Protein and Ceramide Transfer Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; D-MEDIATED PHOSPHORYLATION; ENDOPLASMIC-RETICULUM; HUMAN HEPATOCYTES; APOLIPOPROTEIN-E; RNA REPLICATION; PLASMA-MEMBRANE; GOLGI-APPARATUS; LIPID DROPLET; CELL MOTILITY	Hepatitis C virus (HCV) RNA replicates its genome on specialized endoplasmic reticulum modified membranes termed membranous web and utilizes lipid droplets for initiating the viral nucleocapsid assembly. HCV maturation and/or the egress pathway requires host sphingolipid synthesis, which occur in the Golgi. Ceramide transfer protein (CERT) and oxysterol-binding protein (OSBP) play a crucial role in sphingolipid biosynthesis. Protein kinase D (PKD), a serine/threonine kinase, is recruited to the trans-Golgi network where it influences vesicular trafficking to the plasma membrane by regulation of several important mediators via phosphorylation. PKD attenuates the function of both CERT and OSBP by phosphorylation at their respective Ser(132) and Ser(240) residues (phosphorylation inhibition). Here, we investigated the functional role of PKD in HCV secretion. Our studies show that HCV gene expression down-regulated PKD activation. PKD depletion by shRNA or inhibition by pharmacological inhibitor Go6976 enhanced HCV secretion. Overexpression of a constitutively active form of PKD suppressed HCV secretion. The suppression by PKD was subverted by the ectopic expression of nonphosphorylatable serine mutant CERT S132A or OSBP S240A. These observations imply that PKD negatively regulates HCV secretion/release by attenuating OSBP and CERT functions by phosphorylation inhibition. This study identifies the key role of the Golgi components in the HCV maturation process.	[Amako, Yutaka; Syed, Gulam H.; Siddiqui, Aleem] Univ Calif San Diego, Dept Med, Div Infect Dis, Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Siddiqui, A (corresponding author), Univ Calif San Diego, Dept Med, Div Infect Dis, Moores Canc Ctr, Stein 409,9500 Gilman Dr,0711, La Jolla, CA 92093 USA.	asiddiqui@ucsd.edu	Syed, Gulam/N-7842-2013	Syed, Gulam/0000-0001-8540-6162	National Institutes of Health [DK077704, AI085087]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI085087, R01AI085087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077704] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK077704 and AI085087 (to A.S.).	Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766; Aizaki H, 2008, J VIROL, V82, P5715, DOI 10.1128/JVI.02530-07; Amako Y, 2009, J VIROL, V83, P9237, DOI 10.1128/JVI.00958-09; Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; Anel AMD, 2005, J CELL BIOL, V169, P83, DOI 10.1083/jcb.200412089; Appel N, 2006, J BIOL CHEM, V281, P9833, DOI 10.1074/jbc.R500026200; AVITABILE E, 1994, J VIROL, V68, P7397, DOI 10.1128/JVI.68.11.7397-7405.1994; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; Bossard C, 2007, J CELL BIOL, V179, P1123, DOI 10.1083/jcb.200703166; Boulant S, 2008, TRAFFIC, V9, P1268, DOI 10.1111/j.1600-0854.2008.00767.x; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07; Di Bisceglie AM, 2002, J VASC INTERV RADIOL, V13, pS169, DOI 10.1016/S1051-0443(07)61783-7; Doppler H, 2005, J BIOL CHEM, V280, P15013, DOI 10.1074/jbc.C400575200; Dubuisson J, 2002, TRENDS CELL BIOL, V12, P517, DOI 10.1016/S0962-8924(02)02383-8; Eiseler T, 2010, J BIOL CHEM, V285, P18672, DOI 10.1074/jbc.M109.093880; Eiseler T, 2009, NAT CELL BIOL, V11, P545, DOI 10.1038/ncb1861; Fugmann T, 2007, J CELL BIOL, V178, P15, DOI 10.1083/jcb.200612017; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Gosert R, 2003, J VIROL, V77, P5487, DOI 10.1128/JVI.77.9.5487-5492.2003; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Gusarova V, 2007, J BIOL CHEM, V282, P19453, DOI 10.1074/jbc.M700475200; Hausser A, 2005, NAT CELL BIOL, V7, P880, DOI 10.1038/ncb1289; Heuer D, 2009, NATURE, V457, P731, DOI 10.1038/nature07578; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Jiang JY, 2009, J VIROL, V83, P12680, DOI 10.1128/JVI.01476-09; Jones CT, 2007, J VIROL, V81, P8374, DOI 10.1128/JVI.00690-07; Jones DM, 2010, J BIOL CHEM, V285, P22732, DOI 10.1074/jbc.R110.133017; Kumagai K, 2005, J BIOL CHEM, V280, P6488, DOI 10.1074/jbc.M409290200; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Maeda Y, 2001, EMBO J, V20, P5982, DOI 10.1093/emboj/20.21.5982; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; Merz A, 2011, J BIOL CHEM, V286, P3018, DOI 10.1074/jbc.M110.175018; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Molina S, 2007, J HEPATOL, V46, P411, DOI 10.1016/j.jhep.2006.09.024; Nhek S, 2010, MOL BIOL CELL, V21, P2327, DOI 10.1091/mbc.E10-02-0090; Nielsen SU, 2006, J VIROL, V80, P2418, DOI 10.1128/JVI.80.5.2418-2428.2006; Owen DM, 2009, VIROLOGY, V394, P99, DOI 10.1016/j.virol.2009.08.037; Pawlotsky JM, 2004, TRENDS MICROBIOL, V12, P96, DOI 10.1016/j.tim.2003.12.005; Penin F, 2004, HEPATOLOGY, V39, P5, DOI 10.1002/hep.20032; Peretti D, 2008, MOL BIOL CELL, V19, P3871, DOI 10.1091/mbc.E08-05-0498; Perry RJ, 2005, BBA-MOL CELL BIOL L, V1734, P220, DOI 10.1016/j.bbalip.2005.04.001; Raya A, 1999, J BIOL CHEM, V274, P12642, DOI 10.1074/jbc.274.18.12642; Remillard-Labrosse Gaudeline, 2009, Commun Integr Biol, V2, P434; Remillard-Labrosse G, 2009, TRAFFIC, V10, P1074, DOI 10.1111/j.1600-0854.2009.00939.x; RIDGWAY ND, 1992, J CELL BIOL, V116, P307, DOI 10.1083/jcb.116.2.307; Rybin VO, 2009, J BIOL CHEM, V284, P2332, DOI 10.1074/jbc.M806381200; Siddiqi SA, 2008, BIOCHEM J, V413, P333, DOI 10.1042/BJ20071469; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; Syed GH, 2010, TRENDS ENDOCRIN MET, V21, P33, DOI 10.1016/j.tem.2009.07.005; Van Lint J, 2002, TRENDS CELL BIOL, V12, P193, DOI 10.1016/S0962-8924(02)02262-6; VANDENHOFF MJB, 1992, NUCLEIC ACIDS RES, V20, P2902, DOI 10.1093/nar/20.11.2902; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Waldron RT, 2003, J BIOL CHEM, V278, P154, DOI 10.1074/jbc.M208075200; Wang PY, 2005, SCIENCE, V307, P1472, DOI 10.1126/science.1107710; Ye J, 2007, PLOS PATHOG, V3, P1017, DOI 10.1371/journal.ppat.0030108; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	57	75	77	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11265	11274		10.1074/jbc.M110.182097	http://dx.doi.org/10.1074/jbc.M110.182097			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21285358	Green Published, hybrid			2022-12-27	WOS:000288797100038
J	Kwan, MD; Sellmyer, MA; Quarto, N; Ho, AM; Wandless, TJ; Longaker, MT				Kwan, Matthew D.; Sellmyer, Mark A.; Quarto, Natalina; Ho, Andrew M.; Wandless, Thomas J.; Longaker, Michael T.			Chemical Control of FGF-2 Release for Promoting Calvarial Healing with Adipose Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; PROTEIN STABILITY; BONE-FORMATION; IN-VIVO; HEPARAN-SULFATE; FRACTURE REPAIR; STROMAL CELLS; TISSUE; DIFFERENTIATION; FACTOR-2	Chemical control of protein secretion using a small molecule approach provides a powerful tool to optimize tissue engineering strategies by regulating the spatial and temporal dimensions that are exposed to a specific protein. We placed fibroblast growth factor 2 (FGF-2) under conditional control of a small molecule and demonstrated greater than 50-fold regulation of FGF-2 release as well as tunability, reversibility, and functionality in vitro. We then applied conditional control of FGF-2 secretion to a cell-based, skeletal tissue engineering construct consisting of adipose stem cells (ASCs) on a biomimetic scaffold to promote bone formation in a murine critical-sized calvarial defect model. ASCs are an easily harvested and abundant source of postnatal multipotent cells and have previously been demonstrated to regenerate bone in critical-sized defects. These results suggest that chemically controlled FGF-2 secretion can significantly increase bone formation by ASCs in vivo. This study represents a novel approach toward refining protein delivery for tissue engineering applications.	[Wandless, Thomas J.] Stanford Univ, Sch Med, Clark Ctr, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Kwan, Matthew D.; Quarto, Natalina; Longaker, Michael T.] Stanford Univ, Sch Med, Hagey Lab Pediat Regenerat Med, Stanford, CA 94305 USA; [Longaker, Michael T.] Stanford Univ, Sch Med, Stanford Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Quarto, Natalina] Univ Naples Federico II, Dept Struct & Funct Biol, I-80138 Naples, Italy	Stanford University; Stanford University; Stanford University; University of Naples Federico II	Wandless, TJ (corresponding author), Stanford Univ, Sch Med, Clark Ctr, Dept Chem & Syst Biol, W350A,318 Campus Dr, Stanford, CA 94305 USA.	wandless@stanford.edu; longaker@stanford.edu			National Institutes of Health through the NIDCR [R01DE019434, RC2DE020771, R21DE019274]; Oak Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC2DE020771, R21DE019274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073046] Funding Source: NIH RePORTER	National Institutes of Health through the NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Oak Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DE019434, RC2DE020771, and R21DE019274 through the NIDCR (to M. T. L.). This work was also supported by the Oak Foundation (to M. T. L.).	ABRAHAM JA, 1986, EMBO J, V5, P2523, DOI 10.1002/j.1460-2075.1986.tb04530.x; Banaszynski LA, 2008, NAT MED, V14, P1123, DOI 10.1038/nm.1754; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Behr B, 2010, BONE, V47, P281, DOI 10.1016/j.bone.2010.05.008; Bueno EM, 2009, NAT REV RHEUMATOL, V5, P685, DOI 10.1038/nrrheum.2009.228; CANALIS E, 1988, J CLIN INVEST, V81, P1572, DOI 10.1172/JCI113490; Cartmell S, 2009, J PHARM SCI-US, V98, P430, DOI 10.1002/jps.21431; Chang PC, 2009, HUM GENE THER, V20, P486, DOI 10.1089/hum.2008.114; Chaudhary LR, 2004, BONE, V34, P402, DOI 10.1016/j.bone.2003.11.014; Chen FM, 2010, BIOMATERIALS, V31, P6279, DOI 10.1016/j.biomaterials.2010.04.053; Chen ST, 2007, J CELL BIOCHEM, V100, P1493, DOI 10.1002/jcb.21136; Chen WJ, 2004, J BONE MINER METAB, V22, P303, DOI 10.1007/s00774-004-0487-6; Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958; Debiais F, 1998, J BONE MINER RES, V13, P645, DOI 10.1359/jbmr.1998.13.4.645; FLAUMENHAFT R, 1990, J CELL BIOL, V111, P1651, DOI 10.1083/jcb.111.4.1651; Guilak F, 2006, J CELL PHYSIOL, V206, P229, DOI 10.1002/jcp.20463; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Iwamoto M, 2010, CHEM BIOL, V17, P981, DOI 10.1016/j.chembiol.2010.07.009; KAWAGUCHI H, 1994, ENDOCRINOLOGY, V135, P774, DOI 10.1210/en.135.2.774; Kodama N, 2009, BONE, V44, P699, DOI 10.1016/j.bone.2008.12.017; Lai CF, 2001, J BIOL CHEM, V276, P14443, DOI 10.1074/jbc.M010021200; Mansukhani A, 2000, J CELL BIOL, V149, P1297, DOI 10.1083/jcb.149.6.1297; Maynard-Smith LA, 2007, J BIOL CHEM, V282, P24866, DOI 10.1074/jbc.M703902200; Montero A, 2000, J CLIN INVEST, V105, P1085, DOI 10.1172/JCI8641; MOSCATELLI D, 1987, J CELL PHYSIOL, V131, P123, DOI 10.1002/jcp.1041310118; Naganawa T, 2006, BIOCHEM BIOPH RES CO, V339, P490, DOI 10.1016/j.bbrc.2005.10.215; Nakamura T, 1998, J BONE MINER RES, V13, P942, DOI 10.1359/jbmr.1998.13.6.942; Ornitz DM, 2000, BIOESSAYS, V22, P108, DOI 10.1002/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M; Quarto N, 2008, GENE, V424, P130, DOI 10.1016/j.gene.2008.07.029; Quarto N, 2008, BONE, V42, P1040, DOI 10.1016/j.bone.2008.01.026; Quarto N, 2006, TISSUE ENG, V12, P1405, DOI 10.1089/ten.2006.12.1405; Radomsky ML, 1998, CLIN ORTHOP RELAT R, pS283; RODAN SB, 1989, CONNECT TISSUE RES, V20, P283, DOI 10.3109/03008208909023898; Tessmar JK, 2007, ADV DRUG DELIVER REV, V59, P274, DOI 10.1016/j.addr.2007.03.020; Wang W, 2010, BIOMATERIALS, V31, P5953, DOI 10.1016/j.biomaterials.2010.04.029; Zandstra PW, 2001, ANNU REV BIOMED ENG, V3, P275, DOI 10.1146/annurev.bioeng.3.1.275; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	39	24	29	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11307	11313		10.1074/jbc.M110.180042	http://dx.doi.org/10.1074/jbc.M110.180042			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21262969	hybrid, Green Published			2022-12-27	WOS:000288797100043
J	Nagpal, K; Plantinga, TS; Sirois, CM; Monks, BG; Latz, E; Netea, MG; Golenbock, DT				Nagpal, Kamalpreet; Plantinga, Theo S.; Sirois, Cherilyn M.; Monks, Brian G.; Latz, Eicke; Netea, Mihai G.; Golenbock, Douglas T.			Natural Loss-of-function Mutation of Myeloid Differentiation Protein 88 Disrupts Its Ability to Form Myddosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; SYSTEMIC-LUPUS-ERYTHEMATOSUS; CONTAINING ADAPTER PROTEIN; TOLL-LIKE-RECEPTORS; SIGNAL-TRANSDUCTION; IMMUNE-RESPONSE; INNATE IMMUNITY; MYD88; POLYMORPHISMS; SUSCEPTIBILITY	Myeloid differentiation protein 88 (MyD88) is a key signaling adapter in Toll-like receptor (TLR) signaling. MyD88 is also one of the most polymorphic adapter proteins. We screened the reported nonsynonymous coding mutations in MyD88 to identify variants with altered function. In reporter assays, a death domain variant, S34Y, was found to be inactive. Importantly, in reconstituted macrophage-like cell lines derived from knockout mice, MyD88 S34Y was severely compromised in its ability to respond to all MyD88-dependent TLR ligands. Unlike wildtype MyD88, S34Y is unable to form distinct foci in the cells but is present diffused in the cytoplasm. We observed that IRAK4 co-localizes with MyD88 in these aggregates, and thus these foci appear to be "Myddosomes." The MyD88 S34Y loss-of-function mutant demonstrates how proper cellular localization of MyD88 to the Myddosome is a feature required for MyD88 function.	[Nagpal, Kamalpreet; Sirois, Cherilyn M.; Monks, Brian G.; Latz, Eicke; Golenbock, Douglas T.] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; [Plantinga, Theo S.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6500 HD Nijmegen, Netherlands; [Plantinga, Theo S.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Inst Infect Inflammat & Immun, NL-6500 HD Nijmegen, Netherlands; [Latz, Eicke] Univ Bonn, Inst Innate Immun, D-53127 Bonn, Germany	University of Massachusetts System; University of Massachusetts Worcester; Radboud University Nijmegen; Radboud University Nijmegen; University of Bonn	Golenbock, DT (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA.	douglas.golenbock@umassmed.edu	Latz, Eicke/H-3951-2014; Monks, Brian/B-8362-2015; Netea, Mihai/N-5155-2014; Plantinga, Theo S./A-6895-2015	Latz, Eicke/0000-0003-1488-5666; Monks, Brian/0000-0003-4008-3093; Plantinga, Theo S./0000-0003-4990-6084; Sirois, Cherilyn M./0000-0002-5472-4288	National Institutes of Health [AI084048, GM54060]; Netherlands Organization for Scientific Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083713, U19AI084048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM054060, R01GM054060] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Institutes of Health Grants AI084048 and GM54060.; Supported by a Vici grant from The Netherlands Organization for Scientific Research.	Akahoshi M, 2008, LUPUS, V17, P568, DOI 10.1177/0961203308089340; De Jager PL, 2006, ARTHRITIS RHEUM, V54, P1279, DOI 10.1002/art.21755; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Ferwerda B, 2009, P NATL ACAD SCI USA, V106, P10272, DOI 10.1073/pnas.0811273106; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; George J, 2011, J BIOL CHEM, V286, P1341, DOI 10.1074/jbc.M110.159996; Gottipati S, 2008, CELL SIGNAL, V20, P269, DOI 10.1016/j.cellsig.2007.08.009; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hamann L, 2006, CLIN CHIM ACTA, V364, P303, DOI 10.1016/j.cca.2005.07.017; HAWLEY RG, 1994, GENE THER, V1, P136; Hawn TR, 2006, J INFECT DIS, V194, P1127, DOI 10.1086/507907; Jaunin F, 1998, EXP CELL RES, V243, P67, DOI 10.1006/excr.1998.4131; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Liu YH, 2010, J IMMUNOL, V185, P3391, DOI 10.4049/jimmunol.0903147; Melo MB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001071; Mockenhaupt FP, 2006, P NATL ACAD SCI USA, V103, P177, DOI 10.1073/pnas.0506803102; Nagpal K, 2009, J BIOL CHEM, V284, P25742, DOI 10.1074/jbc.M109.014886; Nishiya T, 2007, FEBS LETT, V581, P3223, DOI 10.1016/j.febslet.2007.06.008; Roberts ZJ, 2007, J EXP MED, V204, P1559, DOI 10.1084/jem.20061845; Schoenemeyer A, 2005, J BIOL CHEM, V280, P17005, DOI 10.1074/jbc.M412584200; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Sweet CR, 2007, CELL MICROBIOL, V9, P2700, DOI 10.1111/j.1462-5822.2007.00990.x; Texereau J, 2005, CLIN INFECT DIS, V41, pS408, DOI 10.1086/431990; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Yamin TT, 1997, J BIOL CHEM, V272, P21540, DOI 10.1074/jbc.272.34.21540	30	20	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11875	11882		10.1074/jbc.M110.199653	http://dx.doi.org/10.1074/jbc.M110.199653			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21325272	hybrid, Green Published			2022-12-27	WOS:000288797100094
J	Pechtl, IC; Kavanagh, D; Mcintosh, N; Harris, CL; Barlow, PN				Pechtl, Isabell C.; Kavanagh, David; Mcintosh, Nicola; Harris, Claire L.; Barlow, Paul N.			Disease-associated N-terminal Complement Factor H Mutations Perturb Cofactor and Decay-accelerating Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMOLYTIC-UREMIC SYNDROME; DENSE DEPOSIT DISEASE; TRANSLATIONAL MINIREVIEW SERIES; MACULAR DEGENERATION; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; ALTERNATIVE PATHWAY; REGULATORY DOMAINS; ENDOTHELIAL-CELLS; BINDING-AFFINITY; PROTEIN CD46	Many mutations associated with atypical hemolytic uremic syndrome (aHUS) lie within complement control protein modules 19-20 at the C terminus of the complement regulator factor H (FH). This region mediates preferential action of FH on self, as opposed to foreign, membranes and surfaces. Hence, speculation on disease mechanisms has focused on deficiencies in regulation of complement activation on glomerular capillary beds. Here, we investigate the consequences of aHUS-linked mutations (R53H and R78G) within the FH N-terminal complement control protein module that also carries the I62V variation linked to dense-deposit disease and age-related macular degeneration. This module contributes to a four-module C3b-binding site (FH1-4) needed for complement regulation and sufficient for fluid-phase regulatory activity. Recombinant FH1-4(V62) and FH1-4(I62) bind immobilized C3b with similar affinities (K-D = 10-14 mu M), whereas FH1-4(I62) is slightly more effective than FH1-4(V62) as cofactor for factor I-mediated cleavage of C3b. The mutant (R53H) FH1-4(V62) binds to C3b with comparable affinity (K-D similar to 12 mu M) yet has decreased cofactor activities both in fluid phase and on surface-bound C3b, and exhibits only weak decay-accelerating activity for C3 convertase (C3bBb). The other mutant, (R78G) FH1-4(V62), binds poorly to immobilized C3b (K-D > 35 mu M) and is severely functionally compromised, having decreased cofactor and decay-accelerating activities. Our data support causal links between these mutations and disease; they demonstrate that mutations affecting the N-terminal activities of FH, not just those in the C terminus, can predispose to aHUS. These observations reinforce the notion that deficiency in any one of several FH functional properties can contribute to the pathogenesis of this disease.	[Pechtl, Isabell C.; Mcintosh, Nicola; Barlow, Paul N.] Univ Edinburgh, Sch Chem, Edinburgh EH9 3JJ, Midlothian, Scotland; [Pechtl, Isabell C.; Mcintosh, Nicola; Barlow, Paul N.] Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JJ, Midlothian, Scotland; [Kavanagh, David] Univ Newcastle, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Harris, Claire L.] Cardiff Univ, Sch Med, Dept Infect Immun & Biochem, Cardiff CF14 4XN, S Glam, Wales	University of Edinburgh; University of Edinburgh; Newcastle University - UK; Cardiff University	Barlow, PN (corresponding author), Univ Edinburgh, Sch Chem, Joseph Black Chem Bldg,Kings Bldg,W Mains Rd, Edinburgh EH9 3JJ, Midlothian, Scotland.	Paul.Barlow@ed.ac.uk	Kavanagh, David/E-8498-2011; Barlow, Paul N/G-2853-2011	Kavanagh, David/0000-0003-4718-0072; 	Medical Research Council United Kingdom [G0701298]; Wellcome Trust [081179]; Kidney Research United Kingdom; Academy of Medical Sciences; MRC [G0701298] Funding Source: UKRI; Medical Research Council [G0701298] Funding Source: researchfish	Medical Research Council United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Kidney Research United Kingdom(Kidney Research UK (KRUK)); Academy of Medical Sciences(Academy of Medical Sciences (AMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Medical Research Council United Kingdom Grant G0701298 (to C. L. H.), Wellcome Trust Grant 081179 (to P. N. B.), and the Kidney Research United Kingdom and the Academy of Medical Sciences (D. K.).	Appel GB, 2005, J AM SOC NEPHROL, V16, P1392, DOI 10.1681/ASN.2005010078; Blackmore TK, 1998, J IMMUNOL, V160, P3342; Blom AM, 2008, J IMMUNOL, V180, P6385, DOI 10.4049/jimmunol.180.9.6385; Buddles MRH, 2000, AM J HUM GENET, V66, P1721, DOI 10.1086/302877; Buttner-Mainik A., 2011, PLANT BIOTE IN PRESS; Caprioli J, 2003, HUM MOL GENET, V12, P3385, DOI 10.1093/hmg/ddg363; Caprioli J, 2006, BLOOD, V108, P1267, DOI 10.1182/blood-2005-10-007252; de Cordoba SR, 2008, CLIN EXP IMMUNOL, V151, P1, DOI 10.1111/j.1365-2249.2007.03574.x; de Cordoba SR, 2004, MOL IMMUNOL, V41, P355, DOI 10.1016/j.molimm.2004.02.005; de Jorge EG, 2007, P NATL ACAD SCI USA, V104, P240, DOI 10.1073/pnas.0603420103; Dhillon B, 2010, INVEST OPHTH VIS SCI, V51, P5858, DOI 10.1167/iovs.09-5124; Dragon-Durey MA, 2005, J AM SOC NEPHROL, V16, P555, DOI 10.1681/ASN.2004050380; Dragon-Durey MA, 2004, J AM SOC NEPHROL, V15, P787, DOI 10.1097/01.ASN.0000115702.28859.A7; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Ferreira VP, 2009, J IMMUNOL, V182, P7009, DOI 10.4049/jimmunol.0804031; Fremeaux-Bacchi V, 2006, J AM SOC NEPHROL, V17, P2017, DOI 10.1681/ASN.2005101051; Fremeaux-Bacchi V, 2008, BLOOD, V112, P4948, DOI 10.1182/blood-2008-01-133702; GORDON DL, 1995, J IMMUNOL, V155, P348; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Harris CL, 2007, J IMMUNOL, V178, P352, DOI 10.4049/jimmunol.178.1.352; Hegasy GA, 2002, AM J PATHOL, V161, P2027, DOI 10.1016/S0002-9440(10)64481-1; Herbert AP, 2007, J BIOL CHEM, V282, P18960, DOI 10.1074/jbc.M609636200; Hocking HG, 2008, J BIOL CHEM, V283, P9475, DOI 10.1074/jbc.M709587200; Jokiranta TS, 2006, EMBO J, V25, P1784, DOI 10.1038/sj.emboj.7601052; Jokiranta TS, 2005, AM J PATHOL, V167, P1173, DOI 10.1016/S0002-9440(10)61205-9; Jozsi M, 2007, BLOOD, V110, P1516, DOI 10.1182/blood-2007-02-071472; Jozsi M, 2006, J AM SOC NEPHROL, V17, P170, DOI 10.1681/ASN.2005080868; Kavanagh D, 2005, J AM SOC NEPHROL, V16, P2150, DOI 10.1681/ASN.2005010103; Kavanagh D, 2010, PEDIATR NEPHROL, V25, P2431, DOI 10.1007/s00467-010-1555-5; Kirkitadze MD, 2001, IMMUNOL REV, V180, P146, DOI 10.1034/j.1600-065X.2001.1800113.x; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; KUHN S, 1995, J IMMUNOL, V155, P5663; Lehtinen MJ, 2009, J BIOL CHEM, V284, P15650, DOI 10.1074/jbc.M900814200; Manuelian T, 2003, J CLIN INVEST, V111, P1181, DOI 10.1172/JCI200316651; Martinez-Barricarte R, 2010, J CLIN INVEST, V120, P3702, DOI 10.1172/JCI43343; Moore I, 2010, BLOOD, V115, P379, DOI 10.1182/blood-2009-05-221549; Mullins RF, 2001, EYE, V15, P390, DOI 10.1038/eye.2001.142; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Neumann HPH, 2003, J MED GENET, V40, P676, DOI 10.1136/jmg.40.9.676; Ormsby RJ, 2006, MOL IMMUNOL, V43, P1624, DOI 10.1016/j.molimm.2005.09.012; PANGBURN MK, 1977, J EXP MED, V146, P257, DOI 10.1084/jem.146.1.257; Pangburn MK, 2000, IMMUNOPHARMACOLOGY, V49, P149, DOI 10.1016/S0162-3109(00)80300-8; Perez-Caballero D, 2001, AM J HUM GENET, V68, P478, DOI 10.1086/318201; Pickering MC, 2007, J EXP MED, V204, P1249, DOI 10.1084/jem.20070301; Pickering MC, 2002, NAT GENET, V31, P424, DOI 10.1038/ng912; Prosser BE, 2007, J EXP MED, V204, P2277, DOI 10.1084/jem.20071069; REID KBM, 1989, IMMUNOL TODAY, V10, P177, DOI 10.1016/0167-5699(89)90317-4; Richards A, 2003, P NATL ACAD SCI USA, V100, P12966, DOI 10.1073/pnas.2135497100; Richards A, 2001, AM J HUM GENET, V68, P485, DOI 10.1086/318203; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; RIPOCHE J, 1988, BIOCHEM J, V249, P593, DOI 10.1042/bj2490593; Sahu A, 1998, J IMMUNOL, V160, P5596; Sanchez-Corral P, 2002, AM J HUM GENET, V71, P1285, DOI 10.1086/344515; Saunders RE, 2007, HUM MUTAT, V28, P222, DOI 10.1002/humu.20435; Schmidt CQ, 2008, CLIN EXP IMMUNOL, V151, P14, DOI 10.1111/j.1365-2249.2007.03553.x; Schmidt CQ, 2008, J IMMUNOL, V181, P2610, DOI 10.4049/jimmunol.181.4.2610; SHARMA AK, 1994, GENE, V143, P301, DOI 10.1016/0378-1119(94)90116-3; Sharma AK, 1996, P NATL ACAD SCI USA, V93, P10996, DOI 10.1073/pnas.93.20.10996; Tortajada A, 2009, HUM MOL GENET, V18, P3452, DOI 10.1093/hmg/ddp289; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Warwicker P, 1998, KIDNEY INT, V53, P836, DOI 10.1111/j.1523-1755.1998.00824.x; Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755	64	64	65	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11082	11090		10.1074/jbc.M110.211839	http://dx.doi.org/10.1074/jbc.M110.211839			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21270465	hybrid, Green Published			2022-12-27	WOS:000288797100019
J	Vo, MN; Yang, XL; Schimmel, P				Vo, My-Nuong; Yang, Xiang-Lei; Schimmel, Paul			Dissociating Quaternary Structure Regulates Cell-signaling Functions of a Secreted Human tRNA Synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOKINE RECEPTORS CXCR1; INDUCED INTERNALIZATION; CYTOKINE ACTIVITIES; DISEASE; ACTIVATION; DIMER; AMINOACYLATION; INTERMEDIATE; ANGIOGENESIS; TRANSLATION	Many tRNA synthetases are homodimers that are catalytically inactive as monomers. An example is the 528-amino acid human tyrosyl-tRNA synthetase, which is made up of an N-terminal catalytic unit (TyrRS(Mini)) and a 164-amino acid C-domain. Although native TyrRS has no known cytokine functions, natural proteolysis of secreted TyrRS releases TyrRS(Mini), which not only has the same aminoacylation activity as native TyrRS but also has strong activity for stimulating migration of polymorphonuclear leukocytes. The migration-stimulating activity is dependent on an ELR tripeptide motif, similar to that in CXC cytokines like IL-8, and also has the familiar bell-shaped concentration dependence seen for CXC cytokines. Here we show that in contrast to IL-8, where the bell-shaped dependence arises from the effects of CXCR1/2 receptor internalization, TyrRS(Mini) does not induce internalization of CXCR1/2. A rationally designed non-associating monomer and a non-dissociating dimer were constructed. With these constructs, the bell-shaped concentration dependence of leukocyte migration was shown to arise from the agonist (for migration) activity of the catalytically inactive monomer and the antagonist activity of the catalytically active dimer. Thus, the dissociating quaternary structure of TyrRS(Mini) regulates two opposing cytokine activities and suggests the possibility of dissociating quaternary structures regulating novel functions of other tRNA synthetases.	Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Yang, XL (corresponding author), BCC379,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	xlyang@scripps.edu; schimmel@scripps.edu	Yang, Xiang-Lei/AAR-7107-2020	Yang, Xiang-Lei/0000-0003-2554-084X	National Institutes of Health from the NCI [CA92577]; National Foundation for Cancer Research; National Institutes of Health [GM23562]; NATIONAL CANCER INSTITUTE [R01CA092577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023562] Funding Source: NIH RePORTER	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Foundation for Cancer Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA92577 (from the NCI) and GM23562 (to P. S.). This work was also supported by a fellowship from the National Foundation for Cancer Research.	Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Antonellis A, 2008, ANNU REV GENOM HUM G, V9, P87, DOI 10.1146/annurev.genom.9.081307.164204; Bonnefond L, 2005, BIOCHIMIE, V87, P873, DOI 10.1016/j.biochi.2005.03.008; BRICK P, 1989, J MOL BIOL, V208, P83, DOI 10.1016/0022-2836(89)90090-9; Chong YE, 2008, J BIOL CHEM, V283, P30073, DOI 10.1074/jbc.M805943200; CLARKLEWIS I, 1995, J LEUKOCYTE BIOL, V57, P703, DOI 10.1002/jlb.57.5.703; Das ST, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011754; Ewalt KL, 2002, BIOCHEMISTRY-US, V41, P13344, DOI 10.1021/bi020537k; Feniger-Barish R, 1999, CYTOKINE, V11, P996, DOI 10.1006/cyto.1999.0510; Guo M, 2010, J PHYS CHEM B, V114, P16273, DOI 10.1021/jp1082517; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; JONES DH, 1985, BIOCHEMISTRY-US, V24, P5852, DOI 10.1021/bi00342a024; Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727; Kapoor M, 2009, CHEM BIOL, V16, P531, DOI 10.1016/j.chembiol.2009.03.006; Levine SM, 2003, CURR OPIN RHEUMATOL, V15, P708, DOI 10.1097/00002281-200311000-00005; Liu JM, 2002, BIOCHEMISTRY-US, V41, P14232, DOI 10.1021/bi0205395; Mukhopadhyay R, 2009, TRENDS BIOCHEM SCI, V34, P324, DOI 10.1016/j.tibs.2009.03.004; Nangle LA, 2007, P NATL ACAD SCI USA, V104, P11239, DOI 10.1073/pnas.0705055104; Nasser MW, 2009, J IMMUNOL, V183, P3425, DOI 10.4049/jimmunol.0900305; Otani A, 2002, P NATL ACAD SCI USA, V99, P178, DOI 10.1073/pnas.012601899; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; Park SG, 2005, P NATL ACAD SCI USA, V102, P6356, DOI 10.1073/pnas.0500226102; Paukstelis PJ, 2008, NATURE, V451, P94, DOI 10.1038/nature06413; Richardson RM, 1998, J BIOL CHEM, V273, P23830, DOI 10.1074/jbc.273.37.23830; Rose JJ, 2004, J BIOL CHEM, V279, P24372, DOI 10.1074/jbc.M401364200; SALDANHA RJ, 1995, BIOCHEMISTRY-US, V34, P1275, DOI 10.1021/bi00004a022; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; Schimmel P, 2008, PROTEIN SCI, V17, P1643, DOI 10.1110/ps.037242.108; STARZYK RM, 1987, SCIENCE, V237, P1614, DOI 10.1126/science.3306924; Wakasugi K, 2002, J BIOL CHEM, V277, P20124, DOI 10.1074/jbc.C200126200; Wakasugi K, 1999, J BIOL CHEM, V274, P23155, DOI 10.1074/jbc.274.33.23155; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; WARD WHJ, 1988, BIOCHEMISTRY-US, V27, P5525, DOI 10.1021/bi00415a021; Yang XL, 2007, CHEM BIOL, V14, P1323, DOI 10.1016/j.chembiol.2007.10.016; Yang XL, 2002, P NATL ACAD SCI USA, V99, P15369, DOI 10.1073/pnas.242611799; Yannay-Cohen N, 2009, MOL CELL, V34, P603, DOI 10.1016/j.molcel.2009.05.019; Yaremchuk A, 2002, EMBO J, V21, P3829, DOI 10.1093/emboj/cdf373	38	20	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11563	11568		10.1074/jbc.C110.213876	http://dx.doi.org/10.1074/jbc.C110.213876			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21310955	Green Published, hybrid			2022-12-27	WOS:000288797100066
J	Li, L; Weinreb, V; Francklyn, C; Carter, CW				Li, Li; Weinreb, Violetta; Francklyn, Christopher; Carter, Charles W., Jr.			Histidyl-tRNA Synthetase Urzymes CLASS I AND II AMINOACYL tRNA SYNTHETASE URZYMES HAVE COMPARABLE CATALYTIC ACTIVITIES FOR COGNATE AMINO ACID ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBONUCLEIC-ACID SYNTHETASE; ESCHERICHIA-COLI; SUBSTRATE-BINDING; EVOLUTION; RECEPTOR; ENZYME; DISCRIMINATION; DESIGN; DOMAIN	Four minimal (119 - 145 residue) active site fragments of Escherichia coli Class II histidyl-tRNA synthetase were constructed, expressed as maltose-binding protein fusions, and assayed for histidine activation as fusion proteins and after TEV cleavage, using the (PPi)-P-32 exchange assay. All contain conserved Motifs 1 and 2. Two contain an N-terminal extension of Motif 1 and two contain Motif 3. Five experimental results argue strongly for the authenticity of the observed catalytic activities: (i) active site titration experiments showing high (similar to 0.1-0.55) fractions of active molecules, (ii) release of cryptic activity by TEV cleavage of the fusion proteins, (iii) reduced activity associated with an active site mutation, (iv) quantitative attribution of increased catalytic activity to the intrinsic effects of Motif 3, the N-terminal extension and their synergistic effect, and (v) significantly altered K-m values for both ATP and histidine substrates. It is therefore plausible that neither the insertion domain nor Motif 3 were essential for catalytic activity in the earliest Class II aminoacyl-tRNA synthetases. The mean rate enhancement of all four cleaved constructs is similar to 10(9) times that of the estimated uncatalyzed rate. As observed for the tryptophanyl-tRNA synthetase (TrpRS) Urzyme, these fragments bind ATP tightly but have reduced affinity for cognate amino acids. These fragments thus likely represent Urzymes (Ur = primitive, original, earliest + enzyme) comparable in size and catalytic activity and coded by sequences proposed to be antisense to that coding the previously described Class I TrpRS Urzyme. Their catalytic activities provide metrics for experimental recapitulation of very early evolutionary events.	[Li, Li; Weinreb, Violetta; Carter, Charles W., Jr.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Francklyn, Christopher] Univ Vermont, Dept Biochem, Burlington, VT 05405 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Vermont	Carter, CW (corresponding author), Univ N Carolina, Dept Biochem & Biophys, CB 7260, Chapel Hill, NC 27599 USA.	carter@med.unc.edu			National Institutes of Health [GM078227]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054899, R01GM078227] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM078227.	Arnez JG, 1997, P NATL ACAD SCI USA, V94, P7144, DOI 10.1073/pnas.94.14.7144; ARNEZ JG, 1995, EMBO J, V14, P4143, DOI 10.1002/j.1460-2075.1995.tb00088.x; Augustine J, 1997, BIOCHEMISTRY-US, V36, P3473, DOI 10.1021/bi962395y; BENNER SA, 1989, CHEM REV, V89, P789, DOI 10.1021/cr00094a004; Benner Steven A., 2007, V75, P1; BOREL F, 1994, NUCLEIC ACIDS RES, V22, P2963, DOI 10.1093/nar/22.15.2963; Bridgham JT, 2009, NATURE, V461, P515, DOI 10.1038/nature08249; Bridgham JT, 2006, SCIENCE, V312, P97, DOI 10.1126/science.1123348; Bullock TL, 2008, P NATL ACAD SCI USA, V105, P7428, DOI 10.1073/pnas.0711812105; Bullock TL, 2003, J MOL BIOL, V328, P395, DOI 10.1016/S0022-2836(03)00305-X; Cleland W. W, 1970, ENZYMES, V2, P1; Cleland WW, 1999, METHOD ENZYMOL, V308, P3; CUSACK S, 1990, NATURE, V347, P249, DOI 10.1038/347249a0; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P1, DOI 10.1021/bi00672a001; FERSHT AR, 1974, PROC R SOC SER B-BIO, V187, P397, DOI 10.1098/rspb.1974.0084; Francklyn CS, 2008, METHODS, V44, P100, DOI 10.1016/j.ymeth.2007.09.007; Gaucher EA, 2008, NATURE, V451, P704, DOI 10.1038/nature06510; Gernert D, 2007, J SCI EXP, V21, P135; Guth EC, 2007, MOL CELL, V25, P531, DOI 10.1016/j.molcel.2007.01.015; JOSEPH DR, 1971, J BIOL CHEM, V246, P7610; JOSEPH DR, 1971, J BIOL CHEM, V246, P7602; KAMTEKAR S, 1993, SCIENCE, V262, P1680, DOI 10.1126/science.8259512; Liu HN, 2008, J PHYS CHEM B, V112, P16874, DOI 10.1021/jp807104b; Moffet DA, 2003, BIOPHYS CHEM, V105, P231, DOI 10.1016/S0301-4622(03)00072-3; Patel SC, 2009, PROTEIN SCI, V18, P1388, DOI 10.1002/pro.147; PHAM YB, 2009, THESIS U N CAROLINA, P95; Pham Y, 2007, MOL CELL, V25, P851, DOI 10.1016/j.molcel.2007.02.010; Pham Y, 2010, J BIOL CHEM, V285, P38590, DOI 10.1074/jbc.M110.136911; RODIN SN, 1995, ORIGINS LIFE EVOL B, V25, P565, DOI 10.1007/BF01582025; *SAS I, 2006, JMP VERS 6 0; Schall OF, 1998, J ORG CHEM, V63, P8661, DOI 10.1021/jo971874f; SCHWOB E, 1993, EMBO J, V12, P5201, DOI 10.1002/j.1460-2075.1993.tb06215.x; Sherlin LD, 2003, STRUCTURE, V11, P591, DOI 10.1016/S0969-2126(03)00074-1; Sievers A, 2004, P NATL ACAD SCI USA, V101, P7897, DOI 10.1073/pnas.0402488101; STACKHOUSE J, 1990, FEBS LETT, V262, P104, DOI 10.1016/0014-5793(90)80164-E; Stockbridge RB, 2009, J BIOL CHEM, V284, P22747, DOI 10.1074/jbc.M109.017806; Thornton JW, 2003, SCIENCE, V301, P1714, DOI 10.1126/science.1086185; Thornton JW, 2001, P NATL ACAD SCI USA, V98, P5671, DOI 10.1073/pnas.091553298; Thornton JW, 2004, NAT REV GENET, V5, P366, DOI 10.1038/nrg1324	40	33	34	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10387	10395		10.1074/jbc.M110.198929	http://dx.doi.org/10.1074/jbc.M110.198929			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21270472	Green Published, hybrid			2022-12-27	WOS:000288547000055
J	Yuan, JS; Chen, JJ				Yuan, Jingsong; Chen, Junjie			The Role of the Human SWI5-MEI5 Complex in Homologous Recombination Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; DNA-REPAIR; SACCHAROMYCES-CEREVISIAE; PROTEIN COMPLEX; CELL-CYCLE; BRCA2; RAD51; YEAST; DMC1; RECA	The Swi5-Mei5 complex and its homologues are involved in specialized recombination pathways in budding and fission yeasts. Although the fission yeast homologue Swi5-Sfr1 is critical for homologous recombination repair, the budding yeast counterpart Sae3-Mei5 is meiosis-specific, interacts with Dmc1, and promotes assembly of Dmc1 on meiotic chromosomes. Here, we identify and characterize the human SWI5-MEI5 (C9orf119-C10orf78) complex. We showed that SWI5 and MEI5 form a stable complex in vitro and in vivo. The C-terminal Swi5 domain of SWI5 and the middle coiled-coil region of MEI5 dictate this conserved interaction. In addition, SWI5-MEI5 directly interacts with RAD51 in vitro. Depletion of SWI5 or MEI5 in human cells causes defects in homologous recombination repair. Finally, SWI5- or MEI5-depleted cells display enhanced sensitivity to ionizing radiation, consistent with the role of this complex in HR repair. Our results suggest that human SWI5-MEI5 has an evolutionarily conserved function in homologous recombination repair.	[Yuan, Jingsong; Chen, Junjie] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Chen, JJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA.	jchen8@mdanderson.org	Yuan, Jingsong/G-4527-2011		National Institutes of Health; Department of Defense [W81XWH-05-1-0470]; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA089239] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from the National Institutes of Health (to J. C.).; Recipient of an Era of Hope Scholar award from the Department of Defense (W81XWH-05-1-0470) and a member of M. D. Anderson Cancer Center (CA016672). To whom correspondence should be addressed. Tel.: 713-792-4863; Fax: 713-745-6141; E-mail: jchen8@mdanderson.org.	Akamatsu Y, 2003, P NATL ACAD SCI USA, V100, P15770, DOI 10.1073/pnas.2632890100; Akamatsu Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001160; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Deans B, 2003, CANCER RES, V63, P8181; Ellermeier C, 2004, GENETICS, V168, P1891, DOI 10.1534/genetics.104.034280; Ferrari SR, 2009, J BIOL CHEM, V284, P11766, DOI 10.1074/jbc.C900023200; Hayase A, 2004, CELL, V119, P927, DOI 10.1016/j.cell.2004.10.031; Huang J, 2009, NAT CELL BIOL, V11, P592, DOI 10.1038/ncb1865; Jeggo P, 2007, ONCOGENE, V26, P7717, DOI 10.1038/sj.onc.1210868; Jia ST, 2004, CELL, V119, P469, DOI 10.1016/j.cell.2004.10.020; Lord CJ, 2007, NAT STRUCT MOL BIOL, V14, P461, DOI 10.1038/nsmb0607-461; McKee AHZ, 1997, GENETICS, V146, P817; McKinnon PJ, 2007, ANNU REV GENOM HUM G, V8, P37, DOI 10.1146/annurev.genom.7.080505.115648; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; OGAWA T, 1993, SCIENCE, V259, P1896, DOI 10.1126/science.8456314; Okada T, 2005, CURR BIOL, V15, pR200, DOI 10.1016/j.cub.2005.03.009; Pellegrini L, 2004, TRENDS BIOCHEM SCI, V29, P310, DOI 10.1016/j.tibs.2004.04.009; Richardson C, 1998, GENE DEV, V12, P3831, DOI 10.1101/gad.12.24.3831; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; SUNG P, 1995, CELL, V82, P453, DOI 10.1016/0092-8674(95)90434-4; Sy SMH, 2009, P NATL ACAD SCI USA, V106, P7155, DOI 10.1073/pnas.0811159106; Takata M, 2001, MOL CELL BIOL, V21, P2858, DOI 10.1128/MCB.21.8.2858-2866.2001; Thorslund T, 2007, ONCOGENE, V26, P7720, DOI 10.1038/sj.onc.1210870; Tsubouchi H, 2004, GENETICS, V168, P1219, DOI 10.1534/genetics.103.025700; Vaz F, 2010, NAT GENET, V42, P406, DOI 10.1038/ng.570; Weinstock DM, 2006, METHOD ENZYMOL, V409, P524, DOI 10.1016/S0076-6879(05)09031-2; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Yuan JS, 2010, J BIOL CHEM, V285, P1097, DOI 10.1074/jbc.M109.078436; Yuan JS, 2009, J BIOL CHEM, V284, P31746, DOI 10.1074/jbc.M109.023424; Yuan JS, 2009, GENE DEV, V23, P2394, DOI 10.1101/gad.1836409; Zhang F, 2009, CURR BIOL, V19, P524, DOI 10.1016/j.cub.2009.02.018	32	30	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9888	9893		10.1074/jbc.M110.207290	http://dx.doi.org/10.1074/jbc.M110.207290			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21252223	Green Published, hybrid			2022-12-27	WOS:000288247700112
J	Qi, XQ; Loiseau, F; Chan, WL; Yan, YH; Wei, ZQ; Milroy, LG; Myers, RM; Ley, SV; Read, RJ; Carrell, RW; Zhou, AW				Qi, Xiaoqiang; Loiseau, Francois; Chan, Wee Lee; Yan, Yahui; Wei, Zhenquan; Milroy, Lech-Gustav; Myers, Rebecca M.; Ley, Steven V.; Read, Randy J.; Carrell, Robin W.; Zhou, Aiwu			Allosteric Modulation of Hormone Release from Thyroxine and Corticosteroid-binding Globulins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; MECHANISM; ANTITHROMBIN; HEPARIN; ALPHA-1-ANTITRYPSIN; ACTIVATION; SERPINS; MODEL; SUPERFAMILY; TRANSITION	The release of hormones from thyroxine-binding globulin (TBG) and corticosteroid-binding globulin (CBG) is regulated by movement of the reactive center loop in and out of the beta-sheet A of the molecule. To investigate how these changes are transmitted to the hormone-binding site, we developed a sensitive assay using a synthesized thyroxine fluorophore and solved the crystal structures of reactive loop cleaved TBG together with its complexes with thyroxine, the thyroxine fluorophores, furosemide, and mefenamic acid. Cleavage of the reactive loop results in its complete insertion into the beta-sheet A and a substantial but incomplete decrease in binding affinity in both TBG and CBG. We show here that the direct interaction between residue Thr(342) of the reactive loop and Tyr(241) of the hormone binding site contributes to thyroxine binding and release following reactive loop insertion. However, a much larger effect occurs allosterically due to stretching of the connecting loop to the top of the D helix (hD), as confirmed in TBG with shortening of the loop by three residues, making it insensitive to the S-to-R transition. The transmission of the changes in the hD loop to the binding pocket is seen to involve coherent movements in the s2/3B loop linked to the hD loop by Lys(243), which is, in turn, linked to the s4/5B loop, flanking the thyroxine-binding site, by Arg(378). Overall, the coordinated movements of the reactive loop, hD, and the hormone binding site allow the allosteric regulation of hormone release, as with the modulation demonstrated here in response to changes in temperature.	[Zhou, Aiwu] Univ Cambridge, Cambridge Inst Med Res, Wellcome Trust, Dept Haematol, Cambridge CB2 0XY, England; [Loiseau, Francois; Milroy, Lech-Gustav; Myers, Rebecca M.; Ley, Steven V.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Qi, Xiaoqiang] Nanjing Univ, Dept Biochem, Nanjing 210098, Peoples R China	University of Cambridge; Wellcome Trust Sanger Institute; University of Cambridge; Nanjing University	Zhou, AW (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Wellcome Trust, Dept Haematol, MRC Bldg,Hills Rd, Cambridge CB2 0XY, England.	awz20@cam.ac.uk	Read, Randy J/L-1418-2013; Ley, Steven V/O-7712-2016	Read, Randy J/0000-0001-8273-0047; Ley, Steven V/0000-0002-7816-0042; Chan, Wee Lee/0000-0001-9672-3841; ZHOU, Aiwu/0000-0002-2555-5091	British Heart Foundation; Wellcome Trust; Isaac Newton Trust of the University of Cambridge; Diamond Light Source	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Isaac Newton Trust of the University of Cambridge; Diamond Light Source	This work was supported by the British Heart Foundation, the Wellcome Trust, the Isaac Newton Trust of the University of Cambridge, and the Diamond Light Source.	Adamczyk M, 1998, BIOCONJUGATE CHEM, V9, P23, DOI 10.1021/bc9701353; Beauchamp NJ, 1998, BLOOD, V92, P2696, DOI 10.1182/blood.V92.8.2696.420a43_2696_2706; Cameron A, 2010, J CLIN ENDOCR METAB, V95, P4689, DOI 10.1210/jc.2010-0942; CARRELL RW, 1985, NATURE, V317, P730, DOI 10.1038/317730a0; Clark A.R., 1996, ENZYMOLOGY LABFAX, P199; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EVANS PR, 1993, P CCP4 STUD WEEK DAT; FLINK IL, 1986, P NATL ACAD SCI USA, V83, P7708, DOI 10.1073/pnas.83.20.7708; Grasberger H, 2002, BIOCHEM J, V365, P311, DOI 10.1042/BJ20020014; HAMMOND GL, 1990, J CLIN ENDOCR METAB, V71, P34, DOI 10.1210/jcem-71-1-34; HAMMOND GL, 1987, P NATL ACAD SCI USA, V84, P5153, DOI 10.1073/pnas.84.15.5153; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; Huntington JA, 1999, J MOL BIOL, V293, P449, DOI 10.1006/jmbi.1999.3184; Huntington JA, 2006, TRENDS BIOCHEM SCI, V31, P427, DOI 10.1016/j.tibs.2006.06.005; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Janssen OE, 2002, J CLIN ENDOCR METAB, V87, P1217, DOI 10.1210/jc.87.3.1217; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; Johnson DJD, 2003, BIOCHEMISTRY-US, V42, P8712, DOI 10.1021/bi034524y; KABSCH W, 1983, FEBS LETT, V155, P179, DOI 10.1016/0014-5793(82)80597-8; Klieber MA, 2007, J BIOL CHEM, V282, P29594, DOI 10.1074/jbc.M705014200; Leslie AGW, 1992, JOINT CCP4 ESF EACMB; Lin HY, 2010, MOL CELL ENDOCRINOL, V316, P3, DOI 10.1016/j.mce.2009.06.015; Lin HY, 2009, J BIOL CHEM, V284, P884, DOI 10.1074/jbc.M807376200; LOEBERMANN H, 1984, J MOL BIOL, V177, P531, DOI 10.1016/0022-2836(84)90298-5; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; OWEN MC, 1983, NEW ENGL J MED, V309, P694, DOI 10.1056/NEJM198309223091203; PEMBERTON PA, 1988, NATURE, V336, P257, DOI 10.1038/336257a0; Perogamvros I, 2010, J CLIN ENDOCR METAB, V95, pE142, DOI 10.1210/jc.2010-0746; Refetoff S, 1996, HORM RES, V45, P128, DOI 10.1159/000184775; ROSS HA, 1992, CLIN CHEM, V38, P880; Schedin-Weiss S, 2010, ARCH BIOCHEM BIOPHYS, V504, P169, DOI 10.1016/j.abb.2010.08.021; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; STOCKIGT JR, 1985, J CLIN ENDOCR METAB, V60, P1025, DOI 10.1210/jcem-60-5-1025; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Zhou AW, 2008, J MOL BIOL, V380, P244, DOI 10.1016/j.jmb.2008.05.012; Zhou AW, 2006, P NATL ACAD SCI USA, V103, P13321, DOI 10.1073/pnas.0604080103	36	38	38	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.171082	http://dx.doi.org/10.1074/jbc.M110.171082			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21325280	Green Published, hybrid			2022-12-27	WOS:000290022800056
J	Chiang, NY; Hsiao, CC; Huang, YS; Chen, HY; Hsieh, IJ; Chang, GW; Lin, HH				Chiang, Nien-Yi; Hsiao, Cheng-Chih; Huang, Yi-Shu; Chen, Hsin-Yi; Hsieh, I-Ju; Chang, Gin-Wen; Lin, Hsi-Hsien			Disease-associated GPR56 Mutations Cause Bilateral Frontoparietal Polymicrogyria via Multiple Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; CELL-ADHESION; TUMOR-GROWTH; EXPRESSION; ROLES; CLEAVAGE; MOTIF; GPCR; TG2	Loss-of-function mutations in the gene encoding G protein-coupled receptor 56 (GPR56) lead to bilateral frontoparietal polymicrogyria (BFPP), an autosomal recessive disorder affecting brain development. The GPR56 receptor is a member of the adhesion-GPCR family characterized by the chimeric composition of a long ectodomain (ECD), a GPCR proteolysis site (GPS), and a seven-pass transmembrane (7TM) moiety. Interestingly, all identified BFPP-associated missense mutations are located within the extracellular region of GPR56 including the ECD, GPS, and the extracellular loops of 7TM. In the present study, a detailed molecular and functional analysis of the wild-type GPR56 and BFPP-associated point mutants shows that individual GPR56 mutants most likely cause BFPP via different combination of multiple mechanisms. These include reduced surface receptor expression, loss of GPS proteolysis, reduced receptor shedding, inability to interact with a novel protein ligand, and differential distribution of the 7TM moiety in lipid rafts. These results provide novel insights into the cellular functions of GPR56 receptor and reveal molecular mechanisms whereby GPR56 mutations induce BFPP.	[Chiang, Nien-Yi; Huang, Yi-Shu; Hsieh, I-Ju] Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Tao Yuan, Taiwan; [Hsiao, Cheng-Chih; Chen, Hsin-Yi; Chang, Gin-Wen; Lin, Hsi-Hsien] Chang Gung Univ, Coll Med, Dept Microbiol & Immunol, Tao Yuan, Taiwan	Chang Gung University; Chang Gung University	Lin, HH (corresponding author), 259 Wen Hwa 1st Rd, Tao Yuan, Taiwan.	hhlin@mail.cgu.edu.tw	LIN, Hsi-Hsien/N-1488-2015; Huang, I-Shu/S-9341-2017	Hsiao, Cheng-Chih/0000-0003-3572-1046; Huang, I-Shu/0000-0001-8770-9298	National Science Council, Taiwan [NSC96-2628-B-182-030-MY2, NSC98-2320-B-182-028-MY3]; Chang Gung Memorial Hospital [CMRPD170013, CMRPD160383]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This study was supported by Grants from National Science Council, Taiwan (NSC96-2628-B-182-030-MY2 and NSC98-2320-B-182-028-MY3) and Chang Gung Memorial Hospital (CMRPD170013 and CMRPD160383) (to H.-H.L.).	Bockaert J, 2010, ANNU REV PHARMACOL, V50, P89, DOI 10.1146/annurev.pharmtox.010909.105705; Borgatti R, 2009, CLIN GENET, V76, P573, DOI 10.1111/j.1399-0004.2009.01262.x; DAAKA Y, 2004, SCI STKE, pRE2; Davies JQ, 2007, J BIOL CHEM, V282, P27343, DOI 10.1074/jbc.M704096200; Della Chiesa M, 2010, INT IMMUNOL, V22, P91, DOI 10.1093/intimm/dxp116; Druey KM, 2009, IMMUNOL RES, V43, P62, DOI 10.1007/s12026-008-8050-0; Hsiao CC, 2009, FEBS LETT, V583, P3285, DOI 10.1016/j.febslet.2009.09.001; Iguchi T, 2008, J BIOL CHEM, V283, P14469, DOI 10.1074/jbc.M708919200; Jin ZH, 2007, HUM MOL GENET, V16, P1972, DOI 10.1093/hmg/ddm144; Ke N, 2008, BIOCHEM BIOPH RES CO, V366, P314, DOI 10.1016/j.bbrc.2007.11.071; Koirala S, 2009, J NEUROSCI, V29, P7439, DOI 10.1523/JNEUROSCI.1182-09.2009; Krasnoperov V, 2002, J BIOL CHEM, V277, P46518, DOI 10.1074/jbc.M206415200; Lattin J, 2007, J LEUKOCYTE BIOL, V82, P16, DOI 10.1189/jlb.0107051; Li SH, 2008, J NEUROSCI, V28, P5817, DOI 10.1523/JNEUROSCI.0853-08.2008; Lin HH, 2004, J BIOL CHEM, V279, P31823, DOI 10.1074/jbc.M402974200; Lin HH, 2005, BIOTECHNIQUES, V38, P696, DOI 10.2144/05385BM03; Liu M, 1999, GENOMICS, V55, P296, DOI 10.1006/geno.1998.5644; Piao XH, 2005, ANN NEUROL, V58, P680, DOI 10.1002/ana.20616; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Shashidhar S, 2005, ONCOGENE, V24, P1673, DOI 10.1038/sj.onc.1208395; Silva JP, 2009, J BIOL CHEM, V284, P6495, DOI 10.1074/jbc.M806979200; Spiegel AM, 2004, ANNU REV MED, V55, P27, DOI 10.1146/annurev.med.55.091902.103843; Stacey M, 2003, BLOOD, V102, P2916, DOI 10.1182/blood-2002-11-3540; Stacey M, 2000, TRENDS BIOCHEM SCI, V25, P284, DOI 10.1016/S0968-0004(00)01583-8; Volynski KE, 2004, EMBO J, V23, P4423, DOI 10.1038/sj.emboj.7600443; Xu L, 2007, CELL CYCLE, V6, P160, DOI 10.4161/cc.6.2.3760; Xu L, 2006, P NATL ACAD SCI USA, V103, P9023, DOI 10.1073/pnas.0602681103; Yona S, 2008, TRENDS BIOCHEM SCI, V33, P491, DOI 10.1016/j.tibs.2008.07.005; Zendman AJW, 1999, FEBS LETT, V446, P292, DOI 10.1016/S0014-5793(99)00230-6	29	56	60	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14215	14225		10.1074/jbc.M110.183830	http://dx.doi.org/10.1074/jbc.M110.183830			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21349848	Green Published, hybrid			2022-12-27	WOS:000289556200045
J	He, T; Hong, SY; Huang, L; Xue, WH; Yu, ZH; Kwon, H; Kirk, M; Ding, SJ; Su, KH; Zhang, ZX				He, Ti; Hong, Sang Yong; Huang, Lin; Xue, Weihua; Yu, Zhihong; Kwon, Hyoung; Kirk, Marion; Ding, Shi-jian; Su, Kaihong; Zhang, Zhixin			Histone Acetyltransferase p300 Acetylates Pax5 and Strongly Enhances Pax5-mediated Transcriptional Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-CELL-DEVELOPMENT; C-TERMINAL DOMAIN; HEAVY-CHAIN GENE; DNA-BINDING; SEQUENCE RECOGNITION; PAIRED DOMAIN; TARGET GENES; AMINO-ACIDS; BSAP PAX-5; PROTEINS	Pax5/B cell lineage specific activator protein (BSAP) is a B lineage-specific regulator that controls the B lineage-specific gene expression program and immunoglobulin gene V-H to DJ(H) recombination. Despite extensive studies on its multiple functions, little is known about how the activity of Pax5 is regulated. Here, we show that co-expression of histone acetyltransferase E1A binding protein p300 dramatically enhances Pax5-mediated transcriptional activation. The p300-mediated enhancement is dependent on its intrinsic histone acetyltransferase activity. Moreover, p300 interacts with the C terminus of Pax5 and acetylates multiple lysine residues within the paired box DNA binding domain of Pax5. Mutations of lysine residues 67 and 87/89 to alanine within Pax5 abolish p300-mediated enhancement of Pax5-induced Luc-CD19 reporter expression in HEK293 cells and prevent Pax5 to activate endogenous Cd19 and Blnk expression in Pax5(-/-) murine pro B cells. These results uncover a novel level of regulation of Pax5 function by p300-mediated acetylation.	[Hong, Sang Yong; Huang, Lin; Xue, Weihua; Ding, Shi-jian; Su, Kaihong; Zhang, Zhixin] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [He, Ti; Hong, Sang Yong] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Yu, Zhihong] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Kirk, Marion] Univ Alabama Birmingham, Ctr Comprehens Canc, Mass Spectrometry Shared Facil, Birmingham, AL 35294 USA; [Kwon, Hyoung] Swarthmore Coll, Swarthmore, PA 19081 USA; [Su, Kaihong] Univ Nebraska Med Ctr, Dept Internal Med, Omaha, NE 68198 USA; [Ding, Shi-jian] Univ Nebraska Med Ctr, Mass Spectrometry & Prote Core Facil, Omaha, NE 68198 USA; [Su, Kaihong; Zhang, Zhixin] Univ Nebraska Med Ctr, Eppley Inst Res Canc, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Swarthmore College; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Zhang, ZX (corresponding author), Univ Nebraska Med Ctr, Dept Pathol & Microbiol, LTC11706A, Omaha, NE 68198 USA.	zhangj@unmc.edu		Zhang, Zhixin/0000-0003-3924-1082	National Institutes of Health [AR048592, AI073174, AI074948, AI076475]; University of Alabama at Birmingham; University of Nebraska Medical Center; Eppley Cancer Institute; National Center for Research Resources (NCRR) Shared Instrumentation [S10 RR13795]; University of Alabama at Birmingham Health Services Foundation; Nebraska Research Initiative; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR013795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076475, R21AI073174, R01AI074948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR048592] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Alabama at Birmingham; University of Nebraska Medical Center; Eppley Cancer Institute; National Center for Research Resources (NCRR) Shared Instrumentation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); University of Alabama at Birmingham Health Services Foundation; Nebraska Research Initiative; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR048592, AI073174, AI074948, and AI076475 (to Z. Z.). This work was also supported by funding from the University of Alabama at Birmingham and the University of Nebraska Medical Center and the Eppley Cancer Institute (to Z. Z.). Purchase of the Q-TOF mass spectrometer in the Shared Facility came from funds provided by the National Center for Research Resources (NCRR) Shared Instrumentation Grants S10 RR13795 and the University of Alabama at Birmingham Health Services Foundation General Endowment Fund (Water/Micromass Q-TOF). The Mass Spectrometry and Proteomics Core Facility at the University of Nebraska Medical Center is supported by the Nebraska Research Initiative.	Barlev NA, 2003, MOL CELL BIOL, V23, P6944, DOI 10.1128/MCB.23.19.6944-6957.2003; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; Bradney C, 2003, J BIOL CHEM, V278, P2370, DOI 10.1074/jbc.M211464200; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; Cobaleda C, 2008, CURR OPIN IMMUNOL, V20, P139, DOI 10.1016/j.coi.2008.03.017; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; CZERNY T, 1995, MOL CELL BIOL, V15, P2858; CZERNY T, 1993, GENE DEV, V7, P2048, DOI 10.1101/gad.7.10.2048; Delogu A, 2006, IMMUNITY, V24, P269, DOI 10.1016/j.immuni.2006.01.012; Eberhard D, 1999, CANCER RES, V59, p1716S; Emelyanov AV, 2002, J BIOL CHEM, V277, P11156, DOI 10.1074/jbc.M111763200; Fitzsimmons D, 1996, GENE DEV, V10, P2198, DOI 10.1101/gad.10.17.2198; Fitzsimmons D, 2001, NUCLEIC ACIDS RES, V29, P4154, DOI 10.1093/nar/29.20.4154; Fuxa M, 2007, J IMMUNOL, V178, P8221, DOI 10.4049/jimmunol.178.12.8221-a; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Garvie CW, 2001, MOL CELL, V8, P1267, DOI 10.1016/S1097-2765(01)00410-5; Gingras S, 1999, NUCLEIC ACIDS RES, V27, P2722, DOI 10.1093/nar/27.13.2722; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hayakawa F, 2008, J BIOL CHEM, V283, P24420, DOI 10.1074/jbc.M802217200; Hesslein DGT, 2003, GENE DEV, V17, P37, DOI 10.1101/gad.1031403; Hsu LY, 2004, J EXP MED, V199, P825, DOI 10.1084/jem.20032249; Johnson K, 2004, NAT IMMUNOL, V5, P853, DOI 10.1038/ni1099; Kasper LH, 2002, NATURE, V419, P738, DOI 10.1038/nature01062; Linderson Y, 2004, EMBO REP, V5, P291, DOI 10.1038/sj.embor.7400089; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; Liu ZJ, 2010, J IMMUNOL, V184, P244, DOI 10.4049/jimmunol.0902324; Nakamura S, 2000, MOL CELL BIOL, V20, P9391, DOI 10.1128/MCB.20.24.9391-9398.2000; Nera KP, 2006, IMMUNITY, V24, P283, DOI 10.1016/j.immuni.2006.02.003; Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476; Nutt SL, 1998, EMBO J, V17, P2319, DOI 10.1093/emboj/17.8.2319; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Nutt SL, 2008, NEW ENGL J MED, V358, P82, DOI 10.1056/NEJMcibr0707112; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Pridans C, 2008, J IMMUNOL, V180, P1719, DOI 10.4049/jimmunol.180.3.1719; Roldan E, 2005, NAT IMMUNOL, V6, P31, DOI 10.1038/ni1150; Rolink AG, 1999, NATURE, V401, P603, DOI 10.1038/44164; Schebesta A, 2007, IMMUNITY, V27, P49, DOI 10.1016/j.immuni.2007.05.019; Schebesta M, 2002, CURR OPIN IMMUNOL, V14, P216, DOI 10.1016/S0952-7915(02)00324-2; Sheppard KA, 1999, MOL CELL BIOL, V19, P6367; Sigvardsson M, 2002, MOL CELL BIOL, V22, P8539, DOI 10.1128/MCB.22.24.8539-8551.2002; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; Xu W, 2006, BLOOD, V107, P4407, DOI 10.1182/blood-2005-08-3263; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Zhang ZX, 2006, NAT IMMUNOL, V7, P616, DOI 10.1038/ni1339	45	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14137	14145		10.1074/jbc.M110.176289	http://dx.doi.org/10.1074/jbc.M110.176289			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21357426	hybrid, Green Published			2022-12-27	WOS:000289556200037
J	Rai, R; Varma, SPMV; Shinde, N; Ghosh, S; Kumaran, SP; Skariah, G; Laloraya, S				Rai, Ragini; Varma, Satya P. M. V.; Shinde, Nikhil; Ghosh, Shilpa; Kumaran, Srikala P.; Skariah, Geena; Laloraya, Shikha			Small Ubiquitin-related Modifier Ligase Activity of Mms21 Is Required for Maintenance of Chromosome Integrity during the Unperturbed Mitotic Cell Division Cycle in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPLICATION STRESS; NUCLEAR-PORE COMPLEX; SMC5/6 COMPLEX; SUMO LIGASE; SMC5-SMC6 COMPLEX; FISSION YEAST; REPAIR; PROTEINS; DAMAGE; CAFFEINE	The SUMO ligase activity of Mms21/Nse2, a conserved member of the Smc5/6 complex, is required for resisting extrinsically induced genotoxic stress. We report that the Mms21 SUMO ligase activity is also required during the unchallenged mitotic cell cycle in Saccharomyces cerevisiae. SUMO ligase-defective cells were slow growing and spontaneously incurred DNA damage. These cells required caffeine-sensitive Mec1 kinase-dependent checkpoint signaling for survival even in the absence of extrinsically induced genotoxic stress. SUMO ligase-defective cells were sensitive to replication stress and displayed synthetic growth defects with DNA damage checkpoint-defective mutants such as mec1, rad9, and rad24. MMS21 SUMO ligase and mediator of replication checkpoint 1 gene (MRC1) were epistatic with respect to hydroxyurea-induced replication stress or methyl methanesulfonate-induced DNA damage sensitivity. Subjecting Mms21 SUMO ligase-deficient cells to transient replication stress resulted in enhancement of cell cycle progression defects such as mitotic delay and accumulation of hyperploid cells. Consistent with the spontaneous activation of the DNA damage checkpoint pathway observed in the Mms21-mediated sumoylation-deficient cells, enhanced frequency of chromosome breakage and loss was detected in these mutant cells. A mutation in the conserved cysteine 221 that is engaged in coordination of the zinc ion in Loop 2 of the Mms21 SPL-RING E3 ligase catalytic domain resulted in strong replication stress sensitivity and also conferred slow growth and Mec1 dependence to unchallenged mitotically dividing cells. Our findings establish Mms21-mediated sumoylation as a determinant of cell cycle progression and maintenance of chromosome integrity during the unperturbed mitotic cell division cycle in budding yeast.	[Rai, Ragini; Varma, Satya P. M. V.; Shinde, Nikhil; Ghosh, Shilpa; Kumaran, Srikala P.; Skariah, Geena; Laloraya, Shikha] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Laloraya, S (corresponding author), Indian Inst Sci, Dept Biochem, CV Raman Ave, Bangalore 560012, Karnataka, India.	slaloraya@biochem.iisc.ernet.in	Laloraya, Shikha/W-2027-2019	Laloraya, Shikha/0000-0002-2843-309X	Wellcome Trust [GR063263MA]; Council for Scientific and Industrial Research, India; Department of Biotechnology	Wellcome Trust(Wellcome TrustEuropean Commission); Council for Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology	This work was supported by a Wellcome Trust International Senior Research Fellowship in Biomedical Science (Grant GR063263MA) and by a grant from the Council for Scientific and Industrial Research, India (to S. L.).; Supported by a Department of Biotechnology junior research fellowship.	Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; Andrews EA, 2005, MOL CELL BIOL, V25, P185, DOI 10.1128/MCB.25.1.185-196.2005; Behlke-Steinert S, 2009, CELL CYCLE, V8, P2211, DOI 10.4161/cc.8.14.8979; Blasina A, 1999, CURR BIOL, V9, P1135, DOI 10.1016/S0960-9822(99)80486-2; Branzei D, 2006, CELL, V127, P509, DOI 10.1016/j.cell.2006.08.050; Branzei D, 2009, DNA REPAIR, V8, P1038, DOI 10.1016/j.dnarep.2009.04.014; Chavez A, 2010, J BIOL CHEM, V285, P11922, DOI 10.1074/jbc.M109.041277; de la Torre-Ruiz MA, 1998, EMBO J, V17, P2687, DOI 10.1093/emboj/17.9.2687; De Piccoli G, 2006, NAT CELL BIOL, V8, P1032, DOI 10.1038/ncb1466; De Piccoli G, 2009, CHROMOSOME RES, V17, P251, DOI 10.1007/s10577-008-9016-8; Duan XY, 2009, MOL CELL, V35, P657, DOI 10.1016/j.molcel.2009.06.032; Emili A, 1998, MOL CELL, V2, P183, DOI 10.1016/S1097-2765(00)80128-8; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; Friedel AM, 2009, CURR OPIN CELL BIOL, V21, P237, DOI 10.1016/j.ceb.2009.01.017; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gilbert CS, 2001, MOL CELL, V8, P129, DOI 10.1016/S1097-2765(01)00267-2; Hall-Jackson CA, 1999, ONCOGENE, V18, P6707, DOI 10.1038/sj.onc.1203077; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Huang CE, 2005, PHILOS T ROY SOC B, V360, P537, DOI 10.1098/rstb.2004.1609; Huang DL, 2003, GENE DEV, V17, P1741, DOI 10.1101/gad.1089203; Huang LX, 2009, PLANT J, V60, P666, DOI 10.1111/j.1365-313X.2009.03992.x; Hudson DF, 2009, CHROMOSOME RES, V17, P131, DOI 10.1007/s10577-008-9009-7; Ishida T, 2009, PLANT CELL, V21, P2284, DOI 10.1105/tpc.109.068072; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; KRAKOFF IH, 1968, CANCER RES, V28, P1559; LEHMANN AR, 1995, MOL CELL BIOL, V15, P7067; Lindroos HB, 2006, MOL CELL, V22, P755, DOI 10.1016/j.molcel.2006.05.014; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Losada A, 2005, GENE DEV, V19, P1269, DOI 10.1101/gad.1320505; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; McDonald WH, 2003, J BIOL CHEM, V278, P45460, DOI 10.1074/jbc.M308828200; Morikawa H, 2004, MOL CELL BIOL, V24, P9401, DOI 10.1128/MCB.24.21.9401-9413.2004; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Osborn AJ, 2003, GENE DEV, V17, P1755, DOI 10.1101/gad.1098303; Paulsen RD, 2007, DNA REPAIR, V6, P953, DOI 10.1016/j.dnarep.2007.02.015; Pebernard S, 2004, MOL BIOL CELL, V15, P4866, DOI 10.1091/mbc.E04-05-0436; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Potts PR, 2007, NAT STRUCT MOL BIOL, V14, P581, DOI 10.1038/nsmb1259; Potts PR, 2005, MOL CELL BIOL, V25, P7021, DOI 10.1128/MCB.25.16.7021-7032.2005; PRAKASH S, 1977, GENETICS, V87, P229; Reinke A, 2006, J BIOL CHEM, V281, P31616, DOI 10.1074/jbc.M603107200; Saitoh H, 1997, TRENDS BIOCHEM SCI, V22, P374, DOI 10.1016/S0968-0004(97)01102-X; Sarkaria JN, 1999, CANCER RES, V59, P4375; Sergeant J, 2005, MOL CELL BIOL, V25, P172, DOI 10.1128/MCB.25.1.172-184.2005; SIKORSKI RS, 1989, GENETICS, V122, P19; Takahashi Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000215; TOLMACH LJ, 1977, RADIAT RES, V71, P653, DOI 10.2307/3574633; Torres-Rosell J, 2005, NAT CELL BIOL, V7, P412, DOI 10.1038/ncb1239; Torres-Rosell J, 2007, SCIENCE, V315, P1411, DOI 10.1126/science.1134025; Tsukamoto Y, 2001, CURR BIOL, V11, P1328, DOI 10.1016/S0960-9822(01)00372-4; Ulrich Helle D., 2009, V497, P3, DOI 10.1007/978-1-59745-566-4_1; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Weinert T, 1998, CELL, V94, P555, DOI 10.1016/S0092-8674(00)81597-4; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102	61	20	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14516	14530		10.1074/jbc.M110.157149	http://dx.doi.org/10.1074/jbc.M110.157149			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21324902	hybrid, Green Published			2022-12-27	WOS:000289556200072
J	Wu, YT; Ouyang, WM; Lazorchak, AS; Liu, D; Shen, HM; Su, B				Wu, You-Tong; Ouyang, Weiming; Lazorchak, Adam S.; Liu, Dou; Shen, Han-Ming; Su, Bing			mTOR Complex 2 Targets Akt for Proteasomal Degradation via Phosphorylation at the Hydrophobic Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-B; GLUCOSE-HOMEOSTASIS; NEGATIVE REGULATOR; FETAL-GROWTH; ACTIVATION; AKT/PKB; CELLS; UBIQUITINATION; STABILITY; PATHWAY	The protein kinase Akt (also known as protein kinase B) is a critical signaling hub downstream of various cellular stimuli such as growth factors that control cell survival, growth, and proliferation. The activity of Akt is tightly regulated, and the aberrant activation of Akt is associated with diverse human diseases including cancer. Although it is well documented that the mammalian target of rapamycin complex 2 (mTORC2)-dependent phosphorylation of the Akt hydrophobic motif (Ser-473 in Akt1) is essential for full Akt activation, it remains unclear whether this phosphorylation has additional roles in regulating Akt activity. In this study, we found that abolishing Akt Ser-473 phosphorylation stabilizes Akt following agonist stimulation. The Akt Ser-473 phosphorylation promotes a Lys-48-linked polyubiquitination of Akt, resulting in its rapid proteasomal degradation. Moreover, blockade of this proteasomal degradation pathway prolongs agonist-induced Akt activation. These data reveal that mTORC2 plays a central role in regulating the Akt protein life cycle by first stabilizing Akt protein folding through the turn motif phosphorylation and then by promoting Akt protein degradation through the hydrophobic motif phosphorylation. Taken together, this study reveals that the Akt Ser-473 phosphorylation-dependent ubiquitination and degradation is an important negative feedback regulation that specifically terminates Akt activation.	[Wu, You-Tong; Ouyang, Weiming; Lazorchak, Adam S.; Liu, Dou; Su, Bing] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Wu, You-Tong; Ouyang, Weiming; Lazorchak, Adam S.; Liu, Dou; Su, Bing] Yale Univ, Sch Med, Vasc Biol & Therapeut Program, New Haven, CT 06520 USA; [Wu, You-Tong; Shen, Han-Ming] Natl Univ Singapore, Dept Epidemiol & Publ Hlth, Yong Loo Lin Sch Med, Grad Sch Integrat Sci & Engn, Singapore 117597, Singapore	Yale University; Yale University; National University of Singapore	Shen, HM (corresponding author), 16 Med Dr, Singapore 117597, Singapore.	ephshm@nus.edu.sg; bing.su@yale.edu	SHEN, Han-Ming/B-5942-2011	SHEN, Han-Ming/0000-0001-7369-5227	National Institutes of Health [AI063348]; Department of Defense [PR093728]; Singapore Biomedical Research Council [08/1/21/19/554]; National University of Singapore; Leukemia & Lymphoma Society; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063348] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); National University of Singapore(National University of Singapore); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI063348. This work was also supported by Department of Defense Grant PR093728 (to B. S.) and Singapore Biomedical Research Council Grant 08/1/21/19/554 (to H.-M.S.).; Supported by a research scholarship from the National University of Singapore.; Supported by a fellowship from the Leukemia & Lymphoma Society.	Adachi M, 2003, FEBS LETT, V554, P77, DOI 10.1016/S0014-5793(03)01109-8; Adhikari A, 2009, DEV CELL, V16, P485, DOI 10.1016/j.devcel.2009.04.001; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Altomare DA, 1998, ONCOGENE, V16, P2407, DOI 10.1038/sj.onc.1201750; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Cheng J, 2005, MOL CELL BIOL, V25, P5955, DOI 10.1128/MCB.25.14.5955-5964.2005; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Du KY, 2005, ONCOGENE, V24, P7401, DOI 10.1038/sj.onc.1209099; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Efeyan A, 2010, CURR OPIN CELL BIOL, V22, P169, DOI 10.1016/j.ceb.2009.10.007; Elghazi L, 2009, TRENDS ENDOCRIN MET, V20, P243, DOI 10.1016/j.tem.2009.03.002; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Lazorchak AS, 2010, MOL CELL, V39, P433, DOI 10.1016/j.molcel.2010.07.031; Liu QR, 1999, GENE DEV, V13, P786, DOI 10.1101/gad.13.7.786; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Martin-Berenjeno I, 2009, CANCER CELL, V16, P449, DOI 10.1016/j.ccr.2009.11.017; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Oh WJ, 2010, EMBO J, V29, P3939, DOI 10.1038/emboj.2010.271; Padmanabhan S, 2009, CELL, V136, P939, DOI 10.1016/j.cell.2009.01.025; Peterson RT, 1999, CURR BIOL, V9, pR521, DOI 10.1016/S0960-9822(99)80326-1; Plas DR, 2005, ONCOGENE, V24, P7435, DOI 10.1038/sj.onc.1209097; Restuccia DF, 2009, SCIENCE, V325, P1083, DOI 10.1126/science.1179972; Rosen N, 2006, CANCER CELL, V10, P254, DOI 10.1016/j.ccr.2006.10.001; Sale EM, 2008, CELL MOL LIFE SCI, V65, P113, DOI 10.1007/s00018-007-7274-9; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Song JJ, 2005, J CELL BIOL, V170, P61, DOI 10.1083/jcb.200502070; Suizu F, 2009, DEV CELL, V17, P800, DOI 10.1016/j.devcel.2009.09.007; Toker A, 2000, J BIOL CHEM, V275, P8271, DOI 10.1074/jbc.275.12.8271; Tschopp O, 2005, DEVELOPMENT, V132, P2943, DOI 10.1242/dev.01864; Woodgett JR, 2005, CURR OPIN CELL BIOL, V17, P150, DOI 10.1016/j.ceb.2005.02.010; Xiang T, 2008, CANCER RES, V68, P10040, DOI 10.1158/0008-5472.CAN-08-3009; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Yang ZZ, 2003, J BIOL CHEM, V278, P32124, DOI 10.1074/jbc.M302847200	39	54	54	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14190	14198		10.1074/jbc.M111.219923	http://dx.doi.org/10.1074/jbc.M111.219923			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21321111	Green Published, hybrid			2022-12-27	WOS:000289556200042
J	Zeng, Y; He, YN; Yang, F; Mooney, SM; Getzenberg, RH; Orban, J; Kulkarni, P				Zeng, Yu; He, Yanan; Yang, Fan; Mooney, Steven M.; Getzenberg, Robert H.; Orban, John; Kulkarni, Prakash			The Cancer/Testis Antigen Prostate-associated Gene 4 (PAGE4) Is a Highly Intrinsically Disordered Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-TESTIS ANTIGEN; BREAST-CANCER; CONFERS RESISTANCE; ANDROGEN RECEPTOR; CELL-LINES; EXPRESSION; SEQUENCE; BINDING; OVEREXPRESSION; ACETYLATION	The cancer/testis antigens (CTAs) are an important group of heterogeneous proteins that are predominantly expressed in the testis in the normal human adult but are aberrantly expressed in several types of cancers. Prostate-associated gene 4 (PAGE4) is a member of the CT-X family of CTAs that in addition to testis, is highly expressed in the fetal prostate, and may also play an important role both in benign and malignant prostate diseases. However, the function of this gene remains poorly understood. Here, we show that PAGE4 is a highly (100%) intrinsically disordered protein (IDP). The primary protein sequence conforms to the features of a typical IDP sequence and the secondary structure prediction algorithm metaPrDOS strongly supported this prediction. Furthermore, SDS-gel electrophoresis and analytical size exclusion chromatography of the recombinant protein revealed an anomalous behavior characteristic of IDPs. UV circular dichroism (CD) and NMR spectroscopy confirmed that PAGE4 is indeed a highly disordered protein. In further bioinformatic analysis, the PredictNLS algorithm uncovered a potential nuclear localization signal, whereas the algorithm DBS-Pred returned a 99.1% probability that PAGE4 is a DNA-binding protein. Consistent with this prediction, biochemical experiments showed that PAGE4 preferentially binds a GC-rich sequence. Silencing PAGE4 expression induced cell death via apoptosis and in mice carrying PCa xenografts, siRNA-mediated knockdown of the PAGE4 mRNA attenuated tumor growth in vivo. Furthermore, overexpressing PAGE4 protected cells from stress-induced death. To our knowledge, PAGE4 is the first example of a CTA that is an IDP with an anti-apoptotic function.	[Zeng, Yu; Mooney, Steven M.; Getzenberg, Robert H.; Kulkarni, Prakash] Johns Hopkins Univ, Sch Med, Dept Urol, James Buchanan Brady Urol Inst, Baltimore, MD 21287 USA; [Zeng, Yu; Mooney, Steven M.; Getzenberg, Robert H.; Kulkarni, Prakash] Johns Hopkins Univ, Sch Med, George OBrien Urol Res Ctr, Baltimore, MD 21287 USA; [Getzenberg, Robert H.; Kulkarni, Prakash] Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21287 USA; [He, Yanan; Orban, John] Univ Maryland, Dept Chem & Biochem, Rockville, MD 20850 USA; [Orban, John] Univ Maryland, Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA; [Yang, Fan] CALTECH, Div Biol 114 96, Pasadena, CA 91125 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; California Institute of Technology	Kulkarni, P (corresponding author), Johns Hopkins Univ, Sch Med, Dept Urol, James Buchanan Brady Urol Inst, 600 N Wolfe St,105B Marburg, Baltimore, MD 21287 USA.	pkulkar4@jhmi.edu	Zhu, Ren-Yuan/V-8966-2019; Yang, Fan/GYU-4249-2022	Zhu, Ren-Yuan/0000-0003-3091-7461; 	National Institutes of Health, NCI [SPORE 2P50CA058236-16]; NIDDK [P50DK082998]; Patrick C. Walsh Prostate Cancer Research Fund; American Urological Association [RS-10-1-508]; NATIONAL CANCER INSTITUTE [P50CA058236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK082998] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Patrick C. Walsh Prostate Cancer Research Fund; American Urological Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant SPORE 2P50CA058236-16 from the NCI, O'Brien Grant P50DK082998 from the NIDDK, and the Patrick C. Walsh Prostate Cancer Research Fund.; Supported by American Urological Association Grant RS-10-1-508.	Ahmad S, 2004, BIOINFORMATICS, V20, P477, DOI 10.1093/bioinformatics/btg432; Ajiro M, 2009, INT J ONCOL, V35, P673, DOI 10.3892/ijo_00000379; Andrade Valeria C C, 2008, Cancer Immun, V8, P2; Bai S, 2008, MOL CELL BIOL, V28, P1947, DOI 10.1128/MCB.01672-07; Bai SX, 2005, MOL CELL BIOL, V25, P1238, DOI 10.1128/MCB.25.4.1238-1257.2005; Barrett A, 2007, INT J CANCER, V121, P265, DOI 10.1002/ijc.22673; Chen Yao-Tseng, 2005, Cancer Immun, V5, P9; Cilensek ZM, 2002, CANCER BIOL THER, V1, P380; Cokol M, 2008, EMBO REP, V9, DOI 10.1038/sj.embor.7401143; Duan ZF, 2003, CLIN CANCER RES, V9, P2778; Grigoriadis A, 2009, P NATL ACAD SCI USA, V106, P13493, DOI 10.1073/pnas.0906840106; Gure AO, 2005, CLIN CANCER RES, V11, P8055, DOI 10.1158/1078-0432.CCR-05-1203; Hazy E, 2009, CHEMPHYSCHEM, V10, P1415, DOI 10.1002/cphc.200900205; Iavarone C, 2002, MOL CANCER THER, V1, P329; Ishida T, 2008, BIOINFORMATICS, V24, P1344, DOI 10.1093/bioinformatics/btn195; Kanehira M, 2007, CANCER RES, V67, P3276, DOI 10.1158/0008-5472.CAN-06-3748; Kasuga C, 2008, J NEUROS-PEDIATR, V1, P305, DOI 10.3171/PED/2008/1/4/305; Kim Y, 2010, J BIOL CHEM, V285, P25957, DOI 10.1074/jbc.M109.095950; Lee JH, 2006, HUM MOL GENET, V15, P201, DOI 10.1093/hmg/ddi430; Liu JT, 2009, P NATL ACAD SCI USA, V106, P19819, DOI 10.1073/pnas.0907710106; McKenzie L, 2010, CELL CYCLE, V9, P4200, DOI 10.4161/cc.9.20.13532; Mooney SM, 2010, J BIOL CHEM, V285, P30443, DOI 10.1074/jbc.M110.143792; Mooney SM, 2010, BIOCHEMISTRY-US, V49, P1, DOI 10.1021/bi901263m; Moriniere J, 2009, NATURE, V461, P664, DOI 10.1038/nature08397; Nallur GN, 1996, P NATL ACAD SCI USA, V93, P1184, DOI 10.1073/pnas.93.3.1184; Napoletano C, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.05.019; Pflug BR, 1999, PROSTATE, V40, P269, DOI 10.1002/(SICI)1097-0045(19990901)40:4<269::AID-PROS9>3.0.CO;2-6; Por E, 2010, J BIOL CHEM, V285, P14475, DOI 10.1074/jbc.M109.084400; Prakash K, 2002, P NATL ACAD SCI USA, V99, P7598, DOI 10.1073/pnas.112191399; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Scanlan Matthew J, 2004, Cancer Immun, V4, P1; Scanlan MJ, 2002, IMMUNOL REV, V188, P22, DOI 10.1034/j.1600-065X.2002.18803.x; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Stevenson BJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-129; Suyama T, 2010, PROSTATE, V70, P1778, DOI 10.1002/pros.21214; Tompa P, 2005, TRENDS BIOCHEM SCI, V30, P484, DOI 10.1016/j.tibs.2005.07.008; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky VN, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/568068; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Vavouri T, 2009, CELL, V138, P198, DOI 10.1016/j.cell.2009.04.029; Velazquez Elsa F, 2007, Cancer Immun, V7, P11; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Zeng Y, 2006, INT J ONCOL, V28, P421; Zeng Y, 2009, J CELL BIOCHEM, V107, P179, DOI 10.1002/jcb.22114	45	48	51	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					13985	13994		10.1074/jbc.M110.210765	http://dx.doi.org/10.1074/jbc.M110.210765			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21357425	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000289556200021
J	Perides, G; Weiss, ER; Michael, ES; Laukkarinen, JM; Duffield, JS; Steer, ML				Perides, George; Weiss, Eric R.; Michael, Emily S.; Laukkarinen, Johanna M.; Duffield, Jeremy S.; Steer, Michael L.			TNF-alpha-dependent Regulation of Acute Pancreatitis Severity by Ly-6C(hi) Monocytes in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; MACROPHAGES; ABLATION; INJURY; MODEL; INTERLEUKIN-1; DISTINCT; SUBSETS; RELEASE; PRODUCE	The roles of monocytes/macrophages and their mechanisms of action in the regulation of pancreatitis are poorly understood. To address these issues, we have employed genetically altered mouse strains that either express the human diphtheria toxin receptor (DTR) coupled to the CD11b promoter or have global deletion of TNF-alpha. Targeted, conditional depletion of monocytes/macrophages was achieved by administration of diphtheria toxin (DT) to CD11b-DTR mice. We show that in the absence of DT administration, pancreatitis is associated with an increase in pancreatic content of Ly-6C(hi) monocytes/macrophages but that this response is prevented by prior administration of DT to CD11b-DTR mice. DT administration also reduces pancreatic edema and acinar cell injury/necrosis in two dissimilar experimental models of acute pancreatitis (a secretagogue-induced model and a model elicited by retrograde pancreatic duct infusion of sodium taurocholate). In the secretagogue-elicited model, the DT-induced decrease in pancreatitis severity is reversed by adoptive transfer of purified Ly-6C(hi) monocytes harvested from non-DT-treated CD11b-DTR mice or by the transfer of purified Ly-6C(hi) monocytes harvested from TNF-alpha(+/+) donor mice, but it is not reversed by the transfer of Ly-6C(hi) monocytes harvested from TNF-alpha(-/-) donors. Our studies indicate that the Ly-6C(hi) monocyte subset regulates the severity of pancreatitis by promoting pancreatic edema and acinar cell injury/necrosis and that this phenomenon is dependent upon the expression of TNF-alpha by those cells. They suggest that therapies targeting Ly-6C(hi) monocytes and/or TNF-alpha expression by Ly-6C(hi) monocytes might prove beneficial in the prevention or treatment of acute pancreatitis.	[Perides, George; Weiss, Eric R.; Michael, Emily S.; Laukkarinen, Johanna M.; Steer, Michael L.] Tufts Med Ctr, Dept Surg, Boston, MA 02111 USA; [Laukkarinen, Johanna M.] Tampere Univ Hosp, Dept Gastroenterol & Alimentary Tract Surg, FI-33521 Tampere, Finland; [Duffield, Jeremy S.] Univ Washington, Dept Med, Seattle, WA 98109 USA	Tufts Medical Center; Tampere University; Tampere University Hospital; University of Washington; University of Washington Seattle	Perides, G (corresponding author), Tufts Med Ctr, Dept Surg, 750 Washington St, Boston, MA 02115 USA.	gperides@tuftsmedicalcenter.org			National Institutes of Health [DK073200, DK31396]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091327, R01DK084077, R01DK031396, R37DK031396] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK073200 (to J. S. D.) and DK31396 (to M. L S.).	An GY, 2008, CIRCULATION, V117, P3227, DOI 10.1161/CIRCULATIONAHA.108.771048; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Bhatia M, 2000, J PATHOL, V190, P117; Cailhier JF, 2005, J IMMUNOL, V174, P2336, DOI 10.4049/jimmunol.174.4.2336; Denham W, 1997, GASTROENTEROLOGY, V113, P1741, DOI 10.1053/gast.1997.v113.pm9352880; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Fink GW, 1996, J SURG RES, V63, P369, DOI 10.1006/jsre.1996.0278; Frangogiannis NG, 2007, CIRCULATION, V115, P584, DOI 10.1161/CIRCULATIONAHA.106.646091; Frossard JL, 2002, CRIT CARE MED, V30, P1541, DOI 10.1097/00003246-200207000-00024; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; GREWAL HP, 1994, AM J SURG, V167, P214, DOI 10.1016/0002-9610(94)90076-0; Gukovskaya AS, 1997, J CLIN INVEST, V100, P1853, DOI 10.1172/JCI119714; Hughes CB, 1996, PANCREAS, V13, P22, DOI 10.1097/00006676-199607000-00003; Jaffray C, 2000, J GASTROINTEST SURG, V4, P370, DOI 10.1016/S1091-255X(00)80015-3; King IL, 2009, BLOOD, V113, P3190, DOI 10.1182/blood-2008-07-168575; LAMPEL M, 1977, VIRCHOWS ARCH A, V373, P97, DOI 10.1007/BF00432156; Laukkarinen JM, 2008, J BIOL CHEM, V283, P20703, DOI 10.1074/jbc.M801779200; Laukkarinen JM, 2007, GUT, V56, P1590, DOI 10.1136/gut.2007.124230; Lin SL, 2009, J IMMUNOL, V183, P6733, DOI 10.4049/jimmunol.0901473; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Norman J, 1997, J INTERF CYTOK RES, V17, P113, DOI 10.1089/jir.1997.17.113; NORMAN JG, 1995, ARCH SURG-CHICAGO, V130, P966; Pulichino AM, 2008, AM J RESP CELL MOL, V39, P324, DOI 10.1165/rcmb.2007-0186OC; Saito M, 2001, NAT BIOTECHNOL, V19, P746, DOI 10.1038/90795; Shifrin AL, 2005, SURGERY, V137, P545, DOI 10.1016/j.surg.2005.01.004; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Swirski FK, 2009, ARTERIOSCL THROM VAS, V29, P1424, DOI 10.1161/ATVBAHA.108.180521; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Van Acker GJD, 2007, J BIOL CHEM, V282, P22140, DOI 10.1074/jbc.M702225200; Yang J, 1998, SHOCK, V10, P169, DOI 10.1097/00024382-199809000-00004	33	38	44	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13327	13335		10.1074/jbc.M111.218388	http://dx.doi.org/10.1074/jbc.M111.218388			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21343291	Green Published, hybrid			2022-12-27	WOS:000289282200053
J	Trecesson, SD; Guillemin, Y; Belanger, A; Bernardi, AC; Preisser, L; Ravon, E; Gamelin, E; Juin, P; Barre, B; Coqueret, O				Trecesson, Sophie de Carne; Guillemin, Yannis; Belanger, Audrey; Bernardi, Anne-Charlotte; Preisser, Laurence; Ravon, Elisa; Gamelin, Erick; Juin, Philippe; Barre, Benjamin; Coqueret, Olivier			Escape from p21-mediated Oncogene-induced Senescence Leads to Cell Dedifferentiation and Dependence on Anti-apoptotic Bcl-xL and MCL1 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOPOISOMERASE-I INHIBITION; EPITHELIAL-MESENCHYMAL TRANSITION; DNA-DAMAGE; AURORA-A; TRANSCRIPTIONAL REPRESSION; GENE-EXPRESSION; CANCER-THERAPY; STEM-CELLS; CHECKPOINT; P21	Oncogene-induced senescence (OIS) is a tumor suppressor response that induces permanent cell cycle arrest in response to oncogenic signaling. Through the combined activation of the p53-p21 and p16-Rb suppressor pathways, OIS leads to the transcriptional repression of proliferative genes. Although this protective mechanism has been essentially described in primary cells, we surprisingly observed in this study that the ON program is conserved in established colorectal cell lines. In response to the RAS oncogene and despite the inactivation of p53 and p16(INK4), HT29 cells enter senescence, up-regulate p21(WAF1), and induce senescence-associated heterochromatin foci formation. The same effect was observed in response to B-RAF(v600E) in LS174T cells. We also observed that p21(WAF1) prevents the expression of the CDC25A and PLK1 genes to induce cell cycle arrest. Using ChIP and luciferase experiments, we have observed that p21(WAF1) binds to the PLK1 promoter to induce its down-regulation during OIS induction. Following 4-5 weeks, several clones were able to resume proliferation and escape this tumor suppressor pathway. Tumor progression was associated with p21(WAF1) down-regulation and CDC25A and PLK1 reexpression. In addition, OIS and p21(WAF1) escape was associated with an increase in DNA damage, an induction of the epithelial-mesenchymal transition program, and an increase in the proportion of cells expressing the CD24(low)/CD44(high) phenotype. Results also indicate that malignant cells having escaped OIS rely on survival pathways induced by Bcl-xL/MCL1 signaling. In light of these observations, it appears that the transcriptional functions of p21(WAF1) are active during OIS and that the inactivation of this protein is associated with cell dedifferentiation and enhanced survival.	[Trecesson, Sophie de Carne; Belanger, Audrey; Bernardi, Anne-Charlotte; Preisser, Laurence; Ravon, Elisa; Gamelin, Erick; Barre, Benjamin] Canc Ctr Paul Papin, INSERM, U892, F-49033 Angers, France; [Guillemin, Yannis; Juin, Philippe; Coqueret, Olivier] INSERM, Dept Canc Res, U892, F-44000 Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut de Cancerologie de l'Ouest (ICO); Universite d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm)	Coqueret, O (corresponding author), Canc Ctr Paul Papin, INSERM, U892, 2 Rue Moll, F-49033 Angers, France.	olivier.coqueret@univ-angers.fr	JUIN, Philippe/Q-1338-2019; Coqueret, Olivier/K-9660-2015; JUIN, Philippe P/H-3636-2014; preisser, laurence/K-7583-2015	JUIN, Philippe/0000-0002-4997-3888; Coqueret, Olivier/0000-0002-2843-7867; JUIN, Philippe P/0000-0002-4997-3888; 	Inserm-Pays de Loire; Ligue Contre le Cancer (comite du Maine et Loire); Institut du Cancer	Inserm-Pays de Loire; Ligue Contre le Cancer (comite du Maine et Loire); Institut du Cancer(Institut National du Cancer (INCA) France)	This work was supported by a fellowship from Inserm-Pays de Loire (to S. d. C. T.) and by an Equipe Labelisee grant from the Ligue Contre le Cancer (comite du Maine et Loire) and from the Institut du Cancer (to O.C.).	Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Andreassen PR, 2001, CANCER RES, V61, P7660; Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bienvenu F, 2005, MOL BIOL CELL, V16, P1850, DOI 10.1091/mbc.e04-08-0654; Bihani T, 2007, J BIOL CHEM, V282, P2666, DOI 10.1074/jbc.M608127200; Chang BD, 2000, P NATL ACAD SCI USA, V97, P4291, DOI 10.1073/pnas.97.8.4291; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; Courapied S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-205; Courapied S, 2010, J BIOL CHEM, V285, P26765, DOI 10.1074/jbc.M109.092304; Delavaine L, 1999, ONCOGENE, V18, P5381, DOI 10.1038/sj.onc.1202923; Devgan V, 2005, GENE DEV, V19, P1485, DOI 10.1101/gad.341405; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fritah A, 2005, MOL CELL BIOL, V25, P2419, DOI 10.1128/MCB.25.6.2419-2430.2005; Giraud S, 2004, ONCOGENE, V23, P7391, DOI 10.1038/sj.onc.1207972; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; HARPER JW, 1993, CELL, V75, P805; Ho CK, 1999, MOL CELL, V3, P405, DOI 10.1016/S1097-2765(00)80468-2; Krystyniak A, 2006, ONCOGENE, V25, P338, DOI 10.1038/sj.onc.1209056; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Liu MR, 2009, P NATL ACAD SCI USA, V106, P19035, DOI 10.1073/pnas.0910009106; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Perkins ND, 2002, CELL CYCLE, V1, P39, DOI 10.4161/cc.1.1.98; Phelps RA, 2009, CELL, V137, P623, DOI 10.1016/j.cell.2009.02.037; Qi Y, 2004, NATURE, V431, P712, DOI 10.1038/nature02958; Roninson IB, 2003, CANCER RES, V63, P2705; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Snowden AW, 2000, MOL CELL BIOL, V20, P2676, DOI 10.1128/MCB.20.8.2676-2686.2000; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Tategu M, 2008, J GENET GENOMICS, V35, P215, DOI 10.1016/S1673-8527(08)60030-2; Uchiumi T, 1997, J BIOL CHEM, V272, P9166; Vigneron A, 2005, CANCER RES, V65, P8927, DOI 10.1158/0008-5472.CAN-05-0461; Vigneron A, 2008, CANCER RES, V68, P815, DOI 10.1158/0008-5472.CAN-07-5115; Vigneron A, 2006, J BIOL CHEM, V281, P34742, DOI 10.1074/jbc.M602492200; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; Waldman T, 1996, NATURE, V381, P713, DOI 10.1038/381713a0; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; Wood A, 2006, GENE DEV, V20, P643, DOI 10.1101/gad.1414506; Yeung TM, 2010, P NATL ACAD SCI USA, V107, P3722, DOI 10.1073/pnas.0915135107; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	50	32	32	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					12825	12838		10.1074/jbc.M110.186437	http://dx.doi.org/10.1074/jbc.M110.186437			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21292770	hybrid, Green Published			2022-12-27	WOS:000289282200003
J	Burns, KA; Li, Y; Arao, Y; Petrovich, RM; Korach, KS				Burns, Katherine A.; Li, Yin; Arao, Yukitomo; Petrovich, Robert M.; Korach, Kenneth S.			Selective Mutations in Estrogen Receptor alpha D-domain Alters Nuclear Translocation and Non-estrogen Response Element Gene Regulatory Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEOXYRIBONUCLEIC-ACID-BINDING; BREAST-CANCER CELLS; ER-ALPHA; HINGE REGION; TRANSCRIPTIONAL ACTIVATION; GLUCOCORTICOID-RECEPTOR; IN-VIVO; LYSINE METHYLATION; PLASMA-MEMBRANE; EXPORT SIGNALS	The three main mechanisms of ER alpha action are: 1) nuclear, genomic, direct DNA binding, 2) nuclear, genomic, "tethered"-mediated, protein-protein interactions, and 3) non-nuclear, non-genomic, rapid action responses. Reports suggest the D-domain or hinge region of ER alpha plays an important role in mechanisms 1 and 2 above. Studies demonstrating the functionality of the ER alpha hinge region have resected the full D-domain; therefore, site directed mutations were made to attribute precise sequence functionality to this domain. This study focuses on the characterization and properties of three novel site directed ER alpha-D-domain mutants. The Hinge 1 (H1) ER alpha mutant has disrupted nuclear localization, can no longer perform tethered mediated responses and has lost interaction with c-Jun, but retains estrogen response element (ERE)-mediated functions as demonstrated by confocal microscopy, reporter assays, endogenous gene expression and co-immunoprecipitation. The H2 ER alpha mutant is non-nuclear, but translocates to the nucleus with estradiol (E-2) treatment and maintains ERE-mediated functionality. The H2 + NES ER alpha mutant does not maintain nuclear translocation with hormone binding, no longer activates ERE-target genes, functions in ERE-or tethered-mediated luciferase assays, but does retain the non-genomic, non-nuclear, rapid action response. These studies reveal the sequence(s) in the ER alpha hinge region that are involved in tethered-mediated actions as well as nuclear localization and attribute important functionality to this region of the receptor. In addition, the properties of these ER alpha mutants will allow future studies to further dissect and characterize the three main ER alpha mechanisms of action and determine the mechanistic role each action has in estrogen hormone regulation.	[Burns, Katherine A.; Li, Yin; Arao, Yukitomo; Korach, Kenneth S.] Natl Inst Environm Hlth Sci, Lab Reprod & Dev Toxicol, NIH, Res Triangle Pk, NC 27709 USA; [Petrovich, Robert M.] Natl Inst Environm Hlth Sci, Prot Express Core Facil, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Korach, KS (corresponding author), 111 TW Alexander Dr, Res Triangle Pk, NC 27790 USA.	Korach@niehs.nih.gov	Arao, Yukitomo/AAL-1665-2021	Korach, Kenneth/0000-0002-7765-418X; Arao, Yukitomo/0000-0003-1560-351X	National Institutes of Health [Z01ES70065, Z01ES102487-01]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES070065, Z01ES070065, ZICES102506, ZICES102487, Z01ES102487] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants Z01ES70065 and Z01ES102487-01.	Acconcia F, 2005, MOL BIOL CELL, V16, P231, DOI 10.1091/mbc.e04-07-0547; Carrigan A, 2007, J BIOL CHEM, V282, P10963, DOI 10.1074/jbc.M602931200; Cazalla D, 2002, MOL CELL BIOL, V22, P6871, DOI 10.1128/MCB.22.19.6871-6882.2002; Chambliss KL, 2005, MOL ENDOCRINOL, V19, P277, DOI 10.1210/me.2004-0008; COUSE JF, 1995, MOL ENDOCRINOL, V9, P1441, DOI 10.1210/me.9.11.1441; FRANCIS MK, 1995, J BIOL CHEM, V270, P11502, DOI 10.1074/jbc.270.19.11502; Fu MF, 2000, J BIOL CHEM, V275, P20853, DOI 10.1074/jbc.M000660200; GLASS CK, 1994, ENDOCR REV, V15, P391, DOI 10.1210/er.15.3.391; Hammes SR, 2007, ENDOCR REV, V28, P726, DOI 10.1210/er.2007-0022; Harrington WR, 2006, MOL ENDOCRINOL, V20, P491, DOI 10.1210/me.2005-0186; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hewitt SC, 2010, J BIOL CHEM, V285, P2676, DOI 10.1074/jbc.M109.043471; Hewitt SC, 2009, MOL ENDOCRINOL, V23, P2111, DOI 10.1210/me.2009-0356; Hong W, 2008, J MOL BIOL, V384, P22, DOI 10.1016/j.jmb.2008.09.010; Huq MDM, 2008, J PROTEOME RES, V7, P4538, DOI 10.1021/pr800375z; Jakacka M, 2001, J BIOL CHEM, V276, P13615, DOI 10.1074/jbc.M008384200; Jakacka M, 2002, MOL ENDOCRINOL, V16, P2188, DOI 10.1210/me.2001-0174; Kim MY, 2006, MOL ENDOCRINOL, V20, P1479, DOI 10.1210/me.2005-0531; Krum SA, 2008, MOL ENDOCRINOL, V22, P2393, DOI 10.1210/me.2008-0100; Kumar R, 1999, STEROIDS, V64, P310, DOI 10.1016/S0039-128X(99)00014-8; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Levin ER, 2005, MOL ENDOCRINOL, V19, P1951, DOI 10.1210/me.2004-0390; Madak-Erdogan Z, 2008, MOL ENDOCRINOL, V22, P2116, DOI 10.1210/me.2008-0059; MADER S, 1993, NUCLEIC ACIDS RES, V21, P1125, DOI 10.1093/nar/21.5.1125; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; McDevitta MA, 2008, MOL CELL ENDOCRINOL, V290, P24, DOI 10.1016/j.mce.2008.04.003; Mueller SO, 2003, J BIOL CHEM, V278, P12255, DOI 10.1074/jbc.M203578200; Nakielny S, 1996, J CELL BIOL, V134, P1365, DOI 10.1083/jcb.134.6.1365; Pedram A, 2007, J BIOL CHEM, V282, P22278, DOI 10.1074/jbc.M611877200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PICARD D, 1990, CELL REGUL, V1, P291, DOI 10.1091/mbc.1.3.291; PONGLIKITMONGKOL M, 1988, EMBO J, V7, P3385, DOI 10.1002/j.1460-2075.1988.tb03211.x; Rai D, 2005, MOL ENDOCRINOL, V19, P1606, DOI 10.1210/me.2004-0468; Razandi M, 2003, MOL CELL BIOL, V23, P1633, DOI 10.1128/MCB.23.5.1633-1646.2003; Razandi M, 1999, MOL ENDOCRINOL, V13, P307, DOI 10.1210/me.13.2.307; Safe S, 2001, VITAM HORM, V62, P231, DOI 10.1016/S0083-6729(01)62006-5; SALMON P, 2006, CURRENT PROTOCOLS NE, V37; Sentis S, 2005, MOL ENDOCRINOL, V19, P2671, DOI 10.1210/me.2005-0042; Shaffer PL, 2005, BIOCHEMISTRY-US, V44, P2678, DOI 10.1021/bi0477182; Song RXD, 2005, TRENDS ENDOCRIN MET, V16, P347, DOI 10.1016/j.tem.2005.06.010; Subramanian K, 2008, MOL CELL, V30, P336, DOI 10.1016/j.molcel.2008.03.022; Tanner TM, 2010, CELL MOL LIFE SCI, V67, P1919, DOI 10.1007/s00018-010-0302-1; Teyssier C, 2001, J BIOL CHEM, V276, P36361, DOI 10.1074/jbc.M101806200; Wang CG, 2001, J BIOL CHEM, V276, P18375, DOI 10.1074/jbc.M100800200; Webb P, 1999, MOL ENDOCRINOL, V13, P1672, DOI 10.1210/me.13.10.1672; WEBB P, 1995, MOL ENDOCRINOL, V9, P443, DOI 10.1210/me.9.4.443; Winuthayanon W, 2009, ENVIRON HEALTH PERSP, V117, P1155, DOI 10.1289/ehp.0900613; Xu PL, 2004, MOL ENDOCRINOL, V18, P1887, DOI 10.1210/me.2003-0334; YLIKOMI T, 1992, EMBO J, V11, P3681, DOI 10.1002/j.1460-2075.1992.tb05453.x; Yoshikawa N, 2008, BIOCHEM BIOPH RES CO, V371, P44, DOI 10.1016/j.bbrc.2008.03.155; Yue W, 2007, J STEROID BIOCHEM, V106, P102, DOI 10.1016/j.jsbmb.2007.05.008; Zhang Z, 2004, J NEUROCHEM, V89, P674, DOI 10.1111/j.1471-4159.2004.02388.x; Zhang ZG, 2002, BIOCHEM BIOPH RES CO, V294, P926, DOI 10.1016/S0006-291X(02)00348-0; Zhou Q, 2009, ENDOCR-RELAT CANCER, V16, P319, DOI 10.1677/ERC-08-0305; ZWART W, J CELL SCI, V123, P1253	56	60	62	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.187773	http://dx.doi.org/10.1074/jbc.M110.187773			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21285458	hybrid, Green Published			2022-12-27	WOS:000289077500075
J	Chung, IYW; Paetzel, M				Chung, Ivy Yeuk Wah; Paetzel, Mark			Crystal Structure of a Viral Protease Intramolecular Acyl-enzyme Complex INSIGHTS INTO cis-CLEAVAGE AT THE VP4/VP3 JUNCTION OF TELLINA BIRNAVIRUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC NECROSIS VIRUS; BURSAL DISEASE VIRUS; BACTERIAL SIGNAL PEPTIDASE; SER-LYS DYAD; CLEAVAGE SITES; VP4 PROTEASE; SUBSTRATE; IDENTIFICATION; BIRNAVIRUS; POLYMERASE	Viruses of the Birnaviridae family are characterized by their bisegmented double-stranded RNA genome that resides within a single-shelled non-enveloped icosahedral particle. They infect birds, aquatic organisms, and insects. Tellina virus 1 (TV-1) is an Aquabirnavirus isolated from the mollusk Tellina tenuis. It encodes a polyprotein (NH2-pVP2-X-VP4-VP3-COOH) that is cleaved by the self-encoded protease VP4 to yield capsid precursor protein pVP2, peptide X, and ribonucleoprotein VP3. Here we report the crystal structure of an intramolecular (cis) acylenzyme complex of TV-1 VP4 at 2.1-angstrom resolution. The structure reveals how the enzyme can recognize its own carboxyl terminus during the VP4/VP3 cleavage event. The methyl side chains of Ala(830)(P1) and Ala(828)(P3) at the VP4/VP3 junction point into complementary shallow and hydrophobic S1 and S3 binding pockets adjacent to the VP4 catalytic residues: nucleophile Ser(738) and general base Lys(777). The electron density clearly shows that the carbonyl carbon of Ala(830) is covalently attached via an ester bond to the O gamma of Ser(738). A highly ordered water molecule in the active site is coordinated in the proper position to act as the deacylating water. A comparative analysis of this intramolecular (cis) acyl-enzyme structure with the previously solved intermolecular (trans) acyl-enzyme structure of infectious pancreatic necrosis virus VP4 explains the narrower specificity observed in the cleavage sites of TV-1 VP4.	[Chung, Ivy Yeuk Wah; Paetzel, Mark] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Paetzel, M (corresponding author), S Sci Bldg,8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	mpaetzel@sfu.ca		Paetzel, Mark/0000-0002-7408-5487	Canadian Institute of Health Research; National Science and Engineering Research Council of Canada; Michael Smith Foundation for Health Research; Canadian Foundation of Innovation; Natural Sciences and Engineering Research Council of Canada; National Research Council; Canadian Institutes of Health Research; University of Saskatchewan	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Foundation of Innovation(Canada Foundation for Innovation); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Research Council; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Saskatchewan	This work was supported in part by grants from the Canadian Institute of Health Research (to M. P.), the National Science and Engineering Research Council of Canada (to M. P.), the Michael Smith Foundation for Health Research (to M. P.), and the Canadian Foundation of Innovation (to M. P.).; We thank the staff at the macromolecular beamline 08ID-1,Canadian Light Source, Saskatoon, Canada, for technical assistance with data collection. The Canadian Light Source is supported by Natural Sciences and Engineering Research Council of Canada, National Research Council, Canadian Institutes of Health Research, and the University of Saskatchewan. We thank Bernard Delmas for providing the initial TV-1 cDNA.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ALBER T, 1976, NATURE, V263, P297, DOI 10.1038/263297a0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Botos I, 2004, J BIOL CHEM, V279, P8140, DOI 10.1074/jbc.M312243200; Botos I, 2007, CURR OPIN STRUC BIOL, V17, P683, DOI 10.1016/j.sbi.2007.08.003; BURGI HB, 1973, J AM CHEM SOC, V95, P5065, DOI 10.1021/ja00796a058; Casanas A, 2008, STRUCTURE, V16, P29, DOI 10.1016/j.str.2007.10.023; Chung HK, 1996, VIROLOGY, V225, P359, DOI 10.1006/viro.1996.0610; Chung IYW, 2011, ACTA CRYSTALLOGR F, V67, P157, DOI 10.1107/S1744309110048803; Coulibaly F, 2005, CELL, V120, P761, DOI 10.1016/j.cell.2005.01.009; Da Costa B, 2002, J VIROL, V76, P2393, DOI 10.1128/JVI.76.5.2393-2402.2002; Da Costa B, 2003, J VIROL, V77, P719, DOI 10.1128/JVI.77.1.719-725.2003; DELANO WL, 2002, PYMOL MOL USERS MANU; Delmas B, 2005, VIRUS TAXONOMY; DING XC, 1994, BIOCHEMISTRY-US, V33, P9285, DOI 10.1021/bi00197a032; DOBOS P, 1995, VIROLOGY, V208, P19, DOI 10.1006/viro.1995.1125; DOBOS P, 1979, J VIROL, V32, P593, DOI 10.1128/JVI.32.2.593-605.1979; Ekici OD, 2008, PROTEIN SCI, V17, P2023, DOI 10.1110/ps.035436.108; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Espinoza JC, 2000, ARCH VIROL, V145, P739, DOI 10.1007/s007050050667; Feldman AR, 2006, J MOL BIOL, V358, P1378, DOI 10.1016/j.jmb.2006.02.045; Ferentz AE, 2001, EMBO J, V20, P4287, DOI 10.1093/emboj/20.15.4287; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Grosse-Kunstleve RW, 2003, ACTA CRYSTALLOGR D, V59, P1966, DOI 10.1107/S0907444903018043; Hill B.J., 1976, P445; Hjalmarsson A, 1999, J VIROL, V73, P3484, DOI 10.1128/JVI.73.4.3484-3490.1999; Katona G, 2002, J BIOL CHEM, V277, P21962, DOI 10.1074/jbc.M200676200; Kim AC, 2008, J MOL BIOL, V376, P352, DOI 10.1016/j.jmb.2007.11.080; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee JY, 2007, J BIOL CHEM, V282, P24928, DOI 10.1074/jbc.M701551200; Lejal N, 2000, J GEN VIROL, V81, P983, DOI 10.1099/0022-1317-81-4-983; Luo Y, 2001, CELL, V106, P585, DOI 10.1016/S0092-8674(01)00479-2; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MENARD R, 1992, BIOL CHEM H-S, V373, P393, DOI 10.1515/bchm3.1992.373.2.393; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nobiron I, 2008, VIROLOGY, V371, P350, DOI 10.1016/j.virol.2007.09.022; Paetzel M, 2002, J BIOL CHEM, V277, P9512, DOI 10.1074/jbc.M110983200; Paetzel M, 1998, NATURE, V396, P186, DOI 10.1038/24196; Paetzel M, 1997, TRENDS BIOCHEM SCI, V22, P28, DOI 10.1016/S0968-0004(96)10065-7; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Petit S, 2000, J VIROL, V74, P2057, DOI 10.1128/JVI.74.5.2057-2066.2000; Radisky ES, 2006, P NATL ACAD SCI USA, V103, P6835, DOI 10.1073/pnas.0601910103; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Sanchez AB, 1999, VIROLOGY, V262, P190, DOI 10.1006/viro.1999.9910; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Tsodikov OV, 2002, J COMPUT CHEM, V23, P600, DOI 10.1002/jcc.10061; UNDERWOOD BO, 1977, J GEN VIROL, V36, P93, DOI 10.1099/0022-1317-36-1-93; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Wilmouth RC, 1997, NAT STRUCT BIOL, V4, P456, DOI 10.1038/nsb0697-456; Wilmouth RC, 1998, BIOCHEMISTRY-US, V37, P17506, DOI 10.1021/bi9816249	53	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.198812	http://dx.doi.org/10.1074/jbc.M110.198812			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21288899	Green Published, hybrid			2022-12-27	WOS:000289077500061
J	Lee, JY; Wei, SJ; Lee, TH				Lee, Ju Yeon; Wei, Sijie; Lee, Tae-Hee			Effects of Histone Acetylation by Piccolo NuA4 on the Structure of a Nucleosome and the Interactions between Two Nucleosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKING NUMBER CHANGE; NM CHROMATIN FIBER; ACETYLTRANSFERASE COMPLEX; ASSEMBLY PROTEIN-1; CORE PARTICLE; RNA SYNTHESIS; TAIL DOMAINS; H4; DNA; H3	We characterized the effect of histone acetylation on the structure of a nucleosome and the interactions between two nucleosomes. In this study, nucleosomes reconstituted with the Selex "Widom 601" sequence were acetylated with the Piccolo NuA4 complex, which acetylates mainly H4 N-terminal tail lysine residues and some H2A/H3 N-terminal tail lysine residues. Upon the acetylation, we observed directional unwrapping of nucleosomal DNA that accompanies topology change of the DNA. Interactions between two nucleosomes in solution were also monitored to discover multiple transient dinucleosomal states that can be categorized to short-lived and long-lived (similar to 1 s) states. The formation of dinucleosomes is strongly Mg2+-dependent, and unacetylated nucleosomes favor the formation of long-lived dinucleosomes 4-fold as much as the acetylated ones. These results suggest that the acetylation of histones by Piccolo NuA4 disturbs not only the structure of a nucleosome but also the interactions between two nucleosomes. Lastly, we suggest a structural model for a stable dinucleosomal state where the two nucleosomes are separated by similar to 2 nm face-to-face and rotated by 34 degrees with respect to each other.	[Lee, Ju Yeon; Wei, Sijie; Lee, Tae-Hee] Penn State Univ, Dept Chem, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Lee, TH (corresponding author), Penn State Univ, Dept Chem, 230 Chem Bldg, University Pk, PA 16802 USA.	txl18@psu.edu	Lee, Tae-Hee/A-1266-2010; Wei, Sijie/J-6678-2019	Wei, Sijie/0000-0003-4882-9566	Searle Scholar Award; Henry and Dreyfus New Faculty Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097286] Funding Source: NIH RePORTER	Searle Scholar Award; Henry and Dreyfus New Faculty Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Searle Scholar Award (to T.-H. L.) and a Henry and Dreyfus New Faculty Award (to T.-H. L.).	ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Anderson JD, 2001, J MOL BIOL, V307, P977, DOI 10.1006/jmbi.2001.4528; Arya G, 2009, J PHYS CHEM A, V113, P4045, DOI 10.1021/jp810375d; AUSIO J, 1986, BIOCHEMISTRY-US, V25, P1421, DOI 10.1021/bi00354a035; Baneres JL, 1997, J MOL BIOL, V273, P503, DOI 10.1006/jmbi.1997.1297; BAUER WR, 1994, J MOL BIOL, V236, P685, DOI 10.1006/jmbi.1994.1180; Berndsen CE, 2005, METHODS, V36, P321, DOI 10.1016/j.ymeth.2005.03.002; Berndsen CE, 2007, BIOCHEMISTRY-US, V46, P2091, DOI 10.1021/bi602366n; Bertin A, 2007, BIOPHYS J, V92, P2633, DOI 10.1529/biophysj.106.093815; Boudreault AA, 2003, GENE DEV, V17, P1415, DOI 10.1101/gad.1056603; Bruno M, 2003, MOL CELL, V12, P1599, DOI 10.1016/S1097-2765(03)00499-4; Choi JK, 2009, BIOCHEM CELL BIOL, V87, P139, DOI 10.1139/O08-112; Choy JS, 2010, J AM CHEM SOC, V132, P1782, DOI 10.1021/ja910264z; Claudet C, 2005, J BIOL CHEM, V280, P19958, DOI 10.1074/jbc.M500121200; Cosgrove MS, 2004, NAT STRUCT MOL BIOL, V11, P1037, DOI 10.1038/nsmb851; Cosgrove MS, 2005, BIOCHEM CELL BIOL, V83, P468, DOI 10.1139/O05-137; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; DURRIN LK, 1991, CELL, V65, P1023, DOI 10.1016/0092-8674(91)90554-C; Faye G, 2005, J BIOL CHEM, V280, P33701, DOI 10.1074/jbc.M507048200; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; FINCH JT, 1976, P NATL ACAD SCI USA, V73, P1897, DOI 10.1073/pnas.73.6.1897; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; FLETCHER TM, 1995, J BIOL CHEM, V270, P25359, DOI 10.1074/jbc.270.43.25359; Gansen A, 2009, J PHYS CHEM B, V113, P2604, DOI 10.1021/jp7114737; Gansen A, 2009, P NATL ACAD SCI USA, V106, P15308, DOI 10.1073/pnas.0903005106; Hansen JC, 2002, ANNU REV BIOPH BIOM, V31, P361, DOI 10.1146/annurev.biophys.31.101101.140858; Hansen JC, 2010, J CELL PHYSIOL, V224, P289, DOI 10.1002/jcp.22150; HEBBES TR, 1988, EMBO J, V7, P1395, DOI 10.1002/j.1460-2075.1988.tb02956.x; Kan PY, 2009, MOL CELL BIOL, V29, P538, DOI 10.1128/MCB.01343-08; Kimura H, 2001, J CELL BIOL, V153, P1341, DOI 10.1083/jcb.153.7.1341; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1998, CURR OPIN GENET DEV, V8, P140, DOI 10.1016/S0959-437X(98)80134-2; MEGEE PC, 1995, GENE DEV, V9, P1716, DOI 10.1101/gad.9.14.1716; NORTON VG, 1989, CELL, V57, P449, DOI 10.1016/0092-8674(89)90920-3; NORTON VG, 1990, J BIOL CHEM, V265, P19848; Park YJ, 2005, J BIOL CHEM, V280, P1817, DOI 10.1074/jbc.M411347200; POGO BGT, 1966, P NATL ACAD SCI USA, V55, P805, DOI 10.1073/pnas.55.4.805; Poirier MG, 2009, NAT STRUCT MOL BIOL, V16, P938, DOI 10.1038/nsmb.1650; Robinson PJJ, 2008, J MOL BIOL, V381, P816, DOI 10.1016/j.jmb.2008.04.050; Robinson PJJ, 2006, P NATL ACAD SCI USA, V103, P6506, DOI 10.1073/pnas.0601212103; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Selleck W, 2005, MOL CELL BIOL, V25, P5535, DOI 10.1128/MCB.25.13.5535-5542.2005; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Sinha D, 2010, J BIOL CHEM, V285, P16572, DOI 10.1074/jbc.M109.091298; SOBEL RE, 1995, P NATL ACAD SCI USA, V92, P1237, DOI 10.1073/pnas.92.4.1237; Staynov DZ, 2008, BIOESSAYS, V30, P1003, DOI 10.1002/bies.20816; Suka N, 2002, NAT GENET, V32, P378, DOI 10.1038/ng1017; Tan S, 2005, PROTEIN EXPRES PURIF, V40, P385, DOI 10.1016/j.pep.2004.12.002; Toth KF, 2005, J BIOL CHEM, V280, P15690, DOI 10.1074/jbc.M413329200; Tremethick DJ, 2007, CELL, V128, P651, DOI 10.1016/j.cell.2007.02.008; Wang XY, 2000, J BIOL CHEM, V275, P35013, DOI 10.1074/jbc.M004998200; Zheng CY, 2003, J BIOL CHEM, V278, P24217, DOI 10.1074/jbc.M302817200; Zhou JS, 2007, NAT STRUCT MOL BIOL, V14, P1070, DOI 10.1038/nsmb1323	54	27	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11099	11109		10.1074/jbc.M110.192047	http://dx.doi.org/10.1074/jbc.M110.192047			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21282115	hybrid, Green Published			2022-12-27	WOS:000288797100021
J	Nishimichi, N; Hayashita-Kinoh, H; Chen, C; Matsuda, H; Sheppard, D; Yokosaki, Y				Nishimichi, Norihisa; Hayashita-Kinoh, Hiromi; Chen, Chun; Matsuda, Haruo; Sheppard, Dean; Yokosaki, Yasuyuki			Osteopontin Undergoes Polymerization in Vivo and Gains Chemotactic Activity for Neutrophils Mediated by Integrin alpha 9 beta 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THROMBIN-CLEAVED OSTEOPONTIN; TISSUE TRANSGLUTAMINASE; ALPHA(9)BETA(1) INTEGRIN; RHEUMATOID-ARTHRITIS; CROSS-LINKING; ADHESIVE PROPERTIES; SPLICE VARIANTS; BREAST-CANCER; UP-REGULATION; BINDING-SITE	Osteopontin (OPN) is an integrin-binding inflammatory cytokine that undergoes polymerization catalyzed by transglutaminase 2. We have previously reported that polymeric OPN (polyOPN), but not unpolymerized OPN (OPN*), attracts neutrophils in vitro by presenting an acquired binding site for integrin alpha 9 beta 1. Among many in vitro substrates for transglutaminase 2, only a few have evidence for in vivo polymerization and concomitant function. Although polyOPN has been identified in bone and aorta, the in vivo functional significance of polyOPN is unknown. To determine whether OPN polymerization contributes to neutrophil recruitment in vivo, we injected OPN* into the peritoneal space of mice. Polymeric OPN was detected by immunoblotting in the peritoneal wash of mice injected with OPN*, and both intraperitoneal and plasma OPN* levels were higher in mice injected with a polymerization-incompetent mutant, confirming that OPN* polymerizes in vivo. OPN* injection induced neutrophil accumulation, which was significantly less following injection of a mutant OPN that was incapable of polymerization. The importance of in vivo polymerization was further confirmed with cystamine, a transglutaminase inhibitor, which blocked the polymerization and attenuated OPN*-mediated neutrophil recruitment. The thrombin-cleaved N-terminal fragment of OPN, another ligand for alpha 9 beta 1, was not responsible for neutrophil accumulation because a thrombin cleavage-incompetent mutant recruited similar numbers of neutrophils as wild type OPN*. Neutrophil accumulation in response to both wild type and thrombin cleavage-incompetent OPN* was reduced in mice lacking the integrin alpha 9 subunit in leukocytes, indicating that alpha 9 beta 1 is required for polymerization-induced recruitment. We have illustrated a physiological role of molecular polymerization by demonstrating acquired chemotactic properties for OPN.	[Nishimichi, Norihisa; Hayashita-Kinoh, Hiromi; Yokosaki, Yasuyuki] Hiroshima Univ, Cell Matrix Frontier Lab, Minami Ku, Biomed Res Unit, Hiroshima 7348551, Japan; [Nishimichi, Norihisa; Matsuda, Haruo] Hiroshima Univ, Immunobiol Lab, Dept Mol & Appl Biosci, Grad Sch Biosphere Sci, Higashihiroshima 7398528, Japan; [Nishimichi, Norihisa; Yokosaki, Yasuyuki] Hiroshima Univ, Hlth Adm Ctr, Higashihiroshima 7398514, Japan; [Chen, Chun; Sheppard, Dean] Univ Calif San Francisco, Lung Biol Ctr, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Chen, Chun; Sheppard, Dean] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	Hiroshima University; Hiroshima University; Immuno-Biological Laboratories Co. Ltd.; Hiroshima University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Yokosaki, Y (corresponding author), Hiroshima Univ, Cell Matrix Frontier Lab, Minami Ku, Biomed Res Unit, 216 Biomed Res Bldg,1-2-3 Kasumi, Hiroshima 7348551, Japan.	yokosaki@hiroshima-u.ac.jp		Hayashita-Kinoh, Hiromi/0000-0002-0986-4177	National Institutes of Health [HL64353]; Japanese Ministry of Science, Sports, and Culture; Japan New Energy and Industrial Technology Development Organization; Tsuchiya Memorial Medical Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064353] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japanese Ministry of Science, Sports, and Culture; Japan New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Tsuchiya Memorial Medical Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL64353 (to D.S.). This work was also supported by a grant-in-aid from the Japanese Ministry of Science, Sports, and Culture (to H.M. and Y.Y.), by a grant from the Japan New Energy and Industrial Technology Development Organization (to N.N., H.M., and Y.Y.), and by a grant from the Tsuchiya Memorial Medical Foundation (to Y.Y.).	Agnihotri R, 2001, J BIOL CHEM, V276, P28261, DOI 10.1074/jbc.M103608200; Apte UM, 2005, TOXICOL APPL PHARM, V207, P25, DOI 10.1016/j.taap.2004.12.018; Banerjee A, 2006, J PATHOL, V208, P473, DOI 10.1002/path.1917; Caccamo D, 2010, AMINO ACIDS, V38, P653, DOI 10.1007/s00726-009-0428-3; Chae S, 2009, INT J ONCOL, V35, P1409, DOI 10.3892/ijo_00000458; CHANG JY, 1985, EUR J BIOCHEM, V151, P217, DOI 10.1111/j.1432-1033.1985.tb09091.x; Christensen B, 2007, J BIOL CHEM, V282, P19463, DOI 10.1074/jbc.M703055200; Christensen B, 2010, J BIOL CHEM, V285, P7929, DOI 10.1074/jbc.M109.075010; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Diao HY, 2004, IMMUNITY, V21, P539, DOI 10.1016/j.immuni.2004.08.012; Esposito C, 2005, FEBS J, V272, P615, DOI 10.1111/j.1742-4658.2004.04476.x; Giachelli CM, 1998, AM J PATHOL, V152, P353; Grassinger J, 2009, BLOOD, V114, P49, DOI 10.1182/blood-2009-01-197988; Hartley DM, 2008, J BIOL CHEM, V283, P16790, DOI 10.1074/jbc.M802215200; Hasegawa M, 2009, J RHEUMATOL, V36, P240, DOI 10.3899/jrheum.080753; He B, 2006, ONCOGENE, V25, P2192, DOI 10.1038/sj.onc.1209248; Higashikawa F, 2007, FEBS LETT, V581, P2697, DOI 10.1016/j.febslet.2007.05.018; Kaartinen MT, 2007, J HISTOCHEM CYTOCHEM, V55, P375, DOI 10.1369/jhc.6A7087.2006; Kaartinen MT, 1997, J BIOL CHEM, V272, P22736, DOI 10.1074/jbc.272.36.22736; Kaartinen MT, 2002, J BONE MINER RES, V17, P2161, DOI 10.1359/jbmr.2002.17.12.2161; Kaartinen MT, 1999, J BIOL CHEM, V274, P1729, DOI 10.1074/jbc.274.3.1729; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Koh A, 2007, IMMUNOLOGY, V122, P466, DOI 10.1111/j.1365-2567.2007.02682.x; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; LORAND L, 1978, J SUPRAMOL STR CELL, V9, P427, DOI 10.1002/jss.400090313; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Mambole A, 2010, J LEUKOCYTE BIOL, V88, P321, DOI 10.1189/jlb.1009704; McAllister SS, 2008, CELL, V133, P994, DOI 10.1016/j.cell.2008.04.045; Mirza M, 2008, INT J CANCER, V122, P889, DOI 10.1002/ijc.23204; Nemes Z, 2009, J BIOL CHEM, V284, P27252, DOI 10.1074/jbc.M109.033969; Nishimichi N, 2009, J BIOL CHEM, V284, P14769, DOI 10.1074/jbc.M901515200; O'Regan A, 2000, INT J EXP PATHOL, V81, P373, DOI 10.1046/j.1365-2613.2000.00163.x; O'Regan AW, 1999, J IMMUNOL, V162, P1024; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; PRINCE CW, 1991, BIOCHEM BIOPH RES CO, V177, P1205, DOI 10.1016/0006-291X(91)90669-X; Rittling SR, 2002, J BIOL CHEM, V277, P9175, DOI 10.1074/jbc.M109028200; Ross EA, 2006, BLOOD, V107, P1178, DOI 10.1182/blood-2005-07-2692; SAITOH Y, 1995, LAB INVEST, V72, P55; Saldanha-Gama RF, 2010, BBA-MOL CELL RES, V1803, P848, DOI 10.1016/j.bbamcr.2010.03.012; Sato Y, 2008, ATHEROSCLEROSIS, V200, P303, DOI 10.1016/j.atherosclerosis.2008.02.001; SENGER DR, 1994, MOL BIOL CELL, V5, P565, DOI 10.1091/mbc.5.5.565; Shang T, 1999, J LEUKOCYTE BIOL, V66, P809, DOI 10.1002/jlb.66.5.809; Shio K, 2010, J RHEUMATOL, V37, P704, DOI 10.3899/jrheum.090582; Singh P, 2009, J INVEST DERMATOL, V129, P217, DOI 10.1038/jid.2008.201; SINGH RP, 1990, J EXP MED, V171, P1931, DOI 10.1084/jem.171.6.1931; Smith LL, 1996, J BIOL CHEM, V271, P28485, DOI 10.1074/jbc.271.45.28485; SORENSEN ES, 1994, BIOCHEM J, V304, P13, DOI 10.1042/bj3040013; Sugimura Y, 2006, J BIOL CHEM, V281, P17699, DOI 10.1074/jbc.M513538200; Sullivan J, 2009, SURGERY, V146, P232, DOI 10.1016/j.surg.2009.03.036; Takahashi H, 2000, J BIOL CHEM, V275, P23589, DOI 10.1074/jbc.M003526200; Weber GF, 1996, SCIENCE, V271, P509, DOI 10.1126/science.271.5248.509; Yamaguchi Y, 2010, BIOCHEM BIOPH RES CO, V393, P487, DOI 10.1016/j.bbrc.2010.02.030; Yamamoto N, 2003, J CLIN INVEST, V112, P181, DOI 10.1172/JCI200317778; Yan W, 2010, NEURO-ONCOLOGY, V12, P765, DOI 10.1093/neuonc/noq006; Yokosaki Y, 2005, MATRIX BIOL, V24, P418, DOI 10.1016/j.matbio.2005.05.005; Yokosaki Y, 1998, J BIOL CHEM, V273, P11423, DOI 10.1074/jbc.273.19.11423; Yokosaki Y, 1999, J BIOL CHEM, V274, P36328, DOI 10.1074/jbc.274.51.36328; Yung S, 2009, PERITON DIALYSIS INT, V29, pS21; Zemskov EA, 2006, FRONT BIOSCI-LANDMRK, V11, P1057, DOI 10.2741/1863	59	42	44	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11170	11178		10.1074/jbc.M110.189258	http://dx.doi.org/10.1074/jbc.M110.189258			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21321126	Green Published, hybrid			2022-12-27	WOS:000288797100027
J	Oliveira, CJF; Sa-Nunes, A; Francischetti, IMB; Carregaro, V; Anatriello, E; Silva, JS; Santos, IKFD; Ribeiro, JMC; Ferreira, BR				Oliveira, Carlo Jose F.; Sa-Nunes, Anderson; Francischetti, Ivo M. B.; Carregaro, Vanessa; Anatriello, Elen; Silva, Joao S.; de Miranda Santos, Isabel K. F.; Ribeiro, Jose M. C.; Ferreira, Beatriz R.			Deconstructing Tick Saliva NON-PROTEIN MOLECULES WITH POTENT IMMUNOMODULATORY PROPERTIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENDRITIC CELL-FUNCTION; TOLL-LIKE RECEPTOR-2; LONE STAR TICK; RHIPICEPHALUS-SANGUINEUS; PROSTAGLANDIN E-2; IXODES-SCAPULARIS; BOOPHILUS-MICROPLUS; AMBLYOMMA-AMERICANUM; MONOCYTE DIFFERENTIATION; BIOLOGICAL SIGNIFICANCE	Dendritic cells (DCs) are powerful initiators of innate and adaptive immune responses. Ticks are blood-sucking ectoparasite arthropods that suppress host immunity by secreting immunomodulatory molecules in their saliva. Here, compounds present in Rhipicephalus sanguineus tick saliva with immunomodulatory effects on DC differentiation, cytokine production, and costimulatory molecule expression were identified. R. sanguineus tick saliva inhibited IL-12p40 and TNF-alpha while potentiating IL-10 cytokine production by bone marrow-derived DCs stimulated by Toll-like receptor-2, -4, and -9 agonists. To identify the molecules responsible for these effects, we fractionated the saliva through microcon filtration and reversed-phase HPLC and tested each fraction for DC maturation. Fractions with proven effects were analyzed by micro-HPLC tandem mass spectrometry or competition ELISA. Thus, we identified for the first time in tick saliva the purine nucleoside adenosine (concentration of similar to 110pmol/mu l) as a potent anti-inflammatory salivary inhibitor of DC cytokine production. We also found prostaglandin E-2 (PGE(2) similar to 100 nM) with comparable effects in modulating cytokine production by DCs. Both Ado and PGE(2) inhibited cytokine production by inducing cAMP-PKA signaling in DCs. Additionally, both Ado and PGE(2) were able to inhibit expression of CD40 in mature DCs. Finally, flow cytometry analysis revealed that PGE(2), but not Ado, is the differentiation inhibitor of bone marrow-derived DCs. The presence of non-protein molecules adenosine and PGE(2) in tick saliva indicates an important evolutionary mechanism used by ticks to subvert host immune cells and allow them to successfully complete their blood meal and life cycle.	[Ferreira, Beatriz R.] Univ Sao Paulo, Sch Nursing Ribeirao Preto, Dept Maternal Child Nursing & Publ Hlth, BR-14040902 Ribeirao Preto, SP, Brazil; [Oliveira, Carlo Jose F.; Carregaro, Vanessa; Anatriello, Elen; Silva, Joao S.; de Miranda Santos, Isabel K. F.; Ferreira, Beatriz R.] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Biochem & Immunol, BR-14049900 Ribeirao Preto, SP, Brazil; [Sa-Nunes, Anderson] Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, BR-05508900 Sao Paulo, Brazil; [Francischetti, Ivo M. B.; Ribeiro, Jose M. C.] NIAID, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Ferreira, BR (corresponding author), Univ Sao Paulo, Sch Nursing Ribeirao Preto, Dept Maternal Child Nursing & Publ Hlth, Av Bandeirantes 3900, BR-14040902 Ribeirao Preto, SP, Brazil.	brferrei@usp.br	de Miranda Santos, Isabel K. F./D-5261-2016; Carregaro, Vanessa/D-2913-2012; Ferreira, Beatriz Rossetti/C-2003-2012; Anatriello, Elen/N-1429-2015; Oliveira, Carlo Jose Freire/AAY-8751-2020; Silva, Joao/A-4484-2008; de Miranda Santos, Isabel KF/B-7597-2012; Sa-Nunes, Anderson/D-8667-2012; Sa-Nunes, Anderson/M-5654-2019	Ferreira, Beatriz Rossetti/0000-0002-6781-2236; Silva, Joao/0000-0002-3410-3927; Sa-Nunes, Anderson/0000-0002-1859-4973; Sa-Nunes, Anderson/0000-0002-1859-4973; Ribeiro, Jose/0000-0002-9107-0818; Carregaro, Vanessa/0000-0002-8435-0766; Kinney Ferreira de Miranda Santos, Isabel/0000-0002-0438-4430	National Institutes of Health of the Division of Intramural Research, NIAID; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [06/54985-4, 07/00035-8]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Millennium Institute for Vaccine Development and Technology (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [CNPq-420067/2005-1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000810] Funding Source: NIH RePORTER	National Institutes of Health of the Division of Intramural Research, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Millennium Institute for Vaccine Development and Technology (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program of the Division of Intramural Research, NIAID. This work was supported in part by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Grants 06/54985-4 and 07/00035-8, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Millennium Institute for Vaccine Development and Technology (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) Grant CNPq-420067/2005-1.	Aljamali M, 2002, INSECT BIOCHEM MOLEC, V32, P331, DOI 10.1016/S0965-1748(01)00113-8; Anguita J, 2002, IMMUNITY, V16, P849, DOI 10.1016/S1074-7613(02)00325-4; Aronoff DM, 2006, J INTERF CYTOK RES, V26, P827, DOI 10.1089/jir.2006.26.827; Bergman DK, 1995, EXP PARASITOL, V81, P262, DOI 10.1006/expr.1995.1117; Blackburn Michael R, 2009, Handb Exp Pharmacol, P215, DOI 10.1007/978-3-540-89615-9_8; Bowman AS, 1996, PARASITOL TODAY, V12, P388, DOI 10.1016/0169-4758(96)10061-2; BROWN SJ, 1985, EXP PARASITOL, V59, P248, DOI 10.1016/0014-4894(85)90079-7; Cavassani KA, 2005, IMMUNOLOGY, V114, P235, DOI 10.1111/j.1365-2567.2004.02079.x; COLLIS MG, 1989, PHARMACOL THERAPEUT, V41, P143, DOI 10.1016/0163-7258(89)90104-6; DANDREA A, 1993, J EXP MED, V178, P1041, DOI 10.1084/jem.178.3.1041; Deruaz M, 2008, J EXP MED, V205, P2019, DOI 10.1084/jem.20072689; DICKINSON RG, 1976, AUST J EXP BIOL MED, V54, P475, DOI 10.1038/icb.1976.48; Ferreira BR, 1999, IMMUNOLOGY, V96, P434, DOI 10.1046/j.1365-2567.1999.00683.x; Ferreira BR, 1998, VET IMMUNOL IMMUNOP, V64, P279, DOI 10.1016/S0165-2427(98)00135-4; Fezza F, 2003, BBA-MOL CELL BIOL L, V1633, P61, DOI 10.1016/S1388-1981(03)00087-8; Filippi CM, 2008, J PATHOL, V214, P224, DOI 10.1002/path.2272; Francischetti IMB, 2009, FRONT BIOSCI-LANDMRK, V14, P2051, DOI 10.2741/3363; Frauenschuh A, 2007, J BIOL CHEM, V282, P27250, DOI 10.1074/jbc.M704706200; Giordano D, 2003, J IMMUNOL, V171, P6421, DOI 10.4049/jimmunol.171.12.6421; GREWAL IS, 1995, NATURE, V378, P617, DOI 10.1038/378617a0; Guo XY, 2009, INFECT IMMUN, V77, P2320, DOI 10.1128/IAI.01507-08; Harizi H, 2003, J LEUKOCYTE BIOL, V73, P756, DOI 10.1189/jlb.1002483; Hasko G, 1996, J IMMUNOL, V157, P4634; Hasko G, 2000, FASEB J, V14, P2065, DOI 10.1096/fj.99-0508com; Hasko G, 2008, J LEUKOCYTE BIOL, V83, P447, DOI 10.1189/jlb.0607359; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; HASLAM RJ, 1975, MOL PHARMACOL, V11, P528; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; HIGGS GA, 1976, B ENTOMOL RES, V66, P665, DOI 10.1017/S0007485300010725; Hollander GA, 1996, P NATL ACAD SCI USA, V93, P4994, DOI 10.1073/pnas.93.10.4994; Hovius JWR, 2008, PLOS MED, V5, P202, DOI 10.1371/journal.pmed.0050043; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Inokuma H, 1997, MED VET ENTOMOL, V11, P401, DOI 10.1111/j.1365-2915.1997.tb00429.x; Inokuma H, 1998, J VET MED SCI, V60, P1013, DOI 10.1292/jvms.60.1013; Inokuma H, 1997, MED VET ENTOMOL, V11, P201, DOI 10.1111/j.1365-2915.1997.tb00315.x; INOKUMA H, 1994, J VET MED SCI, V56, P1217, DOI 10.1292/jvms.56.1217; Kashino SS, 2005, EXP PARASITOL, V110, P12, DOI 10.1016/j.exppara.2005.01.006; KATAMURA K, 1995, J IMMUNOL, V155, P4604; Kronlage M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000588; Kumar V, 2009, EUR J PHARMACOL, V616, P7, DOI 10.1016/j.ejphar.2009.05.005; Link AA, 2000, J IMMUNOL, V164, P436, DOI 10.4049/jimmunol.164.1.436; Mandapathil M, 2010, J BIOL CHEM, V285, P27571, DOI 10.1074/jbc.M110.127100; NAJAR HM, 1990, J LEUKOCYTE BIOL, V47, P429, DOI 10.1002/jlb.47.5.429; Nataraj C, 2001, J CLIN INVEST, V108, P1229, DOI 10.1172/JCI13640; Novitskiy SV, 2008, BLOOD, V112, P1822, DOI 10.1182/blood-2008-02-136325; O'Sullivan B, 2003, CRIT REV IMMUNOL, V23, P83, DOI 10.1615/CritRevImmunol.v23.i12.50; Oliveira CJF, 2008, INT J PARASITOL, V38, P705, DOI 10.1016/j.ijpara.2007.10.006; Oliveira CJF, 2010, VET PARASITOL, V167, P288, DOI 10.1016/j.vetpar.2009.09.031; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Panther E, 2003, BLOOD, V101, P3985, DOI 10.1182/blood-2002-07-2113; Pinhal-Enfield G, 2003, AM J PATHOL, V163, P711, DOI 10.1016/S0002-9440(10)63698-X; Ribeiro JMC, 1999, J EXP BIOL, V202, P1551; RIBEIRO JMC, 1985, J EXP MED, V161, P332, DOI 10.1084/jem.161.2.332; RIBEIRO JMC, 1992, EXP PARASITOL, V74, P112, DOI 10.1016/0014-4894(92)90145-Z; Ribeiro JMC, 2001, J PARASITOL, V87, P915, DOI 10.1645/0022-3395(2001)087[0915:TSAACO]2.0.CO;2; Sa-Nunes A, 2007, J IMMUNOL, V179, P1497, DOI 10.4049/jimmunol.179.3.1497; Sa-Nunes A, 2009, J IMMUNOL, V182, P7422, DOI 10.4049/jimmunol.0900075; Schoeler GB, 1999, EXP PARASITOL, V92, P239, DOI 10.1006/expr.1999.4426; Spaggiari GM, 2009, BLOOD, V113, P6576, DOI 10.1182/blood-2009-02-203943; Stanley D, 2006, ANNU REV ENTOMOL, V51, P25, DOI 10.1146/annurev.ento.51.110104.151021; Steen NA, 2006, TOXICON, V47, P1, DOI 10.1016/j.toxicon.2005.09.010; Stolina M, 2000, J IMMUNOL, V164, P361, DOI 10.4049/jimmunol.164.1.361; Su YY, 2008, CANCER IMMUNOL IMMUN, V57, P1611, DOI 10.1007/s00262-008-0494-5; Subauste CS, 2009, SEMIN IMMUNOL, V21, P273, DOI 10.1016/j.smim.2009.06.003; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.immunol.13.1.251; Tyson KR, 2008, J IMMUNOL, V180, P3964, DOI 10.4049/jimmunol.180.6.3964; Valenzuela JG, 2000, J BIOL CHEM, V275, P18717, DOI 10.1074/jbc.M001486200; Valenzuela JG, 2004, PARASITOLOGY, V129, pS83, DOI 10.1017/S0031182004005189; Van Gool SW, 1999, EUR J IMMUNOL, V29, P2367, DOI 10.1002/(SICI)1521-4141(199908)29:08<2367::AID-IMMU2367>3.3.CO;2-V; Vassiliou E, 2003, CELL IMMUNOL, V223, P120, DOI 10.1016/S0008-8749(03)00158-8; Wang H, 1998, NATURE, V391, P753, DOI 10.1038/35773; Wang H, 1999, CELL MOL LIFE SCI, V56, P286, DOI 10.1007/s000180050430; Wilson JM, 2009, J IMMUNOL, V182, P4616, DOI 10.4049/jimmunol.0801279; Yang L, 2003, J CLIN INVEST, V111, P727, DOI 10.1172/JCI200316492; Zeidner N, 1997, INFECT IMMUN, V65, P3100, DOI 10.1128/IAI.65.8.3100-3106.1997	75	95	97	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					10960	10969		10.1074/jbc.M110.205047	http://dx.doi.org/10.1074/jbc.M110.205047			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21270122	Green Published, hybrid			2022-12-27	WOS:000288797100008
J	Zhang, XYZ; Goemaere, EL; Seddiki, N; Celia, H; Gavioli, M; Cascales, E; Lloubes, R				Zhang, Xiang Y. -Z.; Goemaere, Emilie L.; Seddiki, Nadir; Celia, Herve; Gavioli, Marthe; Cascales, Eric; Lloubes, Roland			Mapping the Interactions between Escherichia coli TolQ Transmembrane Segments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE INTEGRITY; CELL-ENVELOPE INTEGRITY; N-TERMINAL DOMAIN; CONFORMATIONAL-CHANGE; CYTOPLASMIC MEMBRANE; MUTATIONAL ANALYSIS; PERIPLASMIC DOMAIN; PROTONMOTIVE FORCE; STATOR COMPLEX; INNER MEMBRANE	The tolQRAB-pal operon is conserved in Gram-negative genomes. The TolQRA proteins of Escherichia coli form an inner membrane complex in which TolQR uses the proton-motive force to regulate TolA conformation and the in vivo interaction of TolA C-terminal region with the outer membrane Pal lipoprotein. The stoichiometry of the TolQ, TolR, and TolA has been estimated and suggests that 4-6 TolQ molecules are associated in the complex, thus involving interactions between the transmembrane helices (TMHs) of TolQ, TolR, and TolA. It has been proposed that an ion channel forms at the interface between two TolQ and one TolR TMHs involving the TolR-Asp23, TolQ-Thr145, and TolQ-Thr178 residues. To define the organization of the three TMHs of TolQ, we constructed epitope-tagged versions of TolQ. Immunodetection of in vivo and in vitro chemically cross-linked TolQ proteins showed that TolQ exists as multimers in the complex. To understand how TolQ multimerizes, we initiated a cysteine-scanning study. Results of single and tandem cysteine substitution suggest a dynamic model of helix interactions in which the hairpin formed by the two last TMHs of TolQ change conformation, whereas the first TMH of TolQ forms intramolecular interactions.	[Zhang, Xiang Y. -Z.; Goemaere, Emilie L.; Seddiki, Nadir; Celia, Herve; Gavioli, Marthe; Cascales, Eric; Lloubes, Roland] Aix Marseille Univ, CNRS, Lab Ingn Syst Macromol UPR9027, F-13402 Marseille 20, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Lloubes, R (corresponding author), Aix Marseille Univ, CNRS, Lab Ingn Syst Macromol UPR9027, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	roland.lloubes@ifr88.cnrs-mrs.fr	CASCALES, ERIC/G-7420-2011	CASCALES, ERIC/0000-0003-0611-9179; LLOUBES, Roland/0000-0002-9520-1053	CNRS; Agence National de la Recherche [SODATOL (ANR-07-BLAN-67)]; SODATOL; Fondation pour la Recherche Medicale (FRM)	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence National de la Recherche(French National Research Agency (ANR)); SODATOL; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	This work was supported by the CNRS and a grant from the Agence National de la Recherche (SODATOL (ANR-07-BLAN-67)), by a grant from SODATOL (to X. Y.-Z. Z.), and a one-year fellowship from the Fondation pour la Recherche Medicale (FRM) (to E. L. G.).	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Anwari K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008619; Barneoud-Arnoulet A, 2010, J BACTERIOL, V192, P5934, DOI 10.1128/JB.00936-10; BLAIR DF, 1991, J MOL BIOL, V221, P1433, DOI 10.1016/0022-2836(91)90943-Z; Bonsor DA, 2009, EMBO J, V28, P2846, DOI 10.1038/emboj.2009.224; BOUVERET E, 1995, J BIOL CHEM, V270, P11071, DOI 10.1074/jbc.270.19.11071; Braun TF, 2001, BIOCHEMISTRY-US, V40, P13051, DOI 10.1021/bi011264g; Braun TF, 2004, BIOCHEMISTRY-US, V43, P35, DOI 10.1021/bi035406d; Braun V, 2004, J BACTERIOL, V186, P4402, DOI 10.1128/JB.186.13.4402-4406.2004; Cascales E, 2002, J BACTERIOL, V184, P754, DOI 10.1128/JB.184.3.754-759.2002; Cascales E, 2001, MOL MICROBIOL, V42, P795, DOI 10.1046/j.1365-2958.2001.02673.x; Cascales E, 2004, MOL MICROBIOL, V51, P873, DOI 10.1046/j.1365-2958.2003.03881.x; Cascales E, 2000, MOL MICROBIOL, V38, P904, DOI 10.1046/j.1365-2958.2000.02190.x; Deatherage BL, 2009, MOL MICROBIOL, V72, P1395, DOI 10.1111/j.1365-2958.2009.06731.x; DEROUICHE R, 1995, J BIOL CHEM, V270, P11078, DOI 10.1074/jbc.270.19.11078; Ding PZ, 2001, J MEMBRANE BIOL, V183, P33, DOI 10.1007/s00232-001-0053-x; Garcia-Herrero A, 2007, MOL MICROBIOL, V66, P872, DOI 10.1111/j.1365-2958.2007.05957.x; Gerding MA, 2007, MOL MICROBIOL, V63, P1008, DOI 10.1111/j.1365-2958.2006.05571.x; Germon P, 1998, J BACTERIOL, V180, P6433, DOI 10.1128/JB.180.24.6433-6439.1998; Germon P, 2001, J BACTERIOL, V183, P4110, DOI 10.1128/JB.183.14.4110-4114.2001; Goemaere EL, 2007, J BIOL CHEM, V282, P17749, DOI 10.1074/jbc.M701002200; GUIHARD G, 1994, J BIOL CHEM, V269, P5874; Hermolin J, 1999, J BIOL CHEM, V274, P17011, DOI 10.1074/jbc.274.24.17011; Higgs PI, 1998, J BACTERIOL, V180, P6031, DOI 10.1128/JB.180.22.6031-6038.1998; Journet L, 1999, J BACTERIOL, V181, P4476, DOI 10.1128/JB.181.15.4476-4484.1999; Kim EA, 2008, BIOCHEMISTRY-US, V47, P11332, DOI 10.1021/bi801347a; Kojima S, 2004, BIOCHEMISTRY-US, V43, P26, DOI 10.1021/bi035405l; Larsen RA, 1999, MOL MICROBIOL, V31, P1809, DOI 10.1046/j.1365-2958.1999.01317.x; LAZZARONI JC, 1995, J MOL BIOL, V246, P1, DOI 10.1006/jmbi.1994.0058; Lazzaroni JC, 1999, FEMS MICROBIOL LETT, V177, P191, DOI 10.1016/S0378-1097(99)00293-1; LEE GF, 1995, P NATL ACAD SCI USA, V92, P5416, DOI 10.1073/pnas.92.12.5416; LEVENGOODFREYERMUTH SK, 1993, J BACTERIOL, V175, P222, DOI 10.1128/JB.175.1.222-228.1993; Lloubes R, 2001, RES MICROBIOL, V152, P523, DOI 10.1016/S0923-2508(01)01226-8; MULLER MM, 1993, J BACTERIOL, V175, P6059, DOI 10.1128/JB.175.18.6059-6061.1993; Ollis AA, 2009, MOL MICROBIOL, V73, P466, DOI 10.1111/j.1365-2958.2009.06785.x; Parsons LM, 2008, BIOCHEMISTRY-US, V47, P3131, DOI 10.1021/bi702283x; Postle K, 2003, MOL MICROBIOL, V49, P869, DOI 10.1046/j.1365-2958.2003.03629.x; Pramanik A, 2010, BIOCHEMISTRY-US, V49, P8721, DOI 10.1021/bi101143y; Seeger MA, 2008, NAT STRUCT MOL BIOL, V15, P199, DOI 10.1038/nsmb.1379; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; VIANNEY A, 1994, J BACTERIOL, V176, P822, DOI 10.1128/jb.176.3.822-829.1994; Vianney A, 1996, J BACTERIOL, V178, P4031, DOI 10.1128/jb.178.14.4031-4038.1996; Yeh YC, 2010, J BACTERIOL, V192, P4847, DOI 10.1128/JB.00607-10; Zhang XYZ, 2009, J BIOL CHEM, V284, P4275, DOI 10.1074/jbc.M805257200	44	18	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11756	11764		10.1074/jbc.M110.192773	http://dx.doi.org/10.1074/jbc.M110.192773			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21285349	Green Published, hybrid			2022-12-27	WOS:000288797100083
J	Downer, EJ; Clifford, E; Gran, B; Nel, HJ; Fallon, PG; Moynagh, PN				Downer, Eric J.; Clifford, Eileen; Gran, Bruno; Nel, Hendrik J.; Fallon, Padraic G.; Moynagh, Paul N.			Identification of the Synthetic Cannabinoid R(+) WIN55,212-2 as a Novel Regulator of IFN Regulatory Factor 3 Activation and IFN-beta Expression RELEVANCE TO THERAPEUTIC EFFECTS IN MODELS OF MULTIPLE SCLEROSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; TNF-ALPHA; INFLAMMATORY DEMYELINATION; SIGNALING PATHWAY; RECEPTOR AGONIST; INNATE IMMUNITY; DOUBLE-BLIND; CELLS; INDUCTION; SYSTEM	beta-Interferons (IFN-beta s) represent one of the first line treatments for relapsing-remitting multiple sclerosis, slowing disease progression while reducing the frequency of relapses. Despite this, more effective, well tolerated therapeutic strategies are needed. Cannabinoids palliate experimental autoimmune encephalomyelitis (EAE) symptoms and have therapeutic potential in MS patients although the precise molecular mechanism for these effects is not understood. Toll-like receptor (TLR) signaling controls innate immune responses and TLRs are implicated in MS. Here we demonstrate that the synthetic cannabinoid R(+) WIN55,212-2 is a novel regulator of TLR3 and TLR4 signaling by inhibiting the pro-inflammatory signaling axis triggered by TLR3 and TLR4, whereas selectively augmenting TLR3-induced activation of IFN regulatory factor 3 (IRF3) and expression of IFN-beta. We present evidence that R(+) WIN55,212-2 strongly promotes the nuclear localization of IRF3. The potentiation of IFN-beta expression by R(+) WIN55,212-2 is critical for manifesting its protective effects in the murine MS model EAE as evidenced by its reduced therapeutic efficacy in the presence of an anti-IFN-beta antibody. R(+) WIN55,212-2 also induces IFN-beta expression in MS patient peripheral blood mononuclear cells, whereas down-regulating inflammatory signaling in these cells. These findings identify R(+) WIN55,212-2 as a novel regulator of TLR3 signaling to IRF3 activation and IFN-beta expression and highlights a new mechanism that may be open to exploitation in the development of new therapeutics for the treatment of MS.	[Downer, Eric J.; Clifford, Eileen; Moynagh, Paul N.] Natl Univ Ireland Maynooth, Inst Immunol, Co Kildare, Ireland; [Gran, Bruno] Univ Nottingham, Div Clin Neurol, Nottingham NG7 2RD, England; [Nel, Hendrik J.; Fallon, Padraic G.] St James Hosp, Trinity Coll Dublin, Inst Mol Med, Dublin 8, Ireland	Maynooth University; University of Nottingham; Trinity College Dublin	Moynagh, PN (corresponding author), Natl Univ Ireland Maynooth, Inst Immunol, Co Kildare, Ireland.	Paul.Moynagh@nuim.ie	Gran, Bruno/A-2288-2013; Fallon, Padraic/Y-2711-2019; Tuluc, Petronel/C-2527-2011	Gran, Bruno/0000-0001-6384-2342; Fallon, Padraic/0000-0002-8401-7293; Downer, Eric/0000-0002-6012-2291; Moynagh, Paul/0000-0002-4139-3061	Science Foundation Ireland; IRCSET; MS Society of Great Britain and Northern Ireland	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); IRCSET(Irish Research Council for Science, Engineering and Technology); MS Society of Great Britain and Northern Ireland	This work was supported by Science Foundation Ireland (to P. N. M.), an IRCSET postdoctoral fellowship (to E. J. D.), and a research grant from the MS Society of Great Britain and Northern Ireland (to B. G.).	Ashton JC, 2007, CURR OPIN INVEST DR, V8, P373; Baker D, 2006, TRENDS PHARMACOL SCI, V27, P1, DOI 10.1016/j.tips.2005.11.003; Blake DR, 2006, RHEUMATOLOGY, V45, P50, DOI 10.1093/rheumatology/kei183; Bsibsi M, 2002, J NEUROPATH EXP NEUR, V61, P1013, DOI 10.1093/jnen/61.11.1013; Buenafe AC, 2007, J NEUROIMMUNOL, V182, P32, DOI 10.1016/j.jneuroim.2006.09.004; Clement JF, 2008, CELL RES, V18, P889, DOI 10.1038/cr.2008.273; Croxford JL, 2003, J CLIN INVEST, V111, P1231, DOI 10.1172/JCI200317652; Curran NM, 2005, J BIOL CHEM, V280, P35797, DOI 10.1074/jbc.M507959200; Downer EJ, 2010, NEUROBIOL AGING, V31, P118, DOI 10.1016/j.neurobiolaging.2008.03.017; Facchinetti F, 2003, GLIA, V41, P161, DOI 10.1002/glia.10177; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x; Galve-Roperh I, 2008, CURR PHARM DESIGN, V14, P2279, DOI 10.2174/138161208785740117; Germain N, 2002, INT IMMUNOPHARMACOL, V2, P537, DOI 10.1016/S1567-5769(01)00200-4; Goodin DS, 2009, MULT SCLER, V15, P1175, DOI 10.1177/1352458509107007; Guo BC, 2008, J CLIN INVEST, V118, P1680, DOI 10.1172/JCI33342; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; Kraus J, 2008, MULT SCLER J, V14, P843, DOI 10.1177/1352458508088940; Li DKB, 1999, ANN NEUROL, V46, P197, DOI 10.1002/1531-8249(199908)46:2<197::AID-ANA9>3.0.CO;2-P; LYMAN WD, 1989, J NEUROIMMUNOL, V23, P73, DOI 10.1016/0165-5728(89)90075-1; Maresz K, 2007, NAT MED, V13, P492, DOI 10.1038/nm1561; Martin MU, 2002, BBA-MOL CELL RES, V1592, P265, DOI 10.1016/S0167-4889(02)00320-8; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Moynagh PN, 2005, TRENDS IMMUNOL, V26, P469, DOI 10.1016/j.it.2005.06.009; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Nair A, 2008, CELL MOL LIFE SCI, V65, P2702, DOI 10.1007/s00018-008-8059-5; Ni X, 2004, MULT SCLER J, V10, P158, DOI 10.1191/1352458504ms1009oa; Nilsson O, 2006, EUR J PHARMACOL, V547, P165, DOI 10.1016/j.ejphar.2006.07.016; O'Brien K, 2008, CURR MED CHEM, V15, P1105, DOI 10.2174/092986708784221458; O'Sullivan SE, 2007, BRIT J PHARMACOL, V152, P576, DOI 10.1038/sj.bjp.0707423; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Palazuelos J, 2008, J BIOL CHEM, V283, P13320, DOI 10.1074/jbc.M707960200; Pohl D, 2009, J NEUROL SCI, V286, P62, DOI 10.1016/j.jns.2009.03.028; Prinz M, 2006, J CLIN INVEST, V116, P456, DOI 10.1172/JCI26078; Rizzo V, 2009, NEUROSCI LETT, V462, P135, DOI 10.1016/j.neulet.2009.07.014; Servant MJ, 2003, J BIOL CHEM, V278, P9441, DOI 10.1074/jbc.M209851200; Siednienko J, 2010, EUR J IMMUNOL, V40, P3150, DOI 10.1002/eji.201040547; Smith P, 2005, J EXP MED, V202, P1319, DOI 10.1084/jem.20050955; Smith SR, 2000, J PHARMACOL EXP THER, V293, P136; Smith SR, 2001, EUR J PHARMACOL, V432, P107, DOI 10.1016/S0014-2999(01)01477-7; Stasiolek M, 2006, BRAIN, V129, P1293, DOI 10.1093/brain/awl043; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Tomida I, 2006, J GLAUCOMA, V15, P349, DOI 10.1097/01.ijg.0000212260.04488.60; Touil T, 2006, J IMMUNOL, V177, P7505, DOI 10.4049/jimmunol.177.11.7505; Vosoughi R, 2010, CLIN NEUROL NEUROSUR, V112, P365, DOI 10.1016/j.clineuro.2010.03.010; Wade DT, 2004, MULT SCLER, V10, P434, DOI 10.1191/1352458504ms1082oa; Walter L, 2004, BRIT J PHARMACOL, V141, P775, DOI 10.1038/sj.bjp.0705667; Wandinger KP, 1997, J NEUROL SCI, V149, P87, DOI 10.1016/S0022-510X(97)05383-5; Wang T, 2008, CAN MED ASSOC J, V178, P1669, DOI 10.1503/cmaj.071178; Wraith DC, 2009, P NATL ACAD SCI USA, V106, P15466, DOI 10.1073/pnas.0903360106	51	34	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10316	10328		10.1074/jbc.M110.188599	http://dx.doi.org/10.1074/jbc.M110.188599			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21245146	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000288547000049
J	To, WS; Midwood, KS				To, Wing S.; Midwood, Kim S.			Identification of Novel and Distinct Binding Sites within Tenascin-C for Soluble and Fibrillar Fibronectin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA FIBRONECTIN; EXTRACELLULAR-MATRIX; HEPARIN-BINDING; FOCAL ADHESION; III MODULES; HUMAN-SKIN; CELL; FIBRILLOGENESIS; DOMAINS; REGION	Interactions between fibronectin and tenascin-C within the extracellular matrix provide specific environmental cues that dictate tissue structure and cell function. The major binding site for fibronectin lies within the fibronectin type III-like repeats (TNfn) of tenascin-C. Here, we systematically screened TNfn domains for their ability to bind to both soluble and fibrillar fibronectin. All TNfn domains containing the TNfn3 module interact with soluble fibronectin. However, TNfn domains bind differentially to fibrillar fibronectin. This distinct binding pattern is dictated by the fibrillar conformation of FN. TNfn1-3, but not TNfn3-5, binds to immature fibronectin fibrils, and additional TNfn domains are required for binding to mature fibrils. Multiple binding sites for distinct regions of fibronectin exist within tenascin-C. TNfn domains comprise a binding site for the N-terminal 70-kDa domain of fibronectin that is freely available and a binding site for the central binding domain of fibronectin that is cryptic in full-length tenascin-C. The 70-kDa and central binding domain regions are key for fibronectin matrix assembly; accordingly, binding of several TNfn domains to these regions inhibits fibronectin fibrillogenesis. These data highlight the complexity of protein-protein binding, the importance of protein conformation on these interactions, and the implications for the physiological assembly of complex threedimensional matrices.	[To, Wing S.; Midwood, Kim S.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Rheumatol, Dept Matrix Biol,Kennedy Inst, London W6 8LH, England	Imperial College London; University of Oxford	Midwood, KS (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Rheumatol, Dept Matrix Biol,Kennedy Inst, 65 Aspenlea Rd, London W6 8LH, England.	k.midwood@imperial.ac.uk			MRC [G0700108] Funding Source: UKRI; Medical Research Council [G0700108] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Altroff H, 2004, J BIOL CHEM, V279, P55995, DOI 10.1074/jbc.M406976200; Bencharit S, 2007, J MOL BIOL, V367, P303, DOI 10.1016/j.jmb.2006.10.017; BUSBY TF, 1995, J BIOL CHEM, V270, P18558, DOI 10.1074/jbc.270.31.18558; Chen Y, 2007, BIOCHEM BIOPH RES CO, V361, P391, DOI 10.1016/j.bbrc.2007.07.014; CHIQUET M, 1984, J CELL BIOL, V98, P1926, DOI 10.1083/jcb.98.6.1926; CHIQUETEHRISMANN R, 1991, CELL REGUL, V2, P927, DOI 10.1091/mbc.2.11.927; CHIQUETEHRISMANN R, 1988, CELL, V53, P383, DOI 10.1016/0092-8674(88)90158-4; CHUNG CY, 1995, J BIOL CHEM, V270, P29012, DOI 10.1074/jbc.270.48.29012; Chung CY, 1997, J CELL SCI, V110, P1413; Craig D, 2001, P NATL ACAD SCI USA, V98, P5590, DOI 10.1073/pnas.101582198; Gao M, 2003, P NATL ACAD SCI USA, V100, P14784, DOI 10.1073/pnas.2334390100; Ghert MA, 2001, CELL STRUCT FUNCT, V26, P179; Hocking DC, 1996, J CELL BIOL, V133, P431, DOI 10.1083/jcb.133.2.431; HOFFMAN S, 1987, P NATL ACAD SCI USA, V84, P2523, DOI 10.1073/pnas.84.8.2523; Ingham KC, 2004, J BIOL CHEM, V279, P28132, DOI 10.1074/jbc.M312785200; Ingham KC, 1997, J BIOL CHEM, V272, P1718, DOI 10.1074/jbc.272.3.1718; INGHAM KC, 1990, BIOCHEM J, V272, P605, DOI 10.1042/bj2720605; Jang JH, 2004, J BIOL CHEM, V279, P25562, DOI 10.1074/jbc.M403170200; Kii I, 2010, J BIOL CHEM, V285, P2028, DOI 10.1074/jbc.M109.051961; Kusubata M, 1999, J INVEST DERMATOL, V113, P906, DOI 10.1046/j.1523-1747.1999.00802.x; Lange K, 2007, CANCER RES, V67, P6163, DOI 10.1158/0008-5472.CAN-06-3348; Latijnhouwers MA, 1996, J PATHOL, V178, P30, DOI 10.1002/(SICI)1096-9896(199601)178:1<30::AID-PATH442>3.0.CO;2-7; LIGHTNER VA, 1990, J CELL SCI, V95, P263; Magnusson MK, 1998, ARTERIOSCL THROM VAS, V18, P1363, DOI 10.1161/01.ATV.18.9.1363; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; MCKEOWNLONGO PJ, 1983, J CELL BIOL, V97, P466, DOI 10.1083/jcb.97.2.466; Midwood K, 2009, NAT MED, V15, P774, DOI 10.1038/nm.1987; Midwood KS, 2002, MOL BIOL CELL, V13, P3601, DOI 10.1091/mbc.E02-05-0292; MORLA A, 1994, NATURE, V367, P193, DOI 10.1038/367193a0; NARASIMHAN C, 1989, BIOCHEMISTRY-US, V28, P5041, DOI 10.1021/bi00438a021; Orend G, 2003, ONCOGENE, V22, P3917, DOI 10.1038/sj.onc.1206618; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Ramos DM, 1998, INT J CANCER, V75, P680, DOI 10.1002/(SICI)1097-0215(19980302)75:5<680::AID-IJC4>3.3.CO;2-2; RIOU JF, 1990, DEV BIOL, V137, P305, DOI 10.1016/0012-1606(90)90256-I; ROCCO M, 1983, J BIOL CHEM, V258, P4545; SCHWARZBAUER JE, 1991, J CELL BIOL, V113, P1463, DOI 10.1083/jcb.113.6.1463; Sechler JL, 1996, J CELL BIOL, V134, P573, DOI 10.1083/jcb.134.2.573; Sechler JL, 2001, J CELL BIOL, V154, P1081, DOI 10.1083/jcb.200102034; Spitzfaden C, 1997, J MOL BIOL, V265, P565, DOI 10.1006/jmbi.1996.0736; To WS, 2010, MATRIX BIOL, V29, P573, DOI 10.1016/j.matbio.2010.08.003; TRESSEL T, 1991, BIOCHEM J, V274, P731, DOI 10.1042/bj2740731; UGAROVA TP, 1995, BIOCHEMISTRY-US, V34, P4457, DOI 10.1021/bi00013a039; Wenk MB, 2000, J CELL BIOL, V150, P913, DOI 10.1083/jcb.150.4.913; WHITBY DJ, 1991, DEVELOPMENT, V112, P651; WILSON CL, 1992, J CELL BIOL, V119, P923, DOI 10.1083/jcb.119.4.923	45	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14881	14891		10.1074/jbc.M110.189019	http://dx.doi.org/10.1074/jbc.M110.189019			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21324901	Green Published, hybrid			2022-12-27	WOS:000289788300018
J	Williams, AL; Bielopolski, N; Meroz, D; Lam, AD; Passmore, DR; Ben-Tal, N; Ernst, SA; Ashery, U; Stuenkel, EL				Williams, Antionette L.; Bielopolski, Noa; Meroz, Daphna; Lam, Alice D.; Passmore, Daniel R.; Ben-Tal, Nir; Ernst, Stephen A.; Ashery, Uri; Stuenkel, Edward L.			Structural and Functional Analysis of Tomosyn Identifies Domains Important in Exocytotic Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SNARE COMPLEX-FORMATION; NEUROTRANSMITTER RELEASE; CHROMAFFIN CELLS; CORE COMPLEXES; PROTEIN; MEMBRANE; FUSION; SUMOYLATION; MECHANISMS; EXPRESSION	Tomosyn is a 130-kDa cytosolic R-SNARE protein that associates with Q-SNAREs and reduces exocytotic activity. Two paralogous genes, tomosyn-1 and -2, occur in mammals and produce seven different isoforms via alternative splicing. Here, we map the structural differences between the yeast homologue of m-tomosyn-1, Sro7, and tomosyn genes/isoforms to identify domains critical to the regulation of exocytotic activity to tomosyn that are outside the soluble N-ethylmaleimide-sensitive attachment receptor motif. Homology modeling of m-tomosyn-1 based on the known structure of yeast Sro7 revealed a highly conserved functional conformation but with tomosyn containing three additional loop domains that emanate from a beta-propeller core. Notably, deletion of loops 1 and 3 eliminates tomosyn inhibitory activity on secretion without altering its soluble N-ethylmaleimide-sensitive attachment receptor pairing with syntaxin1A. By comparison, deletion of loop 2, which contains the hypervariable splice region, did not reduce the ability of tomosyn to inhibit regulated secretion. However, exon variation within the hypervariable splice region resulted in significant differences in protein accumulation of tomosyn-2 isoforms. Functional analysis of s-tomosyn-1, m-tomosyn-1, m-tomosyn-2, and xb-tomosyn-2 demonstrated that they exert similar inhibitory effects on elevated K+-induced secretion in PC12 cells, although m-tomosyn-2 was novel in strongly augmenting basal secretion. Finally, we report that m-tomosyn-1 is a target substrate for SUMO 2/3 conjugation and that mutation of this small ubiquitin-related modifier target site (Lys-730) enhances m-tomosyn-1 inhibition of secretion without altering interaction with syntaxin1A. Together these results suggest that multiple domains outside the R-SNARE of tomosyn are critical to the efficacy of inhibition by tomosyn on exocytotic secretion.	[Williams, Antionette L.; Lam, Alice D.; Passmore, Daniel R.; Stuenkel, Edward L.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Ernst, Stephen A.] Univ Michigan, Dept Mol & Dev Biol, Ann Arbor, MI 48109 USA; [Bielopolski, Noa; Ashery, Uri] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel; [Meroz, Daphna; Ben-Tal, Nir] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem & Mol Biol, IL-69978 Tel Aviv, Israel	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Tel Aviv University; Tel Aviv University	Stuenkel, EL (corresponding author), 7807 Med Sci Bldg 2,1137 E Catherine St, Ann Arbor, MI 48109 USA.	esterm@umich.edu	Williams, Antionette/GQP-2255-2022	Ashery, Uri/0000-0001-6338-7888; Ben-Tal, Nir/0000-0001-6901-832X; Stuenkel, Edward/0000-0001-8225-5725	National Institutes of Health [NS053978]; Tel Aviv University, Tel Aviv, Israel; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053978] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tel Aviv University, Tel Aviv, Israel; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS053978. D. M. was supported by the Edmond J. Safra Bioinformatics Program, Tel Aviv University, Tel Aviv, Israel.	Ashery U, 2009, TRENDS NEUROSCI, V32, P275, DOI 10.1016/j.tins.2009.01.004; Baba T, 2005, J CELL BIOL, V170, P1113, DOI 10.1083/jcb.200504055; Brose N, 2008, TRAFFIC, V9, P1403, DOI 10.1111/j.1600-0854.2008.00758.x; Cheviet S, 2006, J CELL SCI, V119, P2912, DOI 10.1242/jcs.03037; Constable JRL, 2005, J BIOL CHEM, V280, P31615, DOI 10.1074/jbc.M505858200; Dybbs M, 2005, PLOS GENET, V1, P6, DOI 10.1371/journal.pgen.0010002; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fujita Y, 1998, NEURON, V20, P905, DOI 10.1016/S0896-6273(00)80472-9; Gangar A, 2005, CURR BIOL, V15, P1136, DOI 10.1016/j.cub.2005.05.046; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gerst JE, 2003, BBA-MOL CELL RES, V1641, P99, DOI 10.1016/S0167-4889(03)00096-X; Gladycheva SE, 2004, J PHYSIOL-LONDON, V558, P857, DOI 10.1113/jphysiol.2004.067249; Gladycheva SE, 2007, J BIOL CHEM, V282, P22887, DOI 10.1074/jbc.M701787200; Gracheva EO, 2007, J PHYSIOL-LONDON, V585, P705, DOI 10.1113/jphysiol.2007.138321; Gracheva EO, 2007, J NEUROSCI, V27, P10176, DOI 10.1523/JNEUROSCI.2339-07.2007; Gracheva EO, 2006, PLOS BIOL, V4, P1426, DOI 10.1371/journal.pbio.0040261; Groffen AJA, 2005, J NEUROCHEM, V92, P554, DOI 10.1111/j.1471-4159.2004.02890.x; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hatsuzawa K, 2003, J BIOL CHEM, V278, P31159, DOI 10.1074/jbc.M305500200; Hattendorf DA, 2007, NATURE, V446, P567, DOI 10.1038/nature05635; Hoppe A, 2002, BIOPHYS J, V83, P3652, DOI 10.1016/S0006-3495(02)75365-4; Jewell JL, 2010, AM J PHYSIOL-REG I, V298, pR517, DOI 10.1152/ajpregu.00597.2009; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kagami M, 1998, GENETICS, V149, P1717; Katoh M, 2004, INT J ONCOL, V24, P737; Kweon DH, 2003, NAT STRUCT BIOL, V10, P440, DOI 10.1038/nsb928; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lang T, 2002, J CELL BIOL, V158, P751, DOI 10.1083/jcb.200203088; Lehman K, 1999, J CELL BIOL, V146, P125, DOI 10.1083/jcb.146.1.125; Liu J, 2004, J BIOL CHEM, V279, P55924, DOI 10.1074/jbc.M410024200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Masuda ES, 1998, NEURON, V21, P479, DOI 10.1016/S0896-6273(00)80559-0; McEwen JM, 2006, NEURON, V51, P303, DOI 10.1016/j.neuron.2006.06.025; Min SW, 2007, P NATL ACAD SCI USA, V104, P3823, DOI 10.1073/pnas.0611725104; Musch A, 2002, MOL BIOL CELL, V13, P158, DOI 10.1091/mbc.01-10-0496; Petrey D, 2003, PROTEINS, V53, P430, DOI 10.1002/prot.10550; Pobbati AV, 2004, J BIOL CHEM, V279, P47192, DOI 10.1074/jbc.M408767200; Sakisaka T, 2004, J CELL BIOL, V166, P17, DOI 10.1083/jcb.200405002; Sakisaka T, 2008, J CELL BIOL, V183, P323, DOI 10.1083/jcb.200805150; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sen N, 2010, TRENDS NEUROSCI, V33, P493, DOI 10.1016/j.tins.2010.07.004; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; WICK PF, 1993, J BIOL CHEM, V268, P10983; Widberg CH, 2003, J BIOL CHEM, V278, P35093, DOI 10.1074/jbc.M304261200; Yamamoto Y, 2010, J BIOL CHEM, V285, P40943, DOI 10.1074/jbc.M110.156893; Yamamoto Y, 2010, BIOCHEM BIOPH RES CO, V399, P24, DOI 10.1016/j.bbrc.2010.07.026; Yamamoto Y, 2009, J BIOL CHEM, V284, P12480, DOI 10.1074/jbc.M807182200; Yizhar O, 2004, P NATL ACAD SCI USA, V101, P2578, DOI 10.1073/pnas.0308700100; Yizhar O, 2007, J NEUROCHEM, V103, P604, DOI 10.1111/j.1471-4159.2007.04791.x; Yizhar O, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002694; Yokoyama S, 1999, BIOCHEM BIOPH RES CO, V256, P218, DOI 10.1006/bbrc.1999.0300; Zhang W, 2006, DIABETES, V55, P574, DOI 10.2337/diabetes.55.03.06.db05-0015; Zhao J, 2007, CELL MOL LIFE SCI, V64, P3017, DOI 10.1007/s00018-007-7137-4	53	34	34	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14542	14553		10.1074/jbc.M110.215624	http://dx.doi.org/10.1074/jbc.M110.215624			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21330375	hybrid, Green Published			2022-12-27	WOS:000289556200074
J	He, LJ; Shobnam, N; Wimley, WC; Hristova, K				He, Lijuan; Shobnam, Nadia; Wimley, William C.; Hristova, Kalina			FGFR3 Heterodimerization in Achondroplasia, the Most Common Form of Human Dwarfism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASE; GROWTH-FACTOR RECEPTORS; TRANSMEMBRANE DOMAIN; ACANTHOSIS NIGRICANS; CROUZON-SYNDROME; MUTATIONS; ACTIVATION; DIMERIZATION; DISORDERS; ENERGETICS	The G380R mutation in the transmembrane domain of fibroblast growth factor receptor 3 (FGFR3) causes achondroplasia, the most common form of human dwarfism. Achondroplasia is a heterozygous disorder, and thus the affected individuals express both wild-type and mutant FGFR3. Yet heterodimerization in achondroplasia has not been characterized thus far. To investigate the formation of FGFR3 heterodimers in cellular membranes, we designed an FGFR3 construct that lacks the kinase domain, and we monitored the formation of inactive heterodimers between this construct and wild-type and mutant FGFR3. The formation of the inactive heterodimers depleted the pool of full-length receptors capable of forming active homodimers and ultimately reduced their phosphorylation. By analyzing the effect of the truncated FGFR3 on full-length receptor phosphorylation, we demonstrated that FGFR3 WT/G380R heterodimers form with lower probability than wild-type FGFR3 homodimers at low ligand concentration. These results further our knowledge of FGFR3-associated bone disorders.	[He, Lijuan; Shobnam, Nadia; Hristova, Kalina] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA; [Wimley, William C.] Tulane Univ, Sch Med, Dept Biochem, New Orleans, LA 70112 USA	Johns Hopkins University; Tulane University	Hristova, K (corresponding author), Johns Hopkins Univ, Dept Mat Sci & Engn, 3400 N Charles St, Baltimore, MD 21218 USA.	kh@jhu.edu	Hristova, Kalina/A-3326-2010		National Institutes of Health [GM068619, GM095930, GM060000]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068619, R01GM095930, R01GM060000] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM068619, GM095930 (to K. H.), and GM060000 (to W. C. W.).	Bell CA, 2000, MOL BIOL CELL, V11, P3589, DOI 10.1091/mbc.11.10.3589; Bevington P.R., 1969, DATA REDUCTION ERROR; Chen LR, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001195; Colvin JS, 1996, NAT GENET, V12, P390, DOI 10.1038/ng0496-390; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Han X, 2006, BIOPHYS J, V91, P3736, DOI 10.1529/biophysj.106.092247; Harada D, 2009, J BONE MINER METAB, V27, P9, DOI 10.1007/s00774-008-0009-7; He LJ, 2010, J BIOL CHEM, V285, P30103, DOI 10.1074/jbc.M109.094086; He LJ, 2008, J MOL BIOL, V384, P1130, DOI 10.1016/j.jmb.2008.10.036; Horton WA, 2007, LANCET, V370, P162, DOI 10.1016/S0140-6736(07)61090-3; L'Hote CGM, 2005, EXP CELL RES, V304, P417, DOI 10.1016/j.yexcr.2004.11.012; Li E, 2006, J MOL BIOL, V356, P600, DOI 10.1016/j.jmb.2005.11.077; Li E, 2006, BIOCHEMISTRY-US, V45, P6241, DOI 10.1021/bi060609y; Li E, 2010, CELL ADHES MIGR, V4, P249, DOI 10.4161/cam.4.2.10725; Li Y, 1997, ONCOGENE, V14, P1397, DOI 10.1038/sj.onc.1200983; McIntosh I, 2000, CELL STRUCT FUNCT, V25, P85, DOI 10.1247/csf.25.85; Merzlyakov M, 2006, J MOL BIOL, V358, P1, DOI 10.1016/j.jmb.2006.01.086; MEYERS GA, 1995, NAT GENET, V11, P462, DOI 10.1038/ng1295-462; Naski MC, 1996, NAT GENET, V13, P233, DOI 10.1038/ng0696-233; Passos-Bueno MR, 1999, HUM MUTAT, V14, P115; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; PONSETI IV, 1970, J BONE JOINT SURG AM, VA 52, P701, DOI 10.2106/00004623-197052040-00004; Raffioni S, 1998, J BIOL CHEM, V273, P35250, DOI 10.1074/jbc.273.52.35250; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; Vajo Z, 2000, ENDOCR REV, V21, P23, DOI 10.1210/er.21.1.23; van Rhijn BWG, 2002, EUR J HUM GENET, V10, P819, DOI 10.1038/sj.ejhg.5200883; WILKIE AOM, 1995, CURR BIOL, V5, P500; You M, 2006, BIOCHEMISTRY-US, V45, P5551, DOI 10.1021/bi060113g	29	30	33	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13272	13281		10.1074/jbc.M110.205583	http://dx.doi.org/10.1074/jbc.M110.205583			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21324899	Green Published, hybrid			2022-12-27	WOS:000289282200048
J	Cao, AR; Rabinovich, R; Xu, MX; Xu, XQ; Jin, VX; Farnham, PJ				Cao, Alina R.; Rabinovich, Roman; Xu, Maoxiong; Xu, Xiaoqin; Jin, Victor X.; Farnham, Peggy J.			Genome-wide Analysis of Transcription Factor E2F1 Mutant Proteins Reveals That N- and C-terminal Protein Interaction Domains Do Not Participate in Targeting E2F1 to the Human Genome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIHYDROFOLATE-REDUCTASE PROMOTER; DNA-BINDING-SITES; FAMILY-MEMBER; IN-VIVO; COMPLEX-FORMATION; EPITHELIAL-CELLS; DP FAMILY; ACTIVATION; GENE; IDENTIFICATION	Previous studies of E2F family members have suggested that protein-protein interactions may be the mechanism by which E2F proteins are recruited to specific genomic regions. We have addressed this hypothesis on a genome-wide scale using ChIP-seq analysis of MCF7 cell lines that express tagged wild type and mutant E2F1 proteins. First, we performed ChIP-seq for tagged WT E2F1. Then, we analyzed E2F1 proteins that lacked the N-terminal SP1 and cyclin A binding domains, the C-terminal transactivation and pocket protein binding domains, and the internal marked box domain. Surprisingly, we found that the ChIP-seq patterns of the mutant proteins were identical to that of WT E2F1. However, mutation of the DNA binding domain abrogated all E2F1 binding to the genome. These results suggested that the interaction between the E2F1 DNA binding domain and a consensus motif may be the primary determinant of E2F1 recruitment. To address this possibility, we analyzed the in vivo binding sites for the in vitro-derived consensus E2F1 motif (TTTSSCGC) and also performed de novo motif analysis. We found that only 12% of the ChIP-seq peaks contained the TTTSSCGC motif. De novo motif analysis indicated that most of the in vivo sites lacked the 5` half of the in vitro-derived consensus, having instead the in vivo consensus of CGCGC. In summary, our findings do not provide support for the model that protein-protein interactions are involved in recruiting E2F1 to the genome, but rather suggest that recognition of a motif found at most human promoters is the critical determinant.	[Farnham, Peggy J.] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA; [Cao, Alina R.; Rabinovich, Roman; Xu, Xiaoqin] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Xu, Maoxiong; Jin, Victor X.] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA	University of Southern California; University of California System; University of California Davis; University System of Ohio; Ohio State University	Farnham, PJ (corresponding author), Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Dept Biochem & Mol Biol, 1450 Biggy St,NRT 6503,Mail Code 9601, Los Angeles, CA 90089 USA.	pfarnham@usc.edu		Farnham, Peggy/0000-0003-4469-7914	United States Public Health Service [CA45240, HG004558]; National Institutes of Health [GM007377]; NATIONAL CANCER INSTITUTE [R29CA045240, R01CA045240] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007377] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by United States Public Health Service Grants CA45240 and HG004558.; Supported in part by National Institutes of Health Molecular and Cellular Biology Training Grant GM007377.	BANDARA LR, 1993, EMBO J, V12, P4317, DOI 10.1002/j.1460-2075.1993.tb06116.x; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Batsche E, 1998, MOL CELL BIOL, V18, P3647, DOI 10.1128/MCB.18.7.3647; Bieda M, 2006, GENOME RES, V16, P595, DOI 10.1101/gr.4887606; Blahnik KR, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1012; Campanero MR, 1997, P NATL ACAD SCI USA, V94, P2221, DOI 10.1073/pnas.94.6.2221; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; Christensen J, 2005, NUCLEIC ACIDS RES, V33, P5458, DOI 10.1093/nar/gki855; Cooper SJ, 2007, GENOME RES, V17, P136, DOI 10.1101/gr.5875007; Cress WD, 1996, MOL CELL BIOL, V16, P2119; CRESS WD, 1993, MOL CELL BIOL, V13, P6314, DOI 10.1128/MCB.13.10.6314; de Bruin A, 2003, J BIOL CHEM, V278, P42041, DOI 10.1074/jbc.M308105200; Decary S, 2002, MOL CELL BIOL, V22, P7877, DOI 10.1128/MCB.22.22.7877-7888.2002; DeGregori J, 2006, CURR MOL MED, V6, P739; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Di Stefano L, 2003, EMBO J, V22, P6289, DOI 10.1093/emboj/cdg613; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; EMILI A, 1995, J BIOL CHEM, V270, P13674, DOI 10.1074/jbc.270.23.13674; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Fry CJ, 1999, J BIOL CHEM, V274, P15883, DOI 10.1074/jbc.274.22.15883; Giangrande PH, 2003, MOL CELL BIOL, V23, P3707, DOI 10.1128/MCB.23.11.3707-3720.2003; Giangrande PH, 2004, EMBO J, V23, P1336, DOI 10.1038/sj.emboj.7600134; HAGEMEIER C, 1993, NUCLEIC ACIDS RES, V21, P4998, DOI 10.1093/nar/21.22.4998; Halaban R, 1998, ONCOGENE, V16, P2489, DOI 10.1038/sj.onc.1201773; HELIN K, 1993, GENE DEV, V7, P1850, DOI 10.1101/gad.7.10.1850; HELIN K, 1994, J VIROL, V68, P5027, DOI 10.1128/JVI.68.8.5027-5035.1994; HELIN K, 1993, MOL CELL BIOL, V13, P6501, DOI 10.1128/MCB.13.10.6501; Jin VX, 2009, BIOINFORMATICS, V25, P3191, DOI 10.1093/bioinformatics/btp570; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Karlseder J, 1996, MOL CELL BIOL, V16, P1659; Kong LJ, 2007, ONCOGENE, V26, P321, DOI 10.1038/sj.onc.1209817; KREK W, 1993, SCIENCE, V262, P1557, DOI 10.1126/science.8248803; KREK W, 1994, CELL, V78, P161, DOI 10.1016/0092-8674(94)90582-7; Lan X, 2011, BIOINFORMATICS, V27, P428, DOI 10.1093/bioinformatics/btq669; Lang SE, 2001, J BIOL CHEM, V276, P32627, DOI 10.1074/jbc.M102067200; Lee TA, 2000, ONCOGENE, V19, P2257, DOI 10.1038/sj.onc.1203556; Li J, 2008, DEV CELL, V14, P62, DOI 10.1016/j.devcel.2007.10.017; Lin JM, 2007, GENOME RES, V17, P818, DOI 10.1101/gr.5623407; Lin SY, 1996, MOL CELL BIOL, V16, P1668; Logan N, 2005, ONCOGENE, V24, P5000, DOI 10.1038/sj.onc.1208703; Logan N, 2004, ONCOGENE, V23, P5138, DOI 10.1038/sj.onc.1207649; Maiti B, 2005, J BIOL CHEM, V280, P18211, DOI 10.1074/jbc.M501410200; MAJELLO B, 1995, ONCOGENE, V10, P1841; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Martelli F, 2001, P NATL ACAD SCI USA, V98, P4455, DOI 10.1073/pnas.081061398; Marti A, 1999, NAT CELL BIOL, V1, P14, DOI 10.1038/8984; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; MEANS AL, 1992, MOL CELL BIOL, V12, P1054, DOI 10.1128/MCB.12.3.1054; Milton A, 2006, ONCOGENE, V25, P3212, DOI 10.1038/sj.onc.1209343; ORMONDROYD E, 1995, ONCOGENE, V11, P1437; Pearson A, 1997, ONCOGENE, V15, P2643, DOI 10.1038/sj.onc.1201451; Rabinovich A, 2008, GENOME RES, V18, P1763, DOI 10.1101/gr.080622.108; Revenko AS, 2010, MOL CELL BIOL, V30, P5260, DOI 10.1128/MCB.00484-10; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Rogers KT, 1996, P NATL ACAD SCI USA, V93, P7594, DOI 10.1073/pnas.93.15.7594; Ross JF, 1999, MOL CELL, V3, P195, DOI 10.1016/S1097-2765(00)80310-X; SCHILLING LJ, 1995, CELL GROWTH DIFFER, V6, P541; Schilling Lynda J., 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P19; Schlisio S, 2002, EMBO J, V21, P5775, DOI 10.1093/emboj/cdf577; Shin EK, 1996, J BIOL CHEM, V271, P12261, DOI 10.1074/jbc.271.21.12261; Slansky JE, 1996, BIOESSAYS, V18, P55, DOI 10.1002/bies.950180111; Slansky JE, 1996, CURR TOP MICROBIOL, V208, P1; Stender JD, 2010, MOL CELL BIOL, V30, P3943, DOI 10.1128/MCB.00118-10; Tao YX, 1997, MOL CELL BIOL, V17, P6994, DOI 10.1128/MCB.17.12.6994; Taubert S, 2004, MOL CELL BIOL, V24, P4546, DOI 10.1128/MCB.24.10.4546-4556.2004; Trouche D, 1996, NUCLEIC ACIDS RES, V24, P4139, DOI 10.1093/nar/24.21.4139; Vidal M, 1996, P NATL ACAD SCI USA, V93, P10321, DOI 10.1073/pnas.93.19.10321; WADE M, 1995, J BIOL CHEM, V270, P9783, DOI 10.1074/jbc.270.17.9783; WADE M, 1992, MOL CELL BIOL, V12, P4364, DOI 10.1128/MCB.12.10.4364; WU CL, 1995, MOL CELL BIOL, V15, P2536; Xu XQ, 2007, GENOME RES, V17, P1550, DOI 10.1101/gr.6783507; ZHANG YH, 1995, ONCOGENE, V10, P2085; Zheng N, 1999, GENE DEV, V13, P666, DOI 10.1101/gad.13.6.666; Zhu WC, 2004, EMBO J, V23, P4615, DOI 10.1038/sj.emboj.7600459	74	39	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.217158	http://dx.doi.org/10.1074/jbc.M110.217158			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21310950	hybrid, Green Published			2022-12-27	WOS:000289077500012
J	Cheng, YA; McNamara, DE; Miley, MJ; Nash, RP; Redinbo, MR				Cheng, Yuan; McNamara, Dan E.; Miley, Michael J.; Nash, Rebekah P.; Redinbo, Matthew R.			Functional Characterization of the Multidomain F Plasmid TraI Relaxase-Helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; DIMENSIONAL HOMOGENEOUS LATTICE; NUCLEIC-ACID INTERACTIONS; RAY SOLUTION SCATTERING; ESCHERICHIA-COLI; LARGE LIGANDS; BIOLOGICAL MACROMOLECULES; COOPERATIVE BINDING; PROTEIN HEXAMER; PRIA PROTEIN	TraI, a bifunctional enzyme containing relaxase and helicase activities, initiates and drives the conjugative transfer of the Escherichia coli F plasmid. Here, we examined the structure and function of the TraI helicase. We show that TraI binds to single-stranded DNA (ssDNA) with a site size of similar to 25 nucleotides, which is significantly longer than the site size of other known superfamily I helicases. Low cooperativity was observed with the binding of TraI to ssDNA, and a double-stranded DNA-binding site was identified within the N-terminal region of TraI 1-858, outside the core helicase motifs of TraI. We have revealed that the affinity of TraI for DNA is negatively correlated with the ionic strength of the solution. The binding of AMPPNP or ADP results in a 3-fold increase in the affinity of TraI for ssDNA. Moreover, TraI prefers to bind ssDNA oligomers containing a single type of base. Finally, we elucidated the solution structure of TraI using small angle x-ray scattering. TraI exhibits an ellipsoidal shape in solution with four domains aligning along one axis. Taken together, these data result in the assembly of a model for the multidomain helicase activity of TraI.	[McNamara, Dan E.; Miley, Michael J.; Nash, Rebekah P.; Redinbo, Matthew R.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; [Cheng, Yuan; Redinbo, Matthew R.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Cheng, Yuan; Redinbo, Matthew R.] Univ N Carolina, Program Mol & Cellular Biophys, Chapel Hill, NC 27599 USA; [Redinbo, Matthew R.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Redinbo, MR (corresponding author), Univ N Carolina, Dept Chem, Campus Box 3290, Chapel Hill, NC 27599 USA.	redinbo@unc.edu	, PEP-MX Core/AGV-4051-2022	McNamara, Dan/0000-0003-0600-7847	National Institutes of Health [AI78924, P41 RR001081]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F30ES016488] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant AI78924.; We thank Dr. Liang Guo at beamline 18-ID (Bio-CAT), Advanced Photon Source, Argonne, IL, for assistance in data collection, analysis, and manuscript preparation. Molecular graphics images were produced using the UCSF Chimera package from the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by National Institutes of Health Grant P41 RR001081).	ABDELMONEM M, 1983, P NATL ACAD SCI-BIOL, V80, P4659, DOI 10.1073/pnas.80.15.4659; ABDELMONEM M, 1976, EUR J BIOCHEM, V65, P431, DOI 10.1111/j.1432-1033.1976.tb10358.x; Anderson BJ, 2008, METHOD ENZYMOL, V450, P253, DOI 10.1016/S0076-6879(08)03412-5; Brochet M, 2008, P NATL ACAD SCI USA, V105, P15961, DOI 10.1073/pnas.0803654105; BUJALOWSKI W, 1995, BIOCHEMISTRY-US, V34, P8513, DOI 10.1021/bi00027a001; BUJALOWSKI W, 1989, BIOPOLYMERS, V28, P1637, DOI 10.1002/bip.360280912; BUJALOWSKI W, 1987, J MOL BIOL, V195, P897, DOI 10.1016/0022-2836(87)90493-1; Byrd DR, 2002, J BIOL CHEM, V277, P42645, DOI 10.1074/jbc.M205984200; COMISRUTH FX, 2006, CURR OPIN STRUC BIOL, V16, P744; Csitkovits VC, 2003, J BIOL CHEM, V278, P48696, DOI 10.1074/jbc.M310025200; Datta K, 2003, J BIOL CHEM, V278, P5694, DOI 10.1074/jbc.M208133200; de la Cruz F, 2010, FEMS MICROBIOL REV, V34, P18, DOI 10.1111/j.1574-6976.2009.00195.x; DOSTAL L, 2010, NUCL ACIDS RES; Dostal L, 2010, J BACTERIOL, V192, P3620, DOI 10.1128/JB.00154-10; Dou SX, 2004, J BIOL CHEM, V279, P6354, DOI 10.1074/jbc.M311272200; EPSTEIN IR, 1978, BIOPHYS CHEM, V8, P327, DOI 10.1016/0301-4622(78)80015-5; Frost LS, 2005, NAT REV MICROBIOL, V3, P722, DOI 10.1038/nrmicro1235; Gourves AS, 2000, J BIOL CHEM, V275, P10864, DOI 10.1074/jbc.275.15.10864; HOWARD MT, 1995, J BIOL CHEM, V270, P28381; Jezewska MJ, 1996, J BIOL CHEM, V271, P4261; Jezewska MJ, 1996, BIOCHEMISTRY-US, V35, P2117, DOI 10.1021/bi952344l; Jezewska MJ, 2004, J MOL BIOL, V343, P115, DOI 10.1016/j.jmb.2004.08.021; Jezewska MJ, 1996, BIOCHEMISTRY-US, V35, P2129, DOI 10.1021/bi952345d; Jezewska MJ, 2000, J BIOL CHEM, V275, P27865; Jezewska MJ, 2000, BIOCHEMISTRY-US, V39, P10454, DOI 10.1021/bi001113y; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KORANGY F, 1993, BIOCHEMISTRY-US, V32, P4873, DOI 10.1021/bi00069a024; KOWALCZYKOWSKI SC, 1981, J MOL BIOL, V145, P75, DOI 10.1016/0022-2836(81)90335-1; KUHN B, 1979, J BIOL CHEM, V254, P1343; LAHUE EE, 1988, J BIOL CHEM, V263, P3208; LANKA E, 1995, ANNU REV BIOCHEM, V64, P141, DOI 10.1146/annurev.bi.64.070195.001041; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Maluf NK, 2003, J MOL BIOL, V325, P913, DOI 10.1016/S0022-2836(02)01277-9; MATSON SW, 1991, J BIOL CHEM, V266, P16232; Matson SW, 2005, J BACTERIOL, V187, P697, DOI 10.1128/JB.187.2.697-706.2005; Matson SW, 2001, J BIOL CHEM, V276, P2372, DOI 10.1074/jbc.M008728200; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; Myong S, 2010, CURR OPIN STRUC BIOL, V20, P121, DOI 10.1016/j.sbi.2009.12.008; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ragonese H, 2007, MOL MICROBIOL, V63, P1173, DOI 10.1111/j.1365-2958.2006.05576.x; Saikrishnan K, 2008, EMBO J, V27, P2222, DOI 10.1038/emboj.2008.144; Saikrishnan K, 2009, CELL, V137, P849, DOI 10.1016/j.cell.2009.03.036; Sikora B, 2006, J BIOL CHEM, V281, P36110, DOI 10.1074/jbc.M604412200; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Street LM, 2003, BBA-PROTEINS PROTEOM, V1646, P86, DOI 10.1016/S1570-9639(02)00553-8; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; TRAXLER BA, 1988, J MOL BIOL, V204, P205, DOI 10.1016/0022-2836(88)90609-2; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang JL, 2004, J BIOL CHEM, V279, P52024, DOI 10.1074/jbc.M408645200; Wriggers W, 2001, J APPL CRYSTALLOGR, V34, P773, DOI 10.1107/S0021889801012869	54	13	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.207563	http://dx.doi.org/10.1074/jbc.M110.207563			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21288910	Green Published, hybrid			2022-12-27	WOS:000289077500078
J	Jama, AM; Gabriel, J; Al-Nagar, AJ; Martin, S; Baig, SZ; Soleymani, H; Chowdhury, Z; Beesley, P; Torok, K				Jama, Abdirahman M.; Gabriel, Jonathan; Al-Nagar, Ahmed J.; Martin, Stephen; Baig, Sana Z.; Soleymani, Homan; Chowdhury, Zawahir; Beesley, Philip; Toeroek, Katalin			Lobe-specific Functions of Ca2+center dot Calmodulin in alpha Ca2+center dot Calmodulin-dependent Protein Kinase II Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; ALPHA-CAMKII; CALCIUM DISSOCIATION; DENDRITIC SPINES; STOPPED-FLOW; BINDING-SITE; CALMODULIN; MECHANISM; AUTOPHOSPHORYLATION; RECEPTOR	N-Methyl-D-aspartic acid receptor-dependent long term potentiation (LTP), a model of memory formation, requires Ca2+center dot calmodulin-dependent protein kinase II (alpha CaMKII) activity and Thr(286) autophosphorylation via both global and local Ca2+ signaling, but the mechanisms of signal transduction are not understood. We tested the hypothesis that the Ca2+-binding activator protein calmodulin (CaM) is the primary decoder of Ca2+ signals, thereby determining the output, e. g. LTP. Thus, we investigated the function of CaM mutants, deficient in Ca2+ binding at sites 1 and 2 of the N-terminal lobe or sites 3 and 4 of the C-terminal CaM lobe, in the activation of alpha CaMKII. Occupancy of CaM Ca2+ binding sites 1, 3, and 4 is necessary and sufficient for full activation. Moreover, the N- and C-terminal CaM lobes have distinct functions. Ca2+ binding toNlobe Ca2+ binding site 1 increases the turnover rate of the enzyme 5-fold, whereas the Clobe plays a dual role; it is required for full activity, but in addition, via Ca2+ binding site 3, it stabilizes ATP binding to alpha CaMKII 4-fold. Thr(286) autophosphorylation is also dependent on Ca2+ binding sites on both the N and the C lobes of CaM. As the CaM C lobe sites are populated by low amplitude/low frequency (global) Ca2+ signals, but occupancy of N lobe site 1 and thus activation of alpha CaMKII requires high amplitude/high frequency (local) Ca2+ signals, lobe-specific sensing of Ca2+ signaling patterns by CaM is proposed to explain the requirement for both global and local Ca2+ signaling in the induction of LTP via alpha CaMKII.	[Jama, Abdirahman M.; Gabriel, Jonathan; Al-Nagar, Ahmed J.; Baig, Sana Z.; Soleymani, Homan; Chowdhury, Zawahir; Toeroek, Katalin] Univ London, Div Basic Med Sci, London SW17 0RE, England; [Martin, Stephen] Natl Inst Med Res, London NW7 1AA, England; [Beesley, Philip] Univ London, Sch Biol Sci, Egham TW20 0EX, Surrey, England	University of London; MRC National Institute for Medical Research; University of London; Royal Holloway University London	Torok, K (corresponding author), Univ London, Div Basic Med Sci, London SW17 0RE, England.	k.torok@sgul.ac.uk		Torok, Katalin/0000-0002-3107-4534	Wellcome Trust [075931]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Wellcome Trust Project Grant 075931 (to K. T.).	BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Bradshaw JM, 2002, J BIOL CHEM, V277, P20991, DOI 10.1074/jbc.M202154200; Colbran RJ, 2004, CURR OPIN NEUROBIOL, V14, P318, DOI 10.1016/j.conb.2004.05.008; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Dodd R, 2008, J BIOL CHEM, V283, P26911, DOI 10.1074/jbc.M801434200; Evans TIA, 2009, PROTEINS, V76, P47, DOI 10.1002/prot.22317; Forest A, 2008, BIOCHEMISTRY-US, V47, P10587, DOI 10.1021/bi8007033; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Grant PAA, 2008, CELL CALCIUM, V44, P465, DOI 10.1016/j.ceca.2008.03.003; HASHIMOTO Y, 1987, ARCH BIOCHEM BIOPHYS, V252, P418, DOI 10.1016/0003-9861(87)90048-8; Ikura M, 2006, P NATL ACAD SCI USA, V103, P1159, DOI 10.1073/pnas.0508640103; Jama AM, 2009, J BIOL CHEM, V284, P28146, DOI 10.1074/jbc.M109.005900; KEMP BE, 1989, CELL SIGNAL, V1, P303, DOI 10.1016/0898-6568(89)90049-1; KING MM, 1988, ARCH BIOCHEM BIOPHYS, V267, P467, DOI 10.1016/0003-9861(88)90052-5; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; LINSE S, 1991, J BIOL CHEM, V266, P8050; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; Martin SR, 1996, BIOCHEMISTRY-US, V35, P3508, DOI 10.1021/bi952522a; MARTIN SR, 1985, EUR J BIOCHEM, V151, P543, DOI 10.1111/j.1432-1033.1985.tb09137.x; MARTIN SR, 1992, EUR J BIOCHEM, V205, P1107, DOI 10.1111/j.1432-1033.1992.tb16879.x; Migues PV, 2006, J NEUROCHEM, V98, P289, DOI 10.1111/j.1471-4159.2006.03876.x; MILLER SG, 1988, NEURON, V1, P593, DOI 10.1016/0896-6273(88)90109-2; Morris EP, 2001, J MOL BIOL, V308, P1, DOI 10.1006/jmbi.2001.4584; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Ohmae S, 2006, J BIOL CHEM, V281, P20427, DOI 10.1074/jbc.M513212200; Otmakhov N, 2004, J NEUROSCI, V24, P9324, DOI 10.1523/JNEUROSCI.2350-04.2004; Rose J, 2009, NEURON, V61, P351, DOI 10.1016/j.neuron.2008.12.030; Shen K, 2000, NAT NEUROSCI, V3, P881, DOI 10.1038/78783; Shifman JM, 2006, P NATL ACAD SCI USA, V103, P13968, DOI 10.1073/pnas.0606433103; SMITH GL, 1985, BIOCHIM BIOPHYS ACTA, V839, P287, DOI 10.1016/0304-4165(85)90011-X; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; Tadross MR, 2008, CELL, V133, P1228, DOI 10.1016/j.cell.2008.05.025; Thalhammer A, 2006, EMBO J, V25, P5873, DOI 10.1038/sj.emboj.7601420; Topolnik L, 2009, J NEUROSCI, V29, P4658, DOI 10.1523/JNEUROSCI.0493-09.2009; Torok K, 1998, BIOCHEMISTRY-US, V37, P6188, DOI 10.1021/bi972773e; Torok K, 2001, BIOCHEMISTRY-US, V40, P14878, DOI 10.1021/bi010920+; Tzortzopoulos A, 2004, BIOCHEMISTRY-US, V43, P6404, DOI 10.1021/bi036224m; Tzortzopoulos A, 2004, BIOCHEMISTRY-US, V43, P6270, DOI 10.1021/bi035449u; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758	39	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.157057	http://dx.doi.org/10.1074/jbc.M110.157057			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21300804	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000289077500045
J	Shiou, SR; Yu, YY; Chen, SZ; Ciancio, MJ; Petrof, EO; Sun, J; Claud, EC				Shiou, Sheng-Ru; Yu, Yueyue; Chen, Sangzi; Ciancio, Mae J.; Petrof, Elaine O.; Sun, Jun; Claud, Erika C.			Erythropoietin Protects Intestinal Epithelial Barrier Function and Lowers the Incidence of Experimental Neonatal Necrotizing Enterocolitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET-ACTIVATING-FACTOR; NECROSIS-FACTOR-ALPHA; BLOOD-BRAIN-BARRIER; GROWTH-FACTOR-BETA; INTERFERON-GAMMA; TIGHT JUNCTION; HUMAN-MILK; IN-VITRO; INTRAEPITHELIAL LYMPHOCYTES; FLUID ABSORPTION	The impermeant nature of the intestinal barrier is maintained by tight junctions (TJs) formed between adjacent intestinal epithelial cells. Disruption of TJs and loss of barrier function are associated with a number of gastrointestinal diseases, including neonatal necrotizing enterocolitis (NEC), the leading cause of death from gastrointestinal diseases in preterm infants. Human milk is protective against NEC, and the human milk factor erythropoietin (Epo) has been shown to protect endothelial cell-cell and blood-brain barriers. We hypothesized that Epo may also protect intestinal epithelial barriers, thereby lowering the incidence of NEC. Our data demonstrate that Epo protects enterocyte barrier function by supporting expression of the TJ protein ZO-1. As immaturity is a key factor in NEC, Epo regulation of ZO-1 in the human fetal immature H4 intestinal epithelial cell line was examined and demonstrated Epo-stimulated ZO-1 expression in a dose-dependent manner through the PI3K/Akt pathway. In a rat NEC model, oral administration of Epo lowered the incidence of NEC from 45 to 23% with statistical significance. In addition, Epo treatment protected intestinal barrier function and prevented loss of ZO-1 at the TJs in vivo. These effects were associated with elevated Akt phosphorylation in the intestine. This study reveals a novel role of Epo in the regulation of intestinal epithelial TJs and barrier function and suggests the possible use of enteral Epo as a therapeutic agent for gut diseases.	[Shiou, Sheng-Ru; Yu, Yueyue; Chen, Sangzi; Claud, Erika C.] Univ Chicago, Dept Pediat, Sect Neonatol, Chicago, IL 60637 USA; [Claud, Erika C.] Univ Chicago, Gastroenterol Sect, Dept Med, Chicago, IL 60637 USA; [Ciancio, Mae J.] Midwestern Univ, Chicago, IL 60515 USA; [Petrof, Elaine O.] Queens Univ, Dept Med, Kingston, ON K7L 3M6, Canada; [Sun, Jun] Univ Rochester, Dept Med, Rochester, NY 14627 USA	University of Chicago; University of Chicago; Midwestern University; Queens University - Canada; University of Rochester	Claud, EC (corresponding author), Univ Chicago, Dept Pediat, Sect Neonatol, 5841 S Maryland Ave,MC6060, Chicago, IL 60637 USA.	eclaud@peds.bsd.uchicago.edu	Sun, Jun/S-7440-2019	Sun, Jun/0000-0001-7465-3133	National Institutes of Health from NICHD [R21 AT004044, HD055237, R01 HD059123]; Children Research Foundation [HD062144-01A1]; National Institutes of Health [DK42086]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD062144, R01HD059123] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD055237] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT004044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086] Funding Source: NIH RePORTER	National Institutes of Health from NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Children Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R21 AT004044 (to E. C. C. and E. O. P.) and HD055237 and R01 HD059123 (to E. C. C.) from NICHD. This work was also supported by Children Research Foundation Grant and Kirschstein-NRSA Fellowship Award HD062144-01A1 (to S.-R. S.).; We thank Drs. Jerrold Turner and Le Shen from the Department of Pathology for project suggestions and technical support on intestinal ZO-1 staining, Dr. Amy Noffsinger from the Department of Pathology for scoring of the NEC experiment tissues, and Dr. Christine Labno from the Integrated Microscopy Core Facility for confocal microscopy. The Digestive Disease Research Core Center of the University of Chicago (supported by National Institutes of Health Grant DK42086) provided core facilities and services used for this study.	Akisu M, 2001, EUR J PEDIATR SURG, V11, P167, DOI 10.1055/s-2001-15485; Anand RJ, 2007, SHOCK, V27, P124, DOI 10.1097/01.shk.0000239774.02904.65; Anderson JM, 1993, CURR OPIN CELL BIOL, V5, P772, DOI 10.1016/0955-0674(93)90024-K; Bose C, 2008, AM J PHYSIOL-CELL PH, V295, pC394, DOI 10.1152/ajpcell.00423.2007; Buck I, 2008, BIOCHEM PHARMACOL, V76, P1229, DOI 10.1016/j.bcp.2008.08.025; CAPLAN MS, 1990, J PEDIATR-US, V116, P960, DOI 10.1016/S0022-3476(05)80661-4; CAPLAN MS, 1994, PEDIATR PATHOL, V14, P1017, DOI 10.3109/15513819409037698; Clark JA, 2006, AM J PHYSIOL-GASTR L, V291, pG938, DOI 10.1152/ajpgi.00090.2006; Ferrier L, 2003, GASTROENTEROLOGY, V125, P795, DOI 10.1016/S0016-5085(03)01057-6; Ford H, 1997, J PEDIATR SURG, V32, P275, DOI 10.1016/S0022-3468(97)90194-9; FOULKES EC, 1991, P SOC EXP BIOL MED, V197, P477; Halpern MD, 2006, GASTROENTEROLOGY, V130, P359, DOI 10.1053/j.gastro.2005.10.023; HOLMAN RC, 1989, AM J PUBLIC HEALTH, V79, P987, DOI 10.2105/AJPH.79.8.987; Homma H, 2005, AM J PHYSIOL-GASTR L, V288, pG466, DOI 10.1152/ajpgi.00036.2004; ISRAEL EJ, 1994, ACTA PAEDIATR, V83, P27, DOI 10.1111/j.1651-2227.1994.tb13238.x; Juul SE, 1999, PEDIATR RES, V46, P263, DOI 10.1203/00006450-199909000-00003; Juul SE, 1998, EARLY HUM DEV, V52, P235, DOI 10.1016/S0378-3782(98)00030-9; Kling PJ, 1998, PEDIATR RES, V43, P216, DOI 10.1203/00006450-199802000-00010; KOSLOSKE A, 1994, ACTA PAEDIATR, V83, P2, DOI 10.1111/j.1651-2227.1994.tb13232.x; Kumar SM, 2006, MELANOMA RES, V16, P275, DOI 10.1097/01.cmr.0000222594.60611.c3; Kumral A, 2003, BIOL NEONATE, V84, P325, DOI 10.1159/000073642; KURSCHEID T, 1993, EUR J PEDIATR SURG, V3, P139, DOI 10.1055/s-2008-1063530; Ledbetter DJ, 2000, J PEDIATR SURG, V35, P178, DOI 10.1016/S0022-3468(00)90006-X; Lee JF, 2006, J BIOL CHEM, V281, P29190, DOI 10.1074/jbc.M604310200; Lee SM, 2004, BIOCHEM BIOPH RES CO, V320, P1087, DOI 10.1016/j.bbrc.2004.06.060; Li Y, 2007, NEUROCHEM RES, V32, P2132, DOI 10.1007/s11064-007-9387-9; Liu RQ, 2006, J NEUROCHEM, V96, P1101, DOI 10.1111/j.1471-4159.2005.03597.x; LUCAS A, 1990, LANCET, V336, P1519, DOI 10.1016/0140-6736(90)93304-8; MADARA JL, 1989, J CLIN INVEST, V83, P724, DOI 10.1172/JCI113938; Madonna R, 2009, EXP CELL RES, V315, P2921, DOI 10.1016/j.yexcr.2009.07.016; Martinez-Estrada OM, 2003, EUR J NEUROSCI, V18, P2538, DOI 10.1046/j.1460-9568.2003.02987.x; Naftalin RJ, 1999, J PHYSIOL-LONDON, V514, P211, DOI 10.1111/j.1469-7793.1999.211af.x; Napolitano LM, 1996, SHOCK, V5, P202, DOI 10.1097/00024382-199603000-00006; Piena-Spoel M, 2001, J PEDIATR SURG, V36, P587, DOI 10.1053/jpsu.2001.22288; SAITO S, 1993, CLIN EXP IMMUNOL, V94, P220, DOI 10.1111/j.1365-2249.1993.tb06004.x; Sanderson IR, 1996, P NATL ACAD SCI USA, V93, P7717, DOI 10.1073/pnas.93.15.7717; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Semba Richard D, 2002, J Hum Lact, V18, P252, DOI 10.1177/08934402018003007; Shiou SR, 2006, J BIOL CHEM, V281, P33971, DOI 10.1074/jbc.M607010200; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Szakal DN, 2010, VIRCHOWS ARCH, V456, P245, DOI 10.1007/s00428-009-0879-7; Thiagarajah JR, 2000, GUT, V47, P675, DOI 10.1136/gut.47.5.675; Thuijls Geertje, 2010, J Clin Gastroenterol, V44, pe14, DOI 10.1097/MCG.0b013e31819f5652; Tsukita S, 2000, J CELL BIOL, V149, P13, DOI 10.1083/jcb.149.1.13; Tsukita S, 2000, ANN NY ACAD SCI, V915, P129, DOI 10.1111/j.1749-6632.2000.tb05235.x; Viscardi RM, 1997, PEDIATR PATHOL LAB M, V17, P547, DOI 10.1080/107710497174516; Yang H, 2002, ANN SURG, V236, P226, DOI 10.1097/00000658-200208000-00011; Yoo JY, 2009, J NEUROSCI RES, V87, P150, DOI 10.1002/jnr.21832; Youakim A, 1999, AM J PHYSIOL-GASTR L, V276, pG1279, DOI 10.1152/ajpgi.1999.276.5.G1279; Zufferey C, 2009, IMMUNOLOGY, V128, P351, DOI 10.1111/j.1365-2567.2009.03110.x	50	79	87	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.154625	http://dx.doi.org/10.1074/jbc.M110.154625			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21262973	hybrid, Green Published			2022-12-27	WOS:000289077500027
J	Xiao, KH; Shenoy, SK				Xiao, Kunhong; Shenoy, Sudha K.			beta(2)-Adrenergic Receptor Lysosomal Trafficking Is Regulated by Ubiquitination of Lysyl Residues in Two Distinct Receptor Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; AGONIST-PROMOTED UBIQUITINATION; CLATHRIN-MEDIATED ENDOCYTOSIS; BETA-ADRENERGIC-RECEPTOR; BETA-2-ADRENERGIC RECEPTOR; 7-TRANSMEMBRANE RECEPTORS; SIGNALING PATHWAYS; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; DOWN-REGULATION	Agonist stimulation of the beta(2)-adrenergic receptors (beta(2)ARs) leads to their ubiquitination and lysosomal degradation. Inhibition of lysosomal proteases results in the stabilization and retention of internalized full-length beta(2)ARs in the lysosomes, whereas inhibition of proteasomal proteases stabilizes newly synthesized beta(2)ARs in nonlysosomal compartments. Additionally, a lysine-less beta(2)AR(0K-beta(2)AR) that is deficient in ubiquitination and degradation is not sorted to lysosomes unlike the WT beta(2)AR, which is sorted to lysosomes. Thus, lysosomes are the primary sites for the degradation of agonist-activated, ubiquitinated beta(2)ARs. To identify the specific site(s) of ubiquitination required for lysosomal sorting of the beta(2)AR, four mutants, with lysines only in one intracellular domain, namely, loop 1, loop 2, loop 3, and carboxyl tail were generated. All of these receptor mutants coupled to G proteins, recruited beta-arrestin2, and internalized just as the WT beta(2)AR. However, only loop 3 and carboxyl tail beta(2)ARs with lysines in the third intracellular loop or in the carboxyl tail were ubiquitinated and sorted for lysosomal degradation. As a complementary approach, we performed MS-based proteomic analyses to directly identify ubiquitination sites within the beta(2)AR. We overexpressed and purified the beta(2)AR from HEK-293 cells with or without prior agonist exposure and subjected trypsin-cleaved beta(2)AR to LC-MS/MS analyses. We identified ubiquitinated lysines in the third intracellular loop (Lys-263 and Lys-270) and in the carboxyl tail (Lys-348, Lys-372, and Lys-375) of the beta(2)AR. These findings introduce a new concept that two distinct domains in the beta(2)AR are involved in ubiquitination and lysosomal degradation, contrary to the generalization that such regulatory mechanisms occur mainly at the carboxyl tails of GPCRs and other transmembrane receptors.	[Xiao, Kunhong] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Duke University; Duke University	Xiao, KH (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	khxiao@receptor-biol.duke.edu; sudha@receptor-biol.duke.edu	Shenoy, Sudha/AAN-4075-2021; Xiao, Kunhong/AAG-4275-2020	Shenoy, Sudha/0000-0002-2565-4663; Xiao, Kunhong/0000-0002-1069-1226	National Institutes of Health [HL080525]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080525] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL080525 (to S. K. S.).	BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; BARAK LS, 1994, J BIOL CHEM, V269, P2790; Berthouze M, 2009, EMBO J, V28, P1684, DOI 10.1038/emboj.2009.128; CARON MG, 1979, J BIOL CHEM, V254, P2923; Chakir K, 2003, MOL PHARMACOL, V64, P1048, DOI 10.1124/mol.64.5.1048; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Ciechanover A, 2004, TRENDS CELL BIOL, V14, P103, DOI 10.1016/j.tcb.2004.01.004; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; Day PW, 2007, NAT METHODS, V4, P927, DOI 10.1038/NMETH1112; Feng Y, 2000, MOL CELL BIOL, V20, P5350, DOI 10.1128/MCB.20.14.5350-5359.2000; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Freeman K, 2001, J CLIN INVEST, V107, P967, DOI 10.1172/JCI12083; Gagnon AW, 1998, J BIOL CHEM, V273, P6976, DOI 10.1074/jbc.273.12.6976; Haas W, 2006, MOL CELL PROTEOMICS, V5, P1326, DOI 10.1074/mcp.M500339-MCP200; Hall RA, 2004, SEMIN CELL DEV BIOL, V15, P281, DOI 10.1016/j.semcdb.2003.12.017; Hanania NA, 2010, CURR OPIN PULM MED, V16, P1, DOI 10.1097/MCP.0b013e328333def8; HAUSDORFF WP, 1989, J BIOL CHEM, V264, P12657; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hicke L, 1998, J CELL BIOL, V141, P349, DOI 10.1083/jcb.141.2.349; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; Kim YM, 2002, J BIOL CHEM, V277, P30760, DOI 10.1074/jbc.M204528200; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Kirkpatrick DS, 2005, NAT CELL BIOL, V7, P750, DOI 10.1038/ncb0805-750; KOBILKA BK, 1988, SCIENCE, V240, P1310, DOI 10.1126/science.2836950; Lefkowitz RJ, 2000, NAT CELL BIOL, V2, pE133, DOI 10.1038/35017152; Lefkowitz RJ, 2008, NAT BIOTECHNOL, V26, P189, DOI 10.1038/nbt0208-189; Liang W, 2008, BIOCHEMISTRY-US, V47, P11750, DOI 10.1021/bi800219q; Lin FT, 1997, J BIOL CHEM, V272, P31051, DOI 10.1074/jbc.272.49.31051; Lohse MJ, 2003, CIRC RES, V93, P896, DOI 10.1161/01.RES.0000102042.83024.CA; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Malaga-Dieguez L, 2010, MOL PHARMACOL, V77, P940, DOI 10.1124/mol.110.063511; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marotti LA, 2002, BIOCHEMISTRY-US, V41, P5067, DOI 10.1021/bi015940q; Martin NP, 2003, J BIOL CHEM, V278, P45954, DOI 10.1074/jbc.M308285200; Milojevic T, 2006, MOL PHARMACOL, V69, P1083, DOI 10.1124/mol.105.015818; Moore RH, 1999, J CELL SCI, V112, P329; ODOWD BF, 1988, J BIOL CHEM, V263, P15985; Parola AL, 1997, ANAL BIOCHEM, V254, P88, DOI 10.1006/abio.1997.2361; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Petaja-Repo UE, 2001, J BIOL CHEM, V276, P4416, DOI 10.1074/jbc.M007151200; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Shenoy SK, 2003, J BIOL CHEM, V278, P14498, DOI 10.1074/jbc.M209626200; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2008, J BIOL CHEM, V283, P22166, DOI 10.1074/jbc.M709668200; Shenoy SK, 2007, CIRC RES, V100, P1142, DOI 10.1161/01.RES.0000261939.88744.5a; Shenoy SK, 2009, P NATL ACAD SCI USA, V106, P6650, DOI 10.1073/pnas.0901083106; Shin H, 2003, BIOCHEM J, V373, P965, DOI 10.1042/BJ20030583; Sliter DA, 2008, J BIOL CHEM, V283, P35319, DOI 10.1074/jbc.M807288200; Torrecilla I, 2006, CURR PHARM DESIGN, V12, P1797, DOI 10.2174/138161206776873716; Walker JKL, 1999, J BIOL CHEM, V274, P31515, DOI 10.1074/jbc.274.44.31515; Wojcikiewicz RJH, 2004, TRENDS PHARMACOL SCI, V25, P35, DOI 10.1016/j.tips.2003.11.008; Xiang Y, 2003, SCIENCE, V300, P1530, DOI 10.1126/science.1079206; Xiao R P, 2001, Sci STKE, V2001, pre15, DOI 10.1126/stke.2001.104.re15; Xie L, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000444; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; Zamah AM, 2002, J BIOL CHEM, V277, P31249, DOI 10.1074/jbc.M202753200; Zhang J, 1999, J BIOL CHEM, V274, P10999, DOI 10.1074/jbc.274.16.10999	65	40	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.203091	http://dx.doi.org/10.1074/jbc.M110.203091			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21330366	Green Published, hybrid			2022-12-27	WOS:000289077500089
J	Speckmann, B; Bidmon, HJ; Pinto, A; Anlauf, M; Sies, H; Steinbrenner, H				Speckmann, Bodo; Bidmon, Hans-Juergen; Pinto, Antonio; Anlauf, Martin; Sies, Helmut; Steinbrenner, Holger			Induction of Glutathione Peroxidase 4 Expression during Enterocytic Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLORECTAL-CANCER; SELENOPROTEIN-P; MESSENGER-RNA; SELENIUM SUPPLEMENTATION; OXIDATIVE STRESS; CACO-2 CELLS; NF-Y; HYDROPEROXIDE; COLON; MICE	Glutathione peroxidase 4 (GPx4), an abundant selenoenzyme, is ubiquitously expressed in a tissue-, cell-and differentiation-dependent manner, and it is localized in cytoplasmic, mitochondrial, and nuclear cellular compartments. Here, we report cytoplasmic and nuclear localization of GPx4 in Caco-2 intestinal epithelial cells. Enterocytic differentiation of Caco-2 cells triggers an increase in GPx4 mRNA and protein levels, mediated by enhanced promoter activity. We identified a combined cAMP response element (CREB) and CCAAT/enhancer binding protein (C/EBP) site as critical for the differentiation-triggered GPx4 promoter activity. Induction of GPx4 correlated with C/EBP alpha transcript levels during differentiation, suggesting a role of C/EBP alpha as regulator of enterocytic GPx4 expression. Consistent with the in vitro results, GPx4 protein was detected in cytoplasmic and nuclear compartments of enterocytes in human intestinal epithelia. GPx4 is uniformly expressed in colonic crypts and is differentially expressed along the crypt-to-villu saxis in the small intestine with a more pronounced expression of GPx4 in the upper villi, which contain fully differentiated enterocytes. These data suggest that intestinal GPx4 expression is modulated by the enterocytic differentiation program, and the results support a direct role of nuclear GPx4 in the (selenium-dependent) prevention of oxidative damage in the gastrointestinal tract.	[Steinbrenner, Holger] Univ Dusseldorf, Inst Biochem & Mol Biol 1, Fac Med, D-40225 Dusseldorf, Germany; [Bidmon, Hans-Juergen] Univ Dusseldorf, C&O Vogt Inst Brain Res, D-40225 Dusseldorf, Germany; [Anlauf, Martin] Univ Dusseldorf, Inst Pathol, D-40225 Dusseldorf, Germany; [Sies, Helmut] Univ Dusseldorf, Inst Umweltmed Forsch, D-40225 Dusseldorf, Germany; [Sies, Helmut] King Saud Univ, Coll Sci, Riyadh 11451, Saudi Arabia	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; King Saud University	Steinbrenner, H (corresponding author), Univ Dusseldorf, Inst Biochem & Mol Biol 1, Fac Med, Univ Str 1,Geb 22-03, D-40225 Dusseldorf, Germany.	Holger.Steinbrenner@uni-duesseldorf.de	Steinbrenner, Holger/AAD-6323-2019; Sies, Helmut/B-7266-2008; Sies, Helmut/ABE-7355-2020	Sies, Helmut/0000-0002-1000-3198; Steinbrenner, Holger/0000-0003-2754-2435	Deutsche Forschungsgemeinschaft [STE 1782/2-1, SFB 575/B4]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants STE 1782/2-1 and SFB 575/B4.	Arai M, 1999, J BIOL CHEM, V274, P4924, DOI 10.1074/jbc.274.8.4924; Baek IJ, 2007, J MOL HISTOL, V38, P237, DOI 10.1007/s10735-007-9092-7; Bao YP, 1997, FEBS LETT, V410, P210, DOI 10.1016/S0014-5793(97)00591-7; Bartsch H, 2002, BIOL CHEM, V383, P915, DOI 10.1515/BC.2002.098; Bermano G, 2007, GENES NUTR, V2, P225, DOI 10.1007/s12263-007-0052-3; Bestwick CS, 2000, BBA-GEN SUBJECTS, V1474, P47, DOI 10.1016/S0304-4165(99)00212-3; BLAIS S, 1995, DEV DYNAM, V204, P66, DOI 10.1002/aja.1002040109; Boucher MJ, 2005, J CELL PHYSIOL, V202, P178, DOI 10.1002/jcp.20104; Brigelius-Flohe R, 2006, BIOL CHEM, V387, P1329, DOI 10.1515/BC.2006.166; CHANDRASEKARAN C, 1993, P NATL ACAD SCI USA, V90, P8871, DOI 10.1073/pnas.90.19.8871; Clark LC, 1996, JAMA-J AM MED ASSOC, V276, P1957, DOI 10.1001/jama.276.24.1957; Conrad M, 2007, BIOL CHEM, V388, P1019, DOI 10.1515/BC.2007.130; Davis CD, 2002, J NUTR, V132, P292, DOI 10.1093/jn/132.2.292; Engle MJ, 1998, J CELL PHYSIOL, V174, P362, DOI 10.1002/(SICI)1097-4652(199803)174:3<362::AID-JCP10>3.0.CO;2-B; Esworthy RS, 1998, BBA-GEN SUBJECTS, V1381, P213, DOI 10.1016/S0304-4165(98)00032-4; Florian S, 2010, FREE RADICAL BIO MED, V49, P1694, DOI 10.1016/j.freeradbiomed.2010.08.029; Hattori H, 2007, BIOCHEM J, V408, P277, DOI 10.1042/BJ20070245; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Hoffmann PR, 2007, NUCLEIC ACIDS RES, V35, P3963, DOI 10.1093/nar/gkm355; Huang HS, 1999, FEBS LETT, V455, P111, DOI 10.1016/S0014-5793(99)00866-2; Huin C, 2002, BIOL CELL, V94, P15, DOI 10.1016/S0248-4900(01)01178-9; Irons R, 2006, J NUTR, V136, P1311, DOI 10.1093/jn/136.5.1311; Jacobs ET, 2004, J NATL CANCER I, V96, P1669, DOI 10.1093/jnci/djh310; Kelner MJ, 1998, BIOCHEM BIOPH RES CO, V249, P53, DOI 10.1006/bbrc.1998.9086; Mariadason JM, 2002, CANCER RES, V62, P4791; Meplan C, 2010, CARCINOGENESIS, V31, P1074, DOI 10.1093/carcin/bgq076; Miao L, 2009, FREE RADICAL BIO MED, V47, P344, DOI 10.1016/j.freeradbiomed.2009.05.018; Murawaki Y, 2008, CANCER LETT, V259, P218, DOI 10.1016/j.canlet.2007.10.019; Nemoto E, 2009, BONE, V44, P805, DOI 10.1016/j.bone.2008.12.029; Peters U, 2008, CANCER EPIDEM BIOMAR, V17, P1144, DOI 10.1158/1055-9965.EPI-07-2947; Piana C, 2008, EUR J PHARM BIOPHARM, V69, P1187, DOI 10.1016/j.ejpb.2008.03.008; PINTO M, 1983, BIOL CELL, V47, P323; Ran QT, 2003, FREE RADICAL BIO MED, V35, P1101, DOI 10.1016/S0891-5849(03)00466-0; Rayman MP, 2009, BBA-GEN SUBJECTS, V1790, P1533, DOI 10.1016/j.bbagen.2009.03.014; Reid ME, 2006, INT J CANCER, V118, P1777, DOI 10.1002/ijc.21529; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; Speckmann B, 2010, FREE RADICAL BIO MED, V49, P777, DOI 10.1016/j.freeradbiomed.2010.05.035; Steinbrenner H, 2006, FREE RADICAL RES, V40, P936, DOI 10.1080/10715760600806248; Steinbrenner H, 2009, BBA-GEN SUBJECTS, V1790, P1478, DOI 10.1016/j.bbagen.2009.02.014; Suaud L, 1997, BIOCHEM BIOPH RES CO, V235, P820, DOI 10.1006/bbrc.1997.6888; Synnestvedt K, 2002, J CLIN INVEST, V110, P993, DOI 10.1172/JCI200215337; Tham DM, 1998, AM J PHYSIOL-GASTR L, V275, pG1463, DOI 10.1152/ajpgi.1998.275.6.G1463; URSINI F, 1985, BIOCHIM BIOPHYS ACTA, V839, P62, DOI 10.1016/0304-4165(85)90182-5; Wingler K, 1999, EUR J BIOCHEM, V259, P149, DOI 10.1046/j.1432-1327.1999.00012.x; Yoo MH, 2010, ANTIOXID REDOX SIGN, V12, P819, DOI 10.1089/ars.2009.2891; Zhong ZD, 2000, J BIOL CHEM, V275, P18602, DOI 10.1074/jbc.M001389200	46	41	42	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10764	10772		10.1074/jbc.M110.216028	http://dx.doi.org/10.1074/jbc.M110.216028			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21252226	Green Published, hybrid			2022-12-27	WOS:000288547000090
J	Xie, R; Nguyen, S; McKeehan, K; Wang, F; McKeehan, WL; Liu, LY				Xie, Rui; Nguyen, Susan; McKeehan, Kerstin; Wang, Fen; McKeehan, Wallace L.; Liu, Leyuan			Microtubule-associated Protein 1S (MAP1S) Bridges Autophagic Components with Microtubules and Mitochondria to Affect Autophagosomal Biogenesis and Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR RASSF1; DEATH INDUCER C19ORF5; CELL-DEATH; BINDING PROTEIN; APOPTOSIS; FUSION; PARKIN; LYSOSOMES; ISOFORM; COMPLEX	The ubiquitously distributed MAP1S is a homologue of the exclusively neuronal distributed microtubule-associated protein 1A and 1B (MAP1A/B). They give rise to multiple isoforms through similar post-translational modification. Isoforms of MAP1S have been implicated in microtubule dynamics and mitotic abnormalities and mitotic cell death. Here we show that ablation of the Map1s gene in mice caused reduction in the B-cell CLL/lymphoma 2 or xL (Bcl-2/xL) and cyclin-dependent kinase inhibitor 1B (P27) protein levels, accumulation of defective mitochondria, and severe defects in response to nutritive stress, suggesting defects in autophagosomal biogenesis and clearance. Furthermore, MAP1S isoforms interacted with the autophagosome-associated light chain 3 of MAP1A/B (LC3), a homologue of yeast autophagy-related gene 8 (ATG8), and recruited it to stable microtubules in a MAP1S and LC3 isoform-dependent mode. In addition, MAP1S interacted with mitochondrion-associated leucine-rich PPR-motif containing protein (LRPPRC) that interacts with the mitophagy initiator and Parkinson disease-related protein Parkin. The three-way interactions of MAP1S isoforms with LC3 and microtubules as well as the interaction of MAP1S with LRPPRC suggest that MAP1S isoforms may play positive roles in integration of autophagic components with microtubules and mitochondria in both autophagosomal biogenesis and degradation. For the first time, our results clarify roles of MAP1S in bridging microtubules and mitochondria with autophagic and mitophagic initiation, maturation, trafficking, and lysosomal clearance. Defects in the MAP1S-regulated autophagy may impact heart disease, cancers, neurodegenerative diseases, and a wide range of other diseases.	[Xie, Rui; Nguyen, Susan; McKeehan, Kerstin; Wang, Fen; McKeehan, Wallace L.; Liu, Leyuan] TX A&M Hlth Sci Ctr, Ctr Canc & Stem Cell Biol, Inst Biosci & Technol, Houston, TX 77030 USA		Liu, LY (corresponding author), TX A&M Hlth Sci Ctr, Ctr Canc & Stem Cell Biol, Inst Biosci & Technol, 2121 W Holcombe Blvd, Houston, TX 77030 USA.	lliu@ibt.tamhsc.edu	XIE, RUI/N-7325-2014		National Institutes of Health [1R01CA142862, NCI P50 CA140388, CA16672]; Department of Defense [W81XWH]; Susan Komen Foundation; NATIONAL CANCER INSTITUTE [P50CA140388, P30CA016672, R01CA142862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Susan Komen Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01CA142862 (NCI; to L. L.) and NCI P50 CA140388 (NCI; to W. L. M.). This work was also supported by Department of Defense New Investigator Award W81XWH (to L. L.), the Susan Komen Foundation (to W. L. M.), and aid from the John S. Dunn Research Foundation (to W. L. M.).; We thank Drs. Le Sun and Joe Corvera (A&G Pharmaceuticals, Inc., Columbia, MD) for anti-MAP1S mouse monoclonal antibody 4G1, which is now sold by Precision Antibody (TM) with catalog number AG10006. LC3 cDNA and GFP-LC3 transgenic mice were gifts from Dr. Noboru Mizushima, the Department of Physiology and Cell Biology, Tokyo Medical and Dental University Graduate School and Faculty of Medicine. Transmission electron microscopy was performed by the High Resolution Electron Microscopy Facility in the University of Texas MD Anderson Cancer Center supported by National Institutes of Health Cancer Center Core Grant CA16672.	Chen D, 2010, J BIOL CHEM, V285, P38214, DOI 10.1074/jbc.M110.101469; Dallol A, 2007, CANCER RES, V67, P492, DOI 10.1158/0008-5472.CAN-06-3604; Davison EJ, 2009, PROTEOMICS, V9, P4284, DOI 10.1002/pmic.200900126; Ding JQ, 2006, BIOCHEM BIOPH RES CO, V339, P172, DOI 10.1016/j.bbrc.2005.10.199; Fass E, 2006, J BIOL CHEM, V281, P36303, DOI 10.1074/jbc.M607031200; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Jahreiss L, 2008, TRAFFIC, V9, P574, DOI 10.1111/j.1600-0854.2008.00701.x; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kochl R, 2006, TRAFFIC, V7, P129, DOI 10.1111/j.1600-0854.2005.00368.x; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kuwana T, 2003, CURR OPIN CELL BIOL, V15, P691, DOI 10.1016/j.ceb.2003.10.004; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Li H, 2008, P NATL ACAD SCI USA, V105, P2169, DOI 10.1073/pnas.0711647105; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Lin YS, 2007, GENESIS, V45, P554, DOI 10.1002/dvg.20327; Liu LY, 2009, CELL ONCOL, V31, P393, DOI 10.3233/CLO-2009-0484; Liu LY, 2009, CELL CYCLE, V8, P1616, DOI 10.4161/cc.8.10.8577; Liu LM, 2003, ONCOGENE, V22, P8125, DOI 10.1038/sj.onc.1206984; Liu LY, 2005, BIOCHEM BIOPH RES CO, V332, P670, DOI 10.1016/j.bbrc.2005.05.006; Liu LY, 2005, CANCER RES, V65, P4191, DOI 10.1158/0008-5472.CAN-04-3865; Liu LY, 2005, CANCER RES, V65, P1830, DOI 10.1158/0008-5472.CAN-04-3896; Liu LY, 2002, IN VITRO CELL DEV-AN, V38, P582; Liu LY, 2002, GENOMICS, V79, P124, DOI 10.1006/geno.2001.6679; MANN SS, 1994, J BIOL CHEM, V269, P11492; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Monastyrska I, 2009, BIOL REV, V84, P431, DOI 10.1111/j.1469-185X.2009.00082.x; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Orban-Nemeth Z, 2005, J BIOL CHEM, V280, P2257, DOI 10.1074/jbc.M408984200; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Rong R, 2004, ONCOGENE, V23, P8216, DOI 10.1038/sj.onc.1207901; Scarlatti F, 2008, CELL DEATH DIFFER, V15, P1318, DOI 10.1038/cdd.2008.51; Skulachev VP, 2001, TRENDS BIOCHEM SCI, V26, P23, DOI 10.1016/S0968-0004(00)01735-7; Song MS, 2005, J BIOL CHEM, V280, P3920, DOI 10.1074/jbc.M409115200; Song MS, 2004, NAT CELL BIOL, V6, P129, DOI 10.1038/ncb1091; Tanaka A, 2010, FEBS LETT, V584, P1386, DOI 10.1016/j.febslet.2010.02.060; Tanida I, 2004, J BIOL CHEM, V279, P36268, DOI 10.1074/jbc.M401461200; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; van der Weyden L, 2005, MOL CELL BIOL, V25, P8356, DOI 10.1128/MCB.25.18.8356-8367.2005; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wang QJ, 2006, J NEUROSCI, V26, P8057, DOI 10.1523/JNEUROSCI.2261-06.2006; Wong EYM, 2004, BIOL REPROD, V70, P775, DOI 10.1095/biolreprod.103.018531; Xie R, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-89; Zhang G, 2008, J BIOL CHEM, V283, P24343, DOI 10.1074/jbc.M803444200	48	80	82	3	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10367	10377		10.1074/jbc.M110.206532	http://dx.doi.org/10.1074/jbc.M110.206532			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21262964	Green Published, hybrid			2022-12-27	WOS:000288547000053
J	Barneaud-Rocca, D; Borgese, F; Guizouarn, H				Barneaud-Rocca, Damien; Borgese, Franck; Guizouarn, Helene			Dual Transport Properties of Anion Exchanger 1 THE SAME TRANSMEMBRANE SEGMENT IS INVOLVED IN ANION EXCHANGE AND IN A CATION LEAK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL TUBULAR-ACIDOSIS; CELL-VOLUME REGULATION; SCANNING MUTAGENESIS; CHLORIDE CHANNEL; MEMBRANE DOMAIN; POINT MUTATIONS; BAND-3 PROTEIN; IONIC-STRENGTH; HUMAN AE1; ERYTHROCYTE	Previous results suggested that specific point mutations in human anion exchanger 1 (AE1) convert the electroneutral anion exchanger into a monovalent cation conductance. In the present study, the transport site for anion exchange and for the cation leak has been studied by cysteine scanning mutagenesis and sulfhydryl reagent chemistry. Moreover, the role of some highly conserved amino acids within members of the SLC4 family to which AE1 belongs has been assessed in AE1 transport properties. The results suggest that the same transport site within the AE1 spanning domain is involved in anion exchange or in cation transport. A functioning mechanism for this transport site is proposed according to transport properties of the different studied point mutations of AE1.	[Barneaud-Rocca, Damien; Borgese, Franck; Guizouarn, Helene] Univ Nice, IBDC, Ctr Natl Rech Sci, UMR6543, F-06108 Nice 2, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Guizouarn, H (corresponding author), Univ Nice, IBDC, Ctr Natl Rech Sci, UMR6543, Batiment Sci Nat,28 Av Valrose, F-06108 Nice 2, France.	guizouar@unice.fr		BORGESE, Franck/0000-0001-7718-2111; Guizouarn, Helene/0000-0002-8757-6672				BAMBERG E, 1992, PROGR CELL RES; Bruce LJ, 2005, NAT GENET, V37, P1258, DOI 10.1038/ng1656; DeFelice LJ, 2007, ANNU REV PHYSIOL, V69, P87, DOI 10.1146/annurev.physiol.69.031905.164816; Delaunay J, 2004, SEMIN HEMATOL, V41, P165, DOI 10.1053/j.seminhematol.2004.02.005; Ellory JC, 2009, PHILOS T R SOC B, V364, P189, DOI 10.1098/rstb.2008.0154; FIEVET B, 1995, EMBO J, V14, P5158, DOI 10.1002/j.1460-2075.1995.tb00200.x; Frillingos S, 1998, FASEB J, V12, P1281, DOI 10.1096/fasebj.12.13.1281; Fujinaga J, 1999, J BIOL CHEM, V274, P6626, DOI 10.1074/jbc.274.10.6626; GarciaRomeu F, 1996, CELL MOL BIOL, V42, P985; Groves JD, 1999, BIOCHEM J, V344, P699, DOI 10.1042/0264-6021:3440699; Guizouarn H, 1999, AM J PHYSIOL-CELL PH, V276, pC210, DOI 10.1152/ajpcell.1999.276.1.C210; Guizouarn H, 2001, J PHYSIOL-LONDON, V535, P497, DOI 10.1111/j.1469-7793.2001.t01-1-00497.x; Guizouarn H, 2007, BLOOD, V110, P2158, DOI 10.1182/blood-2006-12-063420; JENNINGS ML, 1992, J BIOL CHEM, V267, P13964; KNAUF P, 1992, BAND 3 PROTEINS ANIO, P35; Larsson HP, 1996, BIOPHYS J, V70, P733, DOI 10.1016/S0006-3495(96)79613-3; Lisal J, 2008, NAT STRUCT MOL BIOL, V15, P805, DOI 10.1038/nsmb.1466; Martial S, 2006, J CELL PHYSIOL, V207, P829, DOI 10.1002/jcp.20631; McAlear SD, 2006, J BIOL CHEM, V281, P32417, DOI 10.1074/jbc.M607253200; Miller C, 2006, NATURE, V440, P484, DOI 10.1038/nature04713; MOTAIS R, 1991, BIOCHIM BIOPHYS ACTA, V1075, P169, DOI 10.1016/0304-4165(91)90248-F; Ryan RM, 2005, CLIN EXP PHARMACOL P, V32, P1, DOI 10.1111/j.1440-1681.2005.04164.x; Stewart GW, 2004, CURR OPIN HEMATOL, V11, P244, DOI 10.1097/01.moh.0000132240.20671.33; Takeuchi A, 2008, NATURE, V456, P413, DOI 10.1038/nature07350; Tang XB, 1998, J BIOL CHEM, V273, P22545, DOI 10.1074/jbc.273.35.22545; Tang XB, 1999, J BIOL CHEM, V274, P3557, DOI 10.1074/jbc.274.6.3557; Tanner MJA, 2002, CURR OPIN HEMATOL, V9, P133, DOI 10.1097/00062752-200203000-00009; Vandenberg RJ, 2008, CHANNELS, V2, P51, DOI 10.4161/chan.2.1.6047; Walsh S, 2008, AM J PHYSIOL-RENAL, V295, pF343, DOI 10.1152/ajprenal.00587.2007; Walsh S, 2009, BIOCHEM BIOPH RES CO, V382, P668, DOI 10.1016/j.bbrc.2009.03.062; Wrong O, 2002, KIDNEY INT, V62, P10, DOI 10.1046/j.1523-1755.2002.00417.x; Yamaguchi T, 2010, J STRUCT BIOL, V169, P406, DOI 10.1016/j.jsb.2009.12.009; Yenchitsomanus Pa-Thai, 2005, J Mol Genet Med, V1, P49; Yool AJ, 2002, NEWS PHYSIOL SCI, V17, P68, DOI 10.1152/nips.01372.2001; Zhu QS, 2003, J BIOL CHEM, V278, P3112, DOI 10.1074/jbc.M207797200	35	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8909	8916		10.1074/jbc.M110.166819	http://dx.doi.org/10.1074/jbc.M110.166819			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21257764	Green Published, hybrid			2022-12-27	WOS:000288247700022
J	Song, F; Zhang, X; Ren, XB; Zhu, P; Xu, J; Wang, L; Li, YF; Zhong, N; Ru, Q; Zhang, DW; Jiang, JL; Xia, B; Chen, ZN				Song, Fei; Zhang, Xin; Ren, Xiao-Bai; Zhu, Ping; Xu, Jing; Wang, Li; Li, Yi-Fei; Zhong, Nan; Ru, Qiang; Zhang, Da-Wei; Jiang, Jian-Li; Xia, Bin; Chen, Zhi-Nan			Cyclophilin A (CyPA) Induces Chemotaxis Independent of Its Peptidylprolyl Cis-Trans Isomerase Activity DIRECT BINDING BETWEEN CyPA AND THE ECTODOMAIN OF CD147	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLOSPORINE-A BINDING; SIGNAL-TRANSDUCTION; CD147; ISOMERIZATION; CANCER; CATALYSIS; PROTEIN; CELLS; IDENTIFICATION; HAB18G/CD147	Cyclophilin A (CyPA) is a ubiquitously distributed peptidylprolyl cis-transisomerase (PPIase) that possesses diverse biological functions. Extracellular CyPA is a potent chemokine, which can directly induce leukocyte chemotaxis and contribute to the pathogenesis of inflammation-mediated diseases. Although it has been identified that the chemotaxis activity of CyPA is mediated through its cell surface signaling receptor CD147, the role of CyPA PPIase activity in this process is disputable, and the underlying molecular mechanism is still poorly understood. In this study, we present the first evidence that CyPA induces leukocyte chemotaxis through a direct binding with the ectodomain of CD147 (CD147(ECT)), independent of its PPIase activity. Although NMR study indicates that the CD147(ECT) binding site on CyPA overlaps with the PPIase active site, the PPIase inactive mutant CyPA(R55A) exhibits similar CD147(ECT) binding ability and chemotaxis activity to those of CyPAWT. Furthermore, we have identified three key residues of CyPA involved in CD147(ECT) binding and found that mutations H70A, T107A, and R69A result in similar levels of reduction in CD147(ECT) binding ability and chemotaxis activity for CyPA, without affecting the PPIase activity. Our findings indicate that there exists a novel mechanism for CyPA to regulate cellular signaling processes, shedding new light on its applications in drug development and providing a new targeting site for drug design.	[Ren, Xiao-Bai; Li, Yi-Fei; Xia, Bin] Peking Univ, Beijing Nucl Magnet Resonance Ctr, Beijing 100871, Peoples R China; [Ren, Xiao-Bai; Zhong, Nan; Xia, Bin] Peking Univ, Coll Chem & Mol Engn, Beijing 100871, Peoples R China; [Li, Yi-Fei; Xia, Bin] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Zhu, Ping] Fourth Mil Med Univ, Xijing Hosp, Dept Clin Immunol, Xian 710032, Peoples R China; [Zhang, Da-Wei; Jiang, Jian-Li; Chen, Zhi-Nan] Fourth Mil Med Univ, Xijing Hosp, Cell Engn Res Ctr, Xian 710032, Peoples R China; [Zhang, Da-Wei; Jiang, Jian-Li; Chen, Zhi-Nan] Fourth Mil Med Univ, Xijing Hosp, Dept Cell Biol, State Key Lab Canc Biol, Xian 710032, Peoples R China	Peking University; Peking University; Peking University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Xia, B (corresponding author), Peking Univ, Beijing Nucl Magnet Resonance Ctr, Beijing 100871, Peoples R China.	binxia@pku.edu.cn; znchen@fmmu.edu.cn	Xu, Jing/AAX-7869-2020; Li, Yifei/GYA-2567-2022; Xia, Bin/O-1160-2016	Xu, Jing/0000-0002-2035-3482; Xia, Bin/0000-0002-2197-6403	National Natural Science Foundation of China [30900234]; 973 Program [2009CB521700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China)	This work was supported by Grant 30900234 from the National Natural Science Foundation of China and Grant 2009CB521700 from the 973 Program.	Andreotti AH, 2003, BIOCHEMISTRY-US, V42, P9515, DOI 10.1021/bi0350710; Arora K, 2005, J IMMUNOL, V175, P517, DOI 10.4049/jimmunol.175.1.517; Bosco DA, 2002, P NATL ACAD SCI USA, V99, P5247, DOI 10.1073/pnas.082100499; BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453; Brazin KN, 2002, P NATL ACAD SCI USA, V99, P1899, DOI 10.1073/pnas.042529199; Calhoun CC, 2009, MOL CELL BIOCHEM, V320, P35, DOI 10.1007/s11010-008-9896-0; Chen ZN, 2005, J INFECT DIS, V191, P755, DOI 10.1086/427811; CLARDY J, 1995, P NATL ACAD SCI USA, V92, P56, DOI 10.1073/pnas.92.1.56; Damsker JM, 2007, J LEUKOCYTE BIOL, V82, P613, DOI 10.1189/jlb.0506317; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Elbaz B, 2010, BIOCHEMISTRY-US, V49, P7634, DOI 10.1021/bi1008722; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; GALAT A, 1993, EUR J BIOCHEM, V216, P689, DOI 10.1111/j.1432-1033.1993.tb18189.x; Gwinn WM, 2006, J IMMUNOL, V177, P4870, DOI 10.4049/jimmunol.177.7.4870; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; Howard BR, 2003, NAT STRUCT BIOL, V10, P475, DOI 10.1038/nsb927; Hur S, 2002, J AM CHEM SOC, V124, P7303, DOI 10.1021/ja020222s; Ke HM, 2004, FRONT BIOSCI-LANDMRK, V9, P2285, DOI 10.2741/1396; KOFRON JL, 1991, BIOCHEMISTRY-US, V30, P6127, DOI 10.1021/bi00239a007; Li GH, 2003, J AM CHEM SOC, V125, P15028, DOI 10.1021/ja0367851; Li M, 2006, CANCER-AM CANCER SOC, V106, P2284, DOI 10.1002/cncr.21862; Liu XL, 2009, CELL MICROBIOL, V11, P730, DOI 10.1111/j.1462-5822.2009.01286.x; Mallis RJ, 2002, NAT STRUCT BIOL, V9, P900, DOI 10.1038/nsb864; MOSS ML, 1992, J BIOL CHEM, V267, P22054; Nicholson LK, 2007, MOL CELL, V25, P483, DOI 10.1016/j.molcel.2007.02.005; Obchoei S, 2009, MED SCI MONITOR, V15, pRA221; Pushkarsky T, 2001, P NATL ACAD SCI USA, V98, P6360, DOI 10.1073/pnas.111583198; Schlegel J, 2009, J MOL BIOL, V391, P518, DOI 10.1016/j.jmb.2009.05.080; SHERRY B, 1992, P NATL ACAD SCI USA, V89, P3511, DOI 10.1073/pnas.89.8.3511; SPITZFADEN C, 1994, J BIOMOL NMR, V4, P463, DOI 10.1007/BF00156614; TAKAHASHI N, 1989, NATURE, V337, P473, DOI 10.1038/337473a0; WALSH CT, 1992, J BIOL CHEM, V267, P13115; Yang HR, 2007, BIOCHEM BIOPH RES CO, V361, P763, DOI 10.1016/j.bbrc.2007.07.085; Yu XL, 2008, J BIOL CHEM, V283, P18056, DOI 10.1074/jbc.M802694200; Yurchenko V, 2006, IMMUNOLOGY, V117, P301, DOI 10.1111/j.1365-2567.2005.02316.x; Yurchenko V, 2005, J BIOL CHEM, V280, P17013, DOI 10.1074/jbc.M412851200; Yurchenko V, 2010, CLIN EXP IMMUNOL, V160, P305, DOI 10.1111/j.1365-2249.2010.04115.x; Yurchenko V, 2002, J BIOL CHEM, V277, P22959, DOI 10.1074/jbc.M201593200; Zheng JM, 2008, CANCER RES, V68, P7769, DOI 10.1158/0008-5472.CAN-08-0639; ZYDOWSKY LD, 1992, PROTEIN SCI, V1, P1092, DOI 10.1002/pro.5560010903	40	51	55	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8197	8203		10.1074/jbc.C110.181347	http://dx.doi.org/10.1074/jbc.C110.181347			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21245143	hybrid, Green Published			2022-12-27	WOS:000288013300050
J	Di Bartolo, ND; Hvorup, RN; Locher, KP; Booth, PJ				Di Bartolo, Natalie D.; Hvorup, Rikki N.; Locher, Kaspar P.; Booth, Paula J.			In Vitro Folding and Assembly of the Escherichia coli ATP-binding Cassette Transporter, BtuCD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELICAL MEMBRANE-PROTEIN; ABC TRANSPORTER; HISTIDINE PERMEASE; MUTATIONS; GENE; PURIFICATION; STABILITY; MECHANISM; SUBUNIT; COMPLEX	Studies on membrane protein folding have focused on monomeric alpha-helical proteins and a major challenge is to extend this work to larger oligomeric membrane proteins. Here, we study the Escherichia coli (E. coli) ATP-binding cassette (ABC) transporter that imports vitamin B-12 (the BtuCD protein) and use it as a model system for investigating the folding and assembly of a tetrameric membrane protein complex. Our work takes advantage of the modular organization of BtuCD, which consists of two transmembrane protein subunits, BtuC, and two cytoplasmically located nucleotide-binding protein subunits, BtuD. We show that the BtuCD transporter can be re-assembled from both prefolded and partly unfolded, urea denatured BtuC and BtuD subunits. The in vitro re-assembly leads to a BtuCD complex with the correct, native, BtuC and BtuD subunit stoichiometry. The highest rates of ATP hydrolysis were achieved for BtuCD re-assembled from partly unfolded subunits. This supports the idea of cooperative folding and assembly of the constituent protein subunits of the BtuCD transporter. BtuCD folding also provides an opportunity to investigate how a protein that contains both membrane-bound and aqueous subunits coordinates the folding requirements of the hydrophobic and hydrophilic subunits.	[Di Bartolo, Natalie D.; Booth, Paula J.] Univ Bristol, Sch Med Sci, Dept Biochem, Bristol BS8 1TD, Avon, England; [Hvorup, Rikki N.] Univ Queensland, Div Chem & Struct Biol, Brisbane, Qld 4072, Australia; [Locher, Kaspar P.] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	University of Bristol; University of Queensland; Swiss Federal Institutes of Technology Domain; ETH Zurich	Booth, PJ (corresponding author), Univ Bristol, Sch Med Sci, Dept Biochem, Bristol BS8 1TD, Avon, England.	paula.booth@bristol.ac.uk		Booth, Paula Jane/0000-0003-3893-360X	Biotechnology and Biosciences Research Council; European Union via the European Membrane Protein Consortium (EMeP); Swiss National Science Foundation	Biotechnology and Biosciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union via the European Membrane Protein Consortium (EMeP); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was funded by a Biotechnology and Biosciences Research Council PhD studentship (to N. D. B.), the European Union via the European Membrane Protein Consortium (EMeP), and the Swiss National Science Foundation (to K. L.).	Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; AZZARIA M, 1989, MOL CELL BIOL, V9, P5289, DOI 10.1128/MCB.9.12.5289; Barrera FN, 2005, BIOCHEMISTRY-US, V44, P14344, DOI 10.1021/bi050845t; Barrera NP, 2008, SCIENCE, V321, P243, DOI 10.1126/science.1159292; Bezrukov SM, 2000, CURR OPIN COLLOID IN, V5, P237, DOI 10.1016/S1359-0294(00)00061-3; Biemans-Oldehinkel E, 2006, FEBS LETT, V580, P1023, DOI 10.1016/j.febslet.2005.11.079; Bjelic S, 2006, BIOCHEMISTRY-US, V45, P8931, DOI 10.1021/bi0608156; Booth PJ, 2006, CURR OPIN STRUC BIOL, V16, P480, DOI 10.1016/j.sbi.2006.06.004; Booth PJ, 2009, CURR OPIN STRUC BIOL, V19, P8, DOI 10.1016/j.sbi.2008.12.005; Booth PJ, 1996, BIOCHEMISTRY-US, V35, P5103, DOI 10.1021/bi953053f; Booth PJ, 2001, CRIT REV BIOCHEM MOL, V36, P501, DOI 10.1080/20014091074246; Borths EL, 2005, BIOCHEMISTRY-US, V44, P16301, DOI 10.1021/bi0513103; Borths EL, 2002, P NATL ACAD SCI USA, V99, P16642, DOI 10.1073/pnas.262659699; Bowie JU, 2005, NATURE, V438, P581, DOI 10.1038/nature04395; CHIFFLET S, 1988, ANAL BIOCHEM, V168, P1, DOI 10.1016/0003-2697(88)90002-4; COLLINS FS, 1992, SCIENCE, V256, P774, DOI 10.1126/science.1375392; Curnow P, 2007, P NATL ACAD SCI USA, V104, P18970, DOI 10.1073/pnas.0705067104; Daley DO, 2008, CURR OPIN STRUC BIOL, V18, P420, DOI 10.1016/j.sbi.2008.04.006; Davidson AL, 1997, J BACTERIOL, V179, P5458, DOI 10.1128/jb.179.17.5458-5464.1997; Davidson AL, 1996, J BIOL CHEM, V271, P4858; Dowhan W, 2009, ANNU REV BIOCHEM, V78, P515, DOI 10.1146/annurev.biochem.77.060806.091251; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; Gorzelle BM, 1999, BIOCHEMISTRY-US, V38, P16373, DOI 10.1021/bi991292n; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; Han JH, 2007, NAT REV MOL CELL BIO, V8, P319, DOI 10.1038/nrm2144; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; Jones PM, 2004, CELL MOL LIFE SCI, V61, P682, DOI 10.1007/s00018-003-3336-9; Kulajta C, 2006, J MOL BIOL, V355, P989, DOI 10.1016/j.jmb.2005.11.039; Landmesser H, 2002, BBA-BIOMEMBRANES, V1565, P64, DOI 10.1016/S0005-2736(02)00506-0; Lees JG, 2004, ANAL BIOCHEM, V332, P285, DOI 10.1016/j.ab.2004.06.002; Liu CE, 1997, J BIOL CHEM, V272, P21883, DOI 10.1074/jbc.272.35.21883; Liu PQ, 1998, P NATL ACAD SCI USA, V95, P3495, DOI 10.1073/pnas.95.7.3495; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; LONDON E, 1982, J BIOL CHEM, V257, P7003; Lorch M, 2004, J MOL BIOL, V344, P1109, DOI 10.1016/j.jmb.2004.09.090; Mateu MG, 1999, NAT STRUCT BIOL, V6, P191; MILLA ME, 1995, BIOCHEMISTRY-US, V34, P3344, DOI 10.1021/bi00010a025; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Mourez M, 1998, MOL MICROBIOL, V30, P353, DOI 10.1046/j.1365-2958.1998.01070.x; Nikaido K, 1997, J BIOL CHEM, V272, P27745, DOI 10.1074/jbc.272.44.27745; Otzen DE, 2003, J MOL BIOL, V330, P641, DOI 10.1016/S0022-2836(03)00624-7; Partridge AW, 2004, PROTEINS, V54, P648, DOI 10.1002/prot.10611; Paulusma CC, 1996, SCIENCE, V271, P1126, DOI 10.1126/science.271.5252.1126; Riley ML, 1997, BIOCHEMISTRY-US, V36, P192, DOI 10.1021/bi962199r; Riordan JR, 2005, ANNU REV PHYSIOL, V67, P701, DOI 10.1146/annurev.physiol.67.032003.154107; Rothlisberger D, 2005, J MOL BIOL, V347, P773, DOI 10.1016/j.jmb.2005.01.053; Rumfeldt JAO, 2008, PROG BIOPHYS MOL BIO, V98, P61, DOI 10.1016/j.pbiomolbio.2008.05.004; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Schneider E, 1998, FEMS MICROBIOL REV, V22, P1; Senior AE, 1998, BIOCHEMISTRY-US, V37, P831, DOI 10.1021/bi9719962; Sharma S, 2005, J BACTERIOL, V187, P2908, DOI 10.1128/JB.187.8.2908-2911.2005; Stenberg F, 2007, J MOL BIOL, V371, P765, DOI 10.1016/j.jmb.2007.05.045; THOMAS PM, 1995, SCIENCE, V268, P426, DOI 10.1126/science.7716548; Valiyaveetil FI, 2002, BIOCHEMISTRY-US, V41, P10771, DOI 10.1021/bi026215y; van Veen HW, 1997, SEMIN CANCER BIOL, V8, P183, DOI 10.1006/scbi.1997.0064; YERUSHALMI H, 1995, J BIOL CHEM, V270, P6856, DOI 10.1074/jbc.270.12.6856	59	15	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18807	18815		10.1074/jbc.M110.176891	http://dx.doi.org/10.1074/jbc.M110.176891			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21345797	hybrid, Green Published			2022-12-27	WOS:000290785700053
J	Toivonen, HT; Meinander, A; Asaoka, T; Westerlund, M; Pettersson, F; Mikhailov, A; Eriksson, JE; Saxen, H				Toivonen, Hannu T.; Meinander, Annika; Asaoka, Tomoko; Westerlund, Mia; Pettersson, Frank; Mikhailov, Andrey; Eriksson, John E.; Saxen, Henrik			Modeling Reveals That Dynamic Regulation of c-FLIP Levels Determines Cell-to-Cell Distribution of CD95-mediated Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED APOPTOSIS; CASPASE ACTIVATION; SIGNALING COMPLEX; PETRI NETS; DEATH; BISTABILITY; DEGRADATION; ROBUSTNESS; NETWORKS; PATHWAYS	The expression levels of caspase-8 inhibitory c-FLIP proteins play an important role in regulating death receptor-mediated apoptosis, as their concentration at the moment when the death-inducing signaling complex (DISC) is formed determines the outcome of the DISC signal. Experimental studies have shown that c-FLIP proteins are subject to dynamic turnover and that their stability and expression levels can be rapidly altered. Even though the influence of c-FLIP on the apoptotic behavior of a single cell has been captured in mathematical simulation studies, the effect of c-FLIP turnover and stability has not been investigated. In this study, a mathematical model of apoptosis was developed to analyze how the dynamic turnover and stability of the c-FLIP isoforms regulate apoptotic signaling for both individual cells and cell populations. Intercellular parameter and concentration distributions were used to describe the behavior of cell populations. Monte-Carlo simulations of cell populations showed that c-FLIP turnover is a key determinant of death receptor responses. The fact that the developed model simulates the state of whole cell populations makes it possible to validate it by comparison with empirical data. The proposed modeling approach can be used to further determine limiting factors in the DISC signaling process.	[Meinander, Annika; Asaoka, Tomoko; Mikhailov, Andrey; Eriksson, John E.] Abo Akad Univ, Dept Biosci, FI-20500 Turku, Finland; [Pettersson, Frank; Saxen, Henrik] Abo Akad Univ, Dept Chem Engn, FI-20500 Turku, Finland; [Toivonen, Hannu T.; Westerlund, Mia] Abo Akad Univ, Dept Informat Technol, FI-20500 Turku, Finland; [Asaoka, Tomoko; Eriksson, John E.] Abo Akad Univ, Turku Ctr Biotechnol, FI-20520 Turku, Finland; [Asaoka, Tomoko; Eriksson, John E.] Univ Turku, FI-20520 Turku, Finland	Abo Akademi University; Abo Akademi University; Abo Akademi University; Abo Akademi University; University of Turku; University of Turku	Eriksson, JE (corresponding author), Abo Akad Univ, Dept Biosci, Tykistokatu 6B, FI-20500 Turku, Finland.	john.eriksson@abo.fi; henrik.saxen@abo.fi	Saxen, Henrik/K-5134-2019; Meinander, Annika/E-9260-2017; Saxen, Henrik/I-8352-2014; Pettersson, Frank/AAZ-5408-2020	Meinander, Annika/0000-0002-3878-2293; Saxen, Henrik/0000-0002-5671-8367; Asaoka, Tomoko/0000-0001-5141-2353	Finnish Funding Agency for Technology and Innovation; Abo Akademi University; Turku Graduate School for Biomedical Sciences; Academy of Finland; Sigrid Juselius Foundation; Finnish Cancer Foundations; Research Institute of the Abo Akademi University Foundation	Finnish Funding Agency for Technology and Innovation(Finnish Funding Agency for Technology & Innovation (TEKES)); Abo Akademi University; Turku Graduate School for Biomedical Sciences; Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cancer Foundations; Research Institute of the Abo Akademi University Foundation	This work was in part supported by the Finnish Funding Agency for Technology and Innovation and Abo Akademi University, the Academy of Finland, the Sigrid Juselius Foundation, Finnish Cancer Foundations, and the Research Institute of the Abo Akademi University Foundation.; Supported by the Turku Graduate School for Biomedical Sciences.	Albeck JG, 2008, PLOS BIOL, V6, P2831, DOI 10.1371/journal.pbio.0060299; ALBERGHINA L, 2005, SYSTEMS BIOL DEFINIT; Bagci EZ, 2006, BIOPHYS J, V90, P1546, DOI 10.1529/biophysj.105.068122; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Bentele M, 2004, J CELL BIOL, V166, P839, DOI 10.1083/jcb.200404158; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Bluthgen N, 2003, J THEOR BIOL, V225, P293, DOI 10.1016/S0022-5193(03)00247-9; Boatright KM, 2004, BIOCHEM J, V382, P651, DOI 10.1042/BJ20040809; Chang DW, 2002, EMBO J, V21, P3704, DOI 10.1093/emboj/cdf356; Eissing T, 2005, IEE P SYST BIOL, V152, P221, DOI 10.1049/ip-syb:20050046; Eissing T, 2004, J BIOL CHEM, V279, P36892, DOI 10.1074/jbc.M404893200; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Endy D, 2001, NATURE, V409, P391, DOI 10.1038/35053181; Fricker N, 2010, J CELL BIOL, V190, P377, DOI 10.1083/jcb.201002060; Fussenegger M, 2000, NAT BIOTECHNOL, V18, P768, DOI 10.1038/77589; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Golks A, 2005, J BIOL CHEM, V280, P14507, DOI 10.1074/jbc.M414425200; Harrington HA, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-26; Heiner M, 2004, BIOSYSTEMS, V75, P15, DOI 10.1016/j.biosystems.2004.03.003; Kaunisto A, 2009, CELL DEATH DIFFER, V16, P1215, DOI 10.1038/cdd.2009.35; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Krueger A, 2001, MOL CELL BIOL, V21, P8247, DOI 10.1128/MCB.21.24.8247-8254.2001; Lavrik IN, 2007, J BIOL CHEM, V282, P13664, DOI 10.1074/jbc.M700434200; Legewie S, 2006, PLOS COMPUT BIOL, V2, P1061, DOI 10.1371/journal.pcbi.0020120; Li C, 2007, J BIOSCIENCES, V32, P113; Meinander A, 2007, J IMMUNOL, V178, P3944, DOI 10.4049/jimmunol.178.6.3944; Micheau O, 2002, J BIOL CHEM, V277, P45162, DOI 10.1074/jbc.M206882200; Neumann L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.6; Poukkula M, 2005, J BIOL CHEM, V280, P27345, DOI 10.1074/jbc.M504019200; Shi B, 2009, J BIOL CHEM, V284, P14513, DOI 10.1074/jbc.M807918200; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Stucki JW, 2005, J THEOR BIOL, V234, P123, DOI 10.1016/j.jtbi.2004.11.011; Tran SEF, 2003, CELL DEATH DIFFER, V10, P1137, DOI 10.1038/sj.cdd.4401278; Ueffing N, 2008, CELL DEATH DIFFER, V15, P773, DOI 10.1038/sj.cdd.4402314	34	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18375	18382		10.1074/jbc.M110.177097	http://dx.doi.org/10.1074/jbc.M110.177097			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21324892	hybrid, Green Published			2022-12-27	WOS:000290785700010
J	Borroni, V; Barrantes, FJ				Borroni, Virginia; Barrantes, Francisco J.			Cholesterol Modulates the Rate and Mechanism of Acetylcholine Receptor Internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROMUSCULAR-JUNCTION; PHOSPHOLIPASE-D; LIPID RAFTS; POSTSYNAPTIC APPARATUS; DOWNSTREAM ACTIVATION; ACTIN POLYMERIZATION; MEMBRANE CHOLESTEROL; ANTIGENIC MODULATION; PHOSPHATIDIC-ACID; ENDOCYTIC PATHWAY	Stability of the nicotinic acetylcholine receptor (AChR) at the cell surface is key to the correct functioning of the cholinergic synapse. Cholesterol (Chol) is necessary for homeostasis of AChR levels at the plasmalemma and for ion translocation. Here we characterize the endocytic pathway followed by muscle-type AChR in Chol-depleted cells (Chol(-)). Under such conditions, the AChR is internalized by a ligand-, clathrin-, and dynamin-independent mechanism. Expression of a dominant negative form of the small GTPase Rac1, Rac1N17, abolishes receptor endocytosis. Unlike the endocytic pathway in control CHO cells (1), accelerated AChR internalization proceeds even upon disruption of the actin cytoskeleton. Under Chol(-) conditions, AChR internalization is furthermore found to require the activity of Arf6 and its effectors Rac1 and phospholipase D. The Arf6-dependent mechanism may constitute the default endocytic pathway followed by the AChR in the absence of external ligands, membrane Chol levels acting as a key homeostatic regulator of cell surface receptor levels.	[Borroni, Virginia; Barrantes, Francisco J.] Inst Invest Bioquim Bahia Blanca, UNESCO Chair Biophys & Mol Neurobiol, Bahia Blanca, Buenos Aires, Argentina		Barrantes, FJ (corresponding author), Inst Invest Bioquim Bahia Blanca, UNESCO Chair Biophys & Mol Neurobiol, C Carrindanga Km 7,B8000FWB, Bahia Blanca, Buenos Aires, Argentina.	rtfjb1@criba.edu.ar	; Barrantes, Francisco J./HCH-0258-2022	Borroni, Virginia/0000-0002-6007-0006; Barrantes, Francisco J./0000-0002-4745-681X	Ministry of Science and Technology [PICT 01-12790, 5-20155]; Argentine Scientific Research Council (Consejo Nacional de Investigaciones Cientificas y Tecnicas) [PIP 6367]; Philip Morris USA Inc.; Philip Morris International	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Argentine Scientific Research Council (Consejo Nacional de Investigaciones Cientificas y Tecnicas)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Philip Morris USA Inc.; Philip Morris International	This work was supported in part by Ministry of Science and Technology Grants PICT 01-12790 and 5-20155, Argentine Scientific Research Council (Consejo Nacional de Investigaciones Cientificas y Tecnicas) Grant PIP 6367, Philip Morris USA Inc., and Philip Morris International (to F.J.B.).	Akaaboune M, 1999, SCIENCE, V286, P503, DOI 10.1126/science.286.5439.503; APPEL SH, 1977, P NATL ACAD SCI USA, V74, P2130, DOI 10.1073/pnas.74.5.2130; Bach AS, 2010, MOL BIOL CELL, V21, P2412, DOI 10.1091/mbc.E09-12-1063; Balasubramanian N, 2007, NAT CELL BIOL, V9, P1381, DOI 10.1038/ncb1657; Banks GB, 2003, J NEUROCYTOL, V32, P709, DOI 10.1023/B:NEUR.0000020619.24681.2b; Barabe F, 2002, J BIOL CHEM, V277, P13473, DOI 10.1074/jbc.M112149200; Barrantes FJ, 2004, BRAIN RES REV, V47, P71, DOI 10.1016/j.brainresrev.2004.06.008; Barrantes FJ, 2003, CURR OPIN DRUG DISC, V6, P620; Barrantes FJ, 2007, J NEUROCHEM, V103, P72, DOI 10.1111/j.1471-4159.2007.04719.x; Benmerah A, 1999, J CELL SCI, V112, P1303; Benmerah A, 1996, J BIOL CHEM, V271, P12111, DOI 10.1074/jbc.271.20.12111; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bobeszko M, 2004, BIOCHEM BIOPH RES CO, V317, P689, DOI 10.1016/j.bbrc.2004.03.105; Borroni V, 2007, MOL MEMBR BIOL, V24, P1, DOI 10.1080/09687860600903387; Boshans RL, 2000, MOL CELL BIOL, V20, P3685, DOI 10.1128/MCB.20.10.3685-3694.2000; Brannigan G, 2008, P NATL ACAD SCI USA, V105, P14418, DOI 10.1073/pnas.0803029105; Bruneau E, 2007, J BIOL CHEM, V282, P9932, DOI 10.1074/jbc.M608714200; Bruneau EG, 2008, CURR BIOL, V18, P109, DOI 10.1016/j.cub.2007.12.029; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Chen EH, 2003, CELL, V114, P751, DOI 10.1016/S0092-8674(03)00720-7; Chen XL, 2003, J PHARMACOL EXP THER, V305, P573, DOI 10.1124/jpet.102.047894; Christian AE, 1997, J LIPID RES, V38, P2264; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; D'Souza-Schorey C, 1997, EMBO J, V16, P5445, DOI 10.1093/emboj/16.17.5445; DEKRUIJFF B, 1974, BIOCHIM BIOPHYS ACTA, V339, P44, DOI 10.1016/0005-2736(74)90331-9; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Di Cesare A, 2000, NAT CELL BIOL, V2, P521, DOI 10.1038/35019561; Diaz O, 2005, J IMMUNOL, V175, P8077, DOI 10.4049/jimmunol.175.12.8077; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; ENGEL AG, 1982, CIBA F SYMP, V90, P197; FONG TM, 1987, BIOCHEMISTRY-US, V26, P3871, DOI 10.1021/bi00387a020; Gervasio OL, 2007, DEV BIOL, V305, P262, DOI 10.1016/j.ydbio.2007.02.008; Grimmer S, 2002, J CELL SCI, V115, P2953; HEINEMANN S, 1977, P NATL ACAD SCI USA, V74, P3090, DOI 10.1073/pnas.74.7.3090; Huk KH, 2002, MOL NEUROBIOL, V25, P79; Huttner WB, 2000, CURR OPIN NEUROBIOL, V10, P543, DOI 10.1016/S0959-4388(00)00126-4; John PAS, 2001, J NEUROBIOL, V49, P212, DOI 10.1002/neu.1076; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Kellner RR, 2007, NEUROSCIENCE, V144, P135, DOI 10.1016/j.neuroscience.2006.08.071; Koo TH, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-29; Kumari S, 2008, J CELL BIOL, V181, P1179, DOI 10.1083/jcb.200709086; Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003; Kummer TT, 2004, J CELL BIOL, V164, P1077, DOI 10.1083/jcb.200401115; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; LINDSTROM J, 1979, MUSCLE NERVE, V2, P173, DOI 10.1002/mus.880020304; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Nakanishi M, 2001, CELL BIOL INT, V25, P971, DOI 10.1006/cbir.2001.0750; Naslavsky N, 2004, MOL BIOL CELL, V15, P3542, DOI 10.1091/mbc.E04-02-0151; PEDICONI MF, 1992, LIPIDS, V27, P669, DOI 10.1007/BF02536022; Phillips WD, 1997, MOL CELL NEUROSCI, V10, P16, DOI 10.1006/mcne.1997.0634; PORTER S, 1985, BIOCHEMISTRY-US, V24, P425, DOI 10.1021/bi00323a028; PORTER S, 1983, J BIOL CHEM, V258, P34; Radhakrishna H, 1999, J CELL SCI, V112, P855; Roccamo AM, 1999, EUR J NEUROSCI, V11, P1615, DOI 10.1046/j.1460-9568.1999.00574.x; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Santy LC, 2005, CURR BIOL, V15, P1749, DOI 10.1016/j.cub.2005.08.052; Sato SB, 2004, J BIOL CHEM, V279, P23790, DOI 10.1074/jbc.M313568200; Siddhanta A, 1998, J BIOL CHEM, V273, P17995, DOI 10.1074/jbc.273.29.17995; SPECTOR I, 1983, SCIENCE, V219, P493, DOI 10.1126/science.6681676; Stetzkowski-Marden F, 2006, J MOL NEUROSCI, V30, P37, DOI 10.1385/JMN:30:1:37; Stetzkowski-Marden F, 2006, J LIPID RES, V47, P2121, DOI 10.1194/jlr.M600182-JLR200; TZARTOS SJ, 1986, J IMMUNOL, V136, P3231; Wang ZZ, 1999, J NEUROSCI, V19, P1998; Wenz JJ, 2005, BIOCHEMISTRY-US, V44, P398, DOI 10.1021/bi048026g; Wenz Jorge J, 2008, PMC Biophys, V1, P6, DOI 10.1186/1757-5036-1-6; Willmann R, 2006, EMBO J, V25, P4050, DOI 10.1038/sj.emboj.7601288; YANG SF, 1967, J BIOL CHEM, V242, P477; Zhu D, 2006, J NEUROSCI, V26, P4841, DOI 10.1523/JNEUROSCI.2807-05.2006; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	71	42	43	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17122	17132		10.1074/jbc.M110.211870	http://dx.doi.org/10.1074/jbc.M110.211870			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21357688	hybrid, Green Published			2022-12-27	WOS:000290301900062
J	Liu, XH; Du, Q; Wang, Z; Zhu, DY; Huang, Y; Li, N; Wei, TD; Xu, SJ; Gu, LC				Liu, Xiuhua; Du, Qian; Wang, Zhi; Zhu, Deyu; Huang, Yan; Li, Ning; Wei, Tiandi; Xu, Sujuan; Gu, Lichuan			Crystal Structure and Biochemical Features of EfeB/YcdB from Escherichia coli O157 ASP(235) PLAYS DIVERGENT ROLES IN DIFFERENT ENZYME-CATALYZED PROCESSES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-DIFFRACTION; HEME-DEGRADING ENZYMES; STAPHYLOCOCCUS-AUREUS; PROTOPORPHYRIN-IX; IRON TRANSPORT; OXYGENASE; VIRULENCE; MECHANISM; PROTEINS; BACTERIA	EfeB/YcdB is a member of the dye-decolorizing peroxidase (DyP) protein family. A recent study has shown that this protein can extract iron from heme without breaking the tetrapyrrole ring. We report the crystal structure of EfeB from Escherichia coli O157 bound to heme at 1.95 angstrom resolution. The EfeB monomer contains two domains. The heme molecule is located in a large hydrophobic pocket in the C-terminal domain. Along loop connecting the two domains extensively interacts with the heme, which is a distinctive structural feature of EfeB homologues. A large tunnel formed by this loop and the beta-sheet of C-terminal domain provides a potential cofactor/substrate binding site. Biochemical data show that the production of protoporphyrin IX (PPIX) is closely related to the peroxidation activity. The mutant D235N keeps nearly the same activity of guaiacol peroxidase as the wild-type protein, whereas the corresponding mutation in the classic DyP protein family completely abolished the peroxidation activity. These results suggest that EfeB is a unique member of the DyP protein family. In addition, dramatically enhanced fluorescence excitation and emission of EfeB-PPIX was observed, implying this protein may be used as a red color fluorescence marker.	[Liu, Xiuhua; Du, Qian; Wang, Zhi; Zhu, Deyu; Huang, Yan; Li, Ning; Wei, Tiandi; Xu, Sujuan; Gu, Lichuan] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China	Shandong University	Gu, LC (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	lcgu@sdu.edu.cn	Du, Qian/AAF-1111-2019	Du, Qian/0000-0001-7438-9838	State Key Laboratory of Microbial Technology, Shandong University; Hi-Tech Research and Development Program of China [2006AA02A324]	State Key Laboratory of Microbial Technology, Shandong University; Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by the State Key Laboratory of Microbial Technology, Shandong University and Grant 2006AA02A324 from the Hi-Tech Research and Development Program of China.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Arcovito A, 2008, ARCH BIOCHEM BIOPHYS, V475, P7, DOI 10.1016/j.abb.2008.03.026; Banci L, 1997, J BIOTECHNOL, V53, P253, DOI 10.1016/S0168-1656(97)01677-5; Beitlich T, 2007, J SYNCHROTRON RADIAT, V14, P11, DOI 10.1107/S0909049506049806; Bonacorsi SPP, 2000, INFECT IMMUN, V68, P2096, DOI 10.1128/IAI.68.4.2096-2101.2000; Cao J, 2007, MOL MICROBIOL, V65, P857, DOI 10.1111/j.1365-2958.2007.05802.x; Cartron ML, 2007, ACTA CRYSTALLOGR F, V63, P37, DOI 10.1107/S174430910604509X; Crosa JH, 2002, MICROBIOL MOL BIOL R, V66, P223, DOI 10.1128/MMBR.66.2.223-249.2002; de Montellano PRO, 2000, CURR OPIN CHEM BIOL, V4, P221; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frankenberg-Dinkel N, 2004, ANTIOXID REDOX SIGN, V6, P825, DOI 10.1089/ars.2004.6.825; GOODIN DB, 1993, BIOCHEMISTRY-US, V32, P3313, DOI 10.1021/bi00064a014; Hirotsu S, 2004, J BIOL CHEM, V279, P11937, DOI 10.1074/jbc.M311631200; Karlberg T, 2008, J MOL BIOL, V378, P1074, DOI 10.1016/j.jmb.2008.03.040; Kumar D, 2005, J AM CHEM SOC, V127, P8204, DOI 10.1021/ja0446956; Lasovsky J, 2007, LUMINESCENCE, V22, P501, DOI 10.1002/bio.995; LAW D, 1995, INFECT IMMUN, V63, P700, DOI 10.1128/IAI.63.2.700-702.1995; Lee WC, 2008, J BIOL CHEM, V283, P30957, DOI 10.1074/jbc.M709486200; Letoffe S, 2009, P NATL ACAD SCI USA, V106, P11719, DOI 10.1073/pnas.0903842106; LITWIN CM, 1993, CLIN MICROBIOL REV, V6, P137, DOI 10.1128/CMR.6.2.137-149.1993; MARGALIT R, 1983, BIOCHEM J, V209, P547, DOI 10.1042/bj2090547; Matsui T, 2010, INORG CHEM, V49, P3602, DOI 10.1021/ic901869t; Maurer LM, 2005, J BACTERIOL, V187, P304, DOI 10.1128/JB.187.1.304-319.2005; McNicholas PM, 1997, FEMS MICROBIOL LETT, V146, P143, DOI 10.1016/S0378-1097(96)00467-3; Muller M, 2005, MOL MEMBR BIOL, V22, P113, DOI 10.1080/09687860500041809; Nagy G, 2002, INFECT IMMUN, V70, P4406, DOI 10.1128/IAI.70.8.4406-4413.2002; NEILANDS JB, 1995, J BIOL CHEM, V270, P26723, DOI 10.1074/jbc.270.45.26723; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Podust LM, 2008, BIOCHEMISTRY-US, V47, P12523, DOI 10.1021/bi8012356; Rajasekaran MB, 2010, BIOMETALS, V23, P1, DOI 10.1007/s10534-009-9262-z; Robinson CR, 1997, BIOCHEMISTRY-US, V36, P16141, DOI 10.1021/bi971470h; Schuller DJ, 2001, BIOCHEMISTRY-US, V40, P11552, DOI 10.1021/bi0110239; SCHWARTZ S, 1983, CLIN CHEM, V29, P2061; Scolaro LM, 2002, J PHYS CHEM B, V106, P2453, DOI 10.1021/jp013155h; Stancik LM, 2002, J BACTERIOL, V184, P4246, DOI 10.1128/JB.184.15.4246-4258.2002; Stojiljkovic I, 2002, DNA CELL BIOL, V21, P281, DOI 10.1089/104454902753759708; Sturm A, 2006, J BIOL CHEM, V281, P13972, DOI 10.1074/jbc.M511891200; Sugano Y, 2007, J BIOL CHEM, V282, P36652, DOI 10.1074/jbc.M706996200; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tong Y, 2009, ARCH BIOCHEM BIOPHYS, V481, P1, DOI 10.1016/j.abb.2008.10.013; Torres AG, 2001, INFECT IMMUN, V69, P6179, DOI 10.1128/IAI.69.10.6179-6185.2001; VANDENBERG JWO, 1988, CLIN CHEM, V34, P2125; WELINDER KG, 1992, BIOCHEM SOC T, V20, P337, DOI 10.1042/bst0200337; Wiles TJ, 2008, EXP MOL PATHOL, V85, P11, DOI 10.1016/j.yexmp.2008.03.007; Wilks A, 2002, ANTIOXID REDOX SIGN, V4, P603, DOI 10.1089/15230860260220102; Wu RY, 2005, J BIOL CHEM, V280, P2840, DOI 10.1074/jbc.M409526200; Yoshida T, 2000, J INORG BIOCHEM, V82, P33, DOI 10.1016/S0162-0134(00)00156-2; Zubieta C, 2007, PROTEINS, V69, P223, DOI 10.1002/prot.21550	50	64	66	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14922	14931		10.1074/jbc.M110.197780	http://dx.doi.org/10.1074/jbc.M110.197780			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21324904	Green Published, hybrid			2022-12-27	WOS:000289788300022
J	Chou, CY; Ko, TP; Wu, KJ; Huang, KF; Lin, CH; Wong, CH; Wang, AHJ				Chou, Chien-Yu; Ko, Tzu-Ping; Wu, Kuan-Jung; Huang, Kai-Fa; Lin, Chun-Hung; Wong, Chi-Huey; Wang, Andrew H. -J.			Modulation of Substrate Specificities of D-Sialic Acid Aldolase through Single Mutations of Val-251	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACETYLNEURAMINIC ACID; PSEUDAMINIC ACID; LYASE; HELICOBACTER; MECHANISM; SUBFAMILY; PATHWAY; KDO	In a recent directed-evolution study, Escherichia coli D-sialic acid aldolase was converted by introducing eight point mutations into a new enzyme with relaxed specificity, denoted RS-aldolase (also known formerly as L-3-deoxy-manno-2-octulosonic acid (L-KDO) aldolase), which showed a preferred selectivity toward L-KDO. To investigate the underlying molecular basis, we determined the crystal structures of D-sialic acid aldolase and RS-aldolase. All mutations are away from the catalytic center, except for V251I, which is near the opening of the (alpha/beta)(8)-barrel and proximal to the Schiff base-forming Lys-165. The change of specificity from D-sialic acid to RS-aldolase can be attributed mainly to the V251I substitution, which creates a narrower sugar-binding pocket, but without altering the chirality in the reaction center. The crystal structures of D-sialic acid aldolase. L-arabinose and RS-aldolase.hydroxypyruvate complexes and five mutants (V251I, V251L, V251R, V251W, and V251I/V265I) of the D-sialic acid aldolase were also determined, revealing the location of substrate molecules and how the contour of the active site pocket was shaped. Interestingly, by mutating Val251 alone, the enzyme can accept substrates of varying size in the aldolase reactions and still retain stereoselectivity. The engineered D-sialic acid aldolase may find applications in synthesizing unnatural sugars of C-6 to C-10 for the design of antagonists and inhibitors of glycoenzymes.	[Chou, Chien-Yu; Ko, Tzu-Ping; Wu, Kuan-Jung; Huang, Kai-Fa; Lin, Chun-Hung; Wang, Andrew H. -J.] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan; [Chou, Chien-Yu; Ko, Tzu-Ping; Huang, Kai-Fa; Wang, Andrew H. -J.] Acad Sinica, Core Facil Prot Prod & Xray Struct Anal, Taipei 11529, Taiwan; [Lin, Chun-Hung; Wong, Chi-Huey; Wang, Andrew H. -J.] Acad Sinica, Genom Res Ctr, Taipei 11529, Taiwan; [Chou, Chien-Yu; Lin, Chun-Hung; Wong, Chi-Huey; Wang, Andrew H. -J.] Natl Taiwan Univ, Inst Biochem Sci, Taipei 10617, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University	Wang, AHJ (corresponding author), Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan.	ahjwang@gate.sinica.edu.tw	Lin, Chun-Hung/AAM-9711-2021	Lin, Chun-Hung/0000-0002-6795-8825	Institute of Biological Chemistry; National Research Program for Genomic Medicine, Academia Sinica	Institute of Biological Chemistry; National Research Program for Genomic Medicine, Academia Sinica(Ministry of Science and Technology, TaiwanAcademia Sinica - Taiwan)	This work was supported by grants from the Institute of Biological Chemistry and National Research Program for Genomic Medicine, Academia Sinica.	Barbosa JARG, 2000, J MOL BIOL, V303, P405, DOI 10.1006/jmbi.2000.4138; BENTLEY R, 1990, CRIT REV BIOCHEM MOL, V25, P307, DOI 10.3109/10409239009090615; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Campeotto I, 2010, J MOL BIOL, V404, P56, DOI 10.1016/j.jmb.2010.08.008; DEVRIES GH, 1972, ARCH BIOCHEM BIOPHYS, V151, P234, DOI 10.1016/0003-9861(72)90493-6; GANTT R, 1964, BIOCHEMISTRY-US, V3, P1952, DOI 10.1021/bi00900a029; Hsu CC, 2005, P NATL ACAD SCI USA, V102, P9122, DOI 10.1073/pnas.0504033102; IZARD T, 1994, STRUCTURE, V2, P361, DOI 10.1016/S0969-2126(00)00038-1; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kiefel MJ, 2000, BIOORGAN MED CHEM, V8, P657, DOI 10.1016/S0968-0896(99)00325-9; Koketsu M, 1997, J MED CHEM, V40, P3332, DOI 10.1021/jm9701280; KOLISIS FN, 1986, BIOCHEM INT, V13, P493; Kozlov IA, 2001, CHEMBIOCHEM, V2, P741, DOI 10.1002/1439-7633(20011001)2:10<741::AID-CBIC741>3.0.CO;2-B; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lawrence MC, 1997, J MOL BIOL, V266, P381, DOI 10.1006/jmbi.1996.0769; LIN CH, 1992, J AM CHEM SOC, V114, P10138, DOI 10.1021/ja00052a008; Mahmoudian M, 1997, ENZYME MICROB TECH, V20, P393, DOI 10.1016/S0141-0229(96)00180-9; Maru I, 1998, CARBOHYD RES, V306, P575, DOI 10.1016/S0008-6215(97)10106-9; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RAY PH, 1982, METHOD ENZYMOL, V83, P525; Rietschel E T, 1985, Prog Clin Biol Res, V189, P31; Schoenhofen IC, 2006, GLYCOBIOLOGY, V16, p8C, DOI 10.1093/glycob/cwl010; Schoenhofen IC, 2006, J BIOL CHEM, V281, P723, DOI 10.1074/jbc.M511021200; Schumacher TNM, 1996, SCIENCE, V271, P1854, DOI 10.1126/science.271.5257.1854; Sears P, 1999, ANGEW CHEM INT EDIT, V38, P2301; SIMPSON RJ, 1976, EUR J BIOCHEM, V70, P501, DOI 10.1111/j.1432-1033.1976.tb11041.x; Smith BJ, 1999, J ORG CHEM, V64, P945, DOI 10.1021/jo981960v; SUTTAJIT M, 1971, J BIOL CHEM, V246, P810; YORK WS, 1985, CARBOHYD RES, V138, P109, DOI 10.1016/0008-6215(85)85228-9	30	6	7	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14057	14064		10.1074/jbc.M110.179465	http://dx.doi.org/10.1074/jbc.M110.179465			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21270125	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000289556200028
J	Boergesen, M; Poulsen, LL; Schmidt, SF; Frigerio, F; Maechler, P; Mandrup, S				Boergesen, Michael; Poulsen, Lars la Cour; Schmidt, Soren Fisker; Frigerio, Francesca; Maechler, Pierre; Mandrup, Susanne			ChREBP Mediates Glucose Repression of Peroxisome Proliferator-activated Receptor alpha Expression in Pancreatic beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN; CENTER-DOT-MLX; L-PK GENE; PPAR-ALPHA; TRANSCRIPTION FACTOR; INSULIN; METABOLISM; KINASE; IDENTIFICATION; LIPOGENESIS	Chronic exposure to elevated levels of glucose and fatty acids leads to dysfunction of pancreatic beta-cells by mechanisms that are only partly understood. The transcription factor peroxisome proliferator-activated receptor alpha (PPAR alpha) is an important regulator of genes involved in fatty acid metabolism and has been shown to protect against lipid-induced beta-cell dysfunction. We and others have previously shown that expression of the PPAR alpha gene in beta-cells is rapidly repressed by glucose. Here we show that the PPAR alpha gene is transcribed from five alternative transcription start sites, resulting in three alternative first exons that are spliced to exon 2. Expression of all PPAR alpha transcripts is repressed by glucose both in insulinoma cells and in isolated pancreatic islets. The observation that the dynamics of glucose repression of PPAR alpha transcription are very similar to those of glucose activation of target genes by the carbohydrate response element-binding protein (ChREBP) prompted us to investigate the potential role of ChREBP in the regulation of PPAR alpha expression. We show that a constitutively active ChREBP lacking the N-terminal domain efficiently represses PPAR alpha expression in insulinoma cells and in rodent and human islets. In addition, we demonstrate that siRNA-mediated knockdown of ChREBP abrogates glucose repression of PPAR alpha expression as well as induction of well established ChREBP target genes in insulinoma cells. In conclusion, this work shows that ChREBP is a critical and direct mediator of glucose repression of PPAR alpha gene expression in pancreatic beta-cells, suggesting that ChREBP may be important for glucose suppression of the fatty acid oxidation capacity of beta-cells.	[Boergesen, Michael; Poulsen, Lars la Cour; Schmidt, Soren Fisker; Mandrup, Susanne] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark; [Frigerio, Francesca; Maechler, Pierre] Univ Geneva, Dept Cell Physiol & Metab, CH-1211 Geneva, Switzerland	University of Southern Denmark; University of Geneva	Mandrup, S (corresponding author), Univ So Denmark, Dept Biochem & Mol Biol, Campusvej 55, DK-5230 Odense M, Denmark.	s.mandrup@bmb.sdu.dk		Mandrup, Susanne/0000-0002-0961-5787; Maechler, Pierre/0000-0002-2005-1433; la Cour Poulsen, Lars/0000-0001-5406-3945; Fisker Schmidt, Soren/0000-0003-4449-288X	Juvenile Diabetes Research Foundation; Danish Health Science Research Council; Danish Diabetes Foundation; Nordic Center of Excellence MitoHealth; Swiss National Science Foundation; Novo Nordisk scholarship; Novo Nordisk Foundation	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Danish Health Science Research Council; Danish Diabetes Foundation; Nordic Center of Excellence MitoHealth; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novo Nordisk scholarship(Novo Nordisk); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	We thank Dr. Giuseppe Merla for providing the pcDNA3-MycEGFP-mChREBP zeta construct. Fresh human islets were provided by the Cell Isolation and Transplantation Center of the Geneva School of Medicine, thanks to the European Consortium for Islet Transplantation "Islet for Research" distribution program sponsored by the Juvenile Diabetes Research Foundation (to Thierry Berne).; This work was supported by grants from the Danish Health Science Research Council, the Danish Diabetes Foundation, and NordForsk given to the Nordic Center of Excellence MitoHealth (to S. M.), as well as grants from the Swiss National Science Foundation (to P. M.).; Supported by a Novo Nordisk scholarship and the Novo Nordisk Foundation.	Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678; Berge K, 2003, J LIPID RES, V44, P118, DOI 10.1194/jlr.M200312-JLR200; Burke SJ, 2009, J MOL BIOL, V392, P578, DOI 10.1016/j.jmb.2009.07.053; Burke SJ, 2009, FASEB J, V23, P2855, DOI 10.1096/fj.08-126631; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Cha-Molstad H, 2009, J BIOL CHEM, V284, P16898, DOI 10.1074/jbc.M109.010504; Chew CH, 2003, BIOCHEM BIOPH RES CO, V305, P235, DOI 10.1016/S0006-291X(03)00731-9; Davies MN, 2008, J BIOL CHEM, V283, P24029, DOI 10.1074/jbc.M801539200; Denechaud PD, 2008, J CLIN INVEST, V118, P956, DOI 10.1172/JCI34314; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Djouadi F, 1998, J CLIN INVEST, V102, P1083, DOI 10.1172/JCI3949; EDWARDS DR, 1992, EMBO J, V11, P2415, DOI 10.1002/j.1460-2075.1992.tb05306.x; Fontes G, 2010, DIABETOLOGIA, V53, P2369, DOI 10.1007/s00125-010-1850-5; Frigerio F, 2010, DIABETOLOGIA, V53, P331, DOI 10.1007/s00125-009-1590-6; GOTTLICHER M, 1992, P NATL ACAD SCI USA, V89, P4653, DOI 10.1073/pnas.89.10.4653; Gremlich S, 2005, ENDOCRINOLOGY, V146, P375, DOI 10.1210/en.2004-0667; Gremlich S, 1997, J BIOL CHEM, V272, P30261, DOI 10.1074/jbc.272.48.30261; HEDESKOV CJ, 1975, BIOCHEM J, V152, P571, DOI 10.1042/bj1520571; Hellemans K, 2007, FEBS J, V274, P6094, DOI 10.1111/j.1742-4658.2007.06131.x; Holness MJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE1087, DOI 10.1152/ajpendo.00375.2006; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Iizuka K, 2008, BIOCHEM BIOPH RES CO, V374, P95, DOI 10.1016/j.bbrc.2008.06.101; Ishii S, 2004, P NATL ACAD SCI USA, V101, P15597, DOI 10.1073/pnas.0405238101; Joly E, 2009, J DIABETES, V1, P263, DOI 10.1111/j.1753-0407.2009.00043.x; Kabashima T, 2003, P NATL ACAD SCI USA, V100, P5107, DOI 10.1073/pnas.0730817100; Kawaguchi T, 2002, J BIOL CHEM, V277, P3829, DOI 10.1074/jbc.M107895200; Kawaguchi T, 2001, P NATL ACAD SCI USA, V98, P13710, DOI 10.1073/pnas.231370798; Kelpe CL, 2003, J BIOL CHEM, V278, P30015, DOI 10.1074/jbc.M302548200; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Lalloyer F, 2006, DIABETES, V55, P1605, DOI 10.2337/db06-0016; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Li MV, 2008, MOL ENDOCRINOL, V22, P1658, DOI 10.1210/me.2007-0560; Li MV, 2010, BIOCHEM BIOPH RES CO, V395, P395, DOI 10.1016/j.bbrc.2010.04.028; Li MV, 2006, DIABETES, V55, P1179, DOI 10.2337/db05-0822; Ma L, 2005, J BIOL CHEM, V280, P12019, DOI 10.1074/jbc.M413063200; Ma L, 2006, J BIOL CHEM, V281, P28721, DOI 10.1074/jbc.M601576200; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Merla G, 2004, HUM MOL GENET, V13, P1505, DOI 10.1093/hmg/ddh163; NISHIMURA M, 1994, J BIOL CHEM, V269, P26100; Noordeen NA, 2010, DIABETES, V59, P153, DOI 10.2337/db08-0868; Olofsson CS, 2007, DIABETES, V56, P1888, DOI 10.2337/db06-1150; Ravnskjaer K, 2006, J MOL ENDOCRINOL, V36, P289, DOI 10.1677/jme.1.01965; Ravnskjaer K, 2010, J LIPID RES, V51, P1370, DOI 10.1194/jlr.M001123; Robertson RP, 2003, DIABETES, V52, P581, DOI 10.2337/diabetes.52.3.581; Roduit R, 2000, J BIOL CHEM, V275, P35799, DOI 10.1074/jbc.M006001200; Sakiyama H, 2008, J BIOL CHEM, V283, P24899, DOI 10.1074/jbc.M804308200; Schuit F, 2002, DIABETES, V51, pS326, DOI 10.2337/diabetes.51.2007.S326; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; Shalev A, 2002, ENDOCRINOLOGY, V143, P3695, DOI 10.1210/en.2002-220564; Stoeckman AK, 2004, J BIOL CHEM, V279, P15662, DOI 10.1074/jbc.M311301200; Sun Y, 2008, ENDOCRINOLOGY, V149, P662, DOI 10.1210/en.2007-1275; Torra IP, 2002, MOL ENDOCRINOL, V16, P1013; Tsatsos NG, 2008, BIOCHEM J, V411, P261, DOI 10.1042/BJ20071156; Uyeda K, 2002, BIOCHEM PHARMACOL, V63, P2075, DOI 10.1016/S0006-2952(02)01012-2; Wang HY, 2002, J BIOL CHEM, V277, P32746, DOI 10.1074/jbc.M201635200; Xavier GD, 2006, J LIPID RES, V47, P2482, DOI 10.1194/jlr.M600289-JLR200; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298; Zhou YT, 1998, P NATL ACAD SCI USA, V95, P8898, DOI 10.1073/pnas.95.15.8898	58	32	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13214	13225		10.1074/jbc.M110.215467	http://dx.doi.org/10.1074/jbc.M110.215467			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21282101	hybrid, Green Published			2022-12-27	WOS:000289282200042
J	Coleman, KA; Greenberg, RA				Coleman, Kara A.; Greenberg, Roger A.			The BRCA1-RAP80 Complex Regulates DNA Repair Mechanism Utilization by Restricting End Resection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND-BREAK REPAIR; HOMOLOGOUS RECOMBINATION; CANCER SUSCEPTIBILITY; DAMAGE RESPONSE; TARGETS BRCA1; PROTEIN; DOMAIN; CTIP; ATM; LANDSCAPE	The tumor suppressor protein BRCA1 is a constituent of several different protein complexes and is required for homology-directed repair (HDR) of DNA double strand breaks (DSBs). The most recently discovered BRCA1-RAP80 complex is recruited to ubiquitin structures on chromatin surrounding the break. Deficiency of any member of this complex confers hypersensitivity to DNA-damaging agents by undefined mechanisms. In striking contrast to other BRCA1-containing complexes that are known to promote HDR, we demonstrate that the BRCA1-RAP80 complex restricts end resection in S/G(2) phase of the cell cycle, thereby limiting HDR. RAP80 or BRCC36 deficiency resulted in elevated Mre 11-CtIP-dependent 5' end resection with a concomitant increase in HDR mechanisms that rely on 3' single-stranded overhangs. We propose a model in which the BRCA1-RAP80 complex limits nuclease accessibility to DSBs, thus preventing excessive end resection and potentially deleterious homology-directed DSB repair mechanisms that can impair genome integrity.	[Coleman, Kara A.; Greenberg, Roger A.] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA; [Greenberg, Roger A.] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Pathol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Greenberg, RA (corresponding author), Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Canc Biol, 421 Curie Blvd,BRB 2-3,Rm 513, Philadelphia, PA 19104 USA.	rogergr@mail.med.upenn.edu			National Institutes of Health, NCI [1R01CA138835-01, 1K08CA106597-01, 3K08CA106597-04S1]; National Institutes of Health [T32-GM-007229, T32-CA-115299]; NATIONAL CANCER INSTITUTE [K08CA106597, T32CA115299, R01CA138835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007229] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grant 1R01CA138835-01 and K08 Awards 1K08CA106597-01 and 3K08CA106597-04S1 (to R. A.G.) and National Institutes of Health Grants T32-GM-007229 and T32-CA-115299 (to K. A. C.).	Adamo A, 2010, MOL CELL, V39, P25, DOI 10.1016/j.molcel.2010.06.026; Anantha RW, 2007, J BIOL CHEM, V282, P35910, DOI 10.1074/jbc.M704645200; Antoniou AC, 2010, NAT GENET, V42, P885, DOI 10.1038/ng.669; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Beucher A, 2009, EMBO J, V28, P3413, DOI 10.1038/emboj.2009.276; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Bolton KL, 2010, NAT GENET, V42, P880, DOI 10.1038/ng.666; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Cooper EM, 2009, EMBO J, V28, P621, DOI 10.1038/emboj.2009.27; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Erkko H, 2007, NATURE, V446, P316, DOI 10.1038/nature05609; Feng L, 2010, J BIOL CHEM, V285, P30982, DOI 10.1074/jbc.M110.135392; Feng L, 2009, GENE DEV, V23, P719, DOI 10.1101/gad.1770609; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Greenberg RA, 2006, GENE DEV, V20, P34, DOI 10.1101/gad.1381306; Heikkinen K, 2006, CARCINOGENESIS, V27, P1593, DOI 10.1093/carcin/bgi360; Hicks WM, 2010, SCIENCE, V329, P82, DOI 10.1126/science.1191125; HU Y, 2011, GENES DEV IN PRESS; Huang TT, 2006, NAT REV MOL CELL BIO, V7, P323, DOI 10.1038/nrm1908; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Huertas P, 2009, J BIOL CHEM, V284, P9558, DOI 10.1074/jbc.M808906200; Iijima J, 2010, CANCER RES, V70, P8467, DOI 10.1158/0008-5472.CAN-10-0267; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Kao GD, 2001, ONCOGENE, V20, P3486, DOI 10.1038/sj.onc.1204445; Karran P, 2000, CURR OPIN GENET DEV, V10, P144, DOI 10.1016/S0959-437X(00)00069-1; Kim H, 2007, NAT STRUCT MOL BIOL, V14, P710, DOI 10.1038/nsmb1277; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Litman R, 2005, CANCER CELL, V8, P255, DOI 10.1016/j.ccr.2005.08.004; Liu ZX, 2007, NAT STRUCT MOL BIOL, V14, P716, DOI 10.1038/nsmb1279; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mao ZY, 2008, DNA REPAIR, V7, P1765, DOI 10.1016/j.dnarep.2008.06.018; Messick TE, 2009, J CELL BIOL, V187, P319, DOI 10.1083/jcb.200908074; Mirzoeva OK, 2001, MOL CELL BIOL, V21, P281, DOI 10.1128/MCB.21.1.281-288.2001; Nikkila J, 2009, ONCOGENE, V28, P1843, DOI 10.1038/onc.2009.33; Pace P, 2010, SCIENCE, V329, P219, DOI 10.1126/science.1192277; Patterson-Fortin J, 2010, J BIOL CHEM, V285, P30971, DOI 10.1074/jbc.M110.135319; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Potts PR, 2006, EMBO J, V25, P3377, DOI 10.1038/sj.emboj.7601218; Rahman N, 1998, ANNU REV GENET, V32, P95, DOI 10.1146/annurev.genet.32.1.95; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Scully R, 1999, MOL CELL, V4, P1093, DOI 10.1016/S1097-2765(00)80238-5; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Shao G, 2009, GENE DEV, V23, P740, DOI 10.1101/gad.1739609; Shao G, 2009, P NATL ACAD SCI USA, V106, P3166, DOI 10.1073/pnas.0807485106; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Stark JM, 2004, MOL CELL BIOL, V24, P9305, DOI 10.1128/MCB.24.21.9305-9316.2004; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Stratton MR, 2008, NAT GENET, V40, P17, DOI 10.1038/ng.2007.53; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Sy SMH, 2009, P NATL ACAD SCI USA, V106, P7155, DOI 10.1073/pnas.0811159106; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang B, 2009, GENE DEV, V23, P729, DOI 10.1101/gad.1770309; Wilson DM, 2007, MUTAT RES-FUND MOL M, V616, P11, DOI 10.1016/j.mrfmmm.2006.11.017; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Xie AY, 2004, MOL CELL, V16, P1017, DOI 10.1016/j.molcel.2004.12.007; Yan J, 2007, CANCER RES, V67, P6647, DOI 10.1158/0008-5472.CAN-07-0924; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004; Yun MH, 2009, NATURE, V459, P460, DOI 10.1038/nature07955; Zhang F, 2009, CURR BIOL, V19, P524, DOI 10.1016/j.cub.2009.02.018	69	160	166	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13669	13680		10.1074/jbc.M110.213728	http://dx.doi.org/10.1074/jbc.M110.213728			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21335604	hybrid, Green Published			2022-12-27	WOS:000289282200085
J	Foy, KC; Liu, ZZ; Phillips, G; Miller, M; Kaumaya, PTP				Foy, Kevin C.; Liu, Zhenzhen; Phillips, Gary; Miller, Megan; Kaumaya, Pravin T. P.			Combination Treatment with HER-2 and VEGF Peptide Mimics Induces Potent Anti-tumor and Anti-angiogenic Responses in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; NEU DIFFERENTIATION FACTOR; HUMAN-BREAST-CANCER; MONOCLONAL-ANTIBODY; ENDOMETRIAL CANCER; GENE AMPLIFICATION; DISULFIDE BONDS; ERBB RECEPTORS; TUMOR-GROWTH; EXPRESSION	HER-2 is a member of the EGF receptor family and is overexpressed in 20-30% of breast cancers. HER-2 overexpression causes increased expression of VEGF at both the RNA and protein levels. HER-2 and VEGF are therefore considered good targets for cancer treatment, which has led to the development of two humanized monoclonal antibodies (mAb) pertuzumab and bevacizumab. Although passive immunotherapy with these Abs are approved for treatment of advanced breast cancer, a number of concerns exist. Treatment is expensive, has a limited duration of action, and is usually accompanied by serious side effects. We hypothesized that therapy with conformational peptide mimics aimed at blocking receptor-ligand interaction is potentially safer with little toxicity, cheaper with a longer half-life, and has greater penetrating abilities than inAbs. We designed and synthesized peptides based on the binding of HER-2 with pertuzumab and VEGF with VEGFR2. We show that treatment with the peptide mimics induces potent anti-tumor responses in vitro as determined by cell viability, proliferation, and HER2 phosphorylation assays. We also demonstrate in a transplantable BALB/c mouse tumor model that treatment with the peptide mimics resulted in a greater delay in tumor growth and development. Similarly, treatment with the peptide mimics inhibited angiogenesis in vivo as assessed by a Matrigel plug assay. To address the problem of degradability of L-amino acid peptides in vivo, we synthesized the retro-inverso D-peptide mimics that resulted in higher efficacy in treatment. Our study shows that combination treatment with HER-2 and VEGF peptide mimics provides greater efficacy than individual treatments.	[Foy, Kevin C.; Miller, Megan; Kaumaya, Pravin T. P.] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Liu, Zhenzhen; Kaumaya, Pravin T. P.] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [Foy, Kevin C.; Miller, Megan; Kaumaya, Pravin T. P.] Ohio State Univ, Dept Obstet & Gynecol, Columbus, OH 43210 USA; [Phillips, Gary; Kaumaya, Pravin T. P.] Ohio State Univ, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Kaumaya, PTP (corresponding author), Ohio State Univ, Dept Microbiol, Ste 316 Med Res Facil,420 W 12th Ave, Columbus, OH 43210 USA.	Kaumaya.1@osu.edu	Kaumaya, Pravin T. P/E-3354-2011	Miller, Mitchell/0000-0003-1626-4943	NCI [84356]	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 84356 from NCI.	Agus DB, 2002, CANCER CELL, V2, P127, DOI 10.1016/S1535-6108(02)00097-1; Allen SD, 2005, J PEPT RES, V65, P591, DOI 10.1111/j.1399-3011.2005.00256.x; Allen SD, 2007, J IMMUNOL, V179, P472, DOI 10.4049/jimmunol.179.1.472; BARBACCI EG, 1995, J BIOL CHEM, V270, P9585, DOI 10.1074/jbc.270.16.9585; Baselga J, 2005, J CLIN ONCOL, V23, P2445, DOI 10.1200/JCO.2005.11.890; Baselga J, 2006, SCIENCE, V312, P1175, DOI 10.1126/science.1125951; BEERLI RR, 1995, MOL CELL BIOL, V15, P6496; BERCHUCK A, 1991, AM J OBSTET GYNECOL, V164, P15, DOI 10.1016/0002-9378(91)90615-X; Carpenito C, 2002, INT J RADIAT ONCOL, V54, P1473, DOI 10.1016/S0360-3016(02)03921-4; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Casella I, 2003, BLOOD, V101, P1316, DOI 10.1182/blood-2002-07-2184; Chorev M, 2005, BIOPOLYMERS, V80, P67, DOI 10.1002/bip.20219; CHOREV M, 1995, TRENDS BIOTECHNOL, V13, P438, DOI 10.1016/S0167-7799(00)88999-4; Cirisano FD, 1996, J SOC GYNECOL INVEST, V3, P99, DOI 10.1016/1071-5576(96)00001-9; Cobleigh MA, 2003, SEMIN ONCOL, V30, P117, DOI 10.1053/j.seminoncol.2003.08.013; Dakappagari NK, 2005, J PEPT RES, V65, P189, DOI 10.1111/j.1399-3011.2005.00212.x; Dakappagari NK, 2005, J BIOL CHEM, V280, P54, DOI 10.1074/jbc.M411020200; Dakappagari NK, 2000, CANCER RES, V60, P3782; Dakappagari NK, 2003, J IMMUNOL, V170, P4242, DOI 10.4049/jimmunol.170.8.4242; Eskens FALM, 2006, EUR J CANCER, V42, P3127, DOI 10.1016/j.ejca.2006.09.015; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; FERRARA N, 1989, BIOCHEM BIOPH RES CO, V161, P851, DOI 10.1016/0006-291X(89)92678-8; Ferrara N, 2004, ONCOLOGIST, V9, P2, DOI 10.1634/theoncologist.9-suppl_1-2; Fischer PM, 2003, CURR PROTEIN PEPT SC, V4, P339, DOI 10.2174/1389203033487054; Fletcher MD, 1998, CHEM REV, V98, P763, DOI 10.1021/cr970468t; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; Garrett JT, 2007, J IMMUNOL, V178, P7120, DOI 10.4049/jimmunol.178.11.7120; GOODMAN M, 1992, BIOORG KHIM+, V18, P1375; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; GRAUSPORTA D, 1995, MOL CELL BIOL, V15, P1182; Grothey Axel, 2006, Oncology (Williston Park), V20, P21; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; HOUCK KA, 1991, MOL ENDOCRINOL, V5, P1806, DOI 10.1210/mend-5-12-1806; HUDZIAK RM, 1989, MOL CELL BIOL, V9, P1165, DOI 10.1128/MCB.9.3.1165; HYNES NE, 1994, BBA-REV CANCER, V1198, P165, DOI 10.1016/0304-419X(94)90012-4; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Kaumaya PTP, 2009, J CLIN ONCOL, V27, P5270, DOI 10.1200/JCO.2009.22.3883; Kaumaya PTP, 2006, INT J PEPT RES THER, V12, P65, DOI 10.1007/s10989-005-9000-5; KERN JA, 1990, CANCER RES, V50, P5184; Kim DW, 2006, INT J RADIAT ONCOL, V64, P38, DOI 10.1016/j.ijrobp.2005.02.008; Li B, 2002, HYPERTENSION, V39, P1095, DOI 10.1161/01.HYP.0000018588.56950.7A; Mimura K, 2005, BRIT J CANCER, V92, P1253, DOI 10.1038/sj.bjc.6602499; Monsky WL, 2002, CLIN CANCER RES, V8, P1008; Morrison C, 2006, J CLIN ONCOL, V24, P2376, DOI 10.1200/JCO.2005.03.4827; Nagy P, 2005, CANCER RES, V65, P473; NIEHANS GA, 1993, JNCI-J NATL CANCER I, V85, P1230, DOI 10.1093/jnci/85.15.1230; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Oshima RG, 2004, CANCER RES, V64, P169, DOI 10.1158/0008-5472.CAN-03-1944; PAIK S, 1990, J CLIN ONCOL, V8, P103, DOI 10.1200/JCO.1990.8.1.103; PRESS MF, 1990, ONCOGENE, V5, P953; Riemer AB, 2004, J IMMUNOL, V173, P394, DOI 10.4049/jimmunol.173.1.394; Rovero S, 2000, J IMMUNOL, V165, P5133, DOI 10.4049/jimmunol.165.9.5133; Rugo HS, 2004, ONCOLOGIST, V9, P43, DOI 10.1634/theoncologist.9-suppl_1-43; Ryan AJ, 2005, BRIT J CANCER, V92, pS6, DOI 10.1038/sj.bjc.6602603; Saito H, 1998, BRIT J CANCER, V78, P1573, DOI 10.1038/bjc.1998.725; Scholl S, 2001, ANN ONCOL, V12, P81, DOI 10.1023/A:1011192622688; SHEPARD HM, 1991, J CLIN IMMUNOL, V11, P117, DOI 10.1007/BF00918679; SLAMON DJ, 1987, NEW ENGL J MED, V317, P955, DOI 10.1056/NEJM198710083171509; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Soll R, 2000, J PEPT SCI, V6, P387, DOI 10.1002/1099-1387(200008)6:8<387::AID-PSC267>3.0.CO;2-M; Srinivasan M, 2002, J IMMUNOL, V169, P2180, DOI 10.4049/jimmunol.169.4.2180; Srinivasan M, 2001, J IMMUNOL, V167, P578, DOI 10.4049/jimmunol.167.1.578; Steele JT, 2006, CANC IMMUNOTHERAPY R; STERN DF, 1988, EMBO J, V7, P995, DOI 10.1002/j.1460-2075.1988.tb02906.x; Sundaram R, 2004, J BIOL CHEM, V279, P24141, DOI 10.1074/jbc.M313210200; Taylor EM, 2000, J PHARMACOL EXP THER, V295, P190; TISCHER E, 1991, J BIOL CHEM, V266, P11947; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; Vicari D, 2011, J BIOL CHEM, V286, P13612, DOI 10.1074/jbc.M110.216812; WADA T, 1990, CELL, V61, P1339, DOI 10.1016/0092-8674(90)90697-D; Yang JC, 2003, NEW ENGL J MED, V349, P427, DOI 10.1056/NEJMoa021491; Yano T, 2006, ONCOL REP, V15, P65	73	41	47	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13626	13637		10.1074/jbc.M110.216820	http://dx.doi.org/10.1074/jbc.M110.216820			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21325276	hybrid, Green Published			2022-12-27	WOS:000289282200081
J	Suzuki, H; Lee, K; Matsuoka, M				Suzuki, Hiroaki; Lee, Kikyo; Matsuoka, Masaaki			TDP-43-induced Death Is Associated with Altered Regulation of BIM and Bcl-xL and Attenuated by Caspase-mediated TDP-43 Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; TRANSGENIC MOUSE MODEL; DNA-BINDING PROTEIN; ENDOPLASMIC-RETICULUM STRESS; ER STRESS; CELLULAR TOXICITY; OXIDATIVE STRESS; DROSOPHILA MODEL; MOTONEURON LOSS	Abnormal aggregates of transactive response DNA-binding protein-43 (TDP-43) and its hyperphosphorylated and N-terminal truncated C-terminal fragments (CTFs) are deposited as major components of ubiquitinated inclusions in most cases of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with ubiquitinated inclusions (FTLD-U). The mechanism underlying the contribution of TDP-43 to the pathogenesis of these neurodegenerative diseases remains unknown. In this study, we found that a 2-5-fold increase in TDP-43 expression over the endogenous level induced death of NSC34 motor neuronal cells and primary cortical neurons. TDP-43-induced death is associated with up-regulation of Bim expression and down-regulation of Bcl-xL expression. siRNA-mediated reduction of Bim expression attenuates TDP-43-induced death. Accumulated evidence indicates that caspases are activated in neurons of ALS and FTLD-U patients, and activated caspase-mediated cleavage of TDP-43 generates CTFs of TDP-43. Here, we further found that the ER (endoplasmic reticulum) stress- or staurosporine-mediated activation of caspases leads to cleavage of TDP-43 at Asp(89) and Asp(169), generating CTF35 (TDP-43-(90-414)) and CTF27 (TDP-43-(170- 414)) in cultured neuronal cells. In contrast to TDP-43, CTF27 is unable to induce death while it forms aggregates. CTF35 was weaker than full-length TDP-43 in inducing death. A cleavage-resistant mutant of TDP-43 (TDP-43-D89E/D169E) showed stronger death-inducing activity than wild-type TDP-43. These results suggest that disease-related activation of caspases may attenuate TDP-43-induced toxicity by promoting TDP-43 cleavage.	[Suzuki, Hiroaki; Lee, Kikyo; Matsuoka, Masaaki] Tokyo Med & Dent Univ, Dept Pharmacol, Shinjuku Ku, Tokyo 1608402, Japan	Tokyo Medical & Dental University (TMDU)	Matsuoka, M (corresponding author), Tokyo Med & Dent Univ, Dept Pharmacol, Shinjuku Ku, 6-1-1 Shinjuku, Tokyo 1608402, Japan.	sakimatu@tokyo-med.ac.jp			Scientific Research Young Scientist [(B) 22790261]; Nakabayashi Trust	Scientific Research Young Scientist(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Nakabayashi Trust	This work was supported in part by Grant-in-aid for Scientific Research Young Scientist (B) 22790261 and the Nakabayashi Trust for ALS research (to H. S.).	Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Atkin JD, 2008, NEUROBIOL DIS, V30, P400, DOI 10.1016/j.nbd.2008.02.009; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; Dennis JS, 2009, NEUROSCIENCE, V158, P745, DOI 10.1016/j.neuroscience.2008.10.030; Dormann D, 2009, J NEUROCHEM, V110, P1082, DOI 10.1111/j.1471-4159.2009.06211.x; Gamas P, 2009, LEUKEMIA, V23, P1500, DOI 10.1038/leu.2009.60; Gendron TF, 2010, NEUROPATH APPL NEURO, V36, P97, DOI [10.1111/j.1365-2990.2009.01060.x, 10.1111/j.1365-2990.2010.01060.x]; Hanson KA, 2010, J BIOL CHEM, V285, P11068, DOI 10.1074/jbc.C109.078527; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Hashimoto Y, 2000, J BIOL CHEM, V275, P34541, DOI 10.1074/jbc.M005332200; Hetz C, 2007, CELL DEATH DIFFER, V14, P1386, DOI 10.1038/sj.cdd.4402166; Huang C, 2010, INT J BIOL SCI, V6, P396; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; Ilieva EV, 2007, BRAIN, V130, P3111, DOI 10.1093/brain/awm190; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Inoue H, 2003, EMBO J, V22, P6665, DOI 10.1093/emboj/cdg634; Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105; Kanekura K, 2009, MOL NEUROBIOL, V39, P81, DOI 10.1007/s12035-009-8054-3; Kasai T, 2009, ACTA NEUROPATHOL, V117, P55, DOI 10.1007/s00401-008-0456-1; Kieran D, 2007, P NATL ACAD SCI USA, V104, P20606, DOI 10.1073/pnas.0707906105; Lee J, 2009, FASEB J, V23, P1739, DOI 10.1096/fj.08-121046; Li MW, 2000, SCIENCE, V288, P335, DOI 10.1126/science.288.5464.335; Li Y, 2010, P NATL ACAD SCI USA, V107, P3169, DOI 10.1073/pnas.0913602107; Martin LJ, 1999, J NEUROPATH EXP NEUR, V58, P459, DOI 10.1097/00005072-199905000-00005; Mishra M, 2007, ACTA NEUROPATHOL, V114, P81, DOI 10.1007/s00401-007-0240-7; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nishimoto Y, 2010, J BIOL CHEM, V285, P608, DOI 10.1074/jbc.M109.022012; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Rabinovici GD, 2010, CNS DRUGS, V24, P375, DOI 10.2165/11533100-000000000-00000; Rothstein JD, 2009, ANN NEUROL, V65, pS3, DOI 10.1002/ana.21543; Rutherford NJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000193; Stallings NR, 2010, NEUROBIOL DIS, V40, P404, DOI 10.1016/j.nbd.2010.06.017; Su JH, 2000, EXP NEUROL, V163, P9, DOI 10.1006/exnr.2000.7340; Suzuki H, 2009, J NEUROCHEM, V108, P973, DOI [10.1111/j.1471-4159.2008.05857.x, 10.1111/j.0022-3042.2008.05857.x]; Suzuki M, 2010, ACTA NEUROL SCAND, V122, P367, DOI 10.1111/j.1600-0404.2010.01321.x; Tsai KJ, 2010, J EXP MED, V207, P1661, DOI 10.1084/jem.20092164; Vukosavic S, 1999, J NEUROCHEM, V73, P2460, DOI 10.1046/j.1471-4159.1999.0732460.x; Wakeyama H, 2007, J BONE MINER RES, V22, P1631, DOI 10.1359/JBMR.070619; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Wootz H, 2004, BIOCHEM BIOPH RES CO, V322, P281, DOI 10.1016/j.bbrc.2004.07.118; Xu YF, 2010, J NEUROSCI, V30, P10851, DOI 10.1523/JNEUROSCI.1630-10.2010; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106	48	79	80	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13171	13183		10.1074/jbc.M110.197483	http://dx.doi.org/10.1074/jbc.M110.197483			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21339291	Green Published, hybrid			2022-12-27	WOS:000289282200038
J	Lee, KJ; Lin, YF; Chou, HY; Yajima, H; Fattah, KR; Lee, SC; Chen, BPC				Lee, Kyung-Jong; Lin, Yu-Fen; Chou, Han-Yi; Yajima, Hirohiko; Fattah, Kazi R.; Lee, Sheng-Chung; Chen, Benjamin P. C.			Involvement of DNA-dependent Protein Kinase in Normal Cell Cycle Progression through Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAK; INDUCED REPLICATION STRESS; CATALYTIC SUBUNIT; PHOSPHORYLATION SITES; KINETOCHORE CAPTURE; MITOTIC SPINDLE; IN-VIVO; CHECKPOINT; DAMAGE; LOCALIZATION	The catalytic subunit of DNA-dependent protein kinase (DNA-PKcs) plays an important role in DNA double-strand break (DSB) repair as the underlying mechanism of the non-homologous end joining pathway. When DSBs occur, DNA-PKcs is rapidly phosphorylated at both the Thr-2609 and Ser-2056 residues, and such phosphorylations are critical for DSB repair. In this study we report that, in addition to responding to DSBs, DNA-PKcs is activated and phosphorylated in normal cell cycle progression through mitosis. Mitotic induction of DNA-PKcs phosphorylation is closely associated with the spindle apparatus at centrosomes and kinetochores. Furthermore, depletion of DNA-PKcs protein levels or inhibition of DNA-PKcs kinase activity results in the delay of mitotic transition because of chromosome misalignment. These results demonstrate for the first time that DNA-PKcs, in addition to its role in DSB repair, is a critical regulator of mitosis and could modulate microtubule dynamics in chromosome segregation.	[Lee, Kyung-Jong; Lin, Yu-Fen; Yajima, Hirohiko; Fattah, Kazi R.; Chen, Benjamin P. C.] Univ Texas SW Med Ctr Dallas, Div Mol Radiat Biol, Dept Radiat Oncol, Dallas, TX 75390 USA; [Chou, Han-Yi; Lee, Sheng-Chung] Natl Taiwan Univ, Inst Mol Med, Coll Med, Taipei 10051, Taiwan	University of Texas System; University of Texas Southwestern Medical Center Dallas; National Taiwan University	Chen, BPC (corresponding author), Univ Texas SW Med Ctr Dallas, Div Mol Radiat Biol, Dept Radiat Oncol, 2201 Inwood Rd, Dallas, TX 75390 USA.	benjamin.chen@utsouthwestern.edu	Lin, Yu-Fen/A-2570-2016		National Institutes of Health [CA50519]; National Aeronautics and Space Administration [NNX07AP84G]; National Science Council, Taiwan [NSC96-2321-B002-008]; NATIONAL CANCER INSTITUTE [R37CA050519, R01CA050519] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA50519. This work was also supported by National Aeronautics and Space Administration Grant NNX07AP84G and National Science Council, Taiwan Grant NSC96-2321-B002-008.	Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; Chen BPC, 2007, J BIOL CHEM, V282, P6582, DOI 10.1074/jbc.M611605200; Chen BPC, 2005, J BIOL CHEM, V280, P14709, DOI 10.1074/jbc.M408827200; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Ding Q, 2003, MOL CELL BIOL, V23, P5836, DOI 10.1128/MCB.23.16.5836-5848.2003; Douglas P, 2002, BIOCHEM J, V368, P243, DOI 10.1042/BJ20020973; Douglas P, 2007, MOL CELL BIOL, V27, P1581, DOI 10.1128/MCB.01962-06; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; GOLSTEYN RM, 1995, J CELL BIOL, V129, P1617, DOI 10.1083/jcb.129.6.1617; Hsu JY, 2002, NAT CELL BIOL, V4, P358, DOI 10.1038/ncb785; Kurimasa A, 1999, MOL CELL BIOL, V19, P3877; LEE KS, 1995, MOL CELL BIOL, V15, P7143; LEESMILLER SP, 1995, SCIENCE, V267, P1183, DOI 10.1126/science.7855602; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Ma YM, 2005, J BIOL CHEM, V280, P33839, DOI 10.1074/jbc.M507113200; MOROI Y, 1980, P NATL ACAD SCI-BIOL, V77, P1627, DOI 10.1073/pnas.77.3.1627; Peng YL, 2002, CANCER RES, V62, P6400; Ruis BL, 2008, MOL CELL BIOL, V28, P6182, DOI 10.1128/MCB.00355-08; Shang ZF, 2010, CANCER RES, V70, P3657, DOI 10.1158/0008-5472.CAN-09-3362; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; Tanaka TU, 2005, NAT REV MOL CELL BIO, V6, P929, DOI 10.1038/nrm1764; Tang ZY, 2004, MOL CELL, V16, P387, DOI 10.1016/j.molcel.2004.09.031; Taylor SS, 1997, CELL, V89, P727, DOI 10.1016/S0092-8674(00)80255-X; Wong J, 2006, J CELL BIOL, V173, P879, DOI 10.1083/jcb.200511132; Wong RHF, 2009, CELL, V136, P1056, DOI 10.1016/j.cell.2008.12.040; Yajima H, 2006, MOL CELL BIOL, V26, P7520, DOI 10.1128/MCB.00048-06; Yajima H, 2009, J MOL BIOL, V385, P800, DOI 10.1016/j.jmb.2008.11.036; Yu HT, 1996, CURR BIOL, V6, P455, DOI 10.1016/S0960-9822(02)00513-4; Zhang SS, 2007, J CELL BIOCHEM, V101, P451, DOI 10.1002/jcb.21195	31	60	61	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.212969	http://dx.doi.org/10.1074/jbc.M110.212969			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21330363	hybrid, Green Published			2022-12-27	WOS:000289077500090
J	Ren, YZR; Patel, K; Paun, BC; Kern, SE				Ren, Yunzhao R.; Patel, Kalpesh; Paun, Bogdan C.; Kern, Scott E.			Structural Analysis of the Cancer-specific Promoter in Mesothelin and in Other Genes Overexpressed in Cancers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTORS; PANCREATIC CANCERS; TISSUE MICROARRAY; IMMUNOTOXIN SS1P; SERIAL ANALYSIS; PHASE-I; EXPRESSION; CARCINOMAS; PROTEINS; OVARIAN	Mesothelin (MSLN) may be the most "dramatic" of the tumor markers, being strongly overexpressed in nearly one-third of human malignancies. The biochemical cause is unclear. We previously ascribed this cancer-specific overexpression to an element, Canscript, residing around 50 bp 5` of the transcription start site in cancer (Hucl, T., Brody, J. R., Gallmeier, E., Iacobuzio-Donahue, C. A., Farrance, I. K., and Kern, S. E. (2007) Cancer Res. 67, 9055-9065). Herein, we found a Canscript promoter activity elevated over 100-fold in cancer cells. In addition to a highly conserved TEAD1 (TEA domain family member 1)-binding MCAT motif, nucleotide substitution revealed the consensus core sequence (WCYCCACCC) of an SP1-like motif in Canscript. The unknown transcription factor binding to the SP1-like motif may hold the key for the cancer specificity of Canscript. SP1, GLI1, and RUNX1, -2, and -3 appeared unlikely to be the direct transcription factors acting at the SP1-like motif, but KLF6 had some features of such a candidate. YAP1, a TEAD1-binding protein, appeared necessary, but not sufficient, for Canscript activity; knockdown of YAP1 by small interfering RNAs greatly reduced MSLN levels in MSLN-overexpressing cells, but overexpressing YAP1 in MSLN-negative cells did not induce MSLN expression. Cansript-like sequences were found in other genes up-regulated in pancreatic cancer; reporters driven by the sequences from FXYD3, MUC1, and TIMP1 had activities more than 2 times that of the control. This suggested that the cause of MSLN overexpression might also contribute mechanistically to the overexpression of other tumor markers.	[Ren, Yunzhao R.; Patel, Kalpesh; Paun, Bogdan C.; Kern, Scott E.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine	Kern, SE (corresponding author), CRB1 451,1650 Orleans St, Baltimore, MD 21231 USA.	sk@jhmi.edu	Patel, Kalpesh/G-6685-2012	Patel, Kalpesh/0000-0002-2952-6773	National Institutes of Health [CA62924]; Everett and Marjorie Kovler Professorship in Pancreatic Cancer Research; NATIONAL CANCER INSTITUTE [P50CA062924] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Everett and Marjorie Kovler Professorship in Pancreatic Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA62924. This work was also supported by the Everett and Marjorie Kovler Professorship in Pancreatic Cancer Research.	Argani P, 2001, CLIN CANCER RES, V7, P3862; BERG JM, 1992, P NATL ACAD SCI USA, V89, P11109, DOI 10.1073/pnas.89.23.11109; BYRNE BJ, 1983, P NATL ACAD SCI-BIOL, V80, P721; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chang K, 1996, P NATL ACAD SCI USA, V93, P136, DOI 10.1073/pnas.93.1.136; Cook T, 1999, ANN NY ACAD SCI, V880, P94, DOI 10.1111/j.1749-6632.1999.tb09513.x; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Frierson HF, 2003, HUM PATHOL, V34, P605, DOI 10.1016/S0046-8177(03)00177-1; Harsha HC, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000046; Hassan R, 2004, CLIN CANCER RES, V10, P3937, DOI 10.1158/1078-0432.CCR-03-0801; Hassan R, 2007, CLIN CANCER RES, V13, P5144, DOI 10.1158/1078-0432.CCR-07-0869; HAUCK W, 1994, EUR J BIOCHEM, V223, P529, DOI 10.1111/j.1432-1033.1994.tb19022.x; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; Huang YH, 2010, CANCER BIOL THER, V10, P882, DOI 10.4161/cbt.10.9.13234; Hucl T, 2007, CANCER RES, V67, P9055, DOI 10.1158/0008-5472.CAN-07-0474; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; KINZLER KW, 1990, MOL CELL BIOL, V10, P634, DOI 10.1128/MCB.10.2.634; Kitagawa M, 2007, BIOCHEM BIOPH RES CO, V361, P1022, DOI 10.1016/j.bbrc.2007.07.129; Kreitman RJ, 2009, CLIN CANCER RES, V15, P5274, DOI 10.1158/1078-0432.CCR-09-0062; Larkin SB, 1996, MOL CELL BIOL, V16, P3742; Maitra A, 2003, MODERN PATHOL, V16, P902, DOI 10.1097/01.MP.0000086072.56290.FB; McGarvey KM, 2006, CANCER RES, V66, P3541, DOI 10.1158/0008-5472.CAN-05-2481; Muminova ZE, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-19; Ryu B, 2002, CANCER RES, V62, P819; Sathyanarayana BK, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-1; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Taniuchi I, 2004, ONCOGENE, V23, P4341, DOI 10.1038/sj.onc.1207671; Thiagalingam A, 1996, MOL CELL BIOL, V16, P5335; Urwin Debra, 2000, Molecular Cell Biology Research Communications, V3, P26, DOI 10.1006/mcbr.2000.0181; Vitolol MI, 2007, CANCER BIOL THER, V6, P856, DOI 10.4161/cbt.6.6.4241; WATANABE K, 1987, J BIOL CHEM, V262, P4812; Yoshida T, 2008, ARTERIOSCL THROM VAS, V28, P8, DOI 10.1161/ATVBAHA.107.155788; Zhang YJ, 2006, CLIN CANCER RES, V12, P4695, DOI 10.1158/1078-0432.CCR-06-0346; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao P, 2006, J BIOL CHEM, V281, P429, DOI 10.1074/jbc.M507440200	36	22	24	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.193458	http://dx.doi.org/10.1074/jbc.M110.193458			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21288909	Green Published, hybrid			2022-12-27	WOS:000289077500009
J	Yabe, T; Hosoda-Yabe, R; Kanamaru, Y; Kiso, M				Yabe, Tomio; Hosoda-Yabe, Ritsuko; Kanamaru, Yoshihiro; Kiso, Makoto			A Peptide Found by Phage Display Discriminates a Specific Structure of a Trisaccharide in Heparin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURITE OUTGROWTH; SULFATE PROTEOGLYCANS; ANTITHROMBIN-III; BINDING; ACTIVATION; EXPRESSION; MECHANISM; DOMAINS; PROTEIN; 3-O-SULFOTRANSFERASE	A number of recent studies have shown that heparan sulfate can control several important biological events on the cell surface through changes in sulfation pattern. The in vivo modification of sugar chains with sulfates, however, is complicated, and the discrimination of different sulfation patterns is difficult. Heparin, which is primarily produced by mast cells, is closely approximated by the structural analog heparan sulfate. Screening of heparin-associating peptides using phage display and antithrombin-bound affinity chromatography identified a peptide, heparin-associating peptide Y (HappY), that acts as a target of immobilized heparin. The peptide consists of 12 amino acid residues with characteristic three arginines and exclusively binds to heparin and heparan sulfate but does not associate with other glycosaminoglycans. HappY recognizes three consecutive monosaccharide residues in heparin through its three arginine residues. HappY should be a useful probe to detect heparin and heparan sulfate in studies of glycobiology.	[Yabe, Tomio; Hosoda-Yabe, Ritsuko; Kanamaru, Yoshihiro] Gifu Univ, Fac Appl Biol Sci, Dept Appl Life Sci, Gifu 5011193, Japan; [Kiso, Makoto] Gifu Univ, Fac Appl Biol Sci, Dept Appl Bioorgan Chem, Gifu 5011193, Japan; [Hosoda-Yabe, Ritsuko; Kiso, Makoto] Kyoto Univ, Inst Integrated Cell Mat Sci, Sakyo Ku, Kyoto 6068501, Japan	Gifu University; Gifu University; Kyoto University	Yabe, T (corresponding author), 1-1 Yanagido, Gifu 5011193, Japan.	yabet@gifu-u.ac.jp	Yabe, Tomio/B-5900-2013	Yabe, Tomio/0000-0002-9295-8560	Japan Society for the Promotion of Science (JSPS) [17101007, 16770108]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was partly supported by Japan Society for the Promotion of Science (JSPS) Grant-in-aid for Scientific Research (S) 17101007 (to M. K.) and for Young Scientists (B) 16770108 (to T. Y.).	Arocas V, 1999, BIOCHEMISTRY-US, V38, P10196, DOI 10.1021/bi990686b; Arocas V, 2001, J BIOL CHEM, V276, P43809, DOI 10.1074/jbc.M105294200; BASS S, 1990, PROTEINS, V8, P309, DOI 10.1002/prot.340080405; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Brito AS, 2008, BIOORGAN MED CHEM, V16, P9588, DOI 10.1016/j.bmc.2008.09.020; Brown RA, 2003, BRIT J PHARMACOL, V139, P845, DOI 10.1038/sj.bjp.0705291; Bruinsma IB, 2010, ACTA NEUROPATHOL, V119, P211, DOI 10.1007/s00401-009-0577-1; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Casu B, 2001, ADV CARBOHYD CHEM BI, V57, P159, DOI 10.1016/S0065-2318(01)57017-1; DAMUS PS, 1973, NATURE, V246, P355, DOI 10.1038/246355a0; Deng LW, 1999, VIROLOGY, V253, P271, DOI 10.1006/viro.1998.9509; Desai U, 2000, J BIOL CHEM, V275, P18976, DOI 10.1074/jbc.M001340200; DISCHE Z, 1957, BIOCHIM BIOPHYS ACTA, V24, P193, DOI 10.1016/0006-3002(57)90163-4; Gao YG, 2005, MOL CELLS, V19, P350; GROOTENHUIS PDJ, 1991, J AM CHEM SOC, V113, P2743, DOI 10.1021/ja00007a058; HIRSH J, 1992, BLOOD, V79, P1; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; Johnson DJD, 2006, EMBO J, V25, P2029, DOI 10.1038/sj.emboj.7601089; Kamimura K, 2004, J CELL BIOL, V166, P1069, DOI 10.1083/jcb.200403077; Kim MJ, 2003, J NEUROBIOL, V55, P261, DOI 10.1002/neu.10213; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Kuberan B, 2004, J BIOL CHEM, V279, P5053, DOI 10.1074/jbc.C300492200; LAM LH, 1976, BIOCHEM BIOPH RES CO, V69, P570, DOI 10.1016/0006-291X(76)90558-1; Laremore TN, 2009, CURR OPIN CHEM BIOL, V13, P633, DOI 10.1016/j.cbpa.2009.08.017; Li F, 2008, J BIOL CHEM, V283, P34294, DOI 10.1074/jbc.M806015200; Linhardt RJ, 2003, J MED CHEM, V46, P2551, DOI 10.1021/jm030176m; Liu J, 1996, J BIOL CHEM, V271, P27072, DOI 10.1074/jbc.271.43.27072; Lowman HB, 1997, ANNU REV BIOPH BIOM, V26, P401, DOI 10.1146/annurev.biophys.26.1.401; MACHOVICH R, 1975, BIOCHIM BIOPHYS ACTA, V412, P13, DOI 10.1016/0005-2795(75)90334-7; McKeehan WL, 1999, J BIOL CHEM, V274, P21511, DOI 10.1074/jbc.274.31.21511; Middeldorp S, 2008, THROMB RES, V122, P753, DOI 10.1016/j.thromres.2007.07.004; Munoz E, 2006, BIOCHEM BIOPH RES CO, V339, P597, DOI 10.1016/j.bbrc.2005.11.051; Onoue S, 2003, LIFE SCI, V73, P2793, DOI 10.1016/S0024-3205(03)00705-7; OOSTA GM, 1981, P NATL ACAD SCI-BIOL, V78, P829, DOI 10.1073/pnas.78.2.829; Purushothaman A, 2007, J BIOL CHEM, V282, P19442, DOI 10.1074/jbc.M700630200; ROSENBERG RD, 1973, J BIOL CHEM, V248, P6490; RYDEL RE, 1987, J NEUROSCI, V7, P3639; Schedin-Weiss S, 2002, BIOCHEMISTRY-US, V41, P4779, DOI 10.1021/bi012163l; Schuksz M, 2008, P NATL ACAD SCI USA, V105, P13075, DOI 10.1073/pnas.0805862105; SHEEHAN JP, 1994, P NATL ACAD SCI USA, V91, P5518, DOI 10.1073/pnas.91.12.5518; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Tashiro K, 1999, BIOCHEM J, V340, P119, DOI 10.1042/0264-6021:3400119; Teixeira MM, 1996, J LEUKOCYTE BIOL, V59, P389, DOI 10.1002/jlb.59.3.389; ten Dam GB, 2009, HISTOCHEM CELL BIOL, V132, P117, DOI 10.1007/s00418-009-0592-2; Thompson SM, 2009, J BIOL CHEM, V284, P35621, DOI 10.1074/jbc.M109.009712; Timmer NM, 2010, NEUROSCI RES, V66, P380, DOI 10.1016/j.neures.2009.12.012; van Kuppevelt TH, 1998, J BIOL CHEM, V273, P12960, DOI 10.1074/jbc.273.21.12960; Vanpouille C, 2007, J BIOL CHEM, V282, P24416, DOI 10.1074/jbc.M701835200; Verrecchio A, 2000, J BIOL CHEM, V275, P7701, DOI 10.1074/jbc.275.11.7701; Wang JG, 2002, INFLAMM RES, V51, P435, DOI 10.1007/PL00012403; WEILER JM, 1992, J IMMUNOL, V148, P3210; WRIGHT TC, 1989, J BIOL CHEM, V264, P1534; Yabe T, 2005, GLYCOBIOLOGY, V15, P982, DOI 10.1093/glycob/cwi090; Ye S, 2001, BIOCHEMISTRY-US, V40, P14429, DOI 10.1021/bi011000u	56	4	5	3	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.172155	http://dx.doi.org/10.1074/jbc.M110.172155			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21335559	hybrid, Green Published			2022-12-27	WOS:000289077500054
J	Anunciado-Koza, RP; Zhang, JY; Ukropec, J; Bajpeyi, S; Koza, RA; Rogers, RC; Cefalu, WT; Mynatt, RL; Kozak, LP				Anunciado-Koza, Rea P.; Zhang, Jingying; Ukropec, Jozef; Bajpeyi, Sudip; Koza, Robert A.; Rogers, Richard C.; Cefalu, William T.; Mynatt, Randall L.; Kozak, Leslie P.			Inactivation of the Mitochondrial Carrier SLC25A25 (ATP-Mg2+/P-i Transporter) Reduces Physical Endurance and Metabolic Efficiency in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIET-INDUCED OBESITY; RAT-LIVER MITOCHONDRIA; ATP-MG/PI CARRIER; ENERGY-EXPENDITURE; NONSHIVERING THERMOGENESIS; INSULIN SENSITIVITY; ADENINE-NUCLEOTIDES; UNCOUPLING PROTEIN; BODY-WEIGHT; CALCIUM	An ATP-Mg2+/P-i inner mitochondrial membrane solute transporter (SLC25A25), which is induced during adaptation to cold stress in the skeletal muscle of mice with defective UCP1/brown adipose tissue thermogenesis, has been evaluated for its role in metabolic efficiency. SLC25A25 is thought to control ATP homeostasis by functioning as a Ca2+-regulated shuttle of ATP-Mg2+ and P-i across the inner mitochondrial membrane. Mice with an inactivated Slc25a25 gene have reduced metabolic efficiency as evidenced by enhanced resistance to diet-induced obesity and impaired exercise performance on a treadmill. Mouse embryo fibroblasts from Slc25a25(-/-) mice have reduced Ca2+ flux across the endoplasmic reticulum, basal mitochondrial respiration, and ATP content. Although Slc25a25(-/-) mice are metabolically inefficient, the source of the inefficiency is not from a primary function in thermogenesis, because Slc25a25(-/-) mice maintain body temperature upon acute exposure to the cold (4 degrees C). Rather, the role of SLC25A25 in metabolic efficiency is most likely linked to muscle function as evidenced from the physical endurance test of mutant mice on a treadmill. Consequently, in the absence of SLC25A25 the efficiency of ATP production required for skeletal muscle function is diminished with secondary effects on adiposity. However, in the absence of UCP1-based thermogenesis, induction of Slc25a25 in mice with an intact gene may contribute to an alternative thermogenic pathway for the maintenance of body temperature during cold stress.	[Anunciado-Koza, Rea P.; Zhang, Jingying; Ukropec, Jozef; Bajpeyi, Sudip; Koza, Robert A.; Rogers, Richard C.; Cefalu, William T.; Mynatt, Randall L.; Kozak, Leslie P.] Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Kozak, LP (corresponding author), Polish Acad Sci Olsztyn, Ul Tuwima 10, PL-10747 Olsztyn, Poland.	l.kozak@pan.olsztyn.pl	Rogers, Richard/N-1988-2017; zhang, jingying R/R-4262-2018; Ukropec, Jozef/D-5960-2018; Mynatt, Randall L/N-1980-2017; Ukropec, Jozef/AAI-5590-2020	Ukropec, Jozef/0000-0001-8401-6621; Mynatt, Randall L/0000-0003-4399-0019; Bajpeyi, Sudip/0000-0002-5336-8330	National Institutes of Health [R01-HD008431, 1P30 DK07246, P20-TT021925]; Nutrition Obesity Research Center [1P30 DK07246]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD008431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476, R01DK089641] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nutrition Obesity Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-HD008431 (to L. P. K.) and 1P30 DK07246.; We thank Tamra Mendoza and Cody Giardina for excellent technical assistance. This work used the Genomics and Cell Biology an Bioimaging core facilities supported in part by the Nutrition Obesity Research Center Grant 1P30 DK07246 and COBRE (National Institutes of Health Grant P20-TT021925).	Alekseev AE, 2010, CELL METAB, V11, P58, DOI 10.1016/j.cmet.2009.11.009; Amo T, 2008, GENE, V411, P69, DOI 10.1016/j.gene.2008.01.007; Anunciado-Koza R, 2008, J BIOL CHEM, V283, P27688, DOI 10.1074/jbc.M804268200; APRILLE JR, 1988, FASEB J, V2, P2547, DOI 10.1096/fasebj.2.10.3290024; APRILLE JR, 1993, J BIOENERG BIOMEMBR, V25, P473, DOI 10.1007/BF01108404; Bajpeyi S, 2009, J APPL PHYSIOL, V106, P1079, DOI 10.1152/japplphysiol.91262.2008; BLOCK BA, 1994, ANNU REV PHYSIOL, V56, P535; Brown LJ, 2002, J BIOL CHEM, V277, P32892, DOI 10.1074/jbc.M202408200; BROWN LJ, 1994, J BIOL CHEM, V269, P14363; Cavero S, 2005, BIOCHEM J, V392, P537, DOI 10.1042/BJ20050806; Costanzo-Garvey DL, 2009, CELL METAB, V10, P366, DOI 10.1016/j.cmet.2009.09.010; del Arco A, 2005, BIOCHEM J, V389, P647, DOI 10.1042/BJ20050283; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Golozoubova V, 2001, FASEB J, V15, P2048, DOI 10.1096/fj.00-0536fje; Guerra C, 1998, J CLIN INVEST, V102, P1724, DOI 10.1172/JCI4532; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Hawley JA, 2009, NUTR REV, V67, P172, DOI 10.1111/j.1753-4887.2009.00185.x; HAYNES RC, 1986, J BIOL CHEM, V261, P6121; HEMINGWAY A, 1963, PHYSIOL REV, V43, P397, DOI 10.1152/physrev.1963.43.3.397; Hill BG, 2009, BIOCHEM J, V424, P99, DOI 10.1042/BJ20090934; HOLLOSZY JO, 1976, ANNU REV PHYSIOL, V38, P273, DOI 10.1146/annurev.ph.38.030176.001421; JOYAL JL, 1992, J BIOL CHEM, V267, P19198; Koza RA, 2000, J BIOL CHEM, V275, P34486, DOI 10.1074/jbc.M002136200; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; Kozak LP, 2010, CELL METAB, V11, P263, DOI 10.1016/j.cmet.2010.03.009; Kranias E. G., 2007, V45, P523; Kunji ERS, 2004, FEBS LETT, V564, P239, DOI 10.1016/S0014-5793(04)00242-X; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Liu XT, 2003, J CLIN INVEST, V111, P399, DOI 10.1172/JCI200315737; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; MacLennan DH, 2000, EUR J BIOCHEM, V267, P5291, DOI 10.1046/j.1432-1327.2000.01566.x; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; NOSEK MT, 1990, J BIOL CHEM, V265, P8444; Ochala J, 2009, UPSALA J MED SCI, V114, P235, DOI 10.3109/03009730903276399; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Periasamy M, 1999, J BIOL CHEM, V274, P2556, DOI 10.1074/jbc.274.4.2556; POLLAK JK, 1980, BIOCHEM J, V192, P75, DOI 10.1042/bj1920075; Satrustegui J, 2007, PHYSIOL REV, V87, P29, DOI 10.1152/physrev.00005.2006; Thomas SA, 1997, NATURE, V387, P94, DOI 10.1038/387094a0; TRAYHURN P, 1978, PFLUG ARCH EUR J PHY, V373, P189, DOI 10.1007/BF00584859; Ukropec J, 2006, ENDOCRINOLOGY, V147, P2468, DOI 10.1210/en.2005-1216; Ukropec J, 2006, J BIOL CHEM, V281, P31894, DOI 10.1074/jbc.M606114200; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; ZURLO F, 1990, AM J PHYSIOL, V259, pE650	44	62	62	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11659	11671		10.1074/jbc.M110.203000	http://dx.doi.org/10.1074/jbc.M110.203000			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21296886	hybrid, Green Published			2022-12-27	WOS:000288797100074
J	Chen, L; Cai, Y; Jin, JJ; Florens, L; Swanson, SK; Washburn, MP; Conaway, JW; Conaway, RC				Chen, Lu; Cai, Yong; Jin, Jingji; Florens, Laurence; Swanson, Selene K.; Washburn, Michael P.; Conaway, Joan Weliky; Conaway, Ronald C.			Subunit Organization of the Human INO80 Chromatin Remodeling Complex AN EVOLUTIONARILY CONSERVED CORE COMPLEX CATALYZES ATP-DEPENDENT NUCLEOSOME REMODELING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-RELATED PROTEINS; SPECTRAL ABUNDANCE FACTORS; SACCHAROMYCES-CEREVISIAE; IDENTIFICATION TECHNOLOGY; SHOTGUN PROTEOMICS; TRANSCRIPTION; REPAIR; EXPRESSION; NUCLEOTIDE; PEPTIDES	We previously identified and purified a human ATP-dependent chromatin remodeling complex with similarity to the Saccharomyces cerevisiae INO80 complex (Jin, J., Cai, Y., Yao, T., Gottschalk, A. J., Florens, L., Swanson, S. K., Gutierrez, J. L., Coleman, M. K., Workman, J. L., Mushegian, A., Washburn, M. P., Conaway, R. C., and Conaway, J. W. (2005) J. Biol. Chem. 280, 41207-41212) and demonstrated that it is composed of (i) a Snf2 family ATPase (hIno80) related in sequence to the S. cerevisiae Ino80 ATPase; (ii) seven additional evolutionarily conserved subunits orthologous to yeast INO80 complex subunits; and (iii) six apparently metazoan-specific subunits. In this report, we present evidence that the human INO80 complex is composed of three modules that assemble with three distinct domains of the hIno80 ATPase. These modules include (i) one that is composed of the N terminus of the hIno80 protein and all of the metazoan-specific subunits and is not required for ATP dependent nucleosome remodeling; (ii) a second that is composed of the hIno80 Snf2-like ATPase/helicase and helicase-SANT-associated/ post-HSA (HSA/PTH) domain, the actin-related proteins Arp4 and Arp8, and the GLI-Kruppel family transcription factor YY1; and (iii) a third that is composed of the hIno80 Snf2 ATPase domain, the Ies2 and Ies6 proteins, the AAA(+) ATPases Tip49a and Tip49b, and the actin-related protein Arp5. Through purification and characterization of hINO80 complex subassemblies, we demonstrate that ATP-dependent nucleosome remodeling by the hINO80 complex is catalyzed by a core complex comprising the hIno80 protein HSA/PTH and Snf2 ATPase domains acting in concert with YY1 and the complete set of its evolutionarily conserved subunits. Taken together, our findings shed new light on the structure and function of the INO80 chromatin-remodeling complex.	[Chen, Lu; Florens, Laurence; Swanson, Selene K.; Washburn, Michael P.; Conaway, Joan Weliky; Conaway, Ronald C.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Chen, Lu; Conaway, Joan Weliky; Conaway, Ronald C.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA; [Washburn, Michael P.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA; [Cai, Yong; Jin, Jingji] Jilin Univ, Coll Life Sci, Changchun 130012, Jilin Province, Peoples R China	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; Jilin University	Conaway, RC (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	rcc@stowers.org	Chen, Lu/AAN-4886-2021	Chen, Lu/0000-0002-4571-7975; Washburn, Michael/0000-0001-7568-2585; Conaway, Joan/0000-0002-2786-0663; Florens, Laurence/0000-0002-9310-6650	National Institutes of Health through the NIGMS [GM41628]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041628, R01GM041628] Funding Source: NIH RePORTER	National Institutes of Health through the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM41628 through the NIGMS (to R. C. C. and J. W. C.).	ACTIVITIES IN, 2007, NUMBER MARCH, V67, P2283; Bao YH, 2007, MUTAT RES-FUND MOL M, V618, P18, DOI 10.1016/j.mrfmmm.2006.10.006; Cai Y, 2007, NAT STRUCT MOL BIOL, V14, P872, DOI 10.1038/nsmb1276; Cai Y, 2006, METHODS, V40, P312, DOI 10.1016/j.ymeth.2006.06.023; Conaway RC, 2009, TRENDS BIOCHEM SCI, V34, P71, DOI 10.1016/j.tibs.2008.10.010; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dion V, 2010, CURR OPIN CELL BIOL, V22, P383, DOI 10.1016/j.ceb.2010.02.006; Ebbert R, 1999, MOL MICROBIOL, V32, P741, DOI 10.1046/j.1365-2958.1999.01390.x; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Florens L, 2006, METHODS, V40, P303, DOI 10.1016/j.ymeth.2006.07.028; Florens Laurence, 2006, V328, P159; Harata M, 1999, MOL BIOL CELL, V10, P2595, DOI 10.1091/mbc.10.8.2595; Hogan CJ, 2010, MOL CELL BIOL, V30, P657, DOI 10.1128/MCB.01117-09; Hur SK, 2010, CELL MOL LIFE SCI, V67, P2283, DOI 10.1007/s00018-010-0337-3; Jiang YJ, 2010, P NATL ACAD SCI USA, V107, P17274, DOI 10.1073/pnas.1008388107; Jin JY, 2005, J BIOL CHEM, V280, P41207, DOI 10.1074/jbc.M509128200; Jonsson ZO, 2004, MOL CELL, V16, P465, DOI 10.1016/j.molcel.2004.09.033; Klymenko T, 2006, GENE DEV, V20, P1110, DOI 10.1101/gad.377406; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Marsden RL, 2002, PROTEIN SCI, V11, P2814, DOI 10.1110/ps.0209902; Owen-Hughes T, 1999, METH MOL B, V119, P319; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Park EJ, 2010, BIOCHEM J, V431, P179, DOI 10.1042/BJ20100988; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; Szerlong H, 2008, NAT STRUCT MOL BIOL, V15, P469, DOI 10.1038/nsmb.1403; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wu S, 2007, NAT STRUCT MOL BIOL, V14, P1165, DOI 10.1038/nsmb1332; Wu WH, 2005, NAT STRUCT MOL BIOL, V12, P1064, DOI 10.1038/nsmb1023; Yao T, 2008, MOL CELL, V31, P909, DOI 10.1016/j.molcel.2008.08.027; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	35	83	97	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11283	11289		10.1074/jbc.M111.222505	http://dx.doi.org/10.1074/jbc.M111.222505			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21303910	hybrid, Green Published			2022-12-27	WOS:000288797100040
J	Engqvist, MKM; Kuhn, A; Wienstroer, J; Weber, K; Jansen, EEW; Jakobs, C; Weber, APM; Maurino, VG				Engqvist, Martin K. M.; Kuhn, Anke; Wienstroer, Judith; Weber, Katrin; Jansen, Erwin E. W.; Jakobs, Cornelis; Weber, Andreas P. M.; Maurino, Veronica G.			Plant D-2-Hydroxyglutarate Dehydrogenase Participates in the Catabolism of Lysine Especially during Senescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARABIDOPSIS-THALIANA; L-2-HYDROXYGLUTARIC ACID; ALPHA-HYDROXYGLUTARATE; GENE-EXPRESSION; METABOLISM; OXIDATION; IDENTIFICATION; MITOCHONDRIA; PATHWAYS; PROTEINS	D-2-Hydroxyglutarate dehydrogenase (D-2HGDH) catalyzes the specific and efficient oxidation of D-2-hydroxyglutarate (D-2HG) to 2-oxoglutarate using FAD as a cofactor. In this work, we demonstrate that D-2HGDH localizes to plant mitochondria and that its expression increases gradually during developmental and dark-induced senescence in Arabidopsis thaliana, indicating an enhanced demand of respiration of alternative substrates through this enzymatic system under these conditions. Using loss-of-function mutants in D-2HGDH(d2hgdh1) and stable isotope dilution LC-MS/MS, we found that the D-isomer of 2HG accumulated in leaves of d2hgdh1 during both forms of carbon starvation. In addition to this, d2hgdh1 presented enhanced levels of most TCA cycle intermediates and free amino acids. In contrast to the deleterious effects caused by a deficiency in D-2HGDH in humans, d2hgdh1 and overexpressing lines of D-2HGDH showed normal developmental and senescence phenotypes, indicating a mild role of D-2HGDH in the tested conditions. Moreover, metabolic fingerprinting of leaves of plants grown in media supplemented with putative precursors indicated that D-2HG most probably originates during the catabolism of lysine. Finally, the L-isomer of 2HG was also detected in leaf extracts, indicating that both chiral forms of 2HG participate in plant metabolism.	[Engqvist, Martin K. M.; Kuhn, Anke; Wienstroer, Judith; Maurino, Veronica G.] Univ Cologne, Inst Bot, Biozentrum Koln, D-50674 Cologne, Germany; [Jansen, Erwin E. W.; Jakobs, Cornelis] Vrije Univ Amsterdam Med Ctr, Metab Unit, NL-1081 HV Amsterdam, Netherlands; [Weber, Katrin; Weber, Andreas P. M.] Univ Dusseldorf, Inst Biochem Pflanzen, D-40225 Dusseldorf, Germany	University of Cologne; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Heinrich Heine University Dusseldorf	Maurino, VG (corresponding author), Univ Cologne, Inst Bot, Biozentrum Koln, Zulpicher Str 47B, D-50674 Cologne, Germany.	v.maurino@uni-koeln.de	Weber, Andreas PM/A-6250-2011; Weber, Andreas Paul Michael/O-3043-2019	Weber, Andreas PM/0000-0003-0970-4672; Weber, Andreas Paul Michael/0000-0003-0970-4672; Engqvist, Martin/0000-0003-2174-2225	Deutsche Forschungsgemeinschaft, German Photorespiration Research Network Promics	Deutsche Forschungsgemeinschaft, German Photorespiration Research Network Promics(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft grants (to V. G. M. and A. P. M. W.) as part of the German Photorespiration Research Network Promics.	Achouri Y, 2004, BIOCHEM J, V381, P35, DOI 10.1042/BJ20031933; Albers E, 1998, MICROBIOL-UK, V144, P1683, DOI 10.1099/00221287-144-6-1683; Araujo WL, 2010, PLANT CELL, V22, P1549, DOI 10.1105/tpc.110.075630; Bari R, 2004, J EXP BOT, V55, P623, DOI 10.1093/jxb/erh079; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buchanan-Wollaston V, 2005, PLANT J, V42, P567, DOI 10.1111/j.1365-313X.2005.02399.x; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Diaz C, 2005, PLANT PHYSIOL, V138, P898, DOI 10.1104/pp.105.060764; Engqvist M, 2009, J BIOL CHEM, V284, P25026, DOI 10.1074/jbc.M109.021253; Fahnenstich H, 2007, PLANT PHYSIOL, V145, P640, DOI 10.1104/pp.107.104455; Frerman F.E., 2001, METABOLIC MOL BASES; GIBSON KM, 1993, PEDIATR RES, V34, P277, DOI 10.1203/00006450-199309000-00007; Ishizaki K, 2005, PLANT CELL, V17, P2587, DOI 10.1105/tpc.105.035162; KAUFMAN EE, 1988, J NEUROCHEM, V51, P1079, DOI 10.1111/j.1471-4159.1988.tb03071.x; KOPCHICK JJ, 1979, J BIOL CHEM, V254, P3259; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee CP, 2008, MOL CELL PROTEOMICS, V7, P1297, DOI 10.1074/mcp.M700535-MCP200; Lee DY, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-7; Lehmann M, 2009, MOL PLANT, V2, P390, DOI 10.1093/mp/ssn080; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; SCHREIBER U, 1986, PHOTOSYNTH RES, V10, P51, DOI 10.1007/BF00024185; Schwacke R, 2003, PLANT PHYSIOL, V131, P16, DOI 10.1104/pp.011577; Sheen J, 2001, PLANT PHYSIOL, V127, P1466, DOI 10.1104/pp.010820; Stepansky A, 2006, AMINO ACIDS, V30, P121, DOI 10.1007/s00726-005-0246-1; Struys EA, 2007, J INHERIT METAB DIS, V30, P690, DOI 10.1007/s10545-007-0697-5; Struys EA, 2006, J INHERIT METAB DIS, V29, P21, DOI 10.1007/s10545-006-0317-9; Struys EA, 2005, AM J HUM GENET, V76, P358, DOI 10.1086/427890; Struys EA, 2004, CLIN CHEM, V50, P1391, DOI 10.1373/clinchem.2004.033399; Tomaz T, 2010, PLANT PHYSIOL, V154, P1143, DOI 10.1104/pp.110.161612; TUBBS PK, 1961, BIOCHEM J, V81, P104, DOI 10.1042/bj0810104; WEGENER WS, 1968, ARCH BIOCHEM BIOPHYS, V123, P62, DOI 10.1016/0003-9861(68)90103-3; Wydro M, 2006, ACTA BIOCHIM POL, V53, P289; Zhao GS, 1996, J BACTERIOL, V178, P232, DOI 10.1128/jb.178.1.232-239.1996	34	53	54	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11382	11390		10.1074/jbc.M110.194175	http://dx.doi.org/10.1074/jbc.M110.194175			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21296880	Green Published, hybrid			2022-12-27	WOS:000288797100050
J	Lindsay, AJ; McCaffrey, MW				Lindsay, Andrew J.; McCaffrey, Mary W.			Myosin Va Is Required for P Body but Not Stress Granule Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOPLASMIC PROCESSING BODIES; MESSENGER-RNA TRANSLATION; MOTOR PROTEIN; COMPLEX; TRANSPORT; MICROTUBULE; CELLS; DECAY; GENE; IDENTIFICATION	In the present study we demonstrate an association between mammalian myosin Va and cytoplasmic P bodies, microscopic ribonucleoprotein granules that contain components of the 5'-3' mRNA degradation machinery. Myosin Va colocalizes with several P body markers and its RNAi-mediated knockdown results in the disassembly of P bodies. Overexpression of a dominant-negative mutant of myosin Va reduced the motility of P bodies in living cells. Co-immunoprecipitation experiments demonstrate that myosin Va physically associates with eIF4E, an mRNA binding protein that localizes to P bodies. In contrast, we find that myosin Va does not play a role in stress granule formation. Stress granules are ribonucleoprotein structures that are involved in translational silencing and are spatially, functionally, and compositionally linked to P bodies. Myosin Va is found adjacent to stress granules in stressed cells but displays minimal localization within stress granules, and myosin Va knockdown has no effect on stress granule assembly or disassembly. Combined with recently published reports demonstrating a role for Drosophila and mammalian class V myosins in mRNA transport and the involvement of the yeast myosin V orthologue Myo2p in P body assembly, our results provide further evidence that the class V myosins serve an important role in the transport and turnover of mRNA.	[Lindsay, Andrew J.; McCaffrey, Mary W.] Univ Coll Cork, Biosci Inst, Dept Biochem, Mol Cell Biol Lab, Cork, Ireland	University College Cork	Lindsay, AJ (corresponding author), Inst Curie, CNRS, Unite Mixte Rech 144, Lab Mol Mechanisms Intracellular Transport, F-75248 Paris 05, France.	Andrew.Lindsay@curie.fr	Lindsay, Andrew J/P-9778-2017	Lindsay, Andrew J/0000-0001-9693-7022	Health Research Board, Ireland [PD/2005/25]; Health Research Board/Marie-Curie [HRB MCPD/2009/6]; SFI [05/IN.3/B859]	Health Research Board, Ireland; Health Research Board/Marie-Curie(European Commission); SFI(Science Foundation Ireland)	This work was supported by Health Research Board, Ireland Career Development Fellowship PD/2005/25 and Joint Health Research Board/Marie-Curie Postdoctoral Mobility Fellowship HRB MCPD/2009/6 (to A. J. L.) and SFI Programme Grant 05/IN.3/B859 (to M. W. M.).	Aizer A, 2008, MOL BIOL CELL, V19, P4154, DOI 10.1091/mbc.E08-05-0513; Ali MY, 2008, P NATL ACAD SCI USA, V105, P4691, DOI 10.1073/pnas.0711531105; Ali MY, 2007, P NATL ACAD SCI USA, V104, P4332, DOI 10.1073/pnas.0611471104; Anderson P, 2005, DEV CELL, V9, P311, DOI 10.1016/j.devcel.2005.08.003; Anderson P, 2009, CURR BIOL, V19, pR397, DOI 10.1016/j.cub.2009.03.013; Andrei MA, 2005, RNA, V11, P717, DOI 10.1261/rna.2340405; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Bobola N, 1996, CELL, V84, P699, DOI 10.1016/S0092-8674(00)81048-X; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Cao TT, 2004, MOL BIOL CELL, V15, P151, DOI 10.1091/mbc.E03-07-0504; Chang W, 2008, RNA, V14, P491, DOI 10.1261/rna.665008; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Correia SS, 2008, NAT NEUROSCI, V11, P457, DOI 10.1038/nn2063; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Gonsalvez GB, 2004, J BIOL CHEM, V279, P46286, DOI 10.1074/jbc.M406086200; Hales CM, 2002, J BIOL CHEM, V277, P50415, DOI 10.1074/jbc.M209270200; Hodges AR, 2009, CURR BIOL, V19, P2121, DOI 10.1016/j.cub.2009.10.069; Huang JD, 1999, NATURE, V397, P267, DOI 10.1038/16722; Jagannath A, 2009, MOL BIOL CELL, V20, P521, DOI 10.1091/mbc.E08-08-0796; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Krauss J, 2009, CURR BIOL, V19, P1058, DOI 10.1016/j.cub.2009.04.062; Kwon S, 2007, GENE DEV, V21, P3381, DOI 10.1101/gad.461107; Lian S, 2007, MOL BIOL CELL, V18, P3375, DOI 10.1091/mbc.E07-01-0070; Lindsay AJ, 2009, CELL MOTIL CYTOSKEL, V66, P1057, DOI 10.1002/cm.20408; Loschi M, 2009, J CELL SCI, V122, P3973, DOI 10.1242/jcs.051383; Lykke-Andersen J, 2002, MOL CELL BIOL, V22, P8114, DOI 10.1128/MCB.22.23.8114-8121.2002; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; Ohashi S, 2002, J BIOL CHEM, V277, P37804, DOI 10.1074/jbc.M203608200; Paquin N, 2008, TRENDS CELL BIOL, V18, P105, DOI 10.1016/j.tcb.2007.12.004; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Pastural E, 1997, NAT GENET, V16, P289, DOI 10.1038/ng0797-289; Pauley KM, 2006, EMBO REP, V7, P904, DOI 10.1038/sj.embor.7400783; Prekeris R, 1997, J CELL BIOL, V137, P1589, DOI 10.1083/jcb.137.7.1589; Salerno VP, 2008, CELL MOTIL CYTOSKEL, V65, P422, DOI 10.1002/cm.20272; SEPERACK PK, 1995, EMBO J, V14, P2326, DOI 10.1002/j.1460-2075.1995.tb07227.x; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Sloane JA, 2007, J NEUROSCI, V27, P11366, DOI 10.1523/JNEUROSCI.2326-07.2007; Sonenberg N, 2008, BIOCHEM CELL BIOL, V86, P178, DOI 10.1139/O08-034; Sweet TJ, 2007, RNA, V13, P493, DOI 10.1261/rna.355807; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Trybus KM, 2008, CELL MOL LIFE SCI, V65, P1378, DOI 10.1007/s00018-008-7507-6; Varadi A, 2005, MOL BIOL CELL, V16, P2670, DOI 10.1091/mbc.e04-11-1001; Wu XS, 2005, J CELL BIOL, V171, P201, DOI 10.1083/jcb.200503028; Yoshimura A, 2006, CURR BIOL, V16, P2345, DOI 10.1016/j.cub.2006.10.024	49	14	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11519	11528		10.1074/jbc.M110.182808	http://dx.doi.org/10.1074/jbc.M110.182808			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21245139	Green Published, hybrid			2022-12-27	WOS:000288797100062
J	Sudo, Y; Yuasa, Y; Shibata, J; Suzuki, D; Homma, M				Sudo, Yuki; Yuasa, Yasufumi; Shibata, Jun; Suzuki, Daisuke; Homma, Michio			Spectral Tuning in Sensory Rhodopsin I from Salinibacter ruber	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHARAONIS PHOBORHODOPSIN; PROTON PUMP; WAVELENGTH REGULATION; OPSIN SHIFT; BACTERIORHODOPSIN; PROTEIN; BINDING; TRANSDUCTION; MECHANISM; RESIDUES	Organisms utilize light as energy sources and as signals. Rhodopsins, which have seven transmembrane alpha-helices with retinal covalently linked to a conserved Lys residue, are found in various organisms as distant in evolution as bacteria, archaea, and eukarya. One of the most notable properties of rhodopsin molecules is the large variation in their absorption spectrum. Sensory rhodopsin I (SRI) and sensory rhodopsin II (SRII) function as photosensors and have similar properties (retinal composition, photocycle, structure, and function) except for their lambda(max) (SRI, similar to 560 nm; SRII, similar to 500 nm). An expression system utilizing Escherichia coli and the high protein stability of a newly found SRI-like protein, SrSRI, enables studies of mutant proteins. To determine the residue contributing to the spectral shift from SRI to SRII, we constructed various SRI mutants, in which individual residues were substituted with the corresponding residues of SRII. Three such mutants of SrSRI showed a large spectral blue-shift (> 14 nm) without a large alteration of their retinal composition. Two of them, A136Y and A200T, are newly discovered color tuning residues. In the triple mutant, the lambda(max) was 525 nm. The inverse mutation of SRII (F134H/Y139A/T204A) generated a spectral-shifted SRII toward longer wavelengths, although the effect is smaller than in the case of SRI, which is probably due to the lack of anion binding in the SRII mutant. Thus, half of the spectral shift from SRI to SRII could be explained by only those three residues taking into account the effect of Cl- binding.	[Sudo, Yuki] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Sudo, Yuki] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Nagoya University; Japan Science & Technology Agency (JST)	Sudo, Y (corresponding author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan.	z47867a@cc.nagoya-u.ac.jp	Sudo, Yuki/AGY-0493-2022	Sudo, Yuki/0000-0001-8155-9356	Ministry of Education, Culture, Sports, Science, and Technology of Japan [477]; Japanese Ministry of Education, Culture, Sports, Science, and Technology; Grants-in-Aid for Scientific Research [23657100] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-aid for Scientific Research on Priority Area 477 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. This work was also supported by grants from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (to M. H. and Y. S.).	Balashov SP, 2005, SCIENCE, V309, P2061, DOI 10.1126/science.1118046; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; BLATZ PE, 1972, BIOCHEMISTRY-US, V11, P848, DOI 10.1021/bi00755a026; Brown LS, 2004, PHOTOCH PHOTOBIO SCI, V3, P555, DOI 10.1039/b315527g; Costanzi S, 2009, CURR PHARM DESIGN, V15, P3994, DOI 10.2174/138161209789824795; Haupts U, 1999, ANNU REV BIOPH BIOM, V28, P367, DOI 10.1146/annurev.biophys.28.1.367; Hayashi S, 2001, J PHYS CHEM B, V105, P10124, DOI 10.1021/jp011362b; HONIG B, 1979, J AM CHEM SOC, V101, P7084, DOI 10.1021/ja00517a060; HU JG, 1994, P NATL ACAD SCI USA, V91, P8880, DOI 10.1073/pnas.91.19.8880; Jung KH, 2007, PHOTOCHEM PHOTOBIOL, V83, P63, DOI 10.1562/2006-03-20-IR-853; Kitajima-Ihara T, 2008, J BIOL CHEM, V283, P23533, DOI 10.1074/jbc.M802990200; Lanyi JK, 2006, BBA-BIOENERGETICS, V1757, P1012, DOI 10.1016/j.bbabio.2005.11.003; Lanyi JK, 2004, ANNU REV PHYSIOL, V66, P665, DOI 10.1146/annurev.physiol.66.032102.150049; Lin SL, 1997, PROTEIN ENG, V10, P197, DOI 10.1093/protein/10.3.197; Luecke H, 2001, SCIENCE, V293, P1499, DOI 10.1126/science.1062977; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; Rajamani R, 2002, J COMPUT CHEM, V23, P96, DOI 10.1002/jcc.1159; Ren L, 2001, BIOCHEMISTRY-US, V40, P13906, DOI 10.1021/bi0116487; Royant A, 2001, P NATL ACAD SCI USA, V98, P10131, DOI 10.1073/pnas.181203898; Sasaki J, 2008, PHOTOCHEM PHOTOBIOL, V84, P863, DOI 10.1111/j.1751-1097.2008.00314.x; Sharma AK, 2006, TRENDS MICROBIOL, V14, P463, DOI 10.1016/j.tim.2006.09.006; Shimono K, 2003, J BIOL CHEM, V278, P23882, DOI 10.1074/jbc.M301200200; Shimono K, 2001, BBA-BIOMEMBRANES, V1515, P92, DOI 10.1016/S0005-2736(01)00394-7; Shimono K, 2000, PHOTOCHEM PHOTOBIOL, V72, P141; Spudich JL, 1996, CURR OPIN CELL BIOL, V8, P452, DOI 10.1016/S0955-0674(96)80020-2; Spudich JL, 2002, CURR OPIN STRUC BIOL, V12, P540, DOI 10.1016/S0959-440X(02)00359-7; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; Spudich JL, 2006, TRENDS MICROBIOL, V14, P480, DOI 10.1016/j.tim.2006.09.005; Sudo Y, 2006, J MOL BIOL, V357, P1274, DOI 10.1016/j.jmb.2006.01.061; Sudo Y, 2001, PHOTOCHEM PHOTOBIOL, V74, P489, DOI 10.1562/0031-8655(2001)074<0489:PPBTIC>2.0.CO;2; Sudo Y, 2006, P NATL ACAD SCI USA, V103, P16129, DOI 10.1073/pnas.0607467103; Sudo Y, 2009, BIOCHEMISTRY-US, V48, P10136, DOI 10.1021/bi901338d; Suzuki D, 2010, SENSORS-BASEL, V10, P4010, DOI 10.3390/s100404010; Suzuki D, 2009, J MOL BIOL, V392, P48, DOI 10.1016/j.jmb.2009.06.050; Suzuki D, 2008, BIOCHEMISTRY-US, V47, P12750, DOI 10.1021/bi801358b; Walter JM, 2010, CURR OPIN BIOTECH, V21, P265, DOI 10.1016/j.copbio.2010.03.007; Waschuk SA, 2005, P NATL ACAD SCI USA, V102, P6879, DOI 10.1073/pnas.0409659102; Yagasaki J, 2010, BIOCHEMISTRY-US, V49, P1183, DOI 10.1021/bi901824a; YAN B, 1995, J BIOL CHEM, V270, P29668; Yokoyama S, 2000, PROG RETIN EYE RES, V19, P385, DOI 10.1016/S1350-9462(00)00002-1; Yoshitsugu M, 2008, ANGEW CHEM INT EDIT, V47, P3923, DOI 10.1002/anie.200705989; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192	42	24	25	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11328	11336		10.1074/jbc.M110.187948	http://dx.doi.org/10.1074/jbc.M110.187948			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21288897	Green Published, hybrid			2022-12-27	WOS:000288797100045
J	Chen, YH; Yeh, FL; Yeh, SP; Ma, HT; Hung, SC; Hung, MC; Li, LY				Chen, Ya-Huey; Yeh, Fang-Ling; Yeh, Su-Peng; Ma, Haou-Tzong; Hung, Shih-Chieh; Hung, Mien-Chie; Li, Long-Yuan			Myocyte Enhancer Factor-2 Interacting Transcriptional Repressor (MITR) Is a Switch That Promotes Osteogenesis and Inhibits Adipogenesis of Mesenchymal Stem Cells by Inactivating Peroxisome Proliferator-activated Receptor gamma-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II HISTONE DEACETYLASES; OSTEOBLAST DIFFERENTIATION; METHYLATION; BONE; HYPERTROPHY; METABOLISM; POLYCOMB; MARROW; ENERGY; GENES	EZH2, a catalytic subunit of Polycomb-repressive complex 2 (PRC2), is a histone lysine methyltransferase that methylates lysine 27 of histone H3, resulting in gene silencing. It has been shown that EZH2 plays a pivotal role in fostering self-renewal and inhibiting the differentiation of embryonic stem cells. Mesenchymal stem cells (MSCs) can be induced to differentiate into adipogenic and osteogenic lineages, which are mutually exclusive. However, it is not clear whether the molecular events of EZH2-mediated epigenetic silencing may coordinate differentiation between osteoblasts and adipocytes. Disruption of the balance between adipogenesis and osteogenesis is associated with many diseases; thus, identifying a switch that determines the fate of MSC is critical. In this study, we used EZH2ChIP-on-chip assay to identify differential EZH2 targets in the two differentiation stages on a genome-wide scale. After validating the targets, we found that myocyte enhancer factor-2 interacting transcriptional repressor (MITR)/HDAC9c was expressed in osteoblasts and greatly decreased in adipocytes. We demonstrated that MITR plays a crucial role in the acceleration of MSC osteogenesis and attenuation of MSC adipogenesis through interaction with peroxisome proliferator-activated receptor (PPAR) gamma-2 in the nucleus of osteoblasts, which interrupts PPAR gamma-2 activity and prevents adipogenesis. Together, our results demonstrated that MITR plays a master switch role to balance osteogenic and adipo-genic differentiation of MSCs through regulation of PPAR gamma-2 transcriptional activity.	[Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Chen, Ya-Huey; Yeh, Fang-Ling; Hung, Mien-Chie; Li, Long-Yuan] China Med Univ Hosp, Ctr Mol Med, Taichung 40447, Taiwan; [Chen, Ya-Huey; Yeh, Fang-Ling; Hung, Mien-Chie; Li, Long-Yuan] China Med Univ, Grad Inst Canc Biol, Taichung 40402, Taiwan; [Li, Long-Yuan] Asia Univ, Dept Biotechnol, Taichung 41354, Taiwan; [Yeh, Su-Peng] China Med Univ Hosp, Div Hematol & Oncol, Dept Med, Taichung 40447, Taiwan; [Hung, Shih-Chieh] Natl Yang Ming Univ, Dept Surg, Sch Med, Taipei 112, Taiwan; [Ma, Haou-Tzong; Li, Long-Yuan] China Med Univ, Canc Biol & Drug Discovery PhD Program, Taichung 40402, Taiwan	University of Texas System; UTMD Anderson Cancer Center; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Asia University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Yang Ming Chiao Tung University; China Medical University Taiwan	Hung, MC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	mhung@mdanderson.org; lyl@mail.cmu.edu.tw	Hung, Mien-Chie/ABD-5911-2021	Hung, Mien-Chie/0000-0003-4317-4740; Li, Long-Yuan/0000-0001-7472-8318	Kadoorie Charitable Foundations; MD Anderson Cancer Center-China Medical University Hospital; NSC [99-2632-B-039-001-MY3];  [NSC98-3111-B-039];  [NHRI-EX99-9603BC];  [DOH98-TD-I-111-TM002];  [DOH99-TD-I-111-TM026];  [NSC99-3111-B-039-001];  [DOH100-TD-C-111-005]	Kadoorie Charitable Foundations; MD Anderson Cancer Center-China Medical University Hospital; NSC(Ministry of Science and Technology, Taiwan); ; ; ; ; ; 	This work was supported by Grants NSC98-3111-B-039 (to M.-C.H., L.-Y. L., and S.-P.Y.), NHRI-EX99-9603BC, DOH98-TD-I-111-TM002, DOH99-TD-I-111-TM026, and NSC99-3111-B-039-001 (to L.-Y. L.), DOH100-TD-C-111-005 and NSC 99-2632-B-039-001-MY3 (to M.-C.H. and L.-Y.L.), MD Anderson Cancer Center-China Medical University Hospital Sister Institution Fund, and Kadoorie Charitable Foundations (to M.-C.H.).	Bertos NR, 2001, BIOCHEM CELL BIOL, V79, P243, DOI 10.1139/bcb-79-3-243; Blair HC, 2002, BIOCHEM J, V364, P329, DOI 10.1042/BJ20020165; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Catalioto RM, 2009, EXP CELL RES, V315, P3267, DOI 10.1016/j.yexcr.2009.09.012; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Fischle W, 2001, J BIOL CHEM, V276, P35826, DOI 10.1074/jbc.M104935200; Haberland M, 2010, J BIOL CHEM, V285, P14663, DOI 10.1074/jbc.M109.081679; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Hung SC, 2004, INT J CANCER, V110, P313, DOI 10.1002/ijc.20126; Hung SC, 2002, STEM CELLS, V20, P249, DOI 10.1634/stemcells.20-3-249; Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645; Jensen ED, 2008, J BONE MINER RES, V23, P361, DOI 10.1359/JBMR.071104; Kuzmichev A, 2004, MOL CELL, V14, P183, DOI 10.1016/S1097-2765(04)00185-6; Lee HW, 2006, MOL ENDOCRINOL, V20, P2432, DOI 10.1210/me.2006-0061; Montgomery RL, 2008, J CLIN INVEST, V118, P3588, DOI 10.1172/JCI35847; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Nebbioso A, 2010, J MOL ENDOCRINOL, V45, P219, DOI 10.1677/JME-10-0043; Nuttall ME, 2000, BONE, V27, P177, DOI 10.1016/S8756-3282(00)00317-3; Pei LM, 2004, J CLIN INVEST, V113, P805, DOI 10.1172/JCI200421311; Ramsden D, 2003, NAT IMMUNOL, V4, P101, DOI 10.1038/ni0203-101; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Rival Y, 2004, J PHARMACOL EXP THER, V311, P467, DOI 10.1124/jpet.104.068254; Rosen CJ, 2008, CELL METAB, V7, P7, DOI 10.1016/j.cmet.2007.12.004; Rosen CJ, 2009, AM J MED, V122, P409, DOI 10.1016/j.amjmed.2008.11.027; Rosen ED, 2000, GENE DEV, V14, P1293; Schroeder TM, 2004, J BIOL CHEM, V279, P41998, DOI 10.1074/jbc.M403702200; Shimizu E, 2010, J BIOL CHEM, V285, P9616, DOI 10.1074/jbc.M109.094862; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Suzawa M, 2003, NAT CELL BIOL, V5, P224, DOI 10.1038/ncb942; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tsai CC, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-64; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Wagner EF, 2001, CURR OPIN GENET DEV, V11, P527, DOI 10.1016/S0959-437X(00)00228-8; Wang LF, 2010, P NATL ACAD SCI USA, V107, P7317, DOI 10.1073/pnas.1000031107; Wei YJ, 2011, OSTEOPOROSIS INT, V22, P1469, DOI 10.1007/s00198-010-1352-9; Yang XJ, 2005, MOL CELL BIOL, V25, P2873, DOI 10.1128/MCB.25.8.2873-2884.2005; Yoo EJ, 2006, J BIOL CHEM, V281, P6608, DOI 10.1074/jbc.M508982200; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhou XB, 2000, P NATL ACAD SCI USA, V97, P1056, DOI 10.1073/pnas.97.3.1056; Zhou XB, 2001, P NATL ACAD SCI USA, V98, P10572, DOI 10.1073/pnas.191375098	42	45	50	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10671	10680		10.1074/jbc.M110.199612	http://dx.doi.org/10.1074/jbc.M110.199612			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21247904	Green Published, hybrid			2022-12-27	WOS:000288547000081
J	Hansen, IA; Boudko, DY; Shiao, SH; Voronov, DA; Meleshkevitch, EA; Drake, LL; Aguirre, SE; Fox, JM; Attardo, GM; Raikhel, AS				Hansen, Immo A.; Boudko, Dmitri Y.; Shiao, Shin-Hong; Voronov, Dmitri A.; Meleshkevitch, Ella A.; Drake, Lisa L.; Aguirre, Sarah E.; Fox, Jeffrey M.; Attardo, Geoffrey M.; Raikhel, Alexander S.			AaCAT1 of the Yellow Fever Mosquito, Aedes aegypti A NOVEL HISTIDINE-SPECIFIC AMINO ACID TRANSPORTER FROM THE SLC7 FAMILY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAT-BODY; MECHANISM; METABOLISM; TARGET; CELLS; BULK; STEP	Insect yolk protein precursor gene expression is regulated by nutritional and endocrine signals. A surge of amino acids in the hemolymph of blood-fed female mosquitoes activates a nutrient signaling system in the fat bodies, which subsequently dere-presses yolk protein precursor genes and makes them responsive to activation by steroid hormones. Orphan transporters of the SLC7 family were identified as essential upstream components of the nutrient signaling system in the fat body of fruit flies and the yellow fever mosquito, Aedes aegypti. However, the transport function of these proteins was unknown. We report expression and functional characterization of AaCAT1, cloned from the fat body of A. aegypti. Expression of AaCAT1 transcript and protein undergoes dynamic changes during postembryonic development of the mosquito. Transcript expression was especially high in the third and fourth larval stages; however, the AaCAT1 protein was detected only in pupa and adult stages. Functional expression and analysis of AaCAT1 in Xenopus oocytes revealed that it acts as a sodium-independent cationic amino acid transporter, with unique selectivity to L-histidine at neutral pH (K-0.5(L-His) = 0.34 +/- 0.07 mM, pH 7.2). Acidification to pH 6.2 dramatically increases AaCAT1-specific His(+)-induced current. RNAi-mediated silencing of AaCAT1 reduces egg yield of subsequent ovipositions. Our data show that AaCAT1 has notable differences in its transport mechanism when compared with related mammalian cationic amino acid transporters. It may execute histidine-specific transport and signaling in mosquito tissues.	[Hansen, Immo A.; Drake, Lisa L.; Aguirre, Sarah E.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA; [Hansen, Immo A.; Drake, Lisa L.; Aguirre, Sarah E.] New Mexico State Univ, Inst Appl Biosci, Las Cruces, NM 88003 USA; [Raikhel, Alexander S.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Boudko, Dmitri Y.; Voronov, Dmitri A.; Meleshkevitch, Ella A.; Fox, Jeffrey M.] Rosalind Franklin Univ, Chicago Med Sch, Dept Physiol & Biophys, N Chicago, IL 60064 USA; [Shiao, Shin-Hong] Natl Taiwan Univ, Dept Parasitol, Taipei 106, Taiwan; [Attardo, Geoffrey M.] Yale Univ, Yale Sch Publ Hlth, New Haven, CT 06520 USA	New Mexico State University; New Mexico State University; University of California System; University of California Riverside; Chicago Medical School; Rosalind Franklin University Medical & Science; National Taiwan University; Yale University	Hansen, IA (corresponding author), New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.	immoh@nmsu.edu	Voronov, Dmitry/ABG-1072-2021; Attardo, Geoffrey Michael/I-3320-2019	Attardo, Geoffrey Michael/0000-0001-6265-2969; SHIAO, SHIN-HONG/0000-0002-7749-7807	National Institutes of Health (NIH) NIAID [5R37AI024716, R01 AI-030464]; NIH, NIGMS [1SC2GM092300-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI030464, R37AI024716, R01AI030464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC2GM092300] Funding Source: NIH RePORTER	National Institutes of Health (NIH) NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) NIAID Grant 5R37AI024716 (to A. S. R.), NIH, NIGMS, Grant 1SC2GM092300-01 (to I. A. H.), and NIH, NIAID, Grant R01 AI-030464 (to D. Y. B.).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Attardo GM, 2006, J EXP BIOL, V209, P3071, DOI 10.1242/jeb.02349; Attardo GM, 2005, INSECT BIOCHEM MOLEC, V35, P661, DOI 10.1016/j.ibmb.2005.02.013; Baker KD, 2007, CELL METAB, V6, P257, DOI 10.1016/j.cmet.2007.09.002; Bauch C, 2002, AM J PHYSIOL-RENAL, V283, pF181, DOI 10.1152/ajprenal.00212.2001; Biessmann H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009471; Boudko DY, 2005, P NATL ACAD SCI USA, V102, P1360, DOI 10.1073/pnas.0405183101; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Closs EI, 2006, J MEMBRANE BIOL, V213, P67, DOI 10.1007/s00232-006-0875-7; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Deves R, 1998, PHYSIOL REV, V78, P487, DOI 10.1152/physrev.1998.78.2.487; Dissanayake Sumudu N, 2010, BMC Res Notes, V3, P248, DOI 10.1186/1756-0500-3-248; Drake LL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015578; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ETOH M, 1994, COMP BIOCHEM PHYS A, V109, P361, DOI 10.1016/0300-9629(94)90139-2; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Goberdhan DCI, 2005, DEVELOPMENT, V132, P2365, DOI 10.1242/dev.01821; Gutierrez E, 2007, NATURE, V445, P275, DOI 10.1038/nature05382; Hansen IA, 2005, J BIOL CHEM, V280, P20565, DOI 10.1074/jbc.M500712200; Hansen IA, 2004, P NATL ACAD SCI USA, V101, P10626, DOI 10.1073/pnas.0403460101; HAYS AR, 1990, ROUX ARCH DEV BIOL, V199, P114, DOI 10.1007/BF02029559; Hediger MA, 2004, PFLUG ARCH EUR J PHY, V447, P465, DOI 10.1007/s00424-003-1192-y; Hennig KM, 2006, J CELL BIOL, V173, P963, DOI 10.1083/jcb.200511140; KIM JW, 1991, NATURE, V352, P725, DOI 10.1038/352725a0; Martin JF, 2000, MECH DEVELOP, V92, P155, DOI 10.1016/S0925-4773(99)00338-X; Meleshkevitch EA, 2006, J EXP BIOL, V209, P3183, DOI 10.1242/jeb.02374; Miller A J, 1994, Symp Soc Exp Biol, V48, P167; Miller MM, 2008, INSECT BIOCHEM MOLEC, V38, P923, DOI 10.1016/j.ibmb.2008.07.005; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vekony N, 2001, BIOCHEMISTRY-US, V40, P12387, DOI 10.1021/bi011345c; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z; Zuckerkandl E, 1965, EVOL GENES PROTEINS, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	35	26	27	0	23	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10803	10813		10.1074/jbc.M110.179739	http://dx.doi.org/10.1074/jbc.M110.179739			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21262963	Green Published, hybrid			2022-12-27	WOS:000288547000094
J	Kurihara, S; Suzuki, H; Oshida, M; Benno, Y				Kurihara, Shin; Suzuki, Hideyuki; Oshida, Mayu; Benno, Yoshimi			A Novel Putrescine Importer Required for Type 1 Pili-driven Surface Motility Induced by Extracellular Putrescine in Escherichia coli K-12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYAMINE TRANSPORT; UTILIZATION PATHWAY; VIBRIO-CHOLERAE; GENES; SPERMIDINE; SYSTEM; STIMULATION; CHROMOSOME; EXPRESSION; BIOFILM	Recently, many studies have reported that polyamines play a role in bacterial cell-to-cell signaling processes. The present study describes a novel putrescine importer required for induction of type 1 pili-driven surface motility. The surface motility of the Escherichia coli Delta speAB Delta speC Delta potABCD strain, which cannot produce putrescine and cannot import spermidine from the medium, was induced by extracellular putrescine. Introduction of the gene deletions for known polyamine importers (Delta potE, Delta potFGHI, and Delta puuP) or a putative polyamine importer (Delta ydcSTUV) into the Delta speAB Delta speC Delta potABCD strain did not affect putrescine-induced surface motility. The deletion of yeeF, an annotated putative putrescine importer, in the Delta speAB Delta speC Delta potABCD Delta ydcSTUV strain abolished surface motility in putrescine-supplemented medium. Complementation of yeeF by a plasmid vector restored surface motility. The surface motility observed in the present study was abolished by the deletion of fimA, suggesting that the surface motility is type 1 pili-driven. A transport assay using the yeeF(+) or Delta yeeF strains revealed that YeeF is a novel putrescine importer. The K-m of YeeF (155 mu M) is 40 to 300 times higher than that of other importers reported previously. On the other hand, the V-max of YeeF (9.3 nmol/min/mg) is comparable to that of PotABCD, PotFGHI, and PuuP. The low affinity of YeeF for putrescine may allow E. coli to sense the cell density depending on the concentration of extracellular putrescine.	[Kurihara, Shin; Oshida, Mayu] Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Sakyo Ku, Kyoto 6068502, Japan; [Kurihara, Shin; Benno, Yoshimi] RIKEN, Benno Lab, Wako, Saitama 3510198, Japan; [Kurihara, Shin; Benno, Yoshimi] Grad Sch Sci & Technol, Div Appl Biol, Kyoto 6068585, Japan; [Kurihara, Shin; Suzuki, Hideyuki; Oshida, Mayu] Kyoto Inst Technol, Sakyo Ku, Kyoto 6068585, Japan	Kyoto University; RIKEN; Kyoto Institute of Technology	Kurihara, S (corresponding author), Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Sakyo Ku, Oiwake Cho, Kyoto 6068502, Japan.	kurisin711@livedoor.com			Bio-oriented Technology Research Advancement Institution; Ministry of Education, Culture, Sports, Science and Technology of Japan [21380059]; Japan Society for the Promotion of Science	Bio-oriented Technology Research Advancement Institution; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry by the Bio-oriented Technology Research Advancement Institution. A part of this work was supported by Grant-in-aid for Scientific Research 21380059 from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to H. S.).; Supported by a Japan Society for the Promotion of Science fellowship for young scientists. To whom correspondence should be addressed: Graduate School of Biostudies, Kyoto University, Kitashirakawa, Oiwake-cho, Sakyo-ku, Kyoto 606-8502, Japan. Fax: 81-75-753-6275; E-mail: kurisin711@livedoor.com.	Arnold CN, 2001, J BACTERIOL, V183, P2178, DOI 10.1128/JB.183.7.2178-2186.2001; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BOYLE SM, 1984, GENE, V30, P129, DOI 10.1016/0378-1119(84)90113-6; Brown II, 2001, J BACTERIOL, V183, P3784, DOI 10.1128/JB.183.12.3784-3790.2001; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; FURUCHI T, 1991, J BIOL CHEM, V266, P20928; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Igarashi K, 2006, J BIOCHEM, V139, P11, DOI 10.1093/jb/mvj020; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; Inoue T, 2007, J BACTERIOL, V189, P950, DOI 10.1128/JB.01294-06; Karatan E, 2005, J BACTERIOL, V187, P7434, DOI 10.1128/JB.187.21.7434-7443.2005; KASHIWAGI K, 1990, J BIOL CHEM, V265, P20893; KASHIWAGI K, 1992, P NATL ACAD SCI USA, V89, P4529, DOI 10.1073/pnas.89.10.4529; KASHIWAGI K, 1995, J BIOL CHEM, V270, P25377, DOI 10.1074/jbc.270.43.25377; Kato JI, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100174; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Koyanagi T, 2004, J BACTERIOL, V186, P343, DOI 10.1128/JB.186.2.343-350.2004; KUEHN GD, 1990, PLANT PHYSIOL, V94, P855, DOI 10.1104/pp.94.3.855; Kurihara S, 2005, J BIOL CHEM, V280, P4602, DOI 10.1074/jbc.M411114200; Kurihara S, 2008, J BIOL CHEM, V283, P19981, DOI 10.1074/jbc.M800133200; Kurihara S, 2009, J BACTERIOL, V191, P2776, DOI 10.1128/JB.01314-08; Kurihara S, 2009, FEMS MICROBIOL LETT, V294, P97, DOI 10.1111/j.1574-6968.2009.01552.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Matsumoto M, 2007, MICROBIOL IMMUNOL, V51, P37, DOI 10.1111/j.1348-0421.2007.tb03888.x; Miller J. H., 1992, SHORT COURSE BACTERI, P263; MIYAMOTO S, 1993, ARCH BIOCHEM BIOPHYS, V300, P63, DOI 10.1006/abbi.1993.1009; Patel CN, 2006, J BACTERIOL, V188, P2355, DOI 10.1128/JB.188.7.2355-2363.2006; PEGG AE, 1986, BIOCHEM J, V234, P249, DOI 10.1042/bj2340249; PISTOCCHI R, 1993, J BIOL CHEM, V268, P146; Pomposiello PJ, 2001, J BACTERIOL, V183, P3890, DOI 10.1128/JB.183.13.3890-3902.2001; Schiller D, 2000, J BACTERIOL, V182, P6247, DOI 10.1128/JB.182.21.6247-6249.2000; Sturgill G, 2004, MOL MICROBIOL, V51, P437, DOI 10.1046/j.1365-2958.2003.03835.x; Suzuki H, 2005, J BACTERIOL, V187, P5861, DOI 10.1128/JB.187.17.5861-5867.2005; SUZUKI H, 1987, J BACTERIOL, V169, P3926, DOI 10.1128/jb.169.9.3926-3931.1987; TABOR CW, 1985, MICROBIOL REV, V49, P81, DOI 10.1128/MMBR.49.1.81-99.1985; TABOR CW, 1986, P NATL ACAD SCI USA, V83, P6040, DOI 10.1073/pnas.83.16.6040; Terui Y, 2005, BIOCHEM J, V388, P427, DOI 10.1042/BJ20041778; van Dam L, 2002, NUCLEIC ACIDS RES, V30, P419, DOI 10.1093/nar/30.2.419	38	27	30	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10185	10192		10.1074/jbc.M110.176032	http://dx.doi.org/10.1074/jbc.M110.176032			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21266585	Green Published, hybrid			2022-12-27	WOS:000288547000034
J	Gerken, TA; Jamison, O; Perrine, CL; Collette, JC; Moinova, H; Ravi, L; Markowitz, SD; Shen, W; Patel, H; Tabak, LA				Gerken, Thomas A.; Jamison, Oliver; Perrine, Cynthia L.; Collette, Jeremy C.; Moinova, Helen; Ravi, Lakshmeswari; Markowitz, Sanford D.; Shen, Wei; Patel, Himatkumar; Tabak, Lawrence A.			Emerging Paradigms for the Initiation of Mucin-type Protein O-Glycosylation by the Polypeptide GalNAc Transferase Family of Glycosyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDE ACCEPTOR PREFERENCES; ALPHA-D-GALACTOSAMINE; N-TERMINAL RESIDUES; UDP-GALNAC; LECTIN DOMAINS; SWISS-MODEL; P-SELECTIN; ACETYLGALACTOSAMINYLTRANSFERASE FAMILY; DROSOPHILA DEVELOPMENT; LINKED GLYCOSYLATION	Mammalian mucin-type O-glycosylation is initiated by a large family of similar to 20 UDP-GalNAc: polypeptide alpha-N-acetyl-galactosaminyltransferases (ppGalNAc Ts) that transfer alpha-GalNAc from UDP-GalNAc to Ser and Thr residues of polypeptide acceptors. Characterizing the peptide substrate specificity of each isoform is critical to understanding their properties, biological roles, and significance. Presently, only the specificities of ppGalNAc T1, T2, and T10 and the fly orthologues of T1 and T2 have been systematically characterized utilizing random peptide substrates. We now extend these studies to ppGalNAc T3, T5, and T12, transferases variously associated with human disease. Our results reveal several common features; the most striking is the similar pattern of enhancements for the three residues C-terminal to the site of glycosylation for those transferases that contain a common conserved Trp. In contrast, residues N-terminal to the site of glycosylation show a wide range of isoform-specific enhancements, with elevated preferences for Pro, Val, and Tyr being the most common at the -1 position. Further analysis reveals that the ratio of positive (Arg, Lys, and His) to negative (Asp and Glu) charged residue enhancements varied among transferases, thus further modulating substrate preference in an isoform-specific manner. By utilizing the obtained transferase-specific preferences, the glycosylation patterns of the ppGalNAc Ts against a series of peptide substrates could roughly be reproduced, demonstrating the potential for predicting isoform-specific glycosylation. We conclude that each ppGalNAc T isoform may be uniquely sensitive to pep-tide sequence and overall charge, which together dictates the substrate sites that will be glycosylated.	[Gerken, Thomas A.; Jamison, Oliver; Collette, Jeremy C.] Case Western Reserve Univ, WA Bernbaum Ctr Cyst Fibrosis Res, Dept Pediat, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Gerken, Thomas A.] Case Western Reserve Univ, Dept Biochem, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Gerken, Thomas A.; Perrine, Cynthia L.] Case Western Reserve Univ, Dept Chem, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Moinova, Helen; Ravi, Lakshmeswari; Markowitz, Sanford D.] Case Western Reserve Univ, Dept Med, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Shen, Wei; Patel, Himatkumar; Tabak, Lawrence A.] NIDDK, Sect Biol Chem, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Gerken, TA (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pediat, BRB 823,2109 Adelbert Rd, Cleveland, OH 44104 USA.	txg2@cwru.edu	shen, wei/F-7816-2012		National Institutes of Health from the NCI [CA78834, P30-CA43703, CA130901]; NIDDK; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK070012] Funding Source: NIH RePORTER	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants CA78834 (to T. A. G.), P30-CA43703, and CA130901 (to S. D. M.) from the NCI and NIDDK intramural program grant (to L. A. T.).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bennett EP, 1996, J BIOL CHEM, V271, P17006, DOI 10.1074/jbc.271.29.17006; Bennett EP, 1999, J BIOL CHEM, V274, P25362, DOI 10.1074/jbc.274.36.25362; Bennett EP, 1999, FEBS LETT, V460, P226, DOI 10.1016/S0014-5793(99)01268-5; Bennett EP, 2010, GLYCOCONJUGATE J, V27, P435, DOI 10.1007/s10719-010-9290-5; BROCKHAUSEN I, 2007, COMPREHENSIVE GLYCOS, V3, P33; Brockhausen I, 2009, BBA-GEN SUBJECTS, V1790, P1244, DOI 10.1016/j.bbagen.2009.05.020; Chen YZ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-101; Cheng LM, 2002, FEBS LETT, V531, P115, DOI 10.1016/S0014-5793(02)03399-9; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; ELHAMMER AP, 1993, J BIOL CHEM, V268, P10029; Fritz TA, 2006, J BIOL CHEM, V281, P8613, DOI 10.1074/jbc.M513590200; Fritz TA, 2004, P NATL ACAD SCI USA, V101, P15307, DOI 10.1073/pnas.0405657101; Fu JX, 2008, J CLIN INVEST, V118, P3725, DOI 10.1172/JCI36077; Gerken TA, 2004, BIOCHEMISTRY-US, V43, P9888, DOI 10.1021/bi049178e; Gerken TA, 2002, J BIOL CHEM, V277, P7736, DOI 10.1074/jbc.M111690200; Gerken TA, 1997, J BIOL CHEM, V272, P9709; Gerken TA, 2006, J BIOL CHEM, V281, P32403, DOI 10.1074/jbc.M605149200; Gerken TA, 2008, GLYCOBIOLOGY, V18, P861, DOI 10.1093/glycob/cwn073; Guda K, 2009, P NATL ACAD SCI USA, V106, P12921, DOI 10.1073/pnas.0901454106; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guo JM, 2002, FEBS LETT, V524, P211, DOI 10.1016/S0014-5793(02)03007-7; Guo JM, 2004, ONCOLOGY-BASEL, V67, P271, DOI 10.1159/000081328; Gupta R, 1999, NUCLEIC ACIDS RES, V27, P370, DOI 10.1093/nar/27.1.370; HAGEN FK, 1995, GLYCOCONJUGATE J, V12, P901, DOI 10.1007/BF00731252; Hagen KGT, 2009, GLYCOBIOLOGY, V19, P102, DOI 10.1093/glycob/cwn096; Hanisch FG, 2001, GLYCOBIOLOGY, V11, P731, DOI 10.1093/glycob/11.9.731; Hassan H, 2000, J BIOL CHEM, V275, P38197, DOI 10.1074/jbc.M005783200; Herr P, 2008, DEVELOPMENT, V135, P1813, DOI 10.1242/dev.019323; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kato K, 2006, J BIOL CHEM, V281, P18370, DOI 10.1074/jbc.M602469200; Kato K, 2010, GLYCOCONJUGATE J, V27, P267, DOI 10.1007/s10719-009-9275-4; KEARNS AE, 1991, BIOCHEMISTRY-US, V30, P7477, DOI 10.1021/bi00244a016; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kubota T, 2006, J MOL BIOL, V359, P708, DOI 10.1016/j.jmb.2006.03.061; Lee SH, 2010, J BIOL CHEM, V285, P37683, DOI 10.1074/jbc.M110.162735; Li FG, 1996, J BIOL CHEM, V271, P3255, DOI 10.1074/jbc.271.6.3255; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lin YR, 2008, DEV DYNAM, V237, P3703, DOI 10.1002/dvdy.21775; Liu W, 1998, J BIOL CHEM, V273, P7078, DOI 10.1074/jbc.273.12.7078; Mardberg K, 2004, GLYCOBIOLOGY, V14, P571, DOI 10.1093/glycob/cwh075; Merla G, 2002, HUM GENET, V110, P429, DOI 10.1007/s00439-002-0710-x; Miwa HE, 2010, J BIOL CHEM, V285, P1208, DOI 10.1074/jbc.M109.035436; Nakamura N, 2005, BIOL PHARM BULL, V28, P429, DOI 10.1248/bpb.28.429; Nehrke K, 1996, J BIOL CHEM, V271, P7061, DOI 10.1074/jbc.271.12.7061; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Peng C, 2010, BIOCHEM BIOPH RES CO, V402, P680, DOI 10.1016/j.bbrc.2010.10.084; Perrine C, 2009, GLYCOBIOLOGY, V19, P321, DOI 10.1093/glycob/cwn143; Perrine CL, 2009, J BIOL CHEM, V284, P20387, DOI 10.1074/jbc.M109.017236; Pratt MR, 2004, CHEM BIOL, V11, P1009, DOI 10.1016/j.chembiol.2004.05.009; Raman J, 2008, J BIOL CHEM, V283, P22942, DOI 10.1074/jbc.M803387200; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; Schwientek T, 2002, J BIOL CHEM, V277, P22623, DOI 10.1074/jbc.M202684200; Simmons AD, 1999, HUM MOL GENET, V8, P2155, DOI 10.1093/hmg/8.12.2155; Tabak LA, 2010, SEMIN CELL DEV BIOL, V21, P616, DOI 10.1016/j.semcdb.2010.02.001; Ten Hagen BG, 1998, J BIOL CHEM, V273, P27749; Ten Hagen KG, 2002, J BIOL CHEM, V277, P22616, DOI 10.1074/jbc.M201807200; Tenno M, 2007, MOL CELL BIOL, V27, P8783, DOI 10.1128/MCB.01204-07; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tian E, 2007, GLYCOBIOLOGY, V17, P820, DOI 10.1093/glycob/cwm056; Tian E, 2007, J BIOL CHEM, V282, P606, DOI 10.1074/jbc.M606268200; Tian E, 2009, GLYCOCONJUGATE J, V26, P325, DOI 10.1007/s10719-008-9162-4; Topaz O, 2004, NAT GENET, V36, P579, DOI 10.1038/ng1358; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Walmsley AR, 2003, GLYCOBIOLOGY, V13, P641, DOI 10.1093/glycob/cwg080; Wandall HH, 2007, GLYCOBIOLOGY, V17, P374, DOI 10.1093/glycob/cwl082; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xia LJ, 2004, J CELL BIOL, V164, P451, DOI 10.1083/jcb.200311112; Xia LJ, 2003, BLOOD, V101, P552, DOI 10.1182/blood-2001-11-0036; Zhang LP, 2010, J BIOL CHEM, V285, P34477, DOI 10.1074/jbc.M110.133561; Zhang LP, 2010, J BIOL CHEM, V285, P19491, DOI 10.1074/jbc.M109.098145; Zhang LP, 2008, J BIOL CHEM, V283, P34076, DOI 10.1074/jbc.M804267200	76	114	115	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14493	14507		10.1074/jbc.M111.218701	http://dx.doi.org/10.1074/jbc.M111.218701			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21349845	Green Published, hybrid			2022-12-27	WOS:000289556200070
J	Hondares, E; Iglesias, R; Giralt, A; Gonzalez, FJ; Giralt, M; Mampel, T; Villarroya, F				Hondares, Elayne; Iglesias, Roser; Giralt, Albert; Gonzalez, Frank J.; Giralt, Marta; Mampel, Teresa; Villarroya, Francesc			Thermogenic Activation Induces FGF21 Expression and Release in Brown Adipose Tissue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INCREASES ENERGY-EXPENDITURE; INSULIN SENSITIVITY; PPAR-ALPHA; METABOLIC REGULATOR; GLUCOSE-METABOLISM; LIPID-METABOLISM; GENE-EXPRESSION; BLOOD-FLOW; MICE; FIBROBLAST-GROWTH-FACTOR-21	FGF21 is a novel metabolic regulator involved in the control of glucose homeostasis, insulin sensitivity, and ketogenesis. The liver has been considered the main site of production and release of FGF21 into the blood. Here, we show that, after thermogenic activation, brown adipose tissue becomes a source of systemic FGF21. This is due to a powerful cAMP-mediated pathway of regulation of FGF21 gene transcription. Norepinephrine, acting via beta-adrenergic, cAMP-mediated, mechanisms and subsequent activation of protein kinase A and p38 MAPK, induces FGF21 gene transcription and also FGT21 release in brown adipocytes. ATF2 binding to the FGF21 gene promoter mediates cAMP-dependent induction of FGF21 gene transcription. FGF21 release by brown fat in vivo was assessed directly by analyzing arteriovenous differences in FGF21 concentration across interscapular brown fat, in combination with blood flow to brown adipose tissue and assessment of FGF21 half-life. This analysis demonstrates that exposure of rats to cold induced a marked release of FGF21 by brown fin in vivo, in association with a reduction in systemic FGF21 half-life. The present findings lead to the recognition of a novel pathway of regulation the FGF21 gene and an endocrine role of brown fat, as a source of FGF21 that may be especially relevant in conditions of activation of thermogenic activity.	[Hondares, Elayne] Univ Barcelona, Dept Biochem & Mol Biol, Fac Biol, E-08028 Barcelona, Catalonia, Spain; [Hondares, Elayne; Iglesias, Roser; Giralt, Albert; Giralt, Marta; Mampel, Teresa; Villarroya, Francesc] Univ Barcelona, Inst Biomed, E-08028 Barcelona, Catalonia, Spain; [Hondares, Elayne; Iglesias, Roser; Giralt, Albert; Giralt, Marta; Mampel, Teresa; Villarroya, Francesc] CIBER Fisiopatol Obesidad & Nutr, Barcelona 08028, Catalonia, Spain; [Gonzalez, Frank J.] NCI, Met Lab, NIH, Bethesda, MD 20892 USA	University of Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Hondares, E (corresponding author), Univ Barcelona, Dept Biochem & Mol Biol, Fac Biol, Avda Diagonal 645, E-08028 Barcelona, Catalonia, Spain.	hondareselayne@ub.edu	Mampel, Teresa/C-5571-2017; Villarroya, Francesc/K-4357-2014; Giralt, Marta/A-4756-2013; Iglesias, Roser/C-5561-2017	Giralt, Marta/0000-0001-7968-4190; Iglesias, Roser/0000-0002-7107-8097; Giralt, Albert/0000-0003-4498-063X; Villarroya, Francesc/0000-0003-1266-9142	Ministerio de Ciencia e Innovacion [SAF2008-01896]; Institut de Salud Carlos III [PI081715]; Generalitat de Catalunya (Spain) [2009SGR284]; NATIONAL CANCER INSTITUTE [ZIABC005708] Funding Source: NIH RePORTER	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Institut de Salud Carlos III(Instituto de Salud Carlos III); Generalitat de Catalunya (Spain)(Generalitat de Catalunya); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from Ministerio de Ciencia e Innovacion (SAF2008-01896), the Institut de Salud Carlos III (PI081715), and the Generalitat de Catalunya (Spain) (2009SGR284).	Arner P, 2008, FEBS LETT, V582, P1725, DOI 10.1016/j.febslet.2008.04.038; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Badman MK, 2009, ENDOCRINOLOGY, V150, P4931, DOI 10.1210/en.2009-0532; Berglund ED, 2009, ENDOCRINOLOGY, V150, P4084, DOI 10.1210/en.2009-0221; BUKOWIECKI LJ, 1989, CAN J PHYSIOL PHARM, V67, P382, DOI 10.1139/y89-062; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Carmona MC, 2005, BIOCHEM J, V389, P47, DOI 10.1042/BJ20050009; Collins S, 2004, MOL ENDOCRINOL, V18, P2123, DOI 10.1210/me.2004-0193; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Enerback S, 2010, CELL METAB, V11, P248, DOI 10.1016/j.cmet.2010.03.008; FERNANDEZ JA, 1987, BIOCHEM J, V243, P281, DOI 10.1042/bj2430281; FOSTER DO, 1979, CAN J PHYSIOL PHARM, V57, P257, DOI 10.1139/y79-039; Galman C, 2008, CELL METAB, V8, P169, DOI 10.1016/j.cmet.2008.06.014; Hondares E, 2010, CELL METAB, V11, P206, DOI 10.1016/j.cmet.2010.02.001; Hotta Y, 2009, ENDOCRINOLOGY, V150, P4625, DOI 10.1210/en.2009-0119; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Izumiya Y, 2008, FEBS LETT, V582, P3805, DOI 10.1016/j.febslet.2008.10.021; JONES RG, 1984, BIOSCIENCE REP, V4, P421, DOI 10.1007/BF01122507; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; LANSBERG L, 1983, AUTONOMIC REGULATION, P99; Mai K, 2009, DIABETES, V58, P1532, DOI 10.2337/db08-1775; Moyers JS, 2007, J CELL PHYSIOL, V210, P1, DOI 10.1002/jcp.20847; Muise ES, 2008, MOL PHARMACOL, V74, P403, DOI 10.1124/mol.108.044826; MURAMATSU AL, 1989, MOL CELL BIOL, V9, P831; Petrovic N, 2008, AM J PHYSIOL-ENDOC M, V295, pE287, DOI 10.1152/ajpendo.00035.2008; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Sarruf DA, 2010, DIABETES, V59, P1817, DOI 10.2337/db09-1878; Seale P, 2009, GENE DEV, V23, P788, DOI 10.1101/gad.1779209; SILVA JE, 1985, J CLIN INVEST, V76, P2296, DOI 10.1172/JCI112239; Villena JA, 2007, P NATL ACAD SCI USA, V104, P1418, DOI 10.1073/pnas.0607696104; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Xu J, 2009, AM J PHYSIOL-ENDOC M, V297, pE1105, DOI 10.1152/ajpendo.00348.2009	33	423	438	2	60	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					12983	12990		10.1074/jbc.M110.215889	http://dx.doi.org/10.1074/jbc.M110.215889			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21317437	Green Published, hybrid			2022-12-27	WOS:000289282200018
J	Ingaranno, M; Beckett, D				Ingaranno, Maria; Beckett, Dorothy			Biotinylation, a Post-translational Modification Controlled by the Rate of Protein-Protein Association	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN HOLOCARBOXYLASE SYNTHETASE; PYROCOCCUS-HORIKOSHII OT3; CARBOXYL CARRIER PROTEIN; ACETYL-COA CARBOXYLASE; COLI BIOTIN REPRESSOR; N-TERMINAL DOMAIN; ESCHERICHIA-COLI; TRANSCRIPTIONAL SWITCH; LIGASE; SEQUENCE	Biotin protein ligases catalyze specific covalent linkage of the coenzyme biotin to biotin-dependent carboxylases. The reaction proceeds in two steps, including synthesis of an adenylated intermediate followed by biotin transfer to the carboxylase substrate. In this work specificity in the transfer reaction was investigated using single turnover stopped-flow and quench-flow assays. Cognate and noncognate reactions were measured using the enzymes and minimal biotin acceptor substrates from Escherichia coli, Pyro coccus horikoshii, and Homo sapiens. The kinetic analysis demonstrates that for all enzyme-substrate pairs the bimolecular rate of association of enzyme with substrate limits post-translational biotinylation. In addition, in noncognate reactions the three enzymes displayed a range of selectivities. These results highlight the importance of protein-protein binding kinetics for specific biotin addition to carboxylases and provide one mechanism for determining biotin distribution in metabolism.	[Ingaranno, Maria; Beckett, Dorothy] Univ Maryland, Ctr Biomol Struct & Org, Dept Chem & Biochem, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Beckett, D (corresponding author), Univ Maryland, Ctr Biomol Struct & Org, Dept Chem & Biochem, College Pk, MD 20742 USA.	dbeckett@umd.edu			National Institutes of Health [R01-GM46511, S10-RR15899]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR015899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046511] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM46511 and S10-RR15899.	ABBOTT J, 1993, BIOCHEMISTRY-US, V32, P9649, DOI 10.1021/bi00088a017; Bagautdinov B, 2005, J MOL BIOL, V353, P322, DOI 10.1016/j.jmb.2005.08.032; Bagautdinov B, 2008, J BIOL CHEM, V283, P14739, DOI 10.1074/jbc.M709116200; Bagautdinov B, 2007, ACTA CRYSTALLOGR F, V63, P334, DOI 10.1107/S1744309107011967; BAKER H, 1962, ANAL BIOCHEM, V3, P31, DOI 10.1016/0003-2697(62)90041-6; Brown PH, 2004, J MOL BIOL, V337, P857, DOI 10.1016/j.jmb.2004.01.041; Chapman-Smith A, 1999, J BIOL CHEM, V274, P1449, DOI 10.1074/jbc.274.3.1449; CRONAN JE, 1990, J BIOL CHEM, V265, P10327; Daniels KG, 2010, BIOCHEMISTRY-US, V49, P5358, DOI 10.1021/bi1003958; Eisenstein E, 1999, BIOCHEMISTRY-US, V38, P13077, DOI 10.1021/bi991241q; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gonzalez JM, 1998, EXTREMOPHILES, V2, P123, DOI 10.1007/s007920050051; Healy S, 2009, PROTEIN SCI, V18, P314, DOI 10.1002/pro.37; Ingaramo M, 2009, J BIOL CHEM, V284, P30862, DOI 10.1074/jbc.M109.046201; Jitrapakdee S, 2003, CURR PROTEIN PEPT SC, V4, P217, DOI 10.2174/1389203033487199; KOREN R, 1976, BIOCHEMISTRY-US, V15, P1165, DOI 10.1021/bi00650a032; LANE MD, 1964, J BIOL CHEM, V239, P2865; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee CK, 2010, FEBS LETT, V584, P675, DOI 10.1016/j.febslet.2009.12.059; LEONDELRIO A, 1995, P NATL ACAD SCI USA, V92, P4626, DOI 10.1073/pnas.92.10.4626; LEONDELRIO A, 1994, J BIOL CHEM, V269, P22964; MARINI P, 1995, J BACTERIOL, V177, P7003, DOI 10.1128/jb.177.23.7003-7006.1995; Nenortas E, 1996, J BIOL CHEM, V271, P7559, DOI 10.1074/jbc.271.13.7559; Polyak SW, 1999, J BIOL CHEM, V274, P32847, DOI 10.1074/jbc.274.46.32847; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Slavoff SA, 2008, J AM CHEM SOC, V130, P1160, DOI 10.1021/ja076655i; Streaker ED, 2006, BIOCHEMISTRY-US, V45, P6417, DOI 10.1021/bi052599r; Venezia CF, 2009, BIOCHEMISTRY-US, V48, P9084, DOI 10.1021/bi9010495; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weaver LH, 2001, PROTEIN SCI, V10, P2618, DOI 10.1110/ps.ps.32701; WILSON KP, 1992, P NATL ACAD SCI USA, V89, P9257, DOI 10.1073/pnas.89.19.9257; Zhao HY, 2008, J MOL BIOL, V380, P223, DOI 10.1016/j.jmb.2008.04.068; Zhao HY, 2009, J MOL BIOL, V389, P336, DOI 10.1016/j.jmb.2009.04.009	34	10	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13071	13078		10.1074/jbc.M110.183624	http://dx.doi.org/10.1074/jbc.M110.183624			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21343300	Green Published, hybrid			2022-12-27	WOS:000289282200027
J	Trostchansky, A; Bonilla, L; Thomas, CP; O'Donnell, VB; Marnett, LJ; Radi, R; Rubbo, H				Trostchansky, Andres; Bonilla, Lucia; Thomas, Christopher P.; O'Donnell, Valerie B.; Marnett, Lawrence J.; Radi, Rafael; Rubbo, Homero			Nitroarachidonic Acid, a Novel Peroxidase Inhibitor of Prostaglandin Endoperoxide H Synthases 1 and 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUNSATURATED FATTY-ACIDS; MANGANO PROTOPORPHYRIN-IX; NITRIC-OXIDE; ARACHIDONIC-ACID; CYCLOOXYGENASE INHIBITION; PLATELET-AGGREGATION; NITROGEN-DIOXIDE; MECHANISM; INACTIVATION; PEROXYNITRITE	Prostaglandin endoperoxide H synthase (PGHS) catalyzes the oxidation of arachidonate to prostaglandin H-2. We have previously synthesized and chemically characterized nitroarachidonic acid (AANO(2)), a novel anti-inflammatory signaling mediator. Herein, the interaction of AANO(2) with PGHS was analyzed. AANO(2) inhibited oxygenase activity of PGHS-1 but not PGHS-2. AANO(2) exhibited time- and concentration-dependent inhibition of peroxidase activity in both PGHS-1 and -2. The plot of k(obs) versus AANO(2) concentrations showed a hyperbolic function with k(inact) = 0.045 s(-1) and K-t(infinity aPP) = 0.019 mu m for PGHS-1 and k(inact) = 0.057 and K-t(infinity app) K-t(infinity aPP) = 0.020 mu m for PGHS-2. Kinetic analysis suggests that inactivation of PGHS by AANO(2) involves two sequential steps: an initial reversible binding event (described by K-t) followed by a practically irreversible event (K-t(infinity aPP)) leading to an inactivated enzyme. Inactivation was associated with irreversible disruption of heme binding to the protein. The inhibitory effects of AANO(2) were selective because other nitro-fatty acids tested, such as nitrooleic acid and nitrolinoleic acid, were unable to inhibit enzyme activity. In activated human platelets, AANO(2) significantly decreased PGHS-1-dependent thromboxane B-2 formation in parallel with a decrease in platelet aggregation, thus confirming the biological relevance of this novel inhibitory pathway.	[Trostchansky, Andres; Bonilla, Lucia; Radi, Rafael; Rubbo, Homero] Fac Med, Dept Bioquim, Montevideo, Uruguay; [Trostchansky, Andres; Bonilla, Lucia; Radi, Rafael; Rubbo, Homero] Fac Med, Ctr Free Radical & Biomed Res, Montevideo, Uruguay; [Thomas, Christopher P.; O'Donnell, Valerie B.] Cardiff Univ, Dept Infect Immun & Biochem, Cardiff CF4 4XN, S Glam, Wales; [Marnett, Lawrence J.] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA	Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Cardiff University; Vanderbilt University	Rubbo, H (corresponding author), Fac Med, Dept Bioquim, Avda Gen Flores 2125, Montevideo, Uruguay.	hrubbo@fmed.edu.uy	Thomas, Christopher P/R-5243-2016; O'Donnell, Valerie/C-6948-2012; Trostchansky, Andres/I-5624-2019	Thomas, Christopher P/0000-0001-5840-8613; Trostchansky, Andres/0000-0002-9721-7577; Rubbo, Homero/0000-0002-7897-6551; /0000-0003-4089-8460	National Institutes of Health [GM15431]; Fondo Clemente Estable-ANII [FCE_516]; Programa de Desarrollo Tecnologico-ANII; Wellcome Trust; Howard Hughes Medical Institute; Sistema Nacional de Becas-ANII; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM015431, P01GM015431] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondo Clemente Estable-ANII; Programa de Desarrollo Tecnologico-ANII; Wellcome Trust(Wellcome TrustEuropean Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Sistema Nacional de Becas-ANII; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM15431 (to L. J. M.). This work was also supported by Fondo Clemente Estable-ANII Grant FCE_516 (to A. T.), Programa de Desarrollo Tecnologico-ANII (to H. R.), Wellcome Trust (to H. R. and V. O. D.), and Howard Hughes Medical Institute (to R. R.). L. B. was partially supported by a fellowship from Sistema Nacional de Becas-ANII.	AGWU DE, 1983, CAN J COMP MED, V47, P203; Baker LMS, 2007, J BIOL CHEM, V282, P31085, DOI 10.1074/jbc.M704085200; Baker PRS, 2005, J BIOL CHEM, V280, P42464, DOI 10.1074/jbc.M504212200; Balazy M, 2001, J PHARMACOL EXP THER, V299, P611; Balazy Michael, 2004, Current Vascular Pharmacology, V2, P81, DOI 10.2174/1570161043476465; Batthyany C, 2006, J BIOL CHEM, V281, P20450, DOI 10.1074/jbc.M602814200; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Blobaum AL, 2007, J MED CHEM, V50, P1425, DOI 10.1021/jm0613166; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Coles B, 2002, J BIOL CHEM, V277, P5832, DOI 10.1074/jbc.M105209200; Copeland R.A., 2000, ENZYMES PRACTICAL IN, P305; DiRosa M, 1996, PROSTAG LEUKOTR ESS, V54, P229, DOI 10.1016/S0952-3278(96)90053-8; Goodwin DC, 1999, FASEB J, V13, P1121, DOI 10.1096/fasebj.13.10.1121; Goodwin DC, 1998, J BIOL CHEM, V273, P8903, DOI 10.1074/jbc.273.15.8903; Kalgutkar AS, 1996, BIOCHEMISTRY-US, V35, P9076, DOI 10.1021/bi9605752; KARTHEIN R, 1987, EUR J BIOCHEM, V166, P173, DOI 10.1111/j.1432-1033.1987.tb13499.x; Kelley EE, 2008, J BIOL CHEM, V283, P36176, DOI 10.1074/jbc.M802402200; KITZ R, 1962, J BIOL CHEM, V237, P3245; KULMACZ RJ, 1987, PROSTAGLANDINS, V34, P225, DOI 10.1016/0090-6980(87)90246-2; KULMACZ RJ, 1994, J BIOL CHEM, V269, P5527; Landino LM, 1996, P NATL ACAD SCI USA, V93, P15069, DOI 10.1073/pnas.93.26.15069; Malkowski MG, 2000, SCIENCE, V289, P1933, DOI 10.1126/science.289.5486.1933; MARNETT LJ, 1984, MOL PHARMACOL, V26, P328; Marnett LJ, 1999, J BIOL CHEM, V274, P22903, DOI 10.1074/jbc.274.33.22903; Marnett LJ, 2002, PROSTAG OTH LIPID M, V68-9, P153, DOI 10.1016/S0090-6980(02)00027-8; Maskrey BH, 2007, J BIOL CHEM, V282, P20151, DOI 10.1074/jbc.M611776200; Michibayashi T, 2005, J ATHEROSCLER THROMB, V12, P154, DOI 10.5551/jat.12.154; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; O'Donnell VB, 2000, J BIOL CHEM, V275, P38239, DOI 10.1074/jbc.M001802200; ODENWALLER R, 1990, METHOD ENZYMOL, V187, P479; PRUTZ WA, 1985, ARCH BIOCHEM BIOPHYS, V243, P125, DOI 10.1016/0003-9861(85)90780-5; Rouzer CA, 2003, CHEM REV, V103, P2239, DOI 10.1021/cr000068x; Rudolph V, 2009, J BIOL CHEM, V284, P1461, DOI 10.1074/jbc.M802298200; Salvemini D, 1996, J CLIN INVEST, V97, P2562, DOI 10.1172/JCI118704; Schneider C, 2002, J BIOL CHEM, V277, P478, DOI 10.1074/jbc.M107471200; Schopfer FJ, 2009, FREE RADICAL BIO MED, V46, P1250, DOI 10.1016/j.freeradbiomed.2008.12.025; Schopfer FJ, 2005, J BIOL CHEM, V280, P19289, DOI 10.1074/jbc.M414689200; Smith WL, 1996, J BIOL CHEM, V271, P33157, DOI 10.1074/jbc.271.52.33157; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Song I, 2001, BIOCHEM BIOPH RES CO, V289, P869, DOI 10.1006/bbrc.2001.6071; Trostchansky A, 2007, BIOCHEMISTRY-US, V46, P4645, DOI 10.1021/bi602652j; Trostchansky A, 2007, FREE RADICAL BIO MED, V42, P1029, DOI 10.1016/j.freeradbiomed.2007.01.009; Tsai AL, 1997, J BIOL CHEM, V272, P8885; van der Donk WA, 2002, BIOCHEMISTRY-US, V41, P15451, DOI 10.1021/bi026938h; Wu G, 2001, J BIOL CHEM, V276, P19879, DOI 10.1074/jbc.M100628200	45	42	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					12891	12900		10.1074/jbc.M110.154518	http://dx.doi.org/10.1074/jbc.M110.154518			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21266582	Green Published, hybrid			2022-12-27	WOS:000289282200009
J	Collier, MEW; Ettelaie, C				Collier, Mary E. W.; Ettelaie, Camille			Regulation of the Incorporation of Tissue Factor into Microparticles by Serine Phosphorylation of the Cytoplasmic Domain of Tissue Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL MICROPARTICLES; IN-VITRO; VASCULAR-DISEASE; CELLS; MECHANISM; PROLIFERATION; ISOMERIZATION; ACTIVATION; GENERATION; RELEASE	The mechanisms that regulate the incorporation and release of tissue factors (TFs) into cell-derived microparticles are as yet unidentified. In this study, we have explored the regulation of TF release into microparticles by the phosphorylation of serine residues within the cytoplasmic domain of TF. Wild-type and mutant forms of TF, containing alanine and aspartate substitutions at Ser(253) and Ser(258), were overexpressed in coronary artery and dermal microvascular endothelial cells and microparticle release stimulated with PAR2 agonist peptide (PAR2-AP). The release of TF antigen and activity was then monitored. In addition, the phosphorylation state of the two serine residues within the released microparticles and the cells was monitored for 150 min. The release of wild-type TF as procoagulant microparticles peaked at 90 min and declined thereafter in both cell types. The TF within these microparticles was phosphorylated at Ser(253) but not at Ser(258). Aspartate substitution of Ser(253) resulted in rapid release of TF antigen but not activity, whereas TF release was reduced and delayed by alanine substitution of Ser(253) or aspartate substitution of Ser(258). Alanine substitution of Ser(258) prolonged the release of TF following PAR2-AP activation. The release of TF was concurrent with phosphorylation of Ser(253) and was followed by dephosphorylation at 120 min and phosphorylation of Ser(258). We propose a sequential mechanism in which the phosphorylation of Ser(253) through PAR2 activation results in the incorporation of TF into microparticles, simultaneously inducing Ser(258) phosphorylation. Phosphorylation of Ser(258) in turn promotes the dephosphorylation of Ser(253) and suppresses the release of TF.	[Collier, Mary E. W.; Ettelaie, Camille] Univ Hull, Biomed Sect, Dept Biol Sci, Kingston Upon Hull HU6 7RX, N Humberside, England	University of Hull	Ettelaie, C (corresponding author), Univ Hull, Biomed Sect, Dept Biol Sci, Cottingham Rd, Kingston Upon Hull HU6 7RX, N Humberside, England.	C.Ettelaie@hull.ac.uk			Yorkshire Cancer Research	Yorkshire Cancer Research	This work was supported in part by Yorkshire Cancer Research.	Ahamed J, 2004, J BIOL CHEM, V279, P23038, DOI 10.1074/jbc.M401376200; Carson SD, 2000, THROMB HAEMOSTASIS, V84, P657; Collier MEW, 2010, ARTERIOSCL THROM VAS, V30, P1810, DOI 10.1161/ATVBAHA.110.211854; Combes V, 1999, J CLIN INVEST, V104, P93, DOI 10.1172/JCI4985; Curti AM, 2009, J THROMB HAEMOST, V7, P701, DOI 10.1111/j.1538-7836.2009.03304.x; Diamant M, 2004, EUR J CLIN INVEST, V34, P392, DOI 10.1111/j.1365-2362.2004.01355.x; Dorfleutner A, 2003, BLOOD, V102, P3998, DOI 10.1182/blood-2003-04-1149; Ettelaie C, 1996, ARTERIOSCL THROM VAS, V16, P639, DOI 10.1161/01.ATV.16.5.639; Ettelaie C, 1999, FEBS LETT, V463, P341, DOI 10.1016/S0014-5793(99)01663-4; Ettelaie C, 2008, MICROVASC RES, V76, P152, DOI 10.1016/j.mvr.2008.07.007; Hussein MNA, 2008, THROMB RES, V121, P865, DOI 10.1016/j.thromres.2007.08.005; Jimenez JJ, 2005, ADV CLIN CHEM, V39, P131, DOI 10.1016/S0065-2423(04)39005-0; Lakota K, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/146872; Li C, 2008, CANCER IMMUNOL IMMUN, V57, P1347, DOI 10.1007/s00262-008-0469-6; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; MAYNARD JR, 1975, J CLIN INVEST, V55, P814, DOI 10.1172/JCI107992; Mody RS, 1997, BIOCHEMISTRY-US, V36, P7869, DOI 10.1021/bi9701235; Mueller BM, 1998, J CLIN INVEST, V101, P1372, DOI 10.1172/JCI930; Nasu J, 1998, CLIN EXP IMMUNOL, V113, P379; Nomura S, 2008, THROMB RES, V123, P8, DOI 10.1016/j.thromres.2008.06.006; Ott I, 1998, J CELL BIOL, V140, P1241, DOI 10.1083/jcb.140.5.1241; Pilzer D, 2005, SPRINGER SEMIN IMMUN, V27, P375, DOI 10.1007/s00281-005-0004-1; Pradier A, 2008, J VASC RES, V45, P19, DOI 10.1159/000109074; Rak J, 2006, Vnitr Lek, V52 Suppl 1, P135; Sapet C, 2006, BLOOD, V108, P1868, DOI 10.1182/blood-2006-04-014175; Schecter AD, 2000, CIRC RES, V87, P126, DOI 10.1161/01.RES.87.2.126; Sen Mehmet, 2009, Open Spectrosc J, V3, P58; VanWijk MJ, 2003, CARDIOVASC RES, V59, P277, DOI 10.1016/S0008-6363(03)00367-5; Zhou XZ, 1999, CELL MOL LIFE SCI, V56, P788, DOI 10.1007/s000180050026; ZIONCHECK TF, 1992, J BIOL CHEM, V267, P3561	30	27	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.195214	http://dx.doi.org/10.1074/jbc.M110.195214			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21310953	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000289077500011
J	Hikasa, H; Sokol, SY				Hikasa, Hiroki; Sokol, Sergei Y.			Phosphorylation of TCF Proteins by Homeodomain-interacting Protein Kinase 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS HOMEOBOX GENE; WNT SIGNALING PATHWAY; NEMO-LIKE-KINASE; BETA-CATENIN; DEPENDENT PHOSPHORYLATION; MEDIATED TRANSCRIPTION; POLARITY SIGNALS; DISTINCT ROLES; AXIS FORMATION; MAP KINASE	Wnt pathways play essential roles in cell proliferation, morphogenesis, and cell fate specification during embryonic development. According to the consensus view, the Wnt pathway prevents the degradation of the key signaling component beta-catenin by the protein complex containing the negative regulators Axin and glycogen synthase kinase 3 (GSK3). Stabilized beta-catenin associates with TCF proteins and enters the nucleus to promote target gene expression. This study examines the involvement of HIPK2 (homeodomain-interacting protein kinase (2) under bar) in the regulation of different TCF proteins in Xenopus embryos in vivo. We show that the TCF family members LEF1, TCF4, and TCF3 are phosphorylated in embryonic ectoderm after Wnt8 stimulation and HIPK2 overexpression. We also find that TCF3 phosphorylation is triggered by canonical Wnt ligands, LRP6, and dominant negative mutants for Axin and GSK3, indicating that this process shares the same upstream regulators with beta-catenin stabilization. HIPK2-dependent phosphorylation caused the dissociation of LEF1, TCF4, and TCF3 from a target promoter in vivo. This result provides a mechanistic explanation for the context-dependent function of HIPK2 in Wnt signaling; HIPK2 up-regulates transcription by phosphorylating TCF3, a transcriptional repressor, but inhibits transcription by phosphorylating LEF1, a transcriptional activator. Finally, we show that upon HIPK2-mediated phosphorylation, TCF3 is replaced with positively acting TCF1 at a target promoter. These observations emphasize a critical role for Wnt/HIPK2-dependent TCF phosphorylation and suggest that TCF switching is an important mechanism of Wnt target gene activation in vertebrate embryos.	[Hikasa, Hiroki; Sokol, Sergei Y.] Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Sokol, SY (corresponding author), Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY 10029 USA.	sergei.sokol@mssm.edu		Sokol, Sergei/0000-0002-3963-9202	National Institutes of Health [HD031247, GM096959, NS040972]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R55HD031247, R01HD031247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096959] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS040972, R01NS040972] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants HD031247, GM096959, and NS040972 (to S. Y. S.).	Arce L, 2006, ONCOGENE, V25, P7492, DOI 10.1038/sj.onc.1210056; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Blythe SA, 2009, DEV DYNAM, V238, P1422, DOI 10.1002/dvdy.21931; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Candia AF, 1997, DEVELOPMENT, V124, P4467; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; Choi CY, 2005, J BIOL CHEM, V280, P21427, DOI 10.1074/jbc.M500496200; CHRISTIAN JL, 1991, DEVELOPMENT, V111, P1045; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; Dauth I, 2007, CANCER RES, V67, P2274, DOI 10.1158/0008-5472.CAN-06-2884; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; DOMINGUEZ I, 1995, P NATL ACAD SCI USA, V92, P8498, DOI 10.1073/pnas.92.18.8498; Dorsky RI, 2003, DEVELOPMENT, V130, P1937, DOI 10.1242/dev.00402; Doxakis E, 2004, CURR BIOL, V14, P1761, DOI 10.1016/j.cub.2004.09.050; DU SJ, 1995, MOL CELL BIOL, V15, P2625; Erter CE, 2001, DEVELOPMENT, V128, P3571; Galceran J, 1999, GENE DEV, V13, P709, DOI 10.1101/gad.13.6.709; Gawantka V, 1995, EMBO J, V14, P6268, DOI 10.1002/j.1460-2075.1995.tb00317.x; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; Hata A, 2000, CELL, V100, P229, DOI 10.1016/S0092-8674(00)81561-5; Heasman J, 2000, DEV BIOL, V222, P124, DOI 10.1006/dbio.2000.9720; Hikasa H, 2004, DEVELOPMENT, V131, P4725, DOI 10.1242/dev.01369; Hikasa H, 2002, DEVELOPMENT, V129, P5227; Hikasa H, 2010, DEV CELL, V19, P521, DOI 10.1016/j.devcel.2010.09.005; Hofmann TG, 2003, CANCER RES, V63, P8271; Hoppler S, 1996, GENE DEV, V10, P2805, DOI 10.1101/gad.10.21.2805; Houston DW, 2002, DEVELOPMENT, V129, P4015; Imai Y, 2001, DEVELOPMENT, V128, P2407; Ishitani T, 2003, MOL CELL BIOL, V23, P1379, DOI 10.1128/MCB.23.4.1379-1389.2003; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; Isono K, 2006, MOL CELL BIOL, V26, P2758, DOI 10.1128/MCB.26.7.2758-2771.2006; Itoh K, 1998, MECH DEVELOP, V74, P145, DOI 10.1016/S0925-4773(98)00076-8; Itoh K, 2005, J BIOL, V4; Kaletta T, 1997, NATURE, V390, P294, DOI 10.1038/36869; Kanei-Ishii C, 2004, GENE DEV, V18, P816, DOI 10.1101/gad.1170604; Karaulanov E, 2004, EMBO J, V23, P844, DOI 10.1038/sj.emboj.7600101; Kim CH, 2000, NATURE, V407, P913, DOI 10.1038/35038097; Kim EA, 2010, BIOCHEM BIOPH RES CO, V394, P966, DOI 10.1016/j.bbrc.2010.03.099; Kim GH, 2008, J CELL BIOL, V182, P1073, DOI 10.1083/jcb.200710188; Kim YH, 1998, J BIOL CHEM, V273, P25875, DOI 10.1074/jbc.273.40.25875; Kondo S, 2003, P NATL ACAD SCI USA, V100, P5431, DOI 10.1073/pnas.0530308100; Ladher R, 1996, DEVELOPMENT, V122, P2385; Lee E, 2001, J CELL BIOL, V154, P983, DOI 10.1083/jcb.200102074; Lee W, 2009, DEVELOPMENT, V136, P241, DOI 10.1242/dev.025460; LIN RL, 1995, CELL, V83, P599, DOI 10.1016/0092-8674(95)90100-0; Liu CM, 1999, P NATL ACAD SCI USA, V96, P6273, DOI 10.1073/pnas.96.11.6273; Liu F, 2005, DEVELOPMENT, V132, P5375, DOI 10.1242/dev.02152; Lo MC, 2004, CELL, V117, P95, DOI 10.1016/S0092-8674(04)00203-X; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Louie SH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004310; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Meneghini MD, 1999, NATURE, V399, P793, DOI 10.1038/21666; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Onichtchouk D, 1996, DEVELOPMENT, V122, P3045; Ossipova O, 2009, DEV CELL, V17, P222, DOI 10.1016/j.devcel.2009.06.010; Park JI, 2006, DEV CELL, V11, P683, DOI 10.1016/j.devcel.2006.09.022; PENG HB, 1991, METHOD CELL BIOL, V36, P657; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Phillips BT, 2009, DEV CELL, V17, P27, DOI 10.1016/j.devcel.2009.07.002; Piao S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004046; Pierantoni GM, 2002, BIOCHEM BIOPH RES CO, V290, P942, DOI 10.1006/bbrc.2001.6310; Price MA, 2006, GENE DEV, V20, P399, DOI 10.1101/gad.1394306; Pukrop T, 2001, J BIOL CHEM, V276, P8968, DOI 10.1074/jbc.M007533200; Ramel MC, 2004, DEVELOPMENT, V131, P3991, DOI 10.1242/dev.01277; Rocheleau CE, 1999, CELL, V97, P717, DOI 10.1016/S0092-8674(00)80784-9; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Roel G, 2002, CURR BIOL, V12, P1941, DOI 10.1016/S0960-9822(02)01280-0; Schmidt JE, 1996, DEVELOPMENT, V122, P1711; Shin TH, 1999, MOL CELL, V4, P275, DOI 10.1016/S1097-2765(00)80375-5; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Smit L, 2004, J BIOL CHEM, V279, P17232, DOI 10.1074/jbc.M307801200; Sokol SY, 2007, DEVELOPMENT, V134, P3393, DOI 10.1242/dev.008169; Standley HJ, 2006, DEV BIOL, V289, P318, DOI 10.1016/j.ydbio.2005.10.012; Thorpe CJ, 2004, DEVELOPMENT, V131, P2899, DOI 10.1242/dev.01171; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Tutter AV, 2001, GENE DEV, V15, P3342, DOI 10.1101/gad.946501; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Wei GW, 2007, P NATL ACAD SCI USA, V104, P13040, DOI 10.1073/pnas.0703213104; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zhang C, 2003, DEVELOPMENT, V130, P5609, DOI 10.1242/dev.00798; Zhang OH, 2003, CELL, V115, P177, DOI 10.1016/S0092-8674(03)00802-X	88	80	80	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.185280	http://dx.doi.org/10.1074/jbc.M110.185280			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21285352	Green Published, hybrid			2022-12-27	WOS:000289077500024
J	Jenkins, CM; Yang, JY; Sims, HF; Gross, RW				Jenkins, Christopher M.; Yang, Jingyue; Sims, Harold F.; Gross, Richard W.			Reversible High Affinity Inhibition of Phosphofructokinase-1 by Acyl-CoA A MECHANISM INTEGRATING GLYCOLYTIC FLUX WITH LIPID METABOLISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RABBIT MUSCLE PHOSPHOFRUCTOKINASE; AUTOMATED PROTEIN-STRUCTURE; NITRIC-OXIDE SYNTHASE; FATTY-ACID; FRUCTOSE 2,6-BISPHOSPHATE; I-TASSER; GLUCOSE 1,6-BISPHOSPHATE; INSULIN-RESISTANCE; GLYCOGEN-SYNTHESIS; SKELETAL-MUSCLE	The enzyme phosphofructokinase-1 (PFK-1) catalyzes the first committed step of glycolysis and is regulated by a complex array of allosteric effectors that integrate glycolytic flux with cellular bioenergetics. Here, we demonstrate the direct, potent, and reversible inhibition of purified rabbit muscle PFK-1 by low micromolar concentrations of long chain fatty acyl-CoAs (apparent K-i similar to 1 mu M). In sharp contrast, short chain acyl-CoAs, palmitoylcarnitine, and palmitic acid in the presence of CoASH were without effect. Remarkably, MgAMP and MgADP but not MgATP protected PFK-1 against inhibition by palmitoyl-CoA indicating that acyl-CoAs regulate PFK-1 activity in concert with cellular high energy phosphate status. Furthermore, incubation of PFK-1 with [1-C-14] palmitoyl-CoA resulted in robust acylation of the enzyme that was reversible by incubation with acyl-protein thioesterase-1 (APT1). Importantly, APT1 reversed palmitoyl-CoA-mediated inhibition of PFK-1 activity. Mass spectrometric analyses of palmitoylated PFK-1 revealed four sites of acylation, including Cys-114, Cys-170, Cys-351, and Cys-577. PFK-1 in both skeletal muscle extracts and in purified form was inhibited by S-hexadecyl-CoA, a nonhydrolyzable palmitoyl-CoA analog, demonstrating that covalent acylation of PFK-1 was not required for inhibition. Tryptic footprinting suggested that S-hexadecyl-CoA induced a conformational change in PFK-1. Both palmitoyl-CoA and S-hexadecyl-CoA increased the association of PFK-1 with Ca2+/calmodulin, which attenuated the binding of palmitoylated PFK-1 to membrane vesicles. Collectively, these results demonstrate that fatty acyl-CoA modulates phosphofructokinase activity through both covalent and noncovalent interactions to regulate glycolytic flux and enzyme membrane localization via the branch point metabolic node that mediates lipid flux through anabolic and catabolic pathways.	[Gross, Richard W.] Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, Dept Dev Biol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, Dept Med, St Louis, MO 63110 USA; [Gross, Richard W.] Washington Univ, Dept Chem, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Gross, RW (corresponding author), Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, Dept Dev Biol, 660 S Euclid Ave,Campus Box 8020, St Louis, MO 63110 USA.	rgross@wustl.edu			National Institutes of Health [5PO1HL57278, RO1HL41250]; LipoSpectrum; Platomics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057278, R01HL041250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LipoSpectrum; Platomics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants 5PO1HL57278 and RO1HL41250. R. W. G. has financial relationships with LipoSpectrum and Platomics.	Ashkenazy-Shahar M, 1998, MOL GENET METAB, V65, P213, DOI 10.1006/mgme.1998.2759; Baekkeskov S, 2009, MOL MEMBR BIOL, V26, P42, DOI 10.1080/09687680802680108; Bajaj M, 2005, DIABETES, V54, P3148, DOI 10.2337/diabetes.54.11.3148; BERGER M, 1976, BIOCHEM J, V158, P191, DOI 10.1042/bj1580191; BLOXHAM DP, 1973, ENZYMES, P240; BOCHNER BR, 1982, J BIOL CHEM, V257, P9759; BOCK PE, 1976, J BIOL CHEM, V251, P5637; BODEN G, 1994, J CLIN INVEST, V93, P2438, DOI 10.1172/JCI117252; BODEN G, 1991, J CLIN INVEST, V88, P960, DOI 10.1172/JCI115399; Buchanan J, 2005, ENDOCRINOLOGY, V146, P5341, DOI 10.1210/en.2005-0938; BUSCHMEIER B, 1987, J BIOL CHEM, V262, P9454; Campanella ME, 2005, P NATL ACAD SCI USA, V102, P2402, DOI 10.1073/pnas.0409741102; Chalkley SM, 1998, METABOLISM, V47, P1121, DOI 10.1016/S0026-0495(98)90287-6; CHENZION M, 1992, INT J BIOCHEM, V24, P1661, DOI 10.1016/0020-711X(92)90185-4; CHOATE GL, 1985, J BIOL CHEM, V260, P4815; COLOMBO G, 1975, J BIOL CHEM, V250, P9404; CONSTANTINIDES PP, 1985, J BIOL CHEM, V260, P7573; Dekker FJ, 2010, NAT CHEM BIOL, V6, P449, DOI 10.1038/nchembio.362; Duncan JA, 1998, J BIOL CHEM, V273, P15830, DOI 10.1074/jbc.273.25.15830; Ellis BA, 2000, AM J PHYSIOL-ENDOC M, V279, pE554, DOI 10.1152/ajpendo.2000.279.3.E554; Feuvray D, 2008, DIABETES METAB, V34, pS3, DOI 10.1016/S1262-3636(08)70096-X; Firestein BL, 1999, J BIOL CHEM, V274, P10545, DOI 10.1074/jbc.274.15.10545; Flaumenhaft R, 2007, BLOOD, V110, P1492, DOI 10.1182/blood-2006-11-055772; Frayn KN, 2003, BIOCHEM SOC T, V31, P1115, DOI 10.1042/BST0311115; FROEDE HC, 1968, J BIOL CHEM, V243, P6021; GARLAND PB, 1963, NATURE, V200, P169, DOI 10.1038/200169a0; GlassMarmor L, 1997, EUR J PHARMACOL, V328, P241, DOI 10.1016/S0014-2999(97)83051-8; Golovko MY, 2004, J LIPID RES, V45, P1777, DOI 10.1194/jlr.D400004-JLR200; GROSS RW, 1983, BIOCHEMISTRY-US, V22, P5641, DOI 10.1021/bi00293a028; GROSS RW, 1983, J BIOL CHEM, V258, P5221; HAZEN SL, 1993, J BIOL CHEM, V268, P9892; HAZEN SL, 1994, FEBS LETT, V339, P213, DOI 10.1016/0014-5793(94)80418-4; HILL DE, 1975, BIOCHEMISTRY-US, V14, P203, DOI 10.1021/bi00673a003; Hirabara SM, 2003, FEBS LETT, V541, P109, DOI 10.1016/S0014-5793(03)00316-8; HOOD K, 1976, FEBS LETT, V68, P8, DOI 10.1016/0014-5793(76)80392-4; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; HUSSEY CR, 1977, EUR J BIOCHEM, V80, P497, DOI 10.1111/j.1432-1033.1977.tb11905.x; JENKINS JD, 1984, J BIOL CHEM, V259, P9374; KELLEY DE, 1993, J CLIN INVEST, V92, P91, DOI 10.1172/JCI116603; KEMP RG, 1983, MOL CELL BIOCHEM, V57, P147, DOI 10.1007/BF00849191; KEMP RG, 1969, BIOCHEMISTRY-US, V8, P4490, DOI 10.1021/bi00839a040; KEMP RG, 1968, BIOCHEMISTRY-US, V7, P2596, DOI 10.1021/bi00847a022; LATSHAW SP, 1987, J BIOL CHEM, V262, P10672; LEA MA, 1968, J BIOL CHEM, V243, P1096; Lopaschuk Gary D, 2002, Heart Fail Rev, V7, P149; LUTHER MA, 1986, J BIOL CHEM, V261, P1753; Mansour T E, 1972, Curr Top Cell Regul, V5, P1; Marinho-Carvalho MM, 2006, MOL GENET METAB, V87, P253, DOI 10.1016/j.ymgme.2005.11.002; Marinho-Carvalho MM, 2009, BBA-PROTEINS PROTEOM, V1794, P1175, DOI 10.1016/j.bbapap.2009.02.006; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; MAYR GW, 1984, EUR J BIOCHEM, V143, P521, DOI 10.1111/j.1432-1033.1984.tb08401.x; MAYR GW, 1983, FEBS LETT, V159, P51, DOI 10.1016/0014-5793(83)80415-3; MAYR GW, 1984, EUR J BIOCHEM, V143, P513, DOI 10.1111/j.1432-1033.1984.tb08400.x; NESTERENKO MV, 1994, J BIOCHEM BIOPH METH, V28, P239, DOI 10.1016/0165-022X(94)90020-5; NEWSHOLME EA, 1962, NATURE, V193, P270, DOI 10.1038/193270a0; PETTIGREW DW, 1979, J BIOL CHEM, V254, P1896; PILKIS SJ, 1981, J BIOL CHEM, V256, P3171; Poornima IG, 2006, CIRC RES, V98, P596, DOI 10.1161/01.RES.0000207406.94146.c2; POWELL GL, 1981, J BIOL CHEM, V256, P2740; RAMADOSS CS, 1976, J BIOL CHEM, V251, P98; RANDLE PJ, 1963, LANCET, V1, P785; RANDLE PJ, 1994, J CELL BIOCHEM, V55, P1, DOI 10.1002/jcb.240550002; RENNIE MJ, 1976, BIOCHEM J, V156, P647, DOI 10.1042/bj1560647; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; ROSENDAL J, 1993, BIOCHEM J, V290, P321, DOI 10.1042/bj2900321; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Scherer PE, 1997, J BIOL CHEM, V272, P20698, DOI 10.1074/jbc.272.33.20698; SHIPP JC, 1961, NATURE, V189, P1018, DOI 10.1038/1891018a0; Siegel G, 2009, NAT CELL BIOL, V11, P705, DOI 10.1038/ncb1876; Sola-Penna M, 2002, J BIOCHEM BIOPH METH, V50, P129, DOI 10.1016/S0165-022X(01)00180-4; Sotgia F, 2003, AM J PATHOL, V163, P2619, DOI 10.1016/S0002-9440(10)63616-4; Unger RH, 2010, BBA-MOL CELL BIOL L, V1801, P209, DOI 10.1016/j.bbalip.2009.10.006; UYEDA K, 1981, J BIOL CHEM, V256, P8394; Vallejo J, 2004, BIOCHEMISTRY-US, V43, P16224, DOI 10.1021/bi0490035; Vallejo J, 2004, AM J PHYSIOL-CELL PH, V286, pC43, DOI 10.1152/ajpcell.00483.2002; VANSCHAFTINGEN E, 1981, P NATL ACAD SCI-BIOL, V78, P3483; WALTERS DW, 1986, J BIOL CHEM, V261, P5372; WEBER G, 1966, SCIENCE, V154, P1357, DOI 10.1126/science.154.3754.1357; Wende AR, 2010, BBA-MOL CELL BIOL L, V1801, P311, DOI 10.1016/j.bbalip.2009.09.023; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Yeh DC, 1999, J BIOL CHEM, V274, P33148, DOI 10.1074/jbc.274.46.33148; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588	83	60	63	0	21	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.203661	http://dx.doi.org/10.1074/jbc.M110.203661			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21258134	hybrid, Green Published			2022-12-27	WOS:000289077500007
J	Wu, ZP; Gogonea, V; Lee, X; May, RP; Pipich, V; Wagner, MA; Undurti, A; Tallant, TC; Baleanu-Gogonea, C; Charlton, F; Ioffe, A; DiDonato, JA; Rye, KA; Hazen, SL				Wu, Zhiping; Gogonea, Valentin; Lee, Xavier; May, Roland P.; Pipich, Vitaliy; Wagner, Matthew A.; Undurti, Arundhati; Tallant, Thomas C.; Baleanu-Gogonea, Camelia; Charlton, Francesca; Ioffe, Alexander; DiDonato, Joseph A.; Rye, Kerry-Anne; Hazen, Stanley L.			The Low Resolution Structure of ApoA1 in Spherical High Density Lipoprotein Revealed by Small Angle Neutron Scattering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-A-I; ESTER TRANSFER PROTEIN; COMPUTATIONAL-EXPERIMENTAL-APPROACH; LIPID-BOUND CONFORMATION; CORONARY-ARTERY DISEASE; C-TERMINAL DOMAIN; HEART-DISEASE; SR-BI; X-RAY; CELLULAR CHOLESTEROL	Spherical high density lipoprotein (sHDL), a key player in reverse cholesterol transport and the most abundant form of HDL, is associated with cardiovascular diseases. Small angle neutron scattering with contrast variation was used to determine the solution structure of protein and lipid components of reconstituted sHDL. Apolipoprotein A1, the major protein of sHDL, forms a hollow structure that cradles a central compact lipid core. Three apoA1 chains are arranged within the low resolution structure of the protein component as one of three possible global architectures: (i) a helical dimer with a hairpin (HdHp), (ii) three hairpins (3Hp), or (iii) an integrated trimer (iT) in which the three apoA1 monomers mutually associate over a portion of the sHDL surface. Cross-linking and mass spectrometry analyses help to discriminate among the three molecular models and are most consistent with the HdHp overall architecture of apoA1 within sHDL.	[Wu, Zhiping; Gogonea, Valentin; Lee, Xavier; Wagner, Matthew A.; Undurti, Arundhati; Tallant, Thomas C.; Baleanu-Gogonea, Camelia; DiDonato, Joseph A.; Hazen, Stanley L.] Cleveland Clin, Dept Cell Biol, Cleveland, OH 44195 USA; [Wu, Zhiping; Gogonea, Valentin; Lee, Xavier; Wagner, Matthew A.; Undurti, Arundhati; Tallant, Thomas C.; DiDonato, Joseph A.; Hazen, Stanley L.] Cleveland Clin, Ctr Cardiovasc Diagnost & Prevent, Cleveland, OH 44195 USA; [Hazen, Stanley L.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA; [Gogonea, Valentin; Baleanu-Gogonea, Camelia; Hazen, Stanley L.] Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA; [May, Roland P.] Inst Laue Langevin, F-38042 Grenoble 9, France; [Pipich, Vitaliy; Ioffe, Alexander] Forschungszentrum Julich, Inst Festkorperforsch, Julich Ctr Neutron Sci FRM II, D-85747 Garching, Germany; [Charlton, Francesca; Rye, Kerry-Anne] Heart Res Inst, Lipid Res Grp, Sydney, NSW 2042, Australia; [Rye, Kerry-Anne] Univ Sydney, Fac Med, Sydney, NSW 2006, Australia; [Rye, Kerry-Anne] Univ Melbourne, Dept Med, Melbourne, Vic 3010, Australia	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University System of Ohio; Cleveland State University; Institut Laue-Langevin (ILL); Helmholtz Association; Research Center Julich; University of Sydney; Heart Research Institute; University of Sydney; University of Melbourne	Hazen, SL (corresponding author), Cleveland Clin, Dept Cell Biol, 9500 Euclid Ave,NE-10, Cleveland, OH 44195 USA.	hazens@ccf.org	Hazen, Stanley L/ABD-5845-2021; Ioffe, Alexander/C-1815-2014	Pipich, Vitaliy/0000-0002-3930-3602	National Institutes of Health [P01 HL098055, P01 HL076491-055328, P01 HL087018-02001]; Foundation Leducq; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076491, P01HL087018, P01HL098055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Leducq(Leducq Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 HL098055, P01 HL076491-055328, and P01 HL087018-02001. This work was also supported in part by a grant from the Foundation Leducq.	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; ANDERSON DW, 1978, ATHEROSCLEROSIS, V29, P161, DOI 10.1016/0021-9150(78)90005-9; ATKINSON D, 1976, EUR J BIOCHEM, V64, P541, DOI 10.1111/j.1432-1033.1976.tb10334.x; Atkinson D, 1980, Ann N Y Acad Sci, V348, P284, DOI 10.1111/j.1749-6632.1980.tb21308.x; BALDWIN JP, 1975, NATURE, V253, P245, DOI 10.1038/253245a0; Barter PJ, 2001, CURR OPIN LIPIDOL, V12, P377, DOI 10.1097/00041433-200108000-00002; Bhat S, 2005, J BIOL CHEM, V280, P33015, DOI 10.1074/jbc.M505081200; BLANCHE PJ, 1981, BIOCHIM BIOPHYS ACTA, V665, P408, DOI 10.1016/0005-2760(81)90253-8; Borhani DW, 1997, P NATL ACAD SCI USA, V94, P12291, DOI 10.1073/pnas.94.23.12291; BRESLOW JL, 1991, ANNU REV MED, V42, P357, DOI 10.1146/annurev.me.42.020191.002041; CASTELLI WP, 1977, CIRCULATION, V55, P767, DOI 10.1161/01.CIR.55.5.767; Catte A, 2008, BIOPHYS J, V94, P2306, DOI 10.1529/biophysj.107.115857; CHEUNG MC, 1987, J LIPID RES, V28, P913; DALTON MB, 1993, J BIOL CHEM, V268, P19274; DAVIDSON WS, 1994, J BIOL CHEM, V269, P8959; Davidson WS, 2003, J BIOL CHEM, V278, P27199, DOI 10.1074/jbc.M302764200; DURRINGTON PN, 1988, LANCET, V1, P1070; FIELDING C J, 1981, Proceedings of the National Academy of Sciences of the United States of America, V78, P3911, DOI 10.1073/pnas.78.6.3911; FRANCONE OL, 1989, J BIOL CHEM, V264, P7066; GLATTER O, 1977, J APPL CRYSTALLOGR, V10, P415, DOI 10.1107/S0021889877013879; Gogonea V, 2010, BIOCHEMISTRY-US, V49, P7323, DOI 10.1021/bi100588a; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Gu FF, 2010, J BIOL CHEM, V285, P4652, DOI 10.1074/jbc.M109.069914; GUILBAUD JB, 2010, CHEM SOC REV; JACROT B, 1981, BIOPOLYMERS, V20, P2413, DOI 10.1002/bip.1981.360201110; JONAS A, 1990, J BIOL CHEM, V265, P22123; Jonas A., 2002, BIOCH LIPIDS LIPOPRO, P483; Jones MK, 2010, J BIOL CHEM, V285, P41161, DOI 10.1074/jbc.M110.187799; KARATHANASIS SK, 1983, NATURE, V301, P718, DOI 10.1038/301718a0; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lagerstedt JO, 2011, J BIOL CHEM, V286, P2966, DOI 10.1074/jbc.M110.163097; Li HH, 2002, J BIOL CHEM, V277, P39093, DOI 10.1074/jbc.M206770200; Lund-Katz S, 2003, FRONT BIOSCI-LANDMRK, V8, pD1044, DOI 10.2741/1077; Maiorano JN, 2004, BIOCHEMISTRY-US, V43, P11717, DOI 10.1021/bi0496642; Martin DDO, 2006, J BIOL CHEM, V281, P20418, DOI 10.1074/jbc.M602077200; MAY RP, 1992, EMBO J, V11, P373, DOI 10.1002/j.1460-2075.1992.tb05060.x; Moore RE, 2005, CIRC RES, V97, P763, DOI 10.1161/01.RES.0000185320.82962.F7; Nicholls SJ, 2005, CIRCULATION, V111, P1543, DOI 10.1161/01.CIR.0000159351.95399.50; NORUM RA, 1982, NEW ENGL J MED, V306, P1513, DOI 10.1056/NEJM198206243062503; Oda MN, 2003, NAT STRUCT BIOL, V10, P455, DOI 10.1038/nsb931; Oram JF, 2000, CURR OPIN LIPIDOL, V11, P253, DOI 10.1097/00041433-200006000-00005; Oram JF, 2000, J BIOL CHEM, V275, P34508, DOI 10.1074/jbc.M006738200; Pajkrt D, 1996, J EXP MED, V184, P1601, DOI 10.1084/jem.184.5.1601; PARDON JF, 1977, NUCLEIC ACIDS RES, V4, P3199, DOI 10.1093/nar/4.9.3199; PEKKANEN J, 1990, NEW ENGL J MED, V322, P1700, DOI 10.1056/NEJM199006143222403; Peng DQ, 2005, J BIOL CHEM, V280, P33775, DOI 10.1074/jbc.M504092200; Peters-Libeu CA, 2007, J LIPID RES, V48, P1035, DOI 10.1194/jlr.M600545-JLR200; PLUMP AS, 1994, P NATL ACAD SCI USA, V91, P9607, DOI 10.1073/pnas.91.20.9607; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; RAMAKRISHNAN V, 1986, SCIENCE, V231, P1562, DOI 10.1126/science.3513310; Rogers DP, 1998, BIOCHEMISTRY-US, V37, P11714, DOI 10.1021/bi973112k; RUBIN EM, 1991, NATURE, V353, P265, DOI 10.1038/353265a0; RYE KA, 1995, J BIOL CHEM, V270, P189, DOI 10.1074/jbc.270.1.189; SAIBIL H, 1976, NATURE, V262, P266, DOI 10.1038/262266a0; SCHAEFER EJ, 1982, ARTERIOSCLEROSIS, V2, P16, DOI 10.1161/01.ATV.2.1.16; Segrest JP, 1999, J BIOL CHEM, V274, P31755, DOI 10.1074/jbc.274.45.31755; SERDYUK IN, 2007, METHODS MOL BIOPHYSI, P794; Shih AY, 2009, J R SOC INTERFACE, V6, P863, DOI 10.1098/rsif.2009.0173; Silva RAGD, 2008, P NATL ACAD SCI USA, V105, P12176, DOI 10.1073/pnas.0803626105; Silva RAGD, 2005, BIOCHEMISTRY-US, V44, P8600, DOI 10.1021/bi050421z; SPARKS DL, 1992, J BIOL CHEM, V267, P25830; STUHRMAN.HB, 1970, ACTA CRYSTALL A-CRYS, VA 26, P297, DOI 10.1107/S0567739470000748; Stuhrmann HB, 2008, ACTA CRYSTALLOGR A, V64, P181, DOI 10.1107/S0108767307046569; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 1998, P NATL ACAD SCI USA, V95, P2267, DOI 10.1073/pnas.95.5.2267; Thomas MJ, 2008, J LIPID RES, V49, P1875, DOI 10.1194/jlr.R800010-JLR200; Vanhamme L, 2003, NATURE, V422, P83, DOI 10.1038/nature01461; Vuorela T, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000964; Wang JJ, 2002, P NATL ACAD SCI USA, V99, P1188, DOI 10.1073/pnas.032565999; Wang L, 2005, J BIOL CHEM, V280, P4154, DOI 10.1074/bc.M411618200; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; Wang N, 1996, J BIOL CHEM, V271, P21001, DOI 10.1074/jbc.271.35.21001; Wu Z, 2007, NAT STRUCT MOL BIOL, V14, P861, DOI 10.1038/nsmb1284; Wu ZP, 2009, J BIOL CHEM, V284, P36605, DOI 10.1074/jbc.M109.039537; Zannis VI, 2006, J MOL MED, V84, P276, DOI 10.1007/s00109-005-0030-4; Zhang L, 2011, J LIPID RES, V52, P175, DOI 10.1194/jlr.D010959; Zhang YZ, 2003, CIRCULATION, V108, P661, DOI 10.1161/01.CIR.0000086981.09834.E0	78	42	43	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.209130	http://dx.doi.org/10.1074/jbc.M110.209130			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21292766	Green Published, hybrid			2022-12-27	WOS:000289077500063
J	An, HJ; Kim, YJ; Song, DH; Park, BS; Kim, HM; Lee, JD; Paik, SG; Lee, JO; Lee, H				An, Hyun-Jung; Kim, Young Jin; Song, Dong Hyun; Park, Beom Suk; Kim, Ho Min; Lee, Ju Dong; Paik, Sang-Gi; Lee, Jie-Oh; Lee, Hayyoung			Crystallographic and Mutational Analysis of the CD40-CD154 Complex and Its Implications for Receptor Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CD40 LIGAND; X-LINKED IMMUNODEFICIENCY; HYPER-IGM SYNDROME; CRYSTAL-STRUCTURE; MOLECULAR-MODELS; FACTORS TRAFS; BINDING; DOMAIN; CELLS; GP39	CD40 is a tumor necrosis factor receptor (TNFR) family protein that plays an important role in B cell development. CD154/CD40L is the physiological ligand of CD40. We have determined the crystal structure of the CD40-CD154 complex at 3.5 angstrom resolution. The binding site of CD40 is located in a crevice formed between two CD154 subunits. Charge complementarity plays a critical role in the CD40-CD154 interaction. Some of the missense mutations found in hereditary hyper-IgM syndrome can be mapped to the CD40-CD154 interface. The CD40 interaction area of one of the CD154 subunits is twice as large as that of the other subunit forming the binding crevice. This is because cysteine-rich domain 3 (CRD3) of CD40 has a disulfide bridge in an unusual position that alters the direction of the ladder-like structure of CD40. The Ser(132) loop of CD154 is not involved in CD40 binding but its substitution significantly reduces p38- and ERK-dependent signaling by CD40, whereas JNK-dependent signaling is not affected. These findings suggest that ligand-induced di- or trimerization is necessary but not sufficient for complete activation of CD40.	[Kim, Young Jin; Song, Dong Hyun; Park, Beom Suk; Lee, Jie-Oh] Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea; [An, Hyun-Jung; Paik, Sang-Gi] Chungnam Natl Univ, Coll Biosci & Biotechnol, Dept Biol, Taejon 305764, South Korea; [An, Hyun-Jung; Paik, Sang-Gi] Chungnam Natl Univ, Coll Biosci & Biotechnol, Daedeok R&D Innopolis Bio Brain Ctr BK21, Taejon 305764, South Korea; [Lee, Hayyoung] Chungnam Natl Univ, Coll Biosci & Biotechnol, Inst Biotechnol, Taejon 305764, South Korea; [Kim, Ho Min; Lee, Ju Dong] Korea Adv Inst Sci & Technol, Biomed Res Ctr, Taejon 305701, South Korea; [Lee, Jie-Oh] Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol WCU, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Chungnam National University; Chungnam National University; Chungnam National University; Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Lee, JO (corresponding author), Korea Adv Inst Sci & Technol, Dept Chem, 335 Gwahag No, Taejon 305701, South Korea.	jieoh@kaist.ac.kr; hlee@cnu.ac.kr	Lee, Jie-Oh/C-1581-2011; Lee, Jie-Oh/AAG-4302-2020; Kim, Ho Min/G-2712-2011	Lee, Jie-Oh/0000-0001-6519-6049; kim, youngjin/0000-0001-6505-9212	National Research Foundation [2010-0000101]; Ministry of Education, Science, and Technology of Korea [2008-00539]	National Research Foundation; Ministry of Education, Science, and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the National Research Foundation (2010-0000101) and the Japanese-Korean Cooperative Program (2008-00539) of the Ministry of Education, Science, and Technology of Korea.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ARMITAGE RJ, 1992, NATURE, V357, P80, DOI 10.1038/357080a0; ARUFFO A, 1993, CELL, V72, P291, DOI 10.1016/0092-8674(93)90668-G; BAJORATH J, 1993, PROTEIN SCI, V2, P1798, DOI 10.1002/pro.5560021103; Bajorath J, 1998, J BIOL CHEM, V273, P24603, DOI 10.1074/jbc.273.38.24603; Bajorath J, 1997, PROTEINS, V27, P59; BAJORATH J, 1995, BIOCHEMISTRY-US, V34, P9884, DOI 10.1021/bi00031a009; BAJORATH J, 1995, BIOCHEMISTRY-US, V34, P1833, DOI 10.1021/bi00006a003; Bajorath J, 1996, PROTEIN SCI, V5, P531; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; Chan FKM, 2007, CYTOKINE, V37, P101, DOI 10.1016/j.cyto.2007.03.005; DISANTO JP, 1993, NATURE, V361, P541, DOI 10.1038/361541a0; Eldredge J, 2006, BIOCHEMISTRY-US, V45, P10117, DOI 10.1021/bi060210+; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; GRAF D, 1995, EUR J IMMUNOL, V25, P1749, DOI 10.1002/eji.1830250639; Hassan GS, 2009, TRENDS IMMUNOL, V30, P165, DOI 10.1016/j.it.2009.01.004; Haswell LE, 2001, EUR J IMMUNOL, V31, P3094, DOI 10.1002/1521-4141(2001010)31:10<3094::AID-IMMU3094>3.0.CO;2-F; Hymowitz SG, 1999, MOL CELL, V4, P563, DOI 10.1016/S1097-2765(00)80207-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KARPUSAS M, 1995, STRUCTURE, V3, P1031, DOI 10.1016/S0969-2126(01)00239-8; Karpusas M, 2001, STRUCTURE, V9, P321, DOI 10.1016/S0969-2126(01)00590-1; Kashiwada M, 1998, J EXP MED, V187, P237, DOI 10.1084/jem.187.2.237; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; KIENER PA, 1995, J IMMUNOL, V155, P4917; Kilinc MO, 2006, EXP MOL PATHOL, V80, P252, DOI 10.1016/j.yexmp.2005.12.004; Kim HM, 2003, NAT STRUCT BIOL, V10, P342, DOI 10.1038/nsb925; KORTHAUER U, 1993, NATURE, V361, P539, DOI 10.1038/361539a0; Leveille C, 2007, J BIOL CHEM, V282, P5143, DOI 10.1074/jbc.M608342200; Liu YF, 2003, NATURE, V423, P49, DOI 10.1038/nature01543; MAZZEI GJ, 1995, J BIOL CHEM, V270, P7025, DOI 10.1074/jbc.270.13.7025; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Miconnet I, 2008, VACCINE, V26, P4006, DOI 10.1016/j.vaccine.2008.05.028; Naismith JH, 1998, TRENDS BIOCHEM SCI, V23, P74, DOI 10.1016/S0968-0004(97)01164-X; Park YC, 1999, NATURE, V398, P533, DOI 10.1038/19110; Pearson LL, 2001, INT IMMUNOL, V13, P273, DOI 10.1093/intimm/13.3.273; Piirila H, 2006, HUM MUTAT, V27, P1200, DOI 10.1002/humu.20405; Prasad KSS, 2003, P NATL ACAD SCI USA, V100, P12367, DOI 10.1073/pnas.2032886100; Pullen SS, 1999, BIOCHEMISTRY-US, V38, P10168, DOI 10.1021/bi9909905; Pullen SS, 1999, J BIOL CHEM, V274, P14246, DOI 10.1074/jbc.274.20.14246; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Scott FL, 2009, NATURE, V457, P1019, DOI 10.1038/nature07606; Singh J, 1998, PROTEIN SCI, V7, P1124, DOI 10.1002/pro.5560070506; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; Vonderheide RH, 2007, CLIN CANCER RES, V13, P1083, DOI 10.1158/1078-0432.CCR-06-1893; Wang LW, 2010, NAT STRUCT MOL BIOL, V17, P1324, DOI 10.1038/nsmb.1920; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6	47	65	70	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11226	11235		10.1074/jbc.M110.208215	http://dx.doi.org/10.1074/jbc.M110.208215			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21285457	hybrid, Green Published			2022-12-27	WOS:000288797100034
J	Ito, T; Yamakuchi, M; Lowenstein, CJ				Ito, Takashi; Yamakuchi, Munekazu; Lowenstein, Charles J.			Thioredoxin Increases Exocytosis by Denitrosylating N-Ethylmaleimide-sensitive Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; TRANSGENIC MICE; PROTEIN DENITROSYLATION; S-NITROSYLATION; OVEREXPRESSION; INFLAMMATION; CATALYZES; DECOMPOSITION; GLUTATHIONE; EXPRESSION	Exocytosis involves membrane fusion between granules and the plasma membrane. Nitric oxide (NO) inhibits exocytosis by chemically modifying N-ethylmaleimide-sensitive factor (NSF), a key component of the exocytic machinery. However, cells recover the ability to release messenger molecules within hours of exposure to NO through unknown mechanisms. We now identify thioredoxin (TRX1) as a denitrosylase that reverses NO inhibition of exocytosis. Endogenously synthesized NO increases S-nitrosylated NSF levels, but S-nitrosylated NSF levels decrease within 3 h after exposure to NO. We found that NO increases the interaction between TRX1 and NSF, and endogenous TRX1 removes NO from S-nitrosylated NSF. Knockdown of TRX1 increases the level of S-nitrosylated NSF, prolongs the inhibition of exocytosis, and suppresses leukocyte adhesion. Taken together, these data show that TRX1 promotes exocytosis by denitrosylating NSF. Our findings suggest that TRX1 might regulate exocytosis in a variety of physiological settings, such as vascular inflammation, thrombosis, and insulin release.	[Lowenstein, Charles J.] Univ Rochester, Aab Cardiovasc Res Inst, Sch Med & Dent, Rochester, NY 14642 USA; Univ Rochester, Dept Med, Sch Med & Dent, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Lowenstein, CJ (corresponding author), Univ Rochester, Aab Cardiovasc Res Inst, Sch Med & Dent, Box CVRI,601 Elmwood Ave, Rochester, NY 14642 USA.	charles_lowenstein@urmc.rochester.edu		Lowenstein, Charles/0000-0003-0485-7514				Benhar M, 2008, SCIENCE, V320, P1050, DOI 10.1126/science.1158265; Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764; Bertini R, 1999, J EXP MED, V189, P1783, DOI 10.1084/jem.189.11.1783; Burke-Gaffney A, 2005, TRENDS PHARMACOL SCI, V26, P398, DOI 10.1016/j.tips.2005.06.005; Cirino G, 2003, TRENDS PHARMACOL SCI, V24, P91, DOI 10.1016/S0165-6147(02)00049-4; DAVENPECK KL, 1994, GASTROENTEROLOGY, V107, P1050, DOI 10.1016/0016-5085(94)90229-1; Ebrahimian T, 2008, ANTIOXID REDOX SIGN, V10, P1127, DOI 10.1089/ars.2007.1985; Grisham MB, 1999, AM J PHYSIOL-GASTR L, V276, pG315, DOI 10.1152/ajpgi.1999.276.2.G315; Hattori I, 2004, ANTIOXID REDOX SIGN, V6, P81, DOI 10.1089/152308604771978372; Hausladen A, 2001, P NATL ACAD SCI USA, V98, P10108, DOI 10.1073/pnas.181199698; Hoshino T, 2003, AM J RESP CRIT CARE, V168, P1075, DOI 10.1164/rccm.200209-982OC; Hoshino Y, 2007, ANTIOXID REDOX SIGN, V9, P689, DOI 10.1089/ars.2007.1575; Hou YC, 1996, BIOCHEM BIOPH RES CO, V228, P88, DOI 10.1006/bbrc.1996.1620; Huang Y, 2005, NEURON, V46, P533, DOI 10.1016/j.neuron.2005.03.028; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jourd'heuil D, 1999, ARCH BIOCHEM BIOPHYS, V361, P323, DOI 10.1006/abbi.1998.1010; Kasuno K, 2003, KIDNEY INT, V64, P1273, DOI 10.1046/j.1523-1755.2003.00224.x; Kubes P, 2000, AM J MED, V109, P150, DOI 10.1016/S0002-9343(00)00480-0; KUWADA M, 1980, J BIOCHEM-TOKYO, V88, P859, DOI 10.1093/oxfordjournals.jbchem.a133040; Lefer AM, 1999, AM J PHYSIOL-GASTR L, V276, pG572, DOI 10.1152/ajpgi.1999.276.3.G572; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Lima B., J S CIRC RES, V106, P633; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; Lowenstein CJ, 2007, CARDIOVASC RES, V75, P240, DOI 10.1016/j.cardiores.2007.03.024; Lowenstein CJ, 2005, TRENDS CARDIOVAS MED, V15, P302, DOI 10.1016/j.tcm.2005.09.005; Matsushita K, 2003, CELL, V115, P139, DOI 10.1016/S0092-8674(03)00803-1; MATTHEWS JR, 1992, NUCLEIC ACIDS RES, V20, P3821, DOI 10.1093/nar/20.15.3821; Mellman I, 2000, CELL, V100, P99, DOI 10.1016/S0092-8674(00)81687-6; Mitchell DA, 2005, NAT CHEM BIOL, V1, P154, DOI 10.1038/nchembio720; Nakamura H, 2002, IMMUNOL LETT, V82, P165, DOI 10.1016/S0165-2478(02)00033-0; Nikitovic D, 1996, J BIOL CHEM, V271, P19180, DOI 10.1074/jbc.271.32.19180; Sakurai A, 2004, J CELL PHYSIOL, V198, P22, DOI 10.1002/jcp.10377; Schwertassek U, 2007, EMBO J, V26, P3086, DOI 10.1038/sj.emboj.7601746; Sengupta R, 2007, BIOCHEMISTRY-US, V46, P8472, DOI 10.1021/bi700449x; Shioji K, 2002, CIRCULATION, V106, P1403, DOI 10.1161/01.CIR.0000027817.55925.B4; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Takagi Y, 1999, P NATL ACAD SCI USA, V96, P4131, DOI 10.1073/pnas.96.7.4131; Tao L, 2004, P NATL ACAD SCI USA, V101, P11471, DOI 10.1073/pnas.0402941101; Trujillo M, 1998, J BIOL CHEM, V273, P7828, DOI 10.1074/jbc.273.14.7828; Turoczi T, 2003, J MOL CELL CARDIOL, V35, P695, DOI 10.1016/S0022-2828(03)00117-2; Verdoucq L, 1999, J BIOL CHEM, V274, P19714, DOI 10.1074/jbc.274.28.19714; Wei SJ, 2000, CANCER RES, V60, P6688; WHITEHEART SW, 1992, J BIOL CHEM, V267, P12239; WHITEHEART SW, 1993, NATURE, V362, P353, DOI 10.1038/362353a0; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; Yamawaki H, 2005, J CLIN INVEST, V115, P733, DOI 10.1172/JCI200523001; Yamawaki H, 2003, CIRC RES, V93, P1029, DOI 10.1161/01.RES.0000102869.39150.23; Yoshida T, 2005, ANN NY ACAD SCI, V1055, P1, DOI 10.1196/annals.1323.002; Zamora R, 2000, MOL MED, V6, P347, DOI 10.1007/BF03401781	52	23	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11179	11184		10.1074/jbc.M110.201780	http://dx.doi.org/10.1074/jbc.M110.201780			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21324905	Green Published, hybrid			2022-12-27	WOS:000288797100028
J	Lukashova, V; Szabo, EZ; Jinadasa, T; Mokhov, A; Litchfield, DW; Orlowski, J				Lukashova, Viktoria; Szabo, Eloed Z.; Jinadasa, Tushare; Mokhov, Alexei; Litchfield, David W.; Orlowski, John			CK2 Phosphorylation of an Acidic Ser/Thr Di-isoleucine Motif in the Na+/H+ Exchanger NHE5 Isoform Promotes Association with beta-Arrestin2 and Endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; CASEIN KINASE-II; CLATHRIN-MEDIATED ENDOCYTOSIS; BETA-ARRESTIN TRANSLOCATION; C-TERMINAL DOMAIN; BETA(2)-ADRENERGIC RECEPTOR; HORMONE RECEPTOR; DEPENDENT INTERNALIZATION; CONSTITUTIVE ENDOCYTOSIS; SUBSTRATE DETERMINANTS	Internalization of the Na+/H+ exchanger NHE5 into recycling endosomes is enhanced by the endocytic adaptor proteins beta-arrestin1 and -2, best known for their preferential recognition of ligand-activated G protein-coupled receptors (GPCRs). However, the mechanism underlying their atypical association with non-GPCRs, such as NHE5, is unknown. In this study, we identified a highly acidic, serine/threonine-rich, di-isoleucine motif (amino acids 697-723) in the cytoplasmic C terminus of NHE5 that is recognized by beta-arrestin2. Gross deletions of this site decreased the state of phosphorylation of NHE5 as well as its binding and responsiveness to beta-arrestin2 in intact cells. More refined in vitro analyses showed that this site was robustly phosphorylated by the acidotropic protein kinase CK2, whereas other kinases, such as CK1 or the GPCR kinase GRK2, were considerably less potent. Simultaneous mutation of five Ser/Thr residues within 702-714 to Ala ((ST)-S-702/AA(714)) abolished phosphorylation and binding of beta-arrestin2. In transfected cells, the CK2 catalytic alpha subunit formed a complex with NHE5 and decreased wild-type but not (ST)-S-702/AA(714) NHE5 activity, further supporting a regulatory role for this kinase. The rate of internalization of (ST)-S-702/AA(714) was also diminished and relatively insensitive to overexpression of beta-arrestin2. However, unlike in vitro, this mutant retained its ability to form a complex with beta-arrestin2 despite its lack of responsiveness. Additional mutations of two di-isoleucine-based motifs (I697A/L698A and I722A/I723A) that immediately flank the acidic cluster, either separately or together, were required to disrupt their association. These data demonstrate that discrete elements of an elaborate sorting signal in NHE5 contribute to beta-arrestin2 binding and trafficking along the recycling endosomal pathway.	[Lukashova, Viktoria; Jinadasa, Tushare; Mokhov, Alexei; Orlowski, John] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; [Szabo, Eloed Z.] Hosp Sick Children, Dept Anaesthesia, Toronto, ON M5G 1X8, Canada; [Litchfield, David W.] Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada	McGill University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Western University (University of Western Ontario)	Orlowski, J (corresponding author), McGill Univ, Dept Physiol, Mclntyre Med Sci Bldg,3655 Promenade Sir William, Montreal, PQ H3G 1Y6, Canada.	john.orlowski@mcgill.ca	Litchfield, David/E-4636-2015	Litchfield, David/0000-0002-2425-6620; Orlowski, John/0000-0001-7371-175X	Canadian Institutes for Health Research [MOP-11221]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes for Health Research Grant MOP-11221 (to J. O.).	Allende CC, 1998, J CELL BIOCHEM, P129; Attaphitaya S, 1999, J BIOL CHEM, V274, P4383, DOI 10.1074/jbc.274.7.4383; Barriere H, 2006, TRAFFIC, V7, P282, DOI 10.1111/j.1600-0854.2006.00384.x; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Budd DC, 2000, J BIOL CHEM, V275, P19667, DOI 10.1074/jbc.M000492200; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Chen CH, 2004, J BIOL CHEM, V279, P10020, DOI 10.1074/jbc.M310590200; Chen W, 2003, SCIENCE, V301, P1394, DOI 10.1126/science.1083195; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; Cotlin LF, 1999, J BIOL CHEM, V274, P30550, DOI 10.1074/jbc.274.43.30550; Diering GH, 2009, J BIOL CHEM, V284, P13892, DOI 10.1074/jbc.M807055200; Diviani D, 1997, J BIOL CHEM, V272, P28712, DOI 10.1074/jbc.272.45.28712; Doring M, 2006, J NEUROCHEM, V98, P2013, DOI 10.1111/j.1471-4159.2006.04037.x; Feliciangeli S, 2010, J BIOL CHEM, V285, P4798, DOI 10.1074/jbc.M109.078535; Filhol O, 2003, MOL CELL BIOL, V23, P975, DOI 10.1128/MCB.23.3.975-987.2003; FLOTOW H, 1991, J BIOL CHEM, V266, P3724; FLOTOW H, 1990, J BIOL CHEM, V265, P14264; Fredericks ZL, 1996, J BIOL CHEM, V271, P13796, DOI 10.1074/jbc.271.23.13796; Gabilondo AM, 1997, P NATL ACAD SCI USA, V94, P12285, DOI 10.1073/pnas.94.23.12285; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Galliera E, 2004, J BIOL CHEM, V279, P25590, DOI 10.1074/jbc.M400363200; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; Hammes SR, 1999, BIOCHEMISTRY-US, V38, P9308, DOI 10.1021/bi9902236; Hanyaloglu AC, 2001, J BIOL CHEM, V276, P18066, DOI 10.1074/jbc.M009275200; Jala VR, 2005, J BIOL CHEM, V280, P4880, DOI 10.1074/jbc.M409821200; Jones BW, 2007, J BIOL CHEM, V282, P12893, DOI 10.1074/jbc.M610854200; Kara E, 2006, MOL ENDOCRINOL, V20, P3014, DOI 10.1210/me.2006-0098; Kim YM, 2002, J BIOL CHEM, V277, P16837, DOI 10.1074/jbc.M201379200; Kimura T, 2007, MOL BIOL CELL, V18, P4508, DOI 10.1091/mbc.E06-08-0711; Korn I, 2001, MOL CELL BIOCHEM, V227, P37, DOI 10.1023/A:1013100604191; Korolchuk VI, 2002, TRAFFIC, V3, P428, DOI 10.1034/j.1600-0854.2002.30606.x; Krasel C, 2008, J BIOL CHEM, V283, P31840, DOI 10.1074/jbc.M806086200; LEBIVIC A, 1989, P NATL ACAD SCI USA, V86, P9313; Lee KB, 2000, J BIOL CHEM, V275, P35767, DOI 10.1074/jbc.M002225200; Liang M, 1998, MOL PHARMACOL, V54, P44, DOI 10.1124/mol.54.1.44; Lin FT, 2002, BIOCHEMISTRY-US, V41, P10692, DOI 10.1021/bi025705n; Lin FT, 1998, J BIOL CHEM, V273, P31640, DOI 10.1074/jbc.273.48.31640; Lipsky R, 2008, J BIOL CHEM, V283, P17221, DOI 10.1074/jbc.C800061200; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Marin O, 1999, BIOCHEM BIOPH RES CO, V256, P442, DOI 10.1006/bbrc.1999.0348; Mason AK, 2008, J BIOL CHEM, V283, P5973, DOI 10.1074/jbc.M709756200; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Min L, 2002, J BIOL CHEM, V277, P702, DOI 10.1074/jbc.M106082200; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Mukherjee S, 2002, J BIOL CHEM, V277, P17916, DOI 10.1074/jbc.M110479200; Mundell SJ, 2006, MOL PHARMACOL, V70, P1132, DOI 10.1124/mol.106.023549; Nakata A, 2007, J NEUROSCI RES, V85, P723, DOI 10.1002/jnr.21185; Namkung Y, 2004, J BIOL CHEM, V279, P49533, DOI 10.1074/jbc.M408319200; Niefind K, 2001, EMBO J, V20, P5320, DOI 10.1093/emboj/20.19.5320; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Olsten MEK, 2005, MOL CELL BIOCHEM, V274, P115, DOI 10.1007/s11010-005-3072-6; Orsini MJ, 1999, J BIOL CHEM, V274, P31076, DOI 10.1074/jbc.274.43.31076; Orsini MJ, 2000, J BIOL CHEM, V275, P25876; Pandey KN, 2009, FRONT BIOSCI-LANDMRK, V14, P5339, DOI 10.2741/3599; Penner CG, 1997, J CELL BIOCHEM, V64, P525; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Preisser L, 1999, FEBS LETT, V460, P303, DOI 10.1016/S0014-5793(99)01360-5; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Puckerin A, 2006, J BIOL CHEM, V281, P31131, DOI 10.1074/jbc.M605000200; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Richardson MD, 2003, J NEUROCHEM, V84, P854, DOI 10.1046/j.1471-4159.2003.01577.x; ROTIN D, 1989, AM J PHYSIOL, V257, pC1158, DOI 10.1152/ajpcell.1989.257.6.C1158; Sarker R, 2008, MOL BIOL CELL, V19, P3859, DOI 10.1091/mbc.E08-01-0019; Shenoy SK, 2003, J BIOL CHEM, V278, P14498, DOI 10.1074/jbc.M209626200; SMITH DB, 1994, CURRENT PROTOCOLS MO; Szabo EZ, 2000, J BIOL CHEM, V275, P6302, DOI 10.1074/jbc.275.9.6302; Szabo EZ, 2005, P NATL ACAD SCI USA, V102, P2790, DOI 10.1073/pnas.0407444102; Szaszi K, 2002, J BIOL CHEM, V277, P42623, DOI 10.1074/jbc.M206629200; Teuchert M, 1999, J BIOL CHEM, V274, P36781, DOI 10.1074/jbc.274.51.36781; Tobin AB, 1997, J BIOL CHEM, V272, P20844, DOI 10.1074/jbc.272.33.20844; Tobin AB, 2002, TRENDS PHARMACOL SCI, V23, P337, DOI 10.1016/S0165-6147(02)02043-6; Torrecilla I, 2007, J CELL BIOL, V177, P127, DOI 10.1083/jcb.200610018; Vaughan DJ, 2006, J BIOL CHEM, V281, P7684, DOI 10.1074/jbc.M500328200; von Zastrow M, 2007, CURR OPIN CELL BIOL, V19, P436, DOI 10.1016/j.ceb.2007.04.021; Wang D, 2003, NAT CELL BIOL, V5, P1117, DOI 10.1038/ncb1072; Wang D, 2007, P NATL ACAD SCI USA, V104, P9325, DOI 10.1073/pnas.0611296104; Waugh MG, 1999, BIOCHEM J, V338, P175, DOI 10.1042/0264-6021:3380175; Wu JH, 2003, J BIOL CHEM, V278, P44238, DOI 10.1074/jbc.M309450200; YUAN NY, 1994, J BIOL CHEM, V269, P23032; Zhao BB, 2008, CELL SIGNAL, V20, P1769, DOI 10.1016/j.cellsig.2008.06.011	83	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11456	11468		10.1074/jbc.M110.182881	http://dx.doi.org/10.1074/jbc.M110.182881			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21296876	Green Published, hybrid			2022-12-27	WOS:000288797100057
J	Nishi, M; Akutsu, H; Masui, S; Kondo, A; Nagashima, Y; Kimura, H; Perrem, K; Shigeri, Y; Toyoda, M; Okayama, A; Hirano, H; Umezawa, A; Yamamoto, N; Lee, SW; Ryo, A				Nishi, Mayuko; Akutsu, Hidenori; Masui, Shinji; Kondo, Asami; Nagashima, Yoji; Kimura, Hirokazu; Perrem, Kilian; Shigeri, Yasushi; Toyoda, Masashi; Okayama, Akiko; Hirano, Hisashi; Umezawa, Akihiro; Yamamoto, Naoki; Lee, Sam W.; Ryo, Akihide			A Distinct Role for Pin1 in the Induction and Maintenance of Pluripotency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; PROLYL ISOMERASE PIN1; SELF-RENEWAL; PHOSPHORYLATION; EXPRESSION; DIFFERENTIATION; ISOMERIZATION; SURVIVAL; MICE	The prominent characteristics of pluripotent stem cells are their unique capacity to self-renew and pluripotency. Although pluripotent stem cell proliferation is maintained by specific intracellular phosphorylation signaling events, it has not been well characterized how the resulting phosphorylated proteins are subsequently regulated. We here report that the peptidylprolyl isomerase Pin1 is indispensable for the self-renewal and maintenance of pluripotent stem cells via the regulation of phosphorylated Oct4 and other substrates. Pin1 expression was found to be up-regulated upon the induction of induced pluripotent stem (iPS) cells, and the forced expression of Pin1 with defined reprogramming factors was observed to further enhance the frequency of iPS cell generation. The inhibition of Pin1 activity significantly suppressed colony formation and induced the aberrant differentiation of human iPS cells as well as murine ES cells. We further found that Pin1 interacts with the phosphorylated Ser(12)-Pro motif of Oct4 and that this in turn facilitates the stability and transcriptional activity functions of Oct4. Our current findings thus uncover an atypical role for Pin1 as a putative regulator of the induction and maintenance of pluripotency via the control of phosphorylation signaling. These data suggest that the manipulation of Pin1 function could be a potential strategy for the stable induction and proliferation of human iPS cells.	[Ryo, Akihide] Yokohama City Univ, Sch Med, Dept Microbiol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Nagashima, Yoji] Yokohama City Univ, Sch Med, Dept Pathol, Yokohama, Kanagawa 2360004, Japan; [Okayama, Akiko; Hirano, Hisashi] Yokohama City Univ, Sch Med, Dept Supramol Biol, Yokohama, Kanagawa 2360004, Japan; [Akutsu, Hidenori; Toyoda, Masashi; Umezawa, Akihiro] Natl Res Inst Child Hlth & Dev, Dept Reprod Biol, Tokyo 1578535, Japan; [Masui, Shinji] Int Med Ctr Japan, Res Inst, Dept Regenerat Med, Tokyo 1628655, Japan; [Kimura, Hirokazu] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo 2080011, Japan; [Perrem, Kilian] Commonwealth Sci & Ind Res Org, Dickson, ACT 2602, Australia; [Shigeri, Yasushi] Natl Inst Adv Ind Sci & Technol, Osaka 5638577, Japan; [Yamamoto, Naoki] Natl Univ Singapore, Dept Microbiol, Singapore 117597, Singapore; [Lee, Sam W.] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; [Lee, Sam W.] Harvard Univ, Sch Med, Charlestown, MA 02129 USA	Yokohama City University; Yokohama City University; Yokohama City University; National Center for Child Health & Development - Japan; National Center for Global Health & Medicine - Japan; National Institute of Infectious Diseases (NIID); Commonwealth Scientific & Industrial Research Organisation (CSIRO); National Institute of Advanced Industrial Science & Technology (AIST); National University of Singapore; Harvard University; Massachusetts General Hospital; Harvard University	Ryo, A (corresponding author), Yokohama City Univ, Sch Med, Dept Microbiol, Kanazawa Ku, 3-9 Fuku Ura, Yokohama, Kanagawa 2360004, Japan.	aryo@yokohama-cu.ac.jp	Nagashima, Yoji/AAA-2591-2021	Masui, Shinji/0000-0001-7417-0019	Takeda Science Foundation; Uehara Memorial Foundation; Kanagawa Nanbyo Foundation; NATIONAL CANCER INSTITUTE [R01CA149477] Funding Source: NIH RePORTER	Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Kanagawa Nanbyo Foundation(Kanagawa Nanbyo Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from the Takeda Science Foundation, Uehara Memorial Foundation, and Kanagawa Nanbyo Foundation (to A. R.).	Atchison FW, 2003, BIOL REPROD, V69, P1989, DOI 10.1095/biolreprod.103.020859; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brill LM, 2009, CELL STEM CELL, V5, P204, DOI 10.1016/j.stem.2009.06.002; Dvorak P, 2005, STEM CELLS, V23, P1200, DOI 10.1634/stemcells.2004-0303; Eiselleova L, 2009, STEM CELLS, V27, P1847, DOI 10.1002/stem.128; Esnault S, 2008, CRIT REV IMMUNOL, V28, P45, DOI 10.1615/CritRevImmunol.v28.i1.30; Fujimori F, 1999, BIOCHEM BIOPH RES CO, V265, P658, DOI 10.1006/bbrc.1999.1736; Hennig L, 1998, BIOCHEMISTRY-US, V37, P5953, DOI 10.1021/bi973162p; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Knoepfler PS, 2009, STEM CELLS, V27, P1050, DOI 10.1002/stem.37; Lewitzky M, 2007, CURR OPIN BIOTECH, V18, P467, DOI 10.1016/j.copbio.2007.09.007; Li J, 2007, DIFFERENTIATION, V75, P299, DOI 10.1111/j.1432-0436.2006.00143.x; Liou YC, 2002, P NATL ACAD SCI USA, V99, P1335, DOI 10.1073/pnas.032404099; Liu Y, 2008, STEM CELLS, V26, P2475, DOI 10.1634/stemcells.2008-0269; Lu KP, 1996, NATURE, V380, P544; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu PJ, 2002, J BIOL CHEM, V277, P2381, DOI 10.1074/jbc.C100228200; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Moretto-Zita M, 2010, P NATL ACAD SCI USA, V107, P13312, DOI 10.1073/pnas.1005847107; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Prudhomme W, 2004, P NATL ACAD SCI USA, V101, P2900, DOI 10.1073/pnas.0308768101; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Ryo A, 2007, J BIOL CHEM, V282, P36671, DOI 10.1074/jbc.M704145200; Shen ZJ, 2009, NAT IMMUNOL, V10, P257, DOI 10.1038/ni.1697; SUN H, 1994, TRENDS BIOCHEM SCI, V19, P480, DOI 10.1016/0968-0004(94)90134-1; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi Kazutoshi, 2006, V329, P449; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yamada M, 2010, HUM MOL GENET, V19, P480, DOI 10.1093/hmg/ddp512; Yang HM, 2005, J CELL BIOCHEM, V96, P821, DOI 10.1002/jcb.20588; Zhang ZH, 2007, FASEB J, V21, P3042, DOI 10.1096/fj.06-6914com	35	38	41	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11593	11603		10.1074/jbc.M110.187989	http://dx.doi.org/10.1074/jbc.M110.187989			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21296877	Green Published, hybrid			2022-12-27	WOS:000288797100069
J	Dowil, RT; Lu, XL; Saracco, SA; Vierstra, RD; Downes, BP				Dowil, Rebecca T.; Lu, Xiaolong; Saracco, Scott A.; Vierstra, Richard D.; Downes, Brian P.			Arabidopsis Membrane-anchored Ubiquitin-fold (MUB) Proteins Localize a Specific Subset of Ubiquitin-conjugating (E2) Enzymes to the Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL-CHARACTERIZATION; NONCOVALENT INTERACTION; 26S PROTEASOME; BINDING; COMPLEX; SYSTEM; FAMILY; UBC9; CONSERVATION; VARIANT	The covalent attachment of ubiquitin (Ub) to various intracellular proteins plays important roles in altering the function, localization, processing, and degradation of the modified target. A minimal ubiquitylation pathway uses a three-enzyme cascade (E1, E2, and E3) to activate Ub and select target proteins for modification. Although diverse E3 families provide much of the target specificity, several factors have emerged recently that coordinate the subcellular localization of the ubiquitylation machinery. Here, we show that the family of membrane-anchored ubiquitin-fold (MUB) proteins recruits and docks specific E2s to the plasma membrane. Protein interaction screens with Arabidopsis MUBs revealed that interacting E2s are limited to a well defined subgroup that is phylogenetically related to human UbcH5 and yeast Ubc4/5 families. MUBs appear to interact noncovalently with an E2 surface opposite the active site that forms a covalent linkage with Ub. Bimolecular fluorescence complementation demonstrated that MUBs bind simultaneously to the plasma membrane via a prenyl tail and to the E2 in planta. These findings suggest that MUBs contribute subcellular specificity to ubiquitylation by docking the conjugation machinery to the plasma membrane.	[Dowil, Rebecca T.; Lu, Xiaolong; Downes, Brian P.] St Louis Univ, Dept Biol, St Louis, MO 63103 USA; [Vierstra, Richard D.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Saracco, Scott A.] Monsanto Co, St Louis, MO 63017 USA	Saint Louis University; University of Wisconsin System; University of Wisconsin Madison; Monsanto	Downes, BP (corresponding author), St Louis Univ, Dept Biol, 3507 Laclede Ave, St Louis, MO 63103 USA.	bdownes1@slu.edu	Lu, Xiaolong/Q-5252-2016	Lu, Xiaolong/0000-0003-1730-4644	Saint Louis University; Beaumont faculty development grant; National Science Foundation [MCB-0115870]	Saint Louis University; Beaumont faculty development grant; National Science Foundation(National Science Foundation (NSF))	This work was supported by Saint Louis University and a Beaumont faculty development grant (to B.P.D.).; Supported by National Science Foundation Arabidopsis 2010 Program Grant MCB-0115870.	Bencsath KP, 2002, J BIOL CHEM, V277, P47938, DOI 10.1074/jbc.M207442200; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Brzovic PS, 2006, CELL CYCLE, V5, P2867, DOI 10.4161/cc.5.24.3592; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Busso D, 2005, ANAL BIOCHEM, V343, P313, DOI 10.1016/j.ab.2005.05.015; Capili AD, 2007, J MOL BIOL, V369, P608, DOI 10.1016/j.jmb.2007.04.006; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Citovsky V, 2006, J MOL BIOL, V362, P1120, DOI 10.1016/j.jmb.2006.08.017; David Y, 2010, J BIOL CHEM, V285, P8595, DOI 10.1074/jbc.M109.089003; de la Cruz NB, 2007, PROTEIN SCI, V16, P1479, DOI 10.1110/ps.072834007; Dinkins RD, 2003, PLANT SCI, V165, P33, DOI 10.1016/S0168-9452(03)00123-7; Downes B, 2005, BIOCHEM SOC T, V33, P393, DOI 10.1042/BST0330393; Downes BP, 2006, J BIOL CHEM, V281, P27145, DOI 10.1074/jbc.M602283200; Duda DM, 2007, J MOL BIOL, V369, P619, DOI 10.1016/j.jmb.2007.04.007; Dupre S, 2004, BBA-MOL CELL RES, V1695, P89, DOI 10.1016/j.bbamcr.2004.09.024; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Farmer LM, 2010, PLANT CELL, V22, P124, DOI 10.1105/tpc.109.072660; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fu HY, 2010, TRENDS PLANT SCI, V15, P375, DOI 10.1016/j.tplants.2010.03.004; Fuchs BC, 2007, AM J PHYSIOL-CELL PH, V293, pC55, DOI 10.1152/ajpcell.00330.2006; Gagne JM, 2002, P NATL ACAD SCI USA, V99, P11519, DOI 10.1073/pnas.162339999; Geng JF, 2008, EMBO REP, V9, P859, DOI 10.1038/embor.2008.163; GIROD PA, 1993, J BIOL CHEM, V268, P955; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; James P, 1996, GENETICS, V144, P1425; Khan BR, 2010, PLANT PHYSIOL, V154, P1602, DOI 10.1104/pp.110.162479; Knipscheer P, 2007, EMBO J, V26, P2797, DOI 10.1038/sj.emboj.7601711; Koller A, 1999, J CELL BIOL, V146, P99, DOI 10.1083/jcb.146.1.99; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Kostova Z, 2009, J CELL SCI, V122, P1374, DOI 10.1242/jcs.044255; Kraft E, 2005, PLANT PHYSIOL, V139, P1597, DOI 10.1104/pp.105.067983; Kragt A, 2005, J BIOL CHEM, V280, P7867, DOI 10.1074/jbc.M413553200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lau OS, 2009, BIOCHEM J, V418, P683, DOI 10.1042/BJ20081943; Lee I, 2008, CELL, V134, P268, DOI 10.1016/j.cell.2008.05.046; Lewis MJ, 2006, J BIOMOL NMR, V34, P89, DOI 10.1007/s10858-005-5583-6; Liu LJ, 2010, PLANT J, V61, P893, DOI 10.1111/j.1365-313X.2009.04109.x; Liu Q, 1999, J BIOL CHEM, V274, P16979, DOI 10.1074/jbc.274.24.16979; LIVINGSTONE CD, 1993, COMPUT APPL BIOSCI, V9, P745; Platta HW, 2007, TRENDS CELL BIOL, V17, P474, DOI 10.1016/j.tcb.2007.06.009; Rambaut A, 1996, SEQUENCE ALIGNMENT S; Ravid T, 2007, NAT CELL BIOL, V9, P422, DOI 10.1038/ncb1558; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rossignol P, 2007, J CELL SCI, V120, P3678, DOI 10.1242/jcs.004119; Sakata E, 2010, STRUCTURE, V18, P138, DOI 10.1016/j.str.2009.11.007; Sloper-Mould KE, 2001, J BIOL CHEM, V276, P30483, DOI 10.1074/jbc.M103248200; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Stone SL, 2005, PLANT PHYSIOL, V137, P13, DOI 10.1104/pp.104.052423; Swofford D.L., 2003, PAUP VERSION 40 B10; Tatham MH, 2003, BIOCHEMISTRY-US, V42, P9959, DOI 10.1021/bi0345283; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Vinarov DA, 2004, NAT METHODS, V1, P149, DOI 10.1038/NMETH716; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wen R, 2008, PLANT CELL, V20, P213, DOI 10.1105/tpc.107.051862; Woelk T, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-11; Zolman BK, 2005, PLANT CELL, V17, P3422, DOI 10.1105/tpc.105.035691	58	24	24	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14913	14921		10.1074/jbc.M110.158808	http://dx.doi.org/10.1074/jbc.M110.158808			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21345795	hybrid, Green Published			2022-12-27	WOS:000289788300021
J	Marat, AL; Dokainish, H; McPherson, PS				Marat, Andrea L.; Dokainish, Hatem; McPherson, Peter S.			DENN Domain Proteins: Regulators of Rab GTPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							GUANINE-NUCLEOTIDE EXCHANGE; MYOTUBULARIN-RELATED PROTEIN-2; CLATHRIN-COATED VESICLES; GTP-BINDING PROTEINS; MARIE-TOOTH-DISEASE; CANINE KIDNEY-CELLS; DEATH DOMAIN; PLASMA-MEMBRANE; RAB6-INTERACTING PROTEIN-1; CAENORHABDITIS-ELEGANS	The DENN domain is a common, evolutionarily ancient, and conserved protein module, yet it has gone largely unstudied; until recently, little was known regarding its functional roles. New studies reveal that various DENN domains interact directly with members of the Rab family of small GTPases and that DENN domains function enzymatically as Rab-specific guanine nucleotide exchange factors. Thus, DENN domain proteins appear to be generalized regulators of Rab function. Study of these proteins will provide new insights into Rab-mediated membrane trafficking pathways.	[Marat, Andrea L.; Dokainish, Hatem; McPherson, Peter S.] McGill Univ, Dept Neurol & Neurosurg, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada	McGill University	McPherson, PS (corresponding author), McGill Univ, Dept Neurol & Neurosurg, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada.	peter.mcpherson@mcgill.ca		Marat, Andrea/0000-0001-8571-4253				Allaire PD, 2006, J NEUROSCI, V26, P13202, DOI 10.1523/JNEUROSCI.4608-06.2006; Allaire PD, 2010, MOL CELL, V37, P370, DOI 10.1016/j.molcel.2009.12.037; Azzedine H, 2003, AM J HUM GENET, V72, P1141, DOI 10.1086/375034; Babbey CM, 2006, MOL BIOL CELL, V17, P3156, DOI 10.1091/mbc.E05-08-0799; Becker CE, 2009, J BIOL CHEM, V284, P34531, DOI 10.1074/jbc.M109.046102; Berger P, 2006, HUM MOL GENET, V15, P569, DOI 10.1093/hmg/ddi473; Bloethner S, 2008, GENE CHROMOSOME CANC, V47, P1076, DOI 10.1002/gcc.20598; Blondeau F, 2000, HUM MOL GENET, V9, P2223, DOI 10.1093/oxfordjournals.hmg.a018913; Bolino A, 2000, NAT GENET, V25, P17, DOI 10.1038/75542; Carroll KS, 2001, SCIENCE, V292, P1373, DOI 10.1126/science.1056791; Ceccarelli DFJ, 2006, J BIOL CHEM, V281, P252, DOI 10.1074/jbc.M509188200; Cheng H, 2002, CYTOGENET GENOME RES, V97, P72, DOI 10.1159/000064047; Chevallier J, 2009, FEBS LETT, V583, P1096, DOI 10.1016/j.febslet.2009.03.012; Chow VTK, 1996, DNA SEQUENCE, V6, P263, DOI 10.3109/10425179609020873; Coppola T, 2002, BIOCHEM J, V362, P273, DOI 10.1042/0264-6021:3620273; Del Villar K, 2004, P NATL ACAD SCI USA, V101, P4210, DOI 10.1073/pnas.0307349101; Delprato A, 2004, CELL, V118, P607, DOI 10.1016/j.cell.2004.08.009; Denef N, 2008, DEV CELL, V14, P354, DOI 10.1016/j.devcel.2007.12.012; Efimova EV, 2004, ONCOGENE, V23, P1076, DOI 10.1038/sj.onc.1207210; FERREIRA MA, 2010, EUR J HUM G IN PRESS; Figueiredo AC, 2008, J BIOL CHEM, V283, P23209, DOI 10.1074/jbc.M804134200; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Fukuda M, 2005, J BIOCHEM, V137, P9, DOI 10.1093/jb/mvi002; Gao YJ, 2010, J BIOL CHEM, V285, P17938, DOI 10.1074/jbc.M109.086553; Giannandrea M, 2010, AM J HUM GENET, V86, P185, DOI 10.1016/j.ajhg.2010.01.011; Girard M, 2005, MOL CELL PROTEOMICS, V4, P1145, DOI 10.1074/mcp.M500043-MCP200; Gohring I, 2010, J MED GENET, V47, P91, DOI 10.1136/jmg.2009.069799; Groves JT, 2010, NAT STRUCT MOL BIOL, V17, P659, DOI 10.1038/nsmb.1844; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Harsay E, 2007, MOL BIOL CELL, V18, P1203, DOI 10.1091/mbc.E06-11-1035; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hsu C, 2010, J CELL BIOL, V189, P223, DOI 10.1083/jcb.200911018; Hu YF, 2005, DIABETOLOGIA, V48, P2576, DOI 10.1007/s00125-005-0037-y; Hubbs AE, 1999, ONCOGENE, V18, P2519, DOI 10.1038/sj.onc.1202554; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; Iida H, 2005, MOL REPROD DEV, V71, P178, DOI 10.1002/mrd.20294; JANOUEIXLEROSEY I, 1995, J BIOL CHEM, V270, P14801, DOI 10.1074/jbc.270.24.14801; Kanno E, 2010, TRAFFIC, V11, P491, DOI 10.1111/j.1600-0854.2010.01038.x; Kim SA, 2003, P NATL ACAD SCI USA, V100, P4492, DOI 10.1073/pnas.0431052100; Kloer DP, 2010, J BIOL CHEM, V285, P7794, DOI 10.1074/jbc.M109.069088; Knodler A, 2010, P NATL ACAD SCI USA, V107, P6346, DOI 10.1073/pnas.1002401107; Kouranti I, 2006, CURR BIOL, V16, P1719, DOI 10.1016/j.cub.2006.07.020; Kurada BRVVSN, 2009, J BIOL CHEM, V284, P13533, DOI 10.1074/jbc.M808554200; Laporte J, 2001, TRENDS GENET, V17, P221, DOI 10.1016/S0168-9525(01)02245-4; Lee MTG, 2009, TRAFFIC, V10, P1377, DOI 10.1111/j.1600-0854.2009.00942.x; Lee SH, 2008, FEBS LETT, V582, P4107, DOI 10.1016/j.febslet.2008.11.008; Levivier E, 2001, BIOCHEM BIOPH RES CO, V287, P688, DOI 10.1006/bbrc.2001.5652; Li LC, 2008, CANCER RES, V68, P7352, DOI 10.1158/0008-5472.CAN-07-6311; LICHY JH, 1992, CELL GROWTH DIFFER, V3, P541; Lippe R, 2001, MOL BIOL CELL, V12, P2219, DOI 10.1091/mbc.12.7.2219; Lumb J.H., 2010, MOL BIOL CELL S, V21, P1264; Mahoney TR, 2006, MOL BIOL CELL, V17, P2617, DOI 10.1091/mbc.E05-12-1170; Majidi M, 1998, J BIOL CHEM, V273, P16608, DOI 10.1074/jbc.273.26.16608; Majidi M, 2000, J BIOL CHEM, V275, P6560, DOI 10.1074/jbc.275.9.6560; Marat AL, 2010, NEW ENGL J MED, V363, P988, DOI 10.1056/NEJMc1002262; Marat AL, 2010, J BIOL CHEM, V285, P10627, DOI 10.1074/jbc.M109.050930; Miserey-Lenkei S, 2007, TRAFFIC, V8, P1385, DOI 10.1111/j.1600-0854.2007.00612.x; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Nicot AS, 2008, TRAFFIC, V9, P1240, DOI 10.1111/j.1600-0854.2008.00754.x; Niwa S, 2008, NAT CELL BIOL, V10, P1269, DOI 10.1038/ncb1785; Nordmann M, 2010, CURR BIOL, V20, P1654, DOI 10.1016/j.cub.2010.08.002; OLKKONEN VM, 1993, J CELL SCI, V106, P1249; Patino-Lopez G, 2008, J BIOL CHEM, V283, P18323, DOI 10.1074/jbc.M800056200; Pavlos NJ, 2010, J NEUROSCI, V30, P13441, DOI 10.1523/JNEUROSCI.0907-10.2010; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Postel EH, 1996, P NATL ACAD SCI USA, V93, P6892, DOI 10.1073/pnas.93.14.6892; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; Ramaswamy M, 2004, ONCOGENE, V23, P6083, DOI 10.1038/sj.onc.1207804; Recacha R, 2009, STRUCTURE, V17, P21, DOI 10.1016/j.str.2008.10.014; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Ritter B, 2007, EMBO J, V26, P4066, DOI 10.1038/sj.emboj.7601836; Rivera-Molina FE, 2009, P NATL ACAD SCI USA, V106, P14408, DOI 10.1073/pnas.0906536106; Robinson FL, 2005, J BIOL CHEM, V280, P31699, DOI 10.1074/jbc.M505159200; Rossman KL, 2002, EMBO J, V21, P1315, DOI 10.1093/emboj/21.6.1315; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Sato M, 2008, EMBO J, V27, P1183, DOI 10.1038/emboj.2008.54; Schievella AR, 1997, J BIOL CHEM, V272, P12069, DOI 10.1074/jbc.272.18.12069; Schuck S, 2007, TRAFFIC, V8, P47, DOI 10.1111/j.1600-0854.2006.00506.x; Semova N, 2003, GENOMICS, V82, P343, DOI 10.1016/S0888-7543(03)00103-4; Senderek J, 2003, HUM MOL GENET, V12, P349, DOI 10.1093/hmg/ddg030; Shi AB, 2010, MOL BIOL CELL, V21, P2930, DOI 10.1091/mbc.E10-02-0149; Shim J, 2010, MOL CELL BIOL, V30, P1421, DOI 10.1128/MCB.01463-09; Sleiman PMA, 2010, NEW ENGL J MED, V362, P36, DOI 10.1056/NEJMoa0901867; Stankovic T, 1997, GENOMICS, V40, P267, DOI 10.1006/geno.1996.4595; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Subramanian M, 2009, J CLIN ENDOCR METAB, V94, P1467, DOI 10.1210/jc.2008-2378; Tanaka M, 2001, MOL BIOL CELL, V12, P1421, DOI 10.1091/mbc.12.5.1421; Telliez JB, 2000, BBA-PROTEIN STRUCT M, V1478, P280, DOI 10.1016/S0167-4838(00)00029-7; Wada M, 1997, J BIOL CHEM, V272, P3875, DOI 10.1074/jbc.272.7.3875; Walseng E, 2008, J BIOL CHEM, V283, P14717, DOI 10.1074/jbc.M801070200; Yoshimura S, 2010, J CELL BIOL, V191, P367, DOI 10.1083/jcb.201008051; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang J, 2009, SCIENCE, V325, P1250, DOI 10.1126/science.1174921; Zhang Y, 1998, P NATL ACAD SCI USA, V95, P2586, DOI 10.1073/pnas.95.5.2586	95	165	177	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					13791	13800		10.1074/jbc.R110.217067	http://dx.doi.org/10.1074/jbc.R110.217067			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21330364	Green Published, hybrid			2022-12-27	WOS:000289556200001
J	Rivera, CR; Kollman, JM; Polka, JK; Agard, DA; Mullins, RD				Rivera, Christopher R.; Kollman, Justin M.; Polka, Jessica K.; Agard, David A.; Mullins, R. Dyche			Architecture and Assembly of a Divergent Member of the ParM Family of Bacterial Actin-like Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SEQUENCE ALIGNMENT; DNA SEGREGATION; PLASMID SEGREGATION; DYNAMIC INSTABILITY; KINETIC EVIDENCE; FILAMENTS; CELL; POLYMERIZATION; HOMOLOG; ENDS	Eubacteria and archaea contain a variety of actin-like proteins (ALPs) that form filaments with surprisingly diverse architectures, assembly dynamics, and cellular functions. Although there is much data supporting differences between ALP families, there is little data regarding conservation of structure and function within these families. We asked whether the filament architecture and biochemical properties of the best-understood prokaryotic actin, ParM from plasmid R1, are conserved in a divergent member of the ParM family from plasmid pB171. Previous work demonstrated that R1 ParM assembles into filaments that are structurally distinct from actin and the other characterized ALPs. They also display three biophysical properties thought to be essential for DNA segregation: 1) rapid spontaneous nucleation, 2) symmetrical elongation, and 3) dynamic instability. We used microscopic and biophysical techniques to compare and contrast the architecture and assembly of these related proteins. Despite being only 41% identical, R1 and pB171 ParMs polymerize into nearly identical filaments with similar assembly dynamics. Conservation of the core assembly properties argues for their importance in ParM-mediated DNA segregation and suggests that divergent DNA-segregating ALPs with different assembly properties operate via different mechanisms.	[Rivera, Christopher R.; Polka, Jessica K.; Mullins, R. Dyche] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Kollman, Justin M.; Agard, David A.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Kollman, Justin M.; Agard, David A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Mullins, RD (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	dyche@mullinslab.ucsf.edu	Kollman, Justin/F-3012-2012	Polka, Jessica/0000-0001-6610-9293	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031627] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Becker E, 2006, EMBO J, V25, P5919, DOI 10.1038/sj.emboj.7601443; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Campbell CS, 2007, J CELL BIOL, V179, P1059, DOI 10.1083/jcb.200708206; Cer RZ, 2009, NUCLEIC ACIDS RES, V37, pW441, DOI 10.1093/nar/gkp253; COOPER JA, 1983, BIOCHEMISTRY-US, V22, P2193, DOI 10.1021/bi00278a021; Daniel RA, 2003, CELL, V113, P767, DOI 10.1016/S0092-8674(03)00421-5; Derman AI, 2009, MOL MICROBIOL, V73, P534, DOI 10.1111/j.1365-2958.2009.06771.x; Dion V, 2010, CURR OPIN CELL BIOL, V22, P383, DOI 10.1016/j.ceb.2010.02.006; Ebersbach G, 2001, P NATL ACAD SCI USA, V98, P15078, DOI 10.1073/pnas.261569598; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Egelman EH, 2000, ULTRAMICROSCOPY, V85, P225, DOI 10.1016/S0304-3991(00)00062-0; ERICKSON HP, 1995, CELL, V80, P367, DOI 10.1016/0092-8674(95)90486-7; Esue O, 2006, J BACTERIOL, V188, P968, DOI 10.1128/JB.188.3.968-976.2006; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Flyvbjerg H, 1996, P NATL ACAD SCI USA, V93, P5975, DOI 10.1073/pnas.93.12.5975; Galkin VE, 2009, STRUCTURE, V17, P1253, DOI 10.1016/j.str.2009.07.008; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; Hara F, 2007, J BACTERIOL, V189, P2039, DOI 10.1128/JB.01454-06; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Komeili A, 2006, SCIENCE, V311, P242, DOI 10.1126/science.1123231; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Moller-Jensen J, 2003, MOL CELL, V12, P1477, DOI 10.1016/S1097-2765(03)00451-9; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; Needleman DJ, 2008, CURR BIOL, V18, pR212, DOI 10.1016/j.cub.2008.01.003; NISHIDA E, 1983, J BIOCHEM-TOKYO, V93, P1011, DOI 10.1093/oxfordjournals.jbchem.a134224; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; OOSAWA F, 1962, J MOL BIOL, V4, P10, DOI 10.1016/S0022-2836(62)80112-0; Orlova A, 2007, NAT STRUCT MOL BIOL, V14, P921, DOI 10.1038/nsmb1300; Polka JK, 2009, J BACTERIOL, V191, P6219, DOI 10.1128/JB.00676-09; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; Popp D, 2010, J BIOL CHEM, V285, P10130, DOI 10.1074/jbc.M109.071613; Pradel N, 2006, P NATL ACAD SCI USA, V103, P17485, DOI 10.1073/pnas.0603760103; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schumacher MA, 2008, BIOCHEM J, V412, P1, DOI 10.1042/BJ20080359; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teubner A, 1998, BIOCHEMISTRY-US, V37, P7532, DOI 10.1021/bi972176s; Tobe T, 1999, INFECT IMMUN, V67, P5455, DOI 10.1128/IAI.67.10.5455-5462.1999; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; van den Ent F, 2002, EMBO J, V21, P6935, DOI 10.1093/emboj/cdf672; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wen KK, 2002, J BIOL CHEM, V277, P41101, DOI 10.1074/jbc.M204025200	43	19	19	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14282	14290		10.1074/jbc.M110.203828	http://dx.doi.org/10.1074/jbc.M110.203828			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21339292	Green Published, hybrid			2022-12-27	WOS:000289556200051
J	Dolai, S; Pal, S; Yadav, RK; Adak, S				Dolai, Subhankar; Pal, Swati; Yadav, Rajesh K.; Adak, Subrata			Endoplasmic Reticulum Stress-induced Apoptosis in Leishmania through Ca2+-dependent and Caspase-independent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; UNFOLDED PROTEIN RESPONSE; ENDONUCLEASE-G; ASCORBATE-PEROXIDASE; OXIDATIVE STRESS; CYTOCHROME-C; TUNICAMYCIN; ER; MITOCHONDRIA; DONOVANI	Numerous reports have shown that mitochondrial dysfunctions play a major role in apoptosis of Leishmania parasites, but the endoplasmic reticulum (ER) stress-induced apoptosis in Leishmania remains largely unknown. In this study, we investigate ER stress-induced apoptotic pathways in Leishmania major using tunicamycin as an ER stress inducer. ER stress activates the expression of ER-localized chaperone protein BIP/GRP78 (binding protein/identical to the 78-kDa glucose-regulated protein) with concomitant generation of intracellular reactive oxygen species. Upon exposure to ER stress, the elevation of cytosolic Ca2+ level is observed due to release of Ca2+ from internal stores. Increase in cytosolic Ca2+ causes mitochondrial membrane potential depolarization and ATP loss as ablation of Ca2+ by blocking voltage-gated cation channels with verapamil preserves mitochondrial membrane potential and cellular ATP content. Furthermore, ER stress-induced reactive oxygen species (ROS)-dependent release of cytochrome c and endonuclease G from mitochondria to cytosol and subsequent translocation of endonuclease G to nucleus are observed. Inhibition of caspase-like proteases with the caspase inhibitor benzyloxycarbonyl-VAD-fluoromethyl ketone or metacaspase inhibitor antipain does not prevent nuclear DNA fragmentation and phosphatidylserine exposure. Conversely, significant protection in tunicamycin-induced DNA degradation and phosphatidylserine exposure was achieved by either pretreatment of antioxidants (N-acetyl-L-cysteine, GSH, and L-cysteine), chemical chaperone (4-phenylbutyric acid), or addition of Ca2+ chelator (1,2-bis(2-aminophenoxy)ethane-N,N,N,N-tetraacetic acidacetoxymethyl ester). Taken together, these data strongly demonstrate that ER stress-induced apoptosis in L. major is dependent on ROS and Ca2+-induced mitochondrial toxicity but independent of caspase-like proteases.	[Dolai, Subhankar; Pal, Swati; Yadav, Rajesh K.; Adak, Subrata] Indian Inst Chem Biol, Div Struct Biol & Bioinformat, Kolkata 700032, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Adak, S (corresponding author), Indian Inst Chem Biol, Div Struct Biol & Bioinformat, 4 Raja SC Mullick Rd, Kolkata 700032, India.	adaks@iicb.res.in		Pal, Swati/0000-0001-6179-4316; YADAV, RAJESH/0000-0002-4239-0428	Council of Scientific and Industrial Research [NWP 0038]	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Council of Scientific and Industrial Research Project NWP 0038 and Council of Scientific and Industrial Research fellowships (to S. D., R. K. Y., and S. P.).	Adak S, 2005, BIOCHEM J, V390, P465, DOI 10.1042/BJ20050311; Arnoult D, 2002, CELL DEATH DIFFER, V9, P65, DOI 10.1038/sj.cdd.4400951; Atlante A, 2000, J BIOL CHEM, V275, P37159, DOI 10.1074/jbc.M002361200; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; BoseDasgupta S, 2008, CELL DEATH DIFFER, V15, P1629, DOI 10.1038/cdd.2008.85; Boya P, 2002, CELL DEATH DIFFER, V9, P465, DOI 10.1038/sj.cdd.4401006; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Chae HJ, 2004, MOL CELL, V15, P355, DOI 10.1016/j.molcel.2004.06.038; COTE J, 1993, SCIENCE, V261, P765, DOI 10.1126/science.7688144; DAGGER F, 1984, BIOL CELL, V50, P173, DOI 10.1111/j.1768-322X.1984.tb00264.x; Das M, 2001, J CELL SCI, V114, P2461; Datta R, 2007, P NATL ACAD SCI USA, V104, P19989, DOI 10.1073/pnas.0708725104; Delom F, 2007, CELL DEATH DIFFER, V14, P586, DOI 10.1038/sj.cdd.4402012; Deniaud A, 2008, ONCOGENE, V27, P285, DOI 10.1038/sj.onc.1210638; Dolai S, 2008, FREE RADICAL BIO MED, V45, P1520, DOI 10.1016/j.freeradbiomed.2008.08.029; DOTAI S, 2009, EUKARYOT CELL, V8, P1721; Dricu A, 1997, CANCER RES, V57, P543; ELBEIN AD, 1987, ANNU REV BIOCHEM, V56, P497, DOI 10.1146/annurev.biochem.56.1.497; Gannavaram S, 2008, J CELL SCI, V121, P99, DOI 10.1242/jcs.014050; Gavilan MP, 2006, NEUROBIOL AGING, V27, P973, DOI 10.1016/j.neurobiolaging.2005.05.010; Goldshmidt H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000731; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hacki J, 2000, ONCOGENE, V19, P2286, DOI 10.1038/sj.onc.1203592; Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025; Ishihara Y, 2006, J BIOL CHEM, V281, P6726, DOI 10.1074/jbc.M510382200; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; KINK JA, 1987, P NATL ACAD SCI USA, V84, P1253, DOI 10.1073/pnas.84.5.1253; Kulkarni MM, 2009, J BIOL CHEM, V284, P15496, DOI 10.1074/jbc.M809079200; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lee N, 2007, EUKARYOT CELL, V6, P1745, DOI 10.1128/EC.00123-07; Lemasters JJ, 1999, J BIOENERG BIOMEMBR, V31, P305, DOI 10.1023/A:1005419617371; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Moss CX, 2007, FEBS LETT, V581, P5635, DOI 10.1016/j.febslet.2007.11.009; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; NOLAN TJ, 1985, MOL BIOCHEM PARASIT, V16, P127, DOI 10.1016/0166-6851(85)90081-7; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Oyadomari S, 2002, APOPTOSIS, V7, P335, DOI 10.1023/A:1016175429877; Pal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011271; Parrish J, 2001, NATURE, V412, P90, DOI 10.1038/35083608; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Sen N, 2004, CELL DEATH DIFFER, V11, P924, DOI 10.1038/sj.cdd.4401435; Strauss G, 2008, CELL DEATH DIFFER, V15, P332, DOI 10.1038/sj.cdd.4402272; Sudhandiran G, 2003, J BIOL CHEM, V278, P25120, DOI 10.1074/jbc.M301975200; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; van Loo G, 2001, CELL DEATH DIFFER, V8, P1136, DOI 10.1038/sj.cdd.4400944; Van Zandbergen G, 2007, AUTOIMMUNITY, V40, P349, DOI 10.1080/08916930701356960; van Zandbergen G, 2006, P NATL ACAD SCI USA, V103, P13837, DOI 10.1073/pnas.0600843103; Zangger H, 2002, CELL DEATH DIFFER, V9, P1126, DOI 10.1038/sj.cdd.4401071; Zhang KZ, 2004, J BIOL CHEM, V279, P25935, DOI 10.1074/jbc.R400008200	52	90	99	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13638	13646		10.1074/jbc.M110.201889	http://dx.doi.org/10.1074/jbc.M110.201889			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21330370	hybrid, Green Published			2022-12-27	WOS:000289282200082
J	Jia, LX; Linder, ME; Blumer, KJ				Jia, Lixia; Linder, Maurine E.; Blumer, Kendall J.			G(i/o) Signaling and the Palmitoyltransferase DHHC2 Regulate Palmitate Cycling and Shuttling of RGS7 Family-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE ACCELERATING PROTEIN; MEMBRANE ANCHOR; PLASMA-MEMBRANE; PALMITOYLATION; R7BP; COMPLEXES; R9AP; LOCALIZATION; IDENTIFICATION; STABILITY	R7BP (RGS7 family-binding protein) has been proposed to function in neurons as a palmitoylation-regulated protein that shuttles heterodimeric, G(i/o) alpha-specific GTPase-activating protein (GAP) complexes composed of G beta 5 and RGS7 (R7) isoforms between the plasma membrane and nucleus. To test this hypothesis we studied R7BP palmitoylation and localization in neuronal cells. We report that R7 BP undergoes dynamic, signal-regulated palmitate turnover; the palmitoyltransferase DHHC2 mediates de novo and turnover palmitoylation of R7BP; DHHC2 silencing redistributes R7BP from the plasma membrane to the nucleus; and G(i/o) signaling inhibits R7BP depalmitoylation whereas G(i/o) inactivation induces nuclear accumulation of R7BP. In concert with previous evidence, our findings suggest that agonist-induced changes in pahnitoylation state facilitate GAP action by (i) promoting Gi alpha depalmitoylation to create optimal GAP substrates, and (ii) inhibiting R7BP depalmitoylation to stabilize membrane association of R7-G beta 5 GAP complexes. Regulated palmitate turnover may also enable R7BP-bound GAPs to shuttle between sites of low and high G(i/o) activity or the plasma membrane and nucleus, potentially providing spatio-temporal control of signaling by G(i/o)-coupled receptors.	[Jia, Lixia; Blumer, Kendall J.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Linder, Maurine E.] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA	Washington University (WUSTL); Cornell University	Blumer, KJ (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, Box 8228,660 S Euclid Ave, St Louis, MO 63110 USA.	kblumer@wustl.edu	Blumer, Kendall J/C-5268-2012; Linder, Maurine/AAU-9999-2021	Linder, Maurine/0000-0003-2202-9712	National Institutes of Health [GM044592, HL075632, GM051466]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051466, R01GM044592] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Grants GM044592 and HL075632 (to K. J. B.), and GM051466 (to M. E. L.) from the National Institutes of Health.	Anderson GR, 2007, J BIOL CHEM, V282, P4772, DOI 10.1074/jbc.M610518200; Anderson GR, 2010, NEUROPSYCHOPHARMACOL, V35, P1040, DOI 10.1038/npp.2009.212; Anderson GR, 2009, CELL BIOCHEM BIOPHYS, V54, P33, DOI 10.1007/s12013-009-9052-9; Cabrera JL, 1998, BIOCHEM BIOPH RES CO, V249, P898, DOI 10.1006/bbrc.1998.9218; Chen CA, 2000, J BIOL CHEM, V275, P23516, DOI 10.1074/jbc.M003439200; Chen CK, 2000, NATURE, V403, P557, DOI 10.1038/35000601; Chen FS, 2010, INVEST OPHTH VIS SCI, V51, P686, DOI 10.1167/iovs.09-4084; Chisari M, 2007, J BIOL CHEM, V282, P24092, DOI 10.1074/jbc.M704246200; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Drenan RM, 2005, J CELL BIOL, V169, P623, DOI 10.1083/jcb.200502007; Drenan RM, 2006, J BIOL CHEM, V281, P28222, DOI 10.1074/jbc.M604428200; Duncan JA, 2002, J BIOL CHEM, V277, P31740, DOI 10.1074/jbc.M202505200; Fernandez-Hernando C, 2006, J CELL BIOL, V174, P369, DOI 10.1083/jcb.200601051; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Grabowska D, 2008, NEUROSCIENCE, V151, P969, DOI 10.1016/j.neuroscience.2007.11.045; He JCJ, 2006, CAN J PHYSIOL PHARM, V84, P687, DOI 10.1139/Y06-025; He YH, 2009, J LIPID RES, V50, P398, DOI 10.1194/jlr.M800360-JLR200; Hooks SB, 2003, J BIOL CHEM, V278, P10087, DOI 10.1074/jbc.M211382200; Hooks SB, 2008, BIOCHEM PHARMACOL, V75, P76, DOI 10.1016/j.bcp.2007.07.045; Hu G, 2002, P NATL ACAD SCI USA, V99, P9755, DOI 10.1073/pnas.152094799; Iwanaga T, 2009, PROG LIPID RES, V48, P117, DOI 10.1016/j.plipres.2009.02.001; Jayaraman M, 2009, TRENDS PHARMACOL SCI, V30, P17, DOI 10.1016/j.tips.2008.10.002; Jeffrey BG, 2010, VISUAL NEUROSCI, V27, P9, DOI 10.1017/S0952523809990319; KASLOW HR, 1992, FASEB J, V6, P2684, DOI 10.1096/fasebj.6.9.1612292; Keresztes G, 2004, J BIOL CHEM, V279, P1581, DOI 10.1074/jbc.C300456200; Kim JH, 2009, LUNG CANCER, V64, pS30, DOI 10.1016/S0169-5002(09)70180-1; Martemyanov KA, 2005, J BIOL CHEM, V280, P5133, DOI 10.1074/jbc.C400596200; Mojumder DK, 2009, J NEUROSCI, V29, P7753, DOI 10.1523/JNEUROSCI.1794-09.2009; Nishiguchi KM, 2004, NATURE, V427, P75, DOI 10.1038/nature02170; Noritake J, 2009, J CELL BIOL, V186, P147, DOI 10.1083/jcb.200903101; Panicker LM, 2010, J NEUROCHEM, V113, P1101, DOI 10.1111/j.1471-4159.2010.06616.x; Planey SL, 2009, MOL BIOL CELL, V20, P1454, DOI 10.1091/mbc.E08-08-0849; Posner BA, 1999, J BIOL CHEM, V274, P31087, DOI 10.1074/jbc.274.43.31087; Posokhova E, 2010, CIRC RES, V107, P1350, DOI 10.1161/CIRCRESAHA.110.224212; Rahman Z, 2003, NEURON, V38, P941, DOI 10.1016/S0896-6273(03)00321-0; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Sharma C, 2008, MOL BIOL CELL, V19, P3415, DOI 10.1091/mbc.E07-11-1164; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Snow BE, 1998, P NATL ACAD SCI USA, V95, P13307, DOI 10.1073/pnas.95.22.13307; Song JH, 2007, MOL CELL NEUROSCI, V35, P311, DOI 10.1016/j.mcn.2007.03.006; Song JH, 2006, J BIOL CHEM, V281, P15361, DOI 10.1074/jbc.M600749200; Tsutsumi R, 2009, MOL CELL BIOL, V29, P435, DOI 10.1128/MCB.01144-08; Tu YP, 1997, SCIENCE, V278, P1132, DOI 10.1126/science.278.5340.1132; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Zachariou V, 2003, P NATL ACAD SCI USA, V100, P13656, DOI 10.1073/pnas.2232594100; Zeidman R, 2009, MOL MEMBR BIOL, V26, P32, DOI 10.1080/09687680802629329; Zhang JM, 2010, INVEST OPHTH VIS SCI, V51, P1121, DOI 10.1167/iovs.09-4163	49	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13695	13703		10.1074/jbc.M110.193763	http://dx.doi.org/10.1074/jbc.M110.193763			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21343290	Green Published, hybrid			2022-12-27	WOS:000289282200087
J	Montserrat, N; Garreta, E; Gonzalez, F; Gutierrez, J; Eguizabal, C; Ramos, V; Borros, S; Belmonte, JCI				Montserrat, Nuria; Garreta, Elena; Gonzalez, Federico; Gutierrez, Jordan; Eguizabal, Cristina; Ramos, Victor; Borros, Salvador; Izpisua Belmonte, Juan Carlos			Simple Generation of Human Induced Pluripotent Stem Cells Using Poly-beta-amino Esters As the Non-viral Gene Delivery System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOMATIC-CELLS; FIBROBLASTS; MOUSE; LIBRARY; ADULT; EXPRESSION; INDUCTION	Reprogramming of somatic cells to induced pluripotent stem (iPS) cells can be achieved by the delivery of a combination of transcription factors, including Oct4, Sox2, Klf4, and c-Myc. Retroviral and lentiviral vectors are commonly used to express these four reprogramming factors separately and obtain reprogrammed iPS cells. Although efficient and reproducible, these approaches involve the time-consuming and labor-intensive production of retroviral or lentiviral particles together with a high risk of working with potentially harmful viruses overexpressing potent oncogenes, such as c-Myc. Here, we describe a simple method to produce bona fide iPS cells from human fibroblasts using poly-beta-amino esters as the transfection reagent for the delivery of a single CAG-driven polycistronic plasmid expressing Oct4, Sox2, Klf4, c-Myc, and a GFP reporter gene (OSKMG). We demonstrate for the first time that poly-beta-amino esters can be used to deliver a single polycistronic reprogramming vector into human fibroblasts, achieving significantly higher transfection efficiency than with conventional transfection reagents. After a protocol of serial transfections using poly-beta-amino esters, we report a simple methodology to generate human iPS cells from human fibroblasts avoiding the use of viral vectors.	[Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Montserrat, Nuria; Garreta, Elena; Gonzalez, Federico; Eguizabal, Cristina; Izpisua Belmonte, Juan Carlos] Ctr Regenerat Med Barcelona, Barcelona 08003, Spain; [Gutierrez, Jordan; Ramos, Victor; Borros, Salvador] Univ Ramon Llull, Inst Quim Sarria, Grp Engn Mat, Barcelona 08017, Spain	Salk Institute; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; University of Barcelona; Universitat Ramon Llull; Institut Quimic de Sarria	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu	Garreta, Elena/AAQ-4739-2020; Borrós, Salvador/A-3950-2016; Montserrat, Nuria/F-3136-2016	Garreta, Elena/0000-0002-1071-9794; Borrós, Salvador/0000-0002-4003-0381; Montserrat, Nuria/0000-0002-1603-1755; Gonzalez Grassi, Federico/0000-0002-7147-2246; Eguizabal, Cristina/0000-0002-8738-2077; Ramos Perez, Victor/0000-0002-2099-5557	Sara Borrell program; Juan de La Cierva program; Swiss National Science Foundation; CIBER; MICINN; Fundacion Cellex; SanofiAventis; G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER	Sara Borrell program; Juan de La Cierva program; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); CIBER; MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Fundacion Cellex(Foundation CELLEX); SanofiAventis(Sanofi-Aventis); G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by a fellowship from the Sara Borrell program (to E. G.), by the Juan de La Cierva program (N. M.), the Swiss National Science Foundation (to F. G.), CIBER, MICINN, Fundacion Cellex, SanofiAventis, and the G. Harold and Leila Y. Mathers Charitable Foundation (to J. C. I. B.).	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Anderson DG, 2003, ANGEW CHEM INT EDIT, V42, P3153, DOI 10.1002/anie.200351244; Anderson DG, 2005, MOL THER, V11, P426, DOI 10.1016/j.ymthe.2004.11.015; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Eminli S, 2008, STEM CELLS, V26, P2467, DOI 10.1634/stemcells.2008-0317; Giorgetti A, 2009, CELL STEM CELL, V5, P353, DOI 10.1016/j.stem.2009.09.008; Gonzalez F, 2009, P NATL ACAD SCI USA, V106, P8918, DOI 10.1073/pnas.0901471106; Green JJ, 2008, NANO LETT, V8, P3126, DOI 10.1021/nl8012665; Green JJ, 2008, ACCOUNTS CHEM RES, V41, P749, DOI 10.1021/ar7002336; Green JJ, 2007, ADV MATER, V19, P2836, DOI 10.1002/adma.200700371; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Liu HS, 2008, CELL STEM CELL, V3, P587, DOI 10.1016/j.stem.2008.10.014; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Marson A, 2008, CELL STEM CELL, V3, P132, DOI 10.1016/j.stem.2008.06.019; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Raya A, 2008, COLD SH Q B, V73, P127, DOI 10.1101/sqb.2008.73.038; RYAN MD, 1994, EMBO J, V13, P928, DOI 10.1002/j.1460-2075.1994.tb06337.x; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yang F, 2009, GENE THER, V16, P533, DOI 10.1038/gt.2008.182; Yang F, 2010, P NATL ACAD SCI USA, V107, P3317, DOI 10.1073/pnas.0905432106; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005; Zhou WB, 2009, STEM CELLS, V27, P2667, DOI 10.1002/stem.201; Zugates GT, 2007, MOL THER, V15, P1306, DOI 10.1038/sj.mt.6300132	36	56	60	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.168013	http://dx.doi.org/10.1074/jbc.M110.168013			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21285354	Green Published, hybrid			2022-12-27	WOS:000289077500056
J	Bhattacharyya, S; Balakathiresan, NS; Dalgard, C; Gutti, U; Armistead, D; Jozwik, C; Srivastava, M; Pollard, HB; Biswas, R				Bhattacharyya, Sharmistha; Balakathiresan, Nagaraja S.; Dalgard, Clifton; Gutti, Usha; Armistead, David; Jozwik, Cathy; Srivastava, Meera; Pollard, Harvey B.; Biswas, Roopa			Elevated miR-155 Promotes Inflammation in Cystic Fibrosis by Driving Hyperexpression of Interleukin-8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILITY; MICRORNA; EXPRESSION; SHIP1; BIOGENESIS; REPRESSION; PATHWAYS; CHILDREN; INFANTS; INHIBIT	Cystic Fibrosis (CF) is characterized by a massive proinflammatory phenotype in the lung arising from profound expression of inflammatory genes, including interleukin-8 (IL-8). We have previously reported that IL-8 mRNA is stabilized in CF lung epithelial cells, resulting in concomitant hyperexpression of IL-8 protein. However, the mechanistic link between mutations in CFTR and acquisition of the proinflammatory phenotype in the CF airway has remained elusive. We hypothesized that specific microRNAs (miRNAs) might mediate this linkage. To identify the potential link, we screened an miRNA library for differential expression in Delta F508-CFTR and wild type CFTR lung epithelial cell lines. Of 22 differentially and significantly expressed miRNAs, we found that expression of miR-155 was more than 5-fold elevated in CF IB3-1 lung epithelial cells in culture, compared with control IB3-1/S9 cells. Clinically, miR-155 was also highly expressed in CF lung epithelial cells and circulating CF neutrophils biopsied from CF patients. We report here that high levels of miR-155 specifically reduced levels of SHIP1, thereby promoting PI3K/Akt activation. However, overexpressing SHIP1 or inhibition of PI3K in CF cells suppressed IL-8 expression. Finally, we found that phospho-Akt levels were elevated in CF lung epithelial cells and were specifically lowered by either antagomir-155 or elevated expression of SHIP1. We therefore suggest that elevated miR-155 contributes to the proinflammatory expression of IL-8 in CF lung epithelial cells by lowering SHIP1 expression and thereby activating the PI3K/Akt signaling pathway. These data suggest that miR-155 may play an important role in the activation of IL-8-dependent inflammation in CF.	[Bhattacharyya, Sharmistha; Balakathiresan, Nagaraja S.; Gutti, Usha; Biswas, Roopa] Uniformed Serv Univ Hlth Sci, Grad Sch Nursing, Dept Hlth Syst Risk & Contingency Management, Bethesda, MD 20814 USA; [Dalgard, Clifton; Jozwik, Cathy; Srivastava, Meera; Pollard, Harvey B.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Sch Med, Bethesda, MD 20814 USA; [Armistead, David] Appl Biosyst Inc, Foster City, CA 94404 USA	Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA; Thermo Fisher Scientific; Applied Biosystems	Biswas, R (corresponding author), Uniformed Serv Univ Hlth Sci, Grad Sch Nursing, Dept Hlth Syst Risk & Contingency Management, Rm B4024, Bethesda, MD 20814 USA.	rbiswas@usuhs.mil	Balakathiresan, Nagaraja Sethuraman/O-3213-2019; Biswas, Roopa/AAC-4928-2020	Balakathiresan, Nagaraja Sethuraman/0000-0001-5756-6070; Gutti, Usha/0000-0003-0927-0923; Dalgard, Clifton/0000-0003-2025-8239	USU; National Institutes of Health [RO1-DK053051]; Cystic Fibrosis Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053051] Funding Source: NIH RePORTER	USU; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by USU-Intramural Funds (to R. B.), National Institutes of Health (RO1-DK053051, to H. B. P.) and Cystic Fibrosis Foundation (to R. B. and H. B. P.).	Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Armstrong DS, 1997, AM J RESP CRIT CARE, V156, P1197, DOI 10.1164/ajrccm.156.4.96-11058; Bagga Shveta, 2006, Genet Eng (N Y), V27, P1, DOI 10.1007/0-387-25856-6_1; Balakathiresan NS, 2009, AM J PHYSIOL-LUNG C, V296, pL1012, DOI 10.1152/ajplung.90601.2008; Banerjee A, 2010, EUR J IMMUNOL, V40, P225, DOI 10.1002/eji.200939381; Bhattacharyya SN, 2006, COLD SPRING HARB SYM, V71, P513, DOI 10.1101/sqb.2006.71.038; Bhattacharyya S, 2011, AM J PHYSIOL-LUNG C, V300, pL81, DOI 10.1152/ajplung.00051.2010; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Blenkiron C, 2007, HUM MOL GENET, V16, pR106, DOI 10.1093/hmg/ddm056; Bolisetty MT, 2009, J VIROL, V83, P12009, DOI 10.1128/JVI.01182-09; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; BONFIELD TL, 1995, AM J RESP CRIT CARE, V152, P2111, DOI 10.1164/ajrccm.152.6.8520783; Brooks R, 2010, J IMMUNOL, V184, P3582, DOI 10.4049/jimmunol.0902844; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Cremer TJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008508; DEAN TP, 1993, PEDIATR RES, V34, P159, DOI 10.1203/00006450-199308000-00010; Dubrovska A, 2009, P NATL ACAD SCI USA, V106, P268, DOI 10.1073/pnas.0810956106; Ebner S, 2000, J NEUROSCI RES, V62, P336; Eidelman O, 2001, MOL MED, V7, P523, DOI 10.1007/BF03401858; Felicetti F, 2008, EXPERT REV ANTICANC, V8, P1759, DOI 10.1586/14737140.8.11.1759; Frizzell R A, 1999, Physiol Rev, V79, pS1; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Ikeda S, 2007, PHYSIOL GENOMICS, V31, P367, DOI 10.1152/physiolgenomics.00144.2007; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; John Bino, 2006, V342, P101, DOI 10.1385/1-59745-123-1:101; Jovanovic M, 2006, ONCOGENE, V25, P6176, DOI 10.1038/sj.onc.1209912; KHAN TZ, 1995, AM J RESP CRIT CARE, V151, P1075; Kim VN, 2005, MOL CELLS, V19, P1; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kopito Ron R., 1999, Physiological Reviews, V79, pS167; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; McGlinn E, 2009, P NATL ACAD SCI USA, V106, P18610, DOI 10.1073/pnas.0910374106; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; Ong CJ, 2007, BLOOD, V110, P1942, DOI 10.1182/blood-2007-03-079699; Ooms LM, 2009, BIOCHEM J, V419, P29, DOI 10.1042/BJ20081673; Pedersen IM, 2009, EMBO MOL MED, V1, P288, DOI 10.1002/emmm.200900028; Peng QS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000500; Pollard HB, 2000, ANAT RECORD, V259, pIII; Poy MN, 2007, DIABETES OBES METAB, V9, P67, DOI 10.1111/j.1463-1326.2007.00775.x; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rane S, 2007, CELL CYCLE, V6, P1850, DOI 10.4161/cc.6.15.4551; Rauh MJ, 2004, BIOCHEM SOC T, V32, P785, DOI 10.1042/BST0320785; RICHMANEISENSTAT JBY, 1993, AM J PHYSIOL, V264, pL413, DOI 10.1152/ajplung.1993.264.4.L413; Roebuck KA, 1999, J INTERF CYTOK RES, V19, P429, DOI 10.1089/107999099313866; Srivastava M, 2004, P NATL ACAD SCI USA, V101, P7693, DOI 10.1073/pnas.0402030101; Stahl HF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007158; Tili E, 2009, INT REV IMMUNOL, V28, P264, DOI 10.1080/08830180903093796; Tirouvanziam R, 2000, AM J RESP CELL MOL, V23, P121, DOI 10.1165/ajrcmb.23.2.4214; Van Rooij E, 2007, PHYSIOL GENOMICS, V31, P365, DOI 10.1152/physiolgenomics.00206.2007; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vij N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004664; Roretz C, 2008, J CELL BIOL, V181, P189, DOI 10.1083/jcb.200712054; Wojnarowski C, 1999, EUR RESPIR J, V14, P1136, DOI 10.1183/09031936.99.14511369; Yamanaka Y, 2009, BLOOD, V114, P3265, DOI 10.1182/blood-2009-06-222794; Zhang HL, 2010, CHEMBIOCHEM, V11, P388, DOI 10.1002/cbic.200900545	58	172	181	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11604	11615		10.1074/jbc.M110.198390	http://dx.doi.org/10.1074/jbc.M110.198390			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21282106	hybrid, Green Published			2022-12-27	WOS:000288797100070
J	Frias, JA; Richman, JE; Erickson, JS; Wackett, LP				Frias, Janice A.; Richman, Jack E.; Erickson, Jasmine S.; Wackett, Lawrence P.			Purification and Characterization of OleA from Xanthomonas campestris and Demonstration of a Non-decarboxylative Claisen Condensation Reaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAIN NONISOPRENOID HYDROCARBONS; TO-HEAD HYDROCARBON; LONG-CHAIN; SARCINA-LUTEA; FATTY-ACIDS; BIOSYNTHESIS; BIOCHEMISTRY; SYNTHASE; PROTEIN; INTERMEDIATE	OleA catalyzes the condensation of fatty acyl groups in the first step of bacterial long-chain olefin biosynthesis, but the mechanism of the condensation reaction is controversial. In this study, OleA from Xanthomonas campestris was expressed in Escherichia coli and purified to homogeneity. The purified protein was shown to be active with fatty acyl-CoA substrates that ranged from C-8 to C-16 in length. With limiting myristoyl-CoA (C-14), 1 mol of the free coenzyme A was released/mol of myristoyl-CoA consumed. Using [C-14] myristoyl-CoA, the other products were identified as myristic acid, 2-myristoylmyristic acid, and 14-heptacosanone. 2-Myristoylmyristic acid was indicated to be the physiologically relevant product of OleA in several ways. First, 2-myristoylmyristic acid was the major condensed product in short incubations, but over time, it decreased with the concomitant increase of 14-heptacosanone. Second, synthetic 2-myristoylmyristic acid showed similar decarboxylation kinetics in the absence of OleA. Third, 2-myristoylmyristic acid was shown to be reactive with purified OleC and OleD to generate the olefin 14-heptacosene, a product seen in previous in vivo studies. The decarboxylation product, 14-heptacosanone, did not react with OleC and OleD to produce any demonstrable product. Substantial hydrolysis of fatty acyl-CoA substrates to the corresponding fatty acids was observed, but it is currently unclear if this occurs in vivo. In total, these data are consistent with OleA catalyzing a non-decarboxylative Claisen condensation reaction in the first step of the olefin biosynthetic pathway previously found to be present in at least 70 different bacterial strains.	[Wackett, Lawrence P.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, St Paul, MN 55108 USA; Univ Minnesota, BioTechnol Inst, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Wackett, LP (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, 140 Gortner Lab,1479 Gortner Ave, St Paul, MN 55108 USA.	wacke003@umn.edu			University of Minnesota; Department of Energy [DE-AR0000007]; Initiative for Renewable Energy and the Environment	University of Minnesota(University of Minnesota System); Department of Energy(United States Department of Energy (DOE)); Initiative for Renewable Energy and the Environment(University of Minnesota System)	This work was supported by a University of Minnesota doctoral dissertation fellowship (to J. A. F.) and by Department of Energy ARPA-E Award DE-AR0000007 and the Initiative for Renewable Energy and the Environment (to L. P. W.).	Adams R., 1942, ORGANIC REACTIONS, V1; ALBRO PW, 1969, BIOCHEMISTRY-US, V8, P953, DOI 10.1021/bi00831a028; ALBRO PW, 1969, BIOCHEMISTRY-US, V8, P3317, DOI 10.1021/bi00836a028; ALBRO PW, 1969, BIOCHEMISTRY-US, V8, P1913, DOI 10.1021/bi00833a022; ALBRO PW, 1970, BIOCHEMISTRY-US, V9, P1893, DOI 10.1021/bi00811a005; ALBRO PW, 1969, BIOCHEMISTRY-US, V8, P394, DOI 10.1021/bi00829a055; ALEXSON SEH, 1988, J BIOL CHEM, V263, P13564; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Beller HR, 2010, APPL ENVIRON MICROB, V76, P1212, DOI 10.1128/AEM.02312-09; Briese RR, 1933, J AM CHEM SOC, V55, P1697, DOI 10.1021/ja01331a066; CLINKENBEARD KD, 1975, J BIOL CHEM, V250, P3124; Davies C, 2000, STRUCTURE, V8, P185, DOI 10.1016/S0969-2126(00)00094-0; DAVIS JT, 1987, J BIOL CHEM, V262, P82; Detalle JF, 2004, J ORG CHEM, V69, P6528, DOI 10.1021/jo049464w; ELLMAN GL, 1958, ARCH BIOCHEM BIOPHYS, V74, P443, DOI 10.1016/0003-9861(58)90014-6; Frias JA, 2010, ACTA CRYSTALLOGR F, V66, P1108, DOI 10.1107/S1744309110031751; Frias JA, 2009, APPL ENVIRON MICROB, V75, P1774, DOI 10.1128/AEM.02547-08; FRIEDMAN L, 2008, Patent No. 2008113041; Gavalda S, 2009, J BIOL CHEM, V284, P19255, DOI 10.1074/jbc.M109.006940; Haapalainen AM, 2006, TRENDS BIOCHEM SCI, V31, P64, DOI 10.1016/j.tibs.2005.11.011; Heath RJ, 2002, NAT PROD REP, V19, P581, DOI 10.1039/b110221b; Muntendam R, 2009, APPL MICROBIOL BIOT, V84, P1003, DOI 10.1007/s00253-009-2150-1; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Skaff D. A., 2010, ANAL BIOCHEM, V396, P288; Sleeman MC, 2004, J BIOL CHEM, V279, P6730, DOI 10.1074/jbc.M311824200; Sukovich DJ, 2010, APPL ENVIRON MICROB, V76, P3850, DOI 10.1128/AEM.00436-10; Sukovich DJ, 2010, APPL ENVIRON MICROB, V76, P3842, DOI 10.1128/AEM.00433-10; TORNABEN.TG, 1967, J BACTERIOL, V94, P349, DOI 10.1128/JB.94.2.349-358.1967; Trivedi OA, 2004, NATURE, V428, P441, DOI 10.1038/nature02384; Unell M, 2007, FEMS MICROBIOL LETT, V266, P138, DOI 10.1111/j.1574-6968.2006.00502.x; YASHIRO K, 1995, BBA-LIPID LIPID MET, V1258, P288, DOI 10.1016/0005-2760(95)00136-Z	31	43	47	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					10930	10938		10.1074/jbc.M110.216127	http://dx.doi.org/10.1074/jbc.M110.216127			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21266575	Green Published, hybrid			2022-12-27	WOS:000288797100005
J	Gutierrez-Martin, Y; Bustillo, D; Gomez-Villafuertes, R; Sanchez-Nogueiro, J; Torregrosa-Hetland, C; Binz, T; Gutierrez, LM; Miras-Portugal, MT; Artalejo, AR				Gutierrez-Martin, Yolanda; Bustillo, Diego; Gomez-Villafuertes, Rosa; Sanchez-Nogueiro, Jesus; Torregrosa-Hetland, Cristina; Binz, Thomas; Miguel Gutierrez, Luis; Teresa Miras-Portugal, Maria; Artalejo, Antonio R.			P2X7 Receptors Trigger ATP Exocytosis and Modify Secretory Vesicle Dynamics in Neuroblastoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADRENAL CHROMAFFIN CELLS; BOTULINUM NEUROTOXIN-A; PATCH-CLAMP TECHNIQUES; NEUROTRANSMITTER RELEASE; PLASMA-MEMBRANE; FLUORESCENCE MICROSCOPY; REGULATED EXOCYTOSIS; P2X(7) RECEPTORS; SUBSTANCE-P; PC12 CELLS	Previously, we reported that purinergic ionotropic P2X7 receptors negatively regulate neurite formation in Neuro-2a (N2a) mouse neuroblastoma cells through a Ca2+/calmodulin-dependent kinase II-related mechanism. In the present study we used this cell line to investigate a parallel though faster P2X7 receptor- mediated signaling pathway, namely Ca2+-regulated exocytosis. Selective activation of P2X7 receptors evoked exocytosis as assayed by high resolution membrane capacitance measurements. Using dual-wavelength total internal reflection microscopy, we have observed both the increase in near-membrane Ca2+ concentration and the exocytosis of fluorescently labeled vesicles in response to P2X7 receptor stimulation. Moreover, activation of P2X7 receptors also affects vesicle motion in the vertical and horizontal directions, thus, involving this receptor type in the control of early steps (docking and priming) of the secretory pathway. Immunocytochemical and RT-PCR experiments evidenced that N2a cells express the three neuronal SNAREs as well as vesicular nucleotide and monoamine (VMAT-1 and VMAT-2) transporters. Biochemical measurements indicated that ionomycin induced a significant release of ATP from N2a cells. Finally, P2X7 receptor stimulation and ionomycin increased the incidence of small transient inward currents, reminiscent of postsynaptic quantal events observed at synapses. Small transient inward currents were dependent on extracellular Ca2+ and were abolished by Brilliant Blue G, suggesting they were mediated by P2X7 receptors. Altogether, these results suggest the existence of a positive feedback mechanism mediated by P2X7 receptor-stimulated exocytotic release of ATP that would act on P2X7 receptors on the same or neighbor cells to further stimulate its own release and negatively control N2a cell differentiation.	[Artalejo, Antonio R.] Univ Complutense Madrid, Fac Vet, Dept Farmacol & Toxicol, E-28040 Madrid, Spain; [Gutierrez-Martin, Yolanda; Bustillo, Diego; Gomez-Villafuertes, Rosa; Sanchez-Nogueiro, Jesus; Teresa Miras-Portugal, Maria; Artalejo, Antonio R.] Univ Complutense Madrid, Inst Univ Invest Neuroquim, E-28040 Madrid, Spain; [Torregrosa-Hetland, Cristina; Miguel Gutierrez, Luis] Univ Miguel Hernandez, Ctr Mixto, CSIC, Inst Neurociencias, Sant Joan dAlacant 03550, Spain; [Binz, Thomas] Hannover Med Sch, Inst Biochem, D-30625 Hannover, Germany	Complutense University of Madrid; Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Hannover Medical School	Artalejo, AR (corresponding author), Univ Complutense Madrid, Fac Vet, Dept Farmacol & Toxicol, Avda Puerta de Hierro S-N, E-28040 Madrid, Spain.	antonio.artalejo@vet.ucm.es	Artalejo, Antonio R./ABG-2009-2020; Miras-Portugal, Maria Teresa/L-7137-2014; Gomez-Villafuertes, Rosa/L-7181-2014; Gutierrez, Luis/K-8633-2014; Gutierrez, Yolanda/R-5474-2019; Artalejo, Antonio R./H-4378-2015	Artalejo, Antonio R./0000-0001-9720-9190; Gomez-Villafuertes, Rosa/0000-0002-7064-0906; Gutierrez, Luis/0000-0002-0512-7858; Gutierrez, Yolanda/0000-0002-7552-1092; Artalejo, Antonio R./0000-0001-9720-9190; Pintor, Jesus/0000-0002-9191-7679	Ministerio de Ciencia e Innovacion [BFU2008-02699, BFU2005-0634]; Comunidad de Madrid [S-SAL-0253-2006]; Fundacion Marcelino Botin; "Spanish Ion Channel Initiative" (SICI) [CSD2008-00005]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Comunidad de Madrid(Comunidad de Madrid); Fundacion Marcelino Botin; "Spanish Ion Channel Initiative" (SICI)	This work was supported by Ministerio de Ciencia e Innovacion Grants BFU2008-02699 and BFU2005-0634, Comunidad de Madrid Grant S-SAL-0253-2006, the Fundacion Marcelino Botin, and "Spanish Ion Channel Initiative" (SICI) Grant CSD2008-00005.	Adrian K, 2000, BBA-GENE STRUCT EXPR, V1492, P127, DOI 10.1016/S0167-4781(00)00094-4; Becherer U, 2003, NAT NEUROSCI, V6, P846, DOI 10.1038/nn1087; Becherer U, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000505; Becherer U, 2006, CELL TISSUE RES, V326, P393, DOI 10.1007/s00441-006-0243-z; Bhaskar K, 2004, NEUROCHEM INT, V44, P35, DOI 10.1016/S0197-0186(03)00099-8; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; Bodin P, 2001, J CARDIOVASC PHARM, V38, P900, DOI 10.1097/00005344-200112000-00012; Borisovska M, 2005, EMBO J, V24, P2114, DOI 10.1038/sj.emboj.7600696; Brandle U, 1999, NEUROSCI LETT, V273, P105, DOI 10.1016/S0304-3940(99)00648-5; BURNSTOCK G, 1985, GEN PHARMACOL, V16, P433, DOI 10.1016/0306-3623(85)90001-1; Burnstock G, 2008, NAT REV DRUG DISCOV, V7, P575, DOI 10.1038/nrd2605; Carabelli V, 2003, BIOPHYS J, V85, P1326, DOI 10.1016/S0006-3495(03)74567-6; CHEVRIER D, 1991, MOL CELL ENDOCRINOL, V79, P109, DOI 10.1016/0303-7207(91)90101-W; Coco S, 2003, J BIOL CHEM, V278, P1354, DOI 10.1074/jbc.M209454200; Dernick G, 2005, NAT METHODS, V2, P699, DOI 10.1038/nmeth0905-699; Diaz-Hernandez M, 2008, J CELL SCI, V121, P3717, DOI 10.1242/jcs.034082; Dinkelacker V, 2000, J NEUROSCI, V20, P8377, DOI 10.1523/JNEUROSCI.20-22-08377.2000; Fabbro A, 2004, J PHYSIOL-LONDON, V560, P505, DOI 10.1113/jphysiol.2004.068924; Gil A, 2002, J BIOL CHEM, V277, P9904, DOI 10.1074/jbc.M110182200; Giner D, 2007, NEUROSCIENCE, V146, P659, DOI 10.1016/j.neuroscience.2007.02.039; Gomez-Villafuertes R, 2009, FEBS J, V276, P5307, DOI 10.1111/j.1742-4658.2009.07228.x; Gualix J, 1996, FEBS LETT, V391, P195, DOI 10.1016/0014-5793(96)00732-6; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Han X, 2004, SCIENCE, V304, P289, DOI 10.1126/science.1095801; Heo JS, 2006, STEM CELLS, V24, P2637, DOI 10.1634/stemcells.2005-0588; Holz RW, 2006, CELL MOL NEUROBIOL, V26, P439, DOI 10.1007/s10571-006-9049-5; HUANG NN, 1989, P NATL ACAD SCI USA, V86, P7904, DOI 10.1073/pnas.86.20.7904; Jarvis MF, 2009, NEUROPHARMACOLOGY, V56, P208, DOI 10.1016/j.neuropharm.2008.06.067; Jiang LH, 2000, MOL PHARMACOL, V58, P82, DOI 10.1124/mol.58.1.82; Johns LM, 2001, J CELL BIOL, V153, P177, DOI 10.1083/jcb.153.1.177; Khakh BS, 2001, PHARMACOL REV, V53, P107; Koticha DK, 2002, J CELL SCI, V115, P3341; LEINDERS T, 1992, PFLUG ARCH EUR J PHY, V422, P223, DOI 10.1007/BF00376206; Levesque SA, 2007, BRIT J PHARMACOL, V152, P141, DOI 10.1038/sj.bjp.0707361; LEVRAM V, 1992, J NEUROPHYSIOL, V68, P1167, DOI 10.1152/jn.1992.68.4.1167; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Luna C, 2009, INVEST OPHTH VIS SCI, V50, P5805, DOI 10.1167/iovs.09-3796; Munoz M, 2005, NEUROPEPTIDES, V39, P427, DOI 10.1016/j.npep.2005.03.004; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; Nofal S, 2007, J NEUROSCI, V27, P1386, DOI 10.1523/JNEUROSCI.4714-06.2007; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Oheim M, 2000, EUR BIOPHYS J BIOPHY, V29, P67, DOI 10.1007/s002490050253; Orriss IR, 2009, J CELL PHYSIOL, V220, P155, DOI 10.1002/jcp.21745; Pangrsic T, 2007, J BIOL CHEM, V282, P28749, DOI 10.1074/jbc.M700290200; Pellegatti P, 2005, MOL BIOL CELL, V16, P3659, DOI 10.1091/mbc.E05-03-0222; Plattner H, 1997, J CELL BIOL, V139, P1709, DOI 10.1083/jcb.139.7.1709; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; Raffaghello L, 2006, CANCER RES, V66, P907, DOI 10.1158/0008-5472.CAN-05-3185; Rettig J, 2002, SCIENCE, V298, P781, DOI 10.1126/science.1075375; Rummel A, 2004, MOL MICROBIOL, V51, P631, DOI 10.1046/j.1365-2958.2003.03872.x; Smith C, 1998, NEURON, V20, P1243, DOI 10.1016/S0896-6273(00)80504-8; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sperlagh B, 2007, PURINERG SIGNAL, V3, P269, DOI 10.1007/s11302-007-9080-0; Steyer JA, 1999, BIOPHYS J, V76, P2262, DOI 10.1016/S0006-3495(99)77382-0; Toonen RF, 2006, EMBO J, V25, P3725, DOI 10.1038/sj.emboj.7601256; Verhage M, 2008, TRAFFIC, V9, P1414, DOI 10.1111/j.1600-0854.2008.00759.x; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; Voets T, 1999, NEURON, V23, P607, DOI 10.1016/S0896-6273(00)80812-0; von Kugelgen I, 2000, N-S ARCH PHARMACOL, V362, P310, DOI 10.1007/s002100000310; VONRUDEN L, 1993, SCIENCE, V262, P1061, DOI 10.1126/science.8235626; White N, 2006, TRENDS PHARMACOL SCI, V27, P211, DOI 10.1016/j.tips.2006.02.004; Wu PY, 2009, CELL SIGNAL, V21, P881, DOI 10.1016/j.cellsig.2009.01.036; Wu ZX, 2003, ACTA BIOCH BIOPH SIN, V35, P381; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4; Xu T, 1999, EMBO J, V18, P3293, DOI 10.1093/emboj/18.12.3293; Yamamoto H, 2003, J PHARMACOL SCI, V93, P30, DOI 10.1254/jphs.93.30	67	41	42	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11370	11381		10.1074/jbc.M110.139410	http://dx.doi.org/10.1074/jbc.M110.139410			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21292765	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000288797100049
J	Kim, TH; Shivdasani, RA				Kim, Tae-Hee; Shivdasani, Ramesh A.			Genetic Evidence That Intestinal Notch Functions Vary Regionally and Operate through a Common Mechanism of Math1 Repression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATONAL HOMOLOG 1; STEM-CELLS; SECRETASE INHIBITORS; PROGENITOR CELLS; TRANSGENIC MICE; SELF-RENEWAL; DIFFERENTIATION; FATE; HES-1; RECOMBINATION	Notch signaling is active in many sites, and its diverse activities must require tissue-specific intermediaries, which are largely unknown. In the intestinal epithelium, Notch promotes crypt cell proliferation and inhibits goblet cell differentiation. Pharmacologic studies suggest that the latter effect occurs through the transcription factor Math1/Atoh1, which specifies all intestinal secretory cells. We tested this hypothesis using mouse mutants. Genetic loss of the Notch effector RBP-J kappa alone increases all intestinal secretory lineages, with variation between proximal and distal gut segments. This secretory cell excess observed with RBP-J kappa loss was blocked in the absence of Math1 in RBP-J kappa(Fl/Fl); Math1(Fl/Fl); Villin-Cre((ER-T2)) mice. Loss of both factors also restored progenitor replication, proving that Math1 is epistatic to Notch signaling in both secretory cell differentiation and crypt cell proliferation. Investigating mechanisms downstream of Math1, we found that expression of the known Notch effector protein Hes1 was predictably lost in RBP-J kappa(-/-) mice but surprisingly recovered in RBP-J kappa;Math1 compound conditional mutants. Furthermore, the cell cycle inhibitors p27(Kip1) and p57(Kip2) were selectively overexpressed in duodenal and ileal crypts, respectively, in RBP-J kappa-deficient mice. Regional activation of these products was completely abrogated in the absence of Math1. Thus, all intestinal Notch effects channel through the tissue-restricted factor Math1, which promotes secretory differentiation and cell cycle exit by regionally distinct mechanisms. Our data further suggest that, besides transmitting Notch signals, the transcription factor Hes1 acts downstream of Math1 to regulate expression of cell cycle inhibitors and intestinal crypt cell replication.	Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Shivdasani, RA (corresponding author), 44 Binney St, Boston, MA 02215 USA.	ramesh_shivdasani@dfci.harvard.edu			National Institutes of Health [R01DK081113]; Caring for Carcinoid Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081113] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Caring for Carcinoid Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK081113 (to R. A. S.). This work was also supported by a gift from the Caring for Carcinoid Foundation.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bossuyt W, 2009, PLOS BIOL, V7, P311, DOI 10.1371/journal.pbio.1000039; BRY L, 1994, P NATL ACAD SCI USA, V91, P10335, DOI 10.1073/pnas.91.22.10335; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Crosnier C, 2005, DEVELOPMENT, V132, P1093, DOI 10.1242/dev.01644; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Georgia S, 2006, DEV BIOL, V298, P22, DOI 10.1016/j.ydbio.2006.05.036; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Imayoshi I, 2008, DEVELOPMENT, V135, P2531, DOI 10.1242/dev.021535; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Kazanjian A, 2010, GASTROENTEROLOGY, V139, P918, DOI 10.1053/j.gastro.2010.05.081; Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254; Monahan P, 2009, ENDOCRINOLOGY, V150, P4386, DOI 10.1210/en.2009-0206; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Riccio O, 2008, EMBO REP, V9, P377, DOI 10.1038/embor.2008.7; Rodilla V, 2009, P NATL ACAD SCI USA, V106, P6315, DOI 10.1073/pnas.0813221106; Ross DA, 2004, MOL CELL BIOL, V24, P3505, DOI 10.1128/MCB.24.8.3505-3513.2004; RUBIN DC, 1992, J BIOL CHEM, V267, P15122; Saotome I, 2004, DEV CELL, V6, P855, DOI 10.1016/j.devcel.2004.05.007; Shroyer NF, 2007, GASTROENTEROLOGY, V132, P2478, DOI 10.1053/j.gastro.2007.03.047; Stanger BZ, 2005, P NATL ACAD SCI USA, V102, P12443, DOI 10.1073/pnas.0505690102; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; van Es JH, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1017; VanDussen KL, 2010, DEV BIOL, V346, P215, DOI 10.1016/j.ydbio.2010.07.026; Wilson A, 2006, FEBS LETT, V580, P2860, DOI 10.1016/j.febslet.2006.03.024; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718	30	64	69	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11427	11433		10.1074/jbc.M110.188797	http://dx.doi.org/10.1074/jbc.M110.188797			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21282114	Green Published, hybrid			2022-12-27	WOS:000288797100054
J	Liu, YD; Goetze, AM; Bass, RB; Flynn, GC				Liu, Y. Diana; Goetze, Andrew M.; Bass, Randal B.; Flynn, Gregory C.			N-terminal Glutamate to Pyroglutamate Conversion in Vivo for Human IgG2 Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGLOBULINS; ACID; G1	Therapeutic proteins contain a large number of post-translational modifications, some of which could potentially impact their safety or efficacy. In one of these changes, pyroglutamate can form on the N terminus of the polypeptide chain. Both glutamine and glutamate at the N termini of recombinant monoclonal antibodies can cyclize spontaneously to pyroglutamate (pE) in vitro. Glutamate conversion to pyroglutamate occurs more slowly than from glutamine but has been observed under near physiological conditions. Here we investigated to what extent human IgG2 N-terminal glutamate converts to pE in vivo. Pyroglutamate levels increased over time after injection into humans, with the rate of formation differing between polypeptide chains. These changes were replicated for the same antibodies in vitro under physiological pH and temperature conditions, indicating that the changes observed in vivo were due to chemical conversion not differential clearance. Differences in the conversion rates between the light chain and heavy chain on an antibody were eliminated by denaturing the protein, revealing that structural elements affect pE formation rates. By enzymatically releasing pE from endogenous antibodies isolated from human serum, we could estimate the naturally occurring levels of this post-translational modification. Together, these techniques and results can be used to predict the exposure of pE for therapeutic antibodies and to guide criticality assessments for this attribute.	[Liu, Y. Diana; Goetze, Andrew M.; Bass, Randal B.; Flynn, Gregory C.] Amgen Inc, Dept Proc & Prod Dev, Thousand Oaks, CA 91320 USA	Amgen	Flynn, GC (corresponding author), Amgen Inc, Dept Proc & Prod Dev, 1 Amgen Ctr Dr,Mail Stop 30E-1-C, Thousand Oaks, CA 91320 USA.	gflynn@amgen.com	Liu, Y Diana/AAU-4624-2021					Blomback B., 1967, METHOD ENZYMOL, V11, P389; Chelius D, 2006, ANAL CHEM, V78, P2370, DOI 10.1021/ac051827k; Chirino AJ, 2004, NAT BIOTECHNOL, V22, P1383, DOI 10.1038/nbt1030; Dayhoff MO, 1978, ATLAS PROTEIN SEQUEN, V5; Dick LW, 2007, BIOTECHNOL BIOENG, V97, P544, DOI 10.1002/bit.21260; Flynn GC, 2010, MOL IMMUNOL, V47, P2074, DOI 10.1016/j.molimm.2010.04.006; Liu HC, 2006, J CHROMATOGR B, V837, P35, DOI 10.1016/j.jchromb.2006.03.053; Liu YD, 2008, J BIOL CHEM, V283, P29266, DOI 10.1074/jbc.M804787200; Liu YD, 2009, BIOLOGICALS, V37, P313, DOI 10.1016/j.biologicals.2009.06.001; Mozdzanowski J, 1998, ANAL BIOCHEM, V260, P183, DOI 10.1006/abio.1998.2690; Ouellette D, 2010, ANAL BIOCHEM, V397, P37, DOI 10.1016/j.ab.2009.09.027; Qu J, 2002, ANALYST, V127, P66, DOI 10.1039/b108422b; Rathore AS, 2009, TRENDS BIOTECHNOL, V27, P546, DOI 10.1016/j.tibtech.2009.06.006; Rathore AS, 2009, NAT BIOTECHNOL, V27, P26, DOI 10.1038/nbt0109-26; Rink R, 2010, J PHARMACOL TOX MET, V61, P210, DOI 10.1016/j.vascn.2010.02.010; Schilling S, 2008, BIOL CHEM, V389, P983, DOI 10.1515/BC.2008.111; Yu L, 2006, J PHARMACEUT BIOMED, V42, P455, DOI 10.1016/j.jpba.2006.05.008; Zheng ZQ, 2004, ANAL CHEM, V76, P6374, DOI 10.1021/ac0491206	18	114	123	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11211	11217		10.1074/jbc.M110.185041	http://dx.doi.org/10.1074/jbc.M110.185041			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21282104	Green Published, hybrid			2022-12-27	WOS:000288797100032
J	Xiao, ZG; Brose, J; Schimo, S; Ackland, SM; La Fontaine, S; Wedd, AG				Xiao, Zhiguang; Brose, Jens; Schimo, Sonja; Ackland, Susan M.; La Fontaine, Sharon; Wedd, Anthony G.			Unification of the Copper(I) Binding Affinities of the Metallo-chaperones Atx1, Atox1, and Related Proteins DETECTION PROBES AND AFFINITY STANDARDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILSON-DISEASE PROTEIN; WEAK MOLECULAR-COMPLEXES; ESCHERICHIA-COLI; CU(I); METALLOCHAPERONE; TRAFFICKING; MECHANISMS; DITHIOTHREITOL; TRANSPORTER; HOMEOSTASIS	Literature estimates of metal-protein affinities are widely scattered for many systems, as highlighted by the class of metallo-chaperone proteins, which includes human Atox1. The discrepancies may be attributed to unreliable detection probes and/or inconsistent affinity standards. In this study, application of the four Cu-I ligand probes bicinchoninate, bathocuproine disulfonate, dithiothreitol (Dtt), and glutathione (GSH) is reviewed, and their Cu-I affinities are re-estimated and unified. Excess bicinchoninate or bathocuproine disulfonate reacts with Cu-I to yield distinct 1:2 chromatophoric complexes [(CuL2)-L-I](3-) with formation constants beta(2) = 10(17.2) and 10(19.8) M-2, respectively. These constants do not depend on proton concentration for pH >= 7.0. Consequently, they are a pair of complementary and stable probes capable of detecting free Cu+ concentrations from 10(-12) to 10(-19) M. Dtt binds Cu-I with K-D similar to 10(-15) M at pH 7, but it is air-sensitive, and its Cu-I affinity varies with pH. The Cu-I binding properties of Atox1 and related proteins (including the fifth and sixth domains at the N terminus of the Wilson protein ATP7B) were assessed with these probes. The results demonstrate the following: (i) their use permits the stoichiometry of high affinity Cu-I binding and the individual quantitative affinities (K-D values) to be determined reliably via noncompetitive and competitive reactions, respectively; (ii) the scattered literature values are unified by using reliable probes on a unified scale; and (iii) Atox1-type proteins bind Cu-I with sub-femtomolar affinities, consistent with tight control of labile Cu+ concentrations in living cells.	Univ Melbourne, Inst Bio21, Melbourne, Vic 3010, Australia; Univ Melbourne, Sch Chem, Melbourne, Vic 3010, Australia; [Ackland, Susan M.; La Fontaine, Sharon] Deakin Univ, Sch Life & Environm Sci, Burwood, Vic 3215, Australia	University of Melbourne; University of Melbourne; Deakin University		z.xiao@unimelb.edu.au	La Fontaine, Sharon/G-7113-2018	La Fontaine, Sharon/0000-0002-9948-074X; Xiao, Zhiguang/0000-0001-6908-8897	Australian Research Council [A29930204]; National Health and Medical Research Council [479502]	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Australian Research Council Grant A29930204 and National Health and Medical Research Council Grant 479502.	Arnesano F, 2001, BIOCHEMISTRY-US, V40, P1528, DOI 10.1021/bi0014711; Banci L, 2010, NATURE, V465, P645, DOI 10.1038/nature09018; Banci L, 2010, NAT PROD REP, V27, P695, DOI 10.1039/b906678k; CLELAND WW, 1964, BIOCHEMISTRY-US, V3, P480, DOI 10.1021/bi00892a002; DERANLEA.DA, 1969, J AM CHEM SOC, V91, P4050, DOI 10.1021/ja01043a005; DERANLEAU DA, 1969, J AM CHEM SOC, V91, P4044, DOI 10.1021/ja01043a004; Djoko KY, 2007, INORG CHEM, V46, P4560, DOI 10.1021/ic070107o; Djoko KY, 2010, J AM CHEM SOC, V132, P2005, DOI 10.1021/ja9091903; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Freire E., 1990, ANAL CHEM, V62, p950A; Gonzalez-Guerrero M, 2008, P NATL ACAD SCI USA, V105, P5992, DOI 10.1073/pnas.0711446105; Hamza I, 1999, P NATL ACAD SCI USA, V96, P13363, DOI 10.1073/pnas.96.23.13363; HAWKINS CJ, 1963, J CHEM SOC, P2996, DOI 10.1039/jr9630002996; Hearnshaw S, 2009, BIOCHEMISTRY-US, V48, P9324, DOI 10.1021/bi9011995; Hong L, 2008, J PHYS CHEM B, V112, P604, DOI 10.1021/jp075747r; Huffman DL, 2000, J BIOL CHEM, V275, P18611, DOI 10.1074/jbc.C000172200; Kaplan JH, 2009, J BIOL CHEM, V284, P25461, DOI 10.1074/jbc.R109.031286; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Krezel A, 2001, J INORG BIOCHEM, V84, P77, DOI 10.1016/S0162-0134(00)00212-9; KUBAS GJ, 1990, INORG SYN, V28, P68, DOI 10.1002/9780470132593.ch15; LAPPIN AG, 1980, INORG CHEM, V19, P407, DOI 10.1021/ic50204a025; Lin SJ, 1997, J BIOL CHEM, V272, P9215; Llanos RM, 2002, DNA CELL BIOL, V21, P259, DOI 10.1089/104454902753759681; Ma Z, 2009, J AM CHEM SOC, V131, P18044, DOI 10.1021/ja908372b; Miras R, 2008, J BIOL INORG CHEM, V13, P195, DOI 10.1007/s00775-007-0310-2; Palumaa P, 2004, BIOCHEM J, V382, P307, DOI 10.1042/BJ20040360; PEARD WJ, 1958, J AM CHEM SOC, V80, P1593, DOI 10.1021/ja01540a021; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Ralle M, 2003, J BIOL CHEM, V278, P23163, DOI 10.1074/jbc.M303474200; Wernimont AK, 2004, J BIOL CHEM, V279, P12269, DOI 10.1074/jbc.M311213200; Wernimont AK, 2000, NAT STRUCT BIOL, V7, P766; Williams LE, 2005, TRENDS PLANT SCI, V10, P491, DOI 10.1016/j.tplants.2005.08.008; Xiao ZG, 2004, J AM CHEM SOC, V126, P3081, DOI 10.1021/ja0390350; Xiao ZG, 2008, INORG CHEM, V47, P4338, DOI 10.1021/ic702440e; Xiao ZG, 2010, NAT PROD REP, V27, P768, DOI 10.1039/b906690j; Yatsunyk LA, 2007, J BIOL CHEM, V282, P8622, DOI 10.1074/jbc.M609533200; Zhou L, 2008, BIOCHEM J, V413, P459, DOI 10.1042/BJ20080467; Zimmermann M, 2009, BIOCHEMISTRY-US, V48, P11640, DOI 10.1021/bi901573b	38	181	182	5	49	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11047	11055		10.1074/jbc.M110.213074	http://dx.doi.org/10.1074/jbc.M110.213074			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21258123	Green Published, hybrid			2022-12-27	WOS:000288797100016
J	Lin, CH; Cheng, HW; Ma, HP; Wu, CH; Hong, CY; Chen, BC				Lin, Chien-Huang; Cheng, Hui-Wen; Ma, Hon-Ping; Wu, Chih-Hsiung; Hong, Chuang-Ye; Chen, Bing-Chang			Thrombin Induces NF-kappa B Activation and IL-8/CXCL8 Expression in Lung Epithelial Cells by a Rac1-dependent PI3K/Akt Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; NECROSIS-FACTOR-ALPHA; ENDOTHELIAL-CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; CYCLOOXYGENASE-2 EXPRESSION; INTERLEUKIN-8 PRODUCTION; SIGNALING PATHWAYS; IMMUNE-RESPONSE; GENE-EXPRESSION; RAC ACTIVATION	We previously showed that thrombin induces interleukin (IL)-8/CXCL8 expression via the protein kinase C (PKC)alpha/c-Src-dependent I kappa B kinase alpha/beta (IKK alpha/beta)/NF-kappa B signaling pathway in human lung epithelial cells. In this study, we further investigated the roles of Rac1, phosphoinositide 3-kinase (PI3K), and Akt in thrombin-induced NF-kappa B activation and IL-8/CXCL8 expression. Thrombin-induced IL-8/CXCL8 release and IL-8/CXCL8-luciferase activity were attenuated by a PI3K inhibitor (LY294002), an Akt inhibitor (1-L-6-hydroxymethyl-chiro-inositol-2-((R)-2-O-methyl-3-O-octadecylcarbonate)), and the dominant negative mutants of Rac1 (RacN17) and Akt (AktDN). Treatment of cells with thrombin caused activation of Rac and Akt. The thrombin-induced increase in Akt activation was inhibited by RacN17 and LY294002. Stimulation of cells with thrombin resulted in increases in IKK alpha/beta activation and kappa B-luciferase activity; these effects were inhibited by RacN17, LY294002, an Akt inhibitor, and AktDN. Treatment of cells with thrombin induced G beta gamma, p85 alpha, and Rac1 complex formation in a time-dependent manner. These results imply that thrombin activates the Rac1/PI3K/Akt pathway through formation of the G beta gamma, Rac1, and p85 alpha complex to induce IKK alpha/beta activation, NF-kappa B transactivation, and IL-8/CXCL8 expression in human lung epithelial cells.	[Lin, Chien-Huang; Cheng, Hui-Wen] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei 110, Taiwan; [Chen, Bing-Chang] Taipei Med Univ, Sch Resp Therapy, Coll Med, Taipei 110, Taiwan; [Lin, Chien-Huang; Ma, Hon-Ping; Wu, Chih-Hsiung] Taipei Med Univ, Shuang Ho Hosp, Taipei 235, Taiwan; [Lin, Chien-Huang; Hong, Chuang-Ye] Taipei Med Univ, Wang Fang Hosp, Taipei 116, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital	Chen, BC (corresponding author), 250 Wu Hsing St, Taipei 110, Taiwan.	bcchen@tmu.edu.tw		Lin, Chien-Huang/0000-0002-0916-8737	National Science Council of Taiwan [NSC92-2320-B-038-022, NSC93-2320-B-038-045]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Grants NSC92-2320-B-038-022 and NSC93-2320-B-038-045 from the National Science Council of Taiwan.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Asokananthan N, 2002, J IMMUNOL, V168, P3577, DOI 10.4049/jimmunol.168.7.3577; Azim AC, 2000, BLOOD, V95, P959, DOI 10.1182/blood.V95.3.959.003k22_959_964; Bokoch GM, 2005, TRENDS CELL BIOL, V15, P163, DOI 10.1016/j.tcb.2005.01.002; Bokoch GM, 1996, BIOCHEM J, V315, P775, DOI 10.1042/bj3150775; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chang MS, 2004, MOL PHARMACOL, V66, P561; Chen BC, 2006, J IMMUNOL, V177, P681, DOI 10.4049/jimmunol.177.1.681; Chung Kian F., 2005, Current Drug Targets - Inflammation and Allergy, V4, P619, DOI 10.2174/156801005774912806; Chung SW, 2010, BIOCHEM BIOPH RES CO, V396, P748, DOI 10.1016/j.bbrc.2010.05.009; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Diebold I, 2008, THROMB HAEMOSTASIS, V100, P1021, DOI 10.1160/TH08-07-0473; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Gonzalez E, 2006, J BIOL CHEM, V281, P3210, DOI 10.1074/jbc.M510434200; Hatada EN, 2000, CURR OPIN IMMUNOL, V12, P52, DOI 10.1016/S0952-7915(99)00050-3; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Hsu YL, 2010, CARCINOGENESIS, V31, P587, DOI 10.1093/carcin/bgq030; Huang WC, 2003, J IMMUNOL, V170, P4767, DOI 10.4049/jimmunol.170.9.4767; John AE, 2009, J IMMUNOL, V183, P4682, DOI 10.4049/jimmunol.0803832; Kane LP, 1999, CURR BIOL, V9, P601, DOI 10.1016/S0960-9822(99)80265-6; Kawkitinarong K, 2004, AM J RESP CELL MOL, V31, P517, DOI 10.1165/rcmb.2003-0432OC; Kim H, 2008, EXP MOL MED, V40, P167, DOI 10.3858/emm.2008.40.2.167; KUNKEL SL, 1991, EXP LUNG RES, V17, P17, DOI 10.3109/01902149109063278; Lallena MJ, 1999, MOL CELL BIOL, V19, P2180; Lin CH, 2006, J IMMUNOL, V177, P3427, DOI 10.4049/jimmunol.177.5.3427; Mainiero F, 2000, IMMUNITY, V12, P7, DOI 10.1016/S1074-7613(00)80154-5; Moffatt JD, 2004, BRIT J PHARMACOL, V143, P269, DOI 10.1038/sj.bjp.0705926; Mohan S, 2007, AM J PHYSIOL-CELL PH, V292, pC362, DOI 10.1152/ajpcell.00535.2005; Montaner S, 1998, J BIOL CHEM, V273, P12779, DOI 10.1074/jbc.273.21.12779; MUKAIDA N, 1994, J BIOL CHEM, V269, P13289; MUKAIDA N, 1989, J IMMUNOL, V143, P1366; Newcomb DC, 2005, J BIOL CHEM, V280, P36952, DOI 10.1074/jbc.M502449200; Ogasawara N, 2009, J CELL BIOCHEM, V108, P716, DOI 10.1002/jcb.22308; Osada M, 1999, MOL CELL BIOL, V19, P6333; Ostrowska E, 2008, BIOCHEM BIOPH RES CO, V366, P1030, DOI 10.1016/j.bbrc.2007.12.064; Oudit GY, 2004, J MOL CELL CARDIOL, V37, P449, DOI 10.1016/j.yjmcc.2004.05.015; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; Price LS, 2003, J BIOL CHEM, V278, P39413, DOI 10.1074/jbc.M302083200; Rahman A, 2002, CIRC RES, V91, P398, DOI 10.1161/01.RES.0000033520.95242.A2; Rahman A, 2001, MOL CELL BIOL, V21, P5554, DOI 10.1128/MCB.21.16.5554-5565.2001; Resendiz JC, 2007, J THROMB HAEMOST, V5, P2484, DOI 10.1111/j.1538-7836.2007.02769.x; RICHMANEISENSTAT JBY, 1993, AM J PHYSIOL, V264, pL413, DOI 10.1152/ajplung.1993.264.4.L413; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; Ryu J, 2000, J BIOL CHEM, V275, P29955, DOI 10.1074/jbc.M001220200; Sakito O, 1996, RESPIRATION, V63, P42; Sanlioglu S, 2001, J BIOL CHEM, V276, P30188, DOI 10.1074/jbc.M102061200; Sokolova E, 2007, PHARMACOL THERAPEUT, V115, P70, DOI 10.1016/j.pharmthera.2007.04.002; Soulet C, 2005, J THROMB HAEMOST, V3, P2296, DOI 10.1111/j.1538-7836.2005.01588.x; Steinhoff M, 2005, ENDOCR REV, V26, P1, DOI 10.1210/er.2003-0025; Street M, 2006, J CELL SCI, V119, P1528, DOI 10.1242/jcs.02872; Sulciner DJ, 1996, MOL CELL BIOL, V16, P7115; van Leeuwen FN, 2003, J BIOL CHEM, V278, P400, DOI 10.1074/jbc.M210151200; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Williams LA, 2008, MOL IMMUNOL, V45, P2446, DOI 10.1016/j.molimm.2007.12.011; Zheng L, 2007, J LEUKOCYTE BIOL, V82, P619, DOI 10.1189/jlb.0107009	56	48	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10483	10494		10.1074/jbc.M110.112433	http://dx.doi.org/10.1074/jbc.M110.112433			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21266580	hybrid, Green Published			2022-12-27	WOS:000288547000065
J	Rolfe, MD; Ter Beek, A; Graham, AI; Trotter, EW; Asif, HMS; Sanguinetti, G; de Mattos, JT; Poole, RK; Green, J				Rolfe, Matthew D.; Ter Beek, Alex; Graham, Alison I.; Trotter, Eleanor W.; Asif, H. M. Shahzad; Sanguinetti, Guido; de Mattos, Joost Teixeira; Poole, Robert K.; Green, Jeffrey			Transcript Profiling and Inference of Escherichia coli K-12 ArcA Activity across the Range of Physiologically Relevant Oxygen Concentrations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY-CHAIN; IN-VIVO; PROBABILISTIC INFERENCE; MICROARRAY EXPERIMENTS; 2-COMPONENT SYSTEM; AEROBIC CONDITIONS; 2FE-2S CONVERSION; FNR PROTEIN; REDOX STATE; DNA-BINDING	Oxygen availability is the major determinant of the metabolic modes adopted by Escherichia coli. Although much is known about E. coli gene expression and metabolism under fully aerobic and anaerobic conditions, the intermediate oxygen tensions that are encountered in natural niches are understudied. Here, for the first time, the transcript profiles of E. coli K-12 across the physiologically significant range of oxygen availabilities are described. These suggested a progressive switch to aerobic respiratory metabolism and a remodeling of the cell envelope as oxygen availability increased. The transcriptional responses were consistent with changes in the abundance of cytochrome bd and bo' and the outer membrane protein OmpW. The observed transcript and protein profiles result from changes in the activities of regulators that respond to oxygen itself or to metabolic and environmental signals that are sensitive to oxygen availability (aerobiosis). A probabilistic model (TFInfer) was used to predict the activity of the indirect oxygen-sensing two-component system ArcBA across the aerobiosis range. The model implied that the activity of the regulator ArcA correlated with aerobiosis but not with the redox state of the ubiquinone pool, challenging the idea that ArcA activity is inhibited by oxidized ubiquinone. The amount of phosphorylated ArcA correlated with the predicted ArcA activities and with aerobiosis, suggesting that fermentation product-mediated inhibition of ArcB phosphatase activity is the dominant mechanism for regulating ArcA activity under the conditions used here.	[Rolfe, Matthew D.; Graham, Alison I.; Trotter, Eleanor W.; Poole, Robert K.; Green, Jeffrey] Univ Sheffield, Krebs Inst, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Ter Beek, Alex; de Mattos, Joost Teixeira] Univ Amsterdam, Swammerdam Inst Life Sci, NL-1090 GE Amsterdam, Netherlands; [Asif, H. M. Shahzad; Sanguinetti, Guido] Univ Edinburgh, Edinburgh ED8 9AB, Midlothian, Scotland	University of Sheffield; University of Amsterdam; University of Edinburgh	Green, J (corresponding author), Univ Sheffield, Krebs Inst, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England.	jeff.green@sheffield.ac.uk		Graham, Alison Isobel/0000-0001-7334-9033	Biotechnology and Biological Sciences Research Council UK through SysMO [BB/E019943/1]; Biotechnology and Biological Sciences Research Council [BB/I004122/1, BB/E019943/1] Funding Source: researchfish; BBSRC [BB/I004122/1, BB/E019943/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council UK through SysMO(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council UK through SysMO and Project Grant BB/E019943/1.	Alexeeva S, 2002, J BACTERIOL, V184, P1402, DOI 10.1128/JB.184.5.1402-1406.2002; Allen LAH, 2000, J EXP MED, V191, P1451, DOI 10.1084/jem.191.9.1451; Asif HMS, 2010, BIOINFORMATICS, V26, P2635, DOI 10.1093/bioinformatics/btq469; Barbieri CM, 2008, ANAL BIOCHEM, V376, P73, DOI 10.1016/j.ab.2008.02.004; Bekker M, 2007, MICROBIOL-SGM, V153, P1974, DOI 10.1099/mic.0.2007/006098-0; Bekker M, 2010, J BACTERIOL, V192, P746, DOI 10.1128/JB.01156-09; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Chart H., 1994, METHODS PRACTICAL LA, P1; Constantinidou C, 2006, J BIOL CHEM, V281, P4802, DOI 10.1074/jbc.M512312200; Crack JC, 2007, P NATL ACAD SCI USA, V104, P2092, DOI 10.1073/pnas.0609514104; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dmello R, 1996, MICROBIOL-UK, V142, P755, DOI 10.1099/00221287-142-4-755; DMELLO R, 1995, J BACTERIOL, V177, P867, DOI 10.1128/jb.177.3.867-870.1995; Evans CGT, 1970, METHOD MICROBIOL, V2, P278; Garcia-Ochoa F, 2009, BIOTECHNOL ADV, V27, P153, DOI 10.1016/j.biotechadv.2008.10.006; Gennis R. B., 1996, ESCHERICHIA COLI SAL, P217; Georgellis D, 2001, SCIENCE, V292, P2314, DOI 10.1126/science.1059361; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; Guest John R., 1996, P317; Haikarainen T, 2010, CELL MOL LIFE SCI, V67, P341, DOI 10.1007/s00018-009-0168-2; IUCHI S, 1993, J BIOL CHEM, V268, P23972; Jeon Y, 2001, J BIOL CHEM, V276, P40873, DOI 10.1074/jbc.M104855200; Jervis AJ, 2009, P NATL ACAD SCI USA, V106, P4659, DOI 10.1073/pnas.0804943106; Johansen J, 2006, J MOL BIOL, V364, P1, DOI 10.1016/j.jmb.2006.09.004; Kalnenieks U, 1998, FEMS MICROBIOL LETT, V168, P91; Kang YS, 2005, J BACTERIOL, V187, P1135, DOI 10.1128/JB.187.3.1135-1160.2005; Kern R, 2007, J BACTERIOL, V189, P603, DOI 10.1128/JB.01522-06; Keseler IM, 2009, NUCLEIC ACIDS RES, V37, pD464, DOI 10.1093/nar/gkn751; Khoroshilova N, 1997, P NATL ACAD SCI USA, V94, P6087, DOI 10.1073/pnas.94.12.6087; KITA K, 1986, METHOD ENZYMOL, V126, P94; Lacqua A, 2006, APPL ENVIRON MICROB, V72, P956, DOI 10.1128/AEM.72.1.956-959.2006; Lange HC, 2001, BIOTECHNOL BIOENG, V75, P406, DOI 10.1002/bit.10048; Lazazzera BA, 1996, J BIOL CHEM, V271, P2762, DOI 10.1074/jbc.271.5.2762; Lynch AS, 1996, J BACTERIOL, V178, P6238, DOI 10.1128/JB.178.21.6238-6249.1996; Malpica R, 2004, P NATL ACAD SCI USA, V101, P13318, DOI 10.1073/pnas.0403064101; Marshall FA, 2001, MOL MICROBIOL, V39, P747, DOI 10.1046/j.1365-2958.2001.02262.x; Moreau PL, 2007, J BACTERIOL, V189, P2249, DOI 10.1128/JB.01306-06; Neidhardt FC, 1990, PHYSL BACTERIAL CELL; Partridge JD, 2007, J BIOL CHEM, V282, P11230, DOI 10.1074/jbc.M700728200; Partridge JD, 2006, J BIOL CHEM, V281, P27806, DOI 10.1074/jbc.M603450200; Pirt SJ, 1975, PRINCIPLES MICROBE C, P81; Salmon K, 2003, J BIOL CHEM, V278, P29837, DOI 10.1074/jbc.M213060200; Salmon KA, 2005, J BIOL CHEM, V280, P15084, DOI 10.1074/jbc.M414030200; Sawers G, 1999, CURR OPIN MICROBIOL, V2, P181, DOI 10.1016/S1369-5274(99)80032-0; Singh R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002682; Stolper DA, 2010, P NATL ACAD SCI USA, V107, P18755, DOI 10.1073/pnas.1013435107; Storz G, 2000, BACTERIAL STRESS RESPONSES, P47; Taylor CT, 2007, J MOL MED, V85, P1295, DOI 10.1007/s00109-007-0277-z; Yang YH, 2002, NAT REV GENET, V3, P579, DOI 10.1038/nrg863	51	69	70	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10147	10154		10.1074/jbc.M110.211144	http://dx.doi.org/10.1074/jbc.M110.211144			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21252224	Green Published, hybrid			2022-12-27	WOS:000288547000029
J	Ohya, S; Niwa, S; Yanagi, A; Fukuyo, Y; Yamamura, H; Imaizumi, Y				Ohya, Susumu; Niwa, Satomi; Yanagi, Ayano; Fukuyo, Yuka; Yamamura, Hisao; Imaizumi, Yuji			Involvement of Dominant-negative Spliced Variants of the Intermediate Conductance Ca2+-activated K+ Channel, K(Ca)3.1, in Immune Function of Lymphoid Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED POTASSIUM CHANNELS; AMINO-ACIDS; EXPRESSION; TRAFFICKING; SK3; TARGETS; GENE; TRANSCRIPTION; LYMPHOCYTES; RECEPTOR	The intermediate conductance Ca2+-activated K+ channel (IKCa channel) encoded by K(Ca)3.1 is responsible for the control of proliferation and differentiation in various types of cells. We identified novel spliced variants of K(Ca)3.1 (human (h) K(Ca)3.1b) from the human thymus, which were lacking the N-terminal domains of the original hK(Ca)3.1a as a result of alternative splicing events. hK(Ca)3.1b was significantly expressed in human lymphoid tissues. Western blot analysis showed that hK(Ca)3.1a proteins were mainly expressed in the plasma membrane fraction, whereas hK(Ca)3.1b was in the cytoplasmic fraction. We also identified a similar N terminus lacking K(Ca)3.1 variants from mice and rat lymphoid tissues (mK(Ca)3.1b and rK(Ca)3.1b). In the HEK293 heterologous expression system, the cellular distribution of cyan fluorescent protein-tagged hK(Ca)3.1a and/or YFP-tagged hK(Ca)3.1b isoforms showed that hK(Ca)3.1b suppressed the localization of hK(Ca)3.1a to the plasma membrane. In the Xenopus oocyte translation system, co-expression of hK(Ca)3.1b with hK(Ca)3.1a suppressed IKCa channel activity of hK(Ca)3.1a in a dominant-negative manner. In addition, this study indicated that up-regulation of mK(Ca)3.1b in mouse thymocytes differentiated CD4(+) CD8(+) phenotype thymocytes into CD4(-) CD8(-) ones and suppressed concanavalin-A-stimulated thymocyte growth by down-regulation of mIL-2 transcripts. Anti-proliferative effects and down-regulation of mIL-2 transcripts were also observed in mK(Ca)3.1b-overexpressing mouse thymocytes. These suggest that the N-terminal domain of K(Ca)3.1 is critical for channel trafficking to the plasma membrane and that the fine-tuning of IKCa channel activity modulated through alternative splicing events may be related to the control in physiological and pathophysiological conditions in T-lymphocytes.	[Imaizumi, Yuji] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Mol & Cellular Pharmacol, Mizuho Ku, Nagoya, Aichi 4678603, Japan	Nagoya City University	Imaizumi, Y (corresponding author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Mol & Cellular Pharmacol, Mizuho Ku, 3-1 Tanabedori, Nagoya, Aichi 4678603, Japan.	yimaizum@phar.nagoya-cu.ac.jp	Imaizumi, Yuji/AAF-6585-2020; Ohya, Susumu/AAB-3618-2020	Ohya, Susumu/0000-0002-5765-0667	Ministry of Education, Culture, Sports, Science and Technology, Japan [21590098]; Salt Science Research Foundation [10C6]; Takeda Science Foundation; Ministry of Education, Culture, Sports, Science and Technology [20056027]; Grants-in-Aid for Scientific Research [21590098, 23390020, 23790092, 23136512] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Salt Science Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-aid for Scientific Research (C) 21590098 from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to S. O.), the Salt Science Research Foundation Grant 10C6 (to S. O.), Takeda Science Foundation (to S. O.), a grant-in-aid for scientific research (B) from the Ministry of Education, Culture, Sports, Science and Technology (to Y. I.), and Grant-in-aid for Scientific Research on Priority Areas 20056027 from the Ministry of Education, Culture, Sports, Science and Technology (to Y. I.).	Begenisich T, 2004, J BIOL CHEM, V279, P47681, DOI 10.1074/jbc.M409627200; Boussiotis VA, 2000, NAT MED, V6, P290, DOI 10.1038/73144; Brenner R, 1996, J NEUROSCI, V16, P1827; Brown MR, 2008, J PHYSIOL-LONDON, V586, P5161, DOI 10.1113/jphysiol.2008.160861; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Chandy KG, 2004, TRENDS PHARMACOL SCI, V25, P280, DOI 10.1016/j.tips.2004.03.010; Cheong A, 2005, MOL CELL, V20, P45, DOI 10.1016/j.molcel.2005.08.030; Decimo I, 2006, BIOSCIENCE REP, V26, P399, DOI 10.1007/s10540-006-9029-5; Di L, 2010, P NATL ACAD SCI USA, V107, P1541, DOI 10.1073/pnas.0910133107; Dohda T, 2007, EXP CELL RES, V313, P3141, DOI 10.1016/j.yexcr.2007.04.027; Elliott JL, 2003, EMBO REP, V4, P189, DOI 10.1038/sj.embor.embor722; Fanger CM, 2001, J BIOL CHEM, V276, P12249, DOI 10.1074/jbc.M011342200; Fanger CM, 2000, J IMMUNOL, V164, P1153, DOI 10.4049/jimmunol.164.3.1153; Gao YJ, 2008, J BIOL CHEM, V283, P9049, DOI 10.1074/jbc.M708022200; Gao YJ, 2010, J BIOL CHEM, V285, P17938, DOI 10.1074/jbc.M109.086553; Ghanshani S, 1998, GENOMICS, V51, P160, DOI 10.1006/geno.1998.5333; Ghanshani S, 2000, J BIOL CHEM, V275, P37137, DOI 10.1074/jbc.M003941200; Ghatta S, 2006, PHARMACOL THERAPEUT, V110, P103, DOI 10.1016/j.pharmthera.2005.10.007; Ghiani CA, 1999, J NEUROSCI, V19, P5380; Gillett A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007773; Grgic I, 2009, P NATL ACAD SCI USA, V106, P14518, DOI 10.1073/pnas.0903458106; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; HOPKINS WF, 1994, J NEUROSCI, V14, P1385, DOI 10.1523/JNEUROSCI.14-03-01385.1994; Hu XZ, 2010, MOL IMMUNOL, V47, P1692, DOI 10.1016/j.molimm.2010.03.005; Ishii TM, 1997, P NATL ACAD SCI USA, V94, P11651, DOI 10.1073/pnas.94.21.11651; Jensen BS, 2001, CURR DRUG TARGETS, V2, P401, DOI 10.2174/1389450013348173; Joiner WJ, 2001, J BIOL CHEM, V276, P37980; Joiner WJ, 1997, P NATL ACAD SCI USA, V94, P11013, DOI 10.1073/pnas.94.20.11013; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; Kohler R, 2003, CIRCULATION, V108, P1119, DOI 10.1161/01.CIR.0000086464.04719.DD; Kolski-Andreaco A, 2004, J BIOL CHEM, V279, P6893, DOI 10.1074/jbc.M311725200; Levitan ES, 2000, TRENDS CARDIOVAS MED, V10, P317, DOI 10.1016/S1050-1738(01)00078-0; Logsdon NJ, 1997, J BIOL CHEM, V272, P32723, DOI 10.1074/jbc.272.52.32723; Lundmark F, 2007, NAT GENET, V39, P1108, DOI 10.1038/ng2106; MAHAUTSMITH MP, 1991, J PHYSIOL-LONDON, V439, P513, DOI 10.1113/jphysiol.1991.sp018679; Miller MJ, 2001, J BIOL CHEM, V276, P27753, DOI 10.1074/jbc.C100221200; Monaghan AS, 2004, J BIOL CHEM, V279, P1003, DOI 10.1074/jbc.M308070200; Mourich DV, 2009, CURR OPIN MOL THER, V11, P124; Ohya S, 2005, AM J PHYSIOL-HEART C, V289, pH1635, DOI 10.1152/ajpheart.00016.2005; Ohya S, 1997, FEBS LETT, V401, P252, DOI 10.1016/S0014-5793(96)01485-8; PAULY JL, 1986, J IMMUNOL, V136, P246; Pietrzykowski AZ, 2008, NEURON, V59, P274, DOI 10.1016/j.neuron.2008.05.032; Roncarati R, 2005, MOL CELL NEUROSCI, V28, P314, DOI 10.1016/j.mcn.2004.09.015; Snyders DJ, 1999, CARDIOVASC RES, V42, P377, DOI 10.1016/S0008-6363(99)00071-1; Srivastava S, 2006, MOL BIOL CELL, V17, P146, DOI 10.1091/mbc.e05-08-0763; Stocker M, 2004, NAT REV NEUROSCI, V5, P758, DOI 10.1038/nrn1516; Strang C, 2001, J BIOL CHEM, V276, P28493, DOI 10.1074/jbc.M010540200; Syme CA, 2003, J BIOL CHEM, V278, P8476, DOI 10.1074/jbc.M210072200; Tomita H, 2003, MOL PSYCHIATR, V8, P524, DOI 10.1038/sj.mp.4001271; Wonderlin WF, 1996, J MEMBRANE BIOL, V154, P91, DOI 10.1007/s002329900135; Wulff H, 2003, CURR OPIN DRUG DI DE, V6, P640; Wulff H, 2007, CURR OPIN DRUG DISC, V10, P438	52	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16940	16952		10.1074/jbc.M110.184192	http://dx.doi.org/10.1074/jbc.M110.184192			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21345794	hybrid, Green Published			2022-12-27	WOS:000290301900043
J	Du, Y; Garden, DP; Wang, LX; Zhorov, BS; Dong, K				Du, Yuzhe; Garden, Daniel P.; Wang, Lingxin; Zhorov, Boris S.; Dong, Ke			Identification of New Batrachotoxin-sensing Residues in Segment IIIS6 of the Sodium Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED NA+ CHANNELS; LOCAL-ANESTHETICS; GATING PROPERTIES; MEMBRANE-PROTEIN; CALCIUM-CHANNEL; POINT MUTATIONS; HOMOLOGY MODEL; NUCLEIC-ACIDS; CA2+ CHANNEL; DRUG-BINDING	Ion permeation through voltage-gated sodium channels is modulated by various drugs and toxins. The atomistic mechanisms of action of many toxins are poorly understood. A steroidal alkaloid batrachotoxin (BTX) causes persistent channel activation by inhibiting inactivation and shifting the voltage dependence of activation to more negative potentials. Traditionally, BTX is considered to bind at the channel-lipid interface and allosterically modulate the ion permeation. However, amino acid residues critical for BTX action are found in the inner helices of all four repeats, suggesting that BTX binds in the pore. In the octapeptide segment IEGSFFTL in IIIS6 of a cockroach sodium channel BgNa(v), besides Ser_3i15 and Leu_3i19, which correspond to known BTX-sensing residues of mammalian sodium channels, we found that Gly_3i14 and Phe_3i16 are critical for BTX action. Using these data along with published data as distance constraints, we docked BTX in the Kv1.2-based homology model of the open BgNav channel. We arrived at a model in which BTX adopts a horseshoe conformation with the horseshoe plane normal to the pore axis. The BTX ammonium group is engaged in cation-pi interactions with Phe_3i16 and BTX moieties interact with known BTX-sensing residues in all four repeats. Oxygen atoms at the horseshoe inner surface constitute a transient binding site for permeating cations, whereas the bulky BTX molecule would resist the pore closure, thus causing persistent channel activation. Our study reinforces the concept that steroidal sodium channel agonists bind in the inner pore of sodium channels and elaborates the atomistic mechanism of BTX action.	[Garden, Daniel P.; Zhorov, Boris S.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Du, Yuzhe; Wang, Lingxin; Dong, Ke] Michigan State Univ, Dept Entomol Genet & Neurosci Program, E Lansing, MI 48824 USA	McMaster University; Michigan State University	Zhorov, BS (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, 1280 Main St W, Hamilton, ON L8N 3Z5, Canada.	zhorov@mcmaster.ca	Zhorov, Boris/T-9892-2019; Zhorov, Boris S./V-8072-2019; Wang, Lingxin/ABC-7603-2020	Zhorov, Boris/0000-0002-3630-7114; 	National Institutes of Health [GM057440]; Canadian Institutes of Health Research [MOP-53229]; Natural Sciences and Engineering Council of Canada; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM057440 (to K. D.). This work was also supported by Canadian Institutes of Health Research Grant MOP-53229 (to B. S. Z.) and the Natural Sciences and Engineering Council of Canada.	BEHRENS MI, 1989, J GEN PHYSIOL, V93, P23, DOI 10.1085/jgp.93.1.23; BROWN GB, 1988, INT REV NEUROBIOL, V29, P77, DOI 10.1016/S0074-7742(08)60084-7; Bruhova I, 2008, MOL PHARMACOL, V74, P1033, DOI 10.1124/mol.108.049759; Bruhova I, 2010, J GEN PHYSIOL, V135, P261, DOI 10.1085/jgp.200910288; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; CATTERALL WA, 1977, J BIOL CHEM, V252, P8669; Cheng RCK, 2009, J BIOL CHEM, V284, P28332, DOI 10.1074/jbc.M109.027326; CORREA AM, 1991, J GEN PHYSIOL, V97, P605, DOI 10.1085/jgp.97.3.605; DALY JW, 1965, J AM CHEM SOC, V87, P124, DOI 10.1021/ja01079a026; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Du Y, 2009, BIOCHEM J, V419, P377, DOI 10.1042/BJ20082082; FENG GP, 1995, CELL, V82, P1001, DOI 10.1016/0092-8674(95)90279-1; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; GARBER SS, 1987, J GEN PHYSIOL, V89, P459, DOI 10.1085/jgp.89.3.459; Garden DP, 2010, J COMPUT AID MOL DES, V24, P91, DOI 10.1007/s10822-009-9317-9; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HUANG LYM, 1979, J GEN PHYSIOL, V73, P839, DOI 10.1085/jgp.73.6.839; HUANG LYM, 1984, BIOPHYS J, V45, P313, DOI 10.1016/S0006-3495(84)84157-0; KHODOROV BI, 1992, CELL MOL NEUROBIOL, V12, P59, DOI 10.1007/BF00711639; KHODOROV BI, 1979, NEUROSCIENCE, V4, P1315, DOI 10.1016/0306-4522(79)90159-3; Li HL, 2002, MOL PHARMACOL, V61, P905, DOI 10.1124/mol.61.4.905; LI ZQ, 1987, P NATL ACAD SCI USA, V84, P6611, DOI 10.1073/pnas.84.19.6611; Linford NJ, 1998, P NATL ACAD SCI USA, V95, P13947, DOI 10.1073/pnas.95.23.13947; Lipkind GM, 2005, MOL PHARMACOL, V68, P1611, DOI 10.1124/mol.105.014803; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Meiler J, 2006, PROTEINS, V65, P538, DOI 10.1002/prot.21086; MOZHAEVA G N, 1983, Neirofiziologiya, V15, P571; Narahashi T, 2000, J PHARMACOL EXP THER, V294, P1; O'Reilly AO, 2006, BIOCHEM J, V396, P255, DOI 10.1042/BJ20051925; QUANDT FN, 1982, P NATL ACAD SCI-BIOL, V79, P6732, DOI 10.1073/pnas.79.21.6732; REVENKO S V, 1977, Neirofiziologiya, V9, P313; Song WZ, 2004, J BIOL CHEM, V279, P32554, DOI 10.1074/jbc.M402392200; Tan JG, 2005, MOL PHARMACOL, V67, P513, DOI 10.1124/mol.104.006205; Tan JG, 2002, J NEUROSCI, V22, P5300; Tikhonov DB, 2005, FEBS LETT, V579, P4207, DOI 10.1016/j.febslet.2005.07.017; Tikhonov DB, 2005, BIOPHYS J, V88, P184, DOI 10.1529/biophysj.104.048173; Tikhonov DB, 2007, BIOPHYS J, V93, P1557, DOI 10.1529/biophysj.106.100248; Tikhonov DB, 2006, FEBS LETT, V580, P6027, DOI 10.1016/j.febslet.2006.10.035; Totrov M, 1997, PROTEINS, P215; Vedantham V, 2000, BIOPHYS J, V78, P2943, DOI 10.1016/S0006-3495(00)76834-2; Wang SY, 2007, CHANNELS, V1, pE1, DOI 10.4161/chan.4437; Wang SY, 2007, PFLUG ARCH EUR J PHY, V454, P277, DOI 10.1007/s00424-006-0202-2; Wang SY, 2006, MOL PHARMACOL, V69, P788, DOI 10.1124/mol.105.018200; Wang SY, 2003, CELL SIGNAL, V15, P151, DOI 10.1016/S0898-6568(02)00085-2; Wang SY, 1999, BIOPHYS J, V76, P3141, DOI 10.1016/S0006-3495(99)77465-5; Wang SY, 1998, P NATL ACAD SCI USA, V95, P2653, DOI 10.1073/pnas.95.5.2653; Wang SY, 2001, MOL PHARMACOL, V59, P1100, DOI 10.1124/mol.59.5.1100; Wang SY, 2000, BIOPHYS J, V79, P1379, DOI 10.1016/S0006-3495(00)76390-9; Warmke JW, 1997, J GEN PHYSIOL, V110, P119, DOI 10.1085/jgp.110.2.119; WARNICK JE, 1975, J PHARMACOL EXP THER, V193, P232; WEINER SJ, 1986, J COMPUT CHEM, V7, P230, DOI 10.1002/jcc.540070216; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; Zhen XG, 2005, J GEN PHYSIOL, V126, P193, DOI 10.1085/jgp.200509292; Zhorov BS, 2004, J NEUROCHEM, V88, P782, DOI 10.1111/j.1471-4159.2004.02261.x; ZHOROV BS, 1981, J STRUCT CHEM+, V22, P4, DOI 10.1007/BF00745970; Zhorov BS, 2001, ARCH BIOCHEM BIOPHYS, V393, P22, DOI 10.1006/abbi.2001.2484; ZHOROV BS, 1982, J STRUCT CHEM+, V23, P649, DOI 10.1007/BF00746185; Zlotkin E, 1999, ANNU REV ENTOMOL, V44, P429, DOI 10.1146/annurev.ento.44.1.429	60	45	46	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13151	13160		10.1074/jbc.M110.208496	http://dx.doi.org/10.1074/jbc.M110.208496			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21303907	Green Published, hybrid			2022-12-27	WOS:000289282200036
J	Karki, P; Li, XJ; Schrama, D; Fliegel, L				Karki, Pratap; Li, Xiuju; Schrama, David; Fliegel, Larry			B-Raf Associates with and Activates the NHE1 Isoform of the Na+/H+ Exchanger	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACIDS SER(770); MELANOMA-CELLS; FUNCTIONAL-ANALYSIS; PROTEIN-KINASE; PH; PHOSPHORYLATION; INHIBITORS; COMPLEXES; GROWTH; BRAF	The serine/threonine kinase B-Raf is the second most frequently occurring human oncogene after Ras. Mutations of B-Raf occur with the highest incidences in melanoma, and the most common mutant, V600E, renders B-Raf constitutively active. The sodium proton exchanger isoform 1 (NHE1) is a ubiquitously expressed plasma membrane protein responsible for regulating intracellular pH, cell volume, cell migration, and proliferation. A screen of protein kinases that bind to NHE1 revealed that B-Raf bound to the cytosolic regulatory tail of NHE1 Immunoprecipitation of NHE1 from He La and HEK cells confirmed the association of B-Raf with NHE1 in vivo. The expressed and purified C-terminal 182 amino acids of the NHE1 protein were also shown to associate with B-Raf protein in vitro. Because treatment with the kinase inhibitor sorafenib decreased NHE1 activity in HeLa and HEK cells, we examined the role of B-Raf in regulating NHE1 in malignant melanoma cells. Melanoma cells with the B-Raf(v600E) mutation demonstrated increased resting intracellular pH that was dependent on elevated NHE1 activity. NHE1 activity after an acute acid load was also elevated in these cell lines. Moreover, inhibition of B-Raf activity by either sorafenib, PLX4720, or siRNA reduction of B-Raf levels abolished ERK phosphorylation and decreased NHE1 activity. These results demonstrate that B-Raf associates with and stimulates NHE1 activity and that B-Raf(v600E) also increases NHE1 activity that raises intracellular pH.	[Karki, Pratap; Li, Xiuju; Fliegel, Larry] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Schrama, David] Med Univ Graz, Div Dermatol, A-8036 Graz, Austria	University of Alberta; Medical University of Graz	Fliegel, L (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada.	Ifliegel@ualberta.ca		Schrama, David/0000-0002-6931-8194	Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada; Alberta Heritage Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Alberta Heritage Foundation(Alberta Heritage Foundation for Medical Research)	This work was supported in part by a grant from the Canadian Institutes of Health Research (to L. F.).; Supported in part by the Heart and Stroke Foundation of Canada.; Supported by Alberta Heritage Foundation for Medical Research Scientist award.	ANWER MS, 1994, HEPATOLOGY, V20, P1309, DOI 10.1016/0270-9139(94)90773-0; Avkiran M, 2001, BASIC RES CARDIOL, V96, P306, DOI 10.1007/s003950170037; Baumgartner M, 2004, AM J PHYSIOL-CELL PH, V287, pC844, DOI 10.1152/ajpcell.00094.2004; Camina JP, 2007, J CELL PHYSIOL, V213, P187, DOI 10.1002/jcp.21109; Cardone RA, 2005, NAT REV CANCER, V5, P786, DOI 10.1038/nrc1713; Coccaro E, 2009, AM J PHYSIOL-HEART C, V297, pH846, DOI 10.1152/ajpheart.01231.2008; Cui Y, 2008, ONCOGENE, V27, P3122, DOI 10.1038/sj.onc.1210972; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Edmunds JW, 2004, J CELL SCI, V117, P3715, DOI 10.1242/jcs.01346; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; FLAHERTY K, 2009, J CLIN ONCOL, V27, pS15; Fliegel L, 2005, INT J BIOCHEM CELL B, V37, P33, DOI 10.1016/j.biocel.2004.02.006; Fliegel L, 2009, EXPERT OPIN THER TAR, V13, P55, DOI [10.1517/14728220802600707, 10.1517/14728220802600707 ]; GRINSTEIN S, 1989, BIOCHIM BIOPHYS ACTA, V988, P73, DOI 10.1016/0304-4157(89)90004-X; Haworth RS, 2006, BIOCHEM J, V399, P493, DOI 10.1042/BJ20051628; Kang MG, 1998, BIOL CELL, V90, P477, DOI 10.1016/S0248-4900(99)80006-9; Karki P, 2010, BBA-BIOMEMBRANES, V1798, P1565, DOI 10.1016/j.bbamem.2010.05.005; Karmazyn M., 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P323, DOI 10.2174/1568006054553417; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; LAZDUNSKI M, 1985, J MOL CELL CARDIOL, V17, P1029, DOI 10.1016/S0022-2828(85)80119-X; Leonoudakis D, 2004, J BIOL CHEM, V279, P22331, DOI 10.1074/jbc.M400285200; Li XJ, 2003, BIOCHEMISTRY-US, V42, P7448, DOI 10.1021/bi027143d; Li XJ, 2006, BIOCHEMISTRY-US, V45, P2414, DOI 10.1021/bi051132d; Lundquist JJ, 2006, BRAIN CELL BIOL, V35, P267, DOI 10.1007/s11068-008-9018-7; Malo ME, 2007, J BIOL CHEM, V282, P6292, DOI 10.1074/jbc.M611073200; Malo ME, 2006, CAN J PHYSIOL PHARM, V84, P1081, DOI 10.1139/Y06-065; Meima ME, 2007, CURR OPIN NEPHROL HY, V16, P365, DOI 10.1097/MNH.0b013e3281bd888d; MICHALAK M, 1990, J BIOL CHEM, V265, P5869; Misik AJ, 2005, BIOCHEMISTRY-US, V44, P5842, DOI 10.1021/bi047659s; Murtazina R, 2001, EUR J BIOCHEM, V268, P4674, DOI 10.1046/j.1432-1327.2001.02391.x; Paradiso A, 2004, BREAST CANCER RES, V6, pR616, DOI 10.1186/bcr922; Pratilas CA, 2007, REV RECENT CLIN TRIA, V2, P121, DOI 10.2174/157488707780599393; Ren JG, 2007, P NATL ACAD SCI USA, V104, P10465, DOI 10.1073/pnas.0611308104; Reshkin SJ, 2000, J BIOL CHEM, V275, P5361, DOI 10.1074/jbc.275.8.5361; Reshkin SJ, 2000, FASEB J, V14, P2185, DOI 10.1096/fj.00-0029com; Schrama David, 2008, J Carcinog, V7, P1, DOI 10.1186/1477-3163-7-1; Sheridan C, 2008, J BIOL CHEM, V283, P22128, DOI 10.1074/jbc.M800271200; Silva NLCL, 1997, PFLUG ARCH EUR J PHY, V433, P792, DOI 10.1007/s004240050347; SILVA NLCL, 1995, BIOCHEMISTRY-US, V34, P10412, DOI 10.1021/bi00033a013; Slepkov ER, 2007, BIOCHEM J, V401, P623, DOI 10.1042/BJ20061062; Slepkov ER, 2004, BIOCHEM J, V379, P31, DOI 10.1042/BJ20030884; Smalley KSM, 2009, FUTURE ONCOL, V5, P775, DOI [10.2217/fon.09.56, 10.2217/FON.09.56]; Stock C, 2008, EUR J CELL BIOL, V87, P591, DOI 10.1016/j.ejcb.2008.01.007; Stock C, 2007, CELL PHYSIOL BIOCHEM, V20, P679, DOI 10.1159/000107550; Stuwe L, 2007, J PHYSIOL-LONDON, V585, P351, DOI 10.1113/jphysiol.2007.145185; Takahashi E, 1999, J BIOL CHEM, V274, P20206, DOI 10.1074/jbc.274.29.20206; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Wang HY, 1997, J BIOL CHEM, V272, P26545, DOI 10.1074/jbc.272.42.26545; Wang XN, 2006, J CELL PHYSIOL, V209, P253, DOI 10.1002/jcp.20731; Wu XC, 2008, J CELL BIOCHEM, V105, P167, DOI 10.1002/jcb.21809; Zhao YH, 2008, BIOCHEM BIOPH RES CO, V370, P509, DOI 10.1016/j.bbrc.2008.03.148	51	33	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13096	13105		10.1074/jbc.M110.165134	http://dx.doi.org/10.1074/jbc.M110.165134			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21345796	Green Published, hybrid			2022-12-27	WOS:000289282200030
J	Kim, CS; Epand, RF; Leikina, E; Epand, RM; Chernomordik, LV				Kim, Chang Sup; Epand, Raquel F.; Leikina, Eugenia; Epand, Richard M.; Chernomordik, Leonid V.			The Final Conformation of the Complete Ectodomain of the HA2 Subunit of Influenza Hemagglutinin Can by Itself Drive Low pH-dependent Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS MEMBRANE-FUSION; HEMIFUSION INTERMEDIATE; TRANSMEMBRANE DOMAIN; PORE FORMATION; COILED-COIL; PROTEINS; MECHANISM; PEPTIDE; STABILITY; STATE	One of the best characterized fusion proteins, the influenza virus hemagglutinin (HA), mediates fusion between the viral envelope and the endosomal membrane during viral entry into the cell. In the initial conformation of HA, its fusogenic subunit, the transmembrane protein HA2, is locked in a metastable conformation by the receptor-binding HA1 subunit of HA. Acidification in the endosome triggers HA2 refolding toward the final lowest energy conformation. Is the fusion process driven by this final conformation or, as often suggested, by the energy released by protein restructuring? Here we explored structural properties as well as the fusogenic activity of the full sized trimeric HA2(1-185) (here called HA2*) that presents the final conformation of the HA2 ectodomain. We found HA2* to mediate fusion between lipid bilayers and between biological membranes in a low pH-dependent manner. Two mutations known to inhibit HA-mediated fusion strongly inhibited the fusogenic activity of HA2*. At surface densities similar to those of HA in the influenza virus particle, HA2* formed small fusion pores but did not expand them. Our results confirm that the HA1 subunit responsible for receptor binding as well as the transmembrane and cytosolic domains of HA2 is not required for fusion pore opening and substantiate the hypothesis that the final form of HA2 is more important for fusion than the conformational change that generates this form.	[Kim, Chang Sup] Hanbat Natl Univ, Div Appl Chem & Biotechnol, Dept Biotechnol, Taejon 305719, South Korea; [Epand, Raquel F.; Epand, Richard M.] McMaster Univ, Dept Biochem, Hamilton, ON L8N 3Z5, Canada; [Leikina, Eugenia; Chernomordik, Leonid V.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Membrane Biol, Program Phys Biol, NIH, Bethesda, MD 20892 USA	Hanbat National University; McMaster University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Kim, CS (corresponding author), Hanbat Natl Univ, Div Appl Chem & Biotechnol, Dept Biotechnol, Taejon 305719, South Korea.	changskim@hanbat.ac.kr; epand@mcmaster.ca; chernoml@mail.nih.gov	, Richard/R-2316-2019	, Richard/0000-0002-9602-9558	Ministry of Education, Science and Technology [NRF-2007-313-D00237]; Canadian Institutes of Health Research [MOP 86608]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001501] Funding Source: NIH RePORTER	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of the Eunice Kennedy Shriver NICHD and by an intramural biodefense research grant from the NIAID (both to L. V. C.). This work was also supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (Grant NRF-2007-313-D00237) (to C. S. K.) and in part by Canadian Institutes of Health Research Grant MOP 86608 (to R. M. E.).	Ames B.N., 1966, METHOD ENZYMOL, V8, P115, DOI [10.1016/0076-6879(66)08014-5, DOI 10.1016/0076-6879(66)08014-5]; Armstrong RT, 2000, J CELL BIOL, V151, P425, DOI 10.1083/jcb.151.2.425; Bentz J, 2000, BIOPHYS J, V78, P886, DOI 10.1016/S0006-3495(00)76646-X; Borrego-Diaz E, 2003, VIROLOGY, V316, P234, DOI 10.1016/j.virol.2003.07.006; Bottcher C, 1999, FEBS LETT, V463, P255, DOI 10.1016/S0014-5793(99)01475-1; Brugger B, 2000, EMBO J, V19, P1272, DOI 10.1093/emboj/19.6.1272; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Carr CM, 1997, P NATL ACAD SCI USA, V94, P14306, DOI 10.1073/pnas.94.26.14306; CARR CM, 1993, CELL, V73, P823, DOI 10.1016/0092-8674(93)90260-W; Chen J, 1998, CELL, V95, P409, DOI 10.1016/S0092-8674(00)81771-7; Chen J, 1999, P NATL ACAD SCI USA, V96, P8967, DOI 10.1073/pnas.96.16.8967; CHERNOMORDIK L, 1995, J VIROL, V69, P3049, DOI 10.1128/JVI.69.5.3049-3058.1995; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Chernomordik LV, 1998, J CELL BIOL, V140, P1369, DOI 10.1083/jcb.140.6.1369; Curtis-Fisk J, 2007, J AM CHEM SOC, V129, P11320, DOI 10.1021/ja073644g; Danieli T, 1996, J CELL BIOL, V133, P559, DOI 10.1083/jcb.133.3.559; DANIELS RS, 1985, CELL, V40, P431, DOI 10.1016/0092-8674(85)90157-6; DOXSEY SJ, 1985, J CELL BIOL, V101, P19, DOI 10.1083/jcb.101.1.19; Earp LJ, 2005, CURR TOP MICROBIOL, V285, P25; Epand RF, 2003, BIOCHEMISTRY-US, V42, P5052, DOI 10.1021/bi034094b; Epand RF, 1999, J MOL BIOL, V286, P489, DOI 10.1006/jmbi.1998.2500; Epand RM, 2002, BIOCHEM J, V365, P841, DOI 10.1042/BJ20020290; Epand RM, 2001, BIOCHEMISTRY-US, V40, P8800, DOI 10.1021/bi0107187; Floyd DL, 2008, P NATL ACAD SCI USA, V105, P15382, DOI 10.1073/pnas.0807771105; Frolov VA, 2000, TRAFFIC, V1, P622, DOI 10.1034/j.1600-0854.2000.010806.x; GETHING MJ, 1986, J CELL BIOL, V102, P11, DOI 10.1083/jcb.102.1.11; Han X, 2001, NAT STRUCT BIOL, V8, P715, DOI 10.1038/90434; Huang Q, 2003, BBA-BIOMEMBRANES, V1614, P3, DOI 10.1016/S0005-2736(03)00158-5; Huang Q, 2009, PROTEINS, V74, P291, DOI 10.1002/prot.22157; Jackson MB, 2006, ANNU REV BIOPH BIOM, V35, P135, DOI 10.1146/annurev.biophys.35.040405.101958; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; KEMBLE GW, 1994, CELL, V76, P383, DOI 10.1016/0092-8674(94)90344-1; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; Kim CH, 1998, BIOCHEMISTRY-US, V37, P137, DOI 10.1021/bi971982w; Kim CH, 1996, BIOCHEMISTRY-US, V35, P5359, DOI 10.1021/bi960332+; Kozerski C, 2000, J VIROL, V74, P7529, DOI 10.1128/JVI.74.16.7529-7537.2000; Kozlov MM, 2010, TRENDS BIOCHEM SCI, V35, P699, DOI 10.1016/j.tibs.2010.06.003; Kozlov MM, 1998, BIOPHYS J, V75, P1384, DOI 10.1016/S0006-3495(98)74056-1; LeDuc DL, 2000, BIOCHEMISTRY-US, V39, P2733, DOI 10.1021/bi992457v; Leikina E, 2001, BIOCHEMISTRY-US, V40, P8378, DOI 10.1021/bi010466+; Li JY, 2010, J PHYS CHEM B, V114, P8799, DOI 10.1021/jp1029163; Macosko JC, 1997, J MOL BIOL, V267, P1139, DOI 10.1006/jmbi.1997.0931; Markosyan RM, 2000, MOL BIOL CELL, V11, P1143, DOI 10.1091/mbc.11.4.1143; Mayer A, 2002, ANNU REV CELL DEV BI, V18, P289, DOI 10.1146/annurev.cellbio.18.032202.114809; McNeil AK, 2006, J BIOL CHEM, V281, P35202, DOI 10.1074/jbc.M606406200; Melikyan GB, 2000, MOL BIOL CELL, V11, P3765, DOI 10.1091/mbc.11.11.3765; MELIKYAN GB, 1995, J CELL BIOL, V131, P679, DOI 10.1083/jcb.131.3.679; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; NIR S, 1993, METHOD ENZYMOL, V220, P379, DOI 10.1016/0076-6879(93)20096-L; Nussler F, 1997, BIOPHYS J, V73, P2280; Plonsky I, 2008, BIOL CELL, V100, P377, DOI 10.1042/BC20070040; Qiao H, 1999, MOL BIOL CELL, V10, P2759, DOI 10.1091/mbc.10.8.2759; Rafikova ER, 2009, J BIOL CHEM, V284, P29847, DOI 10.1074/jbc.M109.044453; Ramos C, 2006, BIOCHEM J, V400, P393, DOI 10.1042/BJ20061218; Remeta DP, 2002, BIOCHEMISTRY-US, V41, P2044, DOI 10.1021/bi015614a; RUIGROK RWH, 1986, VIROLOGY, V155, P484, DOI 10.1016/0042-6822(86)90210-2; Sapir A, 2008, DEV CELL, V14, P11, DOI 10.1016/j.devcel.2007.12.008; SATO SB, 1983, P NATL ACAD SCI-BIOL, V80, P3153, DOI 10.1073/pnas.80.11.3153; Shen S, 2009, MOL BIOL CELL, V20, P2438, DOI 10.1091/mbc.E08-10-0987; Sreerama N, 1999, PROTEIN SCI, V8, P370; STEGMANN T, 1990, EMBO J, V9, P4231, DOI 10.1002/j.1460-2075.1990.tb07871.x; Steinhauer DA, 1996, P NATL ACAD SCI USA, V93, P12873, DOI 10.1073/pnas.93.23.12873; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; Swalley SE, 2004, BIOCHEMISTRY-US, V43, P5902, DOI 10.1021/bi049807k; TAYLOR HP, 1987, VIROLOGY, V159, P288, DOI 10.1016/0042-6822(87)90466-1; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Weissenhorn W, 2007, FEBS LETT, V581, P2150, DOI 10.1016/j.febslet.2007.01.093; Xu YB, 2005, NAT STRUCT MOL BIOL, V12, P417, DOI 10.1038/nsmb921; Zhou Z, 2000, BIOPHYS J, V78, P2418, DOI 10.1016/S0006-3495(00)76785-3; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	70	33	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13226	13234		10.1074/jbc.M110.181297	http://dx.doi.org/10.1074/jbc.M110.181297			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21292763	Green Published, hybrid			2022-12-27	WOS:000289282200043
J	Ma, HT; Poon, RYC				Ma, Hoi Tang; Poon, Randy Y. C.			Orderly Inactivation of the Key Checkpoint Protein Mitotic Arrest Deficient 2 (MAD2) during Mitotic Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; ANAPHASE-PROMOTING COMPLEX; CYCLIN-DEPENDENT KINASES; CDC20; CELLS; MITOSIS; BUBR1; APC/C; CDK1; PROTEOLYSIS	Anaphase is promoted by the ubiquitin ligase anaphase-promoting complex/cyclosome (APC/C) only when all the chromosomes have achieved bipolar attachment to the mitotic spindles. Unattached kinetochores or the absence of tension between the paired kinetochores activates a surveillance mechanism termed the spindle-assembly checkpoint. A fundamental principle of the checkpoint is the activation of mitotic arrest deficient 2 (MAD2). MAD2 then forms a diffusible complex called mitotic checkpoint complex (designated as MAD2((MCC))) before it is recruited to APC/C (designated as MAD2((APC/C))). Large gaps in our knowledge remain on how MAD2 is inactivated after the checkpoint is satisfied. In this study, we have investigated the regulation of MAD2-containing complexes during mitotic progression. Using selective immunoprecipitation of checkpoint components and gel filtration chromatography, we found that MAD2((MCC)) and MAD2((APC/C)) were regulated very differently during mitotic exit. Temporally, MAD2((MCC)) was broken down ahead of MAD2((APC/C)). The inactivation of the two complexes also displayed different requirements of proteolysis; although APC/C and proteasome activities were dispensable for MAD2((MCC)) inactivation, they are required for MAD2((APC/C)) inactivation. In fact, the degradation of CDC20 is inextricably linked to the breakdown of MAD2((APC/C)). These data extended our understanding of the checkpoint complexes during checkpoint silencing.	[Ma, Hoi Tang; Poon, Randy Y. C.] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China	Hong Kong University of Science & Technology	Poon, RYC (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China.	rycpoon@ust.hk		MA, Hoi Tang/0000-0001-5876-0107; Poon, Randy/0000-0001-5571-6231	Research Grants Council [662007, 662208]	Research Grants Council(Hong Kong Research Grants Council)	This work was supported in part by the Research Grants Council Grants 662007 and 662208 (to R. Y. C. P.).	Arooz T, 2000, BIOCHEMISTRY-US, V39, P9494, DOI 10.1021/bi0009643; Ausubel FM., 2006, ENZYMATIC MANIPULATI; Bellanger S, 2007, ONCOGENE, V26, P7175, DOI 10.1038/sj.onc.1210539; Chan YW, 2008, CELL CYCLE, V7, P1449, DOI 10.4161/cc.7.10.5880; Chang DC, 2003, J BIOL CHEM, V278, P37865, DOI 10.1074/jbc.M306376200; CHOW JP, 2011, MOL CELL BI IN PRESS; D'Angiolella V, 2003, GENE DEV, V17, P2520, DOI 10.1101/gad.267603; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; De Antoni A, 2005, CURR BIOL, V15, P214, DOI 10.1016/j.cub.2005.01.038; Eytan E, 2008, P NATL ACAD SCI USA, V105, P9181, DOI 10.1073/pnas.0804069105; Fang GW, 2002, MOL BIOL CELL, V13, P755, DOI 10.1091/mbc.01-09-0437; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; Li KKW, 2002, LIVER, V22, P259, DOI 10.1046/j.0106-9543.2002.01629.x; Li Y, 1997, P NATL ACAD SCI USA, V94, P12431, DOI 10.1073/pnas.94.23.12431; Luo XL, 2002, MOL CELL, V9, P59, DOI 10.1016/S1097-2765(01)00435-X; Ma HT, 2009, MOL CELL BIOL, V29, P6500, DOI 10.1128/MCB.00669-09; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nilsson J, 2008, NAT CELL BIOL, V10, P1411, DOI 10.1038/ncb1799; Pan J, 2004, GENE DEV, V18, P1439, DOI 10.1101/gad.1184204; Pesin JA, 2008, ANNU REV CELL DEV BI, V24, P475, DOI 10.1146/annurev.cellbio.041408.115949; Pinsky BA, 2009, CURR BIOL, V19, P1182, DOI 10.1016/j.cub.2009.06.043; POON RYC, 1995, MOL BIOL CELL, V6, P1197, DOI 10.1091/mbc.6.9.1197; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Reis A, 2006, EMBO REP, V7, P1040, DOI 10.1038/sj.embor.7400772; Rudner AD, 2000, J CELL BIOL, V149, P1377, DOI 10.1083/jcb.149.7.1377; Skoufias DA, 2007, J CELL BIOL, V179, P671, DOI 10.1083/jcb.200704117; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Teichner A, 2011, P NATL ACAD SCI USA, V108, P3187, DOI 10.1073/pnas.1100023108; Vanoosthuyse V, 2009, CURR BIOL, V19, P1176, DOI 10.1016/j.cub.2009.05.060; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Vigneron S, 2004, MOL BIOL CELL, V15, P4584, DOI 10.1091/mbc.E04-01-0051; Visconti R, 2010, CELL CYCLE, V9, P564, DOI 10.4161/cc.9.3.10581; Wassmann K, 1998, P NATL ACAD SCI USA, V95, P11193, DOI 10.1073/pnas.95.19.11193; Xia GH, 2004, EMBO J, V23, P3133, DOI 10.1038/sj.emboj.7600322; Yam CH, 2001, P NATL ACAD SCI USA, V98, P497, DOI 10.1073/pnas.240461397	36	25	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13052	13059		10.1074/jbc.M110.201897	http://dx.doi.org/10.1074/jbc.M110.201897			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21335556	Green Published, hybrid			2022-12-27	WOS:000289282200025
J	Shen, S; Bryant, KD; Brown, SM; Randell, SH; Asokan, A				Shen, Shen; Bryant, Kelli D.; Brown, Sarah M.; Randell, Scott H.; Asokan, Aravind			Terminal N-Linked Galactose Is the Primary Receptor for Adeno-associated Virus 9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIALIDASE FUSION PROTEIN; GOLGI VESICLE MEMBRANES; MUTANT DEFICIENT; GENE-THERAPY; IN-VIVO; BINDING; ACID; TRANSDUCTION; VECTORS; LECTIN	Sialylated glycans serve as cell surface attachment factors for a broad range of pathogens. We report an atypical example, where desialylation increases cell surface binding and infectivity of adeno-associated virus (AAV) serotype 9, a human parvovirus isolate. Enzymatic removal of sialic acid, but not heparan sulfate or chondroitin sulfate, increased AAV9 transduction regardless of cell type. Viral binding and transduction assays on mutant Chinese hamster ovary (CHO) cell lines defective in various stages of glycan chain synthesis revealed a potential role for core glycan residues under sialic acid in AAV9 transduction. Treatment with chemical inhibitors of glycosylation and competitive inhibition studies with different lectins suggest that N-linked glycans with terminal galactosyl residues facilitate cell surface binding and transduction by AAV9. In corollary, resialylation of galactosylated glycans on the sialic acid-deficient CHO Lec2 cell line with different sialyltransferases partially blocked AAV9 transduction. Quantitative analysis of AAV9 binding to parental, sialidase-treated or sialic acid-deficient mutant CHO cells revealed a 3-15-fold increase in relative binding potential of AAV9 particles upon desialylation. Finally, pretreatment of well differentiated human airway epithelial cultures and intranasal instillation of recombinant sialidase in murine airways enhanced transduction efficiency of AAV9 by > 1 order of magnitude. Taken together, the studies described herein provide a molecular basis for low infectivity of AAV9 in vitro and a biochemical strategy to enhance gene transfer by AAV9 vectors in general.	[Shen, Shen; Bryant, Kelli D.; Brown, Sarah M.; Asokan, Aravind] Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC 27599 USA; [Shen, Shen; Asokan, Aravind] Univ N Carolina, Mol & Cellular Biophys Program, Chapel Hill, NC 27599 USA; [Shen, Shen] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Randell, Scott H.] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27599 USA; [Asokan, Aravind] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Asokan, A (corresponding author), Univ N Carolina, Gene Therapy Ctr, CB 7352,4101 Thurston Bldg, Chapel Hill, NC 27599 USA.	aravind@med.unc.edu	Core, Vector/CAF-4832-2022		National Institutes of Health [R01HL089221-A1, R01HL089221-A1S2]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL089221-A1 and -A1S2 (to A. A.). This work was also supported by a grant from the American Heart Association (to A. A.).	Akache B, 2007, MOL THER, V15, P330, DOI 10.1038/sj.mt.6300053; Akhtar J, 2009, FEBS J, V276, P7228, DOI 10.1111/j.1742-4658.2009.07402.x; Bai XM, 2001, GLYCOBIOLOGY, V11, P621, DOI 10.1093/glycob/11.8.621; Baker AH, 2007, MOL THER, V15, P1410, DOI 10.1038/sj.mt.6300206; Bowles D.E., 2006, PARVOVIRUSES, P15; Cohen M, 2010, OMICS, V14, P455, DOI 10.1089/omi.2009.0148; Dechecchi MC, 2001, J VIROL, V75, P8772, DOI 10.1128/JVI.75.18.8772-8780.2001; DEUTSCHER SL, 1986, J BIOL CHEM, V261, P96; DEUTSCHER SL, 1984, CELL, V39, P295, DOI 10.1016/0092-8674(84)90007-2; ELBEIN AD, 1981, P NATL ACAD SCI-BIOL, V78, P7393, DOI 10.1073/pnas.78.12.7393; Gao GP, 2004, J VIROL, V78, P6381, DOI 10.1128/JVI.78.12.6381-6388.2004; Gao GP, 2005, CURR GENE THER, V5, P285, DOI 10.2174/1566523054065057; Govindasamy L, 2006, J VIROL, V80, P11556, DOI 10.1128/JVI.01536-06; Grieger JC, 2006, NAT PROTOC, V1, P1412, DOI 10.1038/nprot.2006.207; Guglielmi KM, 2006, CURR TOP MICROBIOL, V309, P1; Hennet T, 1998, P NATL ACAD SCI USA, V95, P4504, DOI 10.1073/pnas.95.8.4504; Hundt C, 2001, EMBO J, V20, P5876, DOI 10.1093/emboj/20.21.5876; Kaludov N, 2001, J VIROL, V75, P6884, DOI 10.1128/JVI.75.15.6884-6893.2001; Kornegay JN, 2010, MOL THER, V18, P1501, DOI 10.1038/mt.2010.94; KUAN SF, 1989, J BIOL CHEM, V264, P19271; Malakhov MP, 2006, ANTIMICROB AGENTS CH, V50, P1470, DOI 10.1128/AAC.50.4.1470-1479.2006; Martin LT, 2002, J BIOL CHEM, V277, P32930, DOI 10.1074/jbc.M203362200; Mitchell AM, 2010, CURR GENE THER, V10, P319; Mountney A, 2010, P NATL ACAD SCI USA, V107, P11561, DOI 10.1073/pnas.1006683107; Mueller C, 2008, GENE THER, V15, P858, DOI 10.1038/gt.2008.68; Nam HJ, 2006, J BIOL CHEM, V281, P25670, DOI 10.1074/jbc.M604421200; Nemerow GR, 2009, VIROLOGY, V384, P380, DOI 10.1016/j.virol.2008.10.016; Neu U, 2009, VIROLOGY, V384, P389, DOI 10.1016/j.virol.2008.12.021; Ng R, 2010, J VIROL, V84, P12945, DOI 10.1128/JVI.01235-10; North SJ, 2010, J BIOL CHEM, V285, P5759, DOI 10.1074/jbc.M109.068353; OHYAMA Y, 1985, J BIOL CHEM, V260, P6882; Olofsson S, 2005, ANN MED, V37, P154, DOI 10.1080/07853890510007340; Pacak CA, 2006, CIRC RES, V99, pE3, DOI 10.1161/01.RES.0000237661.18885.f6; Schmidt M, 2008, J VIROL, V82, P8911, DOI 10.1128/JVI.00672-08; Schmidt M, 2006, J VIROL, V80, P5516, DOI 10.1128/JVI.02393-05; SHIBUYA N, 1987, J BIOL CHEM, V262, P1596; STANLEY P, 1985, MOL CELL BIOL, V5, P1204, DOI 10.1128/MCB.5.6.1204; STULTS NL, 1989, J BIOL CHEM, V264, P19956; Summerford C, 1998, J VIROL, V72, P1438, DOI 10.1128/JVI.72.2.1438-1445.1998; Triana-Baltzer GB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007788; Viswanathan K, 2010, GLYCOCONJUGATE J, V27, P561, DOI 10.1007/s10719-010-9303-4; Walters RW, 2001, J BIOL CHEM, V276, P20610, DOI 10.1074/jbc.M101559200; WANG WC, 1988, J BIOL CHEM, V263, P4576; Wu AM, 2007, GLYCOCONJUGATE J, V24, P591, DOI 10.1007/s10719-007-9063-y; Wu ZJ, 2006, J VIROL, V80, P9093, DOI 10.1128/JVI.00895-06; Wu ZJ, 2006, MOL THER, V14, P316, DOI 10.1016/j.ymthe.2006.05.009; YAMAMOTO K, 1981, BIOCHEMISTRY-US, V20, P5894, DOI 10.1021/bi00523a037; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	48	163	170	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13532	13540		10.1074/jbc.M110.210922	http://dx.doi.org/10.1074/jbc.M110.210922			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21330365	Green Published, hybrid			2022-12-27	WOS:000289282200073
J	Das, S; Oliver, DB				Das, Sanchaita; Oliver, Donald B.			Mapping of the SecA.SecY and SecA.SecG Interfaces by Site-directed in Vivo Photocross-linking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI SECA; PROTEIN-CONDUCTING CHANNEL; PREPROTEIN TRANSLOCASE; MEMBRANE TOPOLOGY; CROSS-LINKING; DIMERIC SECA; AMINO-ACID; SECYEG; BINDING; ATPASE	The two major components of the Eubacteria Sec-dependent protein translocation system are the heterotrimeric channel-forming component SecYEG and its binding partner, the SecA ATPase nanomotor. Once bound to SecYEG, the preprotein substrate, and ATP, SecA undergoes ATP-hydrolytic cycles that drive the stepwise translocation of proteins. Although a previous site-directed in vivo photocross-linking study (Mori, H., and Ito, K. (2006) Proc. Natl. Acad. Sci. U. S. A. 103, 16159-16164) elucidated residues of SecY needed for interaction with SecA, no reciprocal study for SecA protein has been reported to date. In the present study we mapped residues of SecA that interact with SecY or SecG utilizing this approach. Our results show that distinct domains of SecA on two halves of the molecule interact with two corresponding SecY partners as well as with the central cytoplasmic domain of SecG. Our data support the in vivo relevance of the Thermotoga maritima SecA.SecYEG crystal structure that visualized SecYEG interaction for only one-half of SecA as well as previous studies indicating that SecA normally binds two molecules of SecYEG.	[Das, Sanchaita; Oliver, Donald B.] Wesleyan Univ, Dept Mol Biol & Biochem, Middletown, CT 06457 USA	Wesleyan University	Oliver, DB (corresponding author), Wesleyan Univ, Dept Mol Biol & Biochem, 52 Lawn Ave, Middletown, CT 06457 USA.	doliver@wesleyan.edu						AKIYAMA Y, 1987, EMBO J, V6, P3465, DOI 10.1002/j.1460-2075.1987.tb02670.x; Auclair SM, 2010, BIOCHEMISTRY-US, V49, P782, DOI 10.1021/bi901446r; BOST S, 1995, EMBO J, V14, P4412, DOI 10.1002/j.1460-2075.1995.tb00120.x; BREUKINK E, 1995, J BIOL CHEM, V270, P7902, DOI 10.1074/jbc.270.14.7902; Breyton C, 2002, NATURE, V418, P662, DOI 10.1038/nature00827; Chiba K, 2002, J BACTERIOL, V184, P2243, DOI 10.1128/JB.184.8.2243-2250.2002; Cooper DB, 2008, J MOL BIOL, V382, P74, DOI 10.1016/j.jmb.2008.06.049; DOUVILLE K, 1995, J BIOL CHEM, V270, P20106, DOI 10.1074/jbc.270.34.20106; Duong F, 2003, EMBO J, V22, P4375, DOI 10.1093/emboj/cdg418; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Eichler J, 1998, J BACTERIOL, V180, P5776, DOI 10.1128/JB.180.21.5776-5779.1998; Eichler J, 1997, P NATL ACAD SCI USA, V94, P5574, DOI 10.1073/pnas.94.11.5574; Erlandson KJ, 2008, NATURE, V455, P984, DOI 10.1038/nature07439; Farrelli IS, 2005, NAT METHODS, V2, P377, DOI 10.1038/nmeth0505-377; Gelis I, 2007, CELL, V131, P756, DOI 10.1016/j.cell.2007.09.039; HANADA M, 1994, J BIOL CHEM, V269, P23625; Jilaveanu LB, 2005, P NATL ACAD SCI USA, V102, P7511, DOI 10.1073/pnas.0502774102; Jilaveanu LB, 2007, J BIOL CHEM, V282, P4661, DOI 10.1074/jbc.M610828200; Karamanou S, 2008, MOL MICROBIOL, V70, P311, DOI 10.1111/j.1365-2958.2008.06402.x; KAUER JC, 1986, J BIOL CHEM, V261, P695; Kaufmann A, 1999, BIOCHEMISTRY-US, V38, P9115, DOI 10.1021/bi990539d; KIM YJ, 1994, CELL, V78, P845; Manting EH, 1999, J BIOL CHEM, V274, P23868, DOI 10.1074/jbc.274.34.23868; Matsumoto G, 1997, EMBO J, V16, P6384, DOI 10.1093/emboj/16.21.6384; Matsumoto G, 1998, P NATL ACAD SCI USA, V95, P13567, DOI 10.1073/pnas.95.23.13567; Mitra K, 2005, NATURE, V438, P318, DOI 10.1038/nature04133; Mori H, 1998, J BIOCHEM, V124, P122, DOI 10.1093/oxfordjournals.jbchem.a022070; Mori H, 2001, TRENDS MICROBIOL, V9, P494, DOI 10.1016/S0966-842X(01)02174-6; Mori H, 2006, P NATL ACAD SCI USA, V103, P16159, DOI 10.1073/pnas.0606390103; Mori H, 2006, J BIOL CHEM, V281, P36249, DOI 10.1074/jbc.M606906200; Nagamori S, 2002, J BIOCHEM, V132, P629, DOI 10.1093/oxfordjournals.jbchem.a003266; NISHIYAMA K, 1994, EMBO J, V13, P3272, DOI 10.1002/j.1460-2075.1994.tb06628.x; Nishiyama KI, 1996, CELL, V85, P71, DOI 10.1016/S0092-8674(00)81083-1; Osborne AR, 2007, CELL, V129, P97, DOI 10.1016/j.cell.2007.02.036; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; Papanikou E, 2007, NAT REV MICROBIOL, V5, P839, DOI 10.1038/nrmicro1771; Patel CN, 2006, PROTEIN SCI, V15, P1379, DOI 10.1110/ps.062141006; Ramamurthy V, 1998, J BACTERIOL, V180, P6419; Robson A, 2007, J MOL BIOL, V374, P965, DOI 10.1016/j.jmb.2007.09.086; Rusch SL, 2007, BBA-BIOMEMBRANES, V1768, P5, DOI 10.1016/j.bbamem.2006.08.013; Ryu YH, 2006, NAT METHODS, V3, P263, DOI 10.1038/NMETH864; Snyders S, 1997, J BIOL CHEM, V272, P11302; Sugai R, 2007, J BIOL CHEM, V282, P29540, DOI 10.1074/jbc.M704716200; Suzuki H, 1998, MOL MICROBIOL, V29, P331, DOI 10.1046/j.1365-2958.1998.00937.x; Taura T, 1997, BIOCHIMIE, V79, P517, DOI 10.1016/S0300-9084(97)82744-7; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; van der Does C, 2003, METHOD ENZYMOL, V372, P86; van der Does C, 1998, BIOCHEMISTRY-US, V37, P201, DOI 10.1021/bi972105t; van der Slius EO, 2006, J BACTERIOL, V188, P1188, DOI 10.1128/JB.188.3.1188-1190.2006; van der Slurs EO, 2006, J MOL BIOL, V361, P839, DOI 10.1016/j.jmb.2006.07.017; van der Wolk JPW, 1998, EMBO J, V17, P3631, DOI 10.1093/emboj/17.13.3631; vanderDoes C, 1996, MOL MICROBIOL, V22, P619, DOI 10.1046/j.1365-2958.1996.d01-1712.x; Veenendaal AKJ, 2004, BBA-MOL CELL RES, V1694, P81, DOI 10.1016/j.bbamcr.2004.02.009; Vrontou E, 2004, J BIOL CHEM, V279, P22490, DOI 10.1074/jbc.M401008200; Wang L, 2006, ANNU REV BIOPH BIOM, V35, P225, DOI 10.1146/annurev.biophys.35.101105.121507; Zimmer J, 2009, J MOL BIOL, V394, P606, DOI 10.1016/j.jmb.2009.10.024	56	44	46	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.182931	http://dx.doi.org/10.1074/jbc.M110.182931			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21317284	Green Published, hybrid			2022-12-27	WOS:000289077500051
J	Durgan, J; Kaji, N; Jin, D; Hall, A				Durgan, Joanne; Kaji, Noriko; Jin, Dan; Hall, Alan			Par6B and Atypical PKC Regulate Mitotic Spindle Orientation during Epithelial Morphogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; CELL-POLARITY PROTEIN; ELEGANS EMBRYOS; PLASMA-MEMBRANE; ADHERENT CELLS; CDC42 GEF; APKC; COMPLEX; ZETA; ISOFORMS	Cdc42 plays an evolutionarily conserved role in promoting cell polarity and is indispensable during epithelial morphogenesis. To further investigate the role of Cdc42, we have used a three-dimensional matrigel model, in which single Caco-2 cells develop to form polarized cysts. Using this system, we previously reported that Cdc42 controls mitotic spindle orientation during cell division to correctly position the apical surface in a growing epithelial structure. In the present study, we have investigated the specific downstream effectors through which Cdc42 controls this process. Here, we report that Par6B and its binding partner, atypical protein kinase C (aPKC), are required to regulate Caco-2 morphogenesis. Depletion or inhibition of Par6B or aPKC phenocopies the loss of Cdc42, inducing misorientation of the mitotic spindle, mispositioning of the nascent apical surface, and ultimately, the formation of aberrant cysts with multiple lumens. Mechanistically, Par6B and aPKC function interdependently in this context. Par6B localizes to the apical surface of Caco-2 cysts and is required to recruit aPKC to this compartment. Conversely, aPKC protects Par6B from proteasomal degradation, in a kinase-independent manner. In addition, we report that depletion or inhibition of aPKC induces robust apoptotic cell death in Caco-2 cells, significantly reducing both cyst size and number. Cell survival and apical positioning depend upon different thresholds of aPKC expression, suggesting that they are controlled by distinct downstream pathways. We conclude that Par6B and aPKC control mitotic spindle orientation in polarized epithelia and, furthermore, that aPKC coordinately regulates multiple processes to promote morphogenesis.	[Durgan, Joanne; Kaji, Noriko; Jin, Dan; Hall, Alan] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Durgan, J (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, 1275 York Ave, New York, NY 10065 USA.	durganj@mskcc.org			National Institutes of Health [GM081435]; Uehara Memorial Foundation; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081435] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uehara Memorial Foundation(Uehara Memorial Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM081435 (to A. H.).; Supported by the Uehara Memorial Foundation.	ADAMS AEM, 1990, J CELL BIOL, V111, P131, DOI 10.1083/jcb.111.1.131; Anderson DC, 2008, SCIENCE, V320, P1771, DOI 10.1126/science.1156063; Atwood SX, 2007, J CELL SCI, V120, P3200, DOI 10.1242/jcs.014902; BERRA E, 1993, CELL, V74, P555, DOI 10.1016/0092-8674(93)80056-K; Berra E, 1997, MOL CELL BIOL, V17, P4346, DOI 10.1128/MCB.17.8.4346; Cameron AJM, 2010, ADV ENZYME REGUL, V50, P169, DOI 10.1016/j.advenzreg.2009.10.004; Cameron AJM, 2009, NAT STRUCT MOL BIOL, V16, P624, DOI 10.1038/nsmb.1606; Chalmers AD, 2005, DEVELOPMENT, V132, P977, DOI 10.1242/dev.01645; DiazMeco MT, 1996, CELL, V86, P777, DOI 10.1016/S0092-8674(00)80152-X; DOMINGUEZ I, 1992, MOL CELL BIOL, V12, P3776, DOI 10.1128/MCB.12.9.3776; Durgan J, 2008, BIOCHEM J, V411, P319, DOI [10.1042/BJ20071348, 10.1042/bj20071348]; Durgan J, 2007, FEBS LETT, V581, P3377, DOI 10.1016/j.febslet.2007.06.035; Etienne-Manneville S, 2003, CURR OPIN CELL BIOL, V15, P67, DOI 10.1016/S0955-0674(02)00005-4; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Fields AP, 2007, PHARMACOL RES, V55, P487, DOI 10.1016/j.phrs.2007.04.015; Gao L, 2004, J BIOL CHEM, V279, P41557, DOI 10.1074/jbc.M403723200; Garrard SM, 2003, EMBO J, V22, P1125, DOI 10.1093/emboj/cdg110; Gotta M, 2001, CURR BIOL, V11, P482, DOI 10.1016/S0960-9822(01)00142-7; Gutcher I, 2003, CELL MOL LIFE SCI, V60, P1061, DOI 10.1007/s00018-003-2281-y; Henrique D, 2003, CURR OPIN GENET DEV, V13, P341, DOI 10.1016/S0959-437X(03)00077-7; Hirano Y, 2004, J BIOL CHEM, V279, P31883, DOI 10.1074/jbc.M403092200; Horikoshi Y, 2009, J CELL SCI, V122, P1595, DOI 10.1242/jcs.043174; Horne-Badovinac S, 2001, CURR BIOL, V11, P1492, DOI 10.1016/S0960-9822(01)00458-4; Huang L, 2010, CURR OPIN GENET DEV, V20, P41, DOI 10.1016/j.gde.2009.12.001; Hutterer A, 2004, DEV CELL, V6, P845, DOI 10.1016/j.devcel.2004.05.003; Jaffe AB, 2008, J CELL BIOL, V183, P625, DOI 10.1083/jcb.200807121; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Kim M, 2007, J CELL SCI, V120, P2309, DOI 10.1242/jcs.007443; Kim S, 2009, J CELL SCI, V122, P3759, DOI 10.1242/jcs.052514; Kishikawa M, 2008, J CELL SCI, V121, P2481, DOI 10.1242/jcs.024109; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kroschewski R, 1999, NAT CELL BIOL, V1, P8, DOI 10.1038/8977; Lamarche N, 1996, CELL, V87, P519, DOI 10.1016/S0092-8674(00)81371-9; LAMPRECHT J, 1986, ANAT EMBRYOL, V175, P129, DOI 10.1007/BF00315463; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Mitsushima M, 2009, MOL CELL BIOL, V29, P2816, DOI 10.1128/MCB.01713-08; Munson C, 2008, DEV BIOL, V324, P41, DOI 10.1016/j.ydbio.2008.08.033; Noda Y, 2001, GENES CELLS, V6, P107, DOI 10.1046/j.1365-2443.2001.00404.x; Nolan ME, 2008, CANCER RES, V68, P8201, DOI 10.1158/0008-5472.CAN-07-6567; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Parkinson SJ, 2004, EMBO J, V23, P77, DOI 10.1038/sj.emboj.7600023; Peterson RT, 2001, CURR BIOL, V11, P1481, DOI 10.1016/S0960-9822(01)00482-1; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Qin Y, 2010, J CELL BIOL, V189, P661, DOI 10.1083/jcb.201002097; Qiu RG, 2000, CURR BIOL, V10, P697, DOI 10.1016/S0960-9822(00)00535-2; REINSCH S, 1994, J CELL BIOL, V126, P1509, DOI 10.1083/jcb.126.6.1509; Reyland ME, 2009, FRONT BIOSCI-LANDMRK, V14, P2386, DOI 10.2741/3385; Rodriguez-Fraticelli AE, 2010, J CELL BIOL, V189, P725, DOI 10.1083/jcb.201002047; Rojas R, 2001, MOL BIOL CELL, V12, P2257, DOI 10.1091/mbc.12.8.2257; Rolls MM, 2003, J CELL BIOL, V163, P1089, DOI 10.1083/jcb.200306079; Rose LS, 1998, ANNU REV GENET, V32, P521, DOI 10.1146/annurev.genet.32.1.521; Rosse C, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000235; Schluter MA, 2009, MOL BIOL CELL, V20, P4652, DOI 10.1091/mbc.E09-02-0137; Schonegg S, 2006, DEVELOPMENT, V133, P3507, DOI 10.1242/dev.02527; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Soloff RS, 2004, J IMMUNOL, V173, P3250, DOI 10.4049/jimmunol.173.5.3250; Standaert ML, 1997, J BIOL CHEM, V272, P30075, DOI 10.1074/jbc.272.48.30075; Suzuki A, 2002, J CELL SCI, V115, P3565, DOI 10.1242/jcs.00032; Suzuki A, 2001, J CELL BIOL, V152, P1183, DOI 10.1083/jcb.152.6.1183; Toyoshima F, 2007, DEV CELL, V13, P796, DOI 10.1016/j.devcel.2007.10.014; Wallace SW, 2010, MOL BIOL CELL, V21, P2996, DOI 10.1091/mbc.E10-05-0429; Warner SJ, 2010, CURR BIOL, V20, P677, DOI 10.1016/j.cub.2010.03.025; Watts JL, 1996, DEVELOPMENT, V122, P3133; Wells CD, 2006, CELL, V125, P535, DOI 10.1016/j.cell.2006.02.045; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Yamanaka T, 2001, GENES CELLS, V6, P721, DOI 10.1046/j.1365-2443.2001.00453.x; Zheng Z, 2010, J CELL BIOL, V189, P275, DOI 10.1083/jcb.200910021	70	103	104	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.174235	http://dx.doi.org/10.1074/jbc.M110.174235			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21300793	Green Published, hybrid			2022-12-27	WOS:000289077500060
J	Kumar, S; Raj, I; Nagpal, I; Subbarao, N; Gourinath, S				Kumar, Sudhir; Raj, Isha; Nagpal, Isha; Subbarao, Naidu; Gourinath, Samudrala			Structural and Biochemical Studies of Serine Acetyltransferase Reveal Why the Parasite Entamoeba histolytica Cannot Form a Cysteine Synthase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-ACETYLSERINE SULFHYDRYLASE; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; HAEMOPHILUS-INFLUENZAE; MOLECULAR-CLONING; BIOSYNTHESIS; PURIFICATION; MECHANISM; MODEL; SYNTHETASE	Cysteine (Cys) plays a major role in growth and survival of the human parasite Entamoeba histolytica. We report here the crystal structure of serine acetyltransferase (SAT) isoform 1, a cysteine biosynthetic pathway enzyme from E. histolytica (EhSAT1) at 1.77 angstrom, in complex with its substrate serine (Ser) at 1.59 angstrom and inhibitor Cys at 1.78 angstrom resolution. EhSAT1 exists as a trimer both in solution as well as in crystal structure, unlike hexamers formed by other known SATs. The difference in oligomeric state is due to the N-terminal region of the EhSAT1, which has very low sequence similarity to known structures, also differs in orientation and charge distribution. The Ser and Cys bind to the same site, confirming that Cys is a competitive inhibitor of Ser. The disordered C-terminal region and the loop near the active site are responsible for solvent-accessible acetyl-CoA binding site and, thus, lose inhibition to acetyl-CoA by the feedback inhibitor Cys. Docking and fluorescence studies show that EhSAT1 C-terminal-mimicking peptides can bind to O-acetyl serine sulfhydrylase (EhOASS), whereas native C-terminal peptide does not show any binding. To test further, C-terminal end of EhSAT1 was mutated and found that it inhibits EhOASS, confirming modified EhSAT1 can bind to EhOASS. The apparent inability of EhSAT1 to form a hexamer and differences in the C-terminal region are likely to be the major reasons for the lack of formation of the large cysteine synthase complex and loss of a complex regulatory mechanism in E. histolytica.	[Kumar, Sudhir; Raj, Isha; Nagpal, Isha; Gourinath, Samudrala] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India; [Subbarao, Naidu] Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi	Gourinath, S (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	samudralag@yahoo.com	Subbarao, Prof Naidu/AAZ-1832-2020; Kumar, Sudhir/AAE-3615-2020	Subbarao, Prof Naidu/0000-0002-1720-2165; Kumar, Sudhir/0000-0001-9673-5842; Raj, Isha/0000-0003-4686-0498	Council for Scientific and Industrial Research, Government of India; Council of Scientific and Industrial Research (India); Indo-U. S. Science and Technology	Council for Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Council of Scientific and Industrial Research (India)(Council of Scientific & Industrial Research (CSIR) - India); Indo-U. S. Science and Technology	This work was supported by the Council for Scientific and Industrial Research, Government of India.; Recipient of a Council of Scientific and Industrial Research (India) fellowship.; Recipient of a Indo-U. S. Science and Technology Forum fellowship. To whom correspondence should be addressed. E-mail: samudralag@yahoo.com.	Agarwal SM, 2008, INT J PARASITOL, V38, P137, DOI 10.1016/j.ijpara.2007.09.009; BECKER MA, 1969, J BIOL CHEM, V244, P2418; Campanini B, 2005, PROTEIN SCI, V14, P2115, DOI 10.1110/ps.051492805; Chinthalapudi K, 2008, PROTEINS, V72, P1222, DOI 10.1002/prot.22013; COOK PF, 1976, J BIOL CHEM, V251, P2023; DeLano W.L, PYMOL MOL GRAPHICS S; DENK D, 1987, J GEN MICROBIOL, V133, P515; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feldman-Salit A, 2009, J MOL BIOL, V386, P37, DOI 10.1016/j.jmb.2008.08.075; Gorman J, 2004, ACTA CRYSTALLOGR D, V60, P1600, DOI 10.1107/S0907444904015240; Hindson VJ, 2000, J BIOL CHEM, V275, P461, DOI 10.1074/jbc.275.1.461; Hindson VJ, 2003, BIOCHEM J, V375, P745, DOI 10.1042/BJ20030429; Hussain S, 2009, MOL BIOCHEM PARASIT, V163, P39, DOI 10.1016/j.molbiopara.2008.09.006; Johnson CM, 2004, ARCH BIOCHEM BIOPHYS, V429, P115, DOI 10.1016/j.abb.2004.06.006; KREDICH NM, 1969, J BIOL CHEM, V244, P2428; KREDICH NM, 1966, J BIOL CHEM, V241, P4955; Krishna C, 2007, ACTA CRYSTALLOGR F, V63, P512, DOI 10.1107/S1744309107022154; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Mino K, 2000, BIOSCI BIOTECH BIOCH, V64, P1628, DOI 10.1271/bbb.64.1628; Mino K, 1999, BIOSCI BIOTECH BIOCH, V63, P168, DOI 10.1271/bbb.63.168; Mino K, 2000, BIOSCI BIOTECH BIOCH, V64, P1874, DOI 10.1271/bbb.64.1874; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nozaki T, 1999, J BIOL CHEM, V274, P32445, DOI 10.1074/jbc.274.45.32445; Nozaki T, 2005, ADV PARASIT, V60, P1, DOI 10.1016/S0065-308X(05)60001-2; Nozaki T, 1998, MOL BIOCHEM PARASIT, V97, P33, DOI 10.1016/S0166-6851(98)00129-7; Olsen LR, 2004, BIOCHEMISTRY-US, V43, P6013, DOI 10.1021/bi0358521; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pye VE, 2004, J BIOL CHEM, V279, P40729, DOI 10.1074/jbc.M403751200; SAITO K, 1995, J BIOL CHEM, V270, P16321, DOI 10.1074/jbc.270.27.16321; Schnell R, 2007, J BIOL CHEM, V282, P23473, DOI 10.1074/jbc.M703518200; SMITH IK, 1971, BIOCHIM BIOPHYS ACTA, V227, P288, DOI 10.1016/0005-2744(71)90061-1; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; WHO PAHO UNE, 1997, EPIDEMIOL B, V18, P13; Zhao CH, 2006, BIOCHEM BIOPH RES CO, V341, P911, DOI 10.1016/j.bbrc.2006.01.054	34	44	44	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.197376	http://dx.doi.org/10.1074/jbc.M110.197376			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21297164	Green Published, hybrid			2022-12-27	WOS:000289077500066
J	Schmidt, J; Liebscher, K; Merten, N; Grundmann, M; Mielenz, M; Sauerwein, H; Christiansen, E; Due-Hansen, ME; Ulven, T; Ullrich, S; Gomeza, J; Drewke, C; Kostenis, E				Schmidt, Johannes; Liebscher, Kathrin; Merten, Nicole; Grundmann, Manuel; Mielenz, Manfred; Sauerwein, Helga; Christiansen, Elisabeth; Due-Hansen, Maria E.; Ulven, Trond; Ullrich, Susanne; Gomeza, Jesus; Drewke, Christel; Kostenis, Evi			Conjugated Linoleic Acids Mediate Insulin Release through Islet G Protein-coupled Receptor FFA1/GPR40	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAIN FATTY-ACIDS; PANCREATIC BETA-CELLS; WHITE ADIPOSE-TISSUE; GLUCOSE-TOLERANCE; DIETARY SUPPLEMENTATION; ENDOTHELIAL-CELLS; GPR40; SECRETION; OBESITY; MICE	Among dietary components, conjugated linoleic acids (CLAs) have attracted considerable attention as weight loss supplements in the Western world because they reduce fat stores and increase muscle mass. However, a number of adverse effects are also ascribed to the intake of CLAs such as aggravation of insulin resistance and the risk of developing diabetes. However, the mechanisms accounting for the effects of CLAs on glucose homeostasis are incompletely understood. Herein we provide evidence that CLAs specifically activate the cell surface receptor FFA1, an emerging therapeutic target to treat type 2 diabetes. Using different recombinant cellular systems engineered to stably express FFA1 and a set of diverse functional assays including the novel, label-free non-invasive dynamic mass redistribution technology (Corning (R) Epic (R) biosensor), both CLA isomers cis-9, trans-11-CLA and trans-10, cis-12-CLA were found to activate FFA1 in vitro at concentrations sufficient to also account for FFA1 activation in vivo. Each CLA isomer markedly increased glucose-stimulated insulin secretion in insulin-producing INS-1E cells that endogenously express FFA1 and in primary pancreatic beta-cells of wild type but not FFA1(-/-) knock-out mice. Our findings establish a clear mechanistic link between CLAs and insulin production and identify the cell surface receptor FFA1 as a molecular target for CLAs, explaining their acute stimulatory effects on insulin secretion in vivo. CLAs are also revealed as insulinotropic components in widely used nutraceuticals, a finding with significant implication for development of FFA1 modulators to treat type 2 diabetes.	[Schmidt, Johannes; Merten, Nicole; Grundmann, Manuel; Gomeza, Jesus; Drewke, Christel; Kostenis, Evi] Univ Bonn, Inst Pharmaceut Biol, D-53115 Bonn, Germany; [Liebscher, Kathrin; Ullrich, Susanne] Univ Tubingen, Dept Internal Med 4, Div Endocrinol Diabetol Vasc Med Nephrol & Clin C, D-72076 Tubingen, Germany; [Mielenz, Manfred; Sauerwein, Helga] Univ Bonn, Inst Anim Sci, Physiol & Hyg Unit, D-53115 Bonn, Germany; [Christiansen, Elisabeth; Due-Hansen, Maria E.; Ulven, Trond] Univ So Denmark, Dept Chem & Phys, DK-5230 Odense M, Denmark	University of Bonn; Eberhard Karls University of Tubingen; University of Bonn; University of Southern Denmark	Drewke, C (corresponding author), Univ Bonn, Inst Pharmaceut Biol, Nussallee 6, D-53115 Bonn, Germany.	cdrewke@uni-bonn.de; kostenis@uni-bonn.de	Mielenz, Manfred/ABB-2293-2021; Ulven, Trond/H-5500-2015; Due-Hansen, Maria E./K-1823-2019; Sauerwein, Helga/R-8242-2019; Rexen Ulven, Elisabeth/S-2026-2017	Ulven, Trond/0000-0002-8135-1755; Rexen Ulven, Elisabeth/0000-0003-1243-7587; Due-Hansen, Maria Elisabeth/0000-0001-8032-2189; Grundmann, Manuel/0000-0002-4473-7851	German Federal Ministry of Education and Research (BMBF); Danish Council for Independent Research Technology and Production [09-070364]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Danish Council for Independent Research Technology and Production(Det Frie Forskningsrad (DFF))	This work was supported by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e. V.) (to K. L. and S. U.) and the Danish Council for Independent Research Technology and Production (Grant no. 09-070364) (to E. C., M. E. D.-H., and T. U.).	Ahren B, 2009, EUR J CLIN NUTR, V63, P778, DOI 10.1038/ejcn.2008.45; Alquier T, 2009, DIABETES, V58, P2607, DOI 10.2337/db09-0362; Alquier T, 2009, DIABETES, V58, P1035, DOI 10.2337/db09-0215; Antony J, 2009, FASEB J, V23, P442, DOI 10.1096/fj.08-114751; Benito P, 2001, LIPIDS, V36, P229, DOI 10.1007/s11745-001-0712-x; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Christiansen E, 2008, J MED CHEM, V51, P7061, DOI 10.1021/jm8010178; Doyle L, 2005, EUR J CLIN NUTR, V59, P432, DOI 10.1038/sj.ejcn.1602093; Eder K, 2010, MOL NUTR FOOD RES, V54, P17, DOI 10.1002/mnfr.200900042; Fernstrom JD, 2008, PHARMACOL THERAPEUT, V117, P105, DOI 10.1016/j.pharmthera.2007.09.001; Han JC, 2010, LANCET, V375, P1737, DOI 10.1016/S0140-6736(10)60171-7; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Herbel BK, 1998, AM J CLIN NUTR, V67, P332, DOI 10.1093/ajcn/67.2.332; Humphries PS, 2009, BIOORG MED CHEM LETT, V19, P2400, DOI 10.1016/j.bmcl.2009.03.082; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Kebede MA, 2009, DIABETES OBES METAB, V11, P10, DOI 10.1111/j.1463-1326.2009.01114.x; Kenakin T, 2010, NAT BIOTECHNOL, V28, P928, DOI 10.1038/nbt0910-928; Kenakin TP, 2009, NAT REV DRUG DISCOV, V8, P617, DOI 10.1038/nrd2838; Kennedy A, 2010, J NUTR BIOCHEM, V21, P171, DOI 10.1016/j.jnutbio.2009.08.003; Lai KL, 2005, LIPIDS, V40, P1107, DOI 10.1007/s11745-005-1474-1; Latour MG, 2007, DIABETES, V56, P1087, DOI 10.2337/db06-1532; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Miller A, 2002, ANTICANCER RES, V22, P3879; Moloney F, 2007, DIABETES, V56, P574, DOI 10.2337/db06-0384; Moon HS, 2009, J NUTR BIOCHEM, V20, P187, DOI 10.1016/j.jnutbio.2008.02.001; Nagao K, 2005, J BIOSCI BIOENG, V100, P152, DOI 10.1263/jbb.100.152; Nagasumi K, 2009, DIABETES, V58, P1067, DOI 10.2337/db08-1233; Padwal RS, 2007, LANCET, V369, P71, DOI 10.1016/S0140-6736(07)60033-6; Pariza MW, 2004, AM J CLIN NUTR, V79, p1132S, DOI 10.1093/ajcn/79.6.1132S; Poirier H, 2005, DIABETOLOGIA, V48, P1059, DOI 10.1007/s00125-005-1765-8; Poirier H, 2005, BIOCHIMIE, V87, P73, DOI 10.1016/j.biochi.2004.11.006; Poirier H, 2006, DIABETES, V55, P1634, DOI 10.2337/db06-0036; Ryder JW, 2001, DIABETES, V50, P1149, DOI 10.2337/diabetes.50.5.1149; Schnell S, 2007, MOL CELL ENDOCRINOL, V263, P173, DOI 10.1016/j.mce.2006.09.013; Schroder R, 2010, NAT BIOTECHNOL, V28, P943, DOI 10.1038/nbt.1671; Schroder R, 2009, J BIOL CHEM, V284, P1324, DOI 10.1074/jbc.M806867200; Steneberg R, 2005, CELL METAB, V1, P245, DOI 10.1016/j.cmet.2005.03.007; Stoddart LA, 2008, J BIOL CHEM, V283, P32913, DOI 10.1074/jbc.M805601200; Stoddart LA, 2008, PHARMACOL REV, V60, P405, DOI 10.1124/pr.108.00802; Taylor CG, 2004, AM J CLIN NUTR, V79, p1164S, DOI 10.1093/ajcn/79.6.1164S; Ullrich S, 2005, DIABETES, V54, P1090, DOI 10.2337/diabetes.54.4.1090; Winzell MS, 2007, PHARMACOL THERAPEUT, V116, P437, DOI 10.1016/j.pharmthera.2007.08.002; Winzell MS, 2006, AM J PHYSIOL-ENDOC M, V290, pE347, DOI 10.1152/ajpendo.00163.2005; Zhang XD, 2010, BIOMED PHARMACOTHER, V64, P647, DOI 10.1016/j.biopha.2010.06.008	45	42	42	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.C110.200477	http://dx.doi.org/10.1074/jbc.C110.200477			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21339298	Green Published, hybrid			2022-12-27	WOS:000289077500002
J	Arora, D; Stopp, S; Bohmer, SA; Schons, J; Godfrey, R; Masson, K; Razumovskaya, E; Ronnstrand, L; Tanzer, S; Bauer, R; Bohmer, FD; Muller, JP				Arora, Deepika; Stopp, Sabine; Boehmer, Sylvia-Annette; Schons, Julia; Godfrey, Rinesh; Masson, Kristina; Razumovskaya, Elena; Ronnstrand, Lars; Taenzer, Simone; Bauer, Reinhard; Boehmer, Frank-D.; Mueller, Joerg P.			Protein-tyrosine Phosphatase DEP-1 Controls Receptor Tyrosine Kinase FLT3 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; ACUTE MYELOGENOUS LEUKEMIA; JUXTAMEMBRANE DOMAIN; ONCOGENIC FLT3; 32D CELLS; MUTATIONS; IDENTIFICATION; TRANSFORMATION; ACTIVATION; GROWTH	Fms-like tyrosine kinase 3 (FLT3) plays an important role in hematopoietic differentiation, and constitutively active FLT3 mutant proteins contribute to the development of acute myeloid leukemia. Little is known about the protein-tyrosine phosphatases (PTP) affecting the signaling activity of FLT3. To identify such PTP, myeloid cells expressing wild type FLT3 were infected with a panel of lentiviral pseudotypes carrying shRNA expression cassettes targeting different PTP. Out of 20 PTP tested, expressed in hematopoietic cells, or presumed to be involved in oncogenesis or tumor suppression, DEP-1 (PTPRJ) was identified as a PTP negatively regulating FLT3 phosphorylation and signaling. Stable 32D myeloid cell lines with strongly reduced DEP-1 levels showed site-selective hyperphosphorylation of FLT3. In particular, the sites pTyr-589, pTyr-591, and pTyr-842 involved in the FLT3 ligand (FL)-mediated activation of FLT3 were hyperphosphorylated the most. Similarly, acute depletion of DEP-1 in the human AML cell line THP-1 caused elevated FLT3 phosphorylation. Direct interaction of DEP-1 and FLT3 was demonstrated by "substrate trapping" experiments showing association of DEP-1 D1205A or C1239S mutant proteins with FLT3 by co-immunoprecipitation. Moreover, activated FLT3 could be dephosphorylated by recombinant DEP-1 in vitro. Enhanced FLT3 phosphorylation in DEP-1-depleted cells was accompanied by enhanced FLT3-dependent activation of ERK and cell proliferation. Stable overexpression of DEP-1 in 32D cells and transient overexpression with FLT3 in HEK293 cells resulted in reduction of FL-mediated FLT3 signaling activity. Furthermore, FL-stimulated colony formation of 32D cells expressing FLT3 in methylcellulose was induced in response to shRNA-mediated DEP-1 knockdown. This transforming effect of DEP-1 knockdown was consistent with a moderately increased activation of STAT5 upon FL stimulation but did not translate into myeloproliferative disease formation in the 32D-C3H/HeJ mouse model. The data indicate that DEP-1 is negatively regulating FLT3 signaling activity and that its loss may contribute to but is not sufficient for leukemogenic cell transformation.	[Arora, Deepika; Stopp, Sabine; Boehmer, Sylvia-Annette; Schons, Julia; Godfrey, Rinesh; Bauer, Reinhard; Boehmer, Frank-D.; Mueller, Joerg P.] Univ Jena, Ctr Mol Biomed, Inst Mol Cell Biol, D-07745 Jena, Germany; [Masson, Kristina; Razumovskaya, Elena; Ronnstrand, Lars] Lund Univ, Malmo Univ Hosp, Dept Lab Med, SE-20502 Malmo, Sweden; [Taenzer, Simone] Leibniz Inst Age Res Fritz Lipmann Inst, Res Grp Immunol, D-07745 Jena, Germany	Friedrich Schiller University of Jena; Lund University; Skane University Hospital; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Muller, JP (corresponding author), Univ Jena, Ctr Mol Biomed, Inst Mol Cell Biol, D-07745 Jena, Germany.	joerg.mueller2@med.uni-jena.de	Drube, Julia/S-3741-2019	Drube, Julia/0000-0001-6188-2279; Ronnstrand, Lars/0000-0003-1275-5809	European Community [MRTN-CT-2006-035830]; Deutsche Krebshilfe [108401, TP2]	European Community(European Commission); Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported by European Community Grant "PTP-NET" Marie Curie Network MRTN-CT-2006-035830 and Deutsche Krebshilfe Collaborative Grant 108401, TP2 (to F. D. B.).	Berset TA, 2005, GENE DEV, V19, P1328, DOI 10.1101/gad.333505; Beyer WR, 2002, J VIROL, V76, P1488, DOI 10.1128/JVI.76.3.1488-1495.2002; Chabot C, 2009, MOL CELL BIOL, V29, P241, DOI 10.1128/MCB.01374-08; Choudhary C, 2005, INT J HEMATOL, V82, P93, DOI 10.1532/IJH97.05090; Choudhary C, 2005, BLOOD, V106, P265, DOI 10.1182/blood-2004-07-2942; Choudhary C, 2009, MOL CELL, V36, P326, DOI 10.1016/j.molcel.2009.09.019; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Frohling S, 2007, CANCER CELL, V12, P501, DOI 10.1016/j.ccr.2007.11.005; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; GRAZIA LM, 2003, J CELL BIOL, V161, P793, DOI 10.1083/jcb.200209019; Griffith J, 2004, MOL CELL, V13, P169, DOI 10.1016/S1097-2765(03)00505-7; Gross S, 1999, J BIOL CHEM, V274, P26378, DOI 10.1074/jbc.274.37.26378; Grundler R, 2005, BLOOD, V105, P4792, DOI 10.1182/blood-2004-11-4430; Grundler R, 2003, BLOOD, V102, P646, DOI 10.1182/blood-2002-11-3441; Heidel F, 2006, BLOOD, V107, P293, DOI 10.1182/blood-2005-06-2469; Heiss E, 2006, BLOOD, V108, P1542, DOI 10.1182/blood-2005-07-008896; HEYWORTH C, 1992, HAEMOPOIESIS PRACTIC, P37; Jandt E, 2003, ONCOGENE, V22, P4175, DOI 10.1038/sj.onc.1206652; Kappert K, 2007, FASEB J, V21, P523, DOI 10.1096/fj.06-6219com; Kelly LM, 2002, CANCER CELL, V1, P421, DOI 10.1016/S1535-6108(02)00070-3; Kindler T, 2005, BLOOD, V105, P335, DOI 10.1182/blood-2004-02-0660; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Mizuki M, 2000, BLOOD, V96, P3907, DOI 10.1182/blood.V96.12.3907; Mizuki M, 2003, BLOOD, V101, P3164, DOI 10.1182/blood-2002-06-1677; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Muller JP, 2008, LEUKEMIA, V22, P1945, DOI 10.1038/leu.2008.73; Nakao M, 1996, LEUKEMIA, V10, P1911; Ostman A, 2001, TRENDS CELL BIOL, V11, P258, DOI 10.1016/S0962-8924(01)01990-0; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Palka HL, 2003, J BIOL CHEM, V278, P5728, DOI 10.1074/jbc.M210656200; Persson C, 2004, MOL CELL BIOL, V24, P2190, DOI 10.1128/MCB.24.5.2190-2201.2004; Petermann A, 2011, BRAIN PATHOL, V21, P405, DOI 10.1111/j.1750-3639.2010.00464.x; Razumovskaya E, 2009, EXP HEMATOL, V37, P979, DOI 10.1016/j.exphem.2009.05.008; Rocnik JL, 2006, BLOOD, V108, P1339, DOI 10.1182/blood-2005-11-011429; Sacco F, 2009, J BIOL CHEM, V284, P22048, DOI 10.1074/jbc.M109.002758; Schmidt-Arras D, 2004, CURR PHARM DESIGN, V10, P1867, DOI 10.2174/1381612043384394; Schmidt-Arras DE, 2005, MOL CELL BIOL, V25, P3690, DOI 10.1128/MCB.25.9.3690-3703.2005; Schmidt-Arras D, 2009, BLOOD, V113, P3568, DOI 10.1182/blood-2007-10-121426; Small Donald, 2006, Hematology Am Soc Hematol Educ Program, P178; Stirewalt DL, 2003, NAT REV CANCER, V3, P650, DOI 10.1038/nrc1169; Tarcic G, 2009, CURR BIOL, V19, P1788, DOI 10.1016/j.cub.2009.09.048; Thiede C, 2002, BLOOD, V99, P4326, DOI 10.1182/blood.V99.12.4326; Vempati S, 2008, CLIN CANCER RES, V14, P4437, DOI 10.1158/1078-0432.CCR-07-1873; Zhu JW, 2008, IMMUNITY, V28, P183, DOI 10.1016/j.immuni.2007.11.024	44	51	60	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					10918	10929		10.1074/jbc.M110.205021	http://dx.doi.org/10.1074/jbc.M110.205021			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21262971	Green Published, hybrid			2022-12-27	WOS:000288797100004
J	Caino, MC; von Burstin, VA; Lopez-Haber, C; Kazanietz, MG				Caino, M. Cecilia; von Burstin, Vivian A.; Lopez-Haber, Cynthia; Kazanietz, Marcelo G.			Differential Regulation of Gene Expression by Protein Kinase C Isozymes as Determined by Genome-wide Expression Analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; PROSTATE-CANCER CELLS; ESTER-INDUCED APOPTOSIS; PHORBOL ESTER; PKC-EPSILON; FACTOR-ALPHA; DELTA; GROWTH; DEATH; PHOSPHORYLATION	Protein kinase C (PKC) isozymes are key signal transducers involved in normal physiology and disease and have been widely implicated in cancer progression. Despite our extensive knowledge of the signaling pathways regulated by PKC isozymes and their effectors, there is essentially no information on how individual members of the PKC family regulate gene transcription. Here, we report the first PKC isozyme-specific analysis of global gene expression by microarray using RNAi depletion of diacylglycerol/phorbol ester-regulated PKCs. A thorough analysis of this microarray data revealed unique patterns of gene expression controlled by PKC alpha, PKC delta, and PKC epsilon, which are remarkably different in cells growing in serum or in response to phorbol ester stimulation. PKC delta is the most relevant isoform in controlling the induction of genes by phorbol ester stimulation, whereas PKC epsilon predominantly regulates gene expression in serum. We also established that two PKC delta-regulated genes, FOSL1 and BCL2A1, mediate the apoptotic effect of phorbol esters or the chemotherapeutic agent etoposide in prostate cancer cells. Our studies offer a unique opportunity for establishing novel transcriptional effectors for PKC isozymes and may have significant functional and therapeutic implications.	[Caino, M. Cecilia; von Burstin, Vivian A.; Lopez-Haber, Cynthia; Kazanietz, Marcelo G.] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA	University of Pennsylvania	Kazanietz, MG (corresponding author), 421 Curie Blvd,1256 BRB 2-3, Philadelphia, PA 19104 USA.	marcelog@upenn.edu		Caino, M. Cecilia/0000-0001-8294-8070; Lopez Haber, Cynthia/0000-0001-9106-543X	National Institutes of Health [CA89202]; NATIONAL CANCER INSTITUTE [R01CA089202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA89202 (to M.G.K.).	Adiseshaiah P, 2007, CANCER RES, V67, P6204, DOI 10.1158/0008-5472.CAN-06-4687; Adiseshaiah P, 2006, J IMMUNOL, V177, P7193, DOI 10.4049/jimmunol.177.10.7193; Barry OP, 2001, CURR PHARM DESIGN, V7, P1725, DOI 10.2174/1381612013397041; Basu A, 2002, INT J MOL MED, V10, P541; Basu A, 2007, CELL SIGNAL, V19, P1633, DOI 10.1016/j.cellsig.2007.04.008; Belguise K, 2005, ONCOGENE, V24, P1434, DOI 10.1038/sj.onc.1208312; Blass M, 2002, MOL CELL BIOL, V22, P182, DOI 10.1128/MCB.22.1.182-195.2002; BORNER C, 1995, J BIOL CHEM, V270, P78, DOI 10.1074/jbc.270.1.78; Casalino L, 2007, EMBO J, V26, P1878, DOI 10.1038/sj.emboj.7601617; Cerda SR, 2006, ONCOGENE, V25, P3123, DOI 10.1038/sj.onc.1209360; CHIU R, 1987, NATURE, V329, P648, DOI 10.1038/329648a0; Cohen S, 2005, LEUKEMIA RES, V29, P923, DOI 10.1016/j.leukres.2005.01.015; Cornford P, 1999, AM J PATHOL, V154, P137, DOI 10.1016/S0002-9440(10)65260-1; Crosio C, 2006, CELL DEATH DIFFER, V13, P2150, DOI 10.1038/sj.cdd.4401943; DANIEL LW, 1995, CANCER RES, V55, P4844; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; Fujii T, 2000, J BIOL CHEM, V275, P7574, DOI 10.1074/jbc.275.11.7574; Gonzalez-Guerrico AM, 2005, J BIOL CHEM, V280, P38982, DOI 10.1074/jbc.M506767200; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Gringhuis SI, 2005, MOL CELL BIOL, V25, P6454, DOI 10.1128/MCB.25.15.6454-6463.2005; Halatsch ME, 2009, J NEUROSURG, V111, P211, DOI 10.3171/2008.9.JNS08551; Humphries MJ, 2006, J BIOL CHEM, V281, P9728, DOI 10.1074/jbc.M507851200; Kloosterboer FM, 2005, BLOOD, V106, P3955, DOI 10.1182/blood-2004-09-3749; Kucharczak JF, 2005, CELL DEATH DIFFER, V12, P1225, DOI 10.1038/sj.cdd.4401684; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; Leo E, 2001, J BIOL CHEM, V276, P8087, DOI 10.1074/jbc.M009450200; Li YK, 1996, J BIOL CHEM, V271, P27025, DOI 10.1074/jbc.271.43.27025; Lindemann RK, 2003, BIOCHEM J, V372, P787, DOI 10.1042/BJ20030046; Maurer F, 1996, J BIOL CHEM, V271, P26074, DOI 10.1074/jbc.271.42.26074; McJilton MA, 2003, ONCOGENE, V22, P7958, DOI 10.1038/sj.onc.1206795; Meshki J, 2010, J BIOL CHEM, V285, P26033, DOI 10.1074/jbc.M110.128371; MISCHAK H, 1993, J BIOL CHEM, V268, P6090; Parker PJ, 2004, J CELL SCI, V117, P131, DOI 10.1242/jcs.00982; Pickett CA, 2002, MOL ENDOCRINOL, V16, P2840, DOI 10.1210/me.2001-0305; Powell CT, 2006, INT J CANCER, V118, P1572, DOI 10.1002/ijc.21511; Pryhuber GS, 2000, AM J RESP CELL MOL, V22, P150, DOI 10.1165/ajrcmb.22.2.3783; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Reyland ME, 1999, J BIOL CHEM, V274, P19115, DOI 10.1074/jbc.274.27.19115; SASSONECORSI P, 1990, ONCOGENE, V5, P427; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; Slevogt H, 2008, EUR RESPIR J, V31, P725, DOI 10.1183/09031936.00103507; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sumitomo M, 2002, J CLIN INVEST, V109, P827, DOI 10.1172/JCI200214146; Tonnetti L, 2008, CANCER RES, V68, P5648, DOI 10.1158/0008-5472.CAN-07-5850; Townsend KJ, 1998, ONCOGENE, V17, P1223, DOI 10.1038/sj.onc.1202035; Vardarova K, 2009, EUR RESPIR J, V34, P1171, DOI 10.1183/09031936.00171908; von Burstin VA, 2010, MOL PHARMACOL, V78, P325, DOI 10.1124/mol.110.064741; Wu DQ, 2002, CANCER RES, V62, P2423; Xu H, 2008, FREE RADICAL BIO MED, V44, P1656, DOI 10.1016/j.freeradbiomed.2008.01.023	49	28	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11254	11264		10.1074/jbc.M110.194332	http://dx.doi.org/10.1074/jbc.M110.194332			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21252239	hybrid, Green Published			2022-12-27	WOS:000288797100037
J	Huang, GC; Kaufman, AJ; Ramanathan, Y; Singh, B				Huang, Guochang; Kaufman, Andrew J.; Ramanathan, Y.; Singh, Bhuvanesh			SCCRO (DCUN1D1) Promotes Nuclear Translocation and Assembly of the Neddylation E3 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-LIKE PROTEINS; CELL-CYCLE PROGRESSION; CULLIN-RING LIGASES; NEDD8 CONJUGATION; SYSTEM; SCF; PATHWAY; ACTIVATION; SEQUENCE; CUL1	SCCRO/DCUN1D1/DCN1 (squamous cell carcinoma-related oncogene/defective in cullin neddylation 1 domain containing 1/defective in cullin neddylation) serves as an accessory E3 in neddylation by binding to cullin and Ubc12 to allow efficient transfer of Nedd8. In this work we show that SCCRO has broader, pleiotropic effects that are essential for cullin neddylation in vivo. Reduced primary nuclear localization of Cul1 accompanying decreased neddylation and proliferation in SCCRO-/- mouse embryonic fibroblasts led us to investigate whether compartmentalization plays a regulatory role. Decreased nuclear localization, neddylation, and defective proliferation in SCCRO-/- mouse embryonic fibroblasts were rescued by transgenic expression of SCCRO. Expression of reciprocal SCCRO and Cul1-binding mutants confirmed the requirement for SCCRO in nuclear translocation and neddylation of cullins in vivo. Nuclear translocation of Cul1 by tagging with a nuclear localization sequence allowed neddylation independent of SCCRO, but at a lower level. We found that in the nucleus, SCCRO enhances recruitment of Ubc12 to Cul1 to promote neddylation. These findings suggest that SCCRO has an essential role in neddylation in vivo involving nuclear localization of neddylation components and recruitment and proper positioning of Ubc12.	[Huang, Guochang; Kaufman, Andrew J.; Ramanathan, Y.; Singh, Bhuvanesh] Mem Sloan Kettering Canc Ctr, Dept Surg, Lab Epithelial Canc Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Ramanathan, Y (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, Lab Epithelial Canc Biol, 1275 York Ave, New York, NY 10065 USA.	ramanaty@mskcc.org; singhb@mskcc.org			American College of Surgeons; Flight Attendant Medical Research Institute; Falcone Fund; Matheson fellowship; NATIONAL CANCER INSTITUTE [U54CA132378, U54CA137788] Funding Source: NIH RePORTER	American College of Surgeons; Flight Attendant Medical Research Institute; Falcone Fund; Matheson fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a George H. A. Clowes Memorial Research Career Development Award from the American College of Surgeons (to B. S.), a Clinical Innovator Award from Flight Attendant Medical Research Institute (to B. S. and Y. R.), the Falcone Fund (to B. S.), and a Matheson fellowship (to Y. R.).	Bohnsack RN, 2003, J BIOL CHEM, V278, P26823, DOI 10.1074/jbc.M303177200; Capili AD, 2007, CURR OPIN STRUC BIOL, V17, P726, DOI 10.1016/j.sbi.2007.08.018; Dharmasiri S, 2003, EMBO J, V22, P1762, DOI 10.1093/emboj/cdg190; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Dye BT, 2007, ANNU REV BIOPH BIOM, V36, P131, DOI 10.1146/annurev.biophys.36.040306.132820; Furukawa M, 2000, MOL CELL BIOL, V20, P8185, DOI 10.1128/MCB.20.21.8185-8197.2000; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hotton SK, 2008, ANNU REV PLANT BIOL, V59, P467, DOI 10.1146/annurev.arplant.58.032806.104011; Huang DT, 2009, MOL CELL, V33, P483, DOI 10.1016/j.molcel.2009.01.011; Jones D, 2000, DEV BIOL, V226, P152, DOI 10.1006/dbio.2000.9847; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Kawakami T, 2001, EMBO J, V20, P4003, DOI 10.1093/emboj/20.15.4003; Kim AY, 2008, J BIOL CHEM, V283, P33211, DOI 10.1074/jbc.M804440200; Kim SS, 2007, CANCER RES, V67, P9616, DOI 10.1158/0008-5472.CAN-07-0644; Kurz T, 2005, NATURE, V435, P1257, DOI 10.1038/nature03662; Kurz T, 2008, MOL CELL, V29, P23, DOI 10.1016/j.molcel.2007.12.012; Liakopoulos D, 1998, EMBO J, V17, P2208, DOI 10.1093/emboj/17.8.2208; Ma T, 2008, CANCER SCI, V99, P2128, DOI 10.1111/j.1349-7006.2008.00929.x; Meyer-Schaller N, 2009, P NATL ACAD SCI USA, V106, P12365, DOI 10.1073/pnas.0812528106; Morimoto M, 2000, BIOCHEM BIOPH RES CO, V270, P1093, DOI 10.1006/bbrc.2000.2576; Morimoto M, 2003, BIOCHEM BIOPH RES CO, V301, P392, DOI 10.1016/S0006-291X(02)03051-6; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Noureddine MA, 2002, DEV CELL, V2, P757, DOI 10.1016/S1534-5807(02)00164-8; Osaka F, 2000, EMBO J, V19, P3475, DOI 10.1093/emboj/19.13.3475; Osaka F, 1998, GENE DEV, V12, P2263, DOI 10.1101/gad.12.15.2263; Parry G, 2004, SEMIN CELL DEV BIOL, V15, P221, DOI 10.1016/j.semcdb.2003.12.003; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Podust VN, 2000, P NATL ACAD SCI USA, V97, P4579, DOI 10.1073/pnas.090465597; PTAK C, 1994, J BIOL CHEM, V269, P26539; Read MA, 2000, MOL CELL BIOL, V20, P2326, DOI 10.1128/MCB.20.7.2326-2333.2000; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Sarkaria I, 2006, CANCER RES, V66, P9437, DOI 10.1158/0008-5472.CAN-06-2074; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Scott DC, 2010, MOL CELL, V39, P784, DOI 10.1016/j.molcel.2010.08.030; Skaar JR, 2007, CANCER RES, V67, P2006, DOI 10.1158/0008-5472.CAN-06-3241; Tan M, 2009, P NATL ACAD SCI USA, V106, P6203, DOI 10.1073/pnas.0812425106; Tateishi K, 2001, J CELL BIOL, V155, P571, DOI 10.1083/jcb.200104035; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; Wada H, 2000, J BIOL CHEM, V275, P17008, DOI 10.1074/jbc.275.22.17008; Wu K, 2000, J BIOL CHEM, V275, P32317, DOI 10.1074/jbc.M004847200; Wu K, 2002, J BIOL CHEM, V277, P516, DOI 10.1074/jbc.M108008200; Yang XY, 2007, J BIOL CHEM, V282, P24490, DOI 10.1074/jbc.C700038200; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	45	39	41	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10297	10304		10.1074/jbc.M110.203729	http://dx.doi.org/10.1074/jbc.M110.203729			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21247897	Green Published, hybrid			2022-12-27	WOS:000288547000047
J	Pabla, N; Ma, ZW; McIlhatton, MA; Fishel, R; Dong, Z				Pabla, Navjotsingh; Ma, Zhengwei; McIlhatton, Michael A.; Fishel, Richard; Dong, Zheng			hMSH2 Recruits ATR to DNA Damage Sites for Activation during DNA Damage-induced Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MISMATCH-REPAIR SYSTEM; ACUTE KIDNEY INJURY; CELL-CYCLE; CISPLATIN NEPHROTOXICITY; GENOME INTEGRITY; MECHANISMS; P53; CHECKPOINTS; RESISTANCE; PROTEINS	DNA damage response (DDR) activates a complex signaling network that triggers DNA repair, cell cycle arrest, and/or cell death. Depending on the type and severity of DNA lesion, DDR is controlled by "master" regulators including ATM and ATR protein kinases. Cisplatin, a major chemotherapy drug that cross-links DNA, induces ATR-dependent DDR, resulting in apoptosis. However, it is unclear how ATR is activated. To identify the key regulators of ATR, we analyzed the proteins that associate with ATR after cisplatin treatment by blue native-PAGE and co-immunoprecipitation. The mismatch repair protein hMSH2 was found to be a major ATR-binding protein. Functionally, ATR activation and its recruitment to nuclear foci during cisplatin treatment were attenuated, and DNA damage signaling, involving Chk2, p53, and PUMA-alpha, was suppressed in hMSH2-deficient cells. ATR activation induced by the DNA methylating agent N-methyl-N-nitrosourea was also shown to be hMSH2-dependent. Intriguingly, hMSH2-mediated ATR recruitment and activation appeared independent of replication protein A, Rad17, and the Rad9-Hus1-Rad1 protein complex. Together the results support a hMSH2-dependent pathway of ATR activation and downstream Chk2/p53 signaling.	[Pabla, Navjotsingh; Ma, Zhengwei; Dong, Zheng] Med Coll Georgia, Dept Cellular Biol & Anat, Augusta, GA 30912 USA; [McIlhatton, Michael A.; Fishel, Richard] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Fishel, Richard] Ohio State Univ, Dept Phys, Columbus, OH 43210 USA; [Fishel, Richard] Ohio State Univ, Med Ctr, Columbus, OH 43210 USA; [Dong, Zheng] Charlie Norwood Vet Affairs Med Ctr, Augusta, GA 30904 USA	University System of Georgia; Augusta University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Dong, Z (corresponding author), Med Coll Georgia, Dept Cellular Biol & Anat, 1459 Laney Walker Blvd, Augusta, GA 30912 USA.	zdong@mail.mcg.edu	Pabla, Navjotsingh/H-3568-2011	Pabla, Navjot/0000-0001-9408-0539	National Institutes of Health [DK087843, DK058831, CA067007, GM080176]; Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [R01CA067007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058831, R01DK087843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080176] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK087843 and DK058831 (to Z. D.) and CA067007 and GM080176 (to R. F.). This work was also supported by funds from the Department of Veterans Affairs (to Z. D.).	Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Aebi S, 1996, CANCER RES, V56, P3087; Arany I, 2003, SEMIN NEPHROL, V23, P460, DOI 10.1016/S0270-9295(03)00089-5; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Brooks C, 2007, P NATL ACAD SCI USA, V104, P11649, DOI 10.1073/pnas.0703976104; Brooks C, 2009, J CLIN INVEST, V119, P1275, DOI 10.1172/JCI37829; Cepeda V, 2007, ANTI-CANCER AGENT ME, V7, P3, DOI 10.2174/187152007779314044; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Einhorn LH, 2002, P NATL ACAD SCI USA, V99, P4592, DOI 10.1073/pnas.072067999; Fishel R, 1999, NAT MED, V5, P1239, DOI 10.1038/15191; Gong JG, 1999, NATURE, V399, P806; Guggenheim ER, 2009, CHEMBIOCHEM, V10, P141, DOI 10.1002/cbic.200800471; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hurley PJ, 2007, CELL CYCLE, V6, P414, DOI 10.4161/cc.6.4.3886; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jiang M, 2006, ONCOGENE, V25, P4056, DOI 10.1038/sj.onc.1209440; Jiang M, 2008, J PHARMACOL EXP THER, V327, P300, DOI 10.1124/jpet.108.139162; Jiang M, 2007, J BIOL CHEM, V282, P2636, DOI 10.1074/jbc.M606928200; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Jun SH, 2006, FEBS J, V273, P1609, DOI 10.1111/j.1742-4658.2006.05190.x; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Liu YY, 2010, J BIOL CHEM, V285, P5974, DOI 10.1074/jbc.M109.076109; McIlhatton NA, 2007, CANCER RES, V67, P10966, DOI 10.1158/0008-5472.CAN-07-2562; Mello JA, 1996, CHEM BIOL, V3, P579, DOI 10.1016/S1074-5521(96)90149-0; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Meyers M, 1997, CANCER RES, V57, P206; Modrich P, 2006, J BIOL CHEM, V281, P30305, DOI 10.1074/jbc.R600022200; O'Brien V, 2006, CARCINOGENESIS, V27, P682, DOI 10.1093/carcin/bgi298; Pabla N, 2008, KIDNEY INT, V73, P994, DOI 10.1038/sj.ki.5002786; Pabla N, 2008, J BIOL CHEM, V283, P6572, DOI 10.1074/jbc.M707568200; Price PM, 2009, KIDNEY INT, V76, P604, DOI 10.1038/ki.2009.224; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Seth R, 2005, J BIOL CHEM, V280, P31230, DOI 10.1074/jbc.M503305200; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; SWAMY M, 2006, SCI STKE, P14, DOI DOI 10.1126/STKE.3452006PL4; Toft NJ, 1999, P NATL ACAD SCI USA, V96, P3911, DOI 10.1073/pnas.96.7.3911; Topping RP, 2009, J BIOL CHEM, V284, P14029, DOI 10.1074/jbc.M809303200; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wang JYJ, 2006, CANCER CELL, V9, P417, DOI 10.1016/j.ccr.2006.05.013; Wang Y, 2003, P NATL ACAD SCI USA, V100, P15387, DOI 10.1073/pnas.2536810100; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wyatt MD, 2006, CHEM RES TOXICOL, V19, P1580, DOI 10.1021/tx060164e; Yoshioka K, 2006, MOL CELL, V22, P501, DOI 10.1016/j.molcel.2006.04.023; Zhang H, 1999, CANCER RES, V59, P3021; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	47	67	71	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10411	10418		10.1074/jbc.M110.210989	http://dx.doi.org/10.1074/jbc.M110.210989			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21285353	Green Published, hybrid			2022-12-27	WOS:000288547000057
J	Wang, JH; Ma, J; Charboneau, R; Barke, R; Roy, S				Wang, Jinghua; Ma, Jing; Charboneau, Rick; Barke, Roderick; Roy, Sabita			Morphine Inhibits Murine Dendritic Cell IL-23 Production by Modulating Toll-like Receptor 2 and Nod2 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOCOCCUS-PNEUMONIAE; PNEUMOCOCCAL INFECTION; ANTIBACTERIAL DEFENSE; HOST-DEFENSE; T-CELLS; MACROPHAGES; PNEUMOLYSIN; TLR; INDUCTION; RECOGNITION	IL-23, produced by dendritic cells (DCs) and macrophages, plays a critical role in innate immunity against bacterial infection. Our previous studies show that morphine disrupts the IL-23/IL-17 mediated pulmonary mucosal host defense and increases susceptibility to Streptococcus pneumoniae lung infection. To determine the mechanism by which morphine modulates IL-23 production, mouse bone marrow-derived dendritic cells (BMDCs) and macrophages (BMDMs) were treated with morphine, and infected with S. pneumoniae or stimulated with Toll-like receptor (TLR) and Nod2 ligands. We found that a significant increase in IL-23 protein production was observed in S. pneumoniae, TLR2 ligand lipoteichoic acid (LTA), and TLR4 ligand pneumolysin (PLY) stimulated BMDCs and BMDMs. Interestingly, although Nod2 ligand muramyldipeptide (MDP) alone had no effect on IL-23 production, it potentiated LTA induced IL-23 production to the same level as that observed following S. pneumoniae infection, suggesting that S. pneumoniae induced IL-23 production in DCs involves activation of both TLR2 and Nod2 signaling mechanisms. Furthermore, pretreatment of DCs with MyD88 (myeloid differentiation primary response gene 88) and IL-1 receptor-associated kinase (IRAK) 1/4 inhibitors, or TLR2 antibody diminished the S. pneumoniae induced IL-23 and abolished the inhibitory effects of morphine, indicating that S. pneumoniae induced IL-23 production depends on activation of the TLR2-MyD88-IRAK1/4 signaling pathway. Moreover, morphine decreased S. pneumoniae induced phosphorylation of interferon regulatory factor 3 (IRF3) and activating transcription factor 2 in DCs. Taken together, our study shows that morphine impairs S. pneumoniae induced IL-23 production through MyD88-IRAK1/4-dependent TLR2 and Nod2 signaling in DCs.	[Wang, Jinghua; Ma, Jing; Roy, Sabita] Univ Minnesota, Dept Surg, Div Basic & Translat Res, Minneapolis, MN 55455 USA; [Charboneau, Rick; Barke, Roderick] Vet Affairs Med Ctr, Dept Surg, Minneapolis, MN 55417 USA	University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Roy, S (corresponding author), Univ Minnesota, Dept Surg, Div Basic & Translat Res, MMC 195,420 Delaware St SE, Minneapolis, MN 55455 USA.	royxx002@umn.edu	ma, jing/B-5493-2013		National Institutes of Health [R03 DA023353, R01 DA12104, K02 DA015349, R01 DA022935, P50 DA11806]; Minneapolis Veterans Affairs Medical Center; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA015349, R01DA022935, P50DA011806, R01DA012104, R03DA023353] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Minneapolis Veterans Affairs Medical Center; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants R03 DA023353 (to J. W.) and R01 DA12104, K02 DA015349, R01 DA022935, and P50 DA11806 (to S. R.). This work was also supported by funds from the Minneapolis Veterans Affairs Medical Center (to R. B.).	Al-Salleeh F, 2008, J IMMUNOL, V181, P4523, DOI 10.4049/jimmunol.181.7.4523; Albiger B, 2007, CELL MICROBIOL, V9, P633, DOI 10.1111/j.1462-5822.2006.00814.x; Alifrangis C, 2006, INT J STD AIDS, V17, P779, DOI 10.1258/095646206778691130; Borner C, 2009, J IMMUNOL, V183, P882, DOI 10.4049/jimmunol.0802763; Branger J, 2004, INFECT IMMUN, V72, P788, DOI 10.1128/IAI.72.2.788-794.2004; Braun JS, 1999, INFECT IMMUN, V67, P3750, DOI 10.1128/IAI.67.8.3750-3756.1999; Carmody RJ, 2007, J IMMUNOL, V178, P186, DOI 10.4049/jimmunol.178.1.186; Dessing MC, 2008, CELL MICROBIOL, V10, P237, DOI 10.1111/j.1462-5822.2007.01035.x; Dighe SV, 2009, PHARMACOL BIOCHEM BE, V92, P537, DOI 10.1016/j.pbb.2009.02.004; Garrelts JC, 1996, PHARMACOECONOMICS, V10, P36, DOI 10.2165/00019053-199610010-00005; Henneke P, 2008, J IMMUNOL, V180, P6149, DOI 10.4049/jimmunol.180.9.6149; Kelschenbach J, 2008, J IMMUNOL, V180, P3670, DOI 10.4049/jimmunol.180.6.3670; Klein M, 2008, J INFECT DIS, V198, P1028, DOI 10.1086/591626; Knapp S, 2004, J IMMUNOL, V172, P3132, DOI 10.4049/jimmunol.172.5.3132; Lee KS, 2007, CELL IMMUNOL, V245, P103, DOI 10.1016/j.cellimm.2007.04.003; Li XL, 2004, ARTHRITIS RES THER, V6, pR273, DOI 10.1186/ar1175; Ma J, 2010, INFECT IMMUN, V78, P830, DOI 10.1128/IAI.00914-09; Malley R, 2003, P NATL ACAD SCI USA, V100, P1966, DOI 10.1073/pnas.0435928100; Moreira LO, 2008, CELL MICROBIOL, V10, P2067, DOI 10.1111/j.1462-5822.2008.01189.x; Opitz B, 2004, J BIOL CHEM, V279, P36426, DOI 10.1074/jbc.M403861200; Osikowicz M, 2008, PAIN, V139, P117, DOI 10.1016/j.pain.2008.03.017; Picard C, 2007, IMMUNOL RES, V38, P347, DOI 10.1007/s12026-007-0006-2; Reimer T, 2007, J IMMUNOL, V179, P1166, DOI 10.4049/jimmunol.179.2.1166; Riol-Blanco L, 2010, J IMMUNOL, V184, P1710, DOI 10.4049/jimmunol.0902796; Sabroe I, 2008, J PATHOL, V214, P126, DOI 10.1002/path.2264; Srivastava A, 2005, INFECT IMMUN, V73, P6479, DOI 10.1128/IAI.73.10.6479-6487.2005; TISEO PJ, 1995, PAIN, V61, P47, DOI 10.1016/0304-3959(94)00148-8; Wang JH, 2005, J IMMUNOL, V174, P426, DOI 10.4049/jimmunol.174.1.426; Wang JH, 2003, J BIOL CHEM, V278, P37622, DOI 10.1074/jbc.M301224200; Wang JH, 2008, J IMMUNOL, V180, P3594, DOI 10.4049/jimmunol.180.5.3594; Yamamoto M, 2004, MOL IMMUNOL, V40, P861, DOI 10.1016/j.molimm.2003.10.006; Yang HM, 2002, EUR J BIOCHEM, V269, P6142, DOI 10.1046/j.1432-1033.2002.03330.x; Yoshimura A, 1999, J IMMUNOL, V163, P1; Zola TA, 2008, J IMMUNOL, V181, P7909, DOI 10.4049/jimmunol.181.11.7909	34	33	35	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10225	10232		10.1074/jbc.M110.188680	http://dx.doi.org/10.1074/jbc.M110.188680			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21245149	Green Published, hybrid			2022-12-27	WOS:000288547000039
J	Bretones, G; Acosta, JC; Caraballo, JM; Ferrandiz, N; Gomez-Casares, MT; Albajar, M; Blanco, R; Ruiz, P; Hung, WC; Albero, MP; Perez-Roger, I; Leon, J				Bretones, Gabriel; Acosta, Juan C.; Caraballo, Juan M.; Ferrandiz, Nuria; Teresa Gomez-Casares, M.; Albajar, Marta; Blanco, Rosa; Ruiz, Paula; Hung, Wen-Chun; Pilar Albero, M.; Perez-Roger, Ignacio; Leon, Javier			SKP2 Oncogene Is a Direct MYC Target Gene and MYC Down-regulates p27(KIP1) through SKP2 in Human Leukemia Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT KINASE INHIBITOR; CHRONIC MYELOID-LEUKEMIA; C-MYC; CYCLE PROGRESSION; BCR-ABL; NEGATIVE AUTOREGULATION; GENOMIC TARGETS; HUMAN CANCER; DEGRADATION; P27	SKP2 is the ubiquitin ligase subunit that targets p27(KIP1) (p27) for degradation. SKP2 is induced in the G(1)-S transit of the cell cycle, is frequently overexpressed in human cancer, and displays transformation activity in experimental models. Here we show that MYC induces SKP2 expression at the mRNA and protein levels in human myeloid leukemia K562 cells with conditional MYC expression. Importantly, in these systems, induction of MYC did not activate cell proliferation, ruling out SKP2 up-regulation as a consequence of cell cycle entry. MYC-dependent SKP2 expression was also detected in other cell types such as lymphoid, fibroblastic, and epithelial cell lines. MYC induced SKP2 mRNA expression in the absence of protein synthesis and activated the SKP2 promoter in luciferase reporter assays. With chromatin immunoprecipitation assays, MYC was detected bound to a region of human SKP2 gene promoter that includes E-boxes. The K562 cell line derives from human chronic myeloid leukemia. In a cohort of chronic myeloid leukemia bone marrow samples, we found a correlation between MYC and SKP2 mRNA levels. Analysis of cancer expression databases also indicated a correlation between MYC and SKP2 expression in lymphoma. Finally, MYC-induced SKP2 expression resulted in a decrease in p27 protein in K562 cells. Moreover, silencing of SKP2 abrogated the MYC-mediated down-regulation of p27. Our data show that SKP2 is a direct MYC target gene and that MYC-mediated SKP2 induction leads to reduced p27 levels. The results suggest the induction of SKP2 oncogene as a new mechanism for MYC-dependent transformation.	[Leon, Javier] Univ Cantabria, Dept Biol Mol, Inst Biomed & Biotecnol Cantabria,Fac Med, SODERCAN Soc Desarrollo Cantabria,CSIC,IBBTEC, Santander 39011, Spain; [Teresa Gomez-Casares, M.] Hosp Dr Negrin, Serv Hematol, Las Palmas Gran Canaria 35020, Spain; [Albajar, Marta] Hosp Univ Marques de Valdecilla, Serv Hematol, Inst Invest & Formac Marques de Valdecilla, Santander 39009, Spain; [Hung, Wen-Chun] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung 804, Taiwan; [Pilar Albero, M.; Perez-Roger, Ignacio] Cardenal Herrera CEU Univ, Dept Chem Biochem & Mol Biol, Moncada 46113, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Hospital Universitario Marques de Valdecilla (HUMV); National Sun Yat Sen University; Universidad CEU Cardenal Herrera	Leon, J (corresponding author), Univ Cantabria, Dept Biol Mol, Inst Biomed & Biotecnol Cantabria,Fac Med, SODERCAN Soc Desarrollo Cantabria,CSIC,IBBTEC, Cardenal Herrera Oria S-N, Santander 39011, Spain.	leonj@unican.es	Pérez Roger, Ignacio/K-1346-2014; Bretones, Gabriel/AAB-4637-2021; Hung, Wen-Chun/F-4846-2011; Acosta, Juan/AAE-6320-2021; Ferrandiz-Diaz, Nuria/V-4071-2017; Leon, Javier/K-4615-2014; CASARES, MARIA TERESA GOMEZ/R-6060-2018	Pérez Roger, Ignacio/0000-0002-5564-6912; Bretones, Gabriel/0000-0002-1521-5544; Acosta, Juan/0000-0002-7989-7329; Ferrandiz-Diaz, Nuria/0000-0002-7410-3470; CASARES, MARIA TERESA GOMEZ/0000-0003-0505-5126; Leon, Javier/0000-0001-5803-0112	Spanish Ministerio de Ciencia e Innovacion [PN-SAF08-01581]; Spanish Ministerio de Sanidad y Consumo [ISCIII-RETIC RD06/0020/0017]; University of Cantabria-IFIMAV; Proyecto Universidad Cardenal Herrera-Santander;  [PI06-0285]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Spanish Ministerio de Sanidad y Consumo(Instituto de Salud Carlos III); University of Cantabria-IFIMAV; Proyecto Universidad Cardenal Herrera-Santander; 	This study was supported by Grant PN-SAF08-01581 from the Spanish Ministerio de Ciencia e Innovacion, Grant ISCIII-RETIC RD06/0020/0017 from the Spanish Ministerio de Sanidad y Consumo, a grant from University of Cantabria-IFIMAV (to J. L.), and Grants PI06-0285 and Proyecto Universidad Cardenal Herrera-Santander (to I. P.-R.).	Acosta JC, 2008, MOL CELL BIOL, V28, P7286, DOI 10.1128/MCB.00752-08; Agarwal A, 2008, BLOOD, V112, P1960, DOI 10.1182/blood-2007-09-113860; Andreu EJ, 2005, CANCER RES, V65, P3264, DOI 10.1158/0008-5472.CAN-04-1357; Baccarani M, 2009, J CLIN ONCOL, V27, P6041, DOI 10.1200/JCO.2009.25.0779; Bernard D, 2003, J CLIN INVEST, V112, P1724; Bouchard C, 1999, EMBO J, V18, P5321, DOI 10.1093/emboj/18.19.5321; Cappellen D, 2007, EMBO REP, V8, P70, DOI 10.1038/sj.embor.7400849; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Ceballos E, 2000, ONCOGENE, V19, P2194, DOI 10.1038/sj.onc.1203541; Chandramohan V, 2004, J IMMUNOL, V172, P5522, DOI 10.4049/jimmunol.172.9.5522; Chen JY, 2009, LEUKEMIA RES, V33, P1520, DOI 10.1016/j.leukres.2009.03.007; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Coats S, 1996, SCIENCE, V272, P877, DOI 10.1126/science.272.5263.877; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Delgado M Dolores, 2010, Genes Cancer, V1, P605, DOI 10.1177/1947601910377495; Delgado MD, 1999, FEBS LETT, V444, P5, DOI 10.1016/S0014-5793(99)00013-7; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Galea CA, 2008, BIOCHEMISTRY-US, V47, P7598, DOI 10.1021/bi8006803; Gomez-Casares MT, 2004, HAEMATOLOGICA, V89, P241; Grandori C, 1996, EMBO J, V15, P4344, DOI 10.1002/j.1460-2075.1996.tb00808.x; GRIGNANI F, 1990, EMBO J, V9, P3913, DOI 10.1002/j.1460-2075.1990.tb07612.x; Hara T, 2001, J BIOL CHEM, V276, P48937, DOI 10.1074/jbc.M107274200; Hershko DD, 2008, CANCER-AM CANCER SOC, V112, P1415, DOI 10.1002/cncr.23317; Huang YC, 2006, J CELL PHYSIOL, V209, P363, DOI 10.1002/jcp.20741; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Keller UB, 2007, EMBO J, V26, P2562, DOI 10.1038/sj.emboj.7601691; Kiessling A, 2006, CHEM BIOL, V13, P745, DOI 10.1016/j.chembiol.2006.05.011; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Kim J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001798; Kim JW, 2004, MOL CELL BIOL, V24, P5923, DOI 10.1128/MCB.24.13.5923-5936.2004; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Kitagawa K, 2009, CANCER SCI, V100, P1374, DOI 10.1111/j.1349-7006.2009.01196.x; Kossatz U, 2004, GENE DEV, V18, P2602, DOI 10.1101/gad.321004; Leon J, 2009, CELL CYCLE, V8, P1148, DOI 10.4161/cc.8.8.8126; Lerga A, 1999, CELL GROWTH DIFFER, V10, P639; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Lu ZM, 2010, CELL CYCLE, V9, P2342, DOI 10.4161/cc.9.12.11988; Lutz W, 2002, BBA-REV CANCER, V1602, P61, DOI 10.1016/S0304-419X(02)00036-7; Martins CP, 2002, EMBO J, V21, P3739, DOI 10.1093/emboj/cdf364; Mateyak MK, 1997, CELL GROWTH DIFFER, V8, P1039; Melo JV, 2007, NAT REV CANCER, V7, P441, DOI 10.1038/nrc2147; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Miranda-Carboni GA, 2008, GENE DEV, V22, P3121, DOI 10.1101/gad.1692808; Munoz-Alonso MJ, 2005, J BIOL CHEM, V280, P18120, DOI 10.1074/jbc.M500758200; Nakayama K, 2004, DEV CELL, V6, P661, DOI 10.1016/S1534-5807(04)00131-5; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; O'Hagan RC, 2000, GENE DEV, V14, P2185, DOI 10.1101/gad.827200; Old JB, 2010, MOL CANCER RES, V8, P353, DOI 10.1158/1541-7786.MCR-09-0232; Orian A, 2003, GENE DEV, V17, P1101, DOI 10.1101/gad.1066903; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Pajic A, 2000, INT J CANCER, V87, P787, DOI 10.1002/1097-0215(20000915)87:6<787::AID-IJC4>3.0.CO;2-6; Patel JH, 2004, NAT REV CANCER, V4, P562, DOI 10.1038/nrc1393; PENN LJZ, 1990, EMBO J, V9, P1113, DOI 10.1002/j.1460-2075.1990.tb08217.x; Perez-Roger I, 1999, EMBO J, V18, P5310, DOI 10.1093/emboj/18.19.5310; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; Reavie L, 2010, NAT IMMUNOL, V11, P207, DOI 10.1038/ni.1839; Schuhmacher M, 1999, CURR BIOL, V9, P1255, DOI 10.1016/S0960-9822(99)80507-7; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; Sutterluty H, 1999, NAT CELL BIOL, V1, P207, DOI 10.1038/12027; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Warner BJ, 1999, MOL CELL BIOL, V19, P5913; Xie SH, 2002, ONCOGENE, V21, P7137, DOI 10.1038/sj.onc.1205942; Yang W, 2001, ONCOGENE, V20, P1688, DOI 10.1038/sj.onc.1204245; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103	71	64	68	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9815	9825		10.1074/jbc.M110.165977	http://dx.doi.org/10.1074/jbc.M110.165977			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21245140	hybrid, Green Published			2022-12-27	WOS:000288247700104
J	Frase, H; Smith, CA; Toth, M; Champion, MM; Mobashery, S; Vakulenko, SB				Frase, Hilary; Smith, Clyde A.; Toth, Marta; Champion, Matthew M.; Mobashery, Shahriar; Vakulenko, Sergei B.			Identification of Products of Inhibition of GES-2 beta-Lactamase by Tazobactam by X-ray Crystallography and Spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-ENAMINE INTERMEDIATE; CLASS-A CARBAPENEMASE; CRYSTAL-STRUCTURE; SHV-1; RESOLUTION; INACTIVATION; MECHANISM; RESISTANT; INSIGHTS; POPULATIONS	The GES-2 beta-lactamase is a class A carbapenemase, the emergence of which in clinically important bacterial pathogens is a disconcerting development as the enzyme confers resistance to carbapenem antibiotics. Tazobactam is a clinically used inhibitor of class A beta-lactamases, which inhibits the GES-2 enzyme effectively, restoring susceptibility to beta-lactam antibiotics. We have investigated the details of the mechanism of inhibition of the GES-2 enzyme by tazobactam. By the use of UV spectrometry, mass spectroscopy, and x-ray crystallography, we have documented and identified the involvement of a total of seven distinct GES-2 center dot tazobactam complexes and one product of the hydrolysis of tazobactam that contribute to the inhibition profile. The x-ray structures for the GES-2 enzyme are for both the native (1.45 angstrom) and the inhibited complex with tazobactam (1.65 angstrom). This is the first such structure of a carbapenemase in complex with a clinically important beta-lactam inhibitor, shedding light on the structural implications for the inhibition process.	[Smith, Clyde A.] Stanford Univ, Stanford Synchrotron Radiat Lab, Menlo Pk, CA 94025 USA; [Frase, Hilary; Toth, Marta; Champion, Matthew M.; Mobashery, Shahriar; Vakulenko, Sergei B.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of Notre Dame	Smith, CA (corresponding author), Stanford Univ, Stanford Synchrotron Radiat Lab, Menlo Pk, CA 94025 USA.	csmith@slac.stanford.edu; svakulen@nd.edu		Champion, Matthew M./0000-0001-5927-5277	National Science Foundation [CHE-0741793]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089726] Funding Source: NIH RePORTER; Division Of Chemistry [0741793] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by National Science Foundation Grant CHE-0741793.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AMBLER RP, 1991, BIOCHEM J, V276, P269, DOI 10.1042/bj2760269; [Anonymous], 1988, MECH BASED ENZYME IN; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baughman Robert P, 2009, J Intensive Care Med, V24, P230, DOI 10.1177/0885066609335660; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bonomo RA, 2001, BBA-PROTEIN STRUCT M, V1547, P196, DOI 10.1016/S0167-4838(01)00175-3; Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001; Brown NG, 2009, J BIOL CHEM, V284, P33703, DOI 10.1074/jbc.M109.053819; BUSH K, 1993, ANTIMICROB AGENTS CH, V37, P851, DOI 10.1128/AAC.37.4.851; Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; CARTWRIGHT SJ, 1979, NATURE, V278, P360, DOI 10.1038/278360a0; Clinical and Laboratory Standards Institute, 2006, METH DIL ANT SUSC TE, V7; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fisher JF, 2010, J MED CHEM, V53, P4813, DOI 10.1021/jm100086u; Fisher JF, 2005, CHEM REV, V105, P395, DOI 10.1021/cr030102i; Frase H, 2009, J BIOL CHEM, V284, P29509, DOI 10.1074/jbc.M109.011262; Girlich D, 2010, ANTIMICROB AGENTS CH, V54, P328, DOI 10.1128/AAC.00961-09; Goffin C, 2002, MICROBIOL MOL BIOL R, V66, P702, DOI 10.1128/MMBR.66.4.702-738.2002; Ibuka A, 1999, J MOL BIOL, V285, P2079, DOI 10.1006/jmbi.1998.2432; JELSCH C, 1993, PROTEINS, V16, P364, DOI 10.1002/prot.340160406; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kalp M, 2009, BIOCHEMISTRY-US, V48, P9912, DOI 10.1021/bi9012098; Kalp M, 2009, J AM CHEM SOC, V131, P2338, DOI 10.1021/ja808311s; Kattan JN, 2008, CLIN MICROBIOL INFEC, V14, P1102, DOI 10.1111/j.1469-0691.2008.02101.x; Ke W, 2007, BIOCHEMISTRY-US, V46, P5732, DOI 10.1021/bi700300u; KNOX JR, 1991, J MOL BIOL, V220, P435, DOI 10.1016/0022-2836(91)90023-Y; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kuzin AP, 2001, BIOCHEMISTRY-US, V40, P1861, DOI 10.1021/bi0022745; MariotteBoyer S, 1996, FEMS MICROBIOL LETT, V143, P29, DOI 10.1016/0378-1097(96)00288-1; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Meroueh SO, 2005, J AM CHEM SOC, V127, P15397, DOI 10.1021/ja051592u; Moubareck C, 2009, ANTIMICROB AGENTS CH, V53, P3579, DOI 10.1128/AAC.00072-09; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nukaga M, 2003, J MOL BIOL, V328, P289, DOI 10.1016/S0022-2836(03)00210-9; OSTERCAMP DL, 1970, J ORG CHEM, V35, P1632, DOI 10.1021/jo00830a080; Padayatti PS, 2006, J AM CHEM SOC, V128, P13235, DOI 10.1021/ja063715w; Padayatti PS, 2004, BIOCHEMISTRY-US, V43, P843, DOI 10.1021/bi035985m; Pagan-Rodriguez D, 2004, J BIOL CHEM, V279, P19494, DOI 10.1074/jbc.M311669200; Papp-Wallace KM, 2010, ANTIMICROB AGENTS CH, V54, P890, DOI 10.1128/AAC.00693-09; Perez F, 2007, CURR OPIN PHARMACOL, V7, P459, DOI 10.1016/j.coph.2007.08.003; Poirel L, 2000, ANTIMICROB AGENTS CH, V44, P622, DOI 10.1128/AAC.44.3.622-632.2000; Poirel L, 2001, ANTIMICROB AGENTS CH, V45, P2598, DOI 10.1128/AAC.45.9.2598-2603.2001; Poole K, 2004, CELL MOL LIFE SCI, V61, P2200, DOI 10.1007/s00018-004-4060-9; RIZWI I, 1989, BIOCHEM J, V258, P205, DOI 10.1042/bj2580205; Shahid M, 2009, CRIT REV MICROBIOL, V35, P81, DOI 10.1080/10408410902733979; Smith CA, 2007, ACTA CRYSTALLOGR D, V63, P982, DOI 10.1107/S0907444907036955; Sougakoff W, 2002, ACTA CRYSTALLOGR D, V58, P267, DOI 10.1107/S0907444901019606; Sulton D, 2005, J BIOL CHEM, V280, P35528, DOI 10.1074/jbc.M501251200; Sun T, 2004, BIOCHEMISTRY-US, V43, P14111, DOI 10.1021/bi0487903; Swaren P, 1998, J BIOL CHEM, V273, P26714, DOI 10.1074/jbc.273.41.26714; Testero S. A., 2010, BURGERS MED CHEM DRU, P259; Toth M, 2010, J AM CHEM SOC, V132, P816, DOI 10.1021/ja908850p; Totir MA, 2006, BIOCHEMISTRY-US, V45, P11895, DOI 10.1021/bi060990m; Tranier S, 2000, J BIOL CHEM, V275, P28075; Vourli S, 2004, FEMS MICROBIOL LETT, V234, P209, DOI 10.1016/j.femsle.2004.03.028; Walther-Rasmussen J, 2007, J ANTIMICROB CHEMOTH, V60, P470, DOI 10.1093/jac/dkm226; Yang Y, 2000, J BIOL CHEM, V275, P26674	61	18	18	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14396	14409		10.1074/jbc.M110.208744	http://dx.doi.org/10.1074/jbc.M110.208744			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21345789	Green Published, hybrid			2022-12-27	WOS:000289556200061
J	Nag, S; Sarkar, B; Bandyopadhyay, A; Sahoo, B; Sreenivasan, VKA; Kombrabail, M; Muralidharan, C; Maiti, S				Nag, Suman; Sarkar, Bidyut; Bandyopadhyay, Arkarup; Sahoo, Bankanidhi; Sreenivasan, Varun K. A.; Kombrabail, Mamata; Muralidharan, Chandrakesan; Maiti, Sudipta			Nature of the Amyloid-beta Monomer and the Monomer-Oligomer Equilibrium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPAIR SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; PHYSIOLOGICAL CONCENTRATIONS; PROTEIN OLIGOMERIZATION; ENERGY-TRANSFER; CELL-MEMBRANES; FLUORESCENCE; PEPTIDE; DYNAMICS; SPECTROSCOPY	The monomer to oligomer transition initiates the aggregation and pathogenic transformation of Alzheimer amyloid-beta (A beta) peptide. However, the monomeric state of this aggregation-prone peptide has remained beyond the reach of most experimental techniques, and a quantitative understanding of this transition is yet to emerge. Here, we employ single-molecule level fluorescence tools to characterize the monomeric state and the monomer-oligomer transition at physiological concentrations in buffers mimicking the cerebrospinal fluid (CSF). Our measurements show that the monomer has a hydrodynamic radius of 0.9 +/- 0.1 nm, which confirms the prediction made by some of the in silico studies. Surprisingly, at equilibrium, both A beta(40) and A beta(42) remain predominantly monomeric up to 3 mu M, above which it forms large aggregates. This concentration is much higher than the estimated concentrations in the CSF of either normal or diseased brains. If A beta oligomers are present in the CSF and are the key agents in Alzheimer pathology, as is generally believed, then these must be released in the CSF as preformed entities. Although the oligomers are thermodynamically unstable, we find that a large kinetic barrier, which is mostly entropic in origin, strongly impedes their dissociation. Thermodynamic principles therefore allow the development of a pharmacological agent that can catalytically convert metastable oligomers into nontoxic monomers.	[Nag, Suman; Sarkar, Bidyut; Bandyopadhyay, Arkarup; Sahoo, Bankanidhi; Sreenivasan, Varun K. A.; Kombrabail, Mamata; Muralidharan, Chandrakesan; Maiti, Sudipta] Tata Inst Fundamental Res, Dept Chem Sci, Bombay 400005, Maharashtra, India	Tata Institute of Fundamental Research (TIFR)	Maiti, S (corresponding author), Tata Inst Fundamental Res, Dept Chem Sci, 1 Homi Bhabha Rd, Bombay 400005, Maharashtra, India.	maiti@tifr.res.in	Sreenivasan, Varun/D-9646-2014; Sreenivasan, Varun/C-4967-2012; Sahoo, Bankanidhi/C-2295-2017	Sarkar, Bidyut/0000-0001-5023-7581; Maiti, Sudipta/0000-0002-6540-7472; Bandyopadhyay, Arkarup/0000-0003-1979-857X; Sahoo, Bankanidhi/0000-0002-3633-1616; Sreenivasan, Varun/0000-0002-8667-8394				ARBELOA FL, 1989, J LUMIN, V44, P105, DOI 10.1016/0022-2313(89)90027-6; Baumketner A, 2006, PROTEIN SCI, V15, P420, DOI 10.1110/ps.051762406; Bernstein SL, 2005, J AM CHEM SOC, V127, P2075, DOI 10.1021/ja044531p; Bernstein SL, 2009, NAT CHEM, V1, P326, DOI [10.1038/NCHEM.247, 10.1038/nchem.247]; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; Bjerke Maria, 2010, Int J Alzheimers Dis, V2010, DOI 10.4061/2010/986310; Culbertson CT, 2002, TALANTA, V56, P365, DOI 10.1016/S0039-9140(01)00602-6; De Meyer G, 2010, ARCH NEUROL-CHICAGO, V67, P949, DOI 10.1001/archneurol.2010.179; DeMattos RB, 2002, J NEUROCHEM, V81, P229, DOI 10.1046/j.1471-4159.2002.00889.x; Fezoui Y, 2000, AMYLOID, V7, P166, DOI 10.3109/13506120009146831; Garai K, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2822322; Garcia-Ruiz JM, 2003, J STRUCT BIOL, V142, P22, DOI 10.1016/S1047-8477(03)00035-2; GarzonRodriguez W, 1997, J BIOL CHEM, V272, P21037, DOI 10.1074/jbc.272.34.21037; Giuffrida ML, 2009, J NEUROSCI, V29, P10582, DOI 10.1523/JNEUROSCI.1736-09.2009; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; HARAN G, 1992, P NATL ACAD SCI USA, V89, P11764, DOI 10.1073/pnas.89.24.11764; Klyubin I, 2008, J NEUROSCI, V28, P4231, DOI 10.1523/JNEUROSCI.5161-07.2008; Kuo YM, 1999, BIOCHEM BIOPH RES CO, V257, P787, DOI 10.1006/bbrc.1999.0552; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li XF, 2006, CELL BIOCHEM BIOPHYS, V46, P123, DOI 10.1385/CBB:46:2:123; LUBIENSKI MJ, 1994, BIOCHEMISTRY-US, V33, P8866, DOI 10.1021/bi00196a003; Massi F, 2001, BIOPHYS J, V80, P31, DOI 10.1016/S0006-3495(01)75993-0; Mukhopadhyay S, 2006, J MOL BIOL, V358, P935, DOI 10.1016/j.jmb.2006.02.006; Nag S, 2010, BIOPHYS J, V99, P1969, DOI 10.1016/j.bpj.2010.07.020; Santos AN, 2007, J ALZHEIMERS DIS, V11, P117; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Raffa DF, 2007, J PHYS CHEM B, V111, P3789, DOI 10.1021/jp0689621; Ramreddy T, 2007, J PHYS CHEM B, V111, P5757, DOI 10.1021/jp068818f; Sahoo B, 2009, BIOPHYS J, V97, P1454, DOI 10.1016/j.bpj.2009.05.055; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Sengupta P, 2003, BIOCHEMISTRY-US, V42, P10506, DOI 10.1021/bi0341410; Sengupta P, 2002, METHODS, V27, P374, DOI 10.1016/S1046-2023(02)00096-8; Sgourakis NG, 2007, J MOL BIOL, V368, P1448, DOI 10.1016/j.jmb.2007.02.093; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Soong R, 2009, J AM CHEM SOC, V131, P7079, DOI 10.1021/ja900285z; SOREGHAN B, 1994, J BIOL CHEM, V269, P28551; Tseng BP, 1999, BIOCHEMISTRY-US, V38, P10424, DOI 10.1021/bi990718v; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang Y, 2010, J PHYS CHEM B, V114, P7112, DOI 10.1021/jp101496y; Ward RV, 2000, BIOCHEM J, V348, P137, DOI 10.1042/0264-6021:3480137; Zou K, 2002, J NEUROSCI, V22, P4833, DOI 10.1523/JNEUROSCI.22-12-04833.2002	45	133	136	2	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					13827	13833		10.1074/jbc.M110.199885	http://dx.doi.org/10.1074/jbc.M110.199885			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21349839	Green Published, hybrid			2022-12-27	WOS:000289556200005
J	Schilling, S; Kohlmann, S; Bauscher, C; Sedlmeier, R; Koch, B; Eichentopf, R; Becker, A; Cynis, H; Hoffmann, T; Berg, S; Freyse, EJ; von Horsten, S; Rossner, S; Graubner, S; Demuth, HU				Schilling, Stephan; Kohlmann, Stephanie; Baeuscher, Christoph; Sedlmeier, Reinhard; Koch, Birgit; Eichentopf, Rico; Becker, Andreas; Cynis, Holger; Hoffmann, Torsten; Berg, Sabine; Freyse, Ernst-Joachim; von Hoersten, Stephan; Rossner, Steffen; Graubner, Sigrid; Demuth, Hans-Ulrich			Glutaminyl Cyclase Knock-out Mice Exhibit Slight Hypothyroidism but No Hypogonadism IMPLICATIONS FOR ENZYME FUNCTION AND DRUG DEVELOPMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYROGLUTAMIC ACID; A-BETA; AMYLOID PEPTIDES; HORMONE GENE; IN-VITRO; PGLU; INHIBITION; EXPRESSION; RECEPTOR; BRAIN	Glutaminyl cyclases (QCs) catalyze the formation of pyroglutamate (pGlu) residues at the N terminus of peptides and proteins. Hypothalamic pGlu hormones, such as thyrotropin-releasing hormone and gonadotropin-releasing hormone are essential for regulation of metabolism and fertility in the hypothalamic pituitary thyroid and gonadal axes, respectively. Here, we analyzed the consequences of constitutive genetic QC ablation on endocrine functions and on the behavior of adult mice. Adult homozygous QC knock-out mice are fertile and behave indistinguishably from wild type mice in tests of motor function, cognition, general activity, and ingestion behavior. The QC knock-out results in a dramatic drop of enzyme activity in the brain, especially in hypothalamus and in plasma. Other peripheral organs like liver and spleen still contain QC activity, which is most likely caused by its homolog isoQC. The serum gonadotropin-releasing hormone, TSH, and testosterone concentrations were not changed by QC depletion. The serum thyroxine was decreased by 24% in homozygous QC knock-out animals, suggesting a mild hypothyroidism. QC knock-out mice were indistinguishable from wild type with regard to blood glucose and glucose tolerance, thus differing from reports of thyrotropin-releasing hormone knock-out mice significantly. The results suggest a significant formation of the hypothalamic pGlu hormones by alternative mechanisms, like spontaneous cyclization or conversion by isoQC. The different effects of QC depletion on the hypothalamic pituitary thyroid and gonadal axes might indicate slightly different modes of substrate conversion of both enzymes. The absence of significant abnormalities in QC knock-out mice suggests the presence of a therapeutic window for suppression of QC activity in current drug development.	[Eichentopf, Rico; Cynis, Holger; Hoffmann, Torsten; Demuth, Hans-Ulrich] Probiodrug AG, D-06120 Halle, Germany; [Kohlmann, Stephanie; Baeuscher, Christoph; Sedlmeier, Reinhard; Becker, Andreas; Graubner, Sigrid; Demuth, Hans-Ulrich] Ingenium GmbH, D-82152 Martinsried, Germany; [Berg, Sabine; Freyse, Ernst-Joachim] Inst Diabet Endocrinol & Metab Dis, D-17495 Karlsburg, Germany; [von Hoersten, Stephan] Univ Erlangen Nurnberg, Franz Penzoldt Ctr, D-91054 Erlangen, Germany; [Rossner, Steffen] Univ Leipzig, Paul Flechsig Inst Brain Res, D-04109 Leipzig, Germany	Vivoryon Therapeutics; University of Erlangen Nuremberg; Leipzig University		stephan.schilling@probiodrug.de; sigrid.graubner@ingenium-ag.com	von Hörsten, Stephan/G-9005-2015; Rossner, Steffen/A-5184-2017	von Hörsten, Stephan/0000-0001-6409-0664; Cynis, Holger/0000-0001-6655-7539	Bundesministerium fuer Bildung und Forschung [0313185]	Bundesministerium fuer Bildung und Forschung	This work was supported by Bundesministerium fuer Bildung und Forschung Grant 0313185 (to H.-U. D.). S. S., B. K., R. E., H. C., and T. H. are employees of Probiodrug AG and hold stock option of the company. Ingenium Pharmaceuticals GmbH is a daughter company of Probiodrug AG, and therefore S. K., C. B., R. S., A. B., and S. G., as employees of Ingenium Pharmaceuticals, hold stock options of Probiodrug AG. H.-U. D. serves as Chief Scientific Officer of Probiodrug AG and Managing Director/Chief Executive Officer of Ingenium and holds shares and stock options of the Probiodrug group.	ABRAHAM GN, 1981, MOL CELL BIOCHEM, V38, P181, DOI 10.1007/BF00235695; AWADE AC, 1994, PROTEINS, V20, P34, DOI 10.1002/prot.340200106; BLOMBACK B, 1967, BIOCHIM BIOPHYS ACTA, V11, P398; BOCKERS TM, 1995, J NEUROENDOCRINOL, V7, P445, DOI 10.1111/j.1365-2826.1995.tb00780.x; BUSBY WH, 1987, J BIOL CHEM, V262, P8532; Cynis H, 2008, J MOL BIOL, V379, P966, DOI 10.1016/j.jmb.2008.03.078; D'Arrigo C, 2009, BIOPOLYMERS, V91, P861, DOI 10.1002/bip.21271; FISCHER WH, 1987, P NATL ACAD SCI USA, V84, P3628, DOI 10.1073/pnas.84.11.3628; Garavelli JS, 2000, NUCLEIC ACIDS RES, V28, P209, DOI 10.1093/nar/28.1.209; GARCIAPARDO A, 1983, J BIOL CHEM, V258, P2670; GONG JH, 1995, J EXP MED, V181, P631, DOI 10.1084/jem.181.2.631; GOREN HJ, 1977, MOL PHARMACOL, V13, P606; Hartlage-Rubsamen M, 2009, INT J DEV NEUROSCI, V27, P825, DOI 10.1016/j.ijdevneu.2009.08.007; He WL, 1999, BIOCHEMISTRY-US, V38, P10871, DOI 10.1021/bi990563r; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; KARTEN MJ, 1986, ENDOCR REV, V7, P44, DOI 10.1210/edrv-7-1-44; Keire DA, 2003, REGUL PEPTIDES, V113, P115, DOI 10.1016/S0167-0115(03)00005-3; Kinkead B, 2005, J PHARMACOL EXP THER, V315, P256, DOI 10.1124/jpet.105.087437; MASON AJ, 1986, SCIENCE, V234, P1366, DOI 10.1126/science.3024317; Morty RE, 2006, BIOCHEM J, V394, P635, DOI 10.1042/BJ20051593; Nillni EA, 1999, ENDOCRINE, V10, P185, DOI 10.1007/BF02738618; Nillni EA, 1999, ENDOCR REV, V20, P599, DOI 10.1210/er.20.5.599; OKADA Y, 1973, BIOCHEM BIOPH RES CO, V53, P1180, DOI 10.1016/0006-291X(73)90589-5; Piccini A, 2005, J BIOL CHEM, V280, P34186, DOI 10.1074/jbc.M501694200; POHL T, 1991, P NATL ACAD SCI USA, V88, P10059, DOI 10.1073/pnas.88.22.10059; Rehfeld JF, 2006, J MOL MED-JMM, V84, P544, DOI 10.1007/s00109-006-0055-3; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Saido TC, 1996, NEUROSCI LETT, V215, P173, DOI 10.1016/0304-3940(96)12970-0; Schilling S, 2008, NAT MED, V14, P1106, DOI 10.1038/nm.1872; Schilling S, 2006, BIOCHEMISTRY-US, V45, P12393, DOI 10.1021/bi0612667; Schilling S, 2008, J NEUROCHEM, V106, P1225, DOI 10.1111/j.1471-4159.2008.05471.x; Schlenzig D, 2009, BIOCHEMISTRY-US, V48, P7072, DOI 10.1021/bi900818a; Sealfon SC, 1997, ENDOCR REV, V18, P180, DOI 10.1210/er.18.2.180; Seifert F, 2009, BIOCHEMISTRY-US, V48, P11831, DOI 10.1021/bi9018835; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; Tomidokoro Y, 2005, J BIOL CHEM, V280, P36883, DOI 10.1074/jbc.M504038200; Van Coillie E, 1998, BIOCHEMISTRY-US, V37, P12672, DOI 10.1021/bi980497d; Wetsel WC, 2002, PROG BRAIN RES, V141, P221; Yamada M, 2003, THYROID, V13, P1111, DOI 10.1089/10507250360731505; Yamada M, 1997, P NATL ACAD SCI USA, V94, P10862, DOI 10.1073/pnas.94.20.10862	41	26	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14199	14208		10.1074/jbc.M111.229385	http://dx.doi.org/10.1074/jbc.M111.229385			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21330373	Green Published, hybrid			2022-12-27	WOS:000289556200043
J	Abdel-Sater, F; Jean, C; Merhi, A; Vissers, S; Andre, B				Abdel-Sater, Fadi; Jean, Cathy; Merhi, Ahmad; Vissers, Stephan; Andre, Bruno			Amino Acid Signaling in Yeast: Activation of Ssy5 Protease Is Associated with Its Phosphorylation-induced Ubiquitylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASEIN KINASE-I; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; ENDOPROTEOLYTIC ACTIVATION; AGP1 GENE; SENSOR; PATHWAY; STP1; PROTEOLYSIS; UBIQUITIN	The yeast Ssy5 protein is a serine-type endoprotease autoprocessed into a catalytic domain and a large inhibitory prodomain. When external amino acids are detected by the plasma membrane Ssy1 sensor, Ssy5 is activated and catalyzes endoproteolytic processing of the Stp1 and Stp2 transcription factors. These Stp proteins then migrate into the nucleus and activate transcription of several amino acid permease genes. Previous studies showed that Ssy5 activation involves the SCFGrr1 ubiquitin ligase complex, but the molecular mechanisms of this activation remain unclear. We here report that the prodomain of Ssy5 is phosphorylated in a casein kinase I-dependent manner in response to amino acid detection. We describe a mutant form of Ssy5 whose prodomain is not phosphorylated and show that it is nonfunctional. Amino acid detection also induces ubiquitylation of the Ssy5 prodomain. This prodomain ubiquitylation requires its prior phosphorylation and the SCFGrr1 complex. When this ubiquitylation is defective, Ssy5 accumulates as a phosphorylated form but remains inactive. A constitutive Ssy5 form in which the prodomain fails to inhibit the catalytic domain does not need to be phosphorylated or ubiquitylated to be active. Finally, we provide evidence that ubiquitylation of the inhibitory prodomain rather than its subsequent degradation is the key step in the Ssy5 activation mechanism. We propose that the Ssy5 protease is activated by phosphorylation-induced ubiquitylation, the effect of which is relief from inhibition by its prodomain.	[Abdel-Sater, Fadi; Jean, Cathy; Merhi, Ahmad; Vissers, Stephan; Andre, Bruno] Univ Libre Bruxelles, Lab Physiol Mol Cellule CP300, Inst Biol & Med Mol, B-6041 Gosselies, Belgium	Universite Libre de Bruxelles	Andre, B (corresponding author), Univ Libre Bruxelles, Lab Physiol Mol Cellule CP300, Inst Biol & Med Mol, 11 Rue Pr Jeener & Brachet, B-6041 Gosselies, Belgium.	bran@ulb.ac.be	André, Bruno/D-1725-2010	Merhi, Ahmad/0000-0001-7046-2508; abdel-sater, fadi/0000-0003-3590-140X	Fonds de la Recherche Scientifique Medicale [3.4.592.08.FF]; Region Wallonne de Belgique [716760]; Communaute Francaise de Belgique	Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); Region Wallonne de Belgique; Communaute Francaise de Belgique(Australian Research Council)	This work was supported by Fonds de la Recherche Scientifique Medicale Grant 3.4.592.08.FF, CIBLES Grant 716760 of the Region Wallonne de Belgique, and an Actions de Recherche Concertees grant of the Communaute Francaise de Belgique.	Abdel-Sater F, 2004, MOL CELL BIOL, V24, P9771, DOI 10.1128/MCB.24.22.9771-9785.2004; Abdel-Sater F, 2004, GENETICS, V166, P1727, DOI 10.1534/genetics.166.4.1727; Andreasson C, 2004, MOL CELL BIOL, V24, P7503, DOI 10.1128/MCB.24.17.7503-7513.2004; Andreasson C, 2002, GENE DEV, V16, P3158, DOI 10.1101/gad.239202; Andreasson C, 2006, GENE DEV, V20, P1563, DOI 10.1101/gad.374206; Bernard F, 2001, MOL MICROBIOL, V41, P489, DOI 10.1046/j.1365-2958.2001.02538.x; Bernard F, 2001, FEBS LETT, V496, P81, DOI 10.1016/S0014-5793(01)02412-7; BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609; Broemer M, 2009, TRENDS CELL BIOL, V19, P130, DOI 10.1016/j.tcb.2009.01.004; de Boer M, 1998, MOL MICROBIOL, V30, P603, DOI 10.1046/j.1365-2958.1998.01094.x; Didion T, 1998, MOL MICROBIOL, V27, P643, DOI 10.1046/j.1365-2958.1998.00714.x; Ditzel M, 2008, MOL CELL, V32, P540, DOI 10.1016/j.molcel.2008.09.025; Emter R, 2002, FEBS LETT, V521, P57, DOI 10.1016/S0014-5793(02)02818-1; Gauss R, 2005, YEAST, V22, P1, DOI 10.1002/yea.1187; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; Hauske P, 2008, CHEMBIOCHEM, V9, P2920, DOI 10.1002/cbic.200800528; HEINEMEYER W, 1991, EMBO J, V10, P555, DOI 10.1002/j.1460-2075.1991.tb07982.x; HOCHSTRASSER M, 1991, P NATL ACAD SCI USA, V88, P4606, DOI 10.1073/pnas.88.11.4606; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Iraqui I, 1999, MOL CELL BIOL, V19, P989; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Jorgensen MU, 1997, CURR GENET, V31, P241, DOI 10.1007/s002940050201; Jorgensen MU, 1998, YEAST, V14, P103, DOI 10.1002/(SICI)1097-0061(19980130)14:2<103::AID-YEA203>3.0.CO;2-C; Klasson H, 1999, MOL CELL BIOL, V19, P5405; Liu ZC, 2008, MOL CELL BIOL, V28, P551, DOI 10.1128/MCB.00929-07; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pfirrmann T, 2010, MOL CELL BIOL, V30, P3299, DOI 10.1128/MCB.00323-10; Poulsen P, 2006, EUKARYOT CELL, V5, P601, DOI 10.1128/EC.5.3.601-608.2006; Sohn J, 2009, STRUCTURE, V17, P1411, DOI 10.1016/j.str.2009.07.017; Spielewoy N, 2004, MOL CELL BIOL, V24, P8994, DOI 10.1128/MCB.24.20.8994-9005.2004; Wielemans K, 2010, J BIOL CHEM, V285, P855, DOI 10.1074/jbc.M109.015263	32	21	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.200592	http://dx.doi.org/10.1074/jbc.M110.200592			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21310956	Green Published, hybrid			2022-12-27	WOS:000289077500014
J	Calmettes, C; Yu, RH; Silva, LP; Curran, D; Schriemer, DC; Schryvers, AB; Moraes, TF				Calmettes, Charles; Yu, Rong-hua; Silva, Leslie P.; Curran, Dave; Schriemer, David C.; Schryvers, Anthony B.; Moraes, Trevor F.			Structural Variations within the Transferrin Binding Site on Transferrin-binding Protein B, TbpB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTINOBACILLUS-PLEUROPNEUMONIAE; IRON ACQUISITION; BACTERICIDAL ANTIBODIES; NEISSERIA-MENINGITIDIS; PATHOGENIC BACTERIA; RECEPTOR; IDENTIFICATION; INFECTION; COMPLEX; ANTIGEN	Pathogenic bacteria acquire the essential element iron through specialized uptake pathways that are necessary in the iron-limiting environments of the host. Members of the Gram-negative Neisseriaceae and Pasteurellaceae families have adapted to acquire iron from the host iron binding glycoprotein, transferrin (Tf), through a receptor complex comprised of transferring-binding protein (Tbp) A and B. Because of the critical role they play in the host, these surface-exposed proteins are invariably present in clinical isolates and thus are considered prime vaccine targets. The specific interactions between TbpB and Tf are essential and ultimately might be exploited to create a broad-spectrum vaccine. In this study, we report the structure of TbpBs from two porcine pathogens, Actinobacillus pleuropneumoniae and suis. Paradoxically, despite a common Tf target, these swine related TbpBs show substantial sequence variation in their Tf-binding site. The TbpB structures, supported by docking simulations, surface plasmon resonance and hydrogen/deuterium exchange experiments with wild-type and mutant TbpBs, explain why there are structurally conserved elements within TbpB homologs despite major sequence variation that are required for binding Tf.	[Yu, Rong-hua; Curran, Dave; Schryvers, Anthony B.] Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB T2N 4N1, Canada; [Calmettes, Charles; Moraes, Trevor F.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Silva, Leslie P.; Schriemer, David C.; Schryvers, Anthony B.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Toronto; University of Calgary	Schryvers, AB (corresponding author), Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB T2N 4N1, Canada.	schryver@ucalgary.ca; trevor.moraes@utoronto.ca	Schryvers, Anthony B./AAF-3417-2020	calmettes, charles/0000-0002-2542-4382	Canadian Foundation for Innovation (CFI); Alberta Heritage Foundation for Medical Research (AHFMR); Canadian Institutes of Health Research (CIHR)	Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Alberta Heritage Foundation for Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This research was funded with operating and infrastructure support provided by Canadian Foundation for Innovation (CFI), Alberta Heritage Foundation for Medical Research (AHFMR), and Canadian Institutes of Health Research (CIHR).	Bahrami F, 2003, VET MICROBIOL, V94, P79, DOI 10.1016/S0378-1135(03)00082-8; Baltes N, 2002, FEMS MICROBIOL LETT, V209, P283, DOI 10.1111/j.1574-6968.2002.tb11145.x; Cheng Y, 2004, CELL, V116, P565, DOI 10.1016/S0092-8674(04)00130-8; CORNELISSEN CN, 1992, J BACTERIOL, V174, P5788, DOI 10.1128/jb.174.18.5788-5797.1992; Cornelissen CN, 1998, MOL MICROBIOL, V27, P611, DOI 10.1046/j.1365-2958.1998.00710.x; DANVE B, 1993, VACCINE, V11, P1214, DOI 10.1016/0264-410X(93)90045-Y; del Rio ML, 2005, FEMS IMMUNOL MED MIC, V45, P75, DOI 10.1016/j.femsim.2005.02.008; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GONZALEZ GC, 1990, MOL MICROBIOL, V4, P1173, DOI 10.1111/j.1365-2958.1990.tb00692.x; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; GRAYOWEN SD, 1993, MICROB PATHOGENESIS, V14, P389, DOI 10.1006/mpat.1993.1038; GrayOwen SD, 1996, TRENDS MICROBIOL, V4, P185, DOI 10.1016/0966-842X(96)10025-1; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kaplan J, 2002, CELL, V111, P603, DOI 10.1016/S0092-8674(02)01164-9; Ling JML, 2010, MOL MICROBIOL, V77, P1301, DOI 10.1111/j.1365-2958.2010.07289.x; LISSOLO L, 1995, INFECT IMMUN, V63, P884, DOI 10.1128/IAI.63.3.884-890.1995; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moraes TF, 2009, MOL CELL, V35, P523, DOI 10.1016/j.molcel.2009.06.029; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myers LE, 1998, INFECT IMMUN, V66, P4183; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Potter AA, 1999, MICROB PATHOGENESIS, V27, P197, DOI 10.1006/mpat.1999.0297; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Retzer MD, 1998, MICROB PATHOGENESIS, V25, P175, DOI 10.1006/mpat.1998.0226; ROSSICAMPOS A, 1992, VACCINE, V10, P512, DOI 10.1016/0264-410X(92)90349-O; SCHRYVERS AB, 1990, CAN J MICROBIOL, V36, P145, DOI 10.1139/m90-026; Slysz GW, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-162; YU RH, 1993, MICROB PATHOGENESIS, V15, P433, DOI 10.1006/mpat.1993.1092; ZAK O, 1986, BLOOD, V68, P157	29	37	37	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.206102	http://dx.doi.org/10.1074/jbc.M110.206102			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21297163	Green Published, hybrid			2022-12-27	WOS:000289077500079
J	Huang, KF; Liaw, SS; Huang, WL; Chia, CY; Lo, YC; Chen, YL; Wang, AHJ				Huang, Kai-Fa; Liaw, Su-Sen; Huang, Wei-Lin; Chia, Cho-Yun; Lo, Yan-Chung; Chen, Yi-Ling; Wang, Andrew H. -J.			Structures of Human Golgi-resident Glutaminyl Cyclase and Its Complexes with Inhibitors Reveal a Large Loop Movement upon Inhibitor Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; STRUCTURE REFINEMENT; ALZHEIMERS-DISEASE; PYROGLUTAMIC ACID; GENE-EXPRESSION; A-BETA; PROTEIN; BOND; AMINOPEPTIDASE; PITUITARY	Aberrant pyroglutamate formation at the N terminus of certain peptides and proteins, catalyzed by glutaminyl cyclases (QCs), is linked to some pathological conditions, such as Alzheimer disease. Recently, a glutaminyl cyclase (QC) inhibitor, PBD150, was shown to be able to reduce the deposition of pyroglutamate-modified amyloid-beta peptides in brain of transgenic mouse models of Alzheimer disease, leading to a significant improvement of learning and memory in those transgenic animals. Here, we report the 1.05-1.40 angstrom resolution structures, solved by the sulfur single-wavelength anomalous dispersion phasing method, of the Golgi-luminal catalytic domain of the recently identified Golgi-resident QC (gQC) and its complex with PBD150. We also describe the high-resolution structures of secretory QC (sQC)-PBD150 complex and two other gQC-inhibitor complexes. gQC structure has a scaffold similar to that of sQC but with a relatively wider and negatively charged active site, suggesting a distinct substrate specificity from sQC. Upon binding to PBD150, a large loop movement in gQC allows the inhibitor to be tightly held in its active site primarily by hydrophobic interactions. Further comparisons of the inhibitor-bound structures revealed distinct interactions of the inhibitors with gQC and sQC, which are consistent with the results from our inhibitor assays reported here. Because gQC and sQC may play different biological roles in vivo, the different inhibitor binding modes allow the design of specific inhibitors toward gQC and sQC.	[Huang, Kai-Fa; Liaw, Su-Sen; Huang, Wei-Lin; Chia, Cho-Yun; Lo, Yan-Chung; Chen, Yi-Ling; Wang, Andrew H. -J.] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan; [Huang, Kai-Fa; Liaw, Su-Sen; Wang, Andrew H. -J.] Acad Sinica, Core Facil Prot Prod & Xray Struct Anal, Taipei 11529, Taiwan; [Lo, Yan-Chung; Chen, Yi-Ling; Wang, Andrew H. -J.] Natl Yang Ming Univ, Dept Pharmacol, Taipei 11221, Taiwan; [Lo, Yan-Chung; Chen, Yi-Ling; Wang, Andrew H. -J.] Natl Yang Ming Univ, Inst Pharmacol, Taipei 11221, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Wang, AHJ (corresponding author), Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan.	ahjwang@gate.sinica.edu.tw	Chen, Yi/HIR-2608-2022		Academia Sinica; National Research Program for Genomic Medicine [NSC97-3112-B-001-035-B4]	Academia Sinica(Academia Sinica - Taiwan); National Research Program for Genomic Medicine(Ministry of Science and Technology, Taiwan)	This work was supported by the Academia Sinica and Core Facility for Protein Production and X-Ray Structural Analysis of the National Research Program for Genomic Medicine (Grant NSC97-3112-B-001-035-B4 to A. H.-J.W.).	Batliwalla FM, 2005, GENES IMMUN, V6, P388, DOI 10.1038/sj.gene.6364209; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buchholz M, 2006, J MED CHEM, V49, P664, DOI 10.1021/jm050756e; Buchholz M, 2009, J MED CHEM, V52, P7069, DOI 10.1021/jm900969p; BUSBY WH, 1987, J BIOL CHEM, V262, P8532; CHEVRIER B, 1994, STRUCTURE, V2, P283, DOI 10.1016/S0969-2126(00)00030-7; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; Cynis H, 2008, BIOCHEMISTRY-US, V47, P7405, DOI 10.1021/bi800250p; Cynis H, 2008, J MOL BIOL, V379, P966, DOI 10.1016/j.jmb.2008.03.078; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Ezura Y, 2004, J BONE MINER RES, V19, P1296, DOI 10.1359/JBMR.040324; Gillis JS, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-27; GOREN HJ, 1977, MOL PHARMACOL, V13, P606; Greenblatt HM, 1997, J MOL BIOL, V265, P620, DOI 10.1006/jmbi.1996.0729; Guevara T, 2006, BIOL CHEM, V387, P1479, DOI 10.1515/BC.2006.185; Hook V, 2008, BIOL CHEM, V389, P993, DOI 10.1515/BC.2008.124; Huang KF, 2008, BIOCHEM J, V411, P181, DOI 10.1042/BJ20071073; Huang KF, 2005, P NATL ACAD SCI USA, V102, P13117, DOI 10.1073/pnas.0504184102; Huang KF, 2005, PROTEIN EXPRES PURIF, V43, P65, DOI 10.1016/j.pep.2005.02.020; Huang WL, 2010, J MOL BIOL, V401, P374, DOI 10.1016/j.jmb.2010.06.012; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Muthusamy V, 2006, CANCER RES, V66, P11187, DOI 10.1158/0008-5472.CAN-06-1274; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Schilling S, 2003, BIOL CHEM, V384, P1583, DOI 10.1515/BC.2003.175; Schilling S, 2008, NAT MED, V14, P1106, DOI 10.1038/nm.1872; Schilling S, 2007, BIOCHEMISTRY-US, V46, P10921, DOI 10.1021/bi701043x; Schilling S, 2007, BIOL CHEM, V388, P145, DOI 10.1515/BC.2007.016; Schilling S, 2008, J NEUROCHEM, V106, P1225, DOI 10.1111/j.1471-4159.2008.05471.x; Segel I. H., 1993, ENZYME KINETICS BEHA, P100; Seifert F, 2009, BIOCHEMISTRY-US, V48, P11831, DOI 10.1021/bi9018835; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Stephan A, 2009, FEBS J, V276, P6522, DOI 10.1111/j.1742-4658.2009.07337.x; Sykes PA, 1999, FEBS LETT, V455, P159, DOI 10.1016/S0014-5793(99)00872-8; Thouennon E, 2007, J CLIN ENDOCR METAB, V92, P4865, DOI 10.1210/jc.2007-1253; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Valdes-Martinez J, 2004, J CHEM CRYSTALLOGR, V34, P533, DOI 10.1023/B:JOCC.0000042022.16392.99; Van Coillie E, 1998, BIOCHEMISTRY-US, V37, P12672, DOI 10.1021/bi980497d; Wintjens R, 2006, J MOL BIOL, V357, P457, DOI 10.1016/j.jmb.2005.12.029	46	39	42	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.208595	http://dx.doi.org/10.1074/jbc.M110.208595			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21288892	hybrid, Green Published			2022-12-27	WOS:000289077500058
J	Ramachandran, S; Cerione, RA				Ramachandran, Sekar; Cerione, Richard A.			A Dominant-negative G alpha Mutant That Traps a Stable Rhodopsin-G alpha-GTP-beta gamma Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE-BINDING; HETEROTRIMERIC G-PROTEIN; ROD OUTER SEGMENTS; TRANSDUCIN-ALPHA; CRYSTAL-STRUCTURE; SUBUNIT COMPLEX; COUPLED RECEPTORS; STRUCTURAL BASIS; ACTIVATION; MECHANISM	Residues comprising the guanine nucleotide-binding sites of the alpha subunits of heterotrimeric (large) G-proteins (G alpha subunits), as well as the Ras-related (small) G-proteins, are highly conserved. This is especially the case for the phosphate-binding loop (P-loop) where both G alpha subunits and Ras-related G-proteins have a conserved serine or threonine residue. Substitutions for this residue in Ras and related (small) G-proteins yield nucleotide-depleted, dominant-negative mutants. Here we have examined the consequences of changing the conserved serine residue in the P-loop to asparagine, within a chimeric G alpha subunit (designated alpha(T)*) that is mainly comprised of the alpha subunit of the retinal G-protein transducin and a limited region from the alpha subunit of Gi1. The alpha(T)*(S43N) mutant exhibits a significantly higher rate of intrinsic GDP-GTP exchange compared with wild-type alpha(T)*, with light-activated rhodopsin (R*) causing only a moderate increase in the kinetics of nucleotide exchange on alpha(T)*(S43N). The alpha(T)*(S43N) mutant, when bound to either GDP or GTP, was able to significantly slow the rate of R*-catalyzed GDP-GTP exchange on wild-type alpha(T)*. Thus, GTP-bound alpha(T)*(S43N), as well as the GDP-bound mutant, is capable of forming a stable complex with R*. alpha(T)*(S43N) activated the cGMP phosphodiesterase (PDE) with a dose-response similar to wild-type alpha(T)*. Activation of the PDE by alpha(T)*(S43N) was unaffected if either R* or beta 1 gamma 1 alone was present, whereas it was inhibited when R* and the beta 1 gamma 1 subunit were added together. Overall, our studies suggest that the S43N substitution on alpha(T)* stabilizes an intermediate on the G-protein activation pathway consisting of an activated G-protein-coupled receptor, a GTP-bound G alpha subunit, and the beta 1 gamma 1 complex.	[Cerione, Richard A.] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA; Cornell Univ, Dept Chem & Biol Chem, Ithaca, NY 14853 USA	Cornell University; Cornell University	Cerione, RA (corresponding author), Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA.	rac1@cornell.edu	Ramachandran, Sekar/AAP-2287-2020	Ramachandran, Sekar/0000-0002-2243-1368	National Institutes of Health [GM047458]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047458] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM047458.	ABOOD ME, 1982, J BIOL CHEM, V257, P540; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Berlot CH, 2002, J BIOL CHEM, V277, P21080, DOI 10.1074/jbc.M201330200; Burns ME, 2005, NEURON, V48, P387, DOI 10.1016/j.neuron.2005.10.014; Chen CK, 2005, REV PHYSIOL BIOCH P, V154, P101, DOI 10.1007/s10254-005-0004-5; Cleator JH, 1999, FEBS LETT, V443, P205, DOI 10.1016/S0014-5793(98)01704-9; Cleator JH, 2004, J BIOL CHEM, V279, P36601, DOI 10.1074/jbc.M406232200; FAWZI AB, 1990, BIOCHEMISTRY-US, V29, P3804, DOI 10.1021/bi00467a030; FAWZI AB, 1991, J BIOL CHEM, V266, P12194; Feig LA, 1999, NAT CELL BIOL, V1, pE25, DOI 10.1038/10018; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; FERGUSON KM, 1986, J BIOL CHEM, V261, P7393; FUNG BKK, 1983, J BIOL CHEM, V258, P495; Gether U, 1998, J BIOL CHEM, V273, P17979, DOI 10.1074/jbc.273.29.17979; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P762; Iiri T, 1999, P NATL ACAD SCI USA, V96, P499, DOI 10.1073/pnas.96.2.499; Jian XY, 2001, J BIOL CHEM, V276, P48518, DOI 10.1074/jbc.M107129200; JOHN J, 1993, J BIOL CHEM, V268, P923; Kobilka B, 2008, TRENDS PHARMACOL SCI, V29, P79, DOI 10.1016/j.tips.2007.11.009; KROLL S, 1989, J BIOL CHEM, V264, P4490; LAMBRIGHT DG, 1994, NATURE, V369, P621, DOI 10.1038/369621a0; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Li QB, 1997, J BIOL CHEM, V272, P21673, DOI 10.1074/jbc.272.35.21673; LIEBMAN PA, 1982, METHOD ENZYMOL, V81, P532; Majumdar S, 2006, J BIOL CHEM, V281, P9219, DOI 10.1074/jbc.M513837200; Majumdar S, 2004, J BIOL CHEM, V279, P40137, DOI 10.1074/jbc.M405420200; Min KC, 2000, PROTEIN EXPRES PURIF, V20, P514, DOI 10.1006/prep.2000.1326; Mittal R, 1996, SCIENCE, V271, P1413, DOI 10.1126/science.271.5254.1413; Natochin M, 1999, J BIOL CHEM, V274, P7865, DOI 10.1074/jbc.274.12.7865; Natochin M, 2006, BIOCHEMISTRY-US, V45, P6488, DOI 10.1021/bi060381e; NAVON SE, 1984, J BIOL CHEM, V259, P6686; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Oldham WM, 2007, ADV PROTEIN CHEM, V74, P67, DOI 10.1016/S0065-3233(07)74002-0; Pereira R, 2005, J BIOL CHEM, V280, P35696, DOI 10.1074/jbc.M504935200; PHILLIPS WJ, 1988, J BIOL CHEM, V263, P15498; PHILLIPS WJ, 1992, J BIOL CHEM, V267, P17040; PHILLIPS WJ, 1992, J BIOL CHEM, V267, P17032; Skiba NP, 2000, METHOD ENZYMOL, V315, P502; SLEPAK VZ, 1995, J BIOL CHEM, V270, P4037, DOI 10.1074/jbc.270.8.4037; SLEPAK VZ, 1993, J BIOL CHEM, V268, P21889; SONDEK J, 1994, NATURE, V372, P276, DOI 10.1038/372276a0; Sprang SR, 2007, ADV PROTEIN CHEM, V74, P1, DOI 10.1016/S0065-3233(07)74001-9; WILDMAN DE, 1993, P NATL ACAD SCI USA, V90, P794, DOI 10.1073/pnas.90.3.794; Zelent B, 2001, BIOCHEMISTRY-US, V40, P9647, DOI 10.1021/bi010272u	45	11	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.166538	http://dx.doi.org/10.1074/jbc.M110.166538			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21285355	Green Published, hybrid			2022-12-27	WOS:000289077500081
J	Su, X; Ao, LH; Shi, Y; Johnson, TR; Fullerton, DA; Meng, XZ				Su, Xin; Ao, Lihua; Shi, Yi; Johnson, Thomas R.; Fullerton, David A.; Meng, Xianzhong			Oxidized Low Density Lipoprotein Induces Bone Morphogenetic Protein-2 in Coronary Artery Endothelial Cells via Toll-like Receptors 2 and 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VALVE INTERSTITIAL-CELLS; BMP-2 GENE-EXPRESSION; CALCIFICATION IN-VIVO; SMOOTH-MUSCLE-CELLS; VASCULAR CALCIFICATION; ATHEROSCLEROTIC PLAQUES; LECTIN-LIKE; MACROPHAGES; MICE; LDL	Vascular calcification is a common complication in atherosclerosis. Bone morphogenetic protein-2 (BMP-2) plays an important role in atherosclerotic vascular calcification. The aim of this study was to determine the effect of oxidized low density lipoprotein (oxLDL) on BMP-2 protein expression in human coronary artery endothelial cells (CAECs), the roles of Toll-like receptor (TLR) 2 and TLR4 in oxLDL-induced BMP-2 expression, and the signaling pathways involved. Human CAECs were stimulated with oxLDL. The roles of TLR2 and TLR4 in oxLDL-induced BMP-2 expression were determined by pretreatment with neutralizing antibody, siRNA, and overexpression. Stimulation with oxLDL increased cellular BMP-2 protein levels in a dose-dependent manner (40-160 mu g/ml). Pretreatment with neutralizing antibodies against TLR2 and TLR4 or silencing of these two receptors reduced oxLDL-induced BMP-2expression. Overexpression of TLR2 and TLR4 enhanced the cellular BMP-2 response to oxLDL. Furthermore, oxLDL was co-localized with TLR2 and TLR4. BMP-2 expression was associated with activation of nuclear factor-kappa B (NF-kappa B), p38 mitogen-activated protein kinase (MAPK), and extracellular signal-regulated kinase (ERK) 1/2. Inhibition of NF-kappa B and ERK1/2 reduced BMP-2 expression whereas inhibition of p38 MAPK had no effect. In conclusion, oxLDL induces BMP-2 expression through TLR2 and TLR4 in human CAECs. The NF-kappa B and ERK1/2 pathways are involved in the signaling mechanism. These findings underscore an important role for TLR2 and TLR4 in mediating the BMP-2 response to oxLDL in human CAECs and indicate that these two immunoreceptors contribute to the mechanisms underlying atherosclerotic vascular calcification.	[Su, Xin; Ao, Lihua; Johnson, Thomas R.; Fullerton, David A.; Meng, Xianzhong] Univ Colorado Denver, Dept Surg, Aurora, CO 80045 USA; [Su, Xin; Shi, Yi] Nanjing Univ, Sch Med, Jinling Hosp, Dept Resp Med, Nanjing 210002, Peoples R China	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Nanjing University	Meng, XZ (corresponding author), 12700 E 19th Ave,Box C-320, Aurora, CO 80045 USA.	xianzhong.meng@ucdenver.edu	Su, Xin/X-2589-2018	su, Xin/0000-0002-3910-9156	National Institutes of Health [HL079051]; American Heart Association [0850148Z]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079051] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL079051. This work was also supported by American Heart Association Grant 0850148Z.	Ao LH, 2009, AM J PHYSIOL-HEART C, V297, pH21, DOI 10.1152/ajpheart.00292.2009; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; BOSTROM K, 1993, J CLIN INVEST, V91, P1800, DOI 10.1172/JCI116391; Chen MJ, 2002, PHARMACOL THERAPEUT, V95, P89, DOI 10.1016/S0163-7258(02)00236-X; Choi SH, 2009, CIRC RES, V104, P1355, DOI 10.1161/CIRCRESAHA.108.192880; Cola C, 2004, BIOCHEM BIOPH RES CO, V320, P424, DOI 10.1016/j.bbrc.2004.05.181; Csiszar A, 2005, CIRCULATION, V111, P2364, DOI 10.1161/01.CIR.0000164201.40634.1D; de Castellarnau C, 2007, CLIN CHIM ACTA, V376, P233, DOI 10.1016/j.cca.2006.07.024; de Graaf R, 2006, MICROBES INFECT, V8, P1859, DOI 10.1016/j.micinf.2006.02.024; Dhore CR, 2001, ARTERIOSCL THROM VAS, V21, P1998, DOI 10.1161/hq1201.100229; Feng JQ, 2003, J BIOL CHEM, V278, P29130, DOI 10.1074/jbc.M212296200; FITZGERALD PJ, 1992, CIRCULATION, V86, P64, DOI 10.1161/01.CIR.86.1.64; Galle J, 2006, ATHEROSCLEROSIS, V185, P219, DOI 10.1016/j.atherosclerosis.2005.10.005; Hruska KA, 2005, CIRC RES, V97, P105, DOI 10.1161/01.RES.00000175571.53833.6c; Katsargyris A, 2011, CEREBROVASC DIS, V31, P29, DOI 10.1159/000320259; Li XW, 2008, ATHEROSCLEROSIS, V199, P271, DOI 10.1016/j.atherosclerosis.2007.11.031; Liu X, 2008, ATHEROSCLEROSIS, V196, P146, DOI 10.1016/j.atherosclerosis.2007.03.025; Mehta JL, 2006, CARDIOVASC RES, V69, P36, DOI 10.1016/j.cardiores.2005.09.006; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Miller YI, 2005, ARTERIOSCL THROM VAS, V25, P1213, DOI 10.1161/01.ATV.0000159891.73193.31; Miller YI, 2003, J BIOL CHEM, V278, P1561, DOI 10.1074/jbc.M209634200; Monaco C, 2009, CIRCULATION, V120, P2462, DOI 10.1161/CIRCULATIONAHA.109.851881; Mullick AE, 2008, J EXP MED, V205, P373, DOI 10.1084/jem.20071096; Mullick AE, 2005, J CLIN INVEST, V115, P3149, DOI 10.1172/JCI25482; Nakagawa Y, 2010, ARTERIOSCL THROM VAS, V30, P1908, DOI 10.1161/ATVBAHA.110.206185; Nowicki M, 2010, J NEUROSCI RES, V88, P403, DOI 10.1002/jnr.22205; O'Neill LAJ, 2009, PHARMACOL REV, V61, P177, DOI 10.1124/pr.109.001073; Shao JS, 2006, ARTERIOSCL THROM VAS, V26, P1423, DOI 10.1161/01.ATV.0000220441.42041.20; Shao JS, 2010, HYPERTENSION, V55, P579, DOI 10.1161/HYPERTENSIONAHA.109.134205; Speer MY, 2002, J EXP MED, V196, P1047, DOI 10.1084/jem.20020911; Su X, 2008, BBA-MOL CELL RES, V1783, P1623, DOI 10.1016/j.bbamcr.2008.04.009; Su X, 2010, CYTOKINE, V51, P60, DOI 10.1016/j.cyto.2010.04.014; Willette RN, 1999, J VASC RES, V36, P120, DOI 10.1159/000025634; Xu XH, 2001, CIRCULATION, V104, P3103, DOI 10.1161/hc5001.100631; Yang XP, 2009, J THORAC CARDIOV SUR, V138, P1008, DOI 10.1016/j.jtcvs.2009.06.024; Yang XP, 2009, J AM COLL CARDIOL, V53, P491, DOI 10.1016/j.jacc.2008.09.052; Zou N, 2008, AM J PHYSIOL-HEART C, V294, pH2805, DOI 10.1152/ajpheart.00299.2008	37	67	73	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.214619	http://dx.doi.org/10.1074/jbc.M110.214619			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21325271	Green Published, hybrid			2022-12-27	WOS:000289077500036
J	Liu, YS; Baker, JO; Zeng, YN; Himmel, ME; Haas, T; Ding, SY				Liu, Yu-San; Baker, John O.; Zeng, Yining; Himmel, Michael E.; Haas, Thomas; Ding, Shi-You			Cellobiohydrolase Hydrolyzes Crystalline Cellulose on Hydrophobic Faces	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; ENZYMATIC-HYDROLYSIS; TRICHODERMA-REESEI; BACTERIAL CELLULOSE; BINDING MODULES; CELL-WALL; PHASE; VISUALIZATION; MICROFIBRILS; CELLULASES	Biodegradation of plant biomass is a slow process in nature, and hydrolysis of cellulose is also widely considered to be a rate-limiting step in the proposed industrial process of converting lignocellulosic materials to biofuels. It is generally known that a team of enzymes including endo-and exocellulases as well as cellobiases are required to act synergistically to hydrolyze cellulose to glucose. The detailed molecular mechanisms of these enzymes have yet to be convincingly elucidated. In this report, atomic force microscopy (AFM) is used to image in real-time the structural changes in Valonia cellulose crystals acted upon by the exocellulase cellobiohydrolase I (CBH I) from Trichoderma reesei. Under AFM, single enzyme molecules could be observed binding only to one face of the cellulose crystal, apparently the hydrophobic face. The surface roughness of cellulose began increasing after adding CBH I, and the overall size of cellulose crystals decreased during an 11-h period. Interestingly, this size reduction apparently occurred only in the width of the crystal, whereas the height remained relatively constant. In addition, the measured cross-section shape of cellulose crystal changed from asymmetric to nearly symmetric. These observed changes brought about by CBH I action may constitute the first direct visualization supporting the idea that the exocellulase selectively hydrolyzes the hydrophobic faces of cellulose. The limited accessibility of the hydrophobic faces in native cellulose may contribute significantly to the rate-limiting slowness of cellulose hydrolysis.	[Liu, Yu-San; Baker, John O.; Zeng, Yining; Himmel, Michael E.; Haas, Thomas; Ding, Shi-You] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80401 USA; [Liu, Yu-San; Zeng, Yining; Himmel, Michael E.; Haas, Thomas; Ding, Shi-You] Oak Ridge Natl Lab, BioEnergy Sci Ctr, Oak Ridge, TN 37831 USA	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); Oak Ridge National Laboratory; BioEnergy Science Center (BESC)	Ding, SY (corresponding author), Natl Renewable Energy Lab, Biosci Ctr, 1617 Cole Blvd, Golden, CO 80401 USA.	Shi.you.Ding@nrel.gov	DING, SHIYOU/ABD-8519-2021; Ding, Shi-You/O-1209-2013	DING, SHIYOU/0000-0002-1102-1507; Zeng, Yining/0000-0002-0202-2479	United States Department of Energy (DOE), Office of Energy Efficiency and Renewable Energy; United States DOE Office of Science, Office of Biological and Environmental Research through the BioEnergy Science Center; DOE Bioenergy Research Center	United States Department of Energy (DOE), Office of Energy Efficiency and Renewable Energy(United States Department of Energy (DOE)); United States DOE Office of Science, Office of Biological and Environmental Research through the BioEnergy Science Center(United States Department of Energy (DOE)); DOE Bioenergy Research Center(United States Department of Energy (DOE))	This work was supported by the United States Department of Energy (DOE), Office of Energy Efficiency and Renewable Energy, the Office of the Biomass Program for the work to develop enzymes, and the United States DOE Office of Science, Office of Biological and Environmental Research through the BioEnergy Science Center, a DOE Bioenergy Research Center, for the work on AFM visualization and analysis.	ABUJA PM, 1988, EUR BIOPHYS J BIOPHY, V15, P339, DOI 10.1007/BF00254721; Baker AA, 2000, BIOPHYS J, V79, P1139, DOI 10.1016/S0006-3495(00)76367-3; BAKER JO, 1991, ACS SYM SER, V460, P313; Bayer EA, 1998, CURR OPIN STRUC BIOL, V8, P548, DOI 10.1016/S0959-440X(98)80143-7; Bohn A, 2000, MACROMOL CHEM PHYS, V201, P1913, DOI 10.1002/1521-3935(20001001)201:15<1913::AID-MACP1913>3.0.CO;2-U; Boisset C, 2000, APPL ENVIRON MICROB, V66, P1444, DOI 10.1128/AEM.66.4.1444-1452.2000; CHANZY H, 1986, HOLZFORSCHUNG, V40, P25; Ding SY, 2006, BIOTECHNIQUES, V41, P435, DOI 10.2144/000112244; Ding SY, 2006, J AGR FOOD CHEM, V54, P597, DOI 10.1021/jf051851z; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; ENARI TM, 1987, CRIT REV BIOTECHNOL, V5, P67, DOI 10.3109/07388558709044153; FAN LT, 1980, BIOTECHNOL BIOENG, V22, P177, DOI 10.1002/bit.260220113; Gardner K. H., 1971, J POLYM SCI C, V36, P327, DOI DOI 10.1002/POLC.5070360124; Helbert W, 2003, BIOMACROMOLECULES, V4, P481, DOI 10.1021/bm020076i; HENRISSAT B, 1985, BIO-TECHNOL, V3, P722, DOI 10.1038/nbt0885-722; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Igarashi K, 2009, J BIOL CHEM, V284, P36186, DOI 10.1074/jbc.M109.034611; Imai T, 2003, POLYMER, V44, P1871, DOI 10.1016/S0032-3861(02)00861-3; KRAULIS PJ, 1989, BIOCHEMISTRY-US, V28, P7241, DOI 10.1021/bi00444a016; Lee I, 2000, ULTRAMICROSCOPY, V82, P213, DOI 10.1016/S0304-3991(99)00158-8; Lehtio J, 2003, P NATL ACAD SCI USA, V100, P484, DOI 10.1073/pnas.212651999; Liu H, 2009, ENZYME MICROB TECH, V45, P274, DOI 10.1016/j.enzmictec.2009.06.009; Liu Y. S., 2010, P SPIE, V7571; Liu YS, 2009, CELLULOSE, V16, P587, DOI 10.1007/s10570-009-9306-0; Montanari S, 2005, MACROMOLECULES, V38, P1665, DOI 10.1021/ma048396c; Moran-Mirabal JN, 2008, BIOTECHNOL BIOENG, V101, P1129, DOI 10.1002/bit.21990; Park S, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-10; Quirk A, 2010, LANGMUIR, V26, P5007, DOI 10.1021/la9037028; REESE ET, 1950, J BACTERIOL, V59, P485, DOI 10.1128/JB.59.4.485-497.1950; Revol JF, 1982, CARBOHYD POLYM, V2, P123; SUGIYAMA J, 1991, MACROMOLECULES, V24, P4168, DOI 10.1021/ma00014a033; Xu Q, 2009, CELLULOSE, V16, P19, DOI 10.1007/s10570-008-9234-4	32	105	108	0	77	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11195	11201		10.1074/jbc.M110.216556	http://dx.doi.org/10.1074/jbc.M110.216556			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21282110	Green Published, hybrid			2022-12-27	WOS:000288797100030
J	Frank, D; Frey, N				Frank, Derk; Frey, Norbert			Cardiac Z-disc Signaling Network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							INTEGRIN-LINKED KINASE; MUSCLE LIM PROTEIN; MECHANICAL STRETCH SENSOR; ACTIN CAPPING PROTEIN; SARCOMERIC Z-DISC; DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; MYOCARDIAL-INFARCTION; GENE-EXPRESSION; HEART-FAILURE	During the last 15 years, the perception of the cardiac z-disc has undergone substantial changes. Initially viewed as a structural component at the lateral boundaries of the sarcomere, the cardiac z-disc has increasingly become recognized as a nodal point in cardiomyocyte signal transduction and disease. This minireview thus focuses on novel components and recent developments in z-disc biology and their role in cardiac signaling and disease.	[Frank, Derk; Frey, Norbert] Univ Kiel, D-24105 Kiel, Germany	University of Kiel	Frey, N (corresponding author), Univ Kiel, D-24105 Kiel, Germany.	norbert.frey@uk-sh.de	Frey, Norbert/A-9695-2010; Frey, Norbert/M-7749-2019	Frey, Norbert/0000-0001-7611-378X	Bundesministerium fur Bildung und Forschung (Nationales Genomforschungsnetz NGFNplus); Hengstberger Stiftung/German Society of Cardiology (DGK)	Bundesministerium fur Bildung und Forschung (Nationales Genomforschungsnetz NGFNplus)(Federal Ministry of Education & Research (BMBF)); Hengstberger Stiftung/German Society of Cardiology (DGK)	This work was supported by a grant from the Bundesministerium fur Bildung und Forschung (Nationales Genomforschungsnetz NGFNplus; to N. F.) and by a grant from the Hengstberger Stiftung/German Society of Cardiology (DGK; to D. F.). This is the first article in the Thematic Minireview Series on Signaling in Cardiac Sarcomeres in Health and Disease. This minireview will be reprinted in the 2011 Minireview Compendium, which will be available in January, 2012.	Ahmad F, 2005, ANNU REV GENOM HUM G, V6, P185, DOI 10.1146/annurev.genom.6.080604.162132; Arber S, 1997, CELL, V88, P393, DOI 10.1016/S0092-8674(00)81878-4; Arimura T, 2004, J BIOL CHEM, V279, P6746, DOI 10.1074/jbc.M311849200; Bendig G, 2006, GENE DEV, V20, P2361, DOI 10.1101/gad.1448306; Benitah JP, 2010, J MOL CELL CARDIOL, V48, P26, DOI 10.1016/j.yjmcc.2009.07.026; Bespalova IN, 2000, GENOMICS, V63, P69, DOI 10.1006/geno.1999.6049; Boateng SY, 2007, AM J PHYSIOL-HEART C, V292, pH259, DOI 10.1152/ajpheart.00766.2006; Boateng SY, 2009, J MOL CELL CARDIOL, V47, P426, DOI 10.1016/j.yjmcc.2009.04.006; Brancaccio M, 1999, J BIOL CHEM, V274, P29282, DOI 10.1074/jbc.274.41.29282; Brancaccio M, 2003, NAT MED, V9, P68, DOI 10.1038/nm805; Brown JL, 1996, CURR BIOL, V6, P598, DOI 10.1016/S0960-9822(02)00546-8; Cattaruzza M, 2004, HYPERTENSION, V43, P726, DOI 10.1161/01.HYP.0000119189.82659.52; Cheng HQ, 2010, CIRC RES, V107, P348, DOI 10.1161/CIRCRESAHA.110.218735; Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840; De Acetis M, 2005, CIRC RES, V96, P1087, DOI 10.1161/01.RES.0000168028.36081.e0; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; Duboscq-Bidot L, 2008, CARDIOVASC RES, V77, P118, DOI 10.1093/cvr/cvm015; Epstein ND, 2003, CELL, V112, P147, DOI 10.1016/S0092-8674(03)00037-0; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Faul C, 2005, J CELL BIOL, V169, P415, DOI 10.1083/jcb.200411169; Faul C, 2007, MOL CELL BIOL, V27, P8215, DOI 10.1128/MCB.00950-07; Fielitz J, 2007, J CLIN INVEST, V117, P2486, DOI 10.1172/JCI32827; Fielitz J, 2007, P NATL ACAD SCI USA, V104, P4377, DOI 10.1073/pnas.0611726104; Fraley SI, 2010, NAT CELL BIOL, V12, P598, DOI 10.1038/ncb2062; Frank D, 2008, HYPERTENSION, V51, P309, DOI 10.1161/HYPERTENSIONAHA.107.098046; Frank D, 2007, CIRCULATION, V116, P2587, DOI 10.1161/CIRCULATIONAHA.107.711317; Frank D, 2006, J MOL MED, V84, P446, DOI 10.1007/s00109-005-0033-1; Frank D, 2010, J MOL CELL CARDIOL, V49, P673, DOI 10.1016/j.yjmcc.2010.06.009; Frank D, 2007, FUTUR CARDIOL, V3, P611, DOI 10.2217/14796678.3.6.611; Frey N, 2004, NAT MED, V10, P1336, DOI 10.1038/nm1132; Frey N, 2002, J BIOL CHEM, V277, P13998, DOI 10.1074/jbc.M200712200; Frey N, 2000, P NATL ACAD SCI USA, V97, P14632, DOI 10.1073/pnas.260501097; Frey N, 2008, J CLIN INVEST, V118, P3598, DOI 10.1172/JCI36277; Furukawa T, 2001, J MOL BIOL, V313, P775, DOI 10.1006/jmbi.2001.5053; Gehmlich K, 2010, J MOL CELL CARDIOL, V48, P424, DOI 10.1016/j.yjmcc.2009.10.021; Gehmlich K, 2008, J MUSCLE RES CELL M, V29, P155, DOI 10.1007/s10974-008-9159-4; Geier C, 2003, CIRCULATION, V107, P1390, DOI 10.1161/01.CIR.0000056522.82563.5F; Gerull B, 2002, NAT GENET, V30, P201, DOI 10.1038/ng815; Gill GN, 1995, STRUCTURE, V3, P1285, DOI 10.1016/S0969-2126(01)00265-9; Goldfarb LG, 2009, J CLIN INVEST, V119, P1806, DOI 10.1172/JCI38027; Gontier Y, 2005, J CELL SCI, V118, P3739, DOI 10.1242/jcs.02484; Grunig E, 1998, J AM COLL CARDIOL, V31, P186, DOI 10.1016/S0735-1097(97)00434-8; GU X, 1994, CIRC RES, V75, P926, DOI 10.1161/01.RES.75.5.926; Gupta MP, 2008, J BIOL CHEM, V283, P10135, DOI 10.1074/jbc.M710277200; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Hannigan GE, 2007, CIRC RES, V100, P1408, DOI 10.1161/01.RES.0000265233.40455.62; Hassel D, 2009, NAT MED, V15, P1281, DOI 10.1038/nm.2037; Hayashi T, 2004, J AM COLL CARDIOL, V44, P2192, DOI 10.1016/j.jacc.2004.08.058; Heineke J, 2005, P NATL ACAD SCI USA, V102, P1655, DOI 10.1073/pnas.0405488102; Heineke J, 2010, NAT MED, V16, P872, DOI 10.1038/nm.2181; Hoshijima M, 2006, AM J PHYSIOL-HEART C, V290, pH1313, DOI 10.1152/ajpheart.00816.2005; Iwata M, 2005, BIOCHEM BIOPH RES CO, V327, P1105, DOI 10.1016/j.bbrc.2004.12.128; Jeong D, 2008, CIRC RES, V102, P711, DOI 10.1161/CIRCRESAHA.107.165985; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Kato T, 2005, J CLIN INVEST, V115, P2716, DOI 10.1172/JCI24280; Ke YB, 2004, CIRC RES, V94, P194, DOI 10.1161/01.RES.0000111522.02730.56; Ke YB, 2008, PROG BIOPHYS MOL BIO, V98, P238, DOI 10.1016/j.pbiomolbio.2009.01.007; Knoll R, 2007, CIRCULATION, V116, P515, DOI 10.1161/CIRCULATIONAHA.107.689984; Knoll R, 2003, J MOL MED, V81, P750, DOI 10.1007/s00109-003-0488-x; Knoll R, 2002, CELL, V111, P943, DOI 10.1016/S0092-8674(02)01226-6; LAZARIDES E, 1976, P NATL ACAD SCI USA, V73, P4344, DOI 10.1073/pnas.73.12.4344; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Li HH, 2004, J CLIN INVEST, V114, P1058, DOI 10.1172/JCl200422220; Linnemann A, 2010, EUR J CELL BIOL, V89, P681, DOI 10.1016/j.ejcb.2010.04.004; Lu HZ, 2006, CIRCULATION, V114, P2271, DOI 10.1161/CIRCULATIONAHA.106.642330; Luther PK, 2009, J MUSCLE RES CELL M, V30, P171, DOI 10.1007/s10974-009-9189-6; Milner DJ, 1999, J MOL CELL CARDIOL, V31, P2063, DOI 10.1006/jmcc.1999.1037; Mohapatra B, 2003, MOL GENET METAB, V80, P207, DOI 10.1016/S1096-7192(03)00142-2; Moriscot AS, 2010, J STRUCT BIOL, V170, P344, DOI 10.1016/j.jsb.2010.02.001; Osio A, 2007, CIRC RES, V100, P766, DOI 10.1161/01.RES.0000263008.66799.aa; Papa I, 1999, J MUSCLE RES CELL M, V20, P187, DOI 10.1023/A:1005489319058; Paulsson AK, 2010, J MOL CELL CARDIOL, V48, P1206, DOI 10.1016/j.yjmcc.2010.02.009; Pokreisz P, 2009, CIRCULATION, V119, P408, DOI 10.1161/CIRCULATIONAHA.108.822072; Pyle WG, 2006, J MOL CELL CARDIOL, V41, P537, DOI 10.1016/j.yjmcc.2006.06.006; Pyle WG, 2004, CIRC RES, V94, P296, DOI 10.1161/01.RES.0000116143.74830.A9; Pyle WG, 2002, CIRC RES, V90, P1299, DOI 10.1161/01.RES.0000024389.03152.22; Rath N, 2005, MOL CELL BIOL, V25, P8864, DOI 10.1128/MCB.25.20.8864-8873.2005; Robia SL, 2001, BIOPHYS J, V80, P2140, DOI 10.1016/S0006-3495(01)76187-5; Russell B, 2010, J MOL CELL CARDIOL, V48, P817, DOI 10.1016/j.yjmcc.2010.02.016; Satoh M, 1999, BIOCHEM BIOPH RES CO, V262, P411, DOI 10.1006/bbrc.1999.1221; SCHAFER DA, 1994, J CELL BIOL, V127, P453, DOI 10.1083/jcb.127.2.453; SCHAFER DA, 1995, J CELL BIOL, V128, P61, DOI 10.1083/jcb.128.1.61; Selcen D, 2004, NEUROLOGY, V62, P1363, DOI 10.1212/01.WNL.0000123576.74801.75; Senzaki H, 2001, FASEB J, V15, P1718, DOI 10.1096/fj.00-0538com; Song LS, 2006, P NATL ACAD SCI USA, V103, P4305, DOI 10.1073/pnas.0509324103; Spencer JA, 2000, J CELL BIOL, V150, P771, DOI 10.1083/jcb.150.4.771; Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175; Tandan S, 2009, CIRC RES, V105, P51, DOI 10.1161/CIRCRESAHA.109.199828; Vatta M, 2003, J AM COLL CARDIOL, V42, P2014, DOI 10.1016/j.jacc.2003.10.021; von Nandelstadh P, 2009, MOL CELL BIOL, V29, P822, DOI 10.1128/MCB.01454-08; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; Weins A, 2001, J CELL BIOL, V155, P393, DOI 10.1083/jcb.200012039; White DE, 2006, GENE DEV, V20, P2355, DOI 10.1101/gad.1458906; Willis MS, 2010, CIRC RES, V106, P463, DOI 10.1161/CIRCRESAHA.109.208801; Wu GY, 2000, J BIOL CHEM, V275, P29927, DOI 10.1074/jbc.C000380200; Yu YP, 2006, CANCER RES, V66, P7414, DOI 10.1158/0008-5472.CAN-06-0227; Zheng M, 2010, J MOL CELL BIOL, V2, P96, DOI 10.1093/jmcb/mjp038; Zhou Q, 1999, J BIOL CHEM, V274, P19807, DOI 10.1074/jbc.274.28.19807; Zou YZ, 2001, CIRCULATION, V104, P102, DOI 10.1161/hc2601.090987	100	115	115	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					9897	9904		10.1074/jbc.R110.174268	http://dx.doi.org/10.1074/jbc.R110.174268			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21257757	Green Published, hybrid			2022-12-27	WOS:000288547000002
J	Yang, Z; Cooper, PR; Damera, G; Mukhopadhyay, I; Cho, H; Kehrl, JH; Panettieri, RA; Druey, KM				Yang, Zhao; Cooper, Philip R.; Damera, Gautam; Mukhopadhyay, Indranil; Cho, Hyeseon; Kehrl, John H.; Panettieri, Reynold A., Jr.; Druey, Kirk M.			beta-Agonist-associated Reduction in RGS5 Expression Promotes Airway Smooth Muscle Hyper-responsiveness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PULMONARY BETA(2)-ADRENOCEPTOR DESENSITIZATION; DOWN-REGULATION; BLOOD-PRESSURE; PROTEIN; RECEPTORS; G(I); REGULATORS; ASTHMA; ENDOTHELIN-1; HYPERTROPHY	Although short-acting and long-acting inhaled beta(2)-adrenergic receptor agonists (SABA and LABA, respectively) relieve asthma symptoms, use of either agent alone without concomitant anti-inflammatory drugs (corticosteroids) may increase the risk of disease exacerbation in some patients. We found previously that pretreatment of human precision-cut lung slices (PCLS) with SABA impaired subsequent beta(2)-agonist-induced bronchodilation, which occurred independently of changes in receptor quantities. Here we provide evidence that prolonged exposure of cultured human airway smooth muscle (HuASM) cells to beta(2)-agonists directly augments procontractile signaling pathways elicited by several compounds including thrombin, bradykinin, and histamine. Such treatment did not increase surface receptor amounts or expression of G proteins and downstream effectors (phospholipase C beta and myosin light chain). In contrast, beta-agonists decreased expression of regulator of G protein signaling 5 (RGS5), which is an inhibitor of G-protein-coupled receptor (GPCR) activity. RGS5 knockdown in HuASM increased agonist-evoked intracellular calcium flux and myosin light chain (MLC) phosphorylation, which are prerequisites for contraction. PCLS from Rgs5(-/-) mice contracted more to carbachol than those from WT mice, indicating that RGS5 negatively regulates bronchial smooth muscle contraction. Repetitive beta(2)-agonist use may not only lead to reduced bronchoprotection but also to sensitization of excitation-contraction signaling pathways as a result of reduced RGS5 expression.	[Yang, Zhao; Mukhopadhyay, Indranil; Druey, Kirk M.] NIAID, Mol Signal Transduct Sect, Lab Allerg Dis, NIH, Bethesda, MD 20892 USA; [Cho, Hyeseon; Kehrl, John H.] NIAID, Cell Mol Immunol Sect B, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Cooper, Philip R.; Damera, Gautam; Panettieri, Reynold A., Jr.] Univ Penn, Pulm Allergy & Crit Care Div, Airways Biol Initiat, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Pennsylvania	Druey, KM (corresponding author), 10 Ctr Dr,Rm 11N242, Bethesda, MD 20892 USA.	kdruey@niaid.nih.gov	panettieri, reynold/AAG-9485-2019; Kehrl, John/AAE-6292-2019; Yang, Zhiyong/E-7834-2013	Seefeldt, Lance/0000-0002-6457-9504; Yang, Zhiyong/0000-0001-8186-9450; Kehrl, John/0000-0002-6526-159X	National Institutes of Health, NIAID [AI000939];  [HL5452235];  [HL543102];  [HL544157]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000939, Z01AI000939] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the Intramural Research Program of the National Institutes of Health, NIAID (Grant No. AI000939 L. A. D., to K. M. D.) and by Grants HL5452235, HL543102, and HL544157 (to R. A. P.).	Agrawal DK, 2004, J ALLERGY CLIN IMMUN, V113, P503, DOI 10.1016/j.jaci.2003.12.039; Bai Y, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-34; Bansal G, 2008, J IMMUNOL, V181, P7882, DOI 10.4049/jimmunol.181.11.7882; Bansal G, 2007, PHARMACOL THERAPEUT, V116, P473, DOI 10.1016/j.pharmthera.2007.09.005; Bentley J Kelley, 2008, Proc Am Thorac Soc, V5, P89, DOI 10.1513/pats.200705-063VS; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Billington CK, 2003, RESP RES, V4; Black JL, 2009, CHEST, V136, P1095, DOI 10.1378/chest.09-0354; Borchers MT, 2003, AM J PHYSIOL-LUNG C, V285, pL114, DOI 10.1152/ajplung.00322.2002; Broadley KJ, 2006, EUR J PHARMACOL, V533, P15, DOI 10.1016/j.ejphar.2005.12.060; Chen CH, 1997, J BIOL CHEM, V272, P8679, DOI 10.1074/jbc.272.13.8679; Cho H, 2003, FASEB J, V17, P440, DOI 10.1096/fj.02-0340fje; Cho H, 2008, MOL CELL BIOL, V28, P2590, DOI 10.1128/MCB.01889-07; Chowdhury BA, 2010, NEW ENGL J MED, V362, P1169, DOI 10.1056/NEJMp1002074; Cooper PR, 2009, PULM PHARMACOL THER, V22, P398, DOI 10.1016/j.pupt.2008.09.008; Cooper PR, 2008, J ALLERGY CLIN IMMUN, V122, P734, DOI 10.1016/j.jaci.2008.07.040; Cooper PR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010235; Damera G, 2009, BRIT J PHARMACOL, V158, P1429, DOI 10.1111/j.1476-5381.2009.00428.x; Deshpande DA, 2006, CELL SIGNAL, V18, P2105, DOI 10.1016/j.cellsig.2006.04.008; Druey KM, 1996, NATURE, V379, P742, DOI 10.1038/379742a0; Faisy C, 2006, AM J RESP CELL MOL, V34, P410, DOI 10.1165/rcmb.2005-0091OC; Finney PA, 2000, J CLIN INVEST, V106, P125, DOI 10.1172/JCI8374; Finney PA, 2001, BRIT J PHARMACOL, V132, P1261, DOI 10.1038/sj.bjp.0703946; Gu S, 2009, CLIN SCI, V116, P391, DOI 10.1042/CS20080272; Hamzah J, 2008, NATURE, V453, P410, DOI 10.1038/nature06868; Hershenson MB, 2008, ANNU REV PATHOL-MECH, V3, P523, DOI 10.1146/annurev.pathmechdis.1.110304.100213; Hu AH, 2008, AM J PHYSIOL-LUNG C, V294, pL1055, DOI 10.1152/ajplung.00021.2008; Huang CF, 1997, P NATL ACAD SCI USA, V94, P6159, DOI 10.1073/pnas.94.12.6159; Huang XY, 2006, MOL CELL BIOL, V26, P6870, DOI 10.1128/MCB.00314-06; Kehrl JH, 2004, CRIT REV IMMUNOL, V24, P409; Kehrl JH, 2002, INT J BIOCHEM CELL B, V34, P432, DOI 10.1016/S1357-2725(01)00141-8; Krumins AM, 2004, J BIOL CHEM, V279, P2593, DOI 10.1074/jbc.M311600200; Lambert NA, 2010, P NATL ACAD SCI USA, V107, P7066, DOI 10.1073/pnas.0912934107; Li HL, 2010, P NATL ACAD SCI USA, V107, P13818, DOI 10.1073/pnas.1008397107; Mak JCW, 2000, MOL PHARMACOL, V57, P857; McCoy KL, 2009, PROG MOL BIOL TRANSL, V86, P49, DOI 10.1016/S1877-1173(09)86003-1; McGraw DW, 2007, J CLIN INVEST, V117, P1391, DOI 10.1172/JCI30489; McGraw DW, 2006, PHYSIOL GENOMICS, V27, P171, DOI 10.1152/physiolgenomics.00044.2006; McGraw DW, 2003, J CLIN INVEST, V112, P619, DOI 10.1172/JCI200318193; Meurs H, 2008, EUR RESPIR J, V32, P487, DOI 10.1183/09031936.00023608; Misior AM, 2009, AM J RESP CELL MOL, V41, P24, DOI 10.1165/rcmb.2008-0266OC; Munakata Mitsuru, 2006, Allergol Int, V55, P235, DOI 10.2332/allergolint.55.235; Nguyen LP, 2009, P NATL ACAD SCI USA, V106, P2435, DOI 10.1073/pnas.0810902106; Nino G, 2010, J ALLERGY CLIN IMMUN, V125, P1020, DOI 10.1016/j.jaci.2010.02.007; Nino G, 2009, AM J PHYSIOL-LUNG C, V297, pL746, DOI 10.1152/ajplung.00079.2009; Nunn C, 2010, CELL SIGNAL, V22, P1231, DOI 10.1016/j.cellsig.2010.03.015; Penn Raymond B, 2008, Proc Am Thorac Soc, V5, P47, DOI 10.1513/pats.200705-054VS; Penn RB, 2009, P NATL ACAD SCI USA, V106, P2095, DOI 10.1073/pnas.0812935106; Scheschonka A, 2000, MOL PHARMACOL, V58, P719, DOI 10.1124/mol.58.4.719; Seki N, 1998, J HUM GENET, V43, P202, DOI 10.1007/s100380050071; Snabaitis AK, 2005, CELL SIGNAL, V17, P655, DOI 10.1016/j.cellsig.2004.10.008; Song KS, 2009, AM J PHYSIOL-LUNG C, V296, pL684, DOI 10.1152/ajplung.90396.2008; Tovey SC, 2010, J BIOL CHEM, V285, P12979, DOI 10.1074/jbc.M109.096016; Willars GB, 2006, SEMIN CELL DEV BIOL, V17, P363, DOI 10.1016/j.semcdb.2006.03.005	54	30	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11444	11455		10.1074/jbc.M110.212480	http://dx.doi.org/10.1074/jbc.M110.212480			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21454640	Green Published, hybrid			2022-12-27	WOS:000288797100056
